,UserScreenName,UserName,Timestamp,Text,Embedded_text,Emojis,Comments,Likes,Retweets,Image link,Tweet URL
0,Dan Cohen,@biosleuth,2017-01-01T19:37:14.000Z,"$AFMD AFM-13 + $MRK PD-1 trial has now expanded recruitment to 8 US sites, all open https://clinicaltrials.gov/ct2/show/NCT02665650‚Ä¶","$AFMD AFM-13 + $MRK PD-1 trial has now expanded recruitment to 8 US sites, all open https://clinicaltrials.gov/ct2/show/NCT02665650‚Ä¶
3
8
10",,3,8,10,['https://pbs.twimg.com/media/C1G_CMsWEAAP3NT?format=jpg&name=small'],https://twitter.com/biosleuth/status/815643063670415361
1,BackToTheFutures,@Back2DaFutures,2017-01-01T03:45:40.000Z,"Instead of reading parroted mantra on $CALA, see our very in depth article @ http://seekingalpha.com/article/4025651-calithera-biosciences-part-2-tnbc-rcc-catalyst-value-drivers‚Ä¶ $BMY $AZN $CELG $MRK $AGIO #Biotech","Instead of reading parroted mantra on $CALA, see our very in depth article @ http://seekingalpha.com/article/4025651-calithera-biosciences-part-2-tnbc-rcc-catalyst-value-drivers‚Ä¶ $BMY $AZN $CELG $MRK $AGIO #Biotech
1",,,,1,[],https://twitter.com/Back2DaFutures/status/815403592676843520
2,Breaking News,@MarketCurrents,2017-01-03T11:56:30.000Z,Sanofi - Merck vaccine partnership officially over http://seekingalpha.com/news/3233015-sanofi-merck-vaccine-partnership-officially?source=feed_f‚Ä¶ #premarket $SNY $MRK,"Sanofi - Merck vaccine partnership officially over http://seekingalpha.com/news/3233015-sanofi-merck-vaccine-partnership-officially?source=feed_f‚Ä¶ #premarket $SNY $MRK
seekingalpha.com
Sanofi - Merck vaccine partnership officially over (NASDAQ:SNY)
Sanofi (NASDAQ:SNY) and Merck (NYSE:MRK) have confirmed the end of their vaccine joint venture effective January 1.",,,,,['https://pbs.twimg.com/card_img/1495187926770196488/XbSaCIFV?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/816251890933473281
3,Breaking News,@MarketCurrents,2017-01-03T18:56:39.000Z,"After tough year, 9 questions for Gilead http://seekingalpha.com/news/3233187-tough-year-9-questions-gilead?source=feed_f‚Ä¶ $GILD $ESRX $ABBV $MRK","After tough year, 9 questions for Gilead http://seekingalpha.com/news/3233187-tough-year-9-questions-gilead?source=feed_f‚Ä¶ $GILD $ESRX $ABBV $MRK
1",,,,1,[],https://twitter.com/MarketCurrents/status/816357624400621568
4,Einstein,@einstein171717,2017-01-03T18:53:51.000Z,$MRK bouncing nicely off the lower kelt band. This goes to $62 tomorrow if not eod,"$MRK bouncing nicely off the lower kelt band. This goes to $62 tomorrow if not eod
1",,,,1,['https://pbs.twimg.com/media/C1RIST2XUAA12ZX?format=jpg&name=small'],https://twitter.com/einstein171717/status/816356918453211136
5,Drugdoctor1,@Drugdoctor2014,2017-01-02T21:59:25.000Z,$ICNB - it's true! was up 3700% in December 2016! TURNAROUND STORY $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK,"$ICNB - it's true! was up 3700% in December 2016! TURNAROUND STORY $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK
1",,,,1,"['https://pbs.twimg.com/media/C1Mo9WgWIAUWK2G?format=jpg&name=small', 'https://pbs.twimg.com/media/C1Mo9WeXEAEh_h4?format=jpg&name=360x360']",https://twitter.com/Drugdoctor2014/status/816041229205041153
6,George Marcovits,@GemsBot,2017-01-02T20:37:10.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/70657323#70657348‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/70657323#70657348‚Ä¶,,,,,['https://pbs.twimg.com/media/C1MWWNLXUAAgKeP?format=jpg&name=small'],https://twitter.com/GemsBot/status/816020530813923328
7,Merck,@Merck,2017-01-03T12:53:54.000Z,Join us for our fourth-quarter & full-year 2016 sales and earnings conference call on Feb. 2nd at 8 a.m. ET:  http://bit.ly/2hLmaTA $MRK,"Join us for our fourth-quarter & full-year 2016 sales and earnings conference call on Feb. 2nd at 8 a.m. ET:  http://bit.ly/2hLmaTA $MRK
5
9",,,5,9,[],https://twitter.com/Merck/status/816266333906210816
8,intowin2017,@intowin2017,2017-01-02T18:52:38.000Z,"MRK News
 http://dlvr.it/N1S5MD

$MRK $SHLD $COTY #share","MRK News
 http://dlvr.it/N1S5MD

$MRK $SHLD $COTY #share",,,,,[],https://twitter.com/intowin2017/status/815994225363800064
9,Helen Ong,@Lin_ling_88,2017-01-02T06:56:01.000Z,"Use of oncolytic viruses, such as T-VEC, can provide one avenue for augmenting activity of checkpoint blockade $BMY $MRK","Use of oncolytic viruses, such as T-VEC, can provide one avenue for augmenting activity of checkpoint blockade $BMY $MRK
OncLive.com
@OncLive
 ¬∑ 2 Jan 2017
No. 10: Wolchok Discusses T-VEC, Other Immunotherapy Developments in Melanoma http://ht.ly/eGRN307zqLo
2",,,,2,['https://pbs.twimg.com/profile_images/1207309207004950533/hnCTQqRs_mini.jpg'],https://twitter.com/Lin_ling_88/status/815813883441147908
10,mbp212016TA,@mbp212016,2017-01-02T21:48:07.000Z,"SWKS 52Wk Low
 http://dlvr.it/N1VPq5

$SWKS $BIDU $MRK #tradeideas","SWKS 52Wk Low
 http://dlvr.it/N1VPq5

$SWKS $BIDU $MRK #tradeideas",,,,,[],https://twitter.com/mbp212016/status/816038386259529728
11,Invictus,@TBPInvictus,2017-01-03T20:40:45.000Z,"Who let the Dogs out (2017):
$BA $CAT $CSCO $CVX $IBM $KO $MRK $PFE $VZ $XOM","Who let the Dogs out (2017):
$BA $CAT $CSCO $CVX $IBM $KO $MRK $PFE $VZ $XOM
1",,,1,,[],https://twitter.com/TBPInvictus/status/816383822153420804
12,Steam Sports,@Steam_Sports,2017-01-03T19:17:41.000Z,Is $MRK interested in acquiring $ONCS? ,"Is $MRK interested in acquiring $ONCS? 
2
1",üòè,2,,1,[],https://twitter.com/Steam_Sports/status/816362915867529216
13,Pharmaceutical News,@pharma_sector,2017-01-03T14:06:30.000Z,#Merck to Hold FourthQuarter and FullYear 2016 Sales and Earnings Conference Call on Februar... Read more: http://owler.us/ab1Xfq $MRK,#Merck to Hold FourthQuarter and FullYear 2016 Sales and Earnings Conference Call on Februar... Read more: http://owler.us/ab1Xfq $MRK,,,,,[],https://twitter.com/pharma_sector/status/816284603749015552
14,Sweet Platform,@SweetPlatform,2017-01-03T15:52:30.000Z,"MRK Top news - Jan 3rd, 2017 $MRK http://https://goo.gl/PRqzjr","MRK Top news - Jan 3rd, 2017 $MRK http://https://goo.gl/PRqzjr",,,,,[],https://twitter.com/SweetPlatform/status/816311279581282304
15,Watchlist News,@WatchlistN,2017-01-03T23:06:35.000Z,"Meeder Asset Management Inc. Has $6,494,000 Position in Merck & Company, Inc. $MRK http://zpr.io/PquLa","Meeder Asset Management Inc. Has $6,494,000 Position in Merck & Company, Inc. $MRK http://zpr.io/PquLa",,,,,[],https://twitter.com/WatchlistN/status/816420520593854464
16,Ticker Report,@TickerReport,2017-01-03T21:57:34.000Z,"Merck & Company, Inc. $MRK Position Cut by Honeywell International Inc. http://ift.tt/2i7xF8F","Merck & Company, Inc. $MRK Position Cut by Honeywell International Inc. http://ift.tt/2i7xF8F",,,,,[],https://twitter.com/TickerReport/status/816403154447302656
17,MarketBeat,@MarketBeatCom,2017-01-03T05:13:00.000Z,Merck  & Company upgraded by Vetr Inc. to sell. $52.95 PT. http://ift.tt/2iCUPr3 $MRK #MRK,Merck  & Company upgraded by Vetr Inc. to sell. $52.95 PT. http://ift.tt/2iCUPr3 $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/816150345403531265
18,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-01-02T20:37:14.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/IRJRfFUU,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/IRJRfFUU,,,,,[],https://twitter.com/gem_2014/status/816020548513923072
19,Insider Monkey,@insidermonkey,2017-01-03T19:03:33.000Z,"Is It Worth Following $CELG Into Jounce At IPO?
http://insidermonkey.com/blog/is-it-worth-following-celgene-corporation-celg-into-jounce-at-ipo-514310/?utm_source=Stocktwits&utm_campaign=dnan&utm_medium=Social‚Ä¶
$MRK, $BMY","Is It Worth Following $CELG Into Jounce At IPO?
http://insidermonkey.com/blog/is-it-worth-following-celgene-corporation-celg-into-jounce-at-ipo-514310/?utm_source=Stocktwits&utm_campaign=dnan&utm_medium=Social‚Ä¶
$MRK, $BMY
insidermonkey.com
Is It Worth Following Celgene Corporation (CELG) Into Jounce At IPO?
Earlier this year, we looked at a privately held biotech called Jounce Therapeutics.
1",,,,1,[],https://twitter.com/insidermonkey/status/816359362545516544
20,Stockboard Media Inc,@stockboardinc,2017-01-03T11:50:29.000Z,$MRK Merck to Hold Fourth-Quarter and Full-Year 2016 Sales and Earnings Conference Call on February 2... - http://sbml.co/1cd8752c,$MRK Merck to Hold Fourth-Quarter and Full-Year 2016 Sales and Earnings Conference Call on February 2... - http://sbml.co/1cd8752c,,,,,[],https://twitter.com/stockboardinc/status/816250374457884673
21,Vetr,@VetrRatings,2017-01-03T16:22:03.000Z,"Vetr users have upgraded Merck & Company, Inc. to a SELL Rating (2 stars), giving $MRK a target price of $52.95 http://on.vetr.com/1GhW0TK","Vetr users have upgraded Merck & Company, Inc. to a SELL Rating (2 stars), giving $MRK a target price of $52.95 http://on.vetr.com/1GhW0TK",,,,,[],https://twitter.com/VetrRatings/status/816318719400046593
22,cowenresearch,@CowenResearch,2017-01-03T11:21:15.000Z,"Steve Scala releases ""The Three Biggest Pharma Questions To Be Answered In 2017"" $MRK $AZN $BMY $SNY $RHHBY","Steve Scala releases ""The Three Biggest Pharma Questions To Be Answered In 2017"" $MRK $AZN $BMY $SNY $RHHBY
1",,,,1,[],https://twitter.com/CowenResearch/status/816243021020860416
23,Siti van der Meij,@sitivandermeij,2017-01-03T19:06:37.000Z,"After tough year, 9 questions for Gilead http://seekingalpha.com/news/3233187-tough-year-9-questions-gilead?source=feed_f‚Ä¶ $GILD $ESRX $ABBV $MRK #sitifatimah #malaysia #financialplanning","After tough year, 9 questions for Gilead http://seekingalpha.com/news/3233187-tough-year-9-questions-gilead?source=feed_f‚Ä¶ $GILD $ESRX $ABBV $MRK #sitifatimah #malaysia #financialplanning",,,,,[],https://twitter.com/sitivandermeij/status/816360132774924288
24,Insider Monkey News,@insidermonkey_n,2017-01-03T19:02:38.000Z,"Is It Worth Following $CELG Into Jounce At IPO?
http://insidermonkey.com/blog/is-it-worth-following-celgene-corporation-celg-into-jounce-at-ipo-514310/?utm_source=Stocktwits&utm_campaign=dnan&utm_medium=Social‚Ä¶
$MRK, $BMY","Is It Worth Following $CELG Into Jounce At IPO?
http://insidermonkey.com/blog/is-it-worth-following-celgene-corporation-celg-into-jounce-at-ipo-514310/?utm_source=Stocktwits&utm_campaign=dnan&utm_medium=Social‚Ä¶
$MRK, $BMY
insidermonkey.com
Is It Worth Following Celgene Corporation (CELG) Into Jounce At IPO?
Earlier this year, we looked at a privately held biotech called Jounce Therapeutics.",,,,,['https://pbs.twimg.com/card_img/1501981717246054404/SHWaI13n?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/816359130227245056
25,MarketBeat,@MarketBeatCom,2017-01-03T05:28:43.000Z,"Merck & Company, Inc. $MRK Raised to ‚ÄúSell‚Äù at Vetr Inc. http://zpr.io/Pqhe9","Merck & Company, Inc. $MRK Raised to ‚ÄúSell‚Äù at Vetr Inc. http://zpr.io/Pqhe9",,,,,[],https://twitter.com/MarketBeatCom/status/816154301903110144
26,MarketBeat,@MarketBeatCom,2017-01-03T16:10:03.000Z,"Merck & Company, Inc. $MRK Shares Bought by Alps Advisors Inc. http://zpr.io/PqyB6","Merck & Company, Inc. $MRK Shares Bought by Alps Advisors Inc. http://zpr.io/PqyB6",,,,,[],https://twitter.com/MarketBeatCom/status/816315698481926144
27,TalkMarkets,@TalkMarkets,2017-01-02T12:09:03.000Z,Merck (MRK) Does Well In 2016: Reasons For Outperformance $AMGN $GSK $MRK $PFE https://goo.gl/fZxBzj,Merck (MRK) Does Well In 2016: Reasons For Outperformance $AMGN $GSK $MRK $PFE https://goo.gl/fZxBzj,,,,,[],https://twitter.com/TalkMarkets/status/815892662507151360
28,Money Badger,@gomoneybadger,2017-01-03T16:57:44.000Z,"Medical MDMA could be as real as medical weed, and it could spark new investments. But how far away is it? http://moneybadger.stocktwits.com/medical-ecstasy/‚Ä¶ $MRK","Medical MDMA could be as real as medical weed, and it could spark new investments. But how far away is it? http://moneybadger.stocktwits.com/medical-ecstasy/‚Ä¶ $MRK
1",,,,1,[],https://twitter.com/gomoneybadger/status/816327696938582017
29,Muathe,@muathe,2017-01-01T16:06:36.000Z,"[REPOST] World Market Technical Analysis Jan 01, 2017 $VALE $GGB $ABEV $PBR $NOK $BMY $LYG $MRK $BCS $BBD $CX $BABA https://v.gd/kXhkaA","[REPOST] World Market Technical Analysis Jan 01, 2017 $VALE $GGB $ABEV $PBR $NOK $BMY $LYG $MRK $BCS $BBD $CX $BABA https://v.gd/kXhkaA",,,,,[],https://twitter.com/muathe/status/815590055662284800
30,24/7 Wall St.,@247WallSt,2017-01-03T14:47:26.000Z,$VZ $KO $MRK $PFE $PG are in the 2017 Dogs of the Dow for massive dividends,"$VZ $KO $MRK $PFE $PG are in the 2017 Dogs of the Dow for massive dividends
247wallst.com
Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside
One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the Dow. Meet the 2017 Dogs of the Dow!",,,,,['https://pbs.twimg.com/card_img/1501753375704162310/aDuMgMqH?format=jpg&name=small'],https://twitter.com/247WallSt/status/816294907451207680
31,Hamzah Ali Khan,@HamzahKingKhan,2017-01-03T15:30:34.000Z,"@TheTradingNinja
 someone sent me a DM asking whether they should book 200% on $MRK.. #wtf","@TheTradingNinja
 someone sent me a DM asking whether they should book 200% on $MRK.. #wtf
1
1",,,1,1,[],https://twitter.com/HamzahKingKhan/status/816305761185886208
32,TheTradingNinja,@TradeWithNinja,2017-01-03T21:06:36.000Z,"Replying to 
@TradeWithNinja
 and 
@optioninja","Replying to 
@TradeWithNinja
 and 
@optioninja
$Mrk last 3mins of fun Bid vs Ask
2
7",,2,,7,['https://pbs.twimg.com/ext_tw_video_thumb/816389649975287808/pu/img/GzEJi-HObuwoqflm.jpg'],https://twitter.com/TradeWithNinja/status/816390326206263296
33,Robert Duval,@Cessnadriver50,2017-01-03T18:35:53.000Z,"Replying to 
@RetroWallSt","Replying to 
@RetroWallSt
They all do.  $MRK $GILD $CELG all ripping
1",,1,,,[],https://twitter.com/Cessnadriver50/status/816352398792855553
34,Jon Ogg,@jonogg,2017-01-03T14:43:22.000Z,#investing #dividend $VZ $KO $MRK $PFE $PG are in the 2017 Dogs of the Dow for massive dividends,"#investing #dividend $VZ $KO $MRK $PFE $PG are in the 2017 Dogs of the Dow for massive dividends
247wallst.com
Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside
One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the Dow. Meet the 2017 Dogs of the Dow!",,,,,['https://pbs.twimg.com/card_img/1501753375704162310/aDuMgMqH?format=jpg&name=small'],https://twitter.com/jonogg/status/816293884762398721
35,TalkMarkets Recap,@MarketsRecap,2017-01-02T06:09:04.000Z,Merck (MRK) Does Well In 2016: Reasons For Outperformance $AMGN $GSK $MRK $PFE https://goo.gl/fZxBzj,Merck (MRK) Does Well In 2016: Reasons For Outperformance $AMGN $GSK $MRK $PFE https://goo.gl/fZxBzj,,,,,[],https://twitter.com/MarketsRecap/status/815802068946526208
36,Watchlist News,@WatchlistN,2017-01-02T14:31:38.000Z,"Merck & Company, Inc. $MRK Shares Bought by Neuberger Berman Group LLC http://zpr.io/PqMTX","Merck & Company, Inc. $MRK Shares Bought by Neuberger Berman Group LLC http://zpr.io/PqMTX",,,,,[],https://twitter.com/WatchlistN/status/815928541321818116
37,Watchlist News,@WatchlistN,2017-01-03T09:58:07.000Z,"Merck & Company, Inc. $MRK Upgraded to Sell at Vetr Inc. http://zpr.io/PqAuS","Merck & Company, Inc. $MRK Upgraded to Sell at Vetr Inc. http://zpr.io/PqAuS",,,,,[],https://twitter.com/WatchlistN/status/816222098444189696
38,Ticker Report,@TickerReport,2017-01-03T16:17:56.000Z,"Merck & Company, Inc. $MRK Shares Bought by Alps Advisors Inc. http://ift.tt/2i6pnxT","Merck & Company, Inc. $MRK Shares Bought by Alps Advisors Inc. http://ift.tt/2i6pnxT",,,,,[],https://twitter.com/TickerReport/status/816317683302014976
39,Iomab_B,@RolfeNeelsen,2017-01-05T16:07:13.000Z,$AKAO http://mobile.nytimes.com/blogs/dealbook/2014/12/08/merck-agrees-to-acquire-drug-maker-cubist-for-9-5-billion/?referer=‚Ä¶ Study the Cubist $MRK deal to see why former Cubist Dep Gen council Halley Gilbert was appointed to $AKAO BOD.,"$AKAO http://mobile.nytimes.com/blogs/dealbook/2014/12/08/merck-agrees-to-acquire-drug-maker-cubist-for-9-5-billion/?referer=‚Ä¶ Study the Cubist $MRK deal to see why former Cubist Dep Gen council Halley Gilbert was appointed to $AKAO BOD.
1
6
8",,1,6,8,[],https://twitter.com/RolfeNeelsen/status/817039762477432832
40,Matthew Herper,@matthewherper,2017-01-06T15:29:51.000Z,Could Amgen's Patent Victory Be Bad For Medicine? $AMGN $REGN $MRK $GILD $EDIT,"Could Amgen's Patent Victory Be Bad For Medicine? $AMGN $REGN $MRK $GILD $EDIT
forbes.com
Could Amgen's Patent Victory Be Bad For Medicine?
Last night, in a nearly unprecedented move, a federal judge ordered a cholesterol medicine that is on the market and used by patients to be withdrawn because it infringes on the patents of a compet...
14
8",,,14,8,[],https://twitter.com/matthewherper/status/817392744809267200
41,Seeking Alpha,@SeekingAlpha,2017-01-06T13:26:32.000Z,Pennsylvania To Provide HCV Treatment To Mumia Abu-Jamal; A Boon For Gilead? http://seekingalpha.com/article/4034746-pennsylvania-provide-hcv-treatment-mumia-abu-jamal-boon-gilead?source=feed_f‚Ä¶ $BMY $ABBV $MRK $GILD,"Pennsylvania To Provide HCV Treatment To Mumia Abu-Jamal; A Boon For Gilead? http://seekingalpha.com/article/4034746-pennsylvania-provide-hcv-treatment-mumia-abu-jamal-boon-gilead?source=feed_f‚Ä¶ $BMY $ABBV $MRK $GILD
seekingalpha.com
Pennsylvania To Provide HCV Treatment To Mumia Abu-Jamal; A Boon For Gilead? (NASDAQ:GILD)
A judge ordered Pennsylvania to provide HCV treatment to inmate Mumia Abu-Jamal. The ruling could spur other states to make HCV treatments more readily-available to inmates.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501752449014632449/bUBX_30Y?format=jpg&name=240x240'],https://twitter.com/SeekingAlpha/status/817361711967518722
42,Margin Hunt,@MarginHunt,2017-01-06T19:30:40.000Z,"Buy Allergan $AGN If It Dips via 
@chrispycrunch
  $AMAT $IBB $MRK $PFE http://bit.ly/2hXQYnt #ValueInvesting","Buy Allergan $AGN If It Dips via 
@chrispycrunch
  $AMAT $IBB $MRK $PFE http://bit.ly/2hXQYnt #ValueInvesting",,,,,['https://pbs.twimg.com/media/C1gtfHwXgAIOeZY?format=jpg&name=small'],https://twitter.com/MarginHunt/status/817453348156739584
43,Seeking Alpha,@SeekingAlpha,2017-01-06T20:32:41.000Z,Can AbbVie Make A Mark In The Virology Segment In 2017? http://seekingalpha.com/article/4034883-can-abbvie-make-mark-virology-segment-2017?source=feed_f‚Ä¶ $BMY $GILD $MRK $ABBV,"Can AbbVie Make A Mark In The Virology Segment In 2017? http://seekingalpha.com/article/4034883-can-abbvie-make-mark-virology-segment-2017?source=feed_f‚Ä¶ $BMY $GILD $MRK $ABBV
seekingalpha.com
Can AbbVie Make A Mark In The Virology Segment In 2017? (NYSE:ABBV)
Viekira Pak continues to face significant competitive pressures in the U.S. market.
1",,,,1,['https://pbs.twimg.com/card_img/1501752444920995845/PGGMGI6L?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/817468957640650752
44,Seeking Alpha,@SeekingAlpha,2017-01-06T18:10:32.000Z,3 Imminent Second Chances In First-Line Lung Cancer http://seekingalpha.com/article/4034831-3-imminent-second-chances-first-line-lung-cancer?source=feed_f‚Ä¶ $BMY $MRK $RHHBY $AZN,3 Imminent Second Chances In First-Line Lung Cancer http://seekingalpha.com/article/4034831-3-imminent-second-chances-first-line-lung-cancer?source=feed_f‚Ä¶ $BMY $MRK $RHHBY $AZN,,,,,[],https://twitter.com/SeekingAlpha/status/817433184363159552
45,The Chestnut Report,@chestnutreport,2017-01-04T14:12:10.000Z,Biotech Deals Will Bounce Back in 2017 $ABBV $PFE $NVS $CELG $AGN $MRK $GSK $GILD $SNY $BMY $AMGN $BIIB $JNJ,"Biotech Deals Will Bounce Back in 2017 $ABBV $PFE $NVS $CELG $AGN $MRK $GSK $GILD $SNY $BMY $AMGN $BIIB $JNJ
bloomberg.com
Biotech Deals Will Bounce Back in 2017
Despite uncertainties, M&A fundamentals are improving.",,,,,['https://pbs.twimg.com/card_img/1500829713555673089/pQhlbIXa?format=jpg&name=small'],https://twitter.com/chestnutreport/status/816648419724972033
46,"Karl Snyder, CMT",@snyder_karl,2017-01-06T17:49:04.000Z,Dogs of the DOW 7. $MRK P&F is by no means a panacea. lots of choppiness last few months,Dogs of the DOW 7. $MRK P&F is by no means a panacea. lots of choppiness last few months,,,,,['https://pbs.twimg.com/media/C1gWO8eVQAEHEdw?format=jpg&name=small'],https://twitter.com/snyder_karl/status/817427781046964225
47,WLST.com,@wlstcom,2017-01-04T19:04:06.000Z,"Biotech Stocks: Help Me M&A, Youre My Only Hope $MRK http://wlst.com http://blogs.barrons.com/stockstowatchtoday/2017/01/04/biotech-stocks-help-me-ma-youre-my-only-hope‚Ä¶","Biotech Stocks: Help Me M&A, Youre My Only Hope $MRK http://wlst.com http://blogs.barrons.com/stockstowatchtoday/2017/01/04/biotech-stocks-help-me-ma-youre-my-only-hope‚Ä¶",,,,,['https://pbs.twimg.com/media/C1WUOlAXUAAMlU-?format=jpg&name=small'],https://twitter.com/wlstcom/status/816721887329996801
48,Bilo Selhi,@StocksThatDoubl,2017-01-06T19:01:05.000Z,Just one of many big alerts $AQXP  http://BiloSelhi.com  $BP $MET $GM $SYMC $NVDA $IBN $MRK $WMB,Just one of many big alerts $AQXP  http://BiloSelhi.com  $BP $MET $GM $SYMC $NVDA $IBN $MRK $WMB,,,,,['https://pbs.twimg.com/media/CL1ZnJ8WcAApw49?format=png&name=small'],https://twitter.com/StocksThatDoubl/status/817445903137128448
49,Bilo Selhi,@StocksThatDoubl,2017-01-06T19:40:09.000Z,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,"http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW
1",,,,1,['https://pbs.twimg.com/media/CiX8f4PUkAQf2Dy?format=jpg&name=small'],https://twitter.com/StocksThatDoubl/status/817455734183038977
50,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-01-06T22:43:50.000Z,How will #JPM17 Impact Equity Valuations for the Biotech Sector this year?  $IBB $GILD $AGN $MRK $BMY $JUNO $KITE $BLCM  $CELG $AMGN $REGN,"How will #JPM17 Impact Equity Valuations for the Biotech Sector this year?  $IBB $GILD $AGN $MRK $BMY $JUNO $KITE $BLCM  $CELG $AMGN $REGN
Positive
62.4%
Negative
12%
Neutral
25.6%
133 votes
¬∑
Final results
5",,,5,,[],https://twitter.com/DrPaulyDeSantis/status/817501959989043200
51,Brenda Sandburg,@brendasandburg,2017-01-05T14:07:20.000Z,"Brand vs. brand pharma #patent battles heat up. A look at cases over last six years. $GILD $MRK $AMGN $REGN $PFE
https://pink.pharmamedtechbi.com/PS119751/Brand-vs-Brand-Patent-Battles-Heat-Up-Focus-On-Big-Drug-Classes‚Ä¶","Brand vs. brand pharma #patent battles heat up. A look at cases over last six years. $GILD $MRK $AMGN $REGN $PFE
https://pink.pharmamedtechbi.com/PS119751/Brand-vs-Brand-Patent-Battles-Heat-Up-Focus-On-Big-Drug-Classes‚Ä¶
1",,,1,,[],https://twitter.com/brendasandburg/status/817009592156749825
52,TickWatcher,@MITickWatcher,2017-01-05T21:05:02.000Z,"Top #moneyflow for #sp500 today
$MSFT $JPM $NVDA $CSCO $BA $MRK $CVS $CMCSA $JNJ $IBM ...
http://mobileinteractive.com/stockstation/","Top #moneyflow for #sp500 today
$MSFT $JPM $NVDA $CSCO $BA $MRK $CVS $CMCSA $JNJ $IBM ...
http://mobileinteractive.com/stockstation/
1",,,,1,[],https://twitter.com/MITickWatcher/status/817114708864012289
53,Iomab_B,@RolfeNeelsen,2017-01-05T03:59:36.000Z,$AKAO Let the buyout tumors begin. Big Pharma: $2B will get mgmt's attention.  $MRK $RHHBY $NVS $GSK $AZN,"$AKAO Let the buyout tumors begin. Big Pharma: $2B will get mgmt's attention.  $MRK $RHHBY $NVS $GSK $AZN
1",,,,1,[],https://twitter.com/RolfeNeelsen/status/816856649700962325
54,Pharmaceutical News,@pharma_sector,2017-01-06T19:22:57.000Z,#Merck & Co's Ebola vaccine shows impressive efficacy in Phase III trial. Read more: http://owler.us/ab2MLA $MRK,"#Merck & Co's Ebola vaccine shows impressive efficacy in Phase III trial. Read more: http://owler.us/ab2MLA $MRK
1",,,1,,[],https://twitter.com/pharma_sector/status/817451405577334785
55,Roy Friedman,@DewDiligence,2017-01-06T00:49:42.000Z,$MRK's asking Court 2take Sovaldi/Harvoni off market would've been unthinkable from public-health standpoint. Asking4 ONLY $ was right move.,"$MRK's asking Court 2take Sovaldi/Harvoni off market would've been unthinkable from public-health standpoint. Asking4 ONLY $ was right move.
Rachel Sachs
@RESachs
 ¬∑ 6 Jan 2017
Replying to @matthewherper
I'm not @jsherkow but I do a good impression. Very strange - contrast w recent Gilead/Merck dispute. Merck only asked for $.
1
2",,1,,2,['https://pbs.twimg.com/profile_images/772975230985891840/TtSiYQ8A_mini.jpg'],https://twitter.com/DewDiligence/status/817171246588841985
56,Quantcha Trade Ideas,@QuantchaIdeas,2017-01-05T19:10:14.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/01/05/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/01/05/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk/‚Ä¶,,,,,['https://pbs.twimg.com/media/C1bfOKAUkAAbEnu?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/817085819592785920
57,TheTradingNinja,@TradeWithNinja,2017-01-04T14:39:31.000Z,"Replying to 
@TradeWithNinja
 and 
@optioninja","Replying to 
@TradeWithNinja
 and 
@optioninja
approaching $61 for those who rolled into $61 calls if it breaks $61 like it did $60 could see $61.30 next few days $MRK
2
5",,2,,5,['https://pbs.twimg.com/media/C1VXqf_WgAAWa26?format=jpg&name=small'],https://twitter.com/TradeWithNinja/status/816655301789286400
58,InvestorPlace,@InvestorPlace,2017-01-04T16:05:46.000Z,"4 Reasons Why Pfizer Inc. Stock (PFE) Could be a Great Pick in 2017
$PFE $GSK $MRK http://bit.ly/2hSAjSg","4 Reasons Why Pfizer Inc. Stock (PFE) Could be a Great Pick in 2017
$PFE $GSK $MRK http://bit.ly/2hSAjSg",,,,,['https://pbs.twimg.com/media/C1VraOcUQAAnbPD?format=jpg&name=small'],https://twitter.com/InvestorPlace/status/816677008339910656
59,SpoiledrottenBrat,@TaxHavens,2017-01-06T13:52:16.000Z,Commented on Pennsylvania Ordered To Provide HCV Treatment To Inmate; A Boon For Gilead? http://seekingalpha.com/article/4034746-pennsylvania-ordered-provide-hcv-treatment-inmate-boon-gilead?source=tweet‚Ä¶ $BMY $ABBV $MRK $GILD,Commented on Pennsylvania Ordered To Provide HCV Treatment To Inmate; A Boon For Gilead? http://seekingalpha.com/article/4034746-pennsylvania-ordered-provide-hcv-treatment-inmate-boon-gilead?source=tweet‚Ä¶ $BMY $ABBV $MRK $GILD,,,,,[],https://twitter.com/TaxHavens/status/817368188765675521
60,Jeffrey Weber,@jjjinvesting,2017-01-06T21:25:14.000Z,Buy Allergan If It Dips http://seekingalpha.com/article/4034641-buy-allergan-dips?source=tweet‚Ä¶ $AMAT $IBB $MRK $PFE $AGN,"Buy Allergan If It Dips http://seekingalpha.com/article/4034641-buy-allergan-dips?source=tweet‚Ä¶ $AMAT $IBB $MRK $PFE $AGN
seekingalpha.com
Buy Allergan If It Dips (NYSE:AGN)
Allergan is flush with cash and has manageable, investment-grade debt. Valuations are compelling. Shareholder buyback, R&D, marketing spend considerations.",,,,,['https://pbs.twimg.com/card_img/1501752443171975168/bP_R2woW?format=png&name=small'],https://twitter.com/jjjinvesting/status/817482182277140480
61,Open Outcrier,@OpenOutcrier,2017-01-04T14:07:48.000Z,"Goldman Expects Oncology M&A To Be Active In 2017, Sees $GILD $JNJ $PFE $MRK $NVS $SNY $LLY As Possible Acquirers

http://ooc.bz/l/8459","Goldman Expects Oncology M&A To Be Active In 2017, Sees $GILD $JNJ $PFE $MRK $NVS $SNY $LLY As Possible Acquirers

http://ooc.bz/l/8459
1",,,,1,[],https://twitter.com/OpenOutcrier/status/816647321102467072
62,Russell Brett,@RussellKBrett,2017-01-05T16:57:53.000Z,$XLF $KRE $UUP Financials pulling back w/interest rates & USD Healthcare remains strong $XLV $PFE $MRK $JNJ $UNH Utilities up $XLU #Rotation,$XLF $KRE $UUP Financials pulling back w/interest rates & USD Healthcare remains strong $XLV $PFE $MRK $JNJ $UNH Utilities up $XLU #Rotation,,,,,[],https://twitter.com/RussellKBrett/status/817052509738962944
63,Pharmacutical Daily,@PharmacDaily,2017-01-04T13:18:01.000Z,"Sanofi enters New Year with new deal, ends its vaccine joint venture
$SAN #acquisition #jointventure # $MRK $","Sanofi enters New Year with new deal, ends its vaccine joint venture
$SAN #acquisition #jointventure # $MRK $
pharmaceuticaldaily.com
Sanofi enters New Year with new deal, ends its vaccine joint venture
Sanofi has starts new year with big changes. In two separate statements the company announced closing a deal and ending a joint venture.",,,,,['https://pbs.twimg.com/card_img/1501031551240343557/uBeZZSHX?format=png&name=240x240'],https://twitter.com/PharmacDaily/status/816634790673838080
64,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-01-06T14:12:17.000Z,$GILD $MRK Weekly Hep C Tracker: Harvoni TRx/NRx down Scripts for the week ending December 30th are now (cont) http://tl.gd/n_1spgor0,"$GILD $MRK Weekly Hep C Tracker: Harvoni TRx/NRx down Scripts for the week ending December 30th are now (cont) http://tl.gd/n_1spgor0
1",üÖ± üÖæ,,,1,[],https://twitter.com/_B_I_O_T_E_C_H_/status/817373222970753025
65,1 min Stock Insights,@1MinuteStock,2017-01-06T18:04:02.000Z,Do you know that #WallStreet price for $MRK is $67.28 https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=wallstreet&utm_source=twitter‚Ä¶,Do you know that #WallStreet price for $MRK is $67.28 https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=wallstreet&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/817431545963220992
66,Heath Care News,@hc_equipment,2017-01-05T20:00:02.000Z,BioControl acquisition opens F&B growth opportunities - #Merck. Read more: http://owler.us/ab2tGy $MRK,BioControl acquisition opens F&B growth opportunities - #Merck. Read more: http://owler.us/ab2tGy $MRK,,,,,[],https://twitter.com/hc_equipment/status/817098351053148162
67,TalkMarkets,@TalkMarkets,2017-01-05T22:39:02.000Z,Shining A Spotlight On Ailing #HealthCare #ETFs $IBB $JNJ $MRK $PFE $PJP $XLV https://goo.gl/GNjwv5,Shining A Spotlight On Ailing #HealthCare #ETFs $IBB $JNJ $MRK $PFE $PJP $XLV https://goo.gl/GNjwv5,,,,,[],https://twitter.com/TalkMarkets/status/817138364574994432
68,Heath Care News,@hc_equipment,2017-01-06T18:56:22.000Z,#Merck Guardant Health Partners With Pharma Firms to Develop 500-Gene Liquid Biopsy Panel. Read more: http://owler.us/ab2MnM $MRK,#Merck Guardant Health Partners With Pharma Firms to Develop 500-Gene Liquid Biopsy Panel. Read more: http://owler.us/ab2MnM $MRK,,,,,[],https://twitter.com/hc_equipment/status/817444718032265216
69,Tim Collins,@RetroWallSt,2017-01-05T18:14:07.000Z,"$MRK -better looking names out there right now. 
$PFE $AZN $BMY  take your pick","$MRK -better looking names out there right now. 
$PFE $AZN $BMY  take your pick
1
1
1",,1,1,1,[],https://twitter.com/RetroWallSt/status/817071698314989568
70,TalkMarkets Recap,@MarketsRecap,2017-01-05T16:39:43.000Z,Shining A Spotlight On Ailing #HealthCare #ETFs $IBB $JNJ $MRK $PFE $PJP $XLV https://goo.gl/GNjwv5,Shining A Spotlight On Ailing #HealthCare #ETFs $IBB $JNJ $MRK $PFE $PJP $XLV https://goo.gl/GNjwv5,,,,,[],https://twitter.com/MarketsRecap/status/817047940766330880
71,deafdaytrader,@deafdaytrader,2017-01-06T23:54:53.000Z,"Nice and might run more part 2
$CHRW
$TWOU
$FDBL
$VIAB
$CRM
$ADBE
$AAPL
$QQQ
$FB
$HALO
$CSX
$MRK
$BCEI
$SYMC
$VIPS
$AMZN
$WYNN
$GLUU
$CLDX","Nice and might run more part 2
$CHRW
$TWOU
$FDBL
$VIAB
$CRM
$ADBE
$AAPL
$QQQ
$FB
$HALO
$CSX
$MRK
$BCEI
$SYMC
$VIPS
$AMZN
$WYNN
$GLUU
$CLDX
2",,,,2,[],https://twitter.com/deafdaytrader/status/817519840290373636
72,Heath Care News,@hc_equipment,2017-01-06T19:06:16.000Z,"#Merck Guardant Health, Pharma Firms to Develop 500-Gene Liquid Biopsy Panel. Read more: http://owler.us/ab2MyH $MRK","#Merck Guardant Health, Pharma Firms to Develop 500-Gene Liquid Biopsy Panel. Read more: http://owler.us/ab2MyH $MRK",,,,,[],https://twitter.com/hc_equipment/status/817447207049641984
73,Pharmaceutical News,@pharma_sector,2017-01-06T22:30:09.000Z,"GE, #Merck and others invest $30M in Burlington health care IT company. Read more: http://owler.us/ab2QmJ $MRK","GE, #Merck and others invest $30M in Burlington health care IT company. Read more: http://owler.us/ab2QmJ $MRK",,,,,[],https://twitter.com/pharma_sector/status/817498517782413314
74,TW Research Group,@DanCarlson33,2017-01-05T18:16:30.000Z,Best blood brain barrier platform. Top #CNS companies $MRK $PFE $LLY $TEVA $SHPG $AZN $BIIB $ALXN,"Best blood brain barrier platform. Top #CNS companies $MRK $PFE $LLY $TEVA $SHPG $AZN $BIIB $ALXN
twresearchgroup.com
Understanding the biOasis Drug Delivery Platform
True Story: I fell in love with biOasis at a speed dating event. It was, of course, speed dating for investors. Fifteen minutes with a company. Meet the CEO, hear the pitch, shake hands and move onto...",,,,,['https://pbs.twimg.com/card_img/1501753824456986624/QYEGp18g?format=jpg&name=240x240'],https://twitter.com/DanCarlson33/status/817072294346428416
75,SpoiledrottenBrat,@TaxHavens,2017-01-06T19:59:30.000Z,Commented on Pennsylvania To Provide HCV Treatment To Mumia Abu-Jamal; A Boon For Gilead? http://seekingalpha.com/article/4034746-pennsylvania-provide-hcv-treatment-mumia-abu-jamal-boon-gilead?source=tweet‚Ä¶ $BMY $ABBV $MRK $GILD,"Commented on Pennsylvania To Provide HCV Treatment To Mumia Abu-Jamal; A Boon For Gilead? http://seekingalpha.com/article/4034746-pennsylvania-provide-hcv-treatment-mumia-abu-jamal-boon-gilead?source=tweet‚Ä¶ $BMY $ABBV $MRK $GILD
seekingalpha.com
Pennsylvania To Provide HCV Treatment To Mumia Abu-Jamal; A Boon For Gilead? (NASDAQ:GILD)
A judge ordered Pennsylvania to provide HCV treatment to inmate Mumia Abu-Jamal. The ruling could spur other states to make HCV treatments more readily-available to inmates.",,,,,['https://pbs.twimg.com/card_img/1501752449014632449/bUBX_30Y?format=jpg&name=240x240'],https://twitter.com/TaxHavens/status/817460603967021056
76,WallStreetGangsta,@WallStGangsta,2017-01-06T15:42:39.000Z,Biotech Stocks To Watch Out In 2017  https://journaltranscript.com/2017/01/biotech-catalyst-swing-profiles-to-watch-out-in-2017/‚Ä¶  $IBB $GILD $MRK $BMY $OREX $PFE $JNJ $VRX $AMGN $REGN $NVS $AZN $SNY  $LLY,Biotech Stocks To Watch Out In 2017  https://journaltranscript.com/2017/01/biotech-catalyst-swing-profiles-to-watch-out-in-2017/‚Ä¶  $IBB $GILD $MRK $BMY $OREX $PFE $JNJ $VRX $AMGN $REGN $NVS $AZN $SNY  $LLY,,,,,[],https://twitter.com/WallStGangsta/status/817395964537344000
77,leahanne,@leahanneta,2017-01-06T16:03:35.000Z,"10:44 ET Volume Leader #49 - MRK 3,037,510 Merck & Company $MRK 59.97 -0.14 -0.23% High today of 60.25 day low","10:44 ET Volume Leader #49 - MRK 3,037,510 Merck & Company $MRK 59.97 -0.14 -0.23% High today of 60.25 day low
investorshangout.com
10:44 ET Volume Leader #49 - MRK - Momentum Players #4274757 - Investors Hangout
Momentum Players: 10:44 ET Volume Leader #49 - MRK 3,037,510 Merck Company $MRK 59.97 -0.14 -0.23% High today of 60. - #4274757",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/817401235233996800
78,Daily Political,@dailypoliticaln,2017-01-06T07:07:12.000Z,"Merck & Company, Inc. $MRK Upgraded at Vetr Inc. http://ift.tt/2hZ2SgM","Merck & Company, Inc. $MRK Upgraded at Vetr Inc. http://ift.tt/2hZ2SgM",,,,,[],https://twitter.com/dailypoliticaln/status/817266248962568192
79,Daily Political,@dailypoliticaln,2017-01-06T19:57:13.000Z,"Merck & Company, Inc. $MRK Shares Sold by Tdam USA Inc. http://ift.tt/2iZqQqy","Merck & Company, Inc. $MRK Shares Sold by Tdam USA Inc. http://ift.tt/2iZqQqy",,,,,[],https://twitter.com/dailypoliticaln/status/817460029322395648
80,Limex,@LimexMe,2017-01-06T15:06:11.000Z,"2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016 $LLY $MRK $BMY","2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016 $LLY $MRK $BMY
whotrades.com
2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016
Image source: Getty Images. What happened Shares of Merck & Co., Inc.   (NYSE: MRK) , a U.S.-based global drug behemoth, climbed 11% higher in 2016, according to data from‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/817386790558560256
81,Limex,@LimexMe,2017-01-06T16:13:30.000Z,It Was CheckMate for Bristol-Myers Squibb Company in 2016 $BMY $MRK $PFE,"It Was CheckMate for Bristol-Myers Squibb Company in 2016 $BMY $MRK $PFE
whotrades.com
It Was CheckMate for Bristol-Myers Squibb Company in 2016
Image source: Getty Images. What happened According to data from  S&P Global Market Intelligence , shares of global drug giant Bristol-Myers Squibb (NYSE: BMY) tumbled 15%‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/817403729712451587
82,WallStreetGangsta,@WallStGangsta,2017-01-06T15:58:55.000Z,"2017 Product launches, Acquisitions, and Clinical Updates https://journaltranscript.com/2017/01/biotech-catalyst-swing-profiles-to-watch-out-in-2017/‚Ä¶  $IBB $GILD $MRK $BMY $PFE $JNJ $VRX $AMGN $REGN $NVS","2017 Product launches, Acquisitions, and Clinical Updates https://journaltranscript.com/2017/01/biotech-catalyst-swing-profiles-to-watch-out-in-2017/‚Ä¶  $IBB $GILD $MRK $BMY $PFE $JNJ $VRX $AMGN $REGN $NVS",,,,,[],https://twitter.com/WallStGangsta/status/817400059096657921
83,Stockboard Media Inc,@stockboardinc,2017-01-06T13:07:21.000Z,$MRK Merck to Participate at the 35th Annual J.P. Morgan Healthcare Conference... - http://sbml.co/9f796ddc,$MRK Merck to Participate at the 35th Annual J.P. Morgan Healthcare Conference... - http://sbml.co/9f796ddc,,,,,[],https://twitter.com/stockboardinc/status/817356885435318273
84,Daniel Carlson,@tailwindsgroup,2017-01-04T23:22:00.000Z,biOasis video interview with the CEO. Cash flowing in 2017...what??? $MRK $PFE $LLY $TEVA $SHPG $AZN $BIIB $ALXN http://tailwindsresearch.com/2017/01/bioasis-the-enabler-video-series-part-1/‚Ä¶,biOasis video interview with the CEO. Cash flowing in 2017...what??? $MRK $PFE $LLY $TEVA $SHPG $AZN $BIIB $ALXN http://tailwindsresearch.com/2017/01/bioasis-the-enabler-video-series-part-1/‚Ä¶,,,,,[],https://twitter.com/tailwindsgroup/status/816786789826338816
85,Jon Ogg,@jonogg,2017-01-05T21:33:28.000Z,Bullish/Bearish DJIA healthcare case for 2017 $UNH $PFE $JNJ $MRK,"Bullish/Bearish DJIA healthcare case for 2017 $UNH $PFE $JNJ $MRK
247wallst.com
2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.",,,,,['https://pbs.twimg.com/card_img/1501784967063367681/s-tfNFwf?format=jpg&name=small'],https://twitter.com/jonogg/status/817121866217324548
86,Merck,@Merck,2017-01-06T13:15:50.000Z,"We'll be participating at the 35th Annual 
@jpmorgan
 Healthcare Conference: http://bit.ly/2jiMDNo #JPM17 $MRK","We'll be participating at the 35th Annual 
@jpmorgan
 Healthcare Conference: http://bit.ly/2jiMDNo #JPM17 $MRK
2
6",,,2,6,[],https://twitter.com/Merck/status/817359018507333632
87,TheTradingNinja,@TradeWithNinja,2017-01-04T15:12:52.000Z,"Replying to 
@TradeWithNinja
 and 
@optioninja","Replying to 
@TradeWithNinja
 and 
@optioninja
$MRK out all contracts!
9",,,,9,[],https://twitter.com/TradeWithNinja/status/816663693240963073
88,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-01-06T19:44:48.000Z,Anyone have data on the total number of US clinical trials enrolling patients for immuno-oncology checkpoint inhibitors? $BMY $ROG $AZN $MRK,Anyone have data on the total number of US clinical trials enrolling patients for immuno-oncology checkpoint inhibitors? $BMY $ROG $AZN $MRK,,,,,[],https://twitter.com/DrPaulyDeSantis/status/817456905891102720
89,Insider Monkey,@insidermonkey,2017-01-06T17:41:38.000Z,$MRK Joins Forces With M2Gen To Explore The ORIEN Avatar Research Program,"$MRK Joins Forces With M2Gen To Explore The ORIEN Avatar Research Program
insidermonkey.com
Merck & Co., Inc. (MRK) Joins Forces With M2Gen To Explore The ORIEN Avatar Research Program
Merck & Co., Inc.",,,,,[],https://twitter.com/insidermonkey/status/817425910357954560
90,TalkMarkets,@TalkMarkets,2017-01-06T13:45:29.000Z,Here's A List Of The Most Crowded Trades On Wall Street $AAPL $AMZN $FB $GOOGL $JPM $MRK $MSFT $ORLY $PFE $ROST $WFC https://goo.gl/iP9dbN,"Here's A List Of The Most Crowded Trades On Wall Street $AAPL $AMZN $FB $GOOGL $JPM $MRK $MSFT $ORLY $PFE $ROST $WFC https://goo.gl/iP9dbN
1",,,,1,[],https://twitter.com/TalkMarkets/status/817366481310806016
91,cowenresearch,@CowenResearch,2017-01-05T11:29:37.000Z,Steve Scala publishes 2017 animal health market outlook $ZTS $MRK $BI $LLY,Steve Scala publishes 2017 animal health market outlook $ZTS $MRK $BI $LLY,,,,,[],https://twitter.com/CowenResearch/status/816969898882727936
92,Kara Jill Stancell,@kjilly,2017-01-06T21:36:01.000Z,"In a tough year for pharma stocks, $GSK, $JNJ and $MRK delivered biggest 2016 gains http://bit.ly/2il6MOE via 
@FiercePharma","In a tough year for pharma stocks, $GSK, $JNJ and $MRK delivered biggest 2016 gains http://bit.ly/2il6MOE via 
@FiercePharma",,,,,[],https://twitter.com/kjilly/status/817484895886786560
93,Clark Joseph Kent,@JorelLaraKalel,2017-01-06T23:21:25.000Z,"10 Stocks Every Retiree Should Own $AAPL $T $CL $F $GM $IP $MRK $PFE $VZ $WM http://bit.ly/2iL744F 
@kiplinger","10 Stocks Every Retiree Should Own $AAPL $T $CL $F $GM $IP $MRK $PFE $VZ $WM http://bit.ly/2iL744F 
@kiplinger",,,,,[],https://twitter.com/JorelLaraKalel/status/817511417343606784
94,Jack Allen,@JohnK_Allen,2017-01-06T15:17:28.000Z,"Replying to 
@zbiotech","Replying to 
@zbiotech
could the Opdivo+Yervoy be too toxic? @Datamonitor_DP $BMY $MRK
1
2",,1,,2,[],https://twitter.com/JohnK_Allen/status/817389629297016833
95,Insider Monkey News,@insidermonkey_n,2017-01-06T17:41:08.000Z,$MRK Joins Forces With M2Gen To Explore The ORIEN Avatar Research Program,"$MRK Joins Forces With M2Gen To Explore The ORIEN Avatar Research Program
insidermonkey.com
Merck & Co., Inc. (MRK) Joins Forces With M2Gen To Explore The ORIEN Avatar Research Program
Merck & Co., Inc.",,,,,['https://pbs.twimg.com/card_img/1501981830110535683/vAk0jEwD?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/817425784759611393
96,TalkMarkets Recap,@MarketsRecap,2017-01-06T20:39:04.000Z,Here's A List Of The Most Crowded Trades On Wall Street $AAPL $AMZN $FB $GOOGL $JPM $MRK $MSFT $ORLY $PFE $ROST $WFC https://goo.gl/iP9dbN,Here's A List Of The Most Crowded Trades On Wall Street $AAPL $AMZN $FB $GOOGL $JPM $MRK $MSFT $ORLY $PFE $ROST $WFC https://goo.gl/iP9dbN,,,,,[],https://twitter.com/MarketsRecap/status/817470563417464832
97,Ticker Report,@TickerReport,2017-01-06T21:41:06.000Z,"Asset Advisors Corp Boosts Position in Merck & Company, Inc. $MRK http://ift.tt/2i1OK6v","Asset Advisors Corp Boosts Position in Merck & Company, Inc. $MRK http://ift.tt/2i1OK6v",,,,,[],https://twitter.com/TickerReport/status/817486173278965763
98,Ticker Report,@TickerReport,2017-01-05T22:37:07.000Z,"North American Management Corp Purchases 781 Shares of Merck & Company, Inc. $MRK http://zpr.io/PqkUK","North American Management Corp Purchases 781 Shares of Merck & Company, Inc. $MRK http://zpr.io/PqkUK",,,,,[],https://twitter.com/TickerReport/status/817137881303150592
99,Clark Joseph Kent,@JorelLaraKalel,2017-01-04T00:54:37.000Z,"Indexes Score Decent Gains As Disney Tries For Breakout; Oil Reverses $DIS $MRK $NKE $NFLX $GOOGL 
@investors","Indexes Score Decent Gains As Disney Tries For Breakout; Oil Reverses $DIS $MRK $NKE $NFLX $GOOGL 
@investors
investors.com
Indexes Score Decent Gains; Disney Tries For Breakout, Oil Reverses | Stock News & Stock Market...
A flurry of buying in the last hour of trading Tuesday lifted the market off lows in a volatile session as 2017 got off to a reasonable start.",,,,,[],https://twitter.com/JorelLaraKalel/status/816447711205609472
100,Dan Burrows,@danburrows,2017-01-06T19:01:34.000Z,4 Dow Stocks Every Retiree Should Own - http://kiplinger.com/slideshow/investing/T018-S001-4-dow-stocks-every-retiree-should-own/index.html‚Ä¶ $VZ $PFE $MRK $T,"4 Dow Stocks Every Retiree Should Own - http://kiplinger.com/slideshow/investing/T018-S001-4-dow-stocks-every-retiree-should-own/index.html‚Ä¶ $VZ $PFE $MRK $T
kiplinger.com
4 Dow Stocks Every Retiree Should Own | Kiplinger
It's arguably the bluest of the blue-chip stock indexes, dating back to the 19th century.",,,,,[],https://twitter.com/danburrows/status/817446025904394241
101,David Shaywitz,@DShaywitz,2017-01-05T22:40:37.000Z,"Replying to 
@matthewherper
 and 
@ethanjweiss","Replying to 
@matthewherper
 and 
@ethanjweiss
that's how some folks thought of $MRK in post-vioxx era
2
1",,2,,1,[],https://twitter.com/DShaywitz/status/817138761641267200
102,Odi Bruckman,@odibro,2017-01-09T13:09:29.000Z,$INCY  & $MRK to Advance Clinical Development Program Investigating the  Combination of Epacadostat with KEYTRUDA¬Æ http://finance.yahoo.com/news/incyte-merck-advance-clinical-development-130000608.html‚Ä¶,"$INCY  & $MRK to Advance Clinical Development Program Investigating the  Combination of Epacadostat with KEYTRUDA¬Æ http://finance.yahoo.com/news/incyte-merck-advance-clinical-development-130000608.html‚Ä¶
6
7",,,6,7,[],https://twitter.com/odibro/status/818444584133021700
103,WLST.com,@wlstcom,2017-01-09T23:40:41.000Z,"There are illnesses that could bankrupt our society, Merck CEO says #DonaldTrump $MRK #wlst http://cnbc.com/2017/01/09/there-are-illnesses-that-could-bankrupt-our-society-merck-ceo-says.html?__%7Cfinance%7Cheadline%7Cheadline%7Cstory=&par=yahoo&doc=104208360‚Ä¶","There are illnesses that could bankrupt our society, Merck CEO says #DonaldTrump $MRK #wlst http://cnbc.com/2017/01/09/there-are-illnesses-that-could-bankrupt-our-society-merck-ceo-says.html?__%7Cfinance%7Cheadline%7Cheadline%7Cstory=&par=yahoo&doc=104208360‚Ä¶
1",,,,1,['https://pbs.twimg.com/media/C1xDezhWEAAfmXa?format=jpg&name=small'],https://twitter.com/wlstcom/status/818603430759567360
104,Adam Feuerstein,@adamfeuerstein,2017-01-09T14:43:15.000Z,"Met big healthcare fund manager in #JPM17 registration line. More than $ARIA takeout, he was really pumped about $INCY $MRK I-O expansion.","Met big healthcare fund manager in #JPM17 registration line. More than $ARIA takeout, he was really pumped about $INCY $MRK I-O expansion.
2
8
29",,2,8,29,[],https://twitter.com/adamfeuerstein/status/818468181207416832
105,Seeking Alpha,@SeekingAlpha,2017-01-09T15:23:05.000Z,A Long Opportunity In Novo Nordisk http://seekingalpha.com/article/4035228-long-opportunity-novo-nordisk?source=feed_f‚Ä¶ $MRK $ABBV $BMY $SNY $AZN $PFE $GSK $LLY $JNJ $NVO,"A Long Opportunity In Novo Nordisk http://seekingalpha.com/article/4035228-long-opportunity-novo-nordisk?source=feed_f‚Ä¶ $MRK $ABBV $BMY $SNY $AZN $PFE $GSK $LLY $JNJ $NVO
1",,,,1,[],https://twitter.com/SeekingAlpha/status/818478206386769920
106,Seeking Alpha,@SeekingAlpha,2017-01-09T15:34:30.000Z,Interview: Veru Healthcare CEO Dr. Mitchell Steiner http://seekingalpha.com/article/4035250-interview-veru-healthcare-ceo-dr-mitchell-steiner?source=feed_f‚Ä¶ $JNJ $MRK $FHCO,"Interview: Veru Healthcare CEO Dr. Mitchell Steiner http://seekingalpha.com/article/4035250-interview-veru-healthcare-ceo-dr-mitchell-steiner?source=feed_f‚Ä¶ $JNJ $MRK $FHCO
seekingalpha.com
Interview: Veru Healthcare CEO Dr. Mitchell Steiner (NASDAQ:VERU)
FC2 female condom is to be offered as prescription; covered by health insurance. Dr. Steiner explains attention to 505(b)(2) pathways at Veru Healthcare/The Female Health Company.",,,,,[],https://twitter.com/SeekingAlpha/status/818481077882785794
107,Mike Bertelsen,@mikebertelsen,2017-01-07T12:18:28.000Z,"Nick's Picks 2017 http://seekingalpha.com/article/4034684-nicks-picks-2017?source=email_portfolio&ifp=0&app=1‚Ä¶ via 
@SeekingAlpha
 $AAPL $JNJ $DIS $AMGN $MRK $PFE Entire portfolio unveiled. #stocks #markets","Nick's Picks 2017 http://seekingalpha.com/article/4034684-nicks-picks-2017?source=email_portfolio&ifp=0&app=1‚Ä¶ via 
@SeekingAlpha
 $AAPL $JNJ $DIS $AMGN $MRK $PFE Entire portfolio unveiled. #stocks #markets
seekingalpha.com
Nick's Picks 2017
In this piece, I share my top picks for 2017. My 2016 Nick's Picks produced a 2.6% alpha compared to the S&P 500's performance.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/mikebertelsen/status/817706970530611204
108,Breaking News,@MarketCurrents,2017-01-09T16:38:06.000Z,Incyte up 7% on expanded cancer collaboration with Merck; IDO competitor NewLink up 17% http://seekingalpha.com/news/3234167-incyte-7-percent-expanded-cancer-collaboration-merck-ido-competitor-newlink-17-percent?source=feed_f‚Ä¶ $INCY $MRK $NLNK $RHHBY,"Incyte up 7% on expanded cancer collaboration with Merck; IDO competitor NewLink up 17% http://seekingalpha.com/news/3234167-incyte-7-percent-expanded-cancer-collaboration-merck-ido-competitor-newlink-17-percent?source=feed_f‚Ä¶ $INCY $MRK $NLNK $RHHBY
1",,,,1,[],https://twitter.com/MarketCurrents/status/818497085574029312
109,IT,@IncredibleTrade,2017-01-07T03:37:00.000Z,"You know who to thank for drop in $T, $LMT, $TWX, $MRK $PFE $TM -- it's not about trading but 401ks and pension funds are affected","You know who to thank for drop in $T, $LMT, $TWX, $MRK $PFE $TM -- it's not about trading but 401ks and pension funds are affected
1
3",,,1,3,['https://pbs.twimg.com/media/C1icyyoWEAIUXTv?format=jpg&name=small'],https://twitter.com/IncredibleTrade/status/817575737066659841
110,MM+M Magazine,@MMMnews,2017-01-09T22:30:03.000Z,"5 things for #pharma #marketers to know: Mon, Jan 9 $TKPHF $ARIA $MRK #clinicaltrials #cancer $SNY $ABBV $GNMX $LLY http://bit.ly/2iV0EOi","5 things for #pharma #marketers to know: Mon, Jan 9 $TKPHF $ARIA $MRK #clinicaltrials #cancer $SNY $ABBV $GNMX $LLY http://bit.ly/2iV0EOi
1",,,,1,['https://pbs.twimg.com/media/C1vbUK8XgAAm7l3?format=jpg&name=small'],https://twitter.com/MMMnews/status/818585653378224130
111,dough,@semodough,2017-01-09T20:21:42.000Z,https://twitter.com/tgtxdough/status/802142238369259520‚Ä¶ nice call by BAML $INCY and $MRK $INCY up 11 now,"https://twitter.com/tgtxdough/status/802142238369259520‚Ä¶ nice call by BAML $INCY and $MRK $INCY up 11 now
dough
@semodough
 ¬∑ 25 Nov 2016
Baml $INCY inflection point will be a decision for $MRK to enter Phase 3 trial in NSCLC by 2H17. Buy on INCY &raise PO from $103 to $118.
1
4",,,1,4,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/818553354456629250
112,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-01-09T14:20:13.000Z,"$MRK presenting today at 4PM today, should be interesting to see what they say on $INCY next steps","$MRK presenting today at 4PM today, should be interesting to see what they say on $INCY next steps
1
2",,,1,2,[],https://twitter.com/DrPaulyDeSantis/status/818462385228906496
113,John Carroll,@JohnCendpts,2017-01-09T14:54:02.000Z,"Amgen, Sanofi and Merck announce a string of deals at #JPM17
$AMGN, $SFY, $MRK","Amgen, Sanofi and Merck announce a string of deals at #JPM17
$AMGN, $SFY, $MRK
endpts.com
Amgen, Sanofi and Merck announce a string of deals at #JPM17; McDonough out at Sobi
‚Ä¢ Amgen has tied the knot with Germany‚Äôs Immatics, paying $30 million upfront and offering hundreds of millions more in possible milestones for the development of bispecific T cell-engaging therape...
8
2",,,8,2,[],https://twitter.com/JohnCendpts/status/818470894905401344
114,Peter Loftus,@Loftus,2017-01-09T14:39:07.000Z,"Merck, Incyte widen studies of cancer immunotherapy combination to more tumor types including lung $MRK $INCY #JPM17 http://mercknewsroom.com/news-release/oncology-newsroom/incyte-and-merck-advance-clinical-development-program-investigating-c‚Ä¶","Merck, Incyte widen studies of cancer immunotherapy combination to more tumor types including lung $MRK $INCY #JPM17 http://mercknewsroom.com/news-release/oncology-newsroom/incyte-and-merck-advance-clinical-development-program-investigating-c‚Ä¶
7
5",,,7,5,[],https://twitter.com/Loftus/status/818467139573006337
115,Lisa LaMotta,@lisalamotta,2017-01-09T21:54:35.000Z,"Packed house for $INCY #JPM17 
@bradloncar
 says INCY could have the first big I/O combo with $MRK","Packed house for $INCY #JPM17 
@bradloncar
 says INCY could have the first big I/O combo with $MRK
1",,,,1,['https://pbs.twimg.com/media/C1wrMJUUkAAQ409?format=jpg&name=small'],https://twitter.com/lisalamotta/status/818576730264768512
116,Loncar Biotech ETFs,@LoncarFunds,2017-01-09T14:55:00.000Z,$CNCR ETF holdings that are scheduled to present at #JPM17 today (Monday 1/9): $CLLS $NVS $ADRO $INCY $AMGN $MRK. http://loncarfunds.com/cncr-holdings/,"$CNCR ETF holdings that are scheduled to present at #JPM17 today (Monday 1/9): $CLLS $NVS $ADRO $INCY $AMGN $MRK. http://loncarfunds.com/cncr-holdings/
1",,,,1,['https://pbs.twimg.com/media/C1XxLgZVQAAGCWd?format=png&name=small'],https://twitter.com/LoncarFunds/status/818471140037394432
117,Vikas Dandekar,@VikasReports,2017-01-08T11:17:05.000Z,These 3 ugly patent battles could rock biopharma's 2017 $AMGN $SNY $REGN $MRK $GILD $NVS,"These 3 ugly patent battles could rock biopharma's 2017 $AMGN $SNY $REGN $MRK $GILD $NVS
fortune.com
These 3 Ugly Patent Battles Could Rock Biopharma‚Äôs 2017
Amgen won a stunning IP victory over Sanofi and Regeneron, whose cholesterol med Praluent was yanked off the market. There's more to come.
1
3
5",,1,3,5,['https://pbs.twimg.com/card_img/1501752387710636034/Y_S6gnDo?format=jpg&name=small'],https://twitter.com/VikasReports/status/818053911994994689
118,ICI Research,@iciresearch,2017-01-09T13:23:47.000Z,"$MRK $INCY New Ph 3 trials of pembrolizumab + epacadostat in NSCLC, renal, bladder, and SCCHN planned","$MRK $INCY New Ph 3 trials of pembrolizumab + epacadostat in NSCLC, renal, bladder, and SCCHN planned
Merck
@Merck
 ¬∑ 9 Jan 2017
We're advancing our #oncology partnership with @Incyte. Read more: http://bit.ly/2iVk6fM
1",,,1,,['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg'],https://twitter.com/iciresearch/status/818448182434758656
119,Ed,@vivazapata173,2017-01-09T04:22:39.000Z,"$ACAD Big pharm $PFE, $JNJ, $MRK will not let $ACAD go cheap to the likes of $BIIB. $75-85.","$ACAD Big pharm $PFE, $JNJ, $MRK will not let $ACAD go cheap to the likes of $BIIB. $75-85.
2",,,,2,[],https://twitter.com/vivazapata173/status/818312003315826688
120,Joe,@GantosJ,2017-01-09T13:59:00.000Z,"We started the #JPM17 week with $ARIA and $MACK deals.
2017 is the M&A year.
Big pharma like $PFE $SNY $GILD $MRK & more need to show growth","We started the #JPM17 week with $ARIA and $MACK deals.
2017 is the M&A year.
Big pharma like $PFE $SNY $GILD $MRK & more need to show growth
1
1",,,1,1,[],https://twitter.com/GantosJ/status/818457044453912576
121,Siti van der Meij,@sitivandermeij,2017-01-09T16:41:06.000Z,Incyte up 7% on expanded cancer collaboration with Merck; IDO competitor NewLink up 17% http://seekingalpha.com/news/3234167-incyte-7-percent-expanded-cancer-collaboration-merck-ido-competitor-newlink-17-percent?source=feed_f‚Ä¶ $INCY $MRK $NLNK $RHHBY #s‚Ä¶,"Incyte up 7% on expanded cancer collaboration with Merck; IDO competitor NewLink up 17% http://seekingalpha.com/news/3234167-incyte-7-percent-expanded-cancer-collaboration-merck-ido-competitor-newlink-17-percent?source=feed_f‚Ä¶ $INCY $MRK $NLNK $RHHBY #s‚Ä¶
1
1",,,1,1,[],https://twitter.com/sitivandermeij/status/818497839403769858
122,Limex,@LimexMe,2017-01-09T15:28:45.000Z,Here's a Biotech IPO You'll Want to Watch $CELG $MRK $BMY,"Here's a Biotech IPO You'll Want to Watch $CELG $MRK $BMY
whotrades.com
Here's a Biotech IPO You'll Want to Watch
You might be too busy to pay much attention to every tiny biotech that goes public. There's one initial public offering (IPO) coming up, though, that I think you'll want to keep your eyes‚Ä¶
1",,,,1,[],https://twitter.com/LimexMe/status/818479633243013120
123,Odi Bruckman,@odibro,2017-01-09T13:11:45.000Z,$ADRO: Clinical Collab w/ $MRK to Evaluate the Combination of CRS-207 with Keytruda for treatment of gastric cancer  http://finance.yahoo.com/news/aduro-biotech-announces-clinical-collaboration-130000930.html‚Ä¶,"$ADRO: Clinical Collab w/ $MRK to Evaluate the Combination of CRS-207 with Keytruda for treatment of gastric cancer  http://finance.yahoo.com/news/aduro-biotech-announces-clinical-collaboration-130000930.html‚Ä¶
1",,,,1,[],https://twitter.com/odibro/status/818445155925639171
124,Stanislav Drastich,@drastichs,2017-01-07T12:27:58.000Z,"Replying to 
@drastichs","Replying to 
@drastichs
#Prognosis of #stocks to #grow #significantly #bullish

$CHK $INTC $ITC $JPM $KSS $M $MRK $MSFT $MT $MU $NFLX $NVDA
drastichs.wordpress.com
Advertisement
My family is facing important health issues enforcing me to ask You for Your kind support. Please, get familiar to full story  
2
2",,,2,2,['https://pbs.twimg.com/card_img/1500905363402539009/G3C-gSbv?format=jpg&name=small'],https://twitter.com/drastichs/status/817709359077748736
125,Muathe,@muathe,2017-01-07T16:12:10.000Z,"[VIDEO] World Market Technical Analysis Jan 07, 2017 $VALE $GGB $ABEV $PBR $NOK $BMY $LYG $MRK $BCS $BBD $CX $BABA","[VIDEO] World Market Technical Analysis Jan 07, 2017 $VALE $GGB $ABEV $PBR $NOK $BMY $LYG $MRK $BCS $BBD $CX $BABA
youtube.com
[ Weekend ] World Market Technical Analysis Jan 07-08, 2017
Ôº¨Ôº©Ôº´Ôº• | Ôº£ÔºØÔº≠Ôº≠Ôº•ÔºÆÔº¥ | Ôº≥Ôº®Ôº°Ôº≤Ôº• | Ôº≥ÔºµÔº¢Ôº≥Ôº£Ôº≤Ôº©Ôº¢Ôº•My Website; http://www.muathe.com/Original Muathe.com Concepts!Many world markets are struggling to hold up their daily cha...
2",,,,2,[],https://twitter.com/muathe/status/817765781140344834
126,Meg Tirrell,@megtirrell,2017-01-09T21:07:56.000Z,"Coming up on 
@CNBC
 from #JPM17: $MRK CEO Ken Frazier joins us on 
@CNBCClosingBell
. What do you want to know?","Coming up on 
@CNBC
 from #JPM17: $MRK CEO Ken Frazier joins us on 
@CNBCClosingBell
. What do you want to know?
2
2
9",,2,2,9,[],https://twitter.com/megtirrell/status/818564988860141569
127,Benzinga,@Benzinga,2017-01-09T12:23:01.000Z,The Year's Biggest Healthcare Conference Commences; Here's What You Need To Know https://benzinga.com/z/8879397 $AGN $ALXN $ANTM $MRK $GILD #JPM17,"The Year's Biggest Healthcare Conference Commences; Here's What You Need To Know https://benzinga.com/z/8879397 $AGN $ALXN $ANTM $MRK $GILD #JPM17
benzinga.com
The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know
The 35th JPMorgan Chase & Co. (NYSE: JPM) Healthcare Conference gets underway on January 9 and will go on until January 13. Touted as the life science industry's largest...
2
1",,,2,1,[],https://twitter.com/Benzinga/status/818432890258104320
128,Jerry Rosenthal,@jerry_rosenthal,2017-01-07T12:54:41.000Z,"The Best Thing About Glaxo's Next Vaccine (Hint: It's Not the Billion-Dollar Sales Estimate) #stocks $MRK, $GSK","The Best Thing About Glaxo's Next Vaccine (Hint: It's Not the Billion-Dollar Sales Estimate) #stocks $MRK, $GSK
fool.com
The Best Thing About Glaxo's Next Vaccine (Hint: It's Not the Billion-Dollar Sales Estimate)...
The pharma's upcoming shingles vaccine should be a blockbuster -- and that's not even the best part.",,,,,['https://pbs.twimg.com/card_img/1501347460668559360/n-m5M8AO?format=jpg&name=small'],https://twitter.com/jerry_rosenthal/status/817716084019236864
129,jodi gralnick,@jodigralnick,2017-01-09T13:20:01.000Z,"MINUTES AWAY: 
@megtirrell
 LIVE EXCLUSIVE intvw w/ $BMRN CEO @ #JPM17 on 
@SquawkCNBC
 ... also on tap today: $LLY $CELG $JNJ $ALXN $MRK CEOs","MINUTES AWAY: 
@megtirrell
 LIVE EXCLUSIVE intvw w/ $BMRN CEO @ #JPM17 on 
@SquawkCNBC
 ... also on tap today: $LLY $CELG $JNJ $ALXN $MRK CEOs
1
1",,,1,1,[],https://twitter.com/jodigralnick/status/818447233779699712
130,Watchlist News,@WatchlistN,2017-01-07T20:02:36.000Z,"Spinnaker Trust Continues to Hold Stake in Merck & Company, Inc. $MRK http://zpr.io/PqvxF","Spinnaker Trust Continues to Hold Stake in Merck & Company, Inc. $MRK http://zpr.io/PqvxF",,,,,[],https://twitter.com/WatchlistN/status/817823772824768516
131,Daily Political,@dailypoliticaln,2017-01-08T16:32:09.000Z,"Merck & Company, Inc. $MRK Stake Held by Amica Pension Fund Board of Trustees http://ift.tt/2i7dKcM","Merck & Company, Inc. $MRK Stake Held by Amica Pension Fund Board of Trustees http://ift.tt/2i7dKcM",,,,,[],https://twitter.com/dailypoliticaln/status/818133200228782080
132,1 min Stock Insights,@1MinuteStock,2017-01-09T20:31:02.000Z,Wondering about risks of $MRK? The 21-day volatility is 4.58%,"Wondering about risks of $MRK? The 21-day volatility is 4.58%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/818555705242386432
133,Ticker Report,@TickerReport,2017-01-08T13:45:55.000Z,"Hamlin Capital Management LLC Has $44,826,000 Position in Merck & Company, Inc. $MRK http://zpr.io/PqBDx","Hamlin Capital Management LLC Has $44,826,000 Position in Merck & Company, Inc. $MRK http://zpr.io/PqBDx",,,,,[],https://twitter.com/TickerReport/status/818091364197994496
134,Daily Political,@dailypoliticaln,2017-01-07T23:37:23.000Z,"Mountain Pacific Investment Advisers Inc. ID Has $392,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2joDq6x","Mountain Pacific Investment Advisers Inc. ID Has $392,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2joDq6x",,,,,[],https://twitter.com/dailypoliticaln/status/817877822756814848
135,Libertarian-In-Chief,@ToddHagopian,2017-01-07T17:53:29.000Z,I am bearish on $MRK with a target price of $54.24 in 6 mos. on Vetr! http://bit.ly/2i2e9K7,I am bearish on $MRK with a target price of $54.24 in 6 mos. on Vetr! http://bit.ly/2i2e9K7,,,,,[],https://twitter.com/ToddHagopian/status/817791277521653760
136,Clark Joseph Kent,@JorelLaraKalel,2017-01-09T20:48:33.000Z,"Incyte Stock Breaks Out, It And Partner Merck Will Advance Key Trial $INCY $MRK $BMY http://bit.ly/2jmiN6T 
@investors
 @incyte","Incyte Stock Breaks Out, It And Partner Merck Will Advance Key Trial $INCY $MRK $BMY http://bit.ly/2jmiN6T 
@investors
 @incyte
investors.com
Incyte Stock Breaks Out, It And Partner Merck Will Advance Key Trial | Stock News & Stock Market...
Incyte stock jumped to a buy point after it and partner Merck announced they would advance a drug trial to include four more types of tumors.",,,,,[],https://twitter.com/JorelLaraKalel/status/818560110393958401
137,Benzinga,@Benzinga,2017-01-09T16:40:40.000Z,"Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare... https://benzinga.com/z/8883742 $MRK $XON $ZIOP","Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare... https://benzinga.com/z/8883742 $MRK $XON $ZIOP
1",,,1,,[],https://twitter.com/Benzinga/status/818497728384745472
138,dough,@semodough,2017-01-09T01:06:35.000Z,"Replying to 
@semodough
 and 
@BrianSkorney","Replying to 
@semodough
 and 
@BrianSkorney
$JNJ $AMGN $MRK $PFE $GILD $SNY could ALL do 5-10 BILLION dollar deal &still have plenty of cash for even a stupid buyback
1
3",üò° üò°,,1,3,[],https://twitter.com/semodough/status/818262662203211776
139,FirstWord Pharma,@fwpharma,2017-01-09T14:49:12.000Z,"Replying to 
@adamfeuerstein","Replying to 
@adamfeuerstein
loads of Big Pharma will be talking up IO combos this week as a means to gain ground but $MRK $BMY out in front here too
1",,,,1,[],https://twitter.com/fwpharma/status/818469678448197632
140,Pharmaceutical News,@pharma_sector,2017-01-09T19:46:06.000Z,"#Merck & Company, Inc. Shares Bought by LaFleur & Godfrey LLC. Read more: http://owler.us/ab3tKq $MRK","#Merck & Company, Inc. Shares Bought by LaFleur & Godfrey LLC. Read more: http://owler.us/ab3tKq $MRK",,,,,[],https://twitter.com/pharma_sector/status/818544397453172736
141,Pharmaceutical News,@pharma_sector,2017-01-09T23:14:49.000Z,Incyte And #Merck & Co.To Advance Clinical Development Program Investigating The Combination... Read more: http://owler.us/ab3uWl $MRK,Incyte And #Merck & Co.To Advance Clinical Development Program Investigating The Combination... Read more: http://owler.us/ab3uWl $MRK,,,,,[],https://twitter.com/pharma_sector/status/818596921962962946
142,Daniel Carlson,@tailwindsgroup,2017-01-08T01:25:50.000Z,Best ways to invest in biotech in 2017! Small cap is the place. $MRK $PFE $IBB $TEVA $SHPG $AZN $BIIB $ALXN http://tailwindsresearch.com/2017/01/the-bull-case-for-biotech-in-2017/‚Ä¶,Best ways to invest in biotech in 2017! Small cap is the place. $MRK $PFE $IBB $TEVA $SHPG $AZN $BIIB $ALXN http://tailwindsresearch.com/2017/01/the-bull-case-for-biotech-in-2017/‚Ä¶,,,,,[],https://twitter.com/tailwindsgroup/status/817905116497883136
143,Ticker Report,@TickerReport,2017-01-08T18:59:45.000Z,"Merck & Company, Inc. $MRK Shares Bought by Coastline Trust Co http://ift.tt/2iWRALe","Merck & Company, Inc. $MRK Shares Bought by Coastline Trust Co http://ift.tt/2iWRALe",,,,,[],https://twitter.com/TickerReport/status/818170344821424129
144,By Any Memes Necessary,@_21stCenturyCox,2017-01-09T17:01:25.000Z,"Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare... https://benzinga.com/z/8883742 $MRK $XON $ZIOP  via 
@benzinga","Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare... https://benzinga.com/z/8883742 $MRK $XON $ZIOP  via 
@benzinga
benzinga.com
Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation
Benzinga recently had the chance to speak with ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) CEO Dr. Laurence James Neil Cooper about the upcoming JPMorgan Healthcare Conference,...
1
1",,,1,1,[],https://twitter.com/_21stCenturyCox/status/818502951962574849
145,John Osborn,@John0sborn,2017-01-09T14:09:30.000Z,".
@Incyte
 and 
@Merck
 to Advance Clinical Development Program Investigating the... | #drug #health #cancer $INCY $MRK",".
@Incyte
 and 
@Merck
 to Advance Clinical Development Program Investigating the... | #drug #health #cancer $INCY $MRK
businesswire.com
Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacado...
Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA (pembrolizumab)",üêá,,,,[],https://twitter.com/John0sborn/status/818459687922388992
146,Yahoo Finance,@YahooFinance,2017-01-11T13:36:59.000Z,"#Stocks to Watch Today: $MRK, $AMZN, $SIG, $ADM
https://yhoo.it/2iFxwda","#Stocks to Watch Today: $MRK, $AMZN, $SIG, $ADM
https://yhoo.it/2iFxwda
1
6
5",,1,6,5,"['https://pbs.twimg.com/media/C15MdGEUsAAMeja?format=jpg&name=small', 'https://pbs.twimg.com/media/C15MenmVEAAs3kL?format=jpg&name=small']",https://twitter.com/YahooFinance/status/819176280339972096
147,Matthew Herper,@matthewherper,2017-01-11T18:28:40.000Z,Trump's Comments Are Big Pharma's Nightmare $AGN $MRK $PFE $GILD $MYL,"Trump's Comments Are Big Pharma's Nightmare $AGN $MRK $PFE $GILD $MYL
forbes.com
Trump's Comments Are Big Pharma's Nightmare
Donald Trump is going to be a populist president. Pharmaceutical companies are a popular villain.
1
17
15",,1,17,15,['https://pbs.twimg.com/card_img/1501877317995536384/fi4n9kTK?format=jpg&name=small'],https://twitter.com/matthewherper/status/819249686104027136
148,Bio Stocks‚Ñ¢,@BioStocks,2017-01-12T15:01:07.000Z,$MRK's Lead in Lung Cancer May Be Unbeatable.  $BMY http://bloomberg.com/gadfly/articles/2017-01-12/merck-keytruda-io-lung-cancer-combo-may-hold-its-market-lead‚Ä¶ #biotech,"$MRK's Lead in Lung Cancer May Be Unbeatable.  $BMY http://bloomberg.com/gadfly/articles/2017-01-12/merck-keytruda-io-lung-cancer-combo-may-hold-its-market-lead‚Ä¶ #biotech
bloomberg.com
Merck's Lead in Lung Cancer May Be Unbeatable
Its Keytruda combo has a safety edge on the competition.
4
6",,,4,6,[],https://twitter.com/BioStocks/status/819559841509339136
149,Yahoo Finance,@YahooFinance,2017-01-11T21:10:53.000Z,"Today‚Äôs #Stocks Winners: $SGMO, $DRMA, $MRK https://yhoo.it/2idU7Bl","Today‚Äôs #Stocks Winners: $SGMO, $DRMA, $MRK https://yhoo.it/2idU7Bl
1
4",,1,4,,[],https://twitter.com/YahooFinance/status/819290509575331850
150,Trader Gang,@RealTraderGang,2017-01-11T15:08:49.000Z,"Stocks to Watch Today: $AMZN, $SIG, $ADM, $MRK
(link: https://yhoo.it/2iFxwda) On The Hunt For The Next BIG PLAY. Join US #TraderGang ;)","Stocks to Watch Today: $AMZN, $SIG, $ADM, $MRK
(link: https://yhoo.it/2iFxwda) On The Hunt For The Next BIG PLAY. Join US #TraderGang ;)
1
2",,,1,2,[],https://twitter.com/RealTraderGang/status/819199390124482565
151,BackToTheFutures,@Back2DaFutures,2017-01-11T14:45:34.000Z,$AFMD Provides Update on NK-Cell Immuno-Oncology Platform https://ca.finance.yahoo.com/news/affimed-provides-nk-cell-immuno-135335689.html?soc_src=social-sh&soc_trk=tw‚Ä¶ $AMGN $CELG $MRK #Immunology #biotech #cancer #tcell #NK,"$AFMD Provides Update on NK-Cell Immuno-Oncology Platform https://ca.finance.yahoo.com/news/affimed-provides-nk-cell-immuno-135335689.html?soc_src=social-sh&soc_trk=tw‚Ä¶ $AMGN $CELG $MRK #Immunology #biotech #cancer #tcell #NK
3",,,,3,[],https://twitter.com/Back2DaFutures/status/819193540211154944
152,Ben Hirschler,@reutersBenHir,2017-01-11T09:53:45.000Z,#Merck steals march on rivals in lung #cancer drug combo race http://reut.rs/2jgkfse $AZN $ROG $MRK $BMY #immunotherapy,"#Merck steals march on rivals in lung #cancer drug combo race http://reut.rs/2jgkfse $AZN $ROG $MRK $BMY #immunotherapy
reuters.com
Merck leapfrogs rivals in lung cancer drug combination race
Merck & Co has pulled ahead of rivals in the race to combine immunotherapy with other drugs as a treatment for lung cancer, potentially giving it a major lift in the battle for the largest cancer...
6
2",,,6,2,['https://pbs.twimg.com/card_img/1489661867526017024/ZUuUrqwR?format=png&name=small'],https://twitter.com/reutersBenHir/status/819120102897545216
153,Joseph Cusick,@thecusickgroup,2017-01-11T13:23:29.000Z,"Early Movers up: $ENPH +19.5%, $RAD +3.4%, $UAL +2.8%, $MRK +1.9%, $DE +1.2%, $DB +1.1%, $GFI +0.9%, $SYK +0.8%, $MX +0.8%, $VRX +0.6%","Early Movers up: $ENPH +19.5%, $RAD +3.4%, $UAL +2.8%, $MRK +1.9%, $DE +1.2%, $DB +1.1%, $GFI +0.9%, $SYK +0.8%, $MX +0.8%, $VRX +0.6%
1",,,,1,['https://pbs.twimg.com/media/C15JXoZUQAEM84z?format=jpg&name=small'],https://twitter.com/thecusickgroup/status/819172883603816448
154,Stockrow,@stockrow1,2017-01-11T14:49:33.000Z,$JNJ return on invested capital of 27% is way above competitors $AMGN $PFE $MRK $BMY #stocks #investing #BigPharma,"$JNJ return on invested capital of 27% is way above competitors $AMGN $PFE $MRK $BMY #stocks #investing #BigPharma
1",,,,1,['https://pbs.twimg.com/media/C15dC2-WEAEouYr?format=jpg&name=small'],https://twitter.com/stockrow1/status/819194543329464320
155,Bruce Japsen,@brucejapsen,2017-01-11T18:25:33.000Z,"Trump Press Conference Snuffs Out Stock Rally, Slams Drug Companies via 
@forbes
 http://forbes.com/sites/steveschaefer/2017/01/11/stocks-take-a-tumble-as-trump-lashes-out-at-pharma-companies-lockheed/#63d5e13070c3‚Ä¶ $ABT $PFE $JNJ $MRK $ABBV $AMGN","Trump Press Conference Snuffs Out Stock Rally, Slams Drug Companies via 
@forbes
 http://forbes.com/sites/steveschaefer/2017/01/11/stocks-take-a-tumble-as-trump-lashes-out-at-pharma-companies-lockheed/#63d5e13070c3‚Ä¶ $ABT $PFE $JNJ $MRK $ABBV $AMGN
forbes.com
Trump Press Conference Snuffs Out Stock Rally, Slams Drug Companies
Trump takes aim at drug prices and torpedoes stocks in Wednesday's press conference.",,,,,[],https://twitter.com/brucejapsen/status/819248901396066306
156,FierceBiotech,@FierceBiotech,2017-01-10T11:13:10.000Z,"Moderna finally unveils pipeline at JPM, with 5 candidates in testing, updates on $MRK and $AZN partnered meds:","Moderna finally unveils pipeline at JPM, with 5 candidates in testing, updates on $MRK and $AZN partnered meds:
fiercebiotech.com
Moderna finally unveils pipeline at JPM, with 5 candidates in testing
Moderna, often accused of being secretive after failing to reveal, publicly at least, its pipeline of meds, finally did so on Monday with its candidates targeting a host of infectious diseases, I-O |...
8
8",,,8,8,[],https://twitter.com/FierceBiotech/status/818777698982133760
157,Dustin Phan,@Dustn_P,2017-01-10T21:29:55.000Z,"$MRK FDA accepts sBLA for #Keytruda + chemo for first-line metastatic non-squamous #NSCLC. PDUFA May 10, 2017. http://bit.ly/2j4ZlPm","$MRK FDA accepts sBLA for #Keytruda + chemo for first-line metastatic non-squamous #NSCLC. PDUFA May 10, 2017. http://bit.ly/2j4ZlPm
4
2",,,4,2,[],https://twitter.com/Dustn_P/status/818932909751070721
158,dough,@semodough,2017-01-12T14:15:20.000Z,$MRK boring stock -but imho needs to be owned here -$70 coming this YR+4%DIV +2 call options BACE/CTEP -MS 30% odds onboth-BACE 5-10$upside,"$MRK boring stock -but imho needs to be owned here -$70 coming this YR+4%DIV +2 call options BACE/CTEP -MS 30% odds onboth-BACE 5-10$upside
1
2
7",,1,2,7,['https://pbs.twimg.com/media/C1-e2IgUUAEZX1L?format=jpg&name=900x900'],https://twitter.com/semodough/status/819548318627987458
159,Lucie Ellis-Taitt,@LucieLEllis,2017-01-11T15:33:35.000Z,Game Changer: #Merck's Stealth #Keytruda-Chemo Filing Stirs #NSCLC Market Dynamics ¬£https://scrip.pharmamedtechbi.com/SC098026/Game-Changer-Mercks-Stealth-KeytrudaChemo-Filing-Stirs-NSCLC-Market-Dynamics‚Ä¶ $MRK #pharma,"Game Changer: #Merck's Stealth #Keytruda-Chemo Filing Stirs #NSCLC Market Dynamics ¬£https://scrip.pharmamedtechbi.com/SC098026/Game-Changer-Mercks-Stealth-KeytrudaChemo-Filing-Stirs-NSCLC-Market-Dynamics‚Ä¶ $MRK #pharma
4
2",,,4,2,[],https://twitter.com/LucieLEllis/status/819205625922064385
160,David Moadel,@davidmoadel,2017-01-12T04:26:48.000Z,$IBB Buy Today‚Äôs Trump Dump in #Biotech #Stocks http://investorplace.com/2017/01/donald-trump-biotech-stocks-xbi-ibb/#.WHcEtVPR-Is‚Ä¶ $XBI #stockmarket #investing #finance $SPY $QQQ $XLV $PFE $MRK $LLY,"$IBB Buy Today‚Äôs Trump Dump in #Biotech #Stocks http://investorplace.com/2017/01/donald-trump-biotech-stocks-xbi-ibb/#.WHcEtVPR-Is‚Ä¶ $XBI #stockmarket #investing #finance $SPY $QQQ $XLV $PFE $MRK $LLY
investorplace.com
Buy Today‚Äôs Trump Dump in Biotech Stocks - XBI IBB
Biotech stocks and ETFs like iShares' IBB and SPDR's XBI were hammered Wednesday on Donald Trump's drug pricing comments. Opportunity knocks.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501434342807117824/uFHbMNmF?format=jpg&name=240x240'],https://twitter.com/davidmoadel/status/819400211390988288
161,FirstWord Pharma,@fwpharma,2017-01-11T00:05:23.000Z,#JPM17 Stealing their thunder? ‚Äì Merck & Co. does it again $MRK $BMY,"#JPM17 Stealing their thunder? ‚Äì Merck & Co. does it again $MRK $BMY
old.firstwordpharma.com
JP Morgan 2017: Stealing their thunder? ‚Äì Merck & Co. does it again
With the race heating up to deliver combination immunotherapies to market for first-line non-small-cell lung cancer, Bristol-Myers Squibb's presence at JPM17 was guaranteed to attract attention. The...
4
5",,,4,5,['https://pbs.twimg.com/card_img/1499018913929068544/DJz24aKa?format=jpg&name=240x240'],https://twitter.com/fwpharma/status/818972035678236672
162,Bio Stocks‚Ñ¢,@BioStocks,2017-01-11T11:46:30.000Z,"$LLY and $MRK Expand Immuno-Oncology Collaboration. To Evaluate Combination of Lartruvo, Keytruda.","$LLY and $MRK Expand Immuno-Oncology Collaboration. To Evaluate Combination of Lartruvo, Keytruda.
4
4",,,4,4,[],https://twitter.com/BioStocks/status/819148478320406528
163,SprinkleBit,@SprinkleBit,2017-01-10T14:01:18.000Z,"Nothing like the smell of some fresh #HighVPI stocks in the morning! 
$PLAY $CCE $GRUB $LULU $MDVN $MRK $MS $KSS

http://ow.ly/6LUR307PI2S","Nothing like the smell of some fresh #HighVPI stocks in the morning! 
$PLAY $CCE $GRUB $LULU $MDVN $MRK $MS $KSS

http://ow.ly/6LUR307PI2S
2",,,,2,[],https://twitter.com/SprinkleBit/status/818820011636703232
164,BioPharma Dive,@BioPharmaDive,2017-01-11T23:19:00.000Z,"$MRK submits Keytruda, chemotherapy combo http://bit.ly/2j7Toks","$MRK submits Keytruda, chemotherapy combo http://bit.ly/2j7Toks
2
2",,,2,2,[],https://twitter.com/BioPharmaDive/status/819322751001341954
165,Headlne,@headlneapp,2017-01-12T03:37:48.000Z,Stocks Rebound in Wake of Trump Volatility https://scutify.com/articles/2017-01-12-stocks-rebound-in-wake-of-trump-volatility-trump-sent-biotechs-reeling-but-nasdaq-notched-another-record‚Ä¶  $SPX $DJIA $COMP $RUT $AXL $RAD $WBA $MRK $SVU $UBT #stocks #trump,"Stocks Rebound in Wake of Trump Volatility https://scutify.com/articles/2017-01-12-stocks-rebound-in-wake-of-trump-volatility-trump-sent-biotechs-reeling-but-nasdaq-notched-another-record‚Ä¶  $SPX $DJIA $COMP $RUT $AXL $RAD $WBA $MRK $SVU $UBT #stocks #trump
1",,,1,,['https://pbs.twimg.com/media/C18M5ixWEAAw-O8?format=jpg&name=small'],https://twitter.com/headlneapp/status/819387881072578560
166,FBN:AM,@FoxBusinessAM,2017-01-11T13:24:09.000Z,"#StockAlert- Stocks to watch today on #WallStreet $MRK $F $KBH #FBNAM 
@SimonettiLauren","#StockAlert- Stocks to watch today on #WallStreet $MRK $F $KBH #FBNAM 
@SimonettiLauren
3",,,,3,['https://pbs.twimg.com/media/C15I513UoAMd5Xk.jpg'],https://twitter.com/FoxBusinessAM/status/819173050352443392
167,Open Outcrier,@OpenOutcrier,2017-01-12T13:59:33.000Z,"$MRK (+1.5% pre) Merck Receives Upgrades To Top Rating Recommendation From 3 Firms - SI

http://ooc.bz/l/8656","$MRK (+1.5% pre) Merck Receives Upgrades To Top Rating Recommendation From 3 Firms - SI

http://ooc.bz/l/8656
1
3
4",,1,3,4,[],https://twitter.com/OpenOutcrier/status/819544345732902912
168,TradeTexasBig,@TradeTexasBig,2017-01-11T18:42:49.000Z,$MRK chart: $MRK chart.,"$MRK chart: $MRK chart.
tradingview.com
$MRK chart for NYSE:MRK by TradeTexasBig
back in the channel
1",,,,1,[],https://twitter.com/TradeTexasBig/status/819253247739248640
169,Michael Santoli,@michaelsantoli,2017-01-11T16:24:51.000Z,"Trump's mention of squeezing drug companies on prices/domestic manufacturing takes a quick 50c off $MRK, which had been dragging up the Dow.","Trump's mention of squeezing drug companies on prices/domestic manufacturing takes a quick 50c off $MRK, which had been dragging up the Dow.
2
2
6",,2,2,6,[],https://twitter.com/michaelsantoli/status/819218525290188801
170,TheTradingNinja,@TradeWithNinja,2017-01-12T17:33:49.000Z,"Replying to 
@TradeWithNinja
 and 
@optioninja","Replying to 
@TradeWithNinja
 and 
@optioninja
$MRk up .40cents lol
2
3",,2,,3,['https://pbs.twimg.com/media/C1_MR3tVQAAm6LH?format=jpg&name=small'],https://twitter.com/TradeWithNinja/status/819598271513563136
171,TheTradingNinja,@TradeWithNinja,2017-01-12T17:41:51.000Z,"Replying to 
@TradeWithNinja
 and 
@optioninja","Replying to 
@TradeWithNinja
 and 
@optioninja
$mrk .55cents
1
5",,1,,5,['https://pbs.twimg.com/media/C1_OHgmUsAAhph3?format=jpg&name=small'],https://twitter.com/TradeWithNinja/status/819600292283027457
172,Jack Allen,@JohnK_Allen,2017-01-12T16:43:41.000Z,FREE: Great insight from #NSCLC analyst @Datamonitor_DP on the market impact of Keytruda+Chemo combo filed earlier this week $MRK $BMY $IBB,"FREE: Great insight from #NSCLC analyst @Datamonitor_DP on the market impact of Keytruda+Chemo combo filed earlier this week $MRK $BMY $IBB
Dustin Phan
@Dustn_P
 ¬∑ 12 Jan 2017
$MRK looks to strengthen Keytruda‚Äôs first-line lead in NSCLC with chemotherapy combination. @Datamonitor_HC http://bit.ly/2jIstNl
2",,,2,,['https://pbs.twimg.com/profile_images/806004442210463744/IIIu5zbJ_mini.jpg'],https://twitter.com/JohnK_Allen/status/819585653906276354
173,Verified Investing,@InvestVerified,2017-01-10T23:08:28.000Z,Nice pop in shares of $MRK on priority review of lung cancer drug application. #VerifiedProTraderChatter https://verifiedinvesting.com/pro-traders/chatter?id=806‚Ä¶,"Nice pop in shares of $MRK on priority review of lung cancer drug application. #VerifiedProTraderChatter https://verifiedinvesting.com/pro-traders/chatter?id=806‚Ä¶
1",,,,1,[],https://twitter.com/InvestVerified/status/818957709844348928
174,"David Settle, CMT",@davidsettle42,2017-01-12T04:43:00.000Z,01/11/17 - View today's Market Forecast here: http://bit.ly/2jl1GTF  Discussed: $SPX $IWM $GLD $TLT $USO $UUP $EEM $XLV $MRK #Investools,"01/11/17 - View today's Market Forecast here: http://bit.ly/2jl1GTF  Discussed: $SPX $IWM $GLD $TLT $USO $UUP $EEM $XLV $MRK #Investools
1
9",,,1,9,[],https://twitter.com/davidsettle42/status/819404287906152449
175,CGCAPITAL,@CGCAP1TAL,2017-01-12T15:25:44.000Z,Piper's analyst Richard Purkiss gives Merck $MRK 'overweight' rating and $72 target  i.e. 14% upside.,"Piper's analyst Richard Purkiss gives Merck $MRK 'overweight' rating and $72 target  i.e. 14% upside.
1",,,1,,[],https://twitter.com/CGCAP1TAL/status/819566034701156352
176,Playbook Trading,@NDX100,2017-01-12T14:27:07.000Z,In Play Longs: $AAOI $MPEL $FNV $ABCO $CENX $MRK $GOLD $JNUG $NEM,"In Play Longs: $AAOI $MPEL $FNV $ABCO $CENX $MRK $GOLD $JNUG $NEM
1",,,,1,[],https://twitter.com/NDX100/status/819551283384352769
177,,@EatSleepNTrade,2017-01-11T14:43:20.000Z,$MRK up 4% don't forget that $MRK is one of $ONVO big customers for their 3D printed human liver / kidney tissues used in drug testing.,"$MRK up 4% don't forget that $MRK is one of $ONVO big customers for their 3D printed human liver / kidney tissues used in drug testing.
1",üôè,,,1,[],https://twitter.com/EatSleepNTrade/status/819192977134338051
178,Pete Stock,@PeteStock11,2017-01-10T17:07:41.000Z,$SGNL we know what merger partnerships can do crackers can show up at any time $OPGN $MRK,"$SGNL we know what merger partnerships can do crackers can show up at any time $OPGN $MRK
TheNvsibleHand[FOREVER ‚ûû‚Çø]
@TheNvsibleHand
 ¬∑ 10 Jan 2017
$OPGN-  Is starting to tick up.  I would expect news  updates Merck Partnership. https://twitter.com/TheNvsibleHand/status/813752657341018113‚Ä¶
1",üîë,,,1,['https://pbs.twimg.com/profile_images/941764872672387072/pftatnxz_mini.jpg'],https://twitter.com/PeteStock11/status/818866918111215618
179,John Carroll,@JohnCendpts,2017-01-11T15:59:59.000Z,"Eli Lilly, Merck add new combo alliance; Gilead really does want to focus on M&A
$LLY $MRK $GILD","Eli Lilly, Merck add new combo alliance; Gilead really does want to focus on M&A
$LLY $MRK $GILD
endpts.com
Eli Lilly, Merck add new combo alliance; Gilead really does want to focus on M&A
‚Ä¢ Eli Lilly is taking its newly approved cancer drug Lartruvo and combining it with Keytruda in an expanded collaboration deal with Merck. This deal is the latest in dozens of pacts Merck inked for...
1
2",,1,2,,['https://pbs.twimg.com/card_img/1500850665232343040/lS4wHh5u?format=png&name=small'],https://twitter.com/JohnCendpts/status/819212268634181634
180,Option Alert,@OptionAlert,2017-01-11T15:16:02.000Z,"Unusually heavy option volume on today's open include $A, $PSX, $LLL, $VRTX, and $MRK.","Unusually heavy option volume on today's open include $A, $PSX, $LLL, $VRTX, and $MRK.
1",,,,1,[],https://twitter.com/OptionAlert/status/819201206425976833
181,Allison Gatlin,@IBD_AGatlin,2017-01-12T22:06:39.000Z,Eli Lilly rebounds on chemo-drug patent win vs. generic Teva $LLY $TEVA $BMY $MRK,"Eli Lilly rebounds on chemo-drug patent win vs. generic Teva $LLY $TEVA $BMY $MRK
investors.com
Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva | Stock News & Stock Market Analysis -...
Lilly stock bounded Thursday after a federal appellate court upheld the patent on chemotherapy Alimta vs. generic drugmaker Teva.
1",,,1,,[],https://twitter.com/IBD_AGatlin/status/819666930655232001
182,George Matlock,@GeorgeMatlock,2017-01-11T15:22:40.000Z,"US stocks open firmer ahead of #Trump speech http://tinyurl.com/hjom6on via 
@proactive_NA
 $MRK $MSM","US stocks open firmer ahead of #Trump speech http://tinyurl.com/hjom6on via 
@proactive_NA
 $MRK $MSM
proactiveinvestors.com
US shares end up as oil investors crowd out depressed pharma post-Trump speech
US shares ended higher on Wednesday, as energy investors shrugged off a jump in US oil stocks, and markets took a sanguine view of...
1",,,,1,[],https://twitter.com/GeorgeMatlock/status/819202876841062400
183,Joanne Fagg,@ByJoFagg,2017-01-11T16:21:02.000Z,"Day two #JPM17 roundup via 
@ByMadeleineA
 and the 
@EPVantage
 gang featuring $MRK $BMY $SNY $JUNO $SRPT $CLVS $VRX http://epvantage.com/Universal/View.aspx?type=Story&id=681540&isEPVantage=yes‚Ä¶","Day two #JPM17 roundup via 
@ByMadeleineA
 and the 
@EPVantage
 gang featuring $MRK $BMY $SNY $JUNO $SRPT $CLVS $VRX http://epvantage.com/Universal/View.aspx?type=Story&id=681540&isEPVantage=yes‚Ä¶
4",,,4,,[],https://twitter.com/ByJoFagg/status/819217567088840706
184,Endpoints News,@endpts,2017-01-12T09:35:00.000Z,"$LLY, $MRK add new combo alliance; $GILD really does want to focus on M&A; plus Pierre Fabry + Piqur deal  http://endpts.com/eli-lilly-merc‚Ä¶ #biotech","$LLY, $MRK add new combo alliance; $GILD really does want to focus on M&A; plus Pierre Fabry + Piqur deal  http://endpts.com/eli-lilly-merc‚Ä¶ #biotech
1
1",,,1,1,[],https://twitter.com/endpts/status/819477772246487041
185,Antonio Costa,@ACInvestorBlog,2017-01-12T12:51:24.000Z,Upgrades $TYPE $TRGP $ENLK $NGL $ETE $HEP $PII $MRK $GLOB $TEL $FAST $HII $CNI $CCJ $ABC $CAFD $RHT $BKD $FLR $VVC $CHH $KN $HII,"Upgrades $TYPE $TRGP $ENLK $NGL $ETE $HEP $PII $MRK $GLOB $TEL $FAST $HII $CNI $CCJ $ABC $CAFD $RHT $BKD $FLR $VVC $CHH $KN $HII
2",,,,2,[],https://twitter.com/ACInvestorBlog/status/819527196654051329
186,M,@bio_clouseau,2017-01-11T16:21:03.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
Did $MRK ever breakdown PD-L1 < 50 ORR? From the 80% for >50 it seems ORR would be pretty similar to C+P arm if not less than
1
1",,1,,1,['https://pbs.twimg.com/media/C15x4IrXAAAeF8_?format=jpg&name=small'],https://twitter.com/bio_clouseau/status/819217568078688256
187,Squawk on the Street,@SquawkStreet,2017-01-12T14:25:56.000Z,Cramer's Mad Dash $MRK,"Cramer's Mad Dash $MRK
1
2
2",,1,2,2,[],https://twitter.com/SquawkStreet/status/819550988260425729
188,FirstWord Pharma,@fwpharma,2017-01-11T11:48:18.000Z,Lilly and Merck Expand Immuno-Oncology Collaboration - PR https://investor.lilly.com/releaseDetail.cfm?ReleaseID=1007544‚Ä¶ $LLY $MRK,"Lilly and Merck Expand Immuno-Oncology Collaboration - PR https://investor.lilly.com/releaseDetail.cfm?ReleaseID=1007544‚Ä¶ $LLY $MRK
1
2",,,1,2,[],https://twitter.com/fwpharma/status/819148928876769280
189,MogulAzam MogulCoin,@MogulAzam,2017-01-11T18:41:28.000Z,"Trump's Comments Are Big Pharma's Nightmare  $AGN $MRK $PFE $GILD $MYL via 
@forbes
 http://forbes.com/sites/matthewherper/2017/01/11/trumps-comments-are-big-pharmas-nightmare/#56b4e9415aaa‚Ä¶","Trump's Comments Are Big Pharma's Nightmare  $AGN $MRK $PFE $GILD $MYL via 
@forbes
 http://forbes.com/sites/matthewherper/2017/01/11/trumps-comments-are-big-pharmas-nightmare/#56b4e9415aaa‚Ä¶",,,,,[],https://twitter.com/MogulAzam/status/819252904393576448
190,Emma Court,@emmarcourt,2017-01-10T00:43:13.000Z,"On cancer combination drugs, $MRK says ""there's not going to be any one magic combination that's going to take over the market"" #JPM17","On cancer combination drugs, $MRK says ""there's not going to be any one magic combination that's going to take over the market"" #JPM17",,,,,[],https://twitter.com/emmarcourt/status/818619167171485696
191,Open Outcrier,@OpenOutcrier,2017-01-11T14:01:52.000Z,"$MRK (+3% pre) Receives FDA Acceptance of Supplemental Biologics License Application for KEYTRUDA¬Æ

http://ooc.bz/l/8624","$MRK (+3% pre) Receives FDA Acceptance of Supplemental Biologics License Application for KEYTRUDA¬Æ

http://ooc.bz/l/8624
1
2",,,1,2,[],https://twitter.com/OpenOutcrier/status/819182543014678528
192,Bruce Japsen,@brucejapsen,2017-01-11T16:50:50.000Z,"#TrumpPressConference Trump goes after 
@PhRMA
 for overseas production of drugs $JNJ $PFE $MRK","#TrumpPressConference Trump goes after 
@PhRMA
 for overseas production of drugs $JNJ $PFE $MRK
1",,,,1,[],https://twitter.com/brucejapsen/status/819225064335966209
193,Dave Mabe,@davemabe,2017-01-11T14:35:32.000Z,"Here's my watchlist for the day: $AKAO, $KRNT, $MRK, $PFGC, $SIG, $TRCO powered by 
@TradeIdeas1
 @TradeIdeas","Here's my watchlist for the day: $AKAO, $KRNT, $MRK, $PFGC, $SIG, $TRCO powered by 
@TradeIdeas1
 @TradeIdeas
1",,,,1,[],https://twitter.com/davemabe/status/819191015747833856
194,Benzinga,@Benzinga,2017-01-12T14:48:35.000Z,8 Biggest Price Target Changes For Thursday http://benzinga.com/z/8899537 $CRM $ESV $FAST $MS $X $MRK $FLR $PII,"8 Biggest Price Target Changes For Thursday http://benzinga.com/z/8899537 $CRM $ESV $FAST $MS $X $MRK $FLR $PII
benzinga.com
8 Biggest Price Target Changes For Thursday
Avondale Partners raised the price target for Fastenal Company (NASDAQ: FAST) from $51 to $54. Fastenal shares closed at $47.43 on Wednesday. BMO Capital boosted the price...
1",,,1,,['https://pbs.twimg.com/card_img/1499875349303205890/mxn4g2w2?format=png&name=240x240'],https://twitter.com/Benzinga/status/819556688026107905
195,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-01-11T01:07:30.000Z,"Replying to 
@AdamSinger
 and 
@Pharmdca","Replying to 
@AdamSinger
 and 
@Pharmdca
yea definitely m&a #1 most important thing from #JPM17 was $MRK phase 3 with epacadostat in NSCLC. If + $INCY $30B+
3",,,,3,[],https://twitter.com/DrPaulyDeSantis/status/818987665211215872
196,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-01-11T16:55:30.000Z,"Replying to 
@techwhitepapers","Replying to 
@techwhitepapers
BINGO - or more: one 4 TandAbs, one 4 AAFs, one 4 TriFlex, an done or even more 4 $AFMD $MRK combination therapies ...
1
1
3",,1,1,3,[],https://twitter.com/dhovekamp42/status/819226238069964801
197,JQ,@jq1234t,2017-01-11T15:52:32.000Z,"Replying to 
@JacobPlieth
 and 
@EPVantage","Replying to 
@JacobPlieth
 and 
@EPVantage
What difference 1 yr makes when almost everyone thought $BMY won NSCLC because $MRK used PD-1 biomarker in 2nd line.
1
1",,1,,1,[],https://twitter.com/jq1234t/status/819210390936678400
198,Cody,@allitrader,2017-01-11T01:05:50.000Z,"Replying to 
@crankijames","Replying to 
@crankijames
Exactly. This is the third time that I could recall that $MRK $BMY traded in dramatically opposite directions. Damn algos haha",,,,,[],https://twitter.com/allitrader/status/818987246560808960
199,G Hawkins,@FilmProfessor9,2017-01-12T16:28:28.000Z,"Replying to 
@NotaBubble
, 
@7wtc
 and 
@yusschr","Replying to 
@NotaBubble
, 
@7wtc
 and 
@yusschr
$MRK has jumped competition on promising treatment for Lung cancer  - http://reut.rs/2jgkfse via 
@Reuters
reuters.com
Merck leapfrogs rivals in lung cancer drug combination race
Merck & Co has pulled ahead of rivals in the race to combine immunotherapy with other drugs as a treatment for lung cancer, potentially giving it a major lift in the battle for the largest cancer...
1",,,1,,['https://pbs.twimg.com/card_img/1501782971220512769/gWB9KIZe?format=png&name=small'],https://twitter.com/FilmProfessor9/status/819581824322195456
200,Jack Allen,@JohnK_Allen,2017-01-10T21:50:15.000Z,"Replying to 
@crankijames
, 
@JacobPlieth
 and 
@bradloncar","Replying to 
@crankijames
, 
@JacobPlieth
 and 
@bradloncar
$MRK filed for approval of Keytruda+chemo combo in NSCLC first line
2
1",,2,,1,[],https://twitter.com/JohnK_Allen/status/818938029364695044
201,Odi Bruckman,@odibro,2017-01-11T11:47:01.000Z,$LLY and $MRK Expand Immuno-Oncology Collaboration http://finance.yahoo.com/news/lilly-merck-expand-immuno-oncology-114500991.html‚Ä¶,"$LLY and $MRK Expand Immuno-Oncology Collaboration http://finance.yahoo.com/news/lilly-merck-expand-immuno-oncology-114500991.html‚Ä¶
1",,,1,,[],https://twitter.com/odibro/status/819148606787747840
202,Seeking Alpha,@SeekingAlpha,2017-01-13T17:09:53.000Z,"Biotech Forum Daily Digest: Trump Dings Biotech, What Now For Conatus Pharmaceuticals? http://seekingalpha.com/article/4036727-biotech-forum-daily-digest-trump-dings-biotech-now-conatus-pharmaceuticals?source=feed_f‚Ä¶ $ABBV $AGN $GILD $MNTA $MRK","Biotech Forum Daily Digest: Trump Dings Biotech, What Now For Conatus Pharmaceuticals? http://seekingalpha.com/article/4036727-biotech-forum-daily-digest-trump-dings-biotech-now-conatus-pharmaceuticals?source=feed_f‚Ä¶ $ABBV $AGN $GILD $MNTA $MRK
1
1",,,1,1,[],https://twitter.com/SeekingAlpha/status/819954633745448960
203,Seeking Alpha,@SeekingAlpha,2017-01-13T12:43:12.000Z,Dissecting The Stockpickers http://seekingalpha.com/article/4036600-dissecting-stockpickers?source=feed_f‚Ä¶ $GOODX $PNEAX $SSHFX $PRFDX $DFLVX $DODGX $SPY $VUVLX $JPM $WPX $XOM $WFC $C $COF $MRK,"Dissecting The Stockpickers http://seekingalpha.com/article/4036600-dissecting-stockpickers?source=feed_f‚Ä¶ $GOODX $PNEAX $SSHFX $PRFDX $DFLVX $DODGX $SPY $VUVLX $JPM $WPX $XOM $WFC $C $COF $MRK
seekingalpha.com
Dissecting The Stockpickers
Barron's cover story is predicting that after over a decade of underperformance active funds which offer a highly differentiated product will thrive.
1",,,1,,['https://pbs.twimg.com/card_img/1501750936657616900/TSYlszR8?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/819887521228148737
204,Ozmosi,@OzmosiHealth,2017-01-13T17:01:56.000Z,"INFOGRAPHIC: $MRK $NVS and $BMY have most to lose from the #patent cliff in 2017 
@DicksonData
 #pharma","INFOGRAPHIC: $MRK $NVS and $BMY have most to lose from the #patent cliff in 2017 
@DicksonData
 #pharma
2
1",,,2,1,['https://pbs.twimg.com/media/C2EOk0mWgAIrxnM?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/819952635465891840
205,Alessandro viva l‚Äô#Ucraina,@pelias01,2017-01-13T15:48:39.000Z,The Strategy Portfolio Approach To Investing http://seekingalpha.com/article/4036476-strategy-portfolio-approach-investing?source=tweet‚Ä¶ $MRK $PFE,"The Strategy Portfolio Approach To Investing http://seekingalpha.com/article/4036476-strategy-portfolio-approach-investing?source=tweet‚Ä¶ $MRK $PFE
seekingalpha.com
The Strategy Portfolio Approach To Investing
Research by Harry Markowitz in the 1950's provides the basis for much of the corpus of modern portfolio theory.",,,,,['https://pbs.twimg.com/card_img/1501750934225006592/9VzpEAfk?format=png&name=240x240'],https://twitter.com/pelias01/status/819934192192593921
206,Seeking Alpha,@SeekingAlpha,2017-01-13T21:12:31.000Z,Sanofi: Key Threats In 2017 And Beyond http://seekingalpha.com/article/4036795-sanofi-key-threats-2017-beyond?source=feed_f‚Ä¶ $AMGN $IPXL $LLY $NVO $ESRX $MRK $MYL $BCNQY $SNY,Sanofi: Key Threats In 2017 And Beyond http://seekingalpha.com/article/4036795-sanofi-key-threats-2017-beyond?source=feed_f‚Ä¶ $AMGN $IPXL $LLY $NVO $ESRX $MRK $MYL $BCNQY $SNY,,,,,[],https://twitter.com/SeekingAlpha/status/820015693542277120
207,Bolt,@__Bolt,2017-01-15T15:34:32.000Z,"$MRK Merck‚Äôs Blockbuster Dreams Look More Realistic by 
@CGrantWSJ
 #keytruda $BMY #opdivio #Immunotherapy","$MRK Merck‚Äôs Blockbuster Dreams Look More Realistic by 
@CGrantWSJ
 #keytruda $BMY #opdivio #Immunotherapy
wsj.com
Merck‚Äôs Blockbuster Dreams Look More Realistic
Merck‚Äôs cancer therapy Keytruda looks set to live up to its lofty expectations after the FDA approved an application to sell the immunotherapy drug in combination with chemotherapy to lung cancer...",,,,,[],https://twitter.com/__Bolt/status/820655414702473216
208,Prudent Biotech,@PrudentBiotech,2017-01-13T05:10:12.000Z,"Biotechnology: Is 2017 A Bonanza Year?
http://buff.ly/2jpSm0S
$pfe $mrk $jnj $snf $agn $gild $amgn $lly $sgen $tsro $exel $incy $bmy $ijr","Biotechnology: Is 2017 A Bonanza Year?
http://buff.ly/2jpSm0S
$pfe $mrk $jnj $snf $agn $gild $amgn $lly $sgen $tsro $exel $incy $bmy $ijr
1",,,,1,[],https://twitter.com/PrudentBiotech/status/819773518866808832
209,Margin Hunt,@MarginHunt,2017-01-13T02:30:25.000Z,Piper Jaffray upgraded Merck & Company $MRK. Fundamentals support #Stocks rating https://finbox.io/MRK?utm_medium=social&utm_campaign=Social-ST-TWTR-FB-SA-HUB&utm_source=st-twtr-fb-sa-hub‚Ä¶,Piper Jaffray upgraded Merck & Company $MRK. Fundamentals support #Stocks rating https://finbox.io/MRK?utm_medium=social&utm_campaign=Social-ST-TWTR-FB-SA-HUB&utm_source=st-twtr-fb-sa-hub‚Ä¶,,,,,['https://pbs.twimg.com/media/C2BHGgGUoAAD6st?format=jpg&name=small'],https://twitter.com/MarginHunt/status/819733311337754624
210,Margin Hunt,@MarginHunt,2017-01-14T03:00:31.000Z,"Bryan, Garnier & Co started Merck & Co $MRK at Buy. Valuation models imply nice #Upside https://finbox.io/MRK?utm_medium=social&utm_campaign=Social-ST-TWTR-FB-SA-HUB&utm_source=st-twtr-fb-sa-hub‚Ä¶","Bryan, Garnier & Co started Merck & Co $MRK at Buy. Valuation models imply nice #Upside https://finbox.io/MRK?utm_medium=social&utm_campaign=Social-ST-TWTR-FB-SA-HUB&utm_source=st-twtr-fb-sa-hub‚Ä¶",,,,,['https://pbs.twimg.com/media/C2GXlBYXUAU3IDb?format=jpg&name=small'],https://twitter.com/MarginHunt/status/820103273277427713
211,MM+M Magazine,@MMMnews,2017-01-13T16:00:03.000Z,"Here are the top 25 #cardiovascular #pharma brands, according to 2015-2016 sales. $MRK $AZN $GILD $AGN $UTHR $ATLN http://bit.ly/2i9sJEl","Here are the top 25 #cardiovascular #pharma brands, according to 2015-2016 sales. $MRK $AZN $GILD $AGN $UTHR $ATLN http://bit.ly/2i9sJEl",,,,,['https://pbs.twimg.com/media/C2D7e-7WQAAHgA1?format=png&name=120x120'],https://twitter.com/MMMnews/status/819937060773470208
212,Allison Gatlin,@IBD_AGatlin,2017-01-13T18:25:18.000Z,"Merck carries Incyte on Keytruda coattails in 4 ""hot"" tumors: Leerink $MRK $INCY $LLY $BMY http://ow.ly/taPG307YTkt","Merck carries Incyte on Keytruda coattails in 4 ""hot"" tumors: Leerink $MRK $INCY $LLY $BMY http://ow.ly/taPG307YTkt
2
1",,,2,1,[],https://twitter.com/IBD_AGatlin/status/819973614879539201
213,John D. Thomason,@thomasonjdt,2017-01-15T14:07:55.000Z,JT's OPTIMUM STOCK INVESTING Daily Blog Update for 01/17/2017 09:00 AM http://optimumstockinvesting.com/DailyBlogHdr.htm‚Ä¶ #dividendstocks $HRZN $GD $PG $CL $MAIN $MRK,"JT's OPTIMUM STOCK INVESTING Daily Blog Update for 01/17/2017 09:00 AM http://optimumstockinvesting.com/DailyBlogHdr.htm‚Ä¶ #dividendstocks $HRZN $GD $PG $CL $MAIN $MRK
1",,,,1,[],https://twitter.com/thomasonjdt/status/820633615117778944
214,ChinaBio¬Æ Group,@ChinaBio,2017-01-14T17:59:03.000Z,"Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy $CCM $VRX $KITE $ABBV $MRK $MRK https://goo.gl/x0Q0pQ","Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy $CCM $VRX $KITE $ABBV $MRK $MRK https://goo.gl/x0Q0pQ
1
1",,,1,1,[],https://twitter.com/ChinaBio/status/820329396561211392
215,Evaluate Pharma,@evaluatepharma,2017-01-13T14:34:55.000Z,"Catch up on all the news from JP Morgan Conference this week http://ow.ly/CFlc307YlF6 
@EPVantage
 #JPM17 #JPMHC35 $MRK $BMY $JUNO $SRPT $VRX","Catch up on all the news from JP Morgan Conference this week http://ow.ly/CFlc307YlF6 
@EPVantage
 #JPM17 #JPMHC35 $MRK $BMY $JUNO $SRPT $VRX
3
2",,,3,2,[],https://twitter.com/evaluatepharma/status/819915633869672448
216,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-01-13T13:32:39.000Z,"$GILD $MRK Gilead Sciences / Merck & Co. Weekly Hep C Tracker: Harvoni TRx down, NRx flat Scripts for the (cont) http://tl.gd/n_1sphckt","$GILD $MRK Gilead Sciences / Merck & Co. Weekly Hep C Tracker: Harvoni TRx down, NRx flat Scripts for the (cont) http://tl.gd/n_1sphckt
3
1",üÖ± üÖæ,,3,1,[],https://twitter.com/_B_I_O_T_E_C_H_/status/819899966432878592
217,Zenect,@zenect,2017-01-15T14:36:30.000Z,#Dividend stocks balance returns with safety‚Ä¶ http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  #workingfromhome,"#Dividend stocks balance returns with safety‚Ä¶ http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  #workingfromhome
1",,,,1,[],https://twitter.com/zenect/status/820640808739241984
218,Bret Jensen,@bret_jensen,2017-01-13T20:18:50.000Z,"Biotech Forum Daily Digest: Trump Dings Biotech, What Now For Conatus Pharmaceuticals? http://seekingalpha.com/article/4036727-biotech-forum-daily-digest-trump-dings-biotech-now-conatus-pharmaceuticals?source=tweet‚Ä¶ $ABBV $AGN $GILD $MNTA $MRK","Biotech Forum Daily Digest: Trump Dings Biotech, What Now For Conatus Pharmaceuticals? http://seekingalpha.com/article/4036727-biotech-forum-daily-digest-trump-dings-biotech-now-conatus-pharmaceuticals?source=tweet‚Ä¶ $ABBV $AGN $GILD $MNTA $MRK
2",,,,2,[],https://twitter.com/bret_jensen/status/820002186583244800
219,Quantcha Trade Ideas,@QuantchaIdeas,2017-01-13T15:10:22.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/01/13/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-2/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/01/13/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-2/‚Ä¶,,,,,['https://pbs.twimg.com/media/C2D1CYxUkAEqPKp?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/819924555615436800
220,Helen Ong,@Lin_ling_88,2017-01-13T10:18:57.000Z,$MRK: News So Good Three Analysts Had to Upgrade It - Barron's,"$MRK: News So Good Three Analysts Had to Upgrade It - Barron's
barrons.com
Merck: News So Good Three Analysts Had to Upgrade It
1",,,,1,['https://pbs.twimg.com/card_img/1500293513501683714/pxGCCUK0?format=jpg&name=360x360'],https://twitter.com/Lin_ling_88/status/819851217505550337
221,markcarson16,@markcarson161,2017-01-15T13:30:39.000Z,"$KTOV Financials Updated Sunday, January 15, 2017 08:15:20 AM $MRK $BAK $EWW $JNK http://dlvr.it/N6fwYR","$KTOV Financials Updated Sunday, January 15, 2017 08:15:20 AM $MRK $BAK $EWW $JNK http://dlvr.it/N6fwYR",,,,,[],https://twitter.com/markcarson161/status/820624236146368514
222,markcarson16,@markcarson161,2017-01-15T13:30:40.000Z,"$WAL Filings Updated Sunday, January 15, 2017 08:15:20 AM $LQD $GRPN $XLF $MRK http://dlvr.it/N6fwZN","$WAL Filings Updated Sunday, January 15, 2017 08:15:20 AM $LQD $GRPN $XLF $MRK http://dlvr.it/N6fwZN",,,,,[],https://twitter.com/markcarson161/status/820624242949562368
223,TheTradingNinja,@TradeWithNinja,2017-01-13T16:56:33.000Z,"Replying to 
@TradeWithNinja
 and 
@optioninja","Replying to 
@TradeWithNinja
 and 
@optioninja
$MRK needs to reclaim $63 into close and hold
2",,,,2,['https://pbs.twimg.com/media/C2ENVm5XcAQyECr?format=jpg&name=900x900'],https://twitter.com/TradeWithNinja/status/819951278126153733
224,Prudent Biotech,@PrudentBiotech,2017-01-13T16:29:03.000Z,"Biotechnology: Is 2017 A Bonanza Year?
http://buff.ly/2ijw83v
$pfe $mrk $jnj $snf $agn $gild $amgn $lly $sgen $tsro $exel $incy $bmy","Biotechnology: Is 2017 A Bonanza Year?
http://buff.ly/2ijw83v
$pfe $mrk $jnj $snf $agn $gild $amgn $lly $sgen $tsro $exel $incy $bmy
prudentbiotech.com
Biotechnology: Is 2017 A Bonanza Year? ‚Ä¢ Prudent Biotech
Biotechnology was one of the worst performing sectors in 2016. Political uncertainty still impairs investor confidence. But things are changing...Read more",,,,,[],https://twitter.com/PrudentBiotech/status/819944358308880384
225,Heath Care News,@hc_equipment,2017-01-13T23:12:15.000Z,#Merck KGaA Licenses 4 Oncology R&D Programs from Vertex. Read more: http://owler.us/ab44ht $MRK,#Merck KGaA Licenses 4 Oncology R&D Programs from Vertex. Read more: http://owler.us/ab44ht $MRK,,,,,[],https://twitter.com/hc_equipment/status/820045826852433920
226,Pharmaceutical News,@pharma_sector,2017-01-15T16:42:50.000Z,#Merck's Keytruda combo could edge out the competition. Read more: http://owler.us/ab5Bq7 $MRK,#Merck's Keytruda combo could edge out the competition. Read more: http://owler.us/ab5Bq7 $MRK,,,,,[],https://twitter.com/pharma_sector/status/820672603991875584
227,Pharmaceutical News,@pharma_sector,2017-01-15T16:42:13.000Z,Here's What #Merck's Keytruda News Means For Bristol-Myers. Read more: http://owler.us/ab5Bq4 $MRK,Here's What #Merck's Keytruda News Means For Bristol-Myers. Read more: http://owler.us/ab5Bq4 $MRK,,,,,[],https://twitter.com/pharma_sector/status/820672448542580736
228,Heath Care News,@hc_equipment,2017-01-14T17:02:23.000Z,Vertex Pharmaceuticals Incorporated : #Merck expands oncology portfolio with four Vertex can... Read more: http://owler.us/ab5nG6 $MRK,Vertex Pharmaceuticals Incorporated : #Merck expands oncology portfolio with four Vertex can... Read more: http://owler.us/ab5nG6 $MRK,,,,,[],https://twitter.com/hc_equipment/status/820315135264768000
229,Pharmaceutical News,@pharma_sector,2017-01-15T16:41:36.000Z,#Merck's Leadership Position In Immuno Oncology Is Improving. Read more: http://owler.us/ab5BqQ $MRK,#Merck's Leadership Position In Immuno Oncology Is Improving. Read more: http://owler.us/ab5BqQ $MRK,,,,,[],https://twitter.com/pharma_sector/status/820672293114253312
230,Tuan Pham,@15minofPham,2017-01-15T02:57:11.000Z,"Daily RSI crossed above 60 & # of days it had been below: $FLSR 56, $MRK 41, $FEYE 39.","Daily RSI crossed above 60 & # of days it had been below: $FLSR 56, $MRK 41, $FEYE 39.
1",,,,1,[],https://twitter.com/15minofPham/status/820464820029767681
231,The Biotech Forum,@thebiotechforum,2017-01-13T19:47:26.000Z,"Biotech Forum Daily Digest: Trump Dings Biotech, What Now For Conatus Pharmaceuticals? http://seekingalpha.com/article/4036727-biotech-forum-daily-digest-trump-dings-biotech-now-conatus-pharmaceuticals?source=tweet‚Ä¶ $ABBV $AGN $GILD $MNTA $MRK","Biotech Forum Daily Digest: Trump Dings Biotech, What Now For Conatus Pharmaceuticals? http://seekingalpha.com/article/4036727-biotech-forum-daily-digest-trump-dings-biotech-now-conatus-pharmaceuticals?source=tweet‚Ä¶ $ABBV $AGN $GILD $MNTA $MRK
seekingalpha.com
Biotech Forum Daily Digest: Trump Dings Biotech, What Now For Conatus Pharmaceuticals? (NASDAQ:HSTO)
Biotech got Trumped on Wednesday but has started to recover after an over three percent loss that day.
1",,,,1,[],https://twitter.com/thebiotechforum/status/819994281846964224
232,cowenresearch,@CowenResearch,2017-01-13T12:36:08.000Z,2/ Scala's #Pharma Pulse covers $BMY $LLY $PFE $NVS $MRK $SNY $GSK $ABBV $RHHBY $AZN $ZTS $NVET,"2/ Scala's #Pharma Pulse covers $BMY $LLY $PFE $NVS $MRK $SNY $GSK $ABBV $RHHBY $AZN $ZTS $NVET
2",,,,2,[],https://twitter.com/CowenResearch/status/819885742663012354
233,Cedric Stocks,@bigbluecup721,2017-01-15T18:37:07.000Z,"$FB Stock Price Updated Sunday, January 15, 2017 1:15:20 PM $ABX $XLF $FB $MRK http://dlvr.it/N6lPKC","$FB Stock Price Updated Sunday, January 15, 2017 1:15:20 PM $ABX $XLF $FB $MRK http://dlvr.it/N6lPKC",,,,,[],https://twitter.com/bigbluecup721/status/820701363885600769
234,Cedric Stocks,@bigbluecup721,2017-01-15T11:17:08.000Z,"$PCRX Recent News Updated Sunday, January 15, 2017 05:15:20 AM $CELG $MRK $TRCH $XIV http://dlvr.it/N6d2RL","$PCRX Recent News Updated Sunday, January 15, 2017 05:15:20 AM $CELG $MRK $TRCH $XIV http://dlvr.it/N6d2RL",,,,,[],https://twitter.com/bigbluecup721/status/820590638236172288
235,leahanne,@leahanneta,2017-01-13T16:14:11.000Z,"10:45 ET Volume Leader #77 - MRK 1,973,328 Merck & Company $MRK 62.37 +0.16 +0.26% High today of 62.50 day low","10:45 ET Volume Leader #77 - MRK 1,973,328 Merck & Company $MRK 62.37 +0.16 +0.26% High today of 62.50 day low
investorshangout.com
10:45 ET Volume Leader #77 - MRK - Most Active Stocks #4289195 - Investors Hangout
Most Active Stocks: 10:45 ET Volume Leader #77 - MRK 1,973,328 Merck Company $MRK 62.37 +0.16 +0.26% High today of 62. - #4289195",,,,,['https://pbs.twimg.com/card_img/1499224644112498691/uNNWn6ac?format=png&name=240x240'],https://twitter.com/leahanneta/status/819940616410894336
236,Cedric Stocks,@bigbluecup721,2017-01-15T18:37:07.000Z,"$MUX Stock Message Board Updated Sunday, January 15, 2017 1:15:20 PM $GS $TRTC $DJP $MRK http://dlvr.it/N6lPJL","$MUX Stock Message Board Updated Sunday, January 15, 2017 1:15:20 PM $GS $TRTC $DJP $MRK http://dlvr.it/N6lPJL",,,,,[],https://twitter.com/bigbluecup721/status/820701361838772225
237,Slingshot Catalysts,@SlingshotCtlyst,2017-01-13T20:07:00.000Z,$VRTX and Merck KgaA $MKGAY $MRK Announce Collaboration and License Agreement Covering Four Oncology R&D Programs,"$VRTX and Merck KgaA $MKGAY $MRK Announce Collaboration and License Agreement Covering Four Oncology R&D Programs
slingshotinsights.com
Strategic Initiative
Vertex (VRTX) and Merck KgaA (MKGAY) Announce Collaboration and License Agreement Covering Four Oncology R&D Programs",,,,,[],https://twitter.com/SlingshotCtlyst/status/819999208090451969
238,Slingshot Catalysts,@SlingshotCtlyst,2017-01-13T17:00:03.000Z,"$LLY and $MRK Expand Existing Oncology Collaboration, Agree to Evaluating Lartruvo/Keytruda in Soft Tissue Sarcoma","$LLY and $MRK Expand Existing Oncology Collaboration, Agree to Evaluating Lartruvo/Keytruda in Soft Tissue Sarcoma
slingshotinsights.com
Strategic Initiative
Lilly (LLY) and Merck (MRK) Expand Existing Oncology Collaboration, Agree to Evaluating Lartruvo + Keytruda in Advanced/Metastatic Soft Tissue Sarcoma",,,,,[],https://twitter.com/SlingshotCtlyst/status/819952159705812993
239,Daily Political,@dailypoliticaln,2017-01-15T11:02:30.000Z,"TIAA CREF Trust Co. FSB MO Sells 2,886 Shares of Merck & Company, Inc. $MRK http://dailypolitical.com/?p=885996","TIAA CREF Trust Co. FSB MO Sells 2,886 Shares of Merck & Company, Inc. $MRK http://dailypolitical.com/?p=885996",,,,,[],https://twitter.com/dailypoliticaln/status/820586953540272133
240,FirstToMarkets,@firsttomarkets,2017-01-13T00:30:46.000Z,Daily Most Covered Stock: 3 reports on $MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,Daily Most Covered Stock: 3 reports on $MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,,,,,[],https://twitter.com/firsttomarkets/status/819703196595593216
241,Vetr,@VetrRatings,2017-01-13T15:40:46.000Z,"Vetr users have upgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $58.15 http://bit.ly/1GhW0TK","Vetr users have upgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $58.15 http://bit.ly/1GhW0TK",,,,,[],https://twitter.com/VetrRatings/status/819932207234084865
242,Hottest Stocks Now,@HottestStockNow,2017-01-13T02:33:34.000Z,$MRK and $LLY To Test New Combo For Soft Tissue Sarcoma,"$MRK and $LLY To Test New Combo For Soft Tissue Sarcoma
crweworld.com
Merck, Lilly to test new combo for soft tissue sarcoma
Merck & Co and Eli Lilly have decided to expand their existing oncology collaboration with another immunotherapy combination trial. Source: PharmaTimes",,,,,['https://pbs.twimg.com/card_img/1500250131861540870/E2xo1-g1?format=jpg&name=240x240'],https://twitter.com/HottestStockNow/status/819734100017721344
243,Fractaurean,@Fractaurean,2017-01-13T15:24:56.000Z,The Strategy Portfolio Approach To Investing http://seekingalpha.com/article/4036476-strategy-portfolio-approach-investing?source=tweet‚Ä¶ $MRK $PFE,"The Strategy Portfolio Approach To Investing http://seekingalpha.com/article/4036476-strategy-portfolio-approach-investing?source=tweet‚Ä¶ $MRK $PFE
seekingalpha.com
The Strategy Portfolio Approach To Investing
Research by Harry Markowitz in the 1950's provides the basis for much of the corpus of modern portfolio theory.",,,,,['https://pbs.twimg.com/card_img/1501750934225006592/9VzpEAfk?format=png&name=240x240'],https://twitter.com/Fractaurean/status/819928221277896704
244,MarketBeat,@MarketBeatCom,2017-01-13T05:14:38.000Z,Merck  & Company upgraded by Vetr Inc. to sell. $58.15 PT. http://ift.tt/2jdBVqC $MRK #MRK,Merck  & Company upgraded by Vetr Inc. to sell. $58.15 PT. http://ift.tt/2jdBVqC $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/819774635214409732
245,MarketBeat,@MarketBeatCom,2017-01-13T15:10:05.000Z,"Merck  & Company initiated by Bryan, Garnier  & Co at buy. http://ift.tt/2iskqSR $MRK #MRK","Merck  & Company initiated by Bryan, Garnier  & Co at buy. http://ift.tt/2iskqSR $MRK #MRK",,,,,[],https://twitter.com/MarketBeatCom/status/819924485918879745
246,Watchlist News,@WatchlistN,2017-01-14T14:54:16.000Z,"Cambridge Advisors Inc. Maintains Position in Merck & Company, Inc. $MRK http://zpr.io/PzEat","Cambridge Advisors Inc. Maintains Position in Merck & Company, Inc. $MRK http://zpr.io/PzEat",,,,,[],https://twitter.com/WatchlistN/status/820282894476341248
247,Ticker Report,@TickerReport,2017-01-15T15:36:23.000Z,"Telos Capital Management Inc. Buys 1,270 Shares of Merck & Company, Inc. $MRK http://zpr.io/Pz3yg","Telos Capital Management Inc. Buys 1,270 Shares of Merck & Company, Inc. $MRK http://zpr.io/Pz3yg",,,,,[],https://twitter.com/TickerReport/status/820655881423622146
248,max pain,@optioncharts,2017-01-13T02:59:17.000Z,$BMY $ANTM $MRK options have the largest change in price. Free options screener. http://bit.ly/1sMwTTY,$BMY $ANTM $MRK options have the largest change in price. Free options screener. http://bit.ly/1sMwTTY,,,,,[],https://twitter.com/optioncharts/status/819740574525759488
249,Ticker Report,@TickerReport,2017-01-14T15:55:18.000Z,"Hourglass Capital LLC Sells 2,800 Shares of Merck & Company, Inc. $MRK http://ift.tt/2juQuUq","Hourglass Capital LLC Sells 2,800 Shares of Merck & Company, Inc. $MRK http://ift.tt/2juQuUq",,,,,[],https://twitter.com/TickerReport/status/820298254227218432
250,The Fly,@theflynews,2017-01-13T21:57:03.000Z,On The Fly: Stocks end week mixed as banks kick off earnings season $FCAU $JPM $WFC $BAC $MRK $AAPL $AMZN $BABA‚Ä¶ http://dlvr.it/N64lnp,"On The Fly: Stocks end week mixed as banks kick off earnings season $FCAU $JPM $WFC $BAC $MRK $AAPL $AMZN $BABA‚Ä¶ http://dlvr.it/N64lnp
2
3",,,2,3,[],https://twitter.com/theflynews/status/820026902035329025
251,Crypto Trader Pro,@CryptoTraderPro,2017-01-15T02:18:10.000Z,MRK @ daily @ BreakedUp m\u2026 $MRK http://dlvr.it/N6VkBL powered by http://bit.do/TradOTO,"MRK @ daily @ BreakedUp m\u2026 $MRK http://dlvr.it/N6VkBL powered by http://bit.do/TradOTO
tradingview.com
MRK @ daily @ BreakedUp mostly (30 dow shares) while last week for NYSE:MRK by 4XSetUps
This is only a trading capability - no recommendation !!! Buying/Selling or even only watching is always your own responsibility ... .zip (with PDF`s) @ my Google Drive Break Downs (Dow Jones Index...",,,,,['https://pbs.twimg.com/card_img/1500891527865769989/fcIAnQvc?format=jpg&name=small'],https://twitter.com/CryptoTraderPro/status/820455002833465345
252,Daily Political,@dailypoliticaln,2017-01-15T12:41:37.000Z,"NJ State Employees Deferred Compensation Plan Has $5,820,000 Stake in Merck & Company, Inc. $MRK http://dailypolitical.com/?p=886096","NJ State Employees Deferred Compensation Plan Has $5,820,000 Stake in Merck & Company, Inc. $MRK http://dailypolitical.com/?p=886096",,,,,[],https://twitter.com/dailypoliticaln/status/820611899020767232
253,StockNews.com,@stocknewsdotcom,2017-01-15T22:04:02.000Z,$MRK Large cap pharma investors should take notice of which stocks are leading out of the gate so far https://stocknews.com/news/mrk-large-cap-pharma-investors-should-take-notice-of-which-stocks/‚Ä¶,$MRK Large cap pharma investors should take notice of which stocks are leading out of the gate so far https://stocknews.com/news/mrk-large-cap-pharma-investors-should-take-notice-of-which-stocks/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/820753435066765312
254,TalkMarkets,@TalkMarkets,2017-01-13T08:09:06.000Z,Analysts See Merck Rally Continuing After Lung Cancer Drug News $MRK Also $BMY $AZN $RHHBY https://goo.gl/Xv1rtd,Analysts See Merck Rally Continuing After Lung Cancer Drug News $MRK Also $BMY $AZN $RHHBY https://goo.gl/Xv1rtd,,,,,[],https://twitter.com/TalkMarkets/status/819818539997609984
255,dough,@semodough,2017-01-14T17:21:08.000Z,"Thoughts $MRK BACE -most analysts giving it 25-30% - free call option $MRK thoughts on compound 
@AF_biotech
 @TheBio_Hunter
 NEURO guys","Thoughts $MRK BACE -most analysts giving it 25-30% - free call option $MRK thoughts on compound 
@AF_biotech
 @TheBio_Hunter
 NEURO guys
1",,,1,,"['https://pbs.twimg.com/media/C2JcjEBVEAAs5O5?format=jpg&name=small', 'https://pbs.twimg.com/media/C2JciHDUcAAgf9S?format=jpg&name=small']",https://twitter.com/semodough/status/820319854708322308
256,Endpoints News,@endpts,2017-01-15T21:33:01.000Z," Trump nukes #biopharma & the fallout is radioactive http://endpts.com/trump-nukes-bi‚Ä¶ #JPM17 #MandA $AGN $GILD $MRK #drugpricing by 
@JohnCendpts"," Trump nukes #biopharma & the fallout is radioactive http://endpts.com/trump-nukes-bi‚Ä¶ #JPM17 #MandA $AGN $GILD $MRK #drugpricing by 
@JohnCendpts
endpts.com
Trump nukes biopharma, and the fallout is radioactive
Endpoints assesses the big biopharma stories of the week, with a little added commentary on what they mean for the industry. The cheap shot heard around the biopharma world Make no mistake, Donald...
1
3",üëç üëé,,1,3,[],https://twitter.com/endpts/status/820745628498165761
257,Allison Gatlin,@IBD_AGatlin,2017-01-13T15:07:33.000Z,"Trump's ""disastrous"" pharma view doesn't rattle JPMorgan drug conference $ALDR $LLY $MRK $TEVA $CELG $AMGN $BIIB http://ow.ly/kPl3307YqLW","Trump's ""disastrous"" pharma view doesn't rattle JPMorgan drug conference $ALDR $LLY $MRK $TEVA $CELG $AMGN $BIIB http://ow.ly/kPl3307YqLW",,,,,[],https://twitter.com/IBD_AGatlin/status/819923848833495045
258,TalkMarkets,@TalkMarkets,2017-01-15T06:39:03.000Z,"Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy $CCM $VRX $KITE $ABBV $MRK $MRK https://goo.gl/x0Q0pQ","Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy $CCM $VRX $KITE $ABBV $MRK $MRK https://goo.gl/x0Q0pQ",,,,,[],https://twitter.com/TalkMarkets/status/820520654508326916
259,Harbor Consulting,@seqidno,2017-01-13T16:59:16.000Z,"These 3 ugly patent battles could rock biopharma's 2017 $AMGN $SNY $REGN $MRK $GILD $NVS via 
@FortuneMagazine
 http://for.tn/2jcl4l3","These 3 ugly patent battles could rock biopharma's 2017 $AMGN $SNY $REGN $MRK $GILD $NVS via 
@FortuneMagazine
 http://for.tn/2jcl4l3",,,,,[],https://twitter.com/seqidno/status/819951962481393664
260,TradingView Ideas,@TradingViewAlt,2017-01-15T02:13:02.000Z,MRK @ daily @ BreakedUp m\u2026 $MRK http://tradingview.com/chart/MRK/5LtImpha-MRK-daily-BreakedUp-mostly-30-dow-shares-while-last-week/‚Ä¶,MRK @ daily @ BreakedUp m\u2026 $MRK http://tradingview.com/chart/MRK/5LtImpha-MRK-daily-BreakedUp-mostly-30-dow-shares-while-last-week/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/820453708823568384
261,TalkMarkets Recap,@MarketsRecap,2017-01-13T02:09:05.000Z,Analysts See Merck Rally Continuing After Lung Cancer Drug News $MRK Also $BMY $AZN $RHHBY https://goo.gl/Xv1rtd,Analysts See Merck Rally Continuing After Lung Cancer Drug News $MRK Also $BMY $AZN $RHHBY https://goo.gl/Xv1rtd,,,,,[],https://twitter.com/MarketsRecap/status/819727940120440833
262,TalkMarkets Recap,@MarketsRecap,2017-01-15T00:39:10.000Z,"Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy $CCM $VRX $KITE $ABBV $MRK $MRK https://goo.gl/x0Q0pQ","Week in Review: China's Sanpower Pays $820 for Provenge, a Prostate Immunotherapy $CCM $VRX $KITE $ABBV $MRK $MRK https://goo.gl/x0Q0pQ",,,,,[],https://twitter.com/MarketsRecap/status/820430088579772416
263,Muathe,@muathe,2017-01-14T16:22:14.000Z,"[VIDEO] World Market Technical Analysis Jan 14, 2017 $VALE $GGB $ABEV $PBR $NOK $BMY $LYG $MRK $BCS $BBD $CX $BABA","[VIDEO] World Market Technical Analysis Jan 14, 2017 $VALE $GGB $ABEV $PBR $NOK $BMY $LYG $MRK $BCS $BBD $CX $BABA
youtube.com
[ Weekend ] World Market Technical Analysis Jan 14-15, 2017
Ôº¨Ôº©Ôº´Ôº• | Ôº£ÔºØÔº≠Ôº≠Ôº•ÔºÆÔº¥ | Ôº≥Ôº®Ôº°Ôº≤Ôº• | Ôº≥ÔºµÔº¢Ôº≥Ôº£Ôº≤Ôº©Ôº¢Ôº•My Website; http://www.muathe.com/Original Muathe.com Concepts!LOG ON TO WWW.MUATHE.COM FOR THE EXCLUSIVE PART TWO VIDEO OF...",,,,,[],https://twitter.com/muathe/status/820305029533929472
264,AZ Value,@AZ_Value,2017-01-14T00:19:55.000Z,"Replying to 
@AZ_Value","Replying to 
@AZ_Value
M. Pearson rose to fame at VRX by telling the same gullible people that $JNJ, $PFE, $MRK etc. were run by old school idiots...
4
1
4",,4,1,4,[],https://twitter.com/AZ_Value/status/820062856985001984
265,Bursatil Biotech,@BursatilBiotech,2017-01-14T11:31:45.000Z,"Replying to 
@BursatilBiotech","Replying to 
@BursatilBiotech
Most significal catalyst for 2017:
PCSK9 outcomes
Checkmate 227/MYSTIC
$BIIB data
$MRK BACE data
APiHINITY data
1",,1,,,[],https://twitter.com/BursatilBiotech/status/820231927311568896
266,JQ,@jq1234t,2017-01-15T22:15:11.000Z,"Replying to 
@ClawBongo
, 
@danwardbio
 and 
@SeattleTechie40","Replying to 
@ClawBongo
, 
@danwardbio
 and 
@SeattleTechie40
$MRK $CBST acquisition would be fine if it weren't for Cubicin patent.
2",,2,,,[],https://twitter.com/jq1234t/status/820756241655984129
267,Breaking News,@MarketCurrents,2017-01-17T14:44:58.000Z,Agenus to collaborate with NCI on combination therapy for brain cancer http://seekingalpha.com/news/3235452-agenus-collaborate-nci-combination-therapy-brain-cancer?source=feed_f‚Ä¶ $AGEN $MRK,"Agenus to collaborate with NCI on combination therapy for brain cancer http://seekingalpha.com/news/3235452-agenus-collaborate-nci-combination-therapy-brain-cancer?source=feed_f‚Ä¶ $AGEN $MRK
2
2",,,2,2,[],https://twitter.com/MarketCurrents/status/821367717299007489
268,Marty Wolf,@martin_wolf_,2017-01-17T20:36:47.000Z,No #slump‚Äî $CSCO CEO sees #TrumpBump for US biz $IBM $CVX $MSFT $AAPL $WMT $DIS $GS $JNJ $JPM $MRK $CAT $BA #DJIA,"No #slump‚Äî $CSCO CEO sees #TrumpBump for US biz $IBM $CVX $MSFT $AAPL $WMT $DIS $GS $JNJ $JPM $MRK $CAT $BA #DJIA
wsj.com
Cisco‚Äôs Chambers Sees Trump Presidency Good for U.S. Business
U.S. business leaders are optimistic that President-elect Donald Trump will boost economic and job growth, said John Chambers, executive chairman of Cisco Systems.
1",,,1,,['https://pbs.twimg.com/card_img/1501925455187881985/vg8RuIdb?format=jpg&name=small'],https://twitter.com/martin_wolf_/status/821456253821980673
269,Helen Ong,@Lin_ling_88,2017-01-18T15:00:56.000Z,Why $BMYMay Be a Merger Target Soon $PFE $MRK $JNJ $NVS #canAffordIt  https://thestreet.com/story/13955786/2/why-bristol-myers-squibb-may-be-a-merger-target-soon.html‚Ä¶,"Why $BMYMay Be a Merger Target Soon $PFE $MRK $JNJ $NVS #canAffordIt  https://thestreet.com/story/13955786/2/why-bristol-myers-squibb-may-be-a-merger-target-soon.html‚Ä¶
1",,,,1,[],https://twitter.com/Lin_ling_88/status/821734123358289923
270,Seeking Alpha,@SeekingAlpha,2017-01-17T21:59:41.000Z,AnaptysBio Sets Terms For $60 Million IPO http://seekingalpha.com/article/4037424-anaptysbio-sets-terms-60-million-ipo?source=feed_f‚Ä¶ $ABBV $AMGN $AZN $BLUE $CELG $GOLD $GSK $JNJ $LLY $MRK $PFE $RHHBY $TSRO,"AnaptysBio Sets Terms For $60 Million IPO http://seekingalpha.com/article/4037424-anaptysbio-sets-terms-60-million-ipo?source=feed_f‚Ä¶ $ABBV $AMGN $AZN $BLUE $CELG $GOLD $GSK $JNJ $LLY $MRK $PFE $RHHBY $TSRO
1
1",,,1,1,[],https://twitter.com/SeekingAlpha/status/821477117296656385
271,Seeking Alpha,@SeekingAlpha,2017-01-17T22:15:53.000Z,Even A $100M Series A Can't Save The Medtech Venture Climate http://seekingalpha.com/article/4037433-even-100m-series-save-medtech-venture-climate?source=feed_f‚Ä¶ $JNJ $GE $QGEN $FMS $PFE $RHHBF $RHHBY $NVS $MRK $IBB,"Even A $100M Series A Can't Save The Medtech Venture Climate http://seekingalpha.com/article/4037433-even-100m-series-save-medtech-venture-climate?source=feed_f‚Ä¶ $JNJ $GE $QGEN $FMS $PFE $RHHBF $RHHBY $NVS $MRK $IBB
2",,,2,,[],https://twitter.com/SeekingAlpha/status/821481194856607744
272,Tuan Pham,@15minofPham,2017-01-18T07:15:38.000Z,Tues highest Call & Put ratio vs OI. CALL - $AMZN $BAC $AKS #CELG $GILD $CL $BX $DF $AAWW. PUT - $TSLA $BP $AMZN $XBI $GM $GOOGL $MRK $ZNGA,"Tues highest Call & Put ratio vs OI. CALL - $AMZN $BAC $AKS #CELG $GILD $CL $BX $DF $AAWW. PUT - $TSLA $BP $AMZN $XBI $GM $GOOGL $MRK $ZNGA
1
2",,,1,2,['https://pbs.twimg.com/media/C2b3pPKWEAEjt1x?format=jpg&name=small'],https://twitter.com/15minofPham/status/821617026137522177
273,Breaking News,@MarketCurrents,2017-01-17T12:59:56.000Z,BioLineRx initiates mid-stage study of BL-8040/KEYTRUDA combo for pancreatic cancer; shares... http://seekingalpha.com/news/3235402-biolinerx-initiates-mid-stage-study-blminus-8040-keytruda-combo-pancreatic-cancer-shares-11?source=feed_f‚Ä¶ #premarket $BLRX $MRK,"BioLineRx initiates mid-stage study of BL-8040/KEYTRUDA combo for pancreatic cancer; shares... http://seekingalpha.com/news/3235402-biolinerx-initiates-mid-stage-study-blminus-8040-keytruda-combo-pancreatic-cancer-shares-11?source=feed_f‚Ä¶ #premarket $BLRX $MRK
seekingalpha.com
BioLineRx initiates mid-stage study of BL-8040/KEYTRUDA combo for pancreatic cancer; shares up 11%...
BioLineRx (NASDAQ:BLRX) initiates a second Phase 2a trial investigating BL-8040, in combination with Merck's (NYSE:MRK) KEYTRUDA (pembrolizumab), in patients with metastatic...",,,,,['https://pbs.twimg.com/card_img/1492196815726252032/umytDCAr?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/821341281989193729
274,John Carroll,@JohnCendpts,2017-01-18T01:57:20.000Z,Isn't it about time for $MRK's anacetrapib to fail?,"Isn't it about time for $MRK's anacetrapib to fail?
2
2
5",,2,2,5,[],https://twitter.com/JohnCendpts/status/821536921046450176
275,dough,@semodough,2017-01-17T13:29:47.000Z,JP $INCY best positive surprise of the week with the announcement that IDO/PD-1 was aggressively moving forward with $MRK,"JP $INCY best positive surprise of the week with the announcement that IDO/PD-1 was aggressively moving forward with $MRK
1
1
2",,1,1,2,[],https://twitter.com/semodough/status/821348797288681473
276,Marty Chilberg,@mchilberg,2017-01-17T15:49:18.000Z,$INCY retracing a bit from recent move on addl $MRK phase 3 trial and M&A talk.  Hoping to see a test of $110,$INCY retracing a bit from recent move on addl $MRK phase 3 trial and M&A talk.  Hoping to see a test of $110,,,,,['https://pbs.twimg.com/media/C2YkTbSUUAET7om?format=jpg&name=small'],https://twitter.com/mchilberg/status/821383907115298816
277,cuttwood00716,@cuttwood00716,2017-01-18T12:21:07.000Z,"$MRK Trending Now 01/18/2017 If you follow MRK Share your opinions here

Go here: ---->  http://dlvr.it/N7yXF2","$MRK Trending Now 01/18/2017 If you follow MRK Share your opinions here

Go here: ---->  http://dlvr.it/N7yXF2",,,,,['https://pbs.twimg.com/media/C2c-P-VVEAESVhL?format=jpg&name=small'],https://twitter.com/cuttwood00716/status/821693904038703105
278,Evaluate Pharma,@evaluatepharma,2017-01-16T17:10:44.000Z,"Weekly #Pharma & #Biotech Market Movers: Global Majors & Industry (to 13 Jan 2017) http://ow.ly/R7zc3083h4Z 
@EPVantage
 $ARIA $MRK","Weekly #Pharma & #Biotech Market Movers: Global Majors & Industry (to 13 Jan 2017) http://ow.ly/R7zc3083h4Z 
@EPVantage
 $ARIA $MRK
4
1",,,4,1,['https://pbs.twimg.com/media/C2TtWyBWQAALXpW?format=png&name=360x360'],https://twitter.com/evaluatepharma/status/821042010996043776
279,WLST.com,@wlstcom,2017-01-18T05:07:57.000Z,Drugmakers in Davos shift focus to chronic diseases of poor $MRK http://wlst.com https://uk.finance.yahoo.com/news/drugmakers-davos-shift-focus-chronic-050001631.html‚Ä¶,Drugmakers in Davos shift focus to chronic diseases of poor $MRK http://wlst.com https://uk.finance.yahoo.com/news/drugmakers-davos-shift-focus-chronic-050001631.html‚Ä¶,,,,,[],https://twitter.com/wlstcom/status/821584894111399938
280,Magnolia Gallery,@MagnoliaG2012,2017-01-18T00:44:46.000Z,Even A $100M Series A Can't Save The Medtech Venture Climate http://seekingalpha.com/article/4037433-even-100m-series-save-medtech-venture-climate?source=tweet‚Ä¶ $JNJ $GE $QGEN $FMS $PFE $RHHBF $RHHBY $NVS $MRK $IBB,"Even A $100M Series A Can't Save The Medtech Venture Climate http://seekingalpha.com/article/4037433-even-100m-series-save-medtech-venture-climate?source=tweet‚Ä¶ $JNJ $GE $QGEN $FMS $PFE $RHHBF $RHHBY $NVS $MRK $IBB
seekingalpha.com
Even A $100M Series A Can't Save The Medtech Venture Climate (NASDAQ:IBB)
Venture funding for medtech companies is getting deeper into an endless winter.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/MagnoliaG2012/status/821518662016319491
281,Zenect,@zenect,2017-01-16T12:42:30.000Z,Our Review of $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  Click here to download http://bit.ly/1sQ7Crl,"Our Review of $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  Click here to download http://bit.ly/1sQ7Crl
1",,,,1,[],https://twitter.com/zenect/status/820974509712900096
282,AJMC-Diabetes Mgt,@EBDiabetes,2017-01-16T18:08:56.000Z,"Safety of #Januvia in oldest patients confirmed 
@AmDiabetesAssn
 #Diabetes Care $MRK 
@Merck
 http://bit.ly/2jRcoRe","Safety of #Januvia in oldest patients confirmed 
@AmDiabetesAssn
 #Diabetes Care $MRK 
@Merck
 http://bit.ly/2jRcoRe",,,,,['https://pbs.twimg.com/media/C2T6iFqUAAAOiN5?format=jpg&name=small'],https://twitter.com/EBDiabetes/status/821056660089274369
283,"BSharma MD, MBA",@bs2537,2017-01-17T21:46:29.000Z,Commented on Dynavax Technologies: Valuation Of The Immune-Oncology Pipeline http://seekingalpha.com/article/4037398-dynavax-technologies-valuation-immune-oncology-pipeline?source=tweet‚Ä¶ $IDRA $MRK $DVAX,"Commented on Dynavax Technologies: Valuation Of The Immune-Oncology Pipeline http://seekingalpha.com/article/4037398-dynavax-technologies-valuation-immune-oncology-pipeline?source=tweet‚Ä¶ $IDRA $MRK $DVAX
seekingalpha.com
Dynavax Technologies: Valuation Of The Immune-Oncology Pipeline (NASDAQ:DVAX)
Dynavax management seems to be positioning it as an immune-oncology company for near future.",,,,,[],https://twitter.com/bs2537/status/821473794371952640
284,markcarson16,@markcarson161,2017-01-16T00:00:05.000Z,"$JBLU Stock Forum Updated Sunday, January 15, 2017 6:15:20 PM $IEZ $DVY $DVY $MRK http://dlvr.it/N6qSjM","$JBLU Stock Forum Updated Sunday, January 15, 2017 6:15:20 PM $IEZ $DVY $DVY $MRK http://dlvr.it/N6qSjM",,,,,[],https://twitter.com/markcarson161/status/820782640378716160
285,Prudent Biotech,@PrudentBiotech,2017-01-16T14:57:52.000Z,"Biotechnology: Is 2017 A Bonanza Year?
http://buff.ly/2iw5PT9
$pfe $mrk $jnj $snf $agn $gild $amgn $lly $sgen $tsro $exel $incy $bmy","Biotechnology: Is 2017 A Bonanza Year?
http://buff.ly/2iw5PT9
$pfe $mrk $jnj $snf $agn $gild $amgn $lly $sgen $tsro $exel $incy $bmy",,,,,[],https://twitter.com/PrudentBiotech/status/821008576374251520
286,Kara Jill Stancell,@kjilly,2017-01-17T17:01:22.000Z,"Lagging further behind, $AZN adds fresh details to its checkpoint comeback strategy - $MRK $BMY","Lagging further behind, $AZN adds fresh details to its checkpoint comeback strategy - $MRK $BMY
endpts.com
Lagging further behind, AstraZeneca adds fresh details to its checkpoint comeback strategy
AstraZeneca has sketched out some fresh details on its mission critical pivotal study on its checkpoint drug approach to non-small cell lung cancer, mapping another likely delay as the pharma giant...",,,,,[],https://twitter.com/kjilly/status/821402043533299712
287,Siti van der Meij,@sitivandermeij,2017-01-17T14:49:35.000Z,Agenus to collaborate with NCI on combination therapy for brain cancer http://seekingalpha.com/news/3235452-agenus-collaborate-nci-combination-therapy-brain-cancer?source=feed_f‚Ä¶ $AGEN $MRK #sitifatimah #malaysia #financia‚Ä¶,"Agenus to collaborate with NCI on combination therapy for brain cancer http://seekingalpha.com/news/3235452-agenus-collaborate-nci-combination-therapy-brain-cancer?source=feed_f‚Ä¶ $AGEN $MRK #sitifatimah #malaysia #financia‚Ä¶
1
1",,,1,1,[],https://twitter.com/sitivandermeij/status/821368880148914176
288,Matthew Suits‚Ñ¢,@BusinessConquer,2017-01-18T21:48:35.000Z,"@Merck
 ( $MRK ) Expands Discovery to New South #SF Facility in Heart of Bay Area and Looks to #Hire 100 Employees. http://bit.ly/2jwbVXZ","@Merck
 ( $MRK ) Expands Discovery to New South #SF Facility in Heart of Bay Area and Looks to #Hire 100 Employees. http://bit.ly/2jwbVXZ
2",,,,2,['https://pbs.twimg.com/media/C2fAIi4WEAEMXth?format=jpg&name=small'],https://twitter.com/BusinessConquer/status/821836711974076418
289,Heath Care News,@hc_equipment,2017-01-18T21:04:02.000Z,"#Merck KGaA Given Consensus Rating of ""Hold"" by Brokerages. Read more: http://owler.us/ab6Avs $MRK","#Merck KGaA Given Consensus Rating of ""Hold"" by Brokerages. Read more: http://owler.us/ab6Avs $MRK",,,,,[],https://twitter.com/hc_equipment/status/821825500792246272
290,Heath Care News,@hc_equipment,2017-01-18T19:24:34.000Z,#Merck opens production facility exclusively for meglumine  . Read more: http://owler.us/ab6x9n $MRK,#Merck opens production facility exclusively for meglumine  . Read more: http://owler.us/ab6x9n $MRK,,,,,[],https://twitter.com/hc_equipment/status/821800466006740992
291,ThomP,@thom59020084,2017-01-17T04:14:14.000Z,Wondering how Big Pharma and the corrupt CDC(Tom Friedan) can market this bug into ANOTHER multi billion $$ boondoggle $mrk $lly $gsk,"Wondering how Big Pharma and the corrupt CDC(Tom Friedan) can market this bug into ANOTHER multi billion $$ boondoggle $mrk $lly $gsk
Helen Branswell
@HelenBranswell
 ¬∑ 17 Jan 2017
CREs - a dangerous type of superbug - are even wilier than we've realized, a new study shows. https://statnews.com/2017/01/16/cre-superbug/‚Ä¶ #AntibioticResistance",,,,,['https://pbs.twimg.com/profile_images/478637253481086977/aE2OOz5k_mini.jpeg'],https://twitter.com/thom59020084/status/821208987123273728
292,Pharmaceutical News,@pharma_sector,2017-01-18T17:32:32.000Z,"FY2016 EPS Estimates for #Merck & Company, Inc. Raised by Analyst. Read more: http://owler.us/ab6vSX $MRK","FY2016 EPS Estimates for #Merck & Company, Inc. Raised by Analyst. Read more: http://owler.us/ab6vSX $MRK",,,,,[],https://twitter.com/pharma_sector/status/821772273954607104
293,dough,@semodough,2017-01-18T14:13:06.000Z,MS Healthcare research Harrison prefers $AMGN $VRTX long $INVA short (see feedback below) Risinger prefers $LLY $MRK in major $AGN,"MS Healthcare research Harrison prefers $AMGN $VRTX long $INVA short (see feedback below) Risinger prefers $LLY $MRK in major $AGN
1
1",,1,,1,[],https://twitter.com/semodough/status/821722083214458881
294,Daily Political,@dailypoliticaln,2017-01-18T05:06:10.000Z,"Rand Wealth LLC Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2izSGNF","Rand Wealth LLC Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2izSGNF",,,,,[],https://twitter.com/dailypoliticaln/status/821584445585104896
295,Daily Political,@dailypoliticaln,2017-01-18T20:01:05.000Z,"Murphy Capital Management Inc. Cuts Stake in Merck & Company, Inc. $MRK http://dailypolitical.com/?p=892070","Murphy Capital Management Inc. Cuts Stake in Merck & Company, Inc. $MRK http://dailypolitical.com/?p=892070",,,,,[],https://twitter.com/dailypoliticaln/status/821809658126102529
296,Daniel Carlson,@tailwindsgroup,2017-01-18T17:18:07.000Z,Are we too complacent about the markets under Trump? $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK $GOOG $GS $HAL $HD,"Are we too complacent about the markets under Trump? $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK $GOOG $GS $HAL $HD
twresearchgroup.com
Our Economic Future‚Ä¶Clear Road, or Danger Around The Corner???
Last night my buddy James and I went for a night ride. We headed out for Pine Mountain, a challenging ride on a good day and one that was certain to be a muddy slog after the recent drought-ending...",,,,,['https://pbs.twimg.com/card_img/1501275065580728321/SCLw16Xd?format=jpg&name=240x240'],https://twitter.com/tailwindsgroup/status/821768645143502848
297,sam,@faceoffgogreen,2017-01-17T03:17:53.000Z,$RNVA $OPXA $MRK calls $FB calls  huge winners for us last week and many more to come this week,"$RNVA $OPXA $MRK calls $FB calls  huge winners for us last week and many more to come this week
winthattrade.com
Social",,,,,['https://pbs.twimg.com/card_img/1500531872690016262/hfBnEtsd?format=jpg&name=240x240'],https://twitter.com/faceoffgogreen/status/821194805116071936
298,Watchlist News,@WatchlistN,2017-01-18T15:29:36.000Z,"Guggenheim Upgrades Merck & Company, Inc. $MRK to Buy http://zpr.io/Pp4cs","Guggenheim Upgrades Merck & Company, Inc. $MRK to Buy http://zpr.io/Pp4cs",,,,,[],https://twitter.com/WatchlistN/status/821741335321395200
299,InsiderSense Notify,@insidersense_,2017-01-17T21:46:46.000Z,Insider Selling in $MRK. Weeks Wendell P sells $3.14k - Avg price of $31.35. Learn more at https://insidersense.com. Free insider newsletter,Insider Selling in $MRK. Weeks Wendell P sells $3.14k - Avg price of $31.35. Learn more at https://insidersense.com. Free insider newsletter,,,,,[],https://twitter.com/insidersense_/status/821473866367270912
300,luis calabuig,@luiscalasa,2017-01-18T15:45:15.000Z,Vet med industry now dominated by four firms; further mergers unlikely $SNY $ZTS $MRK $LLY $BAYRY http://seekingalpha.com/news/3235794,Vet med industry now dominated by four firms; further mergers unlikely $SNY $ZTS $MRK $LLY $BAYRY http://seekingalpha.com/news/3235794,,,,,[],https://twitter.com/luiscalasa/status/821745275828137985
301,Kerry Ramm,@rammco1,2017-01-17T20:21:41.000Z,Dynavax Technologies: Valuation Of The Immune-Oncology Pipeline http://seekingalpha.com/article/4037398-dynavax-technologies-valuation-immune-oncology-pipeline?source=tweet‚Ä¶ $IDRA $MRK $DVAX,"Dynavax Technologies: Valuation Of The Immune-Oncology Pipeline http://seekingalpha.com/article/4037398-dynavax-technologies-valuation-immune-oncology-pipeline?source=tweet‚Ä¶ $IDRA $MRK $DVAX
seekingalpha.com
Dynavax Technologies: Valuation Of The Immune-Oncology Pipeline (NASDAQ:DVAX)
Dynavax management seems to be positioning it as an immune-oncology company for near future.",,,,,['https://pbs.twimg.com/card_img/1501982308265431047/kkY5Hb5T?format=jpg&name=360x360'],https://twitter.com/rammco1/status/821452453040111616
302,This momment,@dpreda,2017-01-18T19:43:25.000Z,"US crude settles at $51.08, down nearly 2.7% on prospect of rising US shale production $XOM $APA $COP $CHK $CVX $HAL $MRK $NE $PBR $ERX $ERY","US crude settles at $51.08, down nearly 2.7% on prospect of rising US shale production $XOM $APA $COP $CHK $CVX $HAL $MRK $NE $PBR $ERX $ERY",,,,,[],https://twitter.com/dpreda/status/821805212910223361
303,dough,@semodough,2017-01-18T11:53:37.000Z,"BMO $AZN MYSTIC Change Incrementally Positive for $MRK, and Less so for $BMY","BMO $AZN MYSTIC Change Incrementally Positive for $MRK, and Less so for $BMY",,,,,[],https://twitter.com/semodough/status/821686981340045313
304,Insider Monkey,@insidermonkey,2017-01-18T19:20:04.000Z,$MRK And Palantir Technologies Inc Agree On Cancer Data Analysis Pact,"$MRK And Palantir Technologies Inc Agree On Cancer Data Analysis Pact
insidermonkey.com
Merck & Co., Inc. (MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact
Palantir Technologies Inc and Merck & Co., Inc. (NYSE:MRK) German parent Merck KGaA have entered into a deal that will see them work together on a cancer data analytics project.",,,,,['https://pbs.twimg.com/card_img/1501737386052669444/IjJD0edi?format=jpg&name=240x240'],https://twitter.com/insidermonkey/status/821799333335068673
305,Allison Gatlin,@IBD_AGatlin,2017-01-17T20:27:23.000Z,FDA track record bodes well for Merck Keytruda plus chemo: Leerink http://ow.ly/6X5f308622x $MRK $LLY $BMY $AZN,"FDA track record bodes well for Merck Keytruda plus chemo: Leerink http://ow.ly/6X5f308622x $MRK $LLY $BMY $AZN
investors.com
FDA Track Record Bodes Well For Merck Keytruda Plus Lilly Chemo: Leerink | Stock News & Stock...
The FDA's track record for oncology ""hits"" under its accelerated approval program bodes well for Merck's Keytruda plus chemo combo, Leerink says.",,,,,[],https://twitter.com/IBD_AGatlin/status/821453887681036289
306,Clark Joseph Kent,@JorelLaraKalel,2017-01-16T18:54:55.000Z,"Amazon, Merck, Freshpet: Jim Cramer's Views $AMZN $MRK $UAL $DAL $WOOF $IDXX $ZTS $FRPT http://bit.ly/2izmUeL","Amazon, Merck, Freshpet: Jim Cramer's Views $AMZN $MRK $UAL $DAL $WOOF $IDXX $ZTS $FRPT http://bit.ly/2izmUeL
youtube.com
Amazon Prime Rewards Visa Signature Credit Card Review. Get 5% back...
Get a $70 Amazon Gift Card & an Amazon Rewards Visa Signature Card. No Annual Fee. Get 5% back on Amazon purchases.Sign up for the card here: amzn.to/2idPIhS...",,,,,['https://pbs.twimg.com/card_img/1500272233259978758/79sTlwA5?format=jpg&name=240x240'],https://twitter.com/JorelLaraKalel/status/821068228436828161
307,ZoZoTrader,@ZoZoStockwatch,2017-01-16T14:10:37.000Z,"Video ZOZOTRADER http://ticker.tv/zozotrader/587cd2‚Ä¶... $AAPL $MRK $SPY $QQQ $GALT $SCYX and more Lets get ready for The week ahead 
@tickertv","Video ZOZOTRADER http://ticker.tv/zozotrader/587cd2‚Ä¶... $AAPL $MRK $SPY $QQQ $GALT $SCYX and more Lets get ready for The week ahead 
@tickertv
1
2",,,1,2,[],https://twitter.com/ZoZoStockwatch/status/820996685535084545
308,Jacob Plieth,@JacobPlieth,2017-01-17T15:07:17.000Z,"Replying to 
@JacobPlieth
 and 
@jq1234t","Replying to 
@JacobPlieth
 and 
@jq1234t
Bernstein: Bears will claim $AZN may have less confidence than before in the CTLA4 combo approach $BMY $MRK $RHHBY
1
2",,1,,2,[],https://twitter.com/JacobPlieth/status/821373333967085568
309,AJMC,@AJMC_Journal,2017-01-17T07:40:00.000Z,"New study in 
@AmDiabetesAssn
 #Diabetes Care confirms #Januvia safety in oldest patients http://bit.ly/2jC5O1F $MRK 
@Merck","New study in 
@AmDiabetesAssn
 #Diabetes Care confirms #Januvia safety in oldest patients http://bit.ly/2jC5O1F $MRK 
@Merck",,,,,[],https://twitter.com/AJMC_Journal/status/821260771577499648
310,Ticker Report,@TickerReport,2017-01-17T00:57:31.000Z,"Papp L Roy & Associates Has $840,000 Stake in Merck & Company, Inc. $MRK http://zpr.io/Pp6Md","Papp L Roy & Associates Has $840,000 Stake in Merck & Company, Inc. $MRK http://zpr.io/Pp6Md",,,,,[],https://twitter.com/TickerReport/status/821159482399006720
311,Insider Monkey News,@insidermonkey_n,2017-01-18T19:19:37.000Z,$MRK And Palantir Technologies Inc Agree On Cancer Data Analysis Pact,"$MRK And Palantir Technologies Inc Agree On Cancer Data Analysis Pact
insidermonkey.com
Merck & Co., Inc. (MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact
Palantir Technologies Inc and Merck & Co., Inc. (NYSE:MRK) German parent Merck KGaA have entered into a deal that will see them work together on a cancer data analytics project.",,,,,['https://pbs.twimg.com/card_img/1501737386052669444/IjJD0edi?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/821799222068596739
312,Clark Joseph Kent,@JorelLaraKalel,2017-01-17T23:28:59.000Z,"FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink $MRK 
@merck
 $LLY $BMY $AZN","FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink $MRK 
@merck
 $LLY $BMY $AZN
investors.com
FDA Track Record Bodes Well For Merck Keytruda Plus Lilly Chemo: Leerink | Stock News & Stock...
The FDA's track record for oncology ""hits"" under its accelerated approval program bodes well for Merck's Keytruda plus chemo combo, Leerink says.",,,,,[],https://twitter.com/JorelLaraKalel/status/821499587387129857
313,Pharmaceutical News,@pharma_sector,2017-01-18T16:34:26.000Z,"#Merck & Co., Inc. And Palantir Technologies Inc Agree On Cancer Data Analysis Pact. Read more: http://owler.us/ab6tKX $MRK","#Merck & Co., Inc. And Palantir Technologies Inc Agree On Cancer Data Analysis Pact. Read more: http://owler.us/ab6tKX $MRK",,,,,[],https://twitter.com/pharma_sector/status/821757651566460928
314,marketexclusive,@marketexclusive,2017-01-18T12:03:46.000Z,"Merck & Co., Inc. (NYSE:MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact http://marketexclusive.com/merck-palantir-cancer-data-analysis-pact/69042/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶  $MRK","Merck & Co., Inc. (NYSE:MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact http://marketexclusive.com/merck-palantir-cancer-data-analysis-pact/69042/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶  $MRK
1",,1,,,[],https://twitter.com/marketexclusive/status/821689536099057665
315,dough,@semodough,2017-01-21T20:52:38.000Z,BIOTECH &pharma earnings dates $IBB $CELG  $BMY $MRK $GILD $VRTX,"BIOTECH &pharma earnings dates $IBB $CELG  $BMY $MRK $GILD $VRTX
2
12
21",,2,12,21,['https://pbs.twimg.com/media/C2uQFO4UoAA36B2?format=jpg&name=900x900'],https://twitter.com/semodough/status/822909793459466246
316,Boaty McBoatface,@srqstockpicker,2017-01-20T16:26:55.000Z,Jimmy Carter looks great! #pd1 $mrk,"Jimmy Carter looks great! #pd1 $mrk
3
14",,,3,14,[],https://twitter.com/srqstockpicker/status/822480536660836352
317,Jacob Plieth,@JacobPlieth,2017-01-20T14:41:51.000Z,$BMY vs $MRK since Checkmate-026 read out at #ESMO16,"$BMY vs $MRK since Checkmate-026 read out at #ESMO16
4
4",,,4,4,['https://pbs.twimg.com/media/C2nxaX6WEAAxwK9?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/822454097630691328
318,dough,@semodough,2017-01-21T20:57:13.000Z,Upcoming PDUFA dates $MRK  $AGN $BMY $IBB $NBIX $TXMD,"Upcoming PDUFA dates $MRK  $AGN $BMY $IBB $NBIX $TXMD
2
6
17",,2,6,17,['https://pbs.twimg.com/media/C2uRIemVQAQs1EJ?format=jpg&name=900x900'],https://twitter.com/semodough/status/822910946888871944
319,RAS Life Science Solutions,@raslss,2017-01-21T07:39:03.000Z,"BMS to make money on Keytruda https://seekingalpha.com/news/3236518?source=ansh‚Ä¶ $BMY, $MRK","BMS to make money on Keytruda https://seekingalpha.com/news/3236518?source=ansh‚Ä¶ $BMY, $MRK
seekingalpha.com
Merck settles Keytruda patent fight with Bristol-Myers and Ono Pharma, agrees to pay $625M plus...
Bristol-Myers Squibb (NYSE:BMY) and Ono Pharmaceutical Company, Ltd. reach a global patent settlement with Merck (NYSE:MRK) related to cancer med Keytruda (pembrolizumab).
2",,,2,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/raslss/status/822710083775655936
320,Breaking News,@MarketCurrents,2017-01-20T12:55:39.000Z,Goldman says Bristol-Myers' Opdivo/Yervoy in front-line lung cancer not dead yet; shares dow... http://seekingalpha.com/news/3236345-goldman-says-bristol-myers-opdivo-yervoy-front-line-lung-cancer-dead-yet-shares-7-percent?source=feed_f‚Ä¶ #premarket $BMY $MRK,"Goldman says Bristol-Myers' Opdivo/Yervoy in front-line lung cancer not dead yet; shares dow... http://seekingalpha.com/news/3236345-goldman-says-bristol-myers-opdivo-yervoy-front-line-lung-cancer-dead-yet-shares-7-percent?source=feed_f‚Ä¶ #premarket $BMY $MRK
seekingalpha.com
Goldman says Bristol-Myers' Opdivo/Yervoy in front-line lung cancer not dead yet; shares down 7%...
Bristol-Myers Squibb (NYSE:BMY) is off 7% premarket on average volume in response to yesterday's announcement that it will not seek accelerated approval of the combination of...
1",,,1,,['https://pbs.twimg.com/card_img/1489660067628519424/VfYFJfDz?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/822427369465987072
321,ETX Capital,@ETXCapital,2017-01-20T15:57:41.000Z,Stock watching $PG and $MRK lead the way on the $DJIA ahead of the #TrumpInauguration,"Stock watching $PG and $MRK lead the way on the $DJIA ahead of the #TrumpInauguration
1",,,,1,['https://pbs.twimg.com/media/C2oC-1iWIAAu90D?format=jpg&name=small'],https://twitter.com/ETXCapital/status/822473181722247168
322,Open Outcrier,@OpenOutcrier,2017-01-20T13:24:34.000Z,"$BMY (-7.2% pre) Bristol-Myers Falls Further Behind Merck $MRK (+3% pre) in Lung Cancer Race - BBG 

http://ooc.bz/l/8822","$BMY (-7.2% pre) Bristol-Myers Falls Further Behind Merck $MRK (+3% pre) in Lung Cancer Race - BBG 

http://ooc.bz/l/8822
2
1",,,2,1,[],https://twitter.com/OpenOutcrier/status/822434646118039552
323,Breaking News,@MarketCurrents,2017-01-20T16:44:40.000Z,Pharma bigwigs acknowledge challenges with perceptions of pricing as Trump prepares to take... http://seekingalpha.com/news/3236443-pharma-bigwigs-acknowledge-challenges-perceptions-pricing-trump-prepares-take-office?source=feed_f‚Ä¶ $NVS $MRK $GSK $RHHBY,"Pharma bigwigs acknowledge challenges with perceptions of pricing as Trump prepares to take... http://seekingalpha.com/news/3236443-pharma-bigwigs-acknowledge-challenges-perceptions-pricing-trump-prepares-take-office?source=feed_f‚Ä¶ $NVS $MRK $GSK $RHHBY
seekingalpha.com
Pharma bigwigs acknowledge challenges with perceptions of pricing as Trump prepares to take office...
At the annual Davos meet-up between the globe's movers and shakers, the CEOs of leading pharma firms weigh in on the political headwinds potentially restraining their ability to routinely...",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/822485004856893440
324,Damian Garde,@damiangarde,2017-01-20T12:50:28.000Z,"""The tweets will be what they will be."" -- $MRK CEO Ken Frazier on at Real Donald Trump, president","""The tweets will be what they will be."" -- $MRK CEO Ken Frazier on at Real Donald Trump, president
reuters.com
Pharma CEOs in Davos put brave face on Trump presidency
Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump for ""getting away with murder"" on drug prices, are putting a brave face on the challenges in their...
1
1",,,1,1,['https://pbs.twimg.com/card_img/1490114281773441024/1_UZ-Gbr?format=png&name=small'],https://twitter.com/damiangarde/status/822426063812829185
325,Œõce,@AceOfWallSt,2017-01-20T16:40:34.000Z,"Top % Gainers $9+: $SWKS 11%, $UWT 6% $CF 5% $QRVO 4%, $POT $ATW $UCO $MOS $MRK $PG $JWN $SYF $AVGO $ESV $CFG $NOV $GPRO $SVXY $XIV $SN $ECA","Top % Gainers $9+: $SWKS 11%, $UWT 6% $CF 5% $QRVO 4%, $POT $ATW $UCO $MOS $MRK $PG $JWN $SYF $AVGO $ESV $CFG $NOV $GPRO $SVXY $XIV $SN $ECA
2
4",,,2,4,['https://pbs.twimg.com/media/C2oMzNpWgAAKHHe?format=jpg&name=small'],https://twitter.com/AceOfWallSt/status/822483969782480896
326,Jacob Plieth,@JacobPlieth,2017-01-20T21:53:57.000Z,So $BMY catches a break at last? http://news.bms.com/press-release/partnering-news/bristol-myers-squibb-and-ono-pharmaceutical-company-enter-settlement-a‚Ä¶ $MRK,"So $BMY catches a break at last? http://news.bms.com/press-release/partnering-news/bristol-myers-squibb-and-ono-pharmaceutical-company-enter-settlement-a‚Ä¶ $MRK
1
2
3",,1,2,3,[],https://twitter.com/JacobPlieth/status/822562838661267459
327,Investors.com,@IBDinvestors,2017-01-20T13:15:46.000Z,"Stock Futures Steer Higher; Merck, Skyworks, Emerge Energy Climb http://ow.ly/eekx308bHUq $MRK $BMY $SWKS","Stock Futures Steer Higher; Merck, Skyworks, Emerge Energy Climb http://ow.ly/eekx308bHUq $MRK $BMY $SWKS
3
2",,,3,2,['https://pbs.twimg.com/media/C2nd8ArWEAA-C7r?format=jpg&name=small'],https://twitter.com/IBDinvestors/status/822432432641208324
328,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-01-20T21:10:33.000Z,$MRK  to Pay $BMY $625M + Royalties on Keytruda through 2026 to Resolve PD-1 Antibody Patent Litigation‚ÄîWOW,"$MRK  to Pay $BMY $625M + Royalties on Keytruda through 2026 to Resolve PD-1 Antibody Patent Litigation‚ÄîWOW
bms.com
Bristol Myers Squibb: Investor Relations
Find information and tools for investors, stockholders and financial analysts, including share and dividend information, acquisition-related information, latest news and corporate reporting.
1
6
1",,1,6,1,['https://pbs.twimg.com/card_img/1500482598098784258/v0WKDpl-?format=jpg&name=360x360'],https://twitter.com/DrPaulyDeSantis/status/822551915447906304
329,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-01-20T13:09:58.000Z,$GILD $MRK Gilead Sciences / Merck & Co. Weekly Hep C Tracker: Harvoni TRx/NRx up Scripts for the week (cont) http://tl.gd/n_1spi1hh,"$GILD $MRK Gilead Sciences / Merck & Co. Weekly Hep C Tracker: Harvoni TRx/NRx up Scripts for the week (cont) http://tl.gd/n_1spi1hh
2
5",üÖ± üÖæ,,2,5,[],https://twitter.com/_B_I_O_T_E_C_H_/status/822430970506788864
330,ITML Finance,@ITMLFinance,2017-01-20T15:07:29.000Z,Bullish money flow this inauguration morning... $SWKS $PG $MRK $IBM $KSU $T $AVGO $QRVO $HAL,"Bullish money flow this inauguration morning... $SWKS $PG $MRK $IBM $KSU $T $AVGO $QRVO $HAL
2",,,,2,[],https://twitter.com/ITMLFinance/status/822460545685065728
331,Open Outcrier,@OpenOutcrier,2017-01-20T21:03:11.000Z,$MRK and $BMY setlling some issues on Keytruda royalies...,"$MRK and $BMY setlling some issues on Keytruda royalies...
2
1",,,2,1,[],https://twitter.com/OpenOutcrier/status/822550063289401349
332,Bosco,@wboscoho,2017-01-21T01:15:09.000Z,"MT Merck settles Keytruda patent fight w/ Bristol-Myers and Ono Pharma, agrees to pay $625M+ royalties http://seekingalpha.com/news/3236518-merck-settles-keytruda-patent-fight-bristol-myers-ono-pharma-agrees-pay-625m-plus-royalties?source=tweet‚Ä¶ $BMY $MRK","MT Merck settles Keytruda patent fight w/ Bristol-Myers and Ono Pharma, agrees to pay $625M+ royalties http://seekingalpha.com/news/3236518-merck-settles-keytruda-patent-fight-bristol-myers-ono-pharma-agrees-pay-625m-plus-royalties?source=tweet‚Ä¶ $BMY $MRK
seekingalpha.com
Merck settles Keytruda patent fight with Bristol-Myers and Ono Pharma, agrees to pay $625M plus...
Bristol-Myers Squibb (NYSE:BMY) and Ono Pharmaceutical Company, Ltd. reach a global patent settlement with Merck (NYSE:MRK) related to cancer med Keytruda (pembrolizumab).
1",,,1,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/wboscoho/status/822613470407430145
333,Charley Grant,@CGrantWSJ,2017-01-20T13:08:00.000Z,$MRK up 3.6% on Bristol-Myers Squibb cancer disappointment.,"$MRK up 3.6% on Bristol-Myers Squibb cancer disappointment.
1
2
1",,1,2,1,[],https://twitter.com/CGrantWSJ/status/822430475989946368
334,Seeking Alpha,@SeekingAlpha,2017-01-20T21:39:04.000Z,Asco-GI: Opdivo Heads Close Pack Of Anti-PD-1s In Gastric Cancer http://seekingalpha.com/article/4038391-asco-gi-opdivo-heads-close-pack-anti-pdminus-1s-gastric-cancer?source=feed_f‚Ä¶ $AZN $RHHBF $RHHBY $PFE $MRK $BMY,Asco-GI: Opdivo Heads Close Pack Of Anti-PD-1s In Gastric Cancer http://seekingalpha.com/article/4038391-asco-gi-opdivo-heads-close-pack-anti-pdminus-1s-gastric-cancer?source=feed_f‚Ä¶ $AZN $RHHBF $RHHBY $PFE $MRK $BMY,,,,,[],https://twitter.com/SeekingAlpha/status/822559093420425216
335,Seeking Alpha,@SeekingAlpha,2017-01-20T21:21:37.000Z,Implications Of The Latest Smash In Bristol-Myers Squibb Stock http://seekingalpha.com/article/4038388-implications-latest-smash-bristol-myers-squibb-stock?source=feed_f‚Ä¶ $BIIB $CELG $CVS $GILD $KO $MORN $MRK $NVO $PFE,"Implications Of The Latest Smash In Bristol-Myers Squibb Stock http://seekingalpha.com/article/4038388-implications-latest-smash-bristol-myers-squibb-stock?source=feed_f‚Ä¶ $BIIB $CELG $CVS $GILD $KO $MORN $MRK $NVO $PFE
2",,,,2,[],https://twitter.com/SeekingAlpha/status/822554699748540417
336,Seeking Alpha,@SeekingAlpha,2017-01-20T22:04:07.000Z,Snippet Roundup: Opdivo's First-Line Lung Combo Delay And Colucid's Lilly Windfall http://seekingalpha.com/article/4038399-snippet-roundup-opdivos-first-line-lung-combo-delay-colucids-lilly-windfall?source=feed_f‚Ä¶ $LLY $CLCD $BMY $MRK $PULM $HCM,Snippet Roundup: Opdivo's First-Line Lung Combo Delay And Colucid's Lilly Windfall http://seekingalpha.com/article/4038399-snippet-roundup-opdivos-first-line-lung-combo-delay-colucids-lilly-windfall?source=feed_f‚Ä¶ $LLY $CLCD $BMY $MRK $PULM $HCM,,,,,[],https://twitter.com/SeekingAlpha/status/822565396532330500
337,Paul Bonanos,@BioBonanos,2017-01-21T02:05:44.000Z,"New acting heads of FDA & CMS, plus a double dose of $MRK & $BMS PD-1 news. Tonight's BioCentury Extra: http://biocentury.com/DailyNews/CurrentIssue/2017-01-20‚Ä¶","New acting heads of FDA & CMS, plus a double dose of $MRK & $BMS PD-1 news. Tonight's BioCentury Extra: http://biocentury.com/DailyNews/CurrentIssue/2017-01-20‚Ä¶",,,,,[],https://twitter.com/BioBonanos/status/822626202066227200
338,John Carroll,@JohnCendpts,2017-01-20T10:15:45.000Z,"$BMY staggered by a fresh checkpoint setback, hands $MRK a free pass on frontline lung cancer combo
$AZN
https://endpts.com/bristol-myers-abruptly-nixes-any-hopes-for-early-opdivoyervoy-move-on-frontline-lung-cancer/‚Ä¶","$BMY staggered by a fresh checkpoint setback, hands $MRK a free pass on frontline lung cancer combo
$AZN
https://endpts.com/bristol-myers-abruptly-nixes-any-hopes-for-early-opdivoyervoy-move-on-frontline-lung-cancer/‚Ä¶
2
2",,,2,2,[],https://twitter.com/JohnCendpts/status/822387130869555200
339,Dan Rosenblum,@sharkbiotech,2017-01-20T12:58:12.000Z,what is amazing is that $BMY p/e is for some reason still higher than $MRK,"what is amazing is that $BMY p/e is for some reason still higher than $MRK
2
2",,2,2,,[],https://twitter.com/sharkbiotech/status/822428012998250496
340,Confident Investor,@ConfidentInvest,2017-01-21T12:05:04.000Z,Confident Investor indicator analysis for 1/21/2017. Interesting results from $AMAT $AZPN $DPZ $GOOGL $MRK - http://bit.ly/2jJEQHS,Confident Investor indicator analysis for 1/21/2017. Interesting results from $AMAT $AZPN $DPZ $GOOGL $MRK - http://bit.ly/2jJEQHS,,,,,[],https://twitter.com/ConfidentInvest/status/822777028793364480
341,MisseJERSEYgirl,@MSurdez,2017-01-20T13:25:02.000Z,"How Johnson & Johnson Beat Every Other Big Pharma Stock in 2016 
@themotleyfool
 #stocks $MRK, $JNJ, $ABBV","How Johnson & Johnson Beat Every Other Big Pharma Stock in 2016 
@themotleyfool
 #stocks $MRK, $JNJ, $ABBV
fool.com
How Johnson & Johnson Beat Every Other Big Pharma Stock in 2016 @themotleyfool #stocks $JNJ $MRK...
AbbVie and Merck might have had better earnings growth, but Johnson & Johnson took the prize as best big pharma stock of 2016.
1",,,,1,[],https://twitter.com/MSurdez/status/822434765215305728
342,The Fly,@theflynews,2017-01-20T16:35:05.000Z,Bristol-Myers slides after another lung cancer drug setback $BMY $MRK $AZN $RHHBY,"Bristol-Myers slides after another lung cancer drug setback $BMY $MRK $AZN $RHHBY
thefly.com
Bristol-Myers slides after another lung cancer drug setback
Shares of Bristol-Myers S... BMY, MRK, AZN, RHHBY
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501412018087071745/bkdQtUJx?format=jpg&name=small'],https://twitter.com/theflynews/status/822482591429238784
343,David Showkz,@mr_showkz99,2017-01-20T14:11:49.000Z,Goldman says Bristol-Myers' Opdivo/Yervoy in front-line lung cancer not dead yet; shares down 7% premarket http://seekingalpha.com/news/3236345-goldman-says-bristol-myers-opdivo-yervoy-front-line-lung-cancer-dead-yet-shares-7-percent?source=tweet‚Ä¶ $BMY $MRK,Goldman says Bristol-Myers' Opdivo/Yervoy in front-line lung cancer not dead yet; shares down 7% premarket http://seekingalpha.com/news/3236345-goldman-says-bristol-myers-opdivo-yervoy-front-line-lung-cancer-dead-yet-shares-7-percent?source=tweet‚Ä¶ $BMY $MRK,,,,,[],https://twitter.com/mr_showkz99/status/822446539280973826
344,Briefing.com,@Briefingcom,2017-01-20T23:05:01.000Z,$MRK: Merck announces settlement and license agreement with Bristol-Myers (BMY) resolving Keytruda patent... http://bit.ly/2jgWuzO,$MRK: Merck announces settlement and license agreement with Bristol-Myers (BMY) resolving Keytruda patent... http://bit.ly/2jgWuzO,,,,,[],https://twitter.com/Briefingcom/status/822580722313654273
345,Ed Carson,@IBD_ECarson,2017-01-20T02:23:28.000Z,Bristol-Myers' Opdivo news gives Merck's Keytruda an even-bigger lead to approval $BMY $MRK,"Bristol-Myers' Opdivo news gives Merck's Keytruda an even-bigger lead to approval $BMY $MRK
Investors.com
@IBDinvestors
 ¬∑ 20 Jan 2017
Bristol-Myers Won't Seek Accelerated Opdivo Lung Cancer OK http://dlvr.it/N8jmvs",,,,,"['https://pbs.twimg.com/profile_images/929121870107918336/gO-6qGSu_mini.jpg', 'https://pbs.twimg.com/media/C2lEGezVQAAI-BI?format=jpg&name=small']",https://twitter.com/IBD_ECarson/status/822268275677626369
346,Bursatil Biotech,@BursatilBiotech,2017-01-20T13:52:46.000Z,"Replying to 
@BursatilBiotech","Replying to 
@BursatilBiotech
Lung Cancer Race 
$BMY (early 2018)
$MRK (2017)
$RHHBY + $AZN both of them jumping ahead due to $BMY's dropdown 
1
1",‚¨á ‚¨Ü ‚§¥,1,1,,[],https://twitter.com/BursatilBiotech/status/822441741366267906
347,zach,@zbiotech,2017-01-20T17:02:18.000Z,"GS currently carries ~1.5B in total risk-adjusted NSCLC opdivo sales for '20, ~20% of total opdivo sales (7.4B) $BMY $MRK $AZN","GS currently carries ~1.5B in total risk-adjusted NSCLC opdivo sales for '20, ~20% of total opdivo sales (7.4B) $BMY $MRK $AZN",,,,,[],https://twitter.com/zbiotech/status/822489441285668869
348,Endpoints News,@endpts,2017-01-21T18:40:01.000Z,"A steady loser on the #checkpoint R&D front, $BMY scores a $625M payout from $MRK to settle patent fracas http://endpts.com/a-steady-loser‚Ä¶ #biotech","A steady loser on the #checkpoint R&D front, $BMY scores a $625M payout from $MRK to settle patent fracas http://endpts.com/a-steady-loser‚Ä¶ #biotech
endpts.com
After repeated setbacks on the checkpoint front, Bristol-Myers scores a $625M payout from Merck to...
Bristol-Myers Squibb may keep losing to Keytruda on key franchise initiatives, but at least now it can share in Merck‚Äôs good fortunes. Bristol-Myers and Ono have agreed to set aside their patent...
2",,,2,,['https://pbs.twimg.com/card_img/1501166467047325698/_jIR-csO?format=jpg&name=small'],https://twitter.com/endpts/status/822876421206982656
349,StockNews.com,@stocknewsdotcom,2017-01-20T21:06:28.000Z,$MRK Merck announces settlement and license agreement with Bristol-Myers resolving Keytruda patent litigation; co ‚Ä¶ https://stocknews.com/news/mrk-merck-announces-settlement-and-license-agreement-with-bristol-myers-resolving-keytruda/‚Ä¶,$MRK Merck announces settlement and license agreement with Bristol-Myers resolving Keytruda patent litigation; co ‚Ä¶ https://stocknews.com/news/mrk-merck-announces-settlement-and-license-agreement-with-bristol-myers-resolving-keytruda/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/822550885788241920
350,Peter Loftus,@Loftus,2017-01-20T15:16:50.000Z,"Bristol-Myers $BMY is down 9+% on setback for immunotherapy combo for lung cancer, rival Merck $MRK up 3.6% on same news","Bristol-Myers $BMY is down 9+% on setback for immunotherapy combo for lung cancer, rival Merck $MRK up 3.6% on same news
2",,,,2,[],https://twitter.com/Loftus/status/822462898383585280
351,Allison Gatlin,@IBD_AGatlin,2017-01-19T21:12:33.000Z,"Gilead, Merck, Alexion 2017 views hazy; Biogen may surge: analyst $GILD $MRK $ALXN $BIIB $JNJ $IONS $INCY $LLY $SYK","Gilead, Merck, Alexion 2017 views hazy; Biogen may surge: analyst $GILD $MRK $ALXN $BIIB $JNJ $IONS $INCY $LLY $SYK
investors.com
Gilead, Merck, Alexion 2017 Views Hazy; Biogen Likely To Surge: Analyst | Stock News & Stock Market...
Barclays analyst Geoff Meacham trailed RBC on Thursday, calling for Gilead Sciences' 2017 outlook to be hindered on limited hepatitis C sales.",,,,,[],https://twitter.com/IBD_AGatlin/status/822190029804027909
352,Allison Gatlin,@IBD_AGatlin,2017-01-20T18:22:44.000Z,"Amgen could gouge ""top pick"" AbbVie with Humira biosimilar: Jefferies $AMGN $ABBV $MRK $LLY $RHHBY $AZN $PFE $BMY http://ow.ly/joxM308cqbu","Amgen could gouge ""top pick"" AbbVie with Humira biosimilar: Jefferies $AMGN $ABBV $MRK $LLY $RHHBY $AZN $PFE $BMY http://ow.ly/joxM308cqbu",,,,,[],https://twitter.com/IBD_AGatlin/status/822509682015305728
353,Allison Gatlin,@IBD_AGatlin,2017-01-20T18:31:55.000Z,"Biotechs stocks might catalyze, or plunge, on four key sectors in 2017 $MRK $BMY $LLY $AZN $AMGN $VRTX $ARIA $TSRO","Biotechs stocks might catalyze, or plunge, on four key sectors in 2017 $MRK $BMY $LLY $AZN $AMGN $VRTX $ARIA $TSRO
investors.com
Biotech Stocks Might Catalyze, Or Plunge, On 4 Key Sectors In 2017 | Stock News & Stock Market...
Biotechs have a lot riding of drug data in 2017 with nearly two dozen firms reporting data in four key segments.",,,,,['https://pbs.twimg.com/card_img/1501750105606705157/rBea1QJf?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/822511995614281728
354,Endpoints News,@endpts,2017-01-20T15:03:54.000Z,"$BMY staggered by stunning #checkpoint setback, hands $MRK free pass on frontline #lungcancer combo https://endpts.com/bristol-myers-abruptly-nixes-any-hopes-for-early-opdivoyervoy-move-on-frontline-lung-cancer/‚Ä¶ by 
@JohnCendpts","$BMY staggered by stunning #checkpoint setback, hands $MRK free pass on frontline #lungcancer combo https://endpts.com/bristol-myers-abruptly-nixes-any-hopes-for-early-opdivoyervoy-move-on-frontline-lung-cancer/‚Ä¶ by 
@JohnCendpts
endpts.com
Bristol-Myers staggered by a stunning checkpoint setback, hands Merck a free pass on frontline lung...
Bristol-Myers Squibb $BMY fans can scratch any hopes of an accelerated filing for a combination of Opdivo and Yervoy as a frontline therapy for lung cancer. The big biotech announced in a terse...",,,,,['https://pbs.twimg.com/card_img/1501754019148148736/CSCZdhv1?format=png&name=small'],https://twitter.com/endpts/status/822459643431702528
355,JQ,@jq1234t,2017-01-21T19:47:18.000Z,"Replying to 
@JackWestMD","Replying to 
@JackWestMD
@JohnCendpts
 That's what journalists and analysts do, write end chapter quickly. Less than 1-yr ago, $BMY did right $MRK wrong
1
1
1",,1,1,1,[],https://twitter.com/jq1234t/status/822893350365908992
356,Joe W.,@w_biltmore85,2017-01-20T01:14:06.000Z,"Replying to 
@semodough
 and 
@OpenOutcrier","Replying to 
@semodough
 and 
@OpenOutcrier
Got that right & $INCY is all combo'd up w/ Keytruda $MRK
1
2",,1,,2,[],https://twitter.com/w_biltmore85/status/822250819852599297
357,Zach Brennan,@ZacharyBrennan,2017-01-20T12:19:11.000Z,"Pharma CEOs in Davos put brave face on Trump presidency $NVS $MRK $GSK $SNY $SHPG http://reut.rs/2iRxSMT via 
@Reuters","Pharma CEOs in Davos put brave face on Trump presidency $NVS $MRK $GSK $SNY $SHPG http://reut.rs/2iRxSMT via 
@Reuters
reuters.com
Pharma CEOs in Davos put brave face on Trump presidency
Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump for ""getting away with murder"" on drug prices, are putting a brave face on the challenges in their...",,,,,['https://pbs.twimg.com/card_img/1500261351813533696/TiWZyjMm?format=png&name=small'],https://twitter.com/ZacharyBrennan/status/822418191255269376
358,Paul R. La Monica,@LaMonicaBuzz,2017-01-20T16:19:03.000Z,This tweet not about Trump. $MRK up 4% today & 7% YTD. Tops in Dow. Positive news on lung cancer drug. Rival $BMY has setback. $BMY down 9%.,This tweet not about Trump. $MRK up 4% today & 7% YTD. Tops in Dow. Positive news on lung cancer drug. Rival $BMY has setback. $BMY down 9%.,,,,,[],https://twitter.com/LaMonicaBuzz/status/822478554969636864
359,Jack Allen,@JohnK_Allen,2017-01-20T14:53:00.000Z,"Replying to 
@AU_Analyst13","Replying to 
@AU_Analyst13
yep looks like $MRK has that advantage at first line
1",,,,1,[],https://twitter.com/JohnK_Allen/status/822456901871042560
360,Benzinga,@Benzinga,2017-01-20T15:41:01.000Z,Bristol-Myers Squibb Falls 10% After Opdivo Decision https://benzinga.com/z/8928204 $BMY $MRK,"Bristol-Myers Squibb Falls 10% After Opdivo Decision https://benzinga.com/z/8928204 $BMY $MRK
1",,,1,,[],https://twitter.com/Benzinga/status/822468983467044865
361,Bio Stocks‚Ñ¢,@BioStocks,2017-01-22T18:08:48.000Z,$BMY's Opdivo Dependence Now Looks Dicey http://bloomberg.com/gadfly/articles/2017-01-20/bristol-opdivo-yervoy-lung-cancer-decision-risks-are-growing‚Ä¶ $MRK #pharma,"$BMY's Opdivo Dependence Now Looks Dicey http://bloomberg.com/gadfly/articles/2017-01-20/bristol-opdivo-yervoy-lung-cancer-decision-risks-are-growing‚Ä¶ $MRK #pharma
bloomberg.com
Bristol's Opdivo Dependence Now Looks Dicey
Missteps with its leading cancer drug threaten its lead over Merck.
3
5",,,3,5,['https://pbs.twimg.com/card_img/1500829713555673089/pQhlbIXa?format=jpg&name=small'],https://twitter.com/BioStocks/status/823230954063982593
362,Michael Goodman,@mikegoodma,2017-01-23T12:59:16.000Z,$MRK's collab on combo of Genexine‚Äôs DNA vaccine GX188E w Keytruda for HPV-induced cervical cancer is one to watch.,"$MRK's collab on combo of Genexine‚Äôs DNA vaccine GX188E w Keytruda for HPV-induced cervical cancer is one to watch.
nytimes.com
Wider Racial Gap Found in Cervical Cancer Deaths (Published 2017)
A new study, which excluded women with hysterectomies, showed the disparity in death rates between blacks and whites was significantly wider.
5
5",,,5,5,['https://pbs.twimg.com/card_img/1499864845759434754/KEp8X29A?format=jpg&name=small'],https://twitter.com/mikegoodma/status/823515442765594624
363,Tom Wrigley,@WrigleyTom,2017-01-23T13:40:05.000Z,"Some Early Movers | CNBC

$HAL $QCOM $MRK $YHOO
$JNJ $TMUS $UAL $AAPL
$BMY $BX $VZ $HLT $GOOGL
$GME $KATE $COH $KORS
http://cnb.cx/2jIRp4g","Some Early Movers | CNBC

$HAL $QCOM $MRK $YHOO
$JNJ $TMUS $UAL $AAPL
$BMY $BX $VZ $HLT $GOOGL
$GME $KATE $COH $KORS
http://cnb.cx/2jIRp4g
3
2",,,3,2,[],https://twitter.com/WrigleyTom/status/823525713127022593
364,Ivica Juracic,@xpertstock,2017-01-22T22:07:47.000Z,$MRK long odds http://tinyurl.com/j8boccy,"$MRK long odds http://tinyurl.com/j8boccy
1
1",,,1,1,['https://pbs.twimg.com/media/C2zq4suWQAAc663?format=jpg&name=small'],https://twitter.com/xpertstock/status/823291093810892800
365,Novateur Ventures,@NovateurBio,2017-01-24T22:21:11.000Z,"$MRK Merck, $BMY Bristol-Myers agree to settle #Keytruda patent suit http://cnb.cx/2knEk3v","$MRK Merck, $BMY Bristol-Myers agree to settle #Keytruda patent suit http://cnb.cx/2knEk3v",,,,,[],https://twitter.com/NovateurBio/status/824019240978001920
366,venkysrinivasan.eth,@sssvenky,2017-01-23T02:20:12.000Z,$MRK Monthly bull flag over 10 EMA. Like it over 63. Inside week as well (not on this chart).,"$MRK Monthly bull flag over 10 EMA. Like it over 63. Inside week as well (not on this chart).
1",üöÄ,,,1,['https://pbs.twimg.com/media/C20khC6WgAASyX9?format=png&name=small'],https://twitter.com/sssvenky/status/823354617245421568
367,Oncology Board,@mb_Oncology,2017-01-23T16:34:10.000Z,"MM&M Magazine: 5 things for #pharma #marketers to know: Mon, Jan 23 $BMY $MRK #oncology #drugpricing‚Ä¶ http://dlvr.it/NBB2l4 #MedicBoard","MM&M Magazine: 5 things for #pharma #marketers to know: Mon, Jan 23 $BMY $MRK #oncology #drugpricing‚Ä¶ http://dlvr.it/NBB2l4 #MedicBoard
1",,,1,,['https://pbs.twimg.com/media/C23oHa4VIAEWnvv?format=jpg&name=small'],https://twitter.com/mb_Oncology/status/823569525916372994
368,David Crow,@bydavidcrow,2017-01-24T22:04:36.000Z,A quick and dirty chart of checkpoint inhibitor sales ahead of Bristol-Myers earnings tomorrow $BMY $MRK $ROG,"A quick and dirty chart of checkpoint inhibitor sales ahead of Bristol-Myers earnings tomorrow $BMY $MRK $ROG
1
3
4",,1,3,4,['https://pbs.twimg.com/media/C299VO9XgAUTtYF?format=jpg&name=small'],https://twitter.com/bydavidcrow/status/824015068740382729
369,JQ,@jq1234t,2017-01-24T01:47:17.000Z,$BMY looks to exploit Opdivo‚Äôs liver cancer advantage $MRK $AZN,"$BMY looks to exploit Opdivo‚Äôs liver cancer advantage $MRK $AZN
Robin Davison
@RobinDavison2
 ¬∑ 23 Jan 2017
My view on checkpoint inhibitors in HCC, post ASCO-GI #GI17 http://ow.ly/yPA3308gBby
1
3",,,1,3,['https://pbs.twimg.com/profile_images/651413991504265216/hJkBhxzD_mini.jpg'],https://twitter.com/jq1234t/status/823708722224566273
370,JQ,@jq1234t,2017-01-24T01:49:39.000Z,Roche challenges Keytruda‚Äôs colorectal cancer pole position $MRK $BMY $EXEL,"Roche challenges Keytruda‚Äôs colorectal cancer pole position $MRK $BMY $EXEL
Robin Davison
@RobinDavison2
 ¬∑ 23 Jan 2017
Roche 's Tecentriq could be the one to watch in CRC, my take from ASCO-GI #GI17 http://ow.ly/Znzc308gBXH
1
5",,,1,5,['https://pbs.twimg.com/profile_images/651413991504265216/hJkBhxzD_mini.jpg'],https://twitter.com/jq1234t/status/823709316591054849
371,MM+M Magazine,@MMMnews,2017-01-24T19:57:00.000Z,"Here are the top 25 metabolic brands, by 2015-2016 #pharma sales. #diabetes $SNY $MRK $NVO $LLY $JNJ $AZN $BMRN $GSK http://bit.ly/2kq0mP6","Here are the top 25 metabolic brands, by 2015-2016 #pharma sales. #diabetes $SNY $MRK $NVO $LLY $JNJ $AZN $BMRN $GSK http://bit.ly/2kq0mP6",,,,,['https://pbs.twimg.com/media/C29fd3wXgAA0SmK?format=png&name=120x120'],https://twitter.com/MMMnews/status/823982955374776320
372,NYCDoc29,@nycdoc29,2017-01-24T01:11:01.000Z,Why buy $BMY? For #nivo? #keytruda the PD-1 of choice in #lungcancer w others getting #Tecentriq $MRK $Nivo is dead,"Why buy $BMY? For #nivo? #keytruda the PD-1 of choice in #lungcancer w others getting #Tecentriq $MRK $Nivo is dead
Meg Tirrell
@megtirrell
 ¬∑ 23 Jan 2017
Jefferies says calm down on $BMY, suggests takeout $50/shr poss if things go further south in lung cancer; likely buyers $JNJ $PFE $SNY $NVS",,,,,"['https://pbs.twimg.com/profile_images/791618485621325824/wBeu2-6V_mini.jpg', 'https://pbs.twimg.com/media/C22-9qrUcAAXnKV?format=jpg&name=small']",https://twitter.com/nycdoc29/status/823699592571133955
373,Matthew Herper,@matthewherper,2017-01-23T22:14:30.000Z,Now absolutely certain: Ken Frazier did not work at McDonald's. $mrk confirms.,"Now absolutely certain: Ken Frazier did not work at McDonald's. $mrk confirms.
6
1
2",,6,1,2,[],https://twitter.com/matthewherper/status/823655172911960064
374,Machilu Machilu‚ôï‚ôï,@Thanx13,2017-01-23T12:41:44.000Z,"Bristol-Myers: An Activist Shows Up, Finally http://seekingalpha.com/article/4038557-bristol-myers-activist-shows-finally?source=tweet‚Ä¶ $AGN $MRK $PFE $WBA $BMY","Bristol-Myers: An Activist Shows Up, Finally http://seekingalpha.com/article/4038557-bristol-myers-activist-shows-finally?source=tweet‚Ä¶ $AGN $MRK $PFE $WBA $BMY
seekingalpha.com
Bristol-Myers: An Activist Shows Up, Finally (NYSE:BMY)
BMY has an activist shareholder. But the big question is whether JANA Partners will step up and push for change.",,,,,['https://pbs.twimg.com/card_img/1501749539287572487/58FWI2OJ?format=png&name=360x360'],https://twitter.com/Thanx13/status/823511030559031297
375,Jeffrey Weber,@jjjinvesting,2017-01-24T21:59:51.000Z,I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY,"I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY
seekingalpha.com
I'm Buying Bristol-Myers Squibb Here At 52-Week Lows (NYSE:BMY)
On Friday, amidst BMY's 11% sell-off, I bought another lot of shares at the stock's 52 week low. In the $50 area I believe there is support. Plus, investors are getting a near 3.2% yield.",,,,,['https://pbs.twimg.com/card_img/1501749533763637252/38vfD1Ar?format=png&name=240x240'],https://twitter.com/jjjinvesting/status/824013873996890116
376,The Biotech Forum,@thebiotechforum,2017-01-23T20:38:36.000Z,Biotech Forum Daily Digest:: Opdivo's Setback - Focus Feature On Fibrogen http://seekingalpha.com/article/4038796-biotech-forum-daily-digest-opdivos-setback-focus-feature-fibrogen?source=tweet‚Ä¶ $AGN $AKAO $ALPMF $AZN $BMY $GILD $MRK,"Biotech Forum Daily Digest:: Opdivo's Setback - Focus Feature On Fibrogen http://seekingalpha.com/article/4038796-biotech-forum-daily-digest-opdivos-setback-focus-feature-fibrogen?source=tweet‚Ä¶ $AGN $AKAO $ALPMF $AZN $BMY $GILD $MRK
seekingalpha.com
Biotech Forum Daily Digest:: Opdivo's Setback - Focus Feature On Fibrogen
The biotech sector drifted down in the holiday shortened week just passed. Helping the pullback on Friday was a setback for Bristol-Myers Squibb's emerging blockbuster oncology drug Opdivo.
1
3",,,1,3,['https://pbs.twimg.com/card_img/1501749748306518021/gpgTYgUm?format=png&name=360x360'],https://twitter.com/thebiotechforum/status/823631040338161667
377,Heath Care News,@hc_equipment,2017-01-24T21:04:24.000Z,"#Merck, Domain Therapeutics partner to co-develop adenosine receptor antagonists. Read more: http://owler.us/ab8wOu $MRK","#Merck, Domain Therapeutics partner to co-develop adenosine receptor antagonists. Read more: http://owler.us/ab8wOu $MRK",,,,,[],https://twitter.com/hc_equipment/status/823999916812865536
378,Pharmaceutical News,@pharma_sector,2017-01-24T16:38:31.000Z,Bristol-Myers Settles Litigation with #Merck for Keytruda . Read more: http://owler.us/ab8qb9 $MRK,Bristol-Myers Settles Litigation with #Merck for Keytruda . Read more: http://owler.us/ab8qb9 $MRK,,,,,[],https://twitter.com/pharma_sector/status/823933009258680320
379,Novateur Ventures,@NovateurBio,2017-01-24T22:23:56.000Z,"$BMY, #Pharmaceutical Co, $MRK settle #Keytruda patent suit - $625 million plus royalties http://pharmatimes.com/news/bms,_ono,_merck_settle_keytruda_patent_suit_1184850‚Ä¶ via 
@PharmaTimes","$BMY, #Pharmaceutical Co, $MRK settle #Keytruda patent suit - $625 million plus royalties http://pharmatimes.com/news/bms,_ono,_merck_settle_keytruda_patent_suit_1184850‚Ä¶ via 
@PharmaTimes
pharmatimes.com
BMS, Ono, Merck settle Keytruda patent suit
Merck & Co has agreed to pay Bristol-Myers Squibb and Ono Pharmaceutical Co $625 million plus royalties to lay to rest a global patent battle relating to cancer immunotherapy Keytruda.
1",,,1,,['https://pbs.twimg.com/card_img/1500541838343737347/50JEkyyg?format=jpg&name=240x240'],https://twitter.com/NovateurBio/status/824019932635463681
380,F.A.S.T. Graphs,@FASTGraphs,2017-01-24T16:01:14.000Z,I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY,"I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY
seekingalpha.com
I'm Buying Bristol-Myers Squibb Here At 52-Week Lows (NYSE:BMY)
On Friday, amidst BMY's 11% sell-off, I bought another lot of shares at the stock's 52 week low. In the $50 area I believe there is support. Plus, investors are getting a near 3.2% yield.",,,,,['https://pbs.twimg.com/card_img/1501749533763637252/38vfD1Ar?format=png&name=240x240'],https://twitter.com/FASTGraphs/status/823923625875087362
381,MM+M Magazine,@MMMnews,2017-01-24T04:15:01.000Z,"5 things for #pharma #marketers to know: Mon., Jan. 23 $BMY $MRK #cancer #drugpricing 
@PhRMA
 #Trump #ACARepeal #FDA http://bit.ly/2iVZ5TD","5 things for #pharma #marketers to know: Mon., Jan. 23 $BMY $MRK #cancer #drugpricing 
@PhRMA
 #Trump #ACARepeal #FDA http://bit.ly/2iVZ5TD",,,,,['https://pbs.twimg.com/media/C23fAIxW8AAVlVU?format=jpg&name=small'],https://twitter.com/MMMnews/status/823745898824007682
382,Pharmaceutical News,@pharma_sector,2017-01-24T18:22:31.000Z,"Bristol-Myers Squibb Co (BMY) To Share In Sales Of #Merck & Co., Inc. Keytruda Following Lit... Read more: http://owler.us/ab8tsv $MRK","Bristol-Myers Squibb Co (BMY) To Share In Sales Of #Merck & Co., Inc. Keytruda Following Lit... Read more: http://owler.us/ab8tsv $MRK",,,,,[],https://twitter.com/pharma_sector/status/823959177852616704
383,BioPharma Dive,@BioPharmaDive,2017-01-23T21:22:01.000Z,Patent battle between $MRK and $BMY finally comes to a close,"Patent battle between $MRK and $BMY finally comes to a close
biopharmadive.com
Merck pays $625M to settle patent battle with Bristol, Ono
In another twist to the two companies' rivalry, Merck will pay up to clear the patent dispute. 
1
1",,1,1,,['https://pbs.twimg.com/card_img/1501982546749390851/lGUGepVY?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/823641963190685697
384,Daniel Carlson,@tailwindsgroup,2017-01-23T16:19:37.000Z,Tailwinds Newsletter discusses complacency in the markets. Danger ahead? $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK,"Tailwinds Newsletter discusses complacency in the markets. Danger ahead? $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK
twresearchgroup.com
Our Economic Future‚Ä¶Clear Road, or Danger Around The Corner???
Last night my buddy James and I went for a night ride. We headed out for Pine Mountain, a challenging ride on a good day and one that was certain to be a muddy slog after the recent drought-ending...",,,,,['https://pbs.twimg.com/card_img/1501275065580728321/SCLw16Xd?format=jpg&name=240x240'],https://twitter.com/tailwindsgroup/status/823565864276357120
385,Limex,@LimexMe,2017-01-24T14:29:33.000Z,Is It Finally OK to Buy Bristol-Myers Squibb? $BMY $MRK $RHHBY,"Is It Finally OK to Buy Bristol-Myers Squibb? $BMY $MRK $RHHBY
whotrades.com
Is It Finally OK to Buy Bristol-Myers Squibb?
After reporting disappointing news for its immunotherapy cancer drug Opdivo in lung cancer, Bristol-Myers Squibb's (NYSE: BMY) shares have lost one-third of their value. Are they a‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/823900553545740288
386,Limex,@LimexMe,2017-01-24T20:48:20.000Z,Gilead Sciences Stock: What Could Go Wrong? $GILD $GSK $MRK $JNJ $ABBV $GLPG http://bit.ly/240117GILD,Gilead Sciences Stock: What Could Go Wrong? $GILD $GSK $MRK $JNJ $ABBV $GLPG http://bit.ly/240117GILD,,,,,[],https://twitter.com/LimexMe/status/823995875189989376
387,MM+M Magazine,@MMMnews,2017-01-24T12:30:02.000Z,"Missed yesterday's news? Here's what to know #pharma $BMY $MRK #oncology #drugpricing 
@PhRMA
 #Trump #ACARepeal #FDA http://bit.ly/2iVZ5TD","Missed yesterday's news? Here's what to know #pharma $BMY $MRK #oncology #drugpricing 
@PhRMA
 #Trump #ACARepeal #FDA http://bit.ly/2iVZ5TD",,,,,['https://pbs.twimg.com/media/C23fLiOXcAgsY3T?format=jpg&name=small'],https://twitter.com/MMMnews/status/823870473427505152
388,Wolfe,@everytimeicash,2017-01-23T18:34:21.000Z,Baby Powder (JNJ)  http://everytimeicash.com/earners/2017/1/23/baby-powder-jnj‚Ä¶  $JNJ #Earnings $BMY $MMM $MRK $PFE $SYK $XLV,Baby Powder (JNJ)  http://everytimeicash.com/earners/2017/1/23/baby-powder-jnj‚Ä¶  $JNJ #Earnings $BMY $MMM $MRK $PFE $SYK $XLV,,,,,[],https://twitter.com/everytimeicash/status/823599768232493056
389,MarketBeat,@MarketBeatCom,2017-01-24T08:08:21.000Z,Merck KGaA given ‚Ç¨105.00 PT by Goldman Sachs Group Inc.. neutral rating. http://ift.tt/2jlsKEn $MRK #MRK,Merck KGaA given ‚Ç¨105.00 PT by Goldman Sachs Group Inc.. neutral rating. http://ift.tt/2jlsKEn $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/823804617507164160
390,Jacob Bell,@realJacobBell,2017-01-23T21:22:01.000Z,Patent battle between $MRK and $BMY finally comes to a close,"Patent battle between $MRK and $BMY finally comes to a close
biopharmadive.com
Merck pays $625M to settle patent battle with Bristol, Ono
In another twist to the two companies' rivalry, Merck will pay up to clear the patent dispute. ",,,,,['https://pbs.twimg.com/card_img/1501982546749390851/lGUGepVY?format=jpg&name=small'],https://twitter.com/realJacobBell/status/823641962695757824
391,TalkMarkets,@TalkMarkets,2017-01-24T02:39:05.000Z,"Morning Call For Monday, Jan. 23 $BBT $COL $FMC $MET $MRK $SLB $STI $VZ $WGO $DISH $QCOM https://goo.gl/uBpW7n","Morning Call For Monday, Jan. 23 $BBT $COL $FMC $MET $MRK $SLB $STI $VZ $WGO $DISH $QCOM https://goo.gl/uBpW7n",,,,,[],https://twitter.com/TalkMarkets/status/823721755500040194
392,Jacob Bell,@realJacobBell,2017-01-23T17:23:01.000Z,$MRK reaches patent settlement with $BMY over Keytruda,"$MRK reaches patent settlement with $BMY over Keytruda
biopharmadive.com
Merck pays $625M to settle patent battle with Bristol, Ono
In another twist to the two companies' rivalry, Merck will pay up to clear the patent dispute. ",,,,,['https://pbs.twimg.com/card_img/1501982546749390851/lGUGepVY?format=jpg&name=small'],https://twitter.com/realJacobBell/status/823581819358638081
393,MarketBeat,@MarketBeatCom,2017-01-24T13:46:24.000Z,Tower Bridge Advisors Raises Stake in Merck & Co. $MRK http://zpr.io/PYRb7,Tower Bridge Advisors Raises Stake in Merck & Co. $MRK http://zpr.io/PYRb7,,,,,[],https://twitter.com/MarketBeatCom/status/823889692630335490
394,Todd Campbell,@ebcapital,2017-01-24T22:23:18.000Z,"Gilead Sciences Stock: What Could Go Wrong? 
@themotleyfool
 #stocks $MRK, $JNJ, $GSK, $GILD, $ABBV, $GLPG http://fool.com/investing/2017/01/24/gilead-sciences-stock-what-could-go-wrong.aspx‚Ä¶","Gilead Sciences Stock: What Could Go Wrong? 
@themotleyfool
 #stocks $MRK, $JNJ, $GSK, $GILD, $ABBV, $GLPG http://fool.com/investing/2017/01/24/gilead-sciences-stock-what-could-go-wrong.aspx‚Ä¶
1",,,,1,[],https://twitter.com/ebcapital/status/824019774493446144
395,Market Realist,@MarketRealist,2017-01-23T22:10:22.000Z,Earnings Preview: How Did 4Q16 Treat Bristol-Myers Squibb? http://marketrealist.com/?p=1873815 $BMY $IYH $PFE $MRK,Earnings Preview: How Did 4Q16 Treat Bristol-Myers Squibb? http://marketrealist.com/?p=1873815 $BMY $IYH $PFE $MRK,,,,,[],https://twitter.com/MarketRealist/status/823654132204601344
396,Endpoints News,@endpts,2017-01-23T12:40:01.000Z,"A steady loser on the #checkpoint R&D front, $BMY scores a $625M payout from $MRK to settle patent fracas http://endpts.com/a-steady-loser‚Ä¶ #biotech","A steady loser on the #checkpoint R&D front, $BMY scores a $625M payout from $MRK to settle patent fracas http://endpts.com/a-steady-loser‚Ä¶ #biotech
1",,,1,,[],https://twitter.com/endpts/status/823510598772133888
397,TalkMarkets Recap,@MarketsRecap,2017-01-23T20:39:05.000Z,"Morning Call For Monday, Jan. 23 $BBT $COL $FMC $MET $MRK $SLB $STI $VZ $WGO $DISH $QCOM https://goo.gl/uBpW7n","Morning Call For Monday, Jan. 23 $BBT $COL $FMC $MET $MRK $SLB $STI $VZ $WGO $DISH $QCOM https://goo.gl/uBpW7n",,,,,[],https://twitter.com/MarketsRecap/status/823631159271759872
398,marketexclusive,@marketexclusive,2017-01-24T12:27:59.000Z,Bristol-Myers Squibb Co (NYSE:BMY) To Share In Sales Of K) Keytruda Following Litigation Settlement https://marketexclusive.com/bristol-myers-squibb-co-nysebmy-share-sales-merck-co-inc-nysemrk-keytruda-following-litigation-settlement/69611/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶  $MRK  $B,"Bristol-Myers Squibb Co (NYSE:BMY) To Share In Sales Of K) Keytruda Following Litigation Settlement https://marketexclusive.com/bristol-myers-squibb-co-nysebmy-share-sales-merck-co-inc-nysemrk-keytruda-following-litigation-settlement/69611/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶  $MRK  $B
10",,,10,,[],https://twitter.com/marketexclusive/status/823869960250331136
399,Magnolia Gallery,@MagnoliaG2012,2017-01-24T15:41:13.000Z,I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY,I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY,,,,,[],https://twitter.com/MagnoliaG2012/status/823918587341664257
400,Ticker Report,@TickerReport,2017-01-24T20:18:40.000Z,"Merck & Co. to Post Q1 2017 Earnings of $0.91 Per Share, Leerink Swann Forecasts $MRK http://ift.tt/2ju6hm1","Merck & Co. to Post Q1 2017 Earnings of $0.91 Per Share, Leerink Swann Forecasts $MRK http://ift.tt/2ju6hm1",,,,,[],https://twitter.com/TickerReport/status/823988408271962118
401,Endpoints News,@endpts,2017-01-23T01:30:01.000Z,"Trending: $BMY stunning #checkpoint setback, hands $MRK free pass on frontline #lungcancer combo http://endpts.com/bristol-myers-‚Ä¶ by 
@JohnCendpts","Trending: $BMY stunning #checkpoint setback, hands $MRK free pass on frontline #lungcancer combo http://endpts.com/bristol-myers-‚Ä¶ by 
@JohnCendpts
endpts.com
Bristol Myers' $9 Celgene CVR is teetering on the brink of disaster as the FDA delays the liso-cel...
The CVR ($BMYRT) tied to Bristol Myers Squibb's big Celgene buyout took one more step right to the brink Monday afternoon. As some analysts had fretted about, the FDA was unable to schedule an...
1",,,,1,['https://pbs.twimg.com/card_img/1499864531614371840/sopf2NQO?format=jpg&name=small'],https://twitter.com/endpts/status/823341987311054848
402,Novateur Ventures,@NovateurBio,2017-01-24T02:07:35.000Z,"After repeated setbacks on the checkpoint front, $BMY scores a $625M payout from $MRK to settle patent fracas https://endpts.com/a-steady-loser-on-the-checkpoint-rd-front-bristol-myers-scores-a-625m-payout-from-merck-to-settle-patent-fracas‚Ä¶","After repeated setbacks on the checkpoint front, $BMY scores a $625M payout from $MRK to settle patent fracas https://endpts.com/a-steady-loser-on-the-checkpoint-rd-front-bristol-myers-scores-a-625m-payout-from-merck-to-settle-patent-fracas‚Ä¶",,,,,[],https://twitter.com/NovateurBio/status/823713831155212288
403,Allison Gatlin,@IBD_AGatlin,2017-01-23T18:20:53.000Z,"Could Merck's ""meaningful"" Keytruda royalty give Bristol-Myers a leg up? $MRK $BMY","Could Merck's ""meaningful"" Keytruda royalty give Bristol-Myers a leg up? $MRK $BMY
investors.com
Could Merck's 'Meaningful' Keytruda Royalty Give Bristol-Myers A Leg Up? | Stock News & Stock...
Bristol-Myers and Ono could benefit from a ""meaningful"" royalty stream on Merck's Keytruda following a $625 million settlement announced Friday.",,,,,[],https://twitter.com/IBD_AGatlin/status/823596379918442497
404,BioPharma Dive,@BioPharmaDive,2017-01-23T17:23:01.000Z,$MRK reaches patent settlement with $BMY over Keytruda,"$MRK reaches patent settlement with $BMY over Keytruda
biopharmadive.com
Merck pays $625M to settle patent battle with Bristol, Ono
In another twist to the two companies' rivalry, Merck will pay up to clear the patent dispute. ",,,,,['https://pbs.twimg.com/card_img/1501982546749390851/lGUGepVY?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/823581818620243969
405,Hotpage News,@Hotpage_News,2017-01-23T13:57:49.000Z,EARLY MOVERS: $UAL $MRK $KATE $GOOG $GOOGL $GME $HLT $BX $VZ $YHOO $TMUS $QCOM $AAPL $JNJ $HAL - CNBC,"EARLY MOVERS: $UAL $MRK $KATE $GOOG $GOOGL $GME $HLT $BX $VZ $YHOO $TMUS $QCOM $AAPL $JNJ $HAL - CNBC
cnbc.com
Early movers: HAL, QCOM, MRK, BX, JNJ, TMUS, UAL & more
These are the stocks posting the largest moves before the bell.",,,,,['https://pbs.twimg.com/card_img/1499701922240073732/In14QTrw?format=jpg&name=small'],https://twitter.com/Hotpage_News/status/823530176084578304
406,Todd Campbell,@ebcapital,2017-01-24T15:00:43.000Z,"Is It Finally OK to Buy Bristol-Myers Squibb? 
@themotleyfool
 #stocks $MRK, $BMY, $RHHBY http://fool.com/investing/2017/01/24/is-it-finally-ok-to-buy-bristol-myers-squibb.aspx?source=iaasitlnk0000003‚Ä¶","Is It Finally OK to Buy Bristol-Myers Squibb? 
@themotleyfool
 #stocks $MRK, $BMY, $RHHBY http://fool.com/investing/2017/01/24/is-it-finally-ok-to-buy-bristol-myers-squibb.aspx?source=iaasitlnk0000003‚Ä¶",,,,,[],https://twitter.com/ebcapital/status/823908396529119232
407,Matthew Herper,@matthewherper,2017-01-22T22:20:25.000Z,"Replying to 
@skathire
 @statesdj
  and 3 others","Replying to 
@skathire
 @statesdj
  and 3 others
if $mrk anacetrib works, will be one of biggest upsets ever...
5",,,,5,[],https://twitter.com/matthewherper/status/823294275085602816
408,David Sobek,@dsobek,2017-01-24T16:33:51.000Z,"Replying to 
@biotechnova
 and 
@sharkbiotech","Replying to 
@biotechnova
 and 
@sharkbiotech
$MRK extension plus momelotinib failure securing jakafi base business for long term
1",,,,1,[],https://twitter.com/dsobek/status/823931833561845763
409,kyookine,@kyookine,2017-01-24T06:56:52.000Z,I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY,I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY,,,,,[],https://twitter.com/kyookine/status/823786630129385472
410,BooRad,@atticusMB,2017-01-24T16:34:37.000Z,"Is It Finally OK to Buy Bristol-Myers Squibb? 
@themotleyfool
 #stocks $MRK, $BMY, $RHHBY http://fool.com/investing/2017/01/24/is-it-finally-ok-to-buy-bristol-myers-squibb.aspx‚Ä¶","Is It Finally OK to Buy Bristol-Myers Squibb? 
@themotleyfool
 #stocks $MRK, $BMY, $RHHBY http://fool.com/investing/2017/01/24/is-it-finally-ok-to-buy-bristol-myers-squibb.aspx‚Ä¶",,,,,[],https://twitter.com/atticusMB/status/823932024876650497
411,Breaking News,@MarketCurrents,2017-01-25T16:43:49.000Z,Novartis aims for leadership position in oncology http://seekingalpha.com/news/3237447-novartis-aims-leadership-position-oncology?source=feed_f‚Ä¶ $NVS $MRK $BMY $RHHBY,"Novartis aims for leadership position in oncology http://seekingalpha.com/news/3237447-novartis-aims-leadership-position-oncology?source=feed_f‚Ä¶ $NVS $MRK $BMY $RHHBY
seekingalpha.com
Novartis aims for leadership position in oncology (NYSE:NVS)
Novartis (NVS +1.9%) does not plan to stay in the back seat in immuno-oncology for long.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/824296730564755458
412,Breaking News,@MarketCurrents,2017-01-26T15:45:57.000Z,"Short sellers backing away from Big Pharma, but only slightly http://seekingalpha.com/news/3237923-short-sellers-backing-away-big-pharma-slightly?source=feed_f‚Ä¶ $XPH $PFE $MRK $TEVA","Short sellers backing away from Big Pharma, but only slightly http://seekingalpha.com/news/3237923-short-sellers-backing-away-big-pharma-slightly?source=feed_f‚Ä¶ $XPH $PFE $MRK $TEVA",,,,,[],https://twitter.com/MarketCurrents/status/824644554234032128
413,Jonathan Rockoff,@jonathanrockoff,2017-01-27T14:29:31.000Z,"$MRK is latest pharmaco to address drug-pricing concerns, in its case by providing overall pricing data, after $JNJ, $AGN & $NVO","$MRK is latest pharmaco to address drug-pricing concerns, in its case by providing overall pricing data, after $JNJ, $AGN & $NVO
Peter Loftus
@Loftus
 ¬∑ 27 Jan 2017
Merck Reveals Details on U.S. Drug-Pricing Practices http://wsj.com/articles/merck-reveals-details-on-u-s-drug-pricing-practices-1485518403‚Ä¶
2
4",,,2,4,['https://pbs.twimg.com/profile_images/1499750782547157002/bK_X21Ry_mini.jpg'],https://twitter.com/jonathanrockoff/status/824987705243205632
414,Jack Allen,@JohnK_Allen,2017-01-26T15:56:44.000Z,"$MRK Keytruda seems to have hit a roadblock, experiencing adverse event in GBM","$MRK Keytruda seems to have hit a roadblock, experiencing adverse event in GBM
Andy Biotech
@AndyBiotech
 ¬∑ 26 Jan 2017
$MRK FDA puts Keytruda brain tumor trial on hold ""due to AE""

https://clinicaltrials.gov/ct2/show/NCT02359565‚Ä¶
5
2",,,5,2,['https://pbs.twimg.com/profile_images/378800000074240482/d961ebeb9f4fe6b084a68663b9a36738_mini.png'],https://twitter.com/JohnK_Allen/status/824647266543792132
415,Sarah Karlin-Smith,@SarahKarlin,2017-01-27T15:50:02.000Z,plus $MRK's Ken Frazier.,"plus $MRK's Ken Frazier.
Donna Young
@DonnaYoungDC
 ¬∑ 27 Jan 2017
$JNJ Alex Gorsky among those participating in Trump's new #Manufacturing #Jobs Initiative
#pharma
3
3",üì∞,,3,3,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/SarahKarlin/status/825007969876193280
416,dough,@semodough,2017-01-26T11:54:19.000Z,"Replying to 
@semodough","Replying to 
@semodough
BMO $MRK 20% KEYTRUDA 1LINE NSCLC market share in mid-January 2017 suggests rapid uptake by our responding physicians.
2
3",,,2,3,['https://pbs.twimg.com/media/C3GE0-_UYAAiEeO?format=jpg&name=small'],https://twitter.com/semodough/status/824586259578380288
417,Rishesh Singh,@androsForm,2017-01-27T15:03:16.000Z,$MRK [bto] FEB17 $61.5 Cs @ 1.39,"$MRK [bto] FEB17 $61.5 Cs @ 1.39
25
5",,,25,5,[],https://twitter.com/androsForm/status/824996198759018497
418,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-01-25T15:47:44.000Z,$MRK Keytruda December Sequential Sales Growth 14%; IO Market Share rises to 26%,"$MRK Keytruda December Sequential Sales Growth 14%; IO Market Share rises to 26%
3
2",üÖ± üÖæ,,3,2,[],https://twitter.com/_B_I_O_T_E_C_H_/status/824282613976367104
419,pharmalot,@pharmalot,2017-01-27T19:06:49.000Z,"Merck provides data on drug prices, but it's only a peek behind the curtain.. see for yourself:  https://statnews.com/pharmalot/2017/01/27/merck-drug-prices/‚Ä¶ #pharma $MRK $AGN","Merck provides data on drug prices, but it's only a peek behind the curtain.. see for yourself:  https://statnews.com/pharmalot/2017/01/27/merck-drug-prices/‚Ä¶ #pharma $MRK $AGN
statnews.com
Merck provides data on drug prices, but it's only a peek behind the curtain
Merck disclosed that it raised list prices to 10.5 percent in 2014, from 7.4 percent in 2010, before declining to 9.6 percent last year.
3
1",,,3,1,['https://pbs.twimg.com/card_img/1501748622039339010/jhslLUAX?format=jpg&name=small'],https://twitter.com/pharmalot/status/825057491050430465
420,WallStreetGangsta,@WallStGangsta,2017-01-27T15:36:42.000Z,"$OBMP Extremely Oversold , Ready To Bounce , Massive Crowd Will Discover This Chart Soon $GILD $MRK $BMY $AMGN $PFE $JNJ $IBB $OREX $BLUE","$OBMP Extremely Oversold , Ready To Bounce , Massive Crowd Will Discover This Chart Soon $GILD $MRK $BMY $AMGN $PFE $JNJ $IBB $OREX $BLUE",,,,,['https://pbs.twimg.com/media/C3MBT-VUYAAT9c3?format=jpg&name=small'],https://twitter.com/WallStGangsta/status/825004612566577152
421,Stock Chat and Forum,@007stockchat,2017-01-26T14:57:34.000Z,"$ITRK .18 gone, .20 up, next trade could set a new HOD. IMO $ITRK $GILD $JNJ $MGN $MRK $BMY $NVS $SPY $AAPL $FB $AMZN $PFE $XOM","$ITRK .18 gone, .20 up, next trade could set a new HOD. IMO $ITRK $GILD $JNJ $MGN $MRK $BMY $NVS $SPY $AAPL $FB $AMZN $PFE $XOM
1
2",,,1,2,[],https://twitter.com/007stockchat/status/824632376546492416
422,Heath Care News,@hc_equipment,2017-01-27T10:41:01.000Z,#Merck KGaA PT Set at ‚Ç¨105.00 by Goldman Sachs Group Inc. Read more: http://owler.us/ab9dwF $MRK,"#Merck KGaA PT Set at ‚Ç¨105.00 by Goldman Sachs Group Inc. Read more: http://owler.us/ab9dwF $MRK
1",,,1,,[],https://twitter.com/hc_equipment/status/824930203080105984
423,SP Schatzi,@SPSchatzi,2017-01-27T16:46:30.000Z,$gild Judge stays payment to $mrk.  Did he rule on treble damages?,"$gild Judge stays payment to $mrk.  Did he rule on treble damages?
1",,,1,,[],https://twitter.com/SPSchatzi/status/825022180622602240
424,Seeking Alpha,@SeekingAlpha,2017-01-27T14:48:37.000Z,Make Money Using Analyst Ratings http://seekingalpha.com/article/4040124-make-money-using-analyst-ratings?source=feed_f‚Ä¶ $AYI $AVY $BRK.B $STZ $FAST $HSIC $MRK $ROP $WAT $XRX,"Make Money Using Analyst Ratings http://seekingalpha.com/article/4040124-make-money-using-analyst-ratings?source=feed_f‚Ä¶ $AYI $AVY $BRK.B $STZ $FAST $HSIC $MRK $ROP $WAT $XRX
seekingalpha.com
Make Money Using Analyst Ratings
Once Again Analyst Ratings Have Become Newsworthy. Seeking Alpha CEO Eli Hoffman re: ‚ÄúBogus‚Äù analyst ratings: ‚ÄúSay It Isn‚Äôt So!‚Äù.",,,,,['https://pbs.twimg.com/card_img/1501748632982376453/_9I0IFsi?format=jpg&name=360x360'],https://twitter.com/SeekingAlpha/status/824992513534554113
425,Bursatil Biotech,@BursatilBiotech,2017-01-26T15:49:06.000Z,"So far, this's not a good day for $BMY or $MRK","So far, this's not a good day for $BMY or $MRK
Andy Biotech
@AndyBiotech
 ¬∑ 26 Jan 2017
$MRK FDA puts Keytruda brain tumor trial on hold ""due to AE""

https://clinicaltrials.gov/ct2/show/NCT02359565‚Ä¶
1",,1,,,['https://pbs.twimg.com/profile_images/378800000074240482/d961ebeb9f4fe6b084a68663b9a36738_mini.png'],https://twitter.com/BursatilBiotech/status/824645345107963905
426,PennyStockSpy,@pennystockspy,2017-01-26T16:25:55.000Z,"ITRK .195 on the offer, above HOD, could see a potential breakout here. $ITRK $GILD $JNJ $MGN $MRK $BMY $NVS $SPY $AAPL $FB $AMZN $PFE $XOM","ITRK .195 on the offer, above HOD, could see a potential breakout here. $ITRK $GILD $JNJ $MGN $MRK $BMY $NVS $SPY $AAPL $FB $AMZN $PFE $XOM
1",,,,1,[],https://twitter.com/pennystockspy/status/824654612963749889
427,Daniel Carlson,@tailwindsgroup,2017-01-27T16:24:38.000Z,Trump Trade Has Disaster Written All Over It‚Ä¶ $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK $MSFT $MKE http://tailwindsresearch.com/2017/01/trump-trade-has-disaster-written-all-over-it/‚Ä¶,"Trump Trade Has Disaster Written All Over It‚Ä¶ $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK $MSFT $MKE http://tailwindsresearch.com/2017/01/trump-trade-has-disaster-written-all-over-it/‚Ä¶
1",,,,1,[],https://twitter.com/tailwindsgroup/status/825016674986315776
428,OptionsFlux,@OptionsFlux,2017-01-27T14:53:10.000Z,"$MRK 2464 FEB 17, 2017 CALL 62 BUY at $1.03 MID = $254k bet; Vol: 5000 vs OI: 693 (09:52:57 EST)  #BULL","$MRK 2464 FEB 17, 2017 CALL 62 BUY at $1.03 MID = $254k bet; Vol: 5000 vs OI: 693 (09:52:57 EST)  #BULL
2",,,,2,[],https://twitter.com/OptionsFlux/status/824993658990649346
429,Open Outcrier,@OpenOutcrier,2017-01-27T21:31:28.000Z,"RECAP 1/27 TRUMPWATCH (2/2):
Manufacturing Jobs Initiative Cos: 
$JNJ $LMT $MMM $MRK $NWL $NUE $TKR $TSLA $UAA $UTX $WHR $X","RECAP 1/27 TRUMPWATCH (2/2):
Manufacturing Jobs Initiative Cos: 
$JNJ $LMT $MMM $MRK $NWL $NUE $TKR $TSLA $UAA $UTX $WHR $X
2
2",,,2,2,[],https://twitter.com/OpenOutcrier/status/825093895495131136
430,Open Outcrier,@OpenOutcrier,2017-01-27T14:55:45.000Z,$MRK Feb 62 Call Buyers +5k for $1.00-1.03,"$MRK Feb 62 Call Buyers +5k for $1.00-1.03
2",,,,2,[],https://twitter.com/OpenOutcrier/status/824994307488808963
431,Benzinga,@Benzinga,2017-01-25T20:23:02.000Z,Dow 10K's Hottest Stocks: Where Are They Now? http://benzinga.com/z/8946256 $DOW $GE $HON $IBM $JNJ $MCD $MRK $UTX $WMT $HON #dow20k,"Dow 10K's Hottest Stocks: Where Are They Now? http://benzinga.com/z/8946256 $DOW $GE $HON $IBM $JNJ $MCD $MRK $UTX $WMT $HON #dow20k
benzinga.com
Dow 10K's Hottest Stocks: Where Are They Now?
The markets are on fire. After stalling in the new year following the post-election rally late last year, the markets have resumed their rally. The Dow Industrials has gone past...
1
2",,,1,2,[],https://twitter.com/Benzinga/status/824351895078785025
432,Ticker Report,@TickerReport,2017-01-27T09:42:07.000Z,"Merck & Company, Inc. $MRK Shares Sold by Manning & Napier Advisors LLC http://ift.tt/2kzYbwu","Merck & Company, Inc. $MRK Shares Sold by Manning & Napier Advisors LLC http://ift.tt/2kzYbwu
1",,,1,,[],https://twitter.com/TickerReport/status/824915379570999296
433,kyookine,@kyookine,2017-01-27T17:58:05.000Z,Merck discloses U.S. price increases; plans to update yearly http://seekingalpha.com/news/3238319-merck-discloses-u-s-price-increases-plans-update-yearly?source=tweet‚Ä¶ $MRK,"Merck discloses U.S. price increases; plans to update yearly http://seekingalpha.com/news/3238319-merck-discloses-u-s-price-increases-plans-update-yearly?source=tweet‚Ä¶ $MRK
seekingalpha.com
Merck discloses U.S. price increases; plans to update yearly (NYSE:MRK)
Merck (NYSE:MRK) says it will release data today on its website showing the annual increases in the list prices of its U.S.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/kyookine/status/825040193342173184
434,David Showkz,@mr_showkz99,2017-01-26T16:29:38.000Z,"Short sellers backing away from Big Pharma, but only slightly http://seekingalpha.com/news/3237923-short-sellers-backing-away-big-pharma-slightly?source=tweet‚Ä¶ $XPH $PFE $MRK $TEVA","Short sellers backing away from Big Pharma, but only slightly http://seekingalpha.com/news/3237923-short-sellers-backing-away-big-pharma-slightly?source=tweet‚Ä¶ $XPH $PFE $MRK $TEVA
seekingalpha.com
Short sellers backing away from Big Pharma, but only slightly (NYSE:PFE)
Now that pro-business Donald Trump sits in the Oval Office, many, if not most, large cap stocks are rallying.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/mr_showkz99/status/824655548159238145
435,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-01-26T17:59:26.000Z,"Replying to 
@Janfr31","Replying to 
@Janfr31
not easy - but I think they might be bought before anyway by $MRK $BMY or some other soon
2
2
2",,2,2,2,['https://pbs.twimg.com/media/C3HYWqbW8AAS53x?format=jpg&name=small'],https://twitter.com/dhovekamp42/status/824678144259031041
436,TalkMarkets,@TalkMarkets,2017-01-27T03:18:52.000Z,The 12 Best High Yield Dow 30 Stocks $BA $CAT $CVX $IBM $KO $MCD $MRK $PFE $PG $VZ $XOM $CSCO Also $XLK https://goo.gl/wd0qZ4,"The 12 Best High Yield Dow 30 Stocks $BA $CAT $CVX $IBM $KO $MCD $MRK $PFE $PG $VZ $XOM $CSCO Also $XLK https://goo.gl/wd0qZ4
1",,,1,,[],https://twitter.com/TalkMarkets/status/824818932695580672
437,Benzinga,@Benzinga,2017-01-26T16:30:02.000Z,Which Pharma Players Dominate The Lung Cancer Space? http://benzinga.com/z/8945361 $MRK $AZN $BMY $CLVS $RHHBY,"Which Pharma Players Dominate The Lung Cancer Space? http://benzinga.com/z/8945361 $MRK $AZN $BMY $CLVS $RHHBY
5
3",,,5,3,[],https://twitter.com/Benzinga/status/824655645936717824
438,FirstWord Pharma,@fwpharma,2017-01-27T17:14:51.000Z,"Merck & Co. unveils details about price increases for branded drugs, vaccines in the US https://firstwordpharma.com/node/1448476 $MRK #drugprices","Merck & Co. unveils details about price increases for branded drugs, vaccines in the US https://firstwordpharma.com/node/1448476 $MRK #drugprices
old.firstwordpharma.com
Merck & Co. unveils details about price increases for branded drugs, vaccines in the US
Merck & Co. on Friday released information showing that average price increases on its branded drugs and vaccines ranged from 7.4 percent to 10.5 percent between 2010 and 2016. The company also noted...
3
1",,,3,1,['https://pbs.twimg.com/card_img/1501672348151386118/EDuK1CYL?format=jpg&name=240x240'],https://twitter.com/fwpharma/status/825029316367044608
439,dough,@semodough,2017-01-26T14:03:31.000Z,$MRK KEYTRUDA momentum building $BMY https://twitter.com/tgtxdough/status/824586259578380288‚Ä¶,"$MRK KEYTRUDA momentum building $BMY https://twitter.com/tgtxdough/status/824586259578380288‚Ä¶
üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR
@_B_I_O_T_E_C_H_
 ¬∑ 25 Jan 2017
$MRK Keytruda December Sequential Sales Growth 14%; IO Market Share rises to 26%
1
1",üÖ± üÖæ,1,1,,['https://pbs.twimg.com/profile_images/1490073125391937538/WdkRt7E4_mini.jpg'],https://twitter.com/semodough/status/824618773810475008
440,Pharmaceutical News,@pharma_sector,2017-01-27T19:07:32.000Z,#Merck A huge drugmaker just took an unprecedented move to counter criticism about rising pr... Read more: http://owler.us/ab9rKd $MRK,#Merck A huge drugmaker just took an unprecedented move to counter criticism about rising pr... Read more: http://owler.us/ab9rKd $MRK,,,,,[],https://twitter.com/pharma_sector/status/825057671741005824
441,Industry Focus,@MFIndustryFocus,2017-01-25T16:26:53.000Z,"Jam-packed HC show today: Bristol-Myers/Merck lawsuit, JNJ earnings, Humana/Aetna merger blocked. $JNJ $BMY $MRK $AET$HUM","Jam-packed HC show today: Bristol-Myers/Merck lawsuit, JNJ earnings, Humana/Aetna merger blocked. $JNJ $BMY $MRK $AET$HUM
1",,,,1,[],https://twitter.com/MFIndustryFocus/status/824292466547363840
442,Jacob Plieth,@JacobPlieth,2017-01-26T17:07:20.000Z,Ridiculous days call for ridiculous thoughts: should $BMY pull some Opdivo uses & just rely on $MRK royalty from Keytruda's bigger share?,"Ridiculous days call for ridiculous thoughts: should $BMY pull some Opdivo uses & just rely on $MRK royalty from Keytruda's bigger share?
6
1
3",,6,1,3,[],https://twitter.com/JacobPlieth/status/824665032877371393
443,Paul R. La Monica,@LaMonicaBuzz,2017-01-25T18:42:44.000Z,Dow 20K isn't a happy day for everyone. Dow components $AXP $MRK $PG $UTX $VZ $WMT all lower.,"Dow 20K isn't a happy day for everyone. Dow components $AXP $MRK $PG $UTX $VZ $WMT all lower.
1
2",,1,,2,[],https://twitter.com/LaMonicaBuzz/status/824326653149118472
444,Amanda Narod,@AmandaBinDC,2017-01-27T13:15:57.000Z,Ok. Step in the right direction. But how do they arrive at price to begin with? #drugpricing $MRK,"Ok. Step in the right direction. But how do they arrive at price to begin with? #drugpricing $MRK
Peter Loftus
@Loftus
 ¬∑ 27 Jan 2017
Merck Reveals Details on U.S. Drug-Pricing Practices http://wsj.com/articles/merck-reveals-details-on-u-s-drug-pricing-practices-1485518403‚Ä¶",,,,,['https://pbs.twimg.com/profile_images/1499750782547157002/bK_X21Ry_mini.jpg'],https://twitter.com/AmandaBinDC/status/824969194827632640
445,Jacob Plieth,@JacobPlieth,2017-01-26T15:58:26.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
What's CHM227 prob of success in light of abandonment of ‚Äúaccelerated"" 1L NSCLC plan? $BMY no comment for competitive reasons $MRK
1
3",,,1,3,[],https://twitter.com/JacobPlieth/status/824647697655361537
446,Bursatil Biotech,@BursatilBiotech,2017-01-26T17:49:12.000Z,"Holy cow..This is not good $BMY .

Btw, just for the record, $MRK's date with FDA is May 10.","Holy cow..This is not good $BMY .

Btw, just for the record, $MRK's date with FDA is May 10.
zach
@zbiotech
 ¬∑ 26 Jan 2017
to quantify it, $BMY has lost 22B since JPM conf this yr and just under 50B since whiffing in front-line NSCLC in aug '16
1",,,,1,['https://pbs.twimg.com/profile_images/2325159264/qel321r9zxqce9paddxl_mini.png'],https://twitter.com/BursatilBiotech/status/824675571108024320
447,Bursatil Biotech,@BursatilBiotech,2017-01-27T20:10:14.000Z,"Does anyone have $MRK's slides from #JPM17? I could ony find the transcript, either on mrk's or in jpm's website","Does anyone have $MRK's slides from #JPM17? I could ony find the transcript, either on mrk's or in jpm's website
1",,1,,,[],https://twitter.com/BursatilBiotech/status/825073449307615233
448,OTC FIRE,@Otcfire,2017-01-26T14:57:33.000Z,"$ITRK .18 gone, .20 up, next trade could set a new HOD. IMO $ITRK $GILD $JNJ $MGN $MRK $BMY $NVS $SPY $AAPL $FB $AMZN $PFE $XOM","$ITRK .18 gone, .20 up, next trade could set a new HOD. IMO $ITRK $GILD $JNJ $MGN $MRK $BMY $NVS $SPY $AAPL $FB $AMZN $PFE $XOM
1",,,,1,[],https://twitter.com/Otcfire/status/824632375875432453
449,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-01-26T22:37:13.000Z,#EquityResearch 11 Favored High-Yield Firms Within The Dow For 2017 $BA $CSCO $CVX $DIA $IBM $IHE $KO $MCD $MRK‚Ä¶ http://dlvr.it/NCjJ4F,#EquityResearch 11 Favored High-Yield Firms Within The Dow For 2017 $BA $CSCO $CVX $DIA $IBM $IHE $KO $MCD $MRK‚Ä¶ http://dlvr.it/NCjJ4F,,,,,['https://pbs.twimg.com/media/C3IX-ZiUkAAB8GD?format=jpg&name=small'],https://twitter.com/AlertTrade/status/824748052804046848
450,The Fly,@theflynews,2017-01-25T21:14:01.000Z,Reports finds latest hep C drugs associated with liver failures: http://bit.ly/2jylLW9 $GILD $MRK $ABBV $BMY,"Reports finds latest hep C drugs associated with liver failures: http://bit.ly/2jylLW9 $GILD $MRK $ABBV $BMY
thefly.com
Reports finds latest hep C drugs associated with liver failures, STAT says
A new report has found se... GILD, MRK, ABBV, BMY
1",,,1,,['https://pbs.twimg.com/card_img/1501406508495642642/64x8MhlL?format=jpg&name=small'],https://twitter.com/theflynews/status/824364727660871680
451,Lewis Krauskopf,@LKrauskopf,2017-01-27T14:56:52.000Z,"Two pharma/healthcare CEOs on Trump manufacturing list: $MRK's Frazier, $JNJ's Gorsky","Two pharma/healthcare CEOs on Trump manufacturing list: $MRK's Frazier, $JNJ's Gorsky
CNBC Now
@CNBCnow
 ¬∑ 27 Jan 2017
JUST IN: President Trump announces group of business leaders and CEOs to be part of his ""Manufacturing Jobs Initiative""",,,,,"['https://pbs.twimg.com/profile_images/1025457837026275329/F51xxiuX_mini.jpg', 'https://pbs.twimg.com/media/C3L13JhW8AISGH6?format=jpg&name=small']",https://twitter.com/LKrauskopf/status/824994588087681025
452,Allison Gatlin,@IBD_AGatlin,2017-01-26T17:02:49.000Z,Bristol-Myers topples on guidance cut amid Merck I-O competition $BMY $MRK http://ow.ly/kgVD308nJL1,Bristol-Myers topples on guidance cut amid Merck I-O competition $BMY $MRK http://ow.ly/kgVD308nJL1,,,,,[],https://twitter.com/IBD_AGatlin/status/824663897382739969
453,Insider Monkey,@insidermonkey,2017-01-26T17:45:04.000Z,"11 Largest Pharmaceutical Companies In The World
$GSK, $MRK, $SNY, $PFE, $NVS,  $RHHBY, $CAH, $ABC, $MCK","11 Largest Pharmaceutical Companies In The World
$GSK, $MRK, $SNY, $PFE, $NVS,  $RHHBY, $CAH, $ABC, $MCK
insidermonkey.com
11 Largest Pharmaceutical Companies In The World
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors given the recession...",,,,,[],https://twitter.com/insidermonkey/status/824674528810987520
454,Allison Gatlin,@IBD_AGatlin,2017-01-27T19:55:09.000Z,"Will Merck let Incyte go after AstraZeneca, Bristol, Roche team-ups too? $MRK $INCY $RHHBY $BMY $AZN","Will Merck let Incyte go after AstraZeneca, Bristol, Roche team-ups too? $MRK $INCY $RHHBY $BMY $AZN
investors.com
Will Merck Let Incyte Go After AstraZeneca, Bristol, Roche Team-Ups Too? | Stock News & Stock...
Incyte could pull $4.8 billion in 2026 peak sales on its Merck partnership alone, Goldman Sachs analyst Salveen Richter said Friday.
1",,,1,,['https://pbs.twimg.com/card_img/1489156100196732928/XmeBg0zM?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/825069654716665857
455,Clark Joseph Kent,@JorelLaraKalel,2017-01-27T19:42:17.000Z,Celgene As Another http://Amazon.com: Buying The Dips $CELG $AMZN $IBB $BMY $MRK $GILD http://bit.ly/2jFIkbP $AABV $BIIB,"Celgene As Another http://Amazon.com: Buying The Dips $CELG $AMZN $IBB $BMY $MRK $GILD http://bit.ly/2jFIkbP $AABV $BIIB
seekingalpha.com
Celgene As Another Amazon.com: Buying The Dips (NASDAQ:CELG)
CELG had pre-announced Q4 results and its 2017 projections, thus as periodically happens, traders sold the news.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/JorelLaraKalel/status/825066418555256833
456,Ticker Report,@TickerReport,2017-01-25T12:48:12.000Z,"Merck & Company, Inc. $MRK Rating Reiterated by BMO Capital Markets http://ift.tt/2jpj77L","Merck & Company, Inc. $MRK Rating Reiterated by BMO Capital Markets http://ift.tt/2jpj77L",,,,,[],https://twitter.com/TickerReport/status/824237433449545728
457,BioPharma Dive,@BioPharmaDive,2017-01-27T18:00:04.000Z,What will next bout of earnings hold? http://bit.ly/2kBexRp $AGN $AZN $GILD $GSK $LLY $MRK $NVO $PFE $RHHBY $SNY,"What will next bout of earnings hold? http://bit.ly/2kBexRp $AGN $AZN $GILD $GSK $LLY $MRK $NVO $PFE $RHHBY $SNY
biopharmadive.com
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
The second week of full-year earnings begins with reports from Merck, Lilly, Pfizer, Roche, Gilead and others. ",,,,,['https://pbs.twimg.com/card_img/1501746891918385163/GaxjqhvO?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/825040695006265346
458,Clark Joseph Kent,@JorelLaraKalel,2017-01-27T23:08:23.000Z,"Will Merck Let Incyte Go After AstraZeneca, Bristol, Roche Team-Ups Too? $MRK $INCY $AZN $BMY $RHHBY","Will Merck Let Incyte Go After AstraZeneca, Bristol, Roche Team-Ups Too? $MRK $INCY $AZN $BMY $RHHBY
investors.com
Will Merck Let Incyte Go After AstraZeneca, Bristol, Roche Team-Ups Too? | Stock News & Stock...
Incyte could pull $4.8 billion in 2026 peak sales on its Merck partnership alone, Goldman Sachs analyst Salveen Richter said Friday.",,,,,[],https://twitter.com/JorelLaraKalel/status/825118284538380288
459,Todd Campbell,@ebcapital,2017-01-25T02:45:05.000Z,"Uh-Oh: This Could Be Johnson & Johnson's Biggest Risk in 2017 
@themotleyfool
 #stocks $PFE, $MRK, $JNJ, $GSK","Uh-Oh: This Could Be Johnson & Johnson's Biggest Risk in 2017 
@themotleyfool
 #stocks $PFE, $MRK, $JNJ, $GSK
fool.com
Uh-Oh: This Could Be Johnson & Johnson's Biggest Risk in 2017 @themotleyfool #stocks $JNJ $PFE $MRK...
Fourth-quarter financials suggest Pfizer's Remicade biosimilar may already be denting Johnson & Johnson's market share.",,,,,[],https://twitter.com/ebcapital/status/824085656423059456
460,dough,@semodough,2017-01-26T14:09:33.000Z,"Replying to 
@semodough","Replying to 
@semodough
@_B_I_O_T_E_C_H_
 $MRK  continue to gain share at the expense of $BMY Opdivo (nivolumab, anti-PD-1), which had a 2% sales increase in Dec
2
1
1",,2,1,1,[],https://twitter.com/semodough/status/824620295629762563
461,a_silverstein,@a_silverstein,2017-01-27T13:28:33.000Z,"Good reporting by 
@Loftus
 on 
@Merck
 transparency on drug prices. I commend $MRK for transparency http://on.wsj.com/2kAVv1z","Good reporting by 
@Loftus
 on 
@Merck
 transparency on drug prices. I commend $MRK for transparency http://on.wsj.com/2kAVv1z
2",,,,2,[],https://twitter.com/a_silverstein/status/824972362282045440
462,Clark Joseph Kent,@JorelLaraKalel,2017-01-27T23:48:18.000Z,Cramer's game plan: What I expect for earnings $AAPL $AMZN $FB $S $AMD $UA $MU $MRK $CLX $AN http://cnb.cx/2kcGx1d,"Cramer's game plan: What I expect for earnings $AAPL $AMZN $FB $S $AMD $UA $MU $MRK $CLX $AN http://cnb.cx/2kcGx1d
youtube.com
Amazon Prime Rewards Visa Signature Credit Card Review. Get 5% back...
Get a $70 Amazon Gift Card & an Amazon Rewards Visa Signature Card. No Annual Fee. Get 5% back on Amazon purchases.Sign up for the card here: amzn.to/2idPIhS...",,,,,['https://pbs.twimg.com/card_img/1500272233259978758/79sTlwA5?format=jpg&name=240x240'],https://twitter.com/JorelLaraKalel/status/825128329875431424
463,Donna Young,@DonnaYoungDC,2017-01-27T15:53:29.000Z,"Yes, $MRK Ken Frazier, too
Thanks 
@SarahKarlin
. I mowed right past that.","Yes, $MRK Ken Frazier, too
Thanks 
@SarahKarlin
. I mowed right past that.
Sarah Karlin-Smith
@SarahKarlin
 ¬∑ 27 Jan 2017
plus $MRK's Ken Frazier. https://twitter.com/DonnaYoungDC/status/824999754199420928‚Ä¶",üì∞,,,,['https://pbs.twimg.com/profile_images/678756794513154048/QnVCh0pe_mini.jpg'],https://twitter.com/DonnaYoungDC/status/825008836654161920
464,Benzinga,@Benzinga,2017-01-26T16:00:05.000Z,Merck's Keytruda Gains Momentum At The Expense Of Bristol-Myers http://benzinga.com/z/8950989 $BMY $MRK $RHHBY,"Merck's Keytruda Gains Momentum At The Expense Of Bristol-Myers http://benzinga.com/z/8950989 $BMY $MRK $RHHBY
benzinga.com
Merck's Keytruda Gains Momentum At The Expense Of Bristol-Myers
Analyzing the monthly immuno-oncology sales data, Leerink said Merck & Co., Inc. (NYSE: MRK)'s Keytruda is picking up speed, but Bristol-Myers Squibb Co (NYSE: BMY)'s...
1
1",,,1,1,[],https://twitter.com/Benzinga/status/824648110383194112
465,Tim,@tstamm7002,2017-01-27T20:16:46.000Z,"Replying to 
@BursatilBiotech","Replying to 
@BursatilBiotech
If I recall correctly, $MRK did a fireside chat.  no slides
1
1",,1,,1,[],https://twitter.com/tstamm7002/status/825075094569549826
466,Ani Anirudhan,@pnani456,2017-01-25T00:07:02.000Z,"Replying to 
@semodough","Replying to 
@semodough
it has to be $CELG. $MRK is a dog, $BMY is dead, $GILD in a coma ... $IBB
1",,,,1,[],https://twitter.com/pnani456/status/824045878033924101
467,Paul R. La Monica,@LaMonicaBuzz,2017-01-27T17:48:26.000Z,Yogi Berra say earnings season ain't over till it's over? Lenny Kravitz? No. But $XOM $UPS $PFE $AAPL $MO $MET $FB $MRK $AMZN $V next week.,Yogi Berra say earnings season ain't over till it's over? Lenny Kravitz? No. But $XOM $UPS $PFE $AAPL $MO $MET $FB $MRK $AMZN $V next week.,,,,,[],https://twitter.com/LaMonicaBuzz/status/825037765830127617
468,Jacob Bell,@realJacobBell,2017-01-27T21:49:01.000Z,Here's what's on tap for earnings http://bit.ly/2kBexRp $NVO $AZN $GILD $PFE $RHHBY $LLY $MRK  $AGN  $SNY $GSK,"Here's what's on tap for earnings http://bit.ly/2kBexRp $NVO $AZN $GILD $PFE $RHHBY $LLY $MRK  $AGN  $SNY $GSK
biopharmadive.com
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
The second week of full-year earnings begins with reports from Merck, Lilly, Pfizer, Roche, Gilead and others. ",,,,,['https://pbs.twimg.com/card_img/1501746891918385163/GaxjqhvO?format=jpg&name=small'],https://twitter.com/realJacobBell/status/825098310482550784
469,BioPharma Dive,@BioPharmaDive,2017-01-27T21:49:01.000Z,Here's what's on tap for earnings http://bit.ly/2kBexRp $NVO $AZN $GILD $PFE $RHHBY $LLY $MRK  $AGN  $SNY $GSK,"Here's what's on tap for earnings http://bit.ly/2kBexRp $NVO $AZN $GILD $PFE $RHHBY $LLY $MRK  $AGN  $SNY $GSK
biopharmadive.com
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
The second week of full-year earnings begins with reports from Merck, Lilly, Pfizer, Roche, Gilead and others. ",,,,,['https://pbs.twimg.com/card_img/1501746891918385163/GaxjqhvO?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/825098309408800770
470,Bio Stocks‚Ñ¢,@BioStocks,2017-01-29T16:30:00.000Z,$MRK reveals seven years of its U.S. drug price increase history http://reut.rs/2kC8iAQ #pharma,"$MRK reveals seven years of its U.S. drug price increase history http://reut.rs/2kC8iAQ #pharma
reuters.com
Merck reveals seven years of its U.S. drug price increase history
Merck & Co on Friday posted seven years of information showing a high single-digit percentage annual average price hike across its portfolio of medicines in a move that provides new details on its...
3
4",,,3,4,['https://pbs.twimg.com/card_img/1490114281773441024/1_UZ-Gbr?format=png&name=small'],https://twitter.com/BioStocks/status/825742802877292544
471,Adam Feuerstein,@adamfeuerstein,2017-01-29T22:45:20.000Z,New $MRK statement sent to me:,"New $MRK statement sent to me:
6
9
14",,6,9,14,['https://pbs.twimg.com/media/C3X2maxVUAA9ERy?format=jpg&name=medium'],https://twitter.com/adamfeuerstein/status/825837260033626113
472,pharmalot,@pharmalot,2017-01-28T15:56:38.000Z,"ICYMI: Merck provides data on drug prices, but it's only a peek behind the curtain.. numbers are here https://statnews.com/pharmalot/2017/01/27/merck-drug-prices/‚Ä¶ #pharma $MRK","ICYMI: Merck provides data on drug prices, but it's only a peek behind the curtain.. numbers are here https://statnews.com/pharmalot/2017/01/27/merck-drug-prices/‚Ä¶ #pharma $MRK
statnews.com
Merck provides data on drug prices, but it's only a peek behind the curtain
Merck disclosed that it raised list prices to 10.5 percent in 2014, from 7.4 percent in 2010, before declining to 9.6 percent last year.
7
4",,,7,4,['https://pbs.twimg.com/card_img/1501748622039339010/jhslLUAX?format=jpg&name=small'],https://twitter.com/pharmalot/status/825372017658576898
473,dough,@semodough,2017-01-29T19:30:42.000Z,Biotech earnings this week $LLY $PFE $MRK $GILD $AZN $AMGN $ILMN,"Biotech earnings this week $LLY $PFE $MRK $GILD $AZN $AMGN $ILMN
8
11",,,8,11,['https://pbs.twimg.com/media/C3XKDoyXAAg-sjA?format=jpg&name=900x900'],https://twitter.com/semodough/status/825788277957472256
474,Alessandro viva l‚Äô#Ucraina,@pelias01,2017-01-30T16:18:55.000Z,Deregulation: A Slam-Dunk For Investors http://seekingalpha.com/article/4039112-deregulation-slam-dunk-investors?source=tweet‚Ä¶ $ABBV $AROW $BHB $BMY $CHK $CXO $DVN $LARK $MRK $PAGP $PSX $PXD $VLO $WB,"Deregulation: A Slam-Dunk For Investors http://seekingalpha.com/article/4039112-deregulation-slam-dunk-investors?source=tweet‚Ä¶ $ABBV $AROW $BHB $BMY $CHK $CXO $DVN $LARK $MRK $PAGP $PSX $PXD $VLO $WB
seekingalpha.com
Deregulation: A Slam-Dunk For Investors (NYSEARCA:XLE)
The new administration in Washington presents an embarrassment of riches when it comes to investment opportunities. The number one area for investors to focus on is deregulation.",,,,,[],https://twitter.com/pelias01/status/826102402109566976
475,Sally Church,@MaverickNY,2017-01-30T22:41:57.000Z,Quote of the Day... what on earth were $MRK thinking here?,"Quote of the Day... what on earth were $MRK thinking here?
Anirban Maitra
@Aiims1742
 ¬∑ 31 Jan 2017
Seriously wow! 
""When I go hiking in the Himalayas I always carry my PD-L1 test results with me."" https://twitter.com/bradloncar/status/826175555145920515‚Ä¶
2
1
3",,2,1,3,['https://pbs.twimg.com/profile_images/1378426780684587012/IU5zJk2E_mini.jpg'],https://twitter.com/MaverickNY/status/826198796451319808
476,Anthony Cheung,@AWMCheung,2017-01-30T09:34:42.000Z,"Some big names reporting this week with 22% of the S&P 500 & 58 Stoxx 600 firms...highlights:

$AAPL $FB $XOM $PFE $MRK $RDSA $AZN $ROG","Some big names reporting this week with 22% of the S&P 500 & 58 Stoxx 600 firms...highlights:

$AAPL $FB $XOM $PFE $MRK $RDSA $AZN $ROG
8
2",,,8,2,[],https://twitter.com/AWMCheung/status/826000676799053824
477,Peter Loftus,@Loftus,2017-01-30T20:55:21.000Z,"First TV ads for Merck's $MRK immunotherapy Keytruda are hitting the air, promoting 1st-line lung cancer treatment: https://keytruda.com","First TV ads for Merck's $MRK immunotherapy Keytruda are hitting the air, promoting 1st-line lung cancer treatment: https://keytruda.com
2
6
11",,2,6,11,[],https://twitter.com/Loftus/status/826171970043514880
478,See It Market,@seeitmarket,2017-01-30T20:34:50.000Z,"NEW Blog - ""6 Stocks I'm Buying Into Market Weakness"" https://seeitmarket.com/6-stocks-im-buying-into-this-stock-market-pullback-16523/‚Ä¶  via 
@CJMendes
 
$JBLU $MRK $FCX $HAL $ABT $BAX $TLT","NEW Blog - ""6 Stocks I'm Buying Into Market Weakness"" https://seeitmarket.com/6-stocks-im-buying-into-this-stock-market-pullback-16523/‚Ä¶  via 
@CJMendes
 
$JBLU $MRK $FCX $HAL $ABT $BAX $TLT
9
6",,,9,6,['https://pbs.twimg.com/media/C3ciDtMVcAEPgzn?format=jpg&name=small'],https://twitter.com/seeitmarket/status/826166804720603136
479,Brad Loncar,@bradloncar,2017-01-29T22:00:01.000Z,"Healthcare earnings 

M: $CORT
T: $ILMN $LLY $PFE
W: $BAX $RHHBY
T: $AMGN $AZN $MRK $NVO
F: $ATHN

Full calendar:","Healthcare earnings 

M: $CORT
T: $ILMN $LLY $PFE
W: $BAX $RHHBY
T: $AMGN $AZN $MRK $NVO
F: $ATHN

Full calendar:
loncarblog.com
Brad Loncar's Blog
Blogs, photos, calendars, launch tracker.
2
7
15",üìÜ,2,7,15,['https://pbs.twimg.com/card_img/1501426347339657216/0pSO75tV?format=jpg&name=240x240'],https://twitter.com/bradloncar/status/825825855939112960
480,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-01-30T16:33:41.000Z,Which Immune Checkpoint (PD1/L1) are you most likely to buy next 3-6 months? $BMY $MRK $NVS $ROG $AZN,"Which Immune Checkpoint (PD1/L1) are you most likely to buy next 3-6 months? $BMY $MRK $NVS $ROG $AZN
BMY
48.5%
MRK
24.2%
NVS or Roche
19.7%
AZN
7.6%
66 votes
¬∑
Final results
1
2
1",,1,2,1,[],https://twitter.com/DrPaulyDeSantis/status/826106116941684736
481,Aspire Trading,@Aspire_Trading,2017-01-30T09:39:03.000Z,"RT AWMCheung: Some big names reporting this week with 22% of the S&P 500 & 58 Stoxx 600 firms...highlights:

$AAPL $FB $XOM $PFE $MRK $RDSA‚Ä¶","RT AWMCheung: Some big names reporting this week with 22% of the S&P 500 & 58 Stoxx 600 firms...highlights:

$AAPL $FB $XOM $PFE $MRK $RDSA‚Ä¶
1",,,,1,[],https://twitter.com/Aspire_Trading/status/826001772292485120
482,Heath Care News,@hc_equipment,2017-01-30T05:17:17.000Z,"#Merck KGaA PT Set at ‚Ç¨105.00 by Goldman Sachs Group, Inc. (The). Read more: http://owler.us/ab9TSY $MRK","#Merck KGaA PT Set at ‚Ç¨105.00 by Goldman Sachs Group, Inc. (The). Read more: http://owler.us/ab9TSY $MRK
2",,,2,,[],https://twitter.com/hc_equipment/status/825935897472364544
483,deafdaytrader,@deafdaytrader,2017-01-28T15:27:03.000Z,"For 4ema cross 8ema stocks 
$GSAT
$TEVA
$MRK
$AMGN
$NVS
$BSMX
$OCN
$BRCD
$NEE
$SM
$NUE
$WTW
$BAX
$CVM - penny
$TMO
$EW
$UMC
Nice cross up","For 4ema cross 8ema stocks 
$GSAT
$TEVA
$MRK
$AMGN
$NVS
$BSMX
$OCN
$BRCD
$NEE
$SM
$NUE
$WTW
$BAX
$CVM - penny
$TMO
$EW
$UMC
Nice cross up
5",,,,5,[],https://twitter.com/deafdaytrader/status/825364571674271745
484,BioPharma Dive,@BioPharmaDive,2017-01-30T20:48:00.000Z,$MRK discloses drug pricing details,"$MRK discloses drug pricing details
biopharmadive.com
Merck ups pricing transparency amid industry ad blitz
As PhRMA rolls out its new ad campaign, companies like Merck and J&J are betting increased transparency can help soften pricing pushback.
3",,,,3,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/826170119285977088
485,FinInvTr,@FinInvTr,2017-01-28T19:41:31.000Z,$5B in NVS Buybacks: Good or Bad Idea? $NVS $GSK $PFE $JNJ $TEVA $BMY $ABT $LLY $MRK $AZN http://bit.ly/2kev1Co,$5B in NVS Buybacks: Good or Bad Idea? $NVS $GSK $PFE $JNJ $TEVA $BMY $ABT $LLY $MRK $AZN http://bit.ly/2kev1Co,,,,,['https://pbs.twimg.com/media/C3SC8nCWAAAKwa6?format=jpg&name=small'],https://twitter.com/FinInvTr/status/825428612610478081
486,HighYieldClub,@HighYieldClub,2017-01-30T23:52:08.000Z,"‚ñ≤ says $MRK is still a buy. This would be a good #portfolio anchor stock. Great dividends with appreciation potential right now. 
@Merck","‚ñ≤ says $MRK is still a buy. This would be a good #portfolio anchor stock. Great dividends with appreciation potential right now. 
@Merck
1",,,1,,[],https://twitter.com/HighYieldClub/status/826216455607820288
487,Value Line,@ValueLine,2017-01-30T20:46:19.000Z,"How did the Dogs of the Dow #stocks perform in 2016? $BA $CVX $CAT $PFE $KO $PG $XOM $VZ $MRK $CSCO $WMT $IBM

http://hubs.ly/H0633Sm0","How did the Dogs of the Dow #stocks perform in 2016? $BA $CVX $CAT $PFE $KO $PG $XOM $VZ $MRK $CSCO $WMT $IBM

http://hubs.ly/H0633Sm0
2",,,,2,['https://pbs.twimg.com/media/C3ck9RWWIAAgQ7R?format=jpg&name=small'],https://twitter.com/ValueLine/status/826169694889590784
488,BioPharma Dive,@BioPharmaDive,2017-01-30T23:38:00.000Z,"$LLY, $PFE keep the earnings ball rolling tomorrow. Here's what to expect http://bit.ly/2kBexRp $NVO $AZN $GILD $MRK $AGN $SNY $GSK $RHHBY","$LLY, $PFE keep the earnings ball rolling tomorrow. Here's what to expect http://bit.ly/2kBexRp $NVO $AZN $GILD $MRK $AGN $SNY $GSK $RHHBY
biopharmadive.com
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
The second week of full-year earnings begins with reports from Merck, Lilly, Pfizer, Roche, Gilead and others. 
3",,,3,,['https://pbs.twimg.com/card_img/1501746891918385163/GaxjqhvO?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/826212901786562560
489,Confident Investor,@ConfidentInvest,2017-01-28T12:05:05.000Z,Confident Investor indicator analysis for 1/28/2017. Interesting results from $AMZN $BABA $CBPO $EW $MRK - http://bit.ly/2jHKO9s,"Confident Investor indicator analysis for 1/28/2017. Interesting results from $AMZN $BABA $CBPO $EW $MRK - http://bit.ly/2jHKO9s
1",,,,1,[],https://twitter.com/ConfidentInvest/status/825313747723907073
490,Heath Care News,@hc_equipment,2017-01-30T05:17:54.000Z,#Merck Pharmaceutical giant partners to push analytics. Read more: http://owler.us/ab9TSS $MRK,#Merck Pharmaceutical giant partners to push analytics. Read more: http://owler.us/ab9TSS $MRK,,,,,[],https://twitter.com/hc_equipment/status/825936052791545856
491,WLST.com,@wlstcom,2017-01-30T16:32:42.000Z,News! News! News! Here's What's Happened in Healthcare Last Week --  The Motley Fool #usmf-health-care $MRK #wlst,"News! News! News! Here's What's Happened in Healthcare Last Week --  The Motley Fool #usmf-health-care $MRK #wlst
fool.com
News! News! News! Here's What's Happened in Healthcare Last Week @themotleyfool #stocks $MRK $JNJ...
From a big-time patent settlement between Merck & Co. and Bristol-Myers Squibb, to Johnson & Johnson's earnings, to Aetna and Humana's $37 billion merger bust, we dive into the details behind last...",,,,,[],https://twitter.com/wlstcom/status/826105869012234241
492,By Any Memes Necessary,@_21stCenturyCox,2017-01-30T19:10:20.000Z,"Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In... https://benzinga.com/z/8962220 $NTRPD $BIIB $LLY $MRK  via 
@benzinga","Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In... https://benzinga.com/z/8962220 $NTRPD $BIIB $LLY $MRK  via 
@benzinga
benzinga.com
Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors...
Alzheimer's has proven to be one of the most stubborn diseases known to modern medicine. An incurable, devastating illness that inspires frustration ‚Äî even anger...
2",,,,2,[],https://twitter.com/_21stCenturyCox/status/826145541818036225
493,Heath Care News,@hc_equipment,2017-01-30T05:16:40.000Z,#Merck KGaA PT Set at ‚Ç¨105.00 by Goldman Sachs Group Inc. Read more: http://owler.us/ab9TSU $MRK,#Merck KGaA PT Set at ‚Ç¨105.00 by Goldman Sachs Group Inc. Read more: http://owler.us/ab9TSU $MRK,,,,,[],https://twitter.com/hc_equipment/status/825935742169866241
494,1 min Stock Insights,@1MinuteStock,2017-01-29T11:19:05.000Z,Explore #fundamental numbers and pros and cons for $MRK https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=proscons&utm_source=twitter‚Ä¶,Explore #fundamental numbers and pros and cons for $MRK https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=proscons&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/825664558857588736
495,Pharmaceutical News,@pharma_sector,2017-01-30T22:10:04.000Z,#Merck becomes latest to offer insight into drug pricing practices. Read more: http://owler.us/ab93CK $MRK,#Merck becomes latest to offer insight into drug pricing practices. Read more: http://owler.us/ab93CK $MRK,,,,,[],https://twitter.com/pharma_sector/status/826190771313258496
496,Zenect,@zenect,2017-01-29T10:48:28.000Z,Is this the only #dividend stock you‚Äôll ever need?  http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,Is this the only #dividend stock you‚Äôll ever need?  http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,,,,,[],https://twitter.com/zenect/status/825656855385034753
497,Pharmaceutical News,@pharma_sector,2017-01-30T17:05:01.000Z,"#Merck & Company, Inc. is South Texas Money Management Ltd.'s 7th Largest Position. Read more: http://owler.us/ab91FU $MRK","#Merck & Company, Inc. is South Texas Money Management Ltd.'s 7th Largest Position. Read more: http://owler.us/ab91FU $MRK",,,,,[],https://twitter.com/pharma_sector/status/826114003835375616
498,Pharmaceutical News,@pharma_sector,2017-01-30T19:28:20.000Z,"#Merck This Pharma Giant Just Revealed 7 Years of Its U.S. Drug Price Increase History
  . Read more: http://owler.us/ab92G3 $MRK","#Merck This Pharma Giant Just Revealed 7 Years of Its U.S. Drug Price Increase History
  . Read more: http://owler.us/ab92G3 $MRK",,,,,[],https://twitter.com/pharma_sector/status/826150069615235073
499,Anirban Maitra,@Aiims1742,2017-01-30T21:07:11.000Z,"Is this the first time ""PD-L1"" has been mentioned in a DTC ad? 
Will PD-L1 now become a part of patient lexicon? $MRK #Keytruda","Is this the first time ""PD-L1"" has been mentioned in a DTC ad? 
Will PD-L1 now become a part of patient lexicon? $MRK #Keytruda
Brad Loncar
@bradloncar
 ¬∑ 31 Jan 2017
Here's an easy link for the Keytruda TV ad. h/t @Loftus https://ispot.tv/ad/AQ3p/keytruda-sharons-story‚Ä¶
1
1
1",,1,1,1,['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg'],https://twitter.com/Aiims1742/status/826174947613605888
500,StockNews.com,@stocknewsdotcom,2017-01-30T11:51:18.000Z,$MRK Cautious commentary on Mad Money show https://stocknews.com/news/mrk-cautious-commentary-on-mad-money-show/‚Ä¶,$MRK Cautious commentary on Mad Money show https://stocknews.com/news/mrk-cautious-commentary-on-mad-money-show/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/826035052513460224
501,Limex,@LimexMe,2017-01-30T15:09:33.000Z,3 Top Pharmaceutical Stocks to Buy in February $CELG $PFE $MRK,"3 Top Pharmaceutical Stocks to Buy in February $CELG $PFE $MRK
whotrades.com
3 Top Pharmaceutical Stocks to Buy in February
Any time is a good time to buy the stock of a well-run company with great prospects. An even better time to buy that kind of stock, though, is when there's a potential upcoming catalyst.‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/826084944770428929
502,Daily Political,@dailypoliticaln,2017-01-30T19:37:22.000Z,"Merck & Company, Inc. $MRK Stake Cut by Palladium Partners LLC http://ift.tt/2jLI9hw","Merck & Company, Inc. $MRK Stake Cut by Palladium Partners LLC http://ift.tt/2jLI9hw",,,,,[],https://twitter.com/dailypoliticaln/status/826152342403817472
503,Salil Kallianpur,@salilkallianpur,2017-01-30T14:59:16.000Z,This pharma giant just pulled back the curtain on its drug price hikes $MRK http://ln.is/fortune.com/2017/01/l7srS‚Ä¶,"This pharma giant just pulled back the curtain on its drug price hikes $MRK http://ln.is/fortune.com/2017/01/l7srS‚Ä¶
1",,,,1,[],https://twitter.com/salilkallianpur/status/826082358797463553
504,Ticker Report,@TickerReport,2017-01-30T15:16:35.000Z,"Merck & Company, Inc. $MRK Raised to ‚ÄúHold‚Äù at Vetr Inc. http://ift.tt/2kGa9la","Merck & Company, Inc. $MRK Raised to ‚ÄúHold‚Äù at Vetr Inc. http://ift.tt/2kGa9la",,,,,[],https://twitter.com/TickerReport/status/826086714800209921
505,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-01-29T19:11:34.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/1IqWFffwt,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/1IqWFffwt,,,,,[],https://twitter.com/gem_2014/status/825783464293257218
506,Vetr,@VetrRatings,2017-01-30T15:40:48.000Z,"Vetr users have downgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $59.51 http://bit.ly/1GhW0TK","Vetr users have downgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $59.51 http://bit.ly/1GhW0TK",,,,,[],https://twitter.com/VetrRatings/status/826092808826155011
507,Graycell Advisors,@GraycellAdvisor,2017-01-30T01:34:15.000Z,"Biotech: Can Trump Be A Catalyst?
http://buff.ly/2kJijZ8
$pfe $mrk $jnj $snf $jpm $regn $agn $gild $amgn $jnj $abbv $nvo $lly $biib $iwc","Biotech: Can Trump Be A Catalyst?
http://buff.ly/2kJijZ8
$pfe $mrk $jnj $snf $jpm $regn $agn $gild $amgn $jnj $abbv $nvo $lly $biib $iwc",,,,,[],https://twitter.com/GraycellAdvisor/status/825879768499359744
508,TalkMarkets,@TalkMarkets,2017-01-30T12:21:40.000Z,"Global #Stocks, #Futures Slide On US Protectionism Worries Following Trump Travel Chaos $VOD $FRO $MRK $PFE $XOM... https://goo.gl/Cd26wF","Global #Stocks, #Futures Slide On US Protectionism Worries Following Trump Travel Chaos $VOD $FRO $MRK $PFE $XOM... https://goo.gl/Cd26wF",,,,,[],https://twitter.com/TalkMarkets/status/826042694472445953
509,Adam Feuerstein,@adamfeuerstein,2017-01-29T15:19:43.000Z,"$MRK spokeswoman on Trump Muslim immigration ban: ""We are still assessing the order and its impact on the company.""","$MRK spokeswoman on Trump Muslim immigration ban: ""We are still assessing the order and its impact on the company.""
8
4
1",,8,4,1,[],https://twitter.com/adamfeuerstein/status/825725115094679552
510,Jeff Taylor,@jttdmd,2017-01-30T19:43:25.000Z,Will Gilead Sciences End Up Like Valeant Pharmaceuticals? http://seekingalpha.com/article/4040607-will-gilead-sciences-end-like-valeant-pharmaceuticals?source=tweet‚Ä¶ $ABBV $UTHR $VRX $GILD $MRK,"Will Gilead Sciences End Up Like Valeant Pharmaceuticals? http://seekingalpha.com/article/4040607-will-gilead-sciences-end-like-valeant-pharmaceuticals?source=tweet‚Ä¶ $ABBV $UTHR $VRX $GILD $MRK
seekingalpha.com
Will Gilead Sciences End Up Like Valeant Pharmaceuticals? (NASDAQ:GILD)
Answers a question from a Client, who wonders if Gilead Sciences will end up like Valeant Pharmaceuticals. A comparative quantitative analysis using a unique free cash flow ratio.",,,,,['https://pbs.twimg.com/card_img/1501746966048518146/iJo2Twb4?format=png&name=240x240'],https://twitter.com/jttdmd/status/826153867922378752
511,Insider Monkey News,@insidermonkey_n,2017-01-30T20:33:16.000Z,"$MRK Is Among Many Drugmakers Being Criticized For Price Hikes
http://insidermonkey.com/blog/merck-co-inc-mrk-is-among-many-drugmakers-being-criticized-for-price-hikes-527737/?utm_source=Stocktwits&utm_campaign=dnan&utm_medium=Social‚Ä¶
$JNJ","$MRK Is Among Many Drugmakers Being Criticized For Price Hikes
http://insidermonkey.com/blog/merck-co-inc-mrk-is-among-many-drugmakers-being-criticized-for-price-hikes-527737/?utm_source=Stocktwits&utm_campaign=dnan&utm_medium=Social‚Ä¶
$JNJ
insidermonkey.com
Merck & Co., Inc. (MRK) Is Among Many Drugmakers Being Criticized For Price Hikes
Merck & Co., Inc. (NYSE:MRK) is one of the pharma industry titans that are currently on the receiving end as a result of exaggerated drug price hikes.",,,,,['https://pbs.twimg.com/card_img/1501981830110535683/vAk0jEwD?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/826166411047337984
512,George Marcovits,@GemsBot,2017-01-29T19:11:18.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/72959391#72959633‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/72959391#72959633‚Ä¶,,,,,['https://pbs.twimg.com/media/C3XFnyWXUAAXEgG?format=jpg&name=small'],https://twitter.com/GemsBot/status/825783396316110848
513,Jacob Bell,@realJacobBell,2017-01-30T18:43:01.000Z,Earnings continues this week http://bit.ly/2kBexRp $SNY $NVO $PFE $AZN $GILD $LLY $AGN $GSK $MRK $RHHBY,"Earnings continues this week http://bit.ly/2kBexRp $SNY $NVO $PFE $AZN $GILD $LLY $AGN $GSK $MRK $RHHBY
biopharmadive.com
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
The second week of full-year earnings begins with reports from Merck, Lilly, Pfizer, Roche, Gilead and others. ",,,,,['https://pbs.twimg.com/card_img/1501746891918385163/GaxjqhvO?format=jpg&name=small'],https://twitter.com/realJacobBell/status/826138666598805505
514,Market Realist,@MarketRealist,2017-01-30T17:15:36.000Z,Bristol-Myers Squibb: What's Its Valuation Post 4Q16 Earnings? http://marketrealist.com/?p=1888489 $BMY $IHE $PFE $MRK,Bristol-Myers Squibb: What's Its Valuation Post 4Q16 Earnings? http://marketrealist.com/?p=1888489 $BMY $IHE $PFE $MRK,,,,,[],https://twitter.com/MarketRealist/status/826116668128636928
515,MarketBeat,@MarketBeatCom,2017-01-28T13:45:43.000Z,"Virginia Retirement Systems ET AL Has $36,210,000 Stake in Merck & Company, Inc. $MRK http://zpr.io/PaMQc","Virginia Retirement Systems ET AL Has $36,210,000 Stake in Merck & Company, Inc. $MRK http://zpr.io/PaMQc",,,,,[],https://twitter.com/MarketBeatCom/status/825339073757863939
516,crossdefault,@crossdefault,2017-01-30T16:41:28.000Z,MAb experts: hear any progress on Homologous Dimerization? TIA. #biotwitter $BMY $MRK etc. for reference: http://pxradia.com/about/,"MAb experts: hear any progress on Homologous Dimerization? TIA. #biotwitter $BMY $MRK etc. for reference: http://pxradia.com/about/
1",,,1,,[],https://twitter.com/crossdefault/status/826108078085005312
517,Sure Dividend,@SureDividend,2017-01-28T21:09:15.000Z,Is Bristol-Meyers A Buy After 39% Price Decline? $MRK Also $BMY https://goo.gl/cy72Az,Is Bristol-Meyers A Buy After 39% Price Decline? $MRK Also $BMY https://goo.gl/cy72Az,,,,,[],https://twitter.com/SureDividend/status/825450690642186240
518,Insider Monkey,@insidermonkey,2017-01-30T20:33:32.000Z,"$MRK Is Among Many Drugmakers Being Criticized For Price Hikes
http://insidermonkey.com/blog/merck-co-inc-mrk-is-among-many-drugmakers-being-criticized-for-price-hikes-527737/?utm_source=Stocktwits&utm_campaign=dnan&utm_medium=Social‚Ä¶
$JNJ","$MRK Is Among Many Drugmakers Being Criticized For Price Hikes
http://insidermonkey.com/blog/merck-co-inc-mrk-is-among-many-drugmakers-being-criticized-for-price-hikes-527737/?utm_source=Stocktwits&utm_campaign=dnan&utm_medium=Social‚Ä¶
$JNJ
insidermonkey.com
Merck & Co., Inc. (MRK) Is Among Many Drugmakers Being Criticized For Price Hikes
Merck & Co., Inc. (NYSE:MRK) is one of the pharma industry titans that are currently on the receiving end as a result of exaggerated drug price hikes.",,,,,['https://pbs.twimg.com/card_img/1501981830110535683/vAk0jEwD?format=jpg&name=240x240'],https://twitter.com/insidermonkey/status/826166479980732418
519,Rishesh Singh,@androsForm,2017-01-29T20:13:57.000Z,"$MRK ""Merck (MRK): Stock To Gain On Likely Earnings Beat In Q4?""","$MRK ""Merck (MRK): Stock To Gain On Likely Earnings Beat In Q4?""
barchart.com
MRK - Merck & Company Stock Price - Barchart.com
Merck & Company stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
24
3",,,24,3,['https://pbs.twimg.com/card_img/1499534478473113605/F33BR8WW?format=png&name=240x240'],https://twitter.com/androsForm/status/825799160863522817
520,Jacob Bell,@realJacobBell,2017-01-30T23:38:00.000Z,"$LLY, $PFE keep the earnings ball rolling tomorrow. Here's what to expect http://bit.ly/2kBexRp $NVO $AZN $GILD $MRK $AGN $SNY $GSK $RHHBY","$LLY, $PFE keep the earnings ball rolling tomorrow. Here's what to expect http://bit.ly/2kBexRp $NVO $AZN $GILD $MRK $AGN $SNY $GSK $RHHBY
biopharmadive.com
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
The second week of full-year earnings begins with reports from Merck, Lilly, Pfizer, Roche, Gilead and others. ",,,,,['https://pbs.twimg.com/card_img/1501746891918385163/GaxjqhvO?format=jpg&name=small'],https://twitter.com/realJacobBell/status/826212900884721667
521,Jeffrey Weber,@jjjinvesting,2017-01-28T19:44:32.000Z,Celgene As Another http://Amazon.com: Buying The Dips http://seekingalpha.com/article/4040185-celgene-another-amazon-com-buying-dips?source=tweet‚Ä¶ $ABBV $AMGN $AMZN $BIIB $BMY $GILD $IBB $MRK $CELG,"Celgene As Another http://Amazon.com: Buying The Dips http://seekingalpha.com/article/4040185-celgene-another-amazon-com-buying-dips?source=tweet‚Ä¶ $ABBV $AMGN $AMZN $BIIB $BMY $GILD $IBB $MRK $CELG
seekingalpha.com
Celgene As Another Amazon.com: Buying The Dips (NASDAQ:CELG)
CELG had pre-announced Q4 results and its 2017 projections, thus as periodically happens, traders sold the news.",,,,,['https://pbs.twimg.com/card_img/1497724725002448899/2TZ3O23_?format=png&name=240x240'],https://twitter.com/jjjinvesting/status/825429371867443200
522,marketexclusive,@marketexclusive,2017-01-30T14:52:24.000Z,"Merck & Co., Inc.(NYSE:MRK) Is Among Many Drugmakers Being Criticized For Price Hikes https://marketexclusive.com/merck-co-inc-nysemrk-among-many-drugmakers-criticized-price-increases/70574/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶   $MRK  $JNJ","Merck & Co., Inc.(NYSE:MRK) Is Among Many Drugmakers Being Criticized For Price Hikes https://marketexclusive.com/merck-co-inc-nysemrk-among-many-drugmakers-criticized-price-increases/70574/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶   $MRK  $JNJ
2",,,2,,[],https://twitter.com/marketexclusive/status/826080629716459521
523,Ticker Report,@TickerReport,2017-01-30T10:51:26.000Z,"Aperio Group LLC Has $99,399,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2jJhNN8","Aperio Group LLC Has $99,399,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2jJhNN8",,,,,[],https://twitter.com/TickerReport/status/826019988762918912
524,TalkMarkets,@TalkMarkets,2017-01-29T09:39:07.000Z,Is Bristol-Meyers A Buy After 39% Price Decline? $MRK Also $BMY https://goo.gl/cy72Az,"Is Bristol-Meyers A Buy After 39% Price Decline? $MRK Also $BMY https://goo.gl/cy72Az
1",,,,1,[],https://twitter.com/TalkMarkets/status/825639401279672321
525,BioPharma Dive,@BioPharmaDive,2017-01-30T18:43:00.000Z,Earnings continues this week http://bit.ly/2kBexRp $SNY $NVO $PFE $AZN $GILD $LLY $AGN $GSK $MRK $RHHBY,"Earnings continues this week http://bit.ly/2kBexRp $SNY $NVO $PFE $AZN $GILD $LLY $AGN $GSK $MRK $RHHBY
biopharmadive.com
Earnings Preview: Merck set to solidify I/O lead, Sanofi still looking for deals and more
The second week of full-year earnings begins with reports from Merck, Lilly, Pfizer, Roche, Gilead and others. ",,,,,['https://pbs.twimg.com/card_img/1501746891918385163/GaxjqhvO?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/826138663457169408
526,Salil Kallianpur,@salilkallianpur,2017-01-28T18:31:31.000Z,"3 Companies Putting the Squeeze on Bristol-Myers Squibb 
@themotleyfool
 #stocks $MRK, $GILD, $BMY, $RHHBY","3 Companies Putting the Squeeze on Bristol-Myers Squibb 
@themotleyfool
 #stocks $MRK, $GILD, $BMY, $RHHBY
fool.com
3 Companies Putting the Squeeze on Bristol-Myers Squibb @themotleyfool #stocks $BMY $MRK $GILD...
Bristol-Myers Squibb's executives acknowledge stiff competition from Merck, Roche, and Gilead Sciences.",,,,,[],https://twitter.com/salilkallianpur/status/825410997892632578
527,Clark Joseph Kent,@JorelLaraKalel,2017-01-30T18:06:33.000Z,"3 Top Pharmaceutical Stocks to Buy in February $CELG $MRK $PFE http://fxn.ws/2jO5Wei 
@celgene
 @merck
 @pfizer","3 Top Pharmaceutical Stocks to Buy in February $CELG $MRK $PFE http://fxn.ws/2jO5Wei 
@celgene
 @merck
 @pfizer",,,,,[],https://twitter.com/JorelLaraKalel/status/826129489751072769
528,Benzinga,@Benzinga,2017-01-30T15:30:01.000Z,Can Merck And Pfizer Beat Low Expectations? https://benzinga.com/z/8961933 $MRK $PFE,"Can Merck And Pfizer Beat Low Expectations? https://benzinga.com/z/8961933 $MRK $PFE
benzinga.com
Can Merck And Pfizer Beat Low Expectations?
The two pharmaceutical Dow components are expected to report earnings this week. Both of them are expected to show a decline in earnings from a year ago. Also, they both...",,,,,[],https://twitter.com/Benzinga/status/826090097380573185
529,Clifton Leaf,@CliftonLeaf,2017-01-30T00:31:56.000Z,This pharma giant just pulled back the curtain on its drug price hikes $MRK http://for.tn/2k1jjZA,"This pharma giant just pulled back the curtain on its drug price hikes $MRK http://for.tn/2k1jjZA
1",,,1,,[],https://twitter.com/CliftonLeaf/status/825864084205817857
530,BooRad,@atticusMB,2017-01-30T15:03:22.000Z,"3 Top Pharmaceutical Stocks to Buy in February 
@themotleyfool
 #stocks $PFE, $MRK, $CELG","3 Top Pharmaceutical Stocks to Buy in February 
@themotleyfool
 #stocks $PFE, $MRK, $CELG
fool.com
3 Top Pharmaceutical Stocks to Buy in February @themotleyfool #stocks $CELG $PFE $MRK
Looking for great pharmaceutical stocks to buy in February? Celgene, Merck, and Pfizer might be just the ticket.",,,,,[],https://twitter.com/atticusMB/status/826083390864646145
531,Ilse Treurnicht,@IlseTreurnicht,2017-01-29T20:37:33.000Z,"This pharma giant (
@merck
) just pulled back the curtain on its drug price hikes $MRK http://ln.is/fortune.com/2017/01/EcnOs‚Ä¶","This pharma giant (
@merck
) just pulled back the curtain on its drug price hikes $MRK http://ln.is/fortune.com/2017/01/EcnOs‚Ä¶",,,,,[],https://twitter.com/IlseTreurnicht/status/825805100622999554
532,Robin G Smith,@robingsmith,2017-01-29T15:17:11.000Z,This pharma giant just pulled back the curtain on its drug price hikes $MRK http://for.tn/2k1jjZA,This pharma giant just pulled back the curtain on its drug price hikes $MRK http://for.tn/2k1jjZA,,,,,[],https://twitter.com/robingsmith/status/825724479057850368
533,Donald J. Pasley,@pas5974,2017-01-29T14:22:07.000Z,This pharma giant just pulled back the curtain on its drug price hikes $MRK http://ln.is/fortune.com/2017/01/Y9rMF‚Ä¶,This pharma giant just pulled back the curtain on its drug price hikes $MRK http://ln.is/fortune.com/2017/01/Y9rMF‚Ä¶,‚ôä üëë,,,,[],https://twitter.com/pas5974/status/825710621098442752
534,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-02-02T06:26:20.000Z,"All I-O Combination Trials as of YE16, via Chen et al 
@genentech
 thx  for the most impressionable I-O review YET $AZN $MRK $BMY $ROG $INCY","All I-O Combination Trials as of YE16, via Chen et al 
@genentech
 thx  for the most impressionable I-O review YET $AZN $MRK $BMY $ROG $INCY
3
33
50",,3,33,50,['https://pbs.twimg.com/media/C3o8xmjXUAAZf9o?format=png&name=small'],https://twitter.com/DrPaulyDeSantis/status/827040437449981953
535,Merck,@Merck,2017-02-02T14:01:12.000Z,A closing word from Ken Frazier on our 4Q and full-year financial results. $MRK,"A closing word from Ken Frazier on our 4Q and full-year financial results. $MRK
2
32
49",,2,32,49,['https://pbs.twimg.com/media/C3qf1cKWQAAISIj?format=jpg&name=small'],https://twitter.com/Merck/status/827154909762088960
536,pharmalot,@pharmalot,2017-02-01T13:47:55.000Z,Pharmalot.. Pharmalittle.. Good Morning.. some pharma execs are confident on pricing: https://statnews.com/pharmalot/2017/02/01/drug-prices-roche-pfizer-trump/‚Ä¶ #pharma $PFE $AMGN $MRK #Trump,"Pharmalot.. Pharmalittle.. Good Morning.. some pharma execs are confident on pricing: https://statnews.com/pharmalot/2017/02/01/drug-prices-roche-pfizer-trump/‚Ä¶ #pharma $PFE $AMGN $MRK #Trump
statnews.com
Pharmalot, Pharmalittle: Some pharma execs exude confidence over US pricing
Pfizer chief executive Ian Read says he will not change his view toward drug pricing or alter when prices are raised.
3
2",,,3,2,['https://pbs.twimg.com/card_img/1500534343600644098/wAHXYJa7?format=jpg&name=small'],https://twitter.com/pharmalot/status/826789176938897410
537,No bears No bulls,@Nobears_Nobulls,2017-02-02T20:17:53.000Z,"U.S. FDA approves Bristol-Myers' Opdivo for bladder cancer
$MRK

http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/u-fda-approves-bristol-myers-201345503.html‚Ä¶","U.S. FDA approves Bristol-Myers' Opdivo for bladder cancer
$MRK

http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/u-fda-approves-bristol-myers-201345503.html‚Ä¶
1
1",,,1,1,[],https://twitter.com/Nobears_Nobulls/status/827249703846703104
538,Seeking Alpha,@SeekingAlpha,2017-02-02T19:48:06.000Z,AstraZeneca Posts Solid 2016 Results; Build-Up To 2017 Trials Showdown Continues http://seekingalpha.com/article/4042139-astrazeneca-posts-solid-2016-results-build-2017-trials-showdown-continues?source=feed_f‚Ä¶ $GSK $JNJ $LLY $MRK $PFE $AZN,"AstraZeneca Posts Solid 2016 Results; Build-Up To 2017 Trials Showdown Continues http://seekingalpha.com/article/4042139-astrazeneca-posts-solid-2016-results-build-2017-trials-showdown-continues?source=feed_f‚Ä¶ $GSK $JNJ $LLY $MRK $PFE $AZN
2
1",,,2,1,[],https://twitter.com/SeekingAlpha/status/827242209636278272
539,FOX Business,@FoxBusiness,2017-02-01T16:32:16.000Z,"Drug Makers:
$PFE
$MRK
$LLY
$JNJ
$NVS","Drug Makers:
$PFE
$MRK
$LLY
$JNJ
$NVS
1
6
5",,1,6,5,['https://pbs.twimg.com/media/C3l99HYVcAAXso_?format=jpg&name=small'],https://twitter.com/FoxBusiness/status/826830537457283072
540,,@EatSleepNTrade,2017-01-31T23:07:03.000Z,$ONVO has bullish engulfed yesterdays candle and tomorrow may be the breakout day of wedge. Keep on watch $IBB $AAPL $FB $EA $LLY $MRK $SPY,"$ONVO has bullish engulfed yesterdays candle and tomorrow may be the breakout day of wedge. Keep on watch $IBB $AAPL $FB $EA $LLY $MRK $SPY
2
3",üôè,,2,3,['https://pbs.twimg.com/media/C3iOgt_VUAAOOhR?format=jpg&name=small'],https://twitter.com/EatSleepNTrade/status/826567500989132804
541,Cboe,@CBOE,2017-02-01T15:39:11.000Z,"upcoming #earnings: $AGNC, $CRUS, $FB, $MET, $NXPI, $WFT, $AZN, $CI, $CME, $COP, $MRK, $SNE, AMZN, $CMG powered by http://livevol.com","upcoming #earnings: $AGNC, $CRUS, $FB, $MET, $NXPI, $WFT, $AZN, $CI, $CME, $COP, $MRK, $SNE, AMZN, $CMG powered by http://livevol.com
2
3",,,2,3,['https://pbs.twimg.com/media/C3lx1zPVcAA2C4V?format=jpg&name=small'],https://twitter.com/CBOE/status/826817178666201088
542,Drugdoctor1,@Drugdoctor2014,2017-02-02T11:43:07.000Z,$ICNB.0245-Chart of YEAR! Christie's 63 B'day today $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT,"$ICNB.0245-Chart of YEAR! Christie's 63 B'day today $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT
1",,,,1,"['https://pbs.twimg.com/media/C3qFJ87UoAEGhxz?format=jpg&name=360x360', 'https://pbs.twimg.com/media/C3qFJ81VYAAvCt2?format=jpg&name=360x360']",https://twitter.com/Drugdoctor2014/status/827120156845412352
543,Kayla Tausche,@kaylatausche,2017-01-31T14:54:13.000Z,"Also: $MRK's Frazier touts HQ in US, says has 23,000 US employees & is bringing manufacturing back to US for immuno-oncology drug","Also: $MRK's Frazier touts HQ in US, says has 23,000 US employees & is bringing manufacturing back to US for immuno-oncology drug
1
7
8",,1,7,8,[],https://twitter.com/kaylatausche/status/826443472521543684
544,Matthias Piesche,@PiescheLab,2017-02-02T14:35:19.000Z,$MRK's Keytruda given European approval for first-line treatment in #NSCLC http://pharmafile.com/news/513031/msd-s-drug-given-european-approval-first-line-treatment-nsclc‚Ä¶ #immunotherapy #lcsm,"$MRK's Keytruda given European approval for first-line treatment in #NSCLC http://pharmafile.com/news/513031/msd-s-drug-given-european-approval-first-line-treatment-nsclc‚Ä¶ #immunotherapy #lcsm
1
1",,,1,1,[],https://twitter.com/PiescheLab/status/827163495447805957
545,Sean McGrath,@sean_uk,2017-02-01T21:08:18.000Z,EU Clears Merck's Keytruda for Un-Treated Lung #Cancer https://shar.es/1OS8f0 #oncology #lungcancer $MRK,EU Clears Merck's Keytruda for Un-Treated Lung #Cancer https://shar.es/1OS8f0 #oncology #lungcancer $MRK,,,,,[],https://twitter.com/sean_uk/status/826900003998330881
546,Jonathan Rockoff,@jonathanrockoff,2017-01-31T21:03:50.000Z,European Commission approves $MRK's Keytruda to treat certain untreated non-small cell lung cancer patients: https://goo.gl/EBSKxv $BMY,"European Commission approves $MRK's Keytruda to treat certain untreated non-small cell lung cancer patients: https://goo.gl/EBSKxv $BMY
1
7
5",,1,7,5,[],https://twitter.com/jonathanrockoff/status/826536491086204929
547,Damian Garde,@damiangarde,2017-02-02T13:30:38.000Z,"$MRK CEO Frazier: PhRMA will  ""have regular check-ins"" with Trump","$MRK CEO Frazier: PhRMA will  ""have regular check-ins"" with Trump
1
4
2",,1,4,2,[],https://twitter.com/damiangarde/status/827147214657056769
548,Stumptown Trader,@daytraderpdx,2017-01-31T21:57:25.000Z,Why I've been long $MRK and $XBI calls. Got long $TEVA and $CELG calls today. Still not full positions. Waiting for earnings on $GILD $AGN.,"Why I've been long $MRK and $XBI calls. Got long $TEVA and $CELG calls today. Still not full positions. Waiting for earnings on $GILD $AGN.
Stumptown Trader
@daytraderpdx
 ¬∑ 1 Feb 2017
Rotation into biotech / healthcare recently. Smart money accum. Today a massive candle in $IBB, engulfing the last 10d on high vol. $XBI too
1",,,1,,"['https://pbs.twimg.com/profile_images/1149822210732806149/lzShAkZ8_mini.png', 'https://pbs.twimg.com/media/C3h-N9wUYAI1Rfj?format=jpg&name=small', 'https://pbs.twimg.com/media/C3h-VlEVYAEcrRQ?format=jpg&name=small']",https://twitter.com/daytraderpdx/status/826549974322208769
549,Cantech Letter,@CantechLetter,2017-01-31T21:00:56.000Z,"Trump seems to understand the drug development space, says NextEdge‚Äôs Rahim: http://cantechletter.com/2017/01/trump-seems-understand-drug-development-space-says-nextedges-rahim/‚Ä¶ $MRK $LLY $PFE $AZN $NVS $BMY $GSK","Trump seems to understand the drug development space, says NextEdge‚Äôs Rahim: http://cantechletter.com/2017/01/trump-seems-understand-drug-development-space-says-nextedges-rahim/‚Ä¶ $MRK $LLY $PFE $AZN $NVS $BMY $GSK
cantechletter.com
Trump seems to understand the drug development space, says NextEdge‚Äôs Rahim
On Tuesday, Trump met with U.S. drugmakers at the White House, following up on his January 12 comments that the sector was ‚Äúgetting away with murder‚Äù.
2
3",,,2,3,[],https://twitter.com/CantechLetter/status/826535762753630213
550,Meg Tirrell,@megtirrell,2017-02-02T13:41:10.000Z,"$MRK CEO: Valuations have come down, and we continue to look hard at deals; still have to find willing seller & price that generates value","$MRK CEO: Valuations have come down, and we continue to look hard at deals; still have to find willing seller & price that generates value
5
4",,,5,4,[],https://twitter.com/megtirrell/status/827149865742368768
551,Cboe,@CBOE,2017-02-01T16:37:03.000Z,"Bulls in $BAC & $FB, $AAPL #earnings & cash stash 
@AngieMiles
 w 
@tradewise
 Tom $AMZN pre earnings IV, $MRK http://bit.ly/2kVURI5","Bulls in $BAC & $FB, $AAPL #earnings & cash stash 
@AngieMiles
 w 
@tradewise
 Tom $AMZN pre earnings IV, $MRK http://bit.ly/2kVURI5
1:56
516 views
4
4",,,4,4,[],https://twitter.com/CBOE/status/826831742963240961
552,JJ Kinahan,@TDAJJKinahan,2017-02-01T16:18:53.000Z,Earnings preview: What might be driving $FB revenue? And what‚Äôs the latest pharma outlook from $MRK? http://bit.ly/2aWT55X,"Earnings preview: What might be driving $FB revenue? And what‚Äôs the latest pharma outlook from $MRK? http://bit.ly/2aWT55X
2
1",,,2,1,['https://pbs.twimg.com/media/C3l64zNWQAE_uo7?format=jpg&name=small'],https://twitter.com/TDAJJKinahan/status/826827167543730179
553,Jack Allen,@JohnK_Allen,2017-02-02T13:38:09.000Z,"$MRK remains interested in broad set of Keytruda combinations including CTLA4, even in light of $BMY setback w/ Opdivo/Yervoy combo","$MRK remains interested in broad set of Keytruda combinations including CTLA4, even in light of $BMY setback w/ Opdivo/Yervoy combo
3",,,3,,[],https://twitter.com/JohnK_Allen/status/827149107223490561
554,Christian Fromhertz,@cfromhertz,2017-01-31T21:28:22.000Z,"Another rotation today - Biotech $XBI hot today - call buying along w/ call activity in $CELG $AGN $SRPT $ISRG $MRK 
big winner in TTG room","Another rotation today - Biotech $XBI hot today - call buying along w/ call activity in $CELG $AGN $SRPT $ISRG $MRK 
big winner in TTG room
1
2",,,1,2,[],https://twitter.com/cfromhertz/status/826542666435395584
555,Kate Rawson Powell,@Kate_Rawson,2017-01-31T13:45:17.000Z,".
@PhRMA
 Hey guys, anyone live-tweeting or Periscoping the big meeting with 
@POTUS
 today? #flyonthewall #Periscope360 $JNJ $LLY $MRK $NVS",".
@PhRMA
 Hey guys, anyone live-tweeting or Periscoping the big meeting with 
@POTUS
 today? #flyonthewall #Periscope360 $JNJ $LLY $MRK $NVS
3
1",,,3,1,[],https://twitter.com/Kate_Rawson/status/826426128692817923
556,AJMC-Diabetes Mgt,@EBDiabetes,2017-02-02T20:36:21.000Z,"#Merck, #Pfizer Publish Results for #Ertugliflozin as Monotherapy in #Type2 #Diabetes $MRK $PFE https://shar.es/1OMZZJ via 
@ajmc_journal","#Merck, #Pfizer Publish Results for #Ertugliflozin as Monotherapy in #Type2 #Diabetes $MRK $PFE https://shar.es/1OMZZJ via 
@ajmc_journal
2
1",,,2,1,[],https://twitter.com/EBDiabetes/status/827254350363844610
557,Hotpage News,@Hotpage_News,2017-01-31T14:55:35.000Z,"#TRUMP VOWS to get drug prices lower, tells drugmakers he wants them to manufacture in the US $MRK $JNJ $AMGN $LLY","#TRUMP VOWS to get drug prices lower, tells drugmakers he wants them to manufacture in the US $MRK $JNJ $AMGN $LLY
cnbc.com
Trump vows to get drug prices lower, tells drugmakers he wants them to manufacture in the US
""We have to get the prices down,"" Trump tells drugmakers at the White House.
2
2
2",,2,2,2,['https://pbs.twimg.com/card_img/1500689886545915904/Ss7WTEAC?format=jpg&name=small'],https://twitter.com/Hotpage_News/status/826443818010550272
558,Robert Duval,@Cessnadriver50,2017-02-01T21:12:51.000Z,$MRK http://schrts.co/R2Pu7m MRK pressing multi year highs primed to pop.,"$MRK http://schrts.co/R2Pu7m MRK pressing multi year highs primed to pop.
1
2",,1,,2,[],https://twitter.com/Cessnadriver50/status/826901146346409984
559,Bio Stocks‚Ñ¢,@BioStocks,2017-02-02T11:50:28.000Z,"Replying to 
@BioStocks","Replying to 
@BioStocks
$MRK Q4 pharmaceutical sales $8.9B
1
2",,,1,2,[],https://twitter.com/BioStocks/status/827122006281822209
560,Rishesh Singh,@androsForm,2017-02-02T21:15:21.000Z,$MRK [stc] FEB17 $61.5 Cs @ 2.7 | Closed 1/2 Position [+94.2%],"$MRK [stc] FEB17 $61.5 Cs @ 2.7 | Closed 1/2 Position [+94.2%]
23
29",,,23,29,[],https://twitter.com/androsForm/status/827264164691210242
561,Peter Loftus,@Loftus,2017-01-31T15:38:56.000Z,'We can save tens of billions of dollars and you people are going to do great' - Trump to pharma CEOs gathered around him $MRK $CELG $AMGN https://twitter.com/JeanneWhalen/status/826453699002302465‚Ä¶,"'We can save tens of billions of dollars and you people are going to do great' - Trump to pharma CEOs gathered around him $MRK $CELG $AMGN https://twitter.com/JeanneWhalen/status/826453699002302465‚Ä¶
This Tweet is unavailable.
2
3",,2,3,,[],https://twitter.com/Loftus/status/826454725637849089
562,MM+M Magazine,@MMMnews,2017-02-02T19:00:02.000Z,"Op-ed: #Pharma/payer collaboration: A kumbaya moment or a passing trend? $MRK $AET #healthcare 
@Marc_Iskowitz
 http://bit.ly/2kSo5sa","Op-ed: #Pharma/payer collaboration: A kumbaya moment or a passing trend? $MRK $AET #healthcare 
@Marc_Iskowitz
 http://bit.ly/2kSo5sa
1",,,,1,['https://pbs.twimg.com/media/C3rIv8yWAAAFCFs?format=jpg&name=small'],https://twitter.com/MMMnews/status/827230110717665280
563,$peedyCalls,@SpeedyCalls,2017-01-31T18:08:14.000Z,"$MRK 61.5 Puts SELLING Activity expiring on 17th Feb, Vol 2500","$MRK 61.5 Puts SELLING Activity expiring on 17th Feb, Vol 2500
1",,,,1,[],https://twitter.com/SpeedyCalls/status/826492299228114944
564,Charley Grant,@CGrantWSJ,2017-02-02T13:30:03.000Z,"$MRK CEO says Pharma CEOs and Trump agreed to have ""regular check-ins.""","$MRK CEO says Pharma CEOs and Trump agreed to have ""regular check-ins.""
5
1",,,5,1,[],https://twitter.com/CGrantWSJ/status/827147069655830534
565,dough,@semodough,2017-02-02T19:16:22.000Z,"ISI $MRK M&A/BD: Mgmt. continues to say that BD is an important priority, and focus continues to be on the early-to-mid stage pipeline.","ISI $MRK M&A/BD: Mgmt. continues to say that BD is an important priority, and focus continues to be on the early-to-mid stage pipeline.
1
2",,1,,2,[],https://twitter.com/semodough/status/827234220632338433
566,Benzinga,@Benzinga,2017-02-02T11:45:56.000Z,"Merck Reports Q4 Adj. EPS $0.89, Inline, Sales $10.1B vs $10.22B Est. $MRK","Merck Reports Q4 Adj. EPS $0.89, Inline, Sales $10.1B vs $10.22B Est. $MRK
1",,,1,,[],https://twitter.com/Benzinga/status/827120867150815232
567,Matthew Herper,@matthewherper,2017-02-02T12:47:03.000Z,"$mrk why would Keytruda beat in US, but miss internationally? What's going on in Europe?","$mrk why would Keytruda beat in US, but miss internationally? What's going on in Europe?
5
2",,5,,2,[],https://twitter.com/matthewherper/status/827136246707318786
568,See It Market,@seeitmarket,2017-01-31T14:23:08.000Z,"6 Stocks I'm Buying Into This Stock Market Pullback https://seeitmarket.com/6-stocks-im-buying-into-this-stock-market-pullback-16523/#.WJCdkM6YRCY.twitter‚Ä¶ blog by 
@CJMendes
 
$JBLU $HAL $MRK $ABT $FCX $TLT","6 Stocks I'm Buying Into This Stock Market Pullback https://seeitmarket.com/6-stocks-im-buying-into-this-stock-market-pullback-16523/#.WJCdkM6YRCY.twitter‚Ä¶ blog by 
@CJMendes
 
$JBLU $HAL $MRK $ABT $FCX $TLT
seeitmarket.com
6 Stocks I'm Buying Into This Stock Market Pullback
CJ Mendes has been looking for a bout of weakness in the US equity markets to begin building positions in stocks he likes. He shares his list here.
1
2",,,1,2,[],https://twitter.com/seeitmarket/status/826435652082343937
569,Charley Grant,@CGrantWSJ,2017-02-02T13:41:56.000Z,"""so a number of questions, Mark. Thanks for that."" $MRK","""so a number of questions, Mark. Thanks for that."" $MRK
Jon Gardner
@ByJonGardner
 ¬∑ 2 Feb 2017
I do love the parsing of what constitutes a question in analyst calls. $MRK
1",,,,1,['https://pbs.twimg.com/profile_images/748064462624661505/dGLsyaPL_mini.jpg'],https://twitter.com/CGrantWSJ/status/827150060471345152
570,Merck,@Merck,2017-02-02T14:01:54.000Z,Thank you to our investors for following & joining our $MRK conversation this morning. Have a great day.,"Thank you to our investors for following & joining our $MRK conversation this morning. Have a great day.
1
1",,,1,1,[],https://twitter.com/Merck/status/827155086166093826
571,Meg Tirrell,@megtirrell,2017-02-02T13:59:18.000Z,Q on $MRK call: Is there a false sense of security building around Trump's comments on Medicare bidding?,"Q on $MRK call: Is there a false sense of security building around Trump's comments on Medicare bidding?
1
1",,,1,1,[],https://twitter.com/megtirrell/status/827154428914393089
572,Benzinga,@Benzinga,2017-02-02T14:30:01.000Z,"The Market In 5 Minutes: Facebook Beats, Trump Tweets https://benzinga.com/z/8984512 $AAPL $ACHN $FB $MRK $PM $EW $SPY $USO $CVS $URI $X $M $MJN","The Market In 5 Minutes: Facebook Beats, Trump Tweets https://benzinga.com/z/8984512 $AAPL $ACHN $FB $MRK $PM $EW $SPY $USO $CVS $URI $X $M $MJN
4",,,4,,[],https://twitter.com/Benzinga/status/827162158089764865
573,Donna Young,@DonnaYoungDC,2017-02-01T12:34:22.000Z,"Trump promises easier drug approvals, but wants lower #pharma prices
http://snl.com/web/client?auth=inherit#news/article?id=39270187&cdid=A-39270187-12840‚Ä¶ #drugprices $MRK $AMGN $NVS $CELG $JNJ $LLY","Trump promises easier drug approvals, but wants lower #pharma prices
http://snl.com/web/client?auth=inherit#news/article?id=39270187&cdid=A-39270187-12840‚Ä¶ #drugprices $MRK $AMGN $NVS $CELG $JNJ $LLY",üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/826770668456910848
574,Emma Court,@emmarcourt,2017-02-02T13:33:35.000Z,$MRK earnings stock gains give way after Keytruda revenue turns out to be a miss,"$MRK earnings stock gains give way after Keytruda revenue turns out to be a miss
marketwatch.com
Merck earnings stock gains give way after Keytruda revenue turns out to be a miss
Merck & Co. Inc. undefined shares surged as much as 1.4% in pre-market trade after company earnings numbers appeared to show its blockbuster Keytruda cancer...",,,,,['https://pbs.twimg.com/card_img/1501020535399931905/F60ICdjx?format=jpg&name=small'],https://twitter.com/emmarcourt/status/827147955933167617
575,Brad Loncar,@bradloncar,2017-02-02T13:35:43.000Z,$MRK was asked about the glioma hold. They said it's nothing.,"$MRK was asked about the glioma hold. They said it's nothing.
clinicaltrials.gov
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade...
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma -...
1",,,,1,['https://pbs.twimg.com/card_img/1499578112115363861/JaVVFVxw?format=png&name=240x240'],https://twitter.com/bradloncar/status/827148492841820160
576,The Fly,@theflynews,2017-02-01T19:57:03.000Z,Notable companies reporting before tomorrow's open $MRK $PM $COP $BDX $CI $EL $IP $DLPH $SNA $RL $SBH,"Notable companies reporting before tomorrow's open $MRK $PM $COP $BDX $CI $EL $IP $DLPH $SNA $RL $SBH
thefly.com
Notable companies reporting before tomorrow's open
Notable companies reporti... MRK, PM, COP, BDX, CI, EL, IP, DLPH, SNA, RL, SBH",,,,,['https://pbs.twimg.com/card_img/1501827093721608193/c2gtLy1C?format=jpg&name=small'],https://twitter.com/theflynews/status/826882073801551877
577,Anna Edney,@annaedney,2017-01-31T13:59:38.000Z,"It's pharma's turn to meet with Trump. CEOs of Merck, Eli Lilly and others are at the White House now $MRK $LLY https://bloomberg.com/politics/articles/2017-01-31/trump-meets-with-drugmakers-as-industry-fears-price-controls‚Ä¶","It's pharma's turn to meet with Trump. CEOs of Merck, Eli Lilly and others are at the White House now $MRK $LLY https://bloomberg.com/politics/articles/2017-01-31/trump-meets-with-drugmakers-as-industry-fears-price-controls‚Ä¶",,,,,[],https://twitter.com/annaedney/status/826429738658967553
578,Briefing.com,@Briefingcom,2017-01-31T23:02:02.000Z,$MRK: Merck: EC approves KEYTRUDA for NSCLC in adults whose tumors have high PD-L1 expression with no EGFR or ALK... http://bit.ly/2knTLIC,$MRK: Merck: EC approves KEYTRUDA for NSCLC in adults whose tumors have high PD-L1 expression with no EGFR or ALK... http://bit.ly/2knTLIC,,,,,[],https://twitter.com/Briefingcom/status/826566238226702338
579,Jacob Plieth,@JacobPlieth,2017-02-01T15:36:13.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
O'Day: Impower-150 might yield PFS readout first. Or maybe PFS & OS will come at same time. Either way, sufficient power $RHHBY $BMY $MRK
1
2",,1,,2,[],https://twitter.com/JacobPlieth/status/826816433380323329
580,Management,@gahtownil,2017-02-02T03:27:39.000Z,"Replying to 
@RealNewmann","Replying to 
@RealNewmann
I sold puts on $XOM $MRK & $SVXY
1",,,,1,[],https://twitter.com/gahtownil/status/826995467770802176
581,FunkyOmnivore,@funky_omnivore,2017-02-02T00:02:50.000Z,"Replying to 
@bio_clouseau","Replying to 
@bio_clouseau
Looks like $ADXS prostate combo study with $mrk is unaffected",,,,,[],https://twitter.com/funky_omnivore/status/826943927903191041
582,Lydia Ramsey Pflanzer,@lydiapflanzer,2017-02-02T14:02:09.000Z,"$MRK CEO on negotiating prices post Trump mtg ""That is not perceived to be the solution to the problem,"" more about getting co-pays down","$MRK CEO on negotiating prices post Trump mtg ""That is not perceived to be the solution to the problem,"" more about getting co-pays down",,,,,[],https://twitter.com/lydiapflanzer/status/827155146803179520
583,Paul R. La Monica,@LaMonicaBuzz,2017-01-31T14:40:42.000Z,"Keep eye on drug stocks. President Trump wants lower prices. $XLV ETF down 1%. $PFE, which also missed on earnings, lower. $MRK $JNJ down.","Keep eye on drug stocks. President Trump wants lower prices. $XLV ETF down 1%. $PFE, which also missed on earnings, lower. $MRK $JNJ down.
2
2",,2,2,,[],https://twitter.com/LaMonicaBuzz/status/826440073541480448
584,Benzinga,@Benzinga,2017-02-01T19:45:02.000Z,"Earnings: Facebook, Merck Scheduled To Open Their Books http://benzinga.com/z/8979196 $FB $MRK","Earnings: Facebook, Merck Scheduled To Open Their Books http://benzinga.com/z/8979196 $FB $MRK",,,,,[],https://twitter.com/Benzinga/status/826879047217078272
585,Steve S.,@stevedoc22,2017-02-02T13:19:39.000Z,"Replying to 
@matthewherper","Replying to 
@matthewherper
$MRK - looks like US Keytruda also missed when u back out $40M in deferred revenue recog'd this qtr.
1
1",,1,1,,[],https://twitter.com/stevedoc22/status/827144450132602880
586,dough,@semodough,2017-02-02T22:18:46.000Z,"@bradloncar
 big pharma cash piles in chart. Compliments of BAIRD 
@BrianSkorney
 $JNJ $MRK $CELG $GILD $AZN $PFE","@bradloncar
 big pharma cash piles in chart. Compliments of BAIRD 
@BrianSkorney
 $JNJ $MRK $CELG $GILD $AZN $PFE
dough
@semodough
 ¬∑ 3 Feb 2017
$AMGN and others $GILD $CELG $BIIB CASH https://twitter.com/tgtxdough/status/797479086817996800‚Ä¶ https://twitter.com/bradloncar/status/827274085390446598‚Ä¶
2
1
2",,2,1,2,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/827280124097634304
587,Rick Newman,@rickjnewman,2017-02-03T13:05:32.000Z,"Some CEOs advising Trump are job killers, not creators: https://yhoo.it/2jF1HWt $IBM $XOM $MRK $LMT 
@YahooFinance","Some CEOs advising Trump are job killers, not creators: https://yhoo.it/2jF1HWt $IBM $XOM $MRK $LMT 
@YahooFinance
2
8
8",,2,8,8,['https://pbs.twimg.com/media/C3vh03MWQAEc3yb?format=jpg&name=small'],https://twitter.com/rickjnewman/status/827503285934358528
588,Bursatil Biotech,@BursatilBiotech,2017-02-03T20:41:04.000Z,"Top #20 Recent Buyouts
Avg Deal Value: USD 30,9 Bn
Avg Premium to MKT: 39%
$PFE $ACT $NVS $RHHBY $MDT $MRK $SHPG $JNJ $ABBV $SNY $VRX $AZN","Top #20 Recent Buyouts
Avg Deal Value: USD 30,9 Bn
Avg Premium to MKT: 39%
$PFE $ACT $NVS $RHHBY $MDT $MRK $SHPG $JNJ $ABBV $SNY $VRX $AZN
2
2
6",,2,2,6,['https://pbs.twimg.com/media/C3xJuWPWEAovNKf?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/827617925414711297
589,dough,@semodough,2017-02-05T14:47:48.000Z,"Replying to 
@semodough","Replying to 
@semodough
big year for Alzheimer‚Äôs  $MRK $AXON $BIIB $ESALY $ROG $IBB
5
6
12",,5,6,12,['https://pbs.twimg.com/media/C36MbEZWYAAJwsV?format=jpg&name=small'],https://twitter.com/semodough/status/828253800330838016
590,Seeking Alpha,@SeekingAlpha,2017-02-05T14:52:15.000Z,Merck: Analyzing 2016 Performance And Outlook For 2017 http://seekingalpha.com/article/4042752-merck-analyzing-2016-performance-outlook-2017?source=feed_f‚Ä¶ $MRK,"Merck: Analyzing 2016 Performance And Outlook For 2017 http://seekingalpha.com/article/4042752-merck-analyzing-2016-performance-outlook-2017?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Merck: Analyzing 2016 Performance And Outlook For 2017 (NYSE:MRK)
This post was written by Bob Ciura for Sure Dividend On February 2, Merck (NYSE:MRK) reported fourth-quarter results that met analyst forecasts on earnings, but missed on revenue.
2",,,,2,['https://pbs.twimg.com/card_img/1501745829589266437/6uNf0W0a?format=jpg&name=240x240'],https://twitter.com/SeekingAlpha/status/828254918817427457
591,Alessandro viva l‚Äô#Ucraina,@pelias01,2017-02-05T09:03:31.000Z,11 Favored High-Yield Firms Within The Dow For 2017 http://seekingalpha.com/article/4039907-11-favored-high-yield-firms-within-dow-2017?source=tweet‚Ä¶ $BA $CSCO $CVX $DIA $IBM $IHE $KO $MCD $MRK $PFE $PG $VZ $XLK,"11 Favored High-Yield Firms Within The Dow For 2017 http://seekingalpha.com/article/4039907-11-favored-high-yield-firms-within-dow-2017?source=tweet‚Ä¶ $BA $CSCO $CVX $DIA $IBM $IHE $KO $MCD $MRK $PFE $PG $VZ $XLK
1",,,1,,[],https://twitter.com/pelias01/status/828167157053845513
592,MM+M Magazine,@MMMnews,2017-02-03T22:00:05.000Z,Sales of Merck's #immunotherapy Keytruda miss analysts' mark. $MRK #pharma #lungcancer http://bit.ly/2l3kgQY,"Sales of Merck's #immunotherapy Keytruda miss analysts' mark. $MRK #pharma #lungcancer http://bit.ly/2l3kgQY
1",,,1,,['https://pbs.twimg.com/media/C3v92zGWAAAklt7?format=jpg&name=small'],https://twitter.com/MMMnews/status/827637809527783424
593,ITML Finance,@ITMLFinance,2017-02-03T19:15:38.000Z,$MRK long term chart. June 65/70 call spread for 1.52 should be enough time for that c&h to breakout.,$MRK long term chart. June 65/70 call spread for 1.52 should be enough time for that c&h to breakout.,,,,,['https://pbs.twimg.com/media/C3w1_pSVcAEmk4L?format=jpg&name=small'],https://twitter.com/ITMLFinance/status/827596426091782144
594,@StockNewsU,@StockNewsU,2017-02-03T20:10:18.000Z,"Pulmatrix, Inc. (Nasdaq: $PULM) Resting After Massive Gains http://ow.ly/XCvO308EFNp #Biotech $CELG $PFE $MRK #cancer $AGN $LLY $BMY","Pulmatrix, Inc. (Nasdaq: $PULM) Resting After Massive Gains http://ow.ly/XCvO308EFNp #Biotech $CELG $PFE $MRK #cancer $AGN $LLY $BMY",,,,,['https://pbs.twimg.com/media/C3xDEvPWEAES2CE?format=jpg&name=900x900'],https://twitter.com/stocknewsu/status/827610182662373377
595,Becky Hiu,@beckyhiu,2017-02-03T21:10:58.000Z,$MRK ending week on a high note post ER.,$MRK ending week on a high note post ER.,,,,,['https://pbs.twimg.com/media/C3xQ9XqWEAAoW2m?format=jpg&name=small'],https://twitter.com/beckyhiu/status/827625449513693185
596,Alexander Le,@AlexanderTLe,2017-02-03T03:33:54.000Z,Surprised market reaction @ $mrk earnings. Arguably lots of fundamental headwinds @ mrk; solid consolidation point if you believe otherwise,Surprised market reaction @ $mrk earnings. Arguably lots of fundamental headwinds @ mrk; solid consolidation point if you believe otherwise,,,,,['https://pbs.twimg.com/media/C3tefUuUEAML1xk?format=jpg&name=small'],https://twitter.com/AlexanderTLe/status/827359429292994560
597,ICI Research,@iciresearch,2017-02-03T12:52:29.000Z,"$MRK gets priority review for 1L and 2L bladder cancer for pembrolizumab PDUFA Jun 14, 2017","$MRK gets priority review for 1L and 2L bladder cancer for pembrolizumab PDUFA Jun 14, 2017
Merck
@Merck
 ¬∑ 3 Feb 2017
Announcing our latest #BladderCancer news: http://bit.ly/2jKn97s
1",,,1,,['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg'],https://twitter.com/iciresearch/status/827500001655918593
598,BioPharma Dive,@BioPharmaDive,2017-02-05T19:29:01.000Z,"$MRK rolls out Keytruda DTC ads, mirroring moves from rival $BMY","$MRK rolls out Keytruda DTC ads, mirroring moves from rival $BMY
biopharmadive.com
Merck unveils new Keytruda DTC ad
With Bristol-Myers' Opdivo faltering, Merck is hammering home Keytruda's competitive advantage in first-line lung cancer.
2
1",,,2,1,['https://pbs.twimg.com/card_img/1501745826116378627/ivgcQwXe?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/828324569815597057
599,Cris Harrie,@TradingWTTrend,2017-02-03T02:50:29.000Z,"Long Stock Picks for February 3 2017

http://tradingwiththetrend.com/2017/02/02/long-stock-picks-february-3-2017/‚Ä¶

$CVX $IONS $MRK $UPS $X $XOM","Long Stock Picks for February 3 2017

http://tradingwiththetrend.com/2017/02/02/long-stock-picks-february-3-2017/‚Ä¶

$CVX $IONS $MRK $UPS $X $XOM
3
1",,,3,1,[],https://twitter.com/TradingWTTrend/status/827348502527119361
600,BioPharma Dive,@BioPharmaDive,2017-02-04T16:27:00.000Z,$MRK gives updates on Keytruda strategy,"$MRK gives updates on Keytruda strategy
biopharmadive.com
Merck's Perlmutter: Cancer not one size fits all
Combination therapies are the next big thing in immuno-oncology, and Merck believes Keytruda will perform well in that regard.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/827916376132067328
601,InvestorPlace,@InvestorPlace,2017-02-03T13:09:42.000Z,Merck: The Long-Awaited Breakout? $MRK http://bit.ly/2kZfgAi,Merck: The Long-Awaited Breakout? $MRK http://bit.ly/2kZfgAi,,,,,['https://pbs.twimg.com/media/C3vizsRVUAIzX1x?format=jpg&name=360x360'],https://twitter.com/InvestorPlace/status/827504337224097792
602,The Fly,@theflynews,2017-02-03T20:24:03.000Z,Trump + Stocks: The Week In Review $AAPL $MSFT $SBUX $NFLX $TSLA $IBM $GS $DAL $GM $F $NVS $MRK $JNJ $CELG $LLY‚Ä¶ http://dlvr.it/NHFq53,"Trump + Stocks: The Week In Review $AAPL $MSFT $SBUX $NFLX $TSLA $IBM $GS $DAL $GM $F $NVS $MRK $JNJ $CELG $LLY‚Ä¶ http://dlvr.it/NHFq53
1
1",,,1,1,[],https://twitter.com/theflynews/status/827613644112306177
603,Jeffrey Weber,@jjjinvesting,2017-02-03T22:30:18.000Z,Pfizer May Be Another IBM http://seekingalpha.com/article/4042443-pfizer-may-another-ibm?source=tweet‚Ä¶ $ALPMY $AZN $BMY $MKGAF $MRK $OPK $REGN $RHHBY $SNY $ZTS $ABBV $ABT $CELG $GILD $MDVN,"Pfizer May Be Another IBM http://seekingalpha.com/article/4042443-pfizer-may-another-ibm?source=tweet‚Ä¶ $ALPMY $AZN $BMY $MKGAF $MRK $OPK $REGN $RHHBY $SNY $ZTS $ABBV $ABT $CELG $GILD $MDVN
1
1",,1,1,,[],https://twitter.com/jjjinvesting/status/827645413813579779
604,MM+M Magazine,@MMMnews,2017-02-03T17:30:02.000Z,"Merck campaign shows impact of #shingles. $MRK #hcmktg 
@Merck
 http://bit.ly/2jHusg1","Merck campaign shows impact of #shingles. $MRK #hcmktg 
@Merck
 http://bit.ly/2jHusg1",,,,,['https://pbs.twimg.com/media/C3rQcZiWIAAU9zY?format=jpg&name=small'],https://twitter.com/MMMnews/status/827569851585617920
605,News and Tips,@MoneyNewsTips,2017-02-03T18:30:00.000Z,"Some CEOs advising Trump are job killers, not creators: http://buff.ly/2k3BHjF $IBM $XOM $MRK $LMT 
@YahooFinance
 http://buff.ly/2k3pBHj","Some CEOs advising Trump are job killers, not creators: http://buff.ly/2k3BHjF $IBM $XOM $MRK $LMT 
@YahooFinance
 http://buff.ly/2k3pBHj",,,,,[],https://twitter.com/MoneyNewsTips/status/827584940879515648
606,Heath Care News,@hc_equipment,2017-02-03T11:56:14.000Z,#Merck KGaA  Strategy SWOT and Corporate Finance Report Prices from USD $175. Read more: http://owler.us/acautV $MRK,#Merck KGaA  Strategy SWOT and Corporate Finance Report Prices from USD $175. Read more: http://owler.us/acautV $MRK,,,,,[],https://twitter.com/hc_equipment/status/827485845074554883
607,dough,@semodough,2017-02-05T15:15:58.000Z,"Replying to 
@semodough","Replying to 
@semodough
BMO  $MRK EPOCH mild to moderate pts results June 2017. APECS Phase 3 in prodromal PTS  is much more likely to succeed;Feb2019.
1
1",,,1,1,['https://pbs.twimg.com/media/C36S3qKWEAArTiR?format=jpg&name=small'],https://twitter.com/semodough/status/828260888708837376
608,Todd Campbell,@ebcapital,2017-02-04T15:18:13.000Z,"Pfizer's New #Biosimilar Is Off and Running 
@themotleyfool
 #stocks $MRK, $JNJ, $PFE","Pfizer's New #Biosimilar Is Off and Running 
@themotleyfool
 #stocks $MRK, $JNJ, $PFE
fool.com
Pfizer's New Biosimilar Is Off and Running @themotleyfool #stocks $PFE $MRK $JNJ
Johnson & Johnson faces stiff competition from Pfizer's new biosimilar to its top-selling Remicade.
2",,,2,,[],https://twitter.com/ebcapital/status/827899063458811908
609,Nvestly,@Nvestly,2017-02-05T02:10:12.000Z,RT @tgtxdough: Upcoming PDUFA/FDA Advisory Committee Meeting/351(k) Dates (1/2) $TSRO $NBIX $CELG $SHPG $IBB $CLVS $MRK $RDUS $BMRN‚Ä¶ #invest,"RT @tgtxdough: Upcoming PDUFA/FDA Advisory Committee Meeting/351(k) Dates (1/2) $TSRO $NBIX $CELG $SHPG $IBB $CLVS $MRK $RDUS $BMRN‚Ä¶ #invest
1",,,,1,[],https://twitter.com/Nvestly/status/828063141397278720
610,Pharmaceutical News,@pharma_sector,2017-02-05T11:55:18.000Z,Keytruda exceeds expectations to keep #Merck & Co sales steady. Read more: http://owler.us/aca1v0 $MRK,Keytruda exceeds expectations to keep #Merck & Co sales steady. Read more: http://owler.us/aca1v0 $MRK,,,,,[],https://twitter.com/pharma_sector/status/828210388709765120
611,Pharmaceutical News,@pharma_sector,2017-02-05T14:54:16.000Z,"#Merck & Company, Inc. Position Boosted by Sector Gamma AS. Read more: http://owler.us/aca6kg $MRK","#Merck & Company, Inc. Position Boosted by Sector Gamma AS. Read more: http://owler.us/aca6kg $MRK",,,,,[],https://twitter.com/pharma_sector/status/828255426915340288
612,WLST.com,@wlstcom,2017-02-03T13:05:35.000Z,Some CEOs advising Trump are job killers $IBM $XOM $MRK $LMT http://wlst.com http://finance.yahoo.com/news/some-ceos-advising-trump-are-job-killers-223341787.html‚Ä¶,Some CEOs advising Trump are job killers $IBM $XOM $MRK $LMT http://wlst.com http://finance.yahoo.com/news/some-ceos-advising-trump-are-job-killers-223341787.html‚Ä¶,,,,,['https://pbs.twimg.com/media/C3vh3RzWQAElCrz?format=jpg&name=small'],https://twitter.com/wlstcom/status/827503298013962240
613,"Mr Foxnose ""Russian Asset""",@asymmetricalpha,2017-02-03T04:38:35.000Z,$MRK Looking good w/ Weekly MACD GC. Needs to break above $64.50 w/ vol to run http://schrts.co/GKVDeg,"$MRK Looking good w/ Weekly MACD GC. Needs to break above $64.50 w/ vol to run http://schrts.co/GKVDeg
1
1",,,1,1,[],https://twitter.com/asymmetricalpha/status/827375709630955521
614,Dekker Hewett Group,@CGWM_DHG,2017-02-03T17:21:10.000Z,"Morning Coffee - CGWM (Feat. $BTO, $BAR, $BCE, $CNQ, $OGC, $Z, $DB, $FB, $RACE, $M, $MRK, $NOK, $RL, etc.) http://ow.ly/5V8T308EM0Z","Morning Coffee - CGWM (Feat. $BTO, $BAR, $BCE, $CNQ, $OGC, $Z, $DB, $FB, $RACE, $M, $MRK, $NOK, $RL, etc.) http://ow.ly/5V8T308EM0Z",,,,,[],https://twitter.com/CGWM_DHG/status/827567619335151621
615,George Moriarty,@geomoriarty,2017-02-03T15:32:59.000Z,Pfizer May Be Another IBM http://seekingalpha.com/article/4042443-pfizer-may-another-ibm?source=tweet‚Ä¶ $ALPMY $AZN $BMY $MKGAF $MRK $OPK $REGN $RHHBY $SNY $ZTS $ABBV $ABT $CELG $GILD $MDVN,"Pfizer May Be Another IBM http://seekingalpha.com/article/4042443-pfizer-may-another-ibm?source=tweet‚Ä¶ $ALPMY $AZN $BMY $MKGAF $MRK $OPK $REGN $RHHBY $SNY $ZTS $ABBV $ABT $CELG $GILD $MDVN
1",,1,,,[],https://twitter.com/geomoriarty/status/827540395315851264
616,Watchlist News,@WatchlistN,2017-02-03T15:05:37.000Z,"Merck & Company, Inc. Forecasted to Earn FY2017 Earnings of $3.68 Per Share $MRK http://zpr.io/PXi7i","Merck & Company, Inc. Forecasted to Earn FY2017 Earnings of $3.68 Per Share $MRK http://zpr.io/PXi7i",,,,,[],https://twitter.com/WatchlistN/status/827533508256096257
617,Daily Political,@dailypoliticaln,2017-02-04T14:25:10.000Z,"Analysts Set Expectations for Merck & Company, Inc.‚Äôs FY2017 Earnings $MRK http://dailypolitical.com/?p=922749","Analysts Set Expectations for Merck & Company, Inc.‚Äôs FY2017 Earnings $MRK http://dailypolitical.com/?p=922749",,,,,[],https://twitter.com/dailypoliticaln/status/827885714591334403
618,Ticker Report,@TickerReport,2017-02-03T11:01:25.000Z,"Pictet North America Advisors SA Increases Position in Merck & Company, Inc. $MRK http://ift.tt/2k8IMln","Pictet North America Advisors SA Increases Position in Merck & Company, Inc. $MRK http://ift.tt/2k8IMln",,,,,[],https://twitter.com/TickerReport/status/827472052768632833
619,Stockboard Media Inc,@stockboardinc,2017-02-03T11:51:03.000Z,$MRK FDA Accepts Two sBLAs for Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) for Locally Advanced or Metastatic Ur... - http://sbml.co/fc426140,$MRK FDA Accepts Two sBLAs for Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) for Locally Advanced or Metastatic Ur... - http://sbml.co/fc426140,,,,,[],https://twitter.com/stockboardinc/status/827484541069692928
620,Jacob Bell,@realJacobBell,2017-02-04T16:27:00.000Z,$MRK gives updates on Keytruda strategy,"$MRK gives updates on Keytruda strategy
biopharmadive.com
Merck's Perlmutter: Cancer not one size fits all
Combination therapies are the next big thing in immuno-oncology, and Merck believes Keytruda will perform well in that regard.",,,,,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/realJacobBell/status/827916376106872832
621,Crypto Trader Pro,@CryptoTraderPro,2017-02-03T14:51:20.000Z,drug in long base broke o\u2026 $MRK http://dlvr.it/NH7L8j powered by http://bit.do/TradOTO,drug in long base broke o\u2026 $MRK http://dlvr.it/NH7L8j powered by http://bit.do/TradOTO,,,,,[],https://twitter.com/CryptoTraderPro/status/827529910327529472
622,Watchlist News,@WatchlistN,2017-02-04T12:29:06.000Z,"SunTrust Banks Research Analysts Lift Earnings Estimates for Merck & Company, Inc. $MRK http://zpr.io/PxnLT","SunTrust Banks Research Analysts Lift Earnings Estimates for Merck & Company, Inc. $MRK http://zpr.io/PxnLT",,,,,[],https://twitter.com/WatchlistN/status/827856506423013376
623,Allison Gatlin,@IBD_AGatlin,2017-02-03T19:27:22.000Z,"Biogen trails Merck, Lilly in Alzheimer's; hemophilia spinoff begins trading $MRK $BIIB $LLY $BIVV $IONS","Biogen trails Merck, Lilly in Alzheimer's; hemophilia spinoff begins trading $MRK $BIIB $LLY $BIVV $IONS
investors.com
Biogen Trails Merck, Lilly In Alzheimer's; Hemophilia Spinoff Begins Trading | Stock News & Stock...
Biogen will trail Merck, AstraZeneca and Eli Lilly in Alzheimer's disease treatment, an analyst said the day Biogen's hemophilia unit began trading.
1",,,,1,['https://pbs.twimg.com/card_img/1501666424485515264/sAGgPhzx?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/827599376335900673
624,The Fly,@theflynews,2017-02-03T21:20:01.000Z,REPORT: Ono is planning over $3.5B in U.S. acquisitions over the next five years: http://bit.ly/2kqxvLA $BMY $MRK,"REPORT: Ono is planning over $3.5B in U.S. acquisitions over the next five years: http://bit.ly/2kqxvLA $BMY $MRK
thefly.com
Ono plans over $3.5B in U.S. acquisitions over next five years, Nikkei reports
Ono Pharmaceutical Presid... BMY, MRK
4",,,4,,[],https://twitter.com/theflynews/status/827627728224477185
625,Novateur Ventures,@NovateurBio,2017-02-03T23:33:11.000Z,"Dear President #Trump: Don‚Äôt destroy the 
@US_FDA
 we know and respect https://endpts.com/dear-president-trump-dont-destroy-the-fda-we-know-and-respect‚Ä¶ #pharma $MRK $JNJ $AMGN $LLY $CELG via 
@endpts","Dear President #Trump: Don‚Äôt destroy the 
@US_FDA
 we know and respect https://endpts.com/dear-president-trump-dont-destroy-the-fda-we-know-and-respect‚Ä¶ #pharma $MRK $JNJ $AMGN $LLY $CELG via 
@endpts
endpts.com
Dear President Trump: Don‚Äôt destroy the FDA we know and respect
On Tuesday, a group of Big Pharma execs from Merck, J&J, Amgen, Eli Lilly and Celgene gathered to pay court to President Donald Trump at the White House. Trump didn‚Äôt disappoint either his admirers...",,,,,['https://pbs.twimg.com/card_img/1501618273640587265/W59vZq3Q?format=png&name=small'],https://twitter.com/NovateurBio/status/827661239417344000
626,Jack Allen,@JohnK_Allen,2017-02-03T11:58:37.000Z,"Days after $BMY Opdivo is granted accelerated approval in urothelial cancer, 
@US_FDA
 accepts $MRK Keytruda applications","Days after $BMY Opdivo is granted accelerated approval in urothelial cancer, 
@US_FDA
 accepts $MRK Keytruda applications
Odi Bruckman
@odibro
 ¬∑ 3 Feb 2017
$MRK: FDA accepts two sBLAs for KEYTRUDA in pats. With locally advanced or metastatic urothelial cancer. Pdufa date June 14, 2017
1",,,,1,['https://pbs.twimg.com/profile_images/1182595151899836417/Y4fMBMd5_mini.jpg'],https://twitter.com/JohnK_Allen/status/827486445522780161
627,Mark Paris,@geneman10,2017-02-04T01:05:27.000Z,"Replying to 
@gulleyj1","Replying to 
@gulleyj1
Anyone seen stats for inflamed sig coupled to PD response or OS?  $MRK is certainly leaning VERY heavily on it.
1
1
1",,1,1,1,[],https://twitter.com/geneman10/status/827684461542268928
628,Ticker Report,@TickerReport,2017-02-04T14:14:08.000Z,"Condor Capital Management Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2k7hedC","Condor Capital Management Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2k7hedC",,,,,[],https://twitter.com/TickerReport/status/827882938096287744
629,MarketBeat,@MarketBeatCom,2017-02-05T14:03:23.000Z,"Airain ltd Increases Stake in Merck & Company, Inc. $MRK http://zpr.io/PxsE7","Airain ltd Increases Stake in Merck & Company, Inc. $MRK http://zpr.io/PxsE7",,,,,[],https://twitter.com/MarketBeatCom/status/828242619545305088
630,Sure Dividend,@SureDividend,2017-02-04T21:32:28.000Z,"Merck: Analyzing 2016 Performance & Outlook for 2017
http://buff.ly/2jPsWZl
$MRK","Merck: Analyzing 2016 Performance & Outlook for 2017
http://buff.ly/2jPsWZl
$MRK",,,,,[],https://twitter.com/SureDividend/status/827993248119549952
631,Ray,@RayTL_,2017-02-04T18:22:04.000Z,DOUBLE TOPS / BREAKOUTS: $WFC $ABX $MRK $PLX $CSC $MYL $WY More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab,DOUBLE TOPS / BREAKOUTS: $WFC $ABX $MRK $PLX $CSC $MYL $WY More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab,,,,,[],https://twitter.com/RayTL_/status/827945332663136256
632,Michael J. Kramer,@MichaelMOTTCM,2017-02-04T02:25:11.000Z,"Do Healthcare and Biotech Stocks Turn To M&A? https://youtu.be/hwRzA-PYaaE via 
@YouTube
 $jnj $pfe $mrk $lly $ibb $xbi $xlv $biib $amgn $gild","Do Healthcare and Biotech Stocks Turn To M&A? https://youtu.be/hwRzA-PYaaE via 
@YouTube
 $jnj $pfe $mrk $lly $ibb $xbi $xlv $biib $amgn $gild
youtube.com
Do Healthcare and Biotech Stocks Turn To M&A?
Let's talk about healthcare stocks, huge issues and lots controversy and lot of interests, and changes coming into this sector. Do you have any guess what we...
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501745875458138112/r05ZnpP2?format=jpg&name=240x240'],https://twitter.com/MichaelMOTTCM/status/827704526970974208
633,Benzinga,@Benzinga,2017-02-03T16:45:01.000Z,Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimers Where Competitors Fail https://benzinga.com/z/8962220 $NTRPD $BIIB $LLY $MRK,Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimers Where Competitors Fail https://benzinga.com/z/8962220 $NTRPD $BIIB $LLY $MRK,,,,,[],https://twitter.com/Benzinga/status/827558520996270080
634,Vikas Dandekar,@VikasReports,2017-02-05T23:24:38.000Z,"Pfizer's New Biosimilar Is Off and Running 
@themotleyfool
 #stocks $MRK, $JNJ, $PFE","Pfizer's New Biosimilar Is Off and Running 
@themotleyfool
 #stocks $MRK, $JNJ, $PFE
fool.com
Pfizer's New Biosimilar Is Off and Running @themotleyfool #stocks $PFE $MRK $JNJ
Johnson & Johnson faces stiff competition from Pfizer's new biosimilar to its top-selling Remicade.",,,,,[],https://twitter.com/VikasReports/status/828383865144279040
635,TalkMarkets,@TalkMarkets,2017-02-05T10:09:07.000Z,Merck: Analyzing 2016 Performance & Outlook For 2017 $MRK Also $ABT $JNJ https://goo.gl/uoejKZ,Merck: Analyzing 2016 Performance & Outlook For 2017 $MRK Also $ABT $JNJ https://goo.gl/uoejKZ,,,,,[],https://twitter.com/TalkMarkets/status/828183667595964416
636,Salil Kallianpur,@salilkallianpur,2017-02-05T03:35:57.000Z,"Pfizer's New Biosimilar Is Off and Running 
@themotleyfool
 #stocks $MRK, $JNJ, $PFE","Pfizer's New Biosimilar Is Off and Running 
@themotleyfool
 #stocks $MRK, $JNJ, $PFE
fool.com
Pfizer's New Biosimilar Is Off and Running @themotleyfool #stocks $PFE $MRK $JNJ
Johnson & Johnson faces stiff competition from Pfizer's new biosimilar to its top-selling Remicade.",,,,,[],https://twitter.com/salilkallianpur/status/828084721292832768
637,TalkMarkets Recap,@MarketsRecap,2017-02-05T04:09:04.000Z,Merck: Analyzing 2016 Performance & Outlook For 2017 $MRK Also $ABT $JNJ https://goo.gl/uoejKZ,Merck: Analyzing 2016 Performance & Outlook For 2017 $MRK Also $ABT $JNJ https://goo.gl/uoejKZ,,,,,[],https://twitter.com/MarketsRecap/status/828093056868040705
638,M,@bio_clouseau,2017-02-07T21:11:55.000Z,$GILD predicts 1.9-2.5B of its 2016 HCV share going to competition in 2017 $ABBV $MRK $ENTA,"$GILD predicts 1.9-2.5B of its 2016 HCV share going to competition in 2017 $ABBV $MRK $ENTA
2
10
9",,2,10,9,['https://pbs.twimg.com/media/C4F3huGWYAM9kj_?format=jpg&name=small'],https://twitter.com/bio_clouseau/status/829075242597351426
639,Tom Silver,@TomSilver39,2017-02-08T03:13:10.000Z,"$SGMO $BLUE $KITE $IMDZ $MRK ISBioTech 7th Spring Meeting  March 6-8, 2017, Washington, DC http://isbiotech.org/pdfs/Spring2017PAAG.pdf‚Ä¶","$SGMO $BLUE $KITE $IMDZ $MRK ISBioTech 7th Spring Meeting  March 6-8, 2017, Washington, DC http://isbiotech.org/pdfs/Spring2017PAAG.pdf‚Ä¶
3
9",,,3,9,['https://pbs.twimg.com/media/C4HKNEwUoAAoKc1?format=jpg&name=small'],https://twitter.com/TomSilver39/status/829166150969806848
640,Seeking Alpha,@SeekingAlpha,2017-02-07T10:53:12.000Z,Dogs Of The Dow 2017: Know The Strategy's Bets http://seekingalpha.com/article/4043198-dogs-dow-2017-know-strategys-bets?source=feed_f‚Ä¶ $MRK $IBM $CSCO $BA $CAT $KO $PFE $CVX $XOM $VZ $DIA $SPY,"Dogs Of The Dow 2017: Know The Strategy's Bets http://seekingalpha.com/article/4043198-dogs-dow-2017-know-strategys-bets?source=feed_f‚Ä¶ $MRK $IBM $CSCO $BA $CAT $KO $PFE $CVX $XOM $VZ $DIA $SPY
seekingalpha.com
Dogs Of The Dow 2017: Know The Strategy's Bets
The Dogs of the Dow strategy is one where investors select the ten stocks that have the highest dividend yield from the stocks in the Dow Jones Industrial Index (NYSEARCA:DIA) after the...
1",,,1,,['https://pbs.twimg.com/card_img/1501345428398301185/MXwhDYyh?format=png&name=360x360'],https://twitter.com/SeekingAlpha/status/828919537445728258
641,Evaluate Vantage,@evaluatevantage,2017-02-08T16:20:35.000Z,Darzalex and Keytruda win 2016‚Äôs sell-side popularity contest http://epvantage.com/Universal/View.aspx?type=Story&id=687138&isEPVantage=yes‚Ä¶ $JNJ $MRK $VRTX $NVS,"Darzalex and Keytruda win 2016‚Äôs sell-side popularity contest http://epvantage.com/Universal/View.aspx?type=Story&id=687138&isEPVantage=yes‚Ä¶ $JNJ $MRK $VRTX $NVS
5
2",,,5,2,"['https://pbs.twimg.com/media/C4J-CcxXAAAyvqm?format=jpg&name=small', 'https://pbs.twimg.com/media/C4J-CczWQAA5bcz?format=jpg&name=small']",https://twitter.com/evaluatevantage/status/829364313911607296
642,MM+M Magazine,@MMMnews,2017-02-08T12:30:02.000Z,Missed yesterday's news? Here's what to know #pharma $TEVA $MYL $CEPH #generics $MRK #FDA #oncology $CLLS #Leukemia http://bit.ly/2kOvdZ1,"Missed yesterday's news? Here's what to know #pharma $TEVA $MYL $CEPH #generics $MRK #FDA #oncology $CLLS #Leukemia http://bit.ly/2kOvdZ1
1",,,,1,['https://pbs.twimg.com/media/C4EtTrTW8AAKlzj?format=jpg&name=small'],https://twitter.com/MMMnews/status/829306290828693506
643,Recall Propecia,@RecallPropecia,2017-02-08T01:56:05.000Z,Looks like Melania has her First Lady pet project cut out for her. #TrumpPropecia #TrumpBookReport #TrumpPressConference $MRK #travelban,"Looks like Melania has her First Lady pet project cut out for her. #TrumpPropecia #TrumpBookReport #TrumpPressConference $MRK #travelban
jeffdouglasmesser
@jeffdouglasmess
 ¬∑ 8 Feb 2017
.@realDonaldTrump takes #Propeica, which causes impotence & mental instability. He traded a limp lil Don for THAT hair. @RecallPropecia
1
3",,,1,3,['https://pbs.twimg.com/profile_images/1040992475610005504/7hK44QIi_mini.jpg'],https://twitter.com/RecallPropecia/status/829146752531865601
644,Ozmosi,@OzmosiHealth,2017-02-06T17:20:34.000Z,Top 10 Drug Launches of 2017 - $MRK and $SNY top the list http://bit.ly/2kzHYEM #pharma,Top 10 Drug Launches of 2017 - $MRK and $SNY top the list http://bit.ly/2kzHYEM #pharma,,,,,['https://pbs.twimg.com/media/C3_4_zrUkAAtPZD?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/828654633396666368
645,Clark Joseph Kent,@JorelLaraKalel,2017-02-08T16:49:13.000Z,"Cramer: Allergan Is the New Pharma Growth Stock 
@jimcramer
 @thestreet
 $AGN http://bit.ly/2kHXNZV $LLY $CELG $BIIB $BMY $PFE $MRK $AZN","Cramer: Allergan Is the New Pharma Growth Stock 
@jimcramer
 @thestreet
 $AGN http://bit.ly/2kHXNZV $LLY $CELG $BIIB $BMY $PFE $MRK $AZN
thestreet.com
Jim Cramer breaks down Allergan's last quarter
Jim Cramer compares Allergan's growth to other pharma stocks.",,,,,['https://pbs.twimg.com/card_img/1501745453297242120/waHlV9LM?format=jpg&name=small'],https://twitter.com/JorelLaraKalel/status/829371518807314433
646,"Jared Louis Wolff, MS",@jaredlouiswolff,2017-02-08T14:50:19.000Z,$BMY 's Opdivo and $MRK 's Keytruda still lead the way in immunotherapy for #HCC while $NVS and $AZN have products in earlier development,"$BMY 's Opdivo and $MRK 's Keytruda still lead the way in immunotherapy for #HCC while $NVS and $AZN have products in earlier development
Nature Reviews Drug Discovery
@NatRevDrugDisc
 ¬∑ 7 Feb 2017
The immuno-oncology race: myths and emerging realities http://go.nature.com/2jYF4wk http://rdcu.be/o47d #cancerresearch #Immunotherapy
3",,,,3,"['https://pbs.twimg.com/profile_images/1187044773900771329/XlelFzYz_mini.jpg', 'https://pbs.twimg.com/media/C4Eue1HWQAEDd9F?format=jpg&name=small']",https://twitter.com/jaredlouiswolff/status/829341594864205825
647,Stockrow,@stockrow1,2017-02-06T21:00:12.000Z,"$CELG is one of the fastest growing large biotechs, revenues are up 23% yoy http://bit.ly/2keWdhr $PFE $AMGN $JNJ $MRK","$CELG is one of the fastest growing large biotechs, revenues are up 23% yoy http://bit.ly/2keWdhr $PFE $AMGN $JNJ $MRK",,,,,['https://pbs.twimg.com/media/C4ArN4fWcAAX9BH?format=jpg&name=small'],https://twitter.com/stockrow1/status/828709905263689729
648,"David Settle, CMT",@davidsettle42,2017-02-07T02:42:00.000Z,02/06/17 - View today's Market Forecast by @BVZ_Investools here: http://bit.ly/2jdK7Er Discussed: $SPX $XLV $MRK $RUT $QQQ #Investools,"02/06/17 - View today's Market Forecast by @BVZ_Investools here: http://bit.ly/2jdK7Er Discussed: $SPX $XLV $MRK $RUT $QQQ #Investools
4
3",,,4,3,[],https://twitter.com/davidsettle42/status/828795921211076608
649,InsiderSense Notify,@insidersense_,2017-02-06T20:36:28.000Z,Insider Selling in $MRK. Weeks Wendell P sells $323k - Avg price of $64.5083. Learn more at https://insidersense.com,Insider Selling in $MRK. Weeks Wendell P sells $323k - Avg price of $64.5083. Learn more at https://insidersense.com,,,,,[],https://twitter.com/insidersense_/status/828703930217541632
650,InsiderSense Notify,@insidersense_,2017-02-06T20:36:36.000Z,Insider Selling in $MRK. Schechter Adam H sells $2.32m - Avg price of $63.7319. Learn more at https://insidersense.com,Insider Selling in $MRK. Schechter Adam H sells $2.32m - Avg price of $63.7319. Learn more at https://insidersense.com,,,,,[],https://twitter.com/insidersense_/status/828703965177069572
651,CBPartners,@CBPartners,2017-02-07T22:10:12.000Z,Following Thursday's approval of #BladderCancer therapy $BMY OPDIVIO - #FDA grants $MRK KEYTRUDA priority review http://bit.ly/2kNuszx,Following Thursday's approval of #BladderCancer therapy $BMY OPDIVIO - #FDA grants $MRK KEYTRUDA priority review http://bit.ly/2kNuszx,,,,,[],https://twitter.com/CBPartners/status/829089906173554688
652,Heath Care News,@hc_equipment,2017-02-08T11:06:15.000Z,#Merck: Goa plant comes to a standstill. Read more: http://owler.us/acbZDt $MRK,#Merck: Goa plant comes to a standstill. Read more: http://owler.us/acbZDt $MRK,,,,,[],https://twitter.com/hc_equipment/status/829285209078190081
653,The Skeptic,@TheSkeptic21,2017-02-07T21:38:25.000Z,HOW THE FUCK DID $GILD GET AWAY WITH NOT RECORDING THE $2.5B CHARGE RELATED TO $MRK LITIGATION?!?!?!,"HOW THE FUCK DID $GILD GET AWAY WITH NOT RECORDING THE $2.5B CHARGE RELATED TO $MRK LITIGATION?!?!?!
1
1",,1,,1,[],https://twitter.com/TheSkeptic21/status/829081909229666304
654,CBPartners,@CBPartners,2017-02-07T16:10:17.000Z,#FDA gives $MRK KEYTRUDA priority review as therapy for metastatic urothelial cancer #BladderCancer http://bit.ly/2kNuszx,#FDA gives $MRK KEYTRUDA priority review as therapy for metastatic urothelial cancer #BladderCancer http://bit.ly/2kNuszx,,,,,[],https://twitter.com/CBPartners/status/828999332472963075
655,Headlne,@headlneapp,2017-02-08T20:35:11.000Z,"Should I Buy Valeant Pharmaceuticals Stock? 3 Pros, 3 Cons https://scutify.com/articles/2017-02-08-should-i-buy-valeant-pharmaceuticals-intl-inc-vrx-stock-3-pros-3-cons‚Ä¶  $VRX $LLY $MRK $PFE #pharmaceuticals #healthcare","Should I Buy Valeant Pharmaceuticals Stock? 3 Pros, 3 Cons https://scutify.com/articles/2017-02-08-should-i-buy-valeant-pharmaceuticals-intl-inc-vrx-stock-3-pros-3-cons‚Ä¶  $VRX $LLY $MRK $PFE #pharmaceuticals #healthcare",,,,,['https://pbs.twimg.com/media/C4K4jhHVMAA6_cu?format=jpg&name=360x360'],https://twitter.com/headlneapp/status/829428382811119616
656,Heath Care News,@hc_equipment,2017-02-07T13:12:03.000Z,#Merck : Millipore settles lawsuit with EPA. Read more: http://owler.us/acbHJS $MRK,#Merck : Millipore settles lawsuit with EPA. Read more: http://owler.us/acbHJS $MRK,,,,,[],https://twitter.com/hc_equipment/status/828954480192286721
657,Heath Care News,@hc_equipment,2017-02-06T19:04:36.000Z,Exosome Diagnostics Announces Agreement With #Merck KGaA. Read more: http://owler.us/acbuFS $MRK,Exosome Diagnostics Announces Agreement With #Merck KGaA. Read more: http://owler.us/acbuFS $MRK,,,,,[],https://twitter.com/hc_equipment/status/828680811138330627
658,Pharmaceutical News,@pharma_sector,2017-02-08T17:18:46.000Z,"FY2017 EPS Estimates for #Merck & Company, Inc. Boosted by Analyst (). Read more: http://owler.us/accbHO $MRK","FY2017 EPS Estimates for #Merck & Company, Inc. Boosted by Analyst (). Read more: http://owler.us/accbHO $MRK",,,,,[],https://twitter.com/pharma_sector/status/829378952967839745
659,Stockaholics,@Stockaholics,2017-02-08T12:32:04.000Z,114% Gain On Picks In 2 Weeks & Our New Penny Stock Pick Is Coming Today! Get Early Access: http://tr.im/21amb #Breakout $INSY $MRK,114% Gain On Picks In 2 Weeks & Our New Penny Stock Pick Is Coming Today! Get Early Access: http://tr.im/21amb #Breakout $INSY $MRK,,,,,[],https://twitter.com/Stockaholics/status/829306804031148032
660,Pharmaceutical News,@pharma_sector,2017-02-08T21:40:30.000Z,#Merck Biotech Director at Cambridge's Merrimack Arrested for Insider Trading Scheme. Read more: http://owler.us/accgM7 $MRK,#Merck Biotech Director at Cambridge's Merrimack Arrested for Insider Trading Scheme. Read more: http://owler.us/accgM7 $MRK,,,,,[],https://twitter.com/pharma_sector/status/829444823467692032
661,CBPartners,@CBPartners,2017-02-07T23:10:13.000Z,Rivalry ahead? #FDA grants $MRK KEYTRUDA priority review in 2 urothelial carcinoma subsets after OPDIVIO approval http://bit.ly/2kNuszx,Rivalry ahead? #FDA grants $MRK KEYTRUDA priority review in 2 urothelial carcinoma subsets after OPDIVIO approval http://bit.ly/2kNuszx,,,,,[],https://twitter.com/CBPartners/status/829105012664053760
662,InsiderSense Notify,@insidersense_,2017-02-06T20:36:32.000Z,Insider Selling in $MRK. Wendell Peter C sells $955k - Avg price of $63.6937. Learn more at https://insidersense.com,Insider Selling in $MRK. Wendell Peter C sells $955k - Avg price of $63.6937. Learn more at https://insidersense.com,,,,,[],https://twitter.com/insidersense_/status/828703946961256453
663,Daily Political,@dailypoliticaln,2017-02-08T23:54:39.000Z,"Merck & Company, Inc. $MRK Shares Bought by HighTower Advisors LLC http://dailypolitical.com/?p=929749","Merck & Company, Inc. $MRK Shares Bought by HighTower Advisors LLC http://dailypolitical.com/?p=929749",,,,,[],https://twitter.com/dailypoliticaln/status/829478581206122497
664,Allison Gatlin,@IBD_AGatlin,2017-02-06T19:26:31.000Z,"AbbVie, Merck pressure Gilead's 2017 Hep C unit; GSK battles HIV biz $ABBV $MRK $GILD $GSK $AMGN","AbbVie, Merck pressure Gilead's 2017 Hep C unit; GSK battles HIV biz $ABBV $MRK $GILD $GSK $AMGN
investors.com
AbbVie, Merck Pressure Gilead's 2017 Hep C Unit; GSK Battles HIV Biz | Stock News & Stock Market...
AbbVie and Merck are pressuring Gilead's Hep C unit, RBC said Monday, a day ahead of Gilead's Q4 earnings report and 2017 guidance.
1",,,,1,[],https://twitter.com/IBD_AGatlin/status/828686326878916608
665,Stockflare US Page,@StockflareUS,2017-02-07T09:36:00.000Z,"$MRK: Forecast sales for Merck & Co., Inc. are no longer forecast to rise this year. (https://stockflare.com/stocks/MRK)","$MRK: Forecast sales for Merck & Co., Inc. are no longer forecast to rise this year. (https://stockflare.com/stocks/MRK)",,,,,[],https://twitter.com/StockflareUS/status/828900105919021056
666,Limex,@LimexMe,2017-02-07T15:23:42.000Z,Better Buy: Merck & Co. Inc. vs. GlaxoSmithKline $GSK $MRK,"Better Buy: Merck & Co. Inc. vs. GlaxoSmithKline $GSK $MRK
whotrades.com
Better Buy: Merck & Co. Inc. vs. GlaxoSmithKline
They're two of the biggest pharmaceutical companies in the world, but Merck (NYSE: MRK) and GlaxoSmithKline (NYSE: GSK) have had very different paths lately. While Merck's stock is‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/828987609477156865
667,MarketBeat,@MarketBeatCom,2017-02-07T14:14:42.000Z,Merck KGaA's neutral rating reiterated at J P Morgan Chase & Co. http://ift.tt/2kIJEOK $MRK #MRK,Merck KGaA's neutral rating reiterated at J P Morgan Chase & Co. http://ift.tt/2kIJEOK $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/828970245557714944
668,Mike Sheikh,@breckskifan,2017-02-08T14:55:04.000Z,The $mrk Ketruda Trial data what great yesterday! Combo Therapy VERY Promising Look at that tumor reduction 3 Doses! http://globenewswire.com/news-release/2017/02/07/914877/0/en/Combination-Immunotherapy-with-Galectin-3-Inhibitor-GR-MD-02-Enhances-Effects-in-Pre-clinical-Models-and-Early-Results-of-Phase-1-Clinical-Trials.html‚Ä¶,The $mrk Ketruda Trial data what great yesterday! Combo Therapy VERY Promising Look at that tumor reduction 3 Doses! http://globenewswire.com/news-release/2017/02/07/914877/0/en/Combination-Immunotherapy-with-Galectin-3-Inhibitor-GR-MD-02-Enhances-Effects-in-Pre-clinical-Models-and-Early-Results-of-Phase-1-Clinical-Trials.html‚Ä¶,,,,,[],https://twitter.com/breckskifan/status/829342792132423682
669,Money Life Show,@MoneyLifeShow,2017-02-07T23:27:17.000Z,"Mike Liss of 
@American
 Century ($TWVLX) talked about $CVX $APC $MDLZ $MDT & $MRK during ""Hold It or Fold It"" in today's #MoneyLifeMarketCall","Mike Liss of 
@American
 Century ($TWVLX) talked about $CVX $APC $MDLZ $MDT & $MRK during ""Hold It or Fold It"" in today's #MoneyLifeMarketCall
1",,,1,,[],https://twitter.com/MoneyLifeShow/status/829109306016530434
670,Limex,@LimexMe,2017-02-06T15:37:14.000Z,These 2 Factors Sent Bristol-Myers Squibb Co. Tumbling by 16% in January $MRK $BMY,"These 2 Factors Sent Bristol-Myers Squibb Co. Tumbling by 16% in January $MRK $BMY
whotrades.com
These 2 Factors Sent Bristol-Myers Squibb Co. Tumbling by 16% in January
What happened Shares of global drug giant Bristol-Myers Squibb (NYSE: BMY) were hammered in January, falling 16% according to data from S&P Global Market Intelligence . Once‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/828628625465417729
671,Daily Political,@dailypoliticaln,2017-02-08T10:14:14.000Z,"Steinberg Global Asset Management Sells 1,995 Shares of Merck & Company, Inc. $MRK http://ift.tt/2kqIZ3z","Steinberg Global Asset Management Sells 1,995 Shares of Merck & Company, Inc. $MRK http://ift.tt/2kqIZ3z",,,,,[],https://twitter.com/dailypoliticaln/status/829272115606069249
672,Watchlist News,@WatchlistN,2017-02-08T12:45:01.000Z,"Traders Buy Merck & Company, Inc. $MRK on Weakness After Insider Selling http://zpr.io/PEtE3","Traders Buy Merck & Company, Inc. $MRK on Weakness After Insider Selling http://zpr.io/PEtE3",,,,,[],https://twitter.com/WatchlistN/status/829310061122113536
673,Rocket,@RocketFinancial,2017-02-07T20:04:35.000Z,"Tweedy Browne bought $WSM and $TMRK last quarter.  Sold out of $ITW, $LMT, and $MRK.  http://rocketfinancial.com/Holdings.aspx?id=347&fC=1‚Ä¶","Tweedy Browne bought $WSM and $TMRK last quarter.  Sold out of $ITW, $LMT, and $MRK.  http://rocketfinancial.com/Holdings.aspx?id=347&fC=1‚Ä¶",,,,,[],https://twitter.com/RocketFinancial/status/829058296053121024
674,Ticker Report,@TickerReport,2017-02-08T15:23:27.000Z,"Merck & Company, Inc. $MRK Director Thomas R. Cech Sells 5,000 Shares http://ift.tt/2k39j0c","Merck & Company, Inc. $MRK Director Thomas R. Cech Sells 5,000 Shares http://ift.tt/2k39j0c",,,,,[],https://twitter.com/TickerReport/status/829349932272406533
675,Watchlist News,@WatchlistN,2017-02-07T22:13:09.000Z,"Westpac Banking Corp Sells 74,253 Shares of Merck & Company, Inc. $MRK http://zpr.io/PxVXu","Westpac Banking Corp Sells 74,253 Shares of Merck & Company, Inc. $MRK http://zpr.io/PxVXu",,,,,[],https://twitter.com/WatchlistN/status/829090649848807426
676,Novateur Ventures,@NovateurBio,2017-02-07T00:13:06.000Z,"The 
@US_FDA
 grants priority review to $MRK #Keytruda for two urothelial cancer indications https://goo.gl/wBch9s via 
@GoHealio","The 
@US_FDA
 grants priority review to $MRK #Keytruda for two urothelial cancer indications https://goo.gl/wBch9s via 
@GoHealio
healio.com
FDA grants priority review to Keytruda for two urothelial cancer indications
The FDA granted priority review to two supplemental biologics license applications that seek approval of pembrolizumab for the treatment of locally advanced or metastatic urothelial cancer.One...
1",,,1,,['https://pbs.twimg.com/card_img/1499882338125111298/mEsc2Euy?format=png&name=small'],https://twitter.com/NovateurBio/status/828758447814434816
677,TW Research Group,@DanCarlson33,2017-02-07T16:45:56.000Z,"Best market technician, Tim Ord. Bull or Bear? See here. $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK $MSFT $MKE  http://tailwindsresearch.com/2017/01/the-ord-oracle-1-30-17/‚Ä¶","Best market technician, Tim Ord. Bull or Bear? See here. $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK $MSFT $MKE  http://tailwindsresearch.com/2017/01/the-ord-oracle-1-30-17/‚Ä¶",,,,,[],https://twitter.com/DanCarlson33/status/829008305309700096
678,Nic,@racernic,2017-02-06T19:03:44.000Z,$MRK still working well. trade is green. leaving it on.,"$MRK still working well. trade is green. leaving it on.
stocktwits.com
Nic (@racernic) | Stocktwits
$MRK still working well. trade is green. leaving it on.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501131579225108483/vDGKeWZr?format=png&name=240x240'],https://twitter.com/racernic/status/828680594888482816
679,Jacob Bell,@realJacobBell,2017-02-06T00:18:01.000Z,"Rx Reading: Trump meets with big pharma, $TENX hits clinical roadblock, $LLY, $MRK, others announce earnings","Rx Reading: Trump meets with big pharma, $TENX hits clinical roadblock, $LLY, $MRK, others announce earnings
biopharmadive.com
Prescribed Reading: A week dominated by politics and earnings
Pharma's sit down with President Trump was a hot topic in earnings calls this week as markets tried to gauge the new administration's approach to the industry. ",,,,,['https://pbs.twimg.com/card_img/1500049809826369538/mq3I7xko?format=jpg&name=small'],https://twitter.com/realJacobBell/status/828397297994231808
680,Roy Friedman,@DewDiligence,2017-02-08T15:11:44.000Z,"Replying to 
@DewDiligence","Replying to 
@DewDiligence
$GILD $ABBV $ENTA $MRK ‚Äî4Q16 HCV/GT1 mkt shares (Harvovi vs Viekira vs Zepatier)‚Äîcorrected table:
investorshub.advfn.com
Biotech Values Post # 208870
1
2",,,1,2,[],https://twitter.com/DewDiligence/status/829346986574884864
681,The Fly,@theflynews,2017-02-07T20:13:03.000Z,Drugmakers dip after Spicer says President 'absolutely' favors price negotiation $BMY $LLY $JNJ $MRK $PFE $MYL‚Ä¶,"Drugmakers dip after Spicer says President 'absolutely' favors price negotiation $BMY $LLY $JNJ $MRK $PFE $MYL‚Ä¶
thefly.com
Drugmakers dip after Spicer says President 'absolutely' favors price negotiation
Shares of some major phar... BMY, LLY, JNJ, MRK, PFE, MYL, CELG, ABBV, AMGN, VRX, AGN
1",,,1,,[],https://twitter.com/theflynews/status/829060426121965571
682,David Crow,@bydavidcrow,2017-02-08T14:54:56.000Z,Nice chart on immunotherapy race: still not much blue.... $MRK $BMY $AZN $PFE $ROG,Nice chart on immunotherapy race: still not much blue.... $MRK $BMY $AZN $PFE $ROG,,,,,[],https://twitter.com/bydavidcrow/status/829342758435438592
683,"David Settle, CMT",@davidsettle42,2017-02-07T12:45:01.000Z,ICYMI: 02/06/17 - View today's Market Forecast by @BVZ_Investools here: http://bit.ly/2jdK7Er Discussed: $SPX $XLV $MRK $IWM #Investools,"ICYMI: 02/06/17 - View today's Market Forecast by @BVZ_Investools here: http://bit.ly/2jdK7Er Discussed: $SPX $XLV $MRK $IWM #Investools
2
5",,,2,5,[],https://twitter.com/davidsettle42/status/828947674254569473
684,Mike Sheikh,@breckskifan,2017-02-06T19:22:34.000Z,"@BioRunUp
 Did you see the price reiteration on $GALT and article on $BMY, $MRK that mentions #GALT please retweet http://seekingalpha.com/article/4042946-bidding-war-galectin-inhibitors-may-heat-gtcbio-conference‚Ä¶","@BioRunUp
 Did you see the price reiteration on $GALT and article on $BMY, $MRK that mentions #GALT please retweet http://seekingalpha.com/article/4042946-bidding-war-galectin-inhibitors-may-heat-gtcbio-conference‚Ä¶
1",,,1,,[],https://twitter.com/breckskifan/status/828685335932514304
685,Recall Propecia,@RecallPropecia,2017-02-06T20:35:40.000Z,"Someone from the 
@TrumpCabinet
 please tell 
@POTUS
 that $MRK lied when they said Propecia side effects ""go away."" http://i.imgur.com/qKSEtK5.png","Someone from the 
@TrumpCabinet
 please tell 
@POTUS
 that $MRK lied when they said Propecia side effects ""go away."" http://i.imgur.com/qKSEtK5.png",,,,,[],https://twitter.com/RecallPropecia/status/828703728563675136
686,Pharmaceutical News,@pharma_sector,2017-02-08T13:16:26.000Z,"#Merck & Company, Inc. is Sphera Funds Management LTD.'s Largest Position. Read more: http://owler.us/acb5ur $MRK","#Merck & Company, Inc. is Sphera Funds Management LTD.'s Largest Position. Read more: http://owler.us/acb5ur $MRK",,,,,[],https://twitter.com/pharma_sector/status/829317968240791552
687,TalkMarkets Recap,@MarketsRecap,2017-02-07T00:39:04.000Z,Q4 Earnings Faring Well For Pharma ETFs $MRK $PJP $IHE $XPH $PPH Also $JNJ $BMY $LLY $PFE https://goo.gl/PqHBTD,Q4 Earnings Faring Well For Pharma ETFs $MRK $PJP $IHE $XPH $PPH Also $JNJ $BMY $LLY $PFE https://goo.gl/PqHBTD,,,,,[],https://twitter.com/MarketsRecap/status/828764982921789441
688,TalkMarkets Recap,@MarketsRecap,2017-02-07T22:09:14.000Z,5 Stocks to Watch After the Market Closes Today - Feb. 7 $DIS $BWLD $GILD $PNRA $ZG Also $MRK https://goo.gl/hhm9un,5 Stocks to Watch After the Market Closes Today - Feb. 7 $DIS $BWLD $GILD $PNRA $ZG Also $MRK https://goo.gl/hhm9un,,,,,[],https://twitter.com/MarketsRecap/status/829089666288775170
689,Insider Monkey News,@insidermonkey_n,2017-02-07T19:08:56.000Z,The FDA Accepts Keytruda From $MRK For Bladder Cancer,"The FDA Accepts Keytruda From $MRK For Bladder Cancer
insidermonkey.com
The FDA Accepts Keytruda From Merck & Co., Inc. (MRK) For Bladder Cancer
Patients with bladder cancer now having something to smile about, after the acceptance of 2 new supplemental biologics license applications, by the FDA.",,,,,['https://pbs.twimg.com/card_img/1501981830110535683/vAk0jEwD?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/829044290462556160
690,Watchlist News,@WatchlistN,2017-02-07T22:46:35.000Z,"Merck & Company, Inc. $MRK Shares Sold by Shufro Rose & Co. LLC http://zpr.io/PxV5J","Merck & Company, Inc. $MRK Shares Sold by Shufro Rose & Co. LLC http://zpr.io/PxV5J",,,,,[],https://twitter.com/WatchlistN/status/829099063442337793
691,Ray,@RayTL_,2017-02-08T04:04:36.000Z,DOUBLE TOPS / BREAKOUTS: $MRK $HPE $HAS $AG $MYL $WY $IBN More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab,DOUBLE TOPS / BREAKOUTS: $MRK $HPE $HAS $AG $MYL $WY $IBN More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab,,,,,[],https://twitter.com/RayTL_/status/829179095095218177
692,Evaluate Pharma,@evaluatepharma,2017-02-08T17:34:42.000Z,"Darzalex and #Keytruda win 2016‚Äôs sell-side popularity contest http://ow.ly/WPup308Oqqp via 
@ByAmyBrown
 @EPVantage
$JNJ $MRK #Pharma #Oncology","Darzalex and #Keytruda win 2016‚Äôs sell-side popularity contest http://ow.ly/WPup308Oqqp via 
@ByAmyBrown
 @EPVantage
$JNJ $MRK #Pharma #Oncology
1
1",,,1,1,[],https://twitter.com/evaluatepharma/status/829382965926977537
693,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-02-07T21:49:47.000Z,"Replying to 
@MaxNisen","Replying to 
@MaxNisen
very true only one gem out there... $INCY proof of concept there with IDO1, via $MRK Ph3 expansion, $INCY only Mid Cap worth buyin
1
1",,1,,1,[],https://twitter.com/DrPaulyDeSantis/status/829084770340634624
694,Ray,@RayTL_,2017-02-08T23:38:20.000Z,DOUBLE TOPS / BREAKOUTS: $KGC $IBN $HPE $MRK $WY $XBI $LC More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab,DOUBLE TOPS / BREAKOUTS: $KGC $IBN $HPE $MRK $WY $XBI $LC More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab,,,,,[],https://twitter.com/RayTL_/status/829474476664320001
695,John LaMattina,@John_LaMattina,2017-02-10T15:37:08.000Z,"$MRK CEO Frazier said of Shkreli ""He is not us."" But Marathon IS part of PhRMA. Big cos. should secede from PhRMA. http://on.forbes.com/60168r6J0","$MRK CEO Frazier said of Shkreli ""He is not us."" But Marathon IS part of PhRMA. Big cos. should secede from PhRMA. http://on.forbes.com/60168r6J0
John Carroll
@JohnCendpts
 ¬∑ 10 Feb 2017
Too bad Martin Shkrelli isn't on Twitter -- he could do a rant on the laws of biopharma guap and Marathon.
1
8
15",,1,8,15,['https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_mini.jpeg'],https://twitter.com/John_LaMattina/status/830078154454740998
696,David Crow,@bydavidcrow,2017-02-09T16:24:42.000Z,Drugmakers are struggling to extend benefits of immunotherapies to more patients $BMY $MRK $ROG $AZN,"Drugmakers are struggling to extend benefits of immunotherapies to more patients $BMY $MRK $ROG $AZN
ft.com
Big pharma faces costly setback in cancer fight
Investors lose billions as immunotherapies fall short of high expectations
4
2",,,4,2,['https://pbs.twimg.com/card_img/1500739606748090370/_800gmBM?format=jpg&name=small'],https://twitter.com/bydavidcrow/status/829727734872076292
697,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-02-09T00:40:18.000Z,#EquityResearch Gilead Sciences: Down It Goes $MRK $GILD http://dlvr.it/NKYhct,#EquityResearch Gilead Sciences: Down It Goes $MRK $GILD http://dlvr.it/NKYhct,,,,,['https://pbs.twimg.com/media/C4Lw0aOVcAAb8JS?format=jpg&name=small'],https://twitter.com/AlertTrade/status/829490070503632899
698,Christian Fromhertz,@cfromhertz,2017-02-10T21:34:36.000Z,"TTG Themes of the day (below) & Option Summary: $IWM $MT $EBAY $XOM $MRK $ARNC $JPM $C $M $CL $WY $UPS $XPO $HD $RCII 
#DailyRecap","TTG Themes of the day (below) & Option Summary: $IWM $MT $EBAY $XOM $MRK $ARNC $JPM $C $M $CL $WY $UPS $XPO $HD $RCII 
#DailyRecap
2
4",,,2,4,['https://pbs.twimg.com/media/C4VZZSfUMAEkIKJ?format=jpg&name=small'],https://twitter.com/cfromhertz/status/830168114096660480
699,Christian Fromhertz,@cfromhertz,2017-02-09T03:39:46.000Z,$MRK showing leadership in Health Care sector,"$MRK showing leadership in Health Care sector
1",,,,1,['https://pbs.twimg.com/media/C4MZpxhVMAEn8v-?format=jpg&name=small'],https://twitter.com/cfromhertz/status/829535232634261506
700,luis carruthers,@orthereaboot,2017-02-09T21:43:24.000Z,$MRK prospective derm sale valuation suggests $vrx worth about -$20- -$50/ share.,"$MRK prospective derm sale valuation suggests $vrx worth about -$20- -$50/ share.
1",,,1,,['https://pbs.twimg.com/media/C4QR6ckW8AAv2iG?format=jpg&name=small'],https://twitter.com/orthereaboot/status/829807937535221761
701,Anirban Maitra,@Aiims1742,2017-02-11T20:20:41.000Z,"$MRK GITR antibody MK-4166 has dual roles - Treg depletion & CD8+ T cell co-stimulation
http://cancerres.aacrjournals.org/content/early/2017/02/08/0008-5472.CAN-16-0797‚Ä¶","$MRK GITR antibody MK-4166 has dual roles - Treg depletion & CD8+ T cell co-stimulation
http://cancerres.aacrjournals.org/content/early/2017/02/08/0008-5472.CAN-16-0797‚Ä¶
clinicaltrials.gov
Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With...
Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001) - Full Text View.
4
7",,,4,7,['https://pbs.twimg.com/card_img/1489429947110285315/i8hE5Jij?format=png&name=240x240'],https://twitter.com/Aiims1742/status/830511896797253632
702,George Marcovits,@GemsBot,2017-02-11T13:20:36.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/74340341#74340362‚Ä¶,"Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/74340341#74340362‚Ä¶
1",,1,,,['https://pbs.twimg.com/media/C4YyBU_XUAAAFU5?format=jpg&name=small'],https://twitter.com/GemsBot/status/830406182040911872
703,SpoiledrottenBrat,@TaxHavens,2017-02-09T19:51:54.000Z,$GILD $MRK PE = 31,$GILD $MRK PE = 31,,,,,[],https://twitter.com/TaxHavens/status/829779880237756416
704,The Chestnut Report,@chestnutreport,2017-02-09T01:44:48.000Z,"How BioVie, Conatus and PhaseRX Tackle Liver Diseases $CNAT $BIVI $PZRX $AGN $GILD $SHGP $AMGN $MRK #biotech #trade
https://finance.yahoo.com/news/biovie-conatus-phaserx-tackle-liver-205704369.html‚Ä¶","How BioVie, Conatus and PhaseRX Tackle Liver Diseases $CNAT $BIVI $PZRX $AGN $GILD $SHGP $AMGN $MRK #biotech #trade
https://finance.yahoo.com/news/biovie-conatus-phaserx-tackle-liver-205704369.html‚Ä¶",,,,,[],https://twitter.com/chestnutreport/status/829506301113880579
705,Bilo Selhi,@StocksThatDoubl,2017-02-09T20:26:52.000Z,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,,,,,['https://pbs.twimg.com/media/CiX8f4PUkAQf2Dy?format=jpg&name=small'],https://twitter.com/StocksThatDoubl/status/829788677140279296
706,Chowdhury,@Chowdhury2019,2017-02-11T16:20:07.000Z,$gild $mrk $cydy,"$gild $mrk $cydy
networknewswire.com
CytoDyn Inc. (CYDY) PRO 140 ‚Äì A Promising Entry in the Treatment of HIV - NetworkNewsWire
The upcoming Conference On Retroviruses And Opportunistic Infections, to be held at the Washington State Convention Center in Seattle from February 13-16, 2017, is billed to feature a heavyweight...
1
1",,1,,1,['https://pbs.twimg.com/card_img/1500324590119096321/_O-5tcU8?format=jpg&name=360x360'],https://twitter.com/Chowdhury2019/status/830451356666359812
707,Dow Stocks,@Top_Dow_Stocks,2017-02-09T08:16:58.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/829604994810671105
708,bay area options,@BayAreaOptions,2017-02-09T20:45:57.000Z,$MRK coming in,$MRK coming in,,,,,[],https://twitter.com/BayAreaOptions/status/829793481098874881
709,Don,@COMMONSENCE10,2017-02-10T15:37:11.000Z,$MRK I down turn today a market condition or is something up ?,$MRK I down turn today a market condition or is something up ?,,,,,[],https://twitter.com/COMMONSENCE10/status/830078164231548930
710,OneTick,@OneMarketData,2017-02-10T18:47:03.000Z,Highest number of trades within 1 second on 2/9: $MRK with 612 trades between 15:45:39.598 and 15:45:40.597,Highest number of trades within 1 second on 2/9: $MRK with 612 trades between 15:45:39.598 and 15:45:40.597,,,,,[],https://twitter.com/OneMarketData/status/830125946917232642
711,F.A.S.T. Graphs,@FASTGraphs,2017-02-10T20:07:37.000Z,I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY,"I'm Buying Bristol-Myers Squibb Here At 52-Week Lows http://seekingalpha.com/article/4038810-buying-bristol-myers-squibb-52-week-lows?source=tweet‚Ä¶ $MRK $BMY
seekingalpha.com
I'm Buying Bristol-Myers Squibb Here At 52-Week Lows (NYSE:BMY)
On Friday, amidst BMY's 11% sell-off, I bought another lot of shares at the stock's 52 week low. In the $50 area I believe there is support. Plus, investors are getting a near 3.2% yield.",,,,,['https://pbs.twimg.com/card_img/1501749533763637252/38vfD1Ar?format=png&name=240x240'],https://twitter.com/FASTGraphs/status/830146224347082752
712,Todd Campbell,@ebcapital,2017-02-11T14:31:36.000Z,"Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017 
@themotleyfool
 #stocks $MRK, $JNJ, $AZN, $CLVS, $TSRO, $OPK","Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017 
@themotleyfool
 #stocks $MRK, $JNJ, $AZN, $CLVS, $TSRO, $OPK
fool.com
Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017 @themotleyfool #stocks $PFE $MRK $JNJ $AZN...
Tesaro's stock is surging higher ahead of the potential approval of a game-changing drug for ovarian cancer.
1
1",,,1,1,[],https://twitter.com/ebcapital/status/830424048848994308
713,InsiderSense Notify,@insidersense_,2017-02-09T17:54:06.000Z,Insider Selling in $MRK. Russo Patricia F sells $322k - Avg price of $64.4242. Learn more at https://insidersense.com,Insider Selling in $MRK. Russo Patricia F sells $322k - Avg price of $64.4242. Learn more at https://insidersense.com,,,,,[],https://twitter.com/insidersense_/status/829750233181614080
714,Chowdhury,@Chowdhury2019,2017-02-11T16:17:03.000Z,Cytodyn inc. $mrk $gild $cydy phase 2a result came and now phase 2b and phase3 on the way http://aac.asm.org/content/54/10/4137.full‚Ä¶,Cytodyn inc. $mrk $gild $cydy phase 2a result came and now phase 2b and phase3 on the way http://aac.asm.org/content/54/10/4137.full‚Ä¶,,,,,[],https://twitter.com/Chowdhury2019/status/830450587145736193
715,Aakash Swaroop,@aakashswaroop,2017-02-10T13:54:35.000Z,Merck mulling sale of dermatology assets - Bloomberg $MRK,"Merck mulling sale of dermatology assets - Bloomberg $MRK
seekingalpha.com
Merck mulling sale of dermatology assets - Bloomberg (NYSE:MRK)
Merck (NYSE:MRK) is rumored to be exploring the divestiture of certain dermatology meds, including one under development.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/aakashswaroop/status/830052344515612672
716,Stockaholics,@Stockaholics,2017-02-09T12:53:33.000Z,As Much As 142% Gains On Penny Stock Alerts In 2 Weeks! See Our New Picks Early: http://tr.im/21amb #Stocks $MRK $LGND,As Much As 142% Gains On Penny Stock Alerts In 2 Weeks! See Our New Picks Early: http://tr.im/21amb #Stocks $MRK $LGND,,,,,[],https://twitter.com/Stockaholics/status/829674597280784385
717,Pharmaceutical News,@pharma_sector,2017-02-11T12:18:45.000Z,"Eagle Global Advisors LLC Sells 3,618 Shares of #Merck & Company, Inc. (). Read more: http://owler.us/acdfda $MRK","Eagle Global Advisors LLC Sells 3,618 Shares of #Merck & Company, Inc. (). Read more: http://owler.us/acdfda $MRK",,,,,[],https://twitter.com/pharma_sector/status/830390616173338624
718,Pharmaceutical News,@pharma_sector,2017-02-11T05:30:52.000Z,#Merck  Co Partnering Deals and Alliances 2010 to 2017 Updated 01022017 Prices from USD $1495. Read more: http://owler.us/acdchm $MRK,#Merck  Co Partnering Deals and Alliances 2010 to 2017 Updated 01022017 Prices from USD $1495. Read more: http://owler.us/acdchm $MRK,,,,,[],https://twitter.com/pharma_sector/status/830287967411281920
719,Pharmaceutical News,@pharma_sector,2017-02-11T12:18:08.000Z,"Adage Capital Partners GP L.L.C. Purchases 1,921,350 Shares of #Merck & Company, Inc. (). Read more: http://owler.us/acdfdc $MRK","Adage Capital Partners GP L.L.C. Purchases 1,921,350 Shares of #Merck & Company, Inc. (). Read more: http://owler.us/acdfdc $MRK",,,,,[],https://twitter.com/pharma_sector/status/830390460925440001
720,Heath Care News,@hc_equipment,2017-02-09T16:56:37.000Z,#Merck Cladribine Tablets Significantly Reduced Brain Atrophy in Patients With Multiple Scle... Read more: http://owler.us/accwA8 $MRK,#Merck Cladribine Tablets Significantly Reduced Brain Atrophy in Patients With Multiple Scle... Read more: http://owler.us/accwA8 $MRK,,,,,[],https://twitter.com/hc_equipment/status/829735768008466432
721,Sweet Platform,@SweetPlatform,2017-02-09T15:08:56.000Z,"MRK Top news - Feb 9th, 2017 $MRK http://https://goo.gl/nTvEby","MRK Top news - Feb 9th, 2017 $MRK http://https://goo.gl/nTvEby",,,,,[],https://twitter.com/SweetPlatform/status/829708669122183174
722,IP... Frequently,@ip_frequently,2017-02-09T13:28:57.000Z,Merck $MRK Announces $625M ++ Settlement & License Agreement Resolving KEYTRUDA¬Æ Patent Litigation,"Merck $MRK Announces $625M ++ Settlement & License Agreement Resolving KEYTRUDA¬Æ Patent Litigation
ipwire.com
Merck Announces Settlement and License Agreement Resolving KEYTRUDA¬Æ (pembrolizumab) Patent...
KENILWORTH, N.J.‚Äì(BUSINESS WIRE)‚ÄìMerck (NYSE:MRK), known as MSD outside the United States and Canada), and certain of its affiliates, today announced it agreed to enter into a settlement and license...
1",,,1,,[],https://twitter.com/ip_frequently/status/829683505961562113
723,marketexclusive,@marketexclusive,2017-02-10T14:48:06.000Z,"Merck & Co., Inc. (NYSE:MRK) HPV Vaccine Gardasil Sales Impress, But For How Long? https://marketexclusive.com/merck-co-inc-nysemrks-hpv-vaccine-gardasil-sales-impress-long/71592/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶   $MRK  $GSK","Merck & Co., Inc. (NYSE:MRK) HPV Vaccine Gardasil Sales Impress, But For How Long? https://marketexclusive.com/merck-co-inc-nysemrks-hpv-vaccine-gardasil-sales-impress-long/71592/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶   $MRK  $GSK
2",,,2,,[],https://twitter.com/marketexclusive/status/830065814048894976
724,Siti van der Meij,@sitivandermeij,2017-02-09T21:07:17.000Z,Merck mulling sale of dermatology assets - Bloomberg http://seekingalpha.com/news/3242228-merck-mulling-sale-dermatology-assets-bloomberg?source=feed_f‚Ä¶ $MRK #sitifatimah #malaysia #financialplanning,Merck mulling sale of dermatology assets - Bloomberg http://seekingalpha.com/news/3242228-merck-mulling-sale-dermatology-assets-bloomberg?source=feed_f‚Ä¶ $MRK #sitifatimah #malaysia #financialplanning,,,,,[],https://twitter.com/sitivandermeij/status/829798848872734721
725,Ticker Report,@TickerReport,2017-02-11T04:05:51.000Z,"Merck & Company, Inc. $MRK Stake Increased by Donaldson Capital Management LLC http://zpr.io/PMphH","Merck & Company, Inc. $MRK Stake Increased by Donaldson Capital Management LLC http://zpr.io/PMphH",,,,,[],https://twitter.com/TickerReport/status/830266572824576000
726,Watchlist News,@WatchlistN,2017-02-09T15:30:07.000Z,"Wendell P. Weeks Sells 5,000 Shares of Merck & Company, Inc. $MRK Stock http://zpr.io/PEusx","Wendell P. Weeks Sells 5,000 Shares of Merck & Company, Inc. $MRK Stock http://zpr.io/PEusx",,,,,[],https://twitter.com/WatchlistN/status/829714000158023682
727,Stockboard Media Inc,@stockboardinc,2017-02-09T14:12:34.000Z,$MRK Merck Foundation Announces Six Program Grant Recipients for Alliance to Advance Patient-Centered Can... - http://sbml.co/38208c52,$MRK Merck Foundation Announces Six Program Grant Recipients for Alliance to Advance Patient-Centered Can... - http://sbml.co/38208c52,,,,,[],https://twitter.com/stockboardinc/status/829694481515569152
728,Confident Investor,@ConfidentInvest,2017-02-11T12:05:03.000Z,Confident Investor indicator analysis for 2/11/2017. Interesting results from $AMAT $EXR $MRK $SUI $THRM - http://bit.ly/2kTaFwH,Confident Investor indicator analysis for 2/11/2017. Interesting results from $AMAT $EXR $MRK $SUI $THRM - http://bit.ly/2kTaFwH,,,,,[],https://twitter.com/ConfidentInvest/status/830387168606507008
729,MarketBeat,@MarketBeatCom,2017-02-11T14:09:08.000Z,"Mairs & Power INC Has $6,050,000 Stake in Merck & Company, Inc. $MRK http://zpr.io/PMxSz","Mairs & Power INC Has $6,050,000 Stake in Merck & Company, Inc. $MRK http://zpr.io/PMxSz",,,,,[],https://twitter.com/MarketBeatCom/status/830418394616909824
730,MarketBeat,@MarketBeatCom,2017-02-10T14:11:24.000Z,"Insider Selling: Merck & Co., Inc. $MRK EVP Sells $5,881,697.64 in Stock http://zpr.io/PEWxF","Insider Selling: Merck & Co., Inc. $MRK EVP Sells $5,881,697.64 in Stock http://zpr.io/PEWxF",,,,,[],https://twitter.com/MarketBeatCom/status/830056578212560896
731,Bolt,@__Bolt,2017-02-10T04:05:26.000Z,"$BMY $MRK Big pharma's costly setback in cancer fight https #immunotherapy //www.ft.com/content/24441526-ede0-11e6-ba01-119a44939bb6 
@FT","$BMY $MRK Big pharma's costly setback in cancer fight https #immunotherapy //www.ft.com/content/24441526-ede0-11e6-ba01-119a44939bb6 
@FT",,,,,[],https://twitter.com/__Bolt/status/829904081082785792
732,SwingTradeBot,@SwingTradeBot,2017-02-09T18:42:41.000Z,Recent $MRK technical alerts: 180 Bullish Setup plus 3 more alerts... http://swingtradebot.com/equities/MRK,Recent $MRK technical alerts: 180 Bullish Setup plus 3 more alerts... http://swingtradebot.com/equities/MRK,,,,,[],https://twitter.com/SwingTradeBot/status/829762459426754564
733,MarketBeat,@MarketBeatCom,2017-02-11T14:09:12.000Z,"Adage Capital Partners GP L.L.C. Purchases 1,921,350 Shares of Merck & Company, Inc. $MRK http://zpr.io/PMxSh","Adage Capital Partners GP L.L.C. Purchases 1,921,350 Shares of Merck & Company, Inc. $MRK http://zpr.io/PMxSh",,,,,[],https://twitter.com/MarketBeatCom/status/830418411649978368
734,Ray,@RayTL_,2017-02-10T01:00:20.000Z,DOUBLE TOPS / BREAKOUTS: $WFC $CTSH $KGC $HPQ $WY $MRK $LPX More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab,"DOUBLE TOPS / BREAKOUTS: $WFC $CTSH $KGC $HPQ $WY $MRK $LPX More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab
1",,,,1,[],https://twitter.com/RayTL_/status/829857498576195584
735,"OpGen, Inc",@OpGen,2017-02-09T16:15:01.000Z,".
@DDNewsOnline
 outlines our research collaboration with #Merck to fight the rise in #AntibioticResistance http://bit.ly/2kLXuNW $OPGN $MRK",".
@DDNewsOnline
 outlines our research collaboration with #Merck to fight the rise in #AntibioticResistance http://bit.ly/2kLXuNW $OPGN $MRK
drugdiscoverynews.com
Resisting antibiotic resistance
OpGen, Merck to develop rapid-fire diagnostics and informatics to combat antibiotic resistance
8
56
243",,8,56,243,[],https://twitter.com/OpGen/status/829725298883178498
736,$peedyCalls,@SpeedyCalls,2017-02-10T18:03:09.000Z,"$MRK 62.5 Puts SELLING Activity expiring on 10th Mar, Vol 2250","$MRK 62.5 Puts SELLING Activity expiring on 10th Mar, Vol 2250",,,,,[],https://twitter.com/SpeedyCalls/status/830114899896496133
737,Ray,@RayTL_,2017-02-11T06:19:50.000Z,DOUBLE TOPS / BREAKOUTS: $IWM $WFC $HPQ $LC $MRK $CTSH $AMX More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab,DOUBLE TOPS / BREAKOUTS: $IWM $WFC $HPQ $LC $MRK $CTSH $AMX More here: https://powerrtrader.com/daily-watchlist/‚Ä¶ under Nightly Watchlist Tab,,,,,[],https://twitter.com/RayTL_/status/830300292381962240
738,Zero Filter,@zerofiltertruth,2017-02-09T16:50:41.000Z,"Very notable news #biotech $PPHM this morn - Fierce #Breakout possible as seeks dev partner  

$IBB $XBI $MRK $CELG 
@GuyAdami
 @jonnajarian","Very notable news #biotech $PPHM this morn - Fierce #Breakout possible as seeks dev partner  

$IBB $XBI $MRK $CELG 
@GuyAdami
 @jonnajarian",,,,,[],https://twitter.com/zerofiltertruth/status/829734275549372416
739,Recall Propecia,@RecallPropecia,2017-02-09T01:18:28.000Z,"Putin can only dream of poisoning as many people as $MRK does.  Maybe Ken Frazier gave the 
@POTUS
 advice to pass on to Vladimir.","Putin can only dream of poisoning as many people as $MRK does.  Maybe Ken Frazier gave the 
@POTUS
 advice to pass on to Vladimir.
1",,,1,,[],https://twitter.com/RecallPropecia/status/829499674008498177
740,G Hawkins,@FilmProfessor9,2017-02-10T16:38:29.000Z,"Replying to 
@NotaBubble
 @7wtc
  and 2 others","Replying to 
@NotaBubble
 @7wtc
  and 2 others
$GILD seems to be holding its $65/66 level thus far. Now $66.31 - Was double $MRK Px not that long ago
2",,2,,,[],https://twitter.com/FilmProfessor9/status/830093592710565894
741,Matthew Herper,@matthewherper,2017-02-14T22:12:41.000Z,$MRK stops one study of its BACE. More bad news for amyloid as a drug target.,"$MRK stops one study of its BACE. More bad news for amyloid as a drug target.
1
20
6",,1,20,6,['https://pbs.twimg.com/media/C4qIkTJUkAAv0jj?format=jpg&name=small'],https://twitter.com/matthewherper/status/831627247228444672
742,Odi Bruckman,@odibro,2017-02-14T21:21:23.000Z,$MRK says Phase 3 doravirine study meets primary efficacy endpoint http://finance.yahoo.com/news/merck-doravirine-investigational-non-nucleoside-210500635.html‚Ä¶,"$MRK says Phase 3 doravirine study meets primary efficacy endpoint http://finance.yahoo.com/news/merck-doravirine-investigational-non-nucleoside-210500635.html‚Ä¶
7
1",,,7,1,[],https://twitter.com/odibro/status/831614339123707905
743,STAT,@statnews,2017-02-14T23:30:17.000Z,$MRK has pulled the plug on a closely watched trial in Alzheimer‚Äôs disease ,"$MRK has pulled the plug on a closely watched trial in Alzheimer‚Äôs disease 
statnews.com
The next big Alzheimer's trial came up a dud
Merck pulled the plug on a trial in Alzheimer's disease after finding out its in-development drug had no effect on patients with mild forms of the disorder.
5
1",üîí,,5,1,['https://pbs.twimg.com/card_img/1499263310818164737/ae0Aoa7S?format=jpg&name=small'],https://twitter.com/statnews/status/831646776104976385
744,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-02-12T21:34:01.000Z,#EquityResearch Pharma M&A In 2017: The Most Likely Deal Hunters $AMGN $GILD $MRK $PFE http://dlvr.it/NMGd4s,"#EquityResearch Pharma M&A In 2017: The Most Likely Deal Hunters $AMGN $GILD $MRK $PFE http://dlvr.it/NMGd4s
1
1",,,1,1,['https://pbs.twimg.com/media/C4fsi6zUYAISikU?format=png&name=small'],https://twitter.com/AlertTrade/status/830892743157125121
745,Investors.com,@IBDinvestors,2017-02-13T13:28:02.000Z,"Apple, Nike, Visa Among Dow's Top 5 Gainers So Far This Year http://ow.ly/gehe308X6UZ $AAPL $NKE $V $MRK $IBM","Apple, Nike, Visa Among Dow's Top 5 Gainers So Far This Year http://ow.ly/gehe308X6UZ $AAPL $NKE $V $MRK $IBM
1
4
8",,1,4,8,['https://pbs.twimg.com/media/C4jG5yBXAAAv13b?format=jpg&name=small'],https://twitter.com/IBDinvestors/status/831132829165694977
746,Odi Bruckman,@odibro,2017-02-14T22:03:45.000Z,$MRK:  EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer‚Äôs Disease to Stop for Lack of Efficacy,"$MRK:  EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer‚Äôs Disease to Stop for Lack of Efficacy
1
1
4",,1,1,4,[],https://twitter.com/odibro/status/831624999085731840
747,David Nichols,@dnicholsjr86,2017-02-13T22:50:47.000Z,BRIEF-Capital World Investors reports 5.1 pct passive stake in Merck & Co as on Dec 30 - SEC Filing http://reut.rs/2lJxOBF  $MRK,"BRIEF-Capital World Investors reports 5.1 pct passive stake in Merck & Co as on Dec 30 - SEC Filing http://reut.rs/2lJxOBF  $MRK
reuters.com
BRIEF-Capital World Investors reports 5.1 pct passive stake in Merck & Co as on Dec 30 - SEC Filing
* Capital World Investors reports 5.1 percent passive stake in Merck & Co Inc as on December 30, 2016 - SEC Filing Source text: [http://bit.ly/2kkIx8A] Further company coverage:",,,,,['https://pbs.twimg.com/card_img/1471138905932316672/2JA4jZJ0?format=png&name=small'],https://twitter.com/dnicholsjr86/status/831274448628088833
748,Anton,@capt_n3m0,2017-02-14T16:00:46.000Z,Merck trying to clear a resistance (area) that goes back to the dot-com bubble era. $MRK http://bit.ly/2l4tBIA,"Merck trying to clear a resistance (area) that goes back to the dot-com bubble era. $MRK http://bit.ly/2l4tBIA
1
2",,,1,2,['https://pbs.twimg.com/media/C4ozOnbWMAAzhjl?format=jpg&name=small'],https://twitter.com/capt_n3m0/status/831533653767364613
749,Donna Young,@DonnaYoungDC,2017-02-14T15:25:15.000Z,"$MRK Gerberding: There's a competitive advantage of having #diversity
#bioceo17 #travelban #biotech","$MRK Gerberding: There's a competitive advantage of having #diversity
#bioceo17 #travelban #biotech
1
1
1",üì∞,1,1,1,[],https://twitter.com/DonnaYoungDC/status/831524714782793728
750,JQ,@jq1234t,2017-02-14T22:05:27.000Z,"$MRK EPOCH ph2/3 Study of Verubecestat (BACE) in Mild to Moderate Alzheimer‚Äôs Disease to Stop for Lack of Efficacy 
http://investors.merck.com/news/press-release-details/2017/Merck-Announces-EPOCH-Study-of-Verubecestat-for-the-Treatment-of-People-with-Mild-to-Moderate-Alzheimers-Disease-to-Stop-for-Lack-of-Efficacy/default.aspx‚Ä¶","$MRK EPOCH ph2/3 Study of Verubecestat (BACE) in Mild to Moderate Alzheimer‚Äôs Disease to Stop for Lack of Efficacy 
http://investors.merck.com/news/press-release-details/2017/Merck-Announces-EPOCH-Study-of-Verubecestat-for-the-Treatment-of-People-with-Mild-to-Moderate-Alzheimers-Disease-to-Stop-for-Lack-of-Efficacy/default.aspx‚Ä¶
2
10
2",,2,10,2,[],https://twitter.com/jq1234t/status/831625428662116352
751,YVRTrader.eth,@YVR_Trader,2017-02-14T23:10:03.000Z,Should see a nice pop tomorrow in $NTRP due to $MRK news,"Should see a nice pop tomorrow in $NTRP due to $MRK news
TommyA
@tommyaaa
 ¬∑ 15 Feb 2017
Replying to @biggercapital
$MRK just halted Alzheimer's trial .. That path way is dead... HELLO  $NTRP & $ARFXF
1
5",,1,,5,['https://pbs.twimg.com/profile_images/1008112421674868741/5dHD_m4n_mini.jpg'],https://twitter.com/YVR_Trader/status/831641686988054529
752,Gi McMurray,@GiMcMurray,2017-02-14T22:32:24.000Z,$MRK falls after hrs on the news that the company will stops trial on Alzheimer's drug.,$MRK falls after hrs on the news that the company will stops trial on Alzheimer's drug.,,,,,['https://pbs.twimg.com/media/C4qNFURWAAEYHWU?format=jpg&name=900x900'],https://twitter.com/GiMcMurray/status/831632209136254976
753,tradewithjoe,@tradewithjoe,2017-02-12T20:17:59.000Z,March 67.50 calls were active on Friday. $MRK,March 67.50 calls were active on Friday. $MRK,,,,,['https://pbs.twimg.com/media/C4fbJInWIAAoNL2?format=jpg&name=small'],https://twitter.com/tradewithjoe/status/830873607974813696
754,Chameleon Options,@MC_OptionTrades,2017-02-14T20:37:13.000Z,"Risk Reversal Trades 2,000 Times in $MRK https://marketchameleon.com/Overview/MRK/OptionChain/?e=2296_20180119&ac=largetradespayout&actrade=361241588‚Ä¶","Risk Reversal Trades 2,000 Times in $MRK https://marketchameleon.com/Overview/MRK/OptionChain/?e=2296_20180119&ac=largetradespayout&actrade=361241588‚Ä¶",ü¶é,,,,['https://pbs.twimg.com/media/C4pyuVDXAAMmvEE?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/831603224738197509
755,Siti van der Meij,@sitivandermeij,2017-02-14T21:27:10.000Z,Merck HIV treatment meats primary endpoint in Phase 3 trial http://seekingalpha.com/news/3243356-merck-hiv-treatment-meats-primary-endpoint-phase-3-trial?source=feed_f‚Ä¶ $MRK #sitifatimah #malaysia #financialplanning,Merck HIV treatment meats primary endpoint in Phase 3 trial http://seekingalpha.com/news/3243356-merck-hiv-treatment-meats-primary-endpoint-phase-3-trial?source=feed_f‚Ä¶ $MRK #sitifatimah #malaysia #financialplanning,,,,,[],https://twitter.com/sitivandermeij/status/831615791523098625
756,dough,@semodough,2017-02-13T19:16:41.000Z,"Replying to 
@OpenOutcrier","Replying to 
@OpenOutcrier
$MRK earlier approval coming only thing I can think of
dough
@semodough
 ¬∑ 4 Feb 2017
Upcoming PDUFA/FDA Advisory Committee Meeting/351(k) Dates (1/2) $TSRO $NBIX $CELG $SHPG $IBB $CLVS $MRK $RDUS $BMRN $HZNP $VRX $TXMD $SPY
3
2",,,3,2,"['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg', 'https://pbs.twimg.com/media/C31K9iHWQAUC4Z1?format=jpg&name=small', 'https://pbs.twimg.com/media/C31K9iGXAAAWuNP?format=jpg&name=small']",https://twitter.com/semodough/status/831220569613991937
757,ChartMill,@ChartMill,2017-02-14T23:03:43.000Z,Breakout alert! $MRK Watch it on http://stockcharts.chartmill.com/u/S1xY16WZFg #Quotes #Mobile,"Breakout alert! $MRK Watch it on http://stockcharts.chartmill.com/u/S1xY16WZFg #Quotes #Mobile
1",,,,1,[],https://twitter.com/ChartMill/status/831640090778730497
758,Jonathan Rockoff,@jonathanrockoff,2017-02-14T22:11:53.000Z,"$MRK stops early a study of its BACE inhibitor Alzheimer's drug ""for lack of efficacy"" https://goo.gl/Qcp1Sw Still studying in earlier pts","$MRK stops early a study of its BACE inhibitor Alzheimer's drug ""for lack of efficacy"" https://goo.gl/Qcp1Sw Still studying in earlier pts
2
1",,,2,1,[],https://twitter.com/jonathanrockoff/status/831627047160147969
759,Erin Hoffman,@eringhoffman,2017-02-14T20:31:29.000Z,Therapy Focus - Immunotherapy Closes In On Triple-Negative Tumors http://seekingalpha.com/article/4031467-therapy-focus-immunotherapy-closes-triple-negative-tumors?source=tweet‚Ä¶ $CELG $RHHBY $MRK $AZN $NVS $BMY $IBB,"Therapy Focus - Immunotherapy Closes In On Triple-Negative Tumors http://seekingalpha.com/article/4031467-therapy-focus-immunotherapy-closes-triple-negative-tumors?source=tweet‚Ä¶ $CELG $RHHBY $MRK $AZN $NVS $BMY $IBB
seekingalpha.com
Therapy Focus - Immunotherapy Closes In On Triple-Negative Tumors (NASDAQ:IBB)
Immunotherapy is on the horizon for another tough tumor type, triple-negative breast cancer.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/eringhoffman/status/831601778458316800
760,Mandy Jackson,@ScripMandy,2017-02-14T22:22:01.000Z,$MRK Announces EPOCH Study of BACE inhibitor Verubecestat for Mild to Moderate #Alzheimers Disease to Stop for Lack of Efficacy $LLY,"$MRK Announces EPOCH Study of BACE inhibitor Verubecestat for Mild to Moderate #Alzheimers Disease to Stop for Lack of Efficacy $LLY
Merck
@Merck
 ¬∑ 15 Feb 2017
Click here for our latest news: http://bit.ly/2l5Itqr
5
1",,,5,1,['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg'],https://twitter.com/ScripMandy/status/831629598634889216
761,Donna Young,@DonnaYoungDC,2017-02-14T15:47:50.000Z,"$MRK Gerberding insists 
@IamBiotech
 is 'walking the walk' on #diversity; wants to be best
#bioceo17 #womeninbiotech #womeninscience #biotech","$MRK Gerberding insists 
@IamBiotech
 is 'walking the walk' on #diversity; wants to be best
#bioceo17 #womeninbiotech #womeninscience #biotech
1
3
1",üì∞,1,3,1,[],https://twitter.com/DonnaYoungDC/status/831530398039539713
762,David Sobek,@dsobek,2017-02-13T20:39:45.000Z,what was the timeline for $MRK BACE data?,"what was the timeline for $MRK BACE data?
2
1",,2,,1,[],https://twitter.com/dsobek/status/831241472125108225
763,Andrew G.,@BioDueDiligence,2017-02-14T22:42:27.000Z,$LGND unchanged after hours on $MRK BACE news? Surprising,"$LGND unchanged after hours on $MRK BACE news? Surprising
1",,,,1,[],https://twitter.com/BioDueDiligence/status/831634741178880002
764,Zenect,@zenect,2017-02-13T10:48:29.000Z,If You Can Pick Only One #Dividend Stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  #securewealth,"If You Can Pick Only One #Dividend Stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  #securewealth
1",,,,1,[],https://twitter.com/zenect/status/831092675055058944
765,ChartMill,@ChartMill,2017-02-13T20:57:43.000Z,"$MRK breaking out, see some in-depth analysis on http://stockcharts.chartmill.com/u/BkebJ09yFl #Rolex #leadership","$MRK breaking out, see some in-depth analysis on http://stockcharts.chartmill.com/u/BkebJ09yFl #Rolex #leadership",,,,,[],https://twitter.com/ChartMill/status/831245994352312321
766,"Maha Elsayed, PhD",@ElsayedSMaha,2017-02-14T22:56:10.000Z,Failure of #verubecestat in EPOCH study not too shocking- assessed in mild to moderate Alzheimer's $MRK,"Failure of #verubecestat in EPOCH study not too shocking- assessed in mild to moderate Alzheimer's $MRK
endpts.com
Merck‚Äôs leading PhIII BACE drug implodes in latest Alzheimer‚Äôs disaster
Scratch yet another Phase III Alzheimer‚Äôs drug hopeful. Merck $MRK announced late Tuesday that it is shuttering its EPOCH trial for the BACE inhibitor verubecestat in mild-to-moderate Alzheimer‚Äôs...",,,,,['https://pbs.twimg.com/card_img/1500378540017164289/qkPO3rLZ?format=jpg&name=small'],https://twitter.com/ElsayedSMaha/status/831638190096277504
767,Magnolia Gallery,@MagnoliaG2012,2017-02-13T16:20:41.000Z,IBB: Merck Joins The Drug Pricing Coalition For Transparency http://seekingalpha.com/article/4045361-ibb-merck-joins-drug-pricing-coalition-transparency?source=tweet‚Ä¶ $ABBV $AGN $MCK $MRK $NVO $JNJ $IBB,"IBB: Merck Joins The Drug Pricing Coalition For Transparency http://seekingalpha.com/article/4045361-ibb-merck-joins-drug-pricing-coalition-transparency?source=tweet‚Ä¶ $ABBV $AGN $MCK $MRK $NVO $JNJ $IBB
seekingalpha.com
IBB: Merck Joins The Drug Pricing Coalition For Transparency (NASDAQ:IBB)
The overall healthcare sector has become volatile on the heels of any statement or tweet from Donald Trump.",,,,,['https://pbs.twimg.com/card_img/1501743782320033794/a3_DjJBJ?format=jpg&name=360x360'],https://twitter.com/MagnoliaG2012/status/831176275020677122
768,$PENNY KING,@groman100,2017-02-14T22:26:06.000Z,"$MRK alzheimers  p3 trial FAILS and is stopped,stanford U is doing amazing things w/alz research using  human plasma from YOUNG people WOW","$MRK alzheimers  p3 trial FAILS and is stopped,stanford U is doing amazing things w/alz research using  human plasma from YOUNG people WOW",,,,,[],https://twitter.com/groman100/status/831630624817442817
769,Stoyan Panayotov,@babylonwealth,2017-02-13T16:07:43.000Z,SDOG - High Dividend ETF With Strong Value Bias http://seekingalpha.com/article/4045310-sdog-high-dividend-etf-strong-value-bias?source=tweet‚Ä¶ $SDOG $VYM $CSCO $EMR $IBM $KMB $LLY $MO $MRK $PM $PPL $SDY $SPHD,SDOG - High Dividend ETF With Strong Value Bias http://seekingalpha.com/article/4045310-sdog-high-dividend-etf-strong-value-bias?source=tweet‚Ä¶ $SDOG $VYM $CSCO $EMR $IBM $KMB $LLY $MO $MRK $PM $PPL $SDY $SPHD,,,,,[],https://twitter.com/babylonwealth/status/831173012288262145
770,WallStreetGangsta,@WallStGangsta,2017-02-13T16:15:24.000Z,$OBMP All You Need To Know About OncBioMune Pharmaceuticals inc http://otcmarkets.net/home/otcqb/all-you-need-to-know-about-oncbiomune-pharmaceuticals-inc/‚Ä¶ $GILD $IBB $MRK $BMY $AMGN $JNJ $NVS,"$OBMP All You Need To Know About OncBioMune Pharmaceuticals inc http://otcmarkets.net/home/otcqb/all-you-need-to-know-about-oncbiomune-pharmaceuticals-inc/‚Ä¶ $GILD $IBB $MRK $BMY $AMGN $JNJ $NVS
1
1
1",,1,1,1,[],https://twitter.com/WallStGangsta/status/831174945615052801
771,Annie Sullivan,@anniemsullivan,2017-02-14T23:42:13.000Z,Merck's leading PhIII BACE drug implodes in latest Alzheimer's disaster: Merck $MRK‚Ä¶ http://dlvr.it/NNHBth http://bit.ly/2CLSSP,Merck's leading PhIII BACE drug implodes in latest Alzheimer's disaster: Merck $MRK‚Ä¶ http://dlvr.it/NNHBth http://bit.ly/2CLSSP,,,,,[],https://twitter.com/anniemsullivan/status/831649779947958272
772,Ticker Report,@TickerReport,2017-02-13T11:37:09.000Z,"Patricia F. Russo Sells 5,000 Shares of Merck & Company, Inc. $MRK Stock http://ift.tt/2lHx67X","Patricia F. Russo Sells 5,000 Shares of Merck & Company, Inc. $MRK Stock http://ift.tt/2lHx67X",,,,,[],https://twitter.com/TickerReport/status/831104924914180097
773,Gregory Krupinski,@G_krupins,2017-02-14T17:34:06.000Z,$MRK Good look. Looks like it wants to crack this level after slight dip. Like it and am long via April 65 calls,"$MRK Good look. Looks like it wants to crack this level after slight dip. Like it and am long via April 65 calls
stocktwits.com
Wolfe (@EveryTimeICash) | Stocktwits
$MRK Close to breaking out of range. $XLV
1
1",,,1,1,[],https://twitter.com/G_krupins/status/831557142117244929
774,Watchlist News,@WatchlistN,2017-02-12T19:10:27.000Z,"Merck & Company, Inc. $MRK Shares Sold by Afam Capital Inc. http://zpr.io/PMezp","Merck & Company, Inc. $MRK Shares Sold by Afam Capital Inc. http://zpr.io/PMezp",,,,,[],https://twitter.com/WatchlistN/status/830856611539333120
775,The Gold & Oil Guy,@coffeetrades,2017-02-12T13:54:29.000Z,McKesson's Misses for 5th Consecutive Quarter....Is this a Buying Opportunity? Noah weighs in > http://tinyurl.com/jdxyghl  $MCK $CVS $CAH $MRK,"McKesson's Misses for 5th Consecutive Quarter....Is this a Buying Opportunity? Noah weighs in > http://tinyurl.com/jdxyghl  $MCK $CVS $CAH $MRK
ino.com
McKesson's Misses For 5th Consecutive Quarter - Buying Opportunity? - INO.com Trader's Blog
Introduction McKesson Corporation (NYSE:MCK) missed Q3 2017 numbers and this marks the fifth consecutive quarter in which McKesson has missed its revenue targets. The stock sold off shapely as a...",,,,,[],https://twitter.com/coffeetrades/status/830777097182253056
776,M&A Finance,@investpro2000,2017-02-13T21:46:48.000Z,IBB: Merck Joins The Drug Pricing Coalition For Transparency http://seekingalpha.com/article/4045361-ibb-merck-joins-drug-pricing-coalition-transparency?source=tweet‚Ä¶ $ABBV $AGN $MCK $MRK $NVO $JNJ $IBB $BMRN $PBYI,IBB: Merck Joins The Drug Pricing Coalition For Transparency http://seekingalpha.com/article/4045361-ibb-merck-joins-drug-pricing-coalition-transparency?source=tweet‚Ä¶ $ABBV $AGN $MCK $MRK $NVO $JNJ $IBB $BMRN $PBYI,,,,,[],https://twitter.com/investpro2000/status/831258345067659264
777,StockNews.com,@stocknewsdotcom,2017-02-14T22:22:11.000Z,$MRK Company halts the EPOCH study of Verubecestat for those with mild to moderate Alzheimer‚Äôs https://stocknews.com/news/mrk-company-halts-the-epoch-study-of-verubecestat-for-those-with/‚Ä¶,$MRK Company halts the EPOCH study of Verubecestat for those with mild to moderate Alzheimer‚Äôs https://stocknews.com/news/mrk-company-halts-the-epoch-study-of-verubecestat-for-those-with/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/831629640670248960
778,StockNews.com,@stocknewsdotcom,2017-02-14T21:08:57.000Z,$MRK Announces its Phase 3 trial of doravirine (MK-1439) met its primary efficacy endpoint of the proportion of pa‚Ä¶ https://stocknews.com/news/mrk-announces-its-phase-3-trial-of-doravirine-mk-1439-met-its/‚Ä¶,"$MRK Announces its Phase 3 trial of doravirine (MK-1439) met its primary efficacy endpoint of the proportion of pa‚Ä¶ https://stocknews.com/news/mrk-announces-its-phase-3-trial-of-doravirine-mk-1439-met-its/‚Ä¶
1",,,,1,[],https://twitter.com/stocknewsdotcom/status/831611208180568089
779,Sure Dividend,@SureDividend,2017-02-12T01:32:02.000Z,"Merck $MRK - 
Analyzing 2016 Performance & Outlook for 2017
http://buff.ly/2k8iu0g","Merck $MRK - 
Analyzing 2016 Performance & Outlook for 2017
http://buff.ly/2k8iu0g",,,,,[],https://twitter.com/SureDividend/status/830590250938425344
780,TalkMarkets,@TalkMarkets,2017-02-14T20:29:14.000Z,Addressable Markets $AXP $BAC $DIS $HD $JNJ $JPM $JWN $LEN $MRK $NVR $PFE $WFC $AMGN $AMZN $NFLX $TGNA $PYPL https://goo.gl/3zqrLn,Addressable Markets $AXP $BAC $DIS $HD $JNJ $JPM $JWN $LEN $MRK $NVR $PFE $WFC $AMGN $AMZN $NFLX $TGNA $PYPL https://goo.gl/3zqrLn,,,,,[],https://twitter.com/TalkMarkets/status/831601215666548736
781,"OpGen, Inc",@OpGen,2017-02-13T19:30:02.000Z,We anticipate completing the large-scale testing program from our research collab with $MRK during H1 2017 http://bit.ly/2kLXuNW $OPGN,"We anticipate completing the large-scale testing program from our research collab with $MRK during H1 2017 http://bit.ly/2kLXuNW $OPGN
drugdiscoverynews.com
Resisting antibiotic resistance
OpGen, Merck to develop rapid-fire diagnostics and informatics to combat antibiotic resistance
2",,,2,,[],https://twitter.com/OpGen/status/831223928865619969
782,Red Acre Investments,@redacre,2017-02-14T21:17:26.000Z,/2 Biotech/HC New or revisited 52-week highs: $GRFS $HCA $ICLR $INCY $KMDA $MDCO $MRK $NBRV $PLSE $PRAH $Q $RMD $USPH $WMGI $THERF $SPY $QQQ,/2 Biotech/HC New or revisited 52-week highs: $GRFS $HCA $ICLR $INCY $KMDA $MDCO $MRK $NBRV $PLSE $PRAH $Q $RMD $USPH $WMGI $THERF $SPY $QQQ,,,,,[],https://twitter.com/redacre/status/831613343555272705
783,Ray,@RayTL_,2017-02-14T01:31:00.000Z,DOUBLE TOPS / BREAKOUTS: $X $IWM $MT $WFC $MRK $TECK $CTSH More here: https://powerrtrader.com/2017/02/13/nightly-automated-scans-automated-2017-02-13/‚Ä¶,DOUBLE TOPS / BREAKOUTS: $X $IWM $MT $WFC $MRK $TECK $CTSH More here: https://powerrtrader.com/2017/02/13/nightly-automated-scans-automated-2017-02-13/‚Ä¶,,,,,[],https://twitter.com/RayTL_/status/831314766706597888
784,Lydia Ramsey Pflanzer,@lydiapflanzer,2017-02-14T22:14:13.000Z,$MRK is stopping its Alzheimer's trial because there's ‚Äúvirtually no chance of finding a positive clinical effect.‚Äù http://investors.merck.com/news/press-release-details/2017/Merck-Announces-EPOCH-Study-of-Verubecestat-for-the-Treatment-of-People-with-Mild-to-Moderate-Alzheimers-Disease-to-Stop-for-Lack-of-Efficacy/default.aspx‚Ä¶,"$MRK is stopping its Alzheimer's trial because there's ‚Äúvirtually no chance of finding a positive clinical effect.‚Äù http://investors.merck.com/news/press-release-details/2017/Merck-Announces-EPOCH-Study-of-Verubecestat-for-the-Treatment-of-People-with-Mild-to-Moderate-Alzheimers-Disease-to-Stop-for-Lack-of-Efficacy/default.aspx‚Ä¶
2
1",,,2,1,[],https://twitter.com/lydiapflanzer/status/831627632613720065
785,Confident Investor,@ConfidentInvest,2017-02-14T23:40:11.000Z,Largest gainers today on my Watch List were: $MRK $ABMD $SAM $MCK $UA - http://bit.ly/2l61Lfe,Largest gainers today on my Watch List were: $MRK $ABMD $SAM $MCK $UA - http://bit.ly/2l61Lfe,,,,,[],https://twitter.com/ConfidentInvest/status/831649268020572161
786,Watchlist News,@WatchlistN,2017-02-13T14:13:53.000Z,"Cullen Capital Management LLC Acquires 32,745 Shares of Merck & Company, Inc. $MRK http://zpr.io/Pmqsr","Cullen Capital Management LLC Acquires 32,745 Shares of Merck & Company, Inc. $MRK http://zpr.io/Pmqsr",,,,,[],https://twitter.com/WatchlistN/status/831144365804417024
787,BAN Traders Central,@options_income,2017-02-13T02:22:59.000Z,McKesson's Misses for 5th Consecutive Quarter....Is this a Buying Opportunity? Noah weighs in > http://tinyurl.com/jdxyghl  $MCK $CVS $CAH $MRK,"McKesson's Misses for 5th Consecutive Quarter....Is this a Buying Opportunity? Noah weighs in > http://tinyurl.com/jdxyghl  $MCK $CVS $CAH $MRK
ino.com
McKesson's Misses For 5th Consecutive Quarter - Buying Opportunity? - INO.com Trader's Blog
Introduction McKesson Corporation (NYSE:MCK) missed Q3 2017 numbers and this marks the fifth consecutive quarter in which McKesson has missed its revenue targets. The stock sold off shapely as a...",,,,,['https://pbs.twimg.com/card_img/1500820693079838720/6X1lUujj?format=png&name=360x360'],https://twitter.com/options_income/status/830965463874105344
788,Stockboard Media Inc,@stockboardinc,2017-02-14T22:05:34.000Z,$MRK Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzhei... - http://sbml.co/a23df8fc,$MRK Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzhei... - http://sbml.co/a23df8fc,,,,,[],https://twitter.com/stockboardinc/status/831625455472099331
789,Donna Young,@DonnaYoungDC,2017-02-14T15:04:47.000Z,"$MRK former #CDC Gerberding: The diversity of US PhD level is not translating into #biotech workforce
#WomenInScience #bioceo17 #STEM","$MRK former #CDC Gerberding: The diversity of US PhD level is not translating into #biotech workforce
#WomenInScience #bioceo17 #STEM",üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/831519564437536768
790,Christian Fromhertz,@cfromhertz,2017-02-14T17:53:23.000Z,"As $BMY is hod - $MRK bull risk reversal trades out in Jan:
2k MRK Jan 70 Calls $2.99  Above Ask!
2k MRK Jan 65 Puts $5.75  BIDSIDE","As $BMY is hod - $MRK bull risk reversal trades out in Jan:
2k MRK Jan 70 Calls $2.99  Above Ask!
2k MRK Jan 65 Puts $5.75  BIDSIDE",,,,,[],https://twitter.com/cfromhertz/status/831561992833994753
791,Michael Bigger,@biggercapital,2017-02-14T23:09:30.000Z,"$NTRP doesn't use such sentence (so far) $MRK: ""with APECS, which is studying verubecestat in people with less advanced disease.‚Äù","$NTRP doesn't use such sentence (so far) $MRK: ""with APECS, which is studying verubecestat in people with less advanced disease.‚Äù",,,,,[],https://twitter.com/biggercapital/status/831641547175235586
792,Endpoints News,@endpts,2017-02-14T23:07:40.000Z,Scratch yet another Phase III Alzheimer‚Äôs drug hopeful. $MRK https://endpts.com/mercks-leading-phiii-bace-drug-implodes-in-latest-alzheimers-disaster/‚Ä¶,"Scratch yet another Phase III Alzheimer‚Äôs drug hopeful. $MRK https://endpts.com/mercks-leading-phiii-bace-drug-implodes-in-latest-alzheimers-disaster/‚Ä¶
1
1",,,1,1,[],https://twitter.com/endpts/status/831641086196060161
793,By Any Memes Necessary,@_21stCenturyCox,2017-02-13T17:49:18.000Z,"Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In... https://benzinga.com/z/8962220 $NTRP $BIIB $LLY $MRK  via 
@benzinga","Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In... https://benzinga.com/z/8962220 $NTRP $BIIB $LLY $MRK  via 
@benzinga
benzinga.com
Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors...
Alzheimer's has proven to be one of the most stubborn diseases known to modern medicine. An incurable, devastating illness that inspires frustration ‚Äî even anger...",,,,,[],https://twitter.com/_21stCenturyCox/status/831198577934336000
794,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-02-13T14:47:53.000Z,"Replying to 
@BillSpadea","Replying to 
@BillSpadea
@nj1015
 @ewdrew1977
 @stevebirnbaum
   Those pension dollars are needed to fund $JNJ $MRK $RHA Christie taxcuts.
1",,,,1,[],https://twitter.com/ZimJay/status/831152921706364929
795,FOX Business,@FoxBusiness,2017-02-15T14:20:01.000Z,Merck stops clinical trial of Alzheimer's drug $MRK  http://fxn.ws/2kItQYQ,"Merck stops clinical trial of Alzheimer's drug $MRK  http://fxn.ws/2kItQYQ
2
8
4",,2,8,4,[],https://twitter.com/FoxBusiness/status/831870684246712321
796,Matthew Herper,@matthewherper,2017-02-15T13:36:51.000Z,"Here is why $MRK's Roger Perlmutter is not abandoing the amyloid hypothesis, even though you are.","Here is why $MRK's Roger Perlmutter is not abandoing the amyloid hypothesis, even though you are.
forbes.com
Another Alzheimer's Drug Study Fails. This Time It's Merck's
Last night, Merck announced that it is stopping a clinical trial of a pill it is developing to treat Alzheimer's is being stopped because there is ""virtually no chance of finding a positive clinical...
1
3
3",,1,3,3,[],https://twitter.com/matthewherper/status/831859821745942528
797,dough,@semodough,2017-02-15T13:38:38.000Z,"Replying to 
@odibro","Replying to 
@odibro
CS agrees. $BIIB no read thru from $MRK AD Data
4
3",,,4,3,['https://pbs.twimg.com/media/C4tcgMoUcAADTWY?format=jpg&name=small'],https://twitter.com/semodough/status/831860271249518592
798,Branko Krstevski,@KrstevskiBranko,2017-02-17T12:49:08.000Z,"$NWBO Northwest Bio improves fundamentals  http://askthebranko.blogspot.com.au/2017/02/northwest-bio-nwbo-improves-fundamentals.html‚Ä¶
at $65M market cap tremendous near-term risk/reward
$BMY $MRK","$NWBO Northwest Bio improves fundamentals  http://askthebranko.blogspot.com.au/2017/02/northwest-bio-nwbo-improves-fundamentals.html‚Ä¶
at $65M market cap tremendous near-term risk/reward
$BMY $MRK
1
12
18",,1,12,18,[],https://twitter.com/KrstevskiBranko/status/832572589356691456
799,Helen Ong,@Lin_ling_88,2017-02-15T05:37:49.000Z,$MRK Stopped EPOCH Study of Verubecestat for the Treatment of Mild to Moderate Alzheimer‚Äôs Disease #fail  http://finance.yahoo.com/news/merck-announces-epoch-study-verubecestat-220000827.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAMwbzkyYWg5Y2E3cTNjBGcDZFhWcFpEeHVjejVqWkdKaE5XVTVaaTFsTURFNExUTTFaRFl0WWpoak15MDJaRGxpTlRBM1kyTmpOamM4Wm1sbGJHUStiWEpyBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwM2BHJlZ2lvbgNVUwRzeW1ib2wDTVJL?.tsrc=applewf‚Ä¶,"$MRK Stopped EPOCH Study of Verubecestat for the Treatment of Mild to Moderate Alzheimer‚Äôs Disease #fail  http://finance.yahoo.com/news/merck-announces-epoch-study-verubecestat-220000827.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAMwbzkyYWg5Y2E3cTNjBGcDZFhWcFpEeHVjejVqWkdKaE5XVTVaaTFsTURFNExUTTFaRFl0WWpoak15MDJaRGxpTlRBM1kyTmpOamM4Wm1sbGJHUStiWEpyBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwM2BHJlZ2lvbgNVUwRzeW1ib2wDTVJL?.tsrc=applewf‚Ä¶
1",,,,1,[],https://twitter.com/Lin_ling_88/status/831739269219753984
800,The Chronicles of Chris Young PSA scrub-your-hands,,2017-02-16T02:14:02.000Z,Pertinent in the wake $LLY Sola Tx. > $MRK BACE Inhibitor failure > $AXON nxt. #Alzheimers #Disease #Amyloid $NTRP $PMN.TO $VTVT $ACAD $PRTA,"Pertinent in the wake $LLY Sola Tx. > $MRK BACE Inhibitor failure > $AXON nxt. #Alzheimers #Disease #Amyloid $NTRP $PMN.TO $VTVT $ACAD $PRTA
Nature Reviews Disease Primers
@DiseasePrimers
 ¬∑ 15 Feb 2017
#Alzheimer's disease is a neurodegenerative disorder hard to diagnose owing to its long preclinical phase http://rdcu.be/o5qV #SharedIt
3
5",,,3,5,"['https://pbs.twimg.com/profile_images/1187285313430966272/mr8TMbvz_mini.jpg', 'https://pbs.twimg.com/media/C4Gd-UJWYAQyFAm?format=jpg&name=small']",https://twitter.com/YoungChris27040/status/832050373573570561
801,Steven Nathan,@snathan360,2017-02-15T04:50:24.000Z,Merck to halt study of mild to moderate Alzheimer's drug http://reut.rs/2l5URH1 via $MRK #Alzheimers,Merck to halt study of mild to moderate Alzheimer's drug http://reut.rs/2l5URH1 via $MRK #Alzheimers,,,,,[],https://twitter.com/snathan360/status/831727336076644352
802,William L. Jorgensen,@JorgensenWL,2017-02-17T17:06:15.000Z,"Verubecestat Halt Fails To Stop The Bace Chase http://seekingalpha.com/article/4046829-verubecestat-halt-fails-stop-bace-chase?source=tweet‚Ä¶ $MRK $LLY $AMGN
https://newdrugapprovals.org/2015/07/22/verubecestat-mk-8931/‚Ä¶","Verubecestat Halt Fails To Stop The Bace Chase http://seekingalpha.com/article/4046829-verubecestat-halt-fails-stop-bace-chase?source=tweet‚Ä¶ $MRK $LLY $AMGN
https://newdrugapprovals.org/2015/07/22/verubecestat-mk-8931/‚Ä¶
1
1",,1,,1,['https://pbs.twimg.com/media/C44e54iUMAA-M0V?format=png&name=small'],https://twitter.com/JorgensenWL/status/832637294007898113
803,Jeff Taylor,@jttdmd,2017-02-16T18:01:01.000Z,Industry Leaders: Relaxing FDA Standards Will Kill The Pharma Golden Goose http://seekingalpha.com/article/4046736-industry-leaders-relaxing-fda-standards-will-kill-pharma-golden-goose?source=tweet‚Ä¶ $ALNY $CSL $MNKD $MRK $SNY $IBB $XBI,"Industry Leaders: Relaxing FDA Standards Will Kill The Pharma Golden Goose http://seekingalpha.com/article/4046736-industry-leaders-relaxing-fda-standards-will-kill-pharma-golden-goose?source=tweet‚Ä¶ $ALNY $CSL $MNKD $MRK $SNY $IBB $XBI
seekingalpha.com
Industry Leaders: Relaxing FDA Standards Will Kill The Pharma Golden Goose
Biotech investors are quick to assume anyone who opposes proposals to reduce FDA regulation is a lefty.",,,,,['https://pbs.twimg.com/card_img/1492196815726252032/umytDCAr?format=png&name=240x240'],https://twitter.com/jttdmd/status/832288688679694336
804,Open Outcrier,@OpenOutcrier,2017-02-15T17:03:12.000Z,$MRK spikes lower on 1.5m shares,"$MRK spikes lower on 1.5m shares
1
1",,,1,1,[],https://twitter.com/OpenOutcrier/status/831911752833056768
805,Open Outcrier,@OpenOutcrier,2017-02-16T17:53:50.000Z,$MRK strength now.  Almost a buck off lows,"$MRK strength now.  Almost a buck off lows
1
1",,,1,1,[],https://twitter.com/OpenOutcrier/status/832286882914516993
806,Chameleon,@MarketChmln,2017-02-15T20:55:54.000Z,Large Caps that increased their most recent #dividend payment $T $PFE $MRK $CMCSA $DIS $AMGN $MMM $BA $ABBV $UPS $NKE $BMY $GILD $LLY,"Large Caps that increased their most recent #dividend payment $T $PFE $MRK $CMCSA $DIS $AMGN $MMM $BA $ABBV $UPS $NKE $BMY $GILD $LLY
3",ü¶é,,,3,['https://pbs.twimg.com/media/C4vASs-WMAAqA5U?format=jpg&name=small'],https://twitter.com/MarketChmln/status/831970314842169348
807,Lisa Jarvis,@lisamjarvis,2017-02-15T00:00:48.000Z,Everyone in field agrees $MRK's drug was hitting its target. Argument from amyloid purists will be that timing of intervention was too late.,"Everyone in field agrees $MRK's drug was hitting its target. Argument from amyloid purists will be that timing of intervention was too late.
Nathan Sadeghi-Nejad
@natesadeghi
 ¬∑ 15 Feb 2017
MRK's BACE inhibitor fails. Yet more evidence against the amyloid hypothesis, but you can bet the amyloidists will defend.
6
5
5",,6,5,5,['https://pbs.twimg.com/profile_images/498900132986105856/ameXoT_j_mini.jpeg'],https://twitter.com/lisamjarvis/status/831654457058402305
808,Generations Now,@Getgenerations,2017-02-16T20:02:01.000Z,Merck Alzheimer Drug Is Latest To Fail In A Big Study http://buff.ly/2kNJgeu #alzheimers $MRK #pharma,"Merck Alzheimer Drug Is Latest To Fail In A Big Study http://buff.ly/2kNJgeu #alzheimers $MRK #pharma
1
1",,1,,1,['https://pbs.twimg.com/media/C4z92RxUkAANl6F?format=jpg&name=small'],https://twitter.com/Getgenerations/status/832319141692440577
809,Helen Ong,@Lin_ling_88,2017-02-15T13:43:46.000Z,"Beta Amyloid may be a consequence, rather than the cause, of #AlzheimersDisease
This has been suspected all along. No surprises here $MRK","Beta Amyloid may be a consequence, rather than the cause, of #AlzheimersDisease
This has been suspected all along. No surprises here $MRK
Matthew Herper
@matthewherper
 ¬∑ 15 Feb 2017
Oooh. Good question. I think the answer is, how would you know? Alzheimer's decline is variable, none of these drugs make patients improve. https://twitter.com/john_evans3/status/831860785538273280‚Ä¶
1
1
2",,1,1,2,['https://pbs.twimg.com/profile_images/1490391236255100928/gJqcVT_B_mini.jpg'],https://twitter.com/Lin_ling_88/status/831861563522969600
810,John G. Singer,@johngsinger,2017-02-15T19:19:37.000Z,"For $MRK $LLY $BIIB in Alzheimer's, re-frame study design: #pharma + #music + #meditation to improve cognition http://bit.ly/2kwOoEm 
@mnt","For $MRK $LLY $BIIB in Alzheimer's, re-frame study design: #pharma + #music + #meditation to improve cognition http://bit.ly/2kwOoEm 
@mnt
medicalnewstoday.com
Alzheimer's disease: Music, meditation may improve early cognitive decline
A West Virginia research team have found that using meditation or music listening programs may have benefits for people with preclinical cognitive decline.
2
3",,,2,3,['https://pbs.twimg.com/card_img/1501548985945067525/gyN0vPgp?format=jpg&name=360x360'],https://twitter.com/johngsinger/status/831946083270017025
811,Anirban Maitra,@Aiims1742,2017-02-16T15:53:13.000Z,"In general, reasonable (but not perfect) correlation between GITR and FoxP3 expression in #cancer
$AZN $MRK
http://tandfonline.com/doi/full/10.1080/2162402X.2017.1280645‚Ä¶","In general, reasonable (but not perfect) correlation between GITR and FoxP3 expression in #cancer
$AZN $MRK
http://tandfonline.com/doi/full/10.1080/2162402X.2017.1280645‚Ä¶
4",,,4,,['https://pbs.twimg.com/media/C4zE5KnVUAMwyf5?format=jpg&name=small'],https://twitter.com/Aiims1742/status/832256528581271552
812,Steven Strazza,@sstrazza,2017-02-16T17:14:46.000Z,"$PFE +0.5% today showing more strength as major indices & $XLV are all red..
Outperforming healthcare sector & $DIA peer $MRK since election","$PFE +0.5% today showing more strength as major indices & $XLV are all red..
Outperforming healthcare sector & $DIA peer $MRK since election",,,,,['https://pbs.twimg.com/media/C4zXAcMWYAUhkRy?format=jpg&name=small'],https://twitter.com/sstrazza/status/832277051319152641
813,Seeking Alpha,@SeekingAlpha,2017-02-16T19:48:43.000Z,Verubecestat Halt Fails To Stop The Bace Chase http://seekingalpha.com/article/4046829-verubecestat-halt-fails-stop-bace-chase?source=feed_f‚Ä¶ $MRK $LLY $BIIB $RHHBY $NVS $AMGN,"Verubecestat Halt Fails To Stop The Bace Chase http://seekingalpha.com/article/4046829-verubecestat-halt-fails-stop-bace-chase?source=feed_f‚Ä¶ $MRK $LLY $BIIB $RHHBY $NVS $AMGN
seekingalpha.com
Verubecestat Halt Fails To Stop The Bace Chase
Yet another chink has appeared in the amyloid hypothesis of Alzheimer‚Äôs with Merck‚Äôs (NYSE:MRK) discontinuation of a study of its Bace inhibitor verubecestat.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/832315791575904257
814,Madeleine Armstrong,@ByMadeleineA,2017-02-15T15:58:07.000Z,"Does another amyloid hypothesis blow make it time to drop the Bace? Not yet for $MRK, via 
@EPVantage
 http://epvantage.com/Universal/View.aspx?type=Story&id=688512&isEPVantage=yes‚Ä¶","Does another amyloid hypothesis blow make it time to drop the Bace? Not yet for $MRK, via 
@EPVantage
 http://epvantage.com/Universal/View.aspx?type=Story&id=688512&isEPVantage=yes‚Ä¶
4",,,4,,['https://pbs.twimg.com/media/C4t7pL1WAAEj8CV?format=jpg&name=small'],https://twitter.com/ByMadeleineA/status/831895374168219648
815,InTheMoneyStocks.com,@ITMS,2017-02-15T13:57:52.000Z,"Today's #StockTrading Action: $AIG, $FOSL, $ADI, $BP, $MRK & More...  http://bit.ly/TodaysStocks","Today's #StockTrading Action: $AIG, $FOSL, $ADI, $BP, $MRK & More...  http://bit.ly/TodaysStocks
1
2",,,1,2,[],https://twitter.com/ITMS/status/831865111186911232
816,Scanz Alerts,@ScanzAlerts,2017-02-16T16:36:24.000Z,"BLOCK TRADE: $MRK 1,817,559 shares @ $64.56 [11:36:23]","BLOCK TRADE: $MRK 1,817,559 shares @ $64.56 [11:36:23]
1",,,,1,[],https://twitter.com/ScanzAlerts/status/832267397214109696
817,Zero Filter,@zerofiltertruth,2017-02-15T19:05:02.000Z,"Just added more loto ticket $PPHM 

Recent news impressive; awaiting strategic partner; chart stunning 

$IBB $XBI $FBT $BIN $MRK 
@GuyAdami","Just added more loto ticket $PPHM 

Recent news impressive; awaiting strategic partner; chart stunning 

$IBB $XBI $FBT $BIN $MRK 
@GuyAdami
1
1
3",,1,1,3,[],https://twitter.com/zerofiltertruth/status/831942413430161409
818,Open Outcrier,@OpenOutcrier,2017-02-15T18:15:04.000Z,"$MRK still nickel off lows, lagging its friends.","$MRK still nickel off lows, lagging its friends.
1",,,1,,[],https://twitter.com/OpenOutcrier/status/831929838390898688
819,Jack Allen,@JohnK_Allen,2017-02-15T01:41:12.000Z,"$MRK EPOC study lacks efficacy, wrong patient pop, prodromal study to continue #Alzheimers","$MRK EPOC study lacks efficacy, wrong patient pop, prodromal study to continue #Alzheimers
Maha Elsayed, PhD
@ElsayedSMaha
 ¬∑ 15 Feb 2017
APECS study in prodromal continues- no serious safety issues have come up with EPOC #verubecestat http://investors.merck.com/news/press-release-details/2017/Merck-Announces-EPOCH-Study-of-Verubecestat-for-the-Treatment-of-People-with-Mild-to-Moderate-Alzheimers-Disease-to-Stop-for-Lack-of-Efficacy/default.aspx‚Ä¶",,,,,['https://pbs.twimg.com/profile_images/703216682672791553/7nhA_2Df_mini.jpg'],https://twitter.com/JohnK_Allen/status/831679723063349249
820,BioPharma Dive,@BioPharmaDive,2017-02-15T22:26:00.000Z,Alzheimer's space sees another treatment shelved: $MRK's verubecestat,"Alzheimer's space sees another treatment shelved: $MRK's verubecestat
biopharmadive.com
Merck scraps late-stage study of Alzheimer's candidate
An independent data monitoring committee saw no hope for finding a positive clinical effect in a Phase 3 study testing the BACE inhibitor verubecestat. 
1",,,,1,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/831992988142153728
821,Endpoints News,@endpts,2017-02-15T12:47:01.000Z,Scratch yet another Phase III #Alzheimers drug hopeful. $MRK https://endpts.com/mercks-leading-phiii-bace-drug-implodes-in-latest-alzheimers-disaster/‚Ä¶ #biotech ->subscribe-> http://get.endpts.com,"Scratch yet another Phase III #Alzheimers drug hopeful. $MRK https://endpts.com/mercks-leading-phiii-bace-drug-implodes-in-latest-alzheimers-disaster/‚Ä¶ #biotech ->subscribe-> http://get.endpts.com
1",,,,1,[],https://twitter.com/endpts/status/831847280298700800
822,Pamela Spicer,@Datamonitor_PS,2017-02-15T13:18:11.000Z,"Not so all about that #BACE: $MRK stops EPOCH study in mild-to-mod #Alzheimers. Continues APECS study in prodromal
https://scrip.pharmamedtechbi.com/articles/2017/02/14/another-nail-in-amyloid-hypothesis-coffin-merck-ends-pivotal-bace-inhibitor-study‚Ä¶","Not so all about that #BACE: $MRK stops EPOCH study in mild-to-mod #Alzheimers. Continues APECS study in prodromal
https://scrip.pharmamedtechbi.com/articles/2017/02/14/another-nail-in-amyloid-hypothesis-coffin-merck-ends-pivotal-bace-inhibitor-study‚Ä¶",,,,,[],https://twitter.com/Datamonitor_PS/status/831855125442478080
823,CBPartners,@CBPartners,2017-02-16T16:10:14.000Z,First #HeadAndNeckCancer therapy in over a decade approved in ARG - $MRK KEYTRUDA expands into the #LatAm market http://bit.ly/2liEtVK,First #HeadAndNeckCancer therapy in over a decade approved in ARG - $MRK KEYTRUDA expands into the #LatAm market http://bit.ly/2liEtVK,,,,,[],https://twitter.com/CBPartners/status/832260810772770816
824,ChartMill,@ChartMill,2017-02-17T04:07:41.000Z,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/ryg_XPlVFx #retweet #SAAS,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/ryg_XPlVFx #retweet #SAAS,,,,,[],https://twitter.com/ChartMill/status/832441363136380928
825,Carly Helfand,@CarlyHFierce,2017-02-15T17:15:28.000Z,Merck recruits football star Jim Kelly to help head-and-neck cancer patients craft their 'game plans': http://bit.ly/2lR3X9L $MRK #pharma,"Merck recruits football star Jim Kelly to help head-and-neck cancer patients craft their 'game plans': http://bit.ly/2lR3X9L $MRK #pharma
1
1",,,1,1,[],https://twitter.com/CarlyHFierce/status/831914840889384960
826,Ben Fidler,@BentheFidler,2017-02-17T13:53:06.000Z,"Bio Roundup: #CRISPR Drama, Marathon and PhRMA, the Price of Vision & More http://xconomy.com/national/2017/02/17/bio-roundup-crispr-drama-marathon-and-phrma-the-price-of-vision-more/‚Ä¶ $MRK $ONCE $CELG $SAGE","Bio Roundup: #CRISPR Drama, Marathon and PhRMA, the Price of Vision & More http://xconomy.com/national/2017/02/17/bio-roundup-crispr-drama-marathon-and-phrma-the-price-of-vision-more/‚Ä¶ $MRK $ONCE $CELG $SAGE
1",,,,1,[],https://twitter.com/BentheFidler/status/832588689171689472
827,1 min Stock Insights,@1MinuteStock,2017-02-15T01:28:02.000Z,Wondering about #sentiment indicator for $MRK? The Short Ratio is 1.35% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=shortratio&utm_source=twitter‚Ä¶,Wondering about #sentiment indicator for $MRK? The Short Ratio is 1.35% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=shortratio&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/831676408866934784
828,Pharmaceutical News,@pharma_sector,2017-02-17T05:56:27.000Z,"After #Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?. Read more: http://owler.us/acfugC $MRK","After #Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?. Read more: http://owler.us/acfugC $MRK",,,,,[],https://twitter.com/pharma_sector/status/832468736065970180
829,Pharmaceutical News,@pharma_sector,2017-02-17T12:18:05.000Z,#Merck News Will drug companies' pricetransparency efforts fall short. Read more: http://owler.us/acfxO3 $MRK,#Merck News Will drug companies' pricetransparency efforts fall short. Read more: http://owler.us/acfxO3 $MRK,,,,,[],https://twitter.com/pharma_sector/status/832564776047833089
830,Pharmaceutical News,@pharma_sector,2017-02-17T10:25:06.000Z,"EOD Risers: Intel Corporation, Johnson & Johnson, McDonald's Corporation, #Merck & Co., Inc. Read more: http://owler.us/acfvZn $MRK","EOD Risers: Intel Corporation, Johnson & Johnson, McDonald's Corporation, #Merck & Co., Inc. Read more: http://owler.us/acfvZn $MRK",,,,,[],https://twitter.com/pharma_sector/status/832536343234256897
831,Allison Gatlin,@IBD_AGatlin,2017-02-15T19:12:30.000Z,"Merck's Alzheimer's drug fails; are Biogen, Roche, AstraZeneca next? $MRK $BIIB $RHHBY $AZN","Merck's Alzheimer's drug fails; are Biogen, Roche, AstraZeneca next? $MRK $BIIB $RHHBY $AZN
investors.com
Merck's Alzheimer's Drug Fails; Are Biogen, Roche, AstraZeneca Next? | Stock News & Stock Market...
Merck delivered a blow late Tuesday to the beta-amyloid theory behind Alzheimer's disease when its drug, verubecestat, failed in two clinical trials.
1",,,1,,['https://pbs.twimg.com/card_img/1501743135554248764/XpRyQXWm?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/831944290435792904
832,Ty,@HCanalyst,2017-02-15T12:25:49.000Z,"$MRK is the stealth AD play

$LLY fails ... oh ... diff mechanism. 

$MRK futility ... only $1.5B in model w/ low expectations","$MRK is the stealth AD play

$LLY fails ... oh ... diff mechanism. 

$MRK futility ... only $1.5B in model w/ low expectations",,,,,[],https://twitter.com/HCanalyst/status/831841944565325825
833,Endpoints News,@endpts,2017-02-17T23:35:01.000Z,"Trending this week: $MRK leading PhIII BACE drug implodes in latest #Alzheimers disaster https://endpts.com/mercks-leading-phiii-bace-drug-implodes-in-latest-alzheimers-disaster/‚Ä¶ #biotech by 
@JohnCendpts","Trending this week: $MRK leading PhIII BACE drug implodes in latest #Alzheimers disaster https://endpts.com/mercks-leading-phiii-bace-drug-implodes-in-latest-alzheimers-disaster/‚Ä¶ #biotech by 
@JohnCendpts
1
2",,,1,2,[],https://twitter.com/endpts/status/832735129890062337
834,Watchlist News,@WatchlistN,2017-02-16T13:59:21.000Z,"Merck & Company, Inc. $MRK Shares Bought by ETRADE Capital Management LLC http://zpr.io/PhKmg","Merck & Company, Inc. $MRK Shares Bought by ETRADE Capital Management LLC http://zpr.io/PhKmg",,,,,[],https://twitter.com/WatchlistN/status/832227871322169344
835,Stockaholics,@stockaholism,2017-02-15T13:40:04.000Z,2/15 Wed. Market Movers & News: $PEP $ANTM $HLT $AMZN $GOOGL $KHC $MRK $AAPL $ESRX $AIG $FOSL CHARTS & DISCUSSION... http://fb.me/1FKpR8TpS,"2/15 Wed. Market Movers & News: $PEP $ANTM $HLT $AMZN $GOOGL $KHC $MRK $AAPL $ESRX $AIG $FOSL CHARTS & DISCUSSION... http://fb.me/1FKpR8TpS
1
1",,,1,1,[],https://twitter.com/stockaholism/status/831860630860734464
836,Watchlist News,@WatchlistN,2017-02-17T14:25:57.000Z,"Merck & Company, Inc. $MRK Stake Cut by Accident Compensation Corp http://zpr.io/Phdip","Merck & Company, Inc. $MRK Stake Cut by Accident Compensation Corp http://zpr.io/Phdip",,,,,[],https://twitter.com/WatchlistN/status/832596954957889540
837,Dr Kanak Kanti De,@DrKanakKantiDe,2017-02-16T11:43:11.000Z,"Premarket Biotech Digest ‚Äì $PLX provides updates, $MRK stops trial, $IART acquires new business http://drkkd.com/premarket-biotech-digest-plx-provides-updates-mrk-stops-trial-iart-acquires-new-business/‚Ä¶","Premarket Biotech Digest ‚Äì $PLX provides updates, $MRK stops trial, $IART acquires new business http://drkkd.com/premarket-biotech-digest-plx-provides-updates-mrk-stops-trial-iart-acquires-new-business/‚Ä¶
1",,,,1,[],https://twitter.com/DrKanakKantiDe/status/832193604642799618
838,Matthew Herper,@matthewherper,2017-02-15T13:37:37.000Z,"Deleted previous $MRK tweet because I spelled Roger Perlmutter's name Peelmutter, which is funny but embarrassing.","Deleted previous $MRK tweet because I spelled Roger Perlmutter's name Peelmutter, which is funny but embarrassing.
5",,,,5,[],https://twitter.com/matthewherper/status/831860015636086785
839,BioPharma Dive,@BioPharmaDive,2017-02-17T23:22:00.000Z,Rx Reading: $AGN continues deal spree; $IMMU has trouble sealing deal with $SGEN; $MRK and $GILD release HIV data http://bit.ly/2l1BQaa,"Rx Reading: $AGN continues deal spree; $IMMU has trouble sealing deal with $SGEN; $MRK and $GILD release HIV data http://bit.ly/2l1BQaa
1",,,,1,[],https://twitter.com/BioPharmaDive/status/832731856277745664
840,FirstWord Pharma,@fwpharma,2017-02-15T09:12:54.000Z,Merck & Co. stops study of BACE inhibitor verubecestat in mild-to-moderate Alzheimer's disease https://firstwordpharma.com/node/1451724 $MRK,"Merck & Co. stops study of BACE inhibitor verubecestat in mild-to-moderate Alzheimer's disease https://firstwordpharma.com/node/1451724 $MRK
2",,,2,,[],https://twitter.com/fwpharma/status/831793397690163200
841,Confident Investor,@ConfidentInvest,2017-02-17T00:59:48.000Z,Largest gainers today on my Watch List were: $CVCO $HSKA $MRK $GTN $HDSN http://bit.ly/2iilFAI,"Largest gainers today on my Watch List were: $CVCO $HSKA $MRK $GTN $HDSN http://bit.ly/2iilFAI
1",,1,,,[],https://twitter.com/ConfidentInvest/status/832394081749774336
842,Ticker Report,@TickerReport,2017-02-17T10:52:02.000Z,"First Heartland Consultants Inc. Has $1,495,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2lpxj2p","First Heartland Consultants Inc. Has $1,495,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2lpxj2p",,,,,[],https://twitter.com/TickerReport/status/832543121259036672
843,MarketBeat,@MarketBeatCom,2017-02-17T14:53:03.000Z,"Merck & Company, Inc. $MRK Price Target Cut to $70.00 http://zpr.io/PhetH","Merck & Company, Inc. $MRK Price Target Cut to $70.00 http://zpr.io/PhetH",,,,,[],https://twitter.com/MarketBeatCom/status/832603773633716224
844,TW Research Group,@DanCarlson33,2017-02-16T14:44:19.000Z,How to profit from Trump‚Äôs policies? Buy Small Cap $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK $MSFT $MKE,"How to profit from Trump‚Äôs policies? Buy Small Cap $MDT $MET $MMM $MO $MDLZ $MON $MS $MRK $MSFT $MKE
twresearchgroup.com
Buying Small Cap, The Trump Play, Part II
The great news about small and micro cap stocks is that they outperform the market. Significantly. According to AQR Capital, such firms have outperformed the broader stock market indexes by almost...",,,,,['https://pbs.twimg.com/card_img/1501524967552262149/jmgzsNIP?format=jpg&name=240x240'],https://twitter.com/DanCarlson33/status/832239186988015616
845,FierceBiotech,@FierceBiotech,2017-02-15T14:22:47.000Z,Merck's lead HIV play hits the mark in first phase 3 challenge: http://ow.ly/At803091MdN $MRK,"Merck's lead HIV play hits the mark in first phase 3 challenge: http://ow.ly/At803091MdN $MRK
1
2",,,1,2,[],https://twitter.com/FierceBiotech/status/831871380144680961
846,SwingTradeBot,@SwingTradeBot,2017-02-15T23:04:27.000Z,Scan results - Shooting Star Candlestick today: $SODA $BEAT $ARCH $HUM $MRK $PEGA $TERP $GWB $MON $JBLU ... http://swingtradebot.com/events/15/equities?selected_date=2017-02-15‚Ä¶,Scan results - Shooting Star Candlestick today: $SODA $BEAT $ARCH $HUM $MRK $PEGA $TERP $GWB $MON $JBLU ... http://swingtradebot.com/events/15/equities?selected_date=2017-02-15‚Ä¶,,,,,[],https://twitter.com/SwingTradeBot/status/832002663839629312
847,Nic,@racernic,2017-02-15T14:38:00.000Z,Commented on StockTwits: perhaps. i booked my free profits. will reengage later. $MRK http://stocktwits.com/racernic/message/74632470#74679193‚Ä¶,Commented on StockTwits: perhaps. i booked my free profits. will reengage later. $MRK http://stocktwits.com/racernic/message/74632470#74679193‚Ä¶,,,,,[],https://twitter.com/racernic/status/831875212769624065
848,Red Acre Investments,@redacre,2017-02-15T21:14:06.000Z,2/ Biotech/HC New or revisited 52-week highs:$GRFS $HCA $HYH $IRWD $MASI $MDCO $MRK $NUVA $NXTM $PRAH $RMD $SAGE $TRUP $UNH $UTHR $WMGI,2/ Biotech/HC New or revisited 52-week highs:$GRFS $HCA $HYH $IRWD $MASI $MDCO $MRK $NUVA $NXTM $PRAH $RMD $SAGE $TRUP $UNH $UTHR $WMGI,,,,,[],https://twitter.com/redacre/status/831974892492959744
849,Allison Gatlin,@IBD_AGatlin,2017-02-17T16:41:22.000Z,These Are The First Immune-System Cancer Drugs OK'd By FDA $MRK $BMY $NVS $GSK $RHHBY,"These Are The First Immune-System Cancer Drugs OK'd By FDA $MRK $BMY $NVS $GSK $RHHBY
investors.com
These Are The First Immune-System Cancer Drugs OK'd By FDA
A handful of products define the new market for drugs that harness the immune system to fight cancer. Here's a list of the drugs and their FDA-approved uses.
1",,,,1,[],https://twitter.com/IBD_AGatlin/status/832631032373338112
850,MarketBeat,@MarketBeatCom,2017-02-16T23:59:14.000Z,"Traders Sell Shares of Merck & Company, Inc. $MRK on Strength After Analyst Downgrade http://zpr.io/PhSB3","Traders Sell Shares of Merck & Company, Inc. $MRK on Strength After Analyst Downgrade http://zpr.io/PhSB3",,,,,[],https://twitter.com/MarketBeatCom/status/832378837124120576
851,Jacob Bell,@realJacobBell,2017-02-17T17:10:01.000Z,"Prescribed Reading: $SAGE CEO talks takeovers, $SNY inks OTC deal with Ipsen, $MRK's Alzheimer's drug flops in Ph. 3","Prescribed Reading: $SAGE CEO talks takeovers, $SNY inks OTC deal with Ipsen, $MRK's Alzheimer's drug flops in Ph. 3
biopharmadive.com
Prescribed Reading: Sage CEO embellishes, Merck stumbles
Plus, Valeant gets an approval, but is still in a tight spot; Allergan continues its deal spree; and PhRMA tries to deal with image issues. ",,,,,[],https://twitter.com/realJacobBell/status/832638241601777664
852,ZoZoTrader,@ZoZoStockwatch,2017-02-16T13:06:28.000Z,$MRK Merck‚Äôs Fight Against Infectious Disease Goes Digital with Launch of IL√öM Health Solutions,$MRK Merck‚Äôs Fight Against Infectious Disease Goes Digital with Launch of IL√öM Health Solutions,,,,,[],https://twitter.com/ZoZoStockwatch/status/832214565303762953
853,Hotpage News,@Hotpage_News,2017-02-15T14:03:30.000Z,EARLY MOVERS: $PEP $ANTM $HLT $AMZN $GOOG $IART $KHC $CAG $MRK $AAPL $ESRX $AIG $FOSL $HUM $PG $TWTR $APO $CSX,"EARLY MOVERS: $PEP $ANTM $HLT $AMZN $GOOG $IART $KHC $CAG $MRK $AAPL $ESRX $AIG $FOSL $HUM $PG $TWTR $APO $CSX
cnbc.com
Early movers: PEP, ANTM, HLT, AMZN, GOOGL, IART & more
These are the stocks posting the largest moves before the bell.",,,,,['https://pbs.twimg.com/card_img/1501743093456023552/haEpVEEh?format=jpg&name=small'],https://twitter.com/Hotpage_News/status/831866530757484544
854,Stockboard Media Inc,@stockboardinc,2017-02-16T13:08:04.000Z,$MRK Merck‚Äôs Fight Against Infectious Disease Goes Digital with Launch of IL√öM Health Solutions... - http://sbml.co/4ed9854a,$MRK Merck‚Äôs Fight Against Infectious Disease Goes Digital with Launch of IL√öM Health Solutions... - http://sbml.co/4ed9854a,,,,,[],https://twitter.com/stockboardinc/status/832214967709491202
855,Allison Gatlin,@IBD_AGatlin,2017-02-17T16:38:42.000Z,"Merck, Bristol-Myers, Incyte Race For A Cure In $25 Billion I-O Market $MRK $BMY $INCY $AZN $RHHBY $GSK $NVS","Merck, Bristol-Myers, Incyte Race For A Cure In $25 Billion I-O Market $MRK $BMY $INCY $AZN $RHHBY $GSK $NVS
investors.com
Merck, Bristol-Myers, Incyte Race For A Cure In $25 Billion I-O Market | Stock News & Stock Market...
Merck and Bristol-Myers researchers aren't ready to call immuno-oncology drugs the cure for cancer, but the drugs represent a potential $25 billion market.",,,,,['https://pbs.twimg.com/card_img/1501742694829367296/j2sfWlqt?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/832630360966053888
856,BioPharm Insight,@BioPharmInsight,2017-02-16T14:50:12.000Z,"$MRK's Phase 3 CVOT of cholesterol drug anacetrapib faces reservation after class failures, trial design offers hope http://bit.ly/2lPubdi","$MRK's Phase 3 CVOT of cholesterol drug anacetrapib faces reservation after class failures, trial design offers hope http://bit.ly/2lPubdi
1
2",,,1,2,[],https://twitter.com/BioPharmInsight/status/832240668177268736
857,BioPharma Dive,@BioPharmaDive,2017-02-17T17:10:01.000Z,"Prescribed Reading: $SAGE CEO talks takeovers, $SNY inks OTC deal with Ipsen, $MRK's Alzheimer's drug flops in Ph. 3 http://bit.ly/2l1BQaa","Prescribed Reading: $SAGE CEO talks takeovers, $SNY inks OTC deal with Ipsen, $MRK's Alzheimer's drug flops in Ph. 3 http://bit.ly/2l1BQaa",,,,,[],https://twitter.com/BioPharmaDive/status/832638241337663488
858,Novateur Ventures,@NovateurBio,2017-02-15T23:42:04.000Z,"$MRK Merck Halts Pivotal #Alzheimer's Disease Drug Trial on DMC Recommendation http://genengnews.com/gen-news-highlights/merck-halts-pivotal-alzheimer-s-disease-drug-trial-on-dmc-recommendation/81253884‚Ä¶ via 
@GENbio","$MRK Merck Halts Pivotal #Alzheimer's Disease Drug Trial on DMC Recommendation http://genengnews.com/gen-news-highlights/merck-halts-pivotal-alzheimer-s-disease-drug-trial-on-dmc-recommendation/81253884‚Ä¶ via 
@GENbio",,,,,[],https://twitter.com/NovateurBio/status/832012132078096384
859,InvestorPlace,@InvestorPlace,2017-02-15T15:25:37.000Z,"3 Stocks to Watch on Wednesday: Berkshire Hathaway, Fossil Group and Merck $BRK.B $FOSL $MRK","3 Stocks to Watch on Wednesday: Berkshire Hathaway, Fossil Group and Merck $BRK.B $FOSL $MRK
investorplace.com
3 Stocks to Watch on Wednesday: Berkshire Hathaway Inc. (BRK.B), Fossil Group Inc (FOSL) and Merck...
Warren Buffett and Berkshire Hathaway (BRK.A,BRK.B) are investing in airlines, Fossil (FOSL) reports earnings and Merck (MRK) halts study.
1",,,1,,['https://pbs.twimg.com/card_img/1501679174540529668/hDd21fni?format=jpg&name=240x240'],https://twitter.com/InvestorPlace/status/831887195514556422
860,Arsalan Arif,@AKAarsalan,2017-02-15T08:59:13.000Z,Merck‚Äôs HIV drug doravirine looks solid ‚Äî though far less stellar than rivals ‚Äî in 1st PhIII https://endpts.com/mercks-hiv-drug-doravirine-looks-solid-though-far-less-stellar-than-rivals-in-1st-phiii/‚Ä¶ $MRK $GSK $GILD,"Merck‚Äôs HIV drug doravirine looks solid ‚Äî though far less stellar than rivals ‚Äî in 1st PhIII https://endpts.com/mercks-hiv-drug-doravirine-looks-solid-though-far-less-stellar-than-rivals-in-1st-phiii/‚Ä¶ $MRK $GSK $GILD
endpts.com
Merck‚Äôs HIV drug doravirine looks solid ‚Äî though far less stellar than rivals ‚Äî in 1st PhIII
Merck‚Äôs late-stage antiviral doravirine (MK-1439) came through in its first Phase III study, matching up nicely against J&J‚Äôs blockbuster Prezista. The non-nucleoside reverse transcriptase inhibitor...",,,,,[],https://twitter.com/AKAarsalan/status/831789952451100672
861,Briefing.com,@Briefingcom,2017-02-15T00:50:40.000Z,$MRK: Merck announces EPOCH study of Verubecestat for the treatment of people with mild to moderate Alzheimer‚Äôs... http://bit.ly/2lhdPwi,$MRK: Merck announces EPOCH study of Verubecestat for the treatment of people with mild to moderate Alzheimer‚Äôs... http://bit.ly/2lhdPwi,,,,,[],https://twitter.com/Briefingcom/status/831667007095332865
862,John Carroll,@JohnCendpts,2017-02-15T13:15:53.000Z,"Trending:
Merck‚Äôs leading PhIII BACE drug implodes in latest Alzheimer‚Äôs disaster
$MRK","Trending:
Merck‚Äôs leading PhIII BACE drug implodes in latest Alzheimer‚Äôs disaster
$MRK
endpts.com
Merck‚Äôs leading PhIII BACE drug implodes in latest Alzheimer‚Äôs disaster
Scratch yet another Phase III Alzheimer‚Äôs drug hopeful. Merck $MRK announced late Tuesday that it is shuttering its EPOCH trial for the BACE inhibitor verubecestat in mild-to-moderate Alzheimer‚Äôs...
2
1",,,2,1,['https://pbs.twimg.com/card_img/1500378540017164289/qkPO3rLZ?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/831854546829848576
863,IndustryPharmacist,@IndustryRPh,2017-02-17T15:56:35.000Z,"Replying to 
@Zackfoot","Replying to 
@Zackfoot
I would normally agree to trim. But sell off from Wed was completely irrational bc of bad $MRK data. $NTRP MOA no relation. Long
1
2",,,1,2,[],https://twitter.com/IndustryRPh/status/832619764585369602
864,Benzinga,@Benzinga,2017-02-17T18:22:00.000Z,"After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline? https://benzinga.com/z/9061803 $MRK $LLY $NTRP","After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline? https://benzinga.com/z/9061803 $MRK $LLY $NTRP
benzinga.com
After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?
Merck & Co, Inc. (NYSE: MRK) Tuesday reported it was halting its Phase 3 study of Alzheimer's treatment verubecestat in people with mild to moderate Alzheimer's...",,,,,[],https://twitter.com/Benzinga/status/832656359955034115
865,dough,@semodough,2017-02-17T18:25:43.000Z,"Replying to 
@semodough","Replying to 
@semodough
$MRK Zepatier TRx is 849 (-2% wk/wk& +7% QTD),NRx is 356 (-5% wk/wk); Zepatier has a 14% share NRx market, flat  14% last week.
1
1",,,1,1,[],https://twitter.com/semodough/status/832657294869532672
866,MarketBeat,@MarketBeatCom,2017-02-17T14:28:17.000Z,"Cutler Investment Counsel LLC Buys 872 Shares of Merck & Company, Inc. $MRK http://zpr.io/Phddz","Cutler Investment Counsel LLC Buys 872 Shares of Merck & Company, Inc. $MRK http://zpr.io/Phddz",,,,,[],https://twitter.com/MarketBeatCom/status/832597542244323328
867,Novateur Ventures,@NovateurBio,2017-02-15T23:44:22.000Z,"$MRK Merck‚Äôs leading PhIII BACE drug implodes in latest #Alzheimer‚Äôs disaster https://endpts.com/mercks-leading-phiii-bace-drug-implodes-in-latest-alzheimers-disaster‚Ä¶ via 
@endpts","$MRK Merck‚Äôs leading PhIII BACE drug implodes in latest #Alzheimer‚Äôs disaster https://endpts.com/mercks-leading-phiii-bace-drug-implodes-in-latest-alzheimers-disaster‚Ä¶ via 
@endpts",,,,,[],https://twitter.com/NovateurBio/status/832012708874645504
868,Novateur Ventures,@NovateurBio,2017-02-15T23:30:09.000Z,"$MRK Merck‚Äôs #HIV drug doravirine looks solid ‚Äî though far less stellar than rivals ‚Äî in 1st PhIII https://endpts.com/mercks-hiv-drug-doravirine-looks-solid-though-far-less-stellar-than-rivals-in-1st-phiii‚Ä¶ via 
@endpts","$MRK Merck‚Äôs #HIV drug doravirine looks solid ‚Äî though far less stellar than rivals ‚Äî in 1st PhIII https://endpts.com/mercks-hiv-drug-doravirine-looks-solid-though-far-less-stellar-than-rivals-in-1st-phiii‚Ä¶ via 
@endpts
endpts.com
Merck‚Äôs HIV drug doravirine looks solid ‚Äî though far less stellar than rivals ‚Äî in 1st PhIII
Merck‚Äôs late-stage antiviral doravirine (MK-1439) came through in its first Phase III study, matching up nicely against J&J‚Äôs blockbuster Prezista. The non-nucleoside reverse transcriptase inhibitor...",,,,,[],https://twitter.com/NovateurBio/status/832009131103916032
869,By Any Memes Necessary,@_21stCenturyCox,2017-02-16T21:17:28.000Z,"After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline? https://benzinga.com/z/9061803 $NTRP $ACIU $AGN $MRK $BIIB via 
@benzinga","After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline? https://benzinga.com/z/9061803 $NTRP $ACIU $AGN $MRK $BIIB via 
@benzinga
benzinga.com
After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?
Merck & Co, Inc. (NYSE: MRK) Tuesday reported it was halting its Phase 3 study of Alzheimer's treatment verubecestat in people with mild to moderate Alzheimer's...",,,,,[],https://twitter.com/_21stCenturyCox/status/832338128815931393
870,Alan Robert Ross,@alanrobertross,2017-02-20T18:16:57.000Z,#PVCT adds clinical trial sites to Phase 3 #PV10 & COMBO #melanoma trial w/ $MRK #immunotherapy #Keytruda,"#PVCT adds clinical trial sites to Phase 3 #PV10 & COMBO #melanoma trial w/ $MRK #immunotherapy #Keytruda
GIF
1",,,1,,[],https://twitter.com/alanrobertross/status/833742252719603714
871,NYCDoc29,@nycdoc29,2017-02-18T21:11:38.000Z,and #Keytruda has no #financialtoxicity ? #GU17 $MRK #CancerMoonshot,"and #Keytruda has no #financialtoxicity ? #GU17 $MRK #CancerMoonshot
Guillermo de Velasco
@g_develasco
 ¬∑ 18 Feb 2017
Replying to @ERPlimackMD
G8 patients live longer & better #GU17
1
2",,,1,2,['https://pbs.twimg.com/profile_images/1450386891086385154/5oT9cl5Z_mini.jpg'],https://twitter.com/nycdoc29/status/833061436628807680
872,Investors.com,@IBDinvestors,2017-02-19T15:25:18.000Z,"Merck, Bristol-Myers, Incyte Race For A Cure In $25 Billion Immuno-Oncology Market http://ow.ly/Oz7w3097l2E $MRK $BMY $INCY $RHHBY $AZN","Merck, Bristol-Myers, Incyte Race For A Cure In $25 Billion Immuno-Oncology Market http://ow.ly/Oz7w3097l2E $MRK $BMY $INCY $RHHBY $AZN
1
3
7",,1,3,7,['https://pbs.twimg.com/media/C5CbR7zUYAIV-sO?format=jpg&name=small'],https://twitter.com/IBDinvestors/status/833336667125796864
873,Ozmosi,@OzmosiHealth,2017-02-20T17:02:31.000Z,Slow and steady wins the race - with a little help from biomarkers - $MRK vs. $BMY  http://bit.ly/2kQTxWM #immunology,Slow and steady wins the race - with a little help from biomarkers - $MRK vs. $BMY  http://bit.ly/2kQTxWM #immunology,,,,,['https://pbs.twimg.com/media/C5H7HqrWIAAZrfi?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/833723518089039873
874,Zaphod Beeblebrox,@AndysCycles,2017-02-18T22:57:25.000Z,$SPX SPDR Health Care sector ETF components. $BMY $GLD $UNH $ABBV $BIIB $JNJ $MDT $XLV $LLY $PFE $CELG $MRK $TMO $AMGN $AGN,$SPX SPDR Health Care sector ETF components. $BMY $GLD $UNH $ABBV $BIIB $JNJ $MDT $XLV $LLY $PFE $CELG $MRK $TMO $AMGN $AGN,,,,,['https://pbs.twimg.com/media/C4-5HC9VUAAo8CU?format=jpg&name=small'],https://twitter.com/AndysCycles/status/833088058694172672
875,BioPharma Dive,@BioPharmaDive,2017-02-19T00:26:00.000Z,The PD-L1 biomarker might be the key to Keytruda upending Opdivo http://bit.ly/2l6C6EP $BMY $MRK,"The PD-L1 biomarker might be the key to Keytruda upending Opdivo http://bit.ly/2l6C6EP $BMY $MRK
biopharmadive.com
How biomarkers cost Bristol-Myers the lung cancer market
A risk-averse approach to biomarkers opened the door for Merck's Keytruda to surpass Bristol-Myers' Opdivo in the highly important lung cancer market. 
3
2",,,3,2,['https://pbs.twimg.com/card_img/1499468307245768711/rsJkhIxR?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/833110349649846273
876,Dow Stocks,@Top_Dow_Stocks,2017-02-20T08:16:57.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/833591256206893056
877,dough,@semodough,2017-02-20T01:09:31.000Z,"Replying to 
@semodough","Replying to 
@semodough
$TSRO one potential catalyst that could move the needle on $TSRO $MRK
1
2",,1,,2,['https://pbs.twimg.com/media/C5Eg_K4VMAAUxso?format=jpg&name=small'],https://twitter.com/semodough/status/833483689568903168
878,M,@bio_clouseau,2017-02-18T18:10:00.000Z,Wide Use of New HCV Drugs Prevents New Cases http://medpagetoday.com/MeetingCoverage/CROI/63242‚Ä¶ $GILD $ABBV $MRK,"Wide Use of New HCV Drugs Prevents New Cases http://medpagetoday.com/MeetingCoverage/CROI/63242‚Ä¶ $GILD $ABBV $MRK
2
3",,,2,3,[],https://twitter.com/bio_clouseau/status/833015727267397633
879,Pullback,@pullbackmx,2017-02-18T00:02:28.000Z,$MRK Possible short. - S: $64.87 / SL: $65.55 http://pullback.mx/e/MRK,$MRK Possible short. - S: $64.87 / SL: $65.55 http://pullback.mx/e/MRK,,,,,[],https://twitter.com/pullbackmx/status/832742040022573057
880,Donna Young,@DonnaYoungDC,2017-02-19T14:40:58.000Z,".
@SpaceX
 #Dragon Go for launch!
#science $MRK #MRSA",".
@SpaceX
 #Dragon Go for launch!
#science $MRK #MRSA
1",üì∞,,,1,[],https://twitter.com/DonnaYoungDC/status/833325509031374849
881,Tom Silver,@TomSilver39,2017-02-19T00:24:16.000Z,$AGIO $CELG $TSRO $CLVS $MRK 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses...  and induces PARP,"$AGIO $CELG $TSRO $CLVS $MRK 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses...  and induces PARP
science.org
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and...
The oncometabolite 2-hydroxyglutarate renders IDH1/2 mutant cancer cells deficient in homologous recombination and confers vulnerability to synthetic lethal targeting with PARP inhibitors.
5",,,,5,[],https://twitter.com/TomSilver39/status/833109913077288961
882,Heath Care News,@hc_equipment,2017-02-20T19:14:01.000Z,#Merck plans India bio-production plant. Read more: http://owler.us/acgu9G $MRK,#Merck plans India bio-production plant. Read more: http://owler.us/acgu9G $MRK,,,,,[],https://twitter.com/hc_equipment/status/833756613202751493
883,Sweet Platform,@SweetPlatform,2017-02-20T15:14:41.000Z,"MRK Top news - Feb 20th, 2017 $MRK http://https://goo.gl/efdjUi","MRK Top news - Feb 20th, 2017 $MRK http://https://goo.gl/efdjUi",,,,,[],https://twitter.com/SweetPlatform/status/833696383743950849
884,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-02-19T13:06:06.000Z,"Replying to 
@VaxCalc","Replying to 
@VaxCalc
Does the 
@washingtonpost
 know drug co $MRK and their faulty, globally rejected #MMR vaccine are being sued by their own scientists?
1
1
1",,1,1,1,[],https://twitter.com/ZimJay/status/833301636860755970
885,ChartMill,@ChartMill,2017-02-18T23:25:40.000Z,Breakout alert! $MRK Watch it on http://stockcharts.chartmill.com/u/B1ebMdUIYl #wine #hashtag,Breakout alert! $MRK Watch it on http://stockcharts.chartmill.com/u/B1ebMdUIYl #wine #hashtag,,,,,[],https://twitter.com/ChartMill/status/833095167653584900
886,BioPharma Dive,@BioPharmaDive,2017-02-18T16:49:01.000Z,"Another week, another shelved Alzheimer's drug. This time it's $MRK's http://bit.ly/2kqtLgv","Another week, another shelved Alzheimer's drug. This time it's $MRK's http://bit.ly/2kqtLgv
1
3",,1,,3,[],https://twitter.com/BioPharmaDive/status/832995346204782592
887,Heath Care News,@hc_equipment,2017-02-20T15:46:54.000Z,Deutsche Bank AG Analysts Give #Merck KGaA a ‚Ç¨118.00 Price Target. Read more: http://owler.us/acgtuV $MRK,Deutsche Bank AG Analysts Give #Merck KGaA a ‚Ç¨118.00 Price Target. Read more: http://owler.us/acgtuV $MRK,,,,,[],https://twitter.com/hc_equipment/status/833704488976281600
888,Heath Care News,@hc_equipment,2017-02-20T19:12:10.000Z,Execution is the challenge in India: #Merck KGaA's Udit Batra. Read more: http://owler.us/acgu8A $MRK,Execution is the challenge in India: #Merck KGaA's Udit Batra. Read more: http://owler.us/acgu8A $MRK,,,,,[],https://twitter.com/hc_equipment/status/833756146770915328
889,ChartMill,@ChartMill,2017-02-19T04:30:40.000Z,Is $MRK breaking out? Take a quick look at http://stockcharts.chartmill.com/u/rylpKkjUFl! #Vaccine #Leads,Is $MRK breaking out? Take a quick look at http://stockcharts.chartmill.com/u/rylpKkjUFl! #Vaccine #Leads,,,,,[],https://twitter.com/ChartMill/status/833171923169320960
890,ChartMill,@ChartMill,2017-02-19T00:50:40.000Z,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/Hyxag3DLKg #Recycled #markets,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/Hyxag3DLKg #Recycled #markets,,,,,[],https://twitter.com/ChartMill/status/833116558411051010
891,@kyleserikawa,@kyleserikawa,2017-02-20T16:24:28.000Z,"I don't know if they'd find anything definitive, but could find predisposing loci? Some co like $SNY or $LLY or $NVO or $MRK with T2D...","I don't know if they'd find anything definitive, but could find predisposing loci? Some co like $SNY or $LLY or $NVO or $MRK with T2D...
@kyleserikawa
@kyleserikawa
 ¬∑ 20 Feb 2017
I wonder if they could team up with #geneticists and, after some #genome sequencing, make a biology-based argument for an exemption? https://twitter.com/kyleserikawa/status/833713289183973376‚Ä¶
2",,,2,,['https://pbs.twimg.com/profile_images/1247013665137504256/F6sJEK___mini.jpg'],https://twitter.com/kyleserikawa/status/833713942354550786
892,Pharmaceutical News,@pharma_sector,2017-02-20T11:52:23.000Z,"Osborn Williams & Donohoe LLC Cuts Position in #Merck & Company, Inc. (). Read more: http://owler.us/acgrSg $MRK","Osborn Williams & Donohoe LLC Cuts Position in #Merck & Company, Inc. (). Read more: http://owler.us/acgrSg $MRK",,,,,[],https://twitter.com/pharma_sector/status/833645473592340482
893,Pharmaceutical News,@pharma_sector,2017-02-20T10:26:10.000Z,"EOD Risers: Johnson & Johnson, McDonald's Corporation, #Merck & Co., Inc., Microsoft Corpora... Read more: http://owler.us/acgqKc $MRK","EOD Risers: Johnson & Johnson, McDonald's Corporation, #Merck & Co., Inc., Microsoft Corpora... Read more: http://owler.us/acgqKc $MRK",,,,,[],https://twitter.com/pharma_sector/status/833623773802700800
894,Zenect,@zenect,2017-02-19T10:48:26.000Z,$BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V All would make a great foundation #investment‚Ä¶ I like this http://bit.ly/1sQ7Crl,"$BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V All would make a great foundation #investment‚Ä¶ I like this http://bit.ly/1sQ7Crl
1",,,,1,[],https://twitter.com/zenect/status/833266989250523137
895,MarketBeat,@MarketBeatCom,2017-02-20T10:42:23.000Z,Merck KGaA given ‚Ç¨118.00 PT by Deutsche Bank AG. buy rating. http://ift.tt/2lCozpt $MRK #MRK,Merck KGaA given ‚Ç¨118.00 PT by Deutsche Bank AG. buy rating. http://ift.tt/2lCozpt $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/833627855011663872
896,Daily Political,@dailypoliticaln,2017-02-20T11:34:07.000Z,"BMO Capital Markets Trims Merck & Company, Inc. $MRK Target Price to $70.00 http://ift.tt/2m3Q0WD","BMO Capital Markets Trims Merck & Company, Inc. $MRK Target Price to $70.00 http://ift.tt/2m3Q0WD",,,,,[],https://twitter.com/dailypoliticaln/status/833640875267854336
897,Daily Political,@dailypoliticaln,2017-02-18T11:18:15.000Z,"RGT Capital Management Ltd. Invests $329,000 in Merck & Company, Inc. $MRK http://ift.tt/2lh5I0I","RGT Capital Management Ltd. Invests $329,000 in Merck & Company, Inc. $MRK http://ift.tt/2lh5I0I",,,,,[],https://twitter.com/dailypoliticaln/status/832912104545882112
898,Ticker Report,@TickerReport,2017-02-20T10:13:12.000Z,"Cornercap Investment Counsel Inc. Buys 56,542 Shares of Merck & Company, Inc. $MRK http://ift.tt/2kDyE64","Cornercap Investment Counsel Inc. Buys 56,542 Shares of Merck & Company, Inc. $MRK http://ift.tt/2kDyE64",,,,,[],https://twitter.com/TickerReport/status/833620509979983872
899,Ticker Report,@TickerReport,2017-02-18T11:22:22.000Z,"Merck & Company, Inc. $MRK Stake Reduced by Feltz Wealth PLAN Inc. http://ift.tt/2lh1czb","Merck & Company, Inc. $MRK Stake Reduced by Feltz Wealth PLAN Inc. http://ift.tt/2lh1czb",,,,,[],https://twitter.com/TickerReport/status/832913141969338374
900,Watchlist News,@WatchlistN,2017-02-18T12:39:05.000Z,"Traders Sell Shares of Merck & Company, Inc. $MRK on Strength on Analyst Downgrade http://zpr.io/PA6Ta","Traders Sell Shares of Merck & Company, Inc. $MRK on Strength on Analyst Downgrade http://zpr.io/PA6Ta",,,,,[],https://twitter.com/WatchlistN/status/832932449277575168
901,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-02-18T17:04:29.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/6lcRzEvWT,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/6lcRzEvWT,,,,,[],https://twitter.com/gem_2014/status/832999236694319104
902,BioPharma Dive,@BioPharmaDive,2017-02-18T19:39:01.000Z,Rx Reading: $SAGE CEO talks takeovers; $AGN continues deal spree; $MRK and $GILD release HIV data http://bit.ly/2l1BQaa,"Rx Reading: $SAGE CEO talks takeovers; $AGN continues deal spree; $MRK and $GILD release HIV data http://bit.ly/2l1BQaa
1",,,,1,[],https://twitter.com/BioPharmaDive/status/833038128470450176
903,MarketBeat,@MarketBeatCom,2017-02-19T12:57:28.000Z,"Orbis Allan Gray Ltd Cuts Stake in Merck & Company, Inc. $MRK http://zpr.io/PAqyp","Orbis Allan Gray Ltd Cuts Stake in Merck & Company, Inc. $MRK http://zpr.io/PAqyp",,,,,[],https://twitter.com/MarketBeatCom/status/833299464660058112
904,StockNews.com,@stocknewsdotcom,2017-02-20T16:06:56.000Z,"$MRK One of several Large Cap Medical-Pharma plays with double-digit returns so far in 2017. Technically, the stoc‚Ä¶ https://stocknews.com/news/mrk-one-of-several-large-cap-medical-pharma-plays-with-double-digit-returns/‚Ä¶","$MRK One of several Large Cap Medical-Pharma plays with double-digit returns so far in 2017. Technically, the stoc‚Ä¶ https://stocknews.com/news/mrk-one-of-several-large-cap-medical-pharma-plays-with-double-digit-returns/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/833709533281316866
905,Benzinga,@Benzinga,2017-02-18T20:30:02.000Z,"After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline? https://benzinga.com/z/9061803 $MRK $NTRP $ACIU $LLY $AGN $BIIB $AXON","After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline? https://benzinga.com/z/9061803 $MRK $NTRP $ACIU $LLY $AGN $BIIB $AXON
benzinga.com
After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?
Merck & Co, Inc. (NYSE: MRK) Tuesday reported it was halting its Phase 3 study of Alzheimer's treatment verubecestat in people with mild to moderate Alzheimer's...
1
1",,,1,1,[],https://twitter.com/Benzinga/status/833050965959901185
906,Donna Young,@DonnaYoungDC,2017-02-19T14:56:27.000Z,"$MRK #Keytruda, 
@Nanobiosym
 #MRSA, 
@MayoClinic
 stem cell, USACEHR tissue healing & other 
@ISS_CASIS
 experiments take flight!
#NASA #science","$MRK #Keytruda, 
@Nanobiosym
 #MRSA, 
@MayoClinic
 stem cell, USACEHR tissue healing & other 
@ISS_CASIS
 experiments take flight!
#NASA #science
NASA
@NASA
 ¬∑ 19 Feb 2017
The @SpaceX #Dragon spacecraft continues to head to orbit to deliver cargo and supplies to @Space_Station. Watch: http://nasa.gov/live
GIF
1",üì∞,,1,,['https://pbs.twimg.com/profile_images/1321163587679784960/0ZxKlEKB_mini.jpg'],https://twitter.com/DonnaYoungDC/status/833329406726725633
907,Pharmaceutical News,@pharma_sector,2017-02-20T10:18:44.000Z,"Traders Sell Shares of #Merck & Company, Inc. on Strength on Analyst Downgrade. Read more: http://owler.us/acgqEu $MRK","Traders Sell Shares of #Merck & Company, Inc. on Strength on Analyst Downgrade. Read more: http://owler.us/acgqEu $MRK",,,,,[],https://twitter.com/pharma_sector/status/833621905387122688
908,Watchlist News,@WatchlistN,2017-02-20T10:12:39.000Z,"10,000 Shares in Merck & Company, Inc. $MRK Acquired by Barometer Capital Management Inc. http://zpr.io/PAj6y","10,000 Shares in Merck & Company, Inc. $MRK Acquired by Barometer Capital Management Inc. http://zpr.io/PAj6y",,,,,[],https://twitter.com/WatchlistN/status/833620374847885312
909,Jason,@JasonHolman5,2017-02-20T14:33:24.000Z,"Replying to 
@JasonHolman5","Replying to 
@JasonHolman5
Good coverage of Omad.(as a tetracyc.)inCABP,safety profile,oral vs. IV&glad they were asked/answered $MRK $NVS collab history
1
1",,1,,1,[],https://twitter.com/JasonHolman5/status/833685990900391938
910,Paula Treneer,@madronapartners,2017-02-18T17:11:08.000Z,"Replying to 
@madronapartners","Replying to 
@madronapartners
sold $SAGE on close Fri.Flattening risk over 3day weekend,staying long $CELG $MRK $BAC $KRE $MSFT & basket of takeout specs",,,,,[],https://twitter.com/madronapartners/status/833000910238257152
911,FOX Business,@FoxBusiness,2017-02-23T21:03:57.000Z,"#Breaking Dow closes at all-time high:
$JNJ
$PFE
$VZ
$MRK","#Breaking Dow closes at all-time high:
$JNJ
$PFE
$VZ
$MRK
3
25
55",,3,25,55,['https://pbs.twimg.com/media/C5YPEtSUoAE6T1Q?format=jpg&name=small'],https://twitter.com/FoxBusiness/status/834871440520466436
912,John Hodgson,@JohnNHodgson,2017-02-21T13:04:13.000Z,#Bayer reports tomorrow: #pharma 2016 results so far very mixed; Down $NVS $MRK $SNY $GILD $AZN; the rest up inc. $PFE $BMY $GSK,"#Bayer reports tomorrow: #pharma 2016 results so far very mixed; Down $NVS $MRK $SNY $GILD $AZN; the rest up inc. $PFE $BMY $GSK
6
2",,,6,2,['https://pbs.twimg.com/media/C5MOIbWWcAAkmHc?format=jpg&name=small'],https://twitter.com/JohnNHodgson/status/834025935158534145
913,c. berry lee,@cberrl,2017-02-23T03:47:32.000Z,Gilead's M&A Growth Strategies Becoming Increasingly Limited http://seekingalpha.com/article/4048212-gileads-m-growth-strategies-becoming-increasingly-limited?source=tweet‚Ä¶ $ABBV $BMY $IBB $JNJ $MRK $VRTX $GILD,"Gilead's M&A Growth Strategies Becoming Increasingly Limited http://seekingalpha.com/article/4048212-gileads-m-growth-strategies-becoming-increasingly-limited?source=tweet‚Ä¶ $ABBV $BMY $IBB $JNJ $MRK $VRTX $GILD
seekingalpha.com
Gilead's M&A Growth Strategies Becoming Increasingly Limited (NASDAQ:GILD)
The decline in Gilead‚Äôs total product sales persists with no end in sight, as HCV product sales continue to drag.
1",,,,1,[],https://twitter.com/cberrl/status/834610620314050560
914,Jonathan Rockoff,@jonathanrockoff,2017-02-23T22:36:59.000Z,$MRK takes $2.9bn charge before taxes for hepatitis C drug candidate uprifosbuvir acquired w/ Idenix https://goo.gl/b8YDGe,"$MRK takes $2.9bn charge before taxes for hepatitis C drug candidate uprifosbuvir acquired w/ Idenix https://goo.gl/b8YDGe
1
2",,,1,2,['https://pbs.twimg.com/media/C5YkQAjXEAAg9Rr?format=jpg&name=900x900'],https://twitter.com/jonathanrockoff/status/834894853410553856
915,Alex,@pablodesaavedra,2017-02-22T02:52:15.000Z,$ONCS $MRK $INO  Immunopulse combination based immunotherapy #DNAvaccine http://abstracts.asco.org/194/AbstView_194_178747.html‚Ä¶,"$ONCS $MRK $INO  Immunopulse combination based immunotherapy #DNAvaccine http://abstracts.asco.org/194/AbstView_194_178747.html‚Ä¶
1
2",,1,,2,['https://pbs.twimg.com/media/C5PLr4cWIAAlcI4?format=jpg&name=small'],https://twitter.com/pablodesaavedra/status/834234318289563648
916,Streetinsider.com,@Street_Insider,2017-02-23T22:22:12.000Z,Merck $MRK to Take $2.9B Pre-Tax Impairment Charge on HCV Drug,"Merck $MRK to Take $2.9B Pre-Tax Impairment Charge on HCV Drug
streetinsider.com
Merck (MRK) to Take $2.9B Pre-Tax Impairment Charge on HCV Drug
Merck (NYSE: MRK) determined that it will record an intangible asset impairment charge related to the research program for MK-3682, uprifosbuvir, a nucleotide prodrug in clinical development that...
1
3",,,1,3,[],https://twitter.com/Street_Insider/status/834891135021637632
917,Barron's,@barronsonline,2017-02-22T19:13:38.000Z,"Biotech: What's Next For Gilead, Glaxo, and Merck HIV Treatments http://on.barrons.com/2l8Z5Nd $GILD $GSK $MRK","Biotech: What's Next For Gilead, Glaxo, and Merck HIV Treatments http://on.barrons.com/2l8Z5Nd $GILD $GSK $MRK
1
3",,,1,3,['https://pbs.twimg.com/media/C5SsT0nWEAEpdAO?format=jpg&name=small'],https://twitter.com/barronsonline/status/834481289755500546
918,Donna Young,@DonnaYoungDC,2017-02-23T20:31:45.000Z,"Q: Why Ivanka at CEO mtg?
Spicer: Her role is to be helpful/provide input on variety of areas she has deep passion/concerns about
$MRK $JNJ","Q: Why Ivanka at CEO mtg?
Spicer: Her role is to be helpful/provide input on variety of areas she has deep passion/concerns about
$MRK $JNJ
2",üì∞,,2,,[],https://twitter.com/DonnaYoungDC/status/834863338194616320
919,Siti van der Meij,@sitivandermeij,2017-02-23T17:08:04.000Z,OncoSec's ImmunoPulse shows treatment effect in mid-stage melanoma study; shares ahead 3% http://seekingalpha.com/news/3245921-oncosecs-immunopulse-shows-treatment-effect-mid-stage-melanoma-study-shares-ahead-3-percent?source=feed_f‚Ä¶ $ONCS $MRK #sitifatimah ‚Ä¶,"OncoSec's ImmunoPulse shows treatment effect in mid-stage melanoma study; shares ahead 3% http://seekingalpha.com/news/3245921-oncosecs-immunopulse-shows-treatment-effect-mid-stage-melanoma-study-shares-ahead-3-percent?source=feed_f‚Ä¶ $ONCS $MRK #sitifatimah ‚Ä¶
seekingalpha.com
OncoSec's ImmunoPulse shows treatment effect in mid-stage melanoma study; shares ahead 3% (NASDAQ...
Thinly traded nano cap OncoSec Medical (ONCS +3.3%) perks up on a 4x surge in volume in response to its announcement of positive results in a Phase 2 open-label study assessing the...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/834812081069228032
920,newyorkcityvine,@newyorkcityvine,2017-02-23T18:52:24.000Z,Is Pfizer's Research Pipeline Truly Undervalued? http://seekingalpha.com/article/4048823-pfizers-research-pipeline-truly-undervalued?source=tweet‚Ä¶ $AZN $BMY $MRK $PFE,"Is Pfizer's Research Pipeline Truly Undervalued? http://seekingalpha.com/article/4048823-pfizers-research-pipeline-truly-undervalued?source=tweet‚Ä¶ $AZN $BMY $MRK $PFE
seekingalpha.com
Is Pfizer's Research Pipeline Truly Undervalued? (NYSE:PFE)
Avelumab will be the backbone therapy in Pfizer‚Äôs immuno-oncology combination regimens. Pfizer has one of the strongest JAK franchises in the pharmaceutical industry.",,,,,[],https://twitter.com/newyorkcityvine/status/834838337064153088
921,Donna Young,@DonnaYoungDC,2017-02-23T20:05:16.000Z,"Spicer says $DOW CEO said Trump admin the most-pro business admin since the Founding Fathers 
$MRK $JNJ #pharma #jobs #manufacturing","Spicer says $DOW CEO said Trump admin the most-pro business admin since the Founding Fathers 
$MRK $JNJ #pharma #jobs #manufacturing
1",üì∞,,,1,[],https://twitter.com/DonnaYoungDC/status/834856673281970178
922,Breaking News,@MarketCurrents,2017-02-23T22:37:12.000Z,Merck to take $2.9B charge related to uprifosbuvir http://seekingalpha.com/news/3246184-merck-take-2_9b-charge-related-uprifosbuvir?source=feed_f‚Ä¶ $MRK,"Merck to take $2.9B charge related to uprifosbuvir http://seekingalpha.com/news/3246184-merck-take-2_9b-charge-related-uprifosbuvir?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Merck to take $2.9B charge related to uprifosbuvir (NYSE:MRK)
The company's best estimate of the asset value of uprifosbuvir is $240M, meaning a pretax charge of $2.9B ($1.9B after-tax) for 2016 results.Previously reported GAAP EPS for Q4 of...",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/834894907764461568
923,Seeking Alpha,@SeekingAlpha,2017-02-22T13:51:45.000Z,Gilead's M&A Growth Strategies Becoming Increasingly Limited http://seekingalpha.com/article/4048212-gileads-m-growth-strategies-becoming-increasingly-limited?source=feed_f‚Ä¶ $ABBV $BMY $IBB $JNJ $MRK $VRTX $GILD,"Gilead's M&A Growth Strategies Becoming Increasingly Limited http://seekingalpha.com/article/4048212-gileads-m-growth-strategies-becoming-increasingly-limited?source=feed_f‚Ä¶ $ABBV $BMY $IBB $JNJ $MRK $VRTX $GILD
seekingalpha.com
Gilead's M&A Growth Strategies Becoming Increasingly Limited (NASDAQ:GILD)
The decline in Gilead‚Äôs total product sales persists with no end in sight, as HCV product sales continue to drag.
1",,,1,,['https://pbs.twimg.com/card_img/1501741899840897026/Cx7atBnU?format=jpg&name=240x240'],https://twitter.com/SeekingAlpha/status/834400287817400322
924,John M. Spallanzani,@JohnSpall247,2017-02-23T17:26:31.000Z,"LIVERIS: MOST PRO BUSINESS #PRESIDENCY SINCE THE FOUNDING FATHERS $DOW 
@realDonaldTrump
 #CEOSurvey #WhiteHouse 
@seanspicer
 $MRK $F $LMT $SPY","LIVERIS: MOST PRO BUSINESS #PRESIDENCY SINCE THE FOUNDING FATHERS $DOW 
@realDonaldTrump
 #CEOSurvey #WhiteHouse 
@seanspicer
 $MRK $F $LMT $SPY
1",,,,1,[],https://twitter.com/JohnSpall247/status/834816724709040128
925,Peter Loftus,@Loftus,2017-02-23T22:59:41.000Z,Merck $MRK cites changing pricing expectations for devaluation of HepC drug (acquired via $3.9B Idenix deal in '14): https://sec.gov/Archives/edgar/data/310158/000162828017001659/a8-k2017_2x23item206xmater.htm‚Ä¶,"Merck $MRK cites changing pricing expectations for devaluation of HepC drug (acquired via $3.9B Idenix deal in '14): https://sec.gov/Archives/edgar/data/310158/000162828017001659/a8-k2017_2x23item206xmater.htm‚Ä¶
3
3",,,3,3,[],https://twitter.com/Loftus/status/834900567180853252
926,Pharmaceutical News,@pharma_sector,2017-02-22T16:54:53.000Z,"#Merck Pharma giant MSD's plant in Swords, Dublin,  for over ‚Ç¨25m. Read more: http://owler.us/acg5Qc $MRK","#Merck Pharma giant MSD's plant in Swords, Dublin,  for over ‚Ç¨25m. Read more: http://owler.us/acg5Qc $MRK",,,,,[],https://twitter.com/pharma_sector/status/834446375584534528
927,Market Call,@marketcall,2017-02-22T23:30:02.000Z,"Past Picks fr Harvest's Paul MacDonald returned +17.03%:
UnitedHealth +17.44%
Amgen +17.47%
Merck & Co +16.19%
$UNH $AMGN $MRK","Past Picks fr Harvest's Paul MacDonald returned +17.03%:
UnitedHealth +17.44%
Amgen +17.47%
Merck & Co +16.19%
$UNH $AMGN $MRK
1
2",,1,,2,[],https://twitter.com/marketcall/status/834545817478320129
928,Pharmaceutical News,@pharma_sector,2017-02-23T12:08:30.000Z,"#Merck & Company, Inc. Stake Reduced by Psagot Investment House Ltd. Read more: http://owler.us/achmpB $MRK","#Merck & Company, Inc. Stake Reduced by Psagot Investment House Ltd. Read more: http://owler.us/achmpB $MRK",,,,,[],https://twitter.com/pharma_sector/status/834736690497359872
929,FancyFinancy,@FancyFinancy,2017-02-22T16:11:01.000Z,"Bristol-Myers Squibb Co., Merck & Co., Inc., And Other Pharmaceutical Firms All Targeting I-O Segment http://buff.ly/2lsWoHj $BMY $MRK","Bristol-Myers Squibb Co., Merck & Co., Inc., And Other Pharmaceutical Firms All Targeting I-O Segment http://buff.ly/2lsWoHj $BMY $MRK",,,,,['https://pbs.twimg.com/media/C5SCg9BVMAEn99_?format=jpg&name=small'],https://twitter.com/FancyFinancy/status/834435336054902784
930,BioPharma Dive,@BioPharmaDive,2017-02-23T21:28:01.000Z,"$PFE, $CELG, $LLY and $MRK heads push for tax reform","$PFE, $CELG, $LLY and $MRK heads push for tax reform
biopharmadive.com
Pharma CEOs sign on to letter urging tax reform
Changes to the tax code, such as a move towards territorial taxation or border adjustment, could push drug manufacturers to move production back to the U.S. 
1
2",,1,,2,['https://pbs.twimg.com/card_img/1501741477751308291/99qwuEwq?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/834877498726961154
931,FiercePharma,@FiercePharma,2017-02-22T16:48:02.000Z,"Pfizer, Merck, Lilly execs urge tax code revamp in letter to Congress http://fiercepharma.com/pharma/pfizer-merck-lilly-execs-urge-tax-code-revamp-letter-to-congress‚Ä¶ $MRK $PFE $LLY","Pfizer, Merck, Lilly execs urge tax code revamp in letter to Congress http://fiercepharma.com/pharma/pfizer-merck-lilly-execs-urge-tax-code-revamp-letter-to-congress‚Ä¶ $MRK $PFE $LLY
fiercepharma.com
Pfizer, Merck, Lilly execs urge tax code revamp in letter to Congress
Pharma‚Äôs top U.S. execs haven‚Äôt been shy about expressing their desire for tax reform‚Äîand now, they‚Äôre taking those wishes directly to Congress. | Pharma‚Äôs top U.S. execs haven‚Äôt been shy about...
6
2",,,6,2,['https://pbs.twimg.com/card_img/1500324246924701696/zG2zn_dA?format=jpg&name=small'],https://twitter.com/FiercePharma/status/834444648521293825
932,zach,@zbiotech,2017-02-23T22:21:11.000Z,"$MRK uprifosbuvir charge due to...'recent changes to the prod profile, as well as changes to its expectations for pricing and the mkt opp'","$MRK uprifosbuvir charge due to...'recent changes to the prod profile, as well as changes to its expectations for pricing and the mkt opp'
1
1",,,1,1,[],https://twitter.com/zbiotech/status/834890876036001793
933,MarketBeat,@MarketBeatCom,2017-02-23T05:10:12.000Z,Merck & Company upgraded by Vetr Inc. to hold. $63.44 PT. http://ift.tt/2lrVTim $MRK #MRK,Merck & Company upgraded by Vetr Inc. to hold. $63.44 PT. http://ift.tt/2lrVTim $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/834631422837141504
934,Insider Monkey,@insidermonkey,2017-02-23T19:32:37.000Z,"Why President Trump Wants To Transform The FDA - And What...
$MRK $NVS $JNJ $AMGN $CELG $VCEL $SGYP $HEB $LLY $AMRN","Why President Trump Wants To Transform The FDA - And What...
$MRK $NVS $JNJ $AMGN $CELG $VCEL $SGYP $HEB $LLY $AMRN
insidermonkey.com
Why President Trump Wants To Transform The FDA ‚Äì And What It Could Mean For Biotech Stocks
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process ""at a level no one has...
1",,,1,,['https://pbs.twimg.com/card_img/1501266736678592512/8Pl8aSrs?format=jpg&name=240x240'],https://twitter.com/insidermonkey/status/834848458825691138
935,marketexclusive,@marketexclusive,2017-02-23T14:53:32.000Z,Trials Of Agenus Inc (NASDAQ:AGEN) Cancer Vaccine Ends In Absolute Failure https://marketexclusive.com/trials-agenus-inc-nasdaqagen-cancer-vaccine-ends-absolute-failure/74687/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶  $AGEN  $INCY  $MRK,"Trials Of Agenus Inc (NASDAQ:AGEN) Cancer Vaccine Ends In Absolute Failure https://marketexclusive.com/trials-agenus-inc-nasdaqagen-cancer-vaccine-ends-absolute-failure/74687/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶  $AGEN  $INCY  $MRK
3",,,3,,[],https://twitter.com/marketexclusive/status/834778225150603265
936,Watchlist News,@WatchlistN,2017-02-22T13:54:26.000Z,"Asset Planning Services Ltd. Has $6,897,000 Stake in Merck & Company, Inc. $MRK http://zpr.io/PAFFw","Asset Planning Services Ltd. Has $6,897,000 Stake in Merck & Company, Inc. $MRK http://zpr.io/PAFFw",,,,,[],https://twitter.com/WatchlistN/status/834400963981086721
937,Ticker Report,@TickerReport,2017-02-23T10:32:19.000Z,"Blackhill Capital Inc. Holds Position in Merck & Company, Inc. $MRK http://ift.tt/2lbVuxE","Blackhill Capital Inc. Holds Position in Merck & Company, Inc. $MRK http://ift.tt/2lbVuxE",,,,,[],https://twitter.com/TickerReport/status/834712485366267904
938,Roy Friedman,@DewDiligence,2017-02-23T23:55:33.000Z,Marketplace irrelevance of $MRK's Idenix nuke (MK-3682) was no secret‚Äîsee bottom of: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126517784‚Ä¶  (1/2),"Marketplace irrelevance of $MRK's Idenix nuke (MK-3682) was no secret‚Äîsee bottom of: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126517784‚Ä¶  (1/2)
investorshub.advfn.com
Biotech Values Post # 206005
1",,1,,,[],https://twitter.com/DewDiligence/status/834914624122277888
939,Watchlist News,@WatchlistN,2017-02-22T10:14:41.000Z,"Massey Quick & Co. LLC Acquires Shares of 7,235 Merck & Company, Inc. $MRK http://zpr.io/PA3T8","Massey Quick & Co. LLC Acquires Shares of 7,235 Merck & Company, Inc. $MRK http://zpr.io/PA3T8",,,,,[],https://twitter.com/WatchlistN/status/834345658513514496
940,Market Call,@marketcall,2017-02-23T00:01:01.000Z,"Top Picks from Harvest's Paul MacDonald: Merck & Co, Anthem & Celgene
$MRK $ANTM $CELG","Top Picks from Harvest's Paul MacDonald: Merck & Co, Anthem & Celgene
$MRK $ANTM $CELG
1",,,,1,[],https://twitter.com/marketcall/status/834553611984068608
941,Daily Political,@dailypoliticaln,2017-02-23T10:30:27.000Z,"33,232 Shares in Merck & Company, Inc. $MRK Acquired by Benson Investment Management Company Inc. http://ift.tt/2lbSLUU","33,232 Shares in Merck & Company, Inc. $MRK Acquired by Benson Investment Management Company Inc. http://ift.tt/2lbSLUU",,,,,[],https://twitter.com/dailypoliticaln/status/834712016292032513
942,Bruce Berger,@bergerb2,2017-02-22T22:29:11.000Z,"Should Merck, BMS Fear Roche's Drug Becoming The I-O King? http://seekingalpha.com/article/4048480-merck-bms-fear-roches-drug-becoming-o-king?source=tweet‚Ä¶ $AZN $BMY $JNJ $MRK $PFE $SNY $RHHBY","Should Merck, BMS Fear Roche's Drug Becoming The I-O King? http://seekingalpha.com/article/4048480-merck-bms-fear-roches-drug-becoming-o-king?source=tweet‚Ä¶ $AZN $BMY $JNJ $MRK $PFE $SNY $RHHBY",,,,,[],https://twitter.com/bergerb2/status/834530501906067457
943,Allison Gatlin,@IBD_AGatlin,2017-02-22T19:00:55.000Z,"Gilead, GSK pitted in HIV battle; both struggle vs. standard drugs $GILD $GSK $MRK","Gilead, GSK pitted in HIV battle; both struggle vs. standard drugs $GILD $GSK $MRK
investors.com
Gilead, GSK Pitted In HIV Battle; Both Struggle Vs. Standard Drugs | Stock News & Stock Market...
Gilead and GSK will have a tough time divorcing HIV patients from their traditional three-pill regimens, Leerink said Wednesday,",,,,,['https://pbs.twimg.com/card_img/1501741936989900805/6jg_3C5o?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/834478092089491456
944,John Carroll,@JohnCendpts,2017-02-23T22:47:21.000Z,"With hep C franchises languishing, Merck‚Äôs MK-3682 goes from blockbuster to bomb
$MRK","With hep C franchises languishing, Merck‚Äôs MK-3682 goes from blockbuster to bomb
$MRK
endpts.com
With hep C franchises languishing, Merck‚Äôs MK-3682 goes from blockbuster to bomb
A little less than three years after acquiring the hepatitis C drug MK-3682 (uprifosbuvir) in its $3.85 billion buyout of Idenix, Merck‚Äôs prospects in the field have cooled dramatically, and its once...
1
2",,,1,2,['https://pbs.twimg.com/card_img/1501741385011060737/zbnmjYSX?format=png&name=small'],https://twitter.com/JohnCendpts/status/834897464465448960
945,dough,@semodough,2017-02-22T14:46:01.000Z,MS believes investors under-appreciate  $MRK opportunity to demonstrate proof concept in 2H:17 for a vaccine that would compete $PFE Prevnar,"MS believes investors under-appreciate  $MRK opportunity to demonstrate proof concept in 2H:17 for a vaccine that would compete $PFE Prevnar
1",,1,,,[],https://twitter.com/semodough/status/834413942751580160
946,Allison Gatlin,@IBD_AGatlin,2017-02-23T18:58:44.000Z,"Merck, Roche gouge Bristol's I-O share after lung cancer approvals $MRK $RHHBY $BMY http://ow.ly/aYiZ309iouU","Merck, Roche gouge Bristol's I-O share after lung cancer approvals $MRK $RHHBY $BMY http://ow.ly/aYiZ309iouU",,,,,[],https://twitter.com/IBD_AGatlin/status/834839930174107649
947,Insider Monkey,@insidermonkey,2017-02-21T19:23:01.000Z,"$BMY, $MRK, And Other Pharmaceutical Firms All Targeting I-O Segment","$BMY, $MRK, And Other Pharmaceutical Firms All Targeting I-O Segment
insidermonkey.com
Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK), And Other Pharmaceutical Firms All Target...
Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years. Pharmaceutical firms such as Bristol-Myers Squibb Co (NYSE:BMY) and Merck & Co., Inc.",,,,,['https://pbs.twimg.com/card_img/1501981830110535683/vAk0jEwD?format=jpg&name=240x240'],https://twitter.com/insidermonkey/status/834121267259256833
948,Zack Capp,@zackcapp,2017-02-23T12:58:05.000Z,"Bristol-Myers Squibb Co., Merck & Co., Inc., And Other Pharmaceutical Firms All Targeting I-O Segment http://buff.ly/2lsPd1F $BMY $MRK","Bristol-Myers Squibb Co., Merck & Co., Inc., And Other Pharmaceutical Firms All Targeting I-O Segment http://buff.ly/2lsPd1F $BMY $MRK",,,,,['https://pbs.twimg.com/media/C5Wf8ZyUYAAOUT1?format=jpg&name=small'],https://twitter.com/zackcapp/status/834749168371564545
949,MarketBeat,@MarketBeatCom,2017-02-23T05:59:28.000Z,"Vetr Inc. Upgrades Merck & Company, Inc. $MRK to ‚ÄúHold‚Äù http://ift.tt/2ma07g2 #acn","Vetr Inc. Upgrades Merck & Company, Inc. $MRK to ‚ÄúHold‚Äù http://ift.tt/2ma07g2 #acn",,,,,[],https://twitter.com/MarketBeatCom/status/834643819165540352
950,Allison Gatlin,@IBD_AGatlin,2017-02-21T22:18:49.000Z,Carl Icahn reportedly invests in potential takeout target Bristol-Myers $BMY $MRK $INCY $RHHBY $AZN $PYPL $XRX http://ow.ly/TVia309eeyk,Carl Icahn reportedly invests in potential takeout target Bristol-Myers $BMY $MRK $INCY $RHHBY $AZN $PYPL $XRX http://ow.ly/TVia309eeyk,,,,,[],https://twitter.com/IBD_AGatlin/status/834165507276304384
951,By Any Memes Necessary,@_21stCenturyCox,2017-02-21T19:00:39.000Z,"Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In... https://benzinga.com/z/8962220 $BIIB $NTRP $MRK  via 
@benzinga","Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In... https://benzinga.com/z/8962220 $BIIB $NTRP $MRK  via 
@benzinga
benzinga.com
Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors...
Alzheimer's has proven to be one of the most stubborn diseases known to modern medicine. An incurable, devastating illness that inspires frustration ‚Äî even anger...",,,,,[],https://twitter.com/_21stCenturyCox/status/834115636989140993
952,Contix Alerts,@contixalerts,2017-02-23T23:00:09.000Z,"Merck $MRK cites changing pricing expectations for devaluation of HepC drug (acquired via $3.9B Idenix de 
@Loftus
 https://app.contix.com/Free-Trial/35788086‚Ä¶","Merck $MRK cites changing pricing expectations for devaluation of HepC drug (acquired via $3.9B Idenix de 
@Loftus
 https://app.contix.com/Free-Trial/35788086‚Ä¶",,,,,[],https://twitter.com/contixalerts/status/834900685795667969
953,JQ,@jq1234t,2017-02-23T03:52:41.000Z,"Replying to 
@AndyBiotech","Replying to 
@AndyBiotech
ROCHE PD-L1 ASSAY NOT CONCORDANT WITH OTHERS $AZN $BMY $MRK
biocentury.com
Roche PD-L1 assay not concordant with others
3",,,,3,[],https://twitter.com/jq1234t/status/834611915934543873
954,Bruno J. Navarro,@Bruno_J_Navarro,2017-02-21T20:54:59.000Z,Just 16 CEOs Embrace Border Tax http://bit.ly/2m58nOi $GE $BA $CAT $DOW $RTN $UTX $ORCL $CELG $LLY $MRK $PFE,"Just 16 CEOs Embrace Border Tax http://bit.ly/2m58nOi $GE $BA $CAT $DOW $RTN $UTX $ORCL $CELG $LLY $MRK $PFE
investors.com
Just 16 CEOs Embrace Border Tax In Letter That Shows Why It's In Trouble | Stock News & Stock...
Boeing and GE are among 16 big exporters to back House GOP corporate tax reform, but overall corporate support appears weak.
1",üåª,,,1,['https://pbs.twimg.com/card_img/1501274243828436995/mHcQIKQ5?format=jpg&name=small'],https://twitter.com/Bruno_J_Navarro/status/834144411437113351
955,Benzinga,@Benzinga,2017-02-22T12:22:01.000Z,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer? https://benzinga.com/z/9076742 $BMY $GILD $MRK $AMGN $SNY $PFE,"Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer? https://benzinga.com/z/9076742 $BMY $GILD $MRK $AMGN $SNY $PFE
benzinga.com
Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?
Bristol-Myers Squibb Co (NYSE: BMY) shares spiked 4.5 percent Tuesday on news that Carl Icahn bought a stake in the company. According to the Wall Street Journal, Icahn allegedly...
1",,,,1,[],https://twitter.com/Benzinga/status/834377704677974016
956,Benzinga,@Benzinga,2017-02-23T19:45:00.000Z,Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market' https://benzinga.com/z/9087784 $BIIB $MRK $TEVA $SNY,"Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market' https://benzinga.com/z/9087784 $BIIB $MRK $TEVA $SNY
benzinga.com
Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market'
Offering its insight into the formulary coverage of multiple sclerosis drugs for 2017, Bernstein said in a note released on Thursday it sees stabilization of formulary coverage...",,,,,[],https://twitter.com/Benzinga/status/834851575218581504
957,Greg Milin,@7wtc,2017-02-23T22:46:01.000Z,"Replying to 
@FilmProfessor9
, 
@yusschr
 and 
@NotaBubble","Replying to 
@FilmProfessor9
, 
@yusschr
 and 
@NotaBubble
Still like $MRK. Watching & adding here. Always sell $TSLA up here & wait for dip. Out of gas ? No $CRM
1",,,,1,[],https://twitter.com/7wtc/status/834897128434647040
958,Damian Garde,@damiangarde,2017-02-22T20:42:08.000Z,"Replying to 
@adamfeuerstein","Replying to 
@adamfeuerstein
oh well in that case no. new here is increased focus in light of $MRK, analyst risk-reward stuff, and Vivek talking price",,,,,[],https://twitter.com/damiangarde/status/834503564269608960
959,Insider Monkey News,@insidermonkey_n,2017-02-21T19:22:47.000Z,"$BMY, $MRK, And Other Pharmaceutical Firms All Targeting I-O Segment","$BMY, $MRK, And Other Pharmaceutical Firms All Targeting I-O Segment
insidermonkey.com
Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK), And Other Pharmaceutical Firms All Target...
Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years. Pharmaceutical firms such as Bristol-Myers Squibb Co (NYSE:BMY) and Merck & Co., Inc.",,,,,['https://pbs.twimg.com/card_img/1501981830110535683/vAk0jEwD?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/834121207922491394
960,Bio Stocks‚Ñ¢,@BioStocks,2017-02-26T16:54:28.000Z,The biosimilar party is getting way too crowded https://bloomberg.com/gadfly/articles/2017-02-24/allergan-biosimilar-pullback-won-t-be-the-last‚Ä¶ $MRK $NVS $BIIB $AGN #pharma,"The biosimilar party is getting way too crowded https://bloomberg.com/gadfly/articles/2017-02-24/allergan-biosimilar-pullback-won-t-be-the-last‚Ä¶ $MRK $NVS $BIIB $AGN #pharma
bloomberg.com
Allergan's Biosimilar Pullback Won't Be the Last
The market just can't support the crowd of current entrants.
4
3",,,4,3,['https://pbs.twimg.com/card_img/1500829713555673089/pQhlbIXa?format=jpg&name=small'],https://twitter.com/BioStocks/status/835895820667011073
961,Joe Kunkle,@OptionsHawk,2017-02-24T01:37:37.000Z,Lots of large cap new highs $JPM $JNJ $BA $MRK $V $MA $PM $BRK.B $MMM,"Lots of large cap new highs $JPM $JNJ $BA $MRK $V $MA $PM $BRK.B $MMM
1
4
11",,1,4,11,[],https://twitter.com/OptionsHawk/status/834940311784808448
962,Bio Stocks‚Ñ¢,@BioStocks,2017-02-24T13:41:14.000Z,"Carl Icahn Can't Make $BMY Buyable 
https://bloomberg.com/gadfly/articles/2017-02-22/carl-icahn-can-t-make-bristol-myers-squibb-buyable‚Ä¶ $MRK","Carl Icahn Can't Make $BMY Buyable 
https://bloomberg.com/gadfly/articles/2017-02-22/carl-icahn-can-t-make-bristol-myers-squibb-buyable‚Ä¶ $MRK
bloomberg.com
Carl Icahn Can't Make Bristol-Myers Buyable
Its uncertain cancer-drug prospects and high market cap make it unattractive.
2",,,2,,['https://pbs.twimg.com/card_img/1500829713555673089/pQhlbIXa?format=jpg&name=small'],https://twitter.com/BioStocks/status/835122414929522688
963,Seeking Alpha,@SeekingAlpha,2017-02-24T14:42:07.000Z,"Synergy: 3 Scenarios, 1 Choice http://seekingalpha.com/article/4049349-synergy-3-scenarios-1-choice?source=feed_f‚Ä¶ $AGN $BMY $CELG $GILD $GOOG $IBM $IRWD $JNJ $JUNO $MACK $MRK $NVO $NWL $PFE $RHHBF","Synergy: 3 Scenarios, 1 Choice http://seekingalpha.com/article/4049349-synergy-3-scenarios-1-choice?source=feed_f‚Ä¶ $AGN $BMY $CELG $GILD $GOOG $IBM $IRWD $JNJ $JUNO $MACK $MRK $NVO $NWL $PFE $RHHBF
seekingalpha.com
Synergy: 3 Scenarios, 1 Choice (NASDAQ:SGYP-OLD)
Synergy has a recently FDA approved product (Trulance) to be used by patients with chronic idiopathic constipation (CIC).
2",,,,2,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/835137738219249668
964,pharmagossip,@pharmagossip,2017-02-24T18:57:58.000Z,"Merck takes $2.9b charge on dampened outlook for hepatitis drug $MRK https://thestreet.com/story/14015558/1/merck-takes-2-9b-charge-on-dampened-outlook-for-hepatitis-drug.html‚Ä¶ via 
@TheStreet","Merck takes $2.9b charge on dampened outlook for hepatitis drug $MRK https://thestreet.com/story/14015558/1/merck-takes-2-9b-charge-on-dampened-outlook-for-hepatitis-drug.html‚Ä¶ via 
@TheStreet
thestreet.com
Merck takes $2.9B charge on dampened outlook for hepatitis drug
In a regulatory filing, Merck said it had determined on Feb. 17 that it will book an impairment charge in connection with the research program for MK-3682.
2
3",,,2,3,['https://pbs.twimg.com/card_img/1501741390652448769/XVHnO6mm?format=jpg&name=small'],https://twitter.com/pharmagossip/status/835202126234206208
965,MM+M Magazine,@MMMnews,2017-02-25T04:15:01.000Z,"5 things for #pharma #marketers to know: Fri, Feb 24 #PBM $MRK #FDA #EMA $NVS $ROG #opioids #Trump #drugprices #hcsm http://bit.ly/2lRPcHl","5 things for #pharma #marketers to know: Fri, Feb 24 #PBM $MRK #FDA #EMA $NVS $ROG #opioids #Trump #drugprices #hcsm http://bit.ly/2lRPcHl
1",,,,1,['https://pbs.twimg.com/media/C5ceDEpWMAE9hMF?format=jpg&name=small'],https://twitter.com/MMMnews/status/835342309101342720
966,FlowerPower,@Flower_Power_67,2017-02-24T18:16:35.000Z,"#FastMoneyEspresso
FINAL CALLS:
SLink‚Ä¶buy $LLY
JLebenthal‚Ä¶buy $BMY $MRK $PFE
Dr J‚Ä¶buy $LB
PNajarian‚Ä¶buy $GS
Kate Moore‚Ä¶buy emerging markets","#FastMoneyEspresso
FINAL CALLS:
SLink‚Ä¶buy $LLY
JLebenthal‚Ä¶buy $BMY $MRK $PFE
Dr J‚Ä¶buy $LB
PNajarian‚Ä¶buy $GS
Kate Moore‚Ä¶buy emerging markets",,,,,"['https://pbs.twimg.com/media/C5cyXjJUwAAZrJR?format=jpg&name=360x360', 'https://pbs.twimg.com/media/C5cyXjPUwAEGOHI?format=jpg&name=360x360', 'https://pbs.twimg.com/media/C5cyXjbUwAARpXH?format=jpg&name=360x360', 'https://pbs.twimg.com/media/C5cyXjfU4AA4xe3?format=jpg&name=360x360']",https://twitter.com/Flower_Power_67/status/835191709000695808
967,Odi Bruckman,@odibro,2017-02-26T18:40:11.000Z,"$MRK Letermovir, for Prevention of CMV Infection in BMT pats. met its primary efficacy endpoint in pivotal P3 Study http://mercknewsroom.com/news-release/research-and-development-news/mercks-letermovir-investigational-antiviral-medicine-prev‚Ä¶","$MRK Letermovir, for Prevention of CMV Infection in BMT pats. met its primary efficacy endpoint in pivotal P3 Study http://mercknewsroom.com/news-release/research-and-development-news/mercks-letermovir-investigational-antiviral-medicine-prev‚Ä¶
5
2",,,5,2,[],https://twitter.com/odibro/status/835922426496225281
968,George Marcovits,@GemsBot,2017-02-25T11:37:59.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/75609712#75609721‚Ä¶,"Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/75609712#75609721‚Ä¶
1",,,,1,['https://pbs.twimg.com/media/C5ggytfU8AUFnWc?format=jpg&name=small'],https://twitter.com/GemsBot/status/835453788374839296
969,MarketSmith,@MarketSmith,2017-02-24T17:22:13.000Z,"Gilead, AbbVie Could Perk Up On Merck's Hep C Downfall: Leerink http://ow.ly/5otd309ksrF $GILD $ABBV $MRK $JNJ $BMY","Gilead, AbbVie Could Perk Up On Merck's Hep C Downfall: Leerink http://ow.ly/5otd309ksrF $GILD $ABBV $MRK $JNJ $BMY
1",,,,1,['https://pbs.twimg.com/media/C5cl_W5WUAAqI1p?format=jpg&name=small'],https://twitter.com/MarketSmith/status/835178029601157121
970,John Carroll,@JohnCendpts,2017-02-26T18:43:40.000Z,"$MRK put out the letermovir PR today, but the news came out at the end of the week.","$MRK put out the letermovir PR today, but the news came out at the end of the week.
endpts.com
Merck tees up US/European applications for letermovir after detailing PhIII antiviral success
Merck has unveiled the positive data behind its Phase III win for its antiviral letermovir. While it‚Äôs no panacea, the drug clearly outperformed a placebo in chopping down on the number of CMV...
1
2",,,1,2,['https://pbs.twimg.com/card_img/1501741398248329222/rIX2KNlb?format=png&name=small'],https://twitter.com/JohnCendpts/status/835923300190670848
971,Donna Young,@DonnaYoungDC,2017-02-24T19:53:22.000Z,"Trump & WH pool said $MRK Frazier at EO signing today, but I didn't see him on camera so asked; $MRK spox said as far as she knows he wasn't","Trump & WH pool said $MRK Frazier at EO signing today, but I didn't see him on camera so asked; $MRK spox said as far as she knows he wasn't
Donna Young
@DonnaYoungDC
 ¬∑ 25 Feb 2017
$MRK Ken Frazier & $JNJ Alex Gorsky made another appearance at @WhiteHouse today; this time for Trump's regs reform task force EO signing
2",üì∞ üì∞,,2,,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/835216067484073985
972,John Carroll,@JohnCendpts,2017-02-24T22:25:24.000Z,"No. 2:
With hep C franchises languishing, Merck‚Äôs MK-3682 goes from blockbuster to bomb
$MRK","No. 2:
With hep C franchises languishing, Merck‚Äôs MK-3682 goes from blockbuster to bomb
$MRK
endpts.com
With hep C franchises languishing, Merck‚Äôs MK-3682 goes from blockbuster to bomb
A little less than three years after acquiring the hepatitis C drug MK-3682 (uprifosbuvir) in its $3.85 billion buyout of Idenix, Merck‚Äôs prospects in the field have cooled dramatically, and its once...
3
1",,,3,1,['https://pbs.twimg.com/card_img/1501741385011060737/zbnmjYSX?format=png&name=small'],https://twitter.com/JohnCendpts/status/835254327770038272
973,ChartMill,@ChartMill,2017-02-25T19:49:37.000Z,$MRK is breaking out! Here's some analysis http://stockcharts.chartmill.com/u/SkxWxgDkcg #NGOT #GrowthHacking,$MRK is breaking out! Here's some analysis http://stockcharts.chartmill.com/u/SkxWxgDkcg #NGOT #GrowthHacking,,,,,[],https://twitter.com/ChartMill/status/835577509177622528
974,FiercePharma,@FiercePharma,2017-02-24T15:41:33.000Z,Merck swallows $2.9B write-down of experimental hep C drug as market plummets http://fiercepharma.com/pharma/merck-swallows-1-9b-writedown-experimental-hep-c-drug-as-market-plummets‚Ä¶ $MRK #pharma,"Merck swallows $2.9B write-down of experimental hep C drug as market plummets http://fiercepharma.com/pharma/merck-swallows-1-9b-writedown-experimental-hep-c-drug-as-market-plummets‚Ä¶ $MRK #pharma
fiercepharma.com
Merck swallows $2.9B write-down of experimental hep C drug as market plummets
Just how drastically is the market for hepatitis C drugs shrinking? | Just how drastically is the market for hepatitis C drugs shrinking? The situation is so bad that less than three years after...
1
2
3",,1,2,3,['https://pbs.twimg.com/card_img/1499619890499629057/BxGqdJpB?format=jpg&name=small'],https://twitter.com/FiercePharma/status/835152694214070272
975,Endpoints News,@endpts,2017-02-24T14:01:01.000Z,"With #hepatitisC franchises languishing, Merck‚Äôs MK-3682 goes from blockbuster to bomb $MRK https://endpts.com/with-hep-c-franchises-languishing-mercks-mk-3682-goes-from-blockbuster-to-bomb/‚Ä¶ #biotech #biopharma","With #hepatitisC franchises languishing, Merck‚Äôs MK-3682 goes from blockbuster to bomb $MRK https://endpts.com/with-hep-c-franchises-languishing-mercks-mk-3682-goes-from-blockbuster-to-bomb/‚Ä¶ #biotech #biopharma
1",,,,1,[],https://twitter.com/endpts/status/835127393857728512
976,ChartMill,@ChartMill,2017-02-26T22:48:35.000Z,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/rkerwiAxcg #Rolex #cxo,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/rkerwiAxcg #Rolex #cxo,,,,,[],https://twitter.com/ChartMill/status/835984938801442817
977,Pharmaceutical News,@pharma_sector,2017-02-26T23:36:35.000Z,#Merck Reports Results Of Pivotal Phase 3 Clinical Study Of Letermovir. Read more: http://owler.us/aciKx0 $MRK,#Merck Reports Results Of Pivotal Phase 3 Clinical Study Of Letermovir. Read more: http://owler.us/aciKx0 $MRK,,,,,[],https://twitter.com/pharma_sector/status/835997017931296770
978,BioWorld,@BioWorld,2017-02-24T17:17:01.000Z,"As $MRK takes $2.9B pre-tax write-down on HCV candidate, uprifosbuvir, $GILD moves to reduce record $2.54B patent infringement award","As $MRK takes $2.9B pre-tax write-down on HCV candidate, uprifosbuvir, $GILD moves to reduce record $2.54B patent infringement award",,,,,[],https://twitter.com/BioWorld/status/835176718214303745
979,Magnolia Gallery,@MagnoliaG2012,2017-02-25T20:45:44.000Z,I'm Sick And Tired Of Gilead Sciences: Part 2 http://seekingalpha.com/article/4049353-sick-tired-gilead-sciences-part-2?source=tweet‚Ä¶ $GSK $MRK $GILD,"I'm Sick And Tired Of Gilead Sciences: Part 2 http://seekingalpha.com/article/4049353-sick-tired-gilead-sciences-part-2?source=tweet‚Ä¶ $GSK $MRK $GILD
seekingalpha.com
I'm Sick And Tired Of Gilead Sciences: Part 2 (NASDAQ:GILD)
After liquidating my GILD position in December at $74.39 for tax loss purposes, I recently bought back GILD shares at $67.48.",,,,,['https://pbs.twimg.com/card_img/1501741398575435783/MmImt_Ah?format=png&name=240x240'],https://twitter.com/MagnoliaG2012/status/835591631051055104
980,FierceBiotech,@FierceBiotech,2017-02-24T14:34:18.000Z,"Delay to hep C drug program behind Merck's write-down decision, say analysts: http://ow.ly/nsGp309k2KR $MRK $GILD","Delay to hep C drug program behind Merck's write-down decision, say analysts: http://ow.ly/nsGp309k2KR $MRK $GILD
5
1",,,5,1,[],https://twitter.com/FierceBiotech/status/835135771631841280
981,Vetr,@VetrRatings,2017-02-24T09:51:03.000Z,"Vetr users have downgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $63.44 http://bit.ly/1GhW0TK","Vetr users have downgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $63.44 http://bit.ly/1GhW0TK",,,,,[],https://twitter.com/VetrRatings/status/835064488877568004
982,Stockboard Media Inc,@stockboardinc,2017-02-24T21:05:37.000Z,"$MRK In First Phase 3 Trial, Merck‚Äôs Investigational Inactivated Varicella Zoster Virus Vaccine (V212) ... - http://sbml.co/a45adf3b","$MRK In First Phase 3 Trial, Merck‚Äôs Investigational Inactivated Varicella Zoster Virus Vaccine (V212) ... - http://sbml.co/a45adf3b",,,,,[],https://twitter.com/stockboardinc/status/835234250249158658
983,Stockboard Media Inc,@stockboardinc,2017-02-26T17:35:31.000Z,"$MRK Merck‚Äôs Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) ... - http://sbml.co/5e870587","$MRK Merck‚Äôs Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) ... - http://sbml.co/5e870587",,,,,[],https://twitter.com/stockboardinc/status/835906152248528901
984,Slingshot Catalysts,@SlingshotCtlyst,2017-02-25T20:30:01.000Z,$MRK Presents Phase 3 Results Evaluating Inactivated Varicella Zoster Vaccine V212 for the Prevention of Shingles,"$MRK Presents Phase 3 Results Evaluating Inactivated Varicella Zoster Vaccine V212 for the Prevention of Shingles
slingshotinsights.com
Catalyst
Merck (MRK) Presents Phase 3 Results Evaluating Inactivated Varicella Zoster Vaccine (VZV) V212 for the Prevention of Herpes Zoster (HZ) (Shingles)",,,,,[],https://twitter.com/SlingshotCtlyst/status/835587679530057728
985,Red Acre Investments,@redacre,2017-02-24T21:05:11.000Z,2/2 Biotech/HC New or revisited 52-Week Highs:  $LNTH $MASI $MGLN $MMM $MMSI $MRK $OSUR $PTLA $SGRY $SPNC $SYK $TFX $VSAR,"2/2 Biotech/HC New or revisited 52-Week Highs:  $LNTH $MASI $MGLN $MMM $MMSI $MRK $OSUR $PTLA $SGRY $SPNC $SYK $TFX $VSAR
1",,,,1,[],https://twitter.com/redacre/status/835234138995163137
986,Donna Young,@DonnaYoungDC,2017-02-24T19:55:37.000Z,"Here's Trump today saying $MRK Ken Frazier at EO, who apparently, was not standing in the room [ $JNJ Gorsky was] https://c-span.org/video/?424518-1/president-trump-signs-executive-action-regulations‚Ä¶","Here's Trump today saying $MRK Ken Frazier at EO, who apparently, was not standing in the room [ $JNJ Gorsky was] https://c-span.org/video/?424518-1/president-trump-signs-executive-action-regulations‚Ä¶
Donna Young
@DonnaYoungDC
 ¬∑ 25 Feb 2017
Trump & WH pool said $MRK Frazier at EO signing today, but I didn't see him on camera so asked; $MRK spox said as far as she knows he wasn't https://twitter.com/DonnaYoungDC/status/835195965988446208‚Ä¶
1
1",üì∞ üì∞,,1,1,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/835216632335183874
987,FirstWord Pharma,@fwpharma,2017-02-24T09:40:10.000Z,Merck & Co. to take $2.9-billion charge related to hepatitis C drug uprifosbuvir https://firstwordpharma.com/node/1452970 $MRK,"Merck & Co. to take $2.9-billion charge related to hepatitis C drug uprifosbuvir https://firstwordpharma.com/node/1452970 $MRK
old.firstwordpharma.com
Merck & Co. to take $2.9-billion charge related to hepatitis C drug uprifosbuvir
Merck & Co. disclosed in a filing with the US Securities and Exchange Commission that it will record a pre-tax impairment charge of $2.9 billion related to its research programme for uprifosbuvir, a...
1",,,1,,['https://pbs.twimg.com/card_img/1501672348151386118/EDuK1CYL?format=jpg&name=240x240'],https://twitter.com/fwpharma/status/835061750605164545
988,StockNews.com,@stocknewsdotcom,2017-02-24T21:07:14.000Z,$MRK Announces its Phase 3 study results for V212 for the prevention of shingles in immunocompromised patients met‚Ä¶ https://stocknews.com/news/mrk-announces-its-phase-3-study-results-for-v212-for-the/‚Ä¶,$MRK Announces its Phase 3 study results for V212 for the prevention of shingles in immunocompromised patients met‚Ä¶ https://stocknews.com/news/mrk-announces-its-phase-3-study-results-for-v212-for-the/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/835234656610054144
989,Crypto Trader Pro,@CryptoTraderPro,2017-02-25T14:28:41.000Z,MRK...monthly view ...buy $MRK http://dlvr.it/NTHWJY powered by http://bit.do/TradOTO,"MRK...monthly view ...buy $MRK http://dlvr.it/NTHWJY powered by http://bit.do/TradOTO
tradingview.com
MRK...monthly view ...buy for NYSE:MRK by pardis
nice uptrend ... passing of a important price level (blue line )... triggered ....buy",,,,,[],https://twitter.com/CryptoTraderPro/status/835496746646028291
990,Hottest Stocks Now,@HottestStockNow,2017-02-24T02:13:26.000Z,"President Trump meets with top US manufacturers - $UTX, $LMT, $GE, $S, $SFTBY, $MRK, $CPB, $JNJ, $EMR, $CAT","President Trump meets with top US manufacturers - $UTX, $LMT, $GE, $S, $SFTBY, $MRK, $CPB, $JNJ, $EMR, $CAT
crweworld.com
Woman rescued from flooded road in Oklahoma
Rescuers in Oklahoma City responded to a call of a woman trapped in her car on a flooded street. Source: BBC News",,,,,['https://pbs.twimg.com/card_img/1499816442249629696/ZyoDobPa?format=jpg&name=240x240'],https://twitter.com/HottestStockNow/status/834949323771146240
991,Art,@mRNAdisrupts,2017-02-24T18:29:50.000Z,Merck swallows $2.9B write-down of experimental hep C drug as market plummets http://fiercepharma.com/pharma/merck-swallows-1-9b-writedown-experimental-hep-c-drug-as-market-plummets‚Ä¶ $MRK $GLD #HepC #pharma,"Merck swallows $2.9B write-down of experimental hep C drug as market plummets http://fiercepharma.com/pharma/merck-swallows-1-9b-writedown-experimental-hep-c-drug-as-market-plummets‚Ä¶ $MRK $GLD #HepC #pharma
fiercepharma.com
Merck swallows $2.9B write-down of experimental hep C drug as market plummets
Just how drastically is the market for hepatitis C drugs shrinking? | Just how drastically is the market for hepatitis C drugs shrinking? The situation is so bad that less than three years after...",,,,,['https://pbs.twimg.com/card_img/1499619890499629057/BxGqdJpB?format=jpg&name=small'],https://twitter.com/mRNAdisrupts/status/835195043816357888
992,Heath Care News,@hc_equipment,2017-02-25T11:42:17.000Z,In First Phase 3 Trial #Mercks Investigational Inactivated Varicella Zoster Virus Vaccine V2... Read more: http://owler.us/aciALR $MRK,In First Phase 3 Trial #Mercks Investigational Inactivated Varicella Zoster Virus Vaccine V2... Read more: http://owler.us/aciALR $MRK,,,,,[],https://twitter.com/hc_equipment/status/835454870819749888
993,Ticker Report,@TickerReport,2017-02-25T04:07:11.000Z,"Sanford C. Bernstein Reiterates ‚ÄúMarket Perform‚Äù Rating for Merck & Company, Inc. $MRK http://ift.tt/2lTzImd","Sanford C. Bernstein Reiterates ‚ÄúMarket Perform‚Äù Rating for Merck & Company, Inc. $MRK http://ift.tt/2lTzImd",,,,,[],https://twitter.com/TickerReport/status/835340340869611521
994,Ticker Report,@TickerReport,2017-02-25T10:16:04.000Z,"Wechter Feldman Wealth Management Inc. Acquires New Position in Merck & Company, Inc. $MRK http://ift.tt/2lG6AMF","Wechter Feldman Wealth Management Inc. Acquires New Position in Merck & Company, Inc. $MRK http://ift.tt/2lG6AMF",,,,,[],https://twitter.com/TickerReport/status/835433174155079680
995,ChimeraResearchGroup,@ChimeraResearch,2017-02-24T15:21:13.000Z,February 24 Biotech Update $kpti $MRK $oncs $STML https://goo.gl/p0ewjt,February 24 Biotech Update $kpti $MRK $oncs $STML https://goo.gl/p0ewjt,,,,,[],https://twitter.com/ChimeraResearch/status/835147577112858624
996,MarketBeat,@MarketBeatCom,2017-02-26T12:53:40.000Z,"138,465 Shares in Merck & Company, Inc. $MRK Acquired by Ffcm LLC http://zpr.io/PyqGg","138,465 Shares in Merck & Company, Inc. $MRK Acquired by Ffcm LLC http://zpr.io/PyqGg",,,,,[],https://twitter.com/MarketBeatCom/status/835835223292194819
997,Fiercelywashyourhands,@PharmaceuticBen,2017-02-24T14:34:22.000Z,"Delay to hep C drug program behind Merck's write-down decision, say analysts: http://ow.ly/nsGp309k2KR $MRK $GILD","Delay to hep C drug program behind Merck's write-down decision, say analysts: http://ow.ly/nsGp309k2KR $MRK $GILD",,,,,[],https://twitter.com/PharmaceuticBen/status/835135787456942080
998,Allison Gatlin,@IBD_AGatlin,2017-02-24T16:53:09.000Z,"Gilead, AbbVie could perk up on Merck's hep C downfall: Leerink $GILD $ABBV $MRK $JNJ $BMY","Gilead, AbbVie could perk up on Merck's hep C downfall: Leerink $GILD $ABBV $MRK $JNJ $BMY
investors.com
Gilead, AbbVie Could Perk Up On Merck's Hep C Downfall: Leerink | Stock News & Stock Market...
Gilead and AbbVie will benefit from Merck's decision to take a $2.9 billion impairment charge on a hepatitis C drug, Leerink says.",,,,,['https://pbs.twimg.com/card_img/1501741399259107331/BsHz2D4Z?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/835170714533707776
999,Insider Monkey,@insidermonkey,2017-02-24T20:22:11.000Z,$MRK In $2.9 Billion Writedown After Market For Hepatitis C Drug Market Shrinks,"$MRK In $2.9 Billion Writedown After Market For Hepatitis C Drug Market Shrinks
insidermonkey.com
Merck & Co., Inc. (MRK) In $2.9 Billion Writedown After Market For Hepatitis C Drug Market Shrinks
Merck & Co., Inc. (NYSE:MRK) has announced that it will be writing down approximately $2.9 billion following the shrinking of the market for a hepatitis drug it owns.",,,,,['https://pbs.twimg.com/card_img/1501737386052669444/IjJD0edi?format=jpg&name=240x240'],https://twitter.com/insidermonkey/status/835223317757972480
1000,The Fly,@theflynews,2017-02-24T18:16:07.000Z,Meet Aduro BioTech: A talk with CEO Stephen Isaacs $ADRO $NVS $MRK,"Meet Aduro BioTech: A talk with CEO Stephen Isaacs $ADRO $NVS $MRK
thefly.com
Meet Aduro BioTech: A talk with CEO Stephen Isaacs
Aduro BioTech (ADRO) is a... ADRO, NVS, MRK",,,,,['https://pbs.twimg.com/card_img/1501305764081721345/GcvAvZOJ?format=jpg&name=small'],https://twitter.com/theflynews/status/835191592176635904
1001,Briefing.com,@Briefingcom,2017-02-26T19:44:20.000Z,$MRK: Merck announces results of the pivotal Phase 3 clinical study of letermovir; study met its primary efficacy... http://bit.ly/2mjMfjd,$MRK: Merck announces results of the pivotal Phase 3 clinical study of letermovir; study met its primary efficacy... http://bit.ly/2mjMfjd,,,,,[],https://twitter.com/Briefingcom/status/835938569512345600
1002,Novateur Ventures,@NovateurBio,2017-02-24T19:54:29.000Z,"With hep C franchises languishing, $MRK Merck‚Äôs MK-3682 (#uprifosbuvir) goes from blockbuster to bomb https://endpts.com/with-hep-c-franchises-languishing-mercks-mk-3682-goes-from-blockbuster-to-bomb‚Ä¶ via 
@endpts","With hep C franchises languishing, $MRK Merck‚Äôs MK-3682 (#uprifosbuvir) goes from blockbuster to bomb https://endpts.com/with-hep-c-franchises-languishing-mercks-mk-3682-goes-from-blockbuster-to-bomb‚Ä¶ via 
@endpts
endpts.com
With hep C franchises languishing, Merck‚Äôs MK-3682 goes from blockbuster to bomb
A little less than three years after acquiring the hepatitis C drug MK-3682 (uprifosbuvir) in its $3.85 billion buyout of Idenix, Merck‚Äôs prospects in the field have cooled dramatically, and its once...",,,,,['https://pbs.twimg.com/card_img/1501741385011060737/zbnmjYSX?format=png&name=small'],https://twitter.com/NovateurBio/status/835216347646722048
1003,Sarah Owermohle,@owermohle,2017-02-24T01:48:31.000Z,"The one trial that did get a significant outcome: Merck's  rVSV-ZEBOV, used in Guinea during late stage of #Ebola outbreak $MRK","The one trial that did get a significant outcome: Merck's  rVSV-ZEBOV, used in Guinea during late stage of #Ebola outbreak $MRK",,,,,[],https://twitter.com/owermohle/status/834943054511493120
1004,Benzinga,@Benzinga,2017-02-24T15:00:02.000Z,Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market' https://benzinga.com/z/9087784 $BAYRY $BIIB $MRK $TEVA,Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market' https://benzinga.com/z/9087784 $BAYRY $BIIB $MRK $TEVA,,,,,[],https://twitter.com/Benzinga/status/835142246219583488
1005,John Carroll,@JohnCendpts,2017-02-24T15:34:37.000Z,"Merck tees up US/European applications for letermovir after detailing PhIII antiviral success
$MRK","Merck tees up US/European applications for letermovir after detailing PhIII antiviral success
$MRK
endpts.com
Merck tees up US/European applications for letermovir after detailing PhIII antiviral success
Merck has unveiled the positive data behind its Phase III win for its antiviral letermovir. While it‚Äôs no panacea, the drug clearly outperformed a placebo in chopping down on the number of CMV...
1",,,,1,['https://pbs.twimg.com/card_img/1501741398248329222/rIX2KNlb?format=png&name=small'],https://twitter.com/JohnCendpts/status/835150950830592000
1006,Biotech Supernova,@biotechnova,2017-02-24T21:02:28.000Z,"Replying to 
@DrPaulyDeSantis","Replying to 
@DrPaulyDeSantis
yea, run started w/ $MRK extending p'ship, what value did you assign for Baric royalties?
1
1",,1,,1,[],https://twitter.com/biotechnova/status/835233457726971905
1007,JQ,@jq1234t,2017-02-24T21:08:23.000Z,"Replying to 
@jq1234t
 and 
@bio_clouseau","Replying to 
@jq1234t
 and 
@bio_clouseau
Sound like $MRK to use lower dose in triple combo, seem asking triple vs doublet trials just follow standard combination rule.",,,,,[],https://twitter.com/jq1234t/status/835234944788090881
1008,dough,@semodough,2017-02-24T14:56:24.000Z,"Replying to 
@semodough","Replying to 
@semodough
$MRK Keytruda‚Äôs share increased from 21% to 23%  Tecentriq now has 7% of market share after 9 months of being on the U.S. market
1",,,1,,[],https://twitter.com/semodough/status/835141333484507136
1009,BioPharma Dive,@BioPharmaDive,2017-02-24T16:53:00.000Z,$MRK writes down hep C business as more patients get cured,"$MRK writes down hep C business as more patients get cured
biopharmadive.com
Merck writes off $2.9B as new hep C reality blooms
The accounting charge will drag down 2016 earnings per share and reflects shifting market and pricing dynamics, the drugmaker said. 
1",,1,,,['https://pbs.twimg.com/card_img/1500822592684716033/YowSVNbO?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/835170677321682944
1010,Endpoints News,@endpts,2017-02-25T16:24:00.000Z,"$MRK tees up US/European applications for letermovir after detailing PhIII #antiviral success http://endpts.com/merck-tees-up-‚Ä¶ #biotech 
@JohnCendpts","$MRK tees up US/European applications for letermovir after detailing PhIII #antiviral success http://endpts.com/merck-tees-up-‚Ä¶ #biotech 
@JohnCendpts
2",,,2,,[],https://twitter.com/endpts/status/835525766435622912
1011,Contix Alerts,@contixalerts,2017-02-24T12:23:49.000Z,"$MRK: Merck tees up US/European applications for letermovir after detailing PhIII antiviral success 
@JohnCendpts
 https://app.contix.com/Free-Trial/35802478‚Ä¶","$MRK: Merck tees up US/European applications for letermovir after detailing PhIII antiviral success 
@JohnCendpts
 https://app.contix.com/Free-Trial/35802478‚Ä¶",,,,,[],https://twitter.com/contixalerts/status/835102935109386240
1012,M,@bio_clouseau,2017-03-01T11:46:28.000Z,$MRK has dumped its BET inhibitor from Oncoethix acquisition,"$MRK has dumped its BET inhibitor from Oncoethix acquisition
1
6
8",,1,6,8,['https://pbs.twimg.com/media/C51I-T_WQAAVu3M?format=jpg&name=large'],https://twitter.com/bio_clouseau/status/836905471491641344
1013,Seeking Alpha,@SeekingAlpha,2017-03-01T15:57:33.000Z,Bristol-Myers Squibb: A High Risk High Return Bet For 2017 http://seekingalpha.com/article/4050982-bristol-myers-squibb-high-risk-high-return-bet-2017?source=feed_f‚Ä¶ $AZN $EXEL $MRK $RHHBY $BMY,"Bristol-Myers Squibb: A High Risk High Return Bet For 2017 http://seekingalpha.com/article/4050982-bristol-myers-squibb-high-risk-high-return-bet-2017?source=feed_f‚Ä¶ $AZN $EXEL $MRK $RHHBY $BMY
1",,,1,,[],https://twitter.com/SeekingAlpha/status/836968661831180289
1014,Natalie Grover,@NatalieGrover,2017-02-28T16:54:27.000Z,"UK rejects #Merck's #Keytruda as initial treatment for #lung #cancer http://reut.rs/2lPP2iE via 
@Reuters
 $MRK $BMY","UK rejects #Merck's #Keytruda as initial treatment for #lung #cancer http://reut.rs/2lPP2iE via 
@Reuters
 $MRK $BMY
2",,,2,,[],https://twitter.com/NatalieGrover/status/836620594212851713
1015,Hannibal Hamlin,@HHamlinVP,2017-02-28T12:07:15.000Z,Idera Pharmaceuticals' Well-Funded And Growing Pipeline Of Potentially Blockbuster Drug Can... http://seekingalpha.com/article/4050165-idera-pharmaceuticals-well-funded-growing-pipeline-potentially-blockbuster-drug-candidates?source=tweet‚Ä¶ $GSK $IONS $MRK,"Idera Pharmaceuticals' Well-Funded And Growing Pipeline Of Potentially Blockbuster Drug Can... http://seekingalpha.com/article/4050165-idera-pharmaceuticals-well-funded-growing-pipeline-potentially-blockbuster-drug-candidates?source=tweet‚Ä¶ $GSK $IONS $MRK
seekingalpha.com
Idera Pharmaceuticals' Well-Funded And Growing Pipeline Of Potentially Blockbuster Drug Candidates...
Idera starts 2017 with a clear strategy; it is well-funded, has a robust and growing pipeline, and expects to deliver powerful near-term catalysts.
1",,,,1,['https://pbs.twimg.com/card_img/1492089810860888067/AW51h289?format=png&name=240x240'],https://twitter.com/HHamlinVP/status/836548316787851265
1016,PennyPower,@BIGPENNY4,2017-03-01T14:25:10.000Z,"#hotnews $KBG.V  King‚Äôs Bay 
@KingsBayRes
 http://fscwire.com/newsrelease/kings-bay-commences-helicopter-borne-vtem-plus-survey-over-lynx-lake-copper-cobalt‚Ä¶ 
@geniusmedia2
$mct $MRK $MYL #TSXV #cobalt #PDAC2017 @BossRickyG","#hotnews $KBG.V  King‚Äôs Bay 
@KingsBayRes
 http://fscwire.com/newsrelease/kings-bay-commences-helicopter-borne-vtem-plus-survey-over-lynx-lake-copper-cobalt‚Ä¶ 
@geniusmedia2
$mct $MRK $MYL #TSXV #cobalt #PDAC2017 @BossRickyG
GIF",üí° üí∞ üí° üí∞ üî• üî• üî• üî•,,,,['https://pbs.twimg.com/tweet_video_thumb/C51tY_uU0AEzX__.jpg'],https://twitter.com/BIGPENNY4/status/836945412191744000
1017,BioPharma Dive,@BioPharmaDive,2017-02-28T22:39:00.000Z,$MRK drug successfully prevents cytomegalovirus in late-stage trial,"$MRK drug successfully prevents cytomegalovirus in late-stage trial
biopharmadive.com
Merck antiviral cuts post-transplant infections
The big pharma readies an NDA submission after reducing CMV infection and boosting survival in bone marrow transplant patients.
1
5",,,1,5,['https://pbs.twimg.com/card_img/1491141785426571270/IAohpzFi?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/836707302476427264
1018,Zero Filter,@zerofiltertruth,2017-02-28T12:42:53.000Z,"Beyond intriguing updates & action $PPHM & $NVAX - $DRRX joins Lotto #biotech land focus w/Buy $3 pt
$IBB $XBI $MRK
@GuyAdami
 @jonnajarian","Beyond intriguing updates & action $PPHM & $NVAX - $DRRX joins Lotto #biotech land focus w/Buy $3 pt
$IBB $XBI $MRK
@GuyAdami
 @jonnajarian
2
1",,,2,1,[],https://twitter.com/zerofiltertruth/status/836557281772830721
1019,WLST.com,@wlstcom,2017-02-28T19:04:15.000Z,Merck Announces Second-Quarter 2017 Dividend $MRK http://wlst.com http://finance.yahoo.com/news/merck-announces-second-quarter-2017-184700238.html‚Ä¶,Merck Announces Second-Quarter 2017 Dividend $MRK http://wlst.com http://finance.yahoo.com/news/merck-announces-second-quarter-2017-184700238.html‚Ä¶,,,,,[],https://twitter.com/wlstcom/status/836653257309184000
1020,Bilo Selhi,@StocksThatDoubl,2017-03-01T17:50:30.000Z,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,,,,,['https://pbs.twimg.com/media/CiX8f4PUkAQf2Dy?format=jpg&name=small'],https://twitter.com/StocksThatDoubl/status/836997086138810376
1021,BioPharma Dive,@BioPharmaDive,2017-02-28T19:00:01.000Z,$MRK's antiviral drug hits the mark in Ph. 3,"$MRK's antiviral drug hits the mark in Ph. 3
biopharmadive.com
Merck antiviral cuts post-transplant infections
The big pharma readies an NDA submission after reducing CMV infection and boosting survival in bone marrow transplant patients.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1491141785426571270/IAohpzFi?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/836652191913910272
1022,Seeking Alpha,@SeekingAlpha,2017-02-27T21:15:24.000Z,Idera Pharmaceuticals' Well-Funded And Growing Pipeline Of Potentially Blockbuster Drug Can... http://seekingalpha.com/article/4050165-idera-pharmaceuticals-well-funded-growing-pipeline-potentially-blockbuster-drug-candidates?source=feed_f‚Ä¶ $GSK $IONS $MRK,"Idera Pharmaceuticals' Well-Funded And Growing Pipeline Of Potentially Blockbuster Drug Can... http://seekingalpha.com/article/4050165-idera-pharmaceuticals-well-funded-growing-pipeline-potentially-blockbuster-drug-candidates?source=feed_f‚Ä¶ $GSK $IONS $MRK
seekingalpha.com
Idera Pharmaceuticals' Well-Funded And Growing Pipeline Of Potentially Blockbuster Drug Candidates...
Idera starts 2017 with a clear strategy; it is well-funded, has a robust and growing pipeline, and expects to deliver powerful near-term catalysts.",,,,,[],https://twitter.com/SeekingAlpha/status/836323875717685248
1023,Heath Care News,@hc_equipment,2017-03-01T14:02:30.000Z,Investment Analysts' Weekly Ratings Changes for #Merck KGaA (). Read more: http://owler.us/acjNkh $MRK,Investment Analysts' Weekly Ratings Changes for #Merck KGaA (). Read more: http://owler.us/acjNkh $MRK,,,,,[],https://twitter.com/hc_equipment/status/836939708282224640
1024,Tina Tan,@MedtechTinaTan,2017-03-01T16:23:56.000Z,"Big Pharma names among #Grail's Series B investors: $JNJ, $BMY $MRK. Amazon, $VAR also included #IVD #cancerdiagnostic #Venturefunding","Big Pharma names among #Grail's Series B investors: $JNJ, $BMY $MRK. Amazon, $VAR also included #IVD #cancerdiagnostic #Venturefunding",,,,,[],https://twitter.com/MedtechTinaTan/status/836975300227514369
1025,Slingshot Catalysts,@SlingshotCtlyst,2017-02-27T16:30:03.000Z,$ONCS ImmunoPulse Il-12 Granted Fast Track Status by #FDA for MM Following Treatment on $MRK KEYTRUDA or $BMY Opdivo,"$ONCS ImmunoPulse Il-12 Granted Fast Track Status by #FDA for MM Following Treatment on $MRK KEYTRUDA or $BMY Opdivo
slingshotinsights.com
Catalyst
OncoSec's (ONCS) ImmunoPulse Il-12 Granted Fast Track Status by FDA for Metastatic Melanoma Following Progression on Merck's (MRK) KEYTRUDA or Bristol-Myers Squibb's (BMY) Opdivo",,,,,[],https://twitter.com/SlingshotCtlyst/status/836252063331926016
1026,ChartMill,@ChartMill,2017-03-01T03:05:34.000Z,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/H1xZoc2X9x #China #CASIO,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/H1xZoc2X9x #China #CASIO,,,,,[],https://twitter.com/ChartMill/status/836774384081719296
1027,Pharmaceutical News,@pharma_sector,2017-03-01T22:46:03.000Z,#Merck & Co. Announces Second-Quarter 2017 Dividend  . Read more: http://owler.us/acjULp $MRK,#Merck & Co. Announces Second-Quarter 2017 Dividend  . Read more: http://owler.us/acjULp $MRK,,,,,[],https://twitter.com/pharma_sector/status/837071462695481346
1028,Pharmaceutical News,@pharma_sector,2017-03-01T12:08:41.000Z,"EOD Risers: JPMorgan Chase & Co., McDonald's Corporation, #Merck & Co., Inc. Read more: http://owler.us/acjLvV $MRK","EOD Risers: JPMorgan Chase & Co., McDonald's Corporation, #Merck & Co., Inc. Read more: http://owler.us/acjLvV $MRK",,,,,[],https://twitter.com/pharma_sector/status/836911063429869569
1029,Tim Collins,@RetroWallSt,2017-02-28T18:28:10.000Z,$MCD and $MRK  still two names I like here,"$MCD and $MRK  still two names I like here
1",,,,1,[],https://twitter.com/RetroWallSt/status/836644174862696451
1030,"Juan P. Serrate, DVM",@JPZaragoza1,2017-02-28T12:07:20.000Z,FDA Accepts BLA for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review. $MRK $PFE,"FDA Accepts BLA for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review. $MRK $PFE
1",,,,1,[],https://twitter.com/JPZaragoza1/status/836548337989976065
1031,Pharmaceutical News,@pharma_sector,2017-03-01T09:52:43.000Z,"Morning Buzz: #Merck & Co., Inc. (NYSE:), J C Penney Company Inc (NYSE:JCP). Read more: http://owler.us/acjI1u $MRK","Morning Buzz: #Merck & Co., Inc. (NYSE:), J C Penney Company Inc (NYSE:JCP). Read more: http://owler.us/acjI1u $MRK",,,,,[],https://twitter.com/pharma_sector/status/836876848831279107
1032,ChartMill,@ChartMill,2017-03-01T12:38:34.000Z,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/Skl61WSV5l #SMWNYC #untj4270,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/Skl61WSV5l #SMWNYC #untj4270,,,,,[],https://twitter.com/ChartMill/status/836918585171800065
1033,$PENNY KING,@groman100,2017-02-28T21:49:30.000Z,$LXRX OUCH $AMGN CHART BEEN SHOUTING THIS SINCE 140 MY ENTRY POINT! LAST 30 DAYS WOW IN A WORD 90 DAYS 190+  $MDCO $PFE $MRK $SNY $AGN $BMY,$LXRX OUCH $AMGN CHART BEEN SHOUTING THIS SINCE 140 MY ENTRY POINT! LAST 30 DAYS WOW IN A WORD 90 DAYS 190+  $MDCO $PFE $MRK $SNY $AGN $BMY,,,,,[],https://twitter.com/groman100/status/836694845066379264
1034,Stockboard Media Inc,@stockboardinc,2017-02-28T18:50:53.000Z,$MRK Merck Announces Second-Quarter 2017 Dividend... - http://sbml.co/23bd27c5,$MRK Merck Announces Second-Quarter 2017 Dividend... - http://sbml.co/23bd27c5,,,,,[],https://twitter.com/stockboardinc/status/836649895394168833
1035,BioWorld,@BioWorld,2017-02-27T17:01:01.000Z,$MRK‚Äôs letermovir meets primary endpoint in prophylactic CMV study involving HSCT patients; regulatory submissions expected this year,$MRK‚Äôs letermovir meets primary endpoint in prophylactic CMV study involving HSCT patients; regulatory submissions expected this year,,,,,[],https://twitter.com/BioWorld/status/836259855983763456
1036,Zero Filter,@zerofiltertruth,2017-02-28T20:30:28.000Z,"$PPHM - Seeking strategic partner 4 cancer detection platform - Seems want it 

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD $AMGN $SHPG $BIIB","$PPHM - Seeking strategic partner 4 cancer detection platform - Seems want it 

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD $AMGN $SHPG $BIIB",,,,,[],https://twitter.com/zerofiltertruth/status/836674956347965444
1037,FiercePharma,@FiercePharma,2017-03-01T17:20:00.000Z,"NICE shoots down Merck's Keytruda in first-line NSCLC‚Äîand the med won't be getting any CDF love, either http://fiercepharma.com/pharma/nice-shoots-down-merck-s-keytruda-first-line-nsclc-and-med-won-t-be-getting-any-cdf-love‚Ä¶ $MRK","NICE shoots down Merck's Keytruda in first-line NSCLC‚Äîand the med won't be getting any CDF love, either http://fiercepharma.com/pharma/nice-shoots-down-merck-s-keytruda-first-line-nsclc-and-med-won-t-be-getting-any-cdf-love‚Ä¶ $MRK
fiercepharma.com
NICE shoots down Merck's Keytruda in first-line NSCLC‚Äîand the med won't be getting any CDF love,...
Sure, Merck & Co.‚Äôs Keytruda is making waves in the U.S. immuno-oncology market as a newly approved first-line treatment for non-small cell lung cancer. | Sure, Merck‚Äôs Keytruda is making waves in...
3",,,3,,['https://pbs.twimg.com/card_img/1501722504192303105/c8yuYbIE?format=jpg&name=small'],https://twitter.com/FiercePharma/status/836989411678162944
1038,Zero Filter,@zerofiltertruth,2017-03-01T12:05:55.000Z,Will $55B bubble $CRM guide to only $0.05-.07 F'18 EPS be as easy huge free money short opp as absurd $TSLA call was? $PG $MRK $VZ $F $HD,"Will $55B bubble $CRM guide to only $0.05-.07 F'18 EPS be as easy huge free money short opp as absurd $TSLA call was? $PG $MRK $VZ $F $HD
Yes
60%
No
40%
5 votes
¬∑
Final results
1",,,,1,[],https://twitter.com/zerofiltertruth/status/836910370266701825
1039,Daily Political,@dailypoliticaln,2017-02-27T10:25:35.000Z,"Alley Co LLC Has $3,263,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2l2GDtu","Alley Co LLC Has $3,263,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2l2GDtu",,,,,[],https://twitter.com/dailypoliticaln/status/836160341717434368
1040,Ticker Report,@TickerReport,2017-02-27T10:46:17.000Z,"Merck & Company, Inc. $MRK Shares Bought by Johnson Financial Group Inc. http://ift.tt/2muVmKZ","Merck & Company, Inc. $MRK Shares Bought by Johnson Financial Group Inc. http://ift.tt/2muVmKZ",,,,,[],https://twitter.com/TickerReport/status/836165553156939776
1041,Watchlist News,@WatchlistN,2017-03-01T10:26:39.000Z,"8,840 Shares in Merck & Company, Inc. $MRK Acquired by Cutter & CO Brokerage Inc. http://zpr.io/PybqW","8,840 Shares in Merck & Company, Inc. $MRK Acquired by Cutter & CO Brokerage Inc. http://zpr.io/PybqW",,,,,[],https://twitter.com/WatchlistN/status/836885388979499008
1042,Novateur Ventures,@NovateurBio,2017-03-01T01:16:27.000Z,"$MRK Merck's #letermovir aces bone marrow transplant study, cutting death rate http://fiercebiotech.com/biotech/merck-s-letermovir-aces-bone-marrow-transplant-study-cutting-death-rate‚Ä¶ via 
@FierceBiotech","$MRK Merck's #letermovir aces bone marrow transplant study, cutting death rate http://fiercebiotech.com/biotech/merck-s-letermovir-aces-bone-marrow-transplant-study-cutting-death-rate‚Ä¶ via 
@FierceBiotech
fiercebiotech.com
Merck's letermovir aces bone marrow transplant study, cutting death rate
Merck & Co.'s fast-tracked antiviral letermovir hit its main target of reducing infections in a trial involving bone marrow transplant patients and topped that by also reducing patient deaths.< |...
1",,,1,,['https://pbs.twimg.com/card_img/1501984014680264716/NjpA0LD2?format=jpg&name=small'],https://twitter.com/NovateurBio/status/836746924325654529
1043,Daily Political,@dailypoliticaln,2017-02-27T10:40:43.000Z,"Stanford Investment Group Inc. Continues to Hold Stake in Merck & Company, Inc. $MRK http://ift.tt/2m1MP4J","Stanford Investment Group Inc. Continues to Hold Stake in Merck & Company, Inc. $MRK http://ift.tt/2m1MP4J",,,,,[],https://twitter.com/dailypoliticaln/status/836164151680634880
1044,CHItrader,@CHItraders,2017-02-27T12:41:38.000Z,$MRK Roche‚Äôs Renal Success Spells Danger For All-Comer Studies  http://stocknewswires.com/2017/02/27/mrk-roches-renal-success-spells-danger-for-all-comer-studies/‚Ä¶,$MRK Roche‚Äôs Renal Success Spells Danger For All-Comer Studies  http://stocknewswires.com/2017/02/27/mrk-roches-renal-success-spells-danger-for-all-comer-studies/‚Ä¶,,,,,[],https://twitter.com/CHItraders/status/836194579594559489
1045,Ticker Report,@TickerReport,2017-02-28T20:17:09.000Z,"Merck & Company, Inc. $MRK Stock Rating Upgraded by Vetr Inc. http://zpr.io/Pyhcc","Merck & Company, Inc. $MRK Stock Rating Upgraded by Vetr Inc. http://zpr.io/Pyhcc",,,,,[],https://twitter.com/TickerReport/status/836671602028867584
1046,Watchlist News,@WatchlistN,2017-02-28T22:28:15.000Z,"Merck & Company, Inc. $MRK Declares $0.47 Quarterly Dividend http://zpr.io/PyAdw","Merck & Company, Inc. $MRK Declares $0.47 Quarterly Dividend http://zpr.io/PyAdw",,,,,[],https://twitter.com/WatchlistN/status/836704596575797254
1047,Dr Kanak Kanti De,@DrKanakKantiDe,2017-02-27T13:06:21.000Z,"Premarket Biotech Digest ‚Äì $ALIM files NDA, $MRK announces +ve results, $ABBV gets EMA nod http://drkkd.com/premarket-biotech-digest-alim-files-nda-mrk-announces-ve-results-abbv-gets-ema-nod/‚Ä¶","Premarket Biotech Digest ‚Äì $ALIM files NDA, $MRK announces +ve results, $ABBV gets EMA nod http://drkkd.com/premarket-biotech-digest-alim-files-nda-mrk-announces-ve-results-abbv-gets-ema-nod/‚Ä¶",,,,,[],https://twitter.com/DrKanakKantiDe/status/836200801500557314
1048,MarketBeat,@MarketBeatCom,2017-03-01T11:42:39.000Z,Merck KGaA given ‚Ç¨116.00 PT by Citigroup Inc.. buy rating. http://ift.tt/2lybURn $MRK #MRK,Merck KGaA given ‚Ç¨116.00 PT by Citigroup Inc.. buy rating. http://ift.tt/2lybURn $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/836904511935496193
1049,Kara Jill Stancell,@kjilly,2017-03-01T18:50:07.000Z,"#NICE shoots down $MRK's #Keytruda in first-line NSCLC‚Äîand the med won't be getting any CDF love, either","#NICE shoots down $MRK's #Keytruda in first-line NSCLC‚Äîand the med won't be getting any CDF love, either
fiercepharma.com
NICE shoots down Merck's Keytruda in first-line NSCLC‚Äîand the med won't be getting any CDF love,...
Sure, Merck & Co.‚Äôs Keytruda is making waves in the U.S. immuno-oncology market as a newly approved first-line treatment for non-small cell lung cancer. | Sure, Merck‚Äôs Keytruda is making waves in...",,,,,['https://pbs.twimg.com/card_img/1501722504192303105/c8yuYbIE?format=jpg&name=small'],https://twitter.com/kjilly/status/837012088258101249
1050,MarketBeat,@MarketBeatCom,2017-02-28T22:06:43.000Z,Merck & Company announces quarterly dividend of $0.47.  Payable on 4/7/2017. 2.85% Yield.  http://ift.tt/2lvEAu3 $MRK #MRK,"Merck & Company announces quarterly dividend of $0.47.  Payable on 4/7/2017. 2.85% Yield.  http://ift.tt/2lvEAu3 $MRK #MRK
marketbeat.com
Merck & Co., Inc. Dividend Yield, History & Payout Ratio (NYSE:MRK) $MRK
Is Merck & Co., Inc. (NYSE:MRK) a good stock for dividend investors? View MRK's dividend history, dividend yield, next payment date, and payout ratio at MarketBeat.",,,,,[],https://twitter.com/MarketBeatCom/status/836699176121532418
1051,Jacob Bell,@realJacobBell,2017-02-28T19:00:03.000Z,$MRK's antiviral drug hits the mark in Ph. 3,"$MRK's antiviral drug hits the mark in Ph. 3
biopharmadive.com
Merck antiviral cuts post-transplant infections
The big pharma readies an NDA submission after reducing CMV infection and boosting survival in bone marrow transplant patients.",,,,,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/realJacobBell/status/836652200034242561
1052,TradeHawk,@TradeHawk,2017-03-01T22:00:10.000Z,$MRK FDA approves Odactra for house dust mite allergies,"$MRK FDA approves Odactra for house dust mite allergies
fda.gov
FDA approves Odactra for house dust mite allergies
The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation...",,,,,['https://pbs.twimg.com/card_img/1499533346971529217/FNlvwyKL?format=png&name=small'],https://twitter.com/TradeHawk/status/837059915680120834
1053,cowenresearch,@CowenResearch,2017-02-27T18:28:58.000Z,"Cowen's Steve Scala out with 38-page report detailing proprietary statistical analyses of #Immuno-oncology trials: $AZN, $BMY, $MRK and more","Cowen's Steve Scala out with 38-page report detailing proprietary statistical analyses of #Immuno-oncology trials: $AZN, $BMY, $MRK and more",,,,,[],https://twitter.com/CowenResearch/status/836281988575334400
1054,Allison Gatlin,@IBD_AGatlin,2017-02-27T18:22:48.000Z,"Exelixis rockets on Bristol, Roche ties following Merck-Incyte team $EXEL $BMY $RHHBY $MRK $INCY $HZNP","Exelixis rockets on Bristol, Roche ties following Merck-Incyte team $EXEL $BMY $RHHBY $MRK $INCY $HZNP
investors.com
Exelixis Rockets On Bristol, Roche I-O Ties Following Merck-Incyte Team | Stock News & Stock Market...
Exelixis is teaming up with Bristol-Myers Squibb and Roche to test its Cabometyx and their immuno-oncology drugs in liver and bladder cancer.",,,,,[],https://twitter.com/IBD_AGatlin/status/836280440201822212
1055,Odi Bruckman,@odibro,2017-03-01T22:32:43.000Z,$MRK FDA approves Odactra to treat house dust mite nasal inflammation,"$MRK FDA approves Odactra to treat house dust mite nasal inflammation
1",,,1,,[],https://twitter.com/odibro/status/837068107655041024
1056,Contix Alerts,@contixalerts,2017-03-01T22:00:18.000Z,"$MRK FDA approves Odactra for house dust mite allergies 
@TradeHawk
 https://app.contix.com/Free-Trial/35988153‚Ä¶","$MRK FDA approves Odactra for house dust mite allergies 
@TradeHawk
 https://app.contix.com/Free-Trial/35988153‚Ä¶",,,,,[],https://twitter.com/contixalerts/status/837059949670772736
1057,Contix Alerts,@contixalerts,2017-03-01T11:47:03.000Z,"$MRK has dumped its BET inhibitor from Oncoethix acquisition 
@bio_clouseau
 https://app.contix.com/Free-Trial/35961830‚Ä¶","$MRK has dumped its BET inhibitor from Oncoethix acquisition 
@bio_clouseau
 https://app.contix.com/Free-Trial/35961830‚Ä¶",,,,,[],https://twitter.com/contixalerts/status/836905622218010624
1058,Lisa LaMotta,@lisalamotta,2017-03-01T14:04:14.000Z,Lots of big names including $JNJ $BMY $CELG $MRK $MCK contribute to $900M Series B for GRAIL cancer detection co https://globenewswire.com/news-release/2017/03/01/929515/0/en/GRAIL-Closes-Over-900-Million-Initial-Investment-in-Series-B-Financing-to-Develop-Blood-Tests-to-Detect-Cancer-Early.html‚Ä¶,Lots of big names including $JNJ $BMY $CELG $MRK $MCK contribute to $900M Series B for GRAIL cancer detection co https://globenewswire.com/news-release/2017/03/01/929515/0/en/GRAIL-Closes-Over-900-Million-Initial-Investment-in-Series-B-Financing-to-Develop-Blood-Tests-to-Detect-Cancer-Early.html‚Ä¶,,,,,[],https://twitter.com/lisalamotta/status/836940145299333120
1059,Kristen Hallam,@kristen_hallam,2017-03-01T17:03:19.000Z,"NICE rejects $MRK's Keytruda in untreated PD-L1-positive metastatic non-small cell lung cancer: 
https://nice.org.uk/guidance/GID-TA10092/documents/appraisal-consultation-document‚Ä¶","NICE rejects $MRK's Keytruda in untreated PD-L1-positive metastatic non-small cell lung cancer: 
https://nice.org.uk/guidance/GID-TA10092/documents/appraisal-consultation-document‚Ä¶
1
1",,1,1,,[],https://twitter.com/kristen_hallam/status/836985209623040000
1060,Briefing.com,@Briefingcom,2017-02-27T11:58:25.000Z,$MRK: Merck announces results of the pivotal Phase 3 clinical study of letermovir; study met its primary efficacy... http://bit.ly/2mjMfjd,$MRK: Merck announces results of the pivotal Phase 3 clinical study of letermovir; study met its primary efficacy... http://bit.ly/2mjMfjd,,,,,[],https://twitter.com/Briefingcom/status/836183706146525184
1061,Joe,@GantosJ,2017-02-27T12:43:08.000Z,"Replying to 
@Dreesenkl","Replying to 
@Dreesenkl
. 
@Dreesenkl
 I think they will keep it going with $MRK's Keytruda. 
The big Q is, would $MRK make a move on $ONCS partnership?
3",,,,3,[],https://twitter.com/GantosJ/status/836194959455842305
1062,See It Market,@seeitmarket,2017-02-27T15:20:40.000Z,"Trading Update: Market Insights & 6 Stocks I Own - https://seeitmarket.com/trading-update-market-insights-6-stocks-own-investing-16609/‚Ä¶  blog by 
@CJMendes
 
$MRK $JBLU $HAL $FCX $BAX $ABT","Trading Update: Market Insights & 6 Stocks I Own - https://seeitmarket.com/trading-update-market-insights-6-stocks-own-investing-16609/‚Ä¶  blog by 
@CJMendes
 
$MRK $JBLU $HAL $FCX $BAX $ABT
seeitmarket.com
Trading Update: Market Insights & 6 Stocks I Own
CJ Mendes provides an update on his current trading positions and stocks he likes. He shares insights on Abbott Labs, JetBlue, Halliburton, Merck, and more.
2
1",,,2,1,['https://pbs.twimg.com/card_img/1501741058849492999/xxSLdZeu?format=jpg&name=small'],https://twitter.com/seeitmarket/status/836234604549898241
1063,StockNews.com,@stocknewsdotcom,2017-03-01T22:16:13.000Z,$MRK FDA approves Odactra for house dust mite allergies https://stocknews.com/news/mrk-fda-approves-odactra-for-house-dust-mite-allergies/‚Ä¶,$MRK FDA approves Odactra for house dust mite allergies https://stocknews.com/news/mrk-fda-approves-odactra-for-house-dust-mite-allergies/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/837063957265465348
1064,dough,@semodough,2017-03-02T12:48:16.000Z,CS $TSRO Raising TP to $198 expect much interest in this LATE stage cancer asset.       - rumor is late stage oncology assets are RARE $MRK,"CS $TSRO Raising TP to $198 expect much interest in this LATE stage cancer asset.       - rumor is late stage oncology assets are RARE $MRK
5
6",,,5,6,['https://pbs.twimg.com/media/C56g0rJVAAMdAoz?format=jpg&name=small'],https://twitter.com/semodough/status/837283414264938496
1065,pharmalot,@pharmalot,2017-03-02T14:13:48.000Z,Pharmalot.. Pharmalittle.. Good Morning.. coffee & headlines are served.. https://statnews.com/pharmalot/2017/03/02/drug-prices-icahn-trump-conflicts/‚Ä¶ #pharma $MRK $PFE $AMGN $BMY #donaldtrump,"Pharmalot.. Pharmalittle.. Good Morning.. coffee & headlines are served.. https://statnews.com/pharmalot/2017/03/02/drug-prices-icahn-trump-conflicts/‚Ä¶ #pharma $MRK $PFE $AMGN $BMY #donaldtrump
statnews.com
Pharmalot, Pharmalittle: Drug makers squelch shareholder proposals on price hikes
Several major drug makers suppressed a campaign led by the Interfaith Center on Corporate Responsibility that hoped to force them to explain price hikes.
1",,,1,,['https://pbs.twimg.com/card_img/1500534343600644098/wAHXYJa7?format=jpg&name=small'],https://twitter.com/pharmalot/status/837304940557119489
1066,Breaking News,@MarketCurrents,2017-03-02T12:52:08.000Z,FDA OKs Merck's allergen extract to treat house dust mite-induced allergic rhinitis http://seekingalpha.com/news/3248065-fda-oks-mercks-allergen-extract-treat-house-dust-mite-induced-allergic-rhinitis?source=feed_f‚Ä¶ #premarket $MRK $CTLT,"FDA OKs Merck's allergen extract to treat house dust mite-induced allergic rhinitis http://seekingalpha.com/news/3248065-fda-oks-mercks-allergen-extract-treat-house-dust-mite-induced-allergic-rhinitis?source=feed_f‚Ä¶ #premarket $MRK $CTLT
seekingalpha.com
FDA OKs Merck's allergen extract to treat house dust mite-induced allergic rhinitis (NYSE:MRK)
The FDA approves Merck's (NYSE:MRK) Odactra, the first allergen extract that is administered sublingually (under the tongue) to treat house dust mite-induced nasal inflammation (allergic...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/837284387926335489
1067,Seeking Alpha,@SeekingAlpha,2017-03-03T15:57:15.000Z,Why Should You Not Ignore Merck And Keytruda In 2017? http://seekingalpha.com/article/4051859-ignore-merck-keytruda-2017?source=feed_f‚Ä¶ $AMGN $BMY $INCY $RHHBY $MRK,"Why Should You Not Ignore Merck And Keytruda In 2017? http://seekingalpha.com/article/4051859-ignore-merck-keytruda-2017?source=feed_f‚Ä¶ $AMGN $BMY $INCY $RHHBY $MRK
1",,,,1,[],https://twitter.com/SeekingAlpha/status/837693358877237248
1068,This momment,@dpreda,2017-03-02T01:02:34.000Z,"Cramer‚Äôs charts uncover 4 pharma stocks ready to explode higher 
$AGN $LLY $PFE $MRK $XLV $LABU $XBI $IBB 
http://ln.is/video.cnbc.com/galle/C8ZNZ‚Ä¶","Cramer‚Äôs charts uncover 4 pharma stocks ready to explode higher 
$AGN $LLY $PFE $MRK $XLV $LABU $XBI $IBB 
http://ln.is/video.cnbc.com/galle/C8ZNZ‚Ä¶
1",,,,1,[],https://twitter.com/dpreda/status/837105816729759744
1069,Activist Stocks,@activiststocks,2017-03-02T17:30:09.000Z,Bristol-Myers: Buyout Bound? $BMY http://ow.ly/2TLJ309wuRk $PFE $AGN $JNJ $MRK $NVS,"Bristol-Myers: Buyout Bound? $BMY http://ow.ly/2TLJ309wuRk $PFE $AGN $JNJ $MRK $NVS
1",,,,1,[],https://twitter.com/activiststocks/status/837354352721412097
1070,Seeking Alpha,@SeekingAlpha,2017-03-03T21:44:41.000Z,Industry Snapshot: Setting Sights On Glaucoma Drug Makers http://seekingalpha.com/article/4052023-industry-snapshot-setting-sights-glaucoma-drug-makers?source=feed_f‚Ä¶ $AGN $MRK $AERI $PFE,Industry Snapshot: Setting Sights On Glaucoma Drug Makers http://seekingalpha.com/article/4052023-industry-snapshot-setting-sights-glaucoma-drug-makers?source=feed_f‚Ä¶ $AGN $MRK $AERI $PFE,,,,,[],https://twitter.com/SeekingAlpha/status/837780794475065344
1071,BackToTheFutures,@Back2DaFutures,2017-03-02T15:28:54.000Z,"Nov. 2016 $CALA In Focus, Part 1 - Checkpoint Inhibition   $AFMD  $BMY  $FPRX  $BLUE  $KITE  $AZN  $MRK  $PFE  $ADAP","Nov. 2016 $CALA In Focus, Part 1 - Checkpoint Inhibition   $AFMD  $BMY  $FPRX  $BLUE  $KITE  $AZN  $MRK  $PFE  $ADAP
1",,,,1,[],https://twitter.com/Back2DaFutures/status/837323836806746112
1072,Nic,@racernic,2017-03-02T15:05:39.000Z,$MRK filled 1 technical setup and almost done with the second. I'd book some and reengage with profits if need b,$MRK filled 1 technical setup and almost done with the second. I'd book some and reengage with profits if need b,,,,,['https://pbs.twimg.com/media/C57ARa5VUAgtkjS?format=jpg&name=small'],https://twitter.com/racernic/status/837317989401825282
1073,Joe,@GantosJ,2017-03-03T13:12:41.000Z,$ONCS need to sign a drug supply partnership with $MRK to get them through the next trial combo pIL-12 & #Keytruda,"$ONCS need to sign a drug supply partnership with $MRK to get them through the next trial combo pIL-12 & #Keytruda
Joe
@GantosJ
 ¬∑ 28 Feb 2017
$ONCS Milestones for 2017
2",,,,2,"['https://pbs.twimg.com/profile_images/1270679020015882240/fdx3DjHC_mini.jpg', 'https://pbs.twimg.com/media/C5xX7-DWMAAWb8A?format=jpg&name=small']",https://twitter.com/GantosJ/status/837651948014829569
1074,Bilo Selhi,@StocksThatDoubl,2017-03-03T21:30:15.000Z,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,,,,,['https://pbs.twimg.com/media/CiX8f4PUkAQf2Dy?format=jpg&name=small'],https://twitter.com/StocksThatDoubl/status/837777163386503168
1075,George Marcovits,@GemsBot,2017-03-04T11:50:21.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/76262060#76262072‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/76262060#76262072‚Ä¶,,,,,['https://pbs.twimg.com/media/C6Emv71XEAI7CHd?format=jpg&name=small'],https://twitter.com/GemsBot/status/837993613149765632
1076,Roy Friedman,@DewDiligence,2017-03-04T21:46:30.000Z,$MRK's HCV mkt share in US is low b/c Zeptatier is not a great drug‚Äînot b/c MRK's rebates2 PBMs are too small.,"$MRK's HCV mkt share in US is low b/c Zeptatier is not a great drug‚Äînot b/c MRK's rebates2 PBMs are too small.
JQ
@jq1234t
 ¬∑ 5 Mar 2017
Replying to @CGrantWSJ
But $MRK somehow priced Zepatier $54,600 a patient for a 12-week treatment.
1
3",,1,,3,['https://pbs.twimg.com/profile_images/1296832284415463424/BCbaYWR9_mini.jpg'],https://twitter.com/DewDiligence/status/838143641336053765
1077,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-03-03T21:48:17.000Z,#EquityResearch Industry Snapshot: Setting Sights On Glaucoma Drug Makers $AGN $MRK $AERI $PFE http://dlvr.it/NXGzxl,"#EquityResearch Industry Snapshot: Setting Sights On Glaucoma Drug Makers $AGN $MRK $AERI $PFE http://dlvr.it/NXGzxl
1",,,,1,['https://pbs.twimg.com/media/C6BmBFgVAAEHZ4H?format=jpg&name=360x360'],https://twitter.com/AlertTrade/status/837781701749161984
1078,WLST.com,@wlstcom,2017-03-02T01:02:36.000Z,Cramers charts uncover 4 pharma stocks ready to explode higher $AGN $LLY $PFE $MRK $XLV http://video.cnbc.com/gallery/?video=3000597577‚Ä¶,Cramers charts uncover 4 pharma stocks ready to explode higher $AGN $LLY $PFE $MRK $XLV http://video.cnbc.com/gallery/?video=3000597577‚Ä¶,,,,,['https://pbs.twimg.com/media/C53_UDpXQAIM5xR?format=jpg&name=small'],https://twitter.com/wlstcom/status/837105827433566208
1079,Sweet Platform,@SweetPlatform,2017-03-03T15:36:30.000Z,"MRK Top news - Mar 3rd, 2017 $MRK http://https://goo.gl/O4BmJq","MRK Top news - Mar 3rd, 2017 $MRK http://https://goo.gl/O4BmJq",,,,,[],https://twitter.com/SweetPlatform/status/837688138403364864
1080,Alex Rued,@alexsrued,2017-03-02T00:03:24.000Z,Looking forward to $RCAR quarterly report. We are overweight. The product sells itself. $IBB $AMGN $SPX $MRK #otc $BMY $NERV $XLV,Looking forward to $RCAR quarterly report. We are overweight. The product sells itself. $IBB $AMGN $SPX $MRK #otc $BMY $NERV $XLV,,,,,[],https://twitter.com/alexsrued/status/837090928145870849
1081,BioPharma Dive,@BioPharmaDive,2017-03-02T21:50:01.000Z,McKinsey & Co. study finds supply chain is responsible for 35% of #pharma's profits and losses http://bit.ly/2lyft9m $MRK,"McKinsey & Co. study finds supply chain is responsible for 35% of #pharma's profits and losses http://bit.ly/2lyft9m $MRK
biopharmadive.com
Report: Why Merck turned to supply chain integration to save costs
The big pharma is transforming its supply chain in and effort to cut costs and increase efficiency. 
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501739702893920261/b2UP5uNc?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/837419749877374976
1082,Stockaholics,@Stockaholics,2017-03-03T23:04:22.000Z,We Have A MASSIVE New Penny Stock Pick Coming Today! Get Early Access: http://tr.im/1o7Rk #Stocks $MRK $LGND,We Have A MASSIVE New Penny Stock Pick Coming Today! Get Early Access: http://tr.im/1o7Rk #Stocks $MRK $LGND,,,,,[],https://twitter.com/Stockaholics/status/837800850097487872
1083,ChartMill,@ChartMill,2017-03-02T00:22:34.000Z,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/rJeT1U1rce #Movado #film,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/rJeT1U1rce #Movado #film,,,,,[],https://twitter.com/ChartMill/status/837095751004061696
1084,Pharmaceutical News,@pharma_sector,2017-03-03T08:52:18.000Z,#Merck FDA approves house dust mite allergen extract. Read more: http://owler.us/ackGK9 $MRK,#Merck FDA approves house dust mite allergen extract. Read more: http://owler.us/ackGK9 $MRK,,,,,[],https://twitter.com/pharma_sector/status/837586417064665089
1085,Heath Care News,@hc_equipment,2017-03-03T22:28:28.000Z,NICE recommends #Merck's Erbitux to treat patients with metastatic colorectal can... Read more: http://owler.us/ackSba $MRK,NICE recommends #Merck's Erbitux to treat patients with metastatic colorectal can... Read more: http://owler.us/ackSba $MRK,,,,,[],https://twitter.com/hc_equipment/status/837791815428255744
1086,Tuan Pham,@15minofPham,2017-03-03T03:47:59.000Z,"Daily bearish MACD crossover & # of days it had been abv: $SLV 40, $MRK 37, $RHT 34, $OPK $NVS 21","Daily bearish MACD crossover & # of days it had been abv: $SLV 40, $MRK 37, $RHT 34, $OPK $NVS 21",,,,,[],https://twitter.com/15minofPham/status/837509835948240896
1087,FancyFinancy,@FancyFinancy,2017-03-03T19:03:03.000Z,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2mezDJs $PFE $MRK $TEVA $BMY $ABBV $LLY,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2mezDJs $PFE $MRK $TEVA $BMY $ABBV $LLY,,,,,['https://pbs.twimg.com/media/C6BAMmbXQAAYCg0?format=jpg&name=small'],https://twitter.com/FancyFinancy/status/837740117653598209
1088,Siti van der Meij,@sitivandermeij,2017-03-02T12:55:05.000Z,FDA OKs Merck's allergen extract to treat house dust mite-induced allergic rhinitis http://seekingalpha.com/news/3248065-fda-oks-mercks-allergen-extract-treat-house-dust-mite-induced-allergic-rhinitis?source=feed_f‚Ä¶ #premarket $MRK $CTLT #sitifat‚Ä¶,"FDA OKs Merck's allergen extract to treat house dust mite-induced allergic rhinitis http://seekingalpha.com/news/3248065-fda-oks-mercks-allergen-extract-treat-house-dust-mite-induced-allergic-rhinitis?source=feed_f‚Ä¶ #premarket $MRK $CTLT #sitifat‚Ä¶
seekingalpha.com
FDA OKs Merck's allergen extract to treat house dust mite-induced allergic rhinitis (NYSE:MRK)
The FDA approves Merck's (NYSE:MRK) Odactra, the first allergen extract that is administered sublingually (under the tongue) to treat house dust mite-induced nasal inflammation (allergic...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/837285127688441857
1089,Bridgewater,@fourifbyair,2017-03-02T17:30:09.000Z,Bristol-Myers: Buyout Bound? $BMY http://ow.ly/2TLJ309wuRk $PFE $AGN $JNJ $MRK $NVS,Bristol-Myers: Buyout Bound? $BMY http://ow.ly/2TLJ309wuRk $PFE $AGN $JNJ $MRK $NVS,,,,,[],https://twitter.com/fourifbyair/status/837354353526784001
1090,Pharmaceutical News,@pharma_sector,2017-03-02T19:18:38.000Z,"Sanford C. Bernstein Reiterates ""Market Perform"" Rating for #Merck & Company, Inc. (). Read more: http://owler.us/ackmSI $MRK","Sanford C. Bernstein Reiterates ""Market Perform"" Rating for #Merck & Company, Inc. (). Read more: http://owler.us/ackmSI $MRK",,,,,[],https://twitter.com/pharma_sector/status/837381651109814272
1091,Pharmaceutical News,@pharma_sector,2017-03-02T17:50:15.000Z,#Merck NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild... Read more: http://owler.us/acklJs $MRK,#Merck NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild... Read more: http://owler.us/acklJs $MRK,,,,,[],https://twitter.com/pharma_sector/status/837359410523463681
1092,$PENNY KING,@groman100,2017-03-03T16:25:17.000Z,$fbio $tgtx up and looking good for a big run soon  $pfe $imnp $mrk $amrn $gild $amgn $alxn $fb $srpt,$fbio $tgtx up and looking good for a big run soon  $pfe $imnp $mrk $amrn $gild $amgn $alxn $fb $srpt,,,,,[],https://twitter.com/groman100/status/837700414925516800
1093,La Casa del Trading,@casadeltrading,2017-03-02T15:37:41.000Z,$MRK-CALL-October-20-2017-STK:75.00-Ask:1.15 Bid:1.03 Last:1.00-V:14990-OI:344-Vega:18.35%-Vega(50):19%-Risk:$1.499.000,$MRK-CALL-October-20-2017-STK:75.00-Ask:1.15 Bid:1.03 Last:1.00-V:14990-OI:344-Vega:18.35%-Vega(50):19%-Risk:$1.499.000,,,,,[],https://twitter.com/casadeltrading/status/837326050531164160
1094,Option Alert,@OptionAlert,2017-03-02T15:01:03.000Z,"Unusually heavy option volume on today's open include $MNST, $AVGO, $MRK, $KR, and $JCI.","Unusually heavy option volume on today's open include $MNST, $AVGO, $MRK, $KR, and $JCI.
1",,,,1,[],https://twitter.com/OptionAlert/status/837316830276505602
1095,Zero Filter,@zerofiltertruth,2017-03-02T19:22:17.000Z,"If only I sold some our extreme outsized pos in disaster $TWTR & bought more $PPHM after that release 

$MRK $CELG $GILD $AMGN $SHPG $BIIB","If only I sold some our extreme outsized pos in disaster $TWTR & bought more $PPHM after that release 

$MRK $CELG $GILD $AMGN $SHPG $BIIB",,,,,[],https://twitter.com/zerofiltertruth/status/837382572913098753
1096,Zero Filter,@zerofiltertruth,2017-03-03T15:51:35.000Z,"Thank Lord $PPHM - Holding gains as aggressively-buying group investors pool power for sway with co

$IBB $XBI $FBT $BIB $CELG $MRK $GILD","Thank Lord $PPHM - Holding gains as aggressively-buying group investors pool power for sway with co

$IBB $XBI $FBT $BIB $CELG $MRK $GILD
1",,,,1,[],https://twitter.com/zerofiltertruth/status/837691936504967169
1097,Zenect,@zenect,2017-03-03T12:42:27.000Z,I assume you‚Äôre going to buy this dividend #stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V and hold it forever‚Ä¶,I assume you‚Äôre going to buy this dividend #stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V and hold it forever‚Ä¶,,,,,[],https://twitter.com/zenect/status/837644337718644736
1098,$PENNY KING,@groman100,2017-03-03T18:14:26.000Z,$amgn blasted right through that trend line top of 179.88 $mrk $srpt $pfe $amrn $gild $teva $bmy $fb $regn $sny,"$amgn blasted right through that trend line top of 179.88 $mrk $srpt $pfe $amrn $gild $teva $bmy $fb $regn $sny
1",,1,,,[],https://twitter.com/groman100/status/837727882705133570
1099,leahanne,@leahanneta,2017-03-02T00:53:17.000Z,"03/01/17 Volume Leader #97 - MRK 10,680,700 Merck & Company $MRK 66.21 +0.34 +0.52% High today of 66.80 day lo","03/01/17 Volume Leader #97 - MRK 10,680,700 Merck & Company $MRK 66.21 +0.34 +0.52% High today of 66.80 day lo
investorshangout.com
03/01/17 Volume Leader #97 - MRK - ALERTS, HOT STOCKS & CHARTS #4386203 - Investors Hangout
ALERTS, HOT STOCKS & CHARTS: 03/01/17 Volume Leader #97 - MRK 10,680,700 Merck Company $MRK 66.21 +0.34 +0.52% High today of 66 - #4386203",,,,,['https://pbs.twimg.com/card_img/1499224644112498691/uNNWn6ac?format=png&name=240x240'],https://twitter.com/leahanneta/status/837103483903954944
1100,leahanne,@leahanneta,2017-03-02T16:46:44.000Z,"11:13 ET Volume Leader #90 - MRK 2,912,574 Merck & Company $MRK 66.11 -0.10 -0.15% High today of 66.58 day low","11:13 ET Volume Leader #90 - MRK 2,912,574 Merck & Company $MRK 66.11 -0.10 -0.15% High today of 66.58 day low
investorshangout.com
11:13 ET Volume Leader #90 - MRK - The Hunt for the Next 10 Bagger #4388233 - Investors Hangout
The Hunt for the Next 10 Bagger: 11:13 ET Volume Leader #90 - MRK 2,912,574 Merck Company $MRK 66.11 -0.10 -0.15% High today of 66. - #4388233",,,,,['https://pbs.twimg.com/card_img/1489662400739565568/VIdpQtc3?format=png&name=240x240'],https://twitter.com/leahanneta/status/837343426626666496
1101,MarketBeat,@MarketBeatCom,2017-03-02T05:27:16.000Z,Merck & Company upgraded by Vetr Inc. to hold. $65.54 PT. http://ift.tt/2mHB150 $MRK #MRK,Merck & Company upgraded by Vetr Inc. to hold. $65.54 PT. http://ift.tt/2mHB150 $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/837172430695247872
1102,Ticker Report,@TickerReport,2017-03-03T10:32:25.000Z,"Bessemer Group Inc. Boosts Stake in Merck & Company, Inc. $MRK http://ift.tt/2mSPXg4","Bessemer Group Inc. Boosts Stake in Merck & Company, Inc. $MRK http://ift.tt/2mSPXg4",,,,,[],https://twitter.com/TickerReport/status/837611615025496064
1103,max pain,@optioncharts,2017-03-03T15:53:24.000Z,$MRK $PG $JPM options have the largest change in volume. Free options screener. http://bit.ly/1sMykla,$MRK $PG $JPM options have the largest change in volume. Free options screener. http://bit.ly/1sMykla,,,,,[],https://twitter.com/optioncharts/status/837692391138164740
1104,Ticker Report,@TickerReport,2017-03-04T10:32:23.000Z,"Merck & Company, Inc. $MRK Stake Raised by Linscomb & Williams Inc. http://ift.tt/2mY0nLh","Merck & Company, Inc. $MRK Stake Raised by Linscomb & Williams Inc. http://ift.tt/2mY0nLh",,,,,[],https://twitter.com/TickerReport/status/837973991608500224
1105,Watchlist News,@WatchlistN,2017-03-03T10:30:58.000Z,"Merck & Company, Inc. $MRK Shares Bought by RFG Advisory Group LLC http://zpr.io/PyeND","Merck & Company, Inc. $MRK Shares Bought by RFG Advisory Group LLC http://zpr.io/PyeND",,,,,[],https://twitter.com/WatchlistN/status/837611247692562432
1106,Watchlist News,@WatchlistN,2017-03-02T13:25:16.000Z,"Barbara Oil Co. Has $3,667,000 Position in Merck & Company, Inc. $MRK http://zpr.io/PyrBJ","Barbara Oil Co. Has $3,667,000 Position in Merck & Company, Inc. $MRK http://zpr.io/PyrBJ",,,,,[],https://twitter.com/WatchlistN/status/837292724256649217
1107,Zack Capp,@zackcapp,2017-03-03T22:57:01.000Z,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2meJGhz $PFE $MRK $TEVA $BMY $ABBV $LLY,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2meJGhz $PFE $MRK $TEVA $BMY $ABBV $LLY,,,,,['https://pbs.twimg.com/media/C6B1v-9VMAAMKdU?format=jpg&name=small'],https://twitter.com/zackcapp/status/837799000120127489
1108,Heath Care News,@hc_equipment,2017-03-03T15:52:12.000Z,#Merck NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild... Read more: http://owler.us/ackMLG $MRK,#Merck NICE Expands Positive Recommendation for Erbitux as First-line Treatment for RAS Wild... Read more: http://owler.us/ackMLG $MRK,,,,,[],https://twitter.com/hc_equipment/status/837692090817495040
1109,Supply Chain Dive,@SupplyChainDive,2017-03-03T15:59:29.000Z,"The #pharmaceutical industry's lead times are far above average. For $MRK, the solution lay in #supplychain","The #pharmaceutical industry's lead times are far above average. For $MRK, the solution lay in #supplychain
supplychaindive.com
Report: Why Merck & Co. turned to supply chain integration to save costs
The global network behind pharmaceuticals complicates demand planning, but new technology can help reduce the industry's inefficiencies.",,,,,[],https://twitter.com/SupplyChainDive/status/837693924617695232
1110,Allison Gatlin,@IBD_AGatlin,2017-03-03T21:39:53.000Z,Gilead hepatitis C sales plunge as Merck swipes share: analyst $GILD $MRK $ABBV,"Gilead hepatitis C sales plunge as Merck swipes share: analyst $GILD $MRK $ABBV
investors.com
Gilead Hepatitis C Sales Plunge As Merck Swipes Share: Analyst
Gilead's hepatitis C franchise has plunged quarter-to-date and RBC analyst Michael Yee is waiting for sales to establish an industry bottom.",,,,,[],https://twitter.com/IBD_AGatlin/status/837779589141258240
1111,Novateur Ventures,@NovateurBio,2017-03-03T18:20:56.000Z,"Merck $MRK will submit applications in the US & EU for #letermovir (MK-8228) to prevent cytomegalovirus https://biocentury.com/bc-extra/clinical-news/2017-02-27/merck-cmv-prophylaxis-headed-us-eu-submissions‚Ä¶ 
@BioCentury","Merck $MRK will submit applications in the US & EU for #letermovir (MK-8228) to prevent cytomegalovirus https://biocentury.com/bc-extra/clinical-news/2017-02-27/merck-cmv-prophylaxis-headed-us-eu-submissions‚Ä¶ 
@BioCentury
biocentury.com
Merck CMV prophylaxis headed for U.S., EU submissions",,,,,[],https://twitter.com/NovateurBio/status/837729520106942464
1112,Zero Filter,@zerofiltertruth,2017-03-02T22:58:19.000Z,"$PPHM up more a/h as several investors pool with inherent threat poten #activism  

$IBB $XBI $MRK $CELG $GILD $AMGN 
@GuyAdami
 @jonnajarian","$PPHM up more a/h as several investors pool with inherent threat poten #activism  

$IBB $XBI $MRK $CELG $GILD $AMGN 
@GuyAdami
 @jonnajarian",,,,,[],https://twitter.com/zerofiltertruth/status/837436937174728704
1113,Benzinga,@Benzinga,2017-03-03T13:58:34.000Z,"Imbalances from 
@TripleDTrader
 on #PreMarket Prep: $CAT 72k to sell, $PFE 165k sell, $MRK 42k sell, $CRM 218k sell. http://bit.ly/13QlghE","Imbalances from 
@TripleDTrader
 on #PreMarket Prep: $CAT 72k to sell, $PFE 165k sell, $MRK 42k sell, $CRM 218k sell. http://bit.ly/13QlghE
1
3",,1,3,,[],https://twitter.com/Benzinga/status/837663493998391297
1114,Javier Hasse,@JavierHasse,2017-03-02T18:07:29.000Z,"Why 
@Bermuda
 Could Be The Next #Switzerland https://benzinga.com/z/9115538 $ACGL $AGII $AHL $MRK $RHHBY $CB $RE $AON $MMC 
@benzinga
 #business #tax","Why 
@Bermuda
 Could Be The Next #Switzerland https://benzinga.com/z/9115538 $ACGL $AGII $AHL $MRK $RHHBY $CB $RE $AON $MMC 
@benzinga
 #business #tax
benzinga.com
Why Bermuda Could Be The Next Switzerland
Bermuda is an island in the North Atlantic Ocean, about 665 miles east of Cape Hatteras, North Carolina. Over time, this subtropical paradise became especially popular among U.S....
1",,,,1,[],https://twitter.com/JavierHasse/status/837363748478283778
1115,JQ,@jq1234t,2017-03-04T19:59:20.000Z,"Replying to 
@CGrantWSJ","Replying to 
@CGrantWSJ
But $MRK somehow priced Zepatier $54,600 a patient for a 12-week treatment.
1
1
1",,1,1,1,[],https://twitter.com/jq1234t/status/838116669251850242
1116,Pharmacutical Daily,@PharmacDaily,2017-03-02T09:12:24.000Z,"@NICEcomms
 ‚Äôs approval of 
@Merck
 ‚Äôs Erbitux combination gives more choice for #mCRC patients in England
$MRK","@NICEcomms
 ‚Äôs approval of 
@Merck
 ‚Äôs Erbitux combination gives more choice for #mCRC patients in England
$MRK
pharmaceuticaldaily.com
NICE‚Äôs approval of Merck‚Äôs Erbitux combination gives more choice for mCRC patients in England
English wild-type metastatic colorectal cancer (mCRC) patients are getting more choice to a first-line effective treatment, as the UK National Institute for Health and Care Excellence (NICE) gave a‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1500294291134066700/XMEkRAJE?format=png&name=240x240'],https://twitter.com/PharmacDaily/status/837229087227785216
1117,Miljenko Zuanic,@Miljenkoz,2017-03-02T02:36:57.000Z,"Replying to 
@ColfaxCapital
, 
@CGrantWSJ
 and 
@DewDiligence","Replying to 
@ColfaxCapital
, 
@CGrantWSJ
 and 
@DewDiligence
And buy $MRK + $JNJ, left-over divided/award (between) top managements.",,,,,[],https://twitter.com/Miljenkoz/status/837129571447144448
1118,TJ Osterman,@gosubpar,2017-03-03T19:06:18.000Z,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2mezDJs $PFE $MRK $TEVA $BMY $ABBV $LLY,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2mezDJs $PFE $MRK $TEVA $BMY $ABBV $LLY,,,,,['https://pbs.twimg.com/media/C6BAMmbXQAAYCg0?format=jpg&name=small'],https://twitter.com/gosubpar/status/837740937145102337
1119,Spencer Israel,@SJisrael,2017-03-03T13:58:34.000Z,"Imbalances from 
@TripleDTrader
 on #PreMarket Prep: $CAT 72k to sell, $PFE 165k sell, $MRK 42k sell, $CRM 218k sell. http://bit.ly/13QlghE","Imbalances from 
@TripleDTrader
 on #PreMarket Prep: $CAT 72k to sell, $PFE 165k sell, $MRK 42k sell, $CRM 218k sell. http://bit.ly/13QlghE
1",,,,1,[],https://twitter.com/SJisrael/status/837663493855772675
1120,JQ,@jq1234t,2017-03-04T19:22:48.000Z,"Replying to 
@jsoriamd","Replying to 
@jsoriamd
Wonder why $MRK discontinued its BETi MK-8628 recently before testing it in combination with Keytrda
M
@bio_clouseau
 ¬∑ 1 Mar 2017
$MRK has dumped its BET inhibitor from Oncoethix acquisition",,,,,"['https://pbs.twimg.com/profile_images/3451258109/6f9bb8881027745473b22d4f74738815_mini.jpeg', 'https://pbs.twimg.com/media/C51I-T_WQAAVu3M?format=jpg&name=large']",https://twitter.com/jq1234t/status/838107476004384769
1121,CNBC's Fast Money,@CNBCFastMoney,2017-03-07T22:37:06.000Z,"'
@RichartRoss
 gives 3 names to buy in health care $XLV $AMGN $MRK $HUM","'
@RichartRoss
 gives 3 names to buy in health care $XLV $AMGN $MRK $HUM
1:25
7,643 views
3
21
34",,3,21,34,['https://pbs.twimg.com/media/C6WXhGQXEAAtKjN.jpg'],https://twitter.com/CNBCFastMoney/status/839243536595824640
1122,Seeking Alpha,@SeekingAlpha,2017-03-06T19:01:33.000Z,Bristol-Myers Squibb And Innate Pharma: Innovation Is Never A Single Event http://seekingalpha.com/article/4052369-bristol-myers-squibb-innate-pharma-innovation-never-single-event?source=feed_f‚Ä¶ $AZN $BMY $MRK $NVO $SNY $IPHYF,"Bristol-Myers Squibb And Innate Pharma: Innovation Is Never A Single Event http://seekingalpha.com/article/4052369-bristol-myers-squibb-innate-pharma-innovation-never-single-event?source=feed_f‚Ä¶ $AZN $BMY $MRK $NVO $SNY $IPHYF
2
1",,,2,1,[],https://twitter.com/SeekingAlpha/status/838826904710860800
1123,dough,@semodough,2017-03-06T18:33:38.000Z,CS top healthcare pics $CELG $MRK $ZTS $INCY $IBB $AET,"CS top healthcare pics $CELG $MRK $ZTS $INCY $IBB $AET
4
4",,,4,4,['https://pbs.twimg.com/media/C6QWO1nU4AUUfM1?format=jpg&name=small'],https://twitter.com/semodough/status/838819879708987393
1124,Chess,@chessNwine,2017-03-07T16:52:51.000Z,$KITE Daily. High/tight bull flag. Alliance with $MRK. Takeover candidate. Shook off recent secondary well.,"$KITE Daily. High/tight bull flag. Alliance with $MRK. Takeover candidate. Shook off recent secondary well.
2
1
3",,2,1,3,['https://pbs.twimg.com/media/C6VIwUEWUAEX1ge?format=png&name=small'],https://twitter.com/chessNwine/status/839156903477379072
1125,Lyn Daintree,@Crystec_Lyn,2017-03-06T14:24:13.000Z,#Health #cancer Why Should You Not Ignore Merck And Keytruda In 2017? http://seekingalpha.com/article/4051859-ignore-merck-keytruda-2017?source=tweet‚Ä¶ $AMGN $BMY $INCY $RHHBY $MRK,"#Health #cancer Why Should You Not Ignore Merck And Keytruda In 2017? http://seekingalpha.com/article/4051859-ignore-merck-keytruda-2017?source=tweet‚Ä¶ $AMGN $BMY $INCY $RHHBY $MRK
1
3",,,1,3,[],https://twitter.com/Crystec_Lyn/status/838757113912516608
1126,MolecularMatch,@MolecularMatch,2017-03-06T03:40:49.000Z,#Pembrolizumab 430 #clinicaltrials 276 enrolling https://app.molecularmatch.com/#sk/SJT8F8qqe #GauraoBhade http://seekingalpha.com/article/4051859-ignore-merck-keytruda-2017?source=tweet‚Ä¶ $AMGN $BMY $INCY $RHHBY $MRK,"#Pembrolizumab 430 #clinicaltrials 276 enrolling https://app.molecularmatch.com/#sk/SJT8F8qqe #GauraoBhade http://seekingalpha.com/article/4051859-ignore-merck-keytruda-2017?source=tweet‚Ä¶ $AMGN $BMY $INCY $RHHBY $MRK
2",,,2,,[],https://twitter.com/MolecularMatch/status/838595196808019968
1127,Squawk Box,@SquawkCNBC,2017-03-07T13:53:28.000Z,"Pharma stocks fall after 
@realDonaldTrump
's tweet about drug prices.

$MRK
$PFE
$NVS
$AZN
$GSK","Pharma stocks fall after 
@realDonaldTrump
's tweet about drug prices.

$MRK
$PFE
$NVS
$AZN
$GSK
3
8
7",,3,8,7,['https://pbs.twimg.com/media/C6UfYtGWMAEaQ8Y?format=jpg&name=360x360'],https://twitter.com/SquawkCNBC/status/839111762628726786
1128,Quantcha Trade Ideas,@QuantchaIdeas,2017-03-06T16:22:35.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/03/06/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-9/‚Ä¶,"Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/03/06/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-9/‚Ä¶
1",,,,1,['https://pbs.twimg.com/media/C6P4PXlU0AE324i?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/838786901205200896
1129,SF Education,@SFEducation,2017-03-07T20:37:43.000Z,Will Republicans Repeal Obamacare? https://aff.whotrades.com/t/b/8gtyt/ $MYL $JNJ $AMGN $GILD $AGN $PFE $GSK $MRK $NVS $ABBV,Will Republicans Repeal Obamacare? https://aff.whotrades.com/t/b/8gtyt/ $MYL $JNJ $AMGN $GILD $AGN $PFE $GSK $MRK $NVS $ABBV,,,,,['https://pbs.twimg.com/media/C6V8OaZU4AADkaa?format=jpg&name=small'],https://twitter.com/SFEducation/status/839213494507548673
1130,APM Health Europe,@apmhealtheurope,2017-03-06T16:41:20.000Z,"Three diabetes filings for 
@Merck
 and 
@Pfizer
's ertugliflozin accepted for review by EMA and FDA http://bit.ly/2mbmvD2 #pharma $MRK $PFE","Three diabetes filings for 
@Merck
 and 
@Pfizer
's ertugliflozin accepted for review by EMA and FDA http://bit.ly/2mbmvD2 #pharma $MRK $PFE
2
1",,,2,1,['https://pbs.twimg.com/media/C6P8R4NWUAEito_?format=jpg&name=small'],https://twitter.com/apmhealtheurope/status/838791616534052864
1131,Hugh J. Robbins,@HughJRobbins,2017-03-07T14:11:09.000Z,"$CASY, earnings gap down ..  $IBB giving up 300 again. $JNJ $MRK $PFE some big pharmas #stocks #investing #tradeideas #trading","$CASY, earnings gap down ..  $IBB giving up 300 again. $JNJ $MRK $PFE some big pharmas #stocks #investing #tradeideas #trading
1",,,,1,[],https://twitter.com/HughJRobbins/status/839116212340670465
1132,WLST.com,@wlstcom,2017-03-07T19:43:10.000Z,"GLOBAL MARKETS-Stocks slip, U.S. dollar firm on Fed outlook $MRK http://wlst.com https://uk.finance.yahoo.com/news/global-markets-stocks-slip-u-191339971.html‚Ä¶","GLOBAL MARKETS-Stocks slip, U.S. dollar firm on Fed outlook $MRK http://wlst.com https://uk.finance.yahoo.com/news/global-markets-stocks-slip-u-191339971.html‚Ä¶",,,,,[],https://twitter.com/wlstcom/status/839199764419866626
1133,Ariad Pharma,@stockseek1,2017-03-05T16:51:05.000Z,$MRK to show....,$MRK to show....,,,,,[],https://twitter.com/stockseek1/status/838431685897244672
1134,dough,@semodough,2017-03-07T01:01:24.000Z,"Replying to 
@semodough","Replying to 
@semodough
immediate events  or PDUFA $IBB $MRK $ACOR$NBIX $TEVA
5
1",,,5,1,['https://pbs.twimg.com/media/C6Ru9iUUwAAhS07?format=jpg&name=small'],https://twitter.com/semodough/status/838917466118041601
1135,Sweet Platform,@SweetPlatform,2017-03-06T15:05:45.000Z,"MRK Top news - Mar 6th, 2017 $MRK http://https://goo.gl/IcWykS","MRK Top news - Mar 6th, 2017 $MRK http://https://goo.gl/IcWykS
1",,,,1,[],https://twitter.com/SweetPlatform/status/838767562322296832
1136,emmanuel,@manu1r0,2017-03-06T23:58:46.000Z,Bristol-Myers Squibb And Innate Pharma: Innovation Is Never A Single Event http://seekingalpha.com/article/4052369-bristol-myers-squibb-innate-pharma-innovation-never-single-event?source=tweet‚Ä¶ $AZN $BMY $MRK $NVO $SNY $IPHYF,"Bristol-Myers Squibb And Innate Pharma: Innovation Is Never A Single Event http://seekingalpha.com/article/4052369-bristol-myers-squibb-innate-pharma-innovation-never-single-event?source=tweet‚Ä¶ $AZN $BMY $MRK $NVO $SNY $IPHYF
seekingalpha.com
Bristol-Myers Squibb And Innate Pharma: Innovation Is Never A Single Event (OTCMKTS:IPHYF)
Cash, cash equivalents and financial assets of Innate Pharma were ‚Ç¨239M at the end of 3Q16. Combinations of checkpoint inhibitors can lead to improved survival.
1",,,1,,[],https://twitter.com/manu1r0/status/838901701935513600
1137,Pharmaceutical News,@pharma_sector,2017-03-07T16:23:22.000Z,#Merck and Pfizer update on ertugliflozin regulatory filings. Read more: http://owler.us/aclUnk $MRK,"#Merck and Pfizer update on ertugliflozin regulatory filings. Read more: http://owler.us/aclUnk $MRK
1",,,,1,[],https://twitter.com/pharma_sector/status/839149485414461441
1138,SpoiledrottenBrat,@TaxHavens,2017-03-07T13:57:49.000Z,"$GILD $ABBV $JNJ $MRK Everything ""drugs"" down plenty in pre market.","$GILD $ABBV $JNJ $MRK Everything ""drugs"" down plenty in pre market.",,,,,[],https://twitter.com/TaxHavens/status/839112856570368002
1139,Bilo Selhi,@StocksThatDoubl,2017-03-07T17:24:11.000Z,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,,,,,['https://pbs.twimg.com/media/CiX8f4PUkAQf2Dy?format=jpg&name=small'],https://twitter.com/StocksThatDoubl/status/839164789473542145
1140,Stockboard Media Inc,@stockboardinc,2017-03-06T13:16:00.000Z,$MRK Merck and Pfizer Announce U.S. FDA and EMA Filing Acceptances of Three Marketing Applications for Er... - http://sbml.co/d450013e,"$MRK Merck and Pfizer Announce U.S. FDA and EMA Filing Acceptances of Three Marketing Applications for Er... - http://sbml.co/d450013e
1",,,,1,[],https://twitter.com/stockboardinc/status/838739946148085763
1141,Matt Soleyn,@MattSoleyn,2017-03-05T04:48:37.000Z,The #ForrestGump #Sessions #SNL open wasn't funny. This #Merck arbitration skit with Octavia Spencer is funny. #TV $MRK,"The #ForrestGump #Sessions #SNL open wasn't funny. This #Merck arbitration skit with Octavia Spencer is funny. #TV $MRK
1",,,,1,[],https://twitter.com/MattSoleyn/status/838249871438118912
1142,Scott Hough,@ScottHoughAuth,2017-03-07T20:50:34.000Z,"$DPZ stock: Domino's Pizza outperforms general market, competitors http://us.blastingnews.com/business/2017/03/dpz-stock-domino-s-pizza-outperforms-general-market-competitors-001529603.html‚Ä¶ $MRK $AMGN","$DPZ stock: Domino's Pizza outperforms general market, competitors http://us.blastingnews.com/business/2017/03/dpz-stock-domino-s-pizza-outperforms-general-market-competitors-001529603.html‚Ä¶ $MRK $AMGN
us.blastingnews.com
DPZ stock: Domino's Pizza outperforms general market, competitors
Jim Cramer spoke with CEO Patrick Doyle last night, and called Domino's one of the 'best plays on the stay-at-home economy.'...",,,,,['https://pbs.twimg.com/card_img/1496336222108758020/M2vP_HYP?format=jpg&name=small'],https://twitter.com/ScottHoughAuth/status/839216729448402952
1143,Donna Young,@DonnaYoungDC,2017-03-06T13:09:02.000Z,"#FDA & #EMA accept/validate 3 $MRK $PFE applications for ertugliflozin-containing diabetes meds http://mrknewsroom.com/news-release/research-and-development-news/merck-and-pfizer-announce-us-fda-and-ema-filing-acceptanc‚Ä¶ 
#pharma #biotech","#FDA & #EMA accept/validate 3 $MRK $PFE applications for ertugliflozin-containing diabetes meds http://mrknewsroom.com/news-release/research-and-development-news/merck-and-pfizer-announce-us-fda-and-ema-filing-acceptanc‚Ä¶ 
#pharma #biotech
1",üì∞,,,1,[],https://twitter.com/DonnaYoungDC/status/838738189779095552
1144,AlbertReport,@HotpageNews,2017-03-07T14:17:21.000Z,EARLY MOVERS: $DKS $MIK $NAV $PFE $MRK $AET $HUM $CI $CSX $CASY $RMBS $WFT $UPS $IBM $CRM $DISH $GE $BHI $THO,"EARLY MOVERS: $DKS $MIK $NAV $PFE $MRK $AET $HUM $CI $CSX $CASY $RMBS $WFT $UPS $IBM $CRM $DISH $GE $BHI $THO
cnbc.com
Early movers: DKS, MIK, NAV, PFE, AET, CSX & more
These are the stocks posting the largest moves before the bell.",,,,,['https://pbs.twimg.com/card_img/1501739000490508289/u0aa7v5v?format=jpg&name=small'],https://twitter.com/HotpageNews/status/839117771992666112
1145,ChartMill,@ChartMill,2017-03-07T13:22:30.000Z,$MRK has a great technical rating! Check out it's strong points at http://stockcharts.chartmill.com/u/SkgpVV42cg #TellYourCrowd #CLSA,$MRK has a great technical rating! Check out it's strong points at http://stockcharts.chartmill.com/u/SkgpVV42cg #TellYourCrowd #CLSA,,,,,[],https://twitter.com/ChartMill/status/839103969016352768
1146,ChartMill,@ChartMill,2017-03-06T16:10:31.000Z,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/rylafcZo9l #Bangle #VC,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/rylafcZo9l #Bangle #VC,,,,,[],https://twitter.com/ChartMill/status/838783864168398848
1147,il falso guaritore,@falsoguaritore,2017-03-07T07:50:15.000Z,"Bristol-Myers Squibb And Innate Pharma: Innovation Is Never A Single Event https://seekingalpha.com/article/4052369?source=ansh‚Ä¶ $IPHYF, $AZN, $BMY, $MRK, $NVO, $SNY","Bristol-Myers Squibb And Innate Pharma: Innovation Is Never A Single Event https://seekingalpha.com/article/4052369?source=ansh‚Ä¶ $IPHYF, $AZN, $BMY, $MRK, $NVO, $SNY
1",,,1,,[],https://twitter.com/falsoguaritore/status/839020355561861120
1148,Sweet Platform,@SweetPlatform,2017-03-07T15:58:29.000Z,"MRK Top news - Mar 7th, 2017 $MRK http://https://goo.gl/8vX5Gy","MRK Top news - Mar 7th, 2017 $MRK http://https://goo.gl/8vX5Gy",,,,,[],https://twitter.com/SweetPlatform/status/839143223339679746
1149,Heath Care News,@hc_equipment,2017-03-07T18:22:06.000Z,"#Merck reports positive data from Phase Ib trial of M1095 in psoriasis patients
 ... Read more: http://owler.us/aclVlf $MRK","#Merck reports positive data from Phase Ib trial of M1095 in psoriasis patients
 ... Read more: http://owler.us/aclVlf $MRK",,,,,[],https://twitter.com/hc_equipment/status/839179365657149440
1150,Pharmaceutical News,@pharma_sector,2017-03-07T15:00:34.000Z,Why Is #Merck Up 3.7% Since the Last Earnings Report?. Read more: http://owler.us/aclTCA $MRK,Why Is #Merck Up 3.7% Since the Last Earnings Report?. Read more: http://owler.us/aclTCA $MRK,,,,,[],https://twitter.com/pharma_sector/status/839128649202749441
1151,ChartMill,@ChartMill,2017-03-07T02:37:30.000Z,"Wow, have you seen the technical rating of $MRK?? Daily analysis at ChartMill, take a peek! http://stockcharts.chartmill.com/u/BygWzp9o9g #Twexit #TEDx","Wow, have you seen the technical rating of $MRK?? Daily analysis at ChartMill, take a peek! http://stockcharts.chartmill.com/u/BygWzp9o9g #Twexit #TEDx",,,,,[],https://twitter.com/ChartMill/status/838941649476648962
1152,Heath Care News,@hc_equipment,2017-03-07T20:22:35.000Z,#Merck MilliporeSigma Advances Lab Water Purification Technology With Milli-Q IQ 7000 System  . Read more: http://owler.us/aclWrC $MRK,#Merck MilliporeSigma Advances Lab Water Purification Technology With Milli-Q IQ 7000 System  . Read more: http://owler.us/aclWrC $MRK,,,,,[],https://twitter.com/hc_equipment/status/839209685211217920
1153,InvestorPlace,@InvestorPlace,2017-03-07T20:05:33.000Z,3 Drug Stocks Hit by Trump‚Äôs Call for Lower Prices $PFE $MRK $AGN,"3 Drug Stocks Hit by Trump‚Äôs Call for Lower Prices $PFE $MRK $AGN
investorplace.com
3 Drug Stocks Hit by Trump's Call for Lower Prices
While stocks in general are looking weak, pharmaceutical stocks in particular are getting hit. Here are three large-cap drug stocks to avoid.
1",,,1,,['https://pbs.twimg.com/card_img/1501738995243433984/sQoarKdc?format=jpg&name=240x240'],https://twitter.com/InvestorPlace/status/839205401220481028
1154,Logribel,@Logribel,2017-03-06T07:15:49.000Z,Ablynx: New data from Merck's anti-IL-17A/F shows strong efficacy in rdmized Ph1b (n=41) in #psoriasis https://globenewswire.com/news-release/2017/03/06/931638/0/en/ABLYNX-S-PARTNER-MERCK-KGaA-HAS-PRESENTED-NEW-DATA-FROM-A-PHASE-Ib-PSORIASIS-STUDY-OF-THE-BI-SPECIFIC-ANTI-IL-17A-F-NANOBODY-AT-THE-ANNUAL-AAD-CONFERENCE.html‚Ä¶ $ABLX $MRK,"Ablynx: New data from Merck's anti-IL-17A/F shows strong efficacy in rdmized Ph1b (n=41) in #psoriasis https://globenewswire.com/news-release/2017/03/06/931638/0/en/ABLYNX-S-PARTNER-MERCK-KGaA-HAS-PRESENTED-NEW-DATA-FROM-A-PHASE-Ib-PSORIASIS-STUDY-OF-THE-BI-SPECIFIC-ANTI-IL-17A-F-NANOBODY-AT-THE-ANNUAL-AAD-CONFERENCE.html‚Ä¶ $ABLX $MRK
2",,,,2,[],https://twitter.com/Logribel/status/838649301102383104
1155,$PENNY KING,@groman100,2017-03-06T15:43:31.000Z,$tgtx took huge profit here $fbio is next huge runner $amrn $amgn $pfe $mrk $bmy $sny $regn $mdco $snap $fb $alxn,$tgtx took huge profit here $fbio is next huge runner $amrn $amgn $pfe $mrk $bmy $sny $regn $mdco $snap $fb $alxn,,,,,[],https://twitter.com/groman100/status/838777066975719424
1156,TalkMarkets Recap,@MarketsRecap,2017-03-07T00:09:07.000Z,5 FDA Decisions To Watch Out For In Mar 2017 $MRK $RHHBY $REGN $SNY $RDUS Also $AMGN $VRX https://goo.gl/OXdmhL,"5 FDA Decisions To Watch Out For In Mar 2017 $MRK $RHHBY $REGN $SNY $RDUS Also $AMGN $VRX https://goo.gl/OXdmhL
1",,,,1,[],https://twitter.com/MarketsRecap/status/838904305604308994
1157,Watchlist News,@WatchlistN,2017-03-05T13:21:56.000Z,"Merck & Co., Inc. $MRK Shares Sold by Sapphire Star Partners LP http://zpr.io/PKtJV","Merck & Co., Inc. $MRK Shares Sold by Sapphire Star Partners LP http://zpr.io/PKtJV",,,,,[],https://twitter.com/WatchlistN/status/838379051882528768
1158,Slingshot Catalysts,@SlingshotCtlyst,2017-03-07T17:17:00.000Z,"FDA and EMA Filing Acceptances of Three Marketing Applications for Ertugliflozin in Type 2 Diabetes $PFE , $MRK http://ddil.si/x1891pgj/","FDA and EMA Filing Acceptances of Three Marketing Applications for Ertugliflozin in Type 2 Diabetes $PFE , $MRK http://ddil.si/x1891pgj/",,,,,[],https://twitter.com/SlingshotCtlyst/status/839162983561428992
1159,Watchlist News,@WatchlistN,2017-03-05T13:37:26.000Z,"Merck & Co., Inc. $MRK Receives Average Rating of ‚ÄúBuy‚Äù from Brokerages http://zpr.io/PKtvN","Merck & Co., Inc. $MRK Receives Average Rating of ‚ÄúBuy‚Äù from Brokerages http://zpr.io/PKtvN",,,,,[],https://twitter.com/WatchlistN/status/838382951146610688
1160,Jon Ogg,@jonogg,2017-03-07T14:41:55.000Z,worst DJIA stocks on Tuesday $MRK $PFE $JNJ -- what 'competition' can you get for patented drugs?,worst DJIA stocks on Tuesday $MRK $PFE $JNJ -- what 'competition' can you get for patented drugs?,,,,,[],https://twitter.com/jonogg/status/839123955881488384
1161,$peedyCalls,@SpeedyCalls,2017-03-07T16:05:44.000Z,"$MRK 62.5 Puts BUYING Activity expiring on 19th Jan, Vol 1000","$MRK 62.5 Puts BUYING Activity expiring on 19th Jan, Vol 1000",,,,,[],https://twitter.com/SpeedyCalls/status/839145048663011329
1162,Donna Young,@DonnaYoungDC,2017-03-05T15:32:05.000Z,"It was funny sketch on #SNL w/ Octavia Spencer; claims $MRK took names of her friends/family for its drugs (in reality, not $MRK's drugs)","It was funny sketch on #SNL w/ Octavia Spencer; claims $MRK took names of her friends/family for its drugs (in reality, not $MRK's drugs)
Donna Young
@DonnaYoungDC
 ¬∑ 5 Mar 2017
Thing is, names #SNL used weren't even $MRK, but $PFE (Lyrica) $AGN (Celexa) $LLY (Cymbalta) Sunovion (Lunesta) $ABBV (Humira) $AZN Crestor https://twitter.com/lisamjarvis/status/838249873174573056‚Ä¶
2
1",üì∞ üì∞,,2,1,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/838411802920824833
1163,MarketBeat,@MarketBeatCom,2017-03-07T14:07:13.000Z,"Formidable Asset Management LLC Lowers Stake in Merck & Co., Inc. $MRK http://zpr.io/PKaVH","Formidable Asset Management LLC Lowers Stake in Merck & Co., Inc. $MRK http://zpr.io/PKaVH",,,,,[],https://twitter.com/MarketBeatCom/status/839115222765957121
1164,Ticker Report,@TickerReport,2017-03-07T10:52:55.000Z,"5,545 Shares in Merck & Co., Inc. $MRK Acquired by Robertson Stephens Advisors LLC http://zpr.io/PKT9Z","5,545 Shares in Merck & Co., Inc. $MRK Acquired by Robertson Stephens Advisors LLC http://zpr.io/PKT9Z",,,,,[],https://twitter.com/TickerReport/status/839066326186528769
1165,Confident Investor,@ConfidentInvest,2017-03-07T12:05:02.000Z,Confident Investor indicator analysis for 3/7/2017. Interesting results from $AMAT $CVCO $FB $MEI $MRK - http://bit.ly/2mhiDC6,Confident Investor indicator analysis for 3/7/2017. Interesting results from $AMAT $CVCO $FB $MEI $MRK - http://bit.ly/2mhiDC6,,,,,[],https://twitter.com/ConfidentInvest/status/839084475212414976
1166,MarketBeat,@MarketBeatCom,2017-03-06T14:11:53.000Z,"MUFG Americas Holdings Corp Boosts Stake in Merck & Co., Inc. $MRK http://zpr.io/PK7Dp","MUFG Americas Holdings Corp Boosts Stake in Merck & Co., Inc. $MRK http://zpr.io/PK7Dp",,,,,[],https://twitter.com/MarketBeatCom/status/838754006780493825
1167,Daily Political,@dailypoliticaln,2017-03-05T12:05:52.000Z,"Merck & Co., Inc. $MRK Receives Average Rating of ‚ÄúBuy‚Äù from Brokerages http://ift.tt/2lNvusT","Merck & Co., Inc. $MRK Receives Average Rating of ‚ÄúBuy‚Äù from Brokerages http://ift.tt/2lNvusT",,,,,[],https://twitter.com/dailypoliticaln/status/838359907560800256
1168,John Carroll,@JohnCendpts,2017-03-07T14:02:53.000Z,"Merck, $PFE line up a big FDA decision on a blockbuster hopeful, staring down some major league competition
$MRK","Merck, $PFE line up a big FDA decision on a blockbuster hopeful, staring down some major league competition
$MRK
endpts.com
Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league...
Two Big Pharma collaborators ‚Äî Merck and Pfizer ‚Äî have moved their SGLT2 diabetes drug hopeful ertugliflozin into the hands of regulators on both sides of the Atlantic. Armed with positive pivotal...
7",,,7,,['https://pbs.twimg.com/card_img/1501738989467938821/4-0u_Ts-?format=png&name=small'],https://twitter.com/JohnCendpts/status/839114132800565248
1169,MarketBeat,@MarketBeatCom,2017-03-07T14:07:12.000Z,"Wetherby Asset Management Inc. Has $5,326,000 Stake in Merck & Co., Inc. $MRK http://zpr.io/PKaVt","Wetherby Asset Management Inc. Has $5,326,000 Stake in Merck & Co., Inc. $MRK http://zpr.io/PKaVt",,,,,[],https://twitter.com/MarketBeatCom/status/839115218110328832
1170,StockNews.com,@stocknewsdotcom,2017-03-06T13:08:01.000Z,$MRK Merck and Pfizer announce that the FDA & EMA have accepted for review three New Drug Applications for medicin‚Ä¶ https://stocknews.com/news/mrk-merck-and-pfizer-announce-that-the-fda-ema-have/‚Ä¶,$MRK Merck and Pfizer announce that the FDA & EMA have accepted for review three New Drug Applications for medicin‚Ä¶ https://stocknews.com/news/mrk-merck-and-pfizer-announce-that-the-fda-ema-have/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/838737933922365441
1171,InvestorPlace,@InvestorPlace,2017-03-07T15:00:15.000Z,"The ""New"" Valeant Is a Crock $VRX $MRK $SHLD -","The ""New"" Valeant Is a Crock $VRX $MRK $SHLD -
investorplace.com
The ""New"" Valeant Pharmaceuticals Intl Inc (VRX) Stock Is a Crock
Valeant Pharmaceuticals (VRX) might have a shiny new turnaround plan, but VRX stock is anything but new and improved.",,,,,['https://pbs.twimg.com/card_img/1501726196186460162/R68v0l_X?format=jpg&name=240x240'],https://twitter.com/InvestorPlace/status/839128567913066498
1172,AJMC,@AJMC_Journal,2017-03-07T16:00:03.000Z,#FDA accepts applications for $MRK $PFE #SGLT2 + #Januvia #ertugliflozin http://bit.ly/2mxrel3,#FDA accepts applications for $MRK $PFE #SGLT2 + #Januvia #ertugliflozin http://bit.ly/2mxrel3,,,,,[],https://twitter.com/AJMC_Journal/status/839143617641971712
1173,Hotpage News,@Hotpage_News,2017-03-07T14:17:21.000Z,EARLY MOVERS: $DKS $MIK $NAV $PFE $MRK $AET $HUM $CI $CSX $CASY $RMBS $WFT $UPS $IBM $CRM $DISH $GE $BHI $THO,"EARLY MOVERS: $DKS $MIK $NAV $PFE $MRK $AET $HUM $CI $CSX $CASY $RMBS $WFT $UPS $IBM $CRM $DISH $GE $BHI $THO
cnbc.com
Early movers: DKS, MIK, NAV, PFE, AET, CSX & more
These are the stocks posting the largest moves before the bell.",,,,,['https://pbs.twimg.com/card_img/1501739000490508289/u0aa7v5v?format=jpg&name=small'],https://twitter.com/Hotpage_News/status/839117771850002432
1174,Nigam Arora,@TheAroraReport,2017-03-07T15:09:26.000Z,3 DEADLY MISTAKES AFTER TRUMP CLAIMS HE WAS WIRETAPPED BY OBAMA $AMD $AMZN $AAPL $BAC $BMY $FCX $JPM $MRK $NVDA... http://fb.me/5MFlyWpFt,3 DEADLY MISTAKES AFTER TRUMP CLAIMS HE WAS WIRETAPPED BY OBAMA $AMD $AMZN $AAPL $BAC $BMY $FCX $JPM $MRK $NVDA... http://fb.me/5MFlyWpFt,,,,,[],https://twitter.com/TheAroraReport/status/839130880090202112
1175,Zero Filter,@zerofiltertruth,2017-03-06T15:15:27.000Z,"Added to $NVAX in lotto #biotech - Lots going on/great recent call 

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD $AMGN 
@GuyAdami
 @jonnajarian","Added to $NVAX in lotto #biotech - Lots going on/great recent call 

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD $AMGN 
@GuyAdami
 @jonnajarian
1",,,,1,[],https://twitter.com/zerofiltertruth/status/838770005596585985
1176,Zero Filter,@zerofiltertruth,2017-03-07T13:50:47.000Z,"Who needs $SNAP when lotto #biotech providing much juice lately. Latest $AEZS today's news 

$MRK $CELG $AMGN $BIIB 
@GuyAdami
 @jonnajarian","Who needs $SNAP when lotto #biotech providing much juice lately. Latest $AEZS today's news 

$MRK $CELG $AMGN $BIIB 
@GuyAdami
 @jonnajarian",,,,,[],https://twitter.com/zerofiltertruth/status/839111087714881538
1177,Clark Joseph Kent,@JorelLaraKalel,2017-03-07T20:43:07.000Z,"3 Drug Stocks Hit by Trump‚Äôs Call for Lower Prices 
@investorplace
 http://bit.ly/2mgbXCn  $PFE $MRK $AGN","3 Drug Stocks Hit by Trump‚Äôs Call for Lower Prices 
@investorplace
 http://bit.ly/2mgbXCn  $PFE $MRK $AGN
investorplace.com
3 Drug Stocks Hit by Trump's Call for Lower Prices
While stocks in general are looking weak, pharmaceutical stocks in particular are getting hit. Here are three large-cap drug stocks to avoid.",,,,,['https://pbs.twimg.com/card_img/1501738995243433984/sQoarKdc?format=jpg&name=240x240'],https://twitter.com/JorelLaraKalel/status/839214854951092224
1178,$PENNY KING,@groman100,2017-03-07T17:24:57.000Z,"What‚Äôs Next For TG Therapeutics (NASDAQ:TGTX) https://marketexclusive.com/heres-whats-next-tg-therapeutics-nasdaqtgtx/79886/‚Ä¶ via 
@marketexclusive
 $imnp $bmy $mrk $ABBV $SNY $REGN $AMGN $AMRN $fb","What‚Äôs Next For TG Therapeutics (NASDAQ:TGTX) https://marketexclusive.com/heres-whats-next-tg-therapeutics-nasdaqtgtx/79886/‚Ä¶ via 
@marketexclusive
 $imnp $bmy $mrk $ABBV $SNY $REGN $AMGN $AMRN $fb",,,,,[],https://twitter.com/groman100/status/839164981127999488
1179,$PENNY KING,@groman100,2017-03-06T17:46:21.000Z,"@PennyStockPope
 did u see $tgtx lol watch $fbio soon :) $amrn $pfe $mrk $amgn $sny $regn $alxs $galt $abmd $fb $mdco $alxn $acad $srpt #MAGA","@PennyStockPope
 did u see $tgtx lol watch $fbio soon :) $amrn $pfe $mrk $amgn $sny $regn $alxs $galt $abmd $fb $mdco $alxn $acad $srpt #MAGA
1",,,,1,[],https://twitter.com/groman100/status/838807979499511808
1180,Ken Odeluga,@Ken_Odeluga,2017-03-07T14:36:53.000Z,"Drug & health stocks at bottom of S&P500 after 
@realDonaldTrump
 tweet on drug pricing. Eli Lilly, Mallinckdrodt, $BMY, $MRK, etc 1.5%-3%","Drug & health stocks at bottom of S&P500 after 
@realDonaldTrump
 tweet on drug pricing. Eli Lilly, Mallinckdrodt, $BMY, $MRK, etc 1.5%-3%",,,,,[],https://twitter.com/Ken_Odeluga/status/839122687725350912
1181,Paul R. La Monica,@LaMonicaBuzz,2017-03-07T14:00:38.000Z,"Watch drug stocks today. $PFE $MRK $JNJ &others have pulled back in #premarket trading following 
@realDonaldTrump
 tweet on drug prices.","Watch drug stocks today. $PFE $MRK $JNJ &others have pulled back in #premarket trading following 
@realDonaldTrump
 tweet on drug prices.",,,,,[],https://twitter.com/LaMonicaBuzz/status/839113565504221184
1182,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-03-07T17:08:26.000Z,"Replying to 
@DEAHQ
 and 
@WahlbergYouth","Replying to 
@DEAHQ
 and 
@WahlbergYouth
So when is the useless 
@DEA
 going to raid too big to jail corporate HQ's $MRK $PFR $JNJ $GSK",,,,,[],https://twitter.com/ZimJay/status/839160828268003328
1183,Pharmaceutical News,@pharma_sector,2017-03-07T13:06:15.000Z,"Wetherby Asset Management Inc. Has $5,326,000 Stake in #Merck & Co., Inc. (). Read more: http://owler.us/aclSQ4 $MRK","Wetherby Asset Management Inc. Has $5,326,000 Stake in #Merck & Co., Inc. (). Read more: http://owler.us/aclSQ4 $MRK",,,,,[],https://twitter.com/pharma_sector/status/839099879083266048
1184,Albert Report,@Albert_Report,2017-03-07T14:17:21.000Z,EARLY MOVERS: $DKS $MIK $NAV $PFE $MRK $AET $HUM $CI $CSX $CASY $RMBS $WFT $UPS $IBM $CRM $DISH $GE $BHI $THO,"EARLY MOVERS: $DKS $MIK $NAV $PFE $MRK $AET $HUM $CI $CSX $CASY $RMBS $WFT $UPS $IBM $CRM $DISH $GE $BHI $THO
cnbc.com
Early movers: DKS, MIK, NAV, PFE, AET, CSX & more
These are the stocks posting the largest moves before the bell.",,,,,['https://pbs.twimg.com/card_img/1501739000490508289/u0aa7v5v?format=jpg&name=small'],https://twitter.com/Albert_Report/status/839117771891933184
1185,Endpoints News,@endpts,2017-03-07T13:59:54.000Z,"$MRK, $PFE line up big #FDA decision on a blockbuster hopeful, staring down some major league competition https://endpts.com/merck-pfizer-line-up-a-big-fda-decision-on-a-blockbuster-hopeful-staring-down-some-major-league-competition/‚Ä¶ #diabetes","$MRK, $PFE line up big #FDA decision on a blockbuster hopeful, staring down some major league competition https://endpts.com/merck-pfizer-line-up-a-big-fda-decision-on-a-blockbuster-hopeful-staring-down-some-major-league-competition/‚Ä¶ #diabetes
endpts.com
Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league...
Two Big Pharma collaborators ‚Äî Merck and Pfizer ‚Äî have moved their SGLT2 diabetes drug hopeful ertugliflozin into the hands of regulators on both sides of the Atlantic. Armed with positive pivotal...",,,,,['https://pbs.twimg.com/card_img/1501738989467938821/4-0u_Ts-?format=png&name=small'],https://twitter.com/endpts/status/839113381571330049
1186,Nigam Arora,@TheAroraReport,2017-03-07T15:30:36.000Z,3 DEADLY MISTAKES AFTER TRUMP CLAIMS HE WAS WIRETAPPED BY OBAMA $FCX $JPM $MRK $NVDA $UAL $X $SNAP $SPY,"3 DEADLY MISTAKES AFTER TRUMP CLAIMS HE WAS WIRETAPPED BY OBAMA $FCX $JPM $MRK $NVDA $UAL $X $SNAP $SPY
blog.thearorareport.com
3 DEADLY MISTAKES AFTER TRUMP CLAIMS HE WAS WIRETAPPED BY OBAMA $AMD $AMZN $AAPL $BAC $BMY $FCX...
President Trump‚Äôs tweet accusing his predecessor of wiretapping him during the campaign ‚Äî followed by Barack Obama‚Äôs denial ‚Äî has created a highly sensitive subject for many people. With this type ...",,,,,['https://pbs.twimg.com/card_img/1500597537819881474/ok8uqz7w?format=png&name=240x240'],https://twitter.com/TheAroraReport/status/839136206252298240
1187,CITY INDEX,@CityIndex,2017-03-07T14:36:53.000Z,"Drug & health stocks at bottom of S&P500 after 
@realDonaldTrump
 tweet on drug pricing. Eli Lilly, Mallinckdrodt, $BMY, $MRK, etc 1.5%-3%","Drug & health stocks at bottom of S&P500 after 
@realDonaldTrump
 tweet on drug pricing. Eli Lilly, Mallinckdrodt, $BMY, $MRK, etc 1.5%-3%",,,,,[],https://twitter.com/CityIndex/status/839122687846932480
1188,Contix Alerts,@contixalerts,2017-03-07T14:00:24.000Z,"$MRK, $PFE line up big #FDA decision on a blockbuster hopeful, staring down some major league competition 
@endpts
 https://app.contix.com/Free-Trial/36164762‚Ä¶","$MRK, $PFE line up big #FDA decision on a blockbuster hopeful, staring down some major league competition 
@endpts
 https://app.contix.com/Free-Trial/36164762‚Ä¶",,,,,[],https://twitter.com/contixalerts/status/839113508125974528
1189,Ken Odeluga,@TheSquareMile,2017-03-07T14:36:53.000Z,"Drug & health stocks at bottom of S&P500 after 
@realDonaldTrump
 tweet on drug pricing. Eli Lilly, Mallinckdrodt, $BMY, $MRK, etc 1.5%-3%","Drug & health stocks at bottom of S&P500 after 
@realDonaldTrump
 tweet on drug pricing. Eli Lilly, Mallinckdrodt, $BMY, $MRK, etc 1.5%-3%",,,,,[],https://twitter.com/TheSquareMile/status/839122687725301760
1190,pharmalot,@pharmalot,2017-03-08T18:03:49.000Z,"R&D spending may not really justify those high drug prices, after all.. https://statnews.com/pharmalot/2017/03/08/research-development-drug-prices/‚Ä¶ #pharma $MRK $PFE $BIIB $BMY $AMGN $NVS","R&D spending may not really justify those high drug prices, after all.. https://statnews.com/pharmalot/2017/03/08/research-development-drug-prices/‚Ä¶ #pharma $MRK $PFE $BIIB $BMY $AMGN $NVS
statnews.com
R&D spending may not really justify those high prices, after all
A new analysis suggests the extra sales drug companies generate in the US compared with four other wealthy countries greatly exceeds global R&D spending.
7
3",,,7,3,['https://pbs.twimg.com/card_img/1501738442761379841/uG2dEc9O?format=jpg&name=small'],https://twitter.com/pharmalot/status/839537150270050304
1191,Seeking Alpha,@SeekingAlpha,2017-03-10T14:06:00.000Z,"Endpoint Watch: Merck, Pfizer Up For December Diabetes Drug Approvals In U.S., Europe http://seekingalpha.com/article/4054088-endpoint-watch-merck-pfizer-december-diabetes-drug-approvals-u-s-europe?source=feed_f‚Ä¶ $PFE $MRK","Endpoint Watch: Merck, Pfizer Up For December Diabetes Drug Approvals In U.S., Europe http://seekingalpha.com/article/4054088-endpoint-watch-merck-pfizer-december-diabetes-drug-approvals-u-s-europe?source=feed_f‚Ä¶ $PFE $MRK
seekingalpha.com
Endpoint Watch: Merck, Pfizer Up For December Diabetes Drug Approvals In U.S., Europe (NYSE:MRK)
Merck and Pfizer's SGLT2 diabetes treatment is heading for US and European Approval. Johnson & Johnson currently dominates the market with a four-year head start.
1
1",,,1,1,[],https://twitter.com/SeekingAlpha/status/840202077678710785
1192,biocqr,@biocqr,2017-03-08T22:16:04.000Z,$CRVS leads the pack in anti-adenosine I/O development $MRK $BMY $AZN $NVS $IPHYF $JUNO,"$CRVS leads the pack in anti-adenosine I/O development $MRK $BMY $AZN $NVS $IPHYF $JUNO
1
2",,,1,2,['https://pbs.twimg.com/media/C6bbVjQXMAAPsqp?format=jpg&name=small'],https://twitter.com/biocqr/status/839600633980284929
1193,"DeShaun‚Äôs Marketing, Inc.",@DeShaunsMrk,2017-03-08T03:25:09.000Z,RT CNBCFastMoney: 'RichartRoss gives 3 names to buy in health care $XLV $AMGN $MRK $HUM,"RT CNBCFastMoney: 'RichartRoss gives 3 names to buy in health care $XLV $AMGN $MRK $HUM
From 
CNBC's Fast Money
1",,,,1,['https://pbs.twimg.com/media/C6WXhGQXEAAtKjN.jpg'],https://twitter.com/DeShaunsMrk/status/839316027494260737
1194,NFLCSFacts,@NFLObjectors,2017-03-09T11:57:46.000Z,Early Beginnings For Alzheimer's Vaccines http://seekingalpha.com/article/4053093-early-beginnings-alzheimers-vaccines?source=tweet‚Ä¶ $RHHBY $ACIU $LLY $MRK $NVS $GIFLF $GIFOF $GIKLY $GRFS $MKGAF $MKGAY,"Early Beginnings For Alzheimer's Vaccines http://seekingalpha.com/article/4053093-early-beginnings-alzheimers-vaccines?source=tweet‚Ä¶ $RHHBY $ACIU $LLY $MRK $NVS $GIFLF $GIFOF $GIKLY $GRFS $MKGAF $MKGAY
seekingalpha.com
Early Beginnings For Alzheimer's Vaccines
The unrelenting series of failures of numerous antibodies against Alzheimer‚Äôs disease has not deterred biopharma, as shown most recently by Roche (OTCQX:RHHBY) starting new phase III trials...",,,,,['https://pbs.twimg.com/card_img/1497724725002448899/2TZ3O23_?format=png&name=240x240'],https://twitter.com/NFLObjectors/status/839807419744141314
1195,ChartMill,@ChartMill,2017-03-10T03:56:29.000Z,$MRK has a great technical rating! Check out it's strong points at http://stockcharts.chartmill.com/u/SyxSGViyjg #NationalPancakeDay #GrowthHacking,"$MRK has a great technical rating! Check out it's strong points at http://stockcharts.chartmill.com/u/SyxSGViyjg #NationalPancakeDay #GrowthHacking
2
3",,,2,3,[],https://twitter.com/ChartMill/status/840048687216807936
1196,Pharmaceutical News,@pharma_sector,2017-03-10T16:37:13.000Z,BerGenBio and #Merck collaborate for BGB324 and Keytruda evaluation in NSCLC and ... Read more: http://owler.us/acnjW5 $MRK,"BerGenBio and #Merck collaborate for BGB324 and Keytruda evaluation in NSCLC and ... Read more: http://owler.us/acnjW5 $MRK
2
1",,,2,1,[],https://twitter.com/pharma_sector/status/840240135685865472
1197,$PENNY KING,@groman100,2017-03-10T02:32:38.000Z,"Fortress Biotech to Present at the 29th Annual ROTH Conference http://finance.yahoo.com/news/fortress-biotech-present-29th-annual-130000918.html?soc_src=social-sh&soc_trk=tw‚Ä¶ via 
@YahooFinance
 $FBIO $TGTX $BMY $MRK $AMGN $MDCO","Fortress Biotech to Present at the 29th Annual ROTH Conference http://finance.yahoo.com/news/fortress-biotech-present-29th-annual-130000918.html?soc_src=social-sh&soc_trk=tw‚Ä¶ via 
@YahooFinance
 $FBIO $TGTX $BMY $MRK $AMGN $MDCO",,,,,[],https://twitter.com/groman100/status/840027588726734848
1198,Don,@COMMONSENCE10,2017-03-10T13:35:36.000Z,$MRK Trump Twitter hit MRK & others PPS this week : ( MRK Strong.,"$MRK Trump Twitter hit MRK & others PPS this week : ( MRK Strong.
1",,,,1,[],https://twitter.com/COMMONSENCE10/status/840194429625356288
1199,FlowerPower,@Flower_Power_67,2017-03-08T03:47:10.000Z,"1/2
MadMoneyEspresso
$MCK‚Äî
$MRK$LLY$AGN$PFE$MYL‚Äî
$ALXN‚Äîa takeout target
$LOGI‚Äî
$THO‚Äî
$THS ‚Äî
$TGTX‚Äî
$KMI‚Äî$MMP mo better","1/2
MadMoneyEspresso
$MCK‚Äî
$MRK$LLY$AGN$PFE$MYL‚Äî
$ALXN‚Äîa takeout target
$LOGI‚Äî
$THO‚Äî
$THS ‚Äî
$TGTX‚Äî
$KMI‚Äî$MMP mo better",üëç üëç üëç üëç,,,,"['https://pbs.twimg.com/media/C6XefgOUsAAPH7e?format=jpg&name=small', 'https://pbs.twimg.com/media/C6XefgPUsAEHXi5?format=jpg&name=small']",https://twitter.com/Flower_Power_67/status/839321570053144576
1200,.¬≥,@4E93C4B107FEA2,2017-03-10T21:00:52.000Z,Sitting in a bar right now and there was just an ad for Keytruda on the flat screen. $Afmd $Mrk,"Sitting in a bar right now and there was just an ad for Keytruda on the flat screen. $Afmd $Mrk
1
3",,1,,3,[],https://twitter.com/4E93C4B107FEA2/status/840306483241840640
1201,Dangerous Drugs,@ddrugsus,2017-03-08T20:25:14.000Z,"R&D spending may not really justify those high drug prices, after all. https://statnews.com/pharmalot/2017/03/08/research-development-drug-prices/‚Ä¶ #pharma $MRK $PFE $BIIB $BMY $AMGN $NVS","R&D spending may not really justify those high drug prices, after all. https://statnews.com/pharmalot/2017/03/08/research-development-drug-prices/‚Ä¶ #pharma $MRK $PFE $BIIB $BMY $AMGN $NVS
1
1",,,1,1,['https://pbs.twimg.com/media/C6bC9GfWQAA_je-?format=jpg&name=small'],https://twitter.com/ddrugsus/status/839572738587168769
1202,WellRounded News,@WellRoundedNews,2017-03-08T03:26:10.000Z,RT CNBCFastMoney: 'RichartRoss gives 3 names to buy in health care $XLV $AMGN $MRK $HUM,"RT CNBCFastMoney: 'RichartRoss gives 3 names to buy in health care $XLV $AMGN $MRK $HUM
From 
CNBC's Fast Money",,,,,['https://pbs.twimg.com/media/C6WXhGQXEAAtKjN.jpg'],https://twitter.com/WellRoundedNews/status/839316284940697601
1203,Titan V,@titan_v16,2017-03-09T18:14:33.000Z,"Despite hype, still much to uncover about immunotherapy $MRK $BMY $RHHBY","Despite hype, still much to uncover about immunotherapy $MRK $BMY $RHHBY
biopharmadive.com
Despite hype, still much to uncover about immunotherapy
Key execs from Novartis and Merck spoke in Washington, DC Wednesday about how best to unlock broader efficacy from immunotherapy.
1",,,,1,['https://pbs.twimg.com/card_img/1501425184036864003/NFYYbNvo?format=jpg&name=small'],https://twitter.com/titan_v16/status/839902241737871360
1204,Allison Gatlin,@IBD_AGatlin,2017-03-10T19:24:46.000Z,Dear Gilead: Buy something -- anything -- analyst pleads $GILD $INCY $AZN $CLVS $TSRO $MRK $SGEN http://ow.ly/dXVZ309NbV0,"Dear Gilead: Buy something -- anything -- analyst pleads $GILD $INCY $AZN $CLVS $TSRO $MRK $SGEN http://ow.ly/dXVZ309NbV0
1
3",,,1,3,[],https://twitter.com/IBD_AGatlin/status/840282299015036930
1205,Insider Monkey News,@insidermonkey_n,2017-03-08T16:49:53.000Z,"Are #HedgeFunds Turning Bearish on Healthcare #Stocks?
$AGN, $GILD, $PFE, $MRK, $JNJ","Are #HedgeFunds Turning Bearish on Healthcare #Stocks?
$AGN, $GILD, $PFE, $MRK, $JNJ
insidermonkey.com
Are Hedge Funds Turning Bearish on Healthcare Stocks?
Healthcare stocks generally offer good dividend yields and a safe stream of cash flow given the recession-proof nature of the industry.",,,,,['https://pbs.twimg.com/card_img/1501738699117240322/wF-YQEtQ?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/839518544370991105
1206,Craig Tolliver,@Craig_Tolliver,2017-03-08T13:24:44.000Z,The ‚ÄúNew‚Äù Valeant Pharmaceuticals Intl Inc Stock Is a Crock https://scutify.com/articles/2017-03-08-the-new-valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-crock‚Ä¶ $VRX $LRLCY $MRK #pharmaceuticals #healthcare #debt,"The ‚ÄúNew‚Äù Valeant Pharmaceuticals Intl Inc Stock Is a Crock https://scutify.com/articles/2017-03-08-the-new-valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-crock‚Ä¶ $VRX $LRLCY $MRK #pharmaceuticals #healthcare #debt
1",,,,1,[],https://twitter.com/Craig_Tolliver/status/839466920080523266
1207,Endpoints News,@endpts,2017-03-10T10:46:00.000Z,"OncoResponse wraps Series A with $22.5M; Plotting #IPO, BerGenBio partners with Merck on #cancer combos http://endpts.com/oncoresponse-w‚Ä¶ $TGTX $MRK","OncoResponse wraps Series A with $22.5M; Plotting #IPO, BerGenBio partners with Merck on #cancer combos http://endpts.com/oncoresponse-w‚Ä¶ $TGTX $MRK
endpts.com
OncoResponse wraps Series A with $22.5M; Plotting IPO, BerGenBio partners with Merck on cancer...
‚Üí The immuno-oncology antibody discovery company OncoResponse, created by MD Anderson and Theraclone Sciences, just completed a long-running Series A with $22.5 million. The biotech has been piecing...
1
2",,,1,2,['https://pbs.twimg.com/card_img/1501446688942215170/w0TqIXM_?format=jpg&name=small'],https://twitter.com/endpts/status/840151748224380928
1208,ChartMill,@ChartMill,2017-03-09T13:57:28.000Z,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/BkxW_kkJog #MGWV #jewelry,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/BkxW_kkJog #MGWV #jewelry,,,,,[],https://twitter.com/ChartMill/status/839837545563312129
1209,Endpoints News,@endpts,2017-03-08T04:02:00.000Z,"$MRK, $PFE line up big #FDA decision on a blockbuster hopeful, staring down some major league competition http://endpts.com/merck-pfizer-l‚Ä¶ #diabetes","$MRK, $PFE line up big #FDA decision on a blockbuster hopeful, staring down some major league competition http://endpts.com/merck-pfizer-l‚Ä¶ #diabetes
endpts.com
Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league...
Two Big Pharma collaborators ‚Äî Merck and Pfizer ‚Äî have moved their SGLT2 diabetes drug hopeful ertugliflozin into the hands of regulators on both sides of the Atlantic. Armed with positive pivotal...
1",,,,1,['https://pbs.twimg.com/card_img/1501738989467938821/4-0u_Ts-?format=png&name=small'],https://twitter.com/endpts/status/839325303449219073
1210,Marcelo Vega,@mr_vega01,2017-03-08T03:29:04.000Z,CNBC: RT CNBCFastMoney: 'RichartRoss gives 3 names to buy in health care $XLV $AMGN $MRK $HUM,"CNBC: RT CNBCFastMoney: 'RichartRoss gives 3 names to buy in health care $XLV $AMGN $MRK $HUM
From 
CNBC's Fast Money",,,,,['https://pbs.twimg.com/media/C6WXhGQXEAAtKjN.jpg'],https://twitter.com/mr_vega01/status/839317015152189440
1211,Scutify,@scutify,2017-03-08T13:24:03.000Z,The ‚ÄúNew‚Äù Valeant Pharmaceuticals Intl Inc Stock Is a Crock https://scutify.com/articles/2017-03-08-the-new-valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-crock‚Ä¶ $VRX $LRLCY $MRK #pharmaceuticals #healthcare #debt,The ‚ÄúNew‚Äù Valeant Pharmaceuticals Intl Inc Stock Is a Crock https://scutify.com/articles/2017-03-08-the-new-valeant-pharmaceuticals-intl-inc-vrx-stock-is-a-crock‚Ä¶ $VRX $LRLCY $MRK #pharmaceuticals #healthcare #debt,,,,,['https://pbs.twimg.com/media/C6Zii69WYAE59h9?format=jpg&name=360x360'],https://twitter.com/scutify/status/839466746201391104
1212,ChartMill,@ChartMill,2017-03-10T13:36:28.000Z,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/S1eEWnmlix #Rolex #TwitterTips,Ready to invest? $MRK is definitely worth checking out today! http://stockcharts.chartmill.com/u/S1eEWnmlix #Rolex #TwitterTips,,,,,[],https://twitter.com/ChartMill/status/840194645128859648
1213,James Klein,@555_MKTG,2017-03-10T04:01:05.000Z,[H-NYC] RT ChartMill: $MRK has a great technical rating! Check out it's strong points at http://bit.ly/2n5D3PW #NationalPancakeDay #Grow‚Ä¶,[H-NYC] RT ChartMill: $MRK has a great technical rating! Check out it's strong points at http://bit.ly/2n5D3PW #NationalPancakeDay #Grow‚Ä¶,,,,,[],https://twitter.com/555_MKTG/status/840049846824370176
1214,Pharmaceutical News,@pharma_sector,2017-03-10T13:48:25.000Z,"#Merck & Co., Inc. Position Raised by Van ECK Associates Corp. Read more: http://owler.us/acniDn $MRK","#Merck & Co., Inc. Position Raised by Van ECK Associates Corp. Read more: http://owler.us/acniDn $MRK",,,,,[],https://twitter.com/pharma_sector/status/840197652973203456
1215,MarketBeat,@MarketBeatCom,2017-03-09T16:20:28.000Z,Merck KGaA given ‚Ç¨114.00 PT by Nord/LB. buy rating. http://ift.tt/2n3SIPP $MRK #MRK,Merck KGaA given ‚Ç¨114.00 PT by Nord/LB. buy rating. http://ift.tt/2n3SIPP $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/839873529218809856
1216,Headlne,@headlneapp,2017-03-08T14:06:18.000Z,Check out The IAm Jim Cramer App for iPhone (http://goo.gl/SmQ0dx) and Android (http://goo.gl/Pr2wTT) $VRX $MRK $PFE $LLY $HRB $HEMP,Check out The IAm Jim Cramer App for iPhone (http://goo.gl/SmQ0dx) and Android (http://goo.gl/Pr2wTT) $VRX $MRK $PFE $LLY $HRB $HEMP,,,,,[],https://twitter.com/headlneapp/status/839477380511117315
1217,CHItrader,@CHItraders,2017-03-09T14:27:33.000Z,"$MRK $BMY: Johnson & Johnson, Merck, Bristol-Myers Squibb Upgraded  http://schaeffersresearch.com/content/news/2017/03/09/johnson-johnson-merck-bristol-myers-squibb-upgraded‚Ä¶","$MRK $BMY: Johnson & Johnson, Merck, Bristol-Myers Squibb Upgraded  http://schaeffersresearch.com/content/news/2017/03/09/johnson-johnson-merck-bristol-myers-squibb-upgraded‚Ä¶",,,,,[],https://twitter.com/CHItraders/status/839845113031426049
1218,BioPharma Dive,@BioPharmaDive,2017-03-10T17:29:01.000Z,"Prescribed reading: lawmakers press Marathon over pricing; $NVS, $MRK execs talk checkpoint inhibitors","Prescribed reading: lawmakers press Marathon over pricing; $NVS, $MRK execs talk checkpoint inhibitors
biopharmadive.com
Prescribed Reading: More backlash to drug pricing
Negotiating Medicare prices is now on the table, lawmakers are not happy with Marathon, and PTC is pushing back at the FDA. 
1
1",,,1,1,[],https://twitter.com/BioPharmaDive/status/840253170978758656
1219,Watchlist News,@WatchlistN,2017-03-10T14:13:26.000Z,"Ruffer LLP Cuts Position in Merck & Co., Inc. $MRK http://zpr.io/PKkey","Ruffer LLP Cuts Position in Merck & Co., Inc. $MRK http://zpr.io/PKkey",,,,,[],https://twitter.com/WatchlistN/status/840203948141211649
1220,Limex,@LimexMe,2017-03-08T15:22:54.000Z,Forget the Distractions: Bristol-Myers Squibb Is a Bargain $BMY $MRK $AZN,"Forget the Distractions: Bristol-Myers Squibb Is a Bargain $BMY $MRK $AZN
whotrades.com
Forget the Distractions: Bristol-Myers Squibb Is a Bargain
What will Carl Icahn do? Will Bristol-Myers Squibb (NYSE: BMY) be acquired? How will Opdivo fare against Merck 's (NYSE: MRK) Keytruda? There are plenty of unanswered questions‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/839496655103746050
1221,Watchlist News,@WatchlistN,2017-03-08T14:10:42.000Z,"Beaumont Financial Partners LLC Cuts Stake in Merck & Co., Inc. $MRK http://zpr.io/PKAdb","Beaumont Financial Partners LLC Cuts Stake in Merck & Co., Inc. $MRK http://zpr.io/PKAdb",,,,,[],https://twitter.com/WatchlistN/status/839478487488548868
1222,Daily Political,@dailypoliticaln,2017-03-09T10:45:36.000Z,"Merck & Co., Inc. $MRK Stake Held by Fifth Third Bancorp http://ift.tt/2m2BQUv","Merck & Co., Inc. $MRK Stake Held by Fifth Third Bancorp http://ift.tt/2m2BQUv",,,,,[],https://twitter.com/dailypoliticaln/status/839789259154403330
1223,Daily Political,@dailypoliticaln,2017-03-09T10:45:36.000Z,"Cleararc Capital Inc. Has $3,647,000 Stake in Merck & Co., Inc. $MRK http://ift.tt/2n2w6ir","Cleararc Capital Inc. Has $3,647,000 Stake in Merck & Co., Inc. $MRK http://ift.tt/2n2w6ir",,,,,[],https://twitter.com/dailypoliticaln/status/839789256902074368
1224,Watchlist News,@WatchlistN,2017-03-10T11:41:18.000Z,"FNY Partners Fund LP Takes Position in Merck & Co., Inc. $MRK http://zpr.io/PK2Qc","FNY Partners Fund LP Takes Position in Merck & Co., Inc. $MRK http://zpr.io/PK2Qc",,,,,[],https://twitter.com/WatchlistN/status/840165663582933000
1225,Insider Monkey,@insidermonkey,2017-03-08T16:50:28.000Z,"Are #HedgeFunds Turning Bearish on Healthcare #Stocks?
$AGN, $GILD, $PFE, $MRK, $JNJ","Are #HedgeFunds Turning Bearish on Healthcare #Stocks?
$AGN, $GILD, $PFE, $MRK, $JNJ
insidermonkey.com
Are Hedge Funds Turning Bearish on Healthcare Stocks?
Healthcare stocks generally offer good dividend yields and a safe stream of cash flow given the recession-proof nature of the industry.",,,,,['https://pbs.twimg.com/card_img/1501738699117240322/wF-YQEtQ?format=jpg&name=240x240'],https://twitter.com/insidermonkey/status/839518691691794432
1226,TalkMarkets,@TalkMarkets,2017-03-10T14:19:00.000Z,How #Incyte #Stock Became A Bull Market Star For Biotech Investors $INCY Also $GILD $NVS $LLY $MRK $RHHBY $AZN https://goo.gl/TYHae4,How #Incyte #Stock Became A Bull Market Star For Biotech Investors $INCY Also $GILD $NVS $LLY $MRK $RHHBY $AZN https://goo.gl/TYHae4,,,,,[],https://twitter.com/TalkMarkets/status/840205348648673280
1227,Nigam Arora,@TheAroraReport,2017-03-09T13:07:18.000Z,‚ÄòOBAMACARE LITE‚Äô--OPPORTUNITIES & PERILS FOR INVESTORS $XBI $MDT $BSX $EW $CYH $THC $PFE $JNJ $MRK $BMY $TEVA $MYL,"‚ÄòOBAMACARE LITE‚Äô--OPPORTUNITIES & PERILS FOR INVESTORS $XBI $MDT $BSX $EW $CYH $THC $PFE $JNJ $MRK $BMY $TEVA $MYL
blog.thearorareport.com
TRUMP‚ÄôS ‚ÄòOBAMACARE LITE‚Äô PRESENTS OPPORTUNITIES AND PERILS FOR INVESTORS $XBI $MDT $BSX $EW $CYH...
Republicans have finally produced a detailed plan to repeal and replace the Affordable Care Act, also known as Obamacare. Setting aside politics and viewing the plan neutrally, two things jump out....",,,,,['https://pbs.twimg.com/card_img/1499535915764666369/jassme0u?format=png&name=240x240'],https://twitter.com/TheAroraReport/status/839824920448286724
1228,Allison Gatlin,@IBD_AGatlin,2017-03-09T20:22:12.000Z,"Will Merck, Glaxo undercut Gilead's next ""Mount Everest"" drug? $MRK $GSK $GILD $ABBV http://ow.ly/Crc1309KURk","Will Merck, Glaxo undercut Gilead's next ""Mount Everest"" drug? $MRK $GSK $GILD $ABBV http://ow.ly/Crc1309KURk",,,,,[],https://twitter.com/IBD_AGatlin/status/839934366100905985
1229,Schaeffer's Investment Research,@schaeffers,2017-03-09T15:00:20.000Z,"Jefferies raised its price targets on $JNJ, $MRK, and $BMY","Jefferies raised its price targets on $JNJ, $MRK, and $BMY
schaeffersresearch.com
Johnson & Johnson, Merck, Bristol-Myers Squibb Upgraded - Schaeffer's Investment Research
Jefferies raised its price targets on drug stocks Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE:MRK), and Bristol-Myers Squibb Co (NYSE:BMY)
1",,,1,,[],https://twitter.com/schaeffers/status/839853362862505984
1230,Allison Gatlin,@IBD_AGatlin,2017-03-10T17:24:25.000Z,How Gilead is paying the price for actually curing a disease $GILD $MRK $ABBV $INCY $GSK,"How Gilead is paying the price for actually curing a disease $GILD $MRK $ABBV $INCY $GSK
investors.com
How Gilead Is Paying The Price For Actually Curing A Disease
Gilead's HCV drugs pulled in north of $44 billion over three years, but sales declined in 2016 and are projected for a repeat performance.",,,,,[],https://twitter.com/IBD_AGatlin/status/840252014206550016
1231,BooRad,@atticusMB,2017-03-08T15:11:51.000Z,"Forget the Distractions: Bristol-Myers Squibb Is a Bargain 
@themotleyfool
 #stocks $PFE, $MRK, $BMY, $RHHBY, $AZN","Forget the Distractions: Bristol-Myers Squibb Is a Bargain 
@themotleyfool
 #stocks $PFE, $MRK, $BMY, $RHHBY, $AZN
fool.com
Forget the Distractions: Bristol-Myers Squibb Is a Bargain @themotleyfool #stocks $BMY $PFE $MRK...
Growth opportunities for Bristol-Myers Squibb make this drug stock a bargain.",,,,,[],https://twitter.com/atticusMB/status/839493873881726976
1232,$PENNY KING,@groman100,2017-03-08T18:41:12.000Z,"ignor $fbio while i cash in on it im in 
@2
.40 10+ soon $Tgtx $amrn $bmy $mrk $amgn $sny $regn $adxs $ftr $fb $mdco $alxn $snap $gbt $blph","ignor $fbio while i cash in on it im in 
@2
.40 10+ soon $Tgtx $amrn $bmy $mrk $amgn $sny $regn $adxs $ftr $fb $mdco $alxn $snap $gbt $blph",,,,,[],https://twitter.com/groman100/status/839546561478602753
1233,Contix Alerts,@contixalerts,2017-03-09T16:49:14.000Z,"Nice to see BerGenBio collaborate w $MRK to test its 1st-in-class axl kinase (licensed from $RIGL) in 
@mikegoodma
 https://app.contix.com/alerts/36257778","Nice to see BerGenBio collaborate w $MRK to test its 1st-in-class axl kinase (licensed from $RIGL) in 
@mikegoodma
 https://app.contix.com/alerts/36257778",,,,,[],https://twitter.com/contixalerts/status/839880770764230656
1234,Insider Monkey News,@insidermonkey_n,2017-03-08T16:38:18.000Z,"FDA Endorses 3 New Drug Applications (NDAs) From $MRK, $PFE","FDA Endorses 3 New Drug Applications (NDAs) From $MRK, $PFE
insidermonkey.com
FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc. (NYSE:PFE).",,,,,['https://pbs.twimg.com/card_img/1501981830110535683/vAk0jEwD?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/839515630046957569
1235,Ticker Report,@TickerReport,2017-03-09T05:46:10.000Z,"Merck & Co., Inc. $MRK Raised to Buy at Vetr Inc. http://ift.tt/2mnPLYA","Merck & Co., Inc. $MRK Raised to Buy at Vetr Inc. http://ift.tt/2mnPLYA",,,,,[],https://twitter.com/TickerReport/status/839713905807147008
1236,BioPharma Dive,@BioPharmaDive,2017-03-09T18:07:00.000Z,"$BMY, $MRK and $RHHBY checkpoint inhibitors are spurring big investments in I/O","$BMY, $MRK and $RHHBY checkpoint inhibitors are spurring big investments in I/O
biopharmadive.com
Despite hype, still much to uncover about immunotherapy
Key execs from Novartis and Merck spoke in Washington, DC Wednesday about how best to unlock broader efficacy from immunotherapy.
2",,,,2,['https://pbs.twimg.com/card_img/1501425184036864003/NFYYbNvo?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/839900342754152450
1237,Contix Alerts,@contixalerts,2017-03-09T15:01:17.000Z,"Jefferies raised its price targets on $JNJ, $MRK, and $BMY 
@schaeffers
 https://app.contix.com/alerts/36252797","Jefferies raised its price targets on $JNJ, $MRK, and $BMY 
@schaeffers
 https://app.contix.com/alerts/36252797",,,,,[],https://twitter.com/contixalerts/status/839853603426746368
1238,Contix Alerts,@contixalerts,2017-03-10T13:07:47.000Z,"Pfizer And Merck Go For An Even Longer Throw Of The Javelin $MRK $BMY $AZN $RHHBY $PFE $MKGAF $MKGA 
@SeekingAlpha
 https://app.contix.com/alerts/36287938","Pfizer And Merck Go For An Even Longer Throw Of The Javelin $MRK $BMY $AZN $RHHBY $PFE $MKGAF $MKGA 
@SeekingAlpha
 https://app.contix.com/alerts/36287938",,,,,[],https://twitter.com/contixalerts/status/840187427901722624
1239,Benzinga,@Benzinga,2017-03-08T19:59:26.000Z,Here's Your March PDUFA Date Preview https://benzinga.com/z/9147705 $MRK $RDUS $REGN,"Here's Your March PDUFA Date Preview https://benzinga.com/z/9147705 $MRK $RDUS $REGN
benzinga.com
Here's Your March PDUFA Date Preview
The PDUFA dates are a key catalyst for any pharma company, especially biotechs, as this is the date when the FDA gives its verdict on the drug‚Äôs NDA. The Prescription Drug...
1",,,,1,[],https://twitter.com/Benzinga/status/839566248459583488
1240,Benzinga,@Benzinga,2017-03-08T19:22:58.000Z,Everything We Know About Merck's Keytruda https://benzinga.com/z/9147190 $MRK,Everything We Know About Merck's Keytruda https://benzinga.com/z/9147190 $MRK,,,,,[],https://twitter.com/Benzinga/status/839557072303837184
1241,Benzinga,@Benzinga,2017-03-10T16:52:01.000Z,".
@adamfeuerstein
 Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump https://benzinga.com/z/9158311 $GILD $IBB $MRK $XBI",".
@adamfeuerstein
 Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump https://benzinga.com/z/9158311 $GILD $IBB $MRK $XBI
benzinga.com
Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump
There‚Äôs a lot of ambiguity surrounding the GOP healthcare strategy ‚Äî enough to render market predictions nearly impossible. In an interview on Benzinga's PreMarket...
2",,,,2,[],https://twitter.com/Benzinga/status/840243858822713345
1242,Limex,@LimexMe,2017-03-10T17:00:29.000Z,"Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump $GILD $MRK http://bit.ly/100317GILD","Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump $GILD $MRK http://bit.ly/100317GILD",,,,,[],https://twitter.com/LimexMe/status/840245991290875910
1243,Seeking Alpha,@SeekingAlpha,2017-03-13T17:54:07.000Z,Therapy Focus - Plugging New Molecules Into The HIV Combinations http://seekingalpha.com/article/4054631-therapy-focus-plugging-new-molecules-hiv-combinations?source=feed_f‚Ä¶ $GILD $BMY $JNJ $ABBV $GSK $MRK,"Therapy Focus - Plugging New Molecules Into The HIV Combinations http://seekingalpha.com/article/4054631-therapy-focus-plugging-new-molecules-hiv-combinations?source=feed_f‚Ä¶ $GILD $BMY $JNJ $ABBV $GSK $MRK
seekingalpha.com
Therapy Focus - Plugging New Molecules Into The HIV Combinations
With hepatitis C therapies in their 15th minute of fame, Gilead Sciences‚Äô (NASDAQ:GILD) investors are looking to the group‚Äôs core HIV drugs as its primary growth driver.
3
2",,,3,2,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/841346650765320192
1244,Donna Young,@DonnaYoungDC,2017-03-12T14:22:58.000Z,#NIH #NCI #cancer #pharma #biotech $MRK $BMY,"#NIH #NCI #cancer #pharma #biotech $MRK $BMY
CBS Sunday Morning
@CBSSunday
 ¬∑ 12 Mar 2017
""Once we knew it could work, we've been working around the clock,""-Dr. Steven Rosenberg
2",üì∞ üåû,,2,,"['https://pbs.twimg.com/profile_images/909133356578697216/a5nP8MHw_mini.jpg', 'https://pbs.twimg.com/media/C6uHCDzWcAEJAE7?format=jpg&name=small']",https://twitter.com/DonnaYoungDC/status/840931126441103360
1245,Seeking Alpha,@SeekingAlpha,2017-03-13T09:50:12.000Z,"Merck Is A Great Healthcare Pick, But Overvalued At This Time http://seekingalpha.com/article/4054468-merck-great-healthcare-pick-overvalued-time?source=feed_f‚Ä¶ $MRK","Merck Is A Great Healthcare Pick, But Overvalued At This Time http://seekingalpha.com/article/4054468-merck-great-healthcare-pick-overvalued-time?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Merck Is A Great Healthcare Pick, But Overvalued At This Time (NYSE:MRK)
Merck recently reported their Q4 results. The company's commitment to R&D is their great advantage.",,,,,['https://pbs.twimg.com/card_img/1492089870126395396/PHrUKX4_?format=jpg&name=360x360'],https://twitter.com/SeekingAlpha/status/841224870025297923
1246,Seeking Alpha,@SeekingAlpha,2017-03-13T17:35:53.000Z,Assessing Jon Meacham's Open Letter To Gilead http://seekingalpha.com/article/4054611-assessing-jon-meachams-open-letter-gilead?source=feed_f‚Ä¶ $ABBV $ALXN $BMY $GSK $JNJ $NVS $PFE $VRTX $INCY $GLPG $MRK $GILD,"Assessing Jon Meacham's Open Letter To Gilead http://seekingalpha.com/article/4054611-assessing-jon-meachams-open-letter-gilead?source=feed_f‚Ä¶ $ABBV $ALXN $BMY $GSK $JNJ $NVS $PFE $VRTX $INCY $GLPG $MRK $GILD
seekingalpha.com
Assessing Geoff Meacham's Open Letter To Gilead (NASDAQ:GILD)
Last week, Barclays and its analyst Geoff Meacham issued an open letter to GILD, though it's behind the company's firewall.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/841342059638214656
1247,MM+M Magazine,@MMMnews,2017-03-13T11:30:02.000Z,Missed Friday's news? Here's what to know #pharma $NVS #Imatinib $NVO $MRK #biosimilars #Trumpcare #healthcare #hcsm http://bit.ly/2n7fndV,"Missed Friday's news? Here's what to know #pharma $NVS #Imatinib $NVO $MRK #biosimilars #Trumpcare #healthcare #hcsm http://bit.ly/2n7fndV
2
4",,,2,4,['https://pbs.twimg.com/media/C6kZq7AWsAAz3MB?format=jpg&name=small'],https://twitter.com/MMMnews/status/841249990953582592
1248,CBPartners,@CBPartners,2017-03-13T22:30:42.000Z,BERGENBIO & $MRK collaborate to focus on clinical evaluation of BGB324 with KEYTRUDA for advanced #NSCLC & #TNBC http://bit.ly/2mmQcRm,"BERGENBIO & $MRK collaborate to focus on clinical evaluation of BGB324 with KEYTRUDA for advanced #NSCLC & #TNBC http://bit.ly/2mmQcRm
1",,,,1,[],https://twitter.com/CBPartners/status/841416252895686656
1249,Quantcha Trade Ideas,@QuantchaIdeas,2017-03-13T16:20:07.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/03/13/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-10/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/03/13/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-10/‚Ä¶,,,,,['https://pbs.twimg.com/media/C6z6zW4V4AAH8fQ?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/841322993682915329
1250,Pharmaceutical News,@pharma_sector,2017-03-13T09:56:59.000Z,New #Merck Technology Aims to Further Optimize Embryo Incubation and Assessment. Read more: http://owler.us/acnQV1 $MRK,New #Merck Technology Aims to Further Optimize Embryo Incubation and Assessment. Read more: http://owler.us/acnQV1 $MRK,,,,,[],https://twitter.com/pharma_sector/status/841226576037535745
1251,Pharmaceutical News,@pharma_sector,2017-03-13T09:56:22.000Z,"#Merck & Co., Inc. Shares Bought by Coldstream Capital Management Inc. Read more: http://owler.us/acnQV2 $MRK","#Merck & Co., Inc. Shares Bought by Coldstream Capital Management Inc. Read more: http://owler.us/acnQV2 $MRK",,,,,[],https://twitter.com/pharma_sector/status/841226420672065536
1252,Kevin Shannon,@kj_shannon15,2017-03-13T13:46:40.000Z,FDA accepts NDA for ertugliflozin monotherapy and FDCs with Januvia and metformin to treat type 2 diabetes $PFE $MRK http://bit.ly/2lSFMI6,"FDA accepts NDA for ertugliflozin monotherapy and FDCs with Januvia and metformin to treat type 2 diabetes $PFE $MRK http://bit.ly/2lSFMI6
2",,,2,,[],https://twitter.com/kj_shannon15/status/841284379267678208
1253,SpoiledrottenBrat,@TaxHavens,2017-03-13T15:01:29.000Z,$GILD $INCY one garbage bag for GILD. $BMY $MRK $JNJ,$GILD $INCY one garbage bag for GILD. $BMY $MRK $JNJ,,,,,[],https://twitter.com/TaxHavens/status/841303205061496832
1254,Dow Stocks,@Top_Dow_Stocks,2017-03-13T07:17:05.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/841186334827978752
1255,BackToTheFutures,@Back2DaFutures,2017-03-11T09:34:28.000Z,"my prediction = $GILD won't buy $INCY, $MRK will","my prediction = $GILD won't buy $INCY, $MRK will
1",,,,1,[],https://twitter.com/Back2DaFutures/status/840496135219294208
1256,Stock Market Picks,@StockWebTrading,2017-03-13T15:10:51.000Z,DowStockTip's Results: $MRK opened SHORT on 3/3 at $66.60 and closed today at $64.50 +3.15% (http://dowstocktips.com) $QQQ $SPY $DIA,DowStockTip's Results: $MRK opened SHORT on 3/3 at $66.60 and closed today at $64.50 +3.15% (http://dowstocktips.com) $QQQ $SPY $DIA,,,,,['https://pbs.twimg.com/media/C6zq7_aW0AAFZXM?format=jpg&name=small'],https://twitter.com/StockWebTrading/status/841305563342479360
1257,TradingView Ideas,@TradingViewAlt,2017-03-13T17:18:50.000Z,MRK - strong return to previous range $MRK http://tradingview.com/chart/MRK/xJemU2m2-MRK-strong-return-to-previous-range/‚Ä¶,"MRK - strong return to previous range $MRK http://tradingview.com/chart/MRK/xJemU2m2-MRK-strong-return-to-previous-range/‚Ä¶
1",,,1,,[],https://twitter.com/TradingViewAlt/status/841337772363272192
1258,Tom Silver,@TomSilver39,2017-03-12T04:32:29.000Z,$OMED $BMY $MRK TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy,"$OMED $BMY $MRK TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
onlinelibrary.wiley.com
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
While therapies targeting the co-inhibitory or immune checkpoint receptors PD-1 and CTLA-4 have shown remarkable success in many cancers, not all patients benefit from these therapies. This has...
3
1",,,3,1,['https://pbs.twimg.com/card_img/1501737988530786304/TckrwAXi?format=jpg&name=240x240'],https://twitter.com/TomSilver39/status/840782523370217472
1259,@NJBeachy,@NJBeachy,2017-03-13T14:16:34.000Z,"Merck $MRK is dipping... may get in as it has Keytruda, immunotherapy drug that is saving lives

#keytruda #immunotherapy","Merck $MRK is dipping... may get in as it has Keytruda, immunotherapy drug that is saving lives

#keytruda #immunotherapy",,,,,[],https://twitter.com/NJBeachy/status/841291903492599808
1260,ChartMill,@ChartMill,2017-03-12T14:44:27.000Z,"Ever woken up thinking: ""Is $MRK breaking out?"" Fullfill your morning thoughts at http://stockcharts.chartmill.com/u/B1xHx1kmix #Breakout #Tits #EHR","Ever woken up thinking: ""Is $MRK breaking out?"" Fullfill your morning thoughts at http://stockcharts.chartmill.com/u/B1xHx1kmix #Breakout #Tits #EHR",,,,,[],https://twitter.com/ChartMill/status/840936531485425665
1261,IECONOMICS,@iECONOMICS,2017-03-13T14:05:15.000Z,Merck & Co $MRK market alert: 4-week low @ 64.41 https://ieconomics.com/merck,Merck & Co $MRK market alert: 4-week low @ 64.41 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/841289055149182977
1262,ChartMill,@ChartMill,2017-03-12T19:24:27.000Z,$MRK has a great technical rating! Check out it's strong points at http://stockcharts.chartmill.com/u/SyxHcxmmsl #Fed #emails,$MRK has a great technical rating! Check out it's strong points at http://stockcharts.chartmill.com/u/SyxHcxmmsl #Fed #emails,,,,,[],https://twitter.com/ChartMill/status/841006996170125313
1263,Zenect,@zenect,2017-03-13T08:54:28.000Z,#Dividend stocks balance returns with safety‚Ä¶ http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  #workingfromhome,#Dividend stocks balance returns with safety‚Ä¶ http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  #workingfromhome,,,,,[],https://twitter.com/zenect/status/841210840762241024
1264,ChartMill,@ChartMill,2017-03-12T14:37:27.000Z,"Wow, have you seen the technical rating of $MRK?? Daily analysis at ChartMill, take a peek! http://stockcharts.chartmill.com/u/r1x-LaRzog #Cuse #contest","Wow, have you seen the technical rating of $MRK?? Daily analysis at ChartMill, take a peek! http://stockcharts.chartmill.com/u/r1x-LaRzog #Cuse #contest",,,,,[],https://twitter.com/ChartMill/status/840934768929886211
1265,Pharmaceutical News,@pharma_sector,2017-03-13T09:57:36.000Z,"EOD Risers: JPMorgan Chase & Co., McDonald's Corporation, #Merck & Co., Inc., Pfizer Inc. Read more: http://owler.us/acnQVY $MRK","EOD Risers: JPMorgan Chase & Co., McDonald's Corporation, #Merck & Co., Inc., Pfizer Inc. Read more: http://owler.us/acnQVY $MRK",,,,,[],https://twitter.com/pharma_sector/status/841226731285487617
1266,MarketBeat,@MarketBeatCom,2017-03-13T09:18:23.000Z,Merck KGaA given ‚Ç¨95.00 PT by HSBC Holdings plc. neutral rating. http://ift.tt/2mB8MVZ $MRK #MRK,Merck KGaA given ‚Ç¨95.00 PT by HSBC Holdings plc. neutral rating. http://ift.tt/2mB8MVZ $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/841216861312303104
1267,MarketBeat,@MarketBeatCom,2017-03-11T18:55:20.000Z,Merck & Co.‚Äôs $MRK ‚ÄúUnderperform‚Äù Rating Reaffirmed at Jefferies Group LLC http://ift.tt/2lOj7RB #acn,Merck & Co.‚Äôs $MRK ‚ÄúUnderperform‚Äù Rating Reaffirmed at Jefferies Group LLC http://ift.tt/2lOj7RB #acn,,,,,[],https://twitter.com/MarketBeatCom/status/840637280406654982
1268,Zero Filter,@zerofiltertruth,2017-03-13T14:24:55.000Z,"$PPHM surging back up after checking-in with technical support 

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD $AMGN $SHPG $BIIB","$PPHM surging back up after checking-in with technical support 

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD $AMGN $SHPG $BIIB",,,,,[],https://twitter.com/zerofiltertruth/status/841294002402017282
1269,Sweet Platform,@SweetPlatform,2017-03-13T16:04:37.000Z,"MRK Top news - Mar 13th, 2017 $MRK http://https://goo.gl/f1bgZm","MRK Top news - Mar 13th, 2017 $MRK http://https://goo.gl/f1bgZm",,,,,[],https://twitter.com/SweetPlatform/status/841319095438041088
1270,Allison Gatlin,@IBD_AGatlin,2017-03-13T17:36:45.000Z,"Lilly, Merck, Amgen top analyst's view for 2017 pharma $LLY $MRK $AMGN $BMY $RHHBY $INCY $ALDR $CRVS $AIMT","Lilly, Merck, Amgen top analyst's view for 2017 pharma $LLY $MRK $AMGN $BMY $RHHBY $INCY $ALDR $CRVS $AIMT
investors.com
Lilly, Merck, Allergan Top Analyst's View For 2017 Pharma
Eli Lilly, Merck and Allergan stand to outperform broad pharma stocks in 2017, a Credit Suisse analyst said Monday.
1",,,1,,['https://pbs.twimg.com/card_img/1496277896259850241/MOQ3QMpa?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/841342278107049985
1271,Watchlist News,@WatchlistN,2017-03-11T18:03:34.000Z,"Merck & Co., Inc. $MRK Rating Reiterated by Jefferies Group LLC http://zpr.io/PK4q3","Merck & Co., Inc. $MRK Rating Reiterated by Jefferies Group LLC http://zpr.io/PK4q3",,,,,[],https://twitter.com/WatchlistN/status/840624252793544704
1272,Ticker Report,@TickerReport,2017-03-11T11:02:19.000Z,"Alethea Capital Management LLC Has $486,000 Position in Merck & Co., Inc. $MRK http://ift.tt/2muVCKr","Alethea Capital Management LLC Has $486,000 Position in Merck & Co., Inc. $MRK http://ift.tt/2muVCKr",,,,,[],https://twitter.com/TickerReport/status/840518243152474112
1273,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-03-11T13:32:01.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/8yMgyGYHb,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/8yMgyGYHb,,,,,[],https://twitter.com/gem_2014/status/840555916021895170
1274,Watchlist News,@WatchlistN,2017-03-11T13:23:13.000Z,"Abbrea Capital LLC Buys Shares of 32,079 Merck & Co., Inc. $MRK http://zpr.io/PKeQb","Abbrea Capital LLC Buys Shares of 32,079 Merck & Co., Inc. $MRK http://zpr.io/PKeQb",,,,,[],https://twitter.com/WatchlistN/status/840553699625844737
1275,Paul D. Rennert,@PDRennert,2017-03-11T12:37:31.000Z,"In March:

I'll b @ Sach's Bio (NYC) & Jefferies IO (BOS)- futurecast PD-1/L1 combo & competitive landscapes = surprise ending! 
$MRK etc","In March:

I'll b @ Sach's Bio (NYC) & Jefferies IO (BOS)- futurecast PD-1/L1 combo & competitive landscapes = surprise ending! 
$MRK etc",,,,,[],https://twitter.com/PDRennert/status/840542197393043456
1276,Sports_Bios,@Sports_bios,2017-03-13T10:10:36.000Z,IF I apply the insane valuation of onco assets in the specs.. guess what the mktcap for $CELG $BMY $MRK etc etc.. would be.. hahahaha..,IF I apply the insane valuation of onco assets in the specs.. guess what the mktcap for $CELG $BMY $MRK etc etc.. would be.. hahahaha..,,,,,[],https://twitter.com/Sports_bios/status/841230003899650048
1277,TalkMarkets,@TalkMarkets,2017-03-11T03:09:04.000Z,How Incyte Stock Became A Bull Market Star For Biotech Investors $INCY Also $GILD $NVS $LLY $MRK $RHHBY $AZN https://goo.gl/TYHae4,How Incyte Stock Became A Bull Market Star For Biotech Investors $INCY Also $GILD $NVS $LLY $MRK $RHHBY $AZN https://goo.gl/TYHae4,,,,,[],https://twitter.com/TalkMarkets/status/840399142916636672
1278,Kelle Bond,@kelleAbond,2017-03-13T00:49:33.000Z,"Billionaire Carl Icahn Is Reportedly Buying Bristol-Myers Squibb Stock 
@themotleyfool
 #stocks $MRK, $BMY","Billionaire Carl Icahn Is Reportedly Buying Bristol-Myers Squibb Stock 
@themotleyfool
 #stocks $MRK, $BMY
fool.com
Billionaire Carl Icahn Is Reportedly Buying Bristol-Myers Squibb Stock -- Should You? @themotleyf...
Could the billionaire's reported investment mean something big is about to happen for Bristol-Myers Squibb?",,,,,[],https://twitter.com/kelleAbond/status/841088809936793601
1279,Endpoints News,@endpts,2017-03-11T22:02:00.000Z,"Trending this week: $MRK, $PFE line up big FDA decision on blockbuster hopeful, staring down some major competition https://endpts.com/merck-pfizer-line-up-a-big-fda-decision-on-a-blockbuster-hopeful-staring-down-some-major-league-competition/‚Ä¶","Trending this week: $MRK, $PFE line up big FDA decision on blockbuster hopeful, staring down some major competition https://endpts.com/merck-pfizer-line-up-a-big-fda-decision-on-a-blockbuster-hopeful-staring-down-some-major-league-competition/‚Ä¶",,,,,[],https://twitter.com/endpts/status/840684258196824066
1280,JQ,@jq1234t,2017-03-13T20:00:17.000Z,"Did FDA miss $MRK Keytruda Mar 8 PDUFA date for microsatellite instability-high cancer?
http://businesswire.com/news/home/20161128005228/en/FDA-Grants-Priority-Review-Merck‚Ä¶‚Äôs-Supplemental-Biologics","Did FDA miss $MRK Keytruda Mar 8 PDUFA date for microsatellite instability-high cancer?
http://businesswire.com/news/home/20161128005228/en/FDA-Grants-Priority-Review-Merck‚Ä¶‚Äôs-Supplemental-Biologics
businesswire.com
FDA Grants Priority Review to Merck‚Äôs Supplemental Biologics License Application (sBLA) Seeking...
FDA Grants Priority Review to Merck‚Äôs Supplemental Biologics License Application (sBLA) Seeking Approval for KEYTRUDA¬Æ (pembrolizumab) for New Indicat
2",,,2,,[],https://twitter.com/jq1234t/status/841378401139195905
1281,Barchart,@Barchart,2017-03-13T20:27:02.000Z,"Markets Right Now: US Stocks Xxx
$MBLY $FCX $MRK 
See Here ","Markets Right Now: US Stocks Xxx
$MBLY $FCX $MRK 
See Here 
barchart.com
Today's Stock Market News, Futures News, Forex News - Barchart.com
Today's top Market Headlines from AP News. Business news, corporate news, finance news, more.",‚û°,,,,[],https://twitter.com/Barchart/status/841385132443488264
1282,haodongvli,@haodongvli,2017-03-11T18:28:31.000Z,"Replying to 
@Gupta_Calling","Replying to 
@Gupta_Calling
all PARP inhibitors in play, street consensus: TSRO rules, similar to $BMY in PD/PDL-1 before $MRK ruined the party
1",,,,1,[],https://twitter.com/haodongvli/status/840630532237082624
1283,Sports_Bios,@Sports_bios,2017-03-13T13:48:01.000Z,"Replying to 
@dsobek","Replying to 
@dsobek
I still know some old hands at $MRK.. these people are not nutz..  even with $GILD, they still need to do things that make sense..
2",,2,,,[],https://twitter.com/Sports_bios/status/841284715801903105
1284,David Sobek,@dsobek,2017-03-13T13:46:17.000Z,"Replying to 
@Sports_bios","Replying to 
@Sports_bios
Not sure who would be interested at these levels.  $MRK perhaps given the collaboration.  A desperate $GILD?
1",,1,,,[],https://twitter.com/dsobek/status/841284278768017410
1285,Daily Political,@dailypoliticaln,2017-03-11T18:33:14.000Z,"Merck & Co., Inc. $MRK Rating Reiterated by Jefferies Group LLC http://ift.tt/2nqD7Wr","Merck & Co., Inc. $MRK Rating Reiterated by Jefferies Group LLC http://ift.tt/2nqD7Wr",,,,,[],https://twitter.com/dailypoliticaln/status/840631718491090946
1286,dough,@semodough,2017-03-16T10:46:34.000Z,NICE job RBC surveying 100 cardiologist on cholesterol lowering drugs   10 key takeaways $AMGN $REGN $MRK $ESPR $MDCO,"NICE job RBC surveying 100 cardiologist on cholesterol lowering drugs   10 key takeaways $AMGN $REGN $MRK $ESPR $MDCO
1
16
43",,1,16,43,['https://pbs.twimg.com/media/C7CLOiuU0AA_CDW?format=jpg&name=small'],https://twitter.com/semodough/status/842326218666049536
1287,Open Outcrier,@OpenOutcrier,2017-03-15T12:23:53.000Z,"$MRK (+0.5% pre) Merck's Keytruda wins FDA nod for treating blood cancer - Reuters

http://ooc.bz/l/10273","$MRK (+0.5% pre) Merck's Keytruda wins FDA nod for treating blood cancer - Reuters

http://ooc.bz/l/10273
2
1",,,2,1,[],https://twitter.com/OpenOutcrier/status/841988318141267972
1288,Seeking Alpha,@SeekingAlpha,2017-03-16T15:28:33.000Z,"When It Rains, It Pours For Gilead http://seekingalpha.com/article/4055773-rains-pours-gilead?source=feed_f‚Ä¶ $ABBV $GSK $MRK $GILD","When It Rains, It Pours For Gilead http://seekingalpha.com/article/4055773-rains-pours-gilead?source=feed_f‚Ä¶ $ABBV $GSK $MRK $GILD
1",,,1,,[],https://twitter.com/SeekingAlpha/status/842397181579472898
1289,FOX Business,@FoxBusiness,2017-03-14T20:07:36.000Z,Big Pharma: $JNJ $MRK $PFE $AGN $LLY,"Big Pharma: $JNJ $MRK $PFE $AGN $LLY
2
4
6",,2,4,6,['https://pbs.twimg.com/media/C654Z3VVAAEE17T?format=jpg&name=small'],https://twitter.com/FoxBusiness/status/841742630539149314
1290,Evaluate Vantage,@evaluatevantage,2017-03-15T11:43:22.000Z,Vantage Snippet ‚Äì Keytruda‚Äôs colorectal cancer delay spurs new PD-1 race $MRK,"Vantage Snippet ‚Äì Keytruda‚Äôs colorectal cancer delay spurs new PD-1 race $MRK
1
3",,,1,3,['https://pbs.twimg.com/media/C69Oh5JWoAEOXrB?format=jpg&name=small'],https://twitter.com/evaluatevantage/status/841978125349195776
1291,TradeHawk,@TradeHawk,2017-03-14T19:23:38.000Z,$MRK FDA approves Merck Keytruda supplemental BLA for treatment of patients w/refractory classical Hodgkin lymphoma http://accessdata.fda.gov/drugsatfda_docs/label/2017/125514s015lbl.pdf‚Ä¶,"$MRK FDA approves Merck Keytruda supplemental BLA for treatment of patients w/refractory classical Hodgkin lymphoma http://accessdata.fda.gov/drugsatfda_docs/label/2017/125514s015lbl.pdf‚Ä¶
15
9",,,15,9,[],https://twitter.com/TradeHawk/status/841731566967504896
1292,pharmalot,@pharmalot,2017-03-14T20:26:05.000Z,"When it comes to needed vaccines, pharma offers a mixed bag.. see the report.. https://statnews.com/pharmalot/2017/03/14/vaccines-ebola-zika-glaxosmithkline/‚Ä¶ #pharma #vaccines $GSK $MRK $SMY $PFE","When it comes to needed vaccines, pharma offers a mixed bag.. see the report.. https://statnews.com/pharmalot/2017/03/14/vaccines-ebola-zika-glaxosmithkline/‚Ä¶ #pharma #vaccines $GSK $MRK $SMY $PFE
statnews.com
When it comes to needed vaccines, pharma offers a mixed bag
For years, vaccines have been lacking for various infectious diseases because drug makers consider certain markets insufficiently profitable.
1",,,1,,[],https://twitter.com/pharmalot/status/841747279551844354
1293,John Carroll,@JohnCendpts,2017-03-15T23:13:51.000Z,"Top story:
FDA OKs Merck‚Äôs Keytruda for Hodgkin lymphoma, a first in blood cancer
$MRK","Top story:
FDA OKs Merck‚Äôs Keytruda for Hodgkin lymphoma, a first in blood cancer
$MRK
endpts.com
FDA OKs Merck‚Äôs Keytruda for Hodgkin lymphoma, a first in blood cancer
Merck has racked up another FDA approval for Keytruda, this time for classical Hodgkin lymphoma, marking the PD-1 blocker's first green-light for use in liquid tumors. Regulators handed out the OK...
16
19",,,16,19,['https://pbs.twimg.com/card_img/1500040128382877696/kss5wBcf?format=png&name=small'],https://twitter.com/JohnCendpts/status/842151889542119424
1294,Joe Caputo,@JoeFCaputo,2017-03-14T18:42:28.000Z,Rumor mill is swirling that $MRK is interested in buying $VRX for ~$20/share #BUYOUT #BTFD,"Rumor mill is swirling that $MRK is interested in buying $VRX for ~$20/share #BUYOUT #BTFD
2
3
4",,2,3,4,[],https://twitter.com/JoeFCaputo/status/841721205438713857
1295,Greg5thTrad,@Greg5thTrad,2017-03-14T00:02:41.000Z,$ Flows: Buying on Weakness: Among stocks that were down MON-these had the largest net INFLOWS of money $MRK $IBM $AMGN $ESRX $CMG $PEP top6,"$ Flows: Buying on Weakness: Among stocks that were down MON-these had the largest net INFLOWS of money $MRK $IBM $AMGN $ESRX $CMG $PEP top6
2",,,,2,['https://pbs.twimg.com/media/C61kqMyVsAAdyEh?format=jpg&name=900x900'],https://twitter.com/Greg5thTrad/status/841439401049759744
1296,Seeking Alpha,@SeekingAlpha,2017-03-15T13:15:24.000Z,Better Out Than In As Pharma Continues To Find Value Externally http://seekingalpha.com/article/4055344-better-pharma-continues-find-value-externally?source=feed_f‚Ä¶ $LLY $ICPT $CSLLY $ACAD $SRPT $MRK $PFE,"Better Out Than In As Pharma Continues To Find Value Externally http://seekingalpha.com/article/4055344-better-pharma-continues-find-value-externally?source=feed_f‚Ä¶ $LLY $ICPT $CSLLY $ACAD $SRPT $MRK $PFE
1",,,1,,[],https://twitter.com/SeekingAlpha/status/842001285142396929
1297,FiercePharma,@FiercePharma,2017-03-14T18:40:16.000Z,Top 15 pharma companies by 2016 revenue http://fiercepharma.com/special-report/top-15-pharma-companies-by-2016-revenues‚Ä¶ $JNJ $PFE $RHHBY $NVS $MRK,"Top 15 pharma companies by 2016 revenue http://fiercepharma.com/special-report/top-15-pharma-companies-by-2016-revenues‚Ä¶ $JNJ $PFE $RHHBY $NVS $MRK
6
3",,,6,3,[],https://twitter.com/FiercePharma/status/841720652574949379
1298,The Coal Trader,@dyer440,2017-03-15T19:03:04.000Z,Entered $MRK calls.,"Entered $MRK calls.
1",,,,1,[],https://twitter.com/dyer440/status/842088778047094791
1299,deafdaytrader,@deafdaytrader,2017-03-16T00:40:51.000Z,"For 25 dollars up stocks part 2
""@"" is 5cross10
$OIH
$HAL
$MRK
$RAI
$LQD
$NEM pinch
$COP
$ENB
$VNQ
$SU
$CAT
$XME pinch
Nice bottom","For 25 dollars up stocks part 2
""@"" is 5cross10
$OIH
$HAL
$MRK
$RAI
$LQD
$NEM pinch
$COP
$ENB
$VNQ
$SU
$CAT
$XME pinch
Nice bottom
1
1",,,1,1,[],https://twitter.com/deafdaytrader/status/842173785251975168
1300,Millennials Grid,@MillennialsGrid,2017-03-14T20:11:23.000Z,Big Pharma: $JNJ $MRK $PFE $AGN $LLY  #business,"Big Pharma: $JNJ $MRK $PFE $AGN $LLY  #business
1
1",,1,,1,['https://pbs.twimg.com/media/C654Z3VVAAEE17T?format=jpg&name=small'],https://twitter.com/MillennialsGrid/status/841743582142824449
1301,Chris Sanders,@Gr8FundManager,2017-03-16T19:57:55.000Z,"$CELG showing excellent RELATIVE STRENGTH today

$BIIB $IBB $LLY $PFE  $REGN $BLUE $AMGN $AGN $MRK","$CELG showing excellent RELATIVE STRENGTH today

$BIIB $IBB $LLY $PFE  $REGN $BLUE $AMGN $AGN $MRK
1",,,,1,[],https://twitter.com/Gr8FundManager/status/842464970541535233
1302,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-03-14T21:20:05.000Z,"FDA needs more time to review Merck's sBLA for Keytruda in MSI-H, action date June 9 http://seekingalpha.com/news/3251122-fda-needs-time-review-mercks-sbla-keytruda-msi-h-action-date-june-9?source=tweet‚Ä¶ $MRK","FDA needs more time to review Merck's sBLA for Keytruda in MSI-H, action date June 9 http://seekingalpha.com/news/3251122-fda-needs-time-review-mercks-sbla-keytruda-msi-h-action-date-june-9?source=tweet‚Ä¶ $MRK
seekingalpha.com
FDA needs more time to review Merck's sBLA for Keytruda in MSI-H, action date June 9 (NYSE:MRK)
Citing the need for more time to review additional data, the FDA extends its action date to June 9 for its review of Merck's (NYSE:MRK) supplemental Biologics License Application (sBLA)...
2",,,,2,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/dhovekamp42/status/841760872959774720
1303,See It Market,@seeitmarket,2017-03-14T03:09:45.000Z,"NEW Blog - ""Market Update: Using Time Frames To Manage Portfolio Risk"" https://seeitmarket.com/stock-market-update-using-time-frames-to-manage-portfolio-risk-16668/‚Ä¶  by 
@CJMendes
$SPY $MRK $XOM $TGT $GE","NEW Blog - ""Market Update: Using Time Frames To Manage Portfolio Risk"" https://seeitmarket.com/stock-market-update-using-time-frames-to-manage-portfolio-risk-16668/‚Ä¶  by 
@CJMendes
$SPY $MRK $XOM $TGT $GE
seeitmarket.com
Stock Market Update: Using Time Frames To Manage Portfolio Risk
The broad market S&P 500 Index (INDEXSP:.INX) is showing some extreme signs of exhaustion following an incredible run post presidential election. This last leg of the 8 year bull market in equities...
5
3",,,5,3,['https://pbs.twimg.com/card_img/1501736993855791106/Kkssptiq?format=jpg&name=small'],https://twitter.com/seeitmarket/status/841486480581226496
1304,Carly Helfand,@CarlyHFierce,2017-03-15T15:23:29.000Z,"Merck's Keytruda nabs first blood-cancer nod, but rare cancer decision has to wait: http://bit.ly/2nsppDB $MRK #pharma #marketing","Merck's Keytruda nabs first blood-cancer nod, but rare cancer decision has to wait: http://bit.ly/2nsppDB $MRK #pharma #marketing
fiercepharma.com
Merck's Keytruda nabs first blood-cancer nod, but rare cancer decision has to wait
Late last year, Merck snagged two FDA priority review tags for Keytruda in one we | Late last year, Merck snagged two FDA priority review tags for Keytruda in one week, winning speedy regulatory...
1",,,1,,['https://pbs.twimg.com/card_img/1499068319969726466/RtX7wKq0?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/842033515671748610
1305,Loncar Biotech ETFs,@LoncarFunds,2017-03-14T20:23:24.000Z,Approved: FDA has granted approval to $MRK's immunotherapy drug Keytruda for refractory classical Hodgkin lymphoma. http://loncarfunds.com/cncr-holdings/,"Approved: FDA has granted approval to $MRK's immunotherapy drug Keytruda for refractory classical Hodgkin lymphoma. http://loncarfunds.com/cncr-holdings/
2",,,,2,['https://pbs.twimg.com/media/C657t0bU0AAcqhQ?format=jpg&name=small'],https://twitter.com/LoncarFunds/status/841746607590653953
1306,Endpoints News,@endpts,2017-03-15T12:24:32.000Z,"#FDA OKs $MRK Keytruda for #HodgkinLymphoma, a first in #bloodcancer https://endpts.com/fda-oks-mercks-keytruda-for-hodgkin-lymphoma-a-first-in-blood-cancer/‚Ä¶ #biotech #drugapproval by 
@AKAarsalan","#FDA OKs $MRK Keytruda for #HodgkinLymphoma, a first in #bloodcancer https://endpts.com/fda-oks-mercks-keytruda-for-hodgkin-lymphoma-a-first-in-blood-cancer/‚Ä¶ #biotech #drugapproval by 
@AKAarsalan
endpts.com
FDA OKs Merck‚Äôs Keytruda for Hodgkin lymphoma, a first in blood cancer
Merck has racked up another FDA approval for Keytruda, this time for classical Hodgkin lymphoma, marking the PD-1 blocker's first green-light for use in liquid tumors. Regulators handed out the OK...
4
2",,,4,2,['https://pbs.twimg.com/card_img/1500040128382877696/kss5wBcf?format=png&name=small'],https://twitter.com/endpts/status/841988483099037701
1307,Evaluate Vantage,@evaluatevantage,2017-03-14T17:02:56.000Z,Better out than in as pharma continues to find value externally http://epvantage.com/Universal/View.aspx?type=Story&id=694087&isEPVantage=yes‚Ä¶ $PFE $ACAD $MRK,Better out than in as pharma continues to find value externally http://epvantage.com/Universal/View.aspx?type=Story&id=694087&isEPVantage=yes‚Ä¶ $PFE $ACAD $MRK,,,,,['https://pbs.twimg.com/media/C65NKZ7XUAEbpRG?format=jpg&name=small'],https://twitter.com/evaluatevantage/status/841696155553714176
1308,Joseph Lizyness,@JosephLizyness,2017-03-14T14:29:18.000Z,Traders have loaded up call options for $mrk 65 and 65.50 versus puts. Interesting on a down market day. #WallStreet #DayTrading,Traders have loaded up call options for $mrk 65 and 65.50 versus puts. Interesting on a down market day. #WallStreet #DayTrading,,,,,[],https://twitter.com/JosephLizyness/status/841657493340213250
1309,ChimeraResearchGroup,@ChimeraResearch,2017-03-15T14:38:14.000Z,March 15 Biotech Update $az $BMRN $BMY $CLVS $MRK https://goo.gl/CkUSie,"March 15 Biotech Update $az $BMRN $BMY $CLVS $MRK https://goo.gl/CkUSie
1",,,,1,[],https://twitter.com/ChimeraResearch/status/842022129575051270
1310,Joseph Lizyness,@JosephLizyness,2017-03-15T09:15:35.000Z,Wall Street is looking for a rebound in premarket trading. $dia $qqq and $spy all positive. $mrk $pfe #wednesdaymotivation,Wall Street is looking for a rebound in premarket trading. $dia $qqq and $spy all positive. $mrk $pfe #wednesdaymotivation,,,,,[],https://twitter.com/JosephLizyness/status/841940930668158977
1311,Dekker Hewett Group,@CGWM_DHG,2017-03-16T17:35:37.000Z,"Morning Coffee - CGWM (Feat. #FOMC, $CXR, $CRH, $EMP, $TOT, $BABA, $AMZN, $EEFT, $MRK, $TWTR, $UPS, $YHOO, etc.) http://ow.ly/fHwH309YzCZ","Morning Coffee - CGWM (Feat. #FOMC, $CXR, $CRH, $EMP, $TOT, $BABA, $AMZN, $EEFT, $MRK, $TWTR, $UPS, $YHOO, etc.) http://ow.ly/fHwH309YzCZ
1",,,,1,[],https://twitter.com/CGWM_DHG/status/842429156696686592
1312,Stockaholics,@Stockaholics,2017-03-15T05:25:54.000Z,We Have A HUGE New Penny Stock Pick Coming Tomorrow Morning! Get Early Access: http://tr.im/1phhi #Breakout $INSY $MRK,We Have A HUGE New Penny Stock Pick Coming Tomorrow Morning! Get Early Access: http://tr.im/1phhi #Breakout $INSY $MRK,,,,,[],https://twitter.com/Stockaholics/status/841883132936785922
1313,XM Capital,@XMCapitalGroup,2017-03-16T14:00:16.000Z,Buying some more $XLV here 76.01. Has had bullish option flow for months. Big upside breakout in Mar. Could see 80-85 soon. $PFE $MRK $JNJ,Buying some more $XLV here 76.01. Has had bullish option flow for months. Big upside breakout in Mar. Could see 80-85 soon. $PFE $MRK $JNJ,,,,,[],https://twitter.com/XMCapitalGroup/status/842374961427820545
1314,$PENNY KING,@groman100,2017-03-14T17:04:36.000Z,$tgtx is melting up what a lovely sight $amrn $amgn $mrk $pfe $sny $regn $mdco $rnn $imnp $adxs $blph $basi,$tgtx is melting up what a lovely sight $amrn $amgn $mrk $pfe $sny $regn $mdco $rnn $imnp $adxs $blph $basi,,,,,[],https://twitter.com/groman100/status/841696575336280070
1315,$PENNY KING,@groman100,2017-03-15T18:40:38.000Z,$TGTX  big pharma is lifting 1 eyebrow & taking a long look at this data imo $gild $teva $mrk $bmy $azn $agn $lly  many more need new drugs,"$TGTX  big pharma is lifting 1 eyebrow & taking a long look at this data imo $gild $teva $mrk $bmy $azn $agn $lly  many more need new drugs
1",,,,1,[],https://twitter.com/groman100/status/842083132610301952
1316,Titan V,@titan_v16,2017-03-15T20:46:37.000Z,"Keytruda's head-to-head against Opdivo rockets meds to Nos. 2 and 3 in ad spending | $MRK $BMY, $ABBV |","Keytruda's head-to-head against Opdivo rockets meds to Nos. 2 and 3 in ad spending | $MRK $BMY, $ABBV |
fiercepharma.com
Keytruda's head-to-head against Opdivo rockets meds to Nos. 2 and 3 in ad spending
It‚Äôs a DTC category that didn‚Äôt even exist on national television two years ago. But last month, dueling immuno-oncology drugs from Merck & Co. | Dueling immuno-oncology drugs from Merck & Co. and...",,,,,['https://pbs.twimg.com/card_img/1501737480835452929/c4VjXbSH?format=jpg&name=small'],https://twitter.com/titan_v16/status/842114838230925312
1317,BioPharma Dive,@BioPharmaDive,2017-03-15T22:20:00.000Z,"$MRK ""stands behind the demonstrated safety and efficacy of Zostavax,"" as lawsuits pile up http://bit.ly/2msY9mH","$MRK ""stands behind the demonstrated safety and efficacy of Zostavax,"" as lawsuits pile up http://bit.ly/2msY9mH
1",,,1,,[],https://twitter.com/BioPharmaDive/status/842138339130105856
1318,Daily Political,@dailypoliticaln,2017-03-14T10:07:24.000Z,"Investec Asset Management LTD Buys 719 Shares of Merck & Co., Inc. $MRK http://ift.tt/2mHMOCl","Investec Asset Management LTD Buys 719 Shares of Merck & Co., Inc. $MRK http://ift.tt/2mHMOCl",,,,,[],https://twitter.com/dailypoliticaln/status/841591583426387968
1319,WallStreetGangsta,@WallStGangsta,2017-03-16T17:59:58.000Z,Cell MedX Corp. a small biotech tracing out big promise https://journaltranscript.com/2017/03/cell-medx-corp-otcmktscmxc-a-small-biotech-tracing-out-big-promise/‚Ä¶ ‚Ä¶  $IBB $GILD $MRK $BMY $PUMA $JNJ $NVS $AMGN $CMXC,Cell MedX Corp. a small biotech tracing out big promise https://journaltranscript.com/2017/03/cell-medx-corp-otcmktscmxc-a-small-biotech-tracing-out-big-promise/‚Ä¶ ‚Ä¶  $IBB $GILD $MRK $BMY $PUMA $JNJ $NVS $AMGN $CMXC,,,,,[],https://twitter.com/WallStGangsta/status/842435284012826624
1320,Vetr,@VetrRatings,2017-03-14T07:03:03.000Z,"Vetr users have downgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $61.33 http://bit.ly/1GhW0TK","Vetr users have downgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $61.33 http://bit.ly/1GhW0TK",,,,,[],https://twitter.com/VetrRatings/status/841545190636687360
1321,Watchlist News,@WatchlistN,2017-03-15T13:19:26.000Z,"Merck & Co., Inc. $MRK Shares Bought by Associated Banc Corp http://zpr.io/PuTi3","Merck & Co., Inc. $MRK Shares Bought by Associated Banc Corp http://zpr.io/PuTi3",,,,,[],https://twitter.com/WatchlistN/status/842002299149000708
1322,Dr Kanak Kanti De,@DrKanakKantiDe,2017-03-15T13:43:03.000Z,"Premarket Biotech Digest ‚Äì $MRK receives FDA approval, $AZN reports +ve results, $BIOC inks new deal http://drkkd.com/premarket-biotech-digest-mrk-receives-fda-approval-azn-reports-ve-results-bioc-inks-new-deal/‚Ä¶","Premarket Biotech Digest ‚Äì $MRK receives FDA approval, $AZN reports +ve results, $BIOC inks new deal http://drkkd.com/premarket-biotech-digest-mrk-receives-fda-approval-azn-reports-ve-results-bioc-inks-new-deal/‚Ä¶
1",,,,1,[],https://twitter.com/DrKanakKantiDe/status/842008241286590464
1323,MarketBeat,@MarketBeatCom,2017-03-16T11:42:33.000Z,Merck & Co. $MRK ‚Äì Investment Analysts‚Äô Recent Ratings Changes http://ift.tt/2mvLJub #acn,Merck & Co. $MRK ‚Äì Investment Analysts‚Äô Recent Ratings Changes http://ift.tt/2mvLJub #acn,,,,,[],https://twitter.com/MarketBeatCom/status/842340305127002113
1324,Contix Alerts,@contixalerts,2017-03-14T19:23:40.000Z,"$MRK FDA approves Merck Keytruda supplemental BLA for treatment of patients w/refractory classical Hod 
@TradeHawk
 https://app.contix.com/alerts/36412849","$MRK FDA approves Merck Keytruda supplemental BLA for treatment of patients w/refractory classical Hod 
@TradeHawk
 https://app.contix.com/alerts/36412849
1",,,,1,[],https://twitter.com/contixalerts/status/841731573250646016
1325,Portfolio Penny,@PortfolioPenny,2017-03-15T18:00:05.000Z,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2mpm1Y9 $PFE $MRK $TEVA $BMY $ABBV $LLY,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2mpm1Y9 $PFE $MRK $TEVA $BMY $ABBV $LLY,,,,,['https://pbs.twimg.com/media/C6-k3PoWsAc1xNt?format=jpg&name=small'],https://twitter.com/PortfolioPenny/status/842072926295855105
1326,Watchlist News,@WatchlistN,2017-03-16T10:06:37.000Z,"Merck & Co., Inc. $MRK Position Lowered by Thornburg Investment Management Inc. http://zpr.io/Puhbx","Merck & Co., Inc. $MRK Position Lowered by Thornburg Investment Management Inc. http://zpr.io/Puhbx",,,,,[],https://twitter.com/WatchlistN/status/842316161903689728
1327,Briefing.com,@Briefingcom,2017-03-14T22:44:18.000Z,$MRK: Merck announces that the FDA has extended the action date for the sBLA for KEYTRUDA for previously treated... http://bit.ly/2mKipng,"$MRK: Merck announces that the FDA has extended the action date for the sBLA for KEYTRUDA for previously treated... http://bit.ly/2mKipng
1",,,,1,[],https://twitter.com/Briefingcom/status/841782064768671744
1328,Briefing.com,@Briefingcom,2017-03-14T23:10:18.000Z,$MRK: Merck receives FDA approval for KEYTRUDA for the treatment of adult and pediatric patients with refractory... http://bit.ly/2mKAce0,"$MRK: Merck receives FDA approval for KEYTRUDA for the treatment of adult and pediatric patients with refractory... http://bit.ly/2mKAce0
1",,,,1,[],https://twitter.com/Briefingcom/status/841788608449134594
1329,cowenresearch,@CowenResearch,2017-03-14T12:44:59.000Z,Steve Scala updates his PD-1/PD-L1 #immunooncology market model $AZN $BMY $MRK $RHHBY $PFE,Steve Scala updates his PD-1/PD-L1 #immunooncology market model $AZN $BMY $MRK $RHHBY $PFE,,,,,[],https://twitter.com/CowenResearch/status/841631243481579520
1330,Insider Monkey,@insidermonkey,2017-03-16T20:22:58.000Z,$MRK Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug,"$MRK Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug
insidermonkey.com
Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug
Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc.",,,,,['https://pbs.twimg.com/card_img/1501737386052669444/IjJD0edi?format=jpg&name=240x240'],https://twitter.com/insidermonkey/status/842471272911192068
1331,Allison Gatlin,@IBD_AGatlin,2017-03-14T15:56:53.000Z,Incyte spikes to year-high on rumors Gilead could acquire it $GILD $INCY $MRK $BMY,"Incyte spikes to year-high on rumors Gilead could acquire it $GILD $INCY $MRK $BMY
investors.com
Incyte Spikes To Record High On Rumors Gilead Could Acquire It
Incyte hit a record high on rumors Gilead Sciences could be looking to acquire it amid dwindling hepatitis C drug sales.",,,,,[],https://twitter.com/IBD_AGatlin/status/841679533229117441
1332,Allison Gatlin,@IBD_AGatlin,2017-03-14T17:21:17.000Z,Amgen could boost rivals on positive heart-disease study $AMGN $MDCO $ESPR $REGN $SNY $MRK,"Amgen could boost rivals on positive heart-disease study $AMGN $MDCO $ESPR $REGN $SNY $MRK
investors.com
Amgen Could Boost Rivals On Positive Heart-Disease Study: Analyst
Amgen could haul up shares of its rivals on Friday if Repatha shows a cardiovascular benefit in a study, an analyst said.",,,,,[],https://twitter.com/IBD_AGatlin/status/841700776250626051
1333,Contix Alerts,@contixalerts,2017-03-16T17:59:23.000Z,"$MRK: 1st #PancreaticCancer pt dosed on Vitamin D analog (paricalcitol) + Keytruda trial (@MDAndersonNew 
@Aiims1742
 https://app.contix.com/alerts/36490676","$MRK: 1st #PancreaticCancer pt dosed on Vitamin D analog (paricalcitol) + Keytruda trial (@MDAndersonNew 
@Aiims1742
 https://app.contix.com/alerts/36490676",,,,,[],https://twitter.com/contixalerts/status/842435139233763329
1334,"Alp Bugra Basat, MD",@AlpBugraBasat,2017-03-14T19:24:15.000Z,"Replying to 
@jimmysil","Replying to 
@jimmysil
Possibly $MRK gave it away. But coming to finish line, it usually doesn't pan out well for small biotech esp for TKIs - SMs.
1",,,,1,[],https://twitter.com/AlpBugraBasat/status/841731719346692098
1335,MarketSmith,@MarketSmith,2017-03-15T20:04:54.000Z,Merck Could Be Nearing This Rival With Another Keytruda Approval: http://ow.ly/g8dE309WEIa $MRK $BMY $AZN $RHHBY $INCY,"Merck Could Be Nearing This Rival With Another Keytruda Approval: http://ow.ly/g8dE309WEIa $MRK $BMY $AZN $RHHBY $INCY
investors.com
Merck Could Be Nearing This Rival With Another Keytruda Approval | Stock News & Stock Market...
The FDA approved Merck's Keytruda to treat classical Hodgkin lymphoma, but needs more time to review a second application.
1",,,,1,[],https://twitter.com/MarketSmith/status/842104340324208640
1336,Piggy Bank People,@PiggyBankPeople,2017-03-15T13:28:03.000Z,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2mpchNR $PFE $MRK $TEVA $BMY $ABBV $LLY,Why Short Sellers Are Making a Massive Bet in Major Pharma http://buff.ly/2mpchNR $PFE $MRK $TEVA $BMY $ABBV $LLY,,,,,['https://pbs.twimg.com/media/C69mmbxWkAI7j10?format=jpg&name=small'],https://twitter.com/PiggyBankPeople/status/842004468422049794
1337,StockNews.com,@stocknewsdotcom,2017-03-14T20:45:03.000Z,$MRK Announces that the FDA has extended the action date for the sBLA for KEYTRUDA for previously treated patients‚Ä¶ https://stocknews.com/news/mrk-announces-that-the-fda-has-extended-the-action-date-for/‚Ä¶,"$MRK Announces that the FDA has extended the action date for the sBLA for KEYTRUDA for previously treated patients‚Ä¶ https://stocknews.com/news/mrk-announces-that-the-fda-has-extended-the-action-date-for/‚Ä¶
1",,,,1,[],https://twitter.com/stocknewsdotcom/status/841752055517704193
1338,StockNews.com,@stocknewsdotcom,2017-03-14T21:10:39.000Z,$MRK Receives FDA approval for KEYTRUDA for the treatment of adult and pediatric patients with refractory classica‚Ä¶ https://stocknews.com/news/mrk-receives-fda-approval-for-keytruda-for-the-treatment-of-adult/‚Ä¶,"$MRK Receives FDA approval for KEYTRUDA for the treatment of adult and pediatric patients with refractory classica‚Ä¶ https://stocknews.com/news/mrk-receives-fda-approval-for-keytruda-for-the-treatment-of-adult/‚Ä¶
1
1",,,1,1,[],https://twitter.com/stocknewsdotcom/status/841758495263358976
1339,Insider Monkey News,@insidermonkey_n,2017-03-16T20:21:52.000Z,$MRK Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug,"$MRK Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug
insidermonkey.com
Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug
Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc.",,,,,['https://pbs.twimg.com/card_img/1501737386052669444/IjJD0edi?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/842470995365621762
1340,Eric Sagonowsky,@EricSFierce,2017-03-14T17:57:37.000Z,"Zostavax patients sue Merck, claiming shingles shot caused injuries and death http://fiercepharma.com/vaccines/merck-targeted-zostavax-injury-suits‚Ä¶ $MRK","Zostavax patients sue Merck, claiming shingles shot caused injuries and death http://fiercepharma.com/vaccines/merck-targeted-zostavax-injury-suits‚Ä¶ $MRK
1",,,,1,[],https://twitter.com/EricSFierce/status/841709918956707840
1341,BioPharma Dive,@BioPharmaDive,2017-03-15T17:22:00.000Z,Lawsuits loom over $MRK and its shingles vaccine http://bit.ly/2msY9mH,"Lawsuits loom over $MRK and its shingles vaccine http://bit.ly/2msY9mH
1",,,,1,[],https://twitter.com/BioPharmaDive/status/842063343854661632
1342,Allison Gatlin,@IBD_AGatlin,2017-03-15T19:48:16.000Z,Merck Could Be Nearing This Rival With Another Keytruda Approval $MRK $BMY $RHHBY $INCY $AZN,"Merck Could Be Nearing This Rival With Another Keytruda Approval $MRK $BMY $RHHBY $INCY $AZN
investors.com
Merck Could Be Nearing This Rival With Another Keytruda Approval | Stock News & Stock Market...
The FDA approved Merck's Keytruda to treat classical Hodgkin lymphoma, but needs more time to review a second application.",,,,,[],https://twitter.com/IBD_AGatlin/status/842100152160681990
1343,Chelli Miller,@cmiller1225,2017-03-14T19:49:10.000Z,Why Short Sellers Are Making a Massive Bet in Major Pharma $PFE $MRK $TEVA $BMY $ABBV $LLY http://bit.ly/2mxDVfP,Why Short Sellers Are Making a Massive Bet in Major Pharma $PFE $MRK $TEVA $BMY $ABBV $LLY http://bit.ly/2mxDVfP,,,,,['https://pbs.twimg.com/media/C650PY8WkAANgUg?format=jpg&name=small'],https://twitter.com/cmiller1225/status/841737990334480385
1344,Pharmaceutical News,@pharma_sector,2017-03-16T23:50:58.000Z,"#Merck & Co., Inc. Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug. Read more: http://owler.us/acpkjA $MRK","#Merck & Co., Inc. Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug. Read more: http://owler.us/acpkjA $MRK",,,,,[],https://twitter.com/pharma_sector/status/842523618533761024
1345,Contix Alerts,@contixalerts,2017-03-14T17:58:26.000Z,"Zostavax patients sue Merck, claiming shingles shot caused injuries and death $MRK 
@FiercePharma
 https://app.contix.com/alerts/36409760","Zostavax patients sue Merck, claiming shingles shot caused injuries and death $MRK 
@FiercePharma
 https://app.contix.com/alerts/36409760",,,,,[],https://twitter.com/contixalerts/status/841710122728480768
1346,See It Market,@seeitmarket,2017-03-19T01:25:59.000Z,"Market Thoughts & Insights Across Multiple Time Frames - https://seeitmarket.com/stock-market-update-using-time-frames-to-manage-portfolio-risk-16668/‚Ä¶  blog by 
@CJMendes
  $SPY $TGT $GE $MRK $XOM","Market Thoughts & Insights Across Multiple Time Frames - https://seeitmarket.com/stock-market-update-using-time-frames-to-manage-portfolio-risk-16668/‚Ä¶  blog by 
@CJMendes
  $SPY $TGT $GE $MRK $XOM
seeitmarket.com
Stock Market Update: Using Time Frames To Manage Portfolio Risk
The broad market S&P 500 Index (INDEXSP:.INX) is showing some extreme signs of exhaustion following an incredible run post presidential election. This last leg of the 8 year bull market in equities...
5
3",,,5,3,['https://pbs.twimg.com/card_img/1501736993855791106/Kkssptiq?format=jpg&name=small'],https://twitter.com/seeitmarket/status/843272306235510784
1347,Pharmaceutical News,@pharma_sector,2017-03-19T14:58:03.000Z,"10,979 Shares in #Merck & Co., Inc. Acquired by First Capital Advisors Group LLC. Read more: http://owler.us/acpXv1 $MRK","10,979 Shares in #Merck & Co., Inc. Acquired by First Capital Advisors Group LLC. Read more: http://owler.us/acpXv1 $MRK",,,,,[],https://twitter.com/pharma_sector/status/843476667817377792
1348,BioPharma Dive,@BioPharmaDive,2017-03-19T23:07:01.000Z,Competition from $GSK and lawsuits from patients are looming over $MRK's shingles vaccine,"Competition from $GSK and lawsuits from patients are looming over $MRK's shingles vaccine
biopharmadive.com
Merck faces growing legal headache over Zostavax: report
Complaints alleging injury from the company's shingles vaccine have been filed in Pennsylvania courts, and some lawyers expect more to come. 
1",,,1,,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/843599720421511169
1349,Pharmaceutical News,@pharma_sector,2017-03-17T17:21:59.000Z,"Zostavax patients sue #Merck, claiming shingles shot caused injuries and death. Read more: http://owler.us/acpEUt $MRK","Zostavax patients sue #Merck, claiming shingles shot caused injuries and death. Read more: http://owler.us/acpEUt $MRK",,,,,[],https://twitter.com/pharma_sector/status/842788115127259136
1350,leahanne,@leahanneta,2017-03-17T23:23:41.000Z,"03/17/17 Volume Leader #76 - MRK 14,448,800 Merck & Company $MRK 63.90 -0.28 -0.44% High today of 64.70 day lo http://investorshangout.com/post/view?id=4422336‚Ä¶","03/17/17 Volume Leader #76 - MRK 14,448,800 Merck & Company $MRK 63.90 -0.28 -0.44% High today of 64.70 day lo http://investorshangout.com/post/view?id=4422336‚Ä¶",,,,,[],https://twitter.com/leahanneta/status/842879141666062336
1351,Watchlist News,@WatchlistN,2017-03-17T13:32:33.000Z,"Glenview Trust Co Invests $3,258,000 in Merck & Co., Inc. $MRK http://zpr.io/PuwMZ","Glenview Trust Co Invests $3,258,000 in Merck & Co., Inc. $MRK http://zpr.io/PuwMZ",,,,,[],https://twitter.com/WatchlistN/status/842730376770600960
1352,TickWatcher,@MITickWatcher,2017-03-17T20:05:02.000Z,"Top #moneyflow for #sp500 today
$JPM $PG $BAC $GS $CVX $IBM $BA $MRK $MCD $PFE ...","Top #moneyflow for #sp500 today
$JPM $PG $BAC $GS $CVX $IBM $BA $MRK $MCD $PFE ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/842829146170540032
1353,Fractaurean,@Fractaurean,2017-03-17T14:27:42.000Z,"When It Rains, It Pours For Gilead http://seekingalpha.com/article/4055773-rains-pours-gilead?source=tweet‚Ä¶ $ABBV $GSK $MRK $GILD","When It Rains, It Pours For Gilead http://seekingalpha.com/article/4055773-rains-pours-gilead?source=tweet‚Ä¶ $ABBV $GSK $MRK $GILD
seekingalpha.com
When It Rains, It Pours For Gilead (NASDAQ:GILD)
Japan recently announced plans to review drug prices, including GILD's Sovaldi.",,,,,[],https://twitter.com/Fractaurean/status/842744255764447233
1354,Pharmaceutical News,@pharma_sector,2017-03-17T17:21:22.000Z,"#Merck & Co., Inc. Shares Bought by Capital Analysts LLC. Read more: http://owler.us/acpEUp $MRK","#Merck & Co., Inc. Shares Bought by Capital Analysts LLC. Read more: http://owler.us/acpEUp $MRK",,,,,[],https://twitter.com/pharma_sector/status/842787959657050113
1355,Ticker Report,@TickerReport,2017-03-18T10:27:45.000Z,"Amtrust Financial Services Inc. Acquires Shares of 17,096 Merck & Co., Inc. $MRK http://ift.tt/2nPs0Xn","Amtrust Financial Services Inc. Acquires Shares of 17,096 Merck & Co., Inc. $MRK http://ift.tt/2nPs0Xn",,,,,[],https://twitter.com/TickerReport/status/843046256461168640
1356,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-03-18T14:10:07.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/149rOrQWg,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/149rOrQWg,,,,,[],https://twitter.com/gem_2014/status/843102217913716738
1357,Slingshot Catalysts,@SlingshotCtlyst,2017-03-17T00:34:51.000Z,KEYTRUDA in treating Relapsed or Refractory Classical Hodgkin Lymphoma Approved by FDA $MRK http://ddil.si/5uab0oq8/,KEYTRUDA in treating Relapsed or Refractory Classical Hodgkin Lymphoma Approved by FDA $MRK http://ddil.si/5uab0oq8/,,,,,[],https://twitter.com/SlingshotCtlyst/status/842534659552624640
1358,Ticker Report,@TickerReport,2017-03-18T10:27:45.000Z,"O Shaughnessy Asset Management LLC Reduces Position in Merck & Co., Inc. $MRK http://ift.tt/2nk46a3","O Shaughnessy Asset Management LLC Reduces Position in Merck & Co., Inc. $MRK http://ift.tt/2nk46a3",,,,,[],https://twitter.com/TickerReport/status/843046257794912256
1359,TradingView Ideas,@TradingViewAlt,2017-03-18T14:04:49.000Z,Approaching completion of Wave Y \u2026 $MRK http://tradingview.com/chart/MRK/ks0VLTWC-Approaching-completion-of-Wave-Y-on-Minor-period/‚Ä¶,Approaching completion of Wave Y \u2026 $MRK http://tradingview.com/chart/MRK/ks0VLTWC-Approaching-completion-of-Wave-Y-on-Minor-period/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/843100882736623616
1360,MarketBeat,@MarketBeatCom,2017-03-19T12:22:35.000Z,"Coho Partners Ltd. Acquires 1,214,182 Shares of Merck & Co., Inc. $MRK http://zpr.io/Puetc","Coho Partners Ltd. Acquires 1,214,182 Shares of Merck & Co., Inc. $MRK http://zpr.io/Puetc",,,,,[],https://twitter.com/MarketBeatCom/status/843437544809336836
1361,TradingView Ideas,@TradingViewAlt,2017-03-18T14:25:46.000Z,Merck & Co Inc on Possible Wave Y Completion? $MRK http://tradingview.com/chart/MRK/RJv3pYtb-Merck-Co-Inc-on-Possible-Wave-Y-Completion/‚Ä¶,Merck & Co Inc on Possible Wave Y Completion? $MRK http://tradingview.com/chart/MRK/RJv3pYtb-Merck-Co-Inc-on-Possible-Wave-Y-Completion/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/843106157195489280
1362,MarketBeat,@MarketBeatCom,2017-03-18T12:22:43.000Z,"CWA Asset Management Group LLC Has $1,403,000 Position in Merck & Co., Inc. $MRK http://zpr.io/Pu2aB","CWA Asset Management Group LLC Has $1,403,000 Position in Merck & Co., Inc. $MRK http://zpr.io/Pu2aB",,,,,[],https://twitter.com/MarketBeatCom/status/843075188736581634
1363,Contix Alerts,@contixalerts,2017-03-17T14:01:52.000Z,"$MRK wants lawsuit in PA state court over shingles vaccine #Zostavax moved to federal court 
@thelegalintel
 https://app.contix.com/alerts/36518143","$MRK wants lawsuit in PA state court over shingles vaccine #Zostavax moved to federal court 
@thelegalintel
 https://app.contix.com/alerts/36518143
1",,,,1,[],https://twitter.com/contixalerts/status/842737755880804353
1364,Novateur Ventures,@NovateurBio,2017-03-17T00:16:45.000Z,"$MRK Merck and $PFE Pfizer‚Äôs #diabetes therapy under US, EU review http://pharmatimes.com/news/merck_and_pfizers_diabetes_therapy_under_us,_eu_review_1188206‚Ä¶ via 
@PharmaTimes","$MRK Merck and $PFE Pfizer‚Äôs #diabetes therapy under US, EU review http://pharmatimes.com/news/merck_and_pfizers_diabetes_therapy_under_us,_eu_review_1188206‚Ä¶ via 
@PharmaTimes
pharmatimes.com
Merck and Pfizer‚Äôs diabetes therapy under US, EU review
Regulators on both sides of the Atlantic are reviewing three new submissions for medicines containing ertugliflozin, an investigational SGLT2 inhibitor being developed by Merck and Pfizer to help...",,,,,[],https://twitter.com/NovateurBio/status/842530107621171200
1365,George Marcovits,@GemsBot,2017-03-18T14:10:00.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/77719307#77719361‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/77719307#77719361‚Ä¶,,,,,['https://pbs.twimg.com/media/C7NM-I3X0AAUw14?format=jpg&name=small'],https://twitter.com/GemsBot/status/843102189425975298
1366,pharmalot,@pharmalot,2017-03-20T15:25:21.000Z,"Lilly takes a stab at pricing transparency, but is it enough of the right data? https://statnews.com/pharmalot/2017/03/20/eli-lilly-drug-pricing-transparency/‚Ä¶ #pharma $LLY $MRK $JNJ $AGN $NOVO","Lilly takes a stab at pricing transparency, but is it enough of the right data? https://statnews.com/pharmalot/2017/03/20/eli-lilly-drug-pricing-transparency/‚Ä¶ #pharma $LLY $MRK $JNJ $AGN $NOVO
statnews.com
Lilly takes a stab at pricing transparency, but is it enough of the right data?
Average discounts off list prices rose to 50 percent from 28 percent over the past five years and Lilly maintained increases in net prices were 2.4 percent.
11
2",,,11,2,[],https://twitter.com/pharmalot/status/843845925932056577
1367,pharmalot,@pharmalot,2017-03-20T17:00:45.000Z,ICYMI: European regulator suffers setback in two cases over releasing trial data.. https://statnews.com/pharmalot/2017/03/17/ema-merck-trial-data-ptc/‚Ä¶ #pharma $MRK $PTCT #EMA,"ICYMI: European regulator suffers setback in two cases over releasing trial data.. https://statnews.com/pharmalot/2017/03/17/ema-merck-trial-data-ptc/‚Ä¶ #pharma $MRK $PTCT #EMA
statnews.com
European regulator suffers setback in two cases over releasing trial data
The European Union Court of Justice has rejected an effort by the European Medicines Agency to release clinical trial data to third parties.
2",,,2,,[],https://twitter.com/pharmalot/status/843869936414015488
1368,Monica Torriani,@Monica_Torriani,2017-03-20T17:19:28.000Z,"About #EMA and #pharma #opendata $PTCT $MRK 
@pharmalot","About #EMA and #pharma #opendata $PTCT $MRK 
@pharmalot
statnews.com
European regulator suffers setback in two cases over releasing trial data
The European Union Court of Justice has rejected an effort by the European Medicines Agency to release clinical trial data to third parties.
2",,,2,,['https://pbs.twimg.com/card_img/1501984768698642432/eA3s1ZEF?format=jpg&name=small'],https://twitter.com/Monica_Torriani/status/843874645510160384
1369,Helen Ong,@Lin_ling_88,2017-03-20T04:17:28.000Z,$MRK $BMY,"$MRK $BMY
Oncology Tube
@oncologytube
 ¬∑ 20 Mar 2017
The toxicities associated with immunotherapy in lung cancer patients http://oncologytube.com/video/the-toxicities-associated-with-immunotherapy-in-lung-cancer-patients/10000777‚Ä¶
1
2",,,1,2,"['https://pbs.twimg.com/profile_images/774339957087346688/z5zor-v9_mini.jpg', 'https://pbs.twimg.com/media/C7VVPT0VsAA3vqb?format=jpg&name=small']",https://twitter.com/Lin_ling_88/status/843677849240440832
1370,dough,@semodough,2017-03-22T15:09:06.000Z,Wow - one of the most powerful stories I read in awhile -  $MRK #KEYTRUDA #cancersurvivor,"Wow - one of the most powerful stories I read in awhile -  $MRK #KEYTRUDA #cancersurvivor
The Lymphoma Club
@LymphomaClub
 ¬∑ 22 Mar 2017
Here's a miracle story for you. This 25-year-old riddled with tumors had been told he had just weeks to live, and... http://fb.me/1P5cMbgw8
2
4",,,2,4,['https://pbs.twimg.com/profile_images/520660156737011712/TJO_1oqL_mini.png'],https://twitter.com/semodough/status/844566612560760832
1371,Qiaoli Vrinat,@QiaoliV,2017-03-20T14:35:19.000Z,Sanofi: What Are The Outlooks? http://seekingalpha.com/article/4056495-sanofi-outlooks?source=tweet‚Ä¶ $NVO $MRK $REG $SNY,"Sanofi: What Are The Outlooks? http://seekingalpha.com/article/4056495-sanofi-outlooks?source=tweet‚Ä¶ $NVO $MRK $REG $SNY
seekingalpha.com
Sanofi: What Are The Outlooks? (NASDAQ:SNY)
Sanofi has been negatively impacted by its large diabetes franchise. The group now has the possibility to react with new drug launches such as Toujeo, Praluent, Dupilumab and Sarilumab.",,,,,[],https://twitter.com/QiaoliV/status/843833335285800960
1372,Natalie Grover,@NatalieGrover,2017-03-22T13:34:28.000Z,"U.S. appeals court revives #Fosamax warning claims against #Merck http://reut.rs/2nRtqkY via 
@Reuters
 $MRK","U.S. appeals court revives #Fosamax warning claims against #Merck http://reut.rs/2nRtqkY via 
@Reuters
 $MRK",,,,,[],https://twitter.com/NatalieGrover/status/844542797709402116
1373,Ozmosi,@OzmosiHealth,2017-03-21T16:01:42.000Z,$MRK & $PFE go for #diabetes combo drug approval - better late than never? Get ready for an uphill battle. http://bit.ly/2o0sfyO #pharma,"$MRK & $PFE go for #diabetes combo drug approval - better late than never? Get ready for an uphill battle. http://bit.ly/2o0sfyO #pharma
1",,,1,,['https://pbs.twimg.com/media/C7dDThEXUAAdj-y?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/844217460580671488
1374,Ozmosi,@OzmosiHealth,2017-03-22T16:46:03.000Z,"More good news for $MRK - FDA OKs Keytruda for Hodgkin lymphoma, a first in blood #cancer http://bit.ly/2nCvdx9","More good news for $MRK - FDA OKs Keytruda for Hodgkin lymphoma, a first in blood #cancer http://bit.ly/2nCvdx9
1
1",,,1,1,['https://pbs.twimg.com/media/C7iXDBgW4AAi-J2?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/844591011116519425
1375,G,@smokiemahoney,2017-03-21T12:58:05.000Z,"* Richard Uihlein * in deep on $GALT. TrumpConnection, follow the money   $CRBP $IDRA $NVLS $MRK $BMY $GILD $PFE","* Richard Uihlein * in deep on $GALT. TrumpConnection, follow the money   $CRBP $IDRA $NVLS $MRK $BMY $GILD $PFE
1",üìà ‚öó,,1,,['https://pbs.twimg.com/media/C7cZRsfU0AAKld2?format=jpg&name=small'],https://twitter.com/smokiemahoney/status/844171253728657410
1376,Colin Macleod,@scalpthatstock,2017-03-22T21:33:10.000Z,"Wednesdays Chart Breakdowns 

http://scalpthatstock.com/breakdown-3-22-2017/‚Ä¶

$NKE $T $CTL $GGP $MRK $CBL $DYN $MNK $ANF $GIS","Wednesdays Chart Breakdowns 

http://scalpthatstock.com/breakdown-3-22-2017/‚Ä¶

$NKE $T $CTL $GGP $MRK $CBL $DYN $MNK $ANF $GIS",,,,,['https://pbs.twimg.com/media/C7jYwcGVwAA__U8?format=jpg&name=small'],https://twitter.com/scalpthatstock/status/844663264927596545
1377,Nick,@realNick1st,2017-03-20T13:51:47.000Z,#BREAKING #stocks to watch $SFM $TIF $ALK $DIS $MRK $AAPL $MSFT Philadelphia Fed CEO Harker won't rule anything out on Rate Hike #WallStreet,#BREAKING #stocks to watch $SFM $TIF $ALK $DIS $MRK $AAPL $MSFT Philadelphia Fed CEO Harker won't rule anything out on Rate Hike #WallStreet,,,,,[],https://twitter.com/realNick1st/status/843822379839213569
1378,Dow Stocks,@Top_Dow_Stocks,2017-03-21T07:16:57.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/844085406140317697
1379,Amanda Micklus,@amandamicklus,2017-03-20T19:09:21.000Z,"After $MRK, $BMY is next most active in #immunotherapy #oncology combo dealmaking, expands $CTMX deal for $200m UF http://bit.ly/2mHutCr","After $MRK, $BMY is next most active in #immunotherapy #oncology combo dealmaking, expands $CTMX deal for $200m UF http://bit.ly/2mHutCr
1",,,1,,[],https://twitter.com/amandamicklus/status/843902297201696768
1380,TickWatcher,@MITickWatcher,2017-03-22T20:05:01.000Z,"Top #moneyflow for #sp500 today
$BAC $GE $PFE $JNJ $MSFT $AMZN $NFLX $MRK $HAS $CELG ...","Top #moneyflow for #sp500 today
$BAC $GE $PFE $JNJ $MSFT $AMZN $NFLX $MRK $HAS $CELG ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/844641084395454465
1381,TickWatcher,@MITickWatcher,2017-03-20T20:05:01.000Z,"Top #moneyflow for #sp500 today
$BAC $JNJ $MRK $JPM $PFE $INTC $MJN $C $MDT $HRB ...","Top #moneyflow for #sp500 today
$BAC $JNJ $MRK $JPM $PFE $INTC $MJN $C $MDT $HRB ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/843916309264056321
1382,TickWatcher,@MITickWatcher,2017-03-20T20:05:00.000Z,"Top #moneyflow for whole #market today
$SPY $BAC $JNJ $MBLY $EEM $EFA $FXI $MRK $JPM $XLF ...","Top #moneyflow for whole #market today
$SPY $BAC $JNJ $MBLY $EEM $EFA $FXI $MRK $JPM $XLF ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/843916304235028480
1383,Michael Daytona,@Mulamakingmike,2017-03-22T13:05:12.000Z,3.22.17 Stock Watch - $QBIO $PFE $AUPH $ESPR $SGYP $MRK $ENDP $BMY $TEVA,3.22.17 Stock Watch - $QBIO $PFE $AUPH $ESPR $SGYP $MRK $ENDP $BMY $TEVA,,,,,[],https://twitter.com/Mulamakingmike/status/844535432327172096
1384,EquitySwing,@EquitySwing,2017-03-20T20:30:01.000Z,"BLOCK SUMMARY: [2017-03-20] : [ $MRK ] : Total Volume[2,000,000] : Cumulative Avg[$64.06] : Day Close[$64.11] #MRK http://equityswing.com/live.html","BLOCK SUMMARY: [2017-03-20] : [ $MRK ] : Total Volume[2,000,000] : Cumulative Avg[$64.06] : Day Close[$64.11] #MRK http://equityswing.com/live.html",,,,,[],https://twitter.com/EquitySwing/status/843922597142286336
1385,Chris Sanders,@Gr8FundManager,2017-03-21T18:15:59.000Z,"$BIIB is GREEN, showing incredible RELATIVE STRENGTH compared to $MRK $PFE $CELG $AGN $BLUE $GILD $INCY $TEVA $JNJ $IBB
BIIB Patent extended","$BIIB is GREEN, showing incredible RELATIVE STRENGTH compared to $MRK $PFE $CELG $AGN $BLUE $GILD $INCY $TEVA $JNJ $IBB
BIIB Patent extended",,,,,[],https://twitter.com/Gr8FundManager/status/844251255509794817
1386,TC,@StockInvestor64,2017-03-22T17:54:44.000Z,$mrk still in distribution and has a gap to fill all which appear to converge on 100 and 150 moving avgs at around $62.45.,$mrk still in distribution and has a gap to fill all which appear to converge on 100 and 150 moving avgs at around $62.45.,,,,,[],https://twitter.com/StockInvestor64/status/844608295579140109
1387,Watchlist News,@WatchlistN,2017-03-21T10:09:15.000Z,"Frontier Wealth Management LLC Acquires 9,741 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pbgtq","Frontier Wealth Management LLC Acquires 9,741 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pbgtq
1",,,,1,[],https://twitter.com/WatchlistN/status/844128767522062337
1388,IECONOMICS,@iECONOMICS,2017-03-21T15:36:33.000Z,Merck & Co $MRK market alert: 6-week low @ 63.75 https://ieconomics.com/merck,Merck & Co $MRK market alert: 6-week low @ 63.75 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/844211133141729280
1389,TalkMarkets,@TalkMarkets,2017-03-21T14:10:20.000Z,Overview of #Schwab HealthCare #Fund (SWHFX) $SWHFX Also $MRK $JNJ $PFE https://goo.gl/NtZUdg,Overview of #Schwab HealthCare #Fund (SWHFX) $SWHFX Also $MRK $JNJ $PFE https://goo.gl/NtZUdg,,,,,[],https://twitter.com/TalkMarkets/status/844189437718396929
1390,Heath Care News,@hc_equipment,2017-03-22T06:24:15.000Z,German #Merck taps up cell-based pyrogen detection kit. Read more: http://owler.us/acqBJv $MRK,German #Merck taps up cell-based pyrogen detection kit. Read more: http://owler.us/acqBJv $MRK,,,,,[],https://twitter.com/hc_equipment/status/844434530807222273
1391,Heath Care News,@hc_equipment,2017-03-22T09:18:02.000Z,"""Bold & Vibrant"": #Merck KGaA, Darmstadt, Germany, Presents Innovations at the European Coat... Read more: http://owler.us/acqG15 $MRK","""Bold & Vibrant"": #Merck KGaA, Darmstadt, Germany, Presents Innovations at the European Coat... Read more: http://owler.us/acqG15 $MRK",,,,,[],https://twitter.com/hc_equipment/status/844478264978685952
1392,John Smith,@smith961,2017-03-22T13:30:28.000Z,A few tickers worth keeping an eye on this AM - $QBIO $ESPR $SGYP $MRK $ENDP $BMY $TEVA $CERU $NKTR $JNJ $NBIO,A few tickers worth keeping an eye on this AM - $QBIO $ESPR $SGYP $MRK $ENDP $BMY $TEVA $CERU $NKTR $JNJ $NBIO,,,,,[],https://twitter.com/smith961/status/844541792464850944
1393,Miguel R,@moremoneymiggy,2017-03-22T13:05:12.000Z,3.22.17 Stock Watch - $QBIO $PFE $AUPH $ESPR $SGYP $MRK $ENDP $BMY $TEVA,3.22.17 Stock Watch - $QBIO $PFE $AUPH $ESPR $SGYP $MRK $ENDP $BMY $TEVA,,,,,[],https://twitter.com/moremoneymiggy/status/844535432612401153
1394,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-03-22T12:35:41.000Z,"U.S. appeals court revives claims against $MRK Merck over Fosamax
Failed to adequately warn about the risks of fosamax --
court ruling","U.S. appeals court revives claims against $MRK Merck over Fosamax
Failed to adequately warn about the risks of fosamax --
court ruling
1",üÖ± üÖæ,,1,,[],https://twitter.com/_B_I_O_T_E_C_H_/status/844528005661818880
1395,Sweet Platform,@SweetPlatform,2017-03-22T15:43:00.000Z,"MRK Top news - Mar 22nd, 2017 $MRK http://https://goo.gl/bDUIFz","MRK Top news - Mar 22nd, 2017 $MRK http://https://goo.gl/bDUIFz",,,,,[],https://twitter.com/SweetPlatform/status/844575143628345344
1396,M,@bio_clouseau,2017-03-21T09:47:49.000Z,"HCV- Down but not out.GT3 underserved, 10's of thousands remain infected despite TX http://medscape.com/viewarticle/877455‚Ä¶ $GILD $ABBV $ENTA $MRK","HCV- Down but not out.GT3 underserved, 10's of thousands remain infected despite TX http://medscape.com/viewarticle/877455‚Ä¶ $GILD $ABBV $ENTA $MRK
medscape.com
Optimism About HCV Treatment Comes With Caveats
New drugs show high safety, tolerability, and treatment response rates in patients with chronic hepatitis C virus genotype 1 infection, a review has found. However, some experts remain cautious.
1
2",,,1,2,[],https://twitter.com/bio_clouseau/status/844123370857873409
1397,Sammy Johnston,@SJstockinvestor,2017-03-22T13:30:28.000Z,A few tickers worth keeping an eye on this AM - $QBIO $ESPR $SGYP $MRK $ENDP $BMY $TEVA $CERU $NKTR $JNJ $NBIO,A few tickers worth keeping an eye on this AM - $QBIO $ESPR $SGYP $MRK $ENDP $BMY $TEVA $CERU $NKTR $JNJ $NBIO,,,,,[],https://twitter.com/SJstockinvestor/status/844541793022726144
1398,Joe Emory,@JoeEmory76,2017-03-22T12:50:10.000Z,$QBIO headlines today's first round of stocks to watch:  $ESPR $SGYP $MRK $ENDP $BMY $TEVA,$QBIO headlines today's first round of stocks to watch:  $ESPR $SGYP $MRK $ENDP $BMY $TEVA,,,,,[],https://twitter.com/JoeEmory76/status/844531650302263298
1399,Scanz Alerts,@ScanzAlerts,2017-03-20T19:49:45.000Z,"BLOCK TRADE: $MRK 2,000,000 shares @ $64.06 [15:49:43]","BLOCK TRADE: $MRK 2,000,000 shares @ $64.06 [15:49:43]",,,,,[],https://twitter.com/ScanzAlerts/status/843912464576237572
1400,Traderific,@Traderific,2017-03-21T20:25:48.000Z,"SELL $JPM 87.38, SELL $MRK 63.90, SELL $PNC 118.82, SELL $RTN 153.61. More stock tips & details at: http://traderific.com/?date=2017-03-21‚Ä¶","SELL $JPM 87.38, SELL $MRK 63.90, SELL $PNC 118.82, SELL $RTN 153.61. More stock tips & details at: http://traderific.com/?date=2017-03-21‚Ä¶",,,,,[],https://twitter.com/Traderific/status/844283924650119168
1401,Zero Filter,@zerofiltertruth,2017-03-21T13:36:08.000Z,"#Biotech / lotto ticket $DRRX getting action on $PTIE celebration 

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD $AMGN 
@GuyAdami
 @jonnajarian","#Biotech / lotto ticket $DRRX getting action on $PTIE celebration 

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD $AMGN 
@GuyAdami
 @jonnajarian
1",,,1,,[],https://twitter.com/zerofiltertruth/status/844180830465548288
1402,StockNews.com,@stocknewsdotcom,2017-03-21T12:17:38.000Z,"$MRK BMO Capital reiterates Buy rating, $70 PT https://stocknews.com/news/mrk-bmo-capital-reiterates-buy-rating-70-pt/‚Ä¶","$MRK BMO Capital reiterates Buy rating, $70 PT https://stocknews.com/news/mrk-bmo-capital-reiterates-buy-rating-70-pt/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/844161074777808897
1403,1 min Stock Insights,@1MinuteStock,2017-03-21T10:14:02.000Z,We calculated 21-day Expected Return of $MRK for you: -1.78% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=expreturn&utm_source=twitter‚Ä¶,We calculated 21-day Expected Return of $MRK for you: -1.78% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=expreturn&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/844129968582004736
1404,Ticker Report,@TickerReport,2017-03-21T09:30:17.000Z,"BMO Capital Markets Reiterates Buy Rating for Merck & Co., Inc. $MRK http://zpr.io/Pb64v","BMO Capital Markets Reiterates Buy Rating for Merck & Co., Inc. $MRK http://zpr.io/Pb64v",,,,,[],https://twitter.com/TickerReport/status/844118959460880384
1405,Daily Political,@dailypoliticaln,2017-03-22T10:04:15.000Z,"Merck & Co., Inc. $MRK Position Boosted by Asset Management One Co. Ltd. http://ift.tt/2nmcs0y","Merck & Co., Inc. $MRK Position Boosted by Asset Management One Co. Ltd. http://ift.tt/2nmcs0y",,,,,[],https://twitter.com/dailypoliticaln/status/844489895204806656
1406,AlpacaAlerts,@AlpacaAlerts,2017-03-21T21:28:00.000Z,$MRK is in Stochastic Oversold  winning 60.56% in the past. https://scan.alpaca.ai/card/2066689?utm_campaign=card_2066689&utm_content=card&utm_medium=tweet&utm_source=twitter‚Ä¶,$MRK is in Stochastic Oversold  winning 60.56% in the past. https://scan.alpaca.ai/card/2066689?utm_campaign=card_2066689&utm_content=card&utm_medium=tweet&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/AlpacaAlerts/status/844299577167695872
1407,MarketBeat,@MarketBeatCom,2017-03-21T09:13:12.000Z,Merck & Co.'s buy rating reiterated at BMO Capital Markets. $70.00 PT. http://ift.tt/2mKOx6Q $MRK #MRK,Merck & Co.'s buy rating reiterated at BMO Capital Markets. $70.00 PT. http://ift.tt/2mKOx6Q $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/844114658340622336
1408,MarketBeat,@MarketBeatCom,2017-03-20T22:12:47.000Z,"Leerink Swann Reiterates ‚ÄúMarket Perform‚Äù Rating for Merck & Co., Inc. $MRK http://ift.tt/2nLCbgy #acn","Leerink Swann Reiterates ‚ÄúMarket Perform‚Äù Rating for Merck & Co., Inc. $MRK http://ift.tt/2nLCbgy #acn",,,,,[],https://twitter.com/MarketBeatCom/status/843948459971543041
1409,StockNews.com,@stocknewsdotcom,2017-03-22T15:31:59.000Z,"$MRK Merck ordered to face claims related to risk disclosures for its osteoporosis drug Fosamax, according to Reut‚Ä¶ https://stocknews.com/news/mrk-merck-ordered-to-face-claims-related-to-risk-disclosures-for/‚Ä¶","$MRK Merck ordered to face claims related to risk disclosures for its osteoporosis drug Fosamax, according to Reut‚Ä¶ https://stocknews.com/news/mrk-merck-ordered-to-face-claims-related-to-risk-disclosures-for/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/844572373609263105
1410,Watchlist News,@WatchlistN,2017-03-21T12:56:17.000Z,"Frontier Wealth Management LLC Acquires 9,741 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pbtme","Frontier Wealth Management LLC Acquires 9,741 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pbtme",,,,,[],https://twitter.com/WatchlistN/status/844170801758834688
1411,Allison Gatlin,@IBD_AGatlin,2017-03-22T19:31:58.000Z,Dow's Merck swipes immuno-oncology share from heavyweight rivals $MRK $BMY $RHHBY $INCY $AZN,"Dow's Merck swipes immuno-oncology share from heavyweight rivals $MRK $BMY $RHHBY $INCY $AZN
investors.com
Dow's Merck Swipes Immuno-Oncology Share From Heavyweight Rivals
Dow leader Merck swiped share from rival Bristol-Myers as Roche remained flat, according to a health tracker.
1",,,,1,['https://pbs.twimg.com/card_img/1501589469643907076/CEq5AwzS?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/844632764603338752
1412,Allison Gatlin,@IBD_AGatlin,2017-03-20T16:59:12.000Z,Bristol-Myers partner hits 18-month high on immuno-oncology deal $BMY $INCY $MRK $RHHBY $CTMX $AZN,"Bristol-Myers partner hits 18-month high on immuno-oncology deal $BMY $INCY $MRK $RHHBY $CTMX $AZN
investors.com
Bristol-Myers Partner Hits 18-Month High On Immuno-Oncology Deal
Cytomx stock rocketed to a 14-month high Monday, breaking out after the firm expanded its deal with Bristol-Myers Squibb.
1",,,,1,[],https://twitter.com/IBD_AGatlin/status/843869544787693569
1413,Michael Harris,@mikeharrisNY,2017-03-21T21:09:41.000Z,"Replying to 
@InterestRateArb","Replying to 
@InterestRateArb
$KO, $PG, $UNH, $MCD, $XOM, $MRK, $PFE, $MMM all < 0.5% and unless these get kicked hard, this is weak hands formation
3",üìà,,,3,[],https://twitter.com/mikeharrisNY/status/844294967887646720
1414,Contix Alerts,@contixalerts,2017-03-22T12:36:06.000Z,"U.S. appeals court revives claims against $MRK Merck over Fosamax Failed to adequately warn abou 
@_B_I_O_T_E_C_H_
 https://app.contix.com/alerts/36657625","U.S. appeals court revives claims against $MRK Merck over Fosamax Failed to adequately warn abou 
@_B_I_O_T_E_C_H_
 https://app.contix.com/alerts/36657625",,,,,[],https://twitter.com/contixalerts/status/844528108099166209
1415,Briefing.com,@Briefingcom,2017-03-21T13:09:07.000Z,$MRK: Merck Canada announced that Zepatier will be listed among the drugs covered by Quebec's health insurance board http://bit.ly/2n9og5F,$MRK: Merck Canada announced that Zepatier will be listed among the drugs covered by Quebec's health insurance board http://bit.ly/2n9og5F,,,,,[],https://twitter.com/Briefingcom/status/844174030307438594
1416,Aniu Student,@AniuStudent,2017-03-20T19:43:48.000Z,"Replying to 
@curiousperson7","Replying to 
@curiousperson7
Depending on upcoming news, I wouldn't count $MRK out of it.  And what $MRK wants, $PFE tries to buy first. $ESPR",,,,,[],https://twitter.com/AniuStudent/status/843910968556052480
1417,Ahmad Tawil,@AHTawil,2017-03-21T11:32:01.000Z,"Replying to 
@AHTawil","Replying to 
@AHTawil
$JNJ & $MRK had higher net price increases last year at 3.5% and 5.5% by comparison. $LLY portfolio dictating this level of discounts 3/",,,,,[],https://twitter.com/AHTawil/status/844149594552504320
1418,Eddie Capital,@eddiejedi,2017-03-22T01:10:56.000Z,"Replying to 
@MadMoneyOnCNBC
 and 
@jimcramer","Replying to 
@MadMoneyOnCNBC
 and 
@jimcramer
What's the better value here $BMY or $MRK? Thx for ur #education",,,,,[],https://twitter.com/eddiejedi/status/844355681104879616
1419,EquitySwing,@EquitySwing,2017-03-20T19:49:45.000Z,"$MRK : BLOCK : [15:49:43] : $64.06 : 2,000,000 :  $DJIA $SPY #stocks #investing #trading http://equityswing.com/live.html","$MRK : BLOCK : [15:49:43] : $64.06 : 2,000,000 :  $DJIA $SPY #stocks #investing #trading http://equityswing.com/live.html",,,,,[],https://twitter.com/EquitySwing/status/843912466413305856
1420,Nick Spazillo,@nicksinvestor,2017-03-22T13:05:12.000Z,3.22.17 Stock Watch - $QBIO $PFE $AUPH $ESPR $SGYP $MRK $ENDP $BMY $TEVA,3.22.17 Stock Watch - $QBIO $PFE $AUPH $ESPR $SGYP $MRK $ENDP $BMY $TEVA,,,,,[],https://twitter.com/nicksinvestor/status/844535431983235077
1421,Stacy Najon,@StacyNajon,2017-03-22T13:30:28.000Z,A few tickers worth keeping an eye on this AM - $QBIO $ESPR $SGYP $MRK $ENDP $BMY $TEVA $CERU $NKTR $JNJ $NBIO,A few tickers worth keeping an eye on this AM - $QBIO $ESPR $SGYP $MRK $ENDP $BMY $TEVA $CERU $NKTR $JNJ $NBIO,,,,,[],https://twitter.com/StacyNajon/status/844541792557191168
1422,Lynn McKinnley,@LMinvestments20,2017-03-22T12:50:10.000Z,$QBIO headlines today's first round of stocks to watch:  $ESPR $SGYP $MRK $ENDP $BMY $TEVA,$QBIO headlines today's first round of stocks to watch:  $ESPR $SGYP $MRK $ENDP $BMY $TEVA,,,,,[],https://twitter.com/LMinvestments20/status/844531650738446336
1423,Daily Political,@dailypoliticaln,2017-03-21T16:30:20.000Z,Merck & Co.‚Äôs $MRK Market Perform Rating Reaffirmed at Leerink Swann http://dailypolitical.com/?p=988325,Merck & Co.‚Äôs $MRK Market Perform Rating Reaffirmed at Leerink Swann http://dailypolitical.com/?p=988325,,,,,[],https://twitter.com/dailypoliticaln/status/844224669377052675
1424,Lance Markel,@lanceinvests,2017-03-22T12:50:10.000Z,$QBIO headlines today's first round of stocks to watch:  $ESPR $SGYP $MRK $ENDP $BMY $TEVA,$QBIO headlines today's first round of stocks to watch:  $ESPR $SGYP $MRK $ENDP $BMY $TEVA,,,,,[],https://twitter.com/lanceinvests/status/844531650587492353
1425,pharmalot,@pharmalot,2017-03-24T14:50:39.000Z,Spain's antitrust watchdog probes drug makers over a pricing scheme..  https://statnews.com/pharmalot/2017/03/23/spain-antitrust-probe/‚Ä¶ #pharma $NVS $JNJ $LLY $SNY $MRK $PFE,"Spain's antitrust watchdog probes drug makers over a pricing scheme..  https://statnews.com/pharmalot/2017/03/23/spain-antitrust-probe/‚Ä¶ #pharma $NVS $JNJ $LLY $SNY $MRK $PFE
statnews.com
Spain's antitrust watchdog probes drug makers over a pricing scheme
At issue is dual pricing, which drug makers use to fight parallel trade, but which wholesalers claim is unfair.
5
1",,,5,1,['https://pbs.twimg.com/card_img/1501729423246172162/Hfm3qswf?format=jpg&name=small'],https://twitter.com/pharmalot/status/845286744438255616
1426,pharmalot,@pharmalot,2017-03-24T21:13:25.000Z,Winners and Losers: Who had a good week - and who didn't.. https://statnews.com/pharmalot/2017/03/24/winners-losers-valeant-merck-lilly/‚Ä¶ #pharma $VRX $MRK $LLY #drugprices,"Winners and Losers: Who had a good week - and who didn't.. https://statnews.com/pharmalot/2017/03/24/winners-losers-valeant-merck-lilly/‚Ä¶ #pharma $VRX $MRK $LLY #drugprices
statnews.com
Winners and losers: Who had a good week - and who didn't
Everyone loves a winner, but who are they? Every week, we provide a quick rundown of who came out ahead, and who didn't.
5",,,5,,['https://pbs.twimg.com/card_img/1500957895067766785/UjfOc-Vy?format=jpg&name=small'],https://twitter.com/pharmalot/status/845383072849821696
1427,dough,@semodough,2017-03-25T14:01:17.000Z,Very depressing slide on #Alzheimers  prevalence expected to increase exponentially $IBB $MRK $AXON $BIIB,"Very depressing slide on #Alzheimers  prevalence expected to increase exponentially $IBB $MRK $AXON $BIIB
3
8
15",,3,8,15,['https://pbs.twimg.com/media/C7xOGAvWsAIpFVs?format=jpg&name=small'],https://twitter.com/semodough/status/845636708796452864
1428,FOX Business,@FoxBusiness,2017-03-23T13:31:51.000Z,"Drugmakers:
$PFE
$MRK
$LLY
$JNJ
$NVS","Drugmakers:
$PFE
$MRK
$LLY
$JNJ
$NVS
1
3
6",,1,3,6,['https://pbs.twimg.com/media/C7m0Ll-VQAAZe13?format=jpg&name=small'],https://twitter.com/FoxBusiness/status/844904528323457024
1429,M,@bio_clouseau,2017-03-23T21:26:24.000Z,$REGN $SNY open P3 in PD-L1+ metastatic NSCLC https://clinicaltrials.gov/ct2/show/NCT03088540‚Ä¶ $MRK $BMY $RHHBY,"$REGN $SNY open P3 in PD-L1+ metastatic NSCLC https://clinicaltrials.gov/ct2/show/NCT03088540‚Ä¶ $MRK $BMY $RHHBY
clinicaltrials.gov
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic...
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) - Full Text View.
2
2
6",,2,2,6,['https://pbs.twimg.com/card_img/1499578112115363861/JaVVFVxw?format=png&name=240x240'],https://twitter.com/bio_clouseau/status/845023949956288512
1430,Loncar Biotech ETFs,@LoncarFunds,2017-03-23T16:15:01.000Z,$INCY and its partner $MRK will have pivotal studies for their PD-1/IDO1 combination in five unique cancers. http://loncarfunds.com/cncr-holdings/,"$INCY and its partner $MRK will have pivotal studies for their PD-1/IDO1 combination in five unique cancers. http://loncarfunds.com/cncr-holdings/
1
2",,,1,2,['https://pbs.twimg.com/media/C7VQQWBVoAANzbu?format=jpg&name=small'],https://twitter.com/LoncarFunds/status/844945591457198080
1431,MM+M Magazine,@MMMnews,2017-03-24T14:34:31.000Z,"5 things for #pharma #marketers to know:Fri, Mar 24 $LLY #Trump #AHCA $PFE $MRK #FDA $MYL $GSK $REGN #Genomics #hcsm http://bit.ly/2n1IOKM","5 things for #pharma #marketers to know:Fri, Mar 24 $LLY #Trump #AHCA $PFE $MRK #FDA $MYL $GSK $REGN #Genomics #hcsm http://bit.ly/2n1IOKM
1
2",,1,2,,['https://pbs.twimg.com/media/C7sLB7bW0AQrre6?format=jpg&name=small'],https://twitter.com/MMMnews/status/845282684364623873
1432,"Robert Kruse, MD, PhD",@RobertLKruse,2017-03-25T00:04:49.000Z,"Looked up $MRK failed checkpoint drug against CEACAM1. Only one lab has ever published it this works, the one that made $95 million upfront.","Looked up $MRK failed checkpoint drug against CEACAM1. Only one lab has ever published it this works, the one that made $95 million upfront.
1
3",,,1,3,[],https://twitter.com/RobertLKruse/status/845426205952217088
1433,SmartBrief Health,@SBHealthCare,2017-03-24T15:16:13.000Z,"Rare skin cancer drug from $MRK, $PFE wins #FDA nod http://buff.ly/2mzfLSz via 
@SmartBrief
 #pharma","Rare skin cancer drug from $MRK, $PFE wins #FDA nod http://buff.ly/2mzfLSz via 
@SmartBrief
 #pharma
1",,,1,,['https://pbs.twimg.com/media/C7sVqtZXUAQxqcn?format=jpg&name=small'],https://twitter.com/SBHealthCare/status/845293181809897472
1434,Jacob Plieth,@JacobPlieth,2017-03-24T08:40:29.000Z,"Re $PFE Bavencio, I reported about Keytruda's potential in Merkel cell carcinoma (1st-line) from #AACR16 $MRK http://bit.ly/252c2tn","Re $PFE Bavencio, I reported about Keytruda's potential in Merkel cell carcinoma (1st-line) from #AACR16 $MRK http://bit.ly/252c2tn
1
3
2",,1,3,2,[],https://twitter.com/JacobPlieth/status/845193590426910725
1435,Sam Riger,@riger_sam,2017-03-23T13:33:28.000Z,"Drugmakers:
$PFE
$MRK
$LLY
$JNJ
$NVS","Drugmakers:
$PFE
$MRK
$LLY
$JNJ
$NVS
1",,,,1,['https://pbs.twimg.com/media/C7m0Ll-VQAAZe13?format=jpg&name=small'],https://twitter.com/riger_sam/status/844904934793469953
1436,BioPharma Dive,@BioPharmaDive,2017-03-25T23:49:01.000Z,"$PFE, Merck KGaA fourth to market with PD-1/L1 inhibitor http://bit.ly/2mxnrFd $BMY $RHHBY $MRK","$PFE, Merck KGaA fourth to market with PD-1/L1 inhibitor http://bit.ly/2mxnrFd $BMY $RHHBY $MRK
biopharmadive.com
Pfizer, Merck KGaA fourth to market with PD-1/L1 inhibitor
The pair secured an FDA approval for avelumab, which will enter the market behind rival drugs Keytruda, Opdivo and Tecentriq. 
2
1",,,2,1,['https://pbs.twimg.com/card_img/1497340987353534471/e_4AkWj6?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/845784616732635136
1437,InvestorsObserver,@IOInvestors,2017-03-24T12:34:41.000Z,"Covered Call Trade Ideas for $BAC, $HD, $MRK, $OCLR, & $SQ : http://investorsobserver.com/pr/032420170/tweet‚Ä¶ ‚Ä¶ ‚Ä¶ ‚Ä¶ ‚Ä¶ 
#OptionsTrading #CoveredCalls #Stocks","Covered Call Trade Ideas for $BAC, $HD, $MRK, $OCLR, & $SQ : http://investorsobserver.com/pr/032420170/tweet‚Ä¶ ‚Ä¶ ‚Ä¶ ‚Ä¶ ‚Ä¶ 
#OptionsTrading #CoveredCalls #Stocks
1",,,1,,[],https://twitter.com/IOInvestors/status/845252527989948416
1438,Bilo Selhi,@StocksThatDoubl,2017-03-23T19:03:08.000Z,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,,,,,['https://pbs.twimg.com/media/CiX8f4PUkAQf2Dy?format=jpg&name=small'],https://twitter.com/StocksThatDoubl/status/844987898764111873
1439,FinInvTr,@FinInvTr,2017-03-24T18:46:33.000Z,Will GOP Healthcare Bill Pass? (Poll) | $PFE $GILD $JNJ $MRK $CELG $BMY $ABBV $AZN $AGN $HCA $HUM $AET $ABT $VRX | http://bit.ly/2nl5mZE,"Will GOP Healthcare Bill Pass? (Poll) | $PFE $GILD $JNJ $MRK $CELG $BMY $ABBV $AZN $AGN $HCA $HUM $AET $ABT $VRX | http://bit.ly/2nl5mZE
1",,,,1,[],https://twitter.com/FinInvTr/status/845346113779613696
1440,ZoomStocks,@ZoomStocks,2017-03-24T13:52:27.000Z,#Germany Stocks: SemiCond $IFX+8.5%.Pharma $MRK+2.3%.Telecom $UTDI+3.9%.Cables $LEO+5.8%.Defense $RHM+4%.BFSI $ALV-1.2%. Luxury $BOSS+1.4%.,#Germany Stocks: SemiCond $IFX+8.5%.Pharma $MRK+2.3%.Telecom $UTDI+3.9%.Cables $LEO+5.8%.Defense $RHM+4%.BFSI $ALV-1.2%. Luxury $BOSS+1.4%.,,,,,[],https://twitter.com/ZoomStocks/status/845272100432760832
1441,finsents,@finsents,2017-03-24T11:16:16.000Z,$MRK:US  Merck KGaA : FDA Approves First Treatment For Rare Form Of Skin Cancer #MERCK & CO  http://tinyurl.com/k35ktzg #SP500,$MRK:US  Merck KGaA : FDA Approves First Treatment For Rare Form Of Skin Cancer #MERCK & CO  http://tinyurl.com/k35ktzg #SP500,,,,,[],https://twitter.com/finsents/status/845232795379208192
1442,John Carroll,@JohnCendpts,2017-03-24T12:45:49.000Z,"That $95M Merck gamble to acquire cCAM? It didn‚Äôt pay off.
$MRK","That $95M Merck gamble to acquire cCAM? It didn‚Äôt pay off.
$MRK
endpts.com
That $95M Merck gamble to acquire cCAM? It didn‚Äôt pay off.
When Merck $MRK acquired cCAM Biotherapeutics in Israel in the summer of 2015, R&D chief Roger Perlmutter and his crew were intrigued by the potential of its lead drug, CM-24, in targeting the immune...
3
1",,,3,1,['https://pbs.twimg.com/card_img/1500975542664790020/yeCAkL06?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/845255329285844993
1443,Tuan Pham,@15minofPham,2017-03-23T04:13:36.000Z,"RSI X below 40 and # of days it had been abv: $NKE 85, $MRK 54, $SCHW 32, $ANF 29, $GIS 21","RSI X below 40 and # of days it had been abv: $NKE 85, $MRK 54, $SCHW 32, $ANF 29, $GIS 21",,,,,[],https://twitter.com/15minofPham/status/844764039070728193
1444,InvestAlert .com,@investalert,2017-03-23T03:37:15.000Z,$MRK looks like a fire drill with few standing after falling just below its Chandelier Exit http://bit.ly/1Fkcxpz #MRK,$MRK looks like a fire drill with few standing after falling just below its Chandelier Exit http://bit.ly/1Fkcxpz #MRK,,,,,[],https://twitter.com/investalert/status/844754890891153408
1445,Pharmaceutical News,@pharma_sector,2017-03-24T16:07:10.000Z,Why #Merck & Co.'s $95 Million Bet on in 2015 Did Not Pay Off  . Read more: http://owler.us/acrDPF $MRK,Why #Merck & Co.'s $95 Million Bet on in 2015 Did Not Pay Off  . Read more: http://owler.us/acrDPF $MRK,,,,,[],https://twitter.com/pharma_sector/status/845306002635313156
1446,Millennials Grid,@MillennialsGrid,2017-03-23T13:33:13.000Z,"Drugmakers:
$PFE
$MRK
$LLY
$JNJ
$NVS  #business","Drugmakers:
$PFE
$MRK
$LLY
$JNJ
$NVS  #business",,,,,['https://pbs.twimg.com/media/C7m0Ll-VQAAZe13?format=jpg&name=small'],https://twitter.com/MillennialsGrid/status/844904870201184256
1447,Sweet Platform,@SweetPlatform,2017-03-24T16:07:04.000Z,"MRK Top news - Mar 24th, 2017 $MRK http://https://goo.gl/sGGzNo","MRK Top news - Mar 24th, 2017 $MRK http://https://goo.gl/sGGzNo",,,,,[],https://twitter.com/SweetPlatform/status/845305977473843202
1448,Pharmaceutical News,@pharma_sector,2017-03-24T15:08:27.000Z,EMA???s Recommends Approval Of #Merck & Co.???s KEYTRUDA (Pembrolizumab) For The Treatment O... Read more: http://owler.us/acrDvI $MRK,EMA???s Recommends Approval Of #Merck & Co.???s KEYTRUDA (Pembrolizumab) For The Treatment O... Read more: http://owler.us/acrDvI $MRK,,,,,[],https://twitter.com/pharma_sector/status/845291226953793540
1449,Pharmaceutical News,@pharma_sector,2017-03-24T15:09:05.000Z,European Medicines Agencys CHMP Recommends Approval of #Mercks KEYTRUDA√Ç pembrolizumab for t... Read more: http://owler.us/acrDvE $MRK,European Medicines Agencys CHMP Recommends Approval of #Mercks KEYTRUDA√Ç pembrolizumab for t... Read more: http://owler.us/acrDvE $MRK,,,,,[],https://twitter.com/pharma_sector/status/845291382533058565
1450,leahanne,@leahanneta,2017-03-23T15:22:34.000Z,"10:46 ET Volume Leader #100 - MRK 1,537,374 Merck & Company $MRK 63.45 -0.05 -0.08% High today of 63.82 day lo","10:46 ET Volume Leader #100 - MRK 1,537,374 Merck & Company $MRK 63.45 -0.05 -0.08% High today of 63.82 day lo
investorshangout.com
10:46 ET Volume Leader #100 - MRK - The Hunt for the Next 10 Bagger #4433884 - Investors Hangout
The Hunt for the Next 10 Bagger: 10:46 ET Volume Leader #100 - MRK 1,537,374 Merck Company $MRK 63.45 -0.05 -0.08% High today of 63 - #4433884",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/844932391986757634
1451,Ticker Report,@TickerReport,2017-03-24T10:13:26.000Z,"Merck & Co., Inc. $MRK Stake Maintained by Stone Run Capital LLC http://ift.tt/2ne3jF2","Merck & Co., Inc. $MRK Stake Maintained by Stone Run Capital LLC http://ift.tt/2ne3jF2",,,,,[],https://twitter.com/TickerReport/status/845216983838711808
1452,Watchlist News,@WatchlistN,2017-03-25T10:07:10.000Z,"Gideon Capital Advisors Inc. Purchases Shares of 4,807 Merck & Co., Inc. $MRK http://zpr.io/PbbUp","Gideon Capital Advisors Inc. Purchases Shares of 4,807 Merck & Co., Inc. $MRK http://zpr.io/PbbUp",,,,,[],https://twitter.com/WatchlistN/status/845577792267980800
1453,Zenect,@zenect,2017-03-23T12:42:44.000Z,Our Review of $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  Click here to download http://bit.ly/1sQ7Crl,Our Review of $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  Click here to download http://bit.ly/1sQ7Crl,,,,,[],https://twitter.com/zenect/status/844892167650856960
1454,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-03-25T13:01:32.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/8lK6bcFbd,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/8lK6bcFbd,,,,,[],https://twitter.com/gem_2014/status/845621672514342912
1455,Daily Political,@dailypoliticaln,2017-03-24T10:19:08.000Z,"Dynamic Technology Lab Private Ltd Takes Position in Merck & Co., Inc. $MRK http://ift.tt/2nL296s","Dynamic Technology Lab Private Ltd Takes Position in Merck & Co., Inc. $MRK http://ift.tt/2nL296s",,,,,[],https://twitter.com/dailypoliticaln/status/845218416051077122
1456,Zenect,@zenect,2017-03-25T10:48:41.000Z,Which one would you pick? http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,Which one would you pick? http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,,,,,[],https://twitter.com/zenect/status/845588240530903041
1457,Daily Political,@dailypoliticaln,2017-03-23T10:04:24.000Z,"Merck & Co., Inc. $MRK Shares Bought by Brown Advisory Inc. http://ift.tt/2nM7R8T","Merck & Co., Inc. $MRK Shares Bought by Brown Advisory Inc. http://ift.tt/2nM7R8T",,,,,[],https://twitter.com/dailypoliticaln/status/844852320382795778
1458,MarketBeat,@MarketBeatCom,2017-03-24T15:52:35.000Z,Merck & Co.‚Äôs $MRK Market Perform Rating Reaffirmed at Leerink Swann http://ift.tt/2mzkWlA #acn,Merck & Co.‚Äôs $MRK Market Perform Rating Reaffirmed at Leerink Swann http://ift.tt/2mzkWlA #acn,,,,,[],https://twitter.com/MarketBeatCom/status/845302331939926016
1459,MarketBeat,@MarketBeatCom,2017-03-25T19:27:25.000Z,"Merck & Co., Inc. $MRK Rating Reiterated by BMO Capital Markets http://ift.tt/2nUruLZ #acn","Merck & Co., Inc. $MRK Rating Reiterated by BMO Capital Markets http://ift.tt/2nUruLZ #acn",,,,,[],https://twitter.com/MarketBeatCom/status/845718785625591808
1460,US Banking News,@AmericanBanking,2017-03-24T14:17:21.000Z,Merck KGaA given ‚Ç¨110.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2odd45E $MRK #MRK,Merck KGaA given ‚Ç¨110.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2odd45E $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/845278365682733056
1461,Jamie Singer,@JSwatercooler,2017-03-23T18:46:54.000Z,DYK? Merck pays BMS 6.5% of next sales of Keytruda until Dec 2023.  Result of PD-1 patent litigation found on page 106 of the $MRK 10K.,"DYK? Merck pays BMS 6.5% of next sales of Keytruda until Dec 2023.  Result of PD-1 patent litigation found on page 106 of the $MRK 10K.
1",,1,,,[],https://twitter.com/JSwatercooler/status/844983810169196548
1462,StockNews.com,@stocknewsdotcom,2017-03-24T12:20:43.000Z,$MRK Confirms positive opinion from the CHMP of the EMA of KEYTRYDA for the treatment of adult patients with relap‚Ä¶ https://stocknews.com/news/mrk-confirms-positive-opinion-from-the-chmp-of-the-ema-of/‚Ä¶,$MRK Confirms positive opinion from the CHMP of the EMA of KEYTRYDA for the treatment of adult patients with relap‚Ä¶ https://stocknews.com/news/mrk-confirms-positive-opinion-from-the-chmp-of-the-ema-of/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/845249012089475073
1463,Market Realist,@MarketRealist,2017-03-24T20:46:36.000Z,What's Driving Merck's Valuation in 2017? http://marketrealist.com/?p=1994129 $MRK $JNJ $PFE $LLY,What's Driving Merck's Valuation in 2017? http://marketrealist.com/?p=1994129 $MRK $JNJ $PFE $LLY,,,,,[],https://twitter.com/MarketRealist/status/845376322633388032
1464,MarketBeat,@MarketBeatCom,2017-03-25T11:59:30.000Z,"Merck & Co., Inc. $MRK Stake Held by Glovista Investments LLC http://zpr.io/PbbMc","Merck & Co., Inc. $MRK Stake Held by Glovista Investments LLC http://zpr.io/PbbMc",,,,,[],https://twitter.com/MarketBeatCom/status/845606062740910080
1465,TalkMarkets,@TalkMarkets,2017-03-25T17:25:44.000Z,Week In Review: Two Major China CROs Move Toward China Public Listings $MRK https://goo.gl/4reEAN,Week In Review: Two Major China CROs Move Toward China Public Listings $MRK https://goo.gl/4reEAN,,,,,[],https://twitter.com/TalkMarkets/status/845688161795788802
1466,George Marcovits,@GemsBot,2017-03-25T13:01:23.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/78373783#78373860‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/78373783#78373860‚Ä¶,,,,,['https://pbs.twimg.com/media/C7xAZLDXgAEXCNV?format=jpg&name=small'],https://twitter.com/GemsBot/status/845621635357048832
1467,ChinaBio¬Æ Group,@ChinaBio,2017-03-25T17:25:44.000Z,Week In Review: Two Major China CROs Move Toward China Public Listings $MRK https://goo.gl/4reEAN,"Week In Review: Two Major China CROs Move Toward China Public Listings $MRK https://goo.gl/4reEAN
1",,,,1,[],https://twitter.com/ChinaBio/status/845688162529751044
1468,Watchlist News,@WatchlistN,2017-03-23T10:05:06.000Z,"J. Goldman & Co LP Acquires Shares of 5,100 Merck & Co., Inc. $MRK http://zpr.io/PbT7h","J. Goldman & Co LP Acquires Shares of 5,100 Merck & Co., Inc. $MRK http://zpr.io/PbT7h",,,,,[],https://twitter.com/WatchlistN/status/844852495344066564
1469,Novateur Ventures,@NovateurBio,2017-03-23T22:39:22.000Z,"The 
@US_FDA
 OKs $MRK Merck‚Äôs #Keytruda for #Hodgkin lymphoma, a first in blood cancer - https://endpts.com/fda-oks-mercks-keytruda-for-hodgkin-lymphoma-a-first-in-blood-cancer‚Ä¶ via 
@endpts","The 
@US_FDA
 OKs $MRK Merck‚Äôs #Keytruda for #Hodgkin lymphoma, a first in blood cancer - https://endpts.com/fda-oks-mercks-keytruda-for-hodgkin-lymphoma-a-first-in-blood-cancer‚Ä¶ via 
@endpts
endpts.com
FDA OKs Merck‚Äôs Keytruda for Hodgkin lymphoma, a first in blood cancer
Merck has racked up another FDA approval for Keytruda, this time for classical Hodgkin lymphoma, marking the PD-1 blocker's first green-light for use in liquid tumors. Regulators handed out the OK...",,,,,['https://pbs.twimg.com/card_img/1500040128382877696/kss5wBcf?format=png&name=small'],https://twitter.com/NovateurBio/status/845042316070969346
1470,APM Health Europe,@apmhealtheurope,2017-03-23T15:02:01.000Z,"French cost-effectiveness opinions for Opdivo and Keytruda $BMS $MRK 
@apmhealtheurope
 http://apmhealtheurope.com/story.php?numero=52356&ctx=d51a83bcd5492fbe0275bd039a90577c‚Ä¶","French cost-effectiveness opinions for Opdivo and Keytruda $BMS $MRK 
@apmhealtheurope
 http://apmhealtheurope.com/story.php?numero=52356&ctx=d51a83bcd5492fbe0275bd039a90577c‚Ä¶",,,,,[],https://twitter.com/apmhealtheurope/status/844927219562635268
1471,Contix Alerts,@contixalerts,2017-03-23T12:42:09.000Z,"$MRK terminates anti-CEACAM1 from $95M cCAM acquisition After dumping BET inhibitor from $110M Oncoe 
@AndyBiotech
 https://app.contix.com/alerts/36698645","$MRK terminates anti-CEACAM1 from $95M cCAM acquisition After dumping BET inhibitor from $110M Oncoe 
@AndyBiotech
 https://app.contix.com/alerts/36698645",,,,,[],https://twitter.com/contixalerts/status/844892017821827080
1472,Contix Alerts,@contixalerts,2017-03-23T20:19:17.000Z,"$MRK: Merck‚Äôs 
@EMDSerono
 wins FDA approval for Bavencio in rare skin cancer 
@BioWorld
 https://app.contix.com/alerts/36717113","$MRK: Merck‚Äôs 
@EMDSerono
 wins FDA approval for Bavencio in rare skin cancer 
@BioWorld
 https://app.contix.com/alerts/36717113",,,,,[],https://twitter.com/contixalerts/status/845007059921727488
1473,Endpoints News,@endpts,2017-03-24T13:10:29.000Z,"That $95M Merck gamble to acquire cCAM? It didn‚Äôt pay off. https://endpts.com/that-95m-merck-gamble-to-acquire-ccam-it-didnt-pay-off/‚Ä¶ $MRK #checkpoint #cancer by 
@JohnCendpts","That $95M Merck gamble to acquire cCAM? It didn‚Äôt pay off. https://endpts.com/that-95m-merck-gamble-to-acquire-ccam-it-didnt-pay-off/‚Ä¶ $MRK #checkpoint #cancer by 
@JohnCendpts
endpts.com
That $95M Merck gamble to acquire cCAM? It didn‚Äôt pay off.
When Merck $MRK acquired cCAM Biotherapeutics in Israel in the summer of 2015, R&D chief Roger Perlmutter and his crew were intrigued by the potential of its lead drug, CM-24, in targeting the immune...",,,,,['https://pbs.twimg.com/card_img/1500975542664790020/yeCAkL06?format=jpg&name=small'],https://twitter.com/endpts/status/845261539057774597
1474,Michelle Fay Cortez,@FayCortez,2017-03-23T17:18:56.000Z,"Pfizer's Read gives a shout out to $MRK's Keytruda, $GILD's Harvoni (plus $PFE drugs). It takes a village.","Pfizer's Read gives a shout out to $MRK's Keytruda, $GILD's Harvoni (plus $PFE drugs). It takes a village.",,,,,[],https://twitter.com/FayCortez/status/844961673484156928
1475,Jack Allen,@JohnK_Allen,2017-03-23T19:58:22.000Z,"Durvalumab $AZN likely to be the 5th PD-1/PD-L1 to market, but will there be much room left @Datamonitor_ZM @Datamonitor_DP ?
$BMY $MRK $PFE","Durvalumab $AZN likely to be the 5th PD-1/PD-L1 to market, but will there be much room left @Datamonitor_ZM @Datamonitor_DP ?
$BMY $MRK $PFE
Zachary McLellan
@biotechzm
 ¬∑ 24 Mar 2017
$MKGAY & $PFE's  #Bavencio (avelumab) gets the green light in metastatic Merkel cell carcinoma. http://bit.ly/2nN2hTA
1",,1,,,['https://pbs.twimg.com/profile_images/703188288769642498/BqsxWHlo_mini.jpg'],https://twitter.com/JohnK_Allen/status/845001796724707330
1476,Kara Jill Stancell,@kjilly,2017-03-24T15:41:57.000Z,That $95M $MRK gamble to acquire cCAM? It didn‚Äôt pay off. -,"That $95M $MRK gamble to acquire cCAM? It didn‚Äôt pay off. -
endpts.com
That $95M Merck gamble to acquire cCAM? It didn‚Äôt pay off.
When Merck $MRK acquired cCAM Biotherapeutics in Israel in the summer of 2015, R&D chief Roger Perlmutter and his crew were intrigued by the potential of its lead drug, CM-24, in targeting the immune...",,,,,['https://pbs.twimg.com/card_img/1500975542664790020/yeCAkL06?format=jpg&name=small'],https://twitter.com/kjilly/status/845299656502358017
1477,Andy Biotech,@AndyBiotech,2017-03-26T16:28:36.000Z,"Different drugs for bad bugs: antivirulence strategies in the age of #AntibioticResistance 

http://nature.com/nrd/journal/vaop/ncurrent/full/nrd.2017.23.html‚Ä¶
$MRK $GSK $AZN $EBS","Different drugs for bad bugs: antivirulence strategies in the age of #AntibioticResistance 

http://nature.com/nrd/journal/vaop/ncurrent/full/nrd.2017.23.html‚Ä¶
$MRK $GSK $AZN $EBS
12
25",,,12,25,['https://pbs.twimg.com/media/C7243R7W4AAhvUv?format=jpg&name=small'],https://twitter.com/AndyBiotech/status/846036169448198145
1478,Stanislav Drastich,@drastichs,2017-03-27T19:27:41.000Z,"Will Trump Send Drug Stocks Tumbling Again? https://seekingalpha.com/article/4058202-will-trump-send-drug-stocks-tumbling?source=tweet‚Ä¶ $GILD $ABBV $IBB $MNK $MRK $VRX

#stocks #news","Will Trump Send Drug Stocks Tumbling Again? https://seekingalpha.com/article/4058202-will-trump-send-drug-stocks-tumbling?source=tweet‚Ä¶ $GILD $ABBV $IBB $MNK $MRK $VRX

#stocks #news
seekingalpha.com
Will Trump Send Drug Stocks Tumbling Again?
Earlier this month, President Trump sounded off again on rising drug costs. Key areas of focus should be having Medicare and Medicaid leverage their buying power to reduce drug costs.
2
1
1",,2,1,1,['https://pbs.twimg.com/card_img/1499126597013626892/KeRQEzrT?format=jpg&name=240x240'],https://twitter.com/drastichs/status/846443625957511169
1479,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-03-26T10:28:37.000Z,Week In Review: 2 Major China CROs Move Toward China Public Listings $MRK http://dlvr.it/NkDgxl #Investing #Stocks,Week In Review: 2 Major China CROs Move Toward China Public Listings $MRK http://dlvr.it/NkDgxl #Investing #Stocks,,,,,[],https://twitter.com/AlertTrade/status/845945578945048576
1480,Seeking Alpha,@SeekingAlpha,2017-03-27T14:46:28.000Z,Alzheimer's Cure Is Science's Holy Grail - Will Biogen Find It? https://seekingalpha.com/article/4058141-alzheimers-cure-sciences-holy-grail-will-biogen-find?source=feed_f‚Ä¶ $BIVV $ESALY $FWP $IONS $LLY $MRK $RHHBF $RHHBY,Alzheimer's Cure Is Science's Holy Grail - Will Biogen Find It? https://seekingalpha.com/article/4058141-alzheimers-cure-sciences-holy-grail-will-biogen-find?source=feed_f‚Ä¶ $BIVV $ESALY $FWP $IONS $LLY $MRK $RHHBF $RHHBY,,,,,[],https://twitter.com/SeekingAlpha/status/846372855973535744
1481,Seeking Alpha,@SeekingAlpha,2017-03-27T18:03:34.000Z,BioLineRx: Expands Cancer Pipeline Significantly By Acquiring Novel Drug Candidate Ready Fo... https://seekingalpha.com/article/4058198-biolinerx-expands-cancer-pipeline-significantly-acquiring-novel-drug-candidate-ready-human?source=feed_f‚Ä¶ $IDRA $MRK $NVS,BioLineRx: Expands Cancer Pipeline Significantly By Acquiring Novel Drug Candidate Ready Fo... https://seekingalpha.com/article/4058198-biolinerx-expands-cancer-pipeline-significantly-acquiring-novel-drug-candidate-ready-human?source=feed_f‚Ä¶ $IDRA $MRK $NVS,,,,,[],https://twitter.com/SeekingAlpha/status/846422459381301248
1482,Greg5thTrad,@Greg5thTrad,2017-03-27T22:00:56.000Z,"$ Flows: Selling on Strength: Among stocks that were up MON, these had the largest net OUTFLOWS of money: $BMY $BABA $GOOGL $AMZN $MRK $AGN","$ Flows: Selling on Strength: Among stocks that were up MON, these had the largest net OUTFLOWS of money: $BMY $BABA $GOOGL $AMZN $MRK $AGN
1
1",,1,,1,['https://pbs.twimg.com/media/C79PDb-VAAAySGl?format=jpg&name=900x900'],https://twitter.com/Greg5thTrad/status/846482192012333057
1483,MM+M Magazine,@MMMnews,2017-03-27T11:30:01.000Z,Missed Friday's news? Here's what to know #pharma $LLY #Trump #AHCA $PFE $MRK #cancer #FDA $MYL $GSK $REGN #Genomics http://bit.ly/2n1IOKM,"Missed Friday's news? Here's what to know #pharma $LLY #Trump #AHCA $PFE $MRK #cancer #FDA $MYL $GSK $REGN #Genomics http://bit.ly/2n1IOKM
1
1",,,1,1,['https://pbs.twimg.com/media/C7sNZbkXgAA3-bl?format=jpg&name=small'],https://twitter.com/MMMnews/status/846323417104175104
1484,WLST.com,@wlstcom,2017-03-26T13:23:11.000Z,3 Tremendously Promising Diabetes Drugs Potentially on the Way --  The Motley Fool $MRK https://fool.com/investing/2017/03/26/3-tremendously-promising-diabetes-drugs-potentiall.aspx‚Ä¶,"3 Tremendously Promising Diabetes Drugs Potentially on the Way --  The Motley Fool $MRK https://fool.com/investing/2017/03/26/3-tremendously-promising-diabetes-drugs-potentiall.aspx‚Ä¶
1
1",,1,,1,['https://pbs.twimg.com/media/C72O-ZpWkAAHJWU?format=jpg&name=small'],https://twitter.com/wlstcom/status/845989510269845504
1485,Dow Stocks,@Top_Dow_Stocks,2017-03-28T07:17:00.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/846622133522329601
1486,Scanz Alerts,@ScanzAlerts,2017-03-28T15:45:33.000Z,"BLOCK TRADE: $MRK 997,564 shares @ $63.10 [11:45:31]","BLOCK TRADE: $MRK 997,564 shares @ $63.10 [11:45:31]",,,,,[],https://twitter.com/ScanzAlerts/status/846750111686430721
1487,Bursatil Biotech,@BursatilBiotech,2017-03-27T20:48:43.000Z,"$TSRO Porfolio 
$MRK 
here's the link to their press release http://ir.tesarobio.com/releasedetail.cfm?releaseid=1018917‚Ä¶","$TSRO Porfolio 
$MRK 
here's the link to their press release http://ir.tesarobio.com/releasedetail.cfm?releaseid=1018917‚Ä¶
2
1",,,2,1,['https://pbs.twimg.com/media/C78-KpiXQAA9Uzy?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/846464018768412673
1488,Helen Ong,@Lin_ling_88,2017-03-28T10:43:59.000Z,Can Pfizer Boost Its Value By $5 Billion By Taking Over Bristol? $MRK $BMY,"Can Pfizer Boost Its Value By $5 Billion By Taking Over Bristol? $MRK $BMY
investors.com
Can Pfizer Boost Its Value By $5 Billion By Taking Over Bristol?
Pfizer could boost its value by $5 billion in a takeover of Bristol-Myers, an analyst said Monday.
2",,,,2,[],https://twitter.com/Lin_ling_88/status/846674219576541184
1489,FiercePharma,@FiercePharma,2017-03-27T14:29:00.000Z,"Appeals court ruling resurrects 5,000 lawsuits tied to Merck & Co. Fosamax dangers http://fiercepharma.com/pharma/appeals-court-ruling-resurrects-5-000-lawsuits-tied-to-merck-co-fosamax-dangers‚Ä¶ $MRK","Appeals court ruling resurrects 5,000 lawsuits tied to Merck & Co. Fosamax dangers http://fiercepharma.com/pharma/appeals-court-ruling-resurrects-5-000-lawsuits-tied-to-merck-co-fosamax-dangers‚Ä¶ $MRK
fiercepharma.com
Appeals court ruling resurrects 5,000 lawsuits tied to Merck & Co. Fosamax dangers
Three years after a federal judge dismissed about 5,000 lawsuits by patients claiming Merck & Co.‚Äôs osteoporosis drug Fosamax was responsible for their femur fractures, a higher court says Merck will...
1",,,1,,[],https://twitter.com/FiercePharma/status/846368461731258368
1490,WLST.com,@wlstcom,2017-03-26T10:28:38.000Z,Week In Review: 2 Major China CROs Move Toward China Public Listings #Investing #Stocks #MRK #ChinaBioToday $MRK,"Week In Review: 2 Major China CROs Move Toward China Public Listings #Investing #Stocks #MRK #ChinaBioToday $MRK
seekingalpha.com
Week In Review: 2 Major China CROs Move Toward China Public Listings
Deals and Financings Wuxi AppTec, China's largest CRO/CMO, has begun the application process for an IPO on a China exchange.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/wlstcom/status/845945582497751040
1491,Seeking Alpha,@SeekingAlpha,2017-03-27T17:44:26.000Z,Will Trump Send Drug Stocks Tumbling Again? https://seekingalpha.com/article/4058202-will-trump-send-drug-stocks-tumbling?source=feed_f‚Ä¶ $GILD $ABBV $IBB $MNK $MRK $VRX,"Will Trump Send Drug Stocks Tumbling Again? https://seekingalpha.com/article/4058202-will-trump-send-drug-stocks-tumbling?source=feed_f‚Ä¶ $GILD $ABBV $IBB $MNK $MRK $VRX
seekingalpha.com
Will Trump Send Drug Stocks Tumbling Again?
Earlier this month, President Trump sounded off again on rising drug costs. Key areas of focus should be having Medicare and Medicaid leverage their buying power to reduce drug costs.",,,,,[],https://twitter.com/SeekingAlpha/status/846417644311855104
1492,Kara Jill Stancell,@kjilly,2017-03-27T17:07:29.000Z,"Appeals court ruling resurrects 5,000 lawsuits tied to $MRK #Fosamax dangers","Appeals court ruling resurrects 5,000 lawsuits tied to $MRK #Fosamax dangers
fiercepharma.com
Appeals court ruling resurrects 5,000 lawsuits tied to Merck & Co. Fosamax dangers
Three years after a federal judge dismissed about 5,000 lawsuits by patients claiming Merck & Co.‚Äôs osteoporosis drug Fosamax was responsible for their femur fractures, a higher court | Three years...",,,,,['https://pbs.twimg.com/card_img/1501985088652775439/zVZjbI5b?format=jpg&name=small'],https://twitter.com/kjilly/status/846408343635714048
1493,Contix Alerts,@contixalerts,2017-03-28T21:21:49.000Z,"$MRK: Woman claims she suffered injuries from Merck's shingles vaccine #healthinnovations #pharma  
@shelleypetersen
 https://app.contix.com/alerts/36860687","$MRK: Woman claims she suffered injuries from Merck's shingles vaccine #healthinnovations #pharma  
@shelleypetersen
 https://app.contix.com/alerts/36860687
1
1",,,1,1,[],https://twitter.com/contixalerts/status/846834736165138432
1494,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-03-28T15:47:28.000Z,"BLOCK TRADE: $MRK 997,564 shares @ $63.10 [11:45:31] #BlockTradeAlert","BLOCK TRADE: $MRK 997,564 shares @ $63.10 [11:45:31] #BlockTradeAlert",,,,,[],https://twitter.com/AlertTrade/status/846750597038563328
1495,IECONOMICS,@iECONOMICS,2017-03-27T13:30:15.000Z,Merck & Co $MRK market alert: 7-week low @ 62.81 https://ieconomics.com/merck,Merck & Co $MRK market alert: 7-week low @ 62.81 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/846353676776157185
1496,CBPartners,@CBPartners,2017-03-28T10:00:46.000Z,$PFE & $MRK secure accelerated approval for BAVENCIO- the first #FDA approved metastatic MCC #SkinCancer treatment http://bit.ly/2n8GYa5,$PFE & $MRK secure accelerated approval for BAVENCIO- the first #FDA approved metastatic MCC #SkinCancer treatment http://bit.ly/2n8GYa5,,,,,[],https://twitter.com/CBPartners/status/846663343968538625
1497,G,@smokiemahoney,2017-03-28T18:26:09.000Z,$GALT below 2? What a steal. Discount shopping here *add* $TBRA $BMY $MRK $AGN ,$GALT below 2? What a steal. Discount shopping here *add* $TBRA $BMY $MRK $AGN ,üõí,,,,[],https://twitter.com/smokiemahoney/status/846790530612760580
1498,Pharmaceutical News,@pharma_sector,2017-03-27T11:29:03.000Z,Why #Merck & Co.'s $95 Million Bet on in 2015 Did Not Pay Off  . Read more: http://owler.us/acsevE $MRK,Why #Merck & Co.'s $95 Million Bet on in 2015 Did Not Pay Off  . Read more: http://owler.us/acsevE $MRK,,,,,[],https://twitter.com/pharma_sector/status/846323174740439044
1499,CBPartners,@CBPartners,2017-03-28T10:30:30.000Z,$PFE & $MRK gain #FDA approval and breakthrough drug designation for metastatic MCC treatment BAVENCIO http://bit.ly/2n8GYa5,$PFE & $MRK gain #FDA approval and breakthrough drug designation for metastatic MCC treatment BAVENCIO http://bit.ly/2n8GYa5,,,,,[],https://twitter.com/CBPartners/status/846670826237841408
1500,US Banking News,@AmericanBanking,2017-03-27T13:16:29.000Z,Merck KGaA given ‚Ç¨105.00 PT by Goldman Sachs Group Inc. neutral rating. http://ift.tt/2nn9CWZ $MRK #MRK,Merck KGaA given ‚Ç¨105.00 PT by Goldman Sachs Group Inc. neutral rating. http://ift.tt/2nn9CWZ $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/846350211614158848
1501,MarketBeat,@MarketBeatCom,2017-03-28T14:04:21.000Z,Merck & Co. $MRK ‚Äì Investment Analysts‚Äô Weekly Ratings Changes http://ift.tt/2nHRKZb #acn,Merck & Co. $MRK ‚Äì Investment Analysts‚Äô Weekly Ratings Changes http://ift.tt/2nHRKZb #acn,,,,,[],https://twitter.com/MarketBeatCom/status/846724647416684548
1502,leahanne,@leahanneta,2017-03-28T18:06:12.000Z,"13:43 ET Volume Leader #62 - MRK 6,044,400 Merck & Company $MRK 63.26 +0.07 +0.11% High today of 63.27 day low","13:43 ET Volume Leader #62 - MRK 6,044,400 Merck & Company $MRK 63.26 +0.07 +0.11% High today of 63.27 day low
investorshangout.com
13:43 ET Volume Leader #62 - MRK - Stock Market News #4443465 - Investors Hangout
Stock Market News: 13:43 ET Volume Leader #62 - MRK 6,044,400 Merck Company $MRK 63.26 +0.07 +0.11% High today of 63. - #4443465",,,,,['https://pbs.twimg.com/card_img/1474439263559290885/SYLhvDaX?format=png&name=240x240'],https://twitter.com/leahanneta/status/846785509779222529
1503,Sweet Platform,@SweetPlatform,2017-03-28T15:34:43.000Z,"MRK Top news - Mar 28th, 2017 $MRK http://https://goo.gl/STUrtP","MRK Top news - Mar 28th, 2017 $MRK http://https://goo.gl/STUrtP",,,,,[],https://twitter.com/SweetPlatform/status/846747384872873984
1504,AlpacaAlerts,@AlpacaAlerts,2017-03-27T23:39:00.000Z,$MRK is in Stochastic Oversold  winning 60.56% in the past. https://scan.alpaca.ai/card/2172847?utm_campaign=card_2172847&utm_content=card&utm_medium=tweet&utm_source=twitter‚Ä¶,"$MRK is in Stochastic Oversold  winning 60.56% in the past. https://scan.alpaca.ai/card/2172847?utm_campaign=card_2172847&utm_content=card&utm_medium=tweet&utm_source=twitter‚Ä¶
1",,,,1,[],https://twitter.com/AlpacaAlerts/status/846506871678783489
1505,Hottest Stocks Now,@HottestStockNow,2017-03-27T11:29:58.000Z,$MRK 's Keytruda Closer to classical Hodgkin Lymphoma nod  http://crweworld.com/article/markets/65493/msds-keytruda-closer-to-classical-hodgkin-lymphoma-nod‚Ä¶,$MRK 's Keytruda Closer to classical Hodgkin Lymphoma nod  http://crweworld.com/article/markets/65493/msds-keytruda-closer-to-classical-hodgkin-lymphoma-nod‚Ä¶,,,,,[],https://twitter.com/HottestStockNow/status/846323404223397889
1506,Daily Political,@dailypoliticaln,2017-03-26T10:03:02.000Z,"Edge Asset Management Inc. Has $93,056,000 Stake in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=992490","Edge Asset Management Inc. Has $93,056,000 Stake in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=992490",,,,,[],https://twitter.com/dailypoliticaln/status/845939138444627972
1507,NY Shock Exchange,@ShockExchange,2017-03-27T17:56:30.000Z,Will #Trump Send Drug Stocks Tumbling Again? https://seekingalpha.com/article/4058202-will-trump-send-drug-stocks-tumbling?source=feed_f‚Ä¶ ‚Ä¶ $GILD $ABBV $IBB $MNK $MRK $VRX #TrumpSyllabusK12,"Will #Trump Send Drug Stocks Tumbling Again? https://seekingalpha.com/article/4058202-will-trump-send-drug-stocks-tumbling?source=feed_f‚Ä¶ ‚Ä¶ $GILD $ABBV $IBB $MNK $MRK $VRX #TrumpSyllabusK12
seekingalpha.com
Will Trump Send Drug Stocks Tumbling Again?
Earlier this month, President Trump sounded off again on rising drug costs. Key areas of focus should be having Medicare and Medicaid leverage their buying power to reduce drug costs.",,,,,['https://pbs.twimg.com/card_img/1501985082583572483/LOOR2uKN?format=jpg&name=240x240'],https://twitter.com/ShockExchange/status/846420679440449541
1508,Vetr,@VetrRatings,2017-03-27T14:31:10.000Z,"The majority of users on Vetr are bullish on Merck & Company, Inc., indicating a HOLD Rating (3 stars) for $MRK http://bit.ly/1GhW0TK","The majority of users on Vetr are bullish on Merck & Company, Inc., indicating a HOLD Rating (3 stars) for $MRK http://bit.ly/1GhW0TK",,,,,[],https://twitter.com/VetrRatings/status/846369004142891008
1509,Lynn McKinnley,@LMinvestments20,2017-03-28T13:05:15.000Z,$REPCF $RP.V and a few other additional tickers to note -  $SGYP $AUPH $VRX $MYL $BIIB $MRK,$REPCF $RP.V and a few other additional tickers to note -  $SGYP $AUPH $VRX $MYL $BIIB $MRK,,,,,[],https://twitter.com/LMinvestments20/status/846709772426579968
1510,Ticker Report,@TickerReport,2017-03-28T10:32:55.000Z,"First Allied Advisory Services Inc. Sells 4,548 Shares of Merck & Co., Inc. $MRK http://zpr.io/PbiWC","First Allied Advisory Services Inc. Sells 4,548 Shares of Merck & Co., Inc. $MRK http://zpr.io/PbiWC",,,,,[],https://twitter.com/TickerReport/status/846671438316781568
1511,Watchlist News,@WatchlistN,2017-03-27T13:30:00.000Z,"29,213 Shares in Merck & Co., Inc. $MRK Acquired by Diligent Investors LLC http://zpr.io/PbrjK","29,213 Shares in Merck & Co., Inc. $MRK Acquired by Diligent Investors LLC http://zpr.io/PbrjK",,,,,[],https://twitter.com/WatchlistN/status/846353614742441985
1512,Ticker Report,@TickerReport,2017-03-28T10:32:54.000Z,"Osterweis Capital Management Inc. Cuts Stake in Merck & Co., Inc. $MRK http://zpr.io/PbiW3","Osterweis Capital Management Inc. Cuts Stake in Merck & Co., Inc. $MRK http://zpr.io/PbiW3",,,,,[],https://twitter.com/TickerReport/status/846671433883402240
1513,MarketBeat,@MarketBeatCom,2017-03-28T05:04:56.000Z,"Merck & Co., Inc. $MRK Shares Bought by Wetherby Asset Management Inc. http://zpr.io/PKaVt","Merck & Co., Inc. $MRK Shares Bought by Wetherby Asset Management Inc. http://zpr.io/PKaVt",,,,,[],https://twitter.com/MarketBeatCom/status/846588896557350912
1514,TalkMarkets,@TalkMarkets,2017-03-26T06:09:05.000Z,Week In Review: Two Major China CROs Move Toward China Public Listings $MRK https://goo.gl/4reEAN,Week In Review: Two Major China CROs Move Toward China Public Listings $MRK https://goo.gl/4reEAN,,,,,[],https://twitter.com/TalkMarkets/status/845880265184555008
1515,Stock Market Picks,@StockWebTrading,2017-03-28T12:57:12.000Z,"$KO $MCD $MMM $MRK $MSFT $NKE $PFE Long and short positions from the Dow Jones, up to 1800% since 2008. http://dowstocktips.com $DJIA $DIA","$KO $MCD $MMM $MRK $MSFT $NKE $PFE Long and short positions from the Dow Jones, up to 1800% since 2008. http://dowstocktips.com $DJIA $DIA
dowstocktips.com
Liquid Stocks from Dow Jones
Trade the largest stocks from Dow Jones index, long and short positions with target and stop loss on each trade, up to 1500% in cumulative profits since 2008, daily stock picks.",,,,,['https://pbs.twimg.com/card_img/1500276043881590785/I2OhqSzR?format=png&name=240x240'],https://twitter.com/StockWebTrading/status/846707744832995328
1516,DDELabs,@DrugDeliveryExp,2017-03-27T15:18:25.000Z,"3 Promising Diabetes Drugs Including glucose responsive insulin 
@themotleyfool
 #stocks $PFE, $MRK, $SNY, $NVO, $LXRX https://fool.com/investing/2017/03/26/3-tremendously-promising-diabetes-drugs-potentiall.aspx‚Ä¶","3 Promising Diabetes Drugs Including glucose responsive insulin 
@themotleyfool
 #stocks $PFE, $MRK, $SNY, $NVO, $LXRX https://fool.com/investing/2017/03/26/3-tremendously-promising-diabetes-drugs-potentiall.aspx‚Ä¶",,,,,[],https://twitter.com/DrugDeliveryExp/status/846380898031288320
1517,Allison Gatlin,@IBD_AGatlin,2017-03-27T16:50:46.000Z,Can Pfizer boost its value by $5 billion by taking over Bristol? $PFE $BMY $MRK $RHHBY $PYPL $XRX $AGN,"Can Pfizer boost its value by $5 billion by taking over Bristol? $PFE $BMY $MRK $RHHBY $PYPL $XRX $AGN
investors.com
Can Pfizer Boost Its Value By $5 Billion By Taking Over Bristol?
Pfizer could boost its value by $5 billion in a takeover of Bristol-Myers, an analyst said Monday.",,,,,[],https://twitter.com/IBD_AGatlin/status/846404137835225088
1518,Allison Gatlin,@IBD_AGatlin,2017-03-28T16:34:20.000Z,Why Clovis' advantage might squash Tesaro in ovarian cancer $CLVS $TSRO $AZN $BMY $MRK $RHHBY $INCY http://ow.ly/6XuV30al0xQ,Why Clovis' advantage might squash Tesaro in ovarian cancer $CLVS $TSRO $AZN $BMY $MRK $RHHBY $INCY http://ow.ly/6XuV30al0xQ,,,,,[],https://twitter.com/IBD_AGatlin/status/846762390846889990
1519,Allison Gatlin,@IBD_AGatlin,2017-03-27T20:50:41.000Z,"Tesaro creeps up on rivals with cancer drug OK, but merger unlikely $TSRO $AZN $CLVS $BMY $MRK $RHHBY","Tesaro creeps up on rivals with cancer drug OK, but merger unlikely $TSRO $AZN $CLVS $BMY $MRK $RHHBY
investors.com
Tesaro Creeps Up On Rivals With Cancer Drug OK, But Merger Unlikely
Tesaro stock fell as oncologists concluded rival drugs are just as effective as its ovarian cancer drug, hurting Tesaro's merger prospects.
1",,1,,,[],https://twitter.com/IBD_AGatlin/status/846464515084599300
1520,Zero Filter,@zerofiltertruth,2017-03-27T14:37:44.000Z,"$SNY beautiful weekly chart gets even better with $VVUS announcement

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD
@GuyAdami
 @BKBrianKelly","$SNY beautiful weekly chart gets even better with $VVUS announcement

$IBB $XBI $FBT $BIB $BBH $MRK $CELG $GILD
@GuyAdami
 @BKBrianKelly",,,,,[],https://twitter.com/zerofiltertruth/status/846370660762963969
1521,Ethan Allen,@ethanallen2013,2017-03-28T00:39:38.000Z,"@adamfeuerstein
 Any insights into what we should look for immuno oncology wise at #AACR17? $bmy $mrk Would appreciate your thoughts.","@adamfeuerstein
 Any insights into what we should look for immuno oncology wise at #AACR17? $bmy $mrk Would appreciate your thoughts.",,,,,[],https://twitter.com/ethanallen2013/status/846522132989337600
1522,Lance Markel,@lanceinvests,2017-03-28T13:05:15.000Z,$REPCF $RP.V and a few other additional tickers to note -  $SGYP $AUPH $VRX $MYL $BIIB $MRK,$REPCF $RP.V and a few other additional tickers to note -  $SGYP $AUPH $VRX $MYL $BIIB $MRK,,,,,[],https://twitter.com/lanceinvests/status/846709772380508160
1523,Watchlist News,@WatchlistN,2017-03-26T12:25:46.000Z,"Merck & Co., Inc. $MRK Shares Sold by Monetary Management Group Inc. http://zpr.io/PbwXG","Merck & Co., Inc. $MRK Shares Sold by Monetary Management Group Inc. http://zpr.io/PbwXG",,,,,[],https://twitter.com/WatchlistN/status/845975061861412864
1524,TalkMarkets Recap,@MarketsRecap,2017-03-26T00:09:03.000Z,Week In Review: Two Major China CROs Move Toward China Public Listings $MRK https://goo.gl/4reEAN,Week In Review: Two Major China CROs Move Toward China Public Listings $MRK https://goo.gl/4reEAN,,,,,[],https://twitter.com/MarketsRecap/status/845789661066940418
1525,Sachin,@sachinpatkar3,2017-03-26T19:54:39.000Z,"3 Tremendously Promising Diabetes Drugs Potentially on the Way 
@themotleyfool
 #stocks $PFE, $MRK, $SNY, $NVO, $LXRX","3 Tremendously Promising Diabetes Drugs Potentially on the Way 
@themotleyfool
 #stocks $PFE, $MRK, $SNY, $NVO, $LXRX
fool.com
3 Tremendously Promising Diabetes Drugs Potentially on the Way @themotleyfool #stocks $PFE $MRK...
Diabetes patients could have new treatment options if Merck, Pfizer, Lexicon, Sanofi, and Novo Nordisk succeed with these three promising drugs.",‚ú≥,,,,['https://pbs.twimg.com/card_img/1500877246743019520/X4vcATLp?format=jpg&name=small'],https://twitter.com/sachinpatkar3/status/846088024656166913
1526,Andy Biotech,@AndyBiotech,2017-03-29T00:20:14.000Z,"Prospects for combining targeted and conventional cancer therapy with #immunotherapy

http://nature.com/nrc/journal/vaop/ncurrent/full/nrc.2017.17.html‚Ä¶
$BMY $MRK $INCY $SNDX $CRVS","Prospects for combining targeted and conventional cancer therapy with #immunotherapy

http://nature.com/nrc/journal/vaop/ncurrent/full/nrc.2017.17.html‚Ä¶
$BMY $MRK $INCY $SNDX $CRVS
2
21
37",,2,21,37,['https://pbs.twimg.com/media/C8C4dcMXgAA99g-?format=jpg&name=small'],https://twitter.com/AndyBiotech/status/846879637649211392
1527,Seeking Alpha,@SeekingAlpha,2017-03-29T14:31:11.000Z,Pro Portfolio Proof VI: 20 Top Pop Hedge Fund 'Go To' Folio Dogs https://seekingalpha.com/article/4058809-pro-portfolio-proof-vi-20-top-pop-hedge-fund-go-to-folio-dogs?source=feed_f‚Ä¶ $SLB $INTC $PFE $MRK $ABBV $V $BAC $MSFT $HD,"Pro Portfolio Proof VI: 20 Top Pop Hedge Fund 'Go To' Folio Dogs https://seekingalpha.com/article/4058809-pro-portfolio-proof-vi-20-top-pop-hedge-fund-go-to-folio-dogs?source=feed_f‚Ä¶ $SLB $INTC $PFE $MRK $ABBV $V $BAC $MSFT $HD
seekingalpha.com
Pro Portfolio Proof VI: 20 Top Pop Hedge Fund 'Go To' Folio Dogs
The same four methods gauged the dividend safety of all Pro Folio equities: (1) Free cash-flow yields; (2) cash dividend payout-ratios; (3) 1-year total-returns (annual); (4) distribution...
2",,,,2,['https://pbs.twimg.com/card_img/1501735167974588418/EhohjTEy?format=jpg&name=240x240'],https://twitter.com/SeekingAlpha/status/847093785959919617
1528,Brad Loncar,@bradloncar,2017-03-31T11:29:01.000Z,You can bet IDO/PD-1 will be a theme at #AACR17 (NewLink & Bristol data). $MRK & $INCY now have 7 pivotals planned. http://businesswire.com/news/home/20170331005124/en/‚Ä¶,"You can bet IDO/PD-1 will be a theme at #AACR17 (NewLink & Bristol data). $MRK & $INCY now have 7 pivotals planned. http://businesswire.com/news/home/20170331005124/en/‚Ä¶
1
17
19",,1,17,19,['https://pbs.twimg.com/media/C8PkyW-UIAAjndk?format=jpg&name=900x900'],https://twitter.com/bradloncar/status/847772716665106433
1529,Bursatil Biotech,@BursatilBiotech,2017-03-31T11:09:17.000Z,"$INCY & $MRK Epa+Pembro
Clinical Program Now Includes 7 Registrational Trials Across 5 Tumor Types
http://businesswire.com/news/home/20170331005124/en/‚Ä¶","$INCY & $MRK Epa+Pembro
Clinical Program Now Includes 7 Registrational Trials Across 5 Tumor Types
http://businesswire.com/news/home/20170331005124/en/‚Ä¶
1
7
6",,1,7,6,['https://pbs.twimg.com/media/C8Pf_EbXsAATD1x?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/847767753285095424
1530,dough,@semodough,2017-03-30T14:53:28.000Z,"Replying to 
@BioValues","Replying to 
@BioValues
$LPTX what does it have common with $MRK $BMY $NVS $AZN    ANTI GITR   On watch
3
6
9",,3,6,9,['https://pbs.twimg.com/media/C8LJ_uQUMAEsvuR?format=jpg&name=small'],https://twitter.com/semodough/status/847461783732342791
1531,Limex,@LimexMe,2017-03-30T19:38:53.000Z,Should Investors Worry About Bristol-Myers Squibb's Recent Setbacks? http://bit.ly/300317BMY $BMY $MRK $RHHBY,Should Investors Worry About Bristol-Myers Squibb's Recent Setbacks? http://bit.ly/300317BMY $BMY $MRK $RHHBY,,,,,['https://pbs.twimg.com/media/C8MLUztVYAATQq8?format=jpg&name=small'],https://twitter.com/LimexMe/status/847533610659926021
1532,dough,@semodough,2017-03-31T13:13:43.000Z,$INCY 28 B mcap If epacadostat is able to realize a fraction of this market potential INCY shares could have significant upside. COWEN $MRK,"$INCY 28 B mcap If epacadostat is able to realize a fraction of this market potential INCY shares could have significant upside. COWEN $MRK
dough
@semodough
 ¬∑ 31 Mar 2017
Replying to @BursatilBiotech
$INCY cowen models PD-1/PD-L1 class supporting WW sales of >$28Bacross epacadostat's 5 pivotal trial indications in 2022
2
2",üò≥,,2,2,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/847799064662089728
1533,Dow Stocks,@Top_Dow_Stocks,2017-03-31T07:16:58.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/847709288608878592
1534,Anirban Maitra,@Aiims1742,2017-03-31T12:22:53.000Z,"See ECHO-207 trial $INCY  includes both $BMY nivolumab &amp; $MRK Keytruda in multiple tumors incl. #PancreaticCancer 
https://clinicaltrials.gov/ct2/show/NCT03085914?term=Ido+pancreatic&rank=4‚Ä¶","See ECHO-207 trial $INCY  includes both $BMY nivolumab &amp; $MRK Keytruda in multiple tumors incl. #PancreaticCancer 
https://clinicaltrials.gov/ct2/show/NCT03085914?term=Ido+pancreatic&rank=4‚Ä¶
Brad Loncar
@bradloncar
 ¬∑ 31 Mar 2017
You can bet IDO/PD-1 will be a theme at #AACR17 (NewLink & Bristol data). $MRK & $INCY now have 7 pivotals planned. http://businesswire.com/news/home/20170331005124/en/‚Ä¶
1
6",,,1,6,"['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg', 'https://pbs.twimg.com/media/C8PkyW-UIAAjndk?format=jpg&name=900x900']",https://twitter.com/Aiims1742/status/847786275906170881
1535,Evaluate Vantage,@evaluatevantage,2017-03-30T20:08:39.000Z,Mind the pay gap? Check out how the salary of $GSK's new CEO stacks up against her (male) peers: http://ow.ly/Bw7730apOsV $MRK $JNJ $ABBV,"Mind the pay gap? Check out how the salary of $GSK's new CEO stacks up against her (male) peers: http://ow.ly/Bw7730apOsV $MRK $JNJ $ABBV
10",,,10,,[],https://twitter.com/evaluatevantage/status/847541101699489792
1536,Kara Jill Stancell,@kjilly,2017-03-31T18:50:11.000Z,"Pharma's most-valuable brands? $JNJ, $PFE and $MRK. $VRX, not so much","Pharma's most-valuable brands? $JNJ, $PFE and $MRK. $VRX, not so much
fiercepharma.com
Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much
U.S. pharma brands jumped in value almost across the board in Brand Finance's annual look at the nation‚Äôs most valuable. The lone exception? | U.S. pharma brands jumped in value almost across the...",,,,,[],https://twitter.com/kjilly/status/847883739824668673
1537,CBPartners,@CBPartners,2017-03-29T16:15:20.000Z,$MRK KEYTRUDA and $BMS OPDIVO given green light from #CHMP for new indications during #EMA‚Äôs advisory board,"$MRK KEYTRUDA and $BMS OPDIVO given green light from #CHMP for new indications during #EMA‚Äôs advisory board
pmlive.com
Keytruda and Opdivo backed for new uses in Europe
CHMP recommendations also include Trumenba, Dinutuximab beta and Refixia",,,,,[],https://twitter.com/CBPartners/status/847119995788283905
1538,Tuan Pham,@15minofPham,2017-03-31T17:20:46.000Z,"Mid-day top of range: $BBY $CPN $EMR $MOS $NOK $UPS $XLRE 100, $ADSK $EXAS $LNG $OKE $RIO $TOT $WFM $WY 98, $DDD $GME $MRK $SO $TXMD $XEL 97","Mid-day top of range: $BBY $CPN $EMR $MOS $NOK $UPS $XLRE 100, $ADSK $EXAS $LNG $OKE $RIO $TOT $WFM $WY 98, $DDD $GME $MRK $SO $TXMD $XEL 97",,,,,[],https://twitter.com/15minofPham/status/847861238717612038
1539,CBPartners,@CBPartners,2017-03-29T16:35:10.000Z,New indication approved for $MRK KEYTRUDA - #CHMP approves drug for the treatment of patients with relapsed #cHL,"New indication approved for $MRK KEYTRUDA - #CHMP approves drug for the treatment of patients with relapsed #cHL
pmlive.com
Keytruda and Opdivo backed for new uses in Europe
CHMP recommendations also include Trumenba, Dinutuximab beta and Refixia",,,,,[],https://twitter.com/CBPartners/status/847124986976485380
1540,Economic Calendar,@EconCalend,2017-03-31T18:54:05.000Z,"Incyte (INCY) and Merck (MRK) Amplify Anti-tumor Collaboration
http://economiccalendar.com/2017/03/31/incyte-incy-and-merck-mrk-amplify-anti-tumor-collaboration/‚Ä¶
#stocks $INCY $MRK","Incyte (INCY) and Merck (MRK) Amplify Anti-tumor Collaboration
http://economiccalendar.com/2017/03/31/incyte-incy-and-merck-mrk-amplify-anti-tumor-collaboration/‚Ä¶
#stocks $INCY $MRK",,,,,[],https://twitter.com/EconCalend/status/847884721036152833
1541,Zenect,@zenect,2017-03-31T12:42:46.000Z,Is this the only #dividend stock you‚Äôll ever need?  http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,Is this the only #dividend stock you‚Äôll ever need?  http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,,,,,[],https://twitter.com/zenect/status/847791276854579200
1542,il falso guaritore,@falsoguaritore,2017-03-30T14:52:06.000Z,Curis Dares To Be Different https://seekingalpha.com/article/4058603-curis-dares-different?source=tweet‚Ä¶ $JNJ $RHHBY $INCY $CRIS $MRK $CELG $SPPI $SNY,Curis Dares To Be Different https://seekingalpha.com/article/4058603-curis-dares-different?source=tweet‚Ä¶ $JNJ $RHHBY $INCY $CRIS $MRK $CELG $SPPI $SNY,,,,,[],https://twitter.com/falsoguaritore/status/847461437769371650
1543,1 min Stock Insights,@1MinuteStock,2017-03-31T12:04:02.000Z,"Btw, Estimated #Earnings Per Share for $MRK is $0.88 it's 1.39% of the current price https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=eps&utm_source=twitter‚Ä¶","Btw, Estimated #Earnings Per Share for $MRK is $0.88 it's 1.39% of the current price https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=eps&utm_source=twitter‚Ä¶",,,,,[],https://twitter.com/1MinuteStock/status/847781530789457921
1544,Pharmaceutical News,@pharma_sector,2017-03-31T15:32:44.000Z,Incyte And #Merck & Co. Provide Additional Details On Previously Announced Collaboration Inv... Read more: http://owler.us/actTLh $MRK,Incyte And #Merck & Co. Provide Additional Details On Previously Announced Collaboration Inv... Read more: http://owler.us/actTLh $MRK,,,,,[],https://twitter.com/pharma_sector/status/847834052027498496
1545,Fractaurean,@Fractaurean,2017-03-31T17:16:34.000Z,My Favorite Stock Market Sector https://seekingalpha.com/article/4059294-favorite-stock-market-sector?source=tweet‚Ä¶ $ABBV $AMGN $BMY $CELG $DIA $GILD $IBB $IHE $IHI $JNJ $MDT $MRK $PFE $SPY $UNH,"My Favorite Stock Market Sector https://seekingalpha.com/article/4059294-favorite-stock-market-sector?source=tweet‚Ä¶ $ABBV $AMGN $BMY $CELG $DIA $GILD $IBB $IHE $IHI $JNJ $MDT $MRK $PFE $SPY $UNH
seekingalpha.com
My Favorite Stock Market Sector
My favorite stock market sector. Consistently positive earnings trends, attractive valuation fundamentals, and improving qualitative risk factors.
1",,,,1,['https://pbs.twimg.com/card_img/1501985181120401423/yizUxA47?format=jpg&name=240x240'],https://twitter.com/Fractaurean/status/847860180746424321
1546,MarketBeat,@MarketBeatCom,2017-03-30T18:07:12.000Z,"Merck & Co., Inc. $MRK Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages http://ift.tt/2nnMHKt #acn","Merck & Co., Inc. $MRK Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages http://ift.tt/2nnMHKt #acn",,,,,[],https://twitter.com/MarketBeatCom/status/847510535851483136
1547,US Banking News,@AmericanBanking,2017-03-30T14:18:51.000Z,Merck KGaA given ‚Ç¨125.00 PT by Credit Suisse Group AG. buy rating. http://ift.tt/2mSGee8 $MRK #MRK,Merck KGaA given ‚Ç¨125.00 PT by Credit Suisse Group AG. buy rating. http://ift.tt/2mSGee8 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/847453071571435520
1548,Vista Partners LLC,@VistaPResearch,2017-03-29T04:34:43.000Z,"@weekinpharma
 thanks for RT! SLl the best! Vista Partners #Investing #biotech #healthcare http://vistapglobal.com $PFE $JNJ $MRK $UNH","@weekinpharma
 thanks for RT! SLl the best! Vista Partners #Investing #biotech #healthcare http://vistapglobal.com $PFE $JNJ $MRK $UNH
vistapglobal.com
Vista Partners LLC | Home
San Francisco-based Vista Partners LLC is a California Registered Investment Advisor based in San Francisco that seeks to invest partner capital while arming investors with a comprehensive global...
1
1",,,1,1,['https://pbs.twimg.com/card_img/1500872662561792007/6xaja1P4?format=png&name=small'],https://twitter.com/VistaPResearch/status/846943679482925056
1549,Sweet Platform,@SweetPlatform,2017-03-30T14:54:50.000Z,"MRK Top news - Mar 30th, 2017 $MRK http://https://goo.gl/LwhmxN","MRK Top news - Mar 30th, 2017 $MRK http://https://goo.gl/LwhmxN",,,,,[],https://twitter.com/SweetPlatform/status/847462125857619968
1550,The Fly,@theflynews,2017-03-31T15:42:03.000Z,Before the Move: Stocks to watch into meeting of cancer researchers $BMY $MRK $INCY $NLNK $LLY $PFE $NVS $AFMD $FATE,"Before the Move: Stocks to watch into meeting of cancer researchers $BMY $MRK $INCY $NLNK $LLY $PFE $NVS $AFMD $FATE
thefly.com
Before the Move: Stocks to watch into meeting of cancer researchers
This year's American... BMY, MRK, INCY, NLNK, LLY, PFE, NVS, AFMD, FATE
2",,,2,,['https://pbs.twimg.com/card_img/1501305764081721345/GcvAvZOJ?format=jpg&name=small'],https://twitter.com/theflynews/status/847836394554707968
1551,Ticker Report,@TickerReport,2017-03-30T10:11:07.000Z,"MML Investors Services LLC Purchases New Position in Merck & Co., Inc. $MRK http://ift.tt/2oe1lYA","MML Investors Services LLC Purchases New Position in Merck & Co., Inc. $MRK http://ift.tt/2oe1lYA",,,,,[],https://twitter.com/TickerReport/status/847390724421107714
1552,Watchlist News,@WatchlistN,2017-03-31T13:28:16.000Z,"Pring Turner Capital Group Inc. Reduces Stake in Merck & Co., Inc. $MRK http://zpr.io/P9z3g","Pring Turner Capital Group Inc. Reduces Stake in Merck & Co., Inc. $MRK http://zpr.io/P9z3g",,,,,[],https://twitter.com/WatchlistN/status/847802728575361024
1553,Ticker Report,@TickerReport,2017-03-31T10:22:19.000Z,"Cantab Capital Partners LLP Has $1,444,000 Position in Merck & Co., Inc. $MRK http://ift.tt/2oibrHO","Cantab Capital Partners LLP Has $1,444,000 Position in Merck & Co., Inc. $MRK http://ift.tt/2oibrHO",,,,,[],https://twitter.com/TickerReport/status/847755932629118976
1554,Brad Loncar,@bradloncar,2017-03-31T12:03:22.000Z,"$MRK/$INCY nice job throwing shade this morning: If you think their early stage data looks good this weekend, check out our pivotals!","$MRK/$INCY nice job throwing shade this morning: If you think their early stage data looks good this weekend, check out our pivotals!
4",,,,4,[],https://twitter.com/bradloncar/status/847781362157453312
1555,MarketSmith,@MarketSmith,2017-03-29T16:09:15.000Z,"Nasdaq Up On Amazon, Alibaba And This Biotech: http://ow.ly/8nQn30anc3p $WMT $MRK $HD $TRV $AMZN $BABA $VRTX $PLAY $OLLI","Nasdaq Up On Amazon, Alibaba And This Biotech: http://ow.ly/8nQn30anc3p $WMT $MRK $HD $TRV $AMZN $BABA $VRTX $PLAY $OLLI",,,,,['https://pbs.twimg.com/media/C8GRwNFXkAEvLxh?format=jpg&name=small'],https://twitter.com/MarketSmith/status/847118464556904450
1556,Odi Bruckman,@odibro,2017-03-31T11:02:05.000Z,$INCY & $MRK Provide Additional Details on Previously Announced Collaboration Investigating Epacadostat and KEYTRUDA,"$INCY & $MRK Provide Additional Details on Previously Announced Collaboration Investigating Epacadostat and KEYTRUDA
businesswire.com
Incyte and Merck Provide Additional Details on Previously Announced Collaboration Investigating...
Incyte and Merck Provide Additional Details on Previously Announced Collaboration Investigating Epacadostat and KEYTRUDA (pembrolizumab)
1
1",,,1,1,[],https://twitter.com/odibro/status/847765941870108672
1557,MarketBeat,@MarketBeatCom,2017-03-31T13:27:45.000Z,"Flinton Capital Management LLC Takes Position in Merck & Co., Inc. $MRK http://zpr.io/P9zwh","Flinton Capital Management LLC Takes Position in Merck & Co., Inc. $MRK http://zpr.io/P9zwh",,,,,[],https://twitter.com/MarketBeatCom/status/847802596962299905
1558,Watchlist News,@WatchlistN,2017-03-30T13:17:47.000Z,"26,200 Shares in Merck & Co., Inc. $MRK Acquired by Ativo Capital Management LLC http://zpr.io/P9tEU","26,200 Shares in Merck & Co., Inc. $MRK Acquired by Ativo Capital Management LLC http://zpr.io/P9tEU",,,,,[],https://twitter.com/WatchlistN/status/847437703364755457
1559,US Banking News,@AmericanBanking,2017-03-30T18:07:26.000Z,"Merck & Co., Inc. $MRK Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages http://ift.tt/2om4Mt9","Merck & Co., Inc. $MRK Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages http://ift.tt/2om4Mt9",,,,,[],https://twitter.com/AmericanBanking/status/847510597105332224
1560,Market Realist,@MarketRealist,2017-03-29T21:21:08.000Z,Analyzing Eli Lilly's 2016 Performance and Developments http://marketrealist.com/?p=2004409 $LLY $BMY $MRK $PFE,Analyzing Eli Lilly's 2016 Performance and Developments http://marketrealist.com/?p=2004409 $LLY $BMY $MRK $PFE,,,,,[],https://twitter.com/MarketRealist/status/847196954320883712
1561,MarketBeat,@MarketBeatCom,2017-03-30T13:23:32.000Z,"Texas Yale Capital Corp. Buys 15,730 Shares of Merck & Co., Inc. $MRK http://zpr.io/P9tmj","Texas Yale Capital Corp. Buys 15,730 Shares of Merck & Co., Inc. $MRK http://zpr.io/P9tmj",,,,,[],https://twitter.com/MarketBeatCom/status/847439147770023937
1562,Market Realist,@MarketRealist,2017-03-30T19:43:07.000Z,Insight into Novartis's Key 2017 Strategies http://marketrealist.com/?p=2003519 $NVS $BMY $PFE $MRK,Insight into Novartis's Key 2017 Strategies http://marketrealist.com/?p=2003519 $NVS $BMY $PFE $MRK,,,,,[],https://twitter.com/MarketRealist/status/847534673928605696
1563,StockNews.com,@stocknewsdotcom,2017-03-31T11:03:00.000Z,$MRK Incyte and Merck announce additional details of their clinical development program investigating the combinat‚Ä¶ https://stocknews.com/news/mrk-incyte-and-merck-announce-additional-details-of-their-clinical-development/‚Ä¶,$MRK Incyte and Merck announce additional details of their clinical development program investigating the combinat‚Ä¶ https://stocknews.com/news/mrk-incyte-and-merck-announce-additional-details-of-their-clinical-development/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/847766172732985344
1564,Market Realist,@MarketRealist,2017-03-31T16:50:29.000Z,Why Investors Should Pay Attention to NVS's Research Pipeline http://marketrealist.com/?p=2008255 $NVS $MRK $BMY $PFE,Why Investors Should Pay Attention to NVS's Research Pipeline http://marketrealist.com/?p=2008255 $NVS $MRK $BMY $PFE,,,,,[],https://twitter.com/MarketRealist/status/847853616987766785
1565,Sports_Bios,@Sports_bios,2017-03-31T14:10:42.000Z,$INCY stk pretty much back down to per-rumor levels.. w/ all these $MRK tie-ups..how likely big G will share the big expensive pie w/others.,$INCY stk pretty much back down to per-rumor levels.. w/ all these $MRK tie-ups..how likely big G will share the big expensive pie w/others.,,,,,[],https://twitter.com/Sports_bios/status/847813406245650432
1566,Allison Gatlin,@IBD_AGatlin,2017-03-31T20:19:14.000Z,Will Bristol prove this longtime theory in cancer defense? $BMY $MRK $INCY $AZN $RHHBY http://ow.ly/DaG630ascaq,Will Bristol prove this longtime theory in cancer defense? $BMY $MRK $INCY $AZN $RHHBY http://ow.ly/DaG630ascaq,,,,,[],https://twitter.com/IBD_AGatlin/status/847906150620291073
1567,Sweet Platform,@SweetPlatform,2017-03-31T15:18:48.000Z,"MRK Top news - Mar 31st, 2017 $MRK http://https://goo.gl/kG8iwR","MRK Top news - Mar 31st, 2017 $MRK http://https://goo.gl/kG8iwR",,,,,[],https://twitter.com/SweetPlatform/status/847830543131693056
1568,EandE Thougths,@EEthougths,2017-03-31T11:02:08.000Z,$INCY $MRK Provide Additional Details on Previously Announced Collaboration Investigating Epacadostat and KEYTRUDA¬Æ (pembrolizumab),$INCY $MRK Provide Additional Details on Previously Announced Collaboration Investigating Epacadostat and KEYTRUDA¬Æ (pembrolizumab),,,,,[],https://twitter.com/EEthougths/status/847765951798030339
1569,Watchlist News,@WatchlistN,2017-03-30T18:22:14.000Z,"Merck & Co., Inc. $MRK Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages http://zpr.io/P9RLe","Merck & Co., Inc. $MRK Given Average Recommendation of ‚ÄúBuy‚Äù by Brokerages http://zpr.io/P9RLe",,,,,[],https://twitter.com/WatchlistN/status/847514321227796482
1570,Allison Gatlin,@IBD_AGatlin,2017-03-31T17:10:49.000Z,What does Big Pharma want to buy? 3 drugmakers on merger track $AGN $ABBV $NVS $MRK $ACAD $LXRX $ICPT http://ow.ly/rGm730arL3y,What does Big Pharma want to buy? 3 drugmakers on merger track $AGN $ABBV $NVS $MRK $ACAD $LXRX $ICPT http://ow.ly/rGm730arL3y,,,,,[],https://twitter.com/IBD_AGatlin/status/847858735276064769
1571,Allison Gatlin,@IBD_AGatlin,2017-03-31T17:08:38.000Z,"Will Trump's FDA chill innovation or kill ""astronomical"" prices? $ALNY $BIIB $CELG $LLY $JNJ $NVS $MRK","Will Trump's FDA chill innovation or kill ""astronomical"" prices? $ALNY $BIIB $CELG $LLY $JNJ $NVS $MRK
investors.com
Will Trump's FDA Chill Innovation Or Kill 'Astronomical' Prices?
It seems clear President Trump wants a leaner and meaner Food and Drug Administration, but how lean and how mean?",,,,,['https://pbs.twimg.com/card_img/1501734916962279424/WTeNw0V2?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/847858187168514051
1572,luisavhand,@luisavhand,2017-03-29T11:09:49.000Z,"3 Tremendously Promising Diabetes Drugs Potentially on the Way 
@themotleyfool
 #stocks $PFE, $MRK, $SNY, $NVO, $LXRX https://fool.com/investing/2017/03/26/3-tremendously-promising-diabetes-drugs-potentiall.aspx‚Ä¶","3 Tremendously Promising Diabetes Drugs Potentially on the Way 
@themotleyfool
 #stocks $PFE, $MRK, $SNY, $NVO, $LXRX https://fool.com/investing/2017/03/26/3-tremendously-promising-diabetes-drugs-potentiall.aspx‚Ä¶
1",,1,,,[],https://twitter.com/luisavhand/status/847043110374965249
1573,Todd Campbell,@ebcapital,2017-03-29T13:42:10.000Z,"Tesaro Nets Surprise Early Approval 
@themotleyfool
 #stocks $MRK, $AZN, $CLVS, $TSRO","Tesaro Nets Surprise Early Approval 
@themotleyfool
 #stocks $MRK, $AZN, $CLVS, $TSRO
fool.com
Tesaro Nets Surprise Early Approval @themotleyfool #stocks $MRK $AZN $CLVS
Tesaro's cancer-fighting drug, niraparib, nabbed FDA approval roughly three months ahead of schedule.",,,,,[],https://twitter.com/ebcapital/status/847081451350831104
1574,Zero Filter,@zerofiltertruth,2017-03-30T12:46:08.000Z,"Great news for lotto-ticket $AEZS 

$IBB $XBI $CELG $AMGN $GILD $BIIB $MRK 
@GuyAdami
 @jonnajarian
 

#Macrilen $PPHM

http://businesswire.com/news/home/20170330005118/en/Aeterna-Zentaris-Intends-File-NDA-Respect-Macrilen%E2%84%A2‚Ä¶","Great news for lotto-ticket $AEZS 

$IBB $XBI $CELG $AMGN $GILD $BIIB $MRK 
@GuyAdami
 @jonnajarian
 

#Macrilen $PPHM

http://businesswire.com/news/home/20170330005118/en/Aeterna-Zentaris-Intends-File-NDA-Respect-Macrilen%E2%84%A2‚Ä¶",,,,,[],https://twitter.com/zerofiltertruth/status/847429735781064704
1575,Matthew Herper,@matthewherper,2017-03-29T12:40:34.000Z,"Replying to 
@megtirrell
 and 
@AndyBiotech","Replying to 
@megtirrell
 and 
@AndyBiotech
I do, but they'll be smaller. I think it's like the Hep C drugs. $MRK priced to $GILD rebated price.
1",,,,1,[],https://twitter.com/matthewherper/status/847065947768852480
1576,Bio Stocks‚Ñ¢,@BioStocks,2017-04-03T11:12:58.000Z,The cost of cancer: new drugs show success at a steep price http://reut.rs/2n3hznk $BMY $MRK #pharma,"The cost of cancer: new drugs show success at a steep price http://reut.rs/2n3hznk $BMY $MRK #pharma
2
3
2",,2,3,2,[],https://twitter.com/BioStocks/status/848855843605012480
1577,Matthew Herper,@matthewherper,2017-04-03T12:39:03.000Z,"$BMY makes survival in melanoma combo trial. $MRK, #AACR17","$BMY makes survival in melanoma combo trial. $MRK, #AACR17
forbes.com
For Bristol-Myers, A Victory And A Mystery
In a relief to investors, the combination of Opdivo and Yervoy extends survival in melanoma. More data being released this afternoon could yield answers to the question of why Opdivo did not show a...
9
7",,,9,7,['https://pbs.twimg.com/card_img/1497400641571885061/7ebgjNhM?format=png&name=small'],https://twitter.com/matthewherper/status/848877507566870529
1578,Helen Ong,@Lin_ling_88,2017-04-03T14:35:15.000Z,$INCY Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals - $MRK $BMY #drooling ,"$INCY Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals - $MRK $BMY #drooling 
thestreet.com
Incyte Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals
The broad development plan across five different types of cancer widens Incyte's lead over other IDO inhibitors in clinical development.
1
5",ü§ë üòù,,1,5,[],https://twitter.com/Lin_ling_88/status/848906750254239746
1579,Limex,@LimexMe,2017-04-03T14:22:31.000Z,Why Dynavax Technologies Corporation Stock Briefly Spiked Today http://bit.ly/030417DVAX $DVAX $GSK $MRK,Why Dynavax Technologies Corporation Stock Briefly Spiked Today http://bit.ly/030417DVAX $DVAX $GSK $MRK,,,,,['https://pbs.twimg.com/media/C8fpRbtUwAAPHW2?format=jpg&name=360x360'],https://twitter.com/LimexMe/status/848903543562149889
1580,dough,@semodough,2017-04-02T01:31:12.000Z,"Replying to 
@semodough
 and 
@bradloncar","Replying to 
@semodough
 and 
@bradloncar
battle for 1L lung dominance begins in mid-2017; by 2H 2018,should have most of pieces fall into place $MRK $BMY $AZN $CELG
2
3",,,2,3,['https://pbs.twimg.com/media/C8XvIRGXcAELE1C?format=jpg&name=small'],https://twitter.com/semodough/status/848347048655114240
1581,Kara Jill Stancell,@kjilly,2017-04-03T15:58:04.000Z,"#AACR17 Fresh from $MRK embrace, fast-growing $INCY pivots into a PhIII IDO1/ #Opdivo tie-up with $BMY -","#AACR17 Fresh from $MRK embrace, fast-growing $INCY pivots into a PhIII IDO1/ #Opdivo tie-up with $BMY -
endpts.com
#AACR17: Fresh from Merck embrace, fast-growing Incyte pivots into a PhIII IDO1/Opdivo tie-up with...
PHOTO: ¬© AACR/Todd Buchanan 2017 Washington, DC ‚Äî Two days after Incyte outlined how it tied the knot with Merck on a slate of six late-stage studies combining its checkpoint Keytruda with the...
1",,,,1,['https://pbs.twimg.com/card_img/1500444417089486848/5rwSFAgp?format=jpg&name=small'],https://twitter.com/kjilly/status/848927590714818560
1582,1stOncology,@1stOncology,2017-04-02T12:48:45.000Z,More Details on Previously Announced Collaboration Investigating #Epacadostat and #KEYTRUDA $INCY $MRK http://1stoncology.com/blog/incytemerck-provide-additional-details-on-previously-announced-collaboration-investigating-epacadostatkeytruda-pembrolizumab‚Ä¶,"More Details on Previously Announced Collaboration Investigating #Epacadostat and #KEYTRUDA $INCY $MRK http://1stoncology.com/blog/incytemerck-provide-additional-details-on-previously-announced-collaboration-investigating-epacadostatkeytruda-pembrolizumab‚Ä¶
1",,,1,,[],https://twitter.com/1stOncology/status/848517560970747908
1583,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-04-03T17:30:12.000Z,$CYCC Cdk inhibitor pipeline Vs $PFE $NVS $MRK $LLY #aacr17,"$CYCC Cdk inhibitor pipeline Vs $PFE $NVS $MRK $LLY #aacr17
üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR
@_B_I_O_T_E_C_H_
 ¬∑ 28 Jul 2016
Replying to @_B_I_O_T_E_C_H_
$CYCC Cdk inhibitor pipeline Vs $PFE $NVS $MRK $LLY
1",üÖ± üÖæ üÖ± üÖæ,,1,,"['https://pbs.twimg.com/profile_images/1490073125391937538/WdkRt7E4_mini.jpg', 'https://pbs.twimg.com/media/CodMIPvWcAEMu2_?format=jpg&name=small']",https://twitter.com/_B_I_O_T_E_C_H_/status/848950775061651456
1584,Matthias Piesche,@PiescheLab,2017-04-03T19:03:29.000Z,"#AACR17 roundup: $BMY, $MRK and $PFE in the spotlight, marking progress with checkpoints https://endpts.com/aacr17-roundup-bristol-myers-merck-kgaa-and-pfizer-in-the-spotlight-marking-progress-with-checkpoints/‚Ä¶ #immunotherapy","#AACR17 roundup: $BMY, $MRK and $PFE in the spotlight, marking progress with checkpoints https://endpts.com/aacr17-roundup-bristol-myers-merck-kgaa-and-pfizer-in-the-spotlight-marking-progress-with-checkpoints/‚Ä¶ #immunotherapy
endpts.com
#AACR17 roundup: Bristol-Myers, Merck KGaA and Pfizer in the spotlight, marking progress with...
PHOTO: ¬© AACR/Todd Buchanan 2017 Bristol-Myers IDs a subset of patients who see a durable, 5-year response to Opdivo Washington, DC ‚Äî Now that the first wave of PD-1 checkpoint inhibitors have been...",,,,,[],https://twitter.com/PiescheLab/status/848974253118586880
1585,dough,@semodough,2017-04-03T16:17:56.000Z,"$MRK HIGHEST EVER Zepatier increased w/w. TRx for week 1,156 (471 were NRx),representing a12.5% increase in TRx& a 25.9% increase in NRx w/w","$MRK HIGHEST EVER Zepatier increased w/w. TRx for week 1,156 (471 were NRx),representing a12.5% increase in TRx& a 25.9% increase in NRx w/w
dough
@semodough
 ¬∑ 31 Mar 2017
$GILD Harvoni NRx &TRx were 1,571&3,615, up by 2.8% up by 3.3% w/w, Sovaldi NRx&TRx were 79&229, up by 16.2%&down by 1.3% w/w,
1",,,1,,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/848932589679382528
1586,Pharmaceutical News,@pharma_sector,2017-04-03T18:14:45.000Z,#Merck to Hold FirstQuarter 2017 Sales and Earnings Conference Call on May 2. Read more: http://owler.us/acurV8 $MRK,#Merck to Hold FirstQuarter 2017 Sales and Earnings Conference Call on May 2. Read more: http://owler.us/acurV8 $MRK,,,,,[],https://twitter.com/pharma_sector/status/848961986595401728
1587,dough,@semodough,2017-04-03T14:24:20.000Z,"EASL Abstracts and Conference - 4/5/2017, 4/19-23/17: Abstracts for this conference will be released April 5, 2017 $GILD $MRK $ENTA","EASL Abstracts and Conference - 4/5/2017, 4/19-23/17: Abstracts for this conference will be released April 5, 2017 $GILD $MRK $ENTA
1",,,,1,[],https://twitter.com/semodough/status/848904003207524354
1588,leahanne,@leahanneta,2017-04-03T15:24:21.000Z,"10:45 ET Volume Leader #99 - MRK 1,474,142 Merck & Company $MRK 63.50 -0.04 -0.06% High today of 63.71 day low","10:45 ET Volume Leader #99 - MRK 1,474,142 Merck & Company $MRK 63.50 -0.04 -0.06% High today of 63.71 day low
investorshangout.com
10:45 ET Volume Leader #99 - MRK - The Launch Pad #4458329 - Investors Hangout
The Launch Pad: 10:45 ET Volume Leader #99 - MRK 1,474,142 Merck Company $MRK 63.50 -0.04 -0.06% High today of 63. - #4458329",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/848919106074140673
1589,TradingView Ideas,@TradingViewAlt,2017-04-03T12:30:20.000Z,New trend? $MRK http://tradingview.com/chart/MRK/O9XI6Isz-New-trend/‚Ä¶,New trend? $MRK http://tradingview.com/chart/MRK/O9XI6Isz-New-trend/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/848875310820884481
1590,9/11 No Planer,@911NoPlaner,2017-04-03T03:12:08.000Z,"The Worst-Case Scenario for #Gilead Sciences, Inc. 
@themotleyfool
 #stocks $MRK, $GSK, $GILD, $INCY","The Worst-Case Scenario for #Gilead Sciences, Inc. 
@themotleyfool
 #stocks $MRK, $GSK, $GILD, $INCY
fool.com
The Worst-Case Scenario for Gilead Sciences, Inc. @themotleyfool #stocks $GILD $MRK $GSK $INCY
Could nothing but doom and despair be ahead for Gilead Sciences?",ü•∂,,,,[],https://twitter.com/911NoPlaner/status/848734837376733184
1591,Watchlist News,@WatchlistN,2017-04-02T08:08:01.000Z,"Merck & Co., Inc. $MRK Upgraded to ‚ÄúBuy‚Äù by Vetr Inc. http://zpr.io/Pundr","Merck & Co., Inc. $MRK Upgraded to ‚ÄúBuy‚Äù by Vetr Inc. http://zpr.io/Pundr",,,,,[],https://twitter.com/WatchlistN/status/848446910587437056
1592,Stoxline Investing,@stoxline,2017-04-02T14:59:50.000Z,"Top Buy Stocks: $HMY, $JNPR, $MRK, $QCOM,$TGT","Top Buy Stocks: $HMY, $JNPR, $MRK, $QCOM,$TGT
stoxline.com
HMY - Harmony Gold Mining Co. Ltd ADR, Stock Quote, Analysis, Rating and News
Stock Quote, Analysis, Rating and News",,,,,['https://pbs.twimg.com/card_img/1490688070869393408/B8b8_Lf4?format=jpg&name=small'],https://twitter.com/stoxline/status/848550545602301952
1593,1 min Stock Insights,@1MinuteStock,2017-04-03T05:27:05.000Z,Wondering about risks of $MRK? The 63-day volatility is 7.94%,"Wondering about risks of $MRK? The 63-day volatility is 7.94%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/848768797553156096
1594,Oncology Board,@mb_Oncology,2017-04-03T18:37:06.000Z,Sarvar: Incyte Dramatically Ups The Immuno-Oncology Combo Ante https://seekingalpha.com/article/4059887-incyte-dramatically-ups-immuno-oncology-combo-ante?source=feed_f‚Ä¶ ‚Ä¶ $MRK $BMY $AZN‚Ä¶ http://dlvr.it/Nnslhd #MedicBoard,Sarvar: Incyte Dramatically Ups The Immuno-Oncology Combo Ante https://seekingalpha.com/article/4059887-incyte-dramatically-ups-immuno-oncology-combo-ante?source=feed_f‚Ä¶ ‚Ä¶ $MRK $BMY $AZN‚Ä¶ http://dlvr.it/Nnslhd #MedicBoard,,,,,['https://pbs.twimg.com/media/C8gjinxUAAAxgEl?format=jpg&name=240x240'],https://twitter.com/mb_Oncology/status/848967611173879809
1595,Buy Cryptocurrency,@cryptosbuy,2017-04-03T12:30:55.000Z,New trend? $MRK http://tradingview.com/chart/MRK/O9XI6Isz-New-trend/‚Ä¶ TV_TradingIdeas,"New trend? $MRK http://tradingview.com/chart/MRK/O9XI6Isz-New-trend/‚Ä¶ TV_TradingIdeas
tradingview.com
New trend? for NYSE:MRK by jduma
Waiting for confirmation",,,,,['https://pbs.twimg.com/card_img/1492089971469131778/-7MGG06l?format=png&name=small'],https://twitter.com/cryptosbuy/status/848875458343174145
1596,Sports_Bios,@Sports_bios,2017-04-03T00:59:03.000Z,"Replying to 
@bradloncar","Replying to 
@bradloncar
Guess we will find out what $MRK see in the $INCY cpd with all those P3s..
1
1",,1,,1,[],https://twitter.com/Sports_bios/status/848701345771253760
1597,M,@bio_clouseau,2017-04-03T11:22:29.000Z,"Replying to 
@JohnCendpts","Replying to 
@JohnCendpts
I find it strange $MRK hasnt signed  commercial agreement http://yet.Win-win for INCY since it can go with $BMY PD1 if cheaper
1
1",,1,,1,[],https://twitter.com/bio_clouseau/status/848858237801725952
1598,Miljenko Zuanic,@Miljenkoz,2017-04-02T16:40:40.000Z,"Replying to 
@Ogut_Ozgur","Replying to 
@Ogut_Ozgur
Is this signal that their own anti-IDO1 is dead, or they wan't to be in front of the learning curve? $BMY, $INCY, $MRK
5",,5,,,[],https://twitter.com/Miljenkoz/status/848575924983353345
1599,Ticker Report,@TickerReport,2017-04-02T08:56:14.000Z,"Merck & Co., Inc. $MRK Receives $67.18 Average PT from Analysts http://ift.tt/2nKpq69","Merck & Co., Inc. $MRK Receives $67.18 Average PT from Analysts http://ift.tt/2nKpq69",,,,,[],https://twitter.com/TickerReport/status/848459044167831552
1600,MarketBeat,@MarketBeatCom,2017-04-02T12:28:15.000Z,"Davy Asset Management Ltd Decreases Position in Merck & Co., Inc. $MRK http://zpr.io/P9EWS","Davy Asset Management Ltd Decreases Position in Merck & Co., Inc. $MRK http://zpr.io/P9EWS",,,,,[],https://twitter.com/MarketBeatCom/status/848512398952734720
1601,Ozgur Ogut,@Ogut_Ozgur,2017-04-03T22:48:06.000Z,"Replying to 
@RobinDavison2","Replying to 
@RobinDavison2
@EPVantage
 Note $MRK 2 yr exclusivity was limited to pivotal trials in adv/met melanoma. Nothing circumvented with $BMY deal.",,,,,[],https://twitter.com/Ogut_Ozgur/status/849030776943394816
1602,Contix Alerts,@contixalerts,2017-04-03T10:10:43.000Z,"$MRK: Merck‚Äôs Keytruda cancer drug records sales surge 
@FTLiveHealth
 https://app.contix.com/alerts/37012171","$MRK: Merck‚Äôs Keytruda cancer drug records sales surge 
@FTLiveHealth
 https://app.contix.com/alerts/37012171",,,,,[],https://twitter.com/contixalerts/status/848840175891365888
1603,Contix Alerts,@contixalerts,2017-04-03T10:45:35.000Z,"Is IDO1 + checkpoint better than PD1/PD-L1 plus CTLA-4? $INCY, $MRK, $BMY 
@JohnCendpts
 https://app.contix.com/alerts/37012905","Is IDO1 + checkpoint better than PD1/PD-L1 plus CTLA-4? $INCY, $MRK, $BMY 
@JohnCendpts
 https://app.contix.com/alerts/37012905",,,,,[],https://twitter.com/contixalerts/status/848848949360205824
1604,Adam Feuerstein,@adamfeuerstein,2017-04-02T15:42:49.000Z,"Replying to 
@ClawBongo","Replying to 
@ClawBongo
It‚Äôs interesting to watch $MRK & $BMY go all-in with $INCY epacadostat. Moving more aggressively than Roche w/ $NLNK IDO.
1
1
3",,1,1,3,[],https://twitter.com/adamfeuerstein/status/848561363404378113
1605,Helen Ong,@Lin_ling_88,2017-04-03T14:58:03.000Z,"Replying to 
@BigCForever","Replying to 
@BigCForever
I think so..there is no need to lay out all cash. $INCY $MRK $BMY
1",,,,1,[],https://twitter.com/Lin_ling_88/status/848912488393527296
1606,MG,@maralgr,2017-04-02T19:23:28.000Z,"Replying to 
@med__twi
, 
@Ogut_Ozgur
 and 
@Miljenkoz","Replying to 
@med__twi
, 
@Ogut_Ozgur
 and 
@Miljenkoz
Strategic decision i guess. 1st preference: defend PD1 market share by not falling more behind $mrk 2nd: leverage with own IDO1 Inhibitor
1
3",,1,,3,[],https://twitter.com/maralgr/status/848616891547623425
1607,pharmalot,@pharmalot,2017-04-06T19:58:55.000Z,Most drug makers lack evidence their access to medicines program actually work.. https://statnews.com/pharmalot/2017/04/06/access-medicines-evidence-lacking/‚Ä¶ #pharma $MRK $NVS $GSK $SNY $GILD,"Most drug makers lack evidence their access to medicines program actually work.. https://statnews.com/pharmalot/2017/04/06/access-medicines-evidence-lacking/‚Ä¶ #pharma $MRK $NVS $GSK $SNY $GILD
statnews.com
Most drug makers promise access for poor patients. There's no evidence their plans work
The researchers could find published evaluations for only seven initiatives, and nearly all of the evaluations were of very low quality.
11
4",,,11,4,['https://pbs.twimg.com/card_img/1499590618762334208/RrwGR6Ef?format=jpg&name=small'],https://twitter.com/pharmalot/status/850075365800280064
1608,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-04-06T05:33:48.000Z,Brace yourselves: Reverse Translational Medicine is here $IBB $MRK $BMY $AZN $ROG This surely has to be a good idea right? ,"Brace yourselves: Reverse Translational Medicine is here $IBB $MRK $BMY $AZN $ROG This surely has to be a good idea right? 
2
9
4",üòÇ,2,9,4,['https://pbs.twimg.com/media/C8tM8BxUQAMvu53?format=jpg&name=900x900'],https://twitter.com/DrPaulyDeSantis/status/849857650024206336
1609,M,@bio_clouseau,2017-04-04T10:18:47.000Z,$MRK Keytruda cancer drug records sales surge at $BMY expense per FT,"$MRK Keytruda cancer drug records sales surge at $BMY expense per FT
ft.com
Merck‚Äôs Keytruda cancer drug records sales surge
Sales of the immunotherapy medicine are up 80% on last year, says data provider IMS
9
4",,,9,4,['https://pbs.twimg.com/card_img/1499676685335154691/SS7fEef2?format=jpg&name=small'],https://twitter.com/bio_clouseau/status/849204595742126080
1610,Seeking Alpha,@SeekingAlpha,2017-04-05T11:37:23.000Z,Dividends And Compounding Returns https://seekingalpha.com/article/4060388-dividends-compounding-returns?source=feed_f‚Ä¶ $ABBV $ABT $BRK.A $BRK.B $CVX $GE $GM $GOOGL $IBM $JNJ $KO $MCD $MMM $MRK $NOBL,"Dividends And Compounding Returns https://seekingalpha.com/article/4060388-dividends-compounding-returns?source=feed_f‚Ä¶ $ABBV $ABT $BRK.A $BRK.B $CVX $GE $GM $GOOGL $IBM $JNJ $KO $MCD $MMM $MRK $NOBL
2
2",,,2,2,[],https://twitter.com/SeekingAlpha/status/849586762343002112
1611,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-04-04T07:21:12.000Z,"$CYCC pipeline comparison of CDK inhibitors
Cyclin Dependent Kinase $PFE $NVS $MRK $LLY #AACR17
CYC065 CDK2/4 CDK2/9 breastcancer lungcancer","$CYCC pipeline comparison of CDK inhibitors
Cyclin Dependent Kinase $PFE $NVS $MRK $LLY #AACR17
CYC065 CDK2/4 CDK2/9 breastcancer lungcancer
3
3",üÖ± üÖæ,,3,3,['https://pbs.twimg.com/media/C8jSIg4XcAEMpYj?format=jpg&name=small'],https://twitter.com/_B_I_O_T_E_C_H_/status/849159903004569600
1612,Oncology Board,@mb_Oncology,2017-04-04T10:31:07.000Z,EP Vantage: Incyte dramatically ups the immuno-oncology combo ante http://epvantage.com/Universal/View.aspx?type=Story&id=698453&isEPVantage=yes‚Ä¶ ‚Ä¶ $INCY $MRK‚Ä¶ http://dlvr.it/Np8FdD #MedicBoard,EP Vantage: Incyte dramatically ups the immuno-oncology combo ante http://epvantage.com/Universal/View.aspx?type=Story&id=698453&isEPVantage=yes‚Ä¶ ‚Ä¶ $INCY $MRK‚Ä¶ http://dlvr.it/Np8FdD #MedicBoard,,,,,['https://pbs.twimg.com/media/C8j95nlV0AAMH7z?format=jpg&name=900x900'],https://twitter.com/mb_Oncology/status/849207699061350400
1613,Kara Jill Stancell,@kjilly,2017-04-04T14:26:59.000Z,"$NLNK grabs the #AACR17 spotlight with IDO pathway, #Keytruda combo #Opdivo $MRK $BMY -- shares blitzed -","$NLNK grabs the #AACR17 spotlight with IDO pathway, #Keytruda combo #Opdivo $MRK $BMY -- shares blitzed -
endpts.com
NewLink grabs the AACR spotlight with IDO pathway, Keytruda combo -- shares blitzed
Attendees, speakers and awardees during AACR's 2017 Opening Ceremony ¬© AACR/Todd Buchanan 2017 WASHINGTON, DC ‚Äî Researchers at NewLink Genetics are in the spotlight at AACR this morning with data...
1",,,1,,[],https://twitter.com/kjilly/status/849267056687980546
1614,Bilo Selhi,@StocksThatDoubl,2017-04-04T21:11:18.000Z,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,,,,,['https://pbs.twimg.com/media/CiX8f4PUkAQf2Dy?format=jpg&name=small'],https://twitter.com/StocksThatDoubl/status/849368807533678597
1615,Limex,@LimexMe,2017-04-04T21:23:50.000Z,Why NewLink Genetics Shares Fell 10.3% Today http://bit.ly/040417NLNK $NLNK $MRK $INCY $RHHBY,Why NewLink Genetics Shares Fell 10.3% Today http://bit.ly/040417NLNK $NLNK $MRK $INCY $RHHBY,,,,,['https://pbs.twimg.com/media/C8mTS6tXUAE8PK9?format=jpg&name=360x360'],https://twitter.com/LimexMe/status/849371960744316930
1616,Gitte Pedersen,@DNABARCODE,2017-04-05T16:00:09.000Z,Presenting our OneRNA solution in Triple Negative #Breast #Cancer Tomorrow @ Conference in #Boston #Merck $MRK http://bit.ly/2nB0XP1],Presenting our OneRNA solution in Triple Negative #Breast #Cancer Tomorrow @ Conference in #Boston #Merck $MRK http://bit.ly/2nB0XP1],,,,,['https://pbs.twimg.com/media/C8qSzORWsAMuYmk?format=jpg&name=small'],https://twitter.com/DNABARCODE/status/849652891044466688
1617,Kyan J Young,@KyanJYoung,2017-04-04T08:42:13.000Z,$CYCC pipeline comparison of CDK inhibitors $PFE $NVS $MRK $LLY #AACR17 CYC065 CDK2/4 CDK2/9 breastcancer lungcancer #stocks,"$CYCC pipeline comparison of CDK inhibitors $PFE $NVS $MRK $LLY #AACR17 CYC065 CDK2/4 CDK2/9 breastcancer lungcancer #stocks
2
1",,,2,1,['https://pbs.twimg.com/media/C8jk9JxXgAEyfFQ?format=jpg&name=small'],https://twitter.com/KyanJYoung/status/849180292640366592
1618,Ryan Jellak,@RJmoneymaker,2017-04-04T13:05:15.000Z,$REPCF $RP.V & few other #biomedical stocks to watch today... $USRM $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK,$REPCF $RP.V & few other #biomedical stocks to watch today... $USRM $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK,,,,,[],https://twitter.com/RJmoneymaker/status/849246487011831808
1619,Tim Kirkpatrick,@tkirkpatrick1,2017-04-05T01:30:55.000Z,"$MRK Non-Small Cell Lung Cancer PDUFA priority review 05/10/2017 PDUFA date May 10, 2017. Priority review  coming up.","$MRK Non-Small Cell Lung Cancer PDUFA priority review 05/10/2017 PDUFA date May 10, 2017. Priority review  coming up.",,,,,[],https://twitter.com/tkirkpatrick1/status/849434142433476611
1620,Alessandro viva l‚Äô#Ucraina,@pelias01,2017-04-05T13:51:46.000Z,Dividends And Compounding Returns https://seekingalpha.com/article/4060388-dividends-compounding-returns?source=tweet‚Ä¶ $ABBV $ABT $BRK.A $BRK.B $CVX $GE $GM $GOOGL $IBM $JNJ $KO $MCD $MMM $MRK $NOBL,"Dividends And Compounding Returns https://seekingalpha.com/article/4060388-dividends-compounding-returns?source=tweet‚Ä¶ $ABBV $ABT $BRK.A $BRK.B $CVX $GE $GM $GOOGL $IBM $JNJ $KO $MCD $MMM $MRK $NOBL
1",,,1,,[],https://twitter.com/pelias01/status/849620580827639808
1621,WLST.com,@wlstcom,2017-04-05T18:05:59.000Z,Large Cap Drug Stocks Enter Recovery Mode #BMY #MRK #LLY #AZN #SNY #CSLLY #TEVA #AGN #NVO #EPVantage $BMY $MRK $LLY,"Large Cap Drug Stocks Enter Recovery Mode #BMY #MRK #LLY #AZN #SNY #CSLLY #TEVA #AGN #NVO #EPVantage $BMY $MRK $LLY
seekingalpha.com
Large Cap Drug Stocks Enter Recovery Mode
President Trump might still be able to strike fear into the heart of a biopharma investor, but it seems his impact is lessening ‚Äì if shares in the world‚Äôs biggest drug makers are any...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/wlstcom/status/849684558991831047
1622,Helen Ong,@Lin_ling_88,2017-04-05T21:20:49.000Z,"$INCY: Step Aside Merck And Bristol: These Are Your Future Rivals In Cancer Drugs 
$MRK $BMY","$INCY: Step Aside Merck And Bristol: These Are Your Future Rivals In Cancer Drugs 
$MRK $BMY
investors.com
Step Aside Merck And Bristol: These Are Your Future Rivals In Cancer Drugs | Stock News & Stock...
Bristol, Roche and Merck tend to grab immuno-oncology headlines, but a conference highlighted competitors waiting in the wings.
1
5",,,1,5,['https://pbs.twimg.com/card_img/1501734120464044034/FfphCbu_?format=jpg&name=small'],https://twitter.com/Lin_ling_88/status/849733590724345856
1623,Pullback,@pullbackmx,2017-04-05T23:18:32.000Z,$MRK Possible short. - S: $63.52 / SL: $64.14 http://pullback.mx/e/MRK,$MRK Possible short. - S: $63.52 / SL: $64.14 http://pullback.mx/e/MRK,,,,,[],https://twitter.com/pullbackmx/status/849763211117080576
1624,Kara Jill Stancell,@kjilly,2017-04-05T15:51:27.000Z,"Will #AACR news give $BMY cancer linchpin #Opdivo a boost? That depends, analysts say #melanoma #lungcancer $MRK","Will #AACR news give $BMY cancer linchpin #Opdivo a boost? That depends, analysts say #melanoma #lungcancer $MRK
fiercepharma.com
Will AACR news give BMS cancer linchpin Opdivo a boost? That depends, analysts say
With the American Association for Cancer Research meeting in full swing, Bristol-Myers Squibb let forth a flurry of announcements on its immuno-oncology star Opdivo over the past few days. | With the...",,,,,['https://pbs.twimg.com/card_img/1499546948675719170/kpjxCqbp?format=jpg&name=small'],https://twitter.com/kjilly/status/849650701613514757
1625,Dow Stocks,@Top_Dow_Stocks,2017-04-06T07:16:57.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/849883611981520896
1626,FinInvTr,@FinInvTr,2017-04-04T18:31:26.000Z,"Making ""Alpha"" In Large Caps? $AAPL $GOOG $MSFT $AMZN $BRK.A $FB $JPM $BABA $BAC $V $MA $MRK $C $UNH $TSLA $GS $T http://bit.ly/2oM6ZNR","Making ""Alpha"" In Large Caps? $AAPL $GOOG $MSFT $AMZN $BRK.A $FB $JPM $BABA $BAC $V $MA $MRK $C $UNH $TSLA $GS $T http://bit.ly/2oM6ZNR
1",,,,1,[],https://twitter.com/FinInvTr/status/849328575866130433
1627,TradeTexasBig,@TradeTexasBig,2017-04-06T16:16:55.000Z,"satisfying , I played $JAZZ $VRTX correctly vs. $PFE $MRK $NVS et al..","satisfying , I played $JAZZ $VRTX correctly vs. $PFE $MRK $NVS et al..",,,,,[],https://twitter.com/TradeTexasBig/status/850019499185229826
1628,Kara Jill Stancell,@kjilly,2017-04-04T18:04:38.000Z,Pharma's digital revolution turns to #Austin as $MRK eyes sites for 600-person IT hub,"Pharma's digital revolution turns to #Austin as $MRK eyes sites for 600-person IT hub
fiercepharma.com
Pharma's digital revolution turns to Austin as Merck eyes sites for 600-person IT hub
Merck & Co. is eyeing Austin, Texas, for a 600-person IT shop, one of four around the globe, as it amps up in personalized and preventative medicine. | After years of restructuring its IT operations...",,,,,[],https://twitter.com/kjilly/status/849321829646958593
1629,dough,@semodough,2017-04-05T13:39:37.000Z,CS $LLY remains one of our three Top Picks alongside $MRK and $AGN. $CELG $ALXN $VRTX in biotech,"CS $LLY remains one of our three Top Picks alongside $MRK and $AGN. $CELG $ALXN $VRTX in biotech
1
3",,,1,3,[],https://twitter.com/semodough/status/849617522051756032
1630,MarketBeat,@MarketBeatCom,2017-04-05T00:09:55.000Z,"Merck & Co., Inc. $MRK EVP Sells $3,418,398.00 in Stock http://zpr.io/P92kB","Merck & Co., Inc. $MRK EVP Sells $3,418,398.00 in Stock http://zpr.io/P92kB
1",,,,1,[],https://twitter.com/MarketBeatCom/status/849413758237777921
1631,Eric Sanstorm,@tkingmktbystorm,2017-04-04T12:25:06.000Z,Tuesday morning stock round up - a look at the biomedical market - $REPCF $RP.V $BIIB $MRK $ENDP $RNN $ABT $TEVA $JUNO $JNJ $ABBV,Tuesday morning stock round up - a look at the biomedical market - $REPCF $RP.V $BIIB $MRK $ENDP $RNN $ABT $TEVA $JUNO $JNJ $ABBV,,,,,[],https://twitter.com/tkingmktbystorm/status/849236383529148417
1632,Kyle,@DonkeyKongKyle,2017-04-06T15:30:04.000Z,Love the institutional ownership. Following big $$ works well.  $MRK $MRKT $MRLN $MRNS $MRO $MRTN http://bit.ly/2o0XtsX,Love the institutional ownership. Following big $$ works well.  $MRK $MRKT $MRLN $MRNS $MRO $MRTN http://bit.ly/2o0XtsX,,,,,[],https://twitter.com/DonkeyKongKyle/status/850007706442321920
1633,Joe Emory,@JoeEmory76,2017-04-04T12:50:12.000Z,Part 1 of Tuesday's stock alert...$REPCF $RP.V $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK $ENDP,Part 1 of Tuesday's stock alert...$REPCF $RP.V $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK $ENDP,,,,,[],https://twitter.com/JoeEmory76/status/849242700817813504
1634,Pharmaceutical News,@pharma_sector,2017-04-06T22:06:15.000Z,Pharma Giant #Merck & Co. Considering 600-Job IT Hub in Austin  . Read more: http://owler.us/acvQov $MRK,Pharma Giant #Merck & Co. Considering 600-Job IT Hub in Austin  . Read more: http://owler.us/acvQov $MRK,,,,,[],https://twitter.com/pharma_sector/status/850107410819670018
1635,Pharmaceutical News,@pharma_sector,2017-04-06T11:56:21.000Z,"EOD Risers: Intel Corporation, McDonald's Corporation, #Merck & Co., Inc. Read more: http://owler.us/acvFWz $MRK","EOD Risers: Intel Corporation, McDonald's Corporation, #Merck & Co., Inc. Read more: http://owler.us/acvFWz $MRK",,,,,[],https://twitter.com/pharma_sector/status/849953924501037057
1636,Phil Ravak,@PRavak,2017-04-04T13:05:15.000Z,$REPCF $RP.V & few other #biomedical stocks to watch today... $USRM $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK,$REPCF $RP.V & few other #biomedical stocks to watch today... $USRM $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK,,,,,[],https://twitter.com/PRavak/status/849246486990925824
1637,FinInvTr,@FinInvTr,2017-04-06T19:23:19.000Z,"Making ""Alpha"" In Large Caps? $AAPL $MSFT $AMZN $BRK.A $BRK.B $FB $JPM $BABA $BAC $V $MA $MRK $C $UNH http://bit.ly/2oM6ZNR","Making ""Alpha"" In Large Caps? $AAPL $MSFT $AMZN $BRK.A $BRK.B $FB $JPM $BABA $BAC $V $MA $MRK $C $UNH http://bit.ly/2oM6ZNR",,,,,[],https://twitter.com/FinInvTr/status/850066405034733573
1638,Linda Moyer,@lindamoyermoney,2017-04-04T12:50:12.000Z,Part 1 of Tuesday's stock alert...$REPCF $RP.V $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK $ENDP,Part 1 of Tuesday's stock alert...$REPCF $RP.V $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK $ENDP,,,,,[],https://twitter.com/lindamoyermoney/status/849242701115609088
1639,Sweet Platform,@SweetPlatform,2017-04-05T15:05:40.000Z,"MRK Top news - Apr 5th, 2017 $MRK http://https://goo.gl/s2Yx0f","MRK Top news - Apr 5th, 2017 $MRK http://https://goo.gl/s2Yx0f",,,,,[],https://twitter.com/SweetPlatform/status/849639181173358592
1640,Allison Gatlin,@IBD_AGatlin,2017-04-05T18:48:40.000Z,"Step aside, Merck and Bristol: These are your future rivals in oncology $MRK $BMY $INCY $RHHBY $AZN $NLNK $CRVS","Step aside, Merck and Bristol: These are your future rivals in oncology $MRK $BMY $INCY $RHHBY $AZN $NLNK $CRVS
investors.com
Step Aside Merck And Bristol: These Are Your Future Rivals In Cancer Drugs | Stock News & Stock...
Bristol, Roche and Merck tend to grab immuno-oncology headlines, but a conference highlighted competitors waiting in the wings.
1",,,1,,['https://pbs.twimg.com/card_img/1501734120464044034/FfphCbu_?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/849695297169174528
1641,marketexclusive,@marketexclusive,2017-04-06T12:57:11.000Z,"Merck & Co., Inc. (NYSE:MRK) To Present New Data From HCV Development Programs https://marketexclusive.com/merck-co-inc-nysemrk-will-present-new-data-chronic-hepatitis-c-virus-hcv-clinical-development-programs/90560/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶ $MRK","Merck & Co., Inc. (NYSE:MRK) To Present New Data From HCV Development Programs https://marketexclusive.com/merck-co-inc-nysemrk-will-present-new-data-chronic-hepatitis-c-virus-hcv-clinical-development-programs/90560/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶ $MRK
10",,,10,,[],https://twitter.com/marketexclusive/status/849969233354043392
1642,WallStreetGangsta,@WallStGangsta,2017-04-04T14:19:53.000Z,This Biotech Stock Could See 300% Gain With The 2 Drug Generating Revenues Aquired http://247wolfst.com/featured/this-biotech-stock-gained-two-revenue-generating-drugs-robust-pipeline-and-extensive-distribution-network/‚Ä¶ $IBB $GILD $NVS $MRK $PFE,"This Biotech Stock Could See 300% Gain With The 2 Drug Generating Revenues Aquired http://247wolfst.com/featured/this-biotech-stock-gained-two-revenue-generating-drugs-robust-pipeline-and-extensive-distribution-network/‚Ä¶ $IBB $GILD $NVS $MRK $PFE
1",,,,1,[],https://twitter.com/WallStGangsta/status/849265267557486592
1643,WallStreetGangsta,@WallStGangsta,2017-04-04T14:09:11.000Z,"This Biotech Stock Gained Two Revenue Generating Drugs, Robust Pipeline http://247wolfst.com/featured/this-biotech-stock-gained-two-revenue-generating-drugs-robust-pipeline-and-extensive-distribution-network/‚Ä¶ $GILD $IBB $NVS $MRK $BMY $PFE $JNJ $AMGN","This Biotech Stock Gained Two Revenue Generating Drugs, Robust Pipeline http://247wolfst.com/featured/this-biotech-stock-gained-two-revenue-generating-drugs-robust-pipeline-and-extensive-distribution-network/‚Ä¶ $GILD $IBB $NVS $MRK $BMY $PFE $JNJ $AMGN
1",,,,1,[],https://twitter.com/WallStGangsta/status/849262578438213632
1644,Daily Political,@dailypoliticaln,2017-04-04T10:30:58.000Z,"Merck & Co., Inc. $MRK Shares Sold by Intact Investment Management Inc. http://ift.tt/2nzrmgj","Merck & Co., Inc. $MRK Shares Sold by Intact Investment Management Inc. http://ift.tt/2nzrmgj",,,,,[],https://twitter.com/dailypoliticaln/status/849207659496697856
1645,Ticker Report,@TickerReport,2017-04-05T10:28:18.000Z,"A.R.T. Advisors LLC Purchases 34,500 Shares of Merck & Co., Inc. $MRK http://zpr.io/P95Ku","A.R.T. Advisors LLC Purchases 34,500 Shares of Merck & Co., Inc. $MRK http://zpr.io/P95Ku",,,,,[],https://twitter.com/TickerReport/status/849569379310239744
1646,Stockboard Media Inc,@stockboardinc,2017-04-05T10:55:31.000Z,$MRK Merck to Present New Data on ZEPATIER¬Æ (elbasvir and grazoprevir) and Investigational Combination T... - http://sbml.co/7c39c4e6,$MRK Merck to Present New Data on ZEPATIER¬Æ (elbasvir and grazoprevir) and Investigational Combination T... - http://sbml.co/7c39c4e6,,,,,[],https://twitter.com/stockboardinc/status/849576227115593728
1647,Stockboard Media Inc,@stockboardinc,2017-04-06T14:05:31.000Z,$MRK Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agenc... - http://sbml.co/241b34ba,$MRK Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agenc... - http://sbml.co/241b34ba,,,,,[],https://twitter.com/stockboardinc/status/849986430646575104
1648,Jacob Plieth,@JacobPlieth,2017-04-05T15:31:28.000Z,"How uncoupling Opdivo and Yervoy could favour Keytruda, via 
@RobinDavison2
 http://bit.ly/2o3ojQQ #AACR17 $BMY $MRK","How uncoupling Opdivo and Yervoy could favour Keytruda, via 
@RobinDavison2
 http://bit.ly/2o3ojQQ #AACR17 $BMY $MRK
4
2",,,4,2,[],https://twitter.com/JacobPlieth/status/849645670445330432
1649,MarketBeat,@MarketBeatCom,2017-04-05T00:09:59.000Z,"Merck & Co., Inc. $MRK EVP Sells $3,418,398.00 in Stock http://zpr.io/P92LP","Merck & Co., Inc. $MRK EVP Sells $3,418,398.00 in Stock http://zpr.io/P92LP",,,,,[],https://twitter.com/MarketBeatCom/status/849413775103012866
1650,SwingTradeBot,@SwingTradeBot,2017-04-06T21:41:42.000Z,Scan results - Expansion Pivot Sell Setup today: $MSM $RPM $SHPG $AER $AL $MRK ... https://swingtradebot.com/events/53/equities?selected_date=2017-04-06‚Ä¶,Scan results - Expansion Pivot Sell Setup today: $MSM $RPM $SHPG $AER $AL $MRK ... https://swingtradebot.com/events/53/equities?selected_date=2017-04-06‚Ä¶,,,,,[],https://twitter.com/SwingTradeBot/status/850101233029394432
1651,Watchlist News,@WatchlistN,2017-04-06T13:12:36.000Z,"Silvercrest Asset Management Group LLC Sells 8,534 Shares of Merck & Co., Inc. $MRK http://zpr.io/P9WgG","Silvercrest Asset Management Group LLC Sells 8,534 Shares of Merck & Co., Inc. $MRK http://zpr.io/P9WgG",,,,,[],https://twitter.com/WatchlistN/status/849973111789322240
1652,Jacob Plieth,@JacobPlieth,2017-04-05T08:01:07.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
Stiefel: $NLNK #AACR17 ORR data are investigator-reported, vs $INCY $MRK centrally confirmed. (No mention of short attack??!!)
1
3",,1,,3,[],https://twitter.com/JacobPlieth/status/849532336169521154
1653,MarketBeat,@MarketBeatCom,2017-04-06T13:15:52.000Z,"Girard Securities Inc. Has $465,000 Position in Merck & Co., Inc. $MRK http://zpr.io/P9WtL","Girard Securities Inc. Has $465,000 Position in Merck & Co., Inc. $MRK http://zpr.io/P9WtL",,,,,[],https://twitter.com/MarketBeatCom/status/849973933273120768
1654,Ticker Report,@TickerReport,2017-04-04T10:25:36.000Z,"Barrington Strategic Wealth Management Group LLC Acquires 65 Shares of Merck & Co., Inc. $MRK http://zpr.io/P93Rg","Barrington Strategic Wealth Management Group LLC Acquires 65 Shares of Merck & Co., Inc. $MRK http://zpr.io/P93Rg",,,,,[],https://twitter.com/TickerReport/status/849206308838535168
1655,Adam Feuerstein,@adamfeuerstein,2017-04-04T11:53:24.000Z,"Replying to 
@ClawBongo","Replying to 
@ClawBongo
Indoximod is pretty much irrelevant, isn‚Äôt it? $MRK doesn‚Äôt care about the drug, choosing $INCY IDO instead. $NLNK on its own.
2
1
1",,2,1,1,[],https://twitter.com/adamfeuerstein/status/849228404427718657
1656,Decamp,@LSinnv,2017-04-05T10:30:19.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
yes. T-VEC similarly yawn-inducing for some reason. Scope of these agents may expand a lot with $MRK collaborating with both $VLA & $AMGN",,,,,[],https://twitter.com/LSinnv/status/849569883377606656
1657,JoeTraderBio,@RSIDayTrader,2017-04-04T11:57:42.000Z,"Replying to 
@adamfeuerstein
 and 
@ClawBongo","Replying to 
@adamfeuerstein
 and 
@ClawBongo
y would $MRK partner with $NLNK on indoximod when $RHBBY has dibs
1",,1,,,[],https://twitter.com/RSIDayTrader/status/849229489469104129
1658,Ricky Smalls,@RickySmalls3,2017-04-04T13:05:15.000Z,$REPCF $RP.V & few other #biomedical stocks to watch today... $USRM $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK,$REPCF $RP.V & few other #biomedical stocks to watch today... $USRM $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK,,,,,[],https://twitter.com/RickySmalls3/status/849246486869266434
1659,Lance Markel,@lanceinvests,2017-04-04T12:50:12.000Z,Part 1 of Tuesday's stock alert...$REPCF $RP.V $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK $ENDP,Part 1 of Tuesday's stock alert...$REPCF $RP.V $PFE $BMY $SGYP $AUPH $VRX $MYL $BIIB $MRK $ENDP,,,,,[],https://twitter.com/lanceinvests/status/849242700822056960
1660,Eric Sagonowsky,@EricSFierce,2017-04-04T16:15:01.000Z,Pharma's digital revolution turns to Austin as $MRK eyes sites for 600-person IT hub,"Pharma's digital revolution turns to Austin as $MRK eyes sites for 600-person IT hub
fiercepharma.com
Pharma's digital revolution turns to Austin as Merck eyes sites for 600-person IT hub
Merck & Co. is eyeing Austin, Texas, for a 600-person IT shop, one of four around the globe, as it amps up in personalized and preventative medicine. | After years of restructuring its IT operations...
1",,,,1,['https://pbs.twimg.com/card_img/1501734126583525379/pbY7DChk?format=jpg&name=small'],https://twitter.com/EricSFierce/status/849294242400940032
1661,Ozgur Ogut,@Ogut_Ozgur,2017-04-04T20:15:58.000Z,"Replying to 
@bradloncar
 and 
@maralgr","Replying to 
@bradloncar
 and 
@maralgr
Roche decision wrt epac the most interesting one imo. Can argue $MRK / $BMY acting defensively, but Roche unlikely to",,,,,[],https://twitter.com/Ogut_Ozgur/status/849354880238190599
1662,Titan V,@titan_v16,2017-04-04T00:32:21.000Z,"Replying to 
@bs2537","Replying to 
@bs2537
$ONCS should rise nicely too once drug supply partnership (w/ $MRK) for melanoma registration combo trial is announced this quarter.",,,,,[],https://twitter.com/titan_v16/status/849057015917891586
1663,dough,@semodough,2017-04-09T14:15:01.000Z,"Understanding Cancer Immune Profiles, and Implications for IO Therapy, Was a Key Theme at #AACR2017 $IBB $MRK $BMY","Understanding Cancer Immune Profiles, and Implications for IO Therapy, Was a Key Theme at #AACR2017 $IBB $MRK $BMY
3
14
20",,3,14,20,"['https://pbs.twimg.com/media/C8-hFBQXcAA5X-L?format=jpg&name=small', 'https://pbs.twimg.com/media/C8-hFBQXsAAHr7S?format=jpg&name=small']",https://twitter.com/semodough/status/851075983469932544
1664,Andy Biotech,@AndyBiotech,2017-04-07T11:50:53.000Z,"Poor $MRK 2 large outcome trials led to 2 CRLs

Zetia/Vytorin IMPROVE-IT: 10-Yr 18,144 patients

Januvia/Janumet TECOS: 7-Yr 14,671 patients","Poor $MRK 2 large outcome trials led to 2 CRLs

Zetia/Vytorin IMPROVE-IT: 10-Yr 18,144 patients

Januvia/Janumet TECOS: 7-Yr 14,671 patients
1
8
9",,1,8,9,[],https://twitter.com/AndyBiotech/status/850314935888474112
1665,Seeking Alpha,@SeekingAlpha,2017-04-07T15:29:27.000Z,What To Watch In Q2: Upcoming Healthcare Data Releases https://seekingalpha.com/article/4061076-watch-q2-upcoming-healthcare-data-releases?source=feed_f‚Ä¶ $NBIX $ABBV $AEZS $AMGN $AUPH $CDTX $CELG $CLVS $MRK $NLNK,"What To Watch In Q2: Upcoming Healthcare Data Releases https://seekingalpha.com/article/4061076-watch-q2-upcoming-healthcare-data-releases?source=feed_f‚Ä¶ $NBIX $ABBV $AEZS $AMGN $AUPH $CDTX $CELG $CLVS $MRK $NLNK
seekingalpha.com
What To Watch In Q2: Upcoming Healthcare Data Releases
Extreme volatility around data events continues to be a major concern for healthcare investors in 2017. Here is our list of healthcare data releases to be watching in the second quarter.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1497724725002448899/2TZ3O23_?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/850369942083981312
1666,MM+M Magazine,@MMMnews,2017-04-07T15:07:52.000Z,"5 things for #pharma #marketers to know: Fri., Apr. 7 #FDA $MRK #diabetes #Startup #Trump #genetics $MNK $IPG #DTC http://bit.ly/2nSwg9b","5 things for #pharma #marketers to know: Fri., Apr. 7 #FDA $MRK #diabetes #Startup #Trump #genetics $MNK $IPG #DTC http://bit.ly/2nSwg9b
1
5
2",,1,5,2,['https://pbs.twimg.com/media/C80Y7QLXgAI4y8L?format=jpg&name=small'],https://twitter.com/MMMnews/status/850364507562151936
1667,pharmalot,@pharmalot,2017-04-07T13:16:44.000Z,"Pharmalot.. Pharmalittle.. Good Morning.. headlines, coffee & weekend daydreams.. https://statnews.com/pharmalot/2017/04/07/actelion-kfc-antibiotics-merck/‚Ä¶ #pharma $JNJ $MRK $ATLN $YUM #KFC","Pharmalot.. Pharmalittle.. Good Morning.. headlines, coffee & weekend daydreams.. https://statnews.com/pharmalot/2017/04/07/actelion-kfc-antibiotics-merck/‚Ä¶ #pharma $JNJ $MRK $ATLN $YUM #KFC
statnews.com
Pharmalot, Pharmalittle: European regulator OKs use of Actelion drug after five deaths
The European Medicines Agency says an Actelion drug called Uptravi can continue to be used following a review sparked by five patient deaths.
1",,,1,,['https://pbs.twimg.com/card_img/1500534343600644098/wAHXYJa7?format=jpg&name=small'],https://twitter.com/pharmalot/status/850336540014379009
1668,Evaluate Vantage,@evaluatevantage,2017-04-07T13:36:47.000Z,Vantage Snippet ‚Äì US FDA tells Merck to try again on Tecos $MRK,"Vantage Snippet ‚Äì US FDA tells Merck to try again on Tecos $MRK
1",,,1,,['https://pbs.twimg.com/media/C80FBUKXsAAPd9J?format=jpg&name=small'],https://twitter.com/evaluatevantage/status/850341585439121408
1669,Donna Young,@DonnaYoungDC,2017-04-07T11:44:09.000Z,"#FDA rejects $MRK's sNDA to add TECOS CV study to #JANUVIA (sitagliptin) label http://investors.merck.com/news/press-release-details/2017/Merck-Receives-Complete-Response-Letter-from-the-US-FDA-for-TECOS-Study-with-Sitagliptin/default.aspx#sthash.XZd8I3ax.dpuf‚Ä¶ 
#pharma #biotech #diabetes","#FDA rejects $MRK's sNDA to add TECOS CV study to #JANUVIA (sitagliptin) label http://investors.merck.com/news/press-release-details/2017/Merck-Receives-Complete-Response-Letter-from-the-US-FDA-for-TECOS-Study-with-Sitagliptin/default.aspx#sthash.XZd8I3ax.dpuf‚Ä¶ 
#pharma #biotech #diabetes
5
2",üì∞,,5,2,[],https://twitter.com/DonnaYoungDC/status/850313242631131136
1670,Stockrow,@stockrow1,2017-04-07T12:33:25.000Z,$JNJ is the largest pharma company with a market cap of $340 bil. $PFE $MRK $AMGN $BMY $GILD #stocks #biotech,$JNJ is the largest pharma company with a market cap of $340 bil. $PFE $MRK $AMGN $BMY $GILD #stocks #biotech,,,,,['https://pbs.twimg.com/media/C8z2mnHXkAEWVXV?format=jpg&name=small'],https://twitter.com/stockrow1/status/850325638594605056
1671,Paul Harwitz,@CowboyPoet,2017-04-08T21:27:50.000Z,"Jim Cramer -- Incyte Stock Is Red-Hot, Worth More Than $200 in a Takeout $INCY $IBB $XBI $MRK $BMY https://thestreet.com/story/14078102/1/jim-cramer-incyte-is-red-hot-worth-more-than-200-in-a-takeout.html‚Ä¶ via 
@TheStreet","Jim Cramer -- Incyte Stock Is Red-Hot, Worth More Than $200 in a Takeout $INCY $IBB $XBI $MRK $BMY https://thestreet.com/story/14078102/1/jim-cramer-incyte-is-red-hot-worth-more-than-200-in-a-takeout.html‚Ä¶ via 
@TheStreet
thestreet.com
Jim Cramer -- Incyte Stock Is Red-Hot, Worth More Than $200 in a Takeout
Incyte has been doing great, locking in deals with Bristol-Myers and Merck. It's worth a lot more in a takeover situation, Cramer said.
1",,,1,,[],https://twitter.com/CowboyPoet/status/850822516176281600
1672,bored2tears,@bored2tears,2017-04-07T11:39:03.000Z,"#Merck receives CRL letter from #FDA about SNDA for Januvia, Janumet, Janumet XR
More: http://twitthat.com/y0KRj
$MRK -1.96% premarket
#pharma","#Merck receives CRL letter from #FDA about SNDA for Januvia, Janumet, Janumet XR
More: http://twitthat.com/y0KRj
$MRK -1.96% premarket
#pharma
1",,,1,,['https://pbs.twimg.com/media/C8zp-oOXkAU0xmU?format=jpg&name=small'],https://twitter.com/bored2tears/status/850311958222000129
1673,Peter Loftus,@Loftus,2017-04-07T12:12:46.000Z,"FDA rejects Merck's bid to market cardiovascular safety of diabetes drugs Januvia/Janumet, a $6.1B franchise $MRK: http://mrknewsroom.com/news-release/corporate-news/merck-receives-complete-response-letter-us-fda-tecos-study-sitagliptin‚Ä¶","FDA rejects Merck's bid to market cardiovascular safety of diabetes drugs Januvia/Janumet, a $6.1B franchise $MRK: http://mrknewsroom.com/news-release/corporate-news/merck-receives-complete-response-letter-us-fda-tecos-study-sitagliptin‚Ä¶
2
6
5",,2,6,5,[],https://twitter.com/Loftus/status/850320442611167237
1674,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-04-08T09:25:08.000Z,3 Things In Biotech You Should Learn Today: Volume 2 $NLNK $BMY $MRK http://dlvr.it/Nr0Kt7 #Investing #Stocks,3 Things In Biotech You Should Learn Today: Volume 2 $NLNK $BMY $MRK http://dlvr.it/Nr0Kt7 #Investing #Stocks,,,,,['https://pbs.twimg.com/media/C84VJ-IU0AEaqgF?format=jpg&name=small'],https://twitter.com/AlertTrade/status/850640643730808832
1675,Gitte Pedersen,@DNABARCODE,2017-04-07T19:03:00.000Z,"First #FDA Approved Drug for Rare Skin #Cancer called Merkel cell carcinoma #PDL1 
@Merck
 @Pfizer
 $PFE $MRK #AACR2017","First #FDA Approved Drug for Rare Skin #Cancer called Merkel cell carcinoma #PDL1 
@Merck
 @Pfizer
 $PFE $MRK #AACR2017
cancer.gov
Avelumab First Approved Drug for Merkel Cell Carcinoma
A Cancer Currents blog on the FDA‚Äôs first-ever approval of a drug for the rare skin cancer Merkel cell carcinoma and updated data on patients‚Äô tumor responses.
6
11",,,6,11,['https://pbs.twimg.com/card_img/1501220676962717698/DXAiWqv3?format=jpg&name=240x240'],https://twitter.com/DNABARCODE/status/850423683508305920
1676,AustinBizJournal,@MyABJ,2017-04-07T21:01:00.000Z,Austin debates incentives for bringing 600-job Merck It hub to city $MRK http://bizj.us/1p4lnb ,"Austin debates incentives for bringing 600-job Merck It hub to city $MRK http://bizj.us/1p4lnb 
bizjournals.com
Merck in Austin: Council incentives debate raises questions over jobs
Several City Council members say incentives bait doesn't lure jobs for people in the middle class who need them the most ‚Äî and one official with the city's economic development arm conceded that,...
6
2",üîí,,6,2,['https://pbs.twimg.com/card_img/1499718417829539841/b54MiJ6j?format=jpg&name=small'],https://twitter.com/MyABJ/status/850453377049923584
1677,John Carroll,@JohnCendpts,2017-04-07T13:07:23.000Z,"FDA nixes Merck‚Äôs shot at getting Januvia cardio safety data onto the label
$MRK","FDA nixes Merck‚Äôs shot at getting Januvia cardio safety data onto the label
$MRK
endpts.com
FDA nixes Merck‚Äôs shot at getting Januvia cardio safety data onto the label
Merck is not going to get any help from the FDA in marketing its big diabetes drug Januvia. A $6 billion earner last year, Merck's flagship DPP-4 drug came out of a massive 14,724-patient study in...
3
3",,,3,3,['https://pbs.twimg.com/card_img/1500440824504541185/VJjW3Ws6?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/850334186615562241
1678,Place Trade,@PlaceTrade,2017-04-08T06:48:49.000Z,Super Scary Stats! Nearly half of US adults infected with genital HPV (CDC) http://bit.ly/2oiBFcC  $MRK $GSK $NOVN https://twitter.com/FOX59/status/850590304919060480‚Ä¶,"Super Scary Stats! Nearly half of US adults infected with genital HPV (CDC) http://bit.ly/2oiBFcC  $MRK $GSK $NOVN https://twitter.com/FOX59/status/850590304919060480‚Ä¶
FOX59 News
@FOX59
 ¬∑ 8 Apr 2017
Nearly half of US adults infected with genital HPV, CDC reports http://bit.ly/2oiBFcC",,,,,"['https://pbs.twimg.com/media/C83nX5YWsAACoFD?format=jpg&name=small', 'https://pbs.twimg.com/profile_images/900065543058796545/u-oPZvu8_mini.jpg', 'https://pbs.twimg.com/media/C83nX5YWsAACoFD?format=jpg&name=240x240']",https://twitter.com/PlaceTrade/status/850601304317501440
1679,Jared Wesley,@ScalpMaster1,2017-04-07T13:01:50.000Z,"Long Watches: $RTN, $LMT, $TWLO, $SBLK, $NEM, $AUPH, $GDX, $ABX!! Short Watches: $CJ, $CBIO, $MRK!!","Long Watches: $RTN, $LMT, $TWLO, $SBLK, $NEM, $AUPH, $GDX, $ABX!! Short Watches: $CJ, $CBIO, $MRK!!
2",,,,2,[],https://twitter.com/ScalpMaster1/status/850332793238417412
1680,FiercePharma,@FiercePharma,2017-04-07T13:49:19.000Z,FDA shoots down Merck's bid to add lack of heart risks to Januvia's label http://fiercepharma.com/pharma/fda-shoots-down-merck-s-bid-to-add-lack-heart-risks-to-januvia-s-label‚Ä¶ $MRK,"FDA shoots down Merck's bid to add lack of heart risks to Januvia's label http://fiercepharma.com/pharma/fda-shoots-down-merck-s-bid-to-add-lack-heart-risks-to-januvia-s-label‚Ä¶ $MRK
fiercepharma.com
FDA shoots down Merck's bid to add lack of heart risks to Januvia's label
With diabetes rivals coming up with heart-helping outcomes data, Merck at least wants data on its label showing its Januvia doesn‚Äôt hurt heart health. U.S. regulators, though, say not so fast. | With...
2
2",,,2,2,['https://pbs.twimg.com/card_img/1500098380491640833/mDhRu8Kw?format=jpg&name=small'],https://twitter.com/FiercePharma/status/850344740671418372
1681,BioPharma Dive,@BioPharmaDive,2017-04-07T21:32:00.000Z,FDA throws wrench in $MRK's attempt to add new data to Januvia label,"FDA throws wrench in $MRK's attempt to add new data to Januvia label
biopharmadive.com
FDA shoots down Merck's bid to expand Januvia label
Merck sought to add cardiovascular outcomes data to the label of its blockbuster DPP-4 inhibitor in an effort to improve competitiveness and extend its lifecycle.  
1",,,,1,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/850461178945875969
1682,leahanne,@leahanneta,2017-04-07T23:28:16.000Z,"04/07/17 Volume Leader #84 - MRK 7,721,053 Merck & Company $MRK 63.13 -0.11 -0.17% High today of 63.33 day low https://investorshangout.com/post/view?id=4470527‚Ä¶","04/07/17 Volume Leader #84 - MRK 7,721,053 Merck & Company $MRK 63.13 -0.11 -0.17% High today of 63.33 day low https://investorshangout.com/post/view?id=4470527‚Ä¶",,,,,[],https://twitter.com/leahanneta/status/850490439769755653
1683,Daily Political,@dailypoliticaln,2017-04-09T10:38:11.000Z,"Freestone Capital Holdings LLC Lowers Stake in Merck & Co., Inc. $MRK http://ift.tt/2odpwn1","Freestone Capital Holdings LLC Lowers Stake in Merck & Co., Inc. $MRK http://ift.tt/2odpwn1",,,,,[],https://twitter.com/dailypoliticaln/status/851021415159549953
1684,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-04-08T17:34:55.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/2ToykRKuG,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/2ToykRKuG,,,,,[],https://twitter.com/gem_2014/status/850763902224916480
1685,WallStreetGangsta,@WallStGangsta,2017-04-09T20:50:10.000Z,$MRK Merck & Co. To Present New Data From HCV Development Programs http://wallstreetgangsta.com/merck-co-to-present-new-data-from-hcv-development-programs/‚Ä¶,$MRK Merck & Co. To Present New Data From HCV Development Programs http://wallstreetgangsta.com/merck-co-to-present-new-data-from-hcv-development-programs/‚Ä¶,,,,,[],https://twitter.com/WallStGangsta/status/851175426345062401
1686,Watchlist News,@WatchlistN,2017-04-09T10:38:00.000Z,"Hampstead Capital LLP Takes Position in Merck & Co., Inc. $MRK http://zpr.io/P8sSu","Hampstead Capital LLP Takes Position in Merck & Co., Inc. $MRK http://zpr.io/P8sSu",,,,,[],https://twitter.com/WatchlistN/status/851021369194274819
1687,Barron's,@barronsonline,2017-04-09T13:17:40.000Z,"Hersh Cohen, Wall Street‚Äôs dividend king, likes #Merck, #Schlumberger http://on.barrons.com/2noiCye $MRK $SLB 
@Clear_Bridge
 #MFQuarterly","Hersh Cohen, Wall Street‚Äôs dividend king, likes #Merck, #Schlumberger http://on.barrons.com/2noiCye $MRK $SLB 
@Clear_Bridge
 #MFQuarterly
2
5",,,2,5,['https://pbs.twimg.com/media/C8-T-A_XsAAsJsb?format=jpg&name=small'],https://twitter.com/barronsonline/status/851061551108956160
1688,Daily Political,@dailypoliticaln,2017-04-07T05:22:57.000Z,"Traders Buy Shares of Merck & Co., Inc. $MRK on Weakness Following Insider Selling http://dailypolitical.com/?p=1006156","Traders Buy Shares of Merck & Co., Inc. $MRK on Weakness Following Insider Selling http://dailypolitical.com/?p=1006156",,,,,[],https://twitter.com/dailypoliticaln/status/850217308706316289
1689,Stockboard Media Inc,@stockboardinc,2017-04-07T11:36:10.000Z,$MRK Merck Receives Complete Response Letter from the U.S. FDA for TECOS Study with Sitagliptin... - http://sbml.co/d8cd6d08,$MRK Merck Receives Complete Response Letter from the U.S. FDA for TECOS Study with Sitagliptin... - http://sbml.co/d8cd6d08,,,,,[],https://twitter.com/stockboardinc/status/850311231592423424
1690,BioPharma Dive,@BioPharmaDive,2017-04-07T19:41:00.000Z,"Prescribed Reading: $BMY shows durability of Opdivo; $INCY, $MRK expand their collaboration; $ACOR cuts staff by 20% http://bit.ly/2oRuvK0","Prescribed Reading: $BMY shows durability of Opdivo; $INCY, $MRK expand their collaboration; $ACOR cuts staff by 20% http://bit.ly/2oRuvK0
1",,,,1,[],https://twitter.com/BioPharmaDive/status/850433244894040064
1691,Insider Monkey News,@insidermonkey_n,2017-04-07T17:32:29.000Z,$MRK Opens in Green Amid FDA Rejection Related to Diabetes Drugs,"$MRK Opens in Green Amid FDA Rejection Related to Diabetes Drugs
insidermonkey.com
Merck & Co. Inc. (MRK) Opens in Green Amid FDA Rejection Related to Diabetes Drugs
Merck & Co. Inc. (NYSE:MRK) entered the markets on April 7 in green, amid a thumbs down from the U.S.",,,,,[],https://twitter.com/insidermonkey_n/status/850400900623544320
1692,Ian Tobin,@iangtobin,2017-04-07T16:44:58.000Z,Credit to $MRK for trying. Reality is it's been rare for novel Rx over last decade to add >1% absolute drop in HbA1c to background regimen,"Credit to $MRK for trying. Reality is it's been rare for novel Rx over last decade to add >1% absolute drop in HbA1c to background regimen
John LaMattina
@John_LaMattina
 ¬∑ 7 Apr 2017
Merck's Diabetes Franchise And The Perils In Proving A Drug's Medical Value via @forbes http://forbes.com/sites/johnlamattina/2017/04/07/mercks-diabetes-franchise-and-the-perils-in-proving-a-drugs-medical-value/#412fd43b5bed‚Ä¶",,,,,['https://pbs.twimg.com/profile_images/1369690050120781830/5v_rj3G2_mini.jpg'],https://twitter.com/iangtobin/status/850388943279357952
1693,US Banking News,@AmericanBanking,2017-04-07T13:48:11.000Z,Merck & Co. downgraded by HSBC Holdings plc to reduce. http://ift.tt/2oJ1zar $MRK #MRK,Merck & Co. downgraded by HSBC Holdings plc to reduce. http://ift.tt/2oJ1zar $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/850344455983046657
1694,US Banking News,@AmericanBanking,2017-04-07T08:48:13.000Z,Merck KGaA given ‚Ç¨95.00 PT by HSBC Holdings plc. sell rating. http://ift.tt/2og23ni $MRK #MRK,Merck KGaA given ‚Ç¨95.00 PT by HSBC Holdings plc. sell rating. http://ift.tt/2og23ni $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/850268966782025731
1695,StockNews.com,@stocknewsdotcom,2017-04-08T14:20:44.000Z,$MRK Fund manager who likes dividend plays is bullish on the stock https://stocknews.com/news/mrk-fund-manager-who-likes-dividend-plays-is-bullish-on-the/‚Ä¶,$MRK Fund manager who likes dividend plays is bullish on the stock https://stocknews.com/news/mrk-fund-manager-who-likes-dividend-plays-is-bullish-on-the/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/850715034015719430
1696,Ticker Report,@TickerReport,2017-04-08T10:32:16.000Z,"Drexel Morgan & Co. Takes Position in Merck & Co., Inc. $MRK http://ift.tt/2oSXIUS","Drexel Morgan & Co. Takes Position in Merck & Co., Inc. $MRK http://ift.tt/2oSXIUS",,,,,[],https://twitter.com/TickerReport/status/850657540698492929
1697,Watchlist News,@WatchlistN,2017-04-09T15:54:49.000Z,"Merck & Co., Inc. $MRK Stake Increased by Pacific Global Investment Management CO http://zpr.io/P8TR6","Merck & Co., Inc. $MRK Stake Increased by Pacific Global Investment Management CO http://zpr.io/P8TR6",,,,,[],https://twitter.com/WatchlistN/status/851101100442873858
1698,MarketBeat,@MarketBeatCom,2017-04-07T18:17:25.000Z,"Glassman Wealth Services Has $268,000 Position in Merck & Co., Inc. $MRK http://zpr.io/P8RyW","Glassman Wealth Services Has $268,000 Position in Merck & Co., Inc. $MRK http://zpr.io/P8RyW",,,,,[],https://twitter.com/MarketBeatCom/status/850412209708556288
1699,Market Realist,@MarketRealist,2017-04-07T16:27:49.000Z,How US Pharmaceutical Companies Performed in 1Q17 http://marketrealist.com/?p=2019463 $JNJ $LLY $ABT $MRK,"How US Pharmaceutical Companies Performed in 1Q17 http://marketrealist.com/?p=2019463 $JNJ $LLY $ABT $MRK
1",,,1,,[],https://twitter.com/MarketRealist/status/850384628296945664
1700,MarketBeat,@MarketBeatCom,2017-04-08T04:23:05.000Z,"Coho Partners Ltd. Raises Position in Merck & Co., Inc. $MRK http://zpr.io/Puetc","Coho Partners Ltd. Raises Position in Merck & Co., Inc. $MRK http://zpr.io/Puetc",,,,,[],https://twitter.com/MarketBeatCom/status/850564632062316544
1701,Zenect,@zenect,2017-04-08T14:36:51.000Z,I always get asked what‚Äôs the one dividend stock people should buy? http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,I always get asked what‚Äôs the one dividend stock people should buy? http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,,,,,[],https://twitter.com/zenect/status/850719090243248128
1702,Evaluate Pharma,@evaluatepharma,2017-04-07T16:47:37.000Z,"Snippet roundup: Merck gets Tecos knockback, Gottlieb moves towards FDA hotseat http://ow.ly/wFnZ30aFruq via 
@EPVantage
 $MRK $JAZZ $GEN","Snippet roundup: Merck gets Tecos knockback, Gottlieb moves towards FDA hotseat http://ow.ly/wFnZ30aFruq via 
@EPVantage
 $MRK $JAZZ $GEN
2
1",,,2,1,['https://pbs.twimg.com/media/C80w2FXWAAAU5Mb?format=jpg&name=small'],https://twitter.com/evaluatepharma/status/850389613063675904
1703,Carly Helfand,@CarlyHFierce,2017-04-07T15:23:54.000Z,FDA shoots down Merck's bid to add lack of heart risks to Januvia's label: http://bit.ly/2nLxamR $MRK #pharma,"FDA shoots down Merck's bid to add lack of heart risks to Januvia's label: http://bit.ly/2nLxamR $MRK #pharma
fiercepharma.com
FDA shoots down Merck's bid to add lack of heart risks to Januvia's label
With diabetes rivals coming up with heart-helping outcomes data, Merck at least wants data on its label showing its Januvia doesn‚Äôt hurt heart health. U.S. regulators, though, say not so fast. | With...",,,,,['https://pbs.twimg.com/card_img/1500098380491640833/mDhRu8Kw?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/850368544453918720
1704,Allison Gatlin,@IBD_AGatlin,2017-04-07T16:35:20.000Z,Dow component Merck pares losses after FDA rejects diabetes label $MRK http://ow.ly/9LeF30aFqed,Dow component Merck pares losses after FDA rejects diabetes label $MRK http://ow.ly/9LeF30aFqed,,,,,[],https://twitter.com/IBD_AGatlin/status/850386520515203082
1705,US Banking News,@AmericanBanking,2017-04-09T02:22:31.000Z,Somewhat Favorable News Coverage Unlikely to Impact Merck & Co. $MRK Stock Price http://ift.tt/2nsTq9G,Somewhat Favorable News Coverage Unlikely to Impact Merck & Co. $MRK Stock Price http://ift.tt/2nsTq9G,,,,,[],https://twitter.com/AmericanBanking/status/850896677745635328
1706,Jacob Bell,@realJacobBell,2017-04-07T19:41:00.000Z,"Prescribed Reading: $BMY shows durability of Opdivo; $INCY, $MRK expand their collaboration; $ACOR cuts staff by 20%","Prescribed Reading: $BMY shows durability of Opdivo; $INCY, $MRK expand their collaboration; $ACOR cuts staff by 20%
biopharmadive.com
Prescribed Reading: AACR, Gottlieb and recalls
Scott Gottlieb faced a Senate committee for the top slot at the FDA, while data pours in from AACR and Mylan and GSK issue U.S. recalls.",,,,,['https://pbs.twimg.com/card_img/1486878715556478977/Jq6PbgTL?format=jpg&name=small'],https://twitter.com/realJacobBell/status/850433245510418432
1707,Jared Wesley,@ScalpMaster1,2017-04-07T13:23:43.000Z,"Favs: $NEM over 35, $GDX over 24, $LMT over 273, $RTN over 156.50, $MRK under 62.75!","Favs: $NEM over 35, $GDX over 24, $LMT over 273, $RTN over 156.50, $MRK under 62.75!",,,,,[],https://twitter.com/ScalpMaster1/status/850338296265940993
1708,MAISA,@MaisaCorp,2017-04-08T02:07:58.000Z,"$MRK  receives a CRL from the FDA regarding its sNDA for JANUVIA, JANUMET, and JANUMET XR","$MRK  receives a CRL from the FDA regarding its sNDA for JANUVIA, JANUMET, and JANUMET XR",,,,,[],https://twitter.com/MaisaCorp/status/850530629997539328
1709,MarketBeat,@MarketBeatCom,2017-04-09T02:24:39.000Z,Somewhat Favorable News Coverage Unlikely to Impact Merck & Co. $MRK Stock Price http://ift.tt/2oRfjzy #acn,Somewhat Favorable News Coverage Unlikely to Impact Merck & Co. $MRK Stock Price http://ift.tt/2oRfjzy #acn,,,,,[],https://twitter.com/MarketBeatCom/status/850897214255902720
1710,Ticker Report,@TickerReport,2017-04-08T10:32:18.000Z,"Merck & Co., Inc. $MRK Stake Lowered by Quest Investment Management Inc. OR http://ift.tt/2oT6YIO","Merck & Co., Inc. $MRK Stake Lowered by Quest Investment Management Inc. OR http://ift.tt/2oT6YIO",,,,,[],https://twitter.com/TickerReport/status/850657545945481218
1711,Insider Monkey,@insidermonkey,2017-04-07T17:32:47.000Z,$MRK Opens in Green Amid FDA Rejection Related to Diabetes Drugs,"$MRK Opens in Green Amid FDA Rejection Related to Diabetes Drugs
insidermonkey.com
Merck & Co. Inc. (MRK) Opens in Green Amid FDA Rejection Related to Diabetes Drugs
Merck & Co. Inc. (NYSE:MRK) entered the markets on April 7 in green, amid a thumbs down from the U.S.",,,,,['https://pbs.twimg.com/card_img/1501985513045069824/yXnp23WP?format=jpg&name=240x240'],https://twitter.com/insidermonkey/status/850400980097269761
1712,Arsalan Arif,@AKAarsalan,2017-04-07T12:49:22.000Z,FDA nixes Merck‚Äôs shot at getting Januvia cardio safety data onto the label $MRK,"FDA nixes Merck‚Äôs shot at getting Januvia cardio safety data onto the label $MRK
endpts.com
FDA nixes Merck‚Äôs shot at getting Januvia cardio safety data onto the label
Merck is not going to get any help from the FDA in marketing its big diabetes drug Januvia. A $6 billion earner last year, Merck's flagship DPP-4 drug came out of a massive 14,724-patient study in...",,,,,['https://pbs.twimg.com/card_img/1500440824504541185/VJjW3Ws6?format=jpg&name=small'],https://twitter.com/AKAarsalan/status/850329653952872452
1713,Sue Sutter,@PinkSheetSutter,2017-04-07T13:01:18.000Z,"$MRK CRL for Januvia (sitagliptin) CV data based on TECOS trial; no 
@US_FDA
 AdComm held on this sNDA http://mrknewsroom.com/news-release/corporate-news/merck-receives-complete-response-letter-us-fda-tecos-study-sitagliptin‚Ä¶","$MRK CRL for Januvia (sitagliptin) CV data based on TECOS trial; no 
@US_FDA
 AdComm held on this sNDA http://mrknewsroom.com/news-release/corporate-news/merck-receives-complete-response-letter-us-fda-tecos-study-sitagliptin‚Ä¶
1",,,1,,[],https://twitter.com/PinkSheetSutter/status/850332654927052804
1714,Bursatil Biotech,@BursatilBiotech,2017-04-07T13:58:13.000Z,"What a great post from 
@PDRennert
 
A must-read to Biotech Investors $MRK $AZN $RHHBY $BMY #Immunotherapy","What a great post from 
@PDRennert
 
A must-read to Biotech Investors $MRK $AZN $RHHBY $BMY #Immunotherapy
sugarconebiotech.com
Angst in the IO Combo field ‚Äì part 2 (lessons from #AACR17)
I posed this question regarding IO combinations in the last post, leading up to AACR: Why the perception of angst then? The sentiment has been summed up as ‚Äúeverything will work a little, so what do...",,,,,['https://pbs.twimg.com/card_img/1500624487661944833/cAOGDcWA?format=jpg&name=240x240'],https://twitter.com/BursatilBiotech/status/850346979410554880
1715,Streetinsider.com,@Street_Insider,2017-04-07T11:52:59.000Z,Merck $MRK Receives CRL from FDA for TECOS Study with Sitagliptin,"Merck $MRK Receives CRL from FDA for TECOS Study with Sitagliptin
streetinsider.com
Merck (MRK) Receives CRL from FDA for TECOS Study with Sitagliptin
Merck (NYSE: MRK) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding Mercks Supplemental New Drug Applications for JANUVIA√Ç¬Æ (sitaglipt...",,,,,[],https://twitter.com/Street_Insider/status/850315462529478656
1716,Benzinga,@Benzinga,2017-04-08T22:00:01.000Z,"Barron's Picks And Pans: Gold, Energy, Dividends And More https://benzinga.com/z/9279601 $ABX $GLD $HK $GKOS $JLL $MRK $SLB","Barron's Picks And Pans: Gold, Energy, Dividends And More https://benzinga.com/z/9279601 $ABX $GLD $HK $GKOS $JLL $MRK $SLB
benzinga.com
Barron's Picks And Pans: Gold, Energy, Dividends And More
This weekend's Barron's takes a look at six undervalued energy stocks and five ways to play the new gold rally. Other featured articles offer the prospects for a...
2",,,2,,[],https://twitter.com/Benzinga/status/850830617675563008
1717,Watchlist News,@WatchlistN,2017-04-09T02:18:51.000Z,Somewhat Favorable News Coverage Unlikely to Impact Merck & Co. $MRK Stock Price http://zpr.io/P8jXN,Somewhat Favorable News Coverage Unlikely to Impact Merck & Co. $MRK Stock Price http://zpr.io/P8jXN,,,,,[],https://twitter.com/WatchlistN/status/850895756894580736
1718,TradeTheNews.com,@Trade_The_News,2017-04-07T11:32:07.000Z,Merck Receives complete response letter from the US FDA for TECOS study with Sitagliptin $MRK,Merck Receives complete response letter from the US FDA for TECOS study with Sitagliptin $MRK,,,,,[],https://twitter.com/Trade_The_News/status/850310212628172800
1719,FDR Investment Group,@FDRInvestments,2017-04-07T11:57:18.000Z,Merck $MRK Receives CRL from FDA for TECOS Study with Sitagliptin,"Merck $MRK Receives CRL from FDA for TECOS Study with Sitagliptin
streetinsider.com
Merck (MRK) Receives CRL from FDA for TECOS Study with Sitagliptin
Merck (NYSE: MRK) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding Mercks Supplemental New Drug Applications for JANUVIA√Ç¬Æ (sitaglipt...",,,,,[],https://twitter.com/FDRInvestments/status/850316551295299585
1720,The Investor Network,@investornetwork,2017-04-12T19:57:01.000Z,The Challenges Behind #Merck's #Diabetes Franchise. #invest $MRK http://hubs.ly/H072bWJ0,"The Challenges Behind #Merck's #Diabetes Franchise. #invest $MRK http://hubs.ly/H072bWJ0
2
1",,2,,1,['https://pbs.twimg.com/media/C9PMJK-XgAEaWUX?format=jpg&name=small'],https://twitter.com/investornetwork/status/852249216453943297
1721,Seeking Alpha,@SeekingAlpha,2017-04-11T20:02:51.000Z,Merck And A Curiously Effective Buyback https://seekingalpha.com/article/4061796-merck-curiously-effective-buyback?source=feed_f‚Ä¶ $MRK,"Merck And A Curiously Effective Buyback https://seekingalpha.com/article/4061796-merck-curiously-effective-buyback?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Merck And A Curiously Effective Buyback (NYSE:MRK)
Merck has spent billions of dollars buying stock in recent years. But it has also been quite loose with its issuance of options, diluting some of the impact of the buyback.",,,,,[],https://twitter.com/SeekingAlpha/status/851888295160070144
1722,Melanoma MRV,@Melanoma_MRV,2017-04-10T03:17:21.000Z,3 Things In Biotech You Should Learn Today: Volume 2 https://seekingalpha.com/article/4061205-3-things-biotech-learn-today-volume-2?source=tweet‚Ä¶ $NLNK $BMY $MRK,"3 Things In Biotech You Should Learn Today: Volume 2 https://seekingalpha.com/article/4061205-3-things-biotech-learn-today-volume-2?source=tweet‚Ä¶ $NLNK $BMY $MRK
seekingalpha.com
3 Things In Biotech You Should Learn Today: Volume 2
NewLink's slam dunk in melanoma combo. Bristol-Myers jumps on the IDO craze, too! Merck confirms activity of Keytruda in Head and Neck cancer.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/Melanoma_MRV/status/851272862967119875
1723,Seeking Alpha,@SeekingAlpha,2017-04-10T19:18:26.000Z,Other Hepatitis Viruses Take The Spotlight Along With Nash https://seekingalpha.com/article/4061546-hepatitis-viruses-take-spotlight-along-nash?source=feed_f‚Ä¶ $GILD $EIGR $ALBO $BMY $ABBV $MRK $ACHN $ICPT,"Other Hepatitis Viruses Take The Spotlight Along With Nash https://seekingalpha.com/article/4061546-hepatitis-viruses-take-spotlight-along-nash?source=feed_f‚Ä¶ $GILD $EIGR $ALBO $BMY $ABBV $MRK $ACHN $ICPT
seekingalpha.com
Other Hepatitis Viruses Take The Spotlight Along With Nash
Hepatitis C may have had its moment in the sun, and now biopharma has turned to other liver diseases.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/851514728710942720
1724,Seeking Alpha,@SeekingAlpha,2017-04-11T16:26:51.000Z,"Large Cap Biotech Review Coming Into Earnings Season, Part 1 https://seekingalpha.com/article/4061734-large-cap-biotech-review-coming-earnings-season-part-1?source=feed_f‚Ä¶ $ABBV $ALXN $AMGN $BIIB $BIVV $BMY $MRK $NVS $OMER","Large Cap Biotech Review Coming Into Earnings Season, Part 1 https://seekingalpha.com/article/4061734-large-cap-biotech-review-coming-earnings-season-part-1?source=feed_f‚Ä¶ $ABBV $ALXN $AMGN $BIIB $BIVV $BMY $MRK $NVS $OMER
seekingalpha.com
Large Cap Biotech Review Coming Into Earnings Season, Part 1 (NASDAQ:IBB)
Large-cap biotechs, or mid-cap for one stock in this group, generally are trading cheap to the market.
1",,,,1,[],https://twitter.com/SeekingAlpha/status/851833938377023488
1725,MM+M Magazine,@MMMnews,2017-04-10T11:30:02.000Z,Missed Friday's news? Here's what to know #pharma #FDA $MRK #diabetes #Digitalhealth #Trump #genetics $MNK $IPG #DTC http://bit.ly/2nSwg9b,"Missed Friday's news? Here's what to know #pharma #FDA $MRK #diabetes #Digitalhealth #Trump #genetics $MNK $IPG #DTC http://bit.ly/2nSwg9b
2
3",,,2,3,['https://pbs.twimg.com/media/C80czwAXYAAhyyQ?format=jpg&name=small'],https://twitter.com/MMMnews/status/851396851685314564
1726,dough,@semodough,2017-04-10T14:01:03.000Z,"Replying to 
@semodough","Replying to 
@semodough
$MRK chart does not bode well for $GILD
1
1",,,1,1,['https://pbs.twimg.com/media/C9DnfM2V0AAoHcH?format=jpg&name=small'],https://twitter.com/semodough/status/851434858928910336
1727,Bilo Selhi,@StocksThatDoubl,2017-04-10T12:12:34.000Z,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,http://BiloSelhi.com members alerted to 10-1800% potential. JOIN TODAY  $MRK $WMB $BSX $SYF $GG $FITB $GLW,,,,,['https://pbs.twimg.com/media/CiX8f4PUkAQf2Dy?format=jpg&name=small'],https://twitter.com/StocksThatDoubl/status/851407555997904896
1728,Meg Tirrell,@megtirrell,2017-04-10T20:42:03.000Z,"$MRK nominates 
@MayoClinic
 CEO Dr. John H. Noseworthy to join board, to replace C. Robert Kidder on his planned retirement","$MRK nominates 
@MayoClinic
 CEO Dr. John H. Noseworthy to join board, to replace C. Robert Kidder on his planned retirement
3
4",,,3,4,[],https://twitter.com/megtirrell/status/851535770577973248
1729,JamesDruryPartners,@JDruryPartners,2017-04-11T16:39:05.000Z,"Merck & Co. Inc. adds John H. Noseworthy (CEO, Mayo Clinic) to Board $MRK #corpgov","Merck & Co. Inc. adds John H. Noseworthy (CEO, Mayo Clinic) to Board $MRK #corpgov
businesswire.com
Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors
Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors
1",,,1,,[],https://twitter.com/JDruryPartners/status/851837016824311808
1730,Quantcha Trade Ideas,@QuantchaIdeas,2017-04-12T15:23:27.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/04/12/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-3/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/04/12/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-3/‚Ä¶,,,,,['https://pbs.twimg.com/media/C9ONh84UAAANqfY?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/852180371617832961
1731,CBPartners,@CBPartners,2017-04-10T12:45:15.000Z,$MRK pledges to launch #RA #biosimilar BRENZYS in AUS - providing alternative to established originator ETANERCEPT http://bit.ly/2nh507Q,$MRK pledges to launch #RA #biosimilar BRENZYS in AUS - providing alternative to established originator ETANERCEPT http://bit.ly/2nh507Q,,,,,[],https://twitter.com/CBPartners/status/851415783024578560
1732,Gitte Pedersen,@DNABARCODE,2017-04-10T20:02:08.000Z,"First #FDA Approved Drug for Rare Skin #Cancer called Merkel cell carcinoma #PDL1 
@Merck
 @Pfizer
 $PFE $MRK #AACR2017","First #FDA Approved Drug for Rare Skin #Cancer called Merkel cell carcinoma #PDL1 
@Merck
 @Pfizer
 $PFE $MRK #AACR2017
cancer.gov
Avelumab First Approved Drug for Merkel Cell Carcinoma
A Cancer Currents blog on the FDA‚Äôs first-ever approval of a drug for the rare skin cancer Merkel cell carcinoma and updated data on patients‚Äô tumor responses.
5
4",,,5,4,['https://pbs.twimg.com/card_img/1501220676962717698/DXAiWqv3?format=jpg&name=240x240'],https://twitter.com/DNABARCODE/status/851525726687907842
1733,BioPharma Dive,@BioPharmaDive,2017-04-12T18:10:01.000Z,$AZN's primary strategy for catching up in the immuno-oncology space: combination therapies http://bit.ly/2o0lSeK $BMY $MRK,"$AZN's primary strategy for catching up in the immuno-oncology space: combination therapies http://bit.ly/2o0lSeK $BMY $MRK
biopharmadive.com
Cancer combos key to AstraZeneca success, but rivals have long lead
Slowed by patent expiries, the British pharma hopes its pairing of durvalumab and tremelimumab will enable it to catch immuno-oncology leaders like Merck and Bristol-Myers. 
2
2",,,2,2,[],https://twitter.com/BioPharmaDive/status/852222287403261966
1734,Robert,@bob56300,2017-04-10T20:55:49.000Z,Other Hepatitis Viruses Take The Spotlight Along With #Nash #genfit https://seekingalpha.com/article/4061546-hepatitis-viruses-take-spotlight-along-nash?source=tweet‚Ä¶ $GILD $EIGR $ALBO $BMY $ABBV $MRK $ACHN $ICPT,"Other Hepatitis Viruses Take The Spotlight Along With #Nash #genfit https://seekingalpha.com/article/4061546-hepatitis-viruses-take-spotlight-along-nash?source=tweet‚Ä¶ $GILD $EIGR $ALBO $BMY $ABBV $MRK $ACHN $ICPT
seekingalpha.com
Other Hepatitis Viruses Take The Spotlight Along With Nash
Hepatitis C may have had its moment in the sun, and now biopharma has turned to other liver diseases.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/bob56300/status/851539237329666048
1735,Dow Stocks,@Top_Dow_Stocks,2017-04-11T07:16:58.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/851695552584572930
1736,TickWatcher,@MITickWatcher,2017-04-11T20:05:04.000Z,"Top #moneyflow for #sp500 today
$AAPL $GE $PFE $CMCSA $T $ORCL $GILD $MJN $GOOG $MRK ...","Top #moneyflow for #sp500 today
$AAPL $GE $PFE $CMCSA $T $ORCL $GILD $MJN $GOOG $MRK ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/851888852444827648
1737,Magnolia Gallery,@MagnoliaG2012,2017-04-11T16:32:40.000Z,"Large Cap Biotech Review Coming Into Earnings Season, Part 1 https://seekingalpha.com/article/4061734-large-cap-biotech-review-coming-earnings-season-part-1?source=tweet‚Ä¶ $ABBV $ALXN $AMGN $BIIB $BIVV $BMY $MRK $NVS $OMER","Large Cap Biotech Review Coming Into Earnings Season, Part 1 https://seekingalpha.com/article/4061734-large-cap-biotech-review-coming-earnings-season-part-1?source=tweet‚Ä¶ $ABBV $ALXN $AMGN $BIIB $BIVV $BMY $MRK $NVS $OMER
seekingalpha.com
Large Cap Biotech Review Coming Into Earnings Season, Part 1 (NASDAQ:IBB)
Large-cap biotechs, or mid-cap for one stock in this group, generally are trading cheap to the market.",,,,,['https://pbs.twimg.com/card_img/1501733147247001603/8WSPdSW9?format=png&name=240x240'],https://twitter.com/MagnoliaG2012/status/851835398942851072
1738,Pharmaceutical News,@pharma_sector,2017-04-12T09:24:17.000Z,"EOD Risers: McDonald's Corporation, #Merck & Co., Inc., Nike Inc, Procter & Gamble Co. Read more: http://owler.us/acw4TS $MRK","EOD Risers: McDonald's Corporation, #Merck & Co., Inc., Nike Inc, Procter & Gamble Co. Read more: http://owler.us/acw4TS $MRK",,,,,[],https://twitter.com/pharma_sector/status/852089980868468736
1739,Tuan Pham,@15minofPham,2017-04-11T02:32:00.000Z,"Bottom of range: $BBRY $P 0, $MYL 1, $BBBY $ETP $EXEL $HBI $LBTYA 2, $BA $LBTYK $MON $MPC $MRK 3, $GILD $MA $SPLS 4, $OLN $STM $SWN $VLO 5","Bottom of range: $BBRY $P 0, $MYL 1, $BBBY $ETP $EXEL $HBI $LBTYA 2, $BA $LBTYK $MON $MPC $MRK 3, $GILD $MA $SPLS 4, $OLN $STM $SWN $VLO 5",,,,,[],https://twitter.com/15minofPham/status/851623839293480960
1740,TW Research Group,@DanCarlson33,2017-04-12T13:49:36.000Z,$BTI.V closes their financing. Good catalysts await in 2017. #BBB $AZN $MRK $BIIB $SHPG,"$BTI.V closes their financing. Good catalysts await in 2017. #BBB $AZN $MRK $BIIB $SHPG
twresearchgroup.com
biOasis Closes Upsized Private Placement
Last night, biOasis Technologies announced that they have closed their non-brokered placement. The Company  issued 5,797,795 units (each a ""Unit"") at a price of CDN$0.70 per unit, for gross proceeds...
1",,,,1,[],https://twitter.com/DanCarlson33/status/852156750002311168
1741,TW Research Group,@DanCarlson33,2017-04-10T14:46:40.000Z,A pathway to the cure for brain cancer? Now funded for trials. #CancerResearch $NVS $MRK $BMY $AZN,"A pathway to the cure for brain cancer? Now funded for trials. #CancerResearch $NVS $MRK $BMY $AZN
twresearchgroup.com
biOasis Announces Oversubscription of Financing
Tailwinds' Take: This is THE catalyst we have been expecting from biOasis. While it took a long time to get this deal done, I fully believe that the Company is now well positioned to bring its unique...",,,,,[],https://twitter.com/DanCarlson33/status/851446337790894080
1742,Amanda L. Bury,@ciaogalchicago,2017-04-12T13:42:55.000Z,$AMZN and $MRK crowdsourcing contest for Alexa underscores interest in voice tech http://medcitynews.com/2017/04/amazon-and-merck-crowdsource-alexa-applications/‚Ä¶ #digitalhealth,"$AMZN and $MRK crowdsourcing contest for Alexa underscores interest in voice tech http://medcitynews.com/2017/04/amazon-and-merck-crowdsource-alexa-applications/‚Ä¶ #digitalhealth
medcitynews.com
Amazon and Merck‚Äôs crowdsourcing contest for Alexa underscores interest in voice tech
The goal of the Alexa Diabetes Challenge is to find new ways to harness Alexa‚Äôs voice technology to make self-management of diabates easier, particularly for those newly diagnosed with the chronic...",,,,,[],https://twitter.com/ciaogalchicago/status/852155070116487168
1743,FiercePharma,@FiercePharma,2017-04-12T08:10:01.000Z,"Merck‚Äôs Frazier gets his first raise, but total package shrinks as sales stall http://fiercepharma.com/financials/merck-s-frazier-gets-his-first-raise-but-total-compensation-drops-as-sales-stall‚Ä¶ $MRK","Merck‚Äôs Frazier gets his first raise, but total package shrinks as sales stall http://fiercepharma.com/financials/merck-s-frazier-gets-his-first-raise-but-total-compensation-drops-as-sales-stall‚Ä¶ $MRK
3
2",,,3,2,[],https://twitter.com/FiercePharma/status/852071291666526208
1744,TalkMarkets,@TalkMarkets,2017-04-12T08:51:15.000Z,#Tocagen #IPO Could Garner Significant Investor Attention $TOCA Also $AZN $BMY $GSK $MRK $PFE $CELG $KITE $ARGS https://goo.gl/OcQ8EN,#Tocagen #IPO Could Garner Significant Investor Attention $TOCA Also $AZN $BMY $GSK $MRK $PFE $CELG $KITE $ARGS https://goo.gl/OcQ8EN,,,,,[],https://twitter.com/TalkMarkets/status/852081670010351616
1745,Vetr,@VetrRatings,2017-04-11T14:30:52.000Z,"The majority of users on Vetr are bullish on Merck & Company, Inc., indicating a HOLD Rating (3 stars) for $MRK http://bit.ly/1GhW0TK","The majority of users on Vetr are bullish on Merck & Company, Inc., indicating a HOLD Rating (3 stars) for $MRK http://bit.ly/1GhW0TK",,,,,[],https://twitter.com/VetrRatings/status/851804748940541952
1746,Don Dion,@DRDInvestments,2017-04-12T08:51:15.000Z,#Tocagen #IPO Could Garner Significant Investor Attention $TOCA Also $AZN $BMY $GSK $MRK $PFE $CELG $KITE $ARGS https://goo.gl/OcQ8EN,"#Tocagen #IPO Could Garner Significant Investor Attention $TOCA Also $AZN $BMY $GSK $MRK $PFE $CELG $KITE $ARGS https://goo.gl/OcQ8EN
1",,,,1,[],https://twitter.com/DRDInvestments/status/852081670748614656
1747,Fearlessgirl,@Trader_gurl,2017-04-10T18:06:09.000Z,"Cardiovascular Players Could Be Eyeing Esperion https://benzinga.com/z/9282574 $AZN $ESPR $MRK  
@benzinga","Cardiovascular Players Could Be Eyeing Esperion https://benzinga.com/z/9282574 $AZN $ESPR $MRK  
@benzinga
1
1",,,1,1,[],https://twitter.com/Trader_gurl/status/851496539658891264
1748,Pharmaceutical News,@pharma_sector,2017-04-11T18:28:32.000Z,"#Merck's Frazier gets his first raise, but total package shrinks as sales stall. Read more: http://owler.us/acwVB6 $MRK","#Merck's Frazier gets his first raise, but total package shrinks as sales stall. Read more: http://owler.us/acwVB6 $MRK",,,,,[],https://twitter.com/pharma_sector/status/851864559065243648
1749,FirstToMarkets,@firsttomarkets,2017-04-12T20:15:59.000Z,Merck & Co. Reiterated Rating by Cowen & Co (Ranked 57th) to Market Perform $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,Merck & Co. Reiterated Rating by Cowen & Co (Ranked 57th) to Market Perform $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,,,,,[],https://twitter.com/firsttomarkets/status/852253986874826752
1750,SpeculatingStocks: Public Companies Raise Funds!,@specstockscom,2017-04-10T15:45:38.000Z,Customized research for $MRK vs. $ABT! http://speculatingstocks.com/stockcomparison/versus.php?stock1=1287&stock2=77‚Ä¶,Customized research for $MRK vs. $ABT! http://speculatingstocks.com/stockcomparison/versus.php?stock1=1287&stock2=77‚Ä¶,,,,,[],https://twitter.com/specstockscom/status/851461177989136384
1751,Daily Political,@dailypoliticaln,2017-04-11T10:03:28.000Z,"Focused Wealth Management Inc Has $564,000 Position in Merck & Co., Inc. $MRK http://ift.tt/2p2xvDK","Focused Wealth Management Inc Has $564,000 Position in Merck & Co., Inc. $MRK http://ift.tt/2p2xvDK",,,,,[],https://twitter.com/dailypoliticaln/status/851737454231080960
1752,Limex,@LimexMe,2017-04-12T02:23:53.000Z,"Lots of rumors around $MNKD takeover, do you it will happen soon? http://bit.ly/100417MNKD $SNY $MRK $GSK","Lots of rumors around $MNKD takeover, do you it will happen soon? http://bit.ly/100417MNKD $SNY $MRK $GSK
whotrades.com
Is MannKind Corporation Getting Ready to Sell?
In just over four months in 2017, MannKind Corporation (NASDAQ: MNKD) stock has lost more than half of its value. It seems that nothing can go right for the long-suffering biotech.‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/851984186642763776
1753,Limex,@LimexMe,2017-04-11T14:17:50.000Z,Commented on StockTwits: do you think $SNY is going to buy $MNKD? or maybe $NVS $PFE $MRK? http://bit.ly/100417MNKD,"Commented on StockTwits: do you think $SNY is going to buy $MNKD? or maybe $NVS $PFE $MRK? http://bit.ly/100417MNKD
stocktwits.com
WhoTrades (@WhoTrades) | Stocktwits
Is MNKD a new buyout target for SNY? Or other pharma? http://bit.ly/100417MNKD $MNKD",,,,,[],https://twitter.com/LimexMe/status/851801468717977601
1754,Nicholas Kitonyi,@nmaithyak,2017-04-12T07:53:17.000Z,9 Blockbuster Drugs Making Debut 2017 $AZN  $LLY  $MRK  $NVO  $NVS  $PFE  $SNY  $RHHBY  $INCY  $REGN  $KITE  $TSRO https://goo.gl/A8oxeC,9 Blockbuster Drugs Making Debut 2017 $AZN  $LLY  $MRK  $NVO  $NVS  $PFE  $SNY  $RHHBY  $INCY  $REGN  $KITE  $TSRO https://goo.gl/A8oxeC,,,,,[],https://twitter.com/nmaithyak/status/852067081449336832
1755,Ticker Report,@TickerReport,2017-04-11T10:09:30.000Z,"Foresters Asset Management Inc. Takes Position in Merck & Co., Inc. $MRK http://ift.tt/2nA2j1g","Foresters Asset Management Inc. Takes Position in Merck & Co., Inc. $MRK http://ift.tt/2nA2j1g",,,,,[],https://twitter.com/TickerReport/status/851738971818381312
1756,Watchlist News,@WatchlistN,2017-04-10T10:08:53.000Z,"Glg LLC Has $10.948 Million Position in Merck & Co., Inc. $MRK http://zpr.io/P8XYw","Glg LLC Has $10.948 Million Position in Merck & Co., Inc. $MRK http://zpr.io/P8XYw",,,,,[],https://twitter.com/WatchlistN/status/851376431154307074
1757,AlpacaAlerts,@AlpacaAlerts,2017-04-12T23:19:00.000Z,$MRK is in Stochastic Oversold  winning 60.56% in the past. https://scan.alpaca.ai/card/2489110?utm_campaign=card_2489110&utm_content=card&utm_medium=tweet&utm_source=twitter‚Ä¶,$MRK is in Stochastic Oversold  winning 60.56% in the past. https://scan.alpaca.ai/card/2489110?utm_campaign=card_2489110&utm_content=card&utm_medium=tweet&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/AlpacaAlerts/status/852300044204199937
1758,Vetr,@VetrRatings,2017-04-12T14:31:01.000Z,"Vetr users have downgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $60.67 http://bit.ly/1GhW0TK","Vetr users have downgraded Merck & Company, Inc. to a SELL Rating (2.5 stars), giving $MRK a target price of $60.67 http://bit.ly/1GhW0TK",,,,,[],https://twitter.com/VetrRatings/status/852167172608708609
1759,Watchlist News,@WatchlistN,2017-04-10T19:41:23.000Z,"Orbimed Advisors LLC Raises Stake in Merck & Co., Inc. $MRK http://zpr.io/P8mqC","Orbimed Advisors LLC Raises Stake in Merck & Co., Inc. $MRK http://zpr.io/P8mqC",,,,,[],https://twitter.com/WatchlistN/status/851520504733290496
1760,Watchlist News,@WatchlistN,2017-04-11T06:38:04.000Z,"Merck & Co., Inc. $MRK Rating Reiterated by Leerink Swann http://zpr.io/PbHcH","Merck & Co., Inc. $MRK Rating Reiterated by Leerink Swann http://zpr.io/PbHcH",,,,,[],https://twitter.com/WatchlistN/status/851685764358447105
1761,Ticker Report,@TickerReport,2017-04-11T10:09:29.000Z,"Merck & Co., Inc. $MRK Shares Sold by Hilltop Holdings Inc. http://ift.tt/2poBxFx","Merck & Co., Inc. $MRK Shares Sold by Hilltop Holdings Inc. http://ift.tt/2poBxFx",,,,,[],https://twitter.com/TickerReport/status/851738967607214081
1762,StockNews.com,@stocknewsdotcom,2017-04-11T17:35:11.000Z,"$MRK Cowen & Company reiterates Market Perform rating, $68 PT https://stocknews.com/news/mrk-cowen-company-reiterates-market-perform-rating-68-pt/‚Ä¶","$MRK Cowen & Company reiterates Market Perform rating, $68 PT https://stocknews.com/news/mrk-cowen-company-reiterates-market-perform-rating-68-pt/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/851851134620889088
1763,Kara Jill Stancell,@kjilly,2017-04-11T14:18:30.000Z,"$MRK CEO doubles his pay #compensation via 
@axios","$MRK CEO doubles his pay #compensation via 
@axios
axios.com
Merck's CEO doubles his pay
Merck CEO Kenneth Frazier has met with Trump, who has criticized drug industry pricing.",,,,,[],https://twitter.com/kjilly/status/851801636561276928
1764,MarketBeat,@MarketBeatCom,2017-04-12T03:53:27.000Z,"Merck & Co. $MRK Receiving Somewhat Favorable News Coverage, Study Finds http://ift.tt/2o3fUtw #acn","Merck & Co. $MRK Receiving Somewhat Favorable News Coverage, Study Finds http://ift.tt/2o3fUtw #acn",,,,,[],https://twitter.com/MarketBeatCom/status/852006724588490752
1765,Kara Jill Stancell,@kjilly,2017-04-11T18:40:49.000Z,"Merck‚Äôs Frazier gets his first raise, but total package shrinks as sales stall #compensation  $MRK","Merck‚Äôs Frazier gets his first raise, but total package shrinks as sales stall #compensation  $MRK
fiercepharma.com
Merck‚Äôs Frazier gets his first raise, but total package shrinks as sales stall
Merck & Co. CEO Ken Frazier has been on the job since 2011, so it‚Äôs no surprise the company decided it‚Äôs about time he got a raise. | Merck & Co. CEO Ken Frazier has been on the job since 2011, so...",,,,,['https://pbs.twimg.com/card_img/1499619890499629057/BxGqdJpB?format=jpg&name=small'],https://twitter.com/kjilly/status/851867651810795520
1766,US Banking News,@AmericanBanking,2017-04-11T16:57:08.000Z,Merck & Co.'s market perform rating reiterated at Cowen and Company. $68.00 PT. http://ift.tt/2o3LfwY $MRK #MRK,Merck & Co.'s market perform rating reiterated at Cowen and Company. $68.00 PT. http://ift.tt/2o3LfwY $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/851841555912695808
1767,Nicholas Kitonyi,@nmaithyak,2017-04-12T08:52:56.000Z,Tocagen IPO Could Garner Investor Attention  $TOCA $AZN  $BMY  $GSK  $MRK  $PFE  $CELG  $KITE  $ARGS  $ADAP https://goo.gl/Y3nVXf,"Tocagen IPO Could Garner Investor Attention  $TOCA $AZN  $BMY  $GSK  $MRK  $PFE  $CELG  $KITE  $ARGS  $ADAP https://goo.gl/Y3nVXf
1",,,,1,[],https://twitter.com/nmaithyak/status/852082092452315138
1768,SwingTradeBot,@SwingTradeBot,2017-04-10T21:28:57.000Z,Scan results - Expansion Breakdown today: $UNFI $NFG $MYCC $TLRD $MRK ... https://swingtradebot.com/events/46/equities?selected_date=2017-04-10‚Ä¶,Scan results - Expansion Breakdown today: $UNFI $NFG $MYCC $TLRD $MRK ... https://swingtradebot.com/events/46/equities?selected_date=2017-04-10‚Ä¶,,,,,[],https://twitter.com/SwingTradeBot/status/851547573324304385
1769,$peedyCalls,@SpeedyCalls,2017-04-12T15:58:45.000Z,"$MRK 62.5 Puts SELLING Activity expiring on 19th May, Vol 2000","$MRK 62.5 Puts SELLING Activity expiring on 19th May, Vol 2000",,,,,[],https://twitter.com/SpeedyCalls/status/852189253903810560
1770,MarketBeat,@MarketBeatCom,2017-04-12T20:59:04.000Z,"Merck & Co., Inc. Forecasted to Post FY2021 Earnings of $4.85 Per Share $MRK http://zpr.io/P8rCM","Merck & Co., Inc. Forecasted to Post FY2021 Earnings of $4.85 Per Share $MRK http://zpr.io/P8rCM",,,,,[],https://twitter.com/MarketBeatCom/status/852264830195167232
1771,SwingTradeBot,@SwingTradeBot,2017-04-12T21:26:45.000Z,Scan results - Stochastic Buy Signal today: $UIS $LFC $NCLH $SEAS $WST $MRK $TBI $ABY $JNJ $SRPT ... https://swingtradebot.com/events/24/equities?selected_date=2017-04-12‚Ä¶,Scan results - Stochastic Buy Signal today: $UIS $LFC $NCLH $SEAS $WST $MRK $TBI $ABY $JNJ $SRPT ... https://swingtradebot.com/events/24/equities?selected_date=2017-04-12‚Ä¶,,,,,[],https://twitter.com/SwingTradeBot/status/852271797693288448
1772,Market Realist,@MarketRealist,2017-04-11T15:59:43.000Z,"Does US Healthcare Need Surgery, or Just Therapy? http://marketrealist.com/?p=2024537 $IHE $XPH $PFE $MRK","Does US Healthcare Need Surgery, or Just Therapy? http://marketrealist.com/?p=2024537 $IHE $XPH $PFE $MRK",,,,,[],https://twitter.com/MarketRealist/status/851827107479072769
1773,US Banking News,@AmericanBanking,2017-04-11T14:39:51.000Z,"FY2017 EPS Estimates for Merck & Co., Inc. $MRK Boosted by Jefferies Group http://ift.tt/2ppzSj4","FY2017 EPS Estimates for Merck & Co., Inc. $MRK Boosted by Jefferies Group http://ift.tt/2ppzSj4",,,,,[],https://twitter.com/AmericanBanking/status/851807010005954560
1774,Jacob Bell,@realJacobBell,2017-04-11T17:26:00.000Z,$AZN is doubling down on cancer combo treatments to catch rivals http://bit.ly/2o0lSeK $BMY $MRK,"$AZN is doubling down on cancer combo treatments to catch rivals http://bit.ly/2o0lSeK $BMY $MRK
biopharmadive.com
Cancer combos key to AstraZeneca success, but rivals have long lead
Slowed by patent expiries, the British pharma hopes its pairing of durvalumab and tremelimumab will enable it to catch immuno-oncology leaders like Merck and Bristol-Myers. ",,,,,[],https://twitter.com/realJacobBell/status/851848822456111104
1775,US Banking News,@AmericanBanking,2017-04-12T03:49:47.000Z,"Merck & Co. $MRK Receiving Somewhat Favorable News Coverage, Study Finds http://ift.tt/2o4J4JB","Merck & Co. $MRK Receiving Somewhat Favorable News Coverage, Study Finds http://ift.tt/2o4J4JB",,,,,[],https://twitter.com/AmericanBanking/status/852005801820434432
1776,Stock Market Picks,@StockWebTrading,2017-04-12T04:13:41.000Z,"$KO $MCD $MMM $MRK $MSFT $NKE $PFE Long and short positions from the Dow Jones, up to 1800% since 2008. http://dowstocktips.com $DJIA $DIA","$KO $MCD $MMM $MRK $MSFT $NKE $PFE Long and short positions from the Dow Jones, up to 1800% since 2008. http://dowstocktips.com $DJIA $DIA",,,,,[],https://twitter.com/StockWebTrading/status/852011818260156416
1777,Benzinga,@Benzinga,2017-04-10T22:30:01.000Z,Cardiovascular Players Could Be Eyeing Esperion https://benzinga.com/z/9282574 $AZN $ESPR $MRK,"Cardiovascular Players Could Be Eyeing Esperion https://benzinga.com/z/9282574 $AZN $ESPR $MRK
1",,,,1,[],https://twitter.com/Benzinga/status/851562943569215488
1778,TalkMarkets,@TalkMarkets,2017-04-12T03:56:41.000Z,9 Blockbuster Drugs Making Their Debut In 2017; Total Revenue Expected To Be $16B By 2021 $AZN $LLY $MRK $NVO ... https://goo.gl/MJQgI0,9 Blockbuster Drugs Making Their Debut In 2017; Total Revenue Expected To Be $16B By 2021 $AZN $LLY $MRK $NVO ... https://goo.gl/MJQgI0,,,,,[],https://twitter.com/TalkMarkets/status/852007539331915776
1779,Allison Gatlin,@IBD_AGatlin,2017-04-10T18:25:51.000Z,Could Dow stock Merck undercut AstraZeneca in lung cancer? $MRK $AZN $BMY $INCY $RHHBY http://ow.ly/24yD30aJPzu,Could Dow stock Merck undercut AstraZeneca in lung cancer? $MRK $AZN $BMY $INCY $RHHBY http://ow.ly/24yD30aJPzu,,,,,[],https://twitter.com/IBD_AGatlin/status/851501496143314945
1780,TW Research Group,@DanCarlson33,2017-04-10T19:33:32.000Z,"In case you've forgotten why $BTI.V is a top pick for @TailwindsRsrch, here's the video explaining all $MRK #roche   http://tailwindsresearch.com/2016/11/bti2/","In case you've forgotten why $BTI.V is a top pick for @TailwindsRsrch, here's the video explaining all $MRK #roche   http://tailwindsresearch.com/2016/11/bti2/",,,,,[],https://twitter.com/DanCarlson33/status/851518530352693249
1781,Benzinga,@Benzinga,2017-04-12T16:15:01.000Z,Healthcare Sector Earnings: Making A Comeback In Q1 2017? https://benzinga.com/z/9293543 $JNJ $LLY $MRK $PFE $XLV,Healthcare Sector Earnings: Making A Comeback In Q1 2017? https://benzinga.com/z/9293543 $JNJ $LLY $MRK $PFE $XLV,,,,,[],https://twitter.com/Benzinga/status/852193346894286848
1782,BenzingaWire,@BenzingaMedia,2017-04-12T15:54:03.000Z,"$JNJ, $LLY, $MRK Healthcare Sector Earnings: Making A Comeback In Q1 2017? -","$JNJ, $LLY, $MRK Healthcare Sector Earnings: Making A Comeback In Q1 2017? -
benzinga.com
Healthcare Sector Earnings: Making A Comeback In Q1 2017?
In 2016, healthcare was the only sector in the S&P 500 (SPX) that ended the year in the red, declining 2.7% versus a positive 12% return for the SPX. However, things appear to...",,,,,['https://pbs.twimg.com/card_img/1499875349303205890/mxn4g2w2?format=png&name=240x240'],https://twitter.com/BenzingaMedia/status/852188069944057860
1783,MarketBeat,@MarketBeatCom,2017-04-11T20:28:48.000Z,"FY2017 EPS Estimates for Merck & Co., Inc. $MRK Boosted by Jefferies Group http://zpr.io/P89wn","FY2017 EPS Estimates for Merck & Co., Inc. $MRK Boosted by Jefferies Group http://zpr.io/P89wn",,,,,[],https://twitter.com/MarketBeatCom/status/851894826694004737
1784,Benzinga,@Benzinga,2017-04-10T16:07:01.000Z,Cardiovascular Players Could Be Eyeing Esperion https://benzinga.com/z/9282574 $ESPR $AZN $MRK $SNY $PFE,"Cardiovascular Players Could Be Eyeing Esperion https://benzinga.com/z/9282574 $ESPR $AZN $MRK $SNY $PFE
1
1",,,1,1,[],https://twitter.com/Benzinga/status/851466556542504960
1785,dough,@semodough,2017-04-14T02:12:44.000Z,JEFF Summary of ‚ÄúMaster 2017 Catalysts‚Äù Blue > Grey > White in terms of relative significance. $ABBV $BMY $MRK $AZN $PFE $IBB $FGEN,"JEFF Summary of ‚ÄúMaster 2017 Catalysts‚Äù Blue > Grey > White in terms of relative significance. $ABBV $BMY $MRK $AZN $PFE $IBB $FGEN
3
17",,,3,17,['https://pbs.twimg.com/media/C9VruMlXkAAEqsz?format=jpg&name=small'],https://twitter.com/semodough/status/852706155428184064
1786,dough,@semodough,2017-04-15T13:50:32.000Z,Key Presentations and Posters at EASL $MRK $GILD $BMY $ABBV,"Key Presentations and Posters at EASL $MRK $GILD $BMY $ABBV
4
3",,,4,3,['https://pbs.twimg.com/media/C9dVByKXgAA9azC?format=jpg&name=small'],https://twitter.com/semodough/status/853244150950617089
1787,Seeking Alpha,@SeekingAlpha,2017-04-13T19:22:34.000Z,Bristol-Myers Squibb: Looking Attractive https://seekingalpha.com/article/4062341-bristol-myers-squibb-looking-attractive?source=feed_f‚Ä¶ $MRK $BMY,"Bristol-Myers Squibb: Looking Attractive https://seekingalpha.com/article/4062341-bristol-myers-squibb-looking-attractive?source=feed_f‚Ä¶ $MRK $BMY
seekingalpha.com
Bristol-Myers Squibb: Looking Attractive (NYSE:BMY)
BMY is well off its recent highs. Rumors of big pharma eyeing the company as a takeover opportunity have brought in new institutional investors.",,,,,['https://pbs.twimg.com/card_img/1489660067628519424/VfYFJfDz?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/852602932507721728
1788,carolinarizo,@carolinarizo,2017-04-14T02:22:12.000Z,3 Things In Biotech You Should Learn Today: Volume 2 https://seekingalpha.com/article/4061205-3-things-biotech-learn-today-volume-2?source=tweet‚Ä¶ $NLNK $BMY $MRK,"3 Things In Biotech You Should Learn Today: Volume 2 https://seekingalpha.com/article/4061205-3-things-biotech-learn-today-volume-2?source=tweet‚Ä¶ $NLNK $BMY $MRK
seekingalpha.com
3 Things In Biotech You Should Learn Today: Volume 2
NewLink's slam dunk in melanoma combo. Bristol-Myers jumps on the IDO craze, too! Merck confirms activity of Keytruda in Head and Neck cancer.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/carolinarizo/status/852708539189477376
1789,Seeking Alpha,@SeekingAlpha,2017-04-15T14:59:00.000Z,Industry Allocations & Compounding Returns https://seekingalpha.com/article/4062539-industry-allocations-and-compounding-returns?source=feed_f‚Ä¶ $BMY $JNJ $KO $MCD $MO $MRK $PEP $PFE $SPHD $SPY $XLB $XLE $XLF $XLK,Industry Allocations & Compounding Returns https://seekingalpha.com/article/4062539-industry-allocations-and-compounding-returns?source=feed_f‚Ä¶ $BMY $JNJ $KO $MCD $MO $MRK $PEP $PFE $SPHD $SPY $XLB $XLE $XLF $XLK,,,,,[],https://twitter.com/SeekingAlpha/status/853261379943321601
1790,Open Outcrier,@OpenOutcrier,2017-04-13T20:06:56.000Z,"RECAP 4/13 Unusual Calls:
$YELP $HUM $VIX $VXX $DAL $CMCSA $WFC $DE $MRK $DHT $NKTR $K $WFT","RECAP 4/13 Unusual Calls:
$YELP $HUM $VIX $VXX $DAL $CMCSA $WFC $DE $MRK $DHT $NKTR $K $WFT
1
4",,,1,4,[],https://twitter.com/OpenOutcrier/status/852614099192217600
1791,Greg Wierenga,@Gdubya1,2017-04-13T21:08:01.000Z,$MRK due to trend higher. Let's say May is their month. Just look at that 200ma.,$MRK due to trend higher. Let's say May is their month. Just look at that 200ma.,,,,,['https://pbs.twimg.com/media/C9Ul5IwUAAAIyJ9?format=jpg&name=small'],https://twitter.com/Gdubya1/status/852629472406679552
1792,Gitte Pedersen,@DNABARCODE,2017-04-13T21:30:49.000Z,"First #FDA Approved Drug for Rare Skin #Cancer called Merkel cell carcinoma #PDL1 
@Merck
 @Pfizer
 $PFE $MRK #AACR2017","First #FDA Approved Drug for Rare Skin #Cancer called Merkel cell carcinoma #PDL1 
@Merck
 @Pfizer
 $PFE $MRK #AACR2017
cancer.gov
Avelumab First Approved Drug for Merkel Cell Carcinoma
A Cancer Currents blog on the FDA‚Äôs first-ever approval of a drug for the rare skin cancer Merkel cell carcinoma and updated data on patients‚Äô tumor responses.
7
13",,,7,13,['https://pbs.twimg.com/card_img/1501220676962717698/DXAiWqv3?format=jpg&name=240x240'],https://twitter.com/DNABARCODE/status/852635209405276161
1793,Scanz Alerts,@ScanzAlerts,2017-04-13T14:06:17.000Z,"BLOCK TRADE: $MRK 500,000 shares @ $62.93 [10:06:16]","BLOCK TRADE: $MRK 500,000 shares @ $62.93 [10:06:16]",,,,,[],https://twitter.com/ScanzAlerts/status/852523336638877696
1794,BioSpace,@biospace,2017-04-14T20:25:06.000Z,Pharma Giant Merck Sharp & Dohme $MRK Could Bring 600 New Jobs to Austin http://ow.ly/OLxX30aRMea,Pharma Giant Merck Sharp & Dohme $MRK Could Bring 600 New Jobs to Austin http://ow.ly/OLxX30aRMea,,,,,['https://pbs.twimg.com/media/C9Zlv72XYAIJBW0?format=jpg&name=small'],https://twitter.com/biospace/status/852981057125273602
1795,Todd Campbell,@ebcapital,2017-04-13T17:44:52.000Z,"The IDO-Inhibitor Race Is On to Improve #Cancer Treatment #health 
@themotleyfool
 #stocks $MRK, $RHHBY, $INCY, $NLNK","The IDO-Inhibitor Race Is On to Improve #Cancer Treatment #health 
@themotleyfool
 #stocks $MRK, $RHHBY, $INCY, $NLNK
fool.com
The IDO-Inhibitor Race Is On to Improve Cancer Treatment @themotleyfool #stocks $NLNK $MRK $RHHBY...
NewLink Genetics and Incyte Corporation's IDO-inhibitors could be the next big advance in cancer treatment.
1
1",,,1,1,[],https://twitter.com/ebcapital/status/852578348161277952
1796,FinInvTr,@FinInvTr,2017-04-14T15:29:42.000Z,Large Caps Outdoing the S&P | $AAPL $MSFT $AMZN $BRK.A $BRK.B $FB $JPM $BABA $BAC $V $MA $MRK $C $UNH $PEP $SQ |,"Large Caps Outdoing the S&P | $AAPL $MSFT $AMZN $BRK.A $BRK.B $FB $JPM $BABA $BAC $V $MA $MRK $C $UNH $PEP $SQ |
whotrades.com
Can‚Äôt Make ‚ÄúAlpha‚Äù In Mega-Caps?
It‚Äôs a common statement that you can‚Äôt make ‚Äúalpha‚Äù in large caps given they‚Äôre researched to death and therefore hard to find inefficiencies in the pricing. However, the assertion‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1501723915294543873/zj2WEa1Z?format=jpg&name=small'],https://twitter.com/FinInvTr/status/852906719969763328
1797,Steve,@nightowl000,2017-04-13T22:39:07.000Z,"Replying to 
@pawcio2009
 and 
@dhovekamp42","Replying to 
@pawcio2009
 and 
@dhovekamp42
$ZIOP has in 30s but outsourced to $XON $MRK KGaA
1
4",,,1,4,[],https://twitter.com/nightowl000/status/852652395637215235
1798,Daily Political,@dailypoliticaln,2017-04-14T18:33:29.000Z,"Merck & Co., Inc. Forecasted to Post FY2021 Earnings of $4.85 Per Share $MRK http://dailypolitical.com/?p=1018126","Merck & Co., Inc. Forecasted to Post FY2021 Earnings of $4.85 Per Share $MRK http://dailypolitical.com/?p=1018126",,,,,[],https://twitter.com/dailypoliticaln/status/852952968630603779
1799,Watchlist News,@WatchlistN,2017-04-14T10:21:50.000Z,"Cigna Investments Inc. New Takes Position in Merck & Co., Inc. $MRK http://zpr.io/P8vNv","Cigna Investments Inc. New Takes Position in Merck & Co., Inc. $MRK http://zpr.io/P8vNv",,,,,[],https://twitter.com/WatchlistN/status/852829240990900225
1800,Ticker Report,@TickerReport,2017-04-13T11:59:12.000Z,"Merck & Co., Inc. $MRK Rating Lowered to Reduce at HSBC Holdings plc http://ift.tt/2pc7wd2","Merck & Co., Inc. $MRK Rating Lowered to Reduce at HSBC Holdings plc http://ift.tt/2pc7wd2",,,,,[],https://twitter.com/TickerReport/status/852491356392087552
1801,Watchlist News,@WatchlistN,2017-04-13T10:09:43.000Z,"Denver Investment Advisors LLC Has $2.195 Million Position in Merck & Co., Inc. $MRK http://zpr.io/P8LVi","Denver Investment Advisors LLC Has $2.195 Million Position in Merck & Co., Inc. $MRK http://zpr.io/P8LVi",,,,,[],https://twitter.com/WatchlistN/status/852463801874173953
1802,US Banking News,@AmericanBanking,2017-04-15T05:28:38.000Z,Merck & Co. $MRK Receives News Impact Score of 0.26 http://ift.tt/2p4yN4o,Merck & Co. $MRK Receives News Impact Score of 0.26 http://ift.tt/2p4yN4o,,,,,[],https://twitter.com/AmericanBanking/status/853117842090323968
1803,David Dierking,@David_Dierking,2017-04-13T14:25:11.000Z,Healthcare Sector Earnings: Making A Comeback In Q1 2017? https://aff.whotrades.com/t/b/ye36z/ $JNJ $LLY $PFE $MRK $XLV,"Healthcare Sector Earnings: Making A Comeback In Q1 2017? https://aff.whotrades.com/t/b/ye36z/ $JNJ $LLY $PFE $MRK $XLV
1
1",,,1,1,[],https://twitter.com/David_Dierking/status/852528094468591616
1804,MarketBeat,@MarketBeatCom,2017-04-14T03:57:52.000Z,"Merck & Co., Inc. $MRK Stake Held by Glovista Investments LLC http://zpr.io/PbbMc","Merck & Co., Inc. $MRK Stake Held by Glovista Investments LLC http://zpr.io/PbbMc",,,,,[],https://twitter.com/MarketBeatCom/status/852732612439232512
1805,US Banking News,@AmericanBanking,2017-04-14T12:43:28.000Z,"Brokers Issue Forecasts for Merck & Co., Inc.‚Äôs Q1 2017 Earnings $MRK http://ift.tt/2oyboqA","Brokers Issue Forecasts for Merck & Co., Inc.‚Äôs Q1 2017 Earnings $MRK http://ift.tt/2oyboqA",,,,,[],https://twitter.com/AmericanBanking/status/852864883251085313
1806,MarketBeat,@MarketBeatCom,2017-04-13T13:23:12.000Z,"837,486 Shares in Merck & Co., Inc. $MRK Acquired by Congress Asset Management Co. MA http://zpr.io/P8isq","837,486 Shares in Merck & Co., Inc. $MRK Acquired by Congress Asset Management Co. MA http://zpr.io/P8isq",,,,,[],https://twitter.com/MarketBeatCom/status/852512496913190912
1807,BioPharma Dive,@BioPharmaDive,2017-04-14T13:08:01.000Z,"Cancer combos key to $AZN success, but rivals have long lead http://bit.ly/2o0lSeK $BMY $MRK","Cancer combos key to $AZN success, but rivals have long lead http://bit.ly/2o0lSeK $BMY $MRK
biopharmadive.com
Cancer combos key to AstraZeneca success, but rivals have long lead
Slowed by patent expiries, the British pharma hopes its pairing of durvalumab and tremelimumab will enable it to catch immuno-oncology leaders like Merck and Bristol-Myers. 
1
1",,,1,1,[],https://twitter.com/BioPharmaDive/status/852871061716774912
1808,Bosco,@wboscoho,2017-04-13T10:11:38.000Z,"Replying to 
@wboscoho","Replying to 
@wboscoho
$CTRV ‚Äôs TXL may b a huge deal but CRV431 & FV100 are also interesting. If $GILD sits on its hand, $MRK might want to take a look at FV100",,,,,[],https://twitter.com/wboscoho/status/852464287775850496
1809,finsents,@finsents,2017-04-14T11:15:45.000Z,"$MRK:US Cigna Investments Inc. New Takes Position in Merck & Co., Inc. (MRK) #MERCK & CO  http://tinyurl.com/kv27pm4 #SP500","$MRK:US Cigna Investments Inc. New Takes Position in Merck & Co., Inc. (MRK) #MERCK & CO  http://tinyurl.com/kv27pm4 #SP500",,,,,[],https://twitter.com/finsents/status/852842809757491200
1810,MarketBeat,@MarketBeatCom,2017-04-15T07:57:43.000Z,Merck & Co. $MRK Receives News Impact Score of 0.26 http://ift.tt/2oJthmC #acn,Merck & Co. $MRK Receives News Impact Score of 0.26 http://ift.tt/2oJthmC #acn,,,,,[],https://twitter.com/MarketBeatCom/status/853155359816601601
1811,Daily Political,@dailypoliticaln,2017-04-14T10:23:02.000Z,"5,389 Shares in Merck & Co., Inc. $MRK Acquired by Fortis Advisors LLC http://dailypolitical.com/?p=1017058","5,389 Shares in Merck & Co., Inc. $MRK Acquired by Fortis Advisors LLC http://dailypolitical.com/?p=1017058",,,,,[],https://twitter.com/dailypoliticaln/status/852829544025178112
1812,Watchlist News,@WatchlistN,2017-04-14T10:21:52.000Z,"L & S Advisors Inc Takes Position in Merck & Co., Inc. $MRK http://zpr.io/P8vNW","L & S Advisors Inc Takes Position in Merck & Co., Inc. $MRK http://zpr.io/P8vNW",,,,,[],https://twitter.com/WatchlistN/status/852829250327527429
1813,Helen Ong,@Lin_ling_88,2017-04-17T21:09:34.000Z,"It is a safe bet that eventually $AUPH will be taken out by $MRK. The licensing deals, partnerships etc are just preludes to the real deal.","It is a safe bet that eventually $AUPH will be taken out by $MRK. The licensing deals, partnerships etc are just preludes to the real deal.
8
18
55",,8,18,55,[],https://twitter.com/Lin_ling_88/status/854079413968941058
1814,Jacob Plieth,@JacobPlieth,2017-04-18T14:39:09.000Z,Evercore ISI's Umer Raffat: this is why you have to go to #ESMO17 $BMY $AZN $MRK $RHHBY,"Evercore ISI's Umer Raffat: this is why you have to go to #ESMO17 $BMY $AZN $MRK $RHHBY
2
9
7",,2,9,7,['https://pbs.twimg.com/media/C9s817JXoAA2T0V?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/854343546899496960
1815,Jacob Plieth,@JacobPlieth,2017-04-18T14:55:29.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
Umer Raffat: preclinical binding assays show $MRK Keytruda has highest target affinity; $AZN durvalumab lowest
2
4
7",,2,4,7,['https://pbs.twimg.com/media/C9s_1VdW0AIZaJF?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/854347659221577730
1816,Colin Macleod,@scalpthatstock,2017-04-18T07:56:44.000Z,"Momentum Hunter $MRK Hammer Analysis Video 4/17/2017

http://scalpthatstock.com/momentum-hunter-mrk-hammer-analysis-video-4172017/‚Ä¶","Momentum Hunter $MRK Hammer Analysis Video 4/17/2017

http://scalpthatstock.com/momentum-hunter-mrk-hammer-analysis-video-4172017/‚Ä¶",,,,,['https://pbs.twimg.com/media/C9rgtYLV0AAD39o?format=jpg&name=small'],https://twitter.com/scalpthatstock/status/854242275894763520
1817,Tim,@MomentumHunter_,2017-04-18T02:08:07.000Z,$MRK one more to watch.,"$MRK one more to watch.
youtube.com
$MRK 4 18 17 HAMMER ANALYSIS
Hammer Candlestick Analysis : How to day trade hammer candlesticks : Easy trading strategy : Make money every day.",,,,,[],https://twitter.com/MomentumHunter_/status/854154544846163968
1818,Limex,@LimexMe,2017-04-18T15:23:52.000Z,Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion http://bit.ly/2pOOvgd $RHHBY $PFE $MRK,Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion http://bit.ly/2pOOvgd $RHHBY $PFE $MRK,,,,,['https://pbs.twimg.com/media/C9tHKVVXkAIr_fx?format=jpg&name=360x360'],https://twitter.com/LimexMe/status/854354799848026113
1819,Quantcha Trade Ideas,@QuantchaIdeas,2017-04-17T16:31:14.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/04/17/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-4/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/04/17/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-4/‚Ä¶,,,,,['https://pbs.twimg.com/media/C9oM_lsUAAA6eOb?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/854009368261603333
1820,Tim,@MomentumHunter_,2017-04-18T19:09:44.000Z,$BP $FAST $FCX $MRK $TER $DG $AAPL $BBY $DD $DVN $MNST $OAS $SLM $TIF $TRIP https://youtu.be/HHMKlPxuEuQ  9W:1L that's how it's done!,"$BP $FAST $FCX $MRK $TER $DG $AAPL $BBY $DD $DVN $MNST $OAS $SLM $TIF $TRIP https://youtu.be/HHMKlPxuEuQ  9W:1L that's how it's done!
youtube.com
4 18 17 RECAP $BP $FAST $FCX $MRK $TER $DG $AAPL $BBY $DD $DVN $MNST...
Hammer Candlestick Analysis : How to day trade hammer candlesticks : Easy trading strategy : Make money every day.",,,,,['https://pbs.twimg.com/card_img/1501578645277749256/eaKwmzL7?format=jpg&name=240x240'],https://twitter.com/MomentumHunter_/status/854411641034858496
1821,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-04-17T21:17:14.000Z,Bristol-Myers Squibb: A Sideways Year? $MRK $BMY http://dlvr.it/Nw27hD #Investing #Stocks,Bristol-Myers Squibb: A Sideways Year? $MRK $BMY http://dlvr.it/Nw27hD #Investing #Stocks,,,,,['https://pbs.twimg.com/media/C9pOcw3UMAAbgNg?format=jpg&name=small'],https://twitter.com/AlertTrade/status/854081342711119872
1822,Gitte Pedersen,@DNABARCODE,2017-04-17T00:04:00.000Z,"First #FDA Approved Drug for Rare Skin #Cancer called Merkel cell carcinoma #PDL1 
@Merck
 @Pfizer
 $PFE $MRK #AACR2017","First #FDA Approved Drug for Rare Skin #Cancer called Merkel cell carcinoma #PDL1 
@Merck
 @Pfizer
 $PFE $MRK #AACR2017
cancer.gov
Avelumab First Approved Drug for Merkel Cell Carcinoma
A Cancer Currents blog on the FDA‚Äôs first-ever approval of a drug for the rare skin cancer Merkel cell carcinoma and updated data on patients‚Äô tumor responses.
6
8",,,6,8,['https://pbs.twimg.com/card_img/1501220676962717698/DXAiWqv3?format=jpg&name=240x240'],https://twitter.com/DNABARCODE/status/853760920807505920
1823,Pharmaceutical News,@pharma_sector,2017-04-18T04:40:18.000Z,Mayo CEO invited to become director at pharma giant #Merck. Read more: http://owler.us/acyPiy $MRK,"Mayo CEO invited to become director at pharma giant #Merck. Read more: http://owler.us/acyPiy $MRK
1",,,,1,[],https://twitter.com/pharma_sector/status/854192843249733632
1824,Dow Stocks,@Top_Dow_Stocks,2017-04-18T07:16:59.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/854232272148480000
1825,cuttwood00716,@cuttwood00716,2017-04-17T09:25:34.000Z,$IDN Check out this site! #InvestorsHangout $ALDR $ILMN $PFBC $PSTB $MRK,"$IDN Check out this site! #InvestorsHangout $ALDR $ILMN $PFBC $PSTB $MRK
investorshangout.com
IDN Stock | Message Board | Intellicheck Mobilisia - Investors Hangout
IDN Stock Message Board for Investors. Intellicheck Mobilisia Stock Price, News and Company Updates. Message Board Total Posts: 5",,,,,['https://pbs.twimg.com/card_img/1499224644112498691/uNNWn6ac?format=png&name=240x240'],https://twitter.com/cuttwood00716/status/853902242990047234
1826,cuttwood00716,@cuttwood00716,2017-04-18T01:40:05.000Z,"$WCC Share your thoughts here #InvestorsHangout $MRK $APFH $MYE $SPPI $PG

 http://dlvr.it/Nw5sLY","$WCC Share your thoughts here #InvestorsHangout $MRK $APFH $MYE $SPPI $PG

 http://dlvr.it/Nw5sLY",,,,,[],https://twitter.com/cuttwood00716/status/854147490668359680
1827,FiercePharma,@FiercePharma,2017-04-18T14:11:27.000Z,"Merck's Keytruda sticks to TV ad spree, but BMS slashes March Opdivo spend http://fiercepharma.com/marketing/merck-keytruda-continues-tv-ad-spree-while-bms-opdivo-drops-march‚Ä¶ $MRK $BMY","Merck's Keytruda sticks to TV ad spree, but BMS slashes March Opdivo spend http://fiercepharma.com/marketing/merck-keytruda-continues-tv-ad-spree-while-bms-opdivo-drops-march‚Ä¶ $MRK $BMY
fiercepharma.com
Merck's Keytruda sticks to TV ad spree, but BMS slashes March Opdivo spend
Bristol-Myers Squibb‚Äôs Opdivo dropped national TV ad spending in March after a bruising battle with a key competitor‚ÄîMerck‚Äôs Keytruda‚Äîin
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501722504192303105/c8yuYbIE?format=jpg&name=small'],https://twitter.com/FiercePharma/status/854336576561786880
1828,Alessandro viva l‚Äô#Ucraina,@pelias01,2017-04-17T21:04:53.000Z,Industry Allocations And Compounding Returns https://seekingalpha.com/article/4062539-industry-allocations-compounding-returns?source=tweet‚Ä¶ $BMY $JNJ $KO $MCD $MO $MRK $PEP $PFE $SPHD $SPY $XLB $XLE $XLF $XLK,Industry Allocations And Compounding Returns https://seekingalpha.com/article/4062539-industry-allocations-compounding-returns?source=tweet‚Ä¶ $BMY $JNJ $KO $MCD $MO $MRK $PEP $PFE $SPHD $SPY $XLB $XLE $XLF $XLK,,,,,[],https://twitter.com/pelias01/status/854078232953589762
1829,Sweet Platform,@SweetPlatform,2017-04-18T15:29:30.000Z,"MRK Top news - Apr 18th, 2017 $MRK http://https://goo.gl/G8M07M","MRK Top news - Apr 18th, 2017 $MRK http://https://goo.gl/G8M07M",,,,,[],https://twitter.com/SweetPlatform/status/854356219028533248
1830,Phil Hamby,@Phil_Hamby,2017-04-17T20:15:18.000Z,Aurinia / Merck Animal Health collaboration - after hours spike for $AUPH http://businesswire.com/news/home/20170417005838/en/Aurinia-Completes-Licensing-Deal-Merck-Animal-Health‚Ä¶ $MRK #daytrading #stock,"Aurinia / Merck Animal Health collaboration - after hours spike for $AUPH http://businesswire.com/news/home/20170417005838/en/Aurinia-Completes-Licensing-Deal-Merck-Animal-Health‚Ä¶ $MRK #daytrading #stock
businesswire.com
Aurinia Completes Licensing Deal with Merck Animal Health for Its Nanomicellar Formulation of...
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP) (‚ÄúAurinia‚Äù or the ‚ÄúCompany‚Äù) today announced that it has signed a Definitive Agreement (‚Äúthe Agreem",,,,,['https://pbs.twimg.com/card_img/1501731705975193609/BKlu1zyy?format=jpg&name=240x240'],https://twitter.com/Phil_Hamby/status/854065756094517253
1831,PolgarStocks,@PolgarStocks,2017-04-17T23:09:03.000Z,$RAS-C Share your opinions here #InvestorsHangout $VLY-A $MRK $STWD $DRH $CYS-B,"$RAS-C Share your opinions here #InvestorsHangout $VLY-A $MRK $STWD $DRH $CYS-B
investorshangout.com
RAS-C Stock | Message Board | Rait Fin Tr Pfd C - Investors Hangout
RAS-C Stock Message Board for Investors. Rait Fin Tr Pfd C Stock Price, News and Company Updates. Message Board Total Posts: 0",,,,,['https://pbs.twimg.com/card_img/1499224644112498691/uNNWn6ac?format=png&name=240x240'],https://twitter.com/PolgarStocks/status/854109479645794305
1832,Pharmaceutical News,@pharma_sector,2017-04-18T04:40:55.000Z,"#Merck Stock History: The Drugmaker's Boom, Bust, and Bounce Back. Read more: http://owler.us/acyPir $MRK","#Merck Stock History: The Drugmaker's Boom, Bust, and Bounce Back. Read more: http://owler.us/acyPir $MRK",,,,,[],https://twitter.com/pharma_sector/status/854192998699081728
1833,1 min Stock Insights,@1MinuteStock,2017-04-18T08:47:02.000Z,Do you know that #WallStreet price for $MRK is $68.9 https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=wallstreet&utm_source=twitter‚Ä¶,Do you know that #WallStreet price for $MRK is $68.9 https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=wallstreet&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/854254935617269761
1834,1 min Stock Insights,@1MinuteStock,2017-04-18T10:54:02.000Z,Recommendation #HOLD for $MRK with UB rating - 2.94 out of 5. https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=ubrecommendation&utm_source=twitter‚Ä¶,Recommendation #HOLD for $MRK with UB rating - 2.94 out of 5. https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=ubrecommendation&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/854286894569590784
1835,Pharmaceutical News,@pharma_sector,2017-04-18T04:39:41.000Z,"#Merck's Frazier gets his first raise, but total package shrinks as sales stall. Read more: http://owler.us/acyPit $MRK","#Merck's Frazier gets his first raise, but total package shrinks as sales stall. Read more: http://owler.us/acyPit $MRK",,,,,[],https://twitter.com/pharma_sector/status/854192687741673472
1836,WLST.com,@wlstcom,2017-04-17T21:17:16.000Z,Bristol-Myers Squibb: A Sideways Year? #Investing #Stocks #MRK #BMY #ActivistStocks $MRK https://seekingalpha.com/article/4062859-bristol-myers-squibb-sideways-year‚Ä¶,Bristol-Myers Squibb: A Sideways Year? #Investing #Stocks #MRK #BMY #ActivistStocks $MRK https://seekingalpha.com/article/4062859-bristol-myers-squibb-sideways-year‚Ä¶,,,,,['https://pbs.twimg.com/media/C9pOda6XoAAp95v?format=jpg&name=small'],https://twitter.com/wlstcom/status/854081348876853248
1837,FinInvTr,@FinInvTr,2017-04-17T17:18:02.000Z,Which Large Caps Have Outperformed the Market? $AAPL $MSFT $AMZN $BRK.A $BRK.B $FB $JPM $BABA $BAC $V $MA $MRK $PEP,"Which Large Caps Have Outperformed the Market? $AAPL $MSFT $AMZN $BRK.A $BRK.B $FB $JPM $BABA $BAC $V $MA $MRK $PEP
whotrades.com
Can‚Äôt Make ‚ÄúAlpha‚Äù In Mega-Caps?
It‚Äôs a common statement that you can‚Äôt make ‚Äúalpha‚Äù in large caps given they‚Äôre researched to death and therefore hard to find inefficiencies in the pricing. However, the assertion‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1501723915294543873/zj2WEa1Z?format=jpg&name=small'],https://twitter.com/FinInvTr/status/854021144009216000
1838,IECONOMICS,@iECONOMICS,2017-04-18T13:32:53.000Z,Merck & Co $MRK market alert: 10-week low @ 62.09 https://ieconomics.com/merck,Merck & Co $MRK market alert: 10-week low @ 62.09 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/854326871668006914
1839,Zenect,@zenect,2017-04-18T08:54:32.000Z,$BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V All would make a great foundation #investment‚Ä¶ I like this http://bit.ly/1sQ7Crl,"$BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V All would make a great foundation #investment‚Ä¶ I like this http://bit.ly/1sQ7Crl
1",,,,1,[],https://twitter.com/zenect/status/854256824371089408
1840,$PENNY KING,@groman100,2017-04-18T16:39:32.000Z,"$tgtx buying single digit dips $fbio ready to go,, $imnp one of top gainers on the day lol $fb $mrk $amgn $regn $kite $juno $xon $fold $bmy","$tgtx buying single digit dips $fbio ready to go,, $imnp one of top gainers on the day lol $fb $mrk $amgn $regn $kite $juno $xon $fold $bmy",,,,,[],https://twitter.com/groman100/status/854373843661606912
1841,Alexander Morris,@tymorapro,2017-04-18T15:03:44.000Z,"$MRK: At/Below 200DaySMA[+62.10]:2M, lm:-3, 0NearLo, AtPivS3, 2:5Accel-, allTFs-, ch:-1.1%, pcGap[-0.5%,ret:0.1%], oPop:-0.5%","$MRK: At/Below 200DaySMA[+62.10]:2M, lm:-3, 0NearLo, AtPivS3, 2:5Accel-, allTFs-, ch:-1.1%, pcGap[-0.5%,ret:0.1%], oPop:-0.5%",,,,,[],https://twitter.com/tymorapro/status/854349733778915328
1842,Vista Partners LLC,@VistaPResearch,2017-04-16T23:40:45.000Z,@1galaxyskytree1 thanks for follow! See Vista Partners #WorldNews Commentary #Investing #Dow30 http://vistapglobal.com $DIA $IBB $MRK $JNJ,"@1galaxyskytree1 thanks for follow! See Vista Partners #WorldNews Commentary #Investing #Dow30 http://vistapglobal.com $DIA $IBB $MRK $JNJ
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/C9kltQBUQAAAtLb.jpg'],https://twitter.com/VistaPResearch/status/853755071301009409
1843,D,@d_voted_1,2017-04-18T05:30:49.000Z,"Replying to 
@Lin_ling_88","Replying to 
@Lin_ling_88
Notice how $AUPH booth is right across from $MRK at the kidney foundation? This deal is just a covert op to get their hands on vocls.  
1
5",üôÑ üòè,1,,5,[],https://twitter.com/d_voted_1/status/854205556982075392
1844,MarketBeat,@MarketBeatCom,2017-04-18T05:07:49.000Z,"Merck & Co., Inc. $MRK Stake Cut by Azimuth Capital Management LLC http://zpr.io/PbBr7","Merck & Co., Inc. $MRK Stake Cut by Azimuth Capital Management LLC http://zpr.io/PbBr7",,,,,[],https://twitter.com/MarketBeatCom/status/854199767588638722
1845,SwingTradeBot,@SwingTradeBot,2017-04-17T17:33:09.000Z,Recent $MRK technical alerts: 180 Bearish Setup plus 2 more alerts...,"Recent $MRK technical alerts: 180 Bearish Setup plus 2 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/854024946913349637
1846,Watchlist News,@WatchlistN,2017-04-18T13:29:52.000Z,"Teachers Retirement System of The State of Kentucky Decreases Position in Merck & Co., Inc. $MRK http://zpr.io/PDTkv","Teachers Retirement System of The State of Kentucky Decreases Position in Merck & Co., Inc. $MRK http://zpr.io/PDTkv",,,,,[],https://twitter.com/WatchlistN/status/854326111408447488
1847,US Banking News,@AmericanBanking,2017-04-17T23:56:22.000Z,"Merck & Co. $MRK Receiving Somewhat Positive News Coverage, Analysis Shows http://ift.tt/2oQelDh","Merck & Co. $MRK Receiving Somewhat Positive News Coverage, Analysis Shows http://ift.tt/2oQelDh",,,,,[],https://twitter.com/AmericanBanking/status/854121390357794818
1848,MarketBeat,@MarketBeatCom,2017-04-18T05:07:56.000Z,"Genovese Burford & Brothers Wealth & Retirement Plan Management LLC Boosts Position in Merck & Co., Inc. $MRK http://zpr.io/PbB3L","Genovese Burford & Brothers Wealth & Retirement Plan Management LLC Boosts Position in Merck & Co., Inc. $MRK http://zpr.io/PbB3L",,,,,[],https://twitter.com/MarketBeatCom/status/854199796869083136
1849,MarketBeat,@MarketBeatCom,2017-04-17T23:54:30.000Z,"Merck & Co. $MRK Receiving Somewhat Positive News Coverage, Analysis Shows http://ift.tt/2pLdtx3 #acn","Merck & Co. $MRK Receiving Somewhat Positive News Coverage, Analysis Shows http://ift.tt/2pLdtx3 #acn",,,,,[],https://twitter.com/MarketBeatCom/status/854120916825112576
1850,Clark Joseph Kent,@JorelLaraKalel,2017-04-18T21:56:10.000Z,"4 Healthcare Stocks That Are Starting to Look Sick http://bit.ly/2pz8tfL $JNJ $MRK $CELG $ABBV 
@investorplace","4 Healthcare Stocks That Are Starting to Look Sick http://bit.ly/2pz8tfL $JNJ $MRK $CELG $ABBV 
@investorplace
1",,,,1,[],https://twitter.com/JorelLaraKalel/status/854453528865251330
1851,TalkMarkets,@TalkMarkets,2017-04-16T15:49:00.000Z,"Pharma Stock Roundup: Merck Gets CRL For Label Expansion Effort, Roche Cancer Drug Tops $AZN $JNJ $MRK $MYL $RHHBY  https://goo.gl/xSTcdk","Pharma Stock Roundup: Merck Gets CRL For Label Expansion Effort, Roche Cancer Drug Tops $AZN $JNJ $MRK $MYL $RHHBY  https://goo.gl/xSTcdk",,,,,[],https://twitter.com/TalkMarkets/status/853636351518027777
1852,Allison Gatlin,@IBD_AGatlin,2017-04-17T19:06:01.000Z,How Biogen's takeover prospects soured in mere months $BIIB $MRK $AGN $PFE $LLY $ABBV $RHHBY $CELG $NVS $SNY $FWP http://ow.ly/9zFY30aVhPl,How Biogen's takeover prospects soured in mere months $BIIB $MRK $AGN $PFE $LLY $ABBV $RHHBY $CELG $NVS $SNY $FWP http://ow.ly/9zFY30aVhPl,,,,,[],https://twitter.com/IBD_AGatlin/status/854048320020500480
1853,blackened,@blackened123,2017-04-16T21:32:01.000Z,"Replying to 
@AswathDamodaran","Replying to 
@AswathDamodaran
Could you run a valuation on $NWBO? Phase 3 readouts soon and looks incredibly undervalued. Possible buyout $BMY $MRK? #Immunotherapy
1
5",,,1,5,[],https://twitter.com/blackened123/status/853722674375380992
1854,dough,@semodough,2017-04-20T10:35:09.000Z,Nice slide by ISI on key IO trials upcoming $MRK $ROG $BMY $AZN #ASCO17,"Nice slide by ISI on key IO trials upcoming $MRK $ROG $BMY $AZN #ASCO17
1
14
14",,1,14,14,['https://pbs.twimg.com/media/C92YPiQUMAEuxf7?format=jpg&name=small'],https://twitter.com/semodough/status/855006918603091968
1855,Meg Tirrell,@megtirrell,2017-04-21T19:18:04.000Z,"FDA approves  $MRK & Samsung Bioepis's Renflixis, second biosimilar to $JNJ's Remicade (per StreetAccount)","FDA approves  $MRK & Samsung Bioepis's Renflixis, second biosimilar to $JNJ's Remicade (per StreetAccount)
2
12
16",,2,12,16,[],https://twitter.com/megtirrell/status/855500905302675464
1856,WLST.com,@wlstcom,2017-04-20T14:38:06.000Z,"The Zacks Analyst Blog Highlights: Berkshire Hathaway, Oracle, Merck, Honeywell and Altria $MRK #wlst http://finance.yahoo.com/news/zacks-analyst-blog-highlights-berkshire-133001263.html‚Ä¶","The Zacks Analyst Blog Highlights: Berkshire Hathaway, Oracle, Merck, Honeywell and Altria $MRK #wlst http://finance.yahoo.com/news/zacks-analyst-blog-highlights-berkshire-133001263.html‚Ä¶",,,,,[],https://twitter.com/wlstcom/status/855068061728198657
1857,Helen Ong,@Lin_ling_88,2017-04-19T12:05:10.000Z,"$MRK Underscores Continued Commitment to Fighting Infectious Dis. With >25 Presentations at ECCMID17

Just buy $AKAO http://finance.yahoo.com/news/merck-underscores-continued-commitment-fighting-120000172.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZANmNjVqYTgxY2Zla2R1BGcDZFhWcFpEeHVjejQyT0dOaFl6STJPUzAzWkRZeUxUTmlabVl0T1dWa05DMHlNMkZoTW1abE5XTXlaakk4Wm1sbGJHUStiWEpyBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwMwBHJlZ2lvbgNVUwRzeW1ib2wDTVJL?.tsrc=applewf‚Ä¶","$MRK Underscores Continued Commitment to Fighting Infectious Dis. With >25 Presentations at ECCMID17

Just buy $AKAO http://finance.yahoo.com/news/merck-underscores-continued-commitment-fighting-120000172.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZANmNjVqYTgxY2Zla2R1BGcDZFhWcFpEeHVjejQyT0dOaFl6STJPUzAzWkRZeUxUTmlabVl0T1dWa05DMHlNMkZoTW1abE5XTXlaakk4Wm1sbGJHUStiWEpyBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwMwBHJlZ2lvbgNVUwRzeW1ib2wDTVJL?.tsrc=applewf‚Ä¶
4",,,,4,[],https://twitter.com/Lin_ling_88/status/854667185725349888
1858,Seeking Alpha,@SeekingAlpha,2017-04-19T20:20:04.000Z,BiolineRx: COMBAT Engagement https://seekingalpha.com/article/4063493-biolinerx-combat-engagement?source=feed_f‚Ä¶ $BMY $GLYC $LLY $MRK $BLRX,"BiolineRx: COMBAT Engagement https://seekingalpha.com/article/4063493-biolinerx-combat-engagement?source=feed_f‚Ä¶ $BMY $GLYC $LLY $MRK $BLRX
seekingalpha.com
BiolineRx: COMBAT Engagement (NASDAQ:BLRX)
Bristol-Myers Squibb terminated the ‚ÄúCXCessoR4‚Äùtrial due to a lack of efficacy in the short term acute phase.
1",,,1,,['https://pbs.twimg.com/card_img/1501730799770652673/JHzoUjhy?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/854791729865662464
1859,Evaluate Vantage,@evaluatevantage,2017-04-20T15:36:38.000Z,Merck leads rivals in novel drug approvals http://epvantage.com/Universal/View.aspx?type=Story&id=697892&isEPVantage=yes‚Ä¶ $MRK $AZN $NVS $SNY,"Merck leads rivals in novel drug approvals http://epvantage.com/Universal/View.aspx?type=Story&id=697892&isEPVantage=yes‚Ä¶ $MRK $AZN $NVS $SNY
3
3",,,3,3,['https://pbs.twimg.com/media/C93cxa5WAAIy2ol?format=jpg&name=small'],https://twitter.com/evaluatevantage/status/855082792199368706
1860,Ben Hirschler,@reutersBenHir,2017-04-19T15:18:45.000Z,"As #AstraZeneca chases rivals, immuno-#oncology gets complicated http://reut.rs/2osiJo3 $AZN $MRK $BMY $ROG","As #AstraZeneca chases rivals, immuno-#oncology gets complicated http://reut.rs/2osiJo3 $AZN $MRK $BMY $ROG
1",,,,1,[],https://twitter.com/reutersBenHir/status/854715901484179457
1861,Colin Macleod,@scalpthatstock,2017-04-19T23:54:33.000Z,"3 Bullish Engulfing Candles to watch for longs

http://scalpthatstock.com/bullish-engulfing-pattern-4-19-2017/‚Ä¶

$VXX $MRK $BSX","3 Bullish Engulfing Candles to watch for longs

http://scalpthatstock.com/bullish-engulfing-pattern-4-19-2017/‚Ä¶

$VXX $MRK $BSX",,,,,['https://pbs.twimg.com/media/C90FobbUwAADwL7?format=jpg&name=small'],https://twitter.com/scalpthatstock/status/854845705315270656
1862,Lisa LaMotta,@lisalamotta,2017-04-21T19:58:50.000Z,Samsung Bioepis and $MRK get approval for a second Remicade #biosimilar $JNJ https://accessdata.fda.gov/drugsatfda_docs/label/2017/761054lbl.pdf‚Ä¶,"Samsung Bioepis and $MRK get approval for a second Remicade #biosimilar $JNJ https://accessdata.fda.gov/drugsatfda_docs/label/2017/761054lbl.pdf‚Ä¶
1
2",,,1,2,[],https://twitter.com/lisalamotta/status/855511164129857536
1863,M,@bio_clouseau,2017-04-21T10:01:18.000Z,WHO report on Hepatitis http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf‚Ä¶ Re HCV $GILD $ABBV $MRK $ENTA,"WHO report on Hepatitis http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf‚Ä¶ Re HCV $GILD $ABBV $MRK $ENTA
2
2",,,2,2,['https://pbs.twimg.com/media/C97aDkpXkAA9-Dv?format=jpg&name=small'],https://twitter.com/bio_clouseau/status/855360788512591874
1864,FinInvTr,@FinInvTr,2017-04-19T17:23:48.000Z,Which Large Caps Have Recently Outperformed? $AAPL $MSFT $AMZN $BRK.A $BRK.B $FB $JPM $BABA $BAC $V $MA $MRK $PEP,"Which Large Caps Have Recently Outperformed? $AAPL $MSFT $AMZN $BRK.A $BRK.B $FB $JPM $BABA $BAC $V $MA $MRK $PEP
whotrades.com
Can‚Äôt Make ‚ÄúAlpha‚Äù In Mega-Caps?
It‚Äôs a common statement that you can‚Äôt make ‚Äúalpha‚Äù in large caps given they‚Äôre researched to death and therefore hard to find inefficiencies in the pricing. However, the assertion‚Ä¶
1",,,,1,['https://pbs.twimg.com/card_img/1501723915294543873/zj2WEa1Z?format=jpg&name=small'],https://twitter.com/FinInvTr/status/854747370608889858
1865,Tuan Pham,@15minofPham,2017-04-21T02:13:33.000Z,Highest Call/Put ratio vs OI. CALL: $SBUX $HAL $LVS $AXP $CMCSA $DHI $XME. PUT: $WNRL $MRK $YHOO $BABA $VOD $OIH  http://tinyurl.com/ls6vzw7,Highest Call/Put ratio vs OI. CALL: $SBUX $HAL $LVS $AXP $CMCSA $DHI $XME. PUT: $WNRL $MRK $YHOO $BABA $VOD $OIH  http://tinyurl.com/ls6vzw7,‚û° ‚û° ‚û°,,,,['https://pbs.twimg.com/media/C95ti9BUIAA_jfY?format=jpg&name=small'],https://twitter.com/15minofPham/status/855243077165953025
1866,John Carroll,@JohnCendpts,2017-04-21T20:15:52.000Z,"J&J faces its second rival Remicade knockoff as FDA gives Merck a shot at a $7B franchise
$JNJ $MRK","J&J faces its second rival Remicade knockoff as FDA gives Merck a shot at a $7B franchise
$JNJ $MRK
endpts.com
J&J faces its second rival Remicade knockoff as FDA gives Merck a shot at a $7B franchise
The FDA has approved a new knockoff of J&J‚Äôs top earning drug Remicade, which may finally start to shift the market dynamics toward greater competition with lower prices. This new one is dubbed...
2
4",,,2,4,['https://pbs.twimg.com/card_img/1501187304265863173/CWThvcdQ?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/855515450364633090
1867,Craig Tolliver,@Craig_Tolliver,2017-04-19T17:07:29.000Z,4 Healthcare Stocks That Are Starting to Look Sick http://ln.is/www.scutify.com/arti/Uvzk7‚Ä¶ $XLV $JNJ $MRK $CELG $ABBV #healthcare #stocks,4 Healthcare Stocks That Are Starting to Look Sick http://ln.is/www.scutify.com/arti/Uvzk7‚Ä¶ $XLV $JNJ $MRK $CELG $ABBV #healthcare #stocks,,,,,[],https://twitter.com/Craig_Tolliver/status/854743265823817728
1868,Zenect,@zenect,2017-04-21T07:03:05.000Z,I assume you‚Äôre going to buy this dividend #stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V and hold it forever‚Ä¶,I assume you‚Äôre going to buy this dividend #stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V and hold it forever‚Ä¶,,,,,[],https://twitter.com/zenect/status/855315938022797313
1869,Evaluate Pharma,@evaluatepharma,2017-04-20T16:45:36.000Z,"Merck leads rivals in novel drug approvals http://ow.ly/Mjfm30b1vPQ via 
@ByAmyBrown
 @EPVantage
 #FDA $MRK","Merck leads rivals in novel drug approvals http://ow.ly/Mjfm30b1vPQ via 
@ByAmyBrown
 @EPVantage
 #FDA $MRK
1
2",,,1,2,"['https://pbs.twimg.com/media/C93tCzAVYAAGliA?format=jpg&name=360x360', 'https://pbs.twimg.com/media/C93tDF_VoAAGUL3?format=jpg&name=360x360']",https://twitter.com/evaluatepharma/status/855100144525733888
1870,Justin Kaspar,@jkaspar11,2017-04-20T21:29:07.000Z,Almost went in on more $AUPH before close‚Ä¶.wish I did with this $MRK 1.2 b offer rumor going around,"Almost went in on more $AUPH before close‚Ä¶.wish I did with this $MRK 1.2 b offer rumor going around
1",,1,,,[],https://twitter.com/jkaspar11/status/855171496456728576
1871,Roy Friedman,@DewDiligence,2017-04-21T19:57:02.000Z,$MRK is Samsung's US partner on Renflexis:,"$MRK is Samsung's US partner on Renflexis:
investorshub.advfn.com
Biotech Values Post # 197120
1",,,1,,[],https://twitter.com/DewDiligence/status/855510711241453569
1872,Dakota Financial,@dakotafinancial,2017-04-21T15:46:42.000Z,"Merck & Co., Inc. $MRK Stake Raised by Numeric Investors LLC http://zpr.io/PDdfD","Merck & Co., Inc. $MRK Stake Raised by Numeric Investors LLC http://zpr.io/PDdfD",,,,,[],https://twitter.com/dakotafinancial/status/855447712313073668
1873,Dakota Financial,@dakotafinancial,2017-04-21T12:31:24.000Z,"GSB Wealth Management LLC Takes Position in Merck & Co., Inc. $MRK http://zpr.io/PDiG5","GSB Wealth Management LLC Takes Position in Merck & Co., Inc. $MRK http://zpr.io/PDiG5",,,,,[],https://twitter.com/dakotafinancial/status/855398560543776768
1874,Dakota Financial,@dakotafinancial,2017-04-21T14:55:13.000Z,"Advantage Investment Management LLC Invests $215,000 in Merck & Co., Inc. $MRK http://zpr.io/PDJwL","Advantage Investment Management LLC Invests $215,000 in Merck & Co., Inc. $MRK http://zpr.io/PDJwL",,,,,[],https://twitter.com/dakotafinancial/status/855434753700507648
1875,Daily Political,@dailypoliticaln,2017-04-19T10:01:28.000Z,Stock Traders Buy High Volume of Call Options on Merck & Co. $MRK http://ift.tt/2pB6980,Stock Traders Buy High Volume of Call Options on Merck & Co. $MRK http://ift.tt/2pB6980,,,,,[],https://twitter.com/dailypoliticaln/status/854636056582529025
1876,Limex,@LimexMe,2017-04-19T21:24:24.000Z,"Is J&J's Pharma Sales Slowdown a Warning for Other Players?
 http://bit.ly/190417JNJ2 $JNJ $NVS $MRK $PFE","Is J&J's Pharma Sales Slowdown a Warning for Other Players?
 http://bit.ly/190417JNJ2 $JNJ $NVS $MRK $PFE
s30388417790.whotrades.com
Is J&J's Pharma Sales Slowdown a Warning for Other Players?
Johnson & Johnson JNJ reported mixed first-quarter 2017 earnings results on Tuesday. While earnings beat the Zacks Consensus Estimate, sales missed due to a slowdown in‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/854807920911032320
1877,Allison Gatlin,@IBD_AGatlin,2017-04-20T18:52:01.000Z,Is Bristol-Myers prepping to outdo itself in immuno-oncology? $BMY $CTMX $MRK $INCY,"Is Bristol-Myers prepping to outdo itself in immuno-oncology? $BMY $CTMX $MRK $INCY
investors.com
Is Bristol-Myers Prepping To Outdo Itself In Immuno-Oncology?
Bristol-Myers Squibb and Cytomx could be working on a less potent version of Yervoy and have data as early as 2018, an analyst said Thursday.
2",,,,2,['https://pbs.twimg.com/card_img/1501731179158024192/aGWKutmV?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/855131961492471809
1878,BooRad,@atticusMB,2017-04-21T16:56:31.000Z,"Should Gilead Sciences Acquire NewLink Genetics? 
@themotleyfool
 #stocks $MRK, $GILD, $INCY, $ABBV, $NLNK","Should Gilead Sciences Acquire NewLink Genetics? 
@themotleyfool
 #stocks $MRK, $GILD, $INCY, $ABBV, $NLNK
fool.com
Should Gilead Sciences Acquire NewLink Genetics? @themotleyfool #stocks $GILD $NLNK $MRK $INCY $ABBV
NewLink Genetics intriguing IDO-inhibitors could make it a target of Gilead Sciences.",,,,,['https://pbs.twimg.com/card_img/1501730758569902082/YqA2dOjX?format=jpg&name=small'],https://twitter.com/atticusMB/status/855465282269323268
1879,TalkMarkets,@TalkMarkets,2017-04-21T07:18:42.000Z,#AbbVie / #Enanta Post Stellar Phase 3 Data But No One Is Cheering $ABBV $ENTA Also $MRK $GILD https://goo.gl/rjusGl,"#AbbVie / #Enanta Post Stellar Phase 3 Data But No One Is Cheering $ABBV $ENTA Also $MRK $GILD https://goo.gl/rjusGl
1",,,1,,[],https://twitter.com/TalkMarkets/status/855319868068974594
1880,kei,@keitrader,2017-04-20T23:08:38.000Z,"Replying to 
@Lin_ling_88","Replying to 
@Lin_ling_88
high chance now $AUPH will be bought out by $MRK
6",üåª üò∏ ü¶ä üê∫ üê∂,,,6,[],https://twitter.com/keitrader/status/855196540784300034
1881,il falso guaritore,@falsoguaritore,2017-04-20T07:12:30.000Z,BiolineRx: COMBAT Engagement https://seekingalpha.com/article/4063493-biolinerx-combat-engagement?source=tweet‚Ä¶ $BMY $GLYC $LLY $MRK $BLRX,"BiolineRx: COMBAT Engagement https://seekingalpha.com/article/4063493-biolinerx-combat-engagement?source=tweet‚Ä¶ $BMY $GLYC $LLY $MRK $BLRX
seekingalpha.com
BiolineRx: COMBAT Engagement (NASDAQ:BLRX)
Bristol-Myers Squibb terminated the ‚ÄúCXCessoR4‚Äùtrial due to a lack of efficacy in the short term acute phase.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501730799770652673/JHzoUjhy?format=png&name=240x240'],https://twitter.com/falsoguaritore/status/854955920580857856
1882,TradingView en Espa√±ol,@es_tradingview,2017-04-20T04:50:00.000Z,"$MRK - Oportunidad Merck & Co Inc, Cypher - https://es.tradingview.com/chart/MRK/dNInOEOl/‚Ä¶","$MRK - Oportunidad Merck & Co Inc, Cypher - https://es.tradingview.com/chart/MRK/dNInOEOl/‚Ä¶",üó∫,,,,[],https://twitter.com/es_tradingview/status/854920059218571266
1883,marketexclusive,@marketexclusive,2017-04-20T12:24:49.000Z,"Merck & Co., Inc. (NYSE:MRK) Says Researchers Have 25 Scientific Data Presentations On Infectious Disease https://marketexclusive.com/merck-co-inc-nysemrk-says-researchers-25-scientific-data-presentations-infectious-disease/95003/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶ $MRK","Merck & Co., Inc. (NYSE:MRK) Says Researchers Have 25 Scientific Data Presentations On Infectious Disease https://marketexclusive.com/merck-co-inc-nysemrk-says-researchers-25-scientific-data-presentations-infectious-disease/95003/?utm_campaign=wp-twitter&utm_medium=twitter&utm_source=twitter‚Ä¶ $MRK
2",,,2,,[],https://twitter.com/marketexclusive/status/855034516624166914
1884,Ticker Report,@TickerReport,2017-04-20T10:24:46.000Z,"Forbes J M & Co. LLP Acquires 516 Shares of Merck & Co., Inc. $MRK http://zpr.io/PDDsU","Forbes J M & Co. LLP Acquires 516 Shares of Merck & Co., Inc. $MRK http://zpr.io/PDDsU",,,,,[],https://twitter.com/TickerReport/status/855004305828569088
1885,Watchlist News,@WatchlistN,2017-04-19T10:40:42.000Z,"Blue Edge Capital LLC Takes Position in Merck & Co., Inc. $MRK http://zpr.io/PDmAd","Blue Edge Capital LLC Takes Position in Merck & Co., Inc. $MRK http://zpr.io/PDmAd",,,,,[],https://twitter.com/WatchlistN/status/854645926845186050
1886,Watchlist News,@WatchlistN,2017-04-19T10:40:44.000Z,"LeJeune Puetz Investment Counsel LLC Purchases New Position in Merck & Co., Inc. $MRK http://zpr.io/PDmAc","LeJeune Puetz Investment Counsel LLC Purchases New Position in Merck & Co., Inc. $MRK http://zpr.io/PDmAc",,,,,[],https://twitter.com/WatchlistN/status/854645935225405440
1887,TalkMarkets,@TalkMarkets,2017-04-20T17:11:41.000Z,"#Tesaro Drops After Zejula Pricing, Competing PARPi Trial Miss $TSRO Also $ABBV $CLVS $MRK https://goo.gl/0HJe9e","#Tesaro Drops After Zejula Pricing, Competing PARPi Trial Miss $TSRO Also $ABBV $CLVS $MRK https://goo.gl/0HJe9e",,,,,[],https://twitter.com/TalkMarkets/status/855106710054346752
1888,Roy Friedman,@DewDiligence,2017-04-21T20:52:38.000Z,This is (paradoxically)efficient4 $MRK insofar as Renflexis will be mrktd similarly2 Remicade‚Äîie by counter-detailing against Humira/Enbrel.,"This is (paradoxically)efficient4 $MRK insofar as Renflexis will be mrktd similarly2 Remicade‚Äîie by counter-detailing against Humira/Enbrel.
Peter Loftus
@Loftus
 ¬∑ 22 Apr 2017
FDA approval of copycat Remicade puts Merck $MRK in odd position of selling branded drug in one market and competing biosimilar in another
1",,,,1,['https://pbs.twimg.com/profile_images/1499750782547157002/bK_X21Ry_mini.jpg'],https://twitter.com/DewDiligence/status/855524703028555776
1889,$peedyCalls,@SpeedyCalls,2017-04-20T15:59:52.000Z,"$MRK 62.5 Puts BUYING Activity expiring on 19th May, Vol 4350","$MRK 62.5 Puts BUYING Activity expiring on 19th May, Vol 4350",,,,,[],https://twitter.com/SpeedyCalls/status/855088636081164289
1890,SF Education,@SFEducation,2017-04-21T16:55:04.000Z,10 Reasons Merck Could Be the World's Most Perfect Stock https://aff.whotrades.com/t/b/brpvu/ $MRK $BMY $GILD,10 Reasons Merck Could Be the World's Most Perfect Stock https://aff.whotrades.com/t/b/brpvu/ $MRK $BMY $GILD,,,,,['https://pbs.twimg.com/media/C984zr3XkAAd18G?format=jpg&name=small'],https://twitter.com/SFEducation/status/855464917805256704
1891,Seeking Alpha,@SeekingAlpha,2017-04-21T12:13:10.000Z,Merck Leads Rivals In Novel Drug Approvals https://seekingalpha.com/article/4064078-merck-leads-rivals-novel-drug-approvals?source=feed_f‚Ä¶ $NVS $GSK $SNY $AZN $PFE $RHHBY $BMY $MRK,Merck Leads Rivals In Novel Drug Approvals https://seekingalpha.com/article/4064078-merck-leads-rivals-novel-drug-approvals?source=feed_f‚Ä¶ $NVS $GSK $SNY $AZN $PFE $RHHBY $BMY $MRK,,,,,[],https://twitter.com/SeekingAlpha/status/855393973908656128
1892,Buy Cryptocurrency,@cryptosbuy,2017-04-20T04:55:20.000Z,"Oportunidad Merck & Co Inc, Cypher $MRK http://es.tradingview.com/chart/MRK/dNInOEOl/‚Ä¶ TV_TradingIdeas","Oportunidad Merck & Co Inc, Cypher $MRK http://es.tradingview.com/chart/MRK/dNInOEOl/‚Ä¶ TV_TradingIdeas",,,,,[],https://twitter.com/cryptosbuy/status/854921400083238912
1893,TradingView Ideas,@TradingViewAlt,2017-04-20T02:57:01.000Z,Bullish Moving Average Cross For Merck $MRK,"Bullish Moving Average Cross For Merck $MRK
tradingview.com
Bullish Moving Average Cross For Merck for NYSE:MRK by StonkSignaler
On April 19, 2017, Merck & Co (NYSE:MRK) crossed above its 150 daily moving average (DMA). Historically this has occurred 227 times and the stock does not always move up. It has a median gain of...",,,,,['https://pbs.twimg.com/card_img/1501985949361721344/B4NT1QAb?format=jpg&name=small'],https://twitter.com/TradingViewAlt/status/854891624513511424
1894,Stock Market Picks,@StockWebTrading,2017-04-21T13:12:39.000Z,"$KO $MCD $MMM $MRK $MSFT $NKE $PFE Long and short positions from the Dow Jones, up to 1800% since 2008. http://dowstocktips.com $DJIA $DIA","$KO $MCD $MMM $MRK $MSFT $NKE $PFE Long and short positions from the Dow Jones, up to 1800% since 2008. http://dowstocktips.com $DJIA $DIA
dowstocktips.com
Liquid Stocks from Dow Jones
Trade the largest stocks from Dow Jones index, long and short positions with target and stop loss on each trade, up to 1500% in cumulative profits since 2008, daily stock picks.",,,,,['https://pbs.twimg.com/card_img/1500276043881590785/I2OhqSzR?format=png&name=240x240'],https://twitter.com/StockWebTrading/status/855408942087852032
1895,Allison Gatlin,@IBD_AGatlin,2017-04-19T19:06:08.000Z,"Bristol-Myers ""holding up better"" but Dow's Merck still gouging share $BMY $MRK $RHHBY","Bristol-Myers ""holding up better"" but Dow's Merck still gouging share $BMY $MRK $RHHBY
investors.com
Bristol-Myers 'Holding Up Better,' But Dow's Merck Still Gouging Share
Merck's Keytruda continued to swipe share from Bristol's immuno-oncology drugs, but Bristol is ""holding up better than expected.""
1",,,,1,[],https://twitter.com/IBD_AGatlin/status/854773122721099776
1896,Mayur Kherdikar,@MayurKherdikar,2017-04-20T17:31:16.000Z,"$MRK leads the pack with 10 NME approvals over last 5 yrs. http://evaluategroup.com/Universal/View.aspx?type=Story&id=701895&isEPVantage=yes‚Ä¶ via 
@EPVantage","$MRK leads the pack with 10 NME approvals over last 5 yrs. http://evaluategroup.com/Universal/View.aspx?type=Story&id=701895&isEPVantage=yes‚Ä¶ via 
@EPVantage",,,,,[],https://twitter.com/MayurKherdikar/status/855111636813664256
1897,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-04-20T15:55:41.000Z,"$ADAP granted confidential treatement regarding contracs with $CLBS PTC, $MRK Keytruda, and 
@MDAnderson
 - SEC-filed http://ir.adaptimmune.com/phoenix.zhtml?c=253991&p=IROL-sec‚Ä¶","$ADAP granted confidential treatement regarding contracs with $CLBS PTC, $MRK Keytruda, and 
@MDAnderson
 - SEC-filed http://ir.adaptimmune.com/phoenix.zhtml?c=253991&p=IROL-sec‚Ä¶
4",,,,4,[],https://twitter.com/dhovekamp42/status/855087585928110081
1898,The Fly,@theflynews,2017-04-20T15:43:04.000Z,"Tesaro drops after Zejula pricing, competing PARPi trial miss $TSRO $ABBV $MRK $CLVS","Tesaro drops after Zejula pricing, competing PARPi trial miss $TSRO $ABBV $MRK $CLVS
thefly.com
Tesaro drops after Zejula pricing, competing PARPi trial miss
The shares of drug maker ... TSRO, ABBV, MRK, CLVS",,,,,[],https://twitter.com/theflynews/status/855084408730116096
1899,Todd Campbell,@ebcapital,2017-04-21T18:28:51.000Z,"Should Gilead Sciences Acquire NewLink Genetics? 
@themotleyfool
 #stocks $MRK, $GILD, $INCY, $ABBV, $NLNK","Should Gilead Sciences Acquire NewLink Genetics? 
@themotleyfool
 #stocks $MRK, $GILD, $INCY, $ABBV, $NLNK
fool.com
Should Gilead Sciences Acquire NewLink Genetics? @themotleyfool #stocks $GILD $NLNK $MRK $INCY $ABBV
NewLink Genetics intriguing IDO-inhibitors could make it a target of Gilead Sciences.",,,,,['https://pbs.twimg.com/card_img/1501730758569902082/YqA2dOjX?format=jpg&name=small'],https://twitter.com/ebcapital/status/855488518218543106
1900,Benzinga,@Benzinga,2017-04-20T18:04:01.000Z,What Would A $5.8 Billion NIH Cut Look Like? Devastation https://benzinga.com/z/9308625 $GSK $ILMN $JNJ $PFE $MRK  $MRNB $VTGN $PRXL $NVS,"What Would A $5.8 Billion NIH Cut Look Like? Devastation https://benzinga.com/z/9308625 $GSK $ILMN $JNJ $PFE $MRK  $MRNB $VTGN $PRXL $NVS
benzinga.com
What Would A $5.8 Billion NIH Cut Look Like? Devastation
Neither Republicans nor Democrats are eager to cut the National Institutes of Health funding by the president‚Äôs suggested $5.8 billion, but with the proposal still on the...",,,,,[],https://twitter.com/Benzinga/status/855119881141964800
1901,SF Education,@SFEducation,2017-04-21T16:52:09.000Z,Should Gilead Sciences Acquire NewLink Genetics? https://aff.whotrades.com/t/b/nj2jn/ $GILD $NLNK $MRK $INCY,Should Gilead Sciences Acquire NewLink Genetics? https://aff.whotrades.com/t/b/nj2jn/ $GILD $NLNK $MRK $INCY,,,,,['https://pbs.twimg.com/media/C984I-gW0AApcUF?format=jpg&name=small'],https://twitter.com/SFEducation/status/855464184502530048
1902,Buy Cryptocurrency,@cryptosbuy,2017-04-20T03:05:26.000Z,Bullish Moving Average Cross For Merck $MRK http://tradingview.com/chart/MRK/UlKAsQq4-Bullish-Moving-Average-Cross-For-Merck/‚Ä¶ TV_TradingIdeas,"Bullish Moving Average Cross For Merck $MRK http://tradingview.com/chart/MRK/UlKAsQq4-Bullish-Moving-Average-Cross-For-Merck/‚Ä¶ TV_TradingIdeas
tradingview.com
Bullish Moving Average Cross For Merck for NYSE:MRK by StonkSignaler
On April 19, 2017, Merck & Co (NYSE:MRK) crossed above its 150 daily moving average (DMA). Historically this has occurred 227 times and the stock does not always move up. It has a median gain of...",,,,,['https://pbs.twimg.com/card_img/1501985949361721344/B4NT1QAb?format=jpg&name=small'],https://twitter.com/cryptosbuy/status/854893746130956288
1903,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-04-21T12:39:23.000Z,Merck Leads Rivals In Novel Drug Approvals https://seekingalpha.com/article/4064078-merck-leads-rivals-novel-drug-approvals?source=tweet‚Ä¶ $NVS $GSK $SNY $AZN $PFE $RHHBY $BMY $MRK,"Merck Leads Rivals In Novel Drug Approvals https://seekingalpha.com/article/4064078-merck-leads-rivals-novel-drug-approvals?source=tweet‚Ä¶ $NVS $GSK $SNY $AZN $PFE $RHHBY $BMY $MRK
seekingalpha.com
Merck Leads Rivals In Novel Drug Approvals (NYSE:MRK)
The annual tally of novel drug approvals is often taken as a barometer of productivity, and an analysis of the companies most responsible for bringing these medicines to market reveals some...
1",,,,1,['https://pbs.twimg.com/card_img/1501730805382590471/_Ix09Gqm?format=jpg&name=240x240'],https://twitter.com/dhovekamp42/status/855400571507015680
1904,Ticker Report,@TickerReport,2017-04-21T10:24:20.000Z,"Merck & Co., Inc. $MRK Stake Raised by Numeric Investors LLC http://ift.tt/2pKofV3","Merck & Co., Inc. $MRK Stake Raised by Numeric Investors LLC http://ift.tt/2pKofV3",,,,,[],https://twitter.com/TickerReport/status/855366583946022912
1905,Benzinga,@Benzinga,2017-04-19T13:15:01.000Z,Leading Biosciences Execs Talk About How The Company Could Save Hospitals Millions Of Dollars Per Year https://benzinga.com/z/9307049 $MRK $XLV,Leading Biosciences Execs Talk About How The Company Could Save Hospitals Millions Of Dollars Per Year https://benzinga.com/z/9307049 $MRK $XLV,,,,,[],https://twitter.com/Benzinga/status/854684762698633217
1906,dough,@semodough,2017-04-21T13:55:31.000Z,"Replying to 
@senhorblade","Replying to 
@senhorblade
agree $PRTK mcap of 500M to low - add cUTI later on and see no reason why $AGN or $MRK will not take this out 2-3 times higher
1
5",,,1,5,[],https://twitter.com/semodough/status/855419730441768962
1907,Palisade Bio,@PalisadeBio,2017-04-20T00:52:17.000Z,"Leading Biosciences Execs Talk About Saving Hospitals Millions of Dollars Each Year https://benzinga.com/z/9307049 $MRK $XLV via 
@benzinga","Leading Biosciences Execs Talk About Saving Hospitals Millions of Dollars Each Year https://benzinga.com/z/9307049 $MRK $XLV via 
@benzinga
benzinga.com
Exclusive: Leading Biosciences Execs Talk About How The Company Could Save Hospitals Millions Of...
Leading Biosciences is a small biopharmaceutical company focused on addressing the breakdown of the intestinal mucosal barrier using a simple technology platform. While privately...
1",,,,1,[],https://twitter.com/PalisadeBio/status/854860237920018433
1908,dough,@semodough,2017-04-22T18:52:03.000Z,Upcoming PDUFA Dates $MRK $IBB $GILD $RDUS $OCUL,"Upcoming PDUFA Dates $MRK $IBB $GILD $RDUS $OCUL
2
10
23",,2,10,23,['https://pbs.twimg.com/media/C-CdKnVWAAEWd6s?format=jpg&name=900x900'],https://twitter.com/semodough/status/855856745280929792
1909,pharmalot,@pharmalot,2017-04-24T14:30:06.000Z,Bristol-Myers Squibb's chief strategy officer will be leaving amid a management shuffle.. https://statnews.com/pharmalot/2017/04/24/bristol-myers-chief-strategy-officer/‚Ä¶ #pharma $BMY $MRK #cancer,"Bristol-Myers Squibb's chief strategy officer will be leaving amid a management shuffle.. https://statnews.com/pharmalot/2017/04/24/bristol-myers-chief-strategy-officer/‚Ä¶ #pharma $BMY $MRK #cancer
statnews.com
Bristol-Myers shuffles management and its chief strategy officer is leaving
This marks the second time in as many months the company has made key managerial changes in the wake of setbacks involving its Opdivo cancer drug.
4
3",,,4,3,['https://pbs.twimg.com/card_img/1498071732237787140/9CUWY7Vr?format=png&name=small'],https://twitter.com/pharmalot/status/856515597148053504
1910,Jeffrey Weber,@jjjinvesting,2017-04-23T20:43:19.000Z,"3 Things In Biotech You Should Learn Today: April 22, 2017 https://seekingalpha.com/article/4064310-3-things-biotech-learn-today-april-22-2017?source=tweet‚Ä¶ $BGNE $BMY $GILD $MRK $XBIT","3 Things In Biotech You Should Learn Today: April 22, 2017 https://seekingalpha.com/article/4064310-3-things-biotech-learn-today-april-22-2017?source=tweet‚Ä¶ $BGNE $BMY $GILD $MRK $XBIT
1
1",,,1,1,[],https://twitter.com/jjjinvesting/status/856247133174980608
1911,bill eijgenberger,@weijgenberger,2017-04-24T12:15:24.000Z,Dogs Of The Dow Falling Further Behind https://seekingalpha.com/article/4064473-dogs-dow-falling-behind?source=tweet‚Ä¶ $BA $CSCO $MRK $KO $PFE $CAT $IBM $VZ $XOM $CVX,"Dogs Of The Dow Falling Further Behind https://seekingalpha.com/article/4064473-dogs-dow-falling-behind?source=tweet‚Ä¶ $BA $CSCO $MRK $KO $PFE $CAT $IBM $VZ $XOM $CVX
1
1",,,1,1,[],https://twitter.com/weijgenberger/status/856481699949142016
1912,Bio Stocks‚Ñ¢,@BioStocks,2017-04-24T11:04:39.000Z,"$PDLI Announces Settlement of Keytruda Patent Infringement Lawsuit with $MRK
$MRK to pay $19.5M 
https://finance.yahoo.com/news/pdl-biopharma-announces-settlement-keytruda-110000733.html‚Ä¶","$PDLI Announces Settlement of Keytruda Patent Infringement Lawsuit with $MRK
$MRK to pay $19.5M 
https://finance.yahoo.com/news/pdl-biopharma-announces-settlement-keytruda-110000733.html‚Ä¶
1",,,1,,[],https://twitter.com/BioStocks/status/856463896764395520
1913,Seeking Alpha,@SeekingAlpha,2017-04-24T12:15:53.000Z,Incyte: Little Upside Left https://seekingalpha.com/article/4064517-incyte-little-upside-left?source=feed_f‚Ä¶ $BMY $LLY $MRK $INCY,"Incyte: Little Upside Left https://seekingalpha.com/article/4064517-incyte-little-upside-left?source=feed_f‚Ä¶ $BMY $LLY $MRK $INCY
seekingalpha.com
Incyte: Little Upside Left (NASDAQ:INCY)
Despite a recent 20% pullback, I don‚Äôt think that Incyte‚Äôs valuation is attractive.",,,,,[],https://twitter.com/SeekingAlpha/status/856481822443577344
1914,FierceBiotech,@FierceBiotech,2017-04-24T08:40:52.000Z,Merck-backed NGM Bio hits its marks in midstage NASH trial: http://ow.ly/4IK230b6Nnv $MRK $GILD $BMS,"Merck-backed NGM Bio hits its marks in midstage NASH trial: http://ow.ly/4IK230b6Nnv $MRK $GILD $BMS
fiercebiotech.com
Merck-backed NGM Bio hits its marks in midstage NASH trial
Fierce 15 company NGM Bio says it met its primary endpoint of reducing liver fat in NASH patients, with hints of antifibrotic activ | Fierce 15 company NGM Bio says it met its primary endpoint of...
2
1",,,2,1,['https://pbs.twimg.com/card_img/1499660815292641281/A2AIgRJJ?format=jpg&name=small'],https://twitter.com/FierceBiotech/status/856427712579334145
1915,Danny Vena,@dannyvena,2017-04-24T19:33:09.000Z,#Bigtech Is #Takingon #Diabetes - $AAPL $AMZN $IBM $MRK $mdt #echo #AWS #Watson #AppleWatch #alexadiabeteschallenge,"#Bigtech Is #Takingon #Diabetes - $AAPL $AMZN $IBM $MRK $mdt #echo #AWS #Watson #AppleWatch #alexadiabeteschallenge
fool.com
Big Tech Is Taking on Diabetes @themotleyfool #stocks $MRK $AMZN $AAPL $IBM $MDT
The combination of big tech and healthcare may be an unlikely matchup, but as these collaborations become more prevalent, patients will be the ultimate beneficiaries.
1
2",,,1,2,['https://pbs.twimg.com/card_img/1499217509362413577/cMwPzJiW?format=jpg&name=small'],https://twitter.com/dannyvena/status/856591862580166656
1916,George Marcovits,@GemsBot,2017-04-22T09:31:10.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/80885114#80885141‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/80885114#80885141‚Ä¶,,,,,['https://pbs.twimg.com/media/C-AczADU0AEDcsj?format=jpg&name=small'],https://twitter.com/GemsBot/status/855715594204852224
1917,Quantcha Trade Ideas,@QuantchaIdeas,2017-04-24T16:20:13.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/04/24/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/04/24/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk/‚Ä¶,,,,,['https://pbs.twimg.com/media/C-MNmaPVYAADi-g?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/856543310009257984
1918,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-04-22T17:00:11.000Z,"3 Things In Biotech You Should Learn Today: April 22, 2017 $BGNE $BMY $GILD $MRK $XBIT http://dlvr.it/NyHc2X #Investing #Stocks","3 Things In Biotech You Should Learn Today: April 22, 2017 $BGNE $BMY $GILD $MRK $XBIT http://dlvr.it/NyHc2X #Investing #Stocks",,,,,['https://pbs.twimg.com/media/C-CDkP-V0AA72Uk?format=jpg&name=small'],https://twitter.com/AlertTrade/status/855828591291977729
1919,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-04-22T16:31:28.000Z,"#FU $MRK - you're being sued by your own whistle-blowing #vaccine scientists bc
#MMR shot little to no efficacy - high adverse reactions. ","#FU $MRK - you're being sued by your own whistle-blowing #vaccine scientists bc
#MMR shot little to no efficacy - high adverse reactions. 
Merck
@Merck
 ¬∑ 18 Apr 2017
We're committed to #InventingForLife. Want to learn why? Visit: http://merck.com/inventing-for-life/home.html‚Ä¶",ü§¢,,,,"['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg', 'https://pbs.twimg.com/media/C9tntf8XkAAD0aV?format=jpg&name=small']",https://twitter.com/ZimJay/status/855821365030649856
1920,Pharmaceutical News,@pharma_sector,2017-04-24T22:21:25.000Z,#Merck & Co. Announces New Phase II Data On Investigational Triple Combination Therapy MK-36... Read more: http://owler.us/acAPGZ $MRK,"#Merck & Co. Announces New Phase II Data On Investigational Triple Combination Therapy MK-36... Read more: http://owler.us/acAPGZ $MRK
1",,,1,,[],https://twitter.com/pharma_sector/status/856634209665900544
1921,finsents,@finsents,2017-04-23T11:14:30.000Z,"$MRK:US Vident Investment Advisory LLC Boosts Stake in Merck & Co., Inc. (MRK) #MERCK & CO  http://tinyurl.com/mqsuhzz #SP500","$MRK:US Vident Investment Advisory LLC Boosts Stake in Merck & Co., Inc. (MRK) #MERCK & CO  http://tinyurl.com/mqsuhzz #SP500",,,,,[],https://twitter.com/finsents/status/856103984830054401
1922,Jack Allen,@JohnK_Allen,2017-04-23T20:13:45.000Z,Thursday $BMY earnings will be watching for Eliquis growth and NSCLC potential erosion of Opdivo by Keytruda $MRK,"Thursday $BMY earnings will be watching for Eliquis growth and NSCLC potential erosion of Opdivo by Keytruda $MRK
Andy Biotech
@AndyBiotech
 ¬∑ 23 Apr 2017
#Biotech Busy wk ahead!

$AKTX PNH
$AEZS P3
$CAPR DMD
$NTRP P2
$INCY Vitiligo

Earnings
T $BIIB
W $AMGN
R $ABBV $ALXN $BMY $CELG $VRTX $SRPT",,,,,['https://pbs.twimg.com/profile_images/378800000074240482/d961ebeb9f4fe6b084a68663b9a36738_mini.png'],https://twitter.com/JohnK_Allen/status/856239691892445184
1923,Pharmaceutical News,@pharma_sector,2017-04-24T21:53:01.000Z,#Merck FDA Approves 2nd Near-Copy of Remicade for Immune Disorders. Read more: http://owler.us/acAPxw $MRK,#Merck FDA Approves 2nd Near-Copy of Remicade for Immune Disorders. Read more: http://owler.us/acAPxw $MRK,,,,,[],https://twitter.com/pharma_sector/status/856627060629884928
1924,TalkMarkets,@TalkMarkets,2017-04-24T14:03:29.000Z,"Premarket #Biotech Digest - BDX Finalizes Acquisition Deal, VNLPF Receives CRL, EYEG Files S-1 $BCR $JNJ $MRK $NVO https://goo.gl/rw0ovm","Premarket #Biotech Digest - BDX Finalizes Acquisition Deal, VNLPF Receives CRL, EYEG Files S-1 $BCR $JNJ $MRK $NVO https://goo.gl/rw0ovm
1",,,,1,[],https://twitter.com/TalkMarkets/status/856508899238838272
1925,Fractaurean,@Fractaurean,2017-04-24T14:32:02.000Z,Dogs Of The Dow Falling Further Behind https://seekingalpha.com/article/4064473-dogs-dow-falling-behind?source=tweet‚Ä¶ $BA $CSCO $MRK $KO $PFE $CAT $IBM $VZ $XOM $CVX,Dogs Of The Dow Falling Further Behind https://seekingalpha.com/article/4064473-dogs-dow-falling-behind?source=tweet‚Ä¶ $BA $CSCO $MRK $KO $PFE $CAT $IBM $VZ $XOM $CVX,,,,,[],https://twitter.com/Fractaurean/status/856516085721567232
1926,FiercePharma,@FiercePharma,2017-04-24T22:40:00.000Z,Samsung biosim nod sets J&J's Remicade up for tough fight with Merck and Pfizer http://fiercepharma.com/pharma/samsung-biosim-nod-sets-j-j-s-remicade-up-for-tough-fight-merck-and-pfizer‚Ä¶ $MRK $PFE $JNJ,"Samsung biosim nod sets J&J's Remicade up for tough fight with Merck and Pfizer http://fiercepharma.com/pharma/samsung-biosim-nod-sets-j-j-s-remicade-up-for-tough-fight-merck-and-pfizer‚Ä¶ $MRK $PFE $JNJ
fiercepharma.com
Samsung biosim nod sets J&J's Remicade up for tough fight with Merck and Pfizer
Johnson & Johnson has kept a positive attitude about its blockbuster immunology drug Remicade and the biosimilar competition it‚Äôs facing. | Johnson & Johnson has kept a positive attitude about its...
1
1",,,1,1,[],https://twitter.com/FiercePharma/status/856638885505269760
1927,cowenresearch,@CowenResearch,2017-04-24T10:34:54.000Z,Steve Scala highlights major #pharma #ASCO17 abstracts $AZN $BMY $MRK $LLY $PFE $RHHBY,"Steve Scala highlights major #pharma #ASCO17 abstracts $AZN $BMY $MRK $LLY $PFE $RHHBY
1",,,,1,[],https://twitter.com/CowenResearch/status/856456406005936128
1928,Carmichael Fisher Executive Search,@CFExecSearch,2017-04-24T10:15:05.000Z,"3 Things In Biotech You Should Learn Today: April 24, 2017 https://seekingalpha.com/article/4064492-3-things-biotech-learn-today-april-24-2017?source=tweet‚Ä¶ $ATRA $GLMD $MRK $NASH $NVS","3 Things In Biotech You Should Learn Today: April 24, 2017 https://seekingalpha.com/article/4064492-3-things-biotech-learn-today-april-24-2017?source=tweet‚Ä¶ $ATRA $GLMD $MRK $NASH $NVS",,,,,[],https://twitter.com/CFExecSearch/status/856451421289558016
1929,Dakota Financial,@dakotafinancial,2017-04-24T16:07:33.000Z,"Ibex Wealth Advisors Raises Stake in Merck & Co., Inc. $MRK http://zpr.io/PwpdW","Ibex Wealth Advisors Raises Stake in Merck & Co., Inc. $MRK http://zpr.io/PwpdW",,,,,[],https://twitter.com/dakotafinancial/status/856540123860791296
1930,Daily Political,@dailypoliticaln,2017-04-24T10:21:26.000Z,"Security Asset Management Has $904,000 Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1034043","Security Asset Management Has $904,000 Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1034043",,,,,[],https://twitter.com/dailypoliticaln/status/856453017012510722
1931,Dakota Financial,@dakotafinancial,2017-04-24T21:11:38.000Z,"Merck & Co., Inc. $MRK Stake Boosted by Employees Retirement System of Texas http://zpr.io/PbJWQ","Merck & Co., Inc. $MRK Stake Boosted by Employees Retirement System of Texas http://zpr.io/PbJWQ",,,,,[],https://twitter.com/dakotafinancial/status/856616645590167552
1932,9/11 No Planer,@911NoPlaner,2017-04-24T01:58:05.000Z,"Thousands Sue #Merck for #Shingles #Vaccine ‚ÄúCausing What It‚Äôs Supposed to Prevent‚Äù http://po.st/AIyGEl via 
@po_st
 $mrk #vaccines","Thousands Sue #Merck for #Shingles #Vaccine ‚ÄúCausing What It‚Äôs Supposed to Prevent‚Äù http://po.st/AIyGEl via 
@po_st
 $mrk #vaccines",ü•∂,,,,[],https://twitter.com/911NoPlaner/status/856326346951323652
1933,Fiercelywashyourhands,@PharmaceuticBen,2017-04-24T08:40:56.000Z,Merck-backed NGM Bio hits its marks in midstage NASH trial: http://ow.ly/4IK230b6Nnv $MRK $GILD $BMS,"Merck-backed NGM Bio hits its marks in midstage NASH trial: http://ow.ly/4IK230b6Nnv $MRK $GILD $BMS
fiercebiotech.com
Merck-backed NGM Bio hits its marks in midstage NASH trial
Fierce 15 company NGM Bio says it met its primary endpoint of reducing liver fat in NASH patients, with hints of antifibrotic activ | Fierce 15 company NGM Bio says it met its primary endpoint of...",,,,,['https://pbs.twimg.com/card_img/1499660815292641281/A2AIgRJJ?format=jpg&name=small'],https://twitter.com/PharmaceuticBen/status/856427726495940608
1934,Watchlist News,@WatchlistN,2017-04-24T10:21:21.000Z,"62,065 Shares in Merck & Co., Inc. $MRK Acquired by Lincoln Capital Corp http://zpr.io/PwqXv","62,065 Shares in Merck & Co., Inc. $MRK Acquired by Lincoln Capital Corp http://zpr.io/PwqXv",,,,,[],https://twitter.com/WatchlistN/status/856452997227925504
1935,Ticker Report,@TickerReport,2017-04-23T10:09:16.000Z,"AE Wealth Management LLC Acquires Shares of 29,568 Merck & Co., Inc. $MRK http://ift.tt/2oB7QAp","AE Wealth Management LLC Acquires Shares of 29,568 Merck & Co., Inc. $MRK http://ift.tt/2oB7QAp",,,,,[],https://twitter.com/TickerReport/status/856087568378720256
1936,Ticker Report,@TickerReport,2017-04-23T10:24:20.000Z,"Vident Investment Advisory LLC Boosts Stake in Merck & Co., Inc. $MRK http://ift.tt/2pS6van","Vident Investment Advisory LLC Boosts Stake in Merck & Co., Inc. $MRK http://ift.tt/2pS6van",,,,,[],https://twitter.com/TickerReport/status/856091360629313537
1937,1 min Stock Insights,@1MinuteStock,2017-04-23T02:23:03.000Z,We calculated 21-day Expected Return of $MRK for you: -2.57% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=expreturn&utm_source=twitter‚Ä¶,We calculated 21-day Expected Return of $MRK for you: -2.57% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=expreturn&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/855970240089513986
1938,wininstocks2014,@wininstocks2014,2017-04-24T06:51:02.000Z,"$SWM See what others are saying! Subscribe to this YouTube Channel for more info on: $MRK $BMTC $JMBA

Go Here:  http://dlvr.it/NysyPW","$SWM See what others are saying! Subscribe to this YouTube Channel for more info on: $MRK $BMTC $JMBA

Go Here:  http://dlvr.it/NysyPW",,,,,[],https://twitter.com/wininstocks2014/status/856400070547128320
1939,Ben Fidler,@BentheFidler,2017-04-22T16:43:55.000Z,"Pursuing Larger Rivals, NGM Bio Tries To Make Mark On Fatty Livers http://xconomy.com/san-francisco/2017/04/22/pursuing-larger-rivals-ngm-bio-tries-to-make-mark-on-fatty-livers/‚Ä¶ by 
@alexlash
 #NASH $ICPT $GILD $MRK","Pursuing Larger Rivals, NGM Bio Tries To Make Mark On Fatty Livers http://xconomy.com/san-francisco/2017/04/22/pursuing-larger-rivals-ngm-bio-tries-to-make-mark-on-fatty-livers/‚Ä¶ by 
@alexlash
 #NASH $ICPT $GILD $MRK
1
5",,,1,5,[],https://twitter.com/BentheFidler/status/855824499882721280
1940,Watchlist News,@WatchlistN,2017-04-22T11:51:39.000Z,"Merck & Co., Inc. $MRK Receives Underperform Rating from Jefferies Group LLC http://zpr.io/PDBE2","Merck & Co., Inc. $MRK Receives Underperform Rating from Jefferies Group LLC http://zpr.io/PDBE2",,,,,[],https://twitter.com/WatchlistN/status/855750948047781888
1941,US Banking News,@AmericanBanking,2017-04-23T15:12:10.000Z,Merck & Co.'s outperform rating reiterated at BMO Capital Markets. $70.00 PT. http://ift.tt/2pTonV8 $MRK #MRK,Merck & Co.'s outperform rating reiterated at BMO Capital Markets. $70.00 PT. http://ift.tt/2pTonV8 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/856163794594222080
1942,Stock Forums,@stock_forums,2017-04-24T01:43:36.000Z,"$MTU Share your opinions here Subscribe to this YouTube Channel for more info on: $DY $MRK $MYOK

Go Here:  http://dlvr.it/Nynx83","$MTU Share your opinions here Subscribe to this YouTube Channel for more info on: $DY $MRK $MYOK

Go Here:  http://dlvr.it/Nynx83",,,,,[],https://twitter.com/stock_forums/status/856322699877990400
1943,US Banking News,@AmericanBanking,2017-04-23T20:04:51.000Z,Merck & Co. $MRK Earns Daily Coverage Optimism Score of -0.02 http://ift.tt/2p6XMBe,Merck & Co. $MRK Earns Daily Coverage Optimism Score of -0.02 http://ift.tt/2p6XMBe,,,,,[],https://twitter.com/AmericanBanking/status/856237450749988864
1944,MarketBeat,@MarketBeatCom,2017-04-24T14:33:37.000Z,"Security Asset Management Has $904,000 Position in Merck & Co., Inc. $MRK http://zpr.io/PwzeJ","Security Asset Management Has $904,000 Position in Merck & Co., Inc. $MRK http://zpr.io/PwzeJ",,,,,[],https://twitter.com/MarketBeatCom/status/856516481911332864
1945,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-04-22T16:33:40.000Z,"Replying to 
@Merck","Replying to 
@Merck
#Divest   #Boycott $MRK  Shameless Corporate Griftopia  #Divest
#divest
2",,,,2,[],https://twitter.com/ZimJay/status/855821917231734785
1946,MarketBeat,@MarketBeatCom,2017-04-24T21:11:38.000Z,"Lyell Wealth Management LP Purchases New Stake in Merck & Co., Inc. $MRK http://zpr.io/PbJQU","Lyell Wealth Management LP Purchases New Stake in Merck & Co., Inc. $MRK http://zpr.io/PbJQU",,,,,[],https://twitter.com/MarketBeatCom/status/856616645573439490
1947,StockNews.com,@stocknewsdotcom,2017-04-22T00:29:29.000Z,"$MRK FDA has approved Renflexis, a second near-copy of Remicade, used for rheumatoid arthritis and other immune sy‚Ä¶ https://stocknews.com/news/mrk-fda-has-approved-renflexis-a-second-near-copy-of-remicade-used/‚Ä¶","$MRK FDA has approved Renflexis, a second near-copy of Remicade, used for rheumatoid arthritis and other immune sy‚Ä¶ https://stocknews.com/news/mrk-fda-has-approved-renflexis-a-second-near-copy-of-remicade-used/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/855579272756563969
1948,TalkMarkets,@TalkMarkets,2017-04-23T00:25:10.000Z,18 Drugs To Lose Patents In 2017; Could Jeopardize $26.5B For Big Pharma $AZN $BMY $GSK $LLY $MRK $PFE $SNY  https://goo.gl/KBJ2cX,18 Drugs To Lose Patents In 2017; Could Jeopardize $26.5B For Big Pharma $AZN $BMY $GSK $LLY $MRK $PFE $SNY  https://goo.gl/KBJ2cX,,,,,[],https://twitter.com/TalkMarkets/status/855940577279475712
1949,SwingTradeBot,@SwingTradeBot,2017-04-22T10:08:11.000Z,"$MRK technical alerts: Lower Bollinger Band Walk, Bollinger Band Squeeze, and Stochastic Reached O...","$MRK technical alerts: Lower Bollinger Band Walk, Bollinger Band Squeeze, and Stochastic Reached O...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/855724908294352897
1950,TalkMarkets,@TalkMarkets,2017-04-22T19:40:13.000Z,Week In Review: Tianjin CanSino Closes $65 Million Round For Vaccine Portfolio $MRK $PFE $CELG $IONS $BGNE https://goo.gl/Z1Amhx,Week In Review: Tianjin CanSino Closes $65 Million Round For Vaccine Portfolio $MRK $PFE $CELG $IONS $BGNE https://goo.gl/Z1Amhx,,,,,[],https://twitter.com/TalkMarkets/status/855868865707954176
1951,Roy Friedman,@DewDiligence,2017-04-22T19:10:52.000Z,Hard2see how $MRK gets traction w 3-DAA regimen requiring 16w WITH ribavirin or 24w w/o riba‚Äîeven in DAA failures:,"Hard2see how $MRK gets traction w 3-DAA regimen requiring 16w WITH ribavirin or 24w w/o riba‚Äîeven in DAA failures:
investorshub.advfn.com
Biotech Values Post # 210801
1
1",,1,,1,[],https://twitter.com/DewDiligence/status/855861480385916928
1952,Roy Friedman,@DewDiligence,2017-04-22T19:12:37.000Z,"Replying to 
@DewDiligence","Replying to 
@DewDiligence
Impotence of these data are reason $MRK took big writedown on MK-3682 (the Idenix nuke):

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=128959583‚Ä¶
$GILD $ABBV $ENTA
investorshub.advfn.com
Biotech Values Post # 209368
1",,,,1,[],https://twitter.com/DewDiligence/status/855861921945399296
1953,Roy Friedman,@DewDiligence,2017-04-24T22:10:03.000Z,"Replying to 
@adar170","Replying to 
@adar170
$MRK tried that (with Medco) but it didn't work out. If multiple drug cos jointly owned a PBM, would be antitrust issues.
2",,2,,,[],https://twitter.com/DewDiligence/status/856631349163282433
1954,Dakota Financial,@dakotafinancial,2017-04-24T21:11:38.000Z,"Lyell Wealth Management LP Purchases New Stake in Merck & Co., Inc. $MRK http://zpr.io/PbJQU","Lyell Wealth Management LP Purchases New Stake in Merck & Co., Inc. $MRK http://zpr.io/PbJQU",,,,,[],https://twitter.com/dakotafinancial/status/856616648224231426
1955,Rickkystocks,@rickkystocks1,2017-04-24T07:04:05.000Z,"$IMH Share your opinions here Subscribe to this YouTube Channel for more info on: $MRK $AXP $CVGI

Go Here:  http://dlvr.it/Nyt829","$IMH Share your opinions here Subscribe to this YouTube Channel for more info on: $MRK $AXP $CVGI

Go Here:  http://dlvr.it/Nyt829",,,,,[],https://twitter.com/rickkystocks1/status/856403352229257217
1956,Daily Political,@dailypoliticaln,2017-04-23T15:36:42.000Z,Merck & Co.‚Äôs $MRK Outperform Rating Reaffirmed at BMO Capital Markets http://dailypolitical.com/?p=1033002,Merck & Co.‚Äôs $MRK Outperform Rating Reaffirmed at BMO Capital Markets http://dailypolitical.com/?p=1033002,,,,,[],https://twitter.com/dailypoliticaln/status/856169969670905858
1957,Daily Political,@dailypoliticaln,2017-04-22T12:43:44.000Z,"Merck & Co., Inc. $MRK Receives Underperform Rating from Jefferies Group LLC http://dailypolitical.com/?p=1031444","Merck & Co., Inc. $MRK Receives Underperform Rating from Jefferies Group LLC http://dailypolitical.com/?p=1031444",,,,,[],https://twitter.com/dailypoliticaln/status/855764053339369472
1958,Watchlist News,@WatchlistN,2017-04-23T20:00:42.000Z,Merck & Co. $MRK Earns Daily Coverage Optimism Score of -0.02 http://zpr.io/PwHxr,Merck & Co. $MRK Earns Daily Coverage Optimism Score of -0.02 http://zpr.io/PwHxr,,,,,[],https://twitter.com/WatchlistN/status/856236408264110083
1959,ChinaBio¬Æ Group,@ChinaBio,2017-04-22T19:40:13.000Z,Week In Review: Tianjin CanSino Closes $65 Million Round For Vaccine Portfolio $MRK $PFE $CELG $IONS $BGNE https://goo.gl/Z1Amhx,"Week In Review: Tianjin CanSino Closes $65 Million Round For Vaccine Portfolio $MRK $PFE $CELG $IONS $BGNE https://goo.gl/Z1Amhx
1",,,,1,[],https://twitter.com/ChinaBio/status/855868866320314368
1960,tvp101,@tvp101,2017-04-24T05:16:34.000Z,"$ALSK Share your thoughts here Subscribe to this YouTube Channel for more info on: $KNX $MRK $PI

Go Here:  http://dlvr.it/NyrZK7","$ALSK Share your thoughts here Subscribe to this YouTube Channel for more info on: $KNX $MRK $PI

Go Here:  http://dlvr.it/NyrZK7",,,,,[],https://twitter.com/tvp101/status/856376295709487104
1961,Community Financial,@CFinancialNews,2017-04-22T16:27:38.000Z,"Merck & Co., Inc. $MRK Receives Underperform Rating from Jefferies Group LLC http://zpr.io/PDQZP","Merck & Co., Inc. $MRK Receives Underperform Rating from Jefferies Group LLC http://zpr.io/PDQZP",,,,,[],https://twitter.com/CFinancialNews/status/855820402517520384
1962,Meg Tirrell,@megtirrell,2017-04-26T18:28:20.000Z,"Biopharmas' overseas cash, from Evercore ISI's Umer Raffat
$AMGN $MRK $BMY $LLY $PFE $ABBV $CELG $GILD $BIIB","Biopharmas' overseas cash, from Evercore ISI's Umer Raffat
$AMGN $MRK $BMY $LLY $PFE $ABBV $CELG $GILD $BIIB
4
31
30",,4,31,30,['https://pbs.twimg.com/media/C-W97-AXYAAl3J9?format=jpg&name=small'],https://twitter.com/megtirrell/status/857300326122221568
1963,Matthew Herper,@matthewherper,2017-04-27T17:03:23.000Z,A Refreshing Voice At Bristol-Myers Squibb $BMY $MRK $AZN,"A Refreshing Voice At Bristol-Myers Squibb $BMY $MRK $AZN
forbes.com
A Refreshing Voice At Bristol-Myers Squibb
Bristol beat earnings forecasts -- and showed off its new R&D boss.
2
4
12",,2,4,12,[],https://twitter.com/matthewherper/status/857641337679728642
1964,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-04-25T17:18:45.000Z,"Oncologists await historic first: a pan-tumor predictive marker,for immunotherapy-Nature $JUNO $KITE $BMY $AZN $MRK https://nature.com/nbt/journal/v35/n4/full/nbt0417-297a.html‚Ä¶","Oncologists await historic first: a pan-tumor predictive marker,for immunotherapy-Nature $JUNO $KITE $BMY $AZN $MRK https://nature.com/nbt/journal/v35/n4/full/nbt0417-297a.html‚Ä¶
1
5
13",,1,5,13,[],https://twitter.com/DrPaulyDeSantis/status/856920427695939586
1965,Chuck Carnevale,@MarketsUpChuck,2017-04-27T14:17:18.000Z,"Merck: #Strong #Research And #Bolt-On #Acquisitions-Dividend Sleuth $MRK
https://seekingalpha.com/article/4064630-merck-strong-research-bolt-acquisitions‚Ä¶","Merck: #Strong #Research And #Bolt-On #Acquisitions-Dividend Sleuth $MRK
https://seekingalpha.com/article/4064630-merck-strong-research-bolt-acquisitions‚Ä¶
1",,,1,,['https://pbs.twimg.com/media/C-bOOuEXkAAAsnM?format=jpg&name=small'],https://twitter.com/MarketsUpChuck/status/857599540375023617
1966,pharmalot,@pharmalot,2017-04-26T18:18:45.000Z,"Strap on your parachutes, pharma faces a mini patent cliff.. how bad? read here.. https://statnews.com/pharmalot/2017/04/26/patent-cliff-biosimilars-generics/‚Ä¶ #pharma $MRK $PFE $BMY $AZN $LLY","Strap on your parachutes, pharma faces a mini patent cliff.. how bad? read here.. https://statnews.com/pharmalot/2017/04/26/patent-cliff-biosimilars-generics/‚Ä¶ #pharma $MRK $PFE $BMY $AZN $LLY
statnews.com
Strap on your parachutes, pharma faces a mini patent cliff
Over the next three years, 40 branded drugs sold by nine large drug makers ‚Äî totaling $60 billion in sales ‚Äî are likely to encounter generic competition.
5
4",,,5,4,[],https://twitter.com/pharmalot/status/857297914514874368
1967,Adam H. Schechter,@AdamHSchechter,2017-04-26T01:25:22.000Z,"Big Tech Is Taking on Diabetes 
@themotleyfool
 #stocks $AAPL, $IBM, $MRK, $AMZN, $MDT","Big Tech Is Taking on Diabetes 
@themotleyfool
 #stocks $AAPL, $IBM, $MRK, $AMZN, $MDT
fool.com
Big Tech Is Taking on Diabetes @themotleyfool #stocks $MRK $AMZN $AAPL $IBM $MDT
The combination of big tech and healthcare may be an unlikely matchup, but as these collaborations become more prevalent, patients will be the ultimate beneficiaries.
1
24
60",,1,24,60,['https://pbs.twimg.com/card_img/1501858931899273217/qtM5Bnni?format=jpg&name=small'],https://twitter.com/AdamHSchechter/status/857042887636393984
1968,Meg Tirrell,@megtirrell,2017-04-27T15:03:17.000Z,"""Highly likely to be much more similarities between these drugs than differences,"" $BMY says of PD-1s, citing ""totality of data"" $MRK","""Highly likely to be much more similarities between these drugs than differences,"" $BMY says of PD-1s, citing ""totality of data"" $MRK
4
5",,,4,5,[],https://twitter.com/megtirrell/status/857611112438800384
1969,Bursatil Biotech,@BursatilBiotech,2017-04-26T13:44:10.000Z,"Replying to 
@BursatilBiotech","Replying to 
@BursatilBiotech
Updated BioCalendar Part 2/3
$NVS $KITE $MRK $JUNO $BMY $TGTX $FATE $AFMD $AVXS $ADXS
2
1
8",,2,1,8,['https://pbs.twimg.com/media/C-V9DDqXsAMEoQy?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/857228814438608897
1970,"V.Lemoine, CFA",@VLemoine_,2017-04-25T06:57:41.000Z,#Merck KgA will divest its biosimilar business to #Fresenius SE in a EUR670m deal (plus single-digit royalties). EPS Accretive. $MRK $FRE,#Merck KgA will divest its biosimilar business to #Fresenius SE in a EUR670m deal (plus single-digit royalties). EPS Accretive. $MRK $FRE,,,,,['https://pbs.twimg.com/media/C-PWbhqXYAEu2Bs?format=jpg&name=small'],https://twitter.com/VLemoine_/status/856764130686107650
1971,Jack Allen,@JohnK_Allen,2017-04-27T11:22:55.000Z,"Opdivo $BMY beats consensus, may be a sign that Opdivo is fending off competition from Keytruda $MRK more effectively than anticipated","Opdivo $BMY beats consensus, may be a sign that Opdivo is fending off competition from Keytruda $MRK more effectively than anticipated
Brad Loncar
@bradloncar
 ¬∑ 27 Apr 2017
$BMY - the Opdivo number of $1,127M beat consensus which was right around a billion. https://investors.bms.com/iframes/press-releases/press-release-details/2017/Bristol-Myers-Squibb-Reports-First-Quarter-Financial-Results/default.aspx‚Ä¶
1
2",,,1,2,"['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg', 'https://pbs.twimg.com/media/C-ahs5-UwAA8x_5?format=jpg&name=small']",https://twitter.com/JohnK_Allen/status/857555655267405824
1972,Ravi Romo,@RaviRomo,2017-04-25T01:56:28.000Z,"Bleak Outlook for Big Drug Makers  https://wsj.com/articles/bleak-outlook-for-big-drug-makers-1493051153‚Ä¶ via 
@WSJ
$IBB $AMGN $AGN $MRK $BMY","Bleak Outlook for Big Drug Makers  https://wsj.com/articles/bleak-outlook-for-big-drug-makers-1493051153‚Ä¶ via 
@WSJ
$IBB $AMGN $AGN $MRK $BMY
wsj.com
Bleak Outlook for Big Drug Makers
Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.",,,,,[],https://twitter.com/RaviRomo/status/856688327621099520
1973,Bio&TechWebinar,@BioTechWebinar,2017-04-27T09:06:06.000Z,R&D big #pharma spendings $ROG $MRK $NVS $PFE $JNG... $CELG highest R&D Share of Revenue 2016,"R&D big #pharma spendings $ROG $MRK $NVS $PFE $JNG... $CELG highest R&D Share of Revenue 2016
John Carroll
@JohnCendpts
 ¬∑ 27 Apr 2017
Top for April now -
The top 15 spenders in the global drug R&D business: 2017
https://endpts.com/special/top-research-budgets-in-pharma-and-biotech/‚Ä¶
1",,,,1,['https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_mini.jpeg'],https://twitter.com/BioTechWebinar/status/857521224456556544
1974,Mike Sheikh,@breckskifan,2017-04-25T17:34:20.000Z,"$GALT commencing partnership. Question is who $ICPT, $BMY, $MRK, $AMGN, $REGN or maybe $GILD - Kramer talking about that this AM.","$GALT commencing partnership. Question is who $ICPT, $BMY, $MRK, $AMGN, $REGN or maybe $GILD - Kramer talking about that this AM.
G
@smokiemahoney
 ¬∑ 25 Apr 2017
https://seekingalpha.com/instablog/19785151-michael-sheikh/4982674-possible-japanese-drug-partner-deal‚Ä¶ article released td puts in perspective todays $GALT patent news and what it means for the co going fwd. #NASH
1",,,,1,['https://pbs.twimg.com/profile_images/1494747087954710528/GYTaV_YF_mini.jpg'],https://twitter.com/breckskifan/status/856924349164535809
1975,blackened,@blackened123,2017-04-26T00:53:30.000Z,"Replying to 
@MDAndersonNews","Replying to 
@MDAndersonNews
$NWBO DCVax could be applicable for all kinds of cancer. Phase 3 results about to be known. Combos with $BMY and $MRK. Linda Liau's trial.
2
8",,,2,8,[],https://twitter.com/blackened123/status/857034869309931520
1976,Greg5thTrad,@Greg5thTrad,2017-04-26T21:34:18.000Z,"$ Flows: Selling on Strength: Among stocks that were up WED, these had the largest net OUTFLOWS of money: $IWM $GDXJ $AIG $JNJ $HD $MRK top6","$ Flows: Selling on Strength: Among stocks that were up WED, these had the largest net OUTFLOWS of money: $IWM $GDXJ $AIG $JNJ $HD $MRK top6",,,,,['https://pbs.twimg.com/media/C-XopuHXgAECvqA?format=jpg&name=small'],https://twitter.com/Greg5thTrad/status/857347125268623361
1977,Jacob Plieth,@JacobPlieth,2017-04-27T06:50:36.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
Impower-150 Tecentriq + chemo + Avastin 1L NSCLC readout late Q3 $RHHBY $BMY $MRK
1",,,,1,['https://pbs.twimg.com/media/C-Zn_NTXgAEDaxl?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/857487123108302849
1978,1stOncology,@1stOncology,2017-04-26T12:12:31.000Z,PDL BioPharma $PDLI Announces Settlement of #Keytruda Patent Infringement Lawsuit with Merck $MRK http://1stoncology.com/blog/pdl-biopharma-announces-settlement-of-keytruda-patent-infringement-lawsuit-with-merck‚Ä¶,"PDL BioPharma $PDLI Announces Settlement of #Keytruda Patent Infringement Lawsuit with Merck $MRK http://1stoncology.com/blog/pdl-biopharma-announces-settlement-of-keytruda-patent-infringement-lawsuit-with-merck‚Ä¶
1",,,1,,[],https://twitter.com/1stOncology/status/857205749029765122
1979,Tuan Pham,@15minofPham,2017-04-27T03:33:06.000Z,Highest Call/Put ratio vs OI. CALL: $AAL $YELP $CMCSA $GILD $COG $STT $LL. PUT: $MRK $BMY $WYN $SCHW $ESRX $DPS  http://tinyurl.com/ls6vzw7,Highest Call/Put ratio vs OI. CALL: $AAL $YELP $CMCSA $GILD $COG $STT $LL. PUT: $MRK $BMY $WYN $SCHW $ESRX $DPS  http://tinyurl.com/ls6vzw7,‚û° ‚û°,,,,['https://pbs.twimg.com/media/C-Y5aSCUQAAoIVf?format=jpg&name=small'],https://twitter.com/15minofPham/status/857437421159538689
1980,Chameleon Options,@MC_OptionTrades,2017-04-26T16:39:18.000Z,"$MRK 16-Jun-17 62.5 Puts traded  8,200 times  for $1.3 Million in premium. http://tinyurl.com/mtu7wep","$MRK 16-Jun-17 62.5 Puts traded  8,200 times  for $1.3 Million in premium. http://tinyurl.com/mtu7wep",ü¶é,,,,['https://pbs.twimg.com/media/C-WlJe6XcAEi4CU?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/857272889002819585
1981,Volatility,@getvolatility,2017-04-26T22:41:47.000Z,"Unusual option activity alert: $NSC 55x average daily volume, $KMX 10x, $CMG 8x, $UAA 7x, $STZ 5x, $MRK 5x, $WYNN 5x","Unusual option activity alert: $NSC 55x average daily volume, $KMX 10x, $CMG 8x, $UAA 7x, $STZ 5x, $MRK 5x, $WYNN 5x
1",,,,1,[],https://twitter.com/getvolatility/status/857364109230301186
1982,Bursatil Biotech,@BursatilBiotech,2017-04-25T21:07:02.000Z,"$MRK will release efficacy & safety of Ph2 KEYNOTE-170 in r/r PMBCL on June 15th, 11 ET #ICML17","$MRK will release efficacy & safety of Ph2 KEYNOTE-170 in r/r PMBCL on June 15th, 11 ET #ICML17
1",,,,1,[],https://twitter.com/BursatilBiotech/status/856977876746473476
1983,Pharmaceutical News,@pharma_sector,2017-04-27T09:44:53.000Z,"EOR Risers: #Merck & Co., Inc., Pfizer Inc., The Coca-Cola Co, Travelers Companies Inc, Unit... Read more: http://owler.us/acBEQV $MRK","EOR Risers: #Merck & Co., Inc., Pfizer Inc., The Coca-Cola Co, Travelers Companies Inc, Unit... Read more: http://owler.us/acBEQV $MRK",,,,,[],https://twitter.com/pharma_sector/status/857530984085954560
1984,Pharmaceutical News,@pharma_sector,2017-04-27T20:40:14.000Z,"#Merck cholesterol drug Vytorin faces competition from Impax, Teva generics. Read more: http://owler.us/acBPSR $MRK","#Merck cholesterol drug Vytorin faces competition from Impax, Teva generics. Read more: http://owler.us/acBPSR $MRK",,,,,[],https://twitter.com/pharma_sector/status/857695910075158528
1985,The Options Insider,@Options,2017-04-26T20:45:09.000Z,"Most Active Stock Options For End Of Day April 26, 2017 - $BX, $NSC, $BAC, $MRK, $V
http://theoptionsinsider.com/active-stock-options-end-day-april-26-2017-bx-nsc-bac-mrk-v/‚Ä¶","Most Active Stock Options For End Of Day April 26, 2017 - $BX, $NSC, $BAC, $MRK, $V
http://theoptionsinsider.com/active-stock-options-end-day-april-26-2017-bx-nsc-bac-mrk-v/‚Ä¶
2",,,2,,[],https://twitter.com/Options/status/857334757465743361
1986,Community Financial,@CFinancialNews,2017-04-26T20:01:06.000Z,"26,200 Shares in Merck & Co., Inc. $MRK Acquired by Ativo Capital Management LLC http://zpr.io/PwCLx","26,200 Shares in Merck & Co., Inc. $MRK Acquired by Ativo Capital Management LLC http://zpr.io/PwCLx",,,,,[],https://twitter.com/CFinancialNews/status/857323674462023680
1987,Community Financial,@CFinancialNews,2017-04-27T02:58:28.000Z,"Merck & Co., Inc. $MRK Stake Reduced by Ladenburg Thalmann Financial Services Inc. http://zpr.io/PwkME","Merck & Co., Inc. $MRK Stake Reduced by Ladenburg Thalmann Financial Services Inc. http://zpr.io/PwkME",,,,,[],https://twitter.com/CFinancialNews/status/857428707522334722
1988,SWINGSTOCKTRADERS,@beleggersclub8,2017-04-25T15:21:14.000Z,"Stocks to watch today! $FCX, $C, $RF, $OFE, $ATI, $MRK, $RIG, $HBAN, $CTRP, $ENDP. http://swingstocktraders.com","Stocks to watch today! $FCX, $C, $RF, $OFE, $ATI, $MRK, $RIG, $HBAN, $CTRP, $ENDP. http://swingstocktraders.com",,,,,[],https://twitter.com/beleggersclub8/status/856890854581166080
1989,Limex,@LimexMe,2017-04-26T16:21:28.000Z,MRK ahead of earning: what should we wait for? http://bit.ly/2p4nd87 $MRK,"MRK ahead of earning: what should we wait for? http://bit.ly/2p4nd87 $MRK
whotrades.com
What's in Store for Merck (MRK) this Earnings Season?
Merck & Co., Inc. MRK will be reporting first-quarter 2017 earnings on May 2, before market opens. Last quarter, the company delivered a positive earnings surprise of 1.14%.‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/857268399688343556
1990,Limex,@LimexMe,2017-04-25T20:07:18.000Z,Tesaro Inc Bulls Need a Reality Check http://bit.ly/250417TSRO $TSRO $AZN $MRK $CLVS,"Tesaro Inc Bulls Need a Reality Check http://bit.ly/250417TSRO $TSRO $AZN $MRK $CLVS
whotrades.com
Tesaro Inc Bulls Need a Reality Check
Tesaro Inc (NASDAQ: TSRO) enjoyed its best summer ever last year, but lately, this biotech has had a case of the blues. Following a peak in February, the stock has lost more than a‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/856962845052997632
1991,Community Financial,@CFinancialNews,2017-04-27T02:10:41.000Z,"Princeton Portfolio Strategies Group LLC Has $6.024 Million Position in Merck & Co., Inc. $MRK http://zpr.io/PwkRY","Princeton Portfolio Strategies Group LLC Has $6.024 Million Position in Merck & Co., Inc. $MRK http://zpr.io/PwkRY",,,,,[],https://twitter.com/CFinancialNews/status/857416680686977025
1992,Alphadogspartan,@alphadogspartan,2017-04-26T18:50:08.000Z,A Clinical Road Less Traveled:Neurotrope Hopes To Succeed In Alzheimers Where Competitors Fail $BIIB $LLY $MRK http://benzinga.com/z/8962220 $ntrp,A Clinical Road Less Traveled:Neurotrope Hopes To Succeed In Alzheimers Where Competitors Fail $BIIB $LLY $MRK http://benzinga.com/z/8962220 $ntrp,,,,,[],https://twitter.com/alphadogspartan/status/857305813416849409
1993,1 min Stock Insights,@1MinuteStock,2017-04-27T05:11:02.000Z,Wondering about #sentiment indicator for $MRK? The Short Ratio is 1.87% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=shortratio&utm_source=twitter‚Ä¶,Wondering about #sentiment indicator for $MRK? The Short Ratio is 1.87% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=shortratio&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/857462067309281281
1994,Fractaurean,@Fractaurean,2017-04-25T15:18:47.000Z,"3% Dividend Yield Is Great, But What Else Do You Need? https://seekingalpha.com/article/4064574-3-percent-dividend-yield-great-else-need?source=tweet‚Ä¶ $CVX $GE $JNJ $JPM $KO $MRK $MSFT $ORC $PFE $PG $RSO $S $T","3% Dividend Yield Is Great, But What Else Do You Need? https://seekingalpha.com/article/4064574-3-percent-dividend-yield-great-else-need?source=tweet‚Ä¶ $CVX $GE $JNJ $JPM $KO $MRK $MSFT $ORC $PFE $PG $RSO $S $T",,,,,[],https://twitter.com/Fractaurean/status/856890235938066433
1995,US Banking News,@AmericanBanking,2017-04-26T10:37:25.000Z,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2ovtBq6 $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2ovtBq6 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/857181816708620288
1996,US Banking News,@AmericanBanking,2017-04-25T14:47:47.000Z,Merck KGaA given ‚Ç¨109.00 PT by Commerzbank Ag. neutral rating. http://ift.tt/2phBjDA $MRK #MRK,Merck KGaA given ‚Ç¨109.00 PT by Commerzbank Ag. neutral rating. http://ift.tt/2phBjDA $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/856882434058616833
1997,TalkMarkets,@TalkMarkets,2017-04-25T08:25:34.000Z,3 #IPOs To Watch For This Week $XRF $CLDR $ZYME Also $LLY $MRK $CELG $ORCL $YHOO $FB $GOOGL https://goo.gl/Cet5CQ,3 #IPOs To Watch For This Week $XRF $CLDR $ZYME Also $LLY $MRK $CELG $ORCL $YHOO $FB $GOOGL https://goo.gl/Cet5CQ,,,,,[],https://twitter.com/TalkMarkets/status/856786245967634433
1998,Biotech Millionaire,@biotechmillions,2017-04-25T16:14:50.000Z,$MRK $ZSAN hmmm $ZSAN could be a great match for $MRK,$MRK $ZSAN hmmm $ZSAN could be a great match for $MRK,,,,,[],https://twitter.com/biotechmillions/status/856904344142315520
1999,Watchlist News,@WatchlistN,2017-04-25T02:37:58.000Z,"Merck & Co., Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Analysts http://zpr.io/PwTwK","Merck & Co., Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Analysts http://zpr.io/PwTwK",,,,,[],https://twitter.com/WatchlistN/status/856698773430468608
2000,TalkMarkets,@TalkMarkets,2017-04-26T20:49:54.000Z,"Most Active #Stock Options For End Of Day - Wednesday, April 26 $BX $BAC $NSC $MRK $V https://goo.gl/Uhdn1t","Most Active #Stock Options For End Of Day - Wednesday, April 26 $BX $BAC $NSC $MRK $V https://goo.gl/Uhdn1t",,,,,[],https://twitter.com/TalkMarkets/status/857335951424724992
2001,Daily Political,@dailypoliticaln,2017-04-25T10:13:48.000Z,"Merck & Co., Inc. $MRK Stake Reduced by Aldebaran Financial Inc. http://dailypolitical.com/?p=1036378","Merck & Co., Inc. $MRK Stake Reduced by Aldebaran Financial Inc. http://dailypolitical.com/?p=1036378",,,,,[],https://twitter.com/dailypoliticaln/status/856813485891760130
2002,Daily Political,@dailypoliticaln,2017-04-27T10:18:14.000Z,"High Point Bank & Trust Co. Has $213,000 Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1040215","High Point Bank & Trust Co. Has $213,000 Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1040215",,,,,[],https://twitter.com/dailypoliticaln/status/857539376078835713
2003,1 min Stock Insights,@1MinuteStock,2017-04-27T04:46:02.000Z,We calculated 63-day Expected Return of $MRK for you: 2.02% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=expreturn&utm_source=twitter‚Ä¶,We calculated 63-day Expected Return of $MRK for you: 2.02% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=expreturn&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/857455777556164608
2004,Watchlist News,@WatchlistN,2017-04-27T21:25:00.000Z,"Brokerages Expect Merck & Co., Inc. $MRK to Announce $0.83 Earnings Per Share http://zpr.io/PwVUd","Brokerages Expect Merck & Co., Inc. $MRK to Announce $0.83 Earnings Per Share http://zpr.io/PwVUd",,,,,[],https://twitter.com/WatchlistN/status/857707174511902720
2005,Ticker Report,@TickerReport,2017-04-25T10:06:54.000Z,"Baltimore Washington Financial Advisors Inc. Raises Position in Merck & Co., Inc. $MRK http://zpr.io/PwNhW","Baltimore Washington Financial Advisors Inc. Raises Position in Merck & Co., Inc. $MRK http://zpr.io/PwNhW",,,,,[],https://twitter.com/TickerReport/status/856811748648734720
2006,Stoxline Investing,@stoxline,2017-04-25T14:40:50.000Z,$MRK Looking for an entry for next leg up. Six months target: 74.24.  http://stoxline.com/quote.php?symbol=MRK‚Ä¶,$MRK Looking for an entry for next leg up. Six months target: 74.24.  http://stoxline.com/quote.php?symbol=MRK‚Ä¶,,,,,[],https://twitter.com/stoxline/status/856880688771026944
2007,MarketBeat,@MarketBeatCom,2017-04-26T21:22:10.000Z,"Texas Yale Capital Corp. Boosts Stake in Merck & Co., Inc. $MRK http://zpr.io/P9tmj","Texas Yale Capital Corp. Boosts Stake in Merck & Co., Inc. $MRK http://zpr.io/P9tmj",,,,,[],https://twitter.com/MarketBeatCom/status/857344072977199104
2008,Market Realist,@MarketRealist,2017-04-25T20:58:41.000Z,Bristol-Myers Squibb‚Äôs 1Q17 Estimates: Expect Growth! http://marketrealist.com/?p=2050004 $BMY $IXJ $GILD $MRK,Bristol-Myers Squibb‚Äôs 1Q17 Estimates: Expect Growth! http://marketrealist.com/?p=2050004 $BMY $IXJ $GILD $MRK,,,,,[],https://twitter.com/MarketRealist/status/856975776020926464
2009,$peedyCalls,@SpeedyCalls,2017-04-25T17:45:26.000Z,"$MRK 60 Puts BUYING Activity expiring on 21st Jul, Vol 1000","$MRK 60 Puts BUYING Activity expiring on 21st Jul, Vol 1000",,,,,[],https://twitter.com/SpeedyCalls/status/856927142004654080
2010,$peedyCalls,@SpeedyCalls,2017-04-26T16:20:20.000Z,"$MRK 62.5 Puts SELLING Activity expiring on 16th Jun, Vol 8200","$MRK 62.5 Puts SELLING Activity expiring on 16th Jun, Vol 8200",,,,,[],https://twitter.com/SpeedyCalls/status/857268114760839172
2011,Market Realist,@MarketRealist,2017-04-26T13:08:05.000Z,What Analysts Predict for AstraZeneca‚Äôs 1Q17 Earnings http://marketrealist.com/?p=2051558 $AZN $IOO $JNJ $MRK,What Analysts Predict for AstraZeneca‚Äôs 1Q17 Earnings http://marketrealist.com/?p=2051558 $AZN $IOO $JNJ $MRK,,,,,[],https://twitter.com/MarketRealist/status/857219732759621632
2012,Tom Silver,@TomSilver39,2017-04-25T03:52:52.000Z,$MRK Pembrolizumab in Non‚ÄìSmall-Cell Lung Cancer ‚Äî NEJM,"$MRK Pembrolizumab in Non‚ÄìSmall-Cell Lung Cancer ‚Äî NEJM
nejm.org
Pembrolizumab in Non‚ÄìSmall-Cell Lung Cancer | NEJM
Correspondence from The New England Journal of Medicine ‚Äî Pembrolizumab in Non‚ÄìSmall-Cell Lung Cancer
1",,,1,,['https://pbs.twimg.com/card_img/1484888102825078786/cdYRWrBr?format=png&name=240x240'],https://twitter.com/TomSilver39/status/856717618912165888
2013,Lisa LaMotta,@lisalamotta,2017-04-26T12:35:32.000Z,$MRK pays $19.5M to settle patent suit related to Keytruda https://law360.com/lifesciences/articles/916286/merck-settles-keytruda-patent-suit-for-19-5m?nl_pk=96756cca-70dd-416d-9a3c-bc5ed205267b&utm_source=newsletter&utm_medium=email&utm_campaign=lifesciences‚Ä¶ #cancer #PD1 #mercksmoneymaker,"$MRK pays $19.5M to settle patent suit related to Keytruda https://law360.com/lifesciences/articles/916286/merck-settles-keytruda-patent-suit-for-19-5m?nl_pk=96756cca-70dd-416d-9a3c-bc5ed205267b&utm_source=newsletter&utm_medium=email&utm_campaign=lifesciences‚Ä¶ #cancer #PD1 #mercksmoneymaker
law360.com
Merck Settles Keytruda Patent Suit For $19.5M - Law360
Merck Sharp & Dohme Corp. and PDL BioPharma Inc. have called a truce in a patent infringement dispute over Merck's cancer drug Keytruda, as the companies announced Monday that Merck will pay $19.5...",,,,,['https://pbs.twimg.com/card_img/1499869781440163840/GWEQGnrF?format=png&name=240x240'],https://twitter.com/lisalamotta/status/857211542152122368
2014,The Options Insider,@Options,2017-04-26T16:55:38.000Z,"Hot Options Report For Midday April 26, 2017 - $BAC, $MRK, $V, $CMCSA, $ABX, $TWTR, $ABBV, $ATVI
http://theoptionsinsider.com/hot-options-report-midday-april-26-2017-bac-mrk-v-cmcsa-abx-twtr-abbv-atvi/‚Ä¶","Hot Options Report For Midday April 26, 2017 - $BAC, $MRK, $V, $CMCSA, $ABX, $TWTR, $ABBV, $ATVI
http://theoptionsinsider.com/hot-options-report-midday-april-26-2017-bac-mrk-v-cmcsa-abx-twtr-abbv-atvi/‚Ä¶
1",,,,1,[],https://twitter.com/Options/status/857276997202055168
2015,Market Realist,@MarketRealist,2017-04-27T18:31:50.000Z,"Novartis's 1Q17 Earnings: Revenues Missed, Earnings Surpassed http://marketrealist.com/?p=2056729 $NVS $SNY $MRK $IOO","Novartis's 1Q17 Earnings: Revenues Missed, Earnings Surpassed http://marketrealist.com/?p=2056729 $NVS $SNY $MRK $IOO",,,,,[],https://twitter.com/MarketRealist/status/857663595521376257
2016,MarketBeat,@MarketBeatCom,2017-04-27T11:02:27.000Z,"Cowen and Company Reaffirms ‚ÄúMarket Perform‚Äù Rating for Merck & Co., Inc. $MRK http://zpr.io/P8d9w","Cowen and Company Reaffirms ‚ÄúMarket Perform‚Äù Rating for Merck & Co., Inc. $MRK http://zpr.io/P8d9w",,,,,[],https://twitter.com/MarketBeatCom/status/857550504469180416
2017,US Banking News,@AmericanBanking,2017-04-26T15:52:20.000Z,"Brokerages Expect Merck & Co., Inc. $MRK Will Announce Quarterly Sales of $9.29 Billion http://ift.tt/2oMsNZY","Brokerages Expect Merck & Co., Inc. $MRK Will Announce Quarterly Sales of $9.29 Billion http://ift.tt/2oMsNZY",,,,,[],https://twitter.com/AmericanBanking/status/857261066480386048
2018,MarketBeat,@MarketBeatCom,2017-04-26T21:22:24.000Z,"Merck & Co., Inc. $MRK Shares Sold by New York State Teachers Retirement System http://zpr.io/P9tEK","Merck & Co., Inc. $MRK Shares Sold by New York State Teachers Retirement System http://zpr.io/P9tEK",,,,,[],https://twitter.com/MarketBeatCom/status/857344133014409217
2019,Lisa LaMotta,@lisalamotta,2017-04-26T13:03:27.000Z,"The I/O market is changing rapidly, but crucial mistakes by $BMY and smart decision by $MRK made a major impact http://biopharmadive.com/news/biomarkers-bristol-myers-opdivo-lost-lung-cancer/435891/‚Ä¶","The I/O market is changing rapidly, but crucial mistakes by $BMY and smart decision by $MRK made a major impact http://biopharmadive.com/news/biomarkers-bristol-myers-opdivo-lost-lung-cancer/435891/‚Ä¶",,,,,[],https://twitter.com/lisalamotta/status/857218567493869568
2020,Dakota Financial,@dakotafinancial,2017-04-26T21:22:10.000Z,"Texas Yale Capital Corp. Boosts Stake in Merck & Co., Inc. $MRK http://zpr.io/P9tmj","Texas Yale Capital Corp. Boosts Stake in Merck & Co., Inc. $MRK http://zpr.io/P9tmj",,,,,[],https://twitter.com/dakotafinancial/status/857344075749617665
2021,Dakota Financial,@dakotafinancial,2017-04-27T11:02:28.000Z,"Cowen and Company Reaffirms ‚ÄúMarket Perform‚Äù Rating for Merck & Co., Inc. $MRK http://zpr.io/P8d9w","Cowen and Company Reaffirms ‚ÄúMarket Perform‚Äù Rating for Merck & Co., Inc. $MRK http://zpr.io/P8d9w",,,,,[],https://twitter.com/dakotafinancial/status/857550507505852416
2022,Dakota Financial,@dakotafinancial,2017-04-26T21:22:25.000Z,"Merck & Co., Inc. $MRK Shares Sold by New York State Teachers Retirement System http://zpr.io/P9tEK","Merck & Co., Inc. $MRK Shares Sold by New York State Teachers Retirement System http://zpr.io/P9tEK",,,,,[],https://twitter.com/dakotafinancial/status/857344135623299072
2023,Watchlist News,@WatchlistN,2017-04-26T14:47:55.000Z,"Brokerages Expect Merck & Co., Inc. $MRK Will Announce Quarterly Sales of $9.29 Billion http://zpr.io/PwDCL","Brokerages Expect Merck & Co., Inc. $MRK Will Announce Quarterly Sales of $9.29 Billion http://zpr.io/PwDCL",,,,,[],https://twitter.com/WatchlistN/status/857244858171392000
2024,Benzinga,@Benzinga,2017-04-25T18:01:01.000Z,Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates https://benzinga.com/z/9341495 $INCY $TXMD $MRK $IBB,"Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates https://benzinga.com/z/9341495 $INCY $TXMD $MRK $IBB
1",,,1,,[],https://twitter.com/Benzinga/status/856931063716827137
2025,Matthew Herper,@matthewherper,2017-04-27T15:33:20.000Z,"Replying to 
@DrMiguelPerales","Replying to 
@DrMiguelPerales
Roger Perlmutter at $MRK has said exactly the same thing to me, I'm pretty sure.
1
2",,,1,2,[],https://twitter.com/matthewherper/status/857618673799921666
2026,LeConte Wealth,@lecontewealth,2017-04-25T20:56:27.000Z,"Replying to 
@MarkYusko","Replying to 
@MarkYusko
I remember how hard it was to get clients to sell SOME $KO and $MRK in 99. Feels very similar today...
1
1
1",,1,1,1,[],https://twitter.com/lecontewealth/status/856975215238287361
2027,dough,@semodough,2017-04-25T16:28:16.000Z,"Replying to 
@senhorblade","Replying to 
@senhorblade
had no idea $NVS was even interested in the infectious area?   $MRK $PFE $AGN first ones that come to mind these days
1",,,,1,[],https://twitter.com/semodough/status/856907721534263297
2028,Brad Loncar,@bradloncar,2017-04-30T18:20:01.000Z,"155 calls this week

M: $EXEL $ZIOP
T: $GILD $MRK $PFE
W: $BPMC $CLVS $NVO
T: $BMRN $INCY $REGN
F: $ALNY

Full list: http://loncarblog.com/may-1-healthcare-earnings‚Ä¶","155 calls this week

M: $EXEL $ZIOP
T: $GILD $MRK $PFE
W: $BPMC $CLVS $NVO
T: $BMRN $INCY $REGN
F: $ALNY

Full list: http://loncarblog.com/may-1-healthcare-earnings‚Ä¶
9
22
51",,9,22,51,['https://pbs.twimg.com/media/C-m5HvaUAAAaBgU?format=jpg&name=small'],https://twitter.com/bradloncar/status/858747786313035776
2029,Stockrow,@stockrow1,2017-04-30T13:27:31.000Z,$GILD is the cheapest big pharma stock out there with a P/S of 2.9 $PFE $AMGN $BMY $MRK #investing #biotech,"$GILD is the cheapest big pharma stock out there with a P/S of 2.9 $PFE $AMGN $BMY $MRK #investing #biotech
2
2",,,2,2,['https://pbs.twimg.com/media/C-qfk60W0AI9r-i?format=jpg&name=small'],https://twitter.com/stockrow1/status/858674176546263040
2030,Faris Sleem,@TradeWithTechs,2017-04-30T20:06:20.000Z,"#Earnings Calendar
$AAPL $TSLA $FB $AMD $SHOP $CHK $S $TWX $YUM $GRPN $TWLO $EXEL $PFE $LL $MO $GILD $WTW $FEYE $MRK
http://tradewithtechs.com","#Earnings Calendar
$AAPL $TSLA $FB $AMD $SHOP $CHK $S $TWX $YUM $GRPN $TWLO $EXEL $PFE $LL $MO $GILD $WTW $FEYE $MRK
http://tradewithtechs.com
10
14",,,10,14,['https://pbs.twimg.com/media/C-r65GcXUAMqXRr?format=jpg&name=small'],https://twitter.com/TradeWithTechs/status/858774541425836032
2031,David Moadel,@davidmoadel,2017-04-28T20:21:53.000Z,$AAPL #Earnings next week include AAPL $PFE $MRK $MA $FB $AMD $COP #stockmarket #stocks #investing #finance $SPY $QQQ $DIA $DJIA #options $T,"$AAPL #Earnings next week include AAPL $PFE $MRK $MA $FB $AMD $COP #stockmarket #stocks #investing #finance $SPY $QQQ $DIA $DJIA #options $T
1
1",,,1,1,['https://pbs.twimg.com/media/C-hqxwRVYAAvENA?format=jpg&name=small'],https://twitter.com/davidmoadel/status/858053678904864769
2032,SF Education,@SFEducation,2017-04-28T17:47:42.000Z,7Drugmakers Relied on Price Hikes for 100% of Their Earnings Rise https://aff.whotrades.com/t/b/mqveg/ $AMGN $LLY $ABBV $MRK $PFE,7Drugmakers Relied on Price Hikes for 100% of Their Earnings Rise https://aff.whotrades.com/t/b/mqveg/ $AMGN $LLY $ABBV $MRK $PFE,,,,,['https://pbs.twimg.com/media/C-hH-0WWsAAJgM4?format=jpg&name=small'],https://twitter.com/SFEducation/status/858014876232544258
2033,WLST.com,@wlstcom,2017-04-28T19:48:14.000Z,"Despite Worries, Bristol-Myers Opdivo Keeps Racking Up Sales --  The Motley Fool $MRK #wlst https://fool.com/investing/2017/04/28/despite-worries-bristol-myers-opdivo-keeps-racking.aspx?yptr=yahoo‚Ä¶","Despite Worries, Bristol-Myers Opdivo Keeps Racking Up Sales --  The Motley Fool $MRK #wlst https://fool.com/investing/2017/04/28/despite-worries-bristol-myers-opdivo-keeps-racking.aspx?yptr=yahoo‚Ä¶",,,,,['https://pbs.twimg.com/media/C-hjkd7XsAEulx0?format=jpg&name=small'],https://twitter.com/wlstcom/status/858045208981901312
2034,WLST.com,@wlstcom,2017-04-30T15:52:00.000Z,5 Big Drugmakers With Important Catalysts in May --  The Motley Fool #usmf-health-care $MRK https://fool.com/investing/2017/04/30/5-big-drugmakers-with-important-catalysts-in-may.aspx?yptr=yahoo‚Ä¶,5 Big Drugmakers With Important Catalysts in May --  The Motley Fool #usmf-health-care $MRK https://fool.com/investing/2017/04/30/5-big-drugmakers-with-important-catalysts-in-may.aspx?yptr=yahoo‚Ä¶,,,,,['https://pbs.twimg.com/media/C-rArpZXcAAVx07?format=jpg&name=small'],https://twitter.com/wlstcom/status/858710536741105665
2035,TW Research Group,@DanCarlson33,2017-04-28T14:06:16.000Z,"If you care about #cancer #diagnostics, check out this CEO interview. New telomere technology $JNJ $MRK $PFE $NVS","If you care about #cancer #diagnostics, check out this CEO interview. New telomere technology $JNJ $MRK $PFE $NVS
youtube.com
3D Signature - Technology helps detect Hodgkin‚Äôs lymphoma & Alzheim...
3D Signatures‚Äô CEO Jason Flowerday shares the company‚Äôs latest progress in validating the disruptive technology behind the TeloView Platform and the upcoming...
1",,,,1,[],https://twitter.com/DanCarlson33/status/857959149694406656
2036,George Marcovits,@GemsBot,2017-04-29T13:23:49.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/81564986#81565076‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/81564986#81565076‚Ä¶,,,,,['https://pbs.twimg.com/media/C-lVLJrUwAAVwMY?format=jpg&name=small'],https://twitter.com/GemsBot/status/858310856639225856
2037,ExileOnBaySt,@ExileOnBaySt,2017-04-30T19:29:11.000Z,"Earnings:
M $DO $L
T $AAPL $MA $MRK $PFE $APC $COP $MO $CVS $HLT
W $FB $MET $AIG $TWX $TSLA $GRPN $TAP $SO $ICE
T $CBS $APA $CAB $K $DNKN","Earnings:
M $DO $L
T $AAPL $MA $MRK $PFE $APC $COP $MO $CVS $HLT
W $FB $MET $AIG $TWX $TSLA $GRPN $TAP $SO $ICE
T $CBS $APA $CAB $K $DNKN
2",,,,2,[],https://twitter.com/ExileOnBaySt/status/858765192313917442
2038,Media Sentiment¬Æ,@mediasentiment,2017-04-30T10:28:42.000Z,$MRK received a new alert. Find out why at http://mediasentiment.com #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 9,"$MRK received a new alert. Find out why at http://mediasentiment.com #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 9
mediasentiment.com
Media Sentiment, Inc.
Strictly speaking, we created the media sentiment field in 2001 and registered the media sentiment trademark in 2006. In 2013, we are shaping a new field for social media sentiment so news and...",,,,,['https://pbs.twimg.com/card_img/1498361770678931462/Y6UDGw-y?format=jpg&name=240x240'],https://twitter.com/mediasentiment/status/858629174545661952
2039,ChinaBio¬Æ Group,@ChinaBio,2017-04-29T17:45:32.000Z,Week In Review: Cathay Fortune Pays $186 Million For German Diagnostic Company $BMY $LLY $MRK $PFE $EPGNF $AMRI  https://goo.gl/lz5hnV,"Week In Review: Cathay Fortune Pays $186 Million For German Diagnostic Company $BMY $LLY $MRK $PFE $EPGNF $AMRI  https://goo.gl/lz5hnV
1",,,,1,[],https://twitter.com/ChinaBio/status/858376718289162240
2040,Pharmaceutical News,@pharma_sector,2017-04-28T17:32:04.000Z,#Merck New immuno-oncology dual therapy to begin clinical trials. Read more: http://owler.us/acB0Tq $MRK,#Merck New immuno-oncology dual therapy to begin clinical trials. Read more: http://owler.us/acB0Tq $MRK,,,,,[],https://twitter.com/pharma_sector/status/858010940897320960
2041,Pharmaceutical News,@pharma_sector,2017-04-28T17:27:44.000Z,"#Merck cholesterol drug Vytorin faces competition from Impax, Teva generics. Read more: http://owler.us/acB0Tr $MRK","#Merck cholesterol drug Vytorin faces competition from Impax, Teva generics. Read more: http://owler.us/acB0Tr $MRK",,,,,[],https://twitter.com/pharma_sector/status/858009852827770880
2042,Pharmaceutical News,@pharma_sector,2017-04-28T17:27:07.000Z,"Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Closes A Licensing Deal With #Merck & Co., Inc (NY... Read more: http://owler.us/acB0Ts $MRK","Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Closes A Licensing Deal With #Merck & Co., Inc (NY... Read more: http://owler.us/acB0Ts $MRK",,,,,[],https://twitter.com/pharma_sector/status/858009697336532992
2043,Sweet Platform,@SweetPlatform,2017-04-28T15:21:22.000Z,"MRK Top news - Apr 28th, 2017 $MRK http://https://goo.gl/adb7Wb","MRK Top news - Apr 28th, 2017 $MRK http://https://goo.gl/adb7Wb",,,,,[],https://twitter.com/SweetPlatform/status/857978049240997891
2044,Allison Gatlin,@IBD_AGatlin,2017-04-28T19:44:39.000Z,"Bristol-Myers beats Gilead, Merck to key approvals in China, Europe $BMY $GILD $MRK","Bristol-Myers beats Gilead, Merck to key approvals in China, Europe $BMY $GILD $MRK
investors.com
Bristol-Myers Beats Gilead, Merck To Key Approvals In China, Europe
Bristol-Myers grabbed a pair of wins Friday after China approved its hepatitis C regimen and Europe blessed immuno-oncology drug Opdivo in head-and-neck cancer.
1",,,1,,[],https://twitter.com/IBD_AGatlin/status/858044308183814144
2045,PolgarStocks,@PolgarStocks,2017-04-29T02:22:04.000Z,stockcharts: MRK 62.33    Updated: 04-28-2017 $MRK Last Trade: 4/28/2017 Last 62.33    Open 62.58 Previous C http://dlvr.it/P1FVrY,stockcharts: MRK 62.33    Updated: 04-28-2017 $MRK Last Trade: 4/28/2017 Last 62.33    Open 62.58 Previous C http://dlvr.it/P1FVrY,,,,,[],https://twitter.com/PolgarStocks/status/858144322981462016
2046,Langan Stocks,@langanstocks,2017-04-28T21:22:34.000Z,"leahanne: 16:14 ET Volume Leader #79 - MRK 9,413,093 Merck & Company $MRK 62.33 -0.25 -0.40% High today of 62.","leahanne: 16:14 ET Volume Leader #79 - MRK 9,413,093 Merck & Company $MRK 62.33 -0.25 -0.40% High today of 62.
investorshangout.com
16:14 ET Volume Leader #79 - MRK - Stock Info #4514609 - Investors Hangout
Stock Info: 16:14 ET Volume Leader #79 - MRK 9,413,093 Merck Company $MRK 62.33 -0.25 -0.40% High today of 62. - #4514609",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/langanstocks/status/858068951359606788
2047,Dakota Financial,@dakotafinancial,2017-04-30T04:02:54.000Z,"Bridgeworth LLC Takes Position in Merck & Co., Inc. $MRK http://zpr.io/PDtkw","Bridgeworth LLC Takes Position in Merck & Co., Inc. $MRK http://zpr.io/PDtkw",,,,,[],https://twitter.com/dakotafinancial/status/858532085119807488
2048,Rickkystocks,@rickkystocks1,2017-04-30T05:43:32.000Z,"$YRCW Share your opinions here Subscribe to this YouTube Channel for more info on: $MRK $I $HRC

Go Here:  http://dlvr.it/P1gv6D","$YRCW Share your opinions here Subscribe to this YouTube Channel for more info on: $MRK $I $HRC

Go Here:  http://dlvr.it/P1gv6D",,,,,[],https://twitter.com/rickkystocks1/status/858557408871718912
2049,Community Financial,@CFinancialNews,2017-04-28T02:24:21.000Z,"Round Hill Asset Management Buys Shares of 109,533 Merck & Co., Inc. $MRK http://zpr.io/PwWnX","Round Hill Asset Management Buys Shares of 109,533 Merck & Co., Inc. $MRK http://zpr.io/PwWnX",,,,,[],https://twitter.com/CFinancialNews/status/857782510088069120
2050,Community Financial,@CFinancialNews,2017-04-29T03:19:47.000Z,"Merck & Co., Inc. $MRK Shares Bought by Cypress Wealth Advisors LLC http://zpr.io/P3qSs","Merck & Co., Inc. $MRK Shares Bought by Cypress Wealth Advisors LLC http://zpr.io/P3qSs",,,,,[],https://twitter.com/CFinancialNews/status/858158845729878016
2051,Transcript Daily,@TranscriptDaily,2017-04-29T13:14:44.000Z,"Opus Point Partners Management LLC Holds Stake in Merck & Co., Inc. $MRK http://ift.tt/2pIAKnp","Opus Point Partners Management LLC Holds Stake in Merck & Co., Inc. $MRK http://ift.tt/2pIAKnp",,,,,[],https://twitter.com/TranscriptDaily/status/858308568977747968
2052,Community Financial,@CFinancialNews,2017-04-29T02:35:11.000Z,"United Capital Financial Advisers LLC Reduces Stake in Merck & Co., Inc. $MRK http://zpr.io/P3qh8","United Capital Financial Advisers LLC Reduces Stake in Merck & Co., Inc. $MRK http://zpr.io/P3qh8",,,,,[],https://twitter.com/CFinancialNews/status/858147624003809280
2053,Stock Charts,@stockcharts247,2017-04-29T02:19:18.000Z,MRK 62.33    Updated: 04-28-2017 $MRK Last Trade: 4/28/2017 Last 62.33    Open 62.58 Previous Close 62.3 https://investorshangout.com/post/view?id=4515650‚Ä¶,MRK 62.33    Updated: 04-28-2017 $MRK Last Trade: 4/28/2017 Last 62.33    Open 62.58 Previous Close 62.3 https://investorshangout.com/post/view?id=4515650‚Ä¶,,,,,[],https://twitter.com/stockcharts247/status/858143624038686720
2054,leahanne,@leahanneta,2017-04-28T21:04:40.000Z,"16:14 ET Volume Leader #79 - MRK 9,413,093 Merck & Company $MRK 62.33 -0.25 -0.40% High today of 62.65 day low","16:14 ET Volume Leader #79 - MRK 9,413,093 Merck & Company $MRK 62.33 -0.25 -0.40% High today of 62.65 day low
investorshangout.com
16:14 ET Volume Leader #79 - MRK - Stock Info #4514609 - Investors Hangout
Stock Info: 16:14 ET Volume Leader #79 - MRK 9,413,093 Merck Company $MRK 62.33 -0.25 -0.40% High today of 62. - #4514609",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/858064444835995652
2055,StockEarnings.com,@StocksEarning,2017-04-29T08:05:07.000Z,$MRK releasing Earnings on 5/2 Before Open (Confirmed). Anybody buying/selling in Earnings? http://ow.ly/Z3C130bgjwK,$MRK releasing Earnings on 5/2 Before Open (Confirmed). Anybody buying/selling in Earnings? http://ow.ly/Z3C130bgjwK,,,,,[],https://twitter.com/StocksEarning/status/858230651056685056
2056,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-04-29T13:23:56.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/8x6j4GLVq,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/8x6j4GLVq,,,,,[],https://twitter.com/gem_2014/status/858310886506856448
2057,Ticker Report,@TickerReport,2017-04-29T20:49:04.000Z,"Brokerages Anticipate Merck & Co., Inc. $MRK to Post $0.83 Earnings Per Share http://ift.tt/2qjKd1w","Brokerages Anticipate Merck & Co., Inc. $MRK to Post $0.83 Earnings Per Share http://ift.tt/2qjKd1w",,,,,[],https://twitter.com/TickerReport/status/858422906786902016
2058,Watchlist News,@WatchlistN,2017-04-30T10:23:18.000Z,"Cacti Asset Management LLC Boosts Position in Merck & Co., Inc. $MRK http://zpr.io/P3aVv","Cacti Asset Management LLC Boosts Position in Merck & Co., Inc. $MRK http://zpr.io/P3aVv",,,,,[],https://twitter.com/WatchlistN/status/858627816761565184
2059,nasdaqfan,@nasdaqfan,2017-04-30T04:57:04.000Z,"$HLIT What do you think about it? Subscribe to this YouTube Channel for more info on: $MRK $IBN $MHK

Go Here:  http://dlvr.it/P1gMZt","$HLIT What do you think about it? Subscribe to this YouTube Channel for more info on: $MRK $IBN $MHK

Go Here:  http://dlvr.it/P1gMZt",,,,,[],https://twitter.com/nasdaqfan/status/858545716909625344
2060,Limex,@LimexMe,2017-04-28T13:28:47.000Z,These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016 http://bit.ly/280417AMGN $AMGN $BIIB $AGN $PFE $LLY $MRK,"These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016 http://bit.ly/280417AMGN $AMGN $BIIB $AGN $PFE $LLY $MRK
whotrades.com
These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016
If I told you that drug companies lean on their exceptional pricing power to grow their top and bottom lines, it probably wouldn't come as a shock in the least. If you've picked up a‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/857949719477309443
2061,Stock Forums,@stock_forums,2017-04-30T02:21:07.000Z,"$LOXO Share your opinions here Subscribe to this YouTube Channel for more info on: $MRK $FCFP $DSX

Go Here:  http://dlvr.it/P1dfzf","$LOXO Share your opinions here Subscribe to this YouTube Channel for more info on: $MRK $FCFP $DSX

Go Here:  http://dlvr.it/P1dfzf",,,,,[],https://twitter.com/stock_forums/status/858506472514125824
2062,MarketBeat,@MarketBeatCom,2017-04-29T04:06:02.000Z,"Cypress Wealth Advisors LLC Has $1.631 Million Stake in Merck & Co., Inc. $MRK http://zpr.io/PDPb5","Cypress Wealth Advisors LLC Has $1.631 Million Stake in Merck & Co., Inc. $MRK http://zpr.io/PDPb5",,,,,[],https://twitter.com/MarketBeatCom/status/858170484755705856
2063,MarketBeat,@MarketBeatCom,2017-04-30T12:02:18.000Z,"Merck & Co., Inc. $MRK Shares Bought by Macquarie Group Ltd. http://zpr.io/P3Nu8","Merck & Co., Inc. $MRK Shares Bought by Macquarie Group Ltd. http://zpr.io/P3Nu8",,,,,[],https://twitter.com/MarketBeatCom/status/858652728490418176
2064,Market Realist,@MarketRealist,2017-04-28T18:18:32.000Z,Must-Read Notes on Eli Lilly &amp; Co.‚Äôs 1Q17 Earnings http://marketrealist.com/?p=2055819 $LLY $VHT $JNJ $MRK,Must-Read Notes on Eli Lilly &amp; Co.‚Äôs 1Q17 Earnings http://marketrealist.com/?p=2055819 $LLY $VHT $JNJ $MRK,,,,,[],https://twitter.com/MarketRealist/status/858022636701573122
2065,US Banking News,@AmericanBanking,2017-04-30T03:10:25.000Z,Somewhat Positive News Coverage Unlikely to Impact Merck & Co. $MRK Stock Price http://ift.tt/2oU6n8A,Somewhat Positive News Coverage Unlikely to Impact Merck & Co. $MRK Stock Price http://ift.tt/2oU6n8A,,,,,[],https://twitter.com/AmericanBanking/status/858518877860495360
2066,MarketBeat,@MarketBeatCom,2017-04-29T20:46:30.000Z,"Brokerages Anticipate Merck & Co., Inc. $MRK Will Announce Quarterly Sales of $9.29 Billion http://zpr.io/P3srG","Brokerages Anticipate Merck & Co., Inc. $MRK Will Announce Quarterly Sales of $9.29 Billion http://zpr.io/P3srG",,,,,[],https://twitter.com/MarketBeatCom/status/858422263284207620
2067,TalkMarkets,@TalkMarkets,2017-04-29T17:45:31.000Z,Week In Review: Cathay Fortune Pays $186 Million For German Diagnostic Company $BMY $LLY $MRK $PFE $EPGNF $AMRI  https://goo.gl/lz5hnV,Week In Review: Cathay Fortune Pays $186 Million For German Diagnostic Company $BMY $LLY $MRK $PFE $EPGNF $AMRI  https://goo.gl/lz5hnV,,,,,[],https://twitter.com/TalkMarkets/status/858376716926013440
2068,Paul R. La Monica,@LaMonicaBuzz,2017-04-28T17:01:35.000Z,April showers bring May earnings? Results next week from $BP $CVS $PFE $CHTR $MRK $AAPL $MDLZ $S $TWX $MET $FB $KHC $VIAB $CBS + many more,"April showers bring May earnings? Results next week from $BP $CVS $PFE $CHTR $MRK $AAPL $MDLZ $S $TWX $MET $FB $KHC $VIAB $CBS + many more
2
1
4",,2,1,4,[],https://twitter.com/LaMonicaBuzz/status/858003271138635777
2069,Watchlist News,@WatchlistN,2017-04-30T10:23:26.000Z,"Merck & Co., Inc. $MRK Shares Bought by Macquarie Group Ltd. http://zpr.io/P3aB6","Merck & Co., Inc. $MRK Shares Bought by Macquarie Group Ltd. http://zpr.io/P3aB6",,,,,[],https://twitter.com/WatchlistN/status/858627850655735808
2070,Zero Filter,@zerofiltertruth,2017-04-28T15:58:56.000Z,"Notable action #biotech lotto $AEZS

$XBI $CELG $MRK $BIIB $AMGN 
@jonnajarian
 @GuyAdami","Notable action #biotech lotto $AEZS

$XBI $CELG $MRK $BIIB $AMGN 
@jonnajarian
 @GuyAdami",,,,,[],https://twitter.com/zerofiltertruth/status/857987506075299840
2071,By Any Memes Necessary,@_21stCenturyCox,2017-04-28T12:10:18.000Z,"Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In... https://benzinga.com/z/8962220 $NTRP $BIIB $LLY $MRK  via 
@benzinga","Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In... https://benzinga.com/z/8962220 $NTRP $BIIB $LLY $MRK  via 
@benzinga
benzinga.com
Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors...
Alzheimer's has proven to be one of the most stubborn diseases known to modern medicine. An incurable, devastating illness that inspires frustration ‚Äî even anger...",,,,,[],https://twitter.com/_21stCenturyCox/status/857929966599712769
2072,Todd Campbell,@ebcapital,2017-04-29T14:40:59.000Z,"Despite Worries, Bristol-Myers' Opdivo Keeps Racking Up Sales 
@themotleyfool
 #stocks $MRK, $BMY","Despite Worries, Bristol-Myers' Opdivo Keeps Racking Up Sales 
@themotleyfool
 #stocks $MRK, $BMY
fool.com
Despite Worries, Bristol-Myers' Opdivo Keeps Racking Up Sales @themotleyfool #stocks $BMY $MRK
If you're not buying Bristol-Myers because of last year's Opdivo trial failure, you ought to reconsider.",,,,,[],https://twitter.com/ebcapital/status/858330277839556608
2073,blackened,@blackened123,2017-04-30T17:00:35.000Z,"@katieellias
 take a look at $NWBO 
@NorthwestBio
. Phase 3 cancer vaccine trial to end soon and everyone is doing better. $BMY $MRK buyout?","@katieellias
 take a look at $NWBO 
@NorthwestBio
. Phase 3 cancer vaccine trial to end soon and everyone is doing better. $BMY $MRK buyout?
2",,,,2,[],https://twitter.com/blackened123/status/858727793936535553
2074,Daily Political,@dailypoliticaln,2017-04-28T10:30:27.000Z,"Merck & Co., Inc. $MRK Shares Bought by Teachers Advisors LLC http://dailypolitical.com/?p=1043945","Merck & Co., Inc. $MRK Shares Bought by Teachers Advisors LLC http://dailypolitical.com/?p=1043945",,,,,[],https://twitter.com/dailypoliticaln/status/857904839107297280
2075,Dakota Financial,@dakotafinancial,2017-04-30T12:02:18.000Z,"Merck & Co., Inc. $MRK Shares Bought by Macquarie Group Ltd. http://zpr.io/P3Nu8","Merck & Co., Inc. $MRK Shares Bought by Macquarie Group Ltd. http://zpr.io/P3Nu8",,,,,[],https://twitter.com/dakotafinancial/status/858652730835034114
2076,Merck,@Merck,2017-05-02T13:00:32.000Z,A closing word from Ken Frazier on our 1Q financial results. $MRK,"A closing word from Ken Frazier on our 1Q financial results. $MRK
2
23
38",,2,23,38,['https://pbs.twimg.com/media/C-0j32SWAAAOK-g?format=jpg&name=small'],https://twitter.com/Merck/status/859392161414082560
2077,Matthew Herper,@matthewherper,2017-05-02T15:02:03.000Z,$MRK's Cancer Sales Soar In White-Hot Market,"$MRK's Cancer Sales Soar In White-Hot Market
forbes.com
Merck's Cancer Sales Soar In White-Hot Market
The drug giant Merck earned $1.55 billion on sales of $9.4 billion in the first quarter of 2017, both about even with the same period last year, as sales of cancer immunotherapy drug Keytruda reached...
1
9
4",,1,9,4,['https://pbs.twimg.com/card_img/1501727433766092802/O6kseshp?format=jpg&name=small'],https://twitter.com/matthewherper/status/859422741371473925
2078,Earnings Whispers,@eWhispers,2017-05-01T17:59:43.000Z,AM #earnings $SHOP $PFE $CVS $MA $BP $CHTR $MO $COP $LL $MRK $AET $COH $EPD $SHPG $AMAG $ADM $CMI $ECA $FLWS $HLT    http://eps.sh/cal,"AM #earnings $SHOP $PFE $CVS $MA $BP $CHTR $MO $COP $LL $MRK $AET $COH $EPD $SHPG $AMAG $ADM $CMI $ECA $FLWS $HLT    http://eps.sh/cal
9
16",,,9,16,['https://pbs.twimg.com/media/C-wnAS-XoAE_QPO?format=jpg&name=small'],https://twitter.com/eWhispers/status/859105064769728512
2079,pharmalot,@pharmalot,2017-05-03T12:59:50.000Z,Pharmalot.. Pharmalittle.. Good Morning.. Perrigo is raided by the feds & more news.. https://statnews.com/pharmalot/2017/05/03/perrigo-prices-astrazeneca-cancer/‚Ä¶ #pharma $PRGO $AZN $MRK $AMGN,"Pharmalot.. Pharmalittle.. Good Morning.. Perrigo is raided by the feds & more news.. https://statnews.com/pharmalot/2017/05/03/perrigo-prices-astrazeneca-cancer/‚Ä¶ #pharma $PRGO $AZN $MRK $AMGN
statnews.com
Pharmalot, Pharmalittle: Feds raid Perrigo in search of pricing information
Perrigo disclosed the Justice Department raided its corporate offices as part of an ongoing investigation into drug pricing in the pharmaceutical industry.
2",,,2,,['https://pbs.twimg.com/card_img/1495429675979612163/Dp8swySF?format=jpg&name=small'],https://twitter.com/pharmalot/status/859754371567034368
2080,Seeking Alpha,@SeekingAlpha,2017-05-02T20:14:42.000Z,Epizyme: Why Is Big Pharma Interested In This Small Biotech? https://seekingalpha.com/article/4067985-epizyme-big-pharma-interested-small-biotech?source=feed_f‚Ä¶ $CELG $GSK $MRK $NVS $SPPI $EPZM,"Epizyme: Why Is Big Pharma Interested In This Small Biotech? https://seekingalpha.com/article/4067985-epizyme-big-pharma-interested-small-biotech?source=feed_f‚Ä¶ $CELG $GSK $MRK $NVS $SPPI $EPZM
seekingalpha.com
Epizyme: Why Is Big Pharma Interested In This Small Biotech? (NASDAQ:EPZM)
Epizyme has million-dollar collaborations with a number of big pharma companies. The company does not yet have any Phase 2 results. However, the company is a pioneer in HMT inhibitors.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501727704961404932/vv2by7hG?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/859501422483718144
2081,Seeking Alpha,@SeekingAlpha,2017-05-03T16:05:23.000Z,Assessing Gilead's Positives And Negatives https://seekingalpha.com/article/4068470-assessing-gileads-positives-negatives?source=feed_f‚Ä¶ $ABBV $ALIOY $ALXN $CELG $IBB $JNJ $MRK $PFE $SPY $GILD,"Assessing Gilead's Positives And Negatives https://seekingalpha.com/article/4068470-assessing-gileads-positives-negatives?source=feed_f‚Ä¶ $ABBV $ALIOY $ALXN $CELG $IBB $JNJ $MRK $PFE $SPY $GILD
seekingalpha.com
Assessing Gilead's Positives And Negatives (NASDAQ:GILD)
GILD had another disappointing quarter, but at least it was not disastrous, and full-year guidance was maintained. Management is not acting as if it's on top of its game.",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/859801069068500992
2082,Sergio Garcia,@Sergio_Mesquite,2017-05-03T13:14:12.000Z,"Wall Street Breakfast: Fed Rate Hike Unlikely - https://seekingalpha.com/article/4068308?source=ansh‚Ä¶ $MRK $UAL  $VZ $GOOG, $GOOGL, $SNE, $TWTR $UBER  #business #markets","Wall Street Breakfast: Fed Rate Hike Unlikely - https://seekingalpha.com/article/4068308?source=ansh‚Ä¶ $MRK $UAL  $VZ $GOOG, $GOOGL, $SNE, $TWTR $UBER  #business #markets
1",,,,1,[],https://twitter.com/Sergio_Mesquite/status/859757987149357057
2083,Stockrow,@stockrow1,2017-05-01T16:19:04.000Z,$PFE and $MRK returns on invested capital are very low compared to $AMGN $JNJ $BMY #stocks #ValueInvesting #biotech,"$PFE and $MRK returns on invested capital are very low compared to $AMGN $JNJ $BMY #stocks #ValueInvesting #biotech
2",,,,2,['https://pbs.twimg.com/media/C-wQbQ_WAAE37T2?format=jpg&name=small'],https://twitter.com/stockrow1/status/859079737335050242
2084,Peter Schacknow,@peterschack,2017-05-02T13:20:53.000Z,"A dose of drug company earnings, and an upgrade for Hilton shareholders - today's stocks to watch: $MRK $PFE $HLT","A dose of drug company earnings, and an upgrade for Hilton shareholders - today's stocks to watch: $MRK $PFE $HLT
cnbc.com
Early movers: MRK, PFE, AET, HLT, BDX, COH, UAL, AZN & more
These are the stocks posting the largest moves before the bell.
1",,,,1,['https://pbs.twimg.com/card_img/1501219954124894213/mQfZN6WM?format=jpg&name=small'],https://twitter.com/peterschack/status/859397280356605953
2085,IPO Weekly,@IPOWeekly,2017-05-02T03:05:04.000Z,Commented on Biohaven Pharmaceuticals Seeks $125 Million IPO https://seekingalpha.com/article/4067595-biohaven-pharmaceuticals-seeks-125-million-ipo?source=tweet‚Ä¶ $ABT $AGN $AZN $BMY $ESALY $GSK $MRK $PFE $BHVN,"Commented on Biohaven Pharmaceuticals Seeks $125 Million IPO https://seekingalpha.com/article/4067595-biohaven-pharmaceuticals-seeks-125-million-ipo?source=tweet‚Ä¶ $ABT $AGN $AZN $BMY $ESALY $GSK $MRK $PFE $BHVN
seekingalpha.com
Biohaven Pharmaceuticals Seeks $125 Million IPO (NYSE:BHVN)
Biohaven Pharmaceuticals wants to raise $125 million in an IPO. The company is in late stage trials for migraine treatments, but won't have topline data until 2018.",,,,,[],https://twitter.com/IPOWeekly/status/859242305869316096
2086,Exact Option Picks,@ExactOptionPick,2017-05-02T11:22:58.000Z,"Don't miss our next FREE OPTION TRADE.  Sign up for our Daily Free Trades at http://ExactOptionPicks.com

$NVDA $TSLA $GS $PFE $MRK $AMD $FB","Don't miss our next FREE OPTION TRADE.  Sign up for our Daily Free Trades at http://ExactOptionPicks.com

$NVDA $TSLA $GS $PFE $MRK $AMD $FB
exactoptionpicks.com
Real Time Option Trades Every Trading Day of the Year
We isolate the most promising set-up w/the best profit-potential each morning and then deliver the pick to your inbox within 90 minutes of the opening bell.
2",,,2,,[],https://twitter.com/ExactOptionPick/status/859367609262891008
2087,Colin Macleod,@scalpthatstock,2017-05-02T12:14:57.000Z,"Earning Reports Before The Bell May 2 2017

http://scalpthatstock.com/earnings-before-the-bell-may-2-2017/‚Ä¶

$PFE $MRK $MO $MA $CHTR $CVS $COP $EPD $SHPG $AET $BDX $EMR","Earning Reports Before The Bell May 2 2017

http://scalpthatstock.com/earnings-before-the-bell-may-2-2017/‚Ä¶

$PFE $MRK $MO $MA $CHTR $CVS $COP $EPD $SHPG $AET $BDX $EMR
1",,,,1,[],https://twitter.com/scalpthatstock/status/859380687907864576
2088,"David Settle, CMT",@davidsettle42,2017-05-02T14:16:13.000Z,"Apple Watch: All Eyes on iPhone Maker, But Don‚Äôt Forget Auto Sales, Fed Mtg http://fw.to/iTFlHQc via 
@TDAJJKinahan
 $AAPL $GOOG $MRK $PFE","Apple Watch: All Eyes on iPhone Maker, But Don‚Äôt Forget Auto Sales, Fed Mtg http://fw.to/iTFlHQc via 
@TDAJJKinahan
 $AAPL $GOOG $MRK $PFE
4
5",,,4,5,[],https://twitter.com/davidsettle42/status/859411207609999361
2089,Scutify,@scutify,2017-05-01T15:56:03.000Z,Check out The IAm Jim Cramer App for iPhone (http://goo.gl/SmQ0dx) & Android (http://goo.gl/Pr2wTT) $DIS $MRK $AKAM $QQQ $JNUG $FB $UA,"Check out The IAm Jim Cramer App for iPhone (http://goo.gl/SmQ0dx) & Android (http://goo.gl/Pr2wTT) $DIS $MRK $AKAM $QQQ $JNUG $FB $UA
1",,,,1,['https://pbs.twimg.com/media/C-wLLkGXgAE9UJ_?format=jpg&name=240x240'],https://twitter.com/scutify/status/859073943852003328
2090,MM+M Magazine,@MMMnews,2017-05-03T03:15:01.000Z,"5 things for #pharma #marketers to know: Tues., May 2 $MRK $AZN #FDA $LLY #drugpricing #PBMs #NIH #Trump #healthcare http://bit.ly/2p4Ce7z","5 things for #pharma #marketers to know: Tues., May 2 $MRK $AZN #FDA $LLY #drugpricing #PBMs #NIH #Trump #healthcare http://bit.ly/2p4Ce7z
1",,,,1,['https://pbs.twimg.com/media/C-1RMNLWAAAvJ09?format=jpg&name=small'],https://twitter.com/MMMnews/status/859607197247995906
2091,MM+M Magazine,@MMMnews,2017-05-03T11:30:00.000Z,Missed yesterday's news? Here's what to know #pharma $MRK $AZN #FDA $LLY #drugpricing #PBMs #NIH #Trump #healthcare http://bit.ly/2p4Ce7z,"Missed yesterday's news? Here's what to know #pharma $MRK $AZN #FDA $LLY #drugpricing #PBMs #NIH #Trump #healthcare http://bit.ly/2p4Ce7z
1",,,,1,['https://pbs.twimg.com/media/C-1RX5cXUAElGyF?format=jpg&name=small'],https://twitter.com/MMMnews/status/859731766269095936
2092,Hot Stocks NYC,@HotStocks_NYC,2017-05-03T12:12:39.000Z,Good Earnings : $MOH $FEYE $OCLR $MOH $TWX $GIB $MYGN $FSLR $HUBS $WCG $YUM $PAPA $WTW $NDLZ $OCN $MRK $CVS $CLVT $VSH $GRMN $NLPR $EL $PZZA,"Good Earnings : $MOH $FEYE $OCLR $MOH $TWX $GIB $MYGN $FSLR $HUBS $WCG $YUM $PAPA $WTW $NDLZ $OCN $MRK $CVS $CLVT $VSH $GRMN $NLPR $EL $PZZA
1
1",,,1,1,[],https://twitter.com/HotStocks_NYC/status/859742496229924865
2093,Biotech Supernova,@biotechnova,2017-05-03T13:23:15.000Z,"$BMY Cut to underperform at BMO after PFE CEO warns of binary risk and competitor data notably $MRK Keytruda combo approval, + $INCY IDO","$BMY Cut to underperform at BMO after PFE CEO warns of binary risk and competitor data notably $MRK Keytruda combo approval, + $INCY IDO
1",,,,1,[],https://twitter.com/biotechnova/status/859760266493517828
2094,TradingWins.com,@TradingWins,2017-05-01T22:42:17.000Z,"Lost Opportunity? - Market Update by Vince Vora for May 1st, 2017 #stocks $GOOGL $AAPL $TLT $MRK $PFE $MA...","Lost Opportunity? - Market Update by Vince Vora for May 1st, 2017 #stocks $GOOGL $AAPL $TLT $MRK $PFE $MA...
youtube.com
Lost Opportunity? - Market Update May 1st, 2017
In tonight's update, Vince covers:1. Monday's choppy session leads to a mixed close for stocks.2. Both bonds and gold do the unexpected but is there still an...
2",,,2,,['https://pbs.twimg.com/card_img/1501621093970464774/QLrlZAZS?format=jpg&name=240x240'],https://twitter.com/TradingWins/status/859176173145911300
2095,thinkorswim¬Æ,@thinkorswim,2017-05-01T18:18:15.000Z,"Earnings Preview: A healthcare checkup with Q1 results from $PFE, $MRK, and $GILD on tap for tomorrow http://bit.ly/2pPXrWM #earnings","Earnings Preview: A healthcare checkup with Q1 results from $PFE, $MRK, and $GILD on tap for tomorrow http://bit.ly/2pPXrWM #earnings
3",,,,3,['https://pbs.twimg.com/media/C-wrvw5V0AAtPjX?format=jpg&name=small'],https://twitter.com/thinkorswim/status/859109730391805955
2096,Benzinga,@Benzinga,2017-05-02T11:00:00.000Z,"12 Stocks To Watch For May 2, 2017 https://benzinga.com/z/9381662 $AAPL $ADM $AMD $PFE $MA $IAC $CVS $GILD $MDLZ $MRK $COH","12 Stocks To Watch For May 2, 2017 https://benzinga.com/z/9381662 $AAPL $ADM $AMD $PFE $MA $IAC $CVS $GILD $MDLZ $MRK $COH
benzinga.com
12 Stocks To Watch For May 2, 2017
Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer Inc. (NYSE: PFE) to report quarterly earnings at $0.67 per share on revenue of $13.09...
4
1",,,4,1,[],https://twitter.com/Benzinga/status/859361828484259841
2097,dough,@semodough,2017-05-03T01:52:10.000Z,"Replying to 
@megtirrell","Replying to 
@megtirrell
$MRK imho badly needs a few acquisitions also this year.  Plenty of cash flow to do them
2
3",,2,,3,['https://pbs.twimg.com/media/C-3dOQzWAAATR2L?format=jpg&name=small'],https://twitter.com/semodough/status/859586349300670469
2098,InvestorPlace,@InvestorPlace,2017-05-02T14:09:39.000Z,3 Big Stock Charts for Tuesday: $COH $MRK and $CMI -,"3 Big Stock Charts for Tuesday: $COH $MRK and $CMI -
investorplace.com
3 Big Stock Charts for Tuesday: Coach Inc (COH), Merck & Co., Inc. (MRK) and Cummins Inc. (CMI)
The market is reacting positively to Cummins (CMI) and Coach (COH), while Merck (MRK) has failed to impress traders.
1",,,,1,['https://pbs.twimg.com/card_img/1501679174540529668/hDd21fni?format=jpg&name=240x240'],https://twitter.com/InvestorPlace/status/859409552554569728
2099,"Jared Louis Wolff, MS",@jaredlouiswolff,2017-05-02T15:28:27.000Z,"Interesting breakdown for one of the hottest immunotherapies on the market, $MRK 's #Keytruda - nice find, @datamonitor_JA!","Interesting breakdown for one of the hottest immunotherapies on the market, $MRK 's #Keytruda - nice find, @datamonitor_JA!
Jack Allen
@JohnK_Allen
 ¬∑ 2 May 2017
$MRK Keytruda-US sales 40% NSCLC,30% melanoma,15% head/neck,15% other;75-80% in US PD-L1 tested;25% US NSCLC receive Keytruda 1L,15% 2L
$BMY
1",,,,1,['https://pbs.twimg.com/profile_images/894566706651078657/pw0zVPjN_mini.jpg'],https://twitter.com/jaredlouiswolff/status/859429385383927809
2100,FierceBiotech,@FierceBiotech,2017-05-01T11:24:25.000Z,Ex- $MRK research exec Robert Plenge jumps ship to $CELG -,"Ex- $MRK research exec Robert Plenge jumps ship to $CELG -
fiercebiotech.com
Ex-Merck R&D exec Robert Plenge jumps ship to Celgene
Robert Plenge is to take the plunge and leave his role at Merck as VP and head of translational medicine to take up a new position at Celgene to run its immunology R&D.  | Robert Plenge is to take...
1
1",,,1,1,[],https://twitter.com/FierceBiotech/status/859005583407681536
2101,ùêÉùêöùê≤ ùêìùê´ùêöùêùùêûùê´ùê¨ ùêÜùê´ùê®ùêÆùê©,@DayTradersGroup,2017-05-02T15:20:39.000Z,Unusually high call volumes today: $AMD $COH $YELP $MRK $MA $TRN $DBA $THC $SQ $ULTA,"Unusually high call volumes today: $AMD $COH $YELP $MRK $MA $TRN $DBA $THC $SQ $ULTA
5
2",,,5,2,[],https://twitter.com/DayTradersGroup/status/859427421896024064
2102,The Fly,@theflynews,2017-05-03T15:07:06.000Z,Bristol-Myers cut to sell with Pfizer takeover seen as unlikely $BMY $PFE $MRK,"Bristol-Myers cut to sell with Pfizer takeover seen as unlikely $BMY $PFE $MRK
thefly.com
Bristol-Myers cut to sell with Pfizer takeover seen as unlikely
The shares of Bristol-Mye... BMY, PFE, MRK
1",,,1,,['https://pbs.twimg.com/card_img/1501305764081721345/GcvAvZOJ?format=jpg&name=small'],https://twitter.com/theflynews/status/859786398861148160
2103,Hotpage News,@Hotpage_News,2017-05-02T12:59:43.000Z,EARLY MOVERS: $MRK $PFE $AET $HLT $BDX $COH $UAL $AZN $AMD $CVS $MO $THC $BP $TWTR $INFY $MS $MSFT $ANGI - CNBC http://hotpagenews.com/r/176384,"EARLY MOVERS: $MRK $PFE $AET $HLT $BDX $COH $UAL $AZN $AMD $CVS $MO $THC $BP $TWTR $INFY $MS $MSFT $ANGI - CNBC http://hotpagenews.com/r/176384
1",,,,1,[],https://twitter.com/Hotpage_News/status/859391954878160901
2104,Jacob Plieth,@JacobPlieth,2017-05-02T12:38:17.000Z,"Replying to 
@JacobPlieth
 and 
@EPVantage","Replying to 
@JacobPlieth
 and 
@EPVantage
$MRK confirms that Keynote-189 design does allow crossover. Key point vs eg $AZN Mystic study
2
2",,,2,2,[],https://twitter.com/JacobPlieth/status/859386559241572354
2105,Paul R. La Monica,@LaMonicaBuzz,2017-05-02T11:40:12.000Z,I want a new drug? Pfizer & Merck topped EPS estimates. Slight miss on revs for Pfizer. Beat for Merck. $PFE down 1% #premarket. $MRK flat.,"I want a new drug? Pfizer & Merck topped EPS estimates. Slight miss on revs for Pfizer. Beat for Merck. $PFE down 1% #premarket. $MRK flat.
2",,,2,,[],https://twitter.com/LaMonicaBuzz/status/859371944218591233
2106,Forbes Health,@forbeshealth,2017-05-02T19:45:02.000Z,"Sales of $MRK's Keytruda were $584M in the first quarter: http://on.forbes.com/601985q7F by 
@matthewherper","Sales of $MRK's Keytruda were $584M in the first quarter: http://on.forbes.com/601985q7F by 
@matthewherper
1",,,,1,['https://pbs.twimg.com/media/C-2JMhIWAAAqKF6?format=jpg&name=small'],https://twitter.com/forbeshealth/status/859493955309899776
2107,Joanne Fagg,@ByJoFagg,2017-05-02T15:14:03.000Z,After Imfinzi's approval in bladder cancer I looked at how crowded the space was getting http://epvantage.com/Universal/View.aspx?type=Story&id=703083&isEPVantage=yes‚Ä¶ # $AZN $RHHBY $MRK $BMY,After Imfinzi's approval in bladder cancer I looked at how crowded the space was getting http://epvantage.com/Universal/View.aspx?type=Story&id=703083&isEPVantage=yes‚Ä¶ # $AZN $RHHBY $MRK $BMY,,,,,[],https://twitter.com/ByJoFagg/status/859425763304538112
2108,Allison Gatlin,@IBD_AGatlin,2017-05-03T18:32:43.000Z,"Did Gilead just provide some ""Incyte"" into a potential deal? $GILD $INCY$BMY $MRK http://ow.ly/y5I930bpai5","Did Gilead just provide some ""Incyte"" into a potential deal? $GILD $INCY$BMY $MRK http://ow.ly/y5I930bpai5",,,,,[],https://twitter.com/IBD_AGatlin/status/859838143905837056
2109,Allison Gatlin,@IBD_AGatlin,2017-05-02T21:19:07.000Z,Gilead topples on consensus-lagging Q1 as hepatitis C sales lag $GILD $MRK $PFE $BMY http://ow.ly/8ZXu30bnlzU,Gilead topples on consensus-lagging Q1 as hepatitis C sales lag $GILD $MRK $PFE $BMY http://ow.ly/8ZXu30bnlzU,,,,,[],https://twitter.com/IBD_AGatlin/status/859517634278301696
2110,Stock Market Picks,@StockWebTrading,2017-05-03T13:09:54.000Z,"$KO $MCD $MMM $MRK $MSFT $NKE $PFE Long and short positions from the Dow Jones, up to 1800% since 2008. http://dowstocktips.com $DJIA $DIA","$KO $MCD $MMM $MRK $MSFT $NKE $PFE Long and short positions from the Dow Jones, up to 1800% since 2008. http://dowstocktips.com $DJIA $DIA",,,,,[],https://twitter.com/StockWebTrading/status/859756904234442752
2111,Allison Gatlin,@IBD_AGatlin,2017-05-03T19:12:08.000Z,"Bristol-Myers ""too risky"" to acquire as Merck, Roche pile on pressure $BMY $MRK $RHHBY $INCY $PFE","Bristol-Myers ""too risky"" to acquire as Merck, Roche pile on pressure $BMY $MRK $RHHBY $INCY $PFE
investors.com
Bristol-Myers 'Too Risky' To Acquire As Merck, Roche Pile On Pressure
Bristol-Myers is too risky to acquire as Merck and Roche pile on the pressure in immuno-oncology, an analyst argued Wednesday.",,,,,['https://pbs.twimg.com/card_img/1501727421162307588/coCEF6nf?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/859848065431293952
2112,Traders Community,@TradersCom,2017-05-02T17:27:03.000Z,#British Petroleum $BP #Earnings Summary May 2 2017K $AET $PFE $COP $CNX $CVS $ECA $LL $MA $MRK $SPX $SPY $QQQ http://traderscommunity.com/forum/index.php?topic=1359.msg7397#msg7397‚Ä¶,"#British Petroleum $BP #Earnings Summary May 2 2017K $AET $PFE $COP $CNX $CVS $ECA $LL $MA $MRK $SPX $SPY $QQQ http://traderscommunity.com/forum/index.php?topic=1359.msg7397#msg7397‚Ä¶
1",,,1,,[],https://twitter.com/TradersCom/status/859459231128354816
2113,MarketGlance,@MarketGlance,2017-05-02T12:26:54.000Z,"Early movers: $MRK, $PFE, $AET, $HLT, $BDX, $COH, $UAL, $AZN & more","Early movers: $MRK, $PFE, $AET, $HLT, $BDX, $COH, $UAL, $AZN & more
cnbc.com
Early movers: MRK, PFE, AET, HLT, BDX, COH, UAL, AZN & more
These are the stocks posting the largest moves before the bell.
1",,,,1,['https://pbs.twimg.com/card_img/1501219954124894213/mQfZN6WM?format=jpg&name=small'],https://twitter.com/MarketGlance/status/859383694733299712
2114,Benzinga,@Benzinga,2017-05-02T12:00:03.000Z,A Peek Into The Markets: U.S. Stock Futures Mostly Lower; Apple Earnings In Focus https://benzinga.com/z/9382526 $AAPL $AMD $ANGI $MRK $COH $PFE,"A Peek Into The Markets: U.S. Stock Futures Mostly Lower; Apple Earnings In Focus https://benzinga.com/z/9382526 $AAPL $AMD $ANGI $MRK $COH $PFE
benzinga.com
A Peek Into The Markets: U.S. Stock Futures Mostly Lower; Apple Earnings In Focus
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade. Apple Inc. (NASDAQ: AAPL) is set to release quarterly earnings after the closing bell. Data on...
2",,,2,,[],https://twitter.com/Benzinga/status/859376941656190976
2115,$peedyCalls,@SpeedyCalls,2017-05-01T20:44:26.000Z,"Pre-Market Earnings Report for May 2, 2017 : $PFE $MRK $MO $MA $CHTR $CVS $COP $EPD $SHPG $AET $BDX $EMR http://nasdaq.com/article/pre-market-earnings-report-for-may-2-2017-pfe-mrk-mo-ma-chtr-cvs-cop-epd-shpg-aet-bdx-emr-cm782272‚Ä¶ via 
@nasdaq","Pre-Market Earnings Report for May 2, 2017 : $PFE $MRK $MO $MA $CHTR $CVS $COP $EPD $SHPG $AET $BDX $EMR http://nasdaq.com/article/pre-market-earnings-report-for-may-2-2017-pfe-mrk-mo-ma-chtr-cvs-cop-epd-shpg-aet-bdx-emr-cm782272‚Ä¶ via 
@nasdaq
1",,,,1,[],https://twitter.com/SpeedyCalls/status/859146518263205889
2116,The Fly,@theflynews,2017-05-01T18:08:03.000Z,Notable companies reporting before tomorrow's open $PFE $MRK $MO $MA $BP $CVS $COP $EPD $SHPG $AET $EMR $ECL $PCG‚Ä¶,"Notable companies reporting before tomorrow's open $PFE $MRK $MO $MA $BP $CVS $COP $EPD $SHPG $AET $EMR $ECL $PCG‚Ä¶
thefly.com
Notable companies reporting before tomorrow's open
Notable companies reporti... PFE, MRK, MO, MA, BP, CVS, COP, EPD, SHPG, AET, EMR, ECL, PCG, ETN, HCA, FIS, ADM, CMI, COH
1",,,1,,['https://pbs.twimg.com/card_img/1501827093721608193/c2gtLy1C?format=jpg&name=small'],https://twitter.com/theflynews/status/859107161762287619
2117,Earnings News,@EPSGUID,2017-05-01T18:31:32.000Z,"Options are priced for bigger-than-average #earnings move for $MRK reporting 5/2/2017 via 
@eWhispers
 #volatility http://eps.sh/s/mrk","Options are priced for bigger-than-average #earnings move for $MRK reporting 5/2/2017 via 
@eWhispers
 #volatility http://eps.sh/s/mrk",,,,,[],https://twitter.com/EPSGUID/status/859113070215475206
2118,Earnings News,@EPSGUID,2017-05-02T10:53:57.000Z,"$MRK reported earnings of $0.88, consensus was $0.83, Earnings Whisper was $0.85 via 
@eWhispers
 #whisperbeat http://eps.sh/d/mrk","$MRK reported earnings of $0.88, consensus was $0.83, Earnings Whisper was $0.85 via 
@eWhispers
 #whisperbeat http://eps.sh/d/mrk",,,,,[],https://twitter.com/EPSGUID/status/859360305486467073
2119,eran cohen,@cool_eran,2017-05-03T03:22:53.000Z,"It happens when a value investor who doesn't know shit about pharma ""detects"" hidden value. They should've just bot $MRK ..","It happens when a value investor who doesn't know shit about pharma ""detects"" hidden value. They should've just bot $MRK ..",,,,,[],https://twitter.com/cool_eran/status/859609176863014912
2120,Estimize,@Estimize,2017-05-02T10:55:52.000Z,$MRK beats the Estimize EPS Consensus by 4c and the Estimize Revenue Consensus by $127.36M - http://estimize.com/mrk/fq1-2017?utm_content=beat_or_miss&utm_medium=tweet&utm_source=twitter‚Ä¶,$MRK beats the Estimize EPS Consensus by 4c and the Estimize Revenue Consensus by $127.36M - http://estimize.com/mrk/fq1-2017?utm_content=beat_or_miss&utm_medium=tweet&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/Estimize/status/859360787814641664
2121,Estimize,@Estimize,2017-05-02T10:55:53.000Z,Great work by Rylle who takes the win for $MRK beating 32 other analysts and the Wall Street Consensus - http://estimize.com/mrk/fq1-2017?utm_content=release_winner&utm_medium=tweet&utm_source=twitter‚Ä¶,Great work by Rylle who takes the win for $MRK beating 32 other analysts and the Wall Street Consensus - http://estimize.com/mrk/fq1-2017?utm_content=release_winner&utm_medium=tweet&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/Estimize/status/859360791253962754
2122,Benzinga,@Benzinga,2017-05-03T19:30:02.000Z,"Ahead Of Merck's Keytruda PDUFA Date, Analyst Says Expect Approval https://benzinga.com/z/9393743 $MRK","Ahead Of Merck's Keytruda PDUFA Date, Analyst Says Expect Approval https://benzinga.com/z/9393743 $MRK",,,,,[],https://twitter.com/Benzinga/status/859852568360493057
2123,Zacks.com,@ZacksResearch,2017-05-02T13:51:32.000Z,".
@TraceyRyniec
  takes a look at this week's most spectacular earnings charts. $MRK $ALL $PLNT $LCI $MA https://zacks.com/stock/news/258752/this-weeks-most-spectacular-earnings-charts‚Ä¶",".
@TraceyRyniec
  takes a look at this week's most spectacular earnings charts. $MRK $ALL $PLNT $LCI $MA https://zacks.com/stock/news/258752/this-weeks-most-spectacular-earnings-charts‚Ä¶",,,,,[],https://twitter.com/ZacksResearch/status/859404996697313280
2124,Brad Loncar,@bradloncar,2017-05-02T13:37:27.000Z,"Replying to 
@AU_Analyst13","Replying to 
@AU_Analyst13
Great, thank you. Looks like for $MRK it has changed a lot, quickly.
2",,,,2,[],https://twitter.com/bradloncar/status/859401449259794432
2125,Jacob Plieth,@JacobPlieth,2017-05-02T12:36:00.000Z,"Replying to 
@JacobPlieth
 and 
@matthewherper","Replying to 
@JacobPlieth
 and 
@matthewherper
That last $MRK reply didn't seem like an attempt to rein in expectations. 40% of Keytruda sales now coming from NSCLC
1",,,,1,[],https://twitter.com/JacobPlieth/status/859385985859289088
2126,Traders Community,@TradersCom,2017-05-01T18:36:21.000Z,Big #Earnings Tomorrow morning May 2 2017 $AET $BP $PFE $COP $CNX $CVS $ECA $LL $MA $MRK $SPX $DJIA $QQQ #drugs #oil http://traderscommunity.com/forum/index.php?topic=1359.0‚Ä¶,"Big #Earnings Tomorrow morning May 2 2017 $AET $BP $PFE $COP $CNX $CVS $ECA $LL $MA $MRK $SPX $DJIA $QQQ #drugs #oil http://traderscommunity.com/forum/index.php?topic=1359.0‚Ä¶
1",,,1,,[],https://twitter.com/TradersCom/status/859114283485081600
2127,Andy Biotech,@AndyBiotech,2017-05-06T15:00:26.000Z,"Is autoimmunity the Achilles' heel of cancer #immunotherapy?

by Carl June et al.
http://nature.com/nm/journal/v23/n5/full/nm.4321.html‚Ä¶
$BMY $MRK $AZN $PFE $RHHBY","Is autoimmunity the Achilles' heel of cancer #immunotherapy?

by Carl June et al.
http://nature.com/nm/journal/v23/n5/full/nm.4321.html‚Ä¶
$BMY $MRK $AZN $PFE $RHHBY
3
30
63",,3,30,63,"['https://pbs.twimg.com/media/C_JrzidXsAAVaI5?format=jpg&name=360x360', 'https://pbs.twimg.com/media/C_JsGh1WsAAiGQv?format=jpg&name=small']",https://twitter.com/AndyBiotech/status/860871887370555393
2128,Seeking Alpha,@SeekingAlpha,2017-05-04T12:16:19.000Z,Why Merck & Co. Is A Buy https://seekingalpha.com/article/4068960-merck-and-co-buy?source=feed_f‚Ä¶ $MRK,"Why Merck & Co. Is A Buy https://seekingalpha.com/article/4068960-merck-and-co-buy?source=feed_f‚Ä¶ $MRK
2
1",,,2,1,[],https://twitter.com/SeekingAlpha/status/860105808553668608
2129,Chelli Miller,@cmiller1225,2017-05-06T21:05:02.000Z,"Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2qA4EKv $MRK #Cancer 
@Merck","Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2qA4EKv $MRK #Cancer 
@Merck
8",,,8,,['https://pbs.twimg.com/media/C_LB3daWsAAikDh?format=jpg&name=small'],https://twitter.com/cmiller1225/status/860963640224223233
2130,dough,@semodough,2017-05-04T23:06:32.000Z,CS top pics big pharma $MRK $AGN $LLY $PFE $BMY $ABBV,"CS top pics big pharma $MRK $AGN $LLY $PFE $BMY $ABBV
2
5",,,2,5,['https://pbs.twimg.com/media/C_BKfbRVYAE7zee?format=jpg&name=small'],https://twitter.com/semodough/status/860269440411344897
2131,Brad Loncar,@bradloncar,2017-05-04T12:00:08.000Z,"$INCY IDO guidance is for all the additional $MRK (NSCLC, renal, bladder, H&N) and $BMY (NSCLC and H&N) pivotals to begin this year.","$INCY IDO guidance is for all the additional $MRK (NSCLC, renal, bladder, H&N) and $BMY (NSCLC and H&N) pivotals to begin this year.
1
6
6",,1,6,6,['https://pbs.twimg.com/media/C--xVIHUIAAf81x?format=jpg&name=medium'],https://twitter.com/bradloncar/status/860101736387817472
2132,Ozmosi,@OzmosiHealth,2017-05-05T16:02:02.000Z,We're starting to see the real market dynamics of #biosimilars. Keep an eye on $MRK launch in Oct. http://bit.ly/2p2TyO3 #pharma $JNJ,We're starting to see the real market dynamics of #biosimilars. Keep an eye on $MRK launch in Oct. http://bit.ly/2p2TyO3 #pharma $JNJ,,,,,['https://pbs.twimg.com/media/C_Ey7OtXYAEwx__?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/860524999114928133
2133,Jon Gardner,@ByJonGardner,2017-05-05T15:31:55.000Z,Dear Big Pharma: The health care bill on which you haven't engaged could block the tax bill that you want: http://ow.ly/sXKT30bsZE6 $PFE $MRK,"Dear Big Pharma: The health care bill on which you haven't engaged could block the tax bill that you want: http://ow.ly/sXKT30bsZE6 $PFE $MRK
5",,,5,,[],https://twitter.com/ByJonGardner/status/860517422968819712
2134,Donna Young,@DonnaYoungDC,2017-05-04T11:33:05.000Z,"Congrats! That's pretty awesome. 
#pharma #biotech $MRK $PFE $NVS $GSK #NTDs","Congrats! That's pretty awesome. 
#pharma #biotech $MRK $PFE $NVS $GSK #NTDs
Natasha Loder
@natashaloder
 ¬∑ 4 May 2017
OMG! @BillGates actually tweeted my piece. And I missed it! What a muppet. Anyway, read it. It is actually pretty good.  https://twitter.com/BillGates/status/855393429555208193‚Ä¶",üì∞ üòÄ,,,,['https://pbs.twimg.com/profile_images/1420030804617535488/v5ldEv6R_mini.jpg'],https://twitter.com/DonnaYoungDC/status/860094930936528896
2135,bored2tears,@bored2tears,2017-05-05T11:19:00.000Z,"EC approves #Merck's Keytruda for patients with hematologic malignancy.
http://twitthat.com/adFZq
$MRK 5/4 close: 63.38
#pharma #stocks","EC approves #Merck's Keytruda for patients with hematologic malignancy.
http://twitthat.com/adFZq
$MRK 5/4 close: 63.38
#pharma #stocks
1",,,1,,['https://pbs.twimg.com/media/C_DxzPSWAAEAiso?format=jpg&name=small'],https://twitter.com/bored2tears/status/860453773600329728
2136,dough,@semodough,2017-05-05T11:04:49.000Z,$MRK First Approval for KEYTRUDA in a Hematologic Malignancy in the EU,"$MRK First Approval for KEYTRUDA in a Hematologic Malignancy in the EU
Merck
@Merck
 ¬∑ 5 May 2017
Proud to share exciting news in #Hodgkinlymphoma: http://bit.ly/2pNsfqk #immunooncology
3",,,,3,['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg'],https://twitter.com/semodough/status/860450203194851330
2137,George Marcovits,@GemsBot,2017-05-06T15:56:50.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/82314213#82314266‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/82314213#82314266‚Ä¶,,,,,['https://pbs.twimg.com/media/C_J7U4LXoAQQLz7?format=jpg&name=small'],https://twitter.com/GemsBot/status/860886079716642816
2138,Volcano,@jayo888,2017-05-04T01:28:34.000Z,"$MRK bullish after Earning Report, today close 63.63 stop 61.5 - $MRK chart","$MRK bullish after Earning Report, today close 63.63 stop 61.5 - $MRK chart
tradingview.com
$MRK bullish after Earning Report, today close 63.63 stop 61.5 for NYSE:MRK by jayo888
MERK Bullish after Earning Report, today close 63.63 stop 61.5
1",,,1,,['https://pbs.twimg.com/card_img/1501986564880011277/jzXtPBVE?format=png&name=small'],https://twitter.com/jayo888/status/859942797796794368
2139,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-05-04T03:17:08.000Z,Consider Exact Sciences On A Pullback - Cramer's Lightning Round (5/3/17) $EXAS $MRK $RTN $GD‚Ä¶ http://dlvr.it/P3RHB9 #Investing #Stocks,Consider Exact Sciences On A Pullback - Cramer's Lightning Round (5/3/17) $EXAS $MRK $RTN $GD‚Ä¶ http://dlvr.it/P3RHB9 #Investing #Stocks,,,,,[],https://twitter.com/AlertTrade/status/859970119425863680
2140,tbirdman,@ChickenReaper,2017-05-05T14:33:13.000Z,$MRLA back in @ .17 // $MRK partner w/ recent pp @ .40 / #cancerdetection app ready for launch with strong backing,"$MRLA back in @ .17 // $MRK partner w/ recent pp @ .40 / #cancerdetection app ready for launch with strong backing
1",,,1,,[],https://twitter.com/ChickenReaper/status/860502649468108800
2141,Benzinga,@Benzinga,2017-05-06T14:00:00.000Z,Near-Term Events Cast Shadow Of Uncertainty On Bristol-Myers https://benzinga.com/z/9394503 $AZN $BMY $INCY $MRK,"Near-Term Events Cast Shadow Of Uncertainty On Bristol-Myers https://benzinga.com/z/9394503 $AZN $BMY $INCY $MRK
1
2",,,1,2,[],https://twitter.com/Benzinga/status/860856678174007296
2142,Kyle,@DonkeyKongKyle,2017-05-04T13:45:02.000Z,Great turn around story. Looking for a reversal into ASCO. http://bit.ly/2pldtqa $MRK $MRKT $MRLN $MRNS $MRO $MRTN,Great turn around story. Looking for a reversal into ASCO. http://bit.ly/2pldtqa $MRK $MRKT $MRLN $MRNS $MRO $MRTN,,,,,[],https://twitter.com/DonkeyKongKyle/status/860128135198760961
2143,Antonio Costa,@ACInvestorBlog,2017-05-06T10:38:49.000Z,"My Watchlist for Monday, May 08 http://ac-investor.blogspot.com/2017/05/my-watchlist-for-monday-may-08.html‚Ä¶ $AFMD $BA $BBRY $HD $MRK $XENE Have a great weekend everyone !!","My Watchlist for Monday, May 08 http://ac-investor.blogspot.com/2017/05/my-watchlist-for-monday-may-08.html‚Ä¶ $AFMD $BA $BBRY $HD $MRK $XENE Have a great weekend everyone !!
1
1
10",,1,1,10,[],https://twitter.com/ACInvestorBlog/status/860806049078669312
2144,Pharmaceutical News,@pharma_sector,2017-05-05T18:48:02.000Z,"<b>Cerveau Technologies, Inc.</b> Signs Clinical Supply Agreement With #Merck & Co. For Inve... Read more: http://owler.us/acEC5I $MRK","<b>Cerveau Technologies, Inc.</b> Signs Clinical Supply Agreement With #Merck & Co. For Inve... Read more: http://owler.us/acEC5I $MRK",,,,,[],https://twitter.com/pharma_sector/status/860566776911847424
2145,Pharmaceutical News,@pharma_sector,2017-05-05T16:12:37.000Z,#Merck European Commission Approves KEYTRUDA√Ç pembrolizumab for Patients with Relapsed or Re... Read more: http://owler.us/acEBwh $MRK,#Merck European Commission Approves KEYTRUDA√Ç pembrolizumab for Patients with Relapsed or Re... Read more: http://owler.us/acEBwh $MRK,,,,,[],https://twitter.com/pharma_sector/status/860527661612912641
2146,EIMCorporate,@EIMCorporate,2017-05-05T20:58:50.000Z,"Health care, financial and insurance report you need. $XLF $TLT $HYG $CI $UNH $AET $MRK $PFE $NVS $SNY","Health care, financial and insurance report you need. $XLF $TLT $HYG $CI $UNH $AET $MRK $PFE $NVS $SNY
2
1",,,2,1,[],https://twitter.com/EIMCorporate/status/860599691620253696
2147,Craig Tolliver,@Craig_Tolliver,2017-05-05T03:55:25.000Z,4 Biotech Stocks That Could Be Rocked and Rolled This Month http://scutify.com.ln.is/ABz8w $MRK $REGN $PBYI $INCY #biotech #stocks,4 Biotech Stocks That Could Be Rocked and Rolled This Month http://scutify.com.ln.is/ABz8w $MRK $REGN $PBYI $INCY #biotech #stocks,,,,,[],https://twitter.com/Craig_Tolliver/status/860342139150118913
2148,(((FabriceBosom))),@FBosom,2017-05-04T12:38:38.000Z,might start $petx if it dips under pricing. If I recall $mrk did pretty good in their vet biz last quarter,"might start $petx if it dips under pricing. If I recall $mrk did pretty good in their vet biz last quarter
1",,,,1,[],https://twitter.com/FBosom/status/860111425779507200
2149,1 min Stock Insights,@1MinuteStock,2017-05-06T07:48:01.000Z,Unicorn Bay rating for $MRK is 2.94 out of 5. https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=rank&utm_source=twitter‚Ä¶,Unicorn Bay rating for $MRK is 2.94 out of 5. https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=rank&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/860763066451058689
2150,StockNews.com,@stocknewsdotcom,2017-05-04T12:35:38.000Z,$MRK Positive commentary on Mad Money show https://stocknews.com/news/mrk-positive-commentary-on-mad-money-show-68631108/‚Ä¶,$MRK Positive commentary on Mad Money show https://stocknews.com/news/mrk-positive-commentary-on-mad-money-show-68631108/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/860110670917812225
2151,leahanne,@leahanneta,2017-05-05T19:57:30.000Z,"15:20 ET Volume Leader #98 - MRK 6,340,776 Merck & Company $MRK 64.00 +0.62 +0.98% High today of 64.08 day low","15:20 ET Volume Leader #98 - MRK 6,340,776 Merck & Company $MRK 64.00 +0.62 +0.98% High today of 64.08 day low
investorshangout.com
15:20 ET Volume Leader #98 - MRK - ALERTS, HOT STOCKS & CHARTS #4529132 - Investors Hangout
ALERTS, HOT STOCKS & CHARTS: 15:20 ET Volume Leader #98 - MRK 6,340,776 Merck Company $MRK 64.00 +0.62 +0.98% High today of 64. - #4529132",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/860584258171281409
2152,Transcript Daily,@TranscriptDaily,2017-05-06T10:27:31.000Z,Merck & Co. $MRK Given Daily Media Sentiment Score of 0.17 http://ift.tt/2p74fPE,Merck & Co. $MRK Given Daily Media Sentiment Score of 0.17 http://ift.tt/2p74fPE,,,,,[],https://twitter.com/TranscriptDaily/status/860803202832379904
2153,Dakota Financial,@dakotafinancial,2017-05-05T07:48:08.000Z,"Numeric Investors LLC Buys 569,800 Shares of Merck & Co., Inc. $MRK http://zpr.io/PDdfD","Numeric Investors LLC Buys 569,800 Shares of Merck & Co., Inc. $MRK http://zpr.io/PDdfD",,,,,[],https://twitter.com/dakotafinancial/status/860400704644632577
2154,Ticker Report,@TickerReport,2017-05-04T12:41:30.000Z,"Merck & Co., Inc. $MRK Updates FY17 Earnings Guidance http://ift.tt/2p0LWf0","Merck & Co., Inc. $MRK Updates FY17 Earnings Guidance http://ift.tt/2p0LWf0",,,,,[],https://twitter.com/TickerReport/status/860112145832443905
2155,Limex,@LimexMe,2017-05-04T21:08:31.000Z,"A Big, New Threat to Gilead Sciences Is Coming http://bit.ly/040517GILD1 $GILD $ABBV $MRK","A Big, New Threat to Gilead Sciences Is Coming http://bit.ly/040517GILD1 $GILD $ABBV $MRK",,,,,[],https://twitter.com/LimexMe/status/860239740087529478
2156,BioPharma Dive,@BioPharmaDive,2017-05-06T22:15:00.000Z,"$MRK sees Keytruda gains, offsetting generic hits to sales","$MRK sees Keytruda gains, offsetting generic hits to sales
biopharmadive.com
Merck sees Keytruda gains, offsetting generic hits to sales
But is Keytruda's edge in first-line lung cancer enough to hold off future rivals? Looming data readouts from Roche and AstraZeneca could signal new competition.
2",,,,2,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/860981249598398464
2157,Dakota Financial,@dakotafinancial,2017-05-05T06:57:23.000Z,"3,659 Shares in Merck & Co., Inc. $MRK Acquired by Advantage Investment Management LLC http://zpr.io/PDJwL","3,659 Shares in Merck & Co., Inc. $MRK Acquired by Advantage Investment Management LLC http://zpr.io/PDJwL",,,,,[],https://twitter.com/dakotafinancial/status/860387935878774784
2158,1 min Stock Insights,@1MinuteStock,2017-05-06T09:35:02.000Z,Wondering about risks of $MRK? The 63-day volatility is 4.76%,"Wondering about risks of $MRK? The 63-day volatility is 4.76%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/860789996856500224
2159,Watchlist News,@WatchlistN,2017-05-04T17:43:21.000Z,"Merck & Co., Inc. $MRK Expected to Post FY2017 Earnings of $3.81 Per Share http://zpr.io/PFZCf","Merck & Co., Inc. $MRK Expected to Post FY2017 Earnings of $3.81 Per Share http://zpr.io/PFZCf",,,,,[],https://twitter.com/WatchlistN/status/860188110067568645
2160,Ticker Report,@TickerReport,2017-05-05T10:06:17.000Z,"Merck & Co., Inc. $MRK Stake Boosted by Rathbone Brothers plc http://ift.tt/2pghBoE","Merck & Co., Inc. $MRK Stake Boosted by Rathbone Brothers plc http://ift.tt/2pghBoE",,,,,[],https://twitter.com/TickerReport/status/860435471771553793
2161,99wallstreet,@99wallstreet,2017-05-04T22:34:22.000Z,"Lots Of Stock Trading Action Today: AMD, MA, MRK, COH & More  $COH $MRK $AMD $MA","Lots Of Stock Trading Action Today: AMD, MA, MRK, COH & More  $COH $MRK $AMD $MA
99wallstreet.com
Lots Of Stock Trading Action Today: AMD, MA, MRK, COH & More
When you are ready to step up your trading and investing game, enter the InTheMoneyStocks services and get all of the live trades now...",,,,,[],https://twitter.com/99wallstreet/status/860261344465104896
2162,AlpacaAlerts,@AlpacaAlerts,2017-05-05T23:42:00.000Z,$MRK is in Ichimoku Golden Cross winning 62.86% in the past. https://goo.gl/dHO4kx,$MRK is in Ichimoku Golden Cross winning 62.86% in the past. https://goo.gl/dHO4kx,,,,,[],https://twitter.com/AlpacaAlerts/status/860640754791796736
2163,Dr Kanak Kanti De,@DrKanakKantiDe,2017-05-05T12:35:12.000Z,"Premarket Biotech Digest ‚Äì $MRK gets EU approval, $GHDX receives LCD, $JNJ to pay $110 million http://drkkd.com/premarket-biotech-digest-mrk-gets-eu-approval-ghdx-receives-lcd-jnj-to-pay-110-million/‚Ä¶","Premarket Biotech Digest ‚Äì $MRK gets EU approval, $GHDX receives LCD, $JNJ to pay $110 million http://drkkd.com/premarket-biotech-digest-mrk-gets-eu-approval-ghdx-receives-lcd-jnj-to-pay-110-million/‚Ä¶",,,,,[],https://twitter.com/DrKanakKantiDe/status/860472948230115331
2164,Watchlist News,@WatchlistN,2017-05-06T16:20:24.000Z,"Equities Analysts Set Expectations for Merck & Co., Inc.‚Äôs Q4 2017 Earnings $MRK http://zpr.io/PF3tF","Equities Analysts Set Expectations for Merck & Co., Inc.‚Äôs Q4 2017 Earnings $MRK http://zpr.io/PF3tF",,,,,[],https://twitter.com/WatchlistN/status/860892011913674752
2165,$peedyCalls,@SpeedyCalls,2017-05-05T15:13:01.000Z,"$MRK 62 Puts BUYING Activity expiring on 19th May, Vol 1024","$MRK 62 Puts BUYING Activity expiring on 19th May, Vol 1024",,,,,[],https://twitter.com/SpeedyCalls/status/860512664199495680
2166,Wilson Cheung,@Sanctuary_Bio,2017-05-05T03:34:16.000Z,$ACHN $RGLS Honestly why the f are investors still playing these after $GILD rev drops and $MRK impairment. Hep C is done. Move on.,$ACHN $RGLS Honestly why the f are investors still playing these after $GILD rev drops and $MRK impairment. Hep C is done. Move on.,,,,,[],https://twitter.com/Sanctuary_Bio/status/860336817421164544
2167,StockNews.com,@stocknewsdotcom,2017-05-05T11:15:15.000Z,$MRK EC has approved KEYTRUDA for the treatment of adult patients with relapsed or refractory classical Hodgkin ly‚Ä¶ https://stocknews.com/news/mrk-ec-has-approved-keytruda-for-the-treatment-of-adult-patients/‚Ä¶,$MRK EC has approved KEYTRUDA for the treatment of adult patients with relapsed or refractory classical Hodgkin ly‚Ä¶ https://stocknews.com/news/mrk-ec-has-approved-keytruda-for-the-treatment-of-adult-patients/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/860452828896276481
2168,Fiercelywashyourhands,@PharmaceuticBen,2017-05-05T08:03:48.000Z,Chutes & Ladders‚ÄîCelgene poaches top Merck R&D exec Plenge: http://ow.ly/k6TK30bs8EG $CELG $MRK,"Chutes & Ladders‚ÄîCelgene poaches top Merck R&D exec Plenge: http://ow.ly/k6TK30bs8EG $CELG $MRK
fiercebiotech.com
Chutes & Ladders‚ÄîCelgene poaches top Merck R&D exec Plenge
Merck & Co.'s head of translational medicine Robert Plenge will lead Celgene's immunology R&D, Sarepta CEO Edward Kaye will step down, Genentech‚Äôs pediatric oncology head Rapha√´l Rousseau left for...",,,,,[],https://twitter.com/PharmaceuticBen/status/860404647919587328
2169,Market Realist,@MarketRealist,2017-05-05T18:47:07.000Z,Pfizer‚Äôs 1Q17 Earnings: A Lower Top Line http://marketrealist.com/?p=2076374 $PFE $IHE $JNJ $MRK,"Pfizer‚Äôs 1Q17 Earnings: A Lower Top Line http://marketrealist.com/?p=2076374 $PFE $IHE $JNJ $MRK
1",,,1,,[],https://twitter.com/MarketRealist/status/860566544467857408
2170,Community Financial,@CFinancialNews,2017-05-06T08:32:01.000Z,"Merck & Co., Inc. $MRK Stock Rating Reaffirmed by Jefferies Group LLC http://zpr.io/PDQZP","Merck & Co., Inc. $MRK Stock Rating Reaffirmed by Jefferies Group LLC http://zpr.io/PDQZP",,,,,[],https://twitter.com/CFinancialNews/status/860774136251125761
2171,TW Research Group,@DanCarlson33,2017-05-04T16:07:23.000Z,New CEO with $ALXN and $BMY background should help with burgeoning partnership pipeline. $MRK $BIIB,"New CEO with $ALXN and $BMY background should help with burgeoning partnership pipeline. $MRK $BIIB
twresearchgroup.com
biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director
Tailwinds' Take: Dr. Day is a well respected thought leader and proven business development executive. The combination of his talents with the pipeline of partnership opportunities developed under...",,,,,['https://pbs.twimg.com/card_img/1501725495049977862/58OMf4vm?format=jpg&name=240x240'],https://twitter.com/DanCarlson33/status/860163957394419712
2172,MarketBeat,@MarketBeatCom,2017-05-06T10:59:03.000Z,"FY2021 EPS Estimates for Merck & Co., Inc. $MRK Cut by Jefferies Group http://zpr.io/PwUPj","FY2021 EPS Estimates for Merck & Co., Inc. $MRK Cut by Jefferies Group http://zpr.io/PwUPj",,,,,[],https://twitter.com/MarketBeatCom/status/860811140179402753
2173,MarketBeat,@MarketBeatCom,2017-05-06T12:09:52.000Z,"Independence Advisors LLC Sells 162 Shares of Merck & Co., Inc. $MRK http://zpr.io/PFDYx","Independence Advisors LLC Sells 162 Shares of Merck & Co., Inc. $MRK http://zpr.io/PFDYx",,,,,[],https://twitter.com/MarketBeatCom/status/860828960313282560
2174,TalkMarkets,@TalkMarkets,2017-05-06T16:20:39.000Z,Merck Vs. Pfizer: Which Stock Looks Better Post-Earnings? $MRK $PFE https://goo.gl/ftFEqO,Merck Vs. Pfizer: Which Stock Looks Better Post-Earnings? $MRK $PFE https://goo.gl/ftFEqO,,,,,[],https://twitter.com/TalkMarkets/status/860892071640608768
2175,Crypto Trader Pro,@CryptoTraderPro,2017-05-04T01:31:20.000Z,$MRK bullish after Ea\u2026 $MRK http://dlvr.it/P3PvxW powered by http://bit.do/BestTradeSetups,"$MRK bullish after Ea\u2026 $MRK http://dlvr.it/P3PvxW powered by http://bit.do/BestTradeSetups
tradingview.com
$MRK bullish after Earning Report, today close 63.63 stop 61.5 for NYSE:MRK by jayo888
MERK Bullish after Earning Report, today close 63.63 stop 61.5",,,,,['https://pbs.twimg.com/card_img/1501986564880011277/jzXtPBVE?format=png&name=small'],https://twitter.com/CryptoTraderPro/status/859943493401157633
2176,FierceBiotech,@FierceBiotech,2017-05-05T08:03:45.000Z,Chutes & Ladders‚ÄîCelgene poaches top Merck R&D exec Plenge: http://ow.ly/k6TK30bs8EG $CELG $MRK,"Chutes & Ladders‚ÄîCelgene poaches top Merck R&D exec Plenge: http://ow.ly/k6TK30bs8EG $CELG $MRK
fiercebiotech.com
Chutes & Ladders‚ÄîCelgene poaches top Merck R&D exec Plenge
| Merck & Co.'s head of translational medicine Robert Plenge will lead Celgene's immunology R&D, Sarepta CEO Edward Kaye will step down, Genentech‚Äôs pediatric oncology head Rapha√´l Rousseau left for...",,,,,['https://pbs.twimg.com/card_img/1501986599009091584/SrQS0M_b?format=jpg&name=small'],https://twitter.com/FierceBiotech/status/860404637605781504
2177,Briefing.com,@Briefingcom,2017-05-05T13:03:40.000Z,$MRK: Merck: EC has approved KEYTRUDA for the treatment of adult patients with relapsed or refractory classical... http://bit.ly/2qzEUOu,$MRK: Merck: EC has approved KEYTRUDA for the treatment of adult patients with relapsed or refractory classical... http://bit.ly/2qzEUOu,,,,,[],https://twitter.com/Briefingcom/status/860480114437402629
2178,Open Outcrier,@OpenOutcrier,2017-05-05T12:31:24.000Z,"$MRK (+0.8% pre) Merck Announces EC Approval of KEYTRUDA for Patients with Relapsed/Refractory cHL - SI

http://ooc.bz/l/11943","$MRK (+0.8% pre) Merck Announces EC Approval of KEYTRUDA for Patients with Relapsed/Refractory cHL - SI

http://ooc.bz/l/11943
1
1",,,1,1,[],https://twitter.com/OpenOutcrier/status/860471992880943108
2179,Brad Loncar,@bradloncar,2017-05-04T12:13:53.000Z,"Replying to 
@Sports_bios","Replying to 
@Sports_bios
Someone asked Roger on the $MRK call if the decision was data driven. He of course said yes...as if he'd say they were just guessing.
1
1",,1,,1,[],https://twitter.com/bradloncar/status/860105198139826177
2180,TradingView Ideas,@TradingViewAlt,2017-05-04T01:28:35.000Z,$MRK bullish after Ea\u2026 $MRK http://tradingview.com/chart/MRK/akr8q3Am-MRK-bullish-after-Earning-Report-today-close-63-63-stop-61-5/‚Ä¶,$MRK bullish after Ea\u2026 $MRK http://tradingview.com/chart/MRK/akr8q3Am-MRK-bullish-after-Earning-Report-today-close-63-63-stop-61-5/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/859942799734525953
2181,EdisonHealthcare,@EdisonHealth,2017-05-04T14:26:13.000Z,"QuickView on 
@BioLineRx_Ltd
 multiple shots on goal and partnerships. #BL8040 #AGI134 #Genentech $MRK, $NVS   http://edisoninvestmentresearch.com/research/report/biolinerx7/full/‚Ä¶ $BLRX","QuickView on 
@BioLineRx_Ltd
 multiple shots on goal and partnerships. #BL8040 #AGI134 #Genentech $MRK, $NVS   http://edisoninvestmentresearch.com/research/report/biolinerx7/full/‚Ä¶ $BLRX",,,,,[],https://twitter.com/EdisonHealth/status/860138501341315073
2182,Buy Cryptocurrency,@cryptosbuy,2017-05-04T01:32:07.000Z,$MRK bullish after Ea\u2026 $MRK http://tradingview.com/chart/MRK/akr8q3Am-MRK-bullish-after-Earning-Report-today-close-63-63-stop-61-5/‚Ä¶ TV_TradingIdeas,"$MRK bullish after Ea\u2026 $MRK http://tradingview.com/chart/MRK/akr8q3Am-MRK-bullish-after-Earning-Report-today-close-63-63-stop-61-5/‚Ä¶ TV_TradingIdeas
tradingview.com
$MRK bullish after Earning Report, today close 63.63 stop 61.5 for NYSE:MRK by jayo888
MERK Bullish after Earning Report, today close 63.63 stop 61.5",,,,,['https://pbs.twimg.com/card_img/1501986564880011277/jzXtPBVE?format=png&name=small'],https://twitter.com/cryptosbuy/status/859943692534198272
2183,dough,@semodough,2017-05-07T14:29:04.000Z,Upcoming PDUFA/FDA Advisory Committee Meeting/351(k) Dates $MRK big PDUFA next week $OCUL $ALKS $IBB $SRPT $PBYI $PTLA,"Upcoming PDUFA/FDA Advisory Committee Meeting/351(k) Dates $MRK big PDUFA next week $OCUL $ALKS $IBB $SRPT $PBYI $PTLA
3
19
35",,3,19,35,['https://pbs.twimg.com/media/C_OwyQPXgAItL7D?format=jpg&name=small'],https://twitter.com/semodough/status/861226382008778752
2184,dough,@semodough,2017-05-07T14:32:02.000Z,Key CHMP Opinions/Regulatory Filings and EMA Meetings/Decisions $MRK $AZN $IBB $NVS $ABBV $VNDA $VRX,"Key CHMP Opinions/Regulatory Filings and EMA Meetings/Decisions $MRK $AZN $IBB $NVS $ABBV $VNDA $VRX
7
12",,,7,12,['https://pbs.twimg.com/media/C_OxfoYW0AAWgX2?format=jpg&name=small'],https://twitter.com/semodough/status/861227125747089410
2185,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-05-07T09:36:11.000Z,"AstraZeneca's New Drug: Too Little, Too Late? $LLY $MRK $AZN http://dlvr.it/P4rBzd #Investing #Stocks","AstraZeneca's New Drug: Too Little, Too Late? $LLY $MRK $AZN http://dlvr.it/P4rBzd #Investing #Stocks",,,,,['https://pbs.twimg.com/media/C_NtynYVYAMDyYP?format=jpg&name=small'],https://twitter.com/AlertTrade/status/861152673323663361
2186,Seeking Alpha,@SeekingAlpha,2017-05-08T20:00:52.000Z,Incyte Below $120: A 'Buy' Range For This Emerging Biotech? https://seekingalpha.com/article/4070756-incyte-120-buy-range-emerging-biotech?source=feed_f‚Ä¶ $AGEN $BMY $CALA $CELG $GILD $LLY $MRK $MRUS $NVS $PFE,"Incyte Below $120: A 'Buy' Range For This Emerging Biotech? https://seekingalpha.com/article/4070756-incyte-120-buy-range-emerging-biotech?source=feed_f‚Ä¶ $AGEN $BMY $CALA $CELG $GILD $LLY $MRK $MRUS $NVS $PFE
1",,,,1,[],https://twitter.com/SeekingAlpha/status/861672270141337600
2187,Seeking Alpha,@SeekingAlpha,2017-05-09T16:07:20.000Z,"3 Things In Biotech You Should Learn Today: May 9, 2017 https://seekingalpha.com/article/4071114-3-things-biotech-learn-today-may-9-2017?source=feed_f‚Ä¶ $BMY $KITE $MRK","3 Things In Biotech You Should Learn Today: May 9, 2017 https://seekingalpha.com/article/4071114-3-things-biotech-learn-today-may-9-2017?source=feed_f‚Ä¶ $BMY $KITE $MRK
1",,,,1,[],https://twitter.com/SeekingAlpha/status/861975886462988288
2188,Bio Stocks‚Ñ¢,@BioStocks,2017-05-08T12:05:39.000Z,$ARRY $MRK clinical trial collaboration to investigate the safety and efficacy of the combination of Binimetinib with KEYTRUDA,"$ARRY $MRK clinical trial collaboration to investigate the safety and efficacy of the combination of Binimetinib with KEYTRUDA
2
5",,,2,5,[],https://twitter.com/BioStocks/status/861552677284712453
2189,Drugdoctor1,@Drugdoctor2014,2017-05-09T13:13:12.000Z,$ARLZ $1.21 -OVERSOLD-NASDAQ PHARMA GAPPING UP on EARNINGS just out!  $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE,"$ARLZ $1.21 -OVERSOLD-NASDAQ PHARMA GAPPING UP on EARNINGS just out!  $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE
1",,,,1,['https://pbs.twimg.com/media/C_YyfldWAAAQ0Og?format=jpg&name=small'],https://twitter.com/Drugdoctor2014/status/861932062303027205
2190,Colin Macleod,@scalpthatstock,2017-05-09T21:50:03.000Z,"Bearish Engulfing Pattern 5 9 2017

http://scalpthatstock.com/bearish-engulfing-pattern-5-9-2017/‚Ä¶

$OAS $XLE $MRK $COP $SN $DB $AR $MET $PM","Bearish Engulfing Pattern 5 9 2017

http://scalpthatstock.com/bearish-engulfing-pattern-5-9-2017/‚Ä¶

$OAS $XLE $MRK $COP $SN $DB $AR $MET $PM",,,,,['https://pbs.twimg.com/media/C_ao73yVYAA-b0l?format=jpg&name=small'],https://twitter.com/scalpthatstock/status/862062133424435200
2191,Kantar,@Kantar,2017-05-09T14:11:14.000Z,The number of drug brands spending $50 million annually on ads have more than doubled since 2012 http://bit.ly/2pUS8En $BMY $MRK $GSK,"The number of drug brands spending $50 million annually on ads have more than doubled since 2012 http://bit.ly/2pUS8En $BMY $MRK $GSK
3
1",,,3,1,['https://pbs.twimg.com/media/C_Y9pdEWAAETAnX?format=jpg&name=small'],https://twitter.com/Kantar/status/861946668064919554
2192,Buy on Strength,@BuyOnStrength,2017-05-07T02:24:40.000Z,$MRK Positioned to Move Higher http://buyonstrength.com/2017/05/06/mrk-positioned-to-move-higher/‚Ä¶,$MRK Positioned to Move Higher http://buyonstrength.com/2017/05/06/mrk-positioned-to-move-higher/‚Ä¶,,,,,['https://pbs.twimg.com/media/C_MK1kjV0AAXK1Z?format=jpg&name=small'],https://twitter.com/BuyOnStrength/status/861044080738013185
2193,Helen Ong,@Lin_ling_88,2017-05-07T12:18:46.000Z,"$AMGN $MRK PCSK9 ing failed

$ESPR's bempedoic acid will work - LDL, hsCRP, orally effective, safe in statin-intolerants, CHEAP","$AMGN $MRK PCSK9 ing failed

$ESPR's bempedoic acid will work - LDL, hsCRP, orally effective, safe in statin-intolerants, CHEAP
Dr Aseem Malhotra
@DrAseemMalhotra
 ¬∑ 7 May 2017
Cholesterol lowering drug NOT 'huge advance' in treating heart disease but 'huge disaster' @JamesTGallagher http://telegraph.co.uk/news/2017/05/06/nhs-wasting-tens-thousands-year-wonder-drug-stroke-heart-attacks/‚Ä¶ #NHS
1
1
4",‚¨á ‚¨á,1,1,4,['https://pbs.twimg.com/profile_images/1184830975299207172/BhPC_cW4_mini.jpg'],https://twitter.com/Lin_ling_88/status/861193589694623745
2194,Helen Ong,@Lin_ling_88,2017-05-07T11:57:47.000Z,"Successes & failures: what did we learn from first-line treatment immunotherapy trials in NSCLC? 

$MRK $BMY $RHHBY","Successes & failures: what did we learn from first-line treatment immunotherapy trials in NSCLC? 

$MRK $BMY $RHHBY
bmcmedicine.biomedcentral.com
Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in...
Immune checkpoint inhibitors have significantly modified the therapeutic landscape of advanced non-small cell lung cancer in second-line settings, with a more recent advancement in first-line...
1",,,,1,['https://pbs.twimg.com/card_img/1500312019492392965/dgcoH6M6?format=jpg&name=240x240'],https://twitter.com/Lin_ling_88/status/861188307740495872
2195,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-05-08T16:34:02.000Z,"$INCY $ADRO modified Phase 2 portion in ovarian cancers, added triplet IO arm Epac+CRS207+Keytruda $MRK","$INCY $ADRO modified Phase 2 portion in ovarian cancers, added triplet IO arm Epac+CRS207+Keytruda $MRK
clinicaltrials.gov
Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or...
Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer - Full Text View.
1
1",,1,1,,['https://pbs.twimg.com/card_img/1499934075531907072/UYy6jAXC?format=png&name=240x240'],https://twitter.com/DrPaulyDeSantis/status/861620218111590400
2196,9/11 No Planer,@911NoPlaner,2017-05-09T03:39:23.000Z,#Gardasil: The Decision We Will Always Regret http://vaccineimpact.com/2015/gardasil-the-decision-we-will-always-regret/‚Ä¶ #merck #vaccine #HPVvaccine #vaccines #hpv $mrk,"#Gardasil: The Decision We Will Always Regret http://vaccineimpact.com/2015/gardasil-the-decision-we-will-always-regret/‚Ä¶ #merck #vaccine #HPVvaccine #vaccines #hpv $mrk
vaccineimpact.com
Gardasil: The Decision We Will Always Regret - Vaccine Impact
We deeply regret consenting to the Gardasil vaccine. We had no idea of the severe side effects some experience post vaccine. Every day, we wish we had been more informed. Parents beware of blindly...",ü•∂,,,,[],https://twitter.com/911NoPlaner/status/861787659219472384
2197,1stOncology,@1stOncology,2017-05-08T15:39:28.000Z,Array BioPharma $ARRY Reports Strategic Collaboration with Merck $MRK on #Binimetinib in Combination with #KEYTRUDA http://1stoncology.com/blog/array-biopharma-announces-strategic-collaboration-with-merck‚Ä¶,"Array BioPharma $ARRY Reports Strategic Collaboration with Merck $MRK on #Binimetinib in Combination with #KEYTRUDA http://1stoncology.com/blog/array-biopharma-announces-strategic-collaboration-with-merck‚Ä¶
1",,,1,,[],https://twitter.com/1stOncology/status/861606485918461952
2198,Kara Jill Stancell,@kjilly,2017-05-08T17:54:05.000Z,Abraxis vet Neil Desai gets $CELG backing for $23M A round; Two more #biotechs set #IPO terms $ARRY $MRK $REGN $INO,"Abraxis vet Neil Desai gets $CELG backing for $23M A round; Two more #biotechs set #IPO terms $ARRY $MRK $REGN $INO
endpts.com
Abraxis vet Neil Desai gets Celgene backing for $23M A round; Two more biotechs set IPO terms
‚Üí Celgene joined the syndicate backing a $23 million Series A for Pacific Palisades, CA-based Aadi Bioscience. The money will be used to support a registration study of its lead drug, ABI-009, its...",,,,,['https://pbs.twimg.com/card_img/1499325937749577728/ppW2Zkw3?format=jpg&name=small'],https://twitter.com/kjilly/status/861640363202695168
2199,OneTick,@OneMarketData,2017-05-09T17:47:03.000Z,Highest number of trades within 1 second on 5/8: $MRK with 557 trades between 15:59:25.107 and 15:59:26.106,Highest number of trades within 1 second on 5/8: $MRK with 557 trades between 15:59:25.107 and 15:59:26.106,,,,,[],https://twitter.com/OneMarketData/status/862000978983256064
2200,bill eijgenberger,@weijgenberger,2017-05-09T09:20:57.000Z,Merck Makes a Move $MRK,"Merck Makes a Move $MRK
stockcharts.com
Merck Makes a Move $MRK",,,,,[],https://twitter.com/weijgenberger/status/861873616761348096
2201,Behavioral Finance,@BehaviorFin,2017-05-08T20:11:38.000Z,$KITE $IBB $KITE esp. considering the great avances against #cancer and progress we see in patient cure $CLLS $JUNO $BMY $NVS $MRK $INCY,"$KITE $IBB $KITE esp. considering the great avances against #cancer and progress we see in patient cure $CLLS $JUNO $BMY $NVS $MRK $INCY
Behavioral Finance
@BehaviorFin
 ¬∑ 9 May 2017
$IBB $XBI down because of $KITE clinical problem? Nobody said a perfect cure for #cancer exists. Treatment always brings risk/benefit.
1",,,1,,['https://pbs.twimg.com/profile_images/841238244490694656/5ud8KdEG_mini.jpg'],https://twitter.com/BehaviorFin/status/861674978177150979
2202,Charles Gordon,@princetongb,2017-05-09T15:46:57.000Z,"$MRK PDUFA for 1rst line NSCLC tomorrow, May 10. http://investors.merck.com/news/press-release-details/2017/Merck-Receives-FDA-Acceptance-of-Supplemental-Biologics-License-Application-for-KEYTRUDA-pembrolizumab-in-Combination-with-Chemotherapy-for-First-Line-Treatment-of-Metastatic-Non-Squamous-Non-Small-Cell-Lung-Cancer/default.aspx‚Ä¶","$MRK PDUFA for 1rst line NSCLC tomorrow, May 10. http://investors.merck.com/news/press-release-details/2017/Merck-Receives-FDA-Acceptance-of-Supplemental-Biologics-License-Application-for-KEYTRUDA-pembrolizumab-in-Combination-with-Chemotherapy-for-First-Line-Treatment-of-Metastatic-Non-Squamous-Non-Small-Cell-Lung-Cancer/default.aspx‚Ä¶
1
1",,1,1,,[],https://twitter.com/princetongb/status/861970757559218177
2203,Seeking Alpha,@SeekingAlpha,2017-05-09T17:32:30.000Z,Chancy Keytruda Move Sets The Stage For Chemo Combos https://seekingalpha.com/article/4071169-chancy-keytruda-move-sets-stage-chemo-combos?source=feed_f‚Ä¶ $AZN $BMY $MRK,Chancy Keytruda Move Sets The Stage For Chemo Combos https://seekingalpha.com/article/4071169-chancy-keytruda-move-sets-stage-chemo-combos?source=feed_f‚Ä¶ $AZN $BMY $MRK,,,,,[],https://twitter.com/SeekingAlpha/status/861997317255188481
2204,Maximum Pain,@themaxpain,2017-05-09T13:10:33.000Z,$MET $MRK $XOM $ABT Bullish MACD crossover,$MET $MRK $XOM $ABT Bullish MACD crossover,,,,,[],https://twitter.com/themaxpain/status/861931398445268996
2205,1 min Stock Insights,@1MinuteStock,2017-05-08T19:07:03.000Z,Do you know that #Book Value for $MRK is $14.58 https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=bookvalue&utm_source=twitter‚Ä¶,Do you know that #Book Value for $MRK is $14.58 https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=bookvalue&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/861658725475635200
2206,Pharmaceutical News,@pharma_sector,2017-05-09T19:50:27.000Z,"Charter Trust Co. Sells 5,998 Shares of #Merck & Co., Inc. (). Read more: http://owler.us/acFIqv $MRK","Charter Trust Co. Sells 5,998 Shares of #Merck & Co., Inc. (). Read more: http://owler.us/acFIqv $MRK",,,,,[],https://twitter.com/pharma_sector/status/862032033849032704
2207,Pharmaceutical News,@pharma_sector,2017-05-09T19:26:18.000Z,Array BioPharma collaborating with #Merck on clinical tests. Read more: http://owler.us/acFH8W $MRK,Array BioPharma collaborating with #Merck on clinical tests. Read more: http://owler.us/acFH8W $MRK,,,,,[],https://twitter.com/pharma_sector/status/862025956885544960
2208,Pharmaceutical News,@pharma_sector,2017-05-09T09:40:35.000Z,"EOD Risers: McDonald's Corporation, #Merck & Co., Inc., Nike Inc. Read more: http://owler.us/acFvLN $MRK","EOD Risers: McDonald's Corporation, #Merck & Co., Inc., Nike Inc. Read more: http://owler.us/acFvLN $MRK",,,,,[],https://twitter.com/pharma_sector/status/861878555860389889
2209,FirstToMarkets,@firsttomarkets,2017-05-09T19:16:29.000Z,Merck & Co. Reiterated Rating by Jefferies & Co (Ranked 20th) to Underperform $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,Merck & Co. Reiterated Rating by Jefferies & Co (Ranked 20th) to Underperform $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,,,,,[],https://twitter.com/firsttomarkets/status/862023488357277696
2210,Peter Blood,@ptrbld,2017-05-08T16:13:59.000Z,"Soothsayer "" $DRG taking a pounding looking for entry points into $LLY $MRK $PFE $BMY long options""","Soothsayer "" $DRG taking a pounding looking for entry points into $LLY $MRK $PFE $BMY long options""",,,,,[],https://twitter.com/ptrbld/status/861615171332169728
2211,Penny Stockington,@PennyStockingt,2017-05-09T07:00:27.000Z,Our Subscribers Saw Our Stock Picks Gain 195% In 4 weeks! Get Access To Our Hot New Picks: http://ow.ly/PnRB30bykPj #Stocks $MRK $LGND,Our Subscribers Saw Our Stock Picks Gain 195% In 4 weeks! Get Access To Our Hot New Picks: http://ow.ly/PnRB30bykPj #Stocks $MRK $LGND,,,,,[],https://twitter.com/PennyStockingt/status/861838258661208065
2212,Tuan Pham,@15minofPham,2017-05-09T17:13:07.000Z,"Mid-day bottom of trading range (from open): $PM -99, $UN -98, $KO -97, $SEE -96, $NFX -95, $AA $PSEC -93, $K -91, $COP $MRK $OXY -90","Mid-day bottom of trading range (from open): $PM -99, $UN -98, $KO -97, $SEE -96, $NFX -95, $AA $PSEC -93, $K -91, $COP $MRK $OXY -90",,,,,[],https://twitter.com/15minofPham/status/861992439216836608
2213,Chris Z,@ckz8780,2017-05-08T12:09:46.000Z,$ARRY nice news with $MRK sponsoring the study,$ARRY nice news with $MRK sponsoring the study,,,,,[],https://twitter.com/ckz8780/status/861553713017651202
2214,Michael Podwill,@MichaelPodwill,2017-05-08T12:26:16.000Z,"$ARRY in collaboration w/ $MRK.
Last week was Dunkirk. This week is the promised land. 
T'was ever thus w/ biotech investing.","$ARRY in collaboration w/ $MRK.
Last week was Dunkirk. This week is the promised land. 
T'was ever thus w/ biotech investing.",,,,,[],https://twitter.com/MichaelPodwill/status/861557866322423809
2215,Sweet Platform,@SweetPlatform,2017-05-09T15:18:47.000Z,"MRK Top news - May 9th, 2017 $MRK http://https://goo.gl/jkqGgY","MRK Top news - May 9th, 2017 $MRK http://https://goo.gl/jkqGgY",,,,,[],https://twitter.com/SweetPlatform/status/861963668757643264
2216,IECONOMICS,@iECONOMICS,2017-05-08T14:06:01.000Z,Merck & Co $MRK market alert: 6-week high @ 64.23 https://ieconomics.com/merck,Merck & Co $MRK market alert: 6-week high @ 64.23 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/861582969114435584
2217,Transcript Daily,@TranscriptDaily,2017-05-08T15:06:06.000Z,"Northstar Group Inc. Buys 58 Shares of Merck & Co., Inc. $MRK http://ift.tt/2pWAMY0","Northstar Group Inc. Buys 58 Shares of Merck & Co., Inc. $MRK http://ift.tt/2pWAMY0",,,,,[],https://twitter.com/TranscriptDaily/status/861598089135738881
2218,Transcript Daily,@TranscriptDaily,2017-05-07T09:57:27.000Z,"Merck & Co., Inc. $MRK Earns Outperform Rating from BMO Capital Markets http://ift.tt/2qPGhFd","Merck & Co., Inc. $MRK Earns Outperform Rating from BMO Capital Markets http://ift.tt/2qPGhFd",,,,,[],https://twitter.com/TranscriptDaily/status/861158026593619968
2219,Daily Political,@dailypoliticaln,2017-05-08T10:15:29.000Z,"CT Financial Advisors LLC Has $260,000 Stake in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1073356","CT Financial Advisors LLC Has $260,000 Stake in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1073356",,,,,[],https://twitter.com/dailypoliticaln/status/861524950284238849
2220,US Banking News,@AmericanBanking,2017-05-08T14:25:39.000Z,Merck KGaA's neutral rating reiterated at JPMorgan Chase & Co.. http://ift.tt/2qhLQjg $MRK #MRK,Merck KGaA's neutral rating reiterated at JPMorgan Chase & Co.. http://ift.tt/2qhLQjg $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/861587909899689987
2221,US Banking News,@AmericanBanking,2017-05-08T07:20:16.000Z,Merck KGaA given ‚Ç¨125.00 PT by Credit Suisse Group AG. buy rating. http://ift.tt/2pbD0n0 $MRK #MRK,Merck KGaA given ‚Ç¨125.00 PT by Credit Suisse Group AG. buy rating. http://ift.tt/2pbD0n0 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/861480856451518465
2222,Daily Political,@dailypoliticaln,2017-05-09T09:53:07.000Z,"Merck & Co., Inc. $MRK Position Cut by New England Research & Management Inc. http://dailypolitical.com/?p=1077191","Merck & Co., Inc. $MRK Position Cut by New England Research & Management Inc. http://dailypolitical.com/?p=1077191",,,,,[],https://twitter.com/dailypoliticaln/status/861881709981310982
2223,StockNews.com,@stocknewsdotcom,2017-05-08T14:41:16.000Z,"$MRK Jefferies reiterates Underperform rating, $51 PT https://stocknews.com/news/mrk-jefferies-reiterates-underperform-rating-51-pt/‚Ä¶","$MRK Jefferies reiterates Underperform rating, $51 PT https://stocknews.com/news/mrk-jefferies-reiterates-underperform-rating-51-pt/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/861591839132057600
2224,Watchlist News,@WatchlistN,2017-05-08T10:19:55.000Z,"Osborn Williams & Donohoe LLC Has $2.232 Million Position in Merck & Co., Inc. $MRK http://zpr.io/PFdgA","Osborn Williams & Donohoe LLC Has $2.232 Million Position in Merck & Co., Inc. $MRK http://zpr.io/PFdgA",,,,,[],https://twitter.com/WatchlistN/status/861526065415692289
2225,Watchlist News,@WatchlistN,2017-05-09T09:51:48.000Z,"Merck & Co., Inc. $MRK Stake Increased by Weaver C. Barksdale & Associates Inc. http://zpr.io/PCnT8","Merck & Co., Inc. $MRK Stake Increased by Weaver C. Barksdale & Associates Inc. http://zpr.io/PCnT8",,,,,[],https://twitter.com/WatchlistN/status/861881381290467329
2226,Hottest Stocks Now,@HottestStockNow,2017-05-08T12:16:48.000Z,First Approval for $MRK 's Keytruda in a Hematologic Malignancy in the EU,"First Approval for $MRK 's Keytruda in a Hematologic Malignancy in the EU
crweworld.com
MSD‚Äôs Keytruda wins EU green light in Hodgkin lymphoma
European regulators have expanded the reach of MSD‚Äôs Keytruda to include some patients with classical Hodgkin lymphoma (cHL), a type of lymphoma that develops in white blood cells of which there are...",,,,,['https://pbs.twimg.com/card_img/1499816442249629696/ZyoDobPa?format=jpg&name=240x240'],https://twitter.com/HottestStockNow/status/861555482489528320
2227,Ticker Report,@TickerReport,2017-05-09T09:59:19.000Z,"Raymond James Trust N.A. Increases Stake in Merck & Co., Inc. $MRK http://ift.tt/2pX9ald","Raymond James Trust N.A. Increases Stake in Merck & Co., Inc. $MRK http://ift.tt/2pX9ald",,,,,[],https://twitter.com/TickerReport/status/861883272107884544
2228,US Banking News,@AmericanBanking,2017-05-08T14:30:47.000Z,Merck & Co.'s underperform rating reiterated at Jefferies Group LLC. $51.00 PT. http://ift.tt/2pnfhf8 $MRK #MRK,Merck & Co.'s underperform rating reiterated at Jefferies Group LLC. $51.00 PT. http://ift.tt/2pnfhf8 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/861589200730304513
2229,$peedyCalls,@SpeedyCalls,2017-05-09T18:24:59.000Z,"$MRK 62.5 Calls SELLING Activity expiring on 19th Jan, Vol 3600","$MRK 62.5 Calls SELLING Activity expiring on 19th Jan, Vol 3600",,,,,[],https://twitter.com/SpeedyCalls/status/862010524334264320
2230,TradeOutLoud,@TradeOutLoud,2017-05-08T14:18:56.000Z,$MRK up-up and away - cleared resistance at $64.00. Next target is $65.00,$MRK up-up and away - cleared resistance at $64.00. Next target is $65.00,,,,,[],https://twitter.com/TradeOutLoud/status/861586216415789056
2231,Antonio Costa,@ACInvestorBlog,2017-05-08T12:10:47.000Z,$ARRY $MRK Array BioPharma Announces Strategic Collaboration with Merck http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=2270726‚Ä¶,"$ARRY $MRK Array BioPharma Announces Strategic Collaboration with Merck http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=2270726‚Ä¶
1",,,,1,[],https://twitter.com/ACInvestorBlog/status/861553965963587584
2232,Confident Investor,@ConfidentInvest,2017-05-09T12:05:05.000Z,Confident Investor indicator analysis for 5/9/2017. Interesting results from $ABMD $EW $GOOGL $HDSN $MRK - http://bit.ly/2pZDoEF,Confident Investor indicator analysis for 5/9/2017. Interesting results from $ABMD $EW $GOOGL $HDSN $MRK - http://bit.ly/2pZDoEF,,,,,[],https://twitter.com/ConfidentInvest/status/861914921012822020
2233,MarketBeat,@MarketBeatCom,2017-05-08T21:52:39.000Z,Stock Traders Purchase High Volume of Call Options on Merck & Co. $MRK http://zpr.io/PDM6p,Stock Traders Purchase High Volume of Call Options on Merck & Co. $MRK http://zpr.io/PDM6p,,,,,[],https://twitter.com/MarketBeatCom/status/861700399904026629
2234,SwingTradeBot,@SwingTradeBot,2017-05-08T18:52:34.000Z,Recent $MRK technical alerts: Crossed Above 50 DMA plus 6 more alerts...,"Recent $MRK technical alerts: Crossed Above 50 DMA plus 6 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/861655079077785600
2235,Transcript Daily,@TranscriptDaily,2017-05-07T09:57:26.000Z,"Merck & Co., Inc. $MRK Earns Outperform Rating from BMO Capital Markets http://ift.tt/2p9ihjL","Merck & Co., Inc. $MRK Earns Outperform Rating from BMO Capital Markets http://ift.tt/2p9ihjL",,,,,[],https://twitter.com/TranscriptDaily/status/861158023292747776
2236,Ticker Report,@TickerReport,2017-05-07T12:27:15.000Z,Investors Purchase Large Volume of Call Options on Merck & Co. $MRK http://ift.tt/2pUlMIf,Investors Purchase Large Volume of Call Options on Merck & Co. $MRK http://ift.tt/2pUlMIf,,,,,[],https://twitter.com/TickerReport/status/861195722678579200
2237,MarketBeat,@MarketBeatCom,2017-05-08T14:24:31.000Z,Merck KGaA's neutral rating reiterated at JPMorgan Chase & Co.. http://ift.tt/2qhLQjg $MRK #MRK,Merck KGaA's neutral rating reiterated at JPMorgan Chase & Co.. http://ift.tt/2qhLQjg $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/861587621100834816
2238,Watchlist News,@WatchlistN,2017-05-09T22:37:22.000Z,Merck & Co.‚Äôs $MRK Underperform Rating Reaffirmed at Jefferies Group LLC http://zpr.io/PCqM2,Merck & Co.‚Äôs $MRK Underperform Rating Reaffirmed at Jefferies Group LLC http://zpr.io/PCqM2,,,,,[],https://twitter.com/WatchlistN/status/862074039350824961
2239,MarketBeat,@MarketBeatCom,2017-05-08T17:13:11.000Z,"Merck & Co., Inc. $MRK Shares Sold by Canal Insurance CO http://zpr.io/P366D","Merck & Co., Inc. $MRK Shares Sold by Canal Insurance CO http://zpr.io/P366D",,,,,[],https://twitter.com/MarketBeatCom/status/861630069021782016
2240,$peedyCalls,@SpeedyCalls,2017-05-09T15:20:07.000Z,"$MRK 75 Calls BUYING Activity expiring on 19th Jan, Vol 3098","$MRK 75 Calls BUYING Activity expiring on 19th Jan, Vol 3098",,,,,[],https://twitter.com/SpeedyCalls/status/861964002158686208
2241,SwingTradeBot,@SwingTradeBot,2017-05-09T21:40:14.000Z,Scan results - Bearish Engulfing today: $PLYA $OAS $AR $XEC $UGI $CSL $MRK $RDS.A $NOW $PAYC ... https://swingtradebot.com/events/14/equities?selected_date=2017-05-09‚Ä¶,Scan results - Bearish Engulfing today: $PLYA $OAS $AR $XEC $UGI $CSL $MRK $RDS.A $NOW $PAYC ... https://swingtradebot.com/events/14/equities?selected_date=2017-05-09‚Ä¶,,,,,[],https://twitter.com/SwingTradeBot/status/862059661360599044
2242,StockNews.com,@stocknewsdotcom,2017-05-08T12:58:48.000Z,$MRK Array Biopharma enters into a collaboration agreement with Merck to investigate the safety and efficacy of it‚Ä¶ https://stocknews.com/news/mrk-array-biopharma-enters-into-a-collaboration-agreement-with-merck-to/‚Ä¶,$MRK Array Biopharma enters into a collaboration agreement with Merck to investigate the safety and efficacy of it‚Ä¶ https://stocknews.com/news/mrk-array-biopharma-enters-into-a-collaboration-agreement-with-merck-to/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/861566050911092736
2243,Jacob Plieth,@JacobPlieth,2017-05-09T14:57:43.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
Everyone noticed that $MRK quietly filed Keytruda + chemo on the back of Keynote-021G in Europe too? http://bit.ly/2pYsC0P
1",,,,1,[],https://twitter.com/JacobPlieth/status/861958367656411137
2244,Jacob Plieth,@JacobPlieth,2017-05-09T14:55:46.000Z,"Replying to 
@JacobPlieth
 and 
@EPVantage","Replying to 
@JacobPlieth
 and 
@EPVantage
More on tomorrow's PDUFA for Keytruda+chemo (Keynote-021G), via 
@RobinDavison2
 http://epvantage.com/Universal/View.aspx?type=Story&id=705970&isEPVantage=yes‚Ä¶ $MRK $BMY $AZN cc 
@ethanallen2013
2
3
1",,2,3,1,[],https://twitter.com/JacobPlieth/status/861957874943229952
2245,Mariano Pazzaglia,@MendoBro26,2017-05-09T23:03:13.000Z,"Replying to 
@bio_clouseau","Replying to 
@bio_clouseau
1 yr ample time for $SCYX to revamp it's website, add/publish more data.  Maybe reference previous 7 Phase 1 studies $MRK conducted.
3",,3,,,[],https://twitter.com/MendoBro26/status/862080544716214272
2246,Ethan Allen,@ethanallen2013,2017-05-07T13:12:55.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
Last Q. Why would BMO Capital assign 80% prob of approval? Plus $MRK was not shying away from this event during their Conf Call
1",,1,,,[],https://twitter.com/ethanallen2013/status/861207217894305794
2247,Ethan Allen,@ethanallen2013,2017-05-09T15:20:46.000Z,"Replying to 
@JacobPlieth
, 
@EPVantage
 and 
@RobinDavison2","Replying to 
@JacobPlieth
, 
@EPVantage
 and 
@RobinDavison2
Wow.... just wow. $MRK Just continues to push the envelope and amaze.",,,,,[],https://twitter.com/ethanallen2013/status/861964165925277696
2248,Jacob Plieth,@JacobPlieth,2017-05-07T13:34:12.000Z,"Replying to 
@ethanallen2013","Replying to 
@ethanallen2013
Because they're sellside analysts? I'm not necessarily saying it won't be approved, just pointing out obvious caveats $MRK
1",,1,,,[],https://twitter.com/JacobPlieth/status/861212572296646657
2249,Community Financial,@CFinancialNews,2017-05-07T08:40:03.000Z,"Merck & Co., Inc. $MRK Stock Rating Reaffirmed by BMO Capital Markets http://zpr.io/Pwtj5","Merck & Co., Inc. $MRK Stock Rating Reaffirmed by BMO Capital Markets http://zpr.io/Pwtj5",,,,,[],https://twitter.com/CFinancialNews/status/861138545179840512
2250,Dakota Financial,@dakotafinancial,2017-05-08T21:52:40.000Z,Stock Traders Purchase High Volume of Call Options on Merck & Co. $MRK http://zpr.io/PDM6p,Stock Traders Purchase High Volume of Call Options on Merck & Co. $MRK http://zpr.io/PDM6p,,,,,[],https://twitter.com/dakotafinancial/status/861700404295475200
2251,Adam Feuerstein,@adamfeuerstein,2017-05-10T21:30:38.000Z,$MRK Extends Immunotherapy Lead With Lung Cancer Combination Therapy Approval ‚Äî>,"$MRK Extends Immunotherapy Lead With Lung Cancer Combination Therapy Approval ‚Äî>
thestreet.com
Merck Extends Immunotherapy Lead With Lung Cancer Combination Therapy Approval
Keytruda is now the only PD-1 or PD-L1 checkpoint inhibitor approved to treat first-line lung cancer either as monotherapy or as part of a combination therapy.
3
20
20",,3,20,20,['https://pbs.twimg.com/card_img/1498512024703283200/YIUK4Go4?format=jpg&name=small'],https://twitter.com/adamfeuerstein/status/862419636381470720
2252,Adam Feuerstein,@adamfeuerstein,2017-05-10T12:14:26.000Z,The Cancer Immunotherapy Fallout from $RHHBY Bladder Cancer Failure https://thestreet.com/story/14128218/1/the-cancer-immunotherapy-fallout-from-roche-s-bladder-cancer-failure.html‚Ä¶ $MRK $BMY $AZN $PFE,"The Cancer Immunotherapy Fallout from $RHHBY Bladder Cancer Failure https://thestreet.com/story/14128218/1/the-cancer-immunotherapy-fallout-from-roche-s-bladder-cancer-failure.html‚Ä¶ $MRK $BMY $AZN $PFE
thestreet.com
The Cancer Immunotherapy Fallout from Roche's Bladder Cancer Failure
Will the FDA revoke Roche's accelerated approval for Tecentriq in bladder cancer?
27
26",,,27,26,[],https://twitter.com/adamfeuerstein/status/862279661140795393
2253,Matthew Herper,@matthewherper,2017-05-12T14:51:11.000Z,"AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next $AZN $BMY $MRK","AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next $AZN $BMY $MRK
forbes.com
AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What's Next
AstraZeneca says its cancer drug Imfinzi slowed the growth of lung tumors that are not treatable with surgery, capping off a week that's driven home a clear message about a a promising class of...
2
25
13",,2,25,13,['https://pbs.twimg.com/card_img/1500263619732377602/CmNi5XVC?format=jpg&name=small'],https://twitter.com/matthewherper/status/863043886486368258
2254,Roy Friedman,@DewDiligence,2017-05-11T21:07:57.000Z,"New HCV infections on the rise in US:

http://mobile.reuters.com/article/BigStory12/idUSKBN1872S4‚Ä¶
$GILD $ABBV $ENTA $MRK","New HCV infections on the rise in US:

http://mobile.reuters.com/article/BigStory12/idUSKBN1872S4‚Ä¶
$GILD $ABBV $ENTA $MRK
1
4
6",,1,4,6,[],https://twitter.com/DewDiligence/status/862776313375010816
2255,Yahoo Finance,@YahooFinance,2017-05-11T13:38:23.000Z,"#Stocks to Watch Today: $STRP, $MRK, $YUM, $WFM http://yhoo.it/2qvNez5","#Stocks to Watch Today: $STRP, $MRK, $YUM, $WFM http://yhoo.it/2qvNez5
2
2",,,2,2,['https://pbs.twimg.com/media/C_jLiiDVYAABn2Q?format=jpg&name=small'],https://twitter.com/YahooFinance/status/862663174654439429
2256,Bursatil Biotech,@BursatilBiotech,2017-05-12T12:56:04.000Z,"Replying to 
@BursatilBiotech","Replying to 
@BursatilBiotech
$MRK $BMY #ASCO17
1
2",,1,,2,['https://pbs.twimg.com/media/C_oLc-6W0AAp8nP?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/863014913245106178
2257,Herkyleese,@herkyleese,2017-05-11T13:40:08.000Z,Patients deserve to live.  15 months not enough. Room for all $juno $kite $bmy $mrk $amgn $nwbo $exel $fgen $gild  http://infocusmagazine.ca/2016/surviving-the-storm/‚Ä¶,"Patients deserve to live.  15 months not enough. Room for all $juno $kite $bmy $mrk $amgn $nwbo $exel $fgen $gild  http://infocusmagazine.ca/2016/surviving-the-storm/‚Ä¶
6
5",,,6,5,[],https://twitter.com/herkyleese/status/862663616197255169
2258,pharmalot,@pharmalot,2017-05-11T13:15:33.000Z,Pharmalot.. Pharmalittle.. Good Morning.. Lilly raises some prices & Merck scores a win.. https://statnews.com/pharmalot/2017/05/11/eli-lilly-drug-prices-merck-cancer/‚Ä¶ #pharma $LLY $MRK $MYL,"Pharmalot.. Pharmalittle.. Good Morning.. Lilly raises some prices & Merck scores a win.. https://statnews.com/pharmalot/2017/05/11/eli-lilly-drug-prices-merck-cancer/‚Ä¶ #pharma $LLY $MRK $MYL
statnews.com
Pharmalot, Pharmalittle: Eli Lilly raised some prices between 6 and 9.9 percent
Eli Lilly raised list prices of nine of its medicines last week between 6 and 9.9 percent, the latest drug maker to try to avoid double-digit increases.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501064820937822212/YW68E-Ya?format=jpg&name=small'],https://twitter.com/pharmalot/status/862657428629934082
2259,Breaking News,@MarketCurrents,2017-05-10T21:51:05.000Z,FDA approves Merck's Keytruda for use with chemo for lung cancer https://seekingalpha.com/news/3266211-fda-approves-mercks-keytruda-use-chemo-lung-cancer?source=feed_f‚Ä¶ $MRK,"FDA approves Merck's Keytruda for use with chemo for lung cancer https://seekingalpha.com/news/3266211-fda-approves-mercks-keytruda-use-chemo-lung-cancer?source=feed_f‚Ä¶ $MRK
1
1",,,1,1,[],https://twitter.com/MarketCurrents/status/862424780741398528
2260,Forbes Health,@forbeshealth,2017-05-11T19:45:02.000Z,"$MRK may have lucked into a $10B drug: http://on.forbes.com/601389uXf by 
@matthewherper","$MRK may have lucked into a $10B drug: http://on.forbes.com/601389uXf by 
@matthewherper
1
2",,,1,2,['https://pbs.twimg.com/media/C_kfgTKW0AAg4pB?format=jpg&name=small'],https://twitter.com/forbeshealth/status/862755445601161218
2261,Forbes Health,@forbeshealth,2017-05-12T17:30:01.000Z,"$MRK just had some great luck with Keytruda: http://on.forbes.com/601089RTm by 
@matthewherper","$MRK just had some great luck with Keytruda: http://on.forbes.com/601089RTm by 
@matthewherper
1",,,,1,['https://pbs.twimg.com/media/C_pKMdqXcAATlp3?format=jpg&name=small'],https://twitter.com/forbeshealth/status/863083858752937984
2262,1stOncology,@1stOncology,2017-05-12T01:46:53.000Z,#OncoSec $ONCS and Merck $MRK to Evaluate Combination of #ImmunoPulseIL12 and #KEYTRUDA for Metastatic #Melanoma http://1stoncology.com/blog/oncosec-announces-clinical-collaboration-with-merck-to-evaluate-combination-of-immunopulse-il-12keytruda-pembrolizumab-for-metastatic-melanoma‚Ä¶,"#OncoSec $ONCS and Merck $MRK to Evaluate Combination of #ImmunoPulseIL12 and #KEYTRUDA for Metastatic #Melanoma http://1stoncology.com/blog/oncosec-announces-clinical-collaboration-with-merck-to-evaluate-combination-of-immunopulse-il-12keytruda-pembrolizumab-for-metastatic-melanoma‚Ä¶
1
1",,,1,1,[],https://twitter.com/1stOncology/status/862846509532008448
2263,Stockaholics,@Stockaholics,2017-05-10T01:42:23.000Z,Our Penny Stock Pick On $GBHL Gained 195% In The Past Month! See Our New Pick Early: http://tr.im/1xG4g #Breakout $INSY $MRK,"Our Penny Stock Pick On $GBHL Gained 195% In The Past Month! See Our New Pick Early: http://tr.im/1xG4g #Breakout $INSY $MRK
1
1",,,1,1,[],https://twitter.com/Stockaholics/status/862120603410722820
2264,ICI Research,@iciresearch,2017-05-11T11:14:14.000Z,$MRK pembrolizumab + chemo combo approved for 1st line lung cancer regardless of PD-L1 status,"$MRK pembrolizumab + chemo combo approved for 1st line lung cancer regardless of PD-L1 status
Merck
@Merck
 ¬∑ 11 May 2017
Pleased to share our latest news in #lungcancer #immunooncology: http://bit.ly/2r1gtpB
1",,,1,,['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg'],https://twitter.com/iciresearch/status/862626899750768641
2265,Investors.com,@IBDinvestors,2017-05-11T01:15:27.000Z,"Stock Futures: Snap Losing Clone War, This Drug Giant Nears Buy http://ow.ly/r8lA30bCsTK $SNAP $FB $MRK","Stock Futures: Snap Losing Clone War, This Drug Giant Nears Buy http://ow.ly/r8lA30bCsTK $SNAP $FB $MRK
1
2
1",,1,2,1,['https://pbs.twimg.com/media/C_ghix1XkAA_q5O?format=jpg&name=small'],https://twitter.com/IBDinvestors/status/862476212173713409
2266,Herkyleese,@herkyleese,2017-05-12T12:15:32.000Z,Patients need a voice! #Dcvax-L gives patients hope! $gild $celg $bmy $mrk $exel $fgen  Combo therepies work $biib $jazz $blue $juno $kite https://twitter.com/ChrisLacoursier/status/862803950956838912‚Ä¶,"Patients need a voice! #Dcvax-L gives patients hope! $gild $celg $bmy $mrk $exel $fgen  Combo therepies work $biib $jazz $blue $juno $kite https://twitter.com/ChrisLacoursier/status/862803950956838912‚Ä¶
This Tweet is unavailable.
1",,,,1,[],https://twitter.com/herkyleese/status/863004713293414400
2267,Jack Allen,@JohnK_Allen,2017-05-12T16:22:17.000Z,"Tons of IO news this week,biggest news in my view, $MRK 1L approval w/o testing requirement,was expected still but game-changer
$BMY $AZN","Tons of IO news this week,biggest news in my view, $MRK 1L approval w/o testing requirement,was expected still but game-changer
$BMY $AZN
Brad Loncar
@bradloncar
 ¬∑ 12 May 2017
The week in checkpoints:

$PFE 2L bladder approved
$REGN PR's combos
$RHHBY 2L bladder miss
$MRK chemo/combo approved
$AZN stage3 NSCLC win
2",,,,2,['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg'],https://twitter.com/JohnK_Allen/status/863066811499253760
2268,MichaelSDeVries,@MichaelSDeVries,2017-05-10T10:13:58.000Z,$ONCS $MRK OncoSec Announces Clinical Collaboration with Merck http://prnewswire.com/news-releases/oncosec-an‚Ä¶...,"$ONCS $MRK OncoSec Announces Clinical Collaboration with Merck http://prnewswire.com/news-releases/oncosec-an‚Ä¶...
stocktwits.com
Michael S DeVries (@MichaelSDeVries) | Stocktwits
$ONCS $MRK OncoSec Announces Clinical Collaboration with Merck http://www.prnewswire.com/news-releases/oncosec-announces-clinical-collaboration-with-merck-to-evaluate-combination-of-immunopulse-il-...
2",,,2,,['https://pbs.twimg.com/card_img/1475202648106278923/bHSgSiCo?format=png&name=240x240'],https://twitter.com/MichaelSDeVries/status/862249347660079104
2269,finvestmonitor,@finvestmonitor,2017-05-11T13:25:06.000Z,"#Stocks in play for #trading:

$YELP
$DRYS
$SGMO
$MRK
$TGI
$PRI
$AGN

#investing #equities #finance","#Stocks in play for #trading:

$YELP
$DRYS
$SGMO
$MRK
$TGI
$PRI
$AGN

#investing #equities #finance
1
2",,,1,2,[],https://twitter.com/finvestmonitor/status/862659832507232256
2270,Tuan Pham,@15minofPham,2017-05-12T02:20:40.000Z,Today's bueno combination of 30 day high in both price & volume: $MRK,"Today's bueno combination of 30 day high in both price & volume: $MRK
1",,,,1,[],https://twitter.com/15minofPham/status/862855011675635712
2271,BioWorld,@BioWorld,2017-05-11T12:48:00.000Z,Tecentriq flunks confirmatory trial in bladder cancer as $MRK jumps ahead in NSCLC with Keytruda http://bit.ly/2pmqMrQ,"Tecentriq flunks confirmatory trial in bladder cancer as $MRK jumps ahead in NSCLC with Keytruda http://bit.ly/2pmqMrQ
2
1",,,2,1,[],https://twitter.com/BioWorld/status/862650497336922114
2272,FiercePharma,@FiercePharma,2017-05-11T15:30:21.000Z,"Pressure mounts on Bristol-Myers, AstraZeneca as Merck bags Keytruda chemo combo approval http://fiercepharma.com/pharma/pressure-mounts-bms-az-as-merck-bags-keytruda-chemo-combo-approval‚Ä¶ $BMY $AZN $MRK","Pressure mounts on Bristol-Myers, AstraZeneca as Merck bags Keytruda chemo combo approval http://fiercepharma.com/pharma/pressure-mounts-bms-az-as-merck-bags-keytruda-chemo-combo-approval‚Ä¶ $BMY $AZN $MRK
fiercepharma.com
Pressure mounts on Bristol-Myers, AstraZeneca as Merck bags Keytruda chemo combo approval
Your move, Bristol-Myers Squibb and AstraZeneca. | Your move, Bristol-Myers Squibb and AstraZeneca. The FDA has blessed Merck‚Äôs Keytruda-chemo combo in first-line lung cancer‚Äîand now it‚Äôs up to BMS...
2
3",,,2,3,['https://pbs.twimg.com/card_img/1501722504192303105/c8yuYbIE?format=jpg&name=small'],https://twitter.com/FiercePharma/status/862691353670692866
2273,Playbook Trading,@NDX100,2017-05-11T13:25:31.000Z,In Play Longs: $WFM $YELP $CAT $MRK $NTES $RELY $XONE $SGMO,"In Play Longs: $WFM $YELP $CAT $MRK $NTES $RELY $XONE $SGMO
1",,,,1,[],https://twitter.com/NDX100/status/862659938438574081
2274,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-05-10T02:06:23.000Z,"Listening to conference call, funny thing to hear is analyst with thick British accent say Roche-->  ""Rauuuche"" $ROG $AZN $BMY $MRK","Listening to conference call, funny thing to hear is analyst with thick British accent say Roche-->  ""Rauuuche"" $ROG $AZN $BMY $MRK
2",,,,2,[],https://twitter.com/DrPaulyDeSantis/status/862126641874477057
2275,Tarmo Seliste,@tarmoseliste,2017-05-11T07:03:05.000Z,FDA approves $MRK Pembrolizumab with chemotherapy in first line lung cancer. http://investors.merck.com/news/press-release-details/2017/FDA-Approves-Mercks-KEYTRUDA-pembrolizumab-as-First-Line-Combination-Therapy-with-Pemetrexed-and-Carboplatin-for-Patients-with-Metastatic-Nonsquamous-Non-Small-Cell-Lung-Cancer-NSCLC-Irrespective-of-PD-L1-Expression/default.aspx‚Ä¶,"FDA approves $MRK Pembrolizumab with chemotherapy in first line lung cancer. http://investors.merck.com/news/press-release-details/2017/FDA-Approves-Mercks-KEYTRUDA-pembrolizumab-as-First-Line-Combination-Therapy-with-Pemetrexed-and-Carboplatin-for-Patients-with-Metastatic-Nonsquamous-Non-Small-Cell-Lung-Cancer-NSCLC-Irrespective-of-PD-L1-Expression/default.aspx‚Ä¶
1",,,1,,[],https://twitter.com/tarmoseliste/status/862563694387056641
2276,BioPharma Dive,@BioPharmaDive,2017-05-11T20:54:00.000Z,FDA approves $MRK's Keytruda paired with chemo as a first-line treatment for NSCLC regardless of PD-L1 expression,"FDA approves $MRK's Keytruda paired with chemo as a first-line treatment for NSCLC regardless of PD-L1 expression
biopharmadive.com
Merck bolsters I/O edge with Keytruda combo approval
Approval is expected to help Merck cement market share in the lucrative lung cancer market and stay a step ahead of fast-moving rivals. 
1
4",,,1,4,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/862772803551895552
2277,Anirban Maitra,@Aiims1742,2017-05-12T20:22:05.000Z,"Coming soon via 
@ALLIANCE_org
 led by 
@theNCI
 @apolo_andrea
  ph 3 of Keytruda in muscle invasive #bladdercancer
Hoping $MRK luck holds ","Coming soon via 
@ALLIANCE_org
 led by 
@theNCI
 @apolo_andrea
  ph 3 of Keytruda in muscle invasive #bladdercancer
Hoping $MRK luck holds 
5
2",,,5,2,[],https://twitter.com/Aiims1742/status/863127158335696897
2278,$peedyCalls,@SpeedyCalls,2017-05-12T18:19:36.000Z,"$MRK 62.5 Calls SELLING Activity expiring on 19th Jan, Vol 2979","$MRK 62.5 Calls SELLING Activity expiring on 19th Jan, Vol 2979
1",,,1,,[],https://twitter.com/SpeedyCalls/status/863096335830065153
2279,Evaluate Pharma,@evaluatepharma,2017-05-11T10:14:46.000Z,"Merck cements its lung cancer lead http://ow.ly/wXDR30bCWWw via 
@EPVantage
 @EPVantage
 $MRK #Keytruda #PD1","Merck cements its lung cancer lead http://ow.ly/wXDR30bCWWw via 
@EPVantage
 @EPVantage
 $MRK #Keytruda #PD1
2",,,2,,[],https://twitter.com/evaluatepharma/status/862611935111639040
2280,BioWorld,@BioWorld,2017-05-10T22:11:22.000Z,Kicking a dog when it's down: $MRK gets accelerated nod for Keytruda in 1L NSCLC same day Roche reports Tecentriq fail in 2L bladder cancer,"Kicking a dog when it's down: $MRK gets accelerated nod for Keytruda in 1L NSCLC same day Roche reports Tecentriq fail in 2L bladder cancer
1",,,1,,[],https://twitter.com/BioWorld/status/862429886346121216
2281,MM+M Magazine,@MMMnews,2017-05-12T11:30:01.000Z,"Missed yesterday's news? Here's what to know #pharma #FDA $MRK $LLY #Immunotherapy 
@PhRMA
 $PFE $SGMO #Doctors #hcsm http://bit.ly/2r5NDFr","Missed yesterday's news? Here's what to know #pharma #FDA $MRK $LLY #Immunotherapy 
@PhRMA
 $PFE $SGMO #Doctors #hcsm http://bit.ly/2r5NDFr
1",,,,1,['https://pbs.twimg.com/media/C_jc9ZcXsAAEd7O?format=jpg&name=small'],https://twitter.com/MMMnews/status/862993259957673984
2282,John Carroll,@JohnCendpts,2017-05-10T21:39:33.000Z,Whoa! $MRK up 4%,"Whoa! $MRK up 4%
endpts.com
Merck increases grip on its lead in lung cancer, winning approval for Keytruda/chemo combo as...
Merck has won its bid to advance its leadership in treating the crucial non-small cell lung cancer market, gaining an FDA approval to start marketing a combination of its PD-1 drug Keytruda with...
1
8",,,1,8,['https://pbs.twimg.com/card_img/1500793422306852869/OnYME0eV?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/862421877511401473
2283,Max Nisen,@MaxNisen,2017-05-10T21:38:26.000Z,$MRK just got approval for its Keytruda/chemo combo- wrote last week about how important it is to the co.,"$MRK just got approval for its Keytruda/chemo combo- wrote last week about how important it is to the co.
bloomberg.com
Merck's Year May Hinge on the Next Eight Days
An FDA decision on a Keytruda combo could be its best shot at IO dominance.
1",,,,1,['https://pbs.twimg.com/card_img/1500621495160094723/qVmE60zb?format=jpg&name=small'],https://twitter.com/MaxNisen/status/862421599206731776
2284,Bio Stocks‚Ñ¢,@BioStocks,2017-05-10T14:08:36.000Z,$MRK European Commission Grants Approval for Pergoveris Pen for Fertility Treatment http://finance.yahoo.com/news/european-commission-grants-approval-mercks-140100870.html?soc_src=social-sh&soc_trk=tw‚Ä¶,$MRK European Commission Grants Approval for Pergoveris Pen for Fertility Treatment http://finance.yahoo.com/news/european-commission-grants-approval-mercks-140100870.html?soc_src=social-sh&soc_trk=tw‚Ä¶,,,,,[],https://twitter.com/BioStocks/status/862308392211185664
2285,Jared Wesley,@ScalpMaster1,2017-05-11T12:59:39.000Z,"Longs: $NTES, $SGMO, $MRK, $WFM, $YELP, $CAT, $LPSN, $YNDX, $AMAT, $MYL, $HIMX! Shorts: $STRP, $SNAP, $M, $MZOR, $CTRP, $SYMC, $CNAT, $KSS!","Longs: $NTES, $SGMO, $MRK, $WFM, $YELP, $CAT, $LPSN, $YNDX, $AMAT, $MYL, $HIMX! Shorts: $STRP, $SNAP, $M, $MZOR, $CTRP, $SYMC, $CNAT, $KSS!
1",,,,1,[],https://twitter.com/ScalpMaster1/status/862653430980112386
2286,Sunny Goklani,@SunnyGoklani,2017-05-11T22:13:57.000Z,Commented on Keytruda Gets Hot And Propels Merck: Analysis https://seekingalpha.com/article/4072352-keytruda-gets-hot-propels-merck-analysis?source=tweet‚Ä¶ $ABBV $AZN $BAYRY $BMY $GILD $LLY $NVO $PFE $RHHBY $MRK,"Commented on Keytruda Gets Hot And Propels Merck: Analysis https://seekingalpha.com/article/4072352-keytruda-gets-hot-propels-merck-analysis?source=tweet‚Ä¶ $ABBV $AZN $BAYRY $BMY $GILD $LLY $NVO $PFE $RHHBY $MRK
1
2",,1,,2,[],https://twitter.com/SunnyGoklani/status/862792922659303424
2287,Breaking News,@MarketCurrents,2017-05-10T15:47:13.000Z,OncoSec readies mid-stage study of ImmunoPulse IL-12 with Merck's Keytruda in treatment-resistant mela... https://seekingalpha.com/news/3265919-oncosec-readies-mid-stage-study-immunopulse-ilminus-12-mercks-keytruda-treatment-resistant?source=feed_f‚Ä¶ $ONCS $MRK,"OncoSec readies mid-stage study of ImmunoPulse IL-12 with Merck's Keytruda in treatment-resistant mela... https://seekingalpha.com/news/3265919-oncosec-readies-mid-stage-study-immunopulse-ilminus-12-mercks-keytruda-treatment-resistant?source=feed_f‚Ä¶ $ONCS $MRK
seekingalpha.com
OncoSec readies mid-stage study of ImmunoPulse IL-12 with Merck's Keytruda in treatment-resistant...
Thinly traded nano cap OncoSec Medical (ONCS +2.8%) is up on a 50% spike in volume, albeit down from its premarket high, in response to its announcement that it will collaborate with Merck...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/862333209563938816
2288,Hotpage News,@Hotpage_News,2017-05-11T12:54:23.000Z,EARLY MOVERS: $STRP $SNAP $FOXA $WFM $KSS $TEVA $YUM $PRXL $X $GSK $AIG $AET $MRK $SYMC $HD $YUM - CNBC,"EARLY MOVERS: $STRP $SNAP $FOXA $WFM $KSS $TEVA $YUM $PRXL $X $GSK $AIG $AET $MRK $SYMC $HD $YUM - CNBC
cnbc.com
Early movers: STRP, SNAP, FOXA, WFM, KSS, TEVA, YUM & more
These are the stocks posting the largest moves before the bell.
1",,,1,,[],https://twitter.com/Hotpage_News/status/862652104174948352
2289,FiercePharma,@FiercePharma,2017-05-11T18:56:10.000Z,"Trending: Pressure mounts on $BMY, $AZN as $MRK bags Keytruda chemo combo approval","Trending: Pressure mounts on $BMY, $AZN as $MRK bags Keytruda chemo combo approval
fiercepharma.com
Pressure mounts on Bristol-Myers, AstraZeneca as Merck bags Keytruda chemo combo approval
Your move, Bristol-Myers Squibb and AstraZeneca. | Your move, Bristol-Myers Squibb and AstraZeneca. The FDA has blessed Merck‚Äôs Keytruda-chemo combo in first-line lung cancer‚Äîand now it‚Äôs up to BMS...
1
2",,,1,2,['https://pbs.twimg.com/card_img/1501722504192303105/c8yuYbIE?format=jpg&name=small'],https://twitter.com/FiercePharma/status/862743149562798081
2290,The Fly,@theflynews,2017-05-11T13:39:05.000Z,On The Fly: Pre-market Movers $PEGA $LPSN $XON $RELY $MRK $SGMO $SNAP $M $VSTO $HOLX $SYMC $KSS $STRP $BMY,"On The Fly: Pre-market Movers $PEGA $LPSN $XON $RELY $MRK $SGMO $SNAP $M $VSTO $HOLX $SYMC $KSS $STRP $BMY
thefly.com
On The Fly: Pre-market Movers
UP AFTER EARNINGS: Pegasy... PEGA, LPSN, XON, RELY, MRK, SGMO, SNAP, M, VSTO, HOLX, SYMC, KSS, STRP, BMY
1",,,,1,['https://pbs.twimg.com/card_img/1493781617860509710/dfbtUYKJ?format=jpg&name=small'],https://twitter.com/theflynews/status/862663354225119232
2291,Seeking Alpha,@SeekingAlpha,2017-05-11T21:16:00.000Z,Keytruda Gets Hot And Propels Merck: Analysis https://seekingalpha.com/article/4072352-keytruda-gets-hot-propels-merck-analysis?source=feed_f‚Ä¶ $ABBV $AZN $BAYRY $BMY $GILD $LLY $NVO $PFE $RHHBY $MRK,Keytruda Gets Hot And Propels Merck: Analysis https://seekingalpha.com/article/4072352-keytruda-gets-hot-propels-merck-analysis?source=feed_f‚Ä¶ $ABBV $AZN $BAYRY $BMY $GILD $LLY $NVO $PFE $RHHBY $MRK,,,,,[],https://twitter.com/SeekingAlpha/status/862778337831165952
2292,FierceBiotech,@FierceBiotech,2017-05-10T15:53:14.000Z,"Roche‚Äôs shocking Tecentriq fail raises red flag for bladder cancer rivals: 
@FiercePharma
 - http://ow.ly/QB3a30bBzxQ $RHHBY $BMS $MRK","Roche‚Äôs shocking Tecentriq fail raises red flag for bladder cancer rivals: 
@FiercePharma
 - http://ow.ly/QB3a30bBzxQ $RHHBY $BMS $MRK
4
2",,,4,2,[],https://twitter.com/FierceBiotech/status/862334723238100992
2293,Jacob Plieth,@JacobPlieth,2017-05-10T14:53:56.000Z,"Replying to 
@adar170","Replying to 
@adar170
From my story today $RHHBY $MRK $BMY
2
1",,2,,1,['https://pbs.twimg.com/media/C_eTSBrXUAAmYjS?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/862319801972162560
2294,Anirban Maitra,@Aiims1742,2017-05-10T14:29:31.000Z,"Who's going to write definitive treatise on why $MRK keeps winning the #Immunotherapy clone wars?
@matthewherper
 
@JohnCendpts
 
@bradloncar","Who's going to write definitive treatise on why $MRK keeps winning the #Immunotherapy clone wars?
@matthewherper
 
@JohnCendpts
 
@bradloncar
1
1
3",,1,1,3,[],https://twitter.com/Aiims1742/status/862313655236513797
2295,The Fly,@theflynews,2017-05-10T22:33:04.000Z,On The Fly: After Hours Movers $RELY $PEGA $WFM $XON $DRYS $WATT $OMER $SGMO $PFE $MRK $ORLY $X $NH $SNAP $MNKD‚Ä¶,"On The Fly: After Hours Movers $RELY $PEGA $WFM $XON $DRYS $WATT $OMER $SGMO $PFE $MRK $ORLY $X $NH $SNAP $MNKD‚Ä¶
thefly.com
On The Fly: After Hours Movers
UP AFTER EARNINGS: Real I... RELY, PEGA, WFM, XON, DRYS, WATT, OMER, SGMO, PFE, MRK, ORLY, X, NH, SNAP, MNKD, AVNW, FRSH, NVCN, SYMC, ELF, FOX, FOXA, CNAT, NYRT, ABR, BMY, BFAM
2",,,2,,['https://pbs.twimg.com/card_img/1501305764081721345/GcvAvZOJ?format=jpg&name=small'],https://twitter.com/theflynews/status/862435346025373696
2296,John Carroll,@JohnCendpts,2017-05-11T12:26:31.000Z,"In 1 day we saw Roche's Tecentriq tumble
https://endpts.com/in-a-stunning-setback-roche-says-its-top-cancer-drug-tecentriq-failed-a-key-phiii-study/‚Ä¶
And $MRK win big. No lack of news in checkpoint R&D","In 1 day we saw Roche's Tecentriq tumble
https://endpts.com/in-a-stunning-setback-roche-says-its-top-cancer-drug-tecentriq-failed-a-key-phiii-study/‚Ä¶
And $MRK win big. No lack of news in checkpoint R&D
endpts.com
Merck increases grip on its lead in lung cancer, winning approval for Keytruda/chemo combo as...
Merck has won its bid to advance its leadership in treating the crucial non-small cell lung cancer market, gaining an FDA approval to start marketing a combination of its PD-1 drug Keytruda with...
1
2",,,1,2,['https://pbs.twimg.com/card_img/1500793422306852869/OnYME0eV?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/862645090518540289
2297,Paul R. La Monica,@LaMonicaBuzz,2017-05-10T19:26:44.000Z,Stralem's Abelson also likes health care. Owns $TMO $CELG $MRK $PFE,"Stralem's Abelson also likes health care. Owns $TMO $CELG $MRK $PFE
2
2",,,2,2,[],https://twitter.com/LaMonicaBuzz/status/862388455493562371
2298,Donna Young,@DonnaYoungDC,2017-05-10T21:42:07.000Z,"#FDA OK'd $MRK #Keytruda in combination w/ pemetrexed & carboplatin as 1st-line treatment of patients w/ metastatic nonsquamous NSCLC
$BMY","#FDA OK'd $MRK #Keytruda in combination w/ pemetrexed & carboplatin as 1st-line treatment of patients w/ metastatic nonsquamous NSCLC
$BMY
Donna Young
@DonnaYoungDC
 ¬∑ 11 May 2017
#FDA OK's expanded use of $MRK #Keytruda chemo combo in 1st-line NSCLC
http://merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf‚Ä¶
#lungcancer #pharma $BMY #Opdivo
2",üì∞ üì∞,,2,,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/862422523866230790
2299,Ben Fidler,@BentheFidler,2017-05-12T11:03:51.000Z,"#Biotech Roundup: Big Apple Mo‚Äô, Checkpoint Yes and No, CAR-T Death & More http://xconomy.com/national/2017/05/12/bio-roundup-big-apple-mo-checkpoint-yes-and-no-car-t-death-more/‚Ä¶ by 
@alexlash
 $KITE $MRK $PTCT $PFE","#Biotech Roundup: Big Apple Mo‚Äô, Checkpoint Yes and No, CAR-T Death & More http://xconomy.com/national/2017/05/12/bio-roundup-big-apple-mo-checkpoint-yes-and-no-car-t-death-more/‚Ä¶ by 
@alexlash
 $KITE $MRK $PTCT $PFE
2",,,,2,[],https://twitter.com/BentheFidler/status/862986673273098240
2300,Evaluate Vantage,@evaluatevantage,2017-05-11T14:46:06.000Z,"ICYMI: $MRK cements its lung cancer lead with Keytruda-chemo combo approval in first-line NSCLC, by 
@ByJonGardner
 http://epvantage.com/Universal/View.aspx?type=Story&id=706826&isEPVantage=yes‚Ä¶","ICYMI: $MRK cements its lung cancer lead with Keytruda-chemo combo approval in first-line NSCLC, by 
@ByJonGardner
 http://epvantage.com/Universal/View.aspx?type=Story&id=706826&isEPVantage=yes‚Ä¶
1",,,1,,[],https://twitter.com/evaluatevantage/status/862680218745679872
2301,Gregory L,@ScatmanGL,2017-05-10T22:25:50.000Z,"Replying to 
@cfromhertz","Replying to 
@cfromhertz
The way to play this is short $BMY and buy $MRK. Would have worked out well
1",,,,1,[],https://twitter.com/ScatmanGL/status/862433524472741892
2302,Benzinga,@Benzinga,2017-05-11T16:30:01.000Z,"Here's What The FDA Approval Of Keytruda Means For Merck, And For Bristol-Myers https://benzinga.com/z/9447190 $BMY $MRK","Here's What The FDA Approval Of Keytruda Means For Merck, And For Bristol-Myers https://benzinga.com/z/9447190 $BMY $MRK",,,,,[],https://twitter.com/Benzinga/status/862706370742673413
2303,M,@bio_clouseau,2017-05-10T07:46:32.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
Probably puts a last minute Kabosh on $MRK AA in 1st line NSCLC
1
1",,1,,1,[],https://twitter.com/bio_clouseau/status/862212241810223104
2304,M,@bio_clouseau,2017-05-10T07:26:19.000Z,"Replying to 
@jq1234t
 and 
@JacobPlieth","Replying to 
@jq1234t
 and 
@JacobPlieth
If $RHHBY used same criteria as IMvigor210 then PD-L1 >= 5% in 211 which may have been their undoing. Didnt learn from $BMY $MRK
2",,,,2,[],https://twitter.com/bio_clouseau/status/862207153892990976
2305,Adam Feuerstein,@adamfeuerstein,2017-05-10T11:22:49.000Z,"Replying to 
@JustTwittin2","Replying to 
@JustTwittin2
$MRK is providing Keytruda to $ONCS for this clinical trial, Merck spox confirmed. Is that really a ‚Äúcollaboration‚Äù? Not my definition.
3
2",,3,,2,[],https://twitter.com/adamfeuerstein/status/862266671167361024
2306,Kyle,@HODLoholicsAnon,2017-05-14T23:08:09.000Z,Upcoming fda activities: $WINT $NVO $BLPH $REGN $SNY $PBYI $MRK $NBIX $IMDZ $ARQL #daytrading #stocks #trading #fda,"Upcoming fda activities: $WINT $NVO $BLPH $REGN $SNY $PBYI $MRK $NBIX $IMDZ $ARQL #daytrading #stocks #trading #fda
4
5",,,4,5,['https://pbs.twimg.com/media/C_0qw4FXcAA4i_r?format=jpg&name=small'],https://twitter.com/HODLoholicsAnon/status/863893724765597698
2307,Herkyleese,@herkyleese,2017-05-15T19:05:17.000Z,#google #Dcvax-L Overall Survival outpacing chemo everyday.$kite $juno $fgen $exel $bmy #opdivo $mrk #keytruda #ASCO17 combo trials positive,"#google #Dcvax-L Overall Survival outpacing chemo everyday.$kite $juno $fgen $exel $bmy #opdivo $mrk #keytruda #ASCO17 combo trials positive
7
10",,,7,10,['https://pbs.twimg.com/media/C_48vl5UwAQbU5U?format=jpg&name=small'],https://twitter.com/herkyleese/status/864194994009239552
2308,dough,@semodough,2017-05-13T02:37:12.000Z,key near term catalysts for Large Cap Pharma $MRK $ABBV $JNJ $AZN $LLY,"key near term catalysts for Large Cap Pharma $MRK $ABBV $JNJ $AZN $LLY
2
5",,,2,5,['https://pbs.twimg.com/media/C_rHbfZUAAEzjAg?format=jpg&name=small'],https://twitter.com/semodough/status/863221560282419200
2309,Brad Loncar,@bradloncar,2017-05-14T18:20:01.000Z,"This week's schedule:

M: $EDIT $FATE $KURA
T: $KMDA
W: $AFMD $IMDZ #ASCO17
T: $EPZM $MRK(DE)
F: -

Full list: http://loncarblog.com/may-15-healthcare-earnings‚Ä¶","This week's schedule:

M: $EDIT $FATE $KURA
T: $KMDA
W: $AFMD $IMDZ #ASCO17
T: $EPZM $MRK(DE)
F: -

Full list: http://loncarblog.com/may-15-healthcare-earnings‚Ä¶
2
9
19",,2,9,19,['https://pbs.twimg.com/media/C_u907GVYAAH2eP?format=jpg&name=small'],https://twitter.com/bradloncar/status/863821216108478465
2310,Greg5thTrad,@Greg5thTrad,2017-05-15T01:44:25.000Z,"$ Flows: Buying on Weakness: Among stocks that were down FRI, these had the largest net INFLOWS of money: $GE $FOXA $IBM $BA $ORLY $MRK $BAC","$ Flows: Buying on Weakness: Among stocks that were down FRI, these had the largest net INFLOWS of money: $GE $FOXA $IBM $BA $ORLY $MRK $BAC",,,,,['https://pbs.twimg.com/media/C_1Og0IXYAY7Yp4?format=jpg&name=900x900'],https://twitter.com/Greg5thTrad/status/863933054389288962
2311,R,@Lucy3370,2017-05-14T16:23:37.000Z,$auph there is 0 reason 2 partner V 4 LN.nuff $ 2 complete ph3.partner only makes sense if V investigated 4 nother use as with $mrk,"$auph there is 0 reason 2 partner V 4 LN.nuff $ 2 complete ph3.partner only makes sense if V investigated 4 nother use as with $mrk
1
6",,1,,6,[],https://twitter.com/Lucy3370/status/863791920753070080
2312,George Marcovits,@GemsBot,2017-05-14T12:26:02.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/83100879#83100908‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/83100879#83100908‚Ä¶,,,,,['https://pbs.twimg.com/media/C_yXy_iUwAAtJSV?format=jpg&name=small'],https://twitter.com/GemsBot/status/863732134271385600
2313,Peter Blood,@ptrbld,2017-05-15T13:27:09.000Z,"Sucker for PD1 ? #Soothsayer (AI) "" $MRK on radar for adding to position""","Sucker for PD1 ? #Soothsayer (AI) "" $MRK on radar for adding to position""",,,,,[],https://twitter.com/ptrbld/status/864109899634155521
2314,Zero Filter,@zerofiltertruth,2017-05-15T13:07:23.000Z,"Round #InsiderBuying driving lotto #biotech $NVAX higher am

Possible break above 50-SMA could get fun 

$IBB $XBI $CELG $MRK","Round #InsiderBuying driving lotto #biotech $NVAX higher am

Possible break above 50-SMA could get fun 

$IBB $XBI $CELG $MRK",,,,,[],https://twitter.com/zerofiltertruth/status/864104928880599040
2315,biostock,@biostock,2017-05-15T04:41:48.000Z,Who could gobble up $ENDP? $TEVA $PFE $BMY $MRK?,Who could gobble up $ENDP? $TEVA $PFE $BMY $MRK?,,,,,[],https://twitter.com/biostock/status/863977690784825344
2316,Peter Blood,@ptrbld,2017-05-13T10:54:20.000Z,"$DRG PD-1 Portfolio  Longs->{ $BMY, $NVS, $MRK, $AZN } it was great week for ROI // #Soothsayer (AI) "" more to come ""","$DRG PD-1 Portfolio  Longs->{ $BMY, $NVS, $MRK, $AZN } it was great week for ROI // #Soothsayer (AI) "" more to come """,,,,,[],https://twitter.com/ptrbld/status/863346665926926337
2317,Chelli Miller,@cmiller1225,2017-05-15T01:05:02.000Z,"FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pLprWW #immunotherapy #lungcancer $MRK 
@Merck","FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pLprWW #immunotherapy #lungcancer $MRK 
@Merck
6
1",,,6,1,['https://pbs.twimg.com/media/C_1FhHaUIAAbfRd?format=jpg&name=small'],https://twitter.com/cmiller1225/status/863923141227278339
2318,BioPharmaDevice,@OneMedWorld,2017-05-15T16:01:08.000Z,4 Biotechs That Could Explode Or Crash In May http://buff.ly/2qIGmOO #biotech $MRK $REGN $PBYI $INCY,4 Biotechs That Could Explode Or Crash In May http://buff.ly/2qIGmOO #biotech $MRK $REGN $PBYI $INCY,,,,,['https://pbs.twimg.com/media/C_4SnilWsAIIA90?format=jpg&name=small'],https://twitter.com/OneMedWorld/status/864148651651866624
2319,TW Research Group,@DanCarlson33,2017-05-15T15:18:41.000Z,See what 3DS is doing for #cancer #diagnostics. $MRK $JNJ $AZN $NVS,"See what 3DS is doing for #cancer #diagnostics. $MRK $JNJ $AZN $NVS
twresearchgroup.com
3D Signatures, Diagnostics For Prostate Cancer
3D Signatures is using telomeres to help diagnose many forms of cancer, including prostate. Hear what they're doing in prostate as well as catalysts for the rest of the year, in this video with CEO...",,,,,[],https://twitter.com/DanCarlson33/status/864137971414388737
2320,Graycell Advisors,@GraycellAdvisor,2017-05-13T01:45:05.000Z,"Biotech At Inflection Point
http://buff.ly/2pHo0Je
$gild $ptla $pfe $mrk $srpt $exls $axon $tsro $exel $sage $exas $kite $vrtx $nbix $clvs","Biotech At Inflection Point
http://buff.ly/2pHo0Je
$gild $ptla $pfe $mrk $srpt $exls $axon $tsro $exel $sage $exas $kite $vrtx $nbix $clvs",,,,,[],https://twitter.com/GraycellAdvisor/status/863208446543503362
2321,PolgarStocks,@PolgarStocks,2017-05-15T19:32:38.000Z,"$MRK What do you think about it? #InvestorsHangout $AMSE $ARWJF $PKKFF $PLZZ $PRHL

 http://dlvr.it/P8ZlxT","$MRK What do you think about it? #InvestorsHangout $AMSE $ARWJF $PKKFF $PLZZ $PRHL

 http://dlvr.it/P8ZlxT",,,,,[],https://twitter.com/PolgarStocks/status/864201877889572864
2322,Pharmaceutical News,@pharma_sector,2017-05-15T21:15:41.000Z,"Will Incyte Shine Under Oncology Spotlight With Dow's #Merck, Bristol?. Read more: http://owler.us/acHSzO $MRK","Will Incyte Shine Under Oncology Spotlight With Dow's #Merck, Bristol?. Read more: http://owler.us/acHSzO $MRK",,,,,[],https://twitter.com/pharma_sector/status/864227811992653824
2323,Trade Academy,@TradeAcademyCo,2017-05-15T12:13:52.000Z,5/15 50D MA Watchlist: $FL $AU $RSX $SPLS $LB $SWN $MRK $ETE $FIT $BX $YPF $OCLR $KMX $EXEL $TSO $TIF $BMY $CSIQ $KR $FCAU $FRED $EOG,5/15 50D MA Watchlist: $FL $AU $RSX $SPLS $LB $SWN $MRK $ETE $FIT $BX $YPF $OCLR $KMX $EXEL $TSO $TIF $BMY $CSIQ $KR $FCAU $FRED $EOG,,,,,[],https://twitter.com/TradeAcademyCo/status/864091457455616000
2324,Pharmaceutical News,@pharma_sector,2017-05-15T12:04:21.000Z,"EOD Risers: #Merck & Co., Inc., Microsoft Corporation, Procter & Gamble Co, The Coca-Cola Co. Read more: http://owler.us/acHJ2p $MRK","EOD Risers: #Merck & Co., Inc., Microsoft Corporation, Procter & Gamble Co, The Coca-Cola Co. Read more: http://owler.us/acHJ2p $MRK",,,,,[],https://twitter.com/pharma_sector/status/864089062159785984
2325,Pharmaceutical News,@pharma_sector,2017-05-15T11:03:11.000Z,"Vaccine alliance says 300,000 doses of #Merck's Ebola shot available for emergencies. Read more: http://owler.us/acHH6t $MRK","Vaccine alliance says 300,000 doses of #Merck's Ebola shot available for emergencies. Read more: http://owler.us/acHH6t $MRK",,,,,[],https://twitter.com/pharma_sector/status/864073670045585408
2326,Peter Blood,@ptrbld,2017-05-15T20:04:50.000Z,"Martini Time 201705151602 "" 90 d time series fractal persistence continues forming pseudo-sine wave recent buys $AZN $MRK $VRX $TOSBF $XON ""","Martini Time 201705151602 "" 90 d time series fractal persistence continues forming pseudo-sine wave recent buys $AZN $MRK $VRX $TOSBF $XON """,,,,,[],https://twitter.com/ptrbld/status/864209980844630016
2327,Sweet Platform,@SweetPlatform,2017-05-15T12:34:35.000Z,"MRK Top news - May 15th, 2017 $MRK http://https://goo.gl/RVZVH3","MRK Top news - May 15th, 2017 $MRK http://https://goo.gl/RVZVH3",,,,,[],https://twitter.com/SweetPlatform/status/864096672321765376
2328,9/11 No Planer,@911NoPlaner,2017-05-15T21:28:24.000Z,"#HPVVaccine Turns Teenager Into 80-Year-Old http://yournewswire.com/hpv-vaccine-teen-80-year-old/‚Ä¶ via 
@yournewswire
 #hpv #vaccine #vaccines #gardasil #merck $mrk","#HPVVaccine Turns Teenager Into 80-Year-Old http://yournewswire.com/hpv-vaccine-teen-80-year-old/‚Ä¶ via 
@yournewswire
 #hpv #vaccine #vaccines #gardasil #merck $mrk",ü•∂,,,,[],https://twitter.com/911NoPlaner/status/864231012661899268
2329,BiotechPickList.com,@BiotechListPick,2017-05-14T16:03:37.000Z,"$MRK 
Merck Receives FDA Approval For Keytruda Treating Lung Cancer http://biotechpicklist.com/merck-receives-fda-approval-for-keytruda-treating-lung-cancer/‚Ä¶","$MRK 
Merck Receives FDA Approval For Keytruda Treating Lung Cancer http://biotechpicklist.com/merck-receives-fda-approval-for-keytruda-treating-lung-cancer/‚Ä¶",,,,,[],https://twitter.com/BiotechListPick/status/863786887550574592
2330,Dakota Financial,@dakotafinancial,2017-05-15T15:47:56.000Z,"Merck & Co., Inc. $MRK PT Raised to $70.00 http://zpr.io/PSFkS","Merck & Co., Inc. $MRK PT Raised to $70.00 http://zpr.io/PSFkS",,,,,[],https://twitter.com/dakotafinancial/status/864145330773929984
2331,Dakota Financial,@dakotafinancial,2017-05-15T14:08:55.000Z,"Merck & Co., Inc. $MRK Shares Bought by Carroll Financial Associates Inc. http://zpr.io/PS3fq","Merck & Co., Inc. $MRK Shares Bought by Carroll Financial Associates Inc. http://zpr.io/PS3fq",,,,,[],https://twitter.com/dakotafinancial/status/864120410832556032
2332,Ticker Report,@TickerReport,2017-05-14T10:09:13.000Z,"Koshinski Asset Management Inc. Increases Stake in Merck & Co., Inc. $MRK http://ift.tt/2rfkLKP","Koshinski Asset Management Inc. Increases Stake in Merck & Co., Inc. $MRK http://ift.tt/2rfkLKP",,,,,[],https://twitter.com/TickerReport/status/863697701048897537
2333,Daily Political,@dailypoliticaln,2017-05-15T09:41:49.000Z,"National Pension Service Has $114.783 Million Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1095746","National Pension Service Has $114.783 Million Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1095746",,,,,[],https://twitter.com/dailypoliticaln/status/864053193042513920
2334,Daily Political,@dailypoliticaln,2017-05-13T09:37:39.000Z,"GW&K Investment Management LLC Buys 18,340 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1091931","GW&K Investment Management LLC Buys 18,340 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1091931",,,,,[],https://twitter.com/dailypoliticaln/status/863327371771994112
2335,Daily Political,@dailypoliticaln,2017-05-15T12:24:22.000Z,"Zacks: Brokerages Expect Merck & Co., Inc. $MRK Will Post Earnings of $0.87 Per Share http://dailypolitical.com/?p=1096138","Zacks: Brokerages Expect Merck & Co., Inc. $MRK Will Post Earnings of $0.87 Per Share http://dailypolitical.com/?p=1096138",,,,,[],https://twitter.com/dailypoliticaln/status/864094102824136705
2336,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-05-14T12:26:17.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/3i0h1qyaI,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/3i0h1qyaI,,,,,[],https://twitter.com/gem_2014/status/863732194187116544
2337,CarnivoresHealth,@HealthierIT,2017-05-15T14:01:15.000Z,"FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pLzTxJ #immunotherapy #lungcancer $MRK 
@Merck","FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pLzTxJ #immunotherapy #lungcancer $MRK 
@Merck
3",,,3,,['https://pbs.twimg.com/media/C_33LkRXsAIOC9O?format=jpg&name=small'],https://twitter.com/HealthierIT/status/864118483352784896
2338,BioPharma Dive,@BioPharmaDive,2017-05-14T16:01:01.000Z,$MRK bolsters I/O edge with Keytruda combo approval,"$MRK bolsters I/O edge with Keytruda combo approval
biopharmadive.com
Merck bolsters I/O edge with Keytruda combo approval
Approval is expected to help Merck cement market share in the lucrative lung cancer market and stay a step ahead of fast-moving rivals. ",,,,,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/863786236103806977
2339,Allison Gatlin,@IBD_AGatlin,2017-05-15T19:56:36.000Z,AstraZeneca has opportunity in lung cancer treatment vs. Dow's Merck $AZN $MRK $BMY $RHHBY,"AstraZeneca has opportunity in lung cancer treatment vs. Dow's Merck $AZN $MRK $BMY $RHHBY
investors.com
AstraZeneca Has Opportunity In Lung Cancer Treatment Vs. Dow's Merck
AstraZeneca will have a ""sizable market opportunity"" in advanced lung cancer including some potential off-label use in earlier-stage patients, an expert says.",,,,,[],https://twitter.com/IBD_AGatlin/status/864207909399527425
2340,Allison Gatlin,@IBD_AGatlin,2017-05-15T18:51:12.000Z,"Will Incyte shine under oncology spotlight with Dow's Merck, Bristol? $INCY $MRK $BMY $AZN $RHHBY http://ow.ly/qjdL30bKcAg","Will Incyte shine under oncology spotlight with Dow's Merck, Bristol? $INCY $MRK $BMY $AZN $RHHBY http://ow.ly/qjdL30bKcAg",,,,,[],https://twitter.com/IBD_AGatlin/status/864191451785252864
2341,BackToTheFutures,@Back2DaFutures,2017-05-14T10:33:21.000Z,"Replying to 
@RolfeNeelsen
 and 
@Lin_ling_88","Replying to 
@RolfeNeelsen
 and 
@Lin_ling_88
As does every other #biotech, and it does not qualify as $KERX's did not. This is why co did that doggie $MRK deal
1",,,,1,[],https://twitter.com/Back2DaFutures/status/863703776862978048
2342,Vista Partners LLC,@VistaPResearch,2017-05-13T19:10:09.000Z,"@BactToTheFuture
 thanks for follow! See Vista Partners #WorldNews #Healthcare #technology commentary http://vistapglobal.com $IBB $MRK $JNJ","@BactToTheFuture
 thanks for follow! See Vista Partners #WorldNews #Healthcare #technology commentary http://vistapglobal.com $IBB $MRK $JNJ
GIF",,,,,[],https://twitter.com/VistaPResearch/status/863471444218454017
2343,cowenresearch,@CowenResearch,2017-05-15T10:54:39.000Z,Steve Scala publishes updated PD-1/PD-L1  market model. Sees ~$2.4 billion market for $AZN $MRK $PFE $RHHBY $BMY in 2022,Steve Scala publishes updated PD-1/PD-L1  market model. Sees ~$2.4 billion market for $AZN $MRK $PFE $RHHBY $BMY in 2022,,,,,[],https://twitter.com/CowenResearch/status/864071523505766400
2344,Transcript Daily,@TranscriptDaily,2017-05-13T11:13:56.000Z,"Investors Buy Shares of Merck & Co., Inc. $MRK on Weakness After Insider Selling http://ift.tt/2r3jmdc","Investors Buy Shares of Merck & Co., Inc. $MRK on Weakness After Insider Selling http://ift.tt/2r3jmdc",,,,,[],https://twitter.com/TranscriptDaily/status/863351598726119424
2345,MarketBeat,@MarketBeatCom,2017-05-15T14:10:24.000Z,"Zacks: Brokerages Expect Merck & Co., Inc. $MRK Will Post Earnings of $0.87 Per Share http://ift.tt/2pC85kc #acn","Zacks: Brokerages Expect Merck & Co., Inc. $MRK Will Post Earnings of $0.87 Per Share http://ift.tt/2pC85kc #acn",,,,,[],https://twitter.com/MarketBeatCom/status/864120785962766337
2346,US Banking News,@AmericanBanking,2017-05-15T12:04:36.000Z,Brokerage Give Consensus Hold Rating to Merck & Co. $MRK http://ift.tt/2qbDsRN,Brokerage Give Consensus Hold Rating to Merck & Co. $MRK http://ift.tt/2qbDsRN,,,,,[],https://twitter.com/AmericanBanking/status/864089126181711872
2347,Puneet @ L2M.co.in,Puneet @ L2M.co.in,2017-05-13T00:20:36.000Z,"Replying to 
@matthewherper","Replying to 
@matthewherper
Nope, for the $MRK & $ABBV etc $GILD will see its cash run out, or smoke it in a useless buyout :) #NASH",,,,,[],https://twitter.com/pbmech/status/863187183397502976
2348,Adam Feuerstein,@adamfeuerstein,2017-05-17T21:49:16.000Z,"My #ASCO17 stories

$INCY https://thestreet.com/story/14133161/1/new-incyte-ido-cancer-immunotherapy-combo-data-revealed-ahead-of-asco-17-meeting.html‚Ä¶

$AGIO $CELG https://thestreet.com/story/14133184/1/celgene-agios-update-blood-cancer-drug-study-results-in-asco-17-abstract.html‚Ä¶

$MRK","My #ASCO17 stories

$INCY https://thestreet.com/story/14133161/1/new-incyte-ido-cancer-immunotherapy-combo-data-revealed-ahead-of-asco-17-meeting.html‚Ä¶

$AGIO $CELG https://thestreet.com/story/14133184/1/celgene-agios-update-blood-cancer-drug-study-results-in-asco-17-abstract.html‚Ä¶

$MRK
thestreet.com
Merck Keytruda-Chemo ASCO '17 Update Shows Lung Cancer Survival Trend
The new Merck survival data were included in a research abstract for next month's American Society of Clinical Oncology (ASCO) annual meeting that was distributed on Wednesday night.
1
30
35",,1,30,35,['https://pbs.twimg.com/card_img/1501721626479669249/dL5wwaJP?format=jpg&name=small'],https://twitter.com/adamfeuerstein/status/864961037858099201
2349,Matthew Herper,@matthewherper,2017-05-16T17:14:56.000Z,"Here's what $ABUS is saying about Moderna and $MRK, too. http://forbes.com/sites/nathanvardi/2017/05/16/moderna-cant-escape-my-intellectual-property-says-arbutus-ceo/#6d007708633a‚Ä¶","Here's what $ABUS is saying about Moderna and $MRK, too. http://forbes.com/sites/nathanvardi/2017/05/16/moderna-cant-escape-my-intellectual-property-says-arbutus-ceo/#6d007708633a‚Ä¶
4
8
7",,4,8,7,['https://pbs.twimg.com/media/C_9tDVTUIAAup2c?format=jpg&name=360x360'],https://twitter.com/matthewherper/status/864529611895558144
2350,Jack Allen,@JohnK_Allen,2017-05-18T13:07:03.000Z,"A simplified graphic of IO pathways may help as you prepare for #ASCO17 #Immunotherapy
$MRK $BMY $AZN $PFE $RHHBY $INCY $NLNK $IBB $BIB","A simplified graphic of IO pathways may help as you prepare for #ASCO17 #Immunotherapy
$MRK $BMY $AZN $PFE $RHHBY $INCY $NLNK $IBB $BIB
1
4
6",,1,4,6,['https://pbs.twimg.com/media/DAHGzOBUIAEAkZO?format=jpg&name=small'],https://twitter.com/JohnK_Allen/status/865192006271815680
2351,Seeking Alpha,@SeekingAlpha,2017-05-18T12:11:32.000Z,"Esperion Therapeutics: Up, Up, And Away? https://seekingalpha.com/article/4074328-esperion-therapeutics-away?source=feed_f‚Ä¶ $AMGN $MRK $SNY $AZN $NVS $BMY $PFE $LLY $REGN $ESPR","Esperion Therapeutics: Up, Up, And Away? https://seekingalpha.com/article/4074328-esperion-therapeutics-away?source=feed_f‚Ä¶ $AMGN $MRK $SNY $AZN $NVS $BMY $PFE $LLY $REGN $ESPR",,,,,[],https://twitter.com/SeekingAlpha/status/865178036487966720
2352,Seeking Alpha,@SeekingAlpha,2017-05-18T13:49:44.000Z,"Chimerix: This Misunderstood Biotech, Trading Near Cash, Offers Substantial Upside https://seekingalpha.com/article/4074355-chimerix-misunderstood-biotech-trading-near-cash-offers-substantial-upside?source=feed_f‚Ä¶ $MRK $CMRX","Chimerix: This Misunderstood Biotech, Trading Near Cash, Offers Substantial Upside https://seekingalpha.com/article/4074355-chimerix-misunderstood-biotech-trading-near-cash-offers-substantial-upside?source=feed_f‚Ä¶ $MRK $CMRX",,,,,[],https://twitter.com/SeekingAlpha/status/865202746730795008
2353,Breaking News,@MarketCurrents,2017-05-18T20:15:31.000Z,FDA OKs Merck's Keytruda for two new uses in bladder cancer; shares ahead 1% after hours https://seekingalpha.com/news/3268621-fda-oks-mercks-keytruda-two-new-uses-bladder-cancer-shares-ahead-1-percent-hours?source=feed_f‚Ä¶ $MRK,"FDA OKs Merck's Keytruda for two new uses in bladder cancer; shares ahead 1% after hours https://seekingalpha.com/news/3268621-fda-oks-mercks-keytruda-two-new-uses-bladder-cancer-shares-ahead-1-percent-hours?source=feed_f‚Ä¶ $MRK
seekingalpha.com
FDA OKs Merck's Keytruda for two new uses in bladder cancer; shares ahead 1% after hours (NYSE:MRK)
The FDA approves the use of Merck's (NYSE:MRK) KEYTRUDA (pembrolizumab) in two bladder cancer populations:The first-line treatment of patients with locally advanced/metastatic urothelial...",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/865299834722562048
2354,Breaking News,@MarketCurrents,2017-05-18T16:20:59.000Z,Combo of Merck's Keytruda and chemo show survival benefit in mid-stage lung cancer study; shares ahead 1% https://seekingalpha.com/news/3268541-combo-mercks-keytruda-chemo-show-survival-benefit-mid-stage-lung-cancer-study-shares-ahead-1?source=feed_f‚Ä¶ $MRK,"Combo of Merck's Keytruda and chemo show survival benefit in mid-stage lung cancer study; shares ahead 1% https://seekingalpha.com/news/3268541-combo-mercks-keytruda-chemo-show-survival-benefit-mid-stage-lung-cancer-study-shares-ahead-1?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Combo of Merck's Keytruda and chemo show survival benefit in mid-stage lung cancer study; shares...
Merck (MRK +0.8%) looks like the one to beat in the race to develop cancer combination therapies.
1",,,,1,['https://pbs.twimg.com/card_img/1485040309126012929/Npe6H9LZ?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/865240811163623424
2355,Leo Adalbert,@StraNexa,2017-05-17T01:58:36.000Z,Merck Cements Its Lung Cancer Lead https://seekingalpha.com/article/4072740-merck-cements-lung-cancer-lead?source=tweet‚Ä¶ $BMY $RHHBY $AZN $MRK,"Merck Cements Its Lung Cancer Lead https://seekingalpha.com/article/4072740-merck-cements-lung-cancer-lead?source=tweet‚Ä¶ $BMY $RHHBY $AZN $MRK
seekingalpha.com
Merck Cements Its Lung Cancer Lead (NYSE:MRK)
Immuno-oncology is Merck & Co's (NYSE:MRK) world - everyone else just lives in it.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/StraNexa/status/864661395689938945
2356,TheStreet,@TheStreet,2017-05-16T15:47:09.000Z,"Despite decent earnings, Pfizer and other drug stocks like Johnson & Johnson and Merck are struggling http://trib.al/jCEJaTv $JNJ $MRK","Despite decent earnings, Pfizer and other drug stocks like Johnson & Johnson and Merck are struggling http://trib.al/jCEJaTv $JNJ $MRK
thestreet.com
Jim Cramer -- Citi's Downgrade of Pfizer Not Totally Reasonable
Citigroup had a 'thoughtful' research piece on Pfizer, but downgrading it partly based on 'transaction risk' seems unreasonable, Cramer said.
1",,,1,,[],https://twitter.com/TheStreet/status/864507520261521409
2357,Mavis Nye Dr (hon) BEM. BCAh,@Grandmamavis,2017-05-17T14:11:52.000Z,Aduro expands clinical collaboration with Merck with #mesothelioma study https://seekingalpha.com/news/3268120-aduro-expands-clinical-collaboration-merck-mesothelioma-study?source=tweet‚Ä¶ $ADRO $MRK,"Aduro expands clinical collaboration with Merck with #mesothelioma study https://seekingalpha.com/news/3268120-aduro-expands-clinical-collaboration-merck-mesothelioma-study?source=tweet‚Ä¶ $ADRO $MRK
seekingalpha.com
Aduro expands clinical collaboration with Merck with mesothelioma study (NASDAQ:ADRO)
Aduro Biotech (ADRO) will collaborate with Merck (MRK -0.5%) on a Phase 2 clinical trial assessing CRS-207, its LADD (live, attenuated double-deleted)-based immunotherapy, with Keytruda...
1",,,1,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/Grandmamavis/status/864845931434450944
2358,HealthyCarnivores,@HealthyCarnivor,2017-05-17T14:20:04.000Z,4 Biotechs That Could Explode Or Crash In May http://buff.ly/2qIS9N7 #biotech $MRK $REGN $PBYI $INCY,"4 Biotechs That Could Explode Or Crash In May http://buff.ly/2qIS9N7 #biotech $MRK $REGN $PBYI $INCY
2
1",,,2,1,['https://pbs.twimg.com/media/DACOqf2UIAEakrP?format=jpg&name=small'],https://twitter.com/HealthyCarnivor/status/864847992259563520
2359,FlowerPower,@Flower_Power_67,2017-05-18T23:22:17.000Z,"1/2
#MadMoneyEspresso
$AMZN$AAPL$NFLX$GOOGL
$MRK$AMAT$ADSK$NVDA‚Äî
$CRM‚Äî
$WMT‚Äî
$USCR‚Äî
$GIS‚Äî
$CBSH ‚Äî","1/2
#MadMoneyEspresso
$AMZN$AAPL$NFLX$GOOGL
$MRK$AMAT$ADSK$NVDA‚Äî
$CRM‚Äî
$WMT‚Äî
$USCR‚Äî
$GIS‚Äî
$CBSH ‚Äî
1",üëç üëç üëç üëç üëç,,1,,"['https://pbs.twimg.com/media/DAJUVyiUAAAHgmd?format=jpg&name=small', 'https://pbs.twimg.com/media/DAJUVypV0AMP5zb?format=jpg&name=small']",https://twitter.com/Flower_Power_67/status/865346836181254144
2360,John M. Spallanzani,@JohnSpall247,2017-05-17T00:39:05.000Z,"$AMZN #AMZN 
@JeffBezos
 #SiliconValley To #Washington #pharmacy #medicaid #drugdiscovery #pricediscovery $mrk $pfe $bmy $ibb 
@jimcramer
 $xph","$AMZN #AMZN 
@JeffBezos
 #SiliconValley To #Washington #pharmacy #medicaid #drugdiscovery #pricediscovery $mrk $pfe $bmy $ibb 
@jimcramer
 $xph
Christina Farr
@chrissyfarr
 ¬∑ 17 May 2017
Scoop: Amazon is hiring a team to break into the pharmacy market 
http://cnb.cx/2qPfn49
1
3",,,1,3,['https://pbs.twimg.com/profile_images/1473534582435704835/91c1NShx_mini.jpg'],https://twitter.com/JohnSpall247/status/864641385743470592
2361,Odi Bruckman,@odibro,2017-05-17T13:08:24.000Z,$ADRO Announces Clinical Collaboration with $MRK to Evaluate the Combination of Aduro‚Äôs CRS-207 with KEYTRUDA,"$ADRO Announces Clinical Collaboration with $MRK to Evaluate the Combination of Aduro‚Äôs CRS-207 with KEYTRUDA
globenewswire.com
Aduro Biotech Announces Clinical Collaboration with Merck to Evaluate the Combination of Aduro‚Äôs...
Second Phase 2 Clinical Collaboration between the Two Companies to Evaluate CRS-207/Pembrolizumab Combination...
2
6",,,2,6,['https://pbs.twimg.com/card_img/1501200613744558087/uh9G23pc?format=png&name=240x240'],https://twitter.com/odibro/status/864829956546867200
2362,Helen Ong,@Lin_ling_88,2017-05-16T04:35:16.000Z,$BMY $MRK $RHHBY,"$BMY $MRK $RHHBY
OncLive.com
@OncLive
 ¬∑ 16 May 2017
In HPV-negative head and neck cancer, PD-L1 shows strong association with radiation resistance #hncsm http://onclive.com/web-exclusives/pdl1-expression-strongly-associated-with-radiation-resistance-in-hpvnegative-hnscc‚Ä¶",,,,,['https://pbs.twimg.com/profile_images/1207309207004950533/hnCTQqRs_mini.jpg'],https://twitter.com/Lin_ling_88/status/864338436886417408
2363,Donna Young,@DonnaYoungDC,2017-05-18T11:14:55.000Z,#WHO Salama: $MRK's #Ebola vaccine must be kept at -80c degrees; poses an enormous challenge; but committed to implement if needed in Congo,"#WHO Salama: $MRK's #Ebola vaccine must be kept at -80c degrees; poses an enormous challenge; but committed to implement if needed in Congo
Donna Young
@DonnaYoungDC
 ¬∑ 18 May 2017
#WHO Peter Salama: No licensed #Ebola vaccine; but do have promising candidate - $MRK's - must seek Congo OK to use under expanded access
1",üì∞ üì∞,,1,,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/865163785971142657
2364,Ned Pagliarulo,@NedPagliarulo,2017-05-17T21:12:20.000Z,"$INCY epacadostat + $MRK Keytruda in ECHO-202

35% ORR (all PR) in NSCLC
35% ORR (all PR) in UC
31% ORR in SCCHN
30% ORR in Kidney #ASCO17","$INCY epacadostat + $MRK Keytruda in ECHO-202

35% ORR (all PR) in NSCLC
35% ORR (all PR) in UC
31% ORR in SCCHN
30% ORR in Kidney #ASCO17
1
1
4",,1,1,4,[],https://twitter.com/NedPagliarulo/status/864951743330881537
2365,GuruFocus,@gurufocus,2017-05-17T16:15:57.000Z,Guru adds 3 new positions to portfolio http://gurufocus.com/news/522474  $BIDU $SIG $MRK,Guru adds 3 new positions to portfolio http://gurufocus.com/news/522474  $BIDU $SIG $MRK,,,,,['https://pbs.twimg.com/media/DACpMNVWsAAs8GJ?format=jpg&name=small'],https://twitter.com/gurufocus/status/864877157482455042
2366,No bears No bulls,@Nobears_Nobulls,2017-05-18T23:38:34.000Z,"Merck's Keytruda gets two bladder cancer approvals from FDA
$MRK 
http://finance.yahoo.com/r/13e1f7e4-5b1f-3393-abdf-fd6c95a11577/Story.aspx?guid=FC8AEEC1-0931-412B-A479-D2A820AE13DC&siteid=yhoof2&yptr=yahoo&.tsrc=rss‚Ä¶","Merck's Keytruda gets two bladder cancer approvals from FDA
$MRK 
http://finance.yahoo.com/r/13e1f7e4-5b1f-3393-abdf-fd6c95a11577/Story.aspx?guid=FC8AEEC1-0931-412B-A479-D2A820AE13DC&siteid=yhoof2&yptr=yahoo&.tsrc=rss‚Ä¶",,,,,[],https://twitter.com/Nobears_Nobulls/status/865350932594388992
2367,Siti van der Meij,@sitivandermeij,2017-05-18T20:19:16.000Z,FDA OKs Merck's Keytruda for two new uses in bladder cancer; shares ahead 1% after hours https://seekingalpha.com/news/3268621-fda-oks-mercks-keytruda-two-new-uses-bladder-cancer-shares-ahead-1-percent-hours?source=feed_f‚Ä¶ $MRK #sitifatimah #malays‚Ä¶,"FDA OKs Merck's Keytruda for two new uses in bladder cancer; shares ahead 1% after hours https://seekingalpha.com/news/3268621-fda-oks-mercks-keytruda-two-new-uses-bladder-cancer-shares-ahead-1-percent-hours?source=feed_f‚Ä¶ $MRK #sitifatimah #malays‚Ä¶
seekingalpha.com
FDA OKs Merck's Keytruda for two new uses in bladder cancer; shares ahead 1% after hours (NYSE:MRK)
The FDA approves the use of Merck's (NYSE:MRK) KEYTRUDA (pembrolizumab) in two bladder cancer populations:The first-line treatment of patients with locally advanced/metastatic urothelial...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/865300776037621760
2368,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-05-17T21:30:49.000Z,"had a dyslexic moment, Grade 3+ TRAEs with Epac + Pembro improved slightly from 19% at ESMO to 16% at ASCO17 $INCY $MRK","had a dyslexic moment, Grade 3+ TRAEs with Epac + Pembro improved slightly from 19% at ESMO to 16% at ASCO17 $INCY $MRK
1",,,,1,[],https://twitter.com/DrPaulyDeSantis/status/864956397707853824
2369,CarnivoresHealth,@HealthierIT,2017-05-16T17:30:10.000Z,4 Biotechs That Could Explode Or Crash In May http://buff.ly/2qIYrMy #biotech $MRK $REGN $PBYI $INCY,"4 Biotechs That Could Explode Or Crash In May http://buff.ly/2qIYrMy #biotech $MRK $REGN $PBYI $INCY
2",,,2,,['https://pbs.twimg.com/media/C_9wlkYUMAE26Wf?format=jpg&name=small'],https://twitter.com/HealthierIT/status/864533446550593538
2370,$peedyCalls,@SpeedyCalls,2017-05-16T14:04:34.000Z,"$MRK 64 Calls BUYING Activity expiring on 9th Jun, Vol 1411","$MRK 64 Calls BUYING Activity expiring on 9th Jun, Vol 1411
1",,,1,,[],https://twitter.com/SpeedyCalls/status/864481705557716993
2371,Bio Stocks‚Ñ¢,@BioStocks,2017-05-17T13:12:50.000Z,$ADRO Collaboration with $MRK to Evaluate CRS-207 with KEYTRUDA for the Treatment of Mesothelioma,"$ADRO Collaboration with $MRK to Evaluate CRS-207 with KEYTRUDA for the Treatment of Mesothelioma
globenewswire.com
Aduro Biotech Announces Clinical Collaboration with Merck to Evaluate the Combination of Aduro‚Äôs...
Second Phase 2 Clinical Collaboration between the Two Companies to Evaluate CRS-207/Pembrolizumab Combination...
1
2",,,1,2,['https://pbs.twimg.com/card_img/1501200613744558087/uh9G23pc?format=png&name=240x240'],https://twitter.com/BioStocks/status/864831072458215424
2372,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-05-18T17:17:23.000Z,"Replying to 
@dhovekamp42
, 
@BehaviorFin
 and 
@Adaptimmune","Replying to 
@dhovekamp42
, 
@BehaviorFin
 and 
@Adaptimmune
$ADAP $MRK combination study with Keytruda Anti-PD1 needs to start and 'trump' the already great NY-ESO TCR data in the long run
1
2",,1,,2,['https://pbs.twimg.com/media/DAIAk8tXgAAVOrN?format=jpg&name=small'],https://twitter.com/dhovekamp42/status/865255003988119552
2373,Breaking News,@MarketCurrents,2017-05-17T13:36:55.000Z,Aduro expands clinical collaboration with Merck with mesothelioma study https://seekingalpha.com/news/3268120-aduro-expands-clinical-collaboration-merck-mesothelioma-study?source=feed_f‚Ä¶ $ADRO $MRK,"Aduro expands clinical collaboration with Merck with mesothelioma study https://seekingalpha.com/news/3268120-aduro-expands-clinical-collaboration-merck-mesothelioma-study?source=feed_f‚Ä¶ $ADRO $MRK
seekingalpha.com
Aduro expands clinical collaboration with Merck with mesothelioma study (NASDAQ:ADRO)
Aduro Biotech (ADRO) will collaborate with Merck (MRK -0.5%) on a Phase 2 clinical trial assessing CRS-207, its LADD (live, attenuated double-deleted)-based immunotherapy, with Keytruda...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/864837135232192512
2374,dough,@semodough,2017-05-18T13:02:26.000Z,"LR $MRK shares should trade higher on OS data for KN-021G show a HR of 0.69, despite a 75% crossover rate in the chemotherapy only arm","LR $MRK shares should trade higher on OS data for KN-021G show a HR of 0.69, despite a 75% crossover rate in the chemotherapy only arm
1
1",,,1,1,[],https://twitter.com/semodough/status/865190846601326593
2375,Stockaholics,@Stockaholics,2017-05-18T17:15:50.000Z,195% Gain On Picks In The Past 2 Months And We Have A New Pick Today! Get Special Access: http://tr.im/1n9cD #Stocks $MRK $LGND,195% Gain On Picks In The Past 2 Months And We Have A New Pick Today! Get Special Access: http://tr.im/1n9cD #Stocks $MRK $LGND,,,,,[],https://twitter.com/Stockaholics/status/865254613360021504
2376,Carly Helfand,@CarlyHFierce,2017-05-18T16:17:00.000Z,#ASCO17 - Merck's Keytruda-chemo combo approach racks up more support with positive overall survival data: http://bit.ly/2q0fcy0 $MRK,"#ASCO17 - Merck's Keytruda-chemo combo approach racks up more support with positive overall survival data: http://bit.ly/2q0fcy0 $MRK
2",,,,2,[],https://twitter.com/CarlyHFierce/status/865239810461401088
2377,TalkMarkets,@TalkMarkets,2017-05-16T18:58:42.000Z,Matinas Well Positioned For June Data Read Outs $MTNB Also $MRK $ABT $PFE https://goo.gl/y6it62,Matinas Well Positioned For June Data Read Outs $MTNB Also $MRK $ABT $PFE https://goo.gl/y6it62,,,,,[],https://twitter.com/TalkMarkets/status/864555726320136192
2378,Jacob Bell,@realJacobBell,2017-05-18T15:50:01.000Z,7 Areas to watch from the ASCO abstracts http://bit.ly/2pXxAbN $INCY $AMGN $KITE $JUNO $RHHBY $LLY $PFE $NVS $MRK $AZN,7 Areas to watch from the ASCO abstracts http://bit.ly/2pXxAbN $INCY $AMGN $KITE $JUNO $RHHBY $LLY $PFE $NVS $MRK $AZN,,,,,[],https://twitter.com/realJacobBell/status/865233018897805312
2379,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-05-18T18:43:37.000Z,Combo of Merck's Keytruda and chemo show survival benefit in mid-stage lung cancer study; shares ahead 1% https://seekingalpha.com/news/3268541-combo-mercks-keytruda-chemo-show-survival-benefit-mid-stage-lung-cancer-study-shares-ahead-1?source=tweet‚Ä¶ $MRK,"Combo of Merck's Keytruda and chemo show survival benefit in mid-stage lung cancer study; shares ahead 1% https://seekingalpha.com/news/3268541-combo-mercks-keytruda-chemo-show-survival-benefit-mid-stage-lung-cancer-study-shares-ahead-1?source=tweet‚Ä¶ $MRK
seekingalpha.com
Combo of Merck's Keytruda and chemo show survival benefit in mid-stage lung cancer study; shares...
Merck (MRK +0.8%) looks like the one to beat in the race to develop cancer combination therapies.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/dhovekamp42/status/865276704666857472
2380,Allison Gatlin,@IBD_AGatlin,2017-05-18T20:55:37.000Z,Conference spotlights drug giant donnybrooks in cancer treatments $MRK $INCY $BMY $LLY $PFE $NVS $RHHBY $TSRO $REGN http://ow.ly/B8e230bQI9j,"Conference spotlights drug giant donnybrooks in cancer treatments $MRK $INCY $BMY $LLY $PFE $NVS $RHHBY $TSRO $REGN http://ow.ly/B8e230bQI9j
1",,,,1,[],https://twitter.com/IBD_AGatlin/status/865309927191040000
2381,#BuyFear,@FordWealth,2017-05-18T18:02:50.000Z,Indexes own large cap. Like 1999 w/ $CSCO $GE $INTC $PFE $IBM $MRK $GM $F all losers for 17 years,"Indexes own large cap. Like 1999 w/ $CSCO $GE $INTC $PFE $IBM $MRK $GM $F all losers for 17 years
La nuit sera calme
@NuitSeraCalme
 ¬∑ 18 May 2017
Contract this w/ his 84 article praising Graham&Dodd. Has he joined the Flat Earth Society?
https://www8.gsb.columbia.edu/articles/columbia-business/superinvestors‚Ä¶
http://cnb.cx/2qSdaF9",,,,,['https://pbs.twimg.com/profile_images/1448448095226789888/I-BD_-zQ_mini.jpg'],https://twitter.com/FordWealth/status/865266443612454912
2382,Matthias Piesche,@PiescheLab,2017-05-18T16:43:02.000Z,$ADRO drug to be tested with Keytruda in second indication http://genengnews.com/gen-news-highlights/merck-aduro-expand-collaboration-to-combine-ladd-cancer-therapy-with-keytruda/81254364‚Ä¶ #biotech #immunotherapy $MRK,"$ADRO drug to be tested with Keytruda in second indication http://genengnews.com/gen-news-highlights/merck-aduro-expand-collaboration-to-combine-ladd-cancer-therapy-with-keytruda/81254364‚Ä¶ #biotech #immunotherapy $MRK
genengnews.com
Merck, Aduro Expand Collaboration to Combine LADD Cancer Therapy with Keytruda
Firms will carry out a Phase II study combining Aduro's live, attenuated double-deleted (LADD) Listeria-based immunotherapy CRS-207 with Keytruda¬Æ in patients with malignant pleural mesothelioma.",,,,,[],https://twitter.com/PiescheLab/status/865246361909952514
2383,1 min Stock Insights,@1MinuteStock,2017-05-18T09:15:02.000Z,"Btw, Estimated #Earnings Per Share for $MRK is $1.07 it's 1.7% of the current price https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=eps&utm_source=twitter‚Ä¶","Btw, Estimated #Earnings Per Share for $MRK is $1.07 it's 1.7% of the current price https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=eps&utm_source=twitter‚Ä¶",,,,,[],https://twitter.com/1MinuteStock/status/865133618024378368
2384,MAISA,@MaisaCorp,2017-05-18T00:05:24.000Z,$SNDX After Hours: 14.50 +0.92 (6.77%) present results from the melanoma cohort of the ongoing Phase 2 ENCORE 601 trial of entinostat $MRK,$SNDX After Hours: 14.50 +0.92 (6.77%) present results from the melanoma cohort of the ongoing Phase 2 ENCORE 601 trial of entinostat $MRK,,,,,[],https://twitter.com/MaisaCorp/status/864995295897288705
2385,TW Research Group,@DanCarlson33,2017-05-18T14:16:35.000Z,Transporting medication over the #BBB is no longer a pipe dream. Lots of potential partners ala $MRK $AZN $NVS $BIIB http://tailwindsresearch.com/2017/04/going-up-the-elevator-has-left-the-basement/‚Ä¶,Transporting medication over the #BBB is no longer a pipe dream. Lots of potential partners ala $MRK $AZN $NVS $BIIB http://tailwindsresearch.com/2017/04/going-up-the-elevator-has-left-the-basement/‚Ä¶,,,,,[],https://twitter.com/DanCarlson33/status/865209505960689664
2386,Scott Spencer,@bullriders1,2017-05-17T14:03:44.000Z,$SNDX +35% $12.73 combo of etinostat and Keytruda has met its pre-specified objective response threshold for non-small cell lung cancer $MRK,$SNDX +35% $12.73 combo of etinostat and Keytruda has met its pre-specified objective response threshold for non-small cell lung cancer $MRK,,,,,[],https://twitter.com/bullriders1/status/864843881468239873
2387,Pharmaceutical News,@pharma_sector,2017-05-18T22:56:34.000Z,ASCO: #Merck's Keytruda-chemo combo approach racks up more support with positive overall sur... Read more: http://owler.us/acJbRX $MRK,"ASCO: #Merck's Keytruda-chemo combo approach racks up more support with positive overall sur... Read more: http://owler.us/acJbRX $MRK
1",,,1,,[],https://twitter.com/pharma_sector/status/865340365049520128
2388,Watchlist News,@WatchlistN,2017-05-17T17:32:06.000Z,"Merck & Co., Inc. $MRK Given New $76.00 Price Target at JPMorgan Chase & Co. http://zpr.io/Prq58","Merck & Co., Inc. $MRK Given New $76.00 Price Target at JPMorgan Chase & Co. http://zpr.io/Prq58",,,,,[],https://twitter.com/WatchlistN/status/864896321412640770
2389,Watchlist News,@WatchlistN,2017-05-18T09:23:58.000Z,"Legacy Private Trust Co. Purchases 1,800 Shares of Merck & Co., Inc. $MRK http://zpr.io/PrsSe","Legacy Private Trust Co. Purchases 1,800 Shares of Merck & Co., Inc. $MRK http://zpr.io/PrsSe",,,,,[],https://twitter.com/WatchlistN/status/865135864787218432
2390,KC,@kcphaeton,2017-05-18T18:38:32.000Z,$MNKDdiabetes challenge exemplifies Amazon CEO Jeff Bezos' letter to shareholders $AMZN  $MRK,"$MNKDdiabetes challenge exemplifies Amazon CEO Jeff Bezos' letter to shareholders $AMZN  $MRK
bizjournals.com
AWS diabetes challenge exemplifies Bezos' letter to shareholders
""Inside AWS (Amazon Web Services), we‚Äôre excited to lower the costs and barriers to machine learning and AI so organizations of all sizes can take advantage of these advanced techniques,"" Bezos said.",,,,,['https://pbs.twimg.com/card_img/1501251024576606217/zZqi-Tz6?format=jpg&name=small'],https://twitter.com/kcphaeton/status/865275426213699585
2391,MarketBeat,@MarketBeatCom,2017-05-17T16:02:45.000Z,"Zacks: Analysts Anticipate Merck & Co., Inc. $MRK Will Post Quarterly Sales of $9.67 Billion http://ift.tt/2qwB5ai #acn","Zacks: Analysts Anticipate Merck & Co., Inc. $MRK Will Post Quarterly Sales of $9.67 Billion http://ift.tt/2qwB5ai #acn",,,,,[],https://twitter.com/MarketBeatCom/status/864873835333603328
2392,Ticker Report,@TickerReport,2017-05-18T09:30:45.000Z,"Mitchell Mcleod Pugh & Williams Inc. Decreases Position in Merck & Co., Inc. $MRK http://ift.tt/2ru4pyl","Mitchell Mcleod Pugh & Williams Inc. Decreases Position in Merck & Co., Inc. $MRK http://ift.tt/2ru4pyl",,,,,[],https://twitter.com/TickerReport/status/865137571319435264
2393,Siti van der Meij,@sitivandermeij,2017-05-18T16:24:19.000Z,Combo of Merck's Keytruda and chemo show survival benefit in mid-stage lung cancer study; shares ahead 1% https://seekingalpha.com/news/3268541-combo-mercks-keytruda-chemo-show-survival-benefit-mid-stage-lung-cancer-study-shares-ahead-1?source=feed_f‚Ä¶ $MRK #si‚Ä¶,Combo of Merck's Keytruda and chemo show survival benefit in mid-stage lung cancer study; shares ahead 1% https://seekingalpha.com/news/3268541-combo-mercks-keytruda-chemo-show-survival-benefit-mid-stage-lung-cancer-study-shares-ahead-1?source=feed_f‚Ä¶ $MRK #si‚Ä¶,,,,,[],https://twitter.com/sitivandermeij/status/865241649617809408
2394,Donna Young,@DonnaYoungDC,2017-05-18T11:10:33.000Z,#WHO Peter Salama: No licensed #Ebola vaccine; but do have promising candidate - $MRK's - must seek Congo OK to use under expanded access,"#WHO Peter Salama: No licensed #Ebola vaccine; but do have promising candidate - $MRK's - must seek Congo OK to use under expanded access
1",üì∞,,1,,[],https://twitter.com/DonnaYoungDC/status/865162689869426688
2395,TradeOutLoud,@TradeOutLoud,2017-05-18T12:12:21.000Z,$INCY up 7% in ahrs trading its IDO1 inhibitor epacadostat in combinations with $MRK Keytruda & $BMY Opdivo showed more responses.,$INCY up 7% in ahrs trading its IDO1 inhibitor epacadostat in combinations with $MRK Keytruda & $BMY Opdivo showed more responses.,,,,,[],https://twitter.com/TradeOutLoud/status/865178241719513088
2396,Carly Helfand,@CarlyHFierce,2017-05-16T21:08:13.000Z,Editor's Corner‚ÄîNotes on a crazy 2 weeks that transformed immuno-oncology: http://bit.ly/2qtkNie $MRK $RHHBY $BMY $AZN $PFE #pharma,"Editor's Corner‚ÄîNotes on a crazy 2 weeks that transformed immuno-oncology: http://bit.ly/2qtkNie $MRK $RHHBY $BMY $AZN $PFE #pharma
fiercepharma.com
Editor's Corner‚ÄîNotes on a crazy 2 weeks that transformed immuno-oncology
It‚Äôs been just a couple of weeks since we wrote up AstraZeneca‚Äôs Imfinzi approval in bladder cancer. | It‚Äôs been just a couple of weeks since we wrote up AstraZeneca‚Äôs Imfinzi approval in bladder...",,,,,['https://pbs.twimg.com/card_img/1501586137940385795/6zSzIJ7d?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/864588322001350657
2397,StockNews.com,@stocknewsdotcom,2017-05-18T16:36:26.000Z,$MRK FDA grants regular approval to pembrolizumab (KEYTRUDA) for patients with locally advanced or metastatic urot‚Ä¶ https://stocknews.com/news/mrk-fda-grants-regular-approval-to-pembrolizumab-keytruda-for-patients-with/‚Ä¶,$MRK FDA grants regular approval to pembrolizumab (KEYTRUDA) for patients with locally advanced or metastatic urot‚Ä¶ https://stocknews.com/news/mrk-fda-grants-regular-approval-to-pembrolizumab-keytruda-for-patients-with/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/865244697878515713
2398,BioWorld,@BioWorld,2017-05-18T18:35:00.000Z,".
@WHO
 seeking to bring unlicensed $MRK #Ebola vaccine to latest outbreak area",".
@WHO
 seeking to bring unlicensed $MRK #Ebola vaccine to latest outbreak area
2",,,,2,[],https://twitter.com/BioWorld/status/865274538984001536
2399,FiercePharma,@FiercePharma,2017-05-17T15:29:14.000Z,"$MRK, Upsher-Smith put ancient K-Dur pay-for-delay case to rest in $60M settlement","$MRK, Upsher-Smith put ancient K-Dur pay-for-delay case to rest in $60M settlement
fiercepharma.com
Merck, Upsher-Smith put ancient K-Dur pay-for-delay case to rest in $60M settlement
Resolving litigation nearly two decades old, Merck & Co. | Resolving litigation nearly two decades old, Merck & Co. and Upsher-Smith agreed to a $60.2 million settlement with drug purchasers that...",,,,,[],https://twitter.com/FiercePharma/status/864865398436614144
2400,Donna Young,@DonnaYoungDC,2017-05-18T12:15:07.000Z,$MRK stands ready to ship its experimental #Ebola vaccine V920 to Congo if it is requested & protocols are approved http://snl.com/web/client?auth=inherit#news/article?id=40720633&cdid=A-40720633-12597‚Ä¶,"$MRK stands ready to ship its experimental #Ebola vaccine V920 to Congo if it is requested & protocols are approved http://snl.com/web/client?auth=inherit#news/article?id=40720633&cdid=A-40720633-12597‚Ä¶
Donna Young
@DonnaYoungDC
 ¬∑ 18 May 2017
#WHO Peter Salama: No licensed #Ebola vaccine; but do have promising candidate - $MRK's - must seek Congo OK to use under expanded access",üì∞ üì∞,,,,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/865178938364088321
2401,Aniu Student,@AniuStudent,2017-05-18T13:47:58.000Z,"Replying to 
@KSSMDPhD","Replying to 
@KSSMDPhD
We're still waiting on $MRK's #CETP results though.  We've been waiting a very long time. Hmmm?  $ESPR $PFE $REGN
1
2",,,1,2,[],https://twitter.com/AniuStudent/status/865202304403853312
2402,"KSS, MD, PhD",@KSSMDPhD,2017-05-18T23:42:39.000Z,"Replying to 
@KSSMDPhD
 and 
@fezziwig2008","Replying to 
@KSSMDPhD
 and 
@fezziwig2008
But $MRK has to be high-fiving itself at having played the game this well with a mere PD-1 binding agent that is oblivious to milieu.
1",,,,1,[],https://twitter.com/KSSMDPhD/status/865351961486512132
2403,Sarah Owermohle,@owermohle,2017-05-18T14:16:43.000Z,"WHO: Ebola cases may be as high as 20, vaccine could reach Congo within a week. $MRK time to shine.
http://bit.ly/2pXoegg","WHO: Ebola cases may be as high as 20, vaccine could reach Congo within a week. $MRK time to shine.
http://bit.ly/2pXoegg",,,,,[],https://twitter.com/owermohle/status/865209538772959232
2404,dough,@semodough,2017-05-18T01:47:28.000Z,"Replying to 
@semodough","Replying to 
@semodough
$MRK Pembro + Rev/dex in rel/ref MM = 50% ORR&38% ORR in Rev refractory pts. need think some more what this means $CELG
2",,,,2,[],https://twitter.com/semodough/status/865020982985191424
2405,Steven Strazza,@sstrazza,2017-05-16T12:37:46.000Z,"Replying to 
@G_krupins","Replying to 
@G_krupins
$BGNE is another interesting one in the space. Big investors: Baker Bro's 25% and $MRK owns 6% I believe they are based in China tho.
1",,,,1,[],https://twitter.com/sstrazza/status/864459861400092672
2406,Roy Friedman,@DewDiligence,2017-05-18T19:26:48.000Z,"Replying to 
@CarolineYLChen
, 
@MaxNisen
 and 
@TheTerminal","Replying to 
@CarolineYLChen
, 
@MaxNisen
 and 
@TheTerminal
Maybe he's lost in a time warp &is thinking of $MRK/Medco.
1",,,,1,[],https://twitter.com/DewDiligence/status/865287574654509059
2407,Eric Sagonowsky,@EricSFierce,2017-05-17T15:29:14.000Z,"$MRK, Upsher-Smith put ancient K-Dur pay-for-delay case to rest in $60M settlement http://fiercepharma.com/legal/merck-upsher-smith-reach-60m-settlement-old-reverse-payment-case‚Ä¶","$MRK, Upsher-Smith put ancient K-Dur pay-for-delay case to rest in $60M settlement http://fiercepharma.com/legal/merck-upsher-smith-reach-60m-settlement-old-reverse-payment-case‚Ä¶
1",,,,1,[],https://twitter.com/EricSFierce/status/864865398310805506
2408,Clark Joseph Kent,@JorelLaraKalel,2017-05-18T22:40:21.000Z,Incyte Teams Up With Dow's Merck To Trounce Roche In Cancer $INCY $MRK $BMY $RHHBY $NLNK http://bit.ly/2rx12GW,"Incyte Teams Up With Dow's Merck To Trounce Roche In Cancer $INCY $MRK $BMY $RHHBY $NLNK http://bit.ly/2rx12GW
1",,,1,,[],https://twitter.com/JorelLaraKalel/status/865336283840864261
2409,Clark Joseph Kent,@JorelLaraKalel,2017-05-18T14:01:47.000Z,Early movers: $WMT $BWLD $BABA $HIBB $PERY $PLCE  $P $MRK $BA $BHP $GM $FCAU $HAL $CSCO $BKE http://cnb.cx/2riHHvA,"Early movers: $WMT $BWLD $BABA $HIBB $PERY $PLCE  $P $MRK $BA $BHP $GM $FCAU $HAL $CSCO $BKE http://cnb.cx/2riHHvA
youtube.com
Children's Place (PLCE) Earnings
Children's Place reports earnings Thursday May 18th after the close.In the last 17 quarters, it's had 14 beats, 2 meets, and 1 miss.It's main competitor, Gym...",,,,,['https://pbs.twimg.com/card_img/1501714353657110529/C-oumD5G?format=jpg&name=240x240'],https://twitter.com/JorelLaraKalel/status/865205779539820544
2410,BiotechBioPharma,@Regencells,2017-05-20T11:07:01.000Z,"Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2r02hkU $MRK #Cancer 
@Merck","Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2r02hkU $MRK #Cancer 
@Merck
8
1",,,8,1,['https://pbs.twimg.com/media/DAQ_QIkXUAE6RZs?format=jpg&name=small'],https://twitter.com/Regencells/status/865886576802504704
2411,Jacob Plieth,@JacobPlieth,2017-05-20T19:33:40.000Z,"Heads up! A new report on anti-PD(L)1 combination studies will be published by 
@EPVantage
 before #ASCO17 $MRK $BMY $RHHBY $AZN $PFE","Heads up! A new report on anti-PD(L)1 combination studies will be published by 
@EPVantage
 before #ASCO17 $MRK $BMY $RHHBY $AZN $PFE
2
21
35",,2,21,35,"['https://pbs.twimg.com/media/DASzBAQXYAAMwNG?format=jpg&name=900x900', 'https://pbs.twimg.com/media/DASzBLDXcAA8rWf?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DASzET7XoAEvxYf?format=jpg&name=360x360']",https://twitter.com/JacobPlieth/status/866014078216663042
2412,Seeking Alpha,@SeekingAlpha,2017-05-20T12:36:44.000Z,"3 Things In Biotech You Should Learn Today: May 20, 2017 https://seekingalpha.com/article/4074970-3-things-biotech-learn-today-may-20-2017?source=feed_f‚Ä¶ $AMGN $MRK $NVS $RHHBF $RHHBY","3 Things In Biotech You Should Learn Today: May 20, 2017 https://seekingalpha.com/article/4074970-3-things-biotech-learn-today-may-20-2017?source=feed_f‚Ä¶ $AMGN $MRK $NVS $RHHBF $RHHBY
seekingalpha.com
3 Things In Biotech You Should Learn Today: May 20, 2017
Merck has entered the bladder cancer fray, with the strongest data to date. Roche's early-stage antibody grabs tumor cells with both arms.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1497724725002448899/2TZ3O23_?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/865909153214078977
2413,BiotechBioPharma,@Regencells,2017-05-19T15:00:57.000Z,"FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pSRZCQ #immunotherapy #lungcancer $MRK 
@Merck","FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pSRZCQ #immunotherapy #lungcancer $MRK 
@Merck
4",,,4,,['https://pbs.twimg.com/media/DAMrM7hV0AAtnW_?format=jpg&name=small'],https://twitter.com/Regencells/status/865583058497425408
2414,Evaluate Vantage,@evaluatevantage,2017-05-19T11:46:48.000Z,Vantage Snippet ‚Äì Keytruda gets full approval in bladder cancer $MRK $RHHBY $BMY $AZN $PFE,"Vantage Snippet ‚Äì Keytruda gets full approval in bladder cancer $MRK $RHHBY $BMY $AZN $PFE
4
4",,,4,4,['https://pbs.twimg.com/media/DAL-UOTVwAATfNA?format=jpg&name=small'],https://twitter.com/evaluatevantage/status/865534199180148736
2415,John Carroll,@JohnCendpts,2017-05-19T11:43:43.000Z,"Merck‚Äôs checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster
$MRK","Merck‚Äôs checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster
$MRK
endpts.com
Merck‚Äôs checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster
Merck‚Äôs Keytruda continues to make a rapid advance to new approvals for expanded use. This time the FDA is approving their PD-1 drug for second-line as well as some first-line cases of bladder cancer...
11
10",,,11,10,['https://pbs.twimg.com/card_img/1498584609684135940/MF4drHmS?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/865533423355535366
2416,Greg5thTrad,@Greg5thTrad,2017-05-20T01:33:24.000Z,"$ Flows: Buying on Weakness: Among stocks that were down FRI, these had the largest net INFLOWS of money $CSCO $MRK $PEP $WBA $UNP $LLY top6","$ Flows: Buying on Weakness: Among stocks that were down FRI, these had the largest net INFLOWS of money $CSCO $MRK $PEP $WBA $UNP $LLY top6",,,,,['https://pbs.twimg.com/media/DAO79CQW0AAz0Sf?format=jpg&name=small'],https://twitter.com/Greg5thTrad/status/865742219617206272
2417,Ozmosi,@OzmosiHealth,2017-05-19T16:02:12.000Z,2 more approvals for Merck's #immunology drug Keytruda - now it's approved to treat 5 types of #cancer http://bit.ly/2qEZESq $MRK $BMY,2 more approvals for Merck's #immunology drug Keytruda - now it's approved to treat 5 types of #cancer http://bit.ly/2qEZESq $MRK $BMY,,,,,['https://pbs.twimg.com/media/DAM5OGGVoAQRVjf?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/865598471251701761
2418,dough,@semodough,2017-05-19T12:04:51.000Z,Question should be asked is #KEYTRUDA just more superior #PD1      LUNG CA BLADDER CA  $MRK $ROG $BMY,"Question should be asked is #KEYTRUDA just more superior #PD1      LUNG CA BLADDER CA  $MRK $ROG $BMY
John Carroll
@JohnCendpts
 ¬∑ 19 May 2017
Merck‚Äôs checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster
$MRK
https://endpts.com/mercks-checkpoint-star-keytruda-grabs-another-fda-ok-steering-past-wreckage-of-a-roche-disaster/‚Ä¶
1
2",,,1,2,['https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_mini.jpeg'],https://twitter.com/semodough/status/865538740189446144
2419,Kara Jill Stancell,@kjilly,2017-05-19T17:49:41.000Z,The gang's all here: $MRK #Keytruda nabs I-O's third #bladdercancer approval this month #immunooncology #biotech,"The gang's all here: $MRK #Keytruda nabs I-O's third #bladdercancer approval this month #immunooncology #biotech
fiercepharma.com
The gang's all here: Merck's Keytruda nabs I-O's third bladder cancer approval this month
The FDA has approved an immuno-oncology med as a new treatment for bladder cancer‚Äîfor the third week in a row. Only this one already has positive overall survival data under its belt. | The FDA has...
1",,,1,,['https://pbs.twimg.com/card_img/1499068319969726466/RtX7wKq0?format=jpg&name=small'],https://twitter.com/kjilly/status/865625521446572032
2420,CarnivoresHealth,@HealthierIT,2017-05-20T17:30:12.000Z,"Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2qZTSOd $MRK #Cancer 
@Merck","Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2qZTSOd $MRK #Cancer 
@Merck
2",,,2,,['https://pbs.twimg.com/media/DASW9CFXoAAnQ7f?format=jpg&name=small'],https://twitter.com/HealthierIT/status/865983006833508352
2421,BioPharmaDevice,@OneMedWorld,2017-05-19T15:01:04.000Z,"FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pSYOUV #immunotherapy #lungcancer $MRK 
@Merck","FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pSYOUV #immunotherapy #lungcancer $MRK 
@Merck
1",,,1,,['https://pbs.twimg.com/media/DAMrOrHXcAAbIEi?format=jpg&name=small'],https://twitter.com/OneMedWorld/status/865583086771286016
2422,Andy Kinley,@AndyKinley,2017-05-19T11:18:48.000Z,A lot of chckpt activity in bladder ca. over last 3 wks - $MRK pembro $AZN durvalumab  $PFE avelumab $RHHBY atezo - how will this shake out,"A lot of chckpt activity in bladder ca. over last 3 wks - $MRK pembro $AZN durvalumab  $PFE avelumab $RHHBY atezo - how will this shake out
Randy Sweis
@RandySweisMD
 ¬∑ 19 May 2017
Pembro approved in #bladdercancer Interesting- it's the last of 5 PD-1/L1 inhibitors approved in blad ca, but the only 1 to show OS benefit https://twitter.com/sitcancer/status/865246205416288256‚Ä¶",,,,,['https://pbs.twimg.com/profile_images/936207310145445888/XPj3pVNT_mini.jpg'],https://twitter.com/AndyKinley/status/865527154053758976
2423,MM+M Magazine,@MMMnews,2017-05-20T03:15:00.000Z,"5 things for #pharma #marketers to know: Fri., May 19 $MRK #FDA #BladderCancer $INCY $JNJ #hcsm #Medicaid #oncology  http://bit.ly/2qyTPYs","5 things for #pharma #marketers to know: Fri., May 19 $MRK #FDA #BladderCancer $INCY $JNJ #hcsm #Medicaid #oncology  http://bit.ly/2qyTPYs
1",,,,1,['https://pbs.twimg.com/media/DAMuNNvUwAAcjLT?format=jpg&name=small'],https://twitter.com/MMMnews/status/865767789390217217
2424,Pharmaceutical News,@pharma_sector,2017-05-19T19:32:35.000Z,Bristol-Incyte Match Beats Dow's #Merck In Combination Trials. Read more: http://owler.us/acJCKy $MRK,Bristol-Incyte Match Beats Dow's #Merck In Combination Trials. Read more: http://owler.us/acJCKy $MRK,,,,,[],https://twitter.com/pharma_sector/status/865651415712120832
2425,Sean McGrath,@sean_uk,2017-05-19T11:47:38.000Z,"Merck‚Äôs $MRK checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster - https://endpts.com/mercks-checkpoint-star-keytruda-grabs-another-fda-ok-steering-past-wreckage-of-a-roche-disaster‚Ä¶ #cancer","Merck‚Äôs $MRK checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster - https://endpts.com/mercks-checkpoint-star-keytruda-grabs-another-fda-ok-steering-past-wreckage-of-a-roche-disaster‚Ä¶ #cancer
endpts.com
Merck‚Äôs checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster
Merck‚Äôs Keytruda continues to make a rapid advance to new approvals for expanded use. This time the FDA is approving their PD-1 drug for second-line as well as some first-line cases of bladder cancer...",,,,,['https://pbs.twimg.com/card_img/1501166467047325698/_jIR-csO?format=jpg&name=small'],https://twitter.com/sean_uk/status/865534407561564160
2426,Zenect,@zenect,2017-05-21T12:42:42.000Z,The company also needs to pay a nice #dividend‚Ä¶ http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,The company also needs to pay a nice #dividend‚Ä¶ http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,,,,,[],https://twitter.com/zenect/status/866273042573537280
2427,Paul,@BWUIC,2017-05-19T16:16:10.000Z,"J&J not rolling over on Remicade competition, sues Samsung Bioepis to block biosimilar https://seekingalpha.com/news/3268819-j-and-j-rolling-remicade-competition-sues-samsung-bioepis-block-biosimilar?source=tweet‚Ä¶ $JNJ $BIIB $MRK","J&J not rolling over on Remicade competition, sues Samsung Bioepis to block biosimilar https://seekingalpha.com/news/3268819-j-and-j-rolling-remicade-competition-sues-samsung-bioepis-block-biosimilar?source=tweet‚Ä¶ $JNJ $BIIB $MRK",,,,,[],https://twitter.com/BWUIC/status/865601987299074048
2428,"Jared Louis Wolff, MS",@jaredlouiswolff,2017-05-19T15:25:52.000Z,"Replying to 
@jaredlouiswolff","Replying to 
@jaredlouiswolff
$RHHBY $PBYI $AZN $LLY $ABBV $MRK $INCY",,,,,[],https://twitter.com/jaredlouiswolff/status/865589327971078145
2429,Bruce Berger,@bergerb2,2017-05-19T23:48:41.000Z,FDA OKs Merck's Keytruda for two new uses in bladder cancer; shares ahead 1% after hours https://seekingalpha.com/news/3268621-fda-oks-mercks-keytruda-two-new-uses-bladder-cancer-shares-ahead-1-percent-hours?source=tweet‚Ä¶ $MRK,"FDA OKs Merck's Keytruda for two new uses in bladder cancer; shares ahead 1% after hours https://seekingalpha.com/news/3268621-fda-oks-mercks-keytruda-two-new-uses-bladder-cancer-shares-ahead-1-percent-hours?source=tweet‚Ä¶ $MRK
seekingalpha.com
FDA OKs Merck's Keytruda for two new uses in bladder cancer; shares ahead 1% after hours (NYSE:MRK)
The FDA approves the use of Merck's (NYSE:MRK) KEYTRUDA (pembrolizumab) in two bladder cancer populations:The first-line treatment of patients with locally advanced/metastatic urothelial...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/bergerb2/status/865715866662576128
2430,GordonGecko,@GGgordonsgin,2017-05-20T07:32:52.000Z,$MRK Newly passed 21st Cent Cures Act shld make FDA far more Alzheimrs drug approval friendly 4 Cortisol inhib Xanamem in P2 trials ASX:ACW,$MRK Newly passed 21st Cent Cures Act shld make FDA far more Alzheimrs drug approval friendly 4 Cortisol inhib Xanamem in P2 trials ASX:ACW,,,,,[],https://twitter.com/GGgordonsgin/status/865832681698754560
2431,Chelli Miller,@cmiller1225,2017-05-20T12:50:15.000Z,"Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2qZLIp4 $MRK #Cancer 
@Merck","Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2qZLIp4 $MRK #Cancer 
@Merck
2",,,2,,['https://pbs.twimg.com/media/DARW4QeVoAASKy-?format=jpg&name=small'],https://twitter.com/cmiller1225/status/865912556032061440
2432,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-05-20T12:41:23.000Z,"3 Things In Biotech You Should Learn Today: May 20, 2017 $AMGN $MRK $NVS $RHHBF $RHHBY http://dlvr.it/PBkYpM #Investing #Stocks","3 Things In Biotech You Should Learn Today: May 20, 2017 $AMGN $MRK $NVS $RHHBF $RHHBY http://dlvr.it/PBkYpM #Investing #Stocks",,,,,['https://pbs.twimg.com/media/DARU2YDUAAEUI_B?format=jpg&name=small'],https://twitter.com/AlertTrade/status/865910324922167296
2433,CarnivoresHealth,@HealthierIT,2017-05-20T13:30:16.000Z,"FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pT3VV2 #immunotherapy #lungcancer $MRK 
@Merck","FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pT3VV2 #immunotherapy #lungcancer $MRK 
@Merck",,,,,['https://pbs.twimg.com/media/DARgCWKW0AEiUqm?format=jpg&name=small'],https://twitter.com/HealthierIT/status/865922625230557185
2434,StockNews.com,@stocknewsdotcom,2017-05-19T12:04:39.000Z,$MRK Announces that the CHMP of the EMA has adopted a positive opinion recommending approval of ISENTRESS 600 mg f‚Ä¶ https://stocknews.com/news/mrk-announces-that-the-chmp-of-the-ema-has-adopted-a/‚Ä¶,"$MRK Announces that the CHMP of the EMA has adopted a positive opinion recommending approval of ISENTRESS 600 mg f‚Ä¶ https://stocknews.com/news/mrk-announces-that-the-chmp-of-the-ema-has-adopted-a/‚Ä¶
1",,,,1,[],https://twitter.com/stocknewsdotcom/status/865538690113601537
2435,GREEN STOCK NEWS,@greenstocknews,2017-05-21T12:17:03.000Z,"3 Things In Biotech You Should Learn Today: May 21, 2017 https://seekingalpha.com/article/4074986-3-things-biotech-learn-today-may-21-2017?source=feed_f‚Ä¶ $INCY $MRK $ONCYF check out this stock and tell us what y‚Ä¶","3 Things In Biotech You Should Learn Today: May 21, 2017 https://seekingalpha.com/article/4074986-3-things-biotech-learn-today-may-21-2017?source=feed_f‚Ä¶ $INCY $MRK $ONCYF check out this stock and tell us what y‚Ä¶
seekingalpha.com
3 Things In Biotech You Should Learn Today: May 21, 2017
Incyte finally shows us the goods in immunotherapy. Pembrolizumab also marches on its own in gastric cancers.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/greenstocknews/status/866266586964996096
2436,Dakota Financial,@dakotafinancial,2017-05-21T12:57:55.000Z,"First National Bank of Omaha Purchases 751 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pr5C6","First National Bank of Omaha Purchases 751 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pr5C6",,,,,[],https://twitter.com/dakotafinancial/status/866276871775956992
2437,Ticker Report,@TickerReport,2017-05-19T09:40:19.000Z,"Merck & Co., Inc. $MRK Shares Sold by E&G Advisors LP http://ift.tt/2rlnMw2","Merck & Co., Inc. $MRK Shares Sold by E&G Advisors LP http://ift.tt/2rlnMw2",,,,,[],https://twitter.com/TickerReport/status/865502369676541953
2438,Dr Kanak Kanti De,@DrKanakKantiDe,2017-05-19T11:55:00.000Z,"Premarket Biotech Digest ‚Äì $CUR completes dosage, $MRK receives FDA nod, $DFFN receives patent http://drkkd.com/premarket-biotech-digest-cur-completes-dosage-mrk-receives-fda-nod-dffn-receives-patent/‚Ä¶","Premarket Biotech Digest ‚Äì $CUR completes dosage, $MRK receives FDA nod, $DFFN receives patent http://drkkd.com/premarket-biotech-digest-cur-completes-dosage-mrk-receives-fda-nod-dffn-receives-patent/‚Ä¶",,,,,[],https://twitter.com/DrKanakKantiDe/status/865536261250994176
2439,Daily Political,@dailypoliticaln,2017-05-19T06:04:09.000Z,"Merck & Co., Inc. $MRK Upgraded to ‚ÄúStrong-Buy‚Äù by Vetr Inc. http://dailypolitical.com/?p=1108525","Merck & Co., Inc. $MRK Upgraded to ‚ÄúStrong-Buy‚Äù by Vetr Inc. http://dailypolitical.com/?p=1108525",,,,,[],https://twitter.com/dailypoliticaln/status/865447966722502657
2440,$PENNY KING,@groman100,2017-05-19T19:17:25.000Z,$FBIO up 30% in 30 days its just heating up! $zsan $tgtx $cala $fite $juno $kite $amgn $pfe $mrk $cara $srne $cost $imnp $fb $hd $pulm $fprx,"$FBIO up 30% in 30 days its just heating up! $zsan $tgtx $cala $fite $juno $kite $amgn $pfe $mrk $cara $srne $cost $imnp $fb $hd $pulm $fprx
1",,,,1,[],https://twitter.com/groman100/status/865647598983462912
2441,US Banking News,@AmericanBanking,2017-05-19T16:43:22.000Z,Merck KGaA given ‚Ç¨115.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2rzBEjF $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2rzBEjF $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/865608830796877826
2442,Limex,@LimexMe,2017-05-19T15:13:02.000Z,Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications http://bit.ly/2qF7N9q $MRK,"Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications http://bit.ly/2qF7N9q $MRK
whotrades.com
Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications
Merck & Co., Inc. ( MRK ) announced that the FDA has approved two new indications for Keytruda (pembrolizumab), the company‚Äôs anti-PD-1 therapy.  The drug is now approved‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/865586100395364353
2443,Ticker Report,@TickerReport,2017-05-20T20:40:10.000Z,"Merck & Co., Inc. $MRK Expected to Announce Quarterly Sales of $9.67 Billion http://ift.tt/2q4lBZY","Merck & Co., Inc. $MRK Expected to Announce Quarterly Sales of $9.67 Billion http://ift.tt/2q4lBZY",,,,,[],https://twitter.com/TickerReport/status/866030813120516098
2444,Daily Political,@dailypoliticaln,2017-05-21T09:24:52.000Z,"CrestPoint Capital Management LLC Raises Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1114357","CrestPoint Capital Management LLC Raises Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1114357",,,,,[],https://twitter.com/dailypoliticaln/status/866223255501361153
2445,Transcript Daily,@TranscriptDaily,2017-05-21T04:08:32.000Z,Positive Media Coverage Somewhat Unlikely to Affect Merck & Co. $MRK Stock Price http://ift.tt/2qDu60J,Positive Media Coverage Somewhat Unlikely to Affect Merck & Co. $MRK Stock Price http://ift.tt/2qDu60J,,,,,[],https://twitter.com/TranscriptDaily/status/866143646311231488
2446,Watchlist News,@WatchlistN,2017-05-20T09:35:27.000Z,"Merck & Co., Inc. $MRK Shares Bought by Gradient Investments LLC http://zpr.io/PrFmM","Merck & Co., Inc. $MRK Shares Bought by Gradient Investments LLC http://zpr.io/PrFmM",,,,,[],https://twitter.com/WatchlistN/status/865863533157916672
2447,Watchlist News,@WatchlistN,2017-05-20T09:35:30.000Z,"Merck & Co., Inc. $MRK Stake Cut by Daiwa SB Investments Ltd. http://zpr.io/PrFmh","Merck & Co., Inc. $MRK Stake Cut by Daiwa SB Investments Ltd. http://zpr.io/PrFmh",,,,,[],https://twitter.com/WatchlistN/status/865863542049828864
2448,MarketBeat,@MarketBeatCom,2017-05-20T21:42:40.000Z,"Brokerages Expect Merck & Co., Inc. $MRK to Post $0.87 EPS http://zpr.io/Pr2yN","Brokerages Expect Merck & Co., Inc. $MRK to Post $0.87 EPS http://zpr.io/Pr2yN",,,,,[],https://twitter.com/MarketBeatCom/status/866046539487207425
2449,Jacob Bell,@realJacobBell,2017-05-19T16:34:00.000Z,"Prescribed Reading: $JNJ expects 10 blockbusters; $ABBV loses Humira patent; $INCY, $BMY $MRK to present at #ASCO17","Prescribed Reading: $JNJ expects 10 blockbusters; $ABBV loses Humira patent; $INCY, $BMY $MRK to present at #ASCO17
biopharmadive.com
Prescribed Reading: ASCO dominates, Icahn BMS interest just a rumor
The abstracts have arrived! Carl Icahn's first quarter holdings are released and J&J gets a black box warning. ",,,,,[],https://twitter.com/realJacobBell/status/865606476894785537
2450,TJ Osterman,@gosubpar,2017-05-20T11:30:34.000Z,RT Regencells: Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2r02hkU $MRK #Cancer Merck,"RT Regencells: Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2r02hkU $MRK #Cancer Merck
1",,,1,,['https://pbs.twimg.com/media/DAQ_QIkXUAE6RZs?format=jpg&name=small'],https://twitter.com/gosubpar/status/865892500183109633
2451,Paul Harwitz,@CowboyPoet,2017-05-19T22:29:35.000Z,"3 Tremendously Promising #Diabetes Drugs Potentially on the Way 
@themotleyfool
 #stocks $PFE, $MRK, $SNY, $NVO, $LXRX","3 Tremendously Promising #Diabetes Drugs Potentially on the Way 
@themotleyfool
 #stocks $PFE, $MRK, $SNY, $NVO, $LXRX
fool.com
3 Tremendously Promising Diabetes Drugs Potentially on the Way @themotleyfool #stocks $PFE $MRK...
Diabetes patients could have new treatment options if Merck, Pfizer, Lexicon, Sanofi, and Novo Nordisk succeed with these three promising drugs.",,,,,['https://pbs.twimg.com/card_img/1500877246743019520/X4vcATLp?format=jpg&name=small'],https://twitter.com/CowboyPoet/status/865695960420286464
2452,US Banking News,@AmericanBanking,2017-05-20T03:08:31.000Z,"Merck & Co., Inc. $MRK Receives Average Recommendation of ‚ÄúHold‚Äù from Analysts http://ift.tt/2rBvlLR","Merck & Co., Inc. $MRK Receives Average Recommendation of ‚ÄúHold‚Äù from Analysts http://ift.tt/2rBvlLR",,,,,[],https://twitter.com/AmericanBanking/status/865766154337386496
2453,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-05-19T17:25:17.000Z,$MRK and $AMGN opened Phase 1 PD1 + CD19 doublet in Adult r/r ALL with high disease burden http://ClinicalTrials.gov,"$MRK and $AMGN opened Phase 1 PD1 + CD19 doublet in Adult r/r ALL with high disease burden http://ClinicalTrials.gov
clinicaltrials.gov
Blinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic...
Blinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia With High Marrow Lymphoblasts - Full Text View.",,,,,['https://pbs.twimg.com/card_img/1497040911091519490/dIrx3EKC?format=png&name=240x240'],https://twitter.com/DrPaulyDeSantis/status/865619382973513728
2454,Allison Gatlin,@IBD_AGatlin,2017-05-19T19:04:18.000Z,Bristol-Incyte match beats Dow's Merck in combination trials $BMY $INCY $MRK $RHHBY $NKTR $TSRO $BGNE,"Bristol-Incyte match beats Dow's Merck in combination trials $BMY $INCY $MRK $RHHBY $NKTR $TSRO $BGNE
investors.com
Bristol-Incyte Match Beats Dow's Merck In Combination Trials
Incyte stock enjoyed a fifth consecutive day of gains Friday after its immuno-oncology drug proved robust in combination trials with Merck and Bristol.
1",,,,1,[],https://twitter.com/IBD_AGatlin/status/865644300700270593
2455,BioWorld,@BioWorld,2017-05-19T23:53:00.000Z,".
@WHO
 seeks to bring unlicensed $MRK #Ebola vaccine to latest outbreak area http://bit.ly/2qZf6Mm",".
@WHO
 seeks to bring unlicensed $MRK #Ebola vaccine to latest outbreak area http://bit.ly/2qZf6Mm
1",,,,1,[],https://twitter.com/BioWorld/status/865716953457061889
2456,Briefing.com,@Briefingcom,2017-05-19T14:11:32.000Z,$MRK: Merck confirms the CHMP of the EMA has adopted a positive opinion recommending approval of ISENTRESS 600 mg... http://bit.ly/2pSqhWX,$MRK: Merck confirms the CHMP of the EMA has adopted a positive opinion recommending approval of ISENTRESS 600 mg... http://bit.ly/2pSqhWX,,,,,[],https://twitter.com/Briefingcom/status/865570621765296128
2457,CR,@CashRocket,2017-05-19T19:49:04.000Z,"Replying to 
@CashRocket","Replying to 
@CashRocket
wonder if the buyer of 2100 Sep 160 calls is betting on a buyout from $MRK or maybe even $BMY considering epacadostat is used with both.
2
1",,2,,1,[],https://twitter.com/CashRocket/status/865655564184862724
2458,BioPharmaDevice,@OneMedWorld,2017-05-20T00:44:02.000Z,"Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2r03B70 $MRK #Cancer 
@Merck","Merck's Cancer Sales Soar In White-Hot Market http://buff.ly/2r03B70 $MRK #Cancer 
@Merck",,,,,['https://pbs.twimg.com/media/DAOwqQMVwAAYS-T?format=jpg&name=small'],https://twitter.com/OneMedWorld/status/865729795736338432
2459,Jeff Taylor,@jttdmd,2017-05-21T14:25:18.000Z,"3 Things In Biotech You Should Learn Today: May 21, 2017 https://seekingalpha.com/article/4074986-3-things-biotech-learn-today-may-21-2017?source=tweet‚Ä¶ $INCY $MRK $ONCYF","3 Things In Biotech You Should Learn Today: May 21, 2017 https://seekingalpha.com/article/4074986-3-things-biotech-learn-today-may-21-2017?source=tweet‚Ä¶ $INCY $MRK $ONCYF
seekingalpha.com
3 Things In Biotech You Should Learn Today: May 21, 2017
Incyte finally shows us the goods in immunotherapy. Pembrolizumab also marches on its own in gastric cancers.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/jttdmd/status/866298863023398913
2460,MarketBeat,@MarketBeatCom,2017-05-21T12:57:52.000Z,"First PREMIER Bank Acquires 570 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pr5CU","First PREMIER Bank Acquires 570 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pr5CU",,,,,[],https://twitter.com/MarketBeatCom/status/866276857016201216
2461,BioWorld,@BioWorld,2017-05-19T15:51:01.000Z,"As #Ebola cases rise, 
@WHO
 seeks to bring $MRK vaccine to latest outbreak area http://bit.ly/2qZf6Mm","As #Ebola cases rise, 
@WHO
 seeks to bring $MRK vaccine to latest outbreak area http://bit.ly/2qZf6Mm
1",,,1,,[],https://twitter.com/BioWorld/status/865595656349646848
2462,WLST.com,@wlstcom,2017-05-20T12:36:46.000Z,"3 Things In Biotech You Should Learn Today: May 20, 2017 #AMGN #MRK #NVS #RHHBF #RHHBY $MRK https://seekingalpha.com/article/4074970-3-things-biotech-learn-today-may-20-2017‚Ä¶","3 Things In Biotech You Should Learn Today: May 20, 2017 #AMGN #MRK #NVS #RHHBF #RHHBY $MRK https://seekingalpha.com/article/4074970-3-things-biotech-learn-today-may-20-2017‚Ä¶",,,,,['https://pbs.twimg.com/media/DARTyuYXUAIxCF5?format=jpg&name=small'],https://twitter.com/wlstcom/status/865909161179189249
2463,Daily Political,@dailypoliticaln,2017-05-21T09:24:51.000Z,"First PREMIER Bank Acquires 570 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1114358","First PREMIER Bank Acquires 570 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1114358",,,,,[],https://twitter.com/dailypoliticaln/status/866223252263358464
2464,BioWorld,@BioWorld,2017-05-19T12:28:00.000Z,".
@WHO
 seeking to bring $MRK #Ebola vaccine to latest outbreak area http://bit.ly/2qZf6Mm",".
@WHO
 seeking to bring $MRK #Ebola vaccine to latest outbreak area http://bit.ly/2qZf6Mm
1",,,1,,[],https://twitter.com/BioWorld/status/865544569173049346
2465,Dakota Financial,@dakotafinancial,2017-05-21T12:57:52.000Z,"First PREMIER Bank Acquires 570 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pr5CU","First PREMIER Bank Acquires 570 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pr5CU",,,,,[],https://twitter.com/dakotafinancial/status/866276859083993089
2466,Hannibal Hamlin,@HHamlinVP,2017-05-21T14:28:12.000Z,"3 Things In Biotech You Should Learn Today: May 21, 2017 https://seekingalpha.com/article/4074986-3-things-biotech-learn-today-may-21-2017?source=tweet‚Ä¶ $INCY $MRK $ONCYF","3 Things In Biotech You Should Learn Today: May 21, 2017 https://seekingalpha.com/article/4074986-3-things-biotech-learn-today-may-21-2017?source=tweet‚Ä¶ $INCY $MRK $ONCYF
seekingalpha.com
3 Things In Biotech You Should Learn Today: May 21, 2017
Incyte finally shows us the goods in immunotherapy. Pembrolizumab also marches on its own in gastric cancers.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/HHamlinVP/status/866299591439863809
2467,Sentiment Stocks,@sentimentstock,2017-05-24T19:45:49.000Z,"$MRK $BMY $KITE $JAZZ $GILD $AZN 
It's $NWBO dance off time again with the shorts.  So what comes next?","$MRK $BMY $KITE $JAZZ $GILD $AZN 
It's $NWBO dance off time again with the shorts.  So what comes next?
GIF
3
8",,,3,8,[],https://twitter.com/sentimentstock/status/867466687871819776
2468,Herkyleese,@herkyleese,2017-05-23T14:00:09.000Z,Dcvax-L the next disruptive technology.  It will play well with others also.  $NWBO $bmy $mrk $kite $juno $exel $nvs $gild $celg $agio $blue,"Dcvax-L the next disruptive technology.  It will play well with others also.  $NWBO $bmy $mrk $kite $juno $exel $nvs $gild $celg $agio $blue
1
9
12",,1,9,12,['https://pbs.twimg.com/media/DAhDo8UXoAAMdlu?format=jpg&name=small'],https://twitter.com/herkyleese/status/867017310976057345
2469,HealthyCarnivores,@HealthyCarnivor,2017-05-22T13:30:12.000Z,"FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pTegjR #immunotherapy #lungcancer $MRK 
@Merck","FDA approves Merck immunotherapy/chemo combo for lung cancer http://buff.ly/2pTegjR #immunotherapy #lungcancer $MRK 
@Merck
2",,,2,,['https://pbs.twimg.com/media/DAbzM3AWAAADC7I?format=jpg&name=small'],https://twitter.com/HealthyCarnivor/status/866647383421145089
2470,Meg Tirrell,@megtirrell,2017-05-24T14:16:36.000Z,IO trials run by 4 big players (from $MRK via Evercore ISI's Umer Raffat),"IO trials run by 4 big players (from $MRK via Evercore ISI's Umer Raffat)
3
14
11",,3,14,11,['https://pbs.twimg.com/media/DAmQ4vlXcAAfNYn?format=jpg&name=small'],https://twitter.com/megtirrell/status/867383835419344896
2471,Dr. David Sweet,@drdavidsweet,2017-05-23T08:36:05.000Z,Our clients! Ten Companies Involved in Asthma https://seekingalpha.com/article/70551-ten-companies-involved-in-treating-asthma?source=tweet‚Ä¶ $GSK $MAPP $MRK $AZN $RHHBY $SEPR $SGP $SNY $INVA #TokyoRecruiter,"Our clients! Ten Companies Involved in Asthma https://seekingalpha.com/article/70551-ten-companies-involved-in-treating-asthma?source=tweet‚Ä¶ $GSK $MAPP $MRK $AZN $RHHBY $SEPR $SGP $SNY $INVA #TokyoRecruiter
seekingalpha.com
Ten Companies Involved in Treating Asthma
Did you know that during the 1930's and 1940's, asthma was considered a psychosomatic disease? It is now one of the fastest increasing medical conditions in the United States, which...
1",,,,1,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/drdavidsweet/status/866935753397358592
2472,Ben Fidler,@BentheFidler,2017-05-23T21:38:02.000Z,"FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type http://xconomy.com/national/2017/05/23/fda-landmark-nod-cancer-drug-to-match-tumor-genes-not-tissue-type/‚Ä¶ $MRK","FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type http://xconomy.com/national/2017/05/23/fda-landmark-nod-cancer-drug-to-match-tumor-genes-not-tissue-type/‚Ä¶ $MRK
1
17
14",,1,17,14,[],https://twitter.com/BentheFidler/status/867132539755954176
2473,Jared S. Hopkins,@JaredSHopkins,2017-05-23T13:07:20.000Z,Slide from $MRK annual shareholder presentation includes license plate from Keytruda patient,"Slide from $MRK annual shareholder presentation includes license plate from Keytruda patient
1
4",,,1,4,['https://pbs.twimg.com/media/DAg3d1GXgAAcM7k?format=jpg&name=small'],https://twitter.com/JaredSHopkins/status/867004015527305220
2474,Brad Loncar,@bradloncar,2017-05-23T19:15:15.000Z,Pretty standard day for $MRK. They got a PDUFA for a new indication in the morning and a historic approval in the afternoon. #keytruda,"Pretty standard day for $MRK. They got a PDUFA for a new indication in the morning and a historic approval in the afternoon. #keytruda
3
10
26",,3,10,26,[],https://twitter.com/bradloncar/status/867096606490939392
2475,pharmalot,@pharmalot,2017-05-24T13:09:29.000Z,"Pharmalot.. Pharmalittle.. Good Morning.. Alexion shakes up mgmt & more news.. coffee, too.. https://statnews.com/pharmalot/2017/05/24/alexion-rare-disease-novartis/‚Ä¶ #pharma $ALXN $MRK $NVS","Pharmalot.. Pharmalittle.. Good Morning.. Alexion shakes up mgmt & more news.. coffee, too.. https://statnews.com/pharmalot/2017/05/24/alexion-rare-disease-novartis/‚Ä¶ #pharma $ALXN $MRK $NVS
statnews.com
Pharmalot, Pharmalittle: Alexion shakes up management as scandal details emerge
Alexion Pharmaceuticals is overhauling management and among those leaving is the newly hired chief financial officer.",,,,,[],https://twitter.com/pharmalot/status/867366944005128193
2476,Adam Feuerstein,@adamfeuerstein,2017-05-23T18:55:24.000Z,$MRK ‚Äî FDA grants first-time accelerated approval to Keytruda for solid tumors with two genetic features MSI-H and dMMR.,"$MRK ‚Äî FDA grants first-time accelerated approval to Keytruda for solid tumors with two genetic features MSI-H and dMMR.
11
14",,,11,14,[],https://twitter.com/adamfeuerstein/status/867091609220939776
2477,Helen Ong,@Lin_ling_88,2017-05-22T15:28:43.000Z,"$MRK Announces Presentation of  Ph2 Results for MK-7264, a P2X3 Receptor Antagonist for Treatment of Chronic Cough https://finance.yahoo.com/news/merck-announces-presentation-phase-2-152000103.html?.tsrc=applewf‚Ä¶","$MRK Announces Presentation of  Ph2 Results for MK-7264, a P2X3 Receptor Antagonist for Treatment of Chronic Cough https://finance.yahoo.com/news/merck-announces-presentation-phase-2-152000103.html?.tsrc=applewf‚Ä¶
1",,,1,,[],https://twitter.com/Lin_ling_88/status/866677208936583168
2478,Herkyleese,@herkyleese,2017-05-22T16:22:29.000Z,This could be in the top 50 disruptive technologies this year.  #dcvax $NWBO $juno $kite $blue $agio $celg $gild $bmy $nvs $mrk $agen $fgen https://twitter.com/ChrisLacoursier/status/866690001354055682‚Ä¶,"This could be in the top 50 disruptive technologies this year.  #dcvax $NWBO $juno $kite $blue $agio $celg $gild $bmy $nvs $mrk $agen $fgen https://twitter.com/ChrisLacoursier/status/866690001354055682‚Ä¶
This Tweet is unavailable.
5
5",,,5,5,[],https://twitter.com/herkyleese/status/866690739576725504
2479,John Carroll,@JohnCendpts,2017-05-23T21:28:52.000Z,"Pioneering Merck makes another breakthrough with PD-1 star Keytruda, grabbing first OK for a cancer biomarker
$MRK","Pioneering Merck makes another breakthrough with PD-1 star Keytruda, grabbing first OK for a cancer biomarker
$MRK
endpts.com
Pioneering Merck makes another breakthrough with PD-1 star Keytruda, grabbing first OK for a cancer...
Merck continues to be the trendsetter to watch in immuno-oncology. On Tuesday the pharma giant nabbed a unique first in the field, grabbing an FDA approval to use Keytruda to fight cancer with a...
1
19
13",,1,19,13,['https://pbs.twimg.com/card_img/1501987322467782672/qxw6XG_g?format=png&name=small'],https://twitter.com/JohnCendpts/status/867130232326823938
2480,Herkyleese,@herkyleese,2017-05-24T13:31:50.000Z,Ordinary people need extraordinary treatment.  4 therapies in the last 30 years not good enough.  #DcVax-L is working.  $bmy $mrk know $NWBO,"Ordinary people need extraordinary treatment.  4 therapies in the last 30 years not good enough.  #DcVax-L is working.  $bmy $mrk know $NWBO
1",,,,1,['https://pbs.twimg.com/media/DAmGvx-XkAAYBZi?format=jpg&name=900x900'],https://twitter.com/herkyleese/status/867372569892179968
2481,MM+M Magazine,@MMMnews,2017-05-24T21:30:01.000Z,"5 things for #pharma #marketers to know: Wed., May 24 $MRK #FDA #oncology $ALXN #insurance $AET $UNH $CI #AHCA $PBYI http://bit.ly/2rQthjF","5 things for #pharma #marketers to know: Wed., May 24 $MRK #FDA #oncology $ALXN #insurance $AET $UNH $CI #AHCA $PBYI http://bit.ly/2rQthjF
1
2",,,1,2,['https://pbs.twimg.com/media/DAmYc7KXsAEO9Sj?format=jpg&name=small'],https://twitter.com/MMMnews/status/867492910786326528
2482,BioSpace,@biospace,2017-05-24T14:30:34.000Z,Merck & Co. $MRK is Looking to Hire Many Scientists at BIO Talent Connect in San Diego http://ow.ly/lNiK30bYDlQ,"Merck & Co. $MRK is Looking to Hire Many Scientists at BIO Talent Connect in San Diego http://ow.ly/lNiK30bYDlQ
2",,,,2,['https://pbs.twimg.com/media/DAmUMvnW0AEwf-f?format=jpg&name=small'],https://twitter.com/biospace/status/867387352515309568
2483,FiercePharma,@FiercePharma,2017-05-24T08:20:00.000Z,"Fresh off two new FDA nods, Merck's high-flying Keytruda nets priority status in stomach cancer http://fiercepharma.com/marketing/fresh-off-bladder-and-lung-nods-merck-s-keytruda-nets-priority-status-gastric-cancer‚Ä¶ $MRK","Fresh off two new FDA nods, Merck's high-flying Keytruda nets priority status in stomach cancer http://fiercepharma.com/marketing/fresh-off-bladder-and-lung-nods-merck-s-keytruda-nets-priority-status-gastric-cancer‚Ä¶ $MRK
fiercepharma.com
Fresh off two new FDA nods, Merck's high-flying Keytruda nets priority status in stomach cancer
It‚Äôs good to be Merck these days. In a month that's featured three FDA approvals for Keytruda, the immuno-oncology med has netted a speedy review for the therapy in stomach cancer. | It‚Äôs good to be...
1
5
3",,1,5,3,[],https://twitter.com/FiercePharma/status/867294096578228224
2484,Kara Jill Stancell,@kjilly,2017-05-24T18:24:26.000Z,"Which #pharma execs win the popularity contest? Roche grabs two top-3 slots, for one $RHHBY $MRK $SHPG $GSK $JNJ","Which #pharma execs win the popularity contest? Roche grabs two top-3 slots, for one $RHHBY $MRK $SHPG $GSK $JNJ
fiercepharma.com
Which pharma execs win the popularity contest? Roche grabs two top-3 slots, for one
Remember the ‚Äúbest all-around‚Äù votes in high school? They've entered adult reality. Only instead of the most popular graduating senior, these votes chose the most congenial CEOs in biopharma‚ÄîRoche,...
1",,,1,,['https://pbs.twimg.com/card_img/1496418076484677632/6NVE-AFO?format=jpg&name=small'],https://twitter.com/kjilly/status/867446203926982657
2485,Jonathan Rockoff,@jonathanrockoff,2017-05-23T19:10:40.000Z,"Keytruda approval juggernaut rolls on, as 
@US_FDA
 okays use in any solid tumor marked by a genetic feature: https://goo.gl/rk7lzZ $MRK","Keytruda approval juggernaut rolls on, as 
@US_FDA
 okays use in any solid tumor marked by a genetic feature: https://goo.gl/rk7lzZ $MRK
3
8",,,3,8,[],https://twitter.com/jonathanrockoff/status/867095451467735040
2486,Seeking Alpha,@SeekingAlpha,2017-05-24T15:28:31.000Z,"Amgen: Comments On Romo, Biosimilars, And Repatha https://seekingalpha.com/article/4076095-amgen-comments-romo-biosimilars-repatha?source=feed_f‚Ä¶ $ABBV $CHRS $MRK $CELG $RHHBY $AMGN","Amgen: Comments On Romo, Biosimilars, And Repatha https://seekingalpha.com/article/4076095-amgen-comments-romo-biosimilars-repatha?source=feed_f‚Ä¶ $ABBV $CHRS $MRK $CELG $RHHBY $AMGN
1",,,,1,[],https://twitter.com/SeekingAlpha/status/867401933434142720
2487,Doni Bloomfield,@DoniBloomfield,2017-05-24T14:00:23.000Z,Interesting $MRK chart on the number of IO clinical trials being run by several key big pharma -- via Umer Raffat,Interesting $MRK chart on the number of IO clinical trials being run by several key big pharma -- via Umer Raffat,,,,,['https://pbs.twimg.com/media/DAmNEzrXcAAl5WN?format=jpg&name=small'],https://twitter.com/DoniBloomfield/status/867379756643307521
2488,Breaking News,@MarketCurrents,2017-05-22T16:46:35.000Z,Merck's MK-7264 successful in mid-stage chronic cough study https://seekingalpha.com/news/3269073-mercks-mkminus-7264-successful-mid-stage-chronic-cough-study?source=feed_f‚Ä¶ $MRK,"Merck's MK-7264 successful in mid-stage chronic cough study https://seekingalpha.com/news/3269073-mercks-mkminus-7264-successful-mid-stage-chronic-cough-study?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Merck's MK-7264 successful in mid-stage chronic cough study (NYSE:MRK)
Merck (MRK +0.7%) announces positive results from a Phase 2 clinical trial assessing MK-7264 for the treatment of chronic cough.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/866696806159101953
2489,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-05-24T17:37:49.000Z,Anyone know how much PCR and IHC testing for MSI-H cost? $MRK TIA,"Anyone know how much PCR and IHC testing for MSI-H cost? $MRK TIA
1
1",,1,,1,[],https://twitter.com/DrPaulyDeSantis/status/867434474237304832
2490,John Hodgson,@JohnNHodgson,2017-05-23T16:25:52.000Z,"$MRK ""broke competition law by abusing dominant position"" against #biosimilars - UK monopoly body. More tactics $ https://invivo.pharmamedtechbi.com/IV005092/US-Biosimilars-Busting-Blockbusters-Or-Managing-Obsolescence‚Ä¶","$MRK ""broke competition law by abusing dominant position"" against #biosimilars - UK monopoly body. More tactics $ https://invivo.pharmamedtechbi.com/IV005092/US-Biosimilars-Busting-Blockbusters-Or-Managing-Obsolescence‚Ä¶
Ian Schofield
@ScripIanS
 ¬∑ 23 May 2017
MSD's discount scheme for Remicade may have broken competition law by limiting #biosimilar competition, says UK CMA http://bit.ly/2rLmpEr",,,,,['https://pbs.twimg.com/profile_images/378800000515319822/b7ff587a56ed94e38b542fbee4518d08_mini.jpeg'],https://twitter.com/JohnNHodgson/status/867053979712225281
2491,FirstWord Pharma,@fwpharma,2017-05-23T10:20:53.000Z,UK regulator accuses Merck & Co. of discount scheme designed to obstruct #biosimilar competition to Remicade https://firstwordpharma.com/node/1474100 $MRK,"UK regulator accuses Merck & Co. of discount scheme designed to obstruct #biosimilar competition to Remicade https://firstwordpharma.com/node/1474100 $MRK
1
3",,1,3,,[],https://twitter.com/fwpharma/status/866962128208617472
2492,Sarah Faulkner,@SarahMedtech,2017-05-24T19:20:27.000Z,"Roundup of news: $MRK lands historic regulatory win, data from #ATS2017 & @Liquidia_Inc touts early results for 3-day pain-reliever. #pharma","Roundup of news: $MRK lands historic regulatory win, data from #ATS2017 & @Liquidia_Inc touts early results for 3-day pain-reliever. #pharma
Drug Delivery Business News
@DrugDeliveryNow
 ¬∑ 25 May 2017
.@Liquidia_Inc touts Phase I data for sustained-release post-surgical #pain reliever. http://drugdeliverybusiness.com/liquidia-touts-phase-data-sustained-release-post-surgical-pain-reliever/‚Ä¶
1",,,,1,['https://pbs.twimg.com/profile_images/783451516891897856/t4s29ZQh_mini.jpg'],https://twitter.com/SarahMedtech/status/867460302543216640
2493,Carly Helfand,@CarlyHFierce,2017-05-23T21:04:17.000Z,Merck's Keytruda picks up a trifecta with FDA approval to treat rare tumor type: http://bit.ly/2reyO6z $MRK #pharma,"Merck's Keytruda picks up a trifecta with FDA approval to treat rare tumor type: http://bit.ly/2reyO6z $MRK #pharma
1
1",,,1,1,[],https://twitter.com/CarlyHFierce/status/867124044444962817
2494,Carly Helfand,@CarlyHFierce,2017-05-23T16:15:01.000Z,"Fresh off two new FDA nods, Merck's high-flying Keytruda nets priority status in stomach cancer: http://bit.ly/2qdjQJY $MRK #pharma","Fresh off two new FDA nods, Merck's high-flying Keytruda nets priority status in stomach cancer: http://bit.ly/2qdjQJY $MRK #pharma
fiercepharma.com
Fresh off two new FDA nods, Merck's high-flying Keytruda nets priority status in stomach cancer
It‚Äôs good to be Merck these days. In a month that's featured three FDA approvals for Keytruda, the immuno-oncology med has netted a speedy review for the therapy in stomach cancer. | It‚Äôs good to be...
2",,,,2,['https://pbs.twimg.com/card_img/1501987111490097181/8e7SHVP8?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/867051247987306497
2495,"Kat Dacules, CPA",@QuartzRUsCEO,2017-05-22T05:30:29.000Z,"Big Tech Is Taking on #Diabetes 
@themotleyfool
 #stocks $AAPL, $IBM, $MRK, $AMZN, $MDT https://fool.com/investing/2017/05/21/cisco-scooping-up-viptela-the-bargain-of-2017.aspx‚Ä¶

#T1D #insulin4all #biotech","Big Tech Is Taking on #Diabetes 
@themotleyfool
 #stocks $AAPL, $IBM, $MRK, $AMZN, $MDT https://fool.com/investing/2017/05/21/cisco-scooping-up-viptela-the-bargain-of-2017.aspx‚Ä¶

#T1D #insulin4all #biotech
fool.com
Cisco Scooping Up Viptela: The Bargain of 2017? @themotleyfool #stocks $CSCO
Cisco plans another acquisition.
7",,,,7,['https://pbs.twimg.com/card_img/1501724532972916738/552s6KuK?format=jpg&name=small'],https://twitter.com/QuartzRUsCEO/status/866526658521464832
2496,Oncology Board,@mb_Oncology,2017-05-24T12:16:15.000Z,ICI Research: $MRK FDA approves pembrolizumab for any cancer with microsatellite instability high‚Ä¶ http://dlvr.it/PDQSdW #MedicBoard,ICI Research: $MRK FDA approves pembrolizumab for any cancer with microsatellite instability high‚Ä¶ http://dlvr.it/PDQSdW #MedicBoard,,,,,['https://pbs.twimg.com/media/DAl1dC-XsAII-Xs?format=jpg&name=360x360'],https://twitter.com/mb_Oncology/status/867353549704798208
2497,BioPharma Dive,@BioPharmaDive,2017-05-24T21:51:00.000Z,$MRK's Keytruda gets first nod in genetically-defective tumors http://bit.ly/2qXxJzj,"$MRK's Keytruda gets first nod in genetically-defective tumors http://bit.ly/2qXxJzj
3",,,,3,[],https://twitter.com/BioPharmaDive/status/867498190433431552
2498,BioPharm Insight,@BioPharmInsight,2017-05-23T19:50:11.000Z,".
@BioPharmInsight
 releases pre #ASCO17 report; $ROG $AZN $TSRO $PFE $LLY $ABBV $BMY $MRK  http://bit.ly/2rMjwCz #BPINews #oncology #cancer",".
@BioPharmInsight
 releases pre #ASCO17 report; $ROG $AZN $TSRO $PFE $LLY $ABBV $BMY $MRK  http://bit.ly/2rMjwCz #BPINews #oncology #cancer
1",,,1,,[],https://twitter.com/BioPharmInsight/status/867105399463436289
2499,GREEN STOCK NEWS,@greenstocknews,2017-05-24T16:34:38.000Z,"3 Things In Biotech You Should Learn Today: May 24, 2017 - FDA Makes History https://seekingalpha.com/article/4076145-3-things-biotech-learn-today-may-24-2017-fda-makes-history?source=feed_f‚Ä¶ $MRK $REGN $SNY check out this stock ‚Ä¶","3 Things In Biotech You Should Learn Today: May 24, 2017 - FDA Makes History https://seekingalpha.com/article/4076145-3-things-biotech-learn-today-may-24-2017-fda-makes-history?source=feed_f‚Ä¶ $MRK $REGN $SNY check out this stock ‚Ä¶
seekingalpha.com
3 Things In Biotech You Should Learn Today: May 24, 2017 - FDA Makes History
The FDA makes history with the pembrolizumab approval for ANY tumor with one catch. Regeneron gets a new approval in rheumatoid arthritis.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/greenstocknews/status/867418573492416512
2500,Trump Tracker Bot,@trumptrackerbot,2017-05-23T21:48:24.000Z,"$MRK - PPT - tax reform (U.S.) Trump Calls for Deep Cuts in Business Taxes, Changes for Individuals Donald Trumps - http://snt.io/eB36WAZZh","$MRK - PPT - tax reform (U.S.) Trump Calls for Deep Cuts in Business Taxes, Changes for Individuals Donald Trumps - http://snt.io/eB36WAZZh",,,,,[],https://twitter.com/trumptrackerbot/status/867135148411805696
2501,Trump Tracker Bot,@trumptrackerbot,2017-05-23T14:26:19.000Z,"$MRK - Transcript - with other industry CEOs, with President Trump in an effort to better familiarize him and - http://snt.io/fB36T6FJ2","$MRK - Transcript - with other industry CEOs, with President Trump in an effort to better familiarize him and - http://snt.io/fB36T6FJ2",,,,,[],https://twitter.com/trumptrackerbot/status/867023894691106816
2502,Endpoints News,@endpts,2017-05-24T12:02:00.000Z,"From y'day: Pioneering $MRK makes another breakthrough w/ PD-1 star Keytruda, grabbing 1st OK for cancer biomarker https://endpts.com/pioneering-merck-makes-another-breakthrough-with-pd-1-star-keytruda-grabbing-first-ok-for-a-cancer-biomarker/‚Ä¶","From y'day: Pioneering $MRK makes another breakthrough w/ PD-1 star Keytruda, grabbing 1st OK for cancer biomarker https://endpts.com/pioneering-merck-makes-another-breakthrough-with-pd-1-star-keytruda-grabbing-first-ok-for-a-cancer-biomarker/‚Ä¶
1
1",,,1,1,[],https://twitter.com/endpts/status/867349965424558081
2503,Carly Helfand,@CarlyHFierce,2017-05-24T15:36:01.000Z,#ICYMI: Merck's Keytruda wins first FDA nod to treat genetically-ID'd tumors anywhere in the body http://bit.ly/2reyO6z $MRK #pharma,#ICYMI: Merck's Keytruda wins first FDA nod to treat genetically-ID'd tumors anywhere in the body http://bit.ly/2reyO6z $MRK #pharma,,,,,[],https://twitter.com/CarlyHFierce/status/867403822678896640
2504,Market Realist,@MarketRealist,2017-05-23T12:44:17.000Z,A Close Look at Merck &amp; Co.‚Äôs Valuation after 1Q17 Earnings http://marketrealist.com/?p=2103648 $MRK $PFE $FHLC $GSK,A Close Look at Merck &amp; Co.‚Äôs Valuation after 1Q17 Earnings http://marketrealist.com/?p=2103648 $MRK $PFE $FHLC $GSK,,,,,[],https://twitter.com/MarketRealist/status/866998215895375872
2505,Hottest Stocks Now,@HottestStockNow,2017-05-24T05:07:00.000Z,$MRK - UK's Competition and Markets Authority issues provisional decision in relation to drug firm's pricing,"$MRK - UK's Competition and Markets Authority issues provisional decision in relation to drug firm's pricing
crweworld.com
Indiana Attorney General returns opinion: CBD oil illegal except for epileptic patients
CBD, a marijuana-derived oil used as medicine, is illegal in Indiana with one limited exception, the state's attorney general said in an advisory opinion. Source: The Cannabist",,,,,['https://pbs.twimg.com/card_img/1499816442249629696/ZyoDobPa?format=jpg&name=240x240'],https://twitter.com/HottestStockNow/status/867245523215958016
2506,MarketBeat,@MarketBeatCom,2017-05-22T12:35:06.000Z,"Merck & Co., Inc. $MRK Shares Sold by Ipswich Investment Management Co. Inc. http://zpr.io/Prvsy","Merck & Co., Inc. $MRK Shares Sold by Ipswich Investment Management Co. Inc. http://zpr.io/Prvsy",,,,,[],https://twitter.com/MarketBeatCom/status/866633515785494529
2507,StockNews.com,@stocknewsdotcom,2017-05-23T21:09:57.000Z,$MRK Company confirmed FDA approved a new indication for KEYTRUDA - in the treatment of adult and pediatric patien‚Ä¶ https://stocknews.com/news/mrk-company-confirmed-fda-approved-a-new-indication-for-keytruda/‚Ä¶,$MRK Company confirmed FDA approved a new indication for KEYTRUDA - in the treatment of adult and pediatric patien‚Ä¶ https://stocknews.com/news/mrk-company-confirmed-fda-approved-a-new-indication-for-keytruda/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/867125470223097856
2508,TW Research Group,@DanCarlson33,2017-05-22T14:15:58.000Z,Great video explains how Telomere technology will disrupt cancer diagnostics as we know it.  $MRK $PFE $ABBV $INCY http://tailwindsresearch.com/2017/04/3d-signatures-telemore-technology-explained-video/‚Ä¶,Great video explains how Telomere technology will disrupt cancer diagnostics as we know it.  $MRK $PFE $ABBV $INCY http://tailwindsresearch.com/2017/04/3d-signatures-telemore-technology-explained-video/‚Ä¶,,,,,[],https://twitter.com/DanCarlson33/status/866658903399976960
2509,MarketBeat,@MarketBeatCom,2017-05-24T09:15:21.000Z,Merck & Co.'s sell rating reiterated at Jefferies Group LLC. $51.00 PT. http://ift.tt/2qV7wPS $MRK #MRK,Merck & Co.'s sell rating reiterated at Jefferies Group LLC. $51.00 PT. http://ift.tt/2qV7wPS $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/867308023647272960
2510,TalkMarkets,@TalkMarkets,2017-05-23T02:58:41.000Z,ASCO Abstracts Week: Biotech Trends And Hot Stocks $MRK $ALNY $IBB $INCY $REGN $AMGN $CLVS $VRTX $FBT $XBI ... https://goo.gl/H3iOBE,ASCO Abstracts Week: Biotech Trends And Hot Stocks $MRK $ALNY $IBB $INCY $REGN $AMGN $CLVS $VRTX $FBT $XBI ... https://goo.gl/H3iOBE,,,,,[],https://twitter.com/TalkMarkets/status/866850844226056192
2511,cowenresearch,@CowenResearch,2017-05-24T10:23:34.000Z,Ahead of #ASCO17 our health care team hosted call on #breastcancer treatment landscape $NVS $LLY $RHHBY $MRK $ABBV $MDVN $TSRO $CLVS $BGNE,"Ahead of #ASCO17 our health care team hosted call on #breastcancer treatment landscape $NVS $LLY $RHHBY $MRK $ABBV $MDVN $TSRO $CLVS $BGNE
1
1",,1,,1,[],https://twitter.com/CowenResearch/status/867325193202667521
2512,Jacob Plieth,@JacobPlieth,2017-05-24T09:18:18.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
So $MRK could beat $BMY to gastric cancer approval. Ono showed OS benefit with Opdivo, but not filed in Japan yet https://ono.co.jp/eng/news/pdf/sm_cn170120.pdf‚Ä¶
1
3",,1,,3,[],https://twitter.com/JacobPlieth/status/867308768257822721
2513,Sarah Faulkner,@SarahMedtech,2017-05-24T14:58:12.000Z,Interesting tech - partnership between @emulatebio and $MRK could help researchers study viral-induced exacerbations of #asthma. #ATS2017,"Interesting tech - partnership between @emulatebio and $MRK could help researchers study viral-induced exacerbations of #asthma. #ATS2017
Drug Delivery Business News
@DrugDeliveryNow
 ¬∑ 24 May 2017
ATS Roundup: @emulatebio models viral infection in ‚Äúasthma-on-a-chip‚Äù. #ATS2017 #asthma #respiratory http://drugdeliverybusiness.com/ats-roundup-emulate-models-viral-infection-asthma-chip/‚Ä¶",,,,,['https://pbs.twimg.com/profile_images/783451516891897856/t4s29ZQh_mini.jpg'],https://twitter.com/SarahMedtech/status/867394306897825794
2514,STAT,@statnews,2017-05-23T17:00:58.000Z,"(+) From 
@pharmalot
: UK regulator accuses Merck of breaking competition laws over biosimilars http://bit.ly/2qRhp37

$MRK","(+) From 
@pharmalot
: UK regulator accuses Merck of breaking competition laws over biosimilars http://bit.ly/2qRhp37

$MRK
statnews.com
UK regulator accuses Merck of breaking competition laws over biosimilars
The UK Competition & Markets Authority provisionally found that Merck was ‚Äúabusing its dominant position.""
1",,,,1,['https://pbs.twimg.com/card_img/1491889846427987969/ovGNBzku?format=jpg&name=small'],https://twitter.com/statnews/status/867062812014768128
2515,Donna Young,@DonnaYoungDC,2017-05-23T20:13:39.000Z,$MRK #Keytruda OK for unresectable/metastatic solid tumors identified w/ microsatellite instability-high/mismatch repair deficient biomarker,"$MRK #Keytruda OK for unresectable/metastatic solid tumors identified w/ microsatellite instability-high/mismatch repair deficient biomarker
Donna Young
@DonnaYoungDC
 ¬∑ 24 May 2017
$MRK #Keytruda 1st drug OK'd by #FDA based on common biomarker rather than location in body where tumor originated https://fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm560167.htm‚Ä¶
1",üì∞ üì∞,,,1,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/867111301511868418
2516,BioWorld,@BioWorld,2017-05-23T17:58:01.000Z,Keytruda gets another priority review for sBLA in recurrent or advanced gastric or GE junction cancers $MRK,Keytruda gets another priority review for sBLA in recurrent or advanced gastric or GE junction cancers $MRK,,,,,[],https://twitter.com/BioWorld/status/867077169171836928
2517,BioWorld,@BioWorld,2017-05-24T18:34:19.000Z,"With newest Keytruda approval, anatomy no longer destiny; tests in tissue-agnostic manner began w/ hunch abt effect across tumor types $MRK","With newest Keytruda approval, anatomy no longer destiny; tests in tissue-agnostic manner began w/ hunch abt effect across tumor types $MRK
1
1",,,1,1,[],https://twitter.com/BioWorld/status/867448693942886400
2518,Joe McCann,@JMac_SI,2017-05-24T15:01:30.000Z,"And we are live with Dr. West. Talking #SCLC, Lurbi, IO & Rova-T $abbv $phm.mc $MRK $BMY & more: https://slingshotinsights.com/projects/491 
@Slingshot_Invst","And we are live with Dr. West. Talking #SCLC, Lurbi, IO & Rova-T $abbv $phm.mc $MRK $BMY & more: https://slingshotinsights.com/projects/491 
@Slingshot_Invst
1",,,1,,[],https://twitter.com/JMac_SI/status/867395136984154112
2519,GREEN STOCK NEWS,@greenstocknews,2017-05-24T17:20:20.000Z,Merck & Co (MRK) Investor Presentation - Slideshow https://seekingalpha.com/article/4076168-merck-and-co-mrk-investor-presentation-slideshow?source=feed_f‚Ä¶ $MRK check out http://docasainc.com Fully Reporting Public‚Ä¶,"Merck & Co (MRK) Investor Presentation - Slideshow https://seekingalpha.com/article/4076168-merck-and-co-mrk-investor-presentation-slideshow?source=feed_f‚Ä¶ $MRK check out http://docasainc.com Fully Reporting Public‚Ä¶
seekingalpha.com
Merck & Co (MRK) Investor Presentation - Slideshow (NYSE:MRK)
The following slide deck was published by Merck & Co Inc.",,,,,['https://pbs.twimg.com/card_img/1500679726922285057/PVKpgAH5?format=png&name=240x240'],https://twitter.com/greenstocknews/status/867430072554323968
2520,Briefing.com,@Briefingcom,2017-05-23T21:06:27.000Z,$MRK: Merck: FDA grants accelerated approval to pembrolizumab for first tissue/site agnostic indication http://bit.ly/2q8a4go,$MRK: Merck: FDA grants accelerated approval to pembrolizumab for first tissue/site agnostic indication http://bit.ly/2q8a4go,,,,,[],https://twitter.com/Briefingcom/status/867124589863682049
2521,Briefing.com,@Briefingcom,2017-05-23T12:58:23.000Z,$MRK: Merck announces that the FDA has accepted for review a supplemental Biologics License Application for... http://bit.ly/2q716A5,$MRK: Merck announces that the FDA has accepted for review a supplemental Biologics License Application for... http://bit.ly/2q716A5,,,,,[],https://twitter.com/Briefingcom/status/867001763861118976
2522,Briefing.com,@Briefingcom,2017-05-22T17:23:13.000Z,"$MRK: Merck presents results from a Phase 2 study evaluating the safety, efficacy and therapeutic dose range of... http://bit.ly/2q3l7Ye","$MRK: Merck presents results from a Phase 2 study evaluating the safety, efficacy and therapeutic dose range of... http://bit.ly/2q3l7Ye",,,,,[],https://twitter.com/Briefingcom/status/866706026485002240
2523,Sarah Owermohle,@owermohle,2017-05-24T18:38:27.000Z,"After convos with people from MSF and $MRK, it looks kind of unlikely that Merck's Ebola vaccine is getting shipped to DRC for this outbreak","After convos with people from MSF and $MRK, it looks kind of unlikely that Merck's Ebola vaccine is getting shipped to DRC for this outbreak",,,,,[],https://twitter.com/owermohle/status/867449731433328640
2524,Jacob Plieth,@JacobPlieth,2017-05-24T09:20:27.000Z,"Replying to 
@JPZaragoza1","Replying to 
@JPZaragoza1
GI cancer makes up only $393m of $MRK Keytruda $9.2bn 2022 sales, per 
@evaluatepharma
1
3",,1,,3,[],https://twitter.com/JacobPlieth/status/867309306751963137
2525,StockNews.com,@stocknewsdotcom,2017-05-23T19:07:37.000Z,$MRK FDA grants accelerated approval to pembrolizumab for first tissue/site agnostic indication https://stocknews.com/news/mrk-fda-grants-accelerated-approval-to-pembrolizumab-for-first-tissuesite-agnostic/‚Ä¶,$MRK FDA grants accelerated approval to pembrolizumab for first tissue/site agnostic indication https://stocknews.com/news/mrk-fda-grants-accelerated-approval-to-pembrolizumab-for-first-tissuesite-agnostic/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/867094684841246720
2526,Herkyleese,@herkyleese,2017-05-25T21:41:40.000Z,#Dcvax-L 4 #gbm #DcvaxDirect 13 cancer indications.  Robust pipeline. #Google $NWBO #disrupt #cancer $kite $juno $bmy $mrk $fgen $gild $celg,"#Dcvax-L 4 #gbm #DcvaxDirect 13 cancer indications.  Robust pipeline. #Google $NWBO #disrupt #cancer $kite $juno $bmy $mrk $fgen $gild $celg
11
16",,,11,16,['https://pbs.twimg.com/ext_tw_video_thumb/867857081621241856/pu/img/Ud_n5CrVJnVsW9Oq.jpg'],https://twitter.com/herkyleese/status/867858228427751424
2527,pharmalot,@pharmalot,2017-05-25T22:45:31.000Z,Nevada bill to limit diabetes drug prices heads to the governor.. https://statnews.com/pharmalot/2017/05/25/nevada-bill-diabetes-drug-prices/‚Ä¶ #pharma #diabetes $LLY $SNY $NOVO $MRK,"Nevada bill to limit diabetes drug prices heads to the governor.. https://statnews.com/pharmalot/2017/05/25/nevada-bill-diabetes-drug-prices/‚Ä¶ #pharma #diabetes $LLY $SNY $NOVO $MRK
statnews.com
Nevada bill to limit diabetes drug prices headed to the governor
The bill would require drug makers to report pricing histories, disclose costs, and notify state officials and insurers of price hikes above inflation.
10
4",,,10,4,['https://pbs.twimg.com/card_img/1500454739498221569/NcaUyOer?format=jpg&name=small'],https://twitter.com/pharmalot/status/867874295845974021
2528,Herkyleese,@herkyleese,2017-05-25T12:25:31.000Z,Introducing Dcvax! $pbyi $fgen $icpt $bmy $mrk $kite $juno all good. But #google it #ASCO17 #asco2017 Dcvax will change the game! $exel $gsk,"Introducing Dcvax! $pbyi $fgen $icpt $bmy $mrk $kite $juno all good. But #google it #ASCO17 #asco2017 Dcvax will change the game! $exel $gsk
1
12
18",,1,12,18,['https://pbs.twimg.com/ext_tw_video_thumb/867717748192931840/pu/img/8PNr2_0T0iJnI4wZ.jpg'],https://twitter.com/herkyleese/status/867718269813313536
2529,Stockrow,@stockrow1,2017-05-27T14:56:20.000Z,"$CELG spends 40% of revenue on R&D, way more than $JNJ $AMGN $GILD $PFE $MRK $BMY #stocks #investing #biotech","$CELG spends 40% of revenue on R&D, way more than $JNJ $AMGN $GILD $PFE $MRK $BMY #stocks #investing #biotech
1",,,1,,['https://pbs.twimg.com/media/DA121ZqXUAAfH-A?format=jpg&name=small'],https://twitter.com/stockrow1/status/868480997603635200
2530,MM+M Magazine,@MMMnews,2017-05-26T20:00:01.000Z,"5 things for #pharma #marketers to know:Fri, May 26 #FDA #Drugprices #patients $AAPL #clinical $NVS $MRK #Alzheimers http://bit.ly/2qjHdWE","5 things for #pharma #marketers to know:Fri, May 26 #FDA #Drugprices #patients $AAPL #clinical $NVS $MRK #Alzheimers http://bit.ly/2qjHdWE
1
2
2",,1,2,2,['https://pbs.twimg.com/media/DAwswGSUAAECzJ4?format=jpg&name=small'],https://twitter.com/MMMnews/status/868195034314788865
2531,sam,@faceoffgogreen,2017-05-27T03:30:44.000Z,$Spywins.com $SPY $CVS $UVXY $AAPL $TSLA $NFLX $MRK $MO $DAL and much more,"$Spywins.com $SPY $CVS $UVXY $AAPL $TSLA $NFLX $MRK $MO $DAL and much more
1
1",,,1,1,[],https://twitter.com/faceoffgogreen/status/868308464103284737
2532,ClemSnide,@ClemsnideClem,2017-05-27T23:40:47.000Z,"Abstracts out for #ASCO17 incl AbbVie $ABBV BlueBird $BLUE Epizyme $EPZM, Juno  $JUNO Merck $MRK Pfizer $PFE $BTK http://traderscommunity.com/forum/index.php?topic=1451.0‚Ä¶","Abstracts out for #ASCO17 incl AbbVie $ABBV BlueBird $BLUE Epizyme $EPZM, Juno  $JUNO Merck $MRK Pfizer $PFE $BTK http://traderscommunity.com/forum/index.php?topic=1451.0‚Ä¶
2
2",,,2,2,[],https://twitter.com/ClemsnideClem/status/868612981965434884
2533,ClemSnide,@ClemsnideClem,2017-05-27T23:26:01.000Z,"Biotech and Pharma Investors Anticipate #ASCO2017 
@ASCO
 @TradersCom
 @HeidsterTrades
 $BTK $PFE $MRK $JUNO $KITE http://traderscommunity.com/forum/index.php?topic=1451.0‚Ä¶","Biotech and Pharma Investors Anticipate #ASCO2017 
@ASCO
 @TradersCom
 @HeidsterTrades
 $BTK $PFE $MRK $JUNO $KITE http://traderscommunity.com/forum/index.php?topic=1451.0‚Ä¶
4
2",,,4,2,['https://pbs.twimg.com/media/DA3rgEHV0AAF8fd?format=jpg&name=360x360'],https://twitter.com/ClemsnideClem/status/868609263421337600
2534,pharmalot,@pharmalot,2017-05-26T11:20:25.000Z,Nevada bill aimed at limiting diabetes drug prices is headed to the governor: https://statnews.com/pharmalot/2017/05/25/nevada-bill-diabetes-drug-prices/‚Ä¶ #pharma $SNY $NOVO $LLY $MRK #diabetes,"Nevada bill aimed at limiting diabetes drug prices is headed to the governor: https://statnews.com/pharmalot/2017/05/25/nevada-bill-diabetes-drug-prices/‚Ä¶ #pharma $SNY $NOVO $LLY $MRK #diabetes
statnews.com
Nevada bill to limit diabetes drug prices headed to the governor
The bill would require drug makers to report pricing histories, disclose costs, and notify state officials and insurers of price hikes above inflation.
6
2",,,6,2,['https://pbs.twimg.com/card_img/1500454739498221569/NcaUyOer?format=jpg&name=small'],https://twitter.com/pharmalot/status/868064272693284864
2535,Art,@mRNAdisrupts,2017-05-25T13:45:53.000Z,$mrk $biib $ions $sgmo imitation is the biggest form of flattery. #Alzheimers #neuroscience #mentalhealth,"$mrk $biib $ions $sgmo imitation is the biggest form of flattery. #Alzheimers #neuroscience #mentalhealth
John Carroll
@JohnCendpts
 ¬∑ 25 May 2017
Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
$MRK
https://endpts.com/right-on-the-heels-of-a-phiii-failure-merck-neuroscience-doubles-down-with-a-new-drug-targeting-tau/‚Ä¶
1
2",,1,,2,['https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_mini.jpeg'],https://twitter.com/mRNAdisrupts/status/867738493866389504
2536,Odi Bruckman,@odibro,2017-05-27T16:25:00.000Z,Top Presentations to Look for at #ASCO17 $PFE $MRK $ABBV $LLY $BLUE $EPZM $JUNO $KITE $MRUS,"Top Presentations to Look for at #ASCO17 $PFE $MRK $ABBV $LLY $BLUE $EPZM $JUNO $KITE $MRUS
247wallst.com
Top Presentations to Look for at ASCO
The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) runs from June 2 to June 6. The following companies have signaled that they will be presenting data, or data will be...
2
4
9",,2,4,9,['https://pbs.twimg.com/card_img/1501724143917711363/AkqmeL3C?format=jpg&name=small'],https://twitter.com/odibro/status/868503314857676800
2537,dough,@semodough,2017-05-25T20:00:36.000Z,June 5 Sunday $MRK $ROG $TGTX $BLUE $INCY Salk  LIVE investor events that evening s #ASCO2017  - please add to list,"June 5 Sunday $MRK $ROG $TGTX $BLUE $INCY Salk  LIVE investor events that evening s #ASCO2017  - please add to list
dough
@semodough
 ¬∑ 26 May 2017
Sunday JUNE 4 $BMY $RDUS and $CELG all having LIVE investor events that evening s #ASCO2017  - please add to list
4
4
7",,4,4,7,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/867832793228881920
2538,BioPharma Dive,@BioPharmaDive,2017-05-27T19:58:00.000Z,$MRK's Keytruda gets first nod in genetically-defective tumors,"$MRK's Keytruda gets first nod in genetically-defective tumors
biopharmadive.com
Merck's Keytruda gets first nod in genetically-defective tumors
The anti-PD-1 drug locked down another indication, this time for solid tumors that have defective genetic code.
2
5",,,2,5,['https://pbs.twimg.com/card_img/1493699591954472961/09HEmVhV?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/868556916523278340
2539,BiotechBioPharma,@Regencells,2017-05-26T17:00:32.000Z,"New study could boost vaccination argument for Merck's Gardasil http://buff.ly/2rHbq1D #HPV $MRK 
@Merck","New study could boost vaccination argument for Merck's Gardasil http://buff.ly/2rHbq1D #HPV $MRK 
@Merck",,,,,['https://pbs.twimg.com/media/DAxJtDtVwAAmrcS?format=jpg&name=small'],https://twitter.com/Regencells/status/868149868891688962
2540,BioWorld,@BioWorld,2017-05-25T22:43:00.000Z,"Behind $MRK Keytruda tissue-agnostic approval, $LOXO has #ASCO17 late-breaker on TRK fusion inhibitor larotrectinib http://bit.ly/2rD0UZe","Behind $MRK Keytruda tissue-agnostic approval, $LOXO has #ASCO17 late-breaker on TRK fusion inhibitor larotrectinib http://bit.ly/2rD0UZe
2
3",,,2,3,[],https://twitter.com/BioWorld/status/867873664984727552
2541,Ben Fidler,@BentheFidler,2017-05-26T11:01:13.000Z,"#Biotech Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More http://xconomy.com/national/2017/05/26/bio-roundup-skinny-cuts-genomic-approvals-unfrozen-fda-more/‚Ä¶ $MRK $AERI $BIVV $CELG","#Biotech Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More http://xconomy.com/national/2017/05/26/bio-roundup-skinny-cuts-genomic-approvals-unfrozen-fda-more/‚Ä¶ $MRK $AERI $BIVV $CELG
1
1",,,1,1,[],https://twitter.com/BentheFidler/status/868059442218229760
2542,Behavioral Finance,@BehaviorFin,2017-05-26T15:38:49.000Z,Anti-tau one of new focus of R&D in CNS treatment and Alzheimer? 1st antibody then #geneediting? $MRK $BIIB $SGMO,"Anti-tau one of new focus of R&D in CNS treatment and Alzheimer? 1st antibody then #geneediting? $MRK $BIIB $SGMO
nasdaq.com
Merck (MRK) Buys Rights to Anti-tau Antibody for Alzheimer
1",,,,1,[],https://twitter.com/BehaviorFin/status/868129304093347843
2543,CBPartners,@CBPartners,2017-05-27T12:30:25.000Z,Is there more to the $MRK REMICADE discounting strategy that has caused the UK #CMA outcry?,"Is there more to the $MRK REMICADE discounting strategy that has caused the UK #CMA outcry?
fiercepharma.com
Merck's Remicade discounting put squeeze on biosims‚Äîand broke U.K. law, officials say
Under biosimilar assault in Europe, Merck rolled out cut-rate deals on Remicade to defend its brand from cheaper options, then-brand-new to the market. | Under biosimilar assault in Europe, Merck...",,,,,['https://pbs.twimg.com/card_img/1501987467678781440/O8uNzXuP?format=jpg&name=small'],https://twitter.com/CBPartners/status/868444278141448192
2544,@AlexandriaTech,@AlexandriaTech,2017-05-25T17:00:13.000Z,Top #sentiment for #SP1500 #stocks at midday: $HPQ $MDT $UNM $MRK $NDAQ (2017/05/25) #stocktrading #predictiveanalytics #bigdata,"Top #sentiment for #SP1500 #stocks at midday: $HPQ $MDT $UNM $MRK $NDAQ (2017/05/25) #stocktrading #predictiveanalytics #bigdata
1",,,1,,[],https://twitter.com/alexandriatech/status/867787398624792577
2545,HealthyCarnivores,@HealthyCarnivor,2017-05-25T15:10:07.000Z,"New study could boost vaccination argument for Merck's Gardasil http://buff.ly/2qcoGGv #HPV $MRK 
@Merck","New study could boost vaccination argument for Merck's Gardasil http://buff.ly/2qcoGGv #HPV $MRK 
@Merck
1",,,1,,['https://pbs.twimg.com/media/DArm155XsAAgN1-?format=jpg&name=small'],https://twitter.com/HealthyCarnivor/status/867759693816582144
2546,BioWorld,@BioWorld,2017-05-25T16:15:26.000Z,Newest Keytruda tissue-agnostic approval marks broadest success of basket trials to date http://bit.ly/2rD0UZe $MRK,"Newest Keytruda tissue-agnostic approval marks broadest success of basket trials to date http://bit.ly/2rD0UZe $MRK
2
2",,,2,2,[],https://twitter.com/BioWorld/status/867776131621154817
2547,Limex,@LimexMe,2017-05-26T14:26:03.000Z,Celldex's Immuno-Oncology Pipeline Continues to Impress http://bit.ly/260517CLDX $CLDX $PFE $MRK,"Celldex's Immuno-Oncology Pipeline Continues to Impress http://bit.ly/260517CLDX $CLDX $PFE $MRK
whotrades.com
Celldex's Immuno-Oncology Pipeline Continues to Impress
On May 25, we issued an updated research report on Hampton, NJ-based Celldex Therapeutics, Inc. CLDX . Celldex is a development-stage biopharmaceutical company focused on the‚Ä¶
1",,,1,,[],https://twitter.com/LimexMe/status/868110989929189376
2548,Seeking Alpha,@SeekingAlpha,2017-05-27T09:09:21.000Z,"3 Things In Biotech You Should Learn Today: May 27, 2017 https://seekingalpha.com/article/4076986-3-things-biotech-learn-today-may-27-2017?source=feed_f‚Ä¶ $AMGN $KITE $MRK $PFE","3 Things In Biotech You Should Learn Today: May 27, 2017 https://seekingalpha.com/article/4076986-3-things-biotech-learn-today-may-27-2017?source=feed_f‚Ä¶ $AMGN $KITE $MRK $PFE",,,,,[],https://twitter.com/SeekingAlpha/status/868393680146644992
2549,Finbox,@FinboxIO,2017-05-25T20:30:38.000Z,The market is valuing Gilead Sciences $GILD at a discount vs peers. Worth a look? $ABBV $BMY $LLY $MRK $PFE https://finbox.io/GILD/charts/peers-ev-ebitda?utm_medium=social&utm_campaign=EBITDA-Mult-Below-Peers-Chart&utm_source=mdh‚Ä¶,The market is valuing Gilead Sciences $GILD at a discount vs peers. Worth a look? $ABBV $BMY $LLY $MRK $PFE https://finbox.io/GILD/charts/peers-ev-ebitda?utm_medium=social&utm_campaign=EBITDA-Mult-Below-Peers-Chart&utm_source=mdh‚Ä¶,,,,,['https://pbs.twimg.com/media/DAswM-DXcAEYB_6?format=jpg&name=small'],https://twitter.com/FinboxIO/status/867840354619445250
2550,Open Outcrier,@OpenOutcrier,2017-05-26T20:08:48.000Z,"RECAP 5/26 Unusual Calls:
$WPX $GT $SPLK $GILD $GNW $MU $GE $HD $SBUX $AMC $RRC $HES $MRK $KMI $P $MAR $SIRI $MSFT","RECAP 5/26 Unusual Calls:
$WPX $GT $SPLK $GILD $GNW $MU $GE $HD $SBUX $AMC $RRC $HES $MRK $KMI $P $MAR $SIRI $MSFT
2
1",,,2,1,[],https://twitter.com/OpenOutcrier/status/868197247124721666
2551,TW Research Group,@DanCarlson33,2017-05-26T15:58:51.000Z,$CYRX has been delivering for investors lately. Partnered with $FDX $KITE $NVS #UPS #DHL $MRK and more,"$CYRX has been delivering for investors lately. Partnered with $FDX $KITE $NVS #UPS #DHL $MRK and more
twresearchgroup.com
Cryoport: Delivering Results
I often refer to Silicon Valley as having a printing press for making money. It literally seems to grow on trees not only down in the valley, but in the whole Bay Area. However, despite the concept...",,,,,[],https://twitter.com/DanCarlson33/status/868134345189478400
2552,FierceBiotech,@FierceBiotech,2017-05-25T12:23:03.000Z,"Months after trial setbacks, Merck licenses Teijin Alzheimer‚Äôs candidate: http://ow.ly/2o3l30c27zJ $MRK","Months after trial setbacks, Merck licenses Teijin Alzheimer‚Äôs candidate: http://ow.ly/2o3l30c27zJ $MRK
fiercebiotech.com
Months after trial setbacks, Merck licenses Teijin Alzheimer‚Äôs candidate
After halting a mid-to-late-stage trial of its doomed-to-fail BACE inhibitor three months ago, Merck has today penned a new licensing deal with Tokyo‚Äôs Teijin Pharma for its investigational tau-tar |...
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501130613063315457/1covOWA9?format=jpg&name=small'],https://twitter.com/FierceBiotech/status/867717648095772673
2553,Flagship Biosciences,@FlagshipBio,2017-05-25T13:01:38.000Z,FDA approves first cancer treatment for any solid tumor with a specific genetic feature http://bit.ly/2qh6Wd2 #Keytruda $MRK,FDA approves first cancer treatment for any solid tumor with a specific genetic feature http://bit.ly/2qh6Wd2 #Keytruda $MRK,,,,,[],https://twitter.com/FlagshipBio/status/867727359566336000
2554,Pharmaceutical News,@pharma_sector,2017-05-26T22:38:18.000Z,"Optum, #Merck to collaborate on value-based reimbursement models for prescription drugs. Read more: http://owler.us/acLUyc $MRK","Optum, #Merck to collaborate on value-based reimbursement models for prescription drugs. Read more: http://owler.us/acLUyc $MRK",,,,,[],https://twitter.com/pharma_sector/status/868234869574438912
2555,CBPartners,@CBPartners,2017-05-27T07:20:07.000Z,How can $MRK win when it offers a competitively priced original REMICADE to NHS and UK #CMA complains?,"How can $MRK win when it offers a competitively priced original REMICADE to NHS and UK #CMA complains?
fiercepharma.com
Merck's Remicade discounting put squeeze on biosims‚Äîand broke U.K. law, officials say
Under biosimilar assault in Europe, Merck rolled out cut-rate deals on Remicade to defend its brand from cheaper options, then-brand-new to the market. | Under biosimilar assault in Europe, Merck...",,,,,['https://pbs.twimg.com/card_img/1501987467678781440/O8uNzXuP?format=jpg&name=small'],https://twitter.com/CBPartners/status/868366190724468736
2556,Finbox,@FinboxIO,2017-05-26T12:30:35.000Z,"Pfizer, $PFE EBITDA multiple trading @ discount to peers: $MRK $BMY $LLY $JNJ $SNY https://finbox.io/PFE/charts/peers-ev-ebitda?utm_medium=social&utm_campaign=EBITDA-Mult-Below-Peers-Chart&utm_source=mdh‚Ä¶","Pfizer, $PFE EBITDA multiple trading @ discount to peers: $MRK $BMY $LLY $JNJ $SNY https://finbox.io/PFE/charts/peers-ev-ebitda?utm_medium=social&utm_campaign=EBITDA-Mult-Below-Peers-Chart&utm_source=mdh‚Ä¶",,,,,['https://pbs.twimg.com/media/DAwL6gnXsAQHq56?format=jpg&name=small'],https://twitter.com/FinboxIO/status/868081930809507840
2557,John Carroll,@JohnCendpts,2017-05-25T13:38:21.000Z,"Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
$MRK","Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
$MRK
endpts.com
Right on the heels of a PhIII failure, Merck neuroscience doubles down with a new drug targeting tau
Merck isn‚Äôt letting its first big Phase III failure in Alzheimer‚Äôs get in the way of its ambitions in the field. The pharma giant just grabbed worldwide rights to a preclinical tau-targeted antibody,...
2
3",,,2,3,['https://pbs.twimg.com/card_img/1501724257860083719/s4hrYi5O?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/867736596522692608
2558,BioPharmaDevice,@OneMedWorld,2017-05-26T19:06:01.000Z,"New study could boost vaccination argument for Merck's Gardasil http://buff.ly/2rGX9BV #HPV $MRK 
@Merck","New study could boost vaccination argument for Merck's Gardasil http://buff.ly/2rGX9BV #HPV $MRK 
@Merck",,,,,['https://pbs.twimg.com/media/DAxmbBxWAAEBz72?format=jpg&name=small'],https://twitter.com/OneMedWorld/status/868181445164109825
2559,Jacob Bell,@realJacobBell,2017-05-25T18:09:00.000Z,$MRK may face financial fine for anti-competitive pricing,"$MRK may face financial fine for anti-competitive pricing
biopharmadive.com
Merck may face financial fine for anti-competitive pricing
A U.K. regulator has issued a provisional ruling against Merck, Sharp & Dohme for engaging in anti-competitive pricing to defend Remicade sales from biosimilar competition.",,,,,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/realJacobBell/status/867804710983553024
2560,US Banking News,@AmericanBanking,2017-05-26T23:58:18.000Z,Merck & Co. Target of Unusually High Options Trading $MRK http://ift.tt/2qsnLlw,Merck & Co. Target of Unusually High Options Trading $MRK http://ift.tt/2qsnLlw,,,,,[],https://twitter.com/AmericanBanking/status/868255000191008768
2561,24/7 Wall St.,@247WallSt,2017-05-25T14:27:42.000Z,5 Big catalysts coming for Big Pharma during rest of 2017 $ABBV $BMY $LLY $MRK $PFE,"5 Big catalysts coming for Big Pharma during rest of 2017 $ABBV $BMY $LLY $MRK $PFE
247wallst.com
Big Pharma Has Big Catalysts Coming for the Rest of 2017
A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow they have for the rest of 2017.
2",,,2,,['https://pbs.twimg.com/card_img/1501724285500465152/K9SkoBGY?format=jpg&name=small'],https://twitter.com/247WallSt/status/867749017391968256
2562,TalkMarkets,@TalkMarkets,2017-05-26T17:27:53.000Z,"Hot Options Report For Midday - Friday, May 26 $F $MAR $AAPL $MU $SIRI $GE $HTZ $MRK $TSLA https://goo.gl/wGPTrg","Hot Options Report For Midday - Friday, May 26 $F $MAR $AAPL $MU $SIRI $GE $HTZ $MRK $TSLA https://goo.gl/wGPTrg",,,,,[],https://twitter.com/TalkMarkets/status/868156749202804738
2563,US Banking News,@AmericanBanking,2017-05-26T15:18:53.000Z,"Merck & Co., Inc. $MRK Raised to ‚ÄúBuy‚Äù at Zacks Investment Research http://ift.tt/2rp3G4w","Merck & Co., Inc. $MRK Raised to ‚ÄúBuy‚Äù at Zacks Investment Research http://ift.tt/2rp3G4w",,,,,[],https://twitter.com/AmericanBanking/status/868124287609307136
2564,MarketBeat,@MarketBeatCom,2017-05-27T11:50:31.000Z,"Merck & Co., Inc. $MRK Shares Sold by Needelman Asset Management Inc. http://zpr.io/P2diW","Merck & Co., Inc. $MRK Shares Sold by Needelman Asset Management Inc. http://zpr.io/P2diW",,,,,[],https://twitter.com/MarketBeatCom/status/868434238735077377
2565,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-05-27T09:17:34.000Z,"3 Things In Biotech You Should Learn Today: May 27, 2017 $AMGN $KITE $MRK $PFE http://dlvr.it/PFhn50 #Investing #Stocks","3 Things In Biotech You Should Learn Today: May 27, 2017 $AMGN $KITE $MRK $PFE http://dlvr.it/PFhn50 #Investing #Stocks
1",,,1,,['https://pbs.twimg.com/media/DA0pVDGUAAQW1b2?format=jpg&name=small'],https://twitter.com/AlertTrade/status/868395747984539648
2566,Jon Ogg,@jonogg,2017-05-25T14:20:30.000Z,"5 Big catalysts coming for Big Pharma in 2017 
$ABBV $BMY $LLY $MRK $PFE 
http://247wallst.com/healthcare-business/2017/05/25/big-pharma-has-big-catalysts-coming-for-the-rest-of-2017/‚Ä¶","5 Big catalysts coming for Big Pharma in 2017 
$ABBV $BMY $LLY $MRK $PFE 
http://247wallst.com/healthcare-business/2017/05/25/big-pharma-has-big-catalysts-coming-for-the-rest-of-2017/‚Ä¶",,,,,['https://pbs.twimg.com/media/DArbeyqW0AE5lmD?format=jpg&name=small'],https://twitter.com/jonogg/status/867747207230914560
2567,MarketBeat,@MarketBeatCom,2017-05-26T23:57:34.000Z,Merck & Co. Target of Unusually High Options Trading $MRK http://ift.tt/2qXN6aC #acn,Merck & Co. Target of Unusually High Options Trading $MRK http://ift.tt/2qXN6aC #acn,,,,,[],https://twitter.com/MarketBeatCom/status/868254818841886721
2568,Market Realist,@MarketRealist,2017-05-26T02:37:41.000Z,Sanofi‚Äôs Valuation after Its 1Q17 Earnings Release http://marketrealist.com/?p=2113657 $SNY $MRK $PFE $NVS,Sanofi‚Äôs Valuation after Its 1Q17 Earnings Release http://marketrealist.com/?p=2113657 $SNY $MRK $PFE $NVS,,,,,[],https://twitter.com/MarketRealist/status/867932723977039872
2569,TalkMarkets,@TalkMarkets,2017-05-25T05:21:15.000Z,Sensex Opens Higher; Lupin Plunges 5.5% On Weak Q4 Numbers $MRK $WIT $SMPQY $INFY $KENSD https://goo.gl/29ijvv,Sensex Opens Higher; Lupin Plunges 5.5% On Weak Q4 Numbers $MRK $WIT $SMPQY $INFY $KENSD https://goo.gl/29ijvv,,,,,[],https://twitter.com/TalkMarkets/status/867611500495724544
2570,StockNews.com,@stocknewsdotcom,2017-05-25T12:03:22.000Z,"$MRK Enters into an exclusive worldwide license agreement with Teijin Pharma for the development, manufacture and ‚Ä¶ https://stocknews.com/news/mrk-enters-into-an-exclusive-worldwide-license-agreement-with-teijin-pharma/‚Ä¶","$MRK Enters into an exclusive worldwide license agreement with Teijin Pharma for the development, manufacture and ‚Ä¶ https://stocknews.com/news/mrk-enters-into-an-exclusive-worldwide-license-agreement-with-teijin-pharma/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/867712695340085248
2571,BioPharma Dive,@BioPharmaDive,2017-05-26T21:00:59.000Z,$MRK snags access to alternative Alzheimer's approach,"$MRK snags access to alternative Alzheimer's approach
biopharmadive.com
Merck snags access to alternative Alzheimer's approach
As interest in the beta amyloid theory lags after a number of failures, Merck & Co. is betting cash on anti-tau.",,,,,['https://pbs.twimg.com/card_img/1475494886845685762/iq7_UkW7?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/868210379217915904
2572,The Options Insider,@Options,2017-05-26T18:13:24.000Z,"Hot Options Report For Midday May 26, 2017 - $MU, $SIRI, $AAPL, $MAR, $F, $GE, $HTZ, $TSLA, $MRK
http://theoptionsinsider.com/hot-options-report-midday-may-26-2017-mu-siri-aapl-mar-f-ge/‚Ä¶","Hot Options Report For Midday May 26, 2017 - $MU, $SIRI, $AAPL, $MAR, $F, $GE, $HTZ, $TSLA, $MRK
http://theoptionsinsider.com/hot-options-report-midday-may-26-2017-mu-siri-aapl-mar-f-ge/‚Ä¶",,,,,[],https://twitter.com/Options/status/868168204606164992
2573,BioPharma Dive,@BioPharmaDive,2017-05-26T22:30:01.000Z,"Value-based deals are gaining traction among healthcare providers, as evidenced by $MRK and $UNH's new partnership","Value-based deals are gaining traction among healthcare providers, as evidenced by $MRK and $UNH's new partnership
biopharmadive.com
Merck, UnitedHealth explore improving value-based contracts
The big pharma and insurer are working on a multiyear project aimed at better understanding and optimizing pay-for-performance deals.",,,,,['https://pbs.twimg.com/card_img/1501987497215082496/sHycNjb1?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/868232783813988352
2574,Ozmosi,@OzmosiHealth,2017-05-26T13:25:56.000Z,"$BMY continues to squander an I/O #pipeline by not extending collaborations like $MRK - one reason Merck has the most trials 
@megtirrell","$BMY continues to squander an I/O #pipeline by not extending collaborations like $MRK - one reason Merck has the most trials 
@megtirrell
Meg Tirrell
@megtirrell
 ¬∑ 24 May 2017
IO trials run by 4 big players (from $MRK via Evercore ISI's Umer Raffat)",,,,,"['https://pbs.twimg.com/profile_images/791618485621325824/wBeu2-6V_mini.jpg', 'https://pbs.twimg.com/media/DAmQ4vlXcAAfNYn?format=jpg&name=small']",https://twitter.com/OzmosiHealth/status/868095860613275648
2575,GREEN STOCK NEWS,@greenstocknews,2017-05-26T17:37:20.000Z,Time For Tau - For Now https://seekingalpha.com/article/4076869-time-tau-now?source=feed_f‚Ä¶ $MRK $TINLF $TINLY $BIIB $BMY $AXN $JNJ $ACIU check out http://docasainc.com Fully Rep‚Ä¶,"Time For Tau - For Now https://seekingalpha.com/article/4076869-time-tau-now?source=feed_f‚Ä¶ $MRK $TINLF $TINLY $BIIB $BMY $AXN $JNJ $ACIU check out http://docasainc.com Fully Rep‚Ä¶
seekingalpha.com
Time For Tau - For Now
After repeated failures with agents targeting amyloid, tau is the new hot ticket in the Alzheimer's world.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/greenstocknews/status/868159126953709570
2576,FierceBiotech,@FierceBiotech,2017-05-25T14:26:57.000Z,"After amyloid trial setback, $MRK licenses Teijin tau Alzheimer‚Äôs candidate:","After amyloid trial setback, $MRK licenses Teijin tau Alzheimer‚Äôs candidate:
fiercebiotech.com
Months after trial setbacks, Merck licenses Teijin Alzheimer‚Äôs candidate
After halting a mid-to-late-stage trial of its doomed-to-fail BACE inhibitor three months ago, Merck has today penned a new licensing deal with Tokyo‚Äôs Teijin Pharma for its investigational tau-tar |...
1",,,1,,['https://pbs.twimg.com/card_img/1501130613063315457/1covOWA9?format=jpg&name=small'],https://twitter.com/FierceBiotech/status/867748830175006721
2577,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-05-25T14:32:32.000Z,#247WallSt 5 Big catalysts coming for Big Pharma during rest of 2017 $ABBV $BMY $LLY $MRK $PFE http://dlvr.it/PDxGmz,#247WallSt 5 Big catalysts coming for Big Pharma during rest of 2017 $ABBV $BMY $LLY $MRK $PFE http://dlvr.it/PDxGmz,,,,,['https://pbs.twimg.com/media/DArePJVWAAA_7KR?format=jpg&name=small'],https://twitter.com/AlertTrade/status/867750233412780032
2578,Fiercelywashyourhands,@PharmaceuticBen,2017-05-25T12:23:05.000Z,"Months after trial setbacks, Merck licenses Teijin Alzheimer‚Äôs candidate: http://ow.ly/2o3l30c27zJ $MRK","Months after trial setbacks, Merck licenses Teijin Alzheimer‚Äôs candidate: http://ow.ly/2o3l30c27zJ $MRK
fiercebiotech.com
Months after trial setbacks, Merck licenses Teijin Alzheimer‚Äôs candidate
After halting a mid-to-late-stage trial of its doomed-to-fail BACE inhibitor three months ago, Merck has today penned a new licensing deal with Tokyo‚Äôs Teijin Pharma for its investigational tau-tar |...",,,,,['https://pbs.twimg.com/card_img/1501130613063315457/1covOWA9?format=jpg&name=small'],https://twitter.com/PharmaceuticBen/status/867717659089088514
2579,MarketBeat,@MarketBeatCom,2017-05-26T23:55:36.000Z,Merck & Co. Target of Unusually High Options Trading $MRK http://zpr.io/P25iW,Merck & Co. Target of Unusually High Options Trading $MRK http://zpr.io/P25iW,,,,,[],https://twitter.com/MarketBeatCom/status/868254320332066818
2580,WLST.com,@wlstcom,2017-05-29T03:46:36.000Z,Major Pharma Short Interest Surges #biotech #stocks $PFE $MRK $BMY $ABBV $LLY #wlst https://finance.yahoo.com/news/major-pharma-short-interest-surges-134519988.html‚Ä¶,"Major Pharma Short Interest Surges #biotech #stocks $PFE $MRK $BMY $ABBV $LLY #wlst https://finance.yahoo.com/news/major-pharma-short-interest-surges-134519988.html‚Ä¶
1",,,1,,['https://pbs.twimg.com/media/DA9wwbxXkAAtvqt?format=jpg&name=small'],https://twitter.com/wlstcom/status/869037233143246848
2581,Herkyleese,@herkyleese,2017-05-30T13:28:39.000Z,"#Dcvax #google it, stories #facebook and #twitter  $jazz $icpt $pbyi $puma $juno $kite $blue all good.  $NWBO is disruptive $bmy & $mrk know","#Dcvax #google it, stories #facebook and #twitter  $jazz $icpt $pbyi $puma $juno $kite $blue all good.  $NWBO is disruptive $bmy & $mrk know
2
4",,,2,4,['https://pbs.twimg.com/media/DBE_i8WUQAAemkg?format=jpg&name=small'],https://twitter.com/herkyleese/status/869546095004790784
2582,Dangerous Drugs,@ddrugsus,2017-05-30T17:16:29.000Z,Nevada bill to limit diabetes drug prices heads to the governor.. https://statnews.com/pharmalot/2017/05/25/nevada-bill-diabetes-drug-prices/‚Ä¶ ‚Ä¶ #pharma #diabetes $LLY $SNY $NOVO $MRK,"Nevada bill to limit diabetes drug prices heads to the governor.. https://statnews.com/pharmalot/2017/05/25/nevada-bill-diabetes-drug-prices/‚Ä¶ ‚Ä¶ #pharma #diabetes $LLY $SNY $NOVO $MRK
2
2",,,2,2,['https://pbs.twimg.com/media/DBFztkCXkAAQW6Y?format=jpg&name=small'],https://twitter.com/ddrugsus/status/869603433380282373
2583,MM+M Magazine,@MMMnews,2017-05-30T21:30:01.000Z,"5 things for #pharma #marketers to know: Tues., May 30 $AZN #healthcare #diabetes #drugprices #ADHD $GILD $MRK #HCSM http://bit.ly/2rAMglB","5 things for #pharma #marketers to know: Tues., May 30 $AZN #healthcare #diabetes #drugprices #ADHD $GILD $MRK #HCSM http://bit.ly/2rAMglB
1
2",,,1,2,['https://pbs.twimg.com/media/DBFSXzPWsAAvZNj?format=jpg&name=small'],https://twitter.com/MMMnews/status/869667235249373184
2584,Tom Silver,@TomSilver39,2017-05-28T03:55:02.000Z,$IMDZ $BMY $MRK  The emerging role of immune checkpoint inhibition in malignant lymphoma http://haematologica.org/content/haematol/102/1/30.full.pdf‚Ä¶,"$IMDZ $BMY $MRK  The emerging role of immune checkpoint inhibition in malignant lymphoma http://haematologica.org/content/haematol/102/1/30.full.pdf‚Ä¶
1
3",,,1,3,"['https://pbs.twimg.com/media/DA4pEHhV0AAciTY?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DA4pFrFVYAIzHj3?format=jpg&name=360x360']",https://twitter.com/TomSilver39/status/868676967289176064
2585,Traders Community,@TradersCom,2017-05-30T13:56:39.000Z,"Heads Up #Biotech and Pharma Investors - Anticipate #ASCO2017 $SPX $BTX $JUNO $PFE $MRK $QQQ $BIIB $AMGN #cancer
http://traderscommunity.com/forum/index.php?topic=1451.0‚Ä¶","Heads Up #Biotech and Pharma Investors - Anticipate #ASCO2017 $SPX $BTX $JUNO $PFE $MRK $QQQ $BIIB $AMGN #cancer
http://traderscommunity.com/forum/index.php?topic=1451.0‚Ä¶
4",,,4,,['https://pbs.twimg.com/media/DBFFwFzUIAEBKN8?format=jpg&name=360x360'],https://twitter.com/TradersCom/status/869553144262512641
2586,Tom Silver,@TomSilver39,2017-05-28T03:11:02.000Z,"Next week #ASCO17 , on watch: $CYTR $IMDZ $NVS $MRK $AFMD ....","Next week #ASCO17 , on watch: $CYTR $IMDZ $NVS $MRK $AFMD ....
2
7",,,2,7,[],https://twitter.com/TomSilver39/status/868665892384538625
2587,Ben Fidler,@BentheFidler,2017-05-30T19:51:17.000Z,"ICYMI: On ASCO‚Äôs Eve, Experts Fret Over Backlash to Cancer Combo Frenzy http://xconomy.com/national/2017/05/30/on-ascos-eve-experts-fret-over-backlash-to-cancer-combo-frenzy/‚Ä¶ #ASCO17 $MRK $BMY $INCY","ICYMI: On ASCO‚Äôs Eve, Experts Fret Over Backlash to Cancer Combo Frenzy http://xconomy.com/national/2017/05/30/on-ascos-eve-experts-fret-over-backlash-to-cancer-combo-frenzy/‚Ä¶ #ASCO17 $MRK $BMY $INCY
6
7",,,6,7,[],https://twitter.com/BentheFidler/status/869642390600122371
2588,Mr Bentley Onelly,@Onellymr,2017-05-30T11:29:46.000Z,"$MRK Merck Receives FDA Approval of ISENTRESS¬Æ HD (raltegravir), a New Once-Daily Option, in Combinati... https://finance.yahoo.com/news/merck-receives-fda-approval-isentress-110000379.html‚Ä¶","$MRK Merck Receives FDA Approval of ISENTRESS¬Æ HD (raltegravir), a New Once-Daily Option, in Combinati... https://finance.yahoo.com/news/merck-receives-fda-approval-isentress-110000379.html‚Ä¶",,,,,[],https://twitter.com/Onellymr/status/869516179228028928
2589,HealthyCarnivores,@HealthyCarnivor,2017-05-30T17:40:02.000Z,"New study could boost vaccination argument for Merck's Gardasil http://buff.ly/2rGRBHM #HPV $MRK 
@Merck","New study could boost vaccination argument for Merck's Gardasil http://buff.ly/2rGRBHM #HPV $MRK 
@Merck
2",,,2,,['https://pbs.twimg.com/media/DBF5GY1XkAAGIzp?format=jpg&name=small'],https://twitter.com/HealthyCarnivor/status/869609357339754498
2590,Ben Fidler,@BentheFidler,2017-05-30T11:11:11.000Z,"On ASCO‚Äôs Eve, Experts Fret Over Backlash To Cancer Combo Frenzy http://xconomy.com/national/2017/05/30/on-ascos-eve-experts-fret-over-backlash-to-cancer-combo-frenzy/‚Ä¶ $BMY $MRK #ASCO17","On ASCO‚Äôs Eve, Experts Fret Over Backlash To Cancer Combo Frenzy http://xconomy.com/national/2017/05/30/on-ascos-eve-experts-fret-over-backlash-to-cancer-combo-frenzy/‚Ä¶ $BMY $MRK #ASCO17
2
3",,,2,3,[],https://twitter.com/BentheFidler/status/869511500821561348
2591,Greg Wierenga,@Gdubya1,2017-05-28T15:43:25.000Z,"$MRK pembro:
""This is the first time a drug has been approved in cancer without a tumor-specific context."" This is a paradigm shift.","$MRK pembro:
""This is the first time a drug has been approved in cancer without a tumor-specific context."" This is a paradigm shift.
Seeking Alpha
@SeekingAlpha
 ¬∑ 28 May 2017
So Merck Just Made History. Should You Care As An Investor? https://seekingalpha.com/article/4077023-merck-just-made-history-care-investor?source=feed_f‚Ä¶ $MRK
2",,,,2,['https://pbs.twimg.com/profile_images/534299535552421888/eHacq8EQ_mini.png'],https://twitter.com/Gdubya1/status/868855235468443649
2592,Margin Hunt,@MarginHunt,2017-05-30T03:15:04.000Z,Dreman Value Management may be interested in AbbVie $ABBV w/ P/E multiple of 16.7x $BMY $LLY $MRK $PFE https://finbox.io/ABBV/models/pe-multiples?utm_medium=social&utm_campaign=MDH-Social-David-Dreman-PE-Mults&utm_source=mdh‚Ä¶,"Dreman Value Management may be interested in AbbVie $ABBV w/ P/E multiple of 16.7x $BMY $LLY $MRK $PFE https://finbox.io/ABBV/models/pe-multiples?utm_medium=social&utm_campaign=MDH-Social-David-Dreman-PE-Mults&utm_source=mdh‚Ä¶
1",,,,1,['https://pbs.twimg.com/media/DBCzIN2XsAIdSpa?format=jpg&name=small'],https://twitter.com/MarginHunt/status/869391684735553541
2593,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-05-28T13:05:31.000Z,So Merck Just Made History. Should You Care As An Investor? $MRK http://dlvr.it/PG67zF #Investing #Stocks,"So Merck Just Made History. Should You Care As An Investor? $MRK http://dlvr.it/PG67zF #Investing #Stocks
seekingalpha.com
So Merck Just Made History. Should You Care As An Investor? (NYSE:MRK)
Merck recently got the first-ever drug approval that is tumor agnostic. While the approval doesn't cast as wide a net as it may seem at first, it could pay dividends.
1",,,,1,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/AlertTrade/status/868815498242211840
2594,Daily Political,@dailypoliticaln,2017-05-28T09:35:39.000Z,"Atria Investments LLC Buys 5,229 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1133707","Atria Investments LLC Buys 5,229 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1133707",,,,,[],https://twitter.com/dailypoliticaln/status/868762683369193472
2595,Tanvi Patel,@catalystinvstor,2017-05-30T19:02:55.000Z,"Global Pulmonary Drug Delivery Devices Market 2017- Glaxo $GSK, AstraZenca, Teva $TEVA , Merck $MRK , MannKind $mnkd https://dailyhover.com/global-pulmonary-drug-delivery-devices-market-2017/‚Ä¶","Global Pulmonary Drug Delivery Devices Market 2017- Glaxo $GSK, AstraZenca, Teva $TEVA , Merck $MRK , MannKind $mnkd https://dailyhover.com/global-pulmonary-drug-delivery-devices-market-2017/‚Ä¶
1",,,,1,[],https://twitter.com/catalystinvstor/status/869630216657915906
2596,Tracy Lynn,@grapedevine,2017-05-29T19:17:38.000Z,"This Pancreatic Cancer Breakthrough Is Big News 
@themotleyfool
 #stocks $MRK, $BMY, $NLNK https://fool.com/investing/general/2016/02/28/this-pancreatic-cancer-breakthrough-is-big-news.aspx‚Ä¶","This Pancreatic Cancer Breakthrough Is Big News 
@themotleyfool
 #stocks $MRK, $BMY, $NLNK https://fool.com/investing/general/2016/02/28/this-pancreatic-cancer-breakthrough-is-big-news.aspx‚Ä¶
1",,,1,,[],https://twitter.com/grapedevine/status/869271533654425600
2597,GREEN STOCK NEWS,@greenstocknews,2017-05-28T13:01:32.000Z,So Merck Just Made History. Should You Care As An Investor? https://seekingalpha.com/article/4077023-merck-just-made-history-care-investor?source=feed_f‚Ä¶ $MRK check out this stock and tell us what you think w‚Ä¶,"So Merck Just Made History. Should You Care As An Investor? https://seekingalpha.com/article/4077023-merck-just-made-history-care-investor?source=feed_f‚Ä¶ $MRK check out this stock and tell us what you think w‚Ä¶
seekingalpha.com
So Merck Just Made History. Should You Care As An Investor? (NYSE:MRK)
Merck recently got the first-ever drug approval that is tumor agnostic. While the approval doesn't cast as wide a net as it may seem at first, it could pay dividends.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/greenstocknews/status/868814495652732928
2598,Zenect,@zenect,2017-05-30T12:42:26.000Z,#Dividend stocks balance returns with safety‚Ä¶ http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  #workingfromhome,#Dividend stocks balance returns with safety‚Ä¶ http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V  #workingfromhome,,,,,[],https://twitter.com/zenect/status/869534465554608128
2599,ChartMill,@ChartMill,2017-05-28T23:27:14.000Z,Breakout alert! $MRK Watch it on http://stockcharts.chartmill.com/u/BJgFWTR_Z- #videogame #waves,Breakout alert! $MRK Watch it on http://stockcharts.chartmill.com/u/BJgFWTR_Z- #videogame #waves,,,,,[],https://twitter.com/ChartMill/status/868971960184733696
2600,Stock Forums,@stock_forums,2017-05-29T23:48:03.000Z,"$NERV Share your opinions here #InvestorsHangout $WRMA $MRK $LEMIF $HTD $TGA

 http://dlvr.it/PGhrnP","$NERV Share your opinions here #InvestorsHangout $WRMA $MRK $LEMIF $HTD $TGA

 http://dlvr.it/PGhrnP",,,,,[],https://twitter.com/stock_forums/status/869339585397915648
2601,Pharmaceutical News,@pharma_sector,2017-05-30T20:25:19.000Z,#Merck Receives FDA Approval of Isentress HD. Read more: http://owler.us/acMDq1 $MRK,#Merck Receives FDA Approval of Isentress HD. Read more: http://owler.us/acMDq1 $MRK,,,,,[],https://twitter.com/pharma_sector/status/869650953099595776
2602,Dakota Financial,@dakotafinancial,2017-05-30T11:57:43.000Z,"Tompkins Financial Corp Cuts Position in Merck & Co., Inc. $MRK http://zpr.io/PkpWk","Tompkins Financial Corp Cuts Position in Merck & Co., Inc. $MRK http://zpr.io/PkpWk",,,,,[],https://twitter.com/dakotafinancial/status/869523214321496064
2603,Dakota Financial,@dakotafinancial,2017-05-30T11:57:53.000Z,"Merck & Co., Inc. $MRK Stake Lowered by Torch Wealth Management LLC http://zpr.io/PkpQj","Merck & Co., Inc. $MRK Stake Lowered by Torch Wealth Management LLC http://zpr.io/PkpQj",,,,,[],https://twitter.com/dakotafinancial/status/869523256595841024
2604,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-05-28T17:20:38.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/BHhaLFLX,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/BHhaLFLX,,,,,[],https://twitter.com/gem_2014/status/868879703570042880
2605,marketexclusive,@marketexclusive,2017-05-30T12:35:26.000Z,"Teijin Pharma Grants Merck & Co., Inc. (NYSE:MRK) Exclusive Rights To Alzheimer‚Äôs Antibody https://marketexclusive.com/teijin-pharma-grants-merck-co-inc-nysemrk-exclusive-global-rights-alzheimers-anti-tau-antibody/112593/‚Ä¶ $BIIB $MRK $BMY","Teijin Pharma Grants Merck & Co., Inc. (NYSE:MRK) Exclusive Rights To Alzheimer‚Äôs Antibody https://marketexclusive.com/teijin-pharma-grants-merck-co-inc-nysemrk-exclusive-global-rights-alzheimers-anti-tau-antibody/112593/‚Ä¶ $BIIB $MRK $BMY",,,,,[],https://twitter.com/marketexclusive/status/869532703636439043
2606,Matthias Piesche,@PiescheLab,2017-05-29T19:59:18.000Z,$MRK ‚Äôs Keytruda gets #FDA‚Äôs approval as first #cancer treatment 4 any solid tumor w a specific genetic feature,"$MRK ‚Äôs Keytruda gets #FDA‚Äôs approval as first #cancer treatment 4 any solid tumor w a specific genetic feature
pharmaceuticaldaily.com
Merck‚Äôs Keytruda gets FDA‚Äôs approval as first cancer treatment for any solid tumor with a specific...
The U.S. Food and Drug Administration on Tuesday approved Merck‚Äôs Keytruda as a first cancer treatment for any solid tumor with a specific genetic feature.
1
2",,,1,2,[],https://twitter.com/PiescheLab/status/869282020010192899
2607,Zenect,@zenect,2017-05-29T07:01:05.000Z,I assume you‚Äôre going to buy this dividend #stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V and hold it forever‚Ä¶,I assume you‚Äôre going to buy this dividend #stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V and hold it forever‚Ä¶,,,,,[],https://twitter.com/zenect/status/869086174576599040
2608,Daily Political,@dailypoliticaln,2017-05-29T09:55:25.000Z,"First National Bank & Trust Co. of Newtown Cuts Stake in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1135261","First National Bank & Trust Co. of Newtown Cuts Stake in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1135261",,,,,[],https://twitter.com/dailypoliticaln/status/869130045515759616
2609,Daily Political,@dailypoliticaln,2017-05-30T09:54:11.000Z,"Merck & Co., Inc. $MRK Shares Sold by Harvest Capital Management Inc http://dailypolitical.com/?p=1138366","Merck & Co., Inc. $MRK Shares Sold by Harvest Capital Management Inc http://dailypolitical.com/?p=1138366",,,,,[],https://twitter.com/dailypoliticaln/status/869492124865179649
2610,WallStreetGangsta,@WallStGangsta,2017-05-30T13:42:14.000Z,$OBMP OncBioMune Pharmaceuticals Inc Continues to Swim in Major Catalysts https://journaltranscript.com/2017/05/oncbiomune-pharmaceuticals-inc-otcmktsobmp-continues-to-swim-in-major-catalysts/‚Ä¶ $GILD $IBB $INSY $NVS $PFE $JNJ $MRK $BMY,$OBMP OncBioMune Pharmaceuticals Inc Continues to Swim in Major Catalysts https://journaltranscript.com/2017/05/oncbiomune-pharmaceuticals-inc-otcmktsobmp-continues-to-swim-in-major-catalysts/‚Ä¶ $GILD $IBB $INSY $NVS $PFE $JNJ $MRK $BMY,,,,,[],https://twitter.com/WallStGangsta/status/869549516504084480
2611,Ticker Report,@TickerReport,2017-05-29T10:52:15.000Z,Merck & Co.‚Äôs $MRK ‚ÄúSell‚Äù Rating Reiterated at Jefferies Group LLC http://ift.tt/2rcBPSk,Merck & Co.‚Äôs $MRK ‚ÄúSell‚Äù Rating Reiterated at Jefferies Group LLC http://ift.tt/2rcBPSk,,,,,[],https://twitter.com/TickerReport/status/869144350806216704
2612,Stockboard Media Inc,@stockboardinc,2017-05-30T11:11:04.000Z,"$MRK Merck Receives FDA Approval of ISENTRESS¬Æ HD (raltegravir), a New Once-Daily Option, in Combination... - http://sbml.co/d2607106","$MRK Merck Receives FDA Approval of ISENTRESS¬Æ HD (raltegravir), a New Once-Daily Option, in Combination... - http://sbml.co/d2607106",,,,,[],https://twitter.com/stockboardinc/status/869511474770792448
2613,Ticker Report,@TickerReport,2017-05-30T10:02:33.000Z,"Merck & Co., Inc. $MRK Shares Bought by Iowa State Bank http://ift.tt/2s9GbcL","Merck & Co., Inc. $MRK Shares Bought by Iowa State Bank http://ift.tt/2s9GbcL",,,,,[],https://twitter.com/TickerReport/status/869494231978696704
2614,Stockboard Media Inc,@stockboardinc,2017-05-30T12:06:53.000Z,$MRK Merck Highlights Ongoing Commitment to Fighting Infectious Diseases With More than 20 Data Presentat... - http://sbml.co/0e23a305,$MRK Merck Highlights Ongoing Commitment to Fighting Infectious Diseases With More than 20 Data Presentat... - http://sbml.co/0e23a305,,,,,[],https://twitter.com/stockboardinc/status/869525521041850370
2615,BioPharma Dive,@BioPharmaDive,2017-05-28T22:30:00.000Z,$MRK may face financial fine for anti-competitive pricing,"$MRK may face financial fine for anti-competitive pricing
biopharmadive.com
Merck may face financial fine for anti-competitive pricing
A U.K. regulator has issued a provisional ruling against Merck, Sharp & Dohme for engaging in anti-competitive pricing to defend Remicade sales from biosimilar competition.
1",,,,1,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/868957556307144704
2616,Allison Gatlin,@IBD_AGatlin,2017-05-30T19:03:32.000Z,Which biotechs benefit most under Trump's tax reform vision? $REGN $GILD $BIIB $ABT $MYL $AGN $PFE $BMY $MRK $AMGN,"Which biotechs benefit most under Trump's tax reform vision? $REGN $GILD $BIIB $ABT $MYL $AGN $PFE $BMY $MRK $AMGN
investors.com
Which Biotechs Benefit Most Under Trump's Tax Reform Vision?
Regeneron, Gilead and Biogen will benefit the most among biotechs under Trump's proposed tax reform, a measure that would cut the corporate tax rate by 20%.",,,,,[],https://twitter.com/IBD_AGatlin/status/869630374015639552
2617,Paul Harwitz,@CowboyPoet,2017-05-30T16:43:21.000Z,"This Pancreatic Cancer Breakthrough Is Big News 
@themotleyfool
 #stocks $MRK, $BMY, $NLNK","This Pancreatic Cancer Breakthrough Is Big News 
@themotleyfool
 #stocks $MRK, $BMY, $NLNK
fool.com
This Pancreatic Cancer Breakthrough Is Big News @themotleyfool #stocks $MRK $BMY $NLNK
New findings from the University of Glasgow offer a key that will help doctors and the pharmaceutical industry more effectively target the weaknesses of what has been, up till now, one of the most...",,,,,[],https://twitter.com/CowboyPoet/status/869595095473041409
2618,MarketSmith,@MarketSmith,2017-05-30T17:24:01.000Z,How Two Biotechs Split On Cancer Partnerships With Bristol-Myers: http://ow.ly/a98B30ca7tB $ARRY $ADXS $BMY $MRK,"How Two Biotechs Split On Cancer Partnerships With Bristol-Myers: http://ow.ly/a98B30ca7tB $ARRY $ADXS $BMY $MRK
investors.com
How Two Biotechs Fell On Cancer Partnerships With Bristol-Myers
Array and Advaxis shares tumbled more than 3% in action Tuesday after the firms announced partnerships with Bristol.
1",,,1,,[],https://twitter.com/MarketSmith/status/869605327108550656
2619,Bio&TechWebinar,@BioTechWebinar,2017-05-29T09:47:19.000Z,"VAXIMM PhI Trial in Glioblastoma w/ Oral T-cell therapy to be Presented 
@ASCO
. Open collab w/ $PFE & $MRK http://vaximm.com/vaximm-announces-data-from-phase-i-trial-in-glioblastoma-with-oral-t-cell-immunotherapy-vxm01-to-be-presented-at-asco-2017-annual-meeting/‚Ä¶","VAXIMM PhI Trial in Glioblastoma w/ Oral T-cell therapy to be Presented 
@ASCO
. Open collab w/ $PFE & $MRK http://vaximm.com/vaximm-announces-data-from-phase-i-trial-in-glioblastoma-with-oral-t-cell-immunotherapy-vxm01-to-be-presented-at-asco-2017-annual-meeting/‚Ä¶",,,,,[],https://twitter.com/BioTechWebinar/status/869128010447892481
2620,MarketBeat,@MarketBeatCom,2017-05-30T11:16:58.000Z,"Short Interest in Merck & Co., Inc. $MRK Expands By 22.5% http://ift.tt/2riWmGS #acn","Short Interest in Merck & Co., Inc. $MRK Expands By 22.5% http://ift.tt/2riWmGS #acn",,,,,[],https://twitter.com/MarketBeatCom/status/869512958321324032
2621,Buy Cryptocurrency,@cryptosbuy,2017-05-30T14:31:00.000Z,$MRK Cupping nicely..  $MRK http://tradingview.com/chart/MRK/TLSP8Qz1-MRK-Cupping-nicely/‚Ä¶ TV_TradingIdeas,"$MRK Cupping nicely..  $MRK http://tradingview.com/chart/MRK/TLSP8Qz1-MRK-Cupping-nicely/‚Ä¶ TV_TradingIdeas
tradingview.com
$MRK Cupping nicely.. for NYSE:MRK by TheTradingNinja
Key break level 65.25/.29 should easily test $66 - Long here holding 65 - anticipating +1-2 move
1",,,,1,['https://pbs.twimg.com/card_img/1501987605595901953/TOTLQeP7?format=png&name=small'],https://twitter.com/cryptosbuy/status/869561787729031169
2622,John Kenten,@JohnKenten,2017-05-28T18:01:40.000Z,So Merck Just Made History. Should You Care As An Investor? $MRK,"So Merck Just Made History. Should You Care As An Investor? $MRK
seekingalpha.com
So Merck Just Made History. Should You Care As An Investor? (NYSE:MRK)
Merck recently got the first-ever drug approval that is tumor agnostic. While the approval doesn't cast as wide a net as it may seem at first, it could pay dividends.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/JohnKenten/status/868890027396300800
2623,MAISA,@MaisaCorp,2017-05-30T22:30:27.000Z,$MRK granted FDA approval for ISENTRESS HD in combination with other antiretroviral agents for the treatment of HIV-1,$MRK granted FDA approval for ISENTRESS HD in combination with other antiretroviral agents for the treatment of HIV-1,,,,,[],https://twitter.com/MaisaCorp/status/869682446559784960
2624,Allison Gatlin,@IBD_AGatlin,2017-05-30T19:00:00.000Z,How two biotechs fell on cancer partnerships with Bristol-Myers $BMY $MRK $ARRY $ADXS,"How two biotechs fell on cancer partnerships with Bristol-Myers $BMY $MRK $ARRY $ADXS
investors.com
How Two Biotechs Fell On Cancer Partnerships With Bristol-Myers
Array and Advaxis shares tumbled more than 3% in action Tuesday after the firms announced partnerships with Bristol.",,,,,[],https://twitter.com/IBD_AGatlin/status/869629484080693249
2625,NYC Health Business,@NYCHBL,2017-05-30T13:30:41.000Z,"RT 
@BunnyEllerin
: Big news 
@US_FDA
 Approves $MRK Keytruda based on cancer genetics, not location http://ow.ly/BxGA30c1qBQ","RT 
@BunnyEllerin
: Big news 
@US_FDA
 Approves $MRK Keytruda based on cancer genetics, not location http://ow.ly/BxGA30c1qBQ",,,,,[],https://twitter.com/NYCHBL/status/869546608307953664
2626,Diana Toli,@sciDiana,2017-05-30T14:00:19.000Z,So Merck Just Made History. Should You Care As An Investor? https://seekingalpha.com/article/4077023-merck-just-made-history-care-investor?source=tweet‚Ä¶ $MRK,"So Merck Just Made History. Should You Care As An Investor? https://seekingalpha.com/article/4077023-merck-just-made-history-care-investor?source=tweet‚Ä¶ $MRK
seekingalpha.com
So Merck Just Made History. Should You Care As An Investor? (NYSE:MRK)
Merck recently got the first-ever drug approval that is tumor agnostic. While the approval doesn't cast as wide a net as it may seem at first, it could pay dividends.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/sciDiana/status/869554064161476609
2627,jeshercab,@jeshercab,2017-05-28T17:13:49.000Z,So Merck Just Made History. Should You Care As An Investor? $MRK http://seekingalpha.com/article/4077023,So Merck Just Made History. Should You Care As An Investor? $MRK http://seekingalpha.com/article/4077023,,,,,[],https://twitter.com/jeshercab/status/868877986254254081
2628,Bruce Japsen,@brucejapsen,2017-05-31T12:55:36.000Z,30% of (health plans) are negotiating for one or more outcome-based contracts now‚Äù with drug makers http://forbes.com/sites/brucejapsen/2017/05/31/as-drug-prices-soar-value-based-pay-hits-pharmaceutical-industry/‚Ä¶ $MRK $AET $UNH,"30% of (health plans) are negotiating for one or more outcome-based contracts now‚Äù with drug makers http://forbes.com/sites/brucejapsen/2017/05/31/as-drug-prices-soar-value-based-pay-hits-pharmaceutical-industry/‚Ä¶ $MRK $AET $UNH
1
8
2",,1,8,2,[],https://twitter.com/brucejapsen/status/869900168258342912
2629,Bio Stocks‚Ñ¢,@BioStocks,2017-06-02T11:34:01.000Z,"$MRK announced updated longer-term OS data from KEYNOTE-006, the phase 3 study evaluating KEYTRUDA #ASCO17 
https://finance.yahoo.com/news/nearly-three-years-keytruda-pembrolizumab-113000638.html‚Ä¶","$MRK announced updated longer-term OS data from KEYNOTE-006, the phase 3 study evaluating KEYTRUDA #ASCO17 
https://finance.yahoo.com/news/nearly-three-years-keytruda-pembrolizumab-113000638.html‚Ä¶
2
3",,,2,3,[],https://twitter.com/BioStocks/status/870604412829519873
2630,pharmalot,@pharmalot,2017-06-01T17:51:07.000Z,More health plans are eyeing deals for drugs on based on patient outcomes.. https://statnews.com/pharmalot/2017/06/01/drug-prices-outcomes-health-plans/‚Ä¶ #pharma $LLY $AMGN $NVS $AZN $MRK,"More health plans are eyeing deals for drugs on based on patient outcomes.. https://statnews.com/pharmalot/2017/06/01/drug-prices-outcomes-health-plans/‚Ä¶ #pharma $LLY $AMGN $NVS $AZN $MRK
statnews.com
More health plans are eyeing deals for drugs based on patient outcomes
A survey suggests that insurers are eager to exploit drug makers willing to strike such deals in order to win favorable insurance coverage.
3
1",,,3,1,['https://pbs.twimg.com/card_img/1499060714169896973/jVLQCgJn?format=jpg&name=small'],https://twitter.com/pharmalot/status/870336924824858624
2631,pharmalot,@pharmalot,2017-05-31T13:00:47.000Z,Pharmalot.. Pharmalittle.. Good Morning.. Calif transparency bill moves forward & more news.. https://statnews.com/pharmalot/2017/05/31/drug-pricing-california-transparency-mallinckrodt/‚Ä¶ #pharma $MNK $NVS $MRK,"Pharmalot.. Pharmalittle.. Good Morning.. Calif transparency bill moves forward & more news.. https://statnews.com/pharmalot/2017/05/31/drug-pricing-california-transparency-mallinckrodt/‚Ä¶ #pharma $MNK $NVS $MRK
statnews.com
Pharmalot, Pharmalittle: California transparency bill moves closer to becoming law
A California bill aimed at providing transparency into prescription drug pricing was approved by the state Senate, 26-to-10.
4",,,4,,[],https://twitter.com/pharmalot/status/869901472883978241
2632,"Jared Louis Wolff, MS",@jaredlouiswolff,2017-06-02T13:55:37.000Z,Have a listen to the latest episode! $TSRO $MRK $LLY,"Have a listen to the latest episode! $TSRO $MRK $LLY
soundcloud.com
6/2/2017
Jared Wolff and Zach McLellan discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. Topics covered in this episode include: - Tesaro buyout rumors and analys
8
5",,,8,5,['https://pbs.twimg.com/card_img/1497921751401046016/m2tg5PUM?format=jpg&name=240x240'],https://twitter.com/jaredlouiswolff/status/870640047447568385
2633,Bruce Japsen,@brucejapsen,2017-05-31T19:44:24.000Z,One in four health plans now have ‚Äúat least one outcomes-based contract‚Äù with a drug maker http://forbes.com/sites/brucejapsen/2017/05/31/as-drug-prices-soar-value-based-pay-hits-pharmaceutical-industry/‚Ä¶ $MRK $UNH $CI $AET,"One in four health plans now have ‚Äúat least one outcomes-based contract‚Äù with a drug maker http://forbes.com/sites/brucejapsen/2017/05/31/as-drug-prices-soar-value-based-pay-hits-pharmaceutical-industry/‚Ä¶ $MRK $UNH $CI $AET
3
2",,,3,2,[],https://twitter.com/brucejapsen/status/870003044049616898
2634,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-06-01T20:17:28.000Z,Eli Lilly Edges Toward The Bladder Cancer Queue $AZN $BMY $RHHBY $RHHBF $MRK $LLY http://dlvr.it/PJ2bMr #Investing #Stocks,"Eli Lilly Edges Toward The Bladder Cancer Queue $AZN $BMY $RHHBY $RHHBF $MRK $LLY http://dlvr.it/PJ2bMr #Investing #Stocks
1",,,,1,['https://pbs.twimg.com/media/DBQwUTXV0AAGpoJ?format=jpg&name=small'],https://twitter.com/AlertTrade/status/870373755981144064
2635,Seeking Alpha,@SeekingAlpha,2017-06-01T16:08:10.000Z,Merck Wows Investors With Stellar Q1 Performance https://seekingalpha.com/article/4078042-merck-wows-investors-stellar-q1-performance?source=feed_f‚Ä¶ $AZN $BMY $INCY $JNJ $LLY $SNY $MRK,"Merck Wows Investors With Stellar Q1 Performance https://seekingalpha.com/article/4078042-merck-wows-investors-stellar-q1-performance?source=feed_f‚Ä¶ $AZN $BMY $INCY $JNJ $LLY $SNY $MRK
seekingalpha.com
Merck Wows Investors With Stellar Q1 Performance (NYSE:MRK)
Keytruda continues to be game-changer in lung cancer segment in 2017.",,,,,[],https://twitter.com/SeekingAlpha/status/870311017820987392
2636,MM+M Magazine,@MMMnews,2017-05-31T03:15:00.000Z,"5 things for #pharma #marketers to know: Tues., May 30 $AZN #healthcare #diabetes #drugprices #ADHD $GILD $MRK #HCSM http://bit.ly/2rAMglB","5 things for #pharma #marketers to know: Tues., May 30 $AZN #healthcare #diabetes #drugprices #ADHD $GILD $MRK #HCSM http://bit.ly/2rAMglB
1
3",,,1,3,['https://pbs.twimg.com/media/DBFSdgLXgAA8nYf?format=jpg&name=small'],https://twitter.com/MMMnews/status/869754054641156098
2637,Amy Brown,@ByAmyBrown,2017-06-01T13:14:22.000Z,The PD-1 combo report that nearly killed us! Studies have more than tripled in 18 months. Free download: http://ow.ly/WLbm30cdSwh $AZN $MRK,"The PD-1 combo report that nearly killed us! Studies have more than tripled in 18 months. Free download: http://ow.ly/WLbm30cdSwh $AZN $MRK
6
9",,,6,9,[],https://twitter.com/ByAmyBrown/status/870267279845593088
2638,dough,@semodough,2017-06-01T22:10:12.000Z,"CS just outUS Pharmaceuticals
Politics, Pipeline&New Products in Focus; Prefer $MRK $LLY $AGN for Large-Caps $ALKS $ALDR and $AIMT in SMID","CS just outUS Pharmaceuticals
Politics, Pipeline&New Products in Focus; Prefer $MRK $LLY $AGN for Large-Caps $ALKS $ALDR and $AIMT in SMID
1
5
6",,1,5,6,[],https://twitter.com/semodough/status/870402123434950658
2639,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-06-02T15:45:24.000Z,"Commented on 3 Things In Biotech You Should Learn Today: May 26, 2017 https://seekingalpha.com/article/4076852-3-things-biotech-learn-today-may-26-2017?source=tweet‚Ä¶ $ADAP $AKAO $BMY $MRK","Commented on 3 Things In Biotech You Should Learn Today: May 26, 2017 https://seekingalpha.com/article/4076852-3-things-biotech-learn-today-may-26-2017?source=tweet‚Ä¶ $ADAP $AKAO $BMY $MRK
seekingalpha.com
3 Things In Biotech You Should Learn Today: May 26, 2017
Opdivo won't leave May without a big news of its own. Achaogen scores a breakthrough for infections.",,,,,['https://pbs.twimg.com/card_img/1494733840761245699/ntVQbPBr?format=png&name=240x240'],https://twitter.com/dhovekamp42/status/870667675424260097
2640,Sasha Damouni Ellis,@SashaDamouni,2017-06-02T21:16:41.000Z,Patients w/ staining for PD-L1 in at least half of tumor cells using 22C3 assay should get frontline Keytruda -Dr Garon UCLA $MRK #ASCO2017,"Patients w/ staining for PD-L1 in at least half of tumor cells using 22C3 assay should get frontline Keytruda -Dr Garon UCLA $MRK #ASCO2017
1
4",,,1,4,['https://pbs.twimg.com/media/DBWHdN7UQAA_kqi?format=jpg&name=small'],https://twitter.com/SashaDamouni/status/870751044887883776
2641,Ozmosi,@OzmosiHealth,2017-06-02T16:01:51.000Z,$MRK not giving up on the #AZ mission - licenses new asset http://bit.ly/2rgtLzT #pharma,"$MRK not giving up on the #AZ mission - licenses new asset http://bit.ly/2rgtLzT #pharma
1",,,1,,['https://pbs.twimg.com/media/DBU_Zq6VoAAl9hs?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/870671816280485888
2642,avidresearch,@avidresearch,2017-06-02T21:30:54.000Z,$DVAX  very likely to land a partnership with $BMY or $MRK in melanoma,"$DVAX  very likely to land a partnership with $BMY or $MRK in melanoma
3
3
4",,3,3,4,[],https://twitter.com/avidresearch/status/870754623329624064
2643,@AlexandriaTech,@AlexandriaTech,2017-05-31T13:30:02.000Z,Top #sentiment for #SP1500 #stocks at market open: $T $MS $BAC $PFE $MRK (2017/05/31) #stocktrading #predictiveanalytics #bigdata,"Top #sentiment for #SP1500 #stocks at market open: $T $MS $BAC $PFE $MRK (2017/05/31) #stocktrading #predictiveanalytics #bigdata
2",,,2,,[],https://twitter.com/alexandriatech/status/869908833380052992
2644,FiercePharma,@FiercePharma,2017-05-31T12:30:02.000Z,Merck's experimental Ebola vaccine poised for emergency use in Congo outbreak http://fiercepharma.com/infectious-diseases/congo-approves-merck-s-ebola-vaccine-amid-local-outbreak‚Ä¶ $MRK,"Merck's experimental Ebola vaccine poised for emergency use in Congo outbreak http://fiercepharma.com/infectious-diseases/congo-approves-merck-s-ebola-vaccine-amid-local-outbreak‚Ä¶ $MRK
1
7",,,1,7,['https://pbs.twimg.com/media/DBJ16pnXoAAbr67?format=jpg&name=small'],https://twitter.com/FiercePharma/status/869893731691790336
2645,Kara Jill Stancell,@kjilly,2017-05-31T18:12:23.000Z,Stampeding #generics expected to trample $LLY now-off-patent #ADHD med #Strattera #pharma $TEVA $MRK $AZN $GSK $PFE,"Stampeding #generics expected to trample $LLY now-off-patent #ADHD med #Strattera #pharma $TEVA $MRK $AZN $GSK $PFE
fiercepharma.com
Stampeding generics expected to trample Lilly's now-off-patent ADHD med Strattera
Eli Lilly‚Äôs big-earning ADHD med Strattera has succumbed to generics. | Eli Lilly‚Äôs $500 million ADHD med Strattera has succumbed to generics. Four drugmakers won FDA green lights for their copycats,...
1",,,1,,['https://pbs.twimg.com/card_img/1501987721723580427/nKYei2Jv?format=jpg&name=small'],https://twitter.com/kjilly/status/869979888312172544
2646,Dakota Financial,@dakotafinancial,2017-05-31T12:38:04.000Z,"Merck & Co., Inc. $MRK Raised to Buy at Zacks Investment Research http://zpr.io/PkmqK","Merck & Co., Inc. $MRK Raised to Buy at Zacks Investment Research http://zpr.io/PkmqK
1",,,1,,[],https://twitter.com/dakotafinancial/status/869895753417850880
2647,Stockboard Media Inc,@stockboardinc,2017-06-01T12:17:06.000Z,$MRK Merck to Present at the Bernstein‚Äôs 33rd Annual Strategic Decisions Conference... - http://sbml.co/de4b2d9a,"$MRK Merck to Present at the Bernstein‚Äôs 33rd Annual Strategic Decisions Conference... - http://sbml.co/de4b2d9a
1",,,1,,[],https://twitter.com/stockboardinc/status/870252864651898880
2648,Herkyleese,@herkyleese,2017-06-02T01:34:31.000Z,$nwbo if you watch I/O O.S. is a key metric for approval.  $cpxx $cytr $gale $kite $juno $bmy $mrk $gsk $azn $blue https://blogs.fda.gov/fdavoice/index.php/2017/06/in-cancer-treatment-theres-more-than-one-way-to-measure-patient-benefit/‚Ä¶,"$nwbo if you watch I/O O.S. is a key metric for approval.  $cpxx $cytr $gale $kite $juno $bmy $mrk $gsk $azn $blue https://blogs.fda.gov/fdavoice/index.php/2017/06/in-cancer-treatment-theres-more-than-one-way-to-measure-patient-benefit/‚Ä¶
1
3",,,1,3,[],https://twitter.com/herkyleese/status/870453544347987968
2649,WLST.com,@wlstcom,2017-06-02T12:10:27.000Z,Merck's Keytruda beats Bristol-Myers' Yervoy in melanoma #premarket #MRK #Merck&amp;CoInc. $MRK $BMY #wlst,"Merck's Keytruda beats Bristol-Myers' Yervoy in melanoma #premarket #MRK #Merck&amp;CoInc. $MRK $BMY #wlst
seekingalpha.com
Merck's Keytruda beats Bristol-Myers' Yervoy in melanoma (NYSE:MRK)
Three-year data from a Phase 3 clinical trial, KEYNOTE-006, showed the superiority of Merck's (NYSE:MRK) KEYTRUDA (pembrolizumab) over Bristol-Myers Squibb's (NYSE:BMY) YERVOY (ipilimumab)...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/wlstcom/status/870613580923719680
2650,ChartMill,@ChartMill,2017-06-01T19:37:12.000Z,"$MRK breaking out, see some in-depth analysis on http://stockcharts.chartmill.com/u/SkxbmTyRW- #iamkimkline #stockscreens","$MRK breaking out, see some in-depth analysis on http://stockcharts.chartmill.com/u/SkxbmTyRW- #iamkimkline #stockscreens
1",,,1,,[],https://twitter.com/ChartMill/status/870363620647063553
2651,Kirk Spano,@KirkSpano,2017-05-31T20:20:26.000Z,"Replying to 
@KirkSpano
 and 
@MarkYusko","Replying to 
@KirkSpano
 and 
@MarkYusko
That makes me need some medicine: $MRK
1
1",,,1,1,['https://pbs.twimg.com/media/DBLnZS8XYAEgUQe?format=jpg&name=small'],https://twitter.com/KirkSpano/status/870012111698759680
2652,$PENNY KING,@groman100,2017-06-02T16:15:35.000Z,$tgtx $fbio looking good 'confefe' ha ha $zsan $juno $kite $amgn $pfe $mrk $azn $pbyi $oncs,"$tgtx $fbio looking good 'confefe' ha ha $zsan $juno $kite $amgn $pfe $mrk $azn $pbyi $oncs
1",,,,1,[],https://twitter.com/groman100/status/870675270725804032
2653,Vista Partners LLC,@VistaPResearch,2017-06-02T10:19:21.000Z,@sharewik thanks for follow! See Vista Partners #Investing #Healthcare #technology http://vistapglobal.com $JNJ $MRK $PFE,"@sharewik thanks for follow! See Vista Partners #Investing #Healthcare #technology http://vistapglobal.com $JNJ $MRK $PFE
GIF
1",,,,1,[],https://twitter.com/VistaPResearch/status/870585620812386304
2654,Kara Jill Stancell,@kjilly,2017-05-31T01:19:14.000Z,$MRK experimental #Ebola #vaccine poised for emergency use in #Congo outbreak #pharma #Ebolavaccine,"$MRK experimental #Ebola #vaccine poised for emergency use in #Congo outbreak #pharma #Ebolavaccine
fiercepharma.com
Merck's experimental Ebola vaccine poised for emergency use in Congo outbreak
The Democratic Republic of the Congo has given initial approval for the emergency use of Merck‚Äôs as-yet-unlicensed Ebola shot to combat a local outbreak, and medical providers are putting together |...
1",,,1,,[],https://twitter.com/kjilly/status/869724919076016128
2655,ChartMill,@ChartMill,2017-06-01T13:15:12.000Z,Is $MRK breaking out? Take a quick look at http://stockcharts.chartmill.com/u/SJlY9Qca-W! #Nasdaq #GainWithTrapa,"Is $MRK breaking out? Take a quick look at http://stockcharts.chartmill.com/u/SJlY9Qca-W! #Nasdaq #GainWithTrapa
1",,,1,,[],https://twitter.com/ChartMill/status/870267487262306304
2656,dough,@semodough,2017-06-02T12:50:58.000Z,$MRK major inflection point happening https://twitter.com/tgtxdough/status/870227980370534400‚Ä¶,"$MRK major inflection point happening https://twitter.com/tgtxdough/status/870227980370534400‚Ä¶
Open Outcrier
@OpenOutcrier
 ¬∑ 2 Jun 2017
$MRK (+0.2% pre) Merck reports pos+ results for late-stage trial comparing Keytruda against Bristol-Myers' Yervoy

http://ooc.bz/l/12808
1
1
1",,1,1,1,['https://pbs.twimg.com/profile_images/839250027012849666/hNeSdoWq_mini.jpg'],https://twitter.com/semodough/status/870623778140815360
2657,$peedyCalls,@SpeedyCalls,2017-06-01T19:26:04.000Z,"$MRK 65 Calls SELLING Activity expiring on 16th Jun, Vol 3250","$MRK 65 Calls SELLING Activity expiring on 16th Jun, Vol 3250
1",,,1,,[],https://twitter.com/SpeedyCalls/status/870360819552354306
2658,Seeking Alpha,@SeekingAlpha,2017-06-01T20:10:29.000Z,Eli Lilly Edges Toward The Bladder Cancer Queue https://seekingalpha.com/article/4078180-eli-lilly-edges-toward-bladder-cancer-queue?source=feed_f‚Ä¶ $AZN $BMY $RHHBY $RHHBF $MRK $LLY,"Eli Lilly Edges Toward The Bladder Cancer Queue https://seekingalpha.com/article/4078180-eli-lilly-edges-toward-bladder-cancer-queue?source=feed_f‚Ä¶ $AZN $BMY $RHHBY $RHHBF $MRK $LLY
seekingalpha.com
Eli Lilly Edges Toward The Bladder Cancer Queue (NYSE:LLY)
The industry‚Äôs PD-1/L1 assets might be charging towards the market in bladder cancer, but Eli Lilly (NYSE:LLY) confirmed today that other novel mechanisms should not be ruled out.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/870371997645066240
2659,Seeking Alpha,@SeekingAlpha,2017-06-01T20:50:18.000Z,Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust https://seekingalpha.com/article/4078189-immuno-oncology-combinations-surge-sector-seeks-fairy-dust?source=feed_f‚Ä¶ $MRK $BMY,"Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust https://seekingalpha.com/article/4078189-immuno-oncology-combinations-surge-sector-seeks-fairy-dust?source=feed_f‚Ä¶ $MRK $BMY
seekingalpha.com
Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust
When in November 2015 EP Vantage published its first immuno-oncology analysis we identified 215 studies of anti-PD-1/PD-L1 projects combined with other approaches, and called this an...
2",,,2,,[],https://twitter.com/SeekingAlpha/status/870382015924678656
2660,$PENNY KING,@groman100,2017-05-31T18:11:04.000Z,$tgtx $amgn $anly $mdco $clls $juno $kite $pbyi $oncs $zsan $flxn $lptx $pfe $mrk $akba $ino $fb $regn $sny $amrn $roka $fate $evok $fite $f,"$tgtx $amgn $anly $mdco $clls $juno $kite $pbyi $oncs $zsan $flxn $lptx $pfe $mrk $akba $ino $fb $regn $sny $amrn $roka $fate $evok $fite $f
$PENNY KING
@groman100
 ¬∑ 31 May 2017
$fbio @ 50 day MA $3.61 good buying opp..",,,,,['https://pbs.twimg.com/profile_images/2380618648/r6wm3a8kcobystrp2w77_mini.jpeg'],https://twitter.com/groman100/status/869979555276050432
2661,Pharmaceutical News,@pharma_sector,2017-06-02T23:01:30.000Z,#Merck With Nearly Three Years of FollowUp KEYTRUDA√Ç pembrolizumab Data Demonstrated Improve... Read more: http://owler.us/acNWTq $MRK,#Merck With Nearly Three Years of FollowUp KEYTRUDA√Ç pembrolizumab Data Demonstrated Improve... Read more: http://owler.us/acNWTq $MRK,,,,,[],https://twitter.com/pharma_sector/status/870777421275971585
2662,Alessandro viva l‚Äô#Ucraina,@pelias01,2017-06-01T13:06:41.000Z,"Ethereum Blasts Above $20 Billion Market Cap, Over Half Of Bitcoin https://seekingalpha.com/article/4077679-ethereum-blasts-20-billion-market-cap-half-bitcoin?source=tweet‚Ä¶ $COIN $GBTC $GLD $INTC $JPM $MRK $MSFT $STT $TM","Ethereum Blasts Above $20 Billion Market Cap, Over Half Of Bitcoin https://seekingalpha.com/article/4077679-ethereum-blasts-20-billion-market-cap-half-bitcoin?source=tweet‚Ä¶ $COIN $GBTC $GLD $INTC $JPM $MRK $MSFT $STT $TM
seekingalpha.com
Ethereum Blasts Above $20 Billion Market Cap, Over Half Of Bitcoin
Ethereum now has a market cap over $20 billion, while bitcoin's is around $36 billion.",,,,,['https://pbs.twimg.com/card_img/1500305320794542087/sGW-fDp8?format=png&name=240x240'],https://twitter.com/pelias01/status/870265342286864384
2663,Pharmaceutical News,@pharma_sector,2017-06-02T23:05:12.000Z,#Merck reports positive results for late-stage trial comparing its Keytruda against Bristol-... Read more: http://owler.us/acNXIO $MRK,#Merck reports positive results for late-stage trial comparing its Keytruda against Bristol-... Read more: http://owler.us/acNXIO $MRK,,,,,[],https://twitter.com/pharma_sector/status/870778354663686144
2664,This momment,@dpreda,2017-06-01T20:05:28.000Z,"Some r working hard in the medical field 2 make a real change #lungcancer 

$MRK $JNJ $PFE $XLF $XBI $IBB $LABU","Some r working hard in the medical field 2 make a real change #lungcancer 

$MRK $JNJ $PFE $XLF $XBI $IBB $LABU
biopharmadive.com
Merck adding more than 300 new jobs to Irish manufacturing plants
The new positions will be at two sites and include positions in engineering, operations and biochemistry, among others.
1",,,,1,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/dpreda/status/870370733997793280
2665,US Banking News,@AmericanBanking,2017-06-01T08:19:24.000Z,Merck KGaA given ‚Ç¨128.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2rnrwuO $MRK #MRK,Merck KGaA given ‚Ç¨128.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2rnrwuO $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/870193045190430721
2666,Hamzah Ali Khan,@HamzahKingKhan,2017-06-02T13:43:14.000Z,"$MRK now getting accumulated under $65.50, look for key break of $65.55 in the next hour and a half","$MRK now getting accumulated under $65.50, look for key break of $65.55 in the next hour and a half",,,,,[],https://twitter.com/HamzahKingKhan/status/870636928772829184
2667,Limex,@LimexMe,2017-05-31T20:40:52.000Z,3 Top Dividend Stocks in Diabetes Treatment http://bit.ly/310517AZN $AZN $PFE $SNY $GSK $MRK,"3 Top Dividend Stocks in Diabetes Treatment http://bit.ly/310517AZN $AZN $PFE $SNY $GSK $MRK
whotrades.com
3 Top Dividend Stocks in Diabetes Treatment
More than 420 million people across the world have diabetes. At least 29 million of those individuals are Americans, including an estimated 8 million undiagnosed cases. And prevalence of‚Ä¶
1",,,1,,[],https://twitter.com/LimexMe/status/870017254330695680
2668,GREEN STOCK NEWS,@greenstocknews,2017-06-01T20:12:16.000Z,Eli Lilly Edges Toward The Bladder Cancer Queue https://seekingalpha.com/article/4078180-eli-lilly-edges-toward-bladder-cancer-queue?source=feed_f‚Ä¶ $AZN $BMY $RHHBY $RHHBF $MRK $LLY OMG-STOCK SYMBOL DCSA www.docasa‚Ä¶,"Eli Lilly Edges Toward The Bladder Cancer Queue https://seekingalpha.com/article/4078180-eli-lilly-edges-toward-bladder-cancer-queue?source=feed_f‚Ä¶ $AZN $BMY $RHHBY $RHHBF $MRK $LLY OMG-STOCK SYMBOL DCSA www.docasa‚Ä¶
seekingalpha.com
Eli Lilly Edges Toward The Bladder Cancer Queue (NYSE:LLY)
The industry‚Äôs PD-1/L1 assets might be charging towards the market in bladder cancer, but Eli Lilly (NYSE:LLY) confirmed today that other novel mechanisms should not be ruled out.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/greenstocknews/status/870372445513015301
2669,Daily Political,@dailypoliticaln,2017-06-02T09:24:17.000Z,"Howard Capital Management Acquires 930 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1147601","Howard Capital Management Acquires 930 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1147601",,,,,[],https://twitter.com/dailypoliticaln/status/870571762483908609
2670,Stockboard Media Inc,@stockboardinc,2017-06-02T11:36:44.000Z,"$MRK With Nearly Three Years of Follow-Up, KEYTRUDA¬Æ (pembrolizumab) Data Demonstrated Improved Survival... - http://sbml.co/69ecc967","$MRK With Nearly Three Years of Follow-Up, KEYTRUDA¬Æ (pembrolizumab) Data Demonstrated Improved Survival... - http://sbml.co/69ecc967",,,,,[],https://twitter.com/stockboardinc/status/870605096882712576
2671,MarketBeat,@MarketBeatCom,2017-06-01T08:11:51.000Z,Merck KGaA given ‚Ç¨128.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2rnrwuO $MRK #MRK,Merck KGaA given ‚Ç¨128.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2rnrwuO $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/870191146231877632
2672,GREEN STOCK NEWS,@greenstocknews,2017-06-01T20:53:05.000Z,Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust https://seekingalpha.com/article/4078189-immuno-oncology-combinations-surge-sector-seeks-fairy-dust?source=feed_f‚Ä¶ $MRK $BMY check out TICKER SYMBOL $DCSA www.doca‚Ä¶,"Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust https://seekingalpha.com/article/4078189-immuno-oncology-combinations-surge-sector-seeks-fairy-dust?source=feed_f‚Ä¶ $MRK $BMY check out TICKER SYMBOL $DCSA www.doca‚Ä¶
seekingalpha.com
Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust
When in November 2015 EP Vantage published its first immuno-oncology analysis we identified 215 studies of anti-PD-1/PD-L1 projects combined with other approaches, and called this an...",,,,,[],https://twitter.com/greenstocknews/status/870382719666188288
2673,Limex,@LimexMe,2017-05-31T22:22:49.000Z,Gilead Single Tablet Regiment for HIV Good in Phase III http://bit.ly/310517GILD1 $GILD $VVUS $GSK $MRK,"Gilead Single Tablet Regiment for HIV Good in Phase III http://bit.ly/310517GILD1 $GILD $VVUS $GSK $MRK
whotrades.com
Gilead Single Tablet Regiment for HIV Good in Phase III
Gilead Sciences, Inc . GILD announced positive results on four phase III studies evaluating bictegravir in combination with FTC/TAF as a single tablet regimen for HIV infection.‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/870042911752278016
2674,Bursatil Biotech,@BursatilBiotech,2017-06-02T22:00:23.000Z,"Keynote 037/ECHO 202 $INCY $MRK #ASCO17
N= 36 with 1-2 prior Tx
ORR (2 CR-8 PR): 34%
DCR (CR+PR+SD): 62%
N=7 w/ >3 prior Tx
ORR: 14%
DCR:43%","Keynote 037/ECHO 202 $INCY $MRK #ASCO17
N= 36 with 1-2 prior Tx
ORR (2 CR-8 PR): 34%
DCR (CR+PR+SD): 62%
N=7 w/ >3 prior Tx
ORR: 14%
DCR:43%
1",,,,1,[],https://twitter.com/BursatilBiotech/status/870762040398405632
2675,Ticker Report,@TickerReport,2017-06-01T22:13:50.000Z,"American Research & Management Co. Decreases Stake in Merck & Co., Inc. $MRK http://ift.tt/2qGPxzK","American Research & Management Co. Decreases Stake in Merck & Co., Inc. $MRK http://ift.tt/2qGPxzK",,,,,[],https://twitter.com/TickerReport/status/870403039785627648
2676,Hottest Stocks Now,@HottestStockNow,2017-05-31T03:56:40.000Z,"$JNJ, $MRK, $PFE, $NVS, $MMM, $BDX, $GSK, $SNY, $ATRS Report Sees Drug Delivery Tech Market Reaching $1.67T by 2021 http://crweworld.com/newsroom/prnewswire?rkey=20170530enUK201705303399&filter=10284‚Ä¶","$JNJ, $MRK, $PFE, $NVS, $MMM, $BDX, $GSK, $SNY, $ATRS Report Sees Drug Delivery Tech Market Reaching $1.67T by 2021 http://crweworld.com/newsroom/prnewswire?rkey=20170530enUK201705303399&filter=10284‚Ä¶",,,,,[],https://twitter.com/HottestStockNow/status/869764540791009280
2677,Ticker Report,@TickerReport,2017-06-01T22:13:47.000Z,"Mountain Pacific Investment Advisers Inc. ID Has $399,000 Position in Merck & Co., Inc. $MRK http://ift.tt/2rq4B1I","Mountain Pacific Investment Advisers Inc. ID Has $399,000 Position in Merck & Co., Inc. $MRK http://ift.tt/2rq4B1I",,,,,[],https://twitter.com/TickerReport/status/870403024908410882
2678,Surge Traders,@SurgeTraders,2017-05-31T04:13:35.000Z,Watchlist Wednesday! https://surgetraders.com/watchlist/ $POT $WMT $EGN $IVR $CPN $ETSY $GDOT $CIGI $GNBC $MRK $AEIS $SQ $DATA $P $ZAYO $CERN & MORE!!,Watchlist Wednesday! https://surgetraders.com/watchlist/ $POT $WMT $EGN $IVR $CPN $ETSY $GDOT $CIGI $GNBC $MRK $AEIS $SQ $DATA $P $ZAYO $CERN & MORE!!,,,,,[],https://twitter.com/SurgeTraders/status/869768798471159808
2679,StockNews.com,@stocknewsdotcom,2017-06-02T11:39:33.000Z,$MRK Presents updated longer-term overall survival data from the phase 3 study evaluating KEYTRUDAin patients with‚Ä¶ https://stocknews.com/news/mrk-presents-updated-longer-term-overall-survival-data-from-the-phase-3/‚Ä¶,$MRK Presents updated longer-term overall survival data from the phase 3 study evaluating KEYTRUDAin patients with‚Ä¶ https://stocknews.com/news/mrk-presents-updated-longer-term-overall-survival-data-from-the-phase-3/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/870605803098697729
2680,MarketBeat,@MarketBeatCom,2017-06-02T13:38:33.000Z,"Berkshire Asset Management LLC PA Buys 7,222 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pkdcu","Berkshire Asset Management LLC PA Buys 7,222 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pkdcu",,,,,[],https://twitter.com/MarketBeatCom/status/870635751343505409
2681,BioPharm Insight,@BioPharmInsight,2017-05-31T10:55:20.000Z,"@BioPharmInsight
 releases pre #ASCO2017 report; $ROG $AZN $TSRO $PFE $LLY $ABBV $BMY $MRK http://biopharminsight.com/download-your-asco-pre-conference-report‚Ä¶","@BioPharmInsight
 releases pre #ASCO2017 report; $ROG $AZN $TSRO $PFE $LLY $ABBV $BMY $MRK http://biopharminsight.com/download-your-asco-pre-conference-report‚Ä¶
2",,,2,,[],https://twitter.com/BioPharmInsight/status/869869901552521220
2682,Market Realist,@MarketRealist,2017-06-01T05:59:35.000Z,What Drives Eli Lilly's Valuation after Its 1Q17 Earnings? http://marketrealist.com/?p=2120626 $LLY $XLV $MRK $BMY,What Drives Eli Lilly's Valuation after Its 1Q17 Earnings? http://marketrealist.com/?p=2120626 $LLY $XLV $MRK $BMY,,,,,[],https://twitter.com/MarketRealist/status/870157861627867136
2683,Limex,@LimexMe,2017-06-02T21:09:03.000Z,"Dow 30 Stock Roundup: GE Inks Deals Worth $5.58B in Vietnam, Merck Buys Rights to Alzheimer Antibody http://bit.ly/020617GE $GE $MRK $BAC","Dow 30 Stock Roundup: GE Inks Deals Worth $5.58B in Vietnam, Merck Buys Rights to Alzheimer Antibody http://bit.ly/020617GE $GE $MRK $BAC
whotrades.com
Dow 30 Stock Roundup: GE Inks Deals Worth $5.58B in Vietnam, Merck Buys Rights to Alzheimer Antibody
The Dow suffered across the holiday shortened week, buoyed only by encouraging private sector hiring. After remaining closed on Monday for a holiday, the index slipped on Tuesday, dragged‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/870749125335298053
2684,US Banking News,@AmericanBanking,2017-05-31T11:20:48.000Z,Weekly Research Analysts‚Äô Ratings Changes for Merck & Co. $MRK http://ift.tt/2rnsYPG,Weekly Research Analysts‚Äô Ratings Changes for Merck & Co. $MRK http://ift.tt/2rnsYPG,,,,,[],https://twitter.com/AmericanBanking/status/869876309169774593
2685,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-06-01T20:54:56.000Z,Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust $MRK $BMY http://dlvr.it/PJ2tSm #Investing #Stocks,Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust $MRK $BMY http://dlvr.it/PJ2tSm #Investing #Stocks,,,,,['https://pbs.twimg.com/media/DBQ45LCVoAAgnU3?format=jpg&name=small'],https://twitter.com/AlertTrade/status/870383184994684928
2686,Pharmaceutical News,@pharma_sector,2017-06-02T23:02:44.000Z,"#Merck & Co. Release: With Nearly Three Years Of Follow-Up, KEYTRUDA (Pembrolizumab) Data De... Read more: http://owler.us/acNWTr $MRK","#Merck & Co. Release: With Nearly Three Years Of Follow-Up, KEYTRUDA (Pembrolizumab) Data De... Read more: http://owler.us/acNWTr $MRK",,,,,[],https://twitter.com/pharma_sector/status/870777732614860801
2687,Watchlist News,@WatchlistN,2017-06-02T09:27:08.000Z,"Berkshire Asset Management LLC PA Buys 7,222 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pkiwx","Berkshire Asset Management LLC PA Buys 7,222 Shares of Merck & Co., Inc. $MRK http://zpr.io/Pkiwx",,,,,[],https://twitter.com/WatchlistN/status/870572478690709504
2688,MarketBeat,@MarketBeatCom,2017-06-01T22:12:54.000Z,"Americafirst Capital Management LLC Has $356,000 Position in Merck & Co., Inc. $MRK http://zpr.io/Pk2dB","Americafirst Capital Management LLC Has $356,000 Position in Merck & Co., Inc. $MRK http://zpr.io/Pk2dB",,,,,[],https://twitter.com/MarketBeatCom/status/870402805189816325
2689,BioPharma Dive,@BioPharmaDive,2017-06-01T20:17:00.000Z,$MRK adding more than 300 new jobs to Irish manufacturing plants,"$MRK adding more than 300 new jobs to Irish manufacturing plants
biopharmadive.com
Merck adding more than 300 new jobs to Irish manufacturing plants
The new positions will be at two sites and include positions in engineering, operations and biochemistry, among others.",,,,,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/870373638398136320
2690,,@BioGraphica1,2017-06-02T14:04:04.000Z,"Replying to 
@semodough","Replying to 
@semodough
$MRK chart looks hopeful but $MRK/$SPY tells a different story - still waiting for a breakout",üëæ,,,,"['https://pbs.twimg.com/media/DBUkU_LW0AAJ--U?format=jpg&name=small', 'https://pbs.twimg.com/media/DBUkWoCXgAAklSI?format=jpg&name=small']",https://twitter.com/BioGraphica1/status/870642173875814405
2691,G Hawkins,@FilmProfessor9,2017-06-02T13:54:29.000Z,"Replying to 
@HamzahKingKhan","Replying to 
@HamzahKingKhan
The Best MDs have echoed this. Stock should've been up way more on Keytruda & survival rates. $MRK will be adopted go to treatment #Patients
1
1",,1,1,,[],https://twitter.com/FilmProfessor9/status/870639762645889024
2692,Terry Smith,@TerryMSmith,2017-05-31T17:31:59.000Z,"Replying to 
@JohnCendpts","Replying to 
@JohnCendpts
$AGN has the oral ones from $MRK in phase 3
1
1",,,1,1,[],https://twitter.com/TerryMSmith/status/869969720258183168
2693,Pearl Freier,@PearlF,2017-06-01T10:35:59.000Z,"Merck/MSD announced creating 330 new jobs & investing ‚Ç¨280M at 2 manufacturing sites in Ireland http://bit.ly/2smCHmL ht 
@IDAIRELAND
 $MRK","Merck/MSD announced creating 330 new jobs & investing ‚Ç¨280M at 2 manufacturing sites in Ireland http://bit.ly/2smCHmL ht 
@IDAIRELAND
 $MRK",,,,,[],https://twitter.com/PearlF/status/870227418761510912
2694,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-06-01T13:28:12.000Z,"Replying to 
@JacobPlieth
 and 
@EPVantage","Replying to 
@JacobPlieth
 and 
@EPVantage
And in addition should know about this long awaited new Keytruda trial http://ir.adaptimmune.com/phoenix.zhtml?c=253991&p=irol-newsArticle&ID=2276577‚Ä¶ $MRK $ADAP
1",,,,1,[],https://twitter.com/dhovekamp42/status/870270759754756096
2695,WLST.com,@wlstcom,2017-06-01T20:54:49.000Z,Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust #Investing #MRK #BMY $MRK https://seekingalpha.com/article/4078189-immuno-oncology-combinations-surge-sector-seeks-fairy-dust‚Ä¶,Immuno-Oncology Combinations Surge As Sector Seeks The Fairy Dust #Investing #MRK #BMY $MRK https://seekingalpha.com/article/4078189-immuno-oncology-combinations-surge-sector-seeks-fairy-dust‚Ä¶,,,,,['https://pbs.twimg.com/media/DBQ43XFWsAMObm5?format=jpg&name=small'],https://twitter.com/wlstcom/status/870383154342842370
2696,Dakota Financial,@dakotafinancial,2017-06-01T22:12:55.000Z,"Americafirst Capital Management LLC Has $356,000 Position in Merck & Co., Inc. $MRK http://zpr.io/Pk2dB","Americafirst Capital Management LLC Has $356,000 Position in Merck & Co., Inc. $MRK http://zpr.io/Pk2dB",,,,,[],https://twitter.com/dakotafinancial/status/870402807928684544
2697,stockassassin,@stockassassin74,2017-06-02T21:48:18.000Z,"Replying to 
@avidresearch","Replying to 
@avidresearch
$dvax or just sell to $mrk
1",,,,1,[],https://twitter.com/stockassassin74/status/870759001813692416
2698,Bursatil Biotech,@BursatilBiotech,2017-06-05T13:50:41.000Z,"Ok, just a review on some of today's new updates $JUNO $TGTX $INCY $MRK $GLYC $BLUE #ASCO17","Ok, just a review on some of today's new updates $JUNO $TGTX $INCY $MRK $GLYC $BLUE #ASCO17
9
19",,,9,19,['https://pbs.twimg.com/media/DBj94KtXsAEs3Yl?format=jpg&name=900x900'],https://twitter.com/BursatilBiotech/status/871725970499260416
2699,Dan Rosenblum,@sharkbiotech,2017-06-05T15:38:03.000Z,"#asco17 report card 
$LOXO +46%
$JUNO -9%
$BMY -4%
$RHHBY -5%
$GLYC -15%
$BLUE  +4%
$IMDZ -9%
$AGIO -3%
$MRK -1%
$PBYI +9%
$KITE -3%","#asco17 report card 
$LOXO +46%
$JUNO -9%
$BMY -4%
$RHHBY -5%
$GLYC -15%
$BLUE  +4%
$IMDZ -9%
$AGIO -3%
$MRK -1%
$PBYI +9%
$KITE -3%
4
27
31",,4,27,31,[],https://twitter.com/sharkbiotech/status/871752989505138689
2700,Adam Feuerstein,@adamfeuerstein,2017-06-04T22:22:54.000Z,Missing Patients Cloud View of $INCY IDO Drug Lung Cancer Study  ‚Äî> https://thestreet.com/story/14161896/1/missing-patients-cloud-view-of-incyte-s-ido-drug-lung-cancer-study.html‚Ä¶ #ASCO17 $MRK,"Missing Patients Cloud View of $INCY IDO Drug Lung Cancer Study  ‚Äî> https://thestreet.com/story/14161896/1/missing-patients-cloud-view-of-incyte-s-ido-drug-lung-cancer-study.html‚Ä¶ #ASCO17 $MRK
thestreet.com
Missing Patients Cloud View of Incyte's IDO Drug Lung Cancer Study
Incyte's actions are another reminder that biotech companies carefully groom and manage the clinical data they want investors to see, even at important, open medical meetings like ASCO.
10
21
35",,10,21,35,['https://pbs.twimg.com/card_img/1500898426552082433/GQMp5Q-i?format=jpg&name=small'],https://twitter.com/adamfeuerstein/status/871492484194594816
2701,Adam Feuerstein,@adamfeuerstein,2017-06-03T13:06:43.000Z,$INCY 'IDO' Combination Lung Cancer Results Improve Slightly at #ASCO17 $MRK ‚Äî>,"$INCY 'IDO' Combination Lung Cancer Results Improve Slightly at #ASCO17 $MRK ‚Äî>
thestreet.com
Incyte 'IDO' Combination Lung Cancer Results Improve Slightly at ASCO17
Incyte and Merck are combining two cancer immunotherapy drugs to treat patients with non-small cell lung cancer.
1
14
25",,1,14,25,['https://pbs.twimg.com/card_img/1500898426409553922/HESy5vQb?format=jpg&name=small'],https://twitter.com/adamfeuerstein/status/870990127178412037
2702,Adam Feuerstein,@adamfeuerstein,2017-06-03T13:54:26.000Z,$INCY $MRK epa-Keytruda lung cancer poster snaps. #ASCO17,"$INCY $MRK epa-Keytruda lung cancer poster snaps. #ASCO17
1
16
13",,1,16,13,"['https://pbs.twimg.com/media/DBZrwZcWAAIvb99?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DBZrxc5XoAEzOVc?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DBZrytzXcAAJnLs?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DBZrzunXkAAvzua?format=jpg&name=360x360']",https://twitter.com/adamfeuerstein/status/871002137542656001
2703,Tom Silver,@TomSilver39,2017-06-05T16:11:59.000Z,$MRK #ASCO17 Updated Data from ECHO-202 Trial of Incyte‚Äôs Epacadostat in Combination with Merck‚Äôs KEYTRUDA¬Æ (Pembrolizumab),"$MRK #ASCO17 Updated Data from ECHO-202 Trial of Incyte‚Äôs Epacadostat in Combination with Merck‚Äôs KEYTRUDA¬Æ (Pembrolizumab)
1
4",,,1,4,['https://pbs.twimg.com/media/DBkeeuZUQAAWUXG?format=jpg&name=900x900'],https://twitter.com/TomSilver39/status/871761528252489729
2704,TomsTruths,@TomsTruths,2017-06-03T16:33:27.000Z,Immune-Oncology Drug Trials Are Getting Crowded - Bloomberg $INCY $MRK $BMY #investing #trading #biotech #TomsTruths,"Immune-Oncology Drug Trials Are Getting Crowded - Bloomberg $INCY $MRK $BMY #investing #trading #biotech #TomsTruths
bloomberg.com
A Hot Cancer-Drug Race Keeps Getting More Crowded
Medicines that turn immune systems against tumors hold promise for patients, risks for investors.
1",,,1,,[],https://twitter.com/TomsTruths/status/871042155338452992
2705,Tom Silver,@TomSilver39,2017-06-03T16:38:38.000Z,#ASCO17 Combination of $INCY Epacadostat plus $MRK KEYTRUDA¬Æ (pembrolizumab) Demonstrates Activity in Clinical Trial Patients with (NSCLC),"#ASCO17 Combination of $INCY Epacadostat plus $MRK KEYTRUDA¬Æ (pembrolizumab) Demonstrates Activity in Clinical Trial Patients with (NSCLC)
2
5",,,2,5,['https://pbs.twimg.com/media/DBaRZubVYAQO8KZ?format=jpg&name=small'],https://twitter.com/TomSilver39/status/871043459683033088
2706,dough,@semodough,2017-06-05T11:30:28.000Z,$LOXO up 32 % $TGTX 15 % $dvax 24 % $INCY $MRK $TSRO no volume,"$LOXO up 32 % $TGTX 15 % $dvax 24 % $INCY $MRK $TSRO no volume
dough
@semodough
 ¬∑ 5 Jun 2017
#ASCO2017 -what's everyone prediction on trading Monday ? Imho $LOXO $MRK $TSRO $AZN $TGTX    $LPTX $DVAX nice implications longer term
4
6",,,4,6,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/871690683685490688
2707,Sentiment Stocks,@sentimentstock,2017-06-05T13:28:56.000Z,"$NWBO $BMY $MRK $AZN $JUNO $KITE #ASCO Dr. Marnix Bosch will update us today on DCVax-L, Info Arm, and Direct.
https://nwbio.com/dr-marnix-bosch-present-updates-dcvax-clinical-programs-today/‚Ä¶","$NWBO $BMY $MRK $AZN $JUNO $KITE #ASCO Dr. Marnix Bosch will update us today on DCVax-L, Info Arm, and Direct.
https://nwbio.com/dr-marnix-bosch-present-updates-dcvax-clinical-programs-today/‚Ä¶
GIF
3
8",,,3,8,[],https://twitter.com/sentimentstock/status/871720497117114369
2708,dough,@semodough,2017-06-05T13:54:11.000Z,After dust settles and profit takers leave. $CELG $BLUE $LOXO $TGTX $MRK $INCY $TSRO $PBYI imho should all trend up today.     Thoughts,"After dust settles and profit takers leave. $CELG $BLUE $LOXO $TGTX $MRK $INCY $TSRO $PBYI imho should all trend up today.     Thoughts
3
4
11",,3,4,11,[],https://twitter.com/semodough/status/871726848157376512
2709,Jacob Plieth,@JacobPlieth,2017-06-04T14:14:44.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
Keynote-059 responses by PD-L1 expression, and safety $MRK $BMY #ASCO17
1
1
6",,1,1,6,"['https://pbs.twimg.com/media/DBe6CpxXYAEIVxs?format=jpg&name=small', 'https://pbs.twimg.com/media/DBe6Cp8WAAISb9B?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DBe6CrlXoAAzo3B?format=jpg&name=360x360']",https://twitter.com/JacobPlieth/status/871369633890131970
2710,BiotechBioPharma,@Regencells,2017-06-05T21:16:01.000Z,FDA approves Keytruda in 2 bladder cancer indications http://buff.ly/2rIIqpH $MRK #bladder #cancer,"FDA approves Keytruda in 2 bladder cancer indications http://buff.ly/2rIIqpH $MRK #bladder #cancer
2",,,2,,['https://pbs.twimg.com/media/DBlkE1sXYAEtexB?format=jpg&name=small'],https://twitter.com/Regencells/status/871838039353565184
2711,Brandon,@bran_chem,2017-06-05T13:28:13.000Z,The future is here #asco17 $mrk,"The future is here #asco17 $mrk
Phillip Scheinberg
@scheinbp
 ¬∑ 4 Jun 2017
Pembro+CART cells. Stepping on the gas and off the brakes at the same time powerful combination, if no excessive toxicity #ASCO17 @MOCBrasil
1
2",,1,2,,"['https://pbs.twimg.com/profile_images/1033750760788582400/V93X4GHH_mini.jpg', 'https://pbs.twimg.com/media/DBfO59WW0AA77Jf?format=jpg&name=small']",https://twitter.com/bran_chem/status/871720316132888576
2712,Beth Williams Liou,@BWilliLiou,2017-06-05T19:00:47.000Z,"Merck stands to win even if its cancer-drug partner loses https://bloomberg.com/gadfly/articles/2017-06-05/eli-lilly-alimta-patent-case-how-merck-wins-if-it-loses‚Ä¶ by 
@MaxNisen
 via 
@Gadfly
 $MRK $LLY","Merck stands to win even if its cancer-drug partner loses https://bloomberg.com/gadfly/articles/2017-06-05/eli-lilly-alimta-patent-case-how-merck-wins-if-it-loses‚Ä¶ by 
@MaxNisen
 via 
@Gadfly
 $MRK $LLY
GIF
1
2",,,1,2,['https://pbs.twimg.com/tweet_video_thumb/DBlFCgwXsAAkot3.jpg'],https://twitter.com/BWilliLiou/status/871804007068692485
2713,jodi gralnick,@jodigralnick,2017-06-05T10:29:44.000Z,"One hour away: 
@cnbc
 @megtirrell
 #ASCO17 coverage kicks off 730amET 
@SquawkCNBC
. Hear exclusively fr #RHHBY. Later: $LOXO, $MRK, $INCY, more","One hour away: 
@cnbc
 @megtirrell
 #ASCO17 coverage kicks off 730amET 
@SquawkCNBC
. Hear exclusively fr #RHHBY. Later: $LOXO, $MRK, $INCY, more
1
3
4",,1,3,4,[],https://twitter.com/jodigralnick/status/871675396114313217
2714,avidresearch,@avidresearch,2017-06-03T20:52:05.000Z,$DVAX study is legitimate and is being done in collaboration with $MRK as part of their Keytruda Combo KEYSTONE studies,"$DVAX study is legitimate and is being done in collaboration with $MRK as part of their Keytruda Combo KEYSTONE studies
1
2",,,1,2,['https://pbs.twimg.com/media/DBbLafnU0AAkE8m?format=jpg&name=900x900'],https://twitter.com/avidresearch/status/871107242388598788
2715,avidresearch,@avidresearch,2017-06-03T20:39:57.000Z,For skeptics the $DVAX study is. kEYNOTE study. See $MRK PR few weeks ago http://investors.merck.com/news/press-release-details/2017/Data-for-KEYTRUDA-pembrolizumab-Across-16-Types-of-Cancer-from-Mercks-Industry-Leading-Immuno-Oncology-Program-to-Be-Presented-at-the-2017-ASCO-Annual-Meeting/default.aspx‚Ä¶,"For skeptics the $DVAX study is. kEYNOTE study. See $MRK PR few weeks ago http://investors.merck.com/news/press-release-details/2017/Data-for-KEYTRUDA-pembrolizumab-Across-16-Types-of-Cancer-from-Mercks-Industry-Leading-Immuno-Oncology-Program-to-Be-Presented-at-the-2017-ASCO-Annual-Meeting/default.aspx‚Ä¶
1
1
2",,1,1,2,['https://pbs.twimg.com/media/DBbIotSVoAEUj5x?format=jpg&name=900x900'],https://twitter.com/avidresearch/status/871104187916062720
2716,Jacob Plieth,@JacobPlieth,2017-06-04T19:50:04.000Z,"Replying to 
@JacobPlieth","Replying to 
@JacobPlieth
$MRK makes an audacious bid for gastric cancer dominance. 
@RobinDavison2
 's take, via 
@EPVantage
 http://epvantage.com/Universal/View.aspx?type=Story&id=711999&isEPVantage=yes‚Ä¶ $BMY $PFE #ASCO17
1
11
4",,1,11,4,[],https://twitter.com/JacobPlieth/status/871454022728904704
2717,FierceBiotech,@FierceBiotech,2017-06-05T11:28:01.000Z,#ASCO2017 data show 'deepening response' to Incyte's epacadostat/Keytruda combo $INCY $MRK,"#ASCO2017 data show 'deepening response' to Incyte's epacadostat/Keytruda combo $INCY $MRK
fiercebiotech.com
ASCO data show 'deepening response' to Incyte's epacadostat/Keytruda combo
Incyte got a boost last month when the ASCO abstract from its closely watched ECHO-202 tria | Analysts say the data back up the potential of using the two immuno-oncology drugs in combination, with...
1
4
1",,1,4,1,['https://pbs.twimg.com/card_img/1500474019610570753/3I1Fz9lO?format=jpg&name=small'],https://twitter.com/FierceBiotech/status/871690067286401024
2718,ChartMill,@ChartMill,2017-06-05T02:22:09.000Z,$MRK breaking out! See some analysis http://stockcharts.chartmill.com/u/rJgTFlHzMZ #NationalDonutDay #iosdev,"$MRK breaking out! See some analysis http://stockcharts.chartmill.com/u/rJgTFlHzMZ #NationalDonutDay #iosdev
1",,,,1,[],https://twitter.com/ChartMill/status/871552695315951616
2719,Pharmaceutical News,@pharma_sector,2017-06-05T21:10:01.000Z,New Data From Phase II I-SPY 2 TRIAL Shows Improved Outcomes With Combination Of #Merck & Co... Read more: http://owler.us/acOv3H $MRK,New Data From Phase II I-SPY 2 TRIAL Shows Improved Outcomes With Combination Of #Merck & Co... Read more: http://owler.us/acOv3H $MRK,,,,,[],https://twitter.com/pharma_sector/status/871836530507079680
2720,BioPharmaDevice,@OneMedWorld,2017-06-05T21:06:01.000Z,FDA approves Keytruda in 2 bladder cancer indications http://buff.ly/2rIBybR $MRK #bladder #cancer,FDA approves Keytruda in 2 bladder cancer indications http://buff.ly/2rIBybR $MRK #bladder #cancer,,,,,['https://pbs.twimg.com/media/DBlhyitXcAM4N3_?format=jpg&name=small'],https://twitter.com/OneMedWorld/status/871835526092947456
2721,Breaking News,@MarketCurrents,2017-06-03T20:20:55.000Z,Combination of Incyte's epacadostat plus Merck's Ketyruda demonstrates activity in trial of... https://seekingalpha.com/news/3271451-combination-incytes-epacadostat-plus-mercks-ketyruda-demonstrates-activity-trial-patients?source=feed_f‚Ä¶ $INCY $MRK $TPS $INCY,"Combination of Incyte's epacadostat plus Merck's Ketyruda demonstrates activity in trial of... https://seekingalpha.com/news/3271451-combination-incytes-epacadostat-plus-mercks-ketyruda-demonstrates-activity-trial-patients?source=feed_f‚Ä¶ $INCY $MRK $TPS $INCY
seekingalpha.com
Combination of Incyte's epacadostat plus Merck's Ketyruda demonstrates activity in trial of...
Incyte (NASDAQ:INCY) and Merck (NYSE:MRK) announce updated data from the advanced non-small cell lung cancer patient cohort of the ongoing Phase 1/2 ECHO-202 trial evaluating epacadostat,...",,,,,['https://pbs.twimg.com/card_img/1497724725002448899/2TZ3O23_?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/871099398217900032
2722,StockNews.com,@stocknewsdotcom,2017-06-05T11:50:29.000Z,$MRK Merck and QuantumLeap Healthcare Collaborative announce results from the Phase 2 I-SPY 2 TRIAL investigating ‚Ä¶ https://stocknews.com/news/mrk-merck-and-quantumleap-healthcare-collaborative-announce-results-from-the-phase/‚Ä¶,"$MRK Merck and QuantumLeap Healthcare Collaborative announce results from the Phase 2 I-SPY 2 TRIAL investigating ‚Ä¶ https://stocknews.com/news/mrk-merck-and-quantumleap-healthcare-collaborative-announce-results-from-the-phase/‚Ä¶
1",,,,1,[],https://twitter.com/stocknewsdotcom/status/871695719954034688
2723,Limex,@LimexMe,2017-06-05T16:39:32.000Z,"Why Dynavax Technologies Corporation Stock Soared Today
What happened http://bit.ly/050617DVAX $DVAX $MRK","Why Dynavax Technologies Corporation Stock Soared Today
What happened http://bit.ly/050617DVAX $DVAX $MRK
whotrades.com
Why Dynavax Technologies Corporation Stock Soared Today
What happened Shares of the clinical-stage biotech Dynavax Technologies Corporation (NASDAQ: DVAX)  bolted higher this morning on elevated volume as a result of the company's 2017‚Ä¶
1",,,,1,[],https://twitter.com/LimexMe/status/871768460723933184
2724,GuruFocus,@gurufocus,2017-06-05T21:55:55.000Z,US Market Indexes Lower to Start the Week https://gurufocus.com/news/529001 $AAPL $UTX $CAT $CSCO $BA $MCD $MRK $PFE,US Market Indexes Lower to Start the Week https://gurufocus.com/news/529001 $AAPL $UTX $CAT $CSCO $BA $MCD $MRK $PFE,,,,,['https://pbs.twimg.com/media/DBltNFPVoAAQMS5?format=jpg&name=small'],https://twitter.com/gurufocus/status/871848079703638026
2725,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-06-03T17:56:40.000Z,JPM #ASCO17 Initial PD-1 Combo Takeaways $BMY $AZN $MRK We are attending ASCO this weekend and wanted to (cont) http://tl.gd/n_1spu239,"JPM #ASCO17 Initial PD-1 Combo Takeaways $BMY $AZN $MRK We are attending ASCO this weekend and wanted to (cont) http://tl.gd/n_1spu239
3
1",üÖ± üÖæ,,3,1,[],https://twitter.com/_B_I_O_T_E_C_H_/status/871063095321534465
2726,InvestorPlace,@InvestorPlace,2017-06-05T16:15:28.000Z,Dynavax Trial Success Sparks a Double-Digit Jump $DVAX $MRK -,"Dynavax Trial Success Sparks a Double-Digit Jump $DVAX $MRK -
investorplace.com
Dynavax Technologies Corporation (DVAX) Stock Earns a Double-Digit Lift
Dynavax's SD-101 just got through a Phase 1b/2 clinical trial with a trio of positive points, sending DVAX stock up by double digits Monday.
1",,,,1,[],https://twitter.com/InvestorPlace/status/871762404237074432
2727,ChartMill,@ChartMill,2017-06-05T18:29:09.000Z,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/HJebEmQmM- #follow #MondayMotivation,What's happening with $MRK? Might be worth checking out at http://stockcharts.chartmill.com/u/HJebEmQmM- #follow #MondayMotivation,,,,,[],https://twitter.com/ChartMill/status/871796046682353666
2728,Lisa LaMotta,@lisalamotta,2017-06-05T12:49:09.000Z,"A lot coming out of #ASCO17 this weekend. Check out 
@BioPharmaDive
 for coverage #cancer #Immunooncology $MRK $INCY $RHHBY $AZN","A lot coming out of #ASCO17 this weekend. Check out 
@BioPharmaDive
 for coverage #cancer #Immunooncology $MRK $INCY $RHHBY $AZN
1
3",,,1,3,[],https://twitter.com/lisalamotta/status/871710484411670528
2729,Matthias Piesche,@PiescheLab,2017-06-05T21:01:12.000Z,F-star & $MRK Agree Up to ‚Ç¨1B Deal to Develop Five #Bispecific Anti-#cancer Antibodies http://genengnews.com/gen-news-highlights/f-star-merck-agree-up-to-1b-deal-to-develop-five-bispecific-anticancer-antibodies/81254448‚Ä¶ #immunotherapy,"F-star & $MRK Agree Up to ‚Ç¨1B Deal to Develop Five #Bispecific Anti-#cancer Antibodies http://genengnews.com/gen-news-highlights/f-star-merck-agree-up-to-1b-deal-to-develop-five-bispecific-anticancer-antibodies/81254448‚Ä¶ #immunotherapy
genengnews.com
F-star, Merck Agree Up to ‚Ç¨1B Deal to Develop Five Bispecific Anticancer Antibodies
Deal includes F-star's bispecific antibody targeting LAG-3 and PD-L1; Merck will pay ‚Ç¨115 upfront plus R&D funding and milestones, and has option to acquire exclusive development and commercializat...",,,,,[],https://twitter.com/PiescheLab/status/871834310394957824
2730,Jacob Bell,@realJacobBell,2017-06-05T15:42:01.000Z,$MRK touts Keytruda bladder benefit post Tecentriq failure http://bit.ly/2rWwFwJ #ASCO17 #ASCO2017,"$MRK touts Keytruda bladder benefit post Tecentriq failure http://bit.ly/2rWwFwJ #ASCO17 #ASCO2017
1",,,,1,[],https://twitter.com/realJacobBell/status/871753985543225344
2731,Pharmaceutical News,@pharma_sector,2017-06-05T21:11:15.000Z,Updated Data from ECHO202 Trial of Incytes Epacadostat in Combination with #Mercks KEYTRUDA√Ç... Read more: http://owler.us/acOv3F $MRK,Updated Data from ECHO202 Trial of Incytes Epacadostat in Combination with #Mercks KEYTRUDA√Ç... Read more: http://owler.us/acOv3F $MRK,,,,,[],https://twitter.com/pharma_sector/status/871836841384697856
2732,GREEN STOCK NEWS,@greenstocknews,2017-06-05T12:53:20.000Z,Biotech Forum Daily Digest: ASCO Boosts Oncology Concerns. Spotlight On Trevena https://seekingalpha.com/article/4078705-biotech-forum-daily-digest-asco-boosts-oncology-concerns-spotlight-trevena?source=feed_f‚Ä¶ $DVAX $FOLD $LOXO $MRK $SUPN $TRVN‚Ä¶,Biotech Forum Daily Digest: ASCO Boosts Oncology Concerns. Spotlight On Trevena https://seekingalpha.com/article/4078705-biotech-forum-daily-digest-asco-boosts-oncology-concerns-spotlight-trevena?source=feed_f‚Ä¶ $DVAX $FOLD $LOXO $MRK $SUPN $TRVN‚Ä¶,,,,,[],https://twitter.com/greenstocknews/status/871711538217930752
2733,Stockboard Media Inc,@stockboardinc,2017-06-05T11:15:34.000Z,$MRK New Data From Phase 2 I-SPY 2 TRIAL Shows Improved Outcomes with Combination of Merck‚Äôs KEYTRUDA¬Æ... - http://sbml.co/471d0f93,$MRK New Data From Phase 2 I-SPY 2 TRIAL Shows Improved Outcomes with Combination of Merck‚Äôs KEYTRUDA¬Æ... - http://sbml.co/471d0f93,,,,,[],https://twitter.com/stockboardinc/status/871686931062640640
2734,Stockboard Media Inc,@stockboardinc,2017-06-05T11:37:56.000Z,$MRK Updated Data from KEYNOTE-024 Show Continued Overall Survival Benefit of Merck‚Äôs KEYTRUDA¬Æ (pembr... - http://sbml.co/834a9988,$MRK Updated Data from KEYNOTE-024 Show Continued Overall Survival Benefit of Merck‚Äôs KEYTRUDA¬Æ (pembr... - http://sbml.co/834a9988,,,,,[],https://twitter.com/stockboardinc/status/871692559130689536
2735,Stockboard Media Inc,@stockboardinc,2017-06-04T14:05:34.000Z,$MRK New Monotherapy Data for Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) in Heavily Pre-Treated Patients with A... - http://sbml.co/e2949f8f,"$MRK New Monotherapy Data for Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) in Heavily Pre-Treated Patients with A... - http://sbml.co/e2949f8f
1",,,1,,[],https://twitter.com/stockboardinc/status/871367326674952192
2736,StockNews.com,@stocknewsdotcom,2017-06-05T12:14:04.000Z,$MRK Presents updated overall survival findings from KEYNOTE-024 in the first-line treatment of patients with adva‚Ä¶ https://stocknews.com/news/mrk-presents-updated-overall-survival-findings-from-keynote-024-in-the-first-line/‚Ä¶,$MRK Presents updated overall survival findings from KEYNOTE-024 in the first-line treatment of patients with adva‚Ä¶ https://stocknews.com/news/mrk-presents-updated-overall-survival-findings-from-keynote-024-in-the-first-line/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/871701656265793538
2737,Watchlist News,@WatchlistN,2017-06-05T09:39:30.000Z,"Reilly Financial Advisors LLC Boosts Position in Merck & Co., Inc. $MRK http://zpr.io/PLpMs","Reilly Financial Advisors LLC Boosts Position in Merck & Co., Inc. $MRK http://zpr.io/PLpMs",,,,,[],https://twitter.com/WatchlistN/status/871662756767944704
2738,Hottest Stocks Now,@HottestStockNow,2017-06-04T17:30:44.000Z,"$GILD, $GSK, $JNJ, $MRK - Report Says Human Immunodeficiency Virus (HIV) Market Expected to Grow http://crweworld.com/newsroom/prnewswire?rkey=20170604MN07166&filter=10284‚Ä¶","$GILD, $GSK, $JNJ, $MRK - Report Says Human Immunodeficiency Virus (HIV) Market Expected to Grow http://crweworld.com/newsroom/prnewswire?rkey=20170604MN07166&filter=10284‚Ä¶",,,,,[],https://twitter.com/HottestStockNow/status/871418960104701952
2739,Hottest Stocks Now,@HottestStockNow,2017-06-03T22:53:27.000Z,Encouraging Interim Trial Data of Combo Lenvatinib + $MRK 's Pembrolizumab in Metastatic Endometrial Cancer Patients http://crweworld.com/newsroom/prnewswire?rkey=20170603NY07827&filter=10284‚Ä¶,Encouraging Interim Trial Data of Combo Lenvatinib + $MRK 's Pembrolizumab in Metastatic Endometrial Cancer Patients http://crweworld.com/newsroom/prnewswire?rkey=20170603NY07827&filter=10284‚Ä¶,,,,,[],https://twitter.com/HottestStockNow/status/871137783594631168
2740,TW Research Group,@DanCarlson33,2017-06-05T16:43:50.000Z,biOasis to present on Lysosomal Storage Disorders next week. Transcend is a great solution here. $MRK $PFE $BMY,"biOasis to present on Lysosomal Storage Disorders next week. Transcend is a great solution here. $MRK $PFE $BMY
twresearchgroup.com
biOasis to Present at the 16th International Postgraduate Course on Lysosomal Storage Disorders
Tailwinds' Take: Lysosomal Storage Disorders is an area in which Transcend should be highly effective. Dr. Scarpa is also presenting at this course, after which I wouldn't be surprised to see...",,,,,[],https://twitter.com/DanCarlson33/status/871769544418840577
2741,Hottest Stocks Now,@HottestStockNow,2017-06-03T22:55:28.000Z,$MRK 's Immunotherapy Drug Keytruda (Pembrolizumab) Effective For Metastatic Triple Negative Breast Cancer  http://crweworld.com/newsroom/prnewswire?rkey=20170603DC05102&filter=10284‚Ä¶,$MRK 's Immunotherapy Drug Keytruda (Pembrolizumab) Effective For Metastatic Triple Negative Breast Cancer  http://crweworld.com/newsroom/prnewswire?rkey=20170603DC05102&filter=10284‚Ä¶,,,,,[],https://twitter.com/HottestStockNow/status/871138291256442882
2742,Bursatil Biotech,@BursatilBiotech,2017-06-04T14:54:55.000Z,"For those attending #ASCO17, anything on why pembro ,despite of remarkable ORR, had those AEs on several Keynote trials ? $MRK","For those attending #ASCO17, anything on why pembro ,despite of remarkable ORR, had those AEs on several Keynote trials ? $MRK",,,,,[],https://twitter.com/BursatilBiotech/status/871379746780741635
2743,StockNews.com,@stocknewsdotcom,2017-06-05T10:42:51.000Z,$MRK Presents new data from KEYTRUDA in heavily pre-treated patients with advanced gastric cancer; showed ORR of 1‚Ä¶ https://stocknews.com/news/mrk-presents-new-data-from-keytruda-in-heavily-pre-treated-patients-with/‚Ä¶,$MRK Presents new data from KEYTRUDA in heavily pre-treated patients with advanced gastric cancer; showed ORR of 1‚Ä¶ https://stocknews.com/news/mrk-presents-new-data-from-keytruda-in-heavily-pre-treated-patients-with/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/871678698776297472
2744,MarketBeat,@MarketBeatCom,2017-06-05T01:02:25.000Z,"Merck & Co. $MRK Receiving Somewhat Positive Media Coverage, Study Finds http://zpr.io/PL78C","Merck & Co. $MRK Receiving Somewhat Positive Media Coverage, Study Finds http://zpr.io/PL78C",,,,,[],https://twitter.com/MarketBeatCom/status/871532626489860096
2745,Pharmaceutical News,@pharma_sector,2017-06-05T21:10:38.000Z,Updated Data From ECHO-202 Trial Of Incyte???s Epacadostat In Combination With #Merck & Co.?... Read more: http://owler.us/acOv3G $MRK,Updated Data From ECHO-202 Trial Of Incyte???s Epacadostat In Combination With #Merck & Co.?... Read more: http://owler.us/acOv3G $MRK,,,,,[],https://twitter.com/pharma_sector/status/871836685813686273
2746,BioPharma Dive,@BioPharmaDive,2017-06-05T15:42:00.000Z,$MRK touts Keytruda bladder benefit post Tecentriq failure http://bit.ly/2rWwFwJ #ASCO17 #ASCO2017,$MRK touts Keytruda bladder benefit post Tecentriq failure http://bit.ly/2rWwFwJ #ASCO17 #ASCO2017,,,,,[],https://twitter.com/BioPharmaDive/status/871753983802490884
2747,Todd Campbell,@ebcapital,2017-06-05T20:45:40.000Z,"Why Regeneron Is Quickly Becoming My Top Biotech Stock Pick 
@themotleyfool
 #stocks $MRK, $BMY, $REGN","Why Regeneron Is Quickly Becoming My Top Biotech Stock Pick 
@themotleyfool
 #stocks $MRK, $BMY, $REGN
fool.com
Why Regeneron Is Quickly Becoming My Top Biotech Stock Pick @themotleyfool #stocks $REGN $MRK $BMY
Approvals of new drugs with nine-figure sales potential and a full pipeline that can fuel future growth make this stock increasingly appealing at these prices.
1",,,,1,[],https://twitter.com/ebcapital/status/871830403484717059
2748,Ali Urman,@aurmanARK,2017-06-05T19:37:00.000Z,"268 combination trials involve Keytruda and 242 with Opdivo, of which 86 combine Opdivo w/ Yervoy #PDL1 $MRK $BMY","268 combination trials involve Keytruda and 242 with Opdivo, of which 86 combine Opdivo w/ Yervoy #PDL1 $MRK $BMY
info.evaluategroup.com
EP Vantage PD-1/PD-L1 Combination Therapies
Immuno-oncology combination trials triple since 2015 Keytruda now partner of choice",,,,,[],https://twitter.com/aurmanARK/status/871813123073855489
2749,Briefing.com,@Briefingcom,2017-06-05T06:16:54.000Z,$MRK: Merck presents first-time findings from KEYNOTE-164 and KEYNOTE-158 http://bit.ly/2rAw7db,$MRK: Merck presents first-time findings from KEYNOTE-164 and KEYNOTE-158 http://bit.ly/2rAw7db,,,,,[],https://twitter.com/Briefingcom/status/871611768421793792
2750,Siti van der Meij,@sitivandermeij,2017-06-03T20:21:19.000Z,Combination of Incyte's epacadostat plus Merck's Ketyruda demonstrates activity in trial of... https://seekingalpha.com/news/3271451-combination-incytes-epacadostat-plus-mercks-ketyruda-demonstrates-activity-trial-patients?source=feed_f‚Ä¶ $INCY $MRK $TPS $IN‚Ä¶,"Combination of Incyte's epacadostat plus Merck's Ketyruda demonstrates activity in trial of... https://seekingalpha.com/news/3271451-combination-incytes-epacadostat-plus-mercks-ketyruda-demonstrates-activity-trial-patients?source=feed_f‚Ä¶ $INCY $MRK $TPS $IN‚Ä¶
seekingalpha.com
Combination of Incyte's epacadostat plus Merck's Ketyruda demonstrates activity in trial of...
Incyte (NASDAQ:INCY) and Merck (NYSE:MRK) announce updated data from the advanced non-small cell lung cancer patient cohort of the ongoing Phase 1/2 ECHO-202 trial evaluating epacadostat,...",,,,,['https://pbs.twimg.com/card_img/1497724725002448899/2TZ3O23_?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/871099499678240768
2751,cowenresearch,@CowenResearch,2017-06-05T10:23:21.000Z,Steve Scala publishes his thoughts on big cap pharma data presented over the weekend at #ASCO17 $LLY $MRK $BMY $AZN,Steve Scala publishes his thoughts on big cap pharma data presented over the weekend at #ASCO17 $LLY $MRK $BMY $AZN,,,,,[],https://twitter.com/CowenResearch/status/871673790018793472
2752,Briefing.com,@Briefingcom,2017-06-05T06:10:53.000Z,$MRK: Merck reports follow-up data with KEYTRUDA in combination with Pemetrexed and Carboplatin http://bit.ly/2qRDSOK,$MRK: Merck reports follow-up data with KEYTRUDA in combination with Pemetrexed and Carboplatin http://bit.ly/2qRDSOK,,,,,[],https://twitter.com/Briefingcom/status/871610258128388096
2753,Junk,@Slambucket,2017-06-03T17:40:24.000Z,"Replying to 
@Slambucket","Replying to 
@Slambucket
$ENUM must feel they have funding to meet the agreement NLT Dec 17. Neither $MRK nor $ENUM would have wasted time amending the agreement...
1
1",,1,,1,[],https://twitter.com/Slambucket/status/871059004474105857
2754,Briefing.com,@Briefingcom,2017-06-05T07:38:54.000Z,$MRK: Merck presents one-year follow-up for KEYTRUDA showing continued overall survival benefit over chemotherapy http://bit.ly/2qRLZec,$MRK: Merck presents one-year follow-up for KEYTRUDA showing continued overall survival benefit over chemotherapy http://bit.ly/2qRLZec,,,,,[],https://twitter.com/Briefingcom/status/871632407069204480
2755,"Sciortino Giuliano, PhD",@Giuliano1922,2017-06-05T17:53:39.000Z,"@PowerLunch
 @SullyCNBC
 @megtirrell
 Very nice segment on the defective DNA polymerase $MRK cancer target drug","@PowerLunch
 @SullyCNBC
 @megtirrell
 Very nice segment on the defective DNA polymerase $MRK cancer target drug
1",,,,1,[],https://twitter.com/Giuliano1922/status/871787112118484996
2756,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-06-03T20:47:16.000Z,"Replying to 
@Slambucket","Replying to 
@Slambucket
This could just be the new work-packages defined in the $MRK addendum. Looks $ENUM didn't reach last goals in time & renegotiated w $MRK
1
1",,1,,1,[],https://twitter.com/dhovekamp42/status/871106031383982082
2757,Daily Political,@dailypoliticaln,2017-06-03T09:23:30.000Z,"Louisiana State Employees Retirement System Has $10.72 Million Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1150977","Louisiana State Employees Retirement System Has $10.72 Million Position in Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1150977",,,,,[],https://twitter.com/dailypoliticaln/status/870933952848113664
2758,dough,@semodough,2017-06-05T11:04:39.000Z,"Replying to 
@Merck","Replying to 
@Merck
$MRK $INCY Updated Data from ECHO-202 Trial of Incyte‚Äôs Epacadostat in Combination with Merck‚Äôs KEYTRUDA¬Æ",,,,,['https://pbs.twimg.com/media/DBjYJDnVwAAye0L?format=jpg&name=900x900'],https://twitter.com/semodough/status/871684185488052225
2759,Herkyleese,@herkyleese,2017-06-07T01:24:15.000Z,By itself it is good! Take the breaks off and you will see unheard of response rates!  It's coming. $nwbo $kite $blue $nvs $bmy $mrk $azn,"By itself it is good! Take the breaks off and you will see unheard of response rates!  It's coming. $nwbo $kite $blue $nvs $bmy $mrk $azn
7
9",,,7,9,['https://pbs.twimg.com/media/DBrmeIEUIAARV_h?format=jpg&name=small'],https://twitter.com/herkyleese/status/872262897275219968
2760,Sentiment Stocks,@sentimentstock,2017-06-07T19:59:12.000Z,$NWBO $KCG $MRK $BMY $KITE $JUNO $CLDX $AZN Curious how manipulative naked shorting is done? Watch this video & see,"$NWBO $KCG $MRK $BMY $KITE $JUNO $CLDX $AZN Curious how manipulative naked shorting is done? Watch this video & see
youtube.com
Naked short selling redefining systemic risk (part 1 of 2)
There is some evidence suggesting the federal government is spending tens of billions of dollars to deal with the accumulation of failed trades caused by ill...
1
6
9",,1,6,9,['https://pbs.twimg.com/card_img/1500944143170023426/r2pRO17U?format=jpg&name=240x240'],https://twitter.com/sentimentstock/status/872543486410596352
2761,Sentiment Stocks,@sentimentstock,2017-06-08T17:06:09.000Z,$NWBO $MRK $BMY $KITE $JUNO No patient w/GBM wants to die in 15 months if there is an alternative like DCVax-L to extend time or cure them.,"$NWBO $MRK $BMY $KITE $JUNO No patient w/GBM wants to die in 15 months if there is an alternative like DCVax-L to extend time or cure them.
5
9",,,5,9,[],https://twitter.com/sentimentstock/status/872862323437821956
2762,Herkyleese,@herkyleese,2017-06-08T14:32:50.000Z,Disrupting the way we treat cancer may be easier than we think.  Meet #dcvax your gonna hear a lot more!  $nvs $kite $bmy $cldx $juno $mrk,"Disrupting the way we treat cancer may be easier than we think.  Meet #dcvax your gonna hear a lot more!  $nvs $kite $bmy $cldx $juno $mrk
1
4",,,1,4,['https://pbs.twimg.com/ext_tw_video_thumb/872823272181702656/pu/img/Rrx2e0RJJ-CPKjdk.jpg'],https://twitter.com/herkyleese/status/872823741335654400
2763,Mavis Nye Dr (hon) BEM. BCAh,@Grandmamavis,2017-06-06T04:32:51.000Z,2017_ASCO_Presentation Slide show #mesothelioma #cancer https://seekingalpha.com/article/4078998-2017_asco_presentation?source=tweet‚Ä¶ $MRK,"2017_ASCO_Presentation Slide show #mesothelioma #cancer https://seekingalpha.com/article/4078998-2017_asco_presentation?source=tweet‚Ä¶ $MRK
seekingalpha.com
2017_ASCO_Presentation (NYSE:MRK)
The following slide deck was published by Merck & Co Inc.
1",,,1,,['https://pbs.twimg.com/card_img/1500679726922285057/PVKpgAH5?format=png&name=240x240'],https://twitter.com/Grandmamavis/status/871947973604896769
2764,Mavis Nye Dr (hon) BEM. BCAh,@Grandmamavis,2017-06-06T06:49:04.000Z,Merck's (MRK) Management Presents at Investor Briefing at 2017 ASCO Annual Meeting  Thank You Merck (MSD) https://seekingalpha.com/article/4079009-mercks-mrk-management-presents-investor-briefing-2017-asco-annual-meeting-conference?source=tweet‚Ä¶ $MRK,"Merck's (MRK) Management Presents at Investor Briefing at 2017 ASCO Annual Meeting  Thank You Merck (MSD) https://seekingalpha.com/article/4079009-mercks-mrk-management-presents-investor-briefing-2017-asco-annual-meeting-conference?source=tweet‚Ä¶ $MRK
seekingalpha.com
Merck's (MRK) Management Presents at Investor Briefing at 2017 ASCO Annual Meeting Conference...
Merck & Co Inc. (NYSE:MRK) Investor Briefing at 2017 ASCO Annual Meeting Call June 5, 2017 18:45 ET Executives Teri Loxam - Investor Relations Roger Perlmutter - President, Merck...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/Grandmamavis/status/871982252456071168
2765,Joe,@GantosJ,2017-06-08T11:55:51.000Z,"$ONCS FDA Orphan Drug Designation: Treatment of Stage IIB, IIc, III, and IV melanoma combination with $MRK's pembro https://accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=568316‚Ä¶","$ONCS FDA Orphan Drug Designation: Treatment of Stage IIB, IIc, III, and IV melanoma combination with $MRK's pembro https://accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=568316‚Ä¶
1
7
4",,1,7,4,[],https://twitter.com/GantosJ/status/872784231902179328
2766,Kara Jill Stancell,@kjilly,2017-06-08T13:33:53.000Z,Actelion‚Äôs R&D group slammed with a setback as execs finalize $30B $JNJ deal #pharma #biotech $MRK $RHHBY,"Actelion‚Äôs R&D group slammed with a setback as execs finalize $30B $JNJ deal #pharma #biotech $MRK $RHHBY
endpts.com
Actelion‚Äôs R&D group slammed with a setback as execs finalize $30B J&J deal
Actelion‚Äôs R&D group will spin off into a new biotech soon with a stinging setback to deal with. The Swiss biotech, which has been at work finalizing the $30 billion J&J deal to acquire the commerc...
1",,,1,,['https://pbs.twimg.com/card_img/1491827193546416128/nwuB5g4f?format=jpg&name=small'],https://twitter.com/kjilly/status/872808904748552197
2767,dough,@semodough,2017-06-06T13:47:41.000Z,$BLUE $CELG $LOXO $MRK $INCY to lead,"$BLUE $CELG $LOXO $MRK $INCY to lead
dough
@semodough
 ¬∑ 6 Jun 2017
Going out on Limb maybe.   Think this post #ASCO17 different.   $IBB rallies rest of week-imho news was good enough &just to much pessimism
1",üëä,,,1,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/872087600173023232
2768,Russo Partners,@russopartners,2017-06-06T16:14:01.000Z,Ramaswamy notches his 5th #biotech startup in 3 years after inking a deal with Merck $MRK for PhIII urology drug -,"Ramaswamy notches his 5th #biotech startup in 3 years after inking a deal with Merck $MRK for PhIII urology drug -
endpts.com
Ramaswamy notches his 5th biotech startup in 3 years after inking a deal with Merck for PhIII...
Vivek Ramaswamy has launched another new biotech company. Ramaswamy‚Äôs umbrella group Roivant Sciences notched its 5th ‚Äú-vant‚Äù startup ‚Äî Urovant Sciences ‚Äî after bagging a Phase III-ready urology drug...
1
1",,,1,1,['https://pbs.twimg.com/card_img/1500198910572253190/9PQe8QpN?format=png&name=small'],https://twitter.com/russopartners/status/872124425856065538
2769,Don,@COMMONSENCE10,2017-06-08T14:25:07.000Z,$MRK WHAT THE h IS GOING ON HERE?,"$MRK WHAT THE h IS GOING ON HERE?
1",,,,1,[],https://twitter.com/COMMONSENCE10/status/872821797468553216
2770,Colin Magowan,@colinmagowan,2017-06-07T14:50:24.000Z,"Replying to 
@AndyBiotech","Replying to 
@AndyBiotech
$MRK's CTLA-4 MK-1308 to be tested in multi-arm, ~148 pt. P1 combo with Keytruda; Several NSCLC focused arms. See:
clinicaltrials.gov
Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors...
Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001) - Full Text View.
2
7",,,2,7,['https://pbs.twimg.com/card_img/1499578112115363861/JaVVFVxw?format=png&name=240x240'],https://twitter.com/colinmagowan/status/872465772378955776
2771,Donna Young,@DonnaYoungDC,2017-06-07T21:47:08.000Z,"ICYMI: Latest Ebola outbreak a reminder of continued need for vaccines, drugs http://snl.com/web/client?auth=inherit#news/article?id=40917568&cdid=A-40917568-9522‚Ä¶ #NIH #Ebola $MRK $JNJ $REGN #pharma","ICYMI: Latest Ebola outbreak a reminder of continued need for vaccines, drugs http://snl.com/web/client?auth=inherit#news/article?id=40917568&cdid=A-40917568-9522‚Ä¶ #NIH #Ebola $MRK $JNJ $REGN #pharma
3
1",üì∞,,3,1,[],https://twitter.com/DonnaYoungDC/status/872570648555659264
2772,Dan Rosenblum,@sharkbiotech,2017-06-08T18:58:22.000Z,any reason $MRK hasn't upticked since #ASCO17 ?,"any reason $MRK hasn't upticked since #ASCO17 ?
1
1
3",,1,1,3,[],https://twitter.com/sharkbiotech/status/872890564542332929
2773,Odi Bruckman,@odibro,2017-06-08T11:42:19.000Z,$MRK Keytruda granted orphan status as follicular lymphoma treatment http://accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=570816‚Ä¶,"$MRK Keytruda granted orphan status as follicular lymphoma treatment http://accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=570816‚Ä¶
1
1",,,1,1,[],https://twitter.com/odibro/status/872780827603730432
2774,Seeking Alpha,@SeekingAlpha,2017-06-07T11:38:31.000Z,Solid Progress For IDO Inhibitors https://seekingalpha.com/article/4079446-solid-progress-ido-inhibitors?source=feed_f‚Ä¶ $MRK $BMY $INCY $NLNK $RHHBY $VRX,Solid Progress For IDO Inhibitors https://seekingalpha.com/article/4079446-solid-progress-ido-inhibitors?source=feed_f‚Ä¶ $MRK $BMY $INCY $NLNK $RHHBY $VRX,,,,,[],https://twitter.com/SeekingAlpha/status/872417483633836032
2775,Quantcha Trade Ideas,@QuantchaIdeas,2017-06-08T13:42:04.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/06/08/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/06/08/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk/‚Ä¶,,,,,['https://pbs.twimg.com/media/DBzY8gBV0AErw8R?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/872810964713967616
2776,Finbox,@FinboxIO,2017-06-06T22:35:06.000Z,BMO Capital reiterated Merck & $MRK at Buy. This editable 5yr DCF shows Upside http://ow.ly/KGJH30cmRGh,BMO Capital reiterated Merck & $MRK at Buy. This editable 5yr DCF shows Upside http://ow.ly/KGJH30cmRGh,,,,,['https://pbs.twimg.com/media/DBq_xCqXgAA2wL0?format=jpg&name=small'],https://twitter.com/FinboxIO/status/872220331154579456
2777,Matthias Piesche,@PiescheLab,2017-06-08T14:45:57.000Z,ECHO-202 Trial of Epacadostat in Combo w KEYTRUDA Demonstrate Clin. Activity Across Multiple Tumor Types http://mrknewsroom.com/news-release/asco/updated-data-echo-202-trial-incytes-epacadostat-combination-mercks-keytruda-pembro?lipi=urn%3Ali%3Apage%3Ad_flagship3_feed%3BP0oAYx%2BtQRapV47WHfzC2A%3D%3D‚Ä¶ $MRK $INCY,ECHO-202 Trial of Epacadostat in Combo w KEYTRUDA Demonstrate Clin. Activity Across Multiple Tumor Types http://mrknewsroom.com/news-release/asco/updated-data-echo-202-trial-incytes-epacadostat-combination-mercks-keytruda-pembro?lipi=urn%3Ali%3Apage%3Ad_flagship3_feed%3BP0oAYx%2BtQRapV47WHfzC2A%3D%3D‚Ä¶ $MRK $INCY,,,,,['https://pbs.twimg.com/media/DBznjyFWsAIHeI7?format=jpg&name=small'],https://twitter.com/PiescheLab/status/872827042571661312
2778,CarnivoresHealth,@HealthierIT,2017-06-06T11:30:26.000Z,FDA approves Keytruda in 2 bladder cancer indications http://buff.ly/2rIhjuS $MRK #bladder #cancer,"FDA approves Keytruda in 2 bladder cancer indications http://buff.ly/2rIhjuS $MRK #bladder #cancer
2",,,2,,['https://pbs.twimg.com/media/DBono4ZXcAIL4L9?format=jpg&name=small'],https://twitter.com/HealthierIT/status/872053063112155136
2779,Kara Jill Stancell,@kjilly,2017-06-08T13:30:03.000Z,"$JNJ woos $MRK Mathai Mammen to helm of #pharma R&D, Hait takes over on external innovation #managementchanges  https://endpts.com/jj-woos-mercks-mathai-mammen-to-helm-of-pharma-rd-hait-takes-over-on-external-innovation‚Ä¶","$JNJ woos $MRK Mathai Mammen to helm of #pharma R&D, Hait takes over on external innovation #managementchanges  https://endpts.com/jj-woos-mercks-mathai-mammen-to-helm-of-pharma-rd-hait-takes-over-on-external-innovation‚Ä¶
1",,,1,,[],https://twitter.com/kjilly/status/872807940746379264
2780,Joe,@Drchik23,2017-06-08T11:47:46.000Z,"$mrk #keytruda orphan designation

 https://accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=570816‚Ä¶","$mrk #keytruda orphan designation

 https://accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=570816‚Ä¶
1",,,,1,[],https://twitter.com/Drchik23/status/872782198948200449
2781,Jonathan Rockoff,@jonathanrockoff,2017-06-07T20:37:25.000Z,"$JNJ says Bill Hait to take new role heading external innovation company-wide, and $MRK's Mathai Mammen will head pharma R&D","$JNJ says Bill Hait to take new role heading external innovation company-wide, and $MRK's Mathai Mammen will head pharma R&D
5",,,,5,[],https://twitter.com/jonathanrockoff/status/872553101550657536
2782,Carly Helfand,@CarlyHFierce,2017-06-07T16:42:43.000Z,"With ASCO data tallied, Bristol-Myers loses ground to Merck in I-O field: http://bit.ly/2rLKpHV $BMY $MRK #ASCO17 #pharma","With ASCO data tallied, Bristol-Myers loses ground to Merck in I-O field: http://bit.ly/2rLKpHV $BMY $MRK #ASCO17 #pharma
fiercepharma.com
With ASCO data tallied, Bristol-Myers loses ground to Merck in I-O field
If Bristol-Myers Squibb needed more evidence to suggest it had lost the immuno-oncology lead to Merck & Co., it got it at the | Thanks to a raft of promising Keytruda results‚Äîin tandem with Incyte's...
1",,,1,,['https://pbs.twimg.com/card_img/1501988025965809687/CQyz0k5u?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/872494039098175492
2783,Vista Partners LLC,@VistaPResearch,2017-06-08T23:08:36.000Z,"@OmarWzz20
 thanks for follow! See Vista Partners #Investing #Dow30 #healthcare http://vistapglobal.com $JNJ $MRK $HIIQ $PFE","@OmarWzz20
 thanks for follow! See Vista Partners #Investing #Dow30 #healthcare http://vistapglobal.com $JNJ $MRK $HIIQ $PFE
GIF
1
2",,,1,2,['https://pbs.twimg.com/tweet_video_thumb/DB1amhcUAAA0rOA.jpg'],https://twitter.com/VistaPResearch/status/872953535578595328
2784,TW Research Group,@DanCarlson33,2017-06-08T14:00:17.000Z,3D Signatures hits the next milestone on their #cancer #diagnostics for Hodgkin's Lymphoma. $MRK $PFE $ABBV $INCY,"3D Signatures hits the next milestone on their #cancer #diagnostics for Hodgkin's Lymphoma. $MRK $PFE $ABBV $INCY
twresearchgroup.com
3D Signatures Advances Hodgkin‚Äôs Lymphoma Test
TORONTO, ON (June 8, 2017) ‚àí 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the ""Company"" or ""3DS""), is pleased to announce that the clinical trial component (the ‚ÄúClinical Trial‚Äù) of its...",,,,,['https://pbs.twimg.com/card_img/1501723078635753478/-cWto207?format=jpg&name=240x240'],https://twitter.com/DanCarlson33/status/872815550107328512
2785,CBPartners,@CBPartners,2017-06-07T16:40:08.000Z,$MRK acquires five bispecific #immunooncology antibodies from UK biotech company F-STAR for upfront EUR 115m http://bit.ly/2qXflrn,$MRK acquires five bispecific #immunooncology antibodies from UK biotech company F-STAR for upfront EUR 115m http://bit.ly/2qXflrn,,,,,[],https://twitter.com/CBPartners/status/872493387353608192
2786,FirstToMarkets,@firsttomarkets,2017-06-06T20:16:41.000Z,Merck &amp; Co Inc  Reiterated Rating by BMO Capital Markets (Ranked 16th) to Buy $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,Merck &amp; Co Inc  Reiterated Rating by BMO Capital Markets (Ranked 16th) to Buy $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,,,,,[],https://twitter.com/firsttomarkets/status/872185495555416065
2787,Pharmaceutical News,@pharma_sector,2017-06-08T13:22:20.000Z,"#Merck Keytruda success a crowning moment for cancer immunotherapies, but are more on their ... Read more: http://owler.us/acPw0G $MRK","#Merck Keytruda success a crowning moment for cancer immunotherapies, but are more on their ... Read more: http://owler.us/acPw0G $MRK",,,,,[],https://twitter.com/pharma_sector/status/872805999681327107
2788,CBPartners,@CBPartners,2017-06-08T07:40:06.000Z,F-STAR to receive payment of EUR 115m plus R&D funding & milestone payments from $MRK for #immunooncology antibodies,"F-STAR to receive payment of EUR 115m plus R&D funding & milestone payments from $MRK for #immunooncology antibodies
biospace.com
New Immuno-Onco Deal With Merck KGaA Could Make This UK Biotech a $1 Billion Company | BioSpace
New Immuno-Onco Deal With Merck KGaA Could Make This UK Biotech a $1 Billion Company - read this article along with other careers information, tips and advice on BioSpace",,,,,[],https://twitter.com/CBPartners/status/872719871297167361
2789,US Banking News,@AmericanBanking,2017-06-07T14:16:41.000Z,Merck KGaA's neutral rating reiterated at JPMorgan Chase & Co.. http://ift.tt/2r5RsJx $MRK #MRK,Merck KGaA's neutral rating reiterated at JPMorgan Chase & Co.. http://ift.tt/2r5RsJx $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/872457288283553792
2790,$PENNY KING,@groman100,2017-06-06T17:19:27.000Z,$imnp could be news in the pipe but bouncing off the 20 day MA atm $tgtx $fbio $bmy $zsan $pfe $mrk $clls $kite $juno $cala $cara $pbyi $fb,$imnp could be news in the pipe but bouncing off the 20 day MA atm $tgtx $fbio $bmy $zsan $pfe $mrk $clls $kite $juno $cala $cara $pbyi $fb,,,,,[],https://twitter.com/groman100/status/872140893314273284
2791,Daily Political,@dailypoliticaln,2017-06-06T09:28:13.000Z,"Farmers & Merchants Investments Inc. Purchases 150 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1157878","Farmers & Merchants Investments Inc. Purchases 150 Shares of Merck & Co., Inc. $MRK http://dailypolitical.com/?p=1157878",,,,,[],https://twitter.com/dailypoliticaln/status/872022305991512066
2792,Limex,@LimexMe,2017-06-08T18:34:23.000Z,"Why Is NewLink Genetics Losing One-Third of Its Value Today?
 http://bit.ly/080617NLNK $NLNK $RHHBY $INCY $MRK","Why Is NewLink Genetics Losing One-Third of Its Value Today?
 http://bit.ly/080617NLNK $NLNK $RHHBY $INCY $MRK
whotrades.com
Why Is NewLink Genetics Losing One-Third of Its Value Today?
What happened After a surprising decision by Roche Holding (NASDAQOTH: RHHBY) to exit its co-development deal on a new cancer drug, NewLink Genetics Corporation (NASDAQ: NLNK)‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/872884527051440128
2793,Ticker Report,@TickerReport,2017-06-06T09:34:03.000Z,"Merck & Co., Inc. $MRK Position Decreased by Lodestar Investment Counsel LLC IL http://ift.tt/2qSGMyI","Merck & Co., Inc. $MRK Position Decreased by Lodestar Investment Counsel LLC IL http://ift.tt/2qSGMyI",,,,,[],https://twitter.com/TickerReport/status/872023773242949633
2794,Watchlist News,@WatchlistN,2017-06-07T20:18:16.000Z,"Capital Investment Advisors LLC Acquires 2,878 Shares of Merck & Co., Inc. $MRK http://zpr.io/PLLQN","Capital Investment Advisors LLC Acquires 2,878 Shares of Merck & Co., Inc. $MRK http://zpr.io/PLLQN",,,,,[],https://twitter.com/WatchlistN/status/872548284421873666
2795,MarketBeat,@MarketBeatCom,2017-06-07T14:14:16.000Z,Merck KGaA's neutral rating reiterated at JPMorgan Chase & Co.. http://ift.tt/2r5RsJx $MRK #MRK,Merck KGaA's neutral rating reiterated at JPMorgan Chase & Co.. http://ift.tt/2r5RsJx $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/872456679643852800
2796,TalkMarkets,@TalkMarkets,2017-06-06T20:01:36.000Z,#Amazon Healthcare Aspirations May Be Bigger Than Just Pharmacy $AMZN Also $AZN $BMY $LLY $GSK $JNJ $MRK $RHHBY... https://goo.gl/1hb77h,#Amazon Healthcare Aspirations May Be Bigger Than Just Pharmacy $AMZN Also $AZN $BMY $LLY $GSK $JNJ $MRK $RHHBY... https://goo.gl/1hb77h,,,,,[],https://twitter.com/TalkMarkets/status/872181700285128704
2797,StockNews.com,@stocknewsdotcom,2017-06-08T10:49:43.000Z,$MRK Granted orphan designation by the FDA for Keytruda for the treatment of follicular lymphoma https://stocknews.com/news/mrk-granted-orphan-designation-by-the-fda-for-keytruda-for-the-22523804/‚Ä¶,$MRK Granted orphan designation by the FDA for Keytruda for the treatment of follicular lymphoma https://stocknews.com/news/mrk-granted-orphan-designation-by-the-fda-for-keytruda-for-the-22523804/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/872767590241796096
2798,SwingTradeBot,@SwingTradeBot,2017-06-08T21:24:29.000Z,Scan results - Fell Below 50 DMA today: $IVC $MZOR $MRK $DVMT $GRA $TMUS $EGN $PG $HIW $EFX ... https://swingtradebot.com/events/2/equities?selected_date=2017-06-08‚Ä¶,Scan results - Fell Below 50 DMA today: $IVC $MZOR $MRK $DVMT $GRA $TMUS $EGN $PG $HIW $EFX ... https://swingtradebot.com/events/2/equities?selected_date=2017-06-08‚Ä¶,,,,,[],https://twitter.com/SwingTradeBot/status/872927334025891840
2799,StockNews.com,@stocknewsdotcom,2017-06-08T14:38:32.000Z,"$MRK Stock's recent pullback continues, coming up against 200-day support below $63 https://stocknews.com/news/mrk-stocks-recent-pullback-continues-coming-up-against-200-day-support-below/‚Ä¶","$MRK Stock's recent pullback continues, coming up against 200-day support below $63 https://stocknews.com/news/mrk-stocks-recent-pullback-continues-coming-up-against-200-day-support-below/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/872825175171051520
2800,Eric Sagonowsky,@EricSFierce,2017-06-06T23:00:02.000Z,"BMS' Opdivo, Merck's Keytruda lead their class in cancer vaccine combo studies: report http://fiercepharma.com/vaccines/bms-merck-lead-pd-1-pd-l1-class-vaccine-combo-studies-report‚Ä¶ $BMY $MRK","BMS' Opdivo, Merck's Keytruda lead their class in cancer vaccine combo studies: report http://fiercepharma.com/vaccines/bms-merck-lead-pd-1-pd-l1-class-vaccine-combo-studies-report‚Ä¶ $BMY $MRK
fiercepharma.com
BMS' Opdivo, Merck's Keytruda lead their class in cancer vaccine combo studies: report
It‚Äôs no secret that combination studies featuring PD-1/PD-L1 checkpoint inhibitors and cancer vaccines have been popping up left and right. | It‚Äôs no secret that combination studies featuring...
1",,,,1,['https://pbs.twimg.com/card_img/1499749978297835520/tp9KtbQs?format=jpg&name=small'],https://twitter.com/EricSFierce/status/872226603207610368
2801,Ben Fidler,@BentheFidler,2017-06-06T17:32:06.000Z,"#ASCO17 Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity http://xconomy.com/national/2017/06/06/asco-roundup-checkpoint-combos-tumor-profiling-financial-toxicity/‚Ä¶ w/
@alexlash
 $MRK $BMY $JNJ $LOXO $NVS $BLUE","#ASCO17 Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity http://xconomy.com/national/2017/06/06/asco-roundup-checkpoint-combos-tumor-profiling-financial-toxicity/‚Ä¶ w/
@alexlash
 $MRK $BMY $JNJ $LOXO $NVS $BLUE
2",,,,2,[],https://twitter.com/BentheFidler/status/872144078456053760
2802,The Fly,@theflynews,2017-06-06T16:04:01.000Z,BMO Capital says Incyte should be bought on recent weakness: http://bit.ly/2scNDH2 $INCY $BMY $MRK,"BMO Capital says Incyte should be bought on recent weakness: http://bit.ly/2scNDH2 $INCY $BMY $MRK
thefly.com
Incyte should be bought on recent weakness, says BMO Capital
BMO Capital analyst M. Ia... INCY, BMY, MRK",,,,,['https://pbs.twimg.com/card_img/1501410844973883393/3PG3Thda?format=jpg&name=small'],https://twitter.com/theflynews/status/872121910032834562
2803,Briefing.com,@Briefingcom,2017-06-08T16:36:34.000Z,$MRK: Merck extends this week's slide down towards its 4-week lows/200-day sma near 62.75 area http://bit.ly/2r5AwYp,$MRK: Merck extends this week's slide down towards its 4-week lows/200-day sma near 62.75 area http://bit.ly/2r5AwYp,,,,,[],https://twitter.com/Briefingcom/status/872854877315112961
2804,GREEN STOCK NEWS,@greenstocknews,2017-06-07T11:50:03.000Z,Solid Progress For IDO Inhibitors https://seekingalpha.com/article/4079446-solid-progress-ido-inhibitors?source=feed_f‚Ä¶ $MRK $BMY $INCY $NLNK $RHHBY $VRX OMG-STOCK SYMBOL DCSA http://docasainc.com,"Solid Progress For IDO Inhibitors https://seekingalpha.com/article/4079446-solid-progress-ido-inhibitors?source=feed_f‚Ä¶ $MRK $BMY $INCY $NLNK $RHHBY $VRX OMG-STOCK SYMBOL DCSA http://docasainc.com
seekingalpha.com
Solid Progress For IDO Inhibitors
The search to expand upon the progress made by checkpoint inhibitors Keytruda and Opdivo and others has put the spotlight on several novel mechanisms.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/greenstocknews/status/872420384120950785
2805,GREEN STOCK NEWS,@greenstocknews,2017-06-07T12:03:46.000Z,Bristol-Myers Fails To Stem The Losses https://seekingalpha.com/article/4079459-bristol-myers-fails-stem-losses?source=feed_f‚Ä¶ $MRK $INCY $BMY check out TICKER SYMBOL $DCSA http://docasainc.com,"Bristol-Myers Fails To Stem The Losses https://seekingalpha.com/article/4079459-bristol-myers-fails-stem-losses?source=feed_f‚Ä¶ $MRK $INCY $BMY check out TICKER SYMBOL $DCSA http://docasainc.com
seekingalpha.com
Bristol-Myers Fails To Stem The Losses (NYSE:BMY)
The loss of $4.3bn in market value yesterday shows how Asco went for Bristol-Myers Squibb (NYSE:BMY) this year - in the minds of investors at least.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/greenstocknews/status/872423839703158785
2806,The Fly,@theflynews,2017-06-06T12:15:03.000Z,"Amazon may be the next threat to drug pricing, says Wells Fargo $AMZN $MRK $SNY $JNJ $BMY $PFE $RHHBY $NVS $AZN‚Ä¶","Amazon may be the next threat to drug pricing, says Wells Fargo $AMZN $MRK $SNY $JNJ $BMY $PFE $RHHBY $NVS $AZN‚Ä¶
thefly.com
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently repor... AMZN, MRK, SNY, JNJ, BMY, PFE, RHHBY, NVS, AZN, GSK, LLY, WBA, FRED, CVS
1",,,1,,[],https://twitter.com/theflynews/status/872064291440017409
2807,kyookine,@kyookine,2017-06-07T23:28:43.000Z,Merck top dog in I-O field with Keytruda juggernaut - FiercePharma https://seekingalpha.com/news/3272166-merck-top-dog-o-field-keytruda-juggernaut-fiercepharma?source=tweet‚Ä¶ $MRK $BMY,"Merck top dog in I-O field with Keytruda juggernaut - FiercePharma https://seekingalpha.com/news/3272166-merck-top-dog-o-field-keytruda-juggernaut-fiercepharma?source=tweet‚Ä¶ $MRK $BMY
seekingalpha.com
Merck top dog in I-O field with Keytruda juggernaut - FiercePharma (NYSE:MRK)
FiercePharma's Carly Helfand reports that Merck (MRK -0.9%) was the hands-down winner in the immuno-oncology arena based on ASCO's datafest.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/kyookine/status/872596209814220800
2808,MarketBeat,@MarketBeatCom,2017-06-06T11:20:12.000Z,"BMO Capital Markets Reaffirms Buy Rating for Merck & Co., Inc. $MRK http://ift.tt/2sz56Xm #acn","BMO Capital Markets Reaffirms Buy Rating for Merck & Co., Inc. $MRK http://ift.tt/2sz56Xm #acn",,,,,[],https://twitter.com/MarketBeatCom/status/872050485531947008
2809,Dakota Financial,@dakotafinancial,2017-06-06T12:02:56.000Z,"Reliance Trust Co. of Delaware Has $6.89 Million Position in Merck & Co., Inc. $MRK http://zpr.io/PLhUJ","Reliance Trust Co. of Delaware Has $6.89 Million Position in Merck & Co., Inc. $MRK http://zpr.io/PLhUJ",,,,,[],https://twitter.com/dakotafinancial/status/872061239291240454
2810,Daily Political,@dailypoliticaln,2017-06-07T19:21:39.000Z,"Merck & Co., Inc. $MRK Given a $72.00 Price Target at Credit Suisse Group AG http://dailypolitical.com/?p=1163585","Merck & Co., Inc. $MRK Given a $72.00 Price Target at Credit Suisse Group AG http://dailypolitical.com/?p=1163585",,,,,[],https://twitter.com/dailypoliticaln/status/872534036119523328
2811,Todd Campbell,@ebcapital,2017-06-08T21:29:37.000Z,"Why Is NewLink Genetics Losing One-Third of Its Value Today? 
@themotleyfool
 #stocks $MRK, $RHHBY, $INCY, $NLNK","Why Is NewLink Genetics Losing One-Third of Its Value Today? 
@themotleyfool
 #stocks $MRK, $RHHBY, $INCY, $NLNK
fool.com
Why Is NewLink Genetics Losing One-Third of Its Value Today? @themotleyfool #stocks $NLNK $MRK...
Roche Holdings will no longer collaborate with NewLink Genetics on GDC-0919.
1",,,1,,['https://pbs.twimg.com/card_img/1501723065759285249/myeUM0uv?format=jpg&name=small'],https://twitter.com/ebcapital/status/872928626165108736
2812,Dennis M Winters,@m_denniswinters,2017-06-06T16:49:53.000Z,"@adamfeuerstein
 $Blue $auph i heard another rumor that $auph has a standing offer of $21/share from $mrk.   Manipulation....","@adamfeuerstein
 $Blue $auph i heard another rumor that $auph has a standing offer of $21/share from $mrk.   Manipulation....
Luke Murray
@EliteDayTraders
 ¬∑ 6 Jun 2017
$BLUE.. Being Circulated now on that vol drop .. Undisclosed lawsuit fraudulent trial data; BCMA ASCO relapse/durability misleads
2
2",,2,,2,['https://pbs.twimg.com/profile_images/918587030057115648/cBhtQkQm_mini.jpg'],https://twitter.com/m_denniswinters/status/872133454573559808
2813,Damian Garde,@damiangarde,2017-06-06T16:25:48.000Z,"new 'vant licenses an overactive bladder drug from $MRK: http://prnewswire.com/news-releases/roivant-sciences-launches-urovant-to-develop-innovative-therapies-in-urology-300469547.html‚Ä¶

here's the Phase II data:","new 'vant licenses an overactive bladder drug from $MRK: http://prnewswire.com/news-releases/roivant-sciences-launches-urovant-to-develop-innovative-therapies-in-urology-300469547.html‚Ä¶

here's the Phase II data:
clinicaltrials.gov
A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder...
A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008) - Study Results.
1",,1,,,['https://pbs.twimg.com/card_img/1499934075531907072/UYy6jAXC?format=png&name=240x240'],https://twitter.com/damiangarde/status/872127391040241664
2814,Tim,@tstamm7002,2017-06-08T20:37:10.000Z,"Replying to 
@DrPaulyDeSantis
, 
@BursatilBiotech
 and 
@bradloncar","Replying to 
@DrPaulyDeSantis
, 
@BursatilBiotech
 and 
@bradloncar
$MRK and $BMY have voted positively on IDO
1",,,,1,[],https://twitter.com/tstamm7002/status/872915428900843520
2815,Branko Krstevski,@KrstevskiBranko,2017-06-09T14:16:54.000Z,"My post-ASCO $NWBO Endpoint analysis is positive
Results ~July with substantial dilution risk
MC is $34M
$BMY $MRK 

http://askthebranko.blogspot.com.au/2017/06/northwest-bio-nwbo-has-real-chance-of.html‚Ä¶","My post-ASCO $NWBO Endpoint analysis is positive
Results ~July with substantial dilution risk
MC is $34M
$BMY $MRK 

http://askthebranko.blogspot.com.au/2017/06/northwest-bio-nwbo-has-real-chance-of.html‚Ä¶
1
16
25",,1,16,25,['https://pbs.twimg.com/media/DB4iXwiUIAA7Sfr?format=jpg&name=small'],https://twitter.com/KrstevskiBranko/status/873182117152268289
2816,Bio Stocks‚Ñ¢,@BioStocks,2017-06-09T10:34:48.000Z,Cancer Setback Leaves $BMY Vulnerable to Possible Sale https://bloomberg.com/news/articles/2017-06-09/cancer-setback-leaves-bristol-myers-vulnerable-to-possible-sale‚Ä¶ #pharma $MRK,"Cancer Setback Leaves $BMY Vulnerable to Possible Sale https://bloomberg.com/news/articles/2017-06-09/cancer-setback-leaves-bristol-myers-vulnerable-to-possible-sale‚Ä¶ #pharma $MRK
bloomberg.com
Cancer Setback Leaves Bristol-Myers Vulnerable to Takeover
At a Chicago convention jammed with thousands of doctors in 2015, a buzz of excitement rippled through the hall as a researcher revealed data showing that a Bristol-Myers Squibb Co. drug cocktail had...
1
7
6",,1,7,6,['https://pbs.twimg.com/card_img/1499562077706498063/miji2GfO?format=jpg&name=small'],https://twitter.com/BioStocks/status/873126225836777473
2817,Bret Jensen,@bret_jensen,2017-06-09T18:13:27.000Z,#biotech  Dynavax: An Analysis Of The Approvability Of Heplisav-B https://seekingalpha.com/article/4080407-dynavax-analysis-approvability-heplisav-b?source=tweet‚Ä¶ $MRK $DVAX,"#biotech  Dynavax: An Analysis Of The Approvability Of Heplisav-B https://seekingalpha.com/article/4080407-dynavax-analysis-approvability-heplisav-b?source=tweet‚Ä¶ $MRK $DVAX
seekingalpha.com
Dynavax: An Analysis Of The Approvability Of Heplisav-B (NASDAQ:DVAX)
Dynavax has an FDA AdCom to review the BLA for Heplisav-B on July 28th that could significantly impact the fortunes of the company.
4
5",,,4,5,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/bret_jensen/status/873241649073328129
2818,dough,@semodough,2017-06-09T12:19:23.000Z,$MRK #KEYTRUDA Cancer Drug Proves to Be Effective Against Multiple Tumors https://nyti.ms/2sYgv2j,"$MRK #KEYTRUDA Cancer Drug Proves to Be Effective Against Multiple Tumors https://nyti.ms/2sYgv2j
2
4",,,2,4,[],https://twitter.com/semodough/status/873152543576272897
2819,Jared S. Hopkins,@JaredSHopkins,2017-06-09T12:51:46.000Z,"Big news: outside docs had voiced concerns over design of failed Opdivo trial, which $BMY wanted to finish b4 $MRK's","Big news: outside docs had voiced concerns over design of failed Opdivo trial, which $BMY wanted to finish b4 $MRK's
bloomberg.com
Cancer Setback Leaves Bristol-Myers Vulnerable to Takeover
At a Chicago convention jammed with thousands of doctors in 2015, a buzz of excitement rippled through the hall as a researcher revealed data showing that a Bristol-Myers Squibb Co. drug cocktail had...
5",,,,5,['https://pbs.twimg.com/card_img/1499562077706498063/miji2GfO?format=jpg&name=small'],https://twitter.com/JaredSHopkins/status/873160692370735104
2820,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-06-10T10:33:26.000Z,Not 8 but 10 stars: A look back at ASCO spotlights the top cancer drugs to watch - https://endpts.com/up-8-stars-a-look-back-at-asco-spotlights-the-top-cancer-drugs-to-watch-and-1-to-forget‚Ä¶ $ADAP $JUNO $KITE $NVS $MRK $LOXO,"Not 8 but 10 stars: A look back at ASCO spotlights the top cancer drugs to watch - https://endpts.com/up-8-stars-a-look-back-at-asco-spotlights-the-top-cancer-drugs-to-watch-and-1-to-forget‚Ä¶ $ADAP $JUNO $KITE $NVS $MRK $LOXO
endpts.com
8 stars: A look back at ASCO spotlights the top cancer drugs to watch, and 1 to forget
I‚Äôve been making the trek to ASCO for some years now, and I don‚Äôt recall any other week that rivals what I‚Äôve just seen. There wasn‚Äôt just important data to report on, there was a lot of it. CAR-T,...
2
2
4",,2,2,4,['https://pbs.twimg.com/card_img/1498584609684135940/MF4drHmS?format=jpg&name=small'],https://twitter.com/dhovekamp42/status/873488267500453888
2821,dough,@semodough,2017-06-09T10:42:38.000Z,"Replying to 
@BioStocks
 and 
@markets","Replying to 
@BioStocks
 and 
@markets
$MRK #KEYTRUDA on track to outsell #OPDIVO in 2018 #Bloomberg
4",,,,4,['https://pbs.twimg.com/media/DB35dnEUwAEO-T3?format=jpg&name=900x900'],https://twitter.com/semodough/status/873128197000282113
2822,John Carroll,@JohnCendpts,2017-06-09T12:35:39.000Z,"Merck cautiously steps into the PD-(L)1/CTLA-4 checkpoint fray. But should it ‚Äògo big or go home‚Äô instead?
$MRK","Merck cautiously steps into the PD-(L)1/CTLA-4 checkpoint fray. But should it ‚Äògo big or go home‚Äô instead?
$MRK
endpts.com
Merck cautiously steps into the PD-(L)1/CTLA-4 checkpoint fray. But should it ‚Äògo big or go home‚Äô...
Merck‚Äôs strategy on developing its PD-1 checkpoint drug Keytruda could be summarized as: If we have any kind of a shot at a legitimate target, we‚Äôre going to take it. Then we‚Äôll start a combo trial...
7
6",,,7,6,[],https://twitter.com/JohnCendpts/status/873156637393133568
2823,George Marcovits,@GemsBot,2017-06-10T17:44:47.000Z,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/85618728#85618827‚Ä¶,Commented on StockTwits: 4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored a... http://stocktwits.com/GemsBot/message/85618728#85618827‚Ä¶,,,,,['https://pbs.twimg.com/media/DB-jrUvUIAAq8qJ?format=jpg&name=small'],https://twitter.com/GemsBot/status/873596819728719873
2824,Pharmaceutical News,@pharma_sector,2017-06-10T18:18:02.000Z,#Merck and Pfizer Announce that Investigational SGLT2 Inhibitor Ertugliflozin Met Primary En... Read more: http://owler.us/acQfAV $MRK,#Merck and Pfizer Announce that Investigational SGLT2 Inhibitor Ertugliflozin Met Primary En... Read more: http://owler.us/acQfAV $MRK,,,,,[],https://twitter.com/pharma_sector/status/873605188484870144
2825,$PENNY KING,@groman100,2017-06-09T17:59:53.000Z,$fbio already testing that new 52 wk hi.its got MOJO $amgn $pfe $mrk $juno $kite $clls $celg $cbay $fate $zsan $oncs $loxo $cala $cara $fb,$fbio already testing that new 52 wk hi.its got MOJO $amgn $pfe $mrk $juno $kite $clls $celg $cbay $fate $zsan $oncs $loxo $cala $cara $fb,,,,,[],https://twitter.com/groman100/status/873238231957024768
2826,leahanne,@leahanneta,2017-06-09T15:12:06.000Z,"10:44 ET Volume Leader #70 - MRK 1,956,529 Merck & Company $MRK 63.81 +0.61 +0.97% High today of 63.96 day low","10:44 ET Volume Leader #70 - MRK 1,956,529 Merck & Company $MRK 63.81 +0.61 +0.97% High today of 63.96 day low
investorshangout.com
10:44 ET Volume Leader #70 - MRK - Xtremepicks Alerts #4598377 - Investors Hangout
Xtremepicks Alerts: 10:44 ET Volume Leader #70 - MRK 1,956,529 Merck Company $MRK 63.81 +0.61 +0.97% High today of 63. - #4598377",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/873196008313937920
2827,FierceBiotech,@FierceBiotech,2017-06-09T11:07:33.000Z,"Merck‚Äôs Mammen joins Johnson & Johnson to head R&D, freeing Hait to take up new innovation position: http://ow.ly/W4iM30csc8s $MRK $JNJ","Merck‚Äôs Mammen joins Johnson & Johnson to head R&D, freeing Hait to take up new innovation position: http://ow.ly/W4iM30csc8s $MRK $JNJ
fiercebiotech.com
Merck‚Äôs Mammen joins Johnson & Johnson to head R&D, freeing Hait to take up new external innovation...
Mathai Mammen, M.D., Ph.D., is leaving Merck after a little more than a year at the company to | Mathai Mammen, M.D., Ph.D., is leaving Merck after a little more than one year at the company to take...
1",,,1,,[],https://twitter.com/FierceBiotech/status/873134468239896576
2828,Hottest Stocks Now,@HottestStockNow,2017-06-09T10:16:25.000Z,"Market Recap for Fri, June 9 - $TSLA, $MRK, $CAT, $JPM, $ENDP, $JWN, $C, $ALXN, $DIS, $YHOO, $NVDA, $PG, $URBN, $XLF","Market Recap for Fri, June 9 - $TSLA, $MRK, $CAT, $JPM, $ENDP, $JWN, $C, $ALXN, $DIS, $YHOO, $NVDA, $PG, $URBN, $XLF
crweworld.com
The Princeton Research Report (TSLA, MRK, CAT, JPM, ENDP, JWN, C, ALXN, DIS, YHOO, NVDA, PG, URBN,...
Daily Commentary Stocks reached their best levels while James Comey was finishing his conversation. It had little effect; and stocks settled back down after he was finished: The Dow had been up Over...",,,,,[],https://twitter.com/HottestStockNow/status/873121599683051520
2829,Ticker Report,@TickerReport,2017-06-10T09:32:55.000Z,"St. Johns Investment Management Company LLC Sells 295 Shares of Merck & Co., Inc. $MRK http://zpr.io/P5ZK4","St. Johns Investment Management Company LLC Sells 295 Shares of Merck & Co., Inc. $MRK http://zpr.io/P5ZK4",,,,,[],https://twitter.com/TickerReport/status/873473038737649665
2830,Watchlist News,@WatchlistN,2017-06-11T02:14:50.000Z,"Merck & Co. $MRK Earning Somewhat Positive News Coverage, Study Shows http://zpr.io/P5NT5","Merck & Co. $MRK Earning Somewhat Positive News Coverage, Study Shows http://zpr.io/P5NT5",,,,,[],https://twitter.com/WatchlistN/status/873725178118799360
2831,Carly Helfand,@CarlyHFierce,2017-06-09T15:03:01.000Z,"Merck, hedging its bets against $BMY and $AZN, strikes up Keytruda-CTLA4 combo trial: http://bit.ly/2r9uN3T $MRK #pharma","Merck, hedging its bets against $BMY and $AZN, strikes up Keytruda-CTLA4 combo trial: http://bit.ly/2r9uN3T $MRK #pharma
fiercepharma.com
Merck, hedging its bets against Bristol-Myers Squibb and AstraZeneca, strikes up Keytruda-CTLA4...
1",,,1,,['https://pbs.twimg.com/card_img/1501988131381252099/PokwsRl5?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/873193724255371265
2832,SwingTradeBot,@SwingTradeBot,2017-06-09T21:34:09.000Z,Scan results - Bullish Engulfing today: $URBN $CATO $SM $BAS $RDS.B $DIS $CCP $MRK $ENLK $CVA ... https://swingtradebot.com/events/13/equities?selected_date=2017-06-09‚Ä¶,Scan results - Bullish Engulfing today: $URBN $CATO $SM $BAS $RDS.B $DIS $CCP $MRK $ENLK $CVA ... https://swingtradebot.com/events/13/equities?selected_date=2017-06-09‚Ä¶,,,,,[],https://twitter.com/SwingTradeBot/status/873292156563333122
2833,MarketBeat,@MarketBeatCom,2017-06-10T11:30:47.000Z,"Benin Management CORP Cuts Stake in Merck & Co., Inc. $MRK http://zpr.io/P5jgJ","Benin Management CORP Cuts Stake in Merck & Co., Inc. $MRK http://zpr.io/P5jgJ",,,,,[],https://twitter.com/MarketBeatCom/status/873502702503854080
2834,MarketBeat,@MarketBeatCom,2017-06-09T14:23:29.000Z,"Merck & Co., Inc. $MRK Earns ‚ÄúBuy‚Äù Rating from BMO Capital Markets http://zpr.io/P5RfJ","Merck & Co., Inc. $MRK Earns ‚ÄúBuy‚Äù Rating from BMO Capital Markets http://zpr.io/P5RfJ",,,,,[],https://twitter.com/MarketBeatCom/status/873183775102029827
2835,US Banking News,@AmericanBanking,2017-06-09T20:11:33.000Z,Merck & Co. Receives Consensus Buy Rating from Analysts $MRK http://ift.tt/2qbDsRN,Merck & Co. Receives Consensus Buy Rating from Analysts $MRK http://ift.tt/2qbDsRN,,,,,[],https://twitter.com/AmericanBanking/status/873271366484717568
2836,US Banking News,@AmericanBanking,2017-06-11T12:52:32.000Z,"$9.67 Billion in Sales Expected for Merck & Co., Inc. $MRK This Quarter http://ift.tt/2rjmWvY","$9.67 Billion in Sales Expected for Merck & Co., Inc. $MRK This Quarter http://ift.tt/2rjmWvY",,,,,[],https://twitter.com/AmericanBanking/status/873885662180769792
2837,SwingTradeBot,@SwingTradeBot,2017-06-10T09:59:15.000Z,$MRK technical alerts: Bullish Engulfing and Crossed Above 50 DMA,"$MRK technical alerts: Bullish Engulfing and Crossed Above 50 DMA
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/873479667499577344
2838,US Banking News,@AmericanBanking,2017-06-09T20:32:14.000Z,"Zacks: Analysts Anticipate Merck & Co., Inc. $MRK Will Post Earnings of $0.87 Per Share http://ift.tt/2smY6jd","Zacks: Analysts Anticipate Merck & Co., Inc. $MRK Will Post Earnings of $0.87 Per Share http://ift.tt/2smY6jd",,,,,[],https://twitter.com/AmericanBanking/status/873276573734117378
2839,Crypto Trader Pro,@CryptoTraderPro,2017-06-09T13:50:11.000Z,"Unusual call buying: $KSU 16x average volume, $YHOO 15x, $TAP 9x, $BABA 8x, $JWN 7x, $BBT 4x, $MRK 4x, $RRC 4x ‚Üí via http://bit.do/TradOTO","Unusual call buying: $KSU 16x average volume, $YHOO 15x, $TAP 9x, $BABA 8x, $JWN 7x, $BBT 4x, $MRK 4x, $RRC 4x ‚Üí via http://bit.do/TradOTO",,,,,[],https://twitter.com/CryptoTraderPro/status/873175395582959620
2840,TalkMarkets,@TalkMarkets,2017-06-09T07:39:21.000Z,Biotech Stocks Best Chance For Breakout! $IBB $XBI Also $AZN $BMY $ELY $MRK $NVS $PFE $INCY $REGN $AMGN $BIIB $CELG https://goo.gl/Bi38QV,Biotech Stocks Best Chance For Breakout! $IBB $XBI Also $AZN $BMY $ELY $MRK $NVS $PFE $INCY $REGN $AMGN $BIIB $CELG https://goo.gl/Bi38QV,,,,,[],https://twitter.com/TalkMarkets/status/873082072180473856
2841,GREEN STOCK NEWS,@greenstocknews,2017-06-09T18:07:22.000Z,Dynavax: An Analysis Of The Approvability Of Heplisav-B https://seekingalpha.com/article/4080407-dynavax-analysis-approvability-heplisav-b?source=feed_f‚Ä¶ $MRK $DVAX OMG-STOCK SYMBOL DCSA http://docasainc.com,"Dynavax: An Analysis Of The Approvability Of Heplisav-B https://seekingalpha.com/article/4080407-dynavax-analysis-approvability-heplisav-b?source=feed_f‚Ä¶ $MRK $DVAX OMG-STOCK SYMBOL DCSA http://docasainc.com
seekingalpha.com
Dynavax: An Analysis Of The Approvability Of Heplisav-B (NASDAQ:DVAX)
Dynavax has an FDA AdCom to review the BLA for Heplisav-B on July 28th that could significantly impact the fortunes of the company.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/greenstocknews/status/873240115929395200
2842,WLST.com,@wlstcom,2017-06-09T18:07:25.000Z,Dynavax: An Analysis Of The Approvability Of Heplisav-B #MRK #DVAX #DecisionAnalytics $MRK https://seekingalpha.com/article/4080407-dynavax-analysis-approvability-heplisav-b‚Ä¶,Dynavax: An Analysis Of The Approvability Of Heplisav-B #MRK #DVAX #DecisionAnalytics $MRK https://seekingalpha.com/article/4080407-dynavax-analysis-approvability-heplisav-b‚Ä¶,,,,,['https://pbs.twimg.com/media/DB5fRKPXoAAU0xH?format=jpg&name=small'],https://twitter.com/wlstcom/status/873240129305026564
2843,Dakota Financial,@dakotafinancial,2017-06-11T12:11:31.000Z,"Everence Capital Management Inc. Holds Stake in Merck & Co., Inc. $MRK http://zpr.io/P5xYn","Everence Capital Management Inc. Holds Stake in Merck & Co., Inc. $MRK http://zpr.io/P5xYn",,,,,[],https://twitter.com/dakotafinancial/status/873875340464140288
2844,Ticker Report,@TickerReport,2017-06-09T12:33:22.000Z,"Merck & Co., Inc. $MRK Earns ‚ÄúBuy‚Äù Rating from BMO Capital Markets http://ift.tt/2r9ad3O","Merck & Co., Inc. $MRK Earns ‚ÄúBuy‚Äù Rating from BMO Capital Markets http://ift.tt/2r9ad3O",,,,,[],https://twitter.com/TickerReport/status/873156063683637248
2845,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-06-09T13:50:11.000Z,"Unusual call buying: $KSU 16x average volume, $YHOO 15x, $TAP 9x, $BABA 8x, $JWN 7x, $BBT 4x, $MRK 4x, $RRC 4x ‚Üí via http://bit.do/TradOTO","Unusual call buying: $KSU 16x average volume, $YHOO 15x, $TAP 9x, $BABA 8x, $JWN 7x, $BBT 4x, $MRK 4x, $RRC 4x ‚Üí via http://bit.do/TradOTO",,,,,[],https://twitter.com/AlertTrade/status/873175392965672961
2846,Dakota Financial,@dakotafinancial,2017-06-10T11:30:48.000Z,"Benin Management CORP Cuts Stake in Merck & Co., Inc. $MRK http://zpr.io/P5jgJ","Benin Management CORP Cuts Stake in Merck & Co., Inc. $MRK http://zpr.io/P5jgJ",,,,,[],https://twitter.com/dakotafinancial/status/873502706916372480
2847,Volatility,@getvolatility,2017-06-09T13:48:54.000Z,"Unusual call buying: $KSU 16x average volume, $YHOO 15x, $TAP 9x, $BABA 8x, $JWN 7x, $BBT 4x, $MRK 4x, $RRC 4x","Unusual call buying: $KSU 16x average volume, $YHOO 15x, $TAP 9x, $BABA 8x, $JWN 7x, $BBT 4x, $MRK 4x, $RRC 4x",,,,,[],https://twitter.com/getvolatility/status/873175072835608576
2848,David Crow,@bydavidcrow,2017-06-12T20:22:24.000Z,"Merck suspends enrolment into Keytruda combo trial with Celgene's Polymast to ""better understand more reports of deaths"" $MRK $CELG","Merck suspends enrolment into Keytruda combo trial with Celgene's Polymast to ""better understand more reports of deaths"" $MRK $CELG
2
2",,,2,2,['https://pbs.twimg.com/media/DCJaws_XoAEXKN-?format=jpg&name=small'],https://twitter.com/bydavidcrow/status/874361264176279552
2849,Christian Fromhertz,@cfromhertz,2017-06-14T21:23:02.000Z,"TTG Themes of the day(below): $TOL $DHI $AKS $BLDR $MO $MRK $GS $STX $CSCO $OCLR $EMES $TROW $XL $TSLA $GIS $RIG $XOP $VNQ $HYG
#DailyRecap","TTG Themes of the day(below): $TOL $DHI $AKS $BLDR $MO $MRK $GS $STX $CSCO $OCLR $EMES $TROW $XL $TSLA $GIS $RIG $XOP $VNQ $HYG
#DailyRecap
3",,,,3,['https://pbs.twimg.com/media/DCT7-PjXYAAfUI3?format=jpg&name=small'],https://twitter.com/cfromhertz/status/875101296059179009
2850,FiercePharma,@FiercePharma,2017-06-13T20:57:13.000Z,"Response to Merck's Ebola vaccine lasts at least a year, study finds http://fiercepharma.com/infectious-diseases/merck-s-ebola-vaccine-gets-new-proof-for-at-least-1-year-protection‚Ä¶ $MRK","Response to Merck's Ebola vaccine lasts at least a year, study finds http://fiercepharma.com/infectious-diseases/merck-s-ebola-vaccine-gets-new-proof-for-at-least-1-year-protection‚Ä¶ $MRK
5
3",,,5,3,[],https://twitter.com/FiercePharma/status/874732413745868802
2851,Vista Partners LLC,@VistaPResearch,2017-06-14T03:55:26.000Z,"@HealthView
 thanks for follow! All the best from #SanFrancisco! See Vista Partners #InvestingForGrowth #biotech http://vistapglobal.com $MRK","@HealthView
 thanks for follow! All the best from #SanFrancisco! See Vista Partners #InvestingForGrowth #biotech http://vistapglobal.com $MRK
GIF
4
2",,,4,2,[],https://twitter.com/VistaPResearch/status/874837658673008648
2852,Bursatil Biotech,@BursatilBiotech,2017-06-14T11:45:19.000Z,"Immune Checkpoint Antibodies $MRK $BMY 
Pembro and Nivo rule
h/t: 
@DrRaulCordoba","Immune Checkpoint Antibodies $MRK $BMY 
Pembro and Nivo rule
h/t: 
@DrRaulCordoba
2
1",,,2,1,['https://pbs.twimg.com/media/DCR3p9tXoAIny-a?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/874955911730692096
2853,Vista Partners LLC,@VistaPResearch,2017-06-12T19:38:49.000Z,"@7crownzteam
 Thanks for follow! See Vista Partners #Investing #biotech #healthcare http://vistapglobal.com $HIIQ $PFE $JNJ $MRK $IBB","@7crownzteam
 Thanks for follow! See Vista Partners #Investing #biotech #healthcare http://vistapglobal.com $HIIQ $PFE $JNJ $MRK $IBB
GIF
3
3",,,3,3,['https://pbs.twimg.com/tweet_video_thumb/DCJQ7sfVYAAwOmx.jpg'],https://twitter.com/VistaPResearch/status/874350295769202689
2854,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-06-14T17:44:09.000Z,#GoTeamUK  Just say no to the failed drug model from $GSK $MRK $JNJ $PFE,"#GoTeamUK  Just say no to the failed drug model from $GSK $MRK $JNJ $PFE
LD
@Dayadog
 ¬∑ 14 Jun 2017
UK first publicly available dedicated cannabis research facility, 'world firsts' in the study of medicinal benefits http://independent.co.uk/news/uk/medipen-cbd-vaporiser-uk-gets-first-publicly-available-dedicated-cannabis-weed-marijuana-research-a7789891.html‚Ä¶
1",,,,1,['https://pbs.twimg.com/profile_images/2914351309/e34776686a80bd5faade4ddde7620fdc_mini.jpeg'],https://twitter.com/ZimJay/status/875046214466756608
2855,John Carroll,@JohnCendpts,2017-06-13T10:04:25.000Z,"Merck halts enrollment on two PhIII Keytruda combo studies as outside monitors flag a worrying rate of deaths
$MRK","Merck halts enrollment on two PhIII Keytruda combo studies as outside monitors flag a worrying rate of deaths
$MRK
endpts.com
Merck halts enrollment on two PhIII Keytruda combo studies as outside monitors flag a worrying rate...
Merck $MRK has had to hit the brakes on enrolling new patients for two of its late-stage combo studies involving its blockbuster checkpoint Keytruda after the monitoring committee raised a red flag...
2
3",,,2,3,['https://pbs.twimg.com/card_img/1501722498299305991/-5qINZp-?format=png&name=small'],https://twitter.com/JohnCendpts/status/874568130768625664
2856,Herkyleese,@herkyleese,2017-06-12T16:49:52.000Z,"https://youtu.be/BymtCdksLrM
#Dcvax-L will change how we treat #GBM  patients living longer than expected! #Wow  $nwbo $juno $kite $bmy $mrk know","https://youtu.be/BymtCdksLrM
#Dcvax-L will change how we treat #GBM  patients living longer than expected! #Wow  $nwbo $juno $kite $bmy $mrk know
youtube.com
dcvax l youtube
$Nwbo #dcvax #ucla #dendritic cell vaccineCancer fighting therapy for (gbm) glioblastoma!
2
4",,,2,4,[],https://twitter.com/herkyleese/status/874307777967136770
2857,FiercePharma,@FiercePharma,2017-06-13T23:00:01.000Z,"In unexpected blow, Merck halts Keytruda myeloma trial enrollment to probe patient deaths http://fiercepharma.com/pharma/merck-halts-keytruda-myeloma-study-enrollment-to-gather-info-trial-deaths‚Ä¶ $MRK","In unexpected blow, Merck halts Keytruda myeloma trial enrollment to probe patient deaths http://fiercepharma.com/pharma/merck-halts-keytruda-myeloma-study-enrollment-to-gather-info-trial-deaths‚Ä¶ $MRK
fiercepharma.com
In unexpected blow, Merck halts Keytruda myeloma trial enrollment to probe patient deaths
The streak of positive Keytruda updates had to end somewhere. | The streak of positive Keytruda updates had to end somewhere. After an onslaught of upbeat trial results and regulatory news, drug...
2
2",,,2,2,['https://pbs.twimg.com/card_img/1501722504192303105/c8yuYbIE?format=jpg&name=small'],https://twitter.com/FiercePharma/status/874763314437533696
2858,AJMC-Diabetes Mgt,@EBDiabetes,2017-06-12T18:18:20.000Z,"Results Show Lower #A1C for #Ertugliflozin, w, Metformin and w. #Sitagliptin #SGLT2 $MRK $PFE https://shar.es/1RVlxt via 
@ajmc_journal","Results Show Lower #A1C for #Ertugliflozin, w, Metformin and w. #Sitagliptin #SGLT2 $MRK $PFE https://shar.es/1RVlxt via 
@ajmc_journal
2
3",,,2,3,[],https://twitter.com/EBDiabetes/status/874330041869508608
2859,Seeking Alpha,@SeekingAlpha,2017-06-14T15:09:43.000Z,"3 Things In Biotech You Should Learn Today: June 14, 2017 https://seekingalpha.com/article/4081373-3-things-biotech-learn-today-june-14-2017?source=feed_f‚Ä¶ $AST $BTX $MRK $XLRN","3 Things In Biotech You Should Learn Today: June 14, 2017 https://seekingalpha.com/article/4081373-3-things-biotech-learn-today-june-14-2017?source=feed_f‚Ä¶ $AST $BTX $MRK $XLRN
1
1",,,1,1,[],https://twitter.com/SeekingAlpha/status/875007349102071808
2860,Seeking Alpha,@SeekingAlpha,2017-06-13T18:44:32.000Z,A Threat To Merck & Co's Lead In Multiple Myeloma https://seekingalpha.com/article/4081178-threat-merck-and-cos-lead-multiple-myeloma?source=feed_f‚Ä¶ $BMY $CELG $AZN $RHHBY $MRK,"A Threat To Merck & Co's Lead In Multiple Myeloma https://seekingalpha.com/article/4081178-threat-merck-and-cos-lead-multiple-myeloma?source=feed_f‚Ä¶ $BMY $CELG $AZN $RHHBY $MRK
1",,,1,,[],https://twitter.com/SeekingAlpha/status/874699023390654464
2861,Kara Jill Stancell,@kjilly,2017-06-13T21:50:18.000Z,"In unexpected blow, $MRK halts #Keytruda #myeloma trial enrollment to probe #patientdeaths #pharma #faileddrugs","In unexpected blow, $MRK halts #Keytruda #myeloma trial enrollment to probe #patientdeaths #pharma #faileddrugs
fiercepharma.com
In unexpected blow, Merck halts Keytruda myeloma trial enrollment to probe patient deaths
The streak of positive Keytruda updates had to end somewhere. | The streak of positive Keytruda updates had to end somewhere. After an onslaught of upbeat trial results and regulatory news, drug...
1",,,1,,['https://pbs.twimg.com/card_img/1501722504192303105/c8yuYbIE?format=jpg&name=small'],https://twitter.com/kjilly/status/874745772595699713
2862,Wall Street Horizon,@WallStHorizon,2017-06-14T15:46:10.000Z,Create a watchlist in Enchilada to keep on top of important corporate events $BAX $GILD $MRK $CELG $AGN $AMGN $jnj http://bit.ly/1O5OFcE,"Create a watchlist in Enchilada to keep on top of important corporate events $BAX $GILD $MRK $CELG $AGN $AMGN $jnj http://bit.ly/1O5OFcE
1
1",,,1,1,['https://pbs.twimg.com/media/DCSueSjUIAAX0n8?format=jpg&name=small'],https://twitter.com/WallStHorizon/status/875016520782499841
2863,$peedyCalls,@SpeedyCalls,2017-06-14T17:21:42.000Z,"$MRK 67.5 Calls BUYING Activity expiring on 18th Aug, Vol 4292","$MRK 67.5 Calls BUYING Activity expiring on 18th Aug, Vol 4292
1",,,1,,[],https://twitter.com/SpeedyCalls/status/875040565452300289
2864,Rishesh Singh,@androsForm,2017-06-13T18:47:29.000Z,Top Sell Money Flow - $QQQ $AMZN $IWM $CSCO $SYMC $LQD $MRK $XL $MDLZ $VOO,"Top Sell Money Flow - $QQQ $AMZN $IWM $CSCO $SYMC $LQD $MRK $XL $MDLZ $VOO
62
2",,,62,2,[],https://twitter.com/androsForm/status/874699763538690048
2865,Rishesh Singh,@androsForm,2017-06-14T17:50:42.000Z,$MRK chart https://tradingview.com/x/ftIgxjDi/ via https://tradingview.com,"$MRK chart https://tradingview.com/x/ftIgxjDi/ via https://tradingview.com
58
3",,,58,3,[],https://twitter.com/androsForm/status/875047862920503296
2866,Ben Fidler,@BentheFidler,2017-06-13T00:50:32.000Z,"In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths http://xconomy.com/new-york/2017/06/12/in-a-myeloma-setback-merck-halts-studies-due-to-patient-deaths/‚Ä¶ $MRK $BMY $AZN","In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths http://xconomy.com/new-york/2017/06/12/in-a-myeloma-setback-merck-halts-studies-due-to-patient-deaths/‚Ä¶ $MRK $BMY $AZN
1
4",,,1,4,[],https://twitter.com/BentheFidler/status/874428741820219392
2867,BioPharma Dive,@BioPharmaDive,2017-06-14T23:12:00.000Z,Plenty of pharma representation in the newest installment of the Fortune 500 list http://bit.ly/2sofZ0D $JNJ $PFE $MRK $ABBV $AMGN $CELG,"Plenty of pharma representation in the newest installment of the Fortune 500 list http://bit.ly/2sofZ0D $JNJ $PFE $MRK $ABBV $AMGN $CELG
biopharmadive.com
J&J, Pfizer, Merck sit atop Fortune's 500 for pharma
In spite their own larger-than-life revenues, pharmas still placed behind many drug wholesalers and PBMs.
2",,,,2,[],https://twitter.com/BioPharmaDive/status/875128720796696577
2868,Vista Partners LLC,@VistaPResearch,2017-06-13T18:43:42.000Z,"@the_lost_gent
 thanks for follow! See Vista Partners #InvestingForGrowth #Dow30 #healthcare http://vistapglobal.com $HIIQ $PFE $MRK $JNJ","@the_lost_gent
 thanks for follow! See Vista Partners #InvestingForGrowth #Dow30 #healthcare http://vistapglobal.com $HIIQ $PFE $MRK $JNJ
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DCON7gzU0AAykf7.jpg'],https://twitter.com/VistaPResearch/status/874698813516038146
2869,Allison Gatlin,@IBD_AGatlin,2017-06-12T15:45:30.000Z,Roche-NewLink drug move shouldn't impact Incyte: Analyst $RHHBY $NLNK $INCY $BMY $MRK,"Roche-NewLink drug move shouldn't impact Incyte: Analyst $RHHBY $NLNK $INCY $BMY $MRK
investors.com
Roche-NewLink Drug Move Shouldn't Impact Incyte, Says Analyst
Roche returned a licensed immuno-oncology drug to NewLink on low efficacy, but analysts say that shouldn't impact Incyte which has a rivaling drug.",,,,,[],https://twitter.com/IBD_AGatlin/status/874291579103662080
2870,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-06-13T19:20:23.000Z,Commented on A Threat To Merck & Co's Lead In Multiple Myeloma https://seekingalpha.com/article/4081178-threat-merck-and-cos-lead-multiple-myeloma?source=tweet‚Ä¶ $BMY $CELG $AZN $RHHBY $MRK,Commented on A Threat To Merck & Co's Lead In Multiple Myeloma https://seekingalpha.com/article/4081178-threat-merck-and-cos-lead-multiple-myeloma?source=tweet‚Ä¶ $BMY $CELG $AZN $RHHBY $MRK,,,,,[],https://twitter.com/dhovekamp42/status/874708042486398977
2871,Helen Ong,@Lin_ling_88,2017-06-13T14:48:13.000Z,"$MRK halts enrollment on two PhIII Keytruda combo studies as monitors flag a worrying rate of deaths

#PartyOver? https://endpts.com/merck-halts-enrollment-on-two-phiii-keytruda-studies-as-outside-monitors-flag-a-worrying-rate-of-deaths/?utm_medium=email&utm_campaign=Tuesday%20%20June%2013%202017&utm_content=Tuesday%20%20June%2013%202017+CID_a8a2b5e43f41ba8f9d5d913405010ccc&utm_source=ENDPOINTS%20emails&utm_term=Merck%20halts%20enrollment%20on%20two%20PhIII%20Keytruda%20combo%20studies%20as%20outside%20monitors%20flag%20a%20worrying%20rate%20of%20deaths‚Ä¶","$MRK halts enrollment on two PhIII Keytruda combo studies as monitors flag a worrying rate of deaths

#PartyOver? https://endpts.com/merck-halts-enrollment-on-two-phiii-keytruda-studies-as-outside-monitors-flag-a-worrying-rate-of-deaths/?utm_medium=email&utm_campaign=Tuesday%20%20June%2013%202017&utm_content=Tuesday%20%20June%2013%202017+CID_a8a2b5e43f41ba8f9d5d913405010ccc&utm_source=ENDPOINTS%20emails&utm_term=Merck%20halts%20enrollment%20on%20two%20PhIII%20Keytruda%20combo%20studies%20as%20outside%20monitors%20flag%20a%20worrying%20rate%20of%20deaths‚Ä¶
1",,,,1,[],https://twitter.com/Lin_ling_88/status/874639550043303937
2872,Pharmaceutical News,@pharma_sector,2017-06-13T21:01:29.000Z,#Merck shares slide as drugs giant forced to halt enrolment of two late-stage cancer studies. Read more: http://owler.us/acQW0n $MRK,#Merck shares slide as drugs giant forced to halt enrolment of two late-stage cancer studies. Read more: http://owler.us/acQW0n $MRK,,,,,[],https://twitter.com/pharma_sector/status/874733484270473216
2873,TW Research Group,@DanCarlson33,2017-06-14T14:36:22.000Z,CEO update from $BTI.V. Company is well positioned in the exciting #neuroscience field. $MRK $BIIB $NVS,"CEO update from $BTI.V. Company is well positioned in the exciting #neuroscience field. $MRK $BIIB $NVS
twresearchgroup.com
biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders
Tailwinds' Take: this long awaited update from the new CEO shows that he's a thoughtful, reasoned leader who understands the technology and its place in the medical field. Going forward, biOasis will...",,,,,['https://pbs.twimg.com/card_img/1501722518582927365/Jsr1BGiI?format=jpg&name=240x240'],https://twitter.com/DanCarlson33/status/874998957637640194
2874,MarketBeat,@MarketBeatCom,2017-06-12T22:29:11.000Z,Investors Purchase High Volume of Merck & Company Call Options $MRK http://ift.tt/2rbRRuK #acn,Investors Purchase High Volume of Merck & Company Call Options $MRK http://ift.tt/2rbRRuK #acn,,,,,[],https://twitter.com/MarketBeatCom/status/874393167470235648
2875,US Banking News,@AmericanBanking,2017-06-13T18:00:48.000Z,Merck & Company's buy rating reiterated at Credit Suisse Group. http://ift.tt/2sp9fjW $MRK #MRK,Merck & Company's buy rating reiterated at Credit Suisse Group. http://ift.tt/2sp9fjW $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/874688015653892097
2876,TalkMarkets,@TalkMarkets,2017-06-13T21:05:00.000Z,Johnson & Johnson Diabetes Data Seen As Boon For #EliLilly $JNJ Also $MRK $LLY https://goo.gl/5bHKBa,Johnson & Johnson Diabetes Data Seen As Boon For #EliLilly $JNJ Also $MRK $LLY https://goo.gl/5bHKBa,,,,,[],https://twitter.com/TalkMarkets/status/874734369373597697
2877,CBPartners,@CBPartners,2017-06-14T11:40:05.000Z,$MRK holds patient enrollment for PIII #MultipleMyeloma KEYTRUDA combination studies to address safety concerns,"$MRK holds patient enrollment for PIII #MultipleMyeloma KEYTRUDA combination studies to address safety concerns
pharmatimes.com
Merck pauses Keytruda studies to assess patient deaths
Merck has paused new enrolment in two studies assessing its immunotherapy Keytruda treatment in combination with other therapies in multiple myeloma to address safety concerns.",,,,,['https://pbs.twimg.com/card_img/1501285273019183106/EKZBvDLs?format=jpg&name=240x240'],https://twitter.com/CBPartners/status/874954594509631489
2878,GREEN STOCK NEWS,@greenstocknews,2017-06-14T15:12:24.000Z,"3 Things In Biotech You Should Learn Today: June 14, 2017 https://seekingalpha.com/article/4081373-3-things-biotech-learn-today-june-14-2017?source=feed_f‚Ä¶ $AST $BTX $MRK $XLRN OMG-STOCK SYMBOL DCSA www.docasainc‚Ä¶","3 Things In Biotech You Should Learn Today: June 14, 2017 https://seekingalpha.com/article/4081373-3-things-biotech-learn-today-june-14-2017?source=feed_f‚Ä¶ $AST $BTX $MRK $XLRN OMG-STOCK SYMBOL DCSA www.docasainc‚Ä¶",,,,,[],https://twitter.com/greenstocknews/status/875008023252676609
2879,GREEN STOCK NEWS,@greenstocknews,2017-06-14T12:07:38.000Z,Bristol-Myers Squibb: Still Too Many Uncertainties In The I/O Space https://seekingalpha.com/article/4081330-bristol-myers-squibb-still-many-uncertainties-o-space?source=feed_f‚Ä¶ $AZN $MRK $RHHBY $BMY OMG-STOCK SYMBOL DCSA ww‚Ä¶,Bristol-Myers Squibb: Still Too Many Uncertainties In The I/O Space https://seekingalpha.com/article/4081330-bristol-myers-squibb-still-many-uncertainties-o-space?source=feed_f‚Ä¶ $AZN $MRK $RHHBY $BMY OMG-STOCK SYMBOL DCSA ww‚Ä¶,,,,,[],https://twitter.com/greenstocknews/status/874961526054105089
2880,Matthias Piesche,@PiescheLab,2017-06-12T20:53:27.000Z,"Not every combo works

$MRK halts enrollment on 2 Ph3 Keytruda combos coz of worrying rate of deaths https://endpts.com/merck-halts-enrollment-on-two-phiii-keytruda-studies-as-outside-monitors-flag-a-worrying-rate-of-deaths/‚Ä¶ #immunotherapy","Not every combo works

$MRK halts enrollment on 2 Ph3 Keytruda combos coz of worrying rate of deaths https://endpts.com/merck-halts-enrollment-on-two-phiii-keytruda-studies-as-outside-monitors-flag-a-worrying-rate-of-deaths/‚Ä¶ #immunotherapy",,,,,[],https://twitter.com/PiescheLab/status/874369074821771264
2881,Ben Fidler,@BentheFidler,2017-06-13T11:08:29.000Z,"IYCMI: In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths http://xconomy.com/new-york/2017/06/12/in-a-myeloma-setback-merck-halts-studies-due-to-patient-deaths/‚Ä¶ $MRK $AZN $BMY","IYCMI: In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths http://xconomy.com/new-york/2017/06/12/in-a-myeloma-setback-merck-halts-studies-due-to-patient-deaths/‚Ä¶ $MRK $AZN $BMY
1
1",,,1,1,[],https://twitter.com/BentheFidler/status/874584251416576000
2882,Carly Helfand,@CarlyHFierce,2017-06-13T20:46:00.000Z,"#ICYMI: In unexpected blow, Merck halts Keytruda myeloma trial enrollment to probe patient deaths http://bit.ly/2rsMgzt $MRK #pharma","#ICYMI: In unexpected blow, Merck halts Keytruda myeloma trial enrollment to probe patient deaths http://bit.ly/2rsMgzt $MRK #pharma
fiercepharma.com
In unexpected blow, Merck halts Keytruda myeloma trial enrollment to probe patient deaths
The streak of positive Keytruda updates had to end somewhere. | The streak of positive Keytruda updates had to end somewhere. After an onslaught of upbeat trial results and regulatory news, drug...
2",,,2,,['https://pbs.twimg.com/card_img/1501722504192303105/c8yuYbIE?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/874729591176216577
2883,MarketBeat,@MarketBeatCom,2017-06-13T17:59:35.000Z,Merck & Company's buy rating reiterated at Credit Suisse Group. http://ift.tt/2sp9fjW $MRK #MRK,Merck & Company's buy rating reiterated at Credit Suisse Group. http://ift.tt/2sp9fjW $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/874687710274965504
2884,1 min Stock Insights,@1MinuteStock,2017-06-12T22:16:03.000Z,Wondering about risks of $MRK? The 21-day volatility is 3.67%,"Wondering about risks of $MRK? The 21-day volatility is 3.67%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/874389862752845825
2885,Hottest Stocks Now,@HottestStockNow,2017-06-14T17:00:50.000Z,"$MRK, $LLY, $PETS, $ZTS - Patented Biotech Formulations Resulting in New Generation of Animal Healthcare Medications http://crweworld.com/newsroom/prnewswire?rkey=20170614enUK201706145115&filter=10284‚Ä¶","$MRK, $LLY, $PETS, $ZTS - Patented Biotech Formulations Resulting in New Generation of Animal Healthcare Medications http://crweworld.com/newsroom/prnewswire?rkey=20170614enUK201706145115&filter=10284‚Ä¶",,,,,[],https://twitter.com/HottestStockNow/status/875035314087231489
2886,Jacob Bell,@realJacobBell,2017-06-13T15:55:01.000Z,"$MRK pauses Keytruda trials, raising concerns about class http://bit.ly/2s700C2","$MRK pauses Keytruda trials, raising concerns about class http://bit.ly/2s700C2",,,,,[],https://twitter.com/realJacobBell/status/874656362445328384
2887,CBPartners,@CBPartners,2017-06-13T18:10:08.000Z,$MRK & $PFE announce investigational oral SGLT-2 inhibitor ERTUGLIFLOZIN meets primary endpoints in key PIII study http://on.pfizer.com/2siVr9F,$MRK & $PFE announce investigational oral SGLT-2 inhibitor ERTUGLIFLOZIN meets primary endpoints in key PIII study http://on.pfizer.com/2siVr9F,,,,,[],https://twitter.com/CBPartners/status/874690363079970818
2888,Jacob Bell,@realJacobBell,2017-06-14T15:56:01.000Z,How $MRK hopes to win in I/O combos: Q&A with Roy Baynes,"How $MRK hopes to win in I/O combos: Q&A with Roy Baynes
biopharmadive.com
How Merck hopes to win in I/O combos: Q&A with Roy Baynes
Combinations are pegged as the next step forward in immuno-oncology. Speaking with BioPharma Dive at ASCO, Merck's Roy Baynes cautioned how little is known about the best pairing and explained why...",,,,,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/realJacobBell/status/875019000824176641
2889,TalkMarkets,@TalkMarkets,2017-06-13T12:07:50.000Z,"Morning Call For Tuesday, June 13 $FR $MRK $RE $WDC $ATHN $CLNT $GTXI $CLVS $STX $SYNA $SAIC $XLRN $AHH https://goo.gl/na0SqO","Morning Call For Tuesday, June 13 $FR $MRK $RE $WDC $ATHN $CLNT $GTXI $CLVS $STX $SYNA $SAIC $XLRN $AHH https://goo.gl/na0SqO",,,,,[],https://twitter.com/TalkMarkets/status/874599187895246849
2890,US Banking News,@AmericanBanking,2017-06-14T02:04:29.000Z,Brokerage Give Consensus Hold Rating to Merck & Company $MRK http://ift.tt/2qbDsRN,Brokerage Give Consensus Hold Rating to Merck & Company $MRK http://ift.tt/2qbDsRN,,,,,[],https://twitter.com/AmericanBanking/status/874809740005711873
2891,TalkMarkets,@TalkMarkets,2017-06-12T05:48:42.000Z,Biotech Avoids Tech Wreck Of June 9 $BAC $BMY $JNJ $MRK $PFE $IBB $AAPL $AMZN $GILD $NFLX $NVDA $TSLA $SMH ... https://goo.gl/RZVAXi,Biotech Avoids Tech Wreck Of June 9 $BAC $BMY $JNJ $MRK $PFE $IBB $AAPL $AMZN $GILD $NFLX $NVDA $TSLA $SMH ... https://goo.gl/RZVAXi,,,,,[],https://twitter.com/TalkMarkets/status/874141388832690179
2892,Ticker Report,@TickerReport,2017-06-14T09:38:44.000Z,"Hartford Financial Management Inc. Has $1.64 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2ruVmMf","Hartford Financial Management Inc. Has $1.64 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2ruVmMf",,,,,[],https://twitter.com/TickerReport/status/874924054536499202
2893,Ticker Report,@TickerReport,2017-06-14T09:38:47.000Z,"Merck & Company, Inc. $MRK Position Lowered by Macnealy Hoover Investment Management Inc. http://ift.tt/2ruTnaV","Merck & Company, Inc. $MRK Position Lowered by Macnealy Hoover Investment Management Inc. http://ift.tt/2ruTnaV",,,,,[],https://twitter.com/TickerReport/status/874924066922221568
2894,JQ,@jq1234t,2017-06-12T21:10:02.000Z,"Replying to 
@jq1234t","Replying to 
@jq1234t
The only other PD1/PD-L1 combo ph3 for multiple myeloma: $BMY CheckMate 602 initiated 6-month after $MRK Keytruda
clinicaltrials.gov
An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations...
An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma - Full Text View.
1
1
2",,1,1,2,['https://pbs.twimg.com/card_img/1499578112115363861/JaVVFVxw?format=png&name=240x240'],https://twitter.com/jq1234t/status/874373249215463424
2895,Richard Nesh,@RNeshwat,2017-06-12T20:54:41.000Z,Merck pauses enrollment in 2 Keytruda combo studies in multiple myeloma to investigate deaths;shares slip 1% AH https://seekingalpha.com/news/3273019?source=ansh‚Ä¶ $MRK,"Merck pauses enrollment in 2 Keytruda combo studies in multiple myeloma to investigate deaths;shares slip 1% AH https://seekingalpha.com/news/3273019?source=ansh‚Ä¶ $MRK
seekingalpha.com
Merck pauses enrollment in two Keytruda combo studies in multiple myeloma to investigate deaths;...
Merck (NYSE:MRK) is down 1% after hours on robust volume in response to its announcement that it will pause new enrollment in two late-stage studies, KEYNOTE-183 and KEYNOTE-185,...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/RNeshwat/status/874369388702351360
2896,Sean McGrath,@sean_uk,2017-06-13T11:59:15.000Z,Merck $MRK halts enrollment on two PhIII Keytruda combo studies in #myeloma #cancer #oncology #immunotherapy https://endpts.com/merck-halts-enrollment-on-two-phiii-keytruda-studies-as-outside-monitors-flag-a-worrying-rate-of-deaths‚Ä¶,"Merck $MRK halts enrollment on two PhIII Keytruda combo studies in #myeloma #cancer #oncology #immunotherapy https://endpts.com/merck-halts-enrollment-on-two-phiii-keytruda-studies-as-outside-monitors-flag-a-worrying-rate-of-deaths‚Ä¶
1",,,,1,[],https://twitter.com/sean_uk/status/874597026561961985
2897,Watchlist News,@WatchlistN,2017-06-14T16:07:53.000Z,"Merck & Company, Inc. $MRK Receives Buy Rating from Credit Suisse Group http://ift.tt/2rs5dY9","Merck & Company, Inc. $MRK Receives Buy Rating from Credit Suisse Group http://ift.tt/2rs5dY9",,,,,[],https://twitter.com/WatchlistN/status/875021987386675200
2898,$PVCT,@Ablate_Cancer,2017-06-14T18:05:08.000Z,"Merck pauses Keytruda trials, raising concerns about class $mrk http://biopharmadive.com/news/merck-keytruda-deaths-myeloma-pause-trial/444881/‚Ä¶","Merck pauses Keytruda trials, raising concerns about class $mrk http://biopharmadive.com/news/merck-keytruda-deaths-myeloma-pause-trial/444881/‚Ä¶
1",,,,1,[],https://twitter.com/Ablate_Cancer/status/875051493975633920
2899,Daily Political,@dailypoliticaln,2017-06-12T09:28:18.000Z,"Merck & Company, Inc. $MRK Position Increased by Trust Department MB Financial Bank N A http://dailypolitical.com/?p=1175477","Merck & Company, Inc. $MRK Position Increased by Trust Department MB Financial Bank N A http://dailypolitical.com/?p=1175477",,,,,[],https://twitter.com/dailypoliticaln/status/874196654798385152
2900,US Banking News,@AmericanBanking,2017-06-14T02:54:39.000Z,"Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2tkhtX2","Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2tkhtX2",,,,,[],https://twitter.com/AmericanBanking/status/874822363782815745
2901,Allison Gatlin,@IBD_AGatlin,2017-06-13T20:10:27.000Z,Dow's J&J hosts a diabetes trial -- and Lilly benefits most $JNJ $LLY $MRK $PFE,"Dow's J&J hosts a diabetes trial -- and Lilly benefits most $JNJ $LLY $MRK $PFE
investors.com
Dow's J&J Hosted A Diabetes Study ‚Äî And Lilly Will Benefit Most
Johnson's diabetes drug, Invokana, cut down on cardiovascular events ‚Äî but Eli Lilly stands to benefit most.",,,,,[],https://twitter.com/IBD_AGatlin/status/874720641152372736
2902,InvestorPlace,@InvestorPlace,2017-06-13T12:03:58.000Z,"3 Stocks to Watch on Tuesday: Shopify, Under Armour and Merck $SHOP $UAA $UA $MRK -","3 Stocks to Watch on Tuesday: Shopify, Under Armour and Merck $SHOP $UAA $UA $MRK -
investorplace.com
3 Stocks to Watch on Tuesday: Shopify Inc (US) (SHOP), Under Armour Inc (UAA) and Merck & Co., Inc....
Shopify's (SHOP) hot run is hitting a wall, Merck & Co. (MRK) stumbles on a trial misstep and Under Armour (UAA) is heating up.
1",,,,1,['https://pbs.twimg.com/card_img/1501254563818446853/c123xFNF?format=jpg&name=240x240'],https://twitter.com/InvestorPlace/status/874598216167063552
2903,Allison Gatlin,@IBD_AGatlin,2017-06-13T20:12:20.000Z,Dow's Merck pauses cancer trials to investigate Keytruda-tied deaths $MRK $BMY $CELG http://ow.ly/Mq6F30cz8y6,Dow's Merck pauses cancer trials to investigate Keytruda-tied deaths $MRK $BMY $CELG http://ow.ly/Mq6F30cz8y6,,,,,[],https://twitter.com/IBD_AGatlin/status/874721115213623296
2904,Briefing.com,@Briefingcom,2017-06-12T09:04:18.000Z,$MRK: Merck and Pfizer (PFE) report that two Phase 3 studies of ertugliflozin met primary endpoints http://bit.ly/2rgJ8M3,$MRK: Merck and Pfizer (PFE) report that two Phase 3 studies of ertugliflozin met primary endpoints http://bit.ly/2rgJ8M3,,,,,[],https://twitter.com/Briefingcom/status/874190611191967744
2905,Briefing.com,@Briefingcom,2017-06-12T22:16:24.000Z,$MRK: Merck updates on two studies of KEYTRUDA in multiple myeloma; to pause new enrollment on KEYNOTE-183 and... http://bit.ly/2s40vwA,$MRK: Merck updates on two studies of KEYTRUDA in multiple myeloma; to pause new enrollment on KEYNOTE-183 and... http://bit.ly/2s40vwA,,,,,[],https://twitter.com/Briefingcom/status/874389951470682113
2906,Todd Campbell,@ebcapital,2017-06-13T22:39:57.000Z,"Will Tesaro Be the Focus of the Next Biotech Bidding War? 
@themotleyfool
 #stocks $MRK, $AZN, $SNY, $CLVS, $TSRO","Will Tesaro Be the Focus of the Next Biotech Bidding War? 
@themotleyfool
 #stocks $MRK, $AZN, $SNY, $CLVS, $TSRO
fool.com
Will Tesaro Be the Focus of the Next Biotech Bidding War? @themotleyfool #stocks $PFE $MRK $AZN...
Tesaro's management knows a thing or two about biotech M&A, and they're entertaining offers.
1
1",,,1,1,[],https://twitter.com/ebcapital/status/874758265418207232
2907,Evaluate Pharma,@evaluatepharma,2017-06-13T15:48:34.000Z,"A threat to Merck & Co‚Äôs lead in multiple myeloma http://ow.ly/iYtZ30cyDZr via 
@ByAmyBrown
 @EPVantage
 $MRK","A threat to Merck & Co‚Äôs lead in multiple myeloma http://ow.ly/iYtZ30cyDZr via 
@ByAmyBrown
 @EPVantage
 $MRK
1",,,,1,[],https://twitter.com/evaluatepharma/status/874654737379065856
2908,Roy Friedman,@DewDiligence,2017-06-12T21:59:48.000Z,"Replying to 
@bradloncar","Replying to 
@bradloncar
$MRK BACE inhibitor failed 4mo ago. (It does seem like longer.)
1
1",,1,,1,[],https://twitter.com/DewDiligence/status/874385772211822594
2909,MarketBeat,@MarketBeatCom,2017-06-14T02:56:12.000Z,"Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2rfAqJS #acn","Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2rfAqJS #acn",,,,,[],https://twitter.com/MarketBeatCom/status/874822753467199493
2910,StockNews.com,@stocknewsdotcom,2017-06-12T10:43:03.000Z,$MRK Merck and Pfizer report that two Phase 3 studies of ertugliflozin met primary endpoints https://stocknews.com/news/mrk-merck-and-pfizer-report-that-two-phase-3-studies-of/‚Ä¶,$MRK Merck and Pfizer report that two Phase 3 studies of ertugliflozin met primary endpoints https://stocknews.com/news/mrk-merck-and-pfizer-report-that-two-phase-3-studies-of/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/874215462921482240
2911,StockNews.com,@stocknewsdotcom,2017-06-12T20:16:56.000Z,$MRK Updates on two studies of KEYTRUDA in multiple myeloma; to pause new enrollment on KEYNOTE-183 and KEYNOTE-18‚Ä¶ https://stocknews.com/news/mrk-updates-on-two-studies-of-keytruda-in-multiple-myeloma-to/‚Ä¶,$MRK Updates on two studies of KEYTRUDA in multiple myeloma; to pause new enrollment on KEYNOTE-183 and KEYNOTE-18‚Ä¶ https://stocknews.com/news/mrk-updates-on-two-studies-of-keytruda-in-multiple-myeloma-to/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/874359884816560130
2912,Watchlist News,@WatchlistN,2017-06-14T02:52:57.000Z,"Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2sqAnin","Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2sqAnin",,,,,[],https://twitter.com/WatchlistN/status/874821934441213952
2913,Herkyleese,@herkyleese,2017-06-16T02:31:58.000Z,"$imuc trial blown up $cldx trial blown up, $nwbo will be the only house standing! Other piggies coming to play $mrk $bmy #opdivo $azn $nvs","$imuc trial blown up $cldx trial blown up, $nwbo will be the only house standing! Other piggies coming to play $mrk $bmy #opdivo $azn $nvs
GIF
3
8",,,3,8,[],https://twitter.com/herkyleese/status/875541429073977345
2914,Herkyleese,@herkyleese,2017-06-16T17:24:36.000Z,Who am I?  I am the T cell. Uninformed I attack my own team.  I need told what to do by Dendritic Cells.  #dcvax $nwbo $juno $kite $mrk $bmy,"Who am I?  I am the T cell. Uninformed I attack my own team.  I need told what to do by Dendritic Cells.  #dcvax $nwbo $juno $kite $mrk $bmy
GIF
1
2
4",,1,2,4,['https://pbs.twimg.com/tweet_video_thumb/DCdYl2wUAAAigx0.jpg'],https://twitter.com/herkyleese/status/875766070870761472
2915,MM+M Magazine,@MMMnews,2017-06-15T21:30:00.000Z,"5 things for #pharma #marketers to know: Thurs., June 15 $NVS #Biotech $GOOGL #oncology $MRK $LLY $TSRO http://bit.ly/2ssLuqr","5 things for #pharma #marketers to know: Thurs., June 15 $NVS #Biotech $GOOGL #oncology $MRK $LLY $TSRO http://bit.ly/2ssLuqr
2
1",,,2,1,['https://pbs.twimg.com/media/DCXspqJW0AAdz4U?format=jpg&name=small'],https://twitter.com/MMMnews/status/875465438959882241
2916,TA Scilab Ichimoku,@tasciccac,2017-06-16T21:06:56.000Z,"Replying to 
@tasciccac","Replying to 
@tasciccac
$DJIA WKLY Best performing $GE $TRV $BA $MMM $HD $JNJ $CVX $PG $XOM Worst $WMT $AAPL $NKE $MRK $INTC $JPM $DD $MSFT $V #Ichimoku #Dashboard
1
1",,,1,1,['https://pbs.twimg.com/media/DCeLVAnXoAIVFtQ?format=jpg&name=small'],https://twitter.com/tasciccac/status/875822021233565696
2917,JQ,@jq1234t,2017-06-15T02:55:22.000Z,"Replying to 
@jq1234t
 and 
@bradloncar","Replying to 
@jq1234t
 and 
@bradloncar
$MRK CMO on question of IO/IO (PD1/CTLA4) combo vs IO/chemo combo at GS HC conference
2
2
5",,2,2,5,['https://pbs.twimg.com/media/DCVIDa7W0AAFXhR?format=jpg&name=small'],https://twitter.com/jq1234t/status/875184933379211264
2918,Christian Fromhertz,@cfromhertz,2017-06-15T02:34:43.000Z,$MRK total of 13k Aug 67.5 calls trade today / ~ $585k option premium,$MRK total of 13k Aug 67.5 calls trade today / ~ $585k option premium,,,,,['https://pbs.twimg.com/media/DCVDLsYXgAEadVS?format=jpg&name=small'],https://twitter.com/cfromhertz/status/875179733239070720
2919,Bursatil Biotech,@BursatilBiotech,2017-06-15T11:51:04.000Z,"Updated results on KEYNOTE-013
r/r PMBCL $MRK","Updated results on KEYNOTE-013
r/r PMBCL $MRK",,,,,['https://pbs.twimg.com/media/DCXCZxWWsAEFc9c?format=jpg&name=medium'],https://twitter.com/BursatilBiotech/status/875319746765500416
2920,WLST.com,@wlstcom,2017-06-15T20:09:40.000Z,Is the Market Wrong About Bristol-Myers Squibb?  --  The Motley Fool #stocks $MRK $BMY $AZN https://fool.com/investing/2017/06/15/is-the-market-wrong-about-bristol-myers-squibb.aspx‚Ä¶,Is the Market Wrong About Bristol-Myers Squibb?  --  The Motley Fool #stocks $MRK $BMY $AZN https://fool.com/investing/2017/06/15/is-the-market-wrong-about-bristol-myers-squibb.aspx‚Ä¶,,,,,['https://pbs.twimg.com/media/DCY0yXGXcAAm-vN?format=jpg&name=small'],https://twitter.com/wlstcom/status/875445220632125442
2921,WLST.com,@wlstcom,2017-06-17T13:17:50.000Z,3 Biotech Stocks That Could Become M&A Targets --  The Motley Fool #stocks $MRK $INCY $ENDP https://fool.com/investing/2017/06/17/3-biotech-stocks-that-could-become-ma-targets.aspx‚Ä¶,3 Biotech Stocks That Could Become M&A Targets --  The Motley Fool #stocks $MRK $INCY $ENDP https://fool.com/investing/2017/06/17/3-biotech-stocks-that-could-become-ma-targets.aspx‚Ä¶,,,,,['https://pbs.twimg.com/media/DChptR5XcAAzAla?format=jpg&name=small'],https://twitter.com/wlstcom/status/876066356453666816
2922,The Banker's Tribune,@bankerstribune,2017-06-17T23:30:15.000Z,AbbVie $ABBV LTM EBITDA multiple trading below majority of peers: $BMY $LLY $MRK $PFE $AMGN http://ow.ly/8s5f30cBfP3,AbbVie $ABBV LTM EBITDA multiple trading below majority of peers: $BMY $LLY $MRK $PFE $AMGN http://ow.ly/8s5f30cBfP3,,,,,['https://pbs.twimg.com/media/DCj14MNUQAAtkq5?format=jpg&name=small'],https://twitter.com/bankerstribune/status/876220475738816513
2923,Kara Jill Stancell,@kjilly,2017-06-15T13:28:39.000Z,#Keytruda bonanza inspires facelift & plans to invest more than $600M in translational research - #VC #biotech $MRK https://endpts.com/keytruda-bonanza-inspires-a-facelift-and-plans-to-invest-more-than-600m-in-translational-research‚Ä¶,"#Keytruda bonanza inspires facelift & plans to invest more than $600M in translational research - #VC #biotech $MRK https://endpts.com/keytruda-bonanza-inspires-a-facelift-and-plans-to-invest-more-than-600m-in-translational-research‚Ä¶
1",,,1,,[],https://twitter.com/kjilly/status/875344303488290816
2924,BioPharma Dive,@BioPharmaDive,2017-06-17T14:10:01.000Z,"$MRK pauses Keytruda trials, raising concerns about class","$MRK pauses Keytruda trials, raising concerns about class
biopharmadive.com
Merck pauses Keytruda trials, raising concerns about class
The big pharma has hit a setback for its blockbuster checkpoint inhibitor in two multiple myeloma studies. 
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/876079489159221248
2925,BioPharma Dive,@BioPharmaDive,2017-06-17T17:27:01.000Z,How $MRK hopes to win in I/O combos: Q&A with Roy Baynes,"How $MRK hopes to win in I/O combos: Q&A with Roy Baynes
biopharmadive.com
How Merck hopes to win in I/O combos: Q&A with Roy Baynes
Combinations are pegged as the next step forward in immuno-oncology. Speaking with BioPharma Dive at ASCO, Merck's Roy Baynes cautioned how little is known about the best pairing and explained why...
1
2",,,1,2,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/876129067313111042
2926,Margin Hunt,@MarginHunt,2017-06-16T10:15:12.000Z,Check out the discounted EBITDA multiple of Sanofi $SNY vs comps: $GSK $BAYRY $AZN $NVS $MRK http://ow.ly/bTFK30cB0ws,Check out the discounted EBITDA multiple of Sanofi $SNY vs comps: $GSK $BAYRY $AZN $NVS $MRK http://ow.ly/bTFK30cB0ws,,,,,['https://pbs.twimg.com/media/DCb2UI2VYAAx_5F?format=jpg&name=small'],https://twitter.com/MarginHunt/status/875658006251184128
2927,BioPharma Dive,@BioPharmaDive,2017-06-17T15:34:00.000Z,"#ICYMI $MRK, $PFE notch success, but late with SGLT-2 data http://bit.ly/2tdfio0 #ADA2017","#ICYMI $MRK, $PFE notch success, but late with SGLT-2 data http://bit.ly/2tdfio0 #ADA2017
1",,,1,,[],https://twitter.com/BioPharmaDive/status/876100625565712385
2928,Vista Partners LLC,@VistaPResearch,2017-06-15T21:36:13.000Z,"Replying to 
@PacificEdgeLtd","Replying to 
@PacificEdgeLtd
@PacificEdgeLtd
 all the best from #SanFrancisco! See Vista Partners #Investing #Healthcare http://vistapglobal.com $HIIQ $MRK $PFE $JNJ
GIF
1
1",,1,,1,['https://pbs.twimg.com/tweet_video_thumb/DCZImMqUIAEgY0d.jpg'],https://twitter.com/VistaPResearch/status/875467004462878720
2929,Sean McGrath,@sean_uk,2017-06-16T15:18:12.000Z,The myth of ‚Äúleaner and meaner‚Äù pharma - https://endpts.com/the-myth-of-leaner-and-meaner-pharma‚Ä¶ #pharma $AZN $PFE $BMY $MRK $JNJ,The myth of ‚Äúleaner and meaner‚Äù pharma - https://endpts.com/the-myth-of-leaner-and-meaner-pharma‚Ä¶ #pharma $AZN $PFE $BMY $MRK $JNJ,,,,,[],https://twitter.com/sean_uk/status/875734261265039362
2930,Sweet Platform,@SweetPlatform,2017-06-16T14:48:38.000Z,"MRK Top news - Jun 16th, 2017 $MRK http://https://goo.gl/rsb7sc","MRK Top news - Jun 16th, 2017 $MRK http://https://goo.gl/rsb7sc",,,,,[],https://twitter.com/SweetPlatform/status/875726819101683712
2931,The Banker's Tribune,@bankerstribune,2017-06-17T22:45:10.000Z,"LTM EBITDA multiple of Merck & Company, $MRK is currently below avg of peers: $BMY $PFE $LLY $SNY $GSK http://ow.ly/dxCR30cBfOY","LTM EBITDA multiple of Merck & Company, $MRK is currently below avg of peers: $BMY $PFE $LLY $SNY $GSK http://ow.ly/dxCR30cBfOY",,,,,['https://pbs.twimg.com/media/DCjrjp8XUAQpClZ?format=jpg&name=small'],https://twitter.com/bankerstribune/status/876209128343031810
2932,Pharmaceutical News,@pharma_sector,2017-06-17T09:16:06.000Z,#Merck & Company Target of Unusually High Options Trading (). Read more: http://owler.us/acSood $MRK,#Merck & Company Target of Unusually High Options Trading (). Read more: http://owler.us/acSood $MRK,,,,,[],https://twitter.com/pharma_sector/status/876005521915994112
2933,Pharmaceutical News,@pharma_sector,2017-06-16T12:02:20.000Z,#Merck Develops Alternative CRISPR Genome Editing Method. Read more: http://owler.us/acR8po $MRK,#Merck Develops Alternative CRISPR Genome Editing Method. Read more: http://owler.us/acR8po $MRK,,,,,[],https://twitter.com/pharma_sector/status/875684968562778113
2934,IECONOMICS,@iECONOMICS,2017-06-16T13:45:03.000Z,Merck & Co $MRK market alert: 6-week low @ 62.81 https://ieconomics.com/merck,Merck & Co $MRK market alert: 6-week low @ 62.81 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/875710816909230082
2935,Tim Reller,@TraderGuruNY,2017-06-16T01:07:26.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/875520157552168960
2936,Pharmaceutical News,@pharma_sector,2017-06-16T19:52:24.000Z,"#Merck Real-world data shows that Simponi√É,√Ç¬Æ (golimumab) is associated with long-term effec... Read more: http://owler.us/acSdR8 $MRK","#Merck Real-world data shows that Simponi√É,√Ç¬Æ (golimumab) is associated with long-term effec... Read more: http://owler.us/acSdR8 $MRK",,,,,[],https://twitter.com/pharma_sector/status/875803263517343744
2937,Alexander Morris,@tymorapro,2017-06-16T13:59:10.000Z,"$MRK: At/Above 200DaySMA[+62.75]:1M, cl:-14, 7NearLo:BrkPHi+PLo[-1.5%], 20:3Accel-, tf:0010000, ch:-0.7%, oPop:+0.4%, bigFlt:2.7B","$MRK: At/Above 200DaySMA[+62.75]:1M, cl:-14, 7NearLo:BrkPHi+PLo[-1.5%], 20:3Accel-, tf:0010000, ch:-0.7%, oPop:+0.4%, bigFlt:2.7B",,,,,[],https://twitter.com/tymorapro/status/875714369463734272
2938,leahanne,@leahanneta,2017-06-16T15:05:02.000Z,"10:45 ET Volume Leader #50 - MRK 4,064,966 Merck & Company $MRK 62.81 -0.38 -0.60% High today of 63.71 day low","10:45 ET Volume Leader #50 - MRK 4,064,966 Merck & Company $MRK 62.81 -0.38 -0.60% High today of 63.71 day low
investorshangout.com
10:45 ET Volume Leader #50 - MRK - Most Active Stocks #4610530 - Investors Hangout
Most Active Stocks: 10:45 ET Volume Leader #50 - MRK 4,064,966 Merck Company $MRK 62.81 -0.38 -0.60% High today of 63. - #4610530",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/875730947026681857
2939,Watchlist News,@WatchlistN,2017-06-17T09:22:15.000Z,"Sanders Morris Harris Inc. Acquires New Position in Merck & Company, Inc. $MRK http://ift.tt/2tdfDI3","Sanders Morris Harris Inc. Acquires New Position in Merck & Company, Inc. $MRK http://ift.tt/2tdfDI3",,,,,[],https://twitter.com/WatchlistN/status/876007070444777472
2940,Ticker Report,@TickerReport,2017-06-17T09:22:05.000Z,"Gemmer Asset Management LLC Purchases 2,787 Shares of Merck & Company, Inc. $MRK http://ift.tt/2sAyL4U","Gemmer Asset Management LLC Purchases 2,787 Shares of Merck & Company, Inc. $MRK http://ift.tt/2sAyL4U",,,,,[],https://twitter.com/TickerReport/status/876007028547870720
2941,Limex,@LimexMe,2017-06-15T15:19:46.000Z,"Johnson & Johnson's Type 2 Diabetes Drug Is Stellar in Cardiovascular Trials, but Comes With a Catch http://bit.ly/2s5g3C7 $JNJ $MRK $LLY","Johnson & Johnson's Type 2 Diabetes Drug Is Stellar in Cardiovascular Trials, but Comes With a Catch http://bit.ly/2s5g3C7 $JNJ $MRK $LLY
whotrades.com
Johnson & Johnson's Type 2 Diabetes Drug Is Stellar in Cardiovascular Trials, but Comes With a Catch
Healthcare conglomerate Johnson & Johnson 's (NYSE: JNJ) long-awaited data from Invokana, its type 2 diabetes blockbuster drug, has arrived! The rise of SGLT-2 inhibitors‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/875372265675923457
2942,The Fly,@theflynews,2017-06-17T15:54:51.000Z,Week in review: How Trump's policies moved stocks $BAC $C $WFC $JPM $MS $GS $ARNC $CENX $MRK $SNY $JNJ $BMY $PFE‚Ä¶,"Week in review: How Trump's policies moved stocks $BAC $C $WFC $JPM $MS $GS $ARNC $CENX $MRK $SNY $JNJ $BMY $PFE‚Ä¶
thefly.com
Week in review: How Trump's policies moved stocks
Catch up on the top indus... BAC, C, WFC, JPM, MS, GS, ARNC, CENX, MRK, SNY, JNJ, BMY, PFE, NVS, AZN, GSK, LLY, FDX, APEI, BPI, CECO, ATGE, LOPE, ESI, STRA
1
1",,,1,1,['https://pbs.twimg.com/card_img/1488732987961315330/Vt4cMnQW?format=jpg&name=small'],https://twitter.com/theflynews/status/876105869003374592
2943,Ticker Report,@TickerReport,2017-06-17T05:08:25.000Z,Positive Press Coverage Somewhat Unlikely to Impact Merck & Company $MRK Share Price http://ift.tt/2txV7kK,Positive Press Coverage Somewhat Unlikely to Impact Merck & Company $MRK Share Price http://ift.tt/2txV7kK,,,,,[],https://twitter.com/TickerReport/status/875943189965938688
2944,Bursatil Biotech,@BursatilBiotech,2017-06-15T14:16:00.000Z,"KEYNOTE 170 r/r PMBCL (Data cut off: 7/12/16) $MRK
N=33, mPrior Tx:3
15 pts discontinued, PD
2 pts death
Remaining 23 pts:
ORR:35% by BICR","KEYNOTE 170 r/r PMBCL (Data cut off: 7/12/16) $MRK
N=33, mPrior Tx:3
15 pts discontinued, PD
2 pts death
Remaining 23 pts:
ORR:35% by BICR
1",,1,,,[],https://twitter.com/BursatilBiotech/status/875356217035685888
2945,Dakota Financial,@dakotafinancial,2017-06-15T12:13:08.000Z,"Cutler Capital Management LLC Sells 2,000 Shares of Merck & Company, Inc. $MRK http://zpr.io/PifAr","Cutler Capital Management LLC Sells 2,000 Shares of Merck & Company, Inc. $MRK http://zpr.io/PifAr",,,,,[],https://twitter.com/dakotafinancial/status/875325297071190016
2946,StockNews.com,@stocknewsdotcom,2017-06-15T10:34:53.000Z,$MRK Granted orphan designation by the FDA for Keytruda for the treatment of hepatocellular carcinoma https://stocknews.com/news/mrk-granted-orphan-designation-by-the-fda-for-keytruda-for-the-90816837/‚Ä¶,$MRK Granted orphan designation by the FDA for Keytruda for the treatment of hepatocellular carcinoma https://stocknews.com/news/mrk-granted-orphan-designation-by-the-fda-for-keytruda-for-the-90816837/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/875300572198514690
2947,MarketBeat,@MarketBeatCom,2017-06-17T01:16:01.000Z,"Merck & Company, Inc. $MRK Receives $68.46 Consensus PT from Analysts http://zpr.io/PixBb","Merck & Company, Inc. $MRK Receives $68.46 Consensus PT from Analysts http://zpr.io/PixBb",,,,,[],https://twitter.com/MarketBeatCom/status/875884705492717568
2948,MarketBeat,@MarketBeatCom,2017-06-16T16:45:19.000Z,"Merck & Company, Inc. $MRK Downgraded by Zacks Investment Research http://zpr.io/Piak8","Merck & Company, Inc. $MRK Downgraded by Zacks Investment Research http://zpr.io/Piak8",,,,,[],https://twitter.com/MarketBeatCom/status/875756182199316480
2949,SwingTradeBot,@SwingTradeBot,2017-06-17T09:11:12.000Z,$MRK technical alerts: MACD Bearish Centerline Cross and Fell Below 50 DMA,"$MRK technical alerts: MACD Bearish Centerline Cross and Fell Below 50 DMA
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/876004288656543745
2950,Jacob Bell,@realJacobBell,2017-06-16T19:12:00.000Z,Prescribed Reading: $NVS teams up with Verily; $MRK's Roy Baynes talks I/O; JSR acquires Selexis,"Prescribed Reading: $NVS teams up with Verily; $MRK's Roy Baynes talks I/O; JSR acquires Selexis
biopharmadive.com
Prescribed Reading: ADA, Mylan, and an executive order?
The SGLT-2 category heats up at ADA, Mylan faces pressure from all sides, and President Trump might put his stamp on drug pricing.",,,,,['https://pbs.twimg.com/card_img/1501983579286372354/UUFlIgZv?format=jpg&name=small'],https://twitter.com/realJacobBell/status/875793098290233344
2951,Todd Campbell,@ebcapital,2017-06-17T13:17:48.000Z,"3 Biotech Stocks That Could Become M&A Targets 
@themotleyfool
 #stocks $MRK, $INCY, $ENDP, $TSRO, $MNK","3 Biotech Stocks That Could Become M&A Targets 
@themotleyfool
 #stocks $MRK, $INCY, $ENDP, $TSRO, $MNK
fool.com
3 Biotech Stocks That Could Become M&A Targets @themotleyfool #stocks $INCY $MRK $ENDP $MNK
There are reasons to think other drugmakers might see Mallinckrodt, Tesaro, and Incyte as tempting acquisitions, which makes them potential opportunities for risk-tolerant investors.",,,,,['https://pbs.twimg.com/card_img/1501721965882744838/R9x5P2Ev?format=jpg&name=small'],https://twitter.com/ebcapital/status/876066349465968640
2952,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-06-15T12:37:58.000Z,Either $MRK now has to show interest to move $AFMD combo faster forward against $BMY or if lower / equal best that #AFM13 only PoC state,"Either $MRK now has to show interest to move $AFMD combo faster forward against $BMY or if lower / equal best that #AFM13 only PoC state
2
4",,2,,4,[],https://twitter.com/dhovekamp42/status/875331548555423744
2953,G Hawkins,@FilmProfessor9,2017-06-15T20:41:10.000Z,"$MRK $GILD talking merger ? just rumours ? $MRK is much bigger, so they would run the show. Would love this.  
@NotaBubble
 @7wtc
 @davidfaber","$MRK $GILD talking merger ? just rumours ? $MRK is much bigger, so they would run the show. Would love this.  
@NotaBubble
 @7wtc
 @davidfaber",,,,,[],https://twitter.com/FilmProfessor9/status/875453149254778880
2954,dough,@semodough,2017-06-16T16:59:09.000Z,"Replying to 
@semodough","Replying to 
@semodough
significantly lower than the c270 patients/arm that were in $BMY failed CM-026 trial  give 65% odds.    $MRK",,,,,[],https://twitter.com/semodough/status/875759665065467908
2955,sirmartin,@rosderek,2017-06-15T21:06:48.000Z,"Replying to 
@EBurgessMD","Replying to 
@EBurgessMD
Seeing a lot of clinical trials with Cabo and the known IO therapies of $BMY, $rhhby, and $MRK. Early results seem positive.",,,,,[],https://twitter.com/rosderek/status/875459598454464512
2956,Dakota Financial,@dakotafinancial,2017-06-17T01:16:02.000Z,"Merck & Company, Inc. $MRK Receives $68.46 Consensus PT from Analysts http://zpr.io/PixBb","Merck & Company, Inc. $MRK Receives $68.46 Consensus PT from Analysts http://zpr.io/PixBb",,,,,[],https://twitter.com/dakotafinancial/status/875884707854114816
2957,FlowerPower,@Flower_Power_67,2017-06-20T17:14:57.000Z,"#FastMoneyEspresso
FINAL CALLS:
Dr J‚Äî>buy $S
PeteNajarian‚Äî>buy $GILD $MRK $PFE
StephanieLink‚Äî>buy $AXP
Joe Terranova‚Äî>buy health care stocks","#FastMoneyEspresso
FINAL CALLS:
Dr J‚Äî>buy $S
PeteNajarian‚Äî>buy $GILD $MRK $PFE
StephanieLink‚Äî>buy $AXP
Joe Terranova‚Äî>buy health care stocks
2
3",,,2,3,['https://pbs.twimg.com/media/DCx8u5cVYAAvtSu?format=jpg&name=small'],https://twitter.com/Flower_Power_67/status/877213192006623233
2958,dough,@semodough,2017-06-19T22:35:30.000Z,CS #PARP market 8-12 BILLION $TSRO $CLVS $AZN -almost 3B split - bigger question is how does $GILD $MRK $PFE $ROG NOT Have one =LOSER,"CS #PARP market 8-12 BILLION $TSRO $CLVS $AZN -almost 3B split - bigger question is how does $GILD $MRK $PFE $ROG NOT Have one =LOSER
3
3
23",,3,3,23,['https://pbs.twimg.com/media/DCt8hUNXUAEb33c?format=jpg&name=small'],https://twitter.com/semodough/status/876931472606642177
2959,Seeking Alpha,@SeekingAlpha,2017-06-18T12:45:58.000Z,Sanofi: A Good Bet On Pharma https://seekingalpha.com/article/4082179-sanofi-good-bet-pharma?source=feed_f‚Ä¶ $MRK $NVO $SNY,"Sanofi: A Good Bet On Pharma https://seekingalpha.com/article/4082179-sanofi-good-bet-pharma?source=feed_f‚Ä¶ $MRK $NVO $SNY
2
1",,,2,1,[],https://twitter.com/SeekingAlpha/status/876420723958439939
2960,Seeking Alpha,@SeekingAlpha,2017-06-20T14:30:15.000Z,More Dividend Growth Coming For Merck's Owners https://seekingalpha.com/article/4082477-dividend-growth-coming-mercks-owners?source=feed_f‚Ä¶ $BMY $MRK,"More Dividend Growth Coming For Merck's Owners https://seekingalpha.com/article/4082477-dividend-growth-coming-mercks-owners?source=feed_f‚Ä¶ $BMY $MRK
1",,,,1,[],https://twitter.com/SeekingAlpha/status/877171743131152385
2961,Clark Joseph Kent,@JorelLaraKalel,2017-06-20T13:13:51.000Z,10 Dividend Stocks for the Upcoming Market Swoon We Might Have http://bit.ly/2slMufI $AAPL $T $BA $PFE $MRK $TSN $TXN $EXPD $HRL $SPGI,"10 Dividend Stocks for the Upcoming Market Swoon We Might Have http://bit.ly/2slMufI $AAPL $T $BA $PFE $MRK $TSN $TXN $EXPD $HRL $SPGI
thestreet.com
10 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer
Here are the names.",,,,,[],https://twitter.com/JorelLaraKalel/status/877152516454195200
2962,MM+M Magazine,@MMMnews,2017-06-19T22:00:03.000Z,"Day 1 at #LionsHealth: Use the data, stay persistent, and avoid being 'innovative.' $GSK #MMMatCannes
$BIIB $MRK http://bit.ly/2rw4VLG","Day 1 at #LionsHealth: Use the data, stay persistent, and avoid being 'innovative.' $GSK #MMMatCannes
$BIIB $MRK http://bit.ly/2rw4VLG
1
2",,,1,2,['https://pbs.twimg.com/media/DCsXhDzVYAQCfz2?format=jpg&name=small'],https://twitter.com/MMMnews/status/876922551527653376
2963,WLST.com,@wlstcom,2017-06-18T20:55:40.000Z,3 Stocks with Universal Display-like Return Potential --  The Motley Fool $WMT $MRK $OLED https://fool.com/investing/2017/06/18/3-stocks-with-universal-display-like-return-potent.aspx‚Ä¶,3 Stocks with Universal Display-like Return Potential --  The Motley Fool $WMT $MRK $OLED https://fool.com/investing/2017/06/18/3-stocks-with-universal-display-like-return-potent.aspx‚Ä¶,,,,,['https://pbs.twimg.com/media/DCocFWvXoAAkdLi?format=jpg&name=small'],https://twitter.com/wlstcom/status/876543959551684609
2964,Helen Ong,@Lin_ling_88,2017-06-19T07:34:06.000Z,"PD-L2 Helps Predict Immunotherapy Responsiveness for Head and Neck Cancer 

#PD-L2 responding to Keytruda
$MRK","PD-L2 Helps Predict Immunotherapy Responsiveness for Head and Neck Cancer 

#PD-L2 responding to Keytruda
$MRK
genengnews.com
PD-L2 Helps Predict Immunotherapy Responsiveness for Head and Neck Cancer
PD-L2 protein expression in human tumors was associated with clinical response to pembrolizumab (Keytruda), an anti-PD-1 immunotherapy, independent of PD-L1 expression
1",,,1,,[],https://twitter.com/Lin_ling_88/status/876704628544557056
2965,Margin Hunt,@MarginHunt,2017-06-20T18:45:19.000Z,LTM EBITDA multiple of Eli Lilly and Company $LLY is currently above all peers: $BMY $MRK $PFE $AZN $TEVA http://ow.ly/NIw530cI63L,LTM EBITDA multiple of Eli Lilly and Company $LLY is currently above all peers: $BMY $MRK $PFE $AZN $TEVA http://ow.ly/NIw530cI63L,,,,,['https://pbs.twimg.com/media/DCyRbhKXYAAisES?format=jpg&name=small'],https://twitter.com/MarginHunt/status/877235932507852802
2966,BioPharma Dive,@BioPharmaDive,2017-06-18T16:45:01.000Z,"$JNJ, $PFE, $MRK sit atop Fortune's 500 for pharma http://bit.ly/2sofZ0D","$JNJ, $PFE, $MRK sit atop Fortune's 500 for pharma http://bit.ly/2sofZ0D
1
1",,,1,1,[],https://twitter.com/BioPharmaDive/status/876480884404342786
2967,The Capitolist,@CapitolistPig,2017-06-20T17:49:52.000Z,"Replying to 
@WallStCynic","Replying to 
@WallStCynic
Yea - and I'm sure big pharma has no idea that $MRK sold an NDA to an upstart company in Al Franken's district/state
GIF
1",,,,1,[],https://twitter.com/CapitolistPig/status/877221977496465409
2968,Zero Filter,@zerofiltertruth,2017-06-19T17:06:42.000Z,"$DRRX #biotech / lotto-ticket followthrough action on #HSR approval of $NVS #POSIMAR collaboration 

$IBB $XBI $FBT $BIB $CELG $GILD $MRK","$DRRX #biotech / lotto-ticket followthrough action on #HSR approval of $NVS #POSIMAR collaboration 

$IBB $XBI $FBT $BIB $CELG $GILD $MRK",,,,,[],https://twitter.com/zerofiltertruth/status/876848727029407744
2969,TalkMarkets,@TalkMarkets,2017-06-18T23:39:37.000Z,Dogs Of The Dow Underperformance Gap Widening $BA $CAT $CVX $IBM $KO $MRK $PFE $VZ $XOM $CSCO https://goo.gl/jVH8vJ,"Dogs Of The Dow Underperformance Gap Widening $BA $CAT $CVX $IBM $KO $MRK $PFE $VZ $XOM $CSCO https://goo.gl/jVH8vJ
1",,,1,,[],https://twitter.com/TalkMarkets/status/876585220287471616
2970,StockMarketVideo.com,@stockmarketvide,2017-06-20T18:26:43.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/877231252071383042
2971,Sweet Platform,@SweetPlatform,2017-06-20T14:52:25.000Z,"MRK Top news - Jun 20th, 2017 $MRK http://https://goo.gl/3MmjBK","MRK Top news - Jun 20th, 2017 $MRK http://https://goo.gl/3MmjBK",,,,,[],https://twitter.com/SweetPlatform/status/877177324176891905
2972,TW Research Group,@DanCarlson33,2017-06-18T01:00:17.000Z,New CEO details plans to develop #braincancer medications. $MRK $BIIB $BMY,"New CEO details plans to develop #braincancer medications. $MRK $BIIB $BMY
twresearchgroup.com
biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders
Tailwinds' Take: this long awaited update from the new CEO shows that he's a thoughtful, reasoned leader who understands the technology and its place in the medical field. Going forward, biOasis will...",,,,,['https://pbs.twimg.com/card_img/1501722518582927365/Jsr1BGiI?format=jpg&name=240x240'],https://twitter.com/DanCarlson33/status/876243133624795137
2973,Pharmaceutical News,@pharma_sector,2017-06-20T23:03:53.000Z,#Merck Newly-rebranded MRCT to invest up to ¬£500 million into research. Read more: http://owler.us/acTnU0 $MRK,#Merck Newly-rebranded MRCT to invest up to ¬£500 million into research. Read more: http://owler.us/acTnU0 $MRK,,,,,[],https://twitter.com/pharma_sector/status/877301003409702912
2974,Tuan Pham,@15minofPham,2017-06-20T17:03:08.000Z,"Mid-day TOP of range from open: $MRK 87, $IMGN 86, $REGN 81, $NK 79, $HOLX 77, $RUN 76, $ADP 75, $PFE 73, $AARY $AXP 72, $EXEL $MYGN 71","Mid-day TOP of range from open: $MRK 87, $IMGN 86, $REGN 81, $NK 79, $HOLX 77, $RUN 76, $ADP 75, $PFE 73, $AARY $AXP 72, $EXEL $MYGN 71",,,,,[],https://twitter.com/15minofPham/status/877210218412855296
2975,Pharmaceutical News,@pharma_sector,2017-06-20T23:03:16.000Z,#Merck & Co. Becomes Member Of The Worldwide Innovative Network In Personalized Cancer Medic... Read more: http://owler.us/acTnVf $MRK,#Merck & Co. Becomes Member Of The Worldwide Innovative Network In Personalized Cancer Medic... Read more: http://owler.us/acTnVf $MRK,,,,,[],https://twitter.com/pharma_sector/status/877300847230636032
2976,Pharmaceutical News,@pharma_sector,2017-06-20T23:02:39.000Z,Data on Medicinal Chemistry Detailed by Researchers at #Merck & Company (Improvement of hERG... Read more: http://owler.us/acTnVc $MRK,Data on Medicinal Chemistry Detailed by Researchers at #Merck & Company (Improvement of hERG... Read more: http://owler.us/acTnVc $MRK,,,,,[],https://twitter.com/pharma_sector/status/877300691638693888
2977,Zenect,@zenect,2017-06-18T12:42:34.000Z,$BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V All would make a great foundation #investment‚Ä¶ I like this http://bit.ly/1sQ7Crl,$BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V All would make a great foundation #investment‚Ä¶ I like this http://bit.ly/1sQ7Crl,,,,,[],https://twitter.com/zenect/status/876419868714819585
2978,David A. Yablon,@day54,2017-06-20T19:50:41.000Z,Top performers on the $OEX have a theme !! $BIIB $MRK $GILD $PFE $AMGN $BMY $CELG,Top performers on the $OEX have a theme !! $BIIB $MRK $GILD $PFE $AMGN $BMY $CELG,,,,,[],https://twitter.com/day54/status/877252383730020352
2979,Vista Partners LLC,@VistaPResearch,2017-06-19T17:55:30.000Z,"@BarbaraWeltman
 thanks for follow! See Vista Partners #InvestingForLife #Dow30 #fintech http://vistapglobal.com $HIIQ $PFE $MRK $JNJ $UNH","@BarbaraWeltman
 thanks for follow! See Vista Partners #InvestingForLife #Dow30 #fintech http://vistapglobal.com $HIIQ $PFE $MRK $JNJ $UNH
GIF
1",,,1,,['https://pbs.twimg.com/tweet_video_thumb/DCs8bstUMAAohXo.jpg'],https://twitter.com/VistaPResearch/status/876861010434326528
2980,$peedyCalls,@SpeedyCalls,2017-06-20T14:55:06.000Z,"$MRK 63.5 Puts BUYING Activity expiring on 21st Jul, Vol 1301","$MRK 63.5 Puts BUYING Activity expiring on 21st Jul, Vol 1301",,,,,[],https://twitter.com/SpeedyCalls/status/877177996502859781
2981,StockNews.com,@stocknewsdotcom,2017-06-19T11:38:33.000Z,$MRK Granted orphan designation by the FDA for Keytruda for the treatment of esophageal carcinoma https://stocknews.com/news/mrk-granted-orphan-designation-by-the-fda-for-keytruda-for-the-59451711/‚Ä¶,$MRK Granted orphan designation by the FDA for Keytruda for the treatment of esophageal carcinoma https://stocknews.com/news/mrk-granted-orphan-designation-by-the-fda-for-keytruda-for-the-59451711/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/876766147005353987
2982,US Banking News,@AmericanBanking,2017-06-18T18:31:28.000Z,"Merck & Company, Inc. $MRK Rating Reiterated by Credit Suisse Group http://ift.tt/2sfilhW","Merck & Company, Inc. $MRK Rating Reiterated by Credit Suisse Group http://ift.tt/2sfilhW",,,,,[],https://twitter.com/AmericanBanking/status/876507671637131267
2983,MarketBeat,@MarketBeatCom,2017-06-20T12:46:45.000Z,"Merck & Company, Inc. $MRK Stake Increased by Hexavest Inc. http://ift.tt/2rQwzCo","Merck & Company, Inc. $MRK Stake Increased by Hexavest Inc. http://ift.tt/2rQwzCo",,,,,[],https://twitter.com/MarketBeatCom/status/877145695341424641
2984,The Fly,@theflynews,2017-06-20T19:47:05.000Z,#BREAKING: PV Nano Cell announces cooperation with Merck on conductive ink: http://bit.ly/2snDvun $MRK,"#BREAKING: PV Nano Cell announces cooperation with Merck on conductive ink: http://bit.ly/2snDvun $MRK
thefly.com
PV Nano Cell announces cooperation with Merck on conductive ink
PV Nano Cell, a producer ... MRK",,,,,[],https://twitter.com/theflynews/status/877251478338940928
2985,Briefing.com,@Briefingcom,2017-06-20T19:05:33.000Z,$MRK: Merck enters research and development collaboration agreement with SerImmune Inc http://bit.ly/2sxfSxR,$MRK: Merck enters research and development collaboration agreement with SerImmune Inc http://bit.ly/2sxfSxR,,,,,[],https://twitter.com/Briefingcom/status/877241025500139520
2986,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-06-19T14:24:20.000Z,"Replying to 
@bradloncar","Replying to 
@bradloncar
Ugly to see pioneer Denderon leading & loosing this list now dominated by a handful $BMY (10) $MRK (10) $AMGN (3) $RHHBY (3) $PFZ (2) $AZN
1
1
3",,1,1,3,[],https://twitter.com/dhovekamp42/status/876807866572828672
2987,Dakota Financial,@dakotafinancial,2017-06-20T12:46:40.000Z,"Merck & Company, Inc. $MRK Stake Increased by Hexavest Inc. http://ift.tt/2rQwzCo","Merck & Company, Inc. $MRK Stake Increased by Hexavest Inc. http://ift.tt/2rQwzCo",,,,,[],https://twitter.com/dakotafinancial/status/877145677700247553
2988,MarketBeat,@MarketBeatCom,2017-06-20T12:16:41.000Z,Merck KGaA given ‚Ç¨116.00 PT by Warburg Research. neutral rating. http://ift.tt/2swerzy $MRK #MRK,Merck KGaA given ‚Ç¨116.00 PT by Warburg Research. neutral rating. http://ift.tt/2swerzy $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/877138131362996224
2989,MarketBeat,@MarketBeatCom,2017-06-18T18:40:35.000Z,"Merck & Company, Inc. $MRK Rating Reiterated by Credit Suisse Group http://ift.tt/2thbcfm #acn","Merck & Company, Inc. $MRK Rating Reiterated by Credit Suisse Group http://ift.tt/2thbcfm #acn",,,,,[],https://twitter.com/MarketBeatCom/status/876509965955063810
2990,Ticker Report,@TickerReport,2017-06-19T09:43:29.000Z,"Merck & Company, Inc. $MRK Shares Sold by Huntington National Bank http://ift.tt/2sGzAtl","Merck & Company, Inc. $MRK Shares Sold by Huntington National Bank http://ift.tt/2sGzAtl",,,,,[],https://twitter.com/TickerReport/status/876737189668900864
2991,StockNews.com,@stocknewsdotcom,2017-06-20T17:04:56.000Z,$MRK Enters research and development collaboration agreement with SerImmune Inc https://stocknews.com/news/mrk-enters-research-and-development-collaboration-agreement-with-serimmune-inc/‚Ä¶,$MRK Enters research and development collaboration agreement with SerImmune Inc https://stocknews.com/news/mrk-enters-research-and-development-collaboration-agreement-with-serimmune-inc/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/877210670802096128
2992,Briefing.com,@Briefingcom,2017-06-20T18:09:33.000Z,$MRK: Merck is the Dow Jones leader today with almost a +2% gain as price rallies off its recent pullback to the... http://bit.ly/2swXS6F,$MRK: Merck is the Dow Jones leader today with almost a +2% gain as price rallies off its recent pullback to the... http://bit.ly/2swXS6F,,,,,[],https://twitter.com/Briefingcom/status/877226930650488832
2993,Traveller,@syntek91,2017-06-20T16:25:49.000Z,"Replying to 
@syntek91","Replying to 
@syntek91
$MRK re shorting here at 64.85 again with HOD as risk
1",,1,,,[],https://twitter.com/syntek91/status/877200828230115328
2994,Traveller,@syntek91,2017-06-20T16:37:17.000Z,"Replying to 
@syntek91","Replying to 
@syntek91
$MRK ok I give up.. no more shorting it... taking my loss and done with it",,,,,[],https://twitter.com/syntek91/status/877203711155621888
2995,Traveller,@syntek91,2017-06-20T15:48:57.000Z,"Replying to 
@syntek91","Replying to 
@syntek91
$MRK respecting the bull strength cut for 10 cents loss for the short position
1",,1,,,[],https://twitter.com/syntek91/status/877191547514568704
2996,Dave Weekley,@weekley,2017-06-19T16:21:44.000Z,"@petenajarian
 Got an opinion on $MRK right here?  My dad asked about it Sunday. I've never had much luck with drug stocks/don't follow 'em.","@petenajarian
 Got an opinion on $MRK right here?  My dad asked about it Sunday. I've never had much luck with drug stocks/don't follow 'em.
1",,,1,,[],https://twitter.com/weekley/status/876837409819947008
2997,dough,@semodough,2017-06-20T14:23:42.000Z,"@zbiotech
 Zach is today when latest IMS for month comes out on $BMY $MRK ? KEYTRUDA?","@zbiotech
 Zach is today when latest IMS for month comes out on $BMY $MRK ? KEYTRUDA?",,,,,[],https://twitter.com/semodough/status/877170096015364096
2998,Herkyleese,@herkyleese,2017-06-22T12:57:19.000Z,"Some days there won't be a song in your heart.  SING ANYWAY! -E. Austin
$nwbo is fighting for patients!  Why? BECAUSE! $KITE $BMY $MRK #HOPE","Some days there won't be a song in your heart.  SING ANYWAY! -E. Austin
$nwbo is fighting for patients!  Why? BECAUSE! $KITE $BMY $MRK #HOPE
5
9",,,5,9,"['https://pbs.twimg.com/media/DC7U4ZWUIAA_ReK?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DC7U6QgU0AAA-kd?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DC7U7fMVwAEa-vq?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DC7U8VtUAAEwHFw?format=jpg&name=360x360']",https://twitter.com/herkyleese/status/877873130726866945
2999,pharmalot,@pharmalot,2017-06-21T17:54:58.000Z,"Pharma discloses some payments to Canadian doctors, but critics want more.. https://statnews.com/pharmalot/2017/06/21/canada-doctors-pharma-payments/‚Ä¶ #pharma $BMY $GSK $MRK $LLY $GILD $AMGN","Pharma discloses some payments to Canadian doctors, but critics want more.. https://statnews.com/pharmalot/2017/06/21/canada-doctors-pharma-payments/‚Ä¶ #pharma $BMY $GSK $MRK $LLY $GILD $AMGN
statnews.com
Pharma discloses some payments to Canadian docs, but critics want more
Ten drug makers on Monday reported for the first time how much money they have paid to doctors and hospitals last year, as well as payments for travel.
11
3",,,11,3,['https://pbs.twimg.com/card_img/1501597851121561606/XhOeAfix?format=jpg&name=small'],https://twitter.com/pharmalot/status/877585649406287872
3000,Herkyleese,@herkyleese,2017-06-21T03:24:57.000Z,Data mounting.  I have a feeling we will hear more about #dcvax soon. $bmy $mrk & $nwbo collaborating already. $jazz $icpt $agio  potential,"Data mounting.  I have a feeling we will hear more about #dcvax soon. $bmy $mrk & $nwbo collaborating already. $jazz $icpt $agio  potential
4
5",,,4,5,"['https://pbs.twimg.com/media/DC0IOGmU0AIlFSi?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DC0IRFEUQAAOg4Y?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DC0ITFqV0AAEIOU?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DC0IWfkUIAAZZLV?format=jpg&name=360x360']",https://twitter.com/herkyleese/status/877366704946507776
3001,Vista Partners LLC,@VistaPResearch,2017-06-22T04:18:58.000Z,"#Biotech #stocks just had their best session of the year, and the best could still be ahead... $IBB $FATE $MRK https://cnbc.com/amp/2017/06/21/chart-check-on-biotech-why-the-hot-stocks-could-keep-rallying.html‚Ä¶ $JNJ","#Biotech #stocks just had their best session of the year, and the best could still be ahead... $IBB $FATE $MRK https://cnbc.com/amp/2017/06/21/chart-check-on-biotech-why-the-hot-stocks-could-keep-rallying.html‚Ä¶ $JNJ
cnbc.com
Biotech stocks just had their best session of the year, and the best could still be ahead
Some strategists forecast the group could see further upside as one popular exchange-traded fund just broke through a round-numbered level.
2
2",,,2,2,[],https://twitter.com/VistaPResearch/status/877742686408654849
3002,Seeking Alpha,@SeekingAlpha,2017-06-23T13:25:24.000Z,Gilead: How Sweet It Is https://seekingalpha.com/article/4083503-gilead-sweet?source=feed_f‚Ä¶ $MRK $GILD,"Gilead: How Sweet It Is https://seekingalpha.com/article/4083503-gilead-sweet?source=feed_f‚Ä¶ $MRK $GILD
seekingalpha.com
Gilead: How Sweet It Is (NASDAQ:GILD)
Gilead has vanquished mighty Merck in the jurisprudential lists once again. The political winds are softening, or so they say.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1492090390631092229/oryFHje3?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/878242589509431300
3003,Divya Grover,@thegirlshewasnt,2017-06-22T01:03:28.000Z,"Gilead Sciences wins victory in its #litigation with Merck over #patent on #hepatitisC #drug Sovaldi I via 
@Reuters
 $GILD $MRK","Gilead Sciences wins victory in its #litigation with Merck over #patent on #hepatitisC #drug Sovaldi I via 
@Reuters
 $GILD $MRK
Reuters Legal
@ReutersLegal
 ¬∑ 22 Jun 2017
#Gilead knocks out #Merck patent on hepatitis C treatment http://reut.rs/2sC9Coq @JanNWolfe ($)
1
7
4",,1,7,4,"['https://pbs.twimg.com/profile_images/877491866706395139/QnLtTu2w_mini.jpg', 'https://pbs.twimg.com/media/DC4wT6ZUIAAnAQB?format=jpg&name=small']",https://twitter.com/thegirlshewasnt/status/877693485670727681
3004,Sentiment Stocks,@sentimentstock,2017-06-22T16:01:43.000Z,$MRK $KITE $JUNO $CLDX $AZN $NWBO Closes on final $5 of $11m debt with  convertible debt exchange w/3 year maturity.,"$MRK $KITE $JUNO $CLDX $AZN $NWBO Closes on final $5 of $11m debt with  convertible debt exchange w/3 year maturity.
prnewswire.com
NWBio Closes 3-Year Convertible Debt Exchange and Financing, and Completes Payoff of Last $5...
/PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) (""NW Bio""), a U.S. biotechnology company developing DCVax¬Æ personalized immune therapies for...
4
9",,,4,9,['https://pbs.twimg.com/card_img/1497294812843843593/Z4WRjp05?format=jpg&name=900x900'],https://twitter.com/sentimentstock/status/877919537760321536
3005,Russo Partners,@russopartners,2017-06-23T13:41:24.000Z,"Germany's Merck $MRK gets EU backing for oral MS drug http://reut.rs/2rYvf5B via 
@Reuters
 #pharma #news","Germany's Merck $MRK gets EU backing for oral MS drug http://reut.rs/2rYvf5B via 
@Reuters
 #pharma #news
1",,,1,,[],https://twitter.com/russopartners/status/878246614342807553
3006,TA Scilab Ichimoku,@tasciccac,2017-06-23T21:49:46.000Z,"Replying to 
@tasciccac","Replying to 
@tasciccac
$DJIA WKLY Best performing $MRK $PFE $NKE $BA $AAPL $UNH $MCD $MSFT Worst $GE $HD $CAT $CVX $INTC $VZ $XOM $GS $DD $TRV #Ichimoku #Dashboard
1
1",,1,1,,['https://pbs.twimg.com/media/DDCX5i3XgAEdOyN?format=jpg&name=small'],https://twitter.com/tasciccac/status/878369517541490689
3007,Margin Hunt,@MarginHunt,2017-06-23T17:05:06.000Z,"The market is valuing Gilead Sciences, Inc. $GILD at a discount vs peers. Worth a look? $ABBV $BMY $LLY $MRK $PFE http://ow.ly/SNCs30cO2mN","The market is valuing Gilead Sciences, Inc. $GILD at a discount vs peers. Worth a look? $ABBV $BMY $LLY $MRK $PFE http://ow.ly/SNCs30cO2mN",,,,,['https://pbs.twimg.com/media/DDBXQ6rXUAAA9HM?format=jpg&name=small'],https://twitter.com/MarginHunt/status/878297877885239297
3008,Margin Hunt,@MarginHunt,2017-06-21T23:00:46.000Z,Zoetis Inc. $ZTS EBITDA multiple of 21.0x doesn't look attractive vs peers: $MRK $PRGO $LLY $PFE $BMY http://ow.ly/rLKF30cI6ap,Zoetis Inc. $ZTS EBITDA multiple of 21.0x doesn't look attractive vs peers: $MRK $PRGO $LLY $PFE $BMY http://ow.ly/rLKF30cI6ap,,,,,['https://pbs.twimg.com/media/DC4VfTJW0AAZ7FO?format=jpg&name=small'],https://twitter.com/MarginHunt/status/877662607284502528
3009,Stock Market Picks,@StockWebTrading,2017-06-21T18:23:10.000Z,DowStockTip's Results: $MRK opened LONG on 6/13 at $63.60 and closed today at $65.00 +2.20% (http://dowstocktips.com) $QQQ $SPY $DIA,DowStockTip's Results: $MRK opened LONG on 6/13 at $63.60 and closed today at $65.00 +2.20% (http://dowstocktips.com) $QQQ $SPY $DIA,,,,,['https://pbs.twimg.com/media/DC3V8DDWsAAsOKh?format=jpg&name=small'],https://twitter.com/StockWebTrading/status/877592747070410764
3010,crosseyedannie,@crosseyedannie,2017-06-22T17:48:49.000Z,Drug stocks rally on GOP draft of healthcare bill https://seekingalpha.com/news/3275099-drug-stocks-rally-gop-draft-healthcare-bill?source=tweet‚Ä¶ $VRX $ABBV $PFE $MRK #Trumpcare Headline says it all  #GOP4Wallst,Drug stocks rally on GOP draft of healthcare bill https://seekingalpha.com/news/3275099-drug-stocks-rally-gop-draft-healthcare-bill?source=tweet‚Ä¶ $VRX $ABBV $PFE $MRK #Trumpcare Headline says it all  #GOP4Wallst,,,,,[],https://twitter.com/crosseyedannie/status/877946489514807296
3011,David A. Yablon,@day54,2017-06-21T13:45:57.000Z,Leading the equity markets again $BIIB $CELG $GILD $AMGN $MRK $UNH $PFE  #healthcare,"Leading the equity markets again $BIIB $CELG $GILD $AMGN $MRK $UNH $PFE  #healthcare
1",,,,1,[],https://twitter.com/day54/status/877522982243094528
3012,dough,@semodough,2017-06-23T02:01:42.000Z,ISI Keytruda‚Äôs uptick in May seems promising especially considering $MRK  only got approval for the combo in 1st line lung on May 10th $BMY,"ISI Keytruda‚Äôs uptick in May seems promising especially considering $MRK  only got approval for the combo in 1st line lung on May 10th $BMY
2",,,,2,[],https://twitter.com/semodough/status/878070528539451392
3013,Equity Clock,@EquityClock,2017-06-22T16:19:08.000Z,Techs by S&P 500 stocks to Noon: Bullish. Breakouts: $RCL $WYN $BMY $HCA $GILD $MRK $AGN $HOLX $UTX $ORCL $NRG $DGX $MCK . Breakdown: $NLSN,"Techs by S&P 500 stocks to Noon: Bullish. Breakouts: $RCL $WYN $BMY $HCA $GILD $MRK $AGN $HOLX $UTX $ORCL $NRG $DGX $MCK . Breakdown: $NLSN
1",,,,1,[],https://twitter.com/EquityClock/status/877923921114300417
3014,Breaking News,@MarketCurrents,2017-06-21T23:22:43.000Z,Biotechs blaze as Trump draft order on drug prices would ease regulations https://seekingalpha.com/news/3274927-biotechs-blaze-trump-draft-order-drug-prices-ease-regulations?source=feed_f‚Ä¶ $IBB $PFE $MRK $BMY,"Biotechs blaze as Trump draft order on drug prices would ease regulations https://seekingalpha.com/news/3274927-biotechs-blaze-trump-draft-order-drug-prices-ease-regulations?source=feed_f‚Ä¶ $IBB $PFE $MRK $BMY
seekingalpha.com
Biotechs blaze as Trump draft order on drug prices would ease regulations (NYSE:PFE)
Biotech stocks (NASDAQ:IBB) were bullish again today, surging another 4.1% and extending this week's sector gain to 8% as sentiment emerges that the Trump Administration's attempt to rein...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/877668129635090432
3015,Vista Partners LLC,@VistaPResearch,2017-06-23T01:42:40.000Z,Biotech on pace for best week of the year $IBB $XBI https://lnkd.in/g8vAdAw #healthcare $JNJ $PFE $MRK,Biotech on pace for best week of the year $IBB $XBI https://lnkd.in/g8vAdAw #healthcare $JNJ $PFE $MRK,,,,,[],https://twitter.com/VistaPResearch/status/878065740594544640
3016,$E,@25k_Trading,2017-06-23T15:23:58.000Z,#Revenge $IBB $XBI $79.25 the sweet spot resistance $CELG $LABU $LABD $BMY $MRK $GILD Live Chat Trades,"#Revenge $IBB $XBI $79.25 the sweet spot resistance $CELG $LABU $LABD $BMY $MRK $GILD Live Chat Trades
youtube.com
All Time Highs with 25kTrading [Pilot]
Want to see more? Hit subscribe and get notified when I'm on! Join us in the free YouTube LIVE chat room where hundreds of online day traders discuss trading...",,,,,['https://pbs.twimg.com/card_img/1501252352812085249/MuOjfNzR?format=jpg&name=240x240'],https://twitter.com/25k_Trading/status/878272425577791489
3017,$E,@25k_Trading,2017-06-23T13:43:46.000Z,"Short on bio open bounce, 3.4%+ in less than 10min #Revenge $IBB $XBI $CELG $LABU $LABD $BMY $MRK $GILD LiveChat","Short on bio open bounce, 3.4%+ in less than 10min #Revenge $IBB $XBI $CELG $LABU $LABD $BMY $MRK $GILD LiveChat
youtube.com
All Time Highs with 25kTrading [Pilot]
Want to see more? Hit subscribe and get notified when I'm on! Join us in the free YouTube LIVE chat room where hundreds of online day traders discuss trading...",,,,,['https://pbs.twimg.com/card_img/1501252352812085249/MuOjfNzR?format=jpg&name=240x240'],https://twitter.com/25k_Trading/status/878247211565535232
3018,ABetter Kayleigh McEnany,@MissElllly,2017-06-22T18:32:02.000Z,$SPY $PFE $GSK $IBB $MRK $GILD #Healthcarebill  would enact deeper long-term cuts to the health-care program for low-income Americans-,$SPY $PFE $GSK $IBB $MRK $GILD #Healthcarebill  would enact deeper long-term cuts to the health-care program for low-income Americans-,,,,,[],https://twitter.com/MissElllly/status/877957366318120961
3019,1 min Stock Insights,@1MinuteStock,2017-06-23T04:02:02.000Z,Wondering about #sentiment indicator for $MRK? The Short Ratio is 1.87%,"Wondering about #sentiment indicator for $MRK? The Short Ratio is 1.87%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/878100810873294848
3020,Pharmaceutical News,@pharma_sector,2017-06-22T17:05:26.000Z,"#Merck & Co. And Premier, Inc. Expand Collaboration To Address Chronic Care And Vaccination ... Read more: http://owler.us/acUM1A $MRK","#Merck & Co. And Premier, Inc. Expand Collaboration To Address Chronic Care And Vaccination ... Read more: http://owler.us/acUM1A $MRK",,,,,[],https://twitter.com/pharma_sector/status/877935571762503681
3021,EdisonHealthcare,@EdisonHealth,2017-06-21T15:35:25.000Z,Check our #ASCO17 report here: http://edisoninvestmentresearch.com/research/sector-commentary‚Ä¶ ‚Ä¶ $BLUE $KITE $JUNO $NVS $MRK $AZN $BMY $MOR $PHM $HCM $PBYI $INCY $VLA $PBMD $LOXO,"Check our #ASCO17 report here: http://edisoninvestmentresearch.com/research/sector-commentary‚Ä¶ ‚Ä¶ $BLUE $KITE $JUNO $NVS $MRK $AZN $BMY $MOR $PHM $HCM $PBYI $INCY $VLA $PBMD $LOXO
edisongroup.com
Our content | Edison",,,,,[],https://twitter.com/EdisonHealth/status/877550532486979585
3022,MarketBeat,@MarketBeatCom,2017-06-22T22:45:53.000Z,"Merck & Company, Inc. $MRK Upgraded at BidaskClub http://ift.tt/2sWGFpq #acn","Merck & Company, Inc. $MRK Upgraded at BidaskClub http://ift.tt/2sWGFpq #acn",,,,,[],https://twitter.com/MarketBeatCom/status/878021250785976322
3023,Christian Fromhertz,@cfromhertz,2017-06-21T15:34:06.000Z,Midday Update con't - Biotech $XBI continues w/ monster week big call buying in $IBB $XLV $MRK $GILD etc this week,"Midday Update con't - Biotech $XBI continues w/ monster week big call buying in $IBB $XLV $MRK $GILD etc this week
1",,,,1,[],https://twitter.com/cfromhertz/status/877550202231689216
3024,Siera Xray,@orion659,2017-06-22T19:20:24.000Z,Drug stocks rally on GOP draft of healthcare bill $VRX $ABBV $PFE $MRK $NVS $LLY $BMY $AGN $TEVA $AZN $GSK,"Drug stocks rally on GOP draft of healthcare bill $VRX $ABBV $PFE $MRK $NVS $LLY $BMY $AGN $TEVA $AZN $GSK
seekingalpha.com
Drug stocks rally on GOP draft of healthcare bill (NYSE:BHC)
Money flow into drug makers has ramped up after the release of Republicans' draft healthcare bill and fears subside that there will be any significant headwinds to future price...",‚úà,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/orion659/status/877969539060903936
3025,Dominic,@Globalmess65,2017-06-22T16:00:53.000Z,$AMGN's Repatha $REGN's Praluent equals $MRK's failed buyout of $SGP Zetia. Look at these study's. Generic Crestor can is just as good alone,"$AMGN's Repatha $REGN's Praluent equals $MRK's failed buyout of $SGP Zetia. Look at these study's. Generic Crestor can is just as good alone
1",,1,,,[],https://twitter.com/Globalmess65/status/877919329936842752
3026,FierceBiotech,@FierceBiotech,2017-06-21T09:13:19.000Z,"Merck, Illumina back immune-mapper SerImmune in $8M round: http://ow.ly/zW2n30cLGCp $MRK $ILMN","Merck, Illumina back immune-mapper SerImmune in $8M round: http://ow.ly/zW2n30cLGCp $MRK $ILMN
fiercebiotech.com
Merck, Illumina back immune-mapper SerImmune in $8M round
SerImmune, whose technology maps the human antibody repertoire, rounded | SerImmune, whose technology maps the human antibody repertoire, rounded up $8 million from Merck, Illumina Ventures and...
1
1",,,1,1,[],https://twitter.com/FierceBiotech/status/877454373932199936
3027,Daily Political,@dailypoliticaln,2017-06-22T09:33:21.000Z,"Abner Herrman & Brock LLC Has $15.40 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2rUmLMQ","Abner Herrman & Brock LLC Has $15.40 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2rUmLMQ",,,,,[],https://twitter.com/dailypoliticaln/status/877821800981250048
3028,Limex,@LimexMe,2017-06-21T22:24:46.000Z,Ligand Gets Milestone Payment on Partner Drug FDA Approval http://bit.ly/2sWWUnb $LGND $AMGN $MRK,"Ligand Gets Milestone Payment on Partner Drug FDA Approval http://bit.ly/2sWWUnb $LGND $AMGN $MRK
whotrades.com
Ligand Gets Milestone Payment on Partner Drug FDA Approval
Ligand Pharmaceuticals Incorporated LGND announced receipt of a milestone payment of $1.5 million after its partner Melinta Therapeutics‚Äô pipeline candidate Baxdela‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/877653549068554242
3029,WLST.com,@wlstcom,2017-06-23T01:42:49.000Z,Biotech on pace for best week of the year #healthcare $IBB $XBI $JNJ $PFE $MRK #wlst https://finance.yahoo.com/video/biotech-pace-best-week-160100583.html‚Ä¶,Biotech on pace for best week of the year #healthcare $IBB $XBI $JNJ $PFE $MRK #wlst https://finance.yahoo.com/video/biotech-pace-best-week-160100583.html‚Ä¶,,,,,['https://pbs.twimg.com/media/DC-EK7yWAAA4EZt?format=jpg&name=small'],https://twitter.com/wlstcom/status/878065777794048000
3030,WLST.com,@wlstcom,2017-06-22T16:52:01.000Z,Drug stocks rally on GOP draft of healthcare bill #ABBV #AbbVieInc. $VRX $ABBV $PFE $MRK $NVS $LLY $BMY $AGN $TEVA,"Drug stocks rally on GOP draft of healthcare bill #ABBV #AbbVieInc. $VRX $ABBV $PFE $MRK $NVS $LLY $BMY $AGN $TEVA
seekingalpha.com
Drug stocks rally on GOP draft of healthcare bill (NYSE:BHC)
Money flow into drug makers has ramped up after the release of Republicans' draft healthcare bill and fears subside that there will be any significant headwinds to future price...",,,,,[],https://twitter.com/wlstcom/status/877932196828520449
3031,Dakota Financial,@dakotafinancial,2017-06-22T13:01:21.000Z,"Merck & Company, Inc. $MRK Stake Raised by OLD Point Trust & Financial Services N A http://ift.tt/2sEL2mR","Merck & Company, Inc. $MRK Stake Raised by OLD Point Trust & Financial Services N A http://ift.tt/2sEL2mR",,,,,[],https://twitter.com/dakotafinancial/status/877874149141741568
3032,1 min Stock Insights,@1MinuteStock,2017-06-23T04:14:02.000Z,Wondering about risks of $MRK? The 63-day volatility is 5.56%,"Wondering about risks of $MRK? The 63-day volatility is 5.56%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/878103831741046785
3033,$PVCT,@Ablate_Cancer,2017-06-23T13:55:53.000Z,"Merck's Keytruda on a Roll: Can it Retain the Momentum? - June 22, 2017 - http://Zacks.com $mrk","Merck's Keytruda on a Roll: Can it Retain the Momentum? - June 22, 2017 - http://Zacks.com $mrk
zacks.com
Merck's Keytruda on a Roll: Can it Retain the Momentum?
As demand for immuno-oncology drugs and their combinations rises, Merck & Co., Inc.'s (MRK) anti-PD-1 therapy, Keytruda, is being touted as a significant top-line driver for this Kenilworth, NJ based...",,,,,[],https://twitter.com/Ablate_Cancer/status/878250258328805377
3034,bake mcbride,@ITRADEVOL,2017-06-22T20:38:15.000Z,MOSt  Active Hours Trading $GDX $EEM $SPY $MU $CSCO $EWZ $BAC $GDXJ $MRK $AAPL $HAL $ABEV $INTC $FTR $T $RSX $KATE https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,MOSt  Active Hours Trading $GDX $EEM $SPY $MU $CSCO $EWZ $BAC $GDXJ $MRK $AAPL $HAL $ABEV $INTC $FTR $T $RSX $KATE https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/877989130277400581
3035,Ticker Report,@TickerReport,2017-06-22T09:46:08.000Z,"Douglas Lane & Associates LLC Sells 8,695 Shares of Merck & Company, Inc. $MRK http://ift.tt/2rUC3RE","Douglas Lane & Associates LLC Sells 8,695 Shares of Merck & Company, Inc. $MRK http://ift.tt/2rUC3RE",,,,,[],https://twitter.com/TickerReport/status/877825017429602305
3036,Watchlist News,@WatchlistN,2017-06-23T10:07:35.000Z,"Wagner Bowman Management Corp Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2tB4IYY","Wagner Bowman Management Corp Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2tB4IYY",,,,,[],https://twitter.com/WatchlistN/status/878192803590938624
3037,Watchlist News,@WatchlistN,2017-06-23T10:07:29.000Z,"Merck & Company, Inc. $MRK is Monarch Capital Management Inc.‚Äôs Largest Position http://ift.tt/2tB9c1Q","Merck & Company, Inc. $MRK is Monarch Capital Management Inc.‚Äôs Largest Position http://ift.tt/2tB9c1Q",,,,,[],https://twitter.com/WatchlistN/status/878192780765540352
3038,US Banking News,@AmericanBanking,2017-06-22T22:51:01.000Z,"Merck & Company, Inc. $MRK Upgraded at BidaskClub http://ift.tt/2tzDulN","Merck & Company, Inc. $MRK Upgraded at BidaskClub http://ift.tt/2tzDulN",,,,,[],https://twitter.com/AmericanBanking/status/878022543633985536
3039,TalkMarkets,@TalkMarkets,2017-06-23T14:01:21.000Z,"$NVS Scores With Positive Data, Shire ADHD Drug Gets FDA Nod $BMY $MRK $NVO $RHHBY $SHPG $NEOS https://goo.gl/7Mxnu8","$NVS Scores With Positive Data, Shire ADHD Drug Gets FDA Nod $BMY $MRK $NVO $RHHBY $SHPG $NEOS https://goo.gl/7Mxnu8",,,,,[],https://twitter.com/TalkMarkets/status/878251635650080768
3040,US Banking News,@AmericanBanking,2017-06-23T15:29:21.000Z,Merck & Company $MRK ‚Äì Investment Analysts‚Äô Weekly Ratings Changes http://ift.tt/2syBA66,Merck & Company $MRK ‚Äì Investment Analysts‚Äô Weekly Ratings Changes http://ift.tt/2syBA66,,,,,[],https://twitter.com/AmericanBanking/status/878273779545378817
3041,MarketBeat,@MarketBeatCom,2017-06-23T02:04:30.000Z,"Merck & Company $MRK Receiving Positive Press Coverage, Report Shows http://ift.tt/2tzMIOP","Merck & Company $MRK Receiving Positive Press Coverage, Report Shows http://ift.tt/2tzMIOP",,,,,[],https://twitter.com/MarketBeatCom/status/878071232985530368
3042,MarketBeat,@MarketBeatCom,2017-06-23T11:49:43.000Z,"Merck & Company, Inc. $MRK Stake Decreased by Nippon Life Insurance Co. http://ift.tt/2rYGBGB","Merck & Company, Inc. $MRK Stake Decreased by Nippon Life Insurance Co. http://ift.tt/2rYGBGB",,,,,[],https://twitter.com/MarketBeatCom/status/878218508684931072
3043,SwingTradeBot,@SwingTradeBot,2017-06-22T15:42:08.000Z,Recent $MRK technical alerts: MACD Bullish Signal Line Cross plus 3 more alerts...,"Recent $MRK technical alerts: MACD Bullish Signal Line Cross plus 3 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/877914611730665472
3044,Dakota Financial,@dakotafinancial,2017-06-23T02:12:09.000Z,"Merck & Company $MRK Receiving Positive Press Coverage, Report Shows http://ift.tt/2tzMIOP","Merck & Company $MRK Receiving Positive Press Coverage, Report Shows http://ift.tt/2tzMIOP",,,,,[],https://twitter.com/dakotafinancial/status/878073158888194048
3045,Ticker Report,@TickerReport,2017-06-23T18:55:16.000Z,"Merck & Company, Inc. $MRK Upgraded to ‚ÄúHold‚Äù by BidaskClub http://ift.tt/2tXw4YA","Merck & Company, Inc. $MRK Upgraded to ‚ÄúHold‚Äù by BidaskClub http://ift.tt/2tXw4YA",,,,,[],https://twitter.com/TickerReport/status/878325602037649410
3046,Magnolia Gallery,@MagnoliaG2012,2017-06-21T23:28:05.000Z,Biotechs blaze as Trump draft order on drug prices would ease regulations https://seekingalpha.com/news/3274927-biotechs-blaze-trump-draft-order-drug-prices-ease-regulations?source=tweet‚Ä¶ $IBB $PFE $MRK $BMY,"Biotechs blaze as Trump draft order on drug prices would ease regulations https://seekingalpha.com/news/3274927-biotechs-blaze-trump-draft-order-drug-prices-ease-regulations?source=tweet‚Ä¶ $IBB $PFE $MRK $BMY
seekingalpha.com
Biotechs blaze as Trump draft order on drug prices would ease regulations (NYSE:PFE)
Biotech stocks (NASDAQ:IBB) were bullish again today, surging another 4.1% and extending this week's sector gain to 8% as sentiment emerges that the Trump Administration's attempt to rein...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/MagnoliaG2012/status/877669481446854656
3047,Laurance Allen,@LarryVNN,2017-06-22T19:18:07.000Z,Drug stocks rally on GOP draft of healthcare bill $VRX $ABBV $PFE $MRK $NVS $LLY $BMY $AGN $TEVA $AZN $GSK,"Drug stocks rally on GOP draft of healthcare bill $VRX $ABBV $PFE $MRK $NVS $LLY $BMY $AGN $TEVA $AZN $GSK
seekingalpha.com
Drug stocks rally on GOP draft of healthcare bill (NYSE:BHC)
Money flow into drug makers has ramped up after the release of Republicans' draft healthcare bill and fears subside that there will be any significant headwinds to future price...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/LarryVNN/status/877968964801921024
3048,Allison Gatlin,@IBD_AGatlin,2017-06-21T20:45:11.000Z,"How Dow's Merck is still beating Bristol, Roche in immuno-oncology $MRK $BMY $RHHBY $PFE $AZN $KITE $BLUE http://ow.ly/pfgz30cMU0D","How Dow's Merck is still beating Bristol, Roche in immuno-oncology $MRK $BMY $RHHBY $PFE $AZN $KITE $BLUE http://ow.ly/pfgz30cMU0D",,,,,[],https://twitter.com/IBD_AGatlin/status/877628488202592256
3049,Mr. Breakout,@sharptraders,2017-06-23T01:17:00.000Z,"Today's ALL TIME NEW HIGHS, Over $1.00, Closed Up on at least 1.10x  ADV(50) ‚ñ∫‚ñ∫‚ñ∫ http://sharptraders.com/AllTimeNewHighs.html‚Ä¶ including 
$MRK $WK $ABBV $USCR etc","Today's ALL TIME NEW HIGHS, Over $1.00, Closed Up on at least 1.10x  ADV(50) ‚ñ∫‚ñ∫‚ñ∫ http://sharptraders.com/AllTimeNewHighs.html‚Ä¶ including 
$MRK $WK $ABBV $USCR etc",,,,,[],https://twitter.com/sharptraders/status/878059281244856320
3050,dough,@semodough,2017-06-23T02:12:23.000Z,"SUN $MRK Next catalyst is anacetrapib Ph-3 REVEAL data, expected imminently from Oxford group. Reiterate Buy/$73PT on 17.2x our ‚Äô18E EPS","SUN $MRK Next catalyst is anacetrapib Ph-3 REVEAL data, expected imminently from Oxford group. Reiterate Buy/$73PT on 17.2x our ‚Äô18E EPS",,,,,[],https://twitter.com/semodough/status/878073218136920064
3051,$E,@25k_Trading,2017-06-22T22:37:20.000Z,My short entry just wasn't timed well enough. Big intra day reversal $IBB $XBI $CELG $LABU $LABD $BMY $MRK $GILD  https://youtu.be/Z9R_vulmdbg,My short entry just wasn't timed well enough. Big intra day reversal $IBB $XBI $CELG $LABU $LABD $BMY $MRK $GILD  https://youtu.be/Z9R_vulmdbg,,,,,[],https://twitter.com/25k_Trading/status/878019098344538112
3052,dough,@semodough,2017-06-21T21:06:30.000Z,"Replying to 
@TraderTexMex
 and 
@shaneblackmon","Replying to 
@TraderTexMex
 and 
@shaneblackmon
$PRTK $50 puts valuation around 1-1.3 billion.  Imho fair value what ultimately I see $AGN $MRK buyout in12-18months
dough
@semodough
 ¬∑ 4 May 2017
$PRTK bottomline imho-patience $PRTK still value over next 12-18 months 1.1-1.3B valuation ultimately partnership/buyout-DERISKED $AGN $MRK https://twitter.com/tgtxdough/status/848997439096983552‚Ä¶
5
4
6",,5,4,6,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/877633850821812224
3053,Siti van der Meij,@sitivandermeij,2017-06-22T16:29:12.000Z,Drug stocks rally on GOP released draft of healthcare bill https://seekingalpha.com/news/3275099-drug-stocks-rally-gop-released-draft-healthcare-bill?source=feed_f‚Ä¶ $VRX $ABBV $PFE $MRK #sitifatimah #malaysia #financialp‚Ä¶,"Drug stocks rally on GOP released draft of healthcare bill https://seekingalpha.com/news/3275099-drug-stocks-rally-gop-released-draft-healthcare-bill?source=feed_f‚Ä¶ $VRX $ABBV $PFE $MRK #sitifatimah #malaysia #financialp‚Ä¶
seekingalpha.com
Drug stocks rally on GOP draft of healthcare bill (NYSE:BHC)
Money flow into drug makers has ramped up after the release of Republicans' draft healthcare bill and fears subside that there will be any significant headwinds to future price...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/877926454230515712
3054,Siera Xray,@orion659,2017-06-22T08:47:40.000Z,Biotechs blaze as Trump draft order on drug pri... $IBB $PFE $MRK $BMY $NVS $LLY $JNJ $AGN $AMGN $BIIB $VRTX http://seekingalpha.com/news/3274927,Biotechs blaze as Trump draft order on drug pri... $IBB $PFE $MRK $BMY $NVS $LLY $JNJ $AGN $AMGN $BIIB $VRTX http://seekingalpha.com/news/3274927,‚úà,,,,[],https://twitter.com/orion659/status/877810305681817600
3055,Siti van der Meij,@sitivandermeij,2017-06-21T23:24:30.000Z,Biotechs blaze as Trump draft order on drug prices would ease regulations https://seekingalpha.com/news/3274927-biotechs-blaze-trump-draft-order-drug-prices-ease-regulations?source=feed_f‚Ä¶ $IBB $PFE $MRK $BMY #sitifatimah #malays‚Ä¶,"Biotechs blaze as Trump draft order on drug prices would ease regulations https://seekingalpha.com/news/3274927-biotechs-blaze-trump-draft-order-drug-prices-ease-regulations?source=feed_f‚Ä¶ $IBB $PFE $MRK $BMY #sitifatimah #malays‚Ä¶
seekingalpha.com
Biotechs blaze as Trump draft order on drug prices would ease regulations (NYSE:PFE)
Biotech stocks (NASDAQ:IBB) were bullish again today, surging another 4.1% and extending this week's sector gain to 8% as sentiment emerges that the Trump Administration's attempt to rein...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/877668582016118784
3056,Seeking Alpha,@SeekingAlpha,2017-06-26T16:56:00.000Z,Biotech Boom!: Overview And Company-By-Company Review https://seekingalpha.com/article/4083947-biotech-boom-overview-company-company-review?source=feed_f‚Ä¶ $ABT $AMGN $BIIB $BMY $GILD $IBB $MRK $NVS $PFE $REGN $RHHBY,"Biotech Boom!: Overview And Company-By-Company Review https://seekingalpha.com/article/4083947-biotech-boom-overview-company-company-review?source=feed_f‚Ä¶ $ABT $AMGN $BIIB $BMY $GILD $IBB $MRK $NVS $PFE $REGN $RHHBY
2
2",,,2,2,[],https://twitter.com/SeekingAlpha/status/879382751748554752
3057,Herkyleese,@herkyleese,2017-06-26T13:20:24.000Z,"1. Top line results soon
2. O.S. 100 alive 23 months after enrollment stop  
3. Target many antigens
4. $bmy $mrk collaborating $nwbo","1. Top line results soon
2. O.S. 100 alive 23 months after enrollment stop  
3. Target many antigens
4. $bmy $mrk collaborating $nwbo
GIF
3
7",üòâ,,3,7,[],https://twitter.com/herkyleese/status/879328492956958720
3058,MM+M Magazine,@MMMnews,2017-06-26T21:30:00.000Z,"5 things for #pharma #marketers to know: Mon., June 26 $PTLA #FDA $SNY #MultipleSclerosis $MRK #Narcolepsy $JAZZ http://bit.ly/2rTHJqU","5 things for #pharma #marketers to know: Mon., June 26 $PTLA #FDA $SNY #MultipleSclerosis $MRK #Narcolepsy $JAZZ http://bit.ly/2rTHJqU
2
1",,,2,1,['https://pbs.twimg.com/media/DDQTo8WW0AAy8hR?format=jpg&name=small'],https://twitter.com/MMMnews/status/879451706077188096
3059,Jeffrey Weber,@jjjinvesting,2017-06-24T22:35:50.000Z,Gilead: How Sweet It Is https://seekingalpha.com/article/4083503-gilead-sweet?source=tweet‚Ä¶ $MRK $GILD 143% #investing profits 3 1/2 years & free #newsletter - http://bit.ly/youryacht,Gilead: How Sweet It Is https://seekingalpha.com/article/4083503-gilead-sweet?source=tweet‚Ä¶ $MRK $GILD 143% #investing profits 3 1/2 years & free #newsletter - http://bit.ly/youryacht,,,,,[],https://twitter.com/jjjinvesting/status/878743496873717762
3060,Prudent Biotech,@PrudentBiotech,2017-06-24T23:45:28.000Z,"Biotech's Best Chance Gets Even Better
http://buff.ly/2s3xIeS
$tsla $regn $exas $vrtx $celg $tsro $incy $kite $blue $jnj $mrk $pfe $labu","Biotech's Best Chance Gets Even Better
http://buff.ly/2s3xIeS
$tsla $regn $exas $vrtx $celg $tsro $incy $kite $blue $jnj $mrk $pfe $labu
seekingalpha.com
Biotech's Best Chance Has Gotten Even Better
An Executive Order expected to be issued shortly clarifying health care policy. The measures outlined are expected to be industry-friendly.
1",,1,,,['https://pbs.twimg.com/card_img/1501721590341541894/CVJ7NiJo?format=jpg&name=small'],https://twitter.com/PrudentBiotech/status/878761021405630464
3061,Herkyleese,@herkyleese,2017-06-26T17:30:45.000Z,Some therapies turn the lights on to find cancer. $kite $juno $bmy $mrk  #Dcvax turns the lights out!  $nwbo  #facebook of #cancer therapy,"Some therapies turn the lights on to find cancer. $kite $juno $bmy $mrk  #Dcvax turns the lights out!  $nwbo  #facebook of #cancer therapy
GIF
1",,,,1,['https://pbs.twimg.com/tweet_video_thumb/DDQ55j7UMAAaJqY.jpg'],https://twitter.com/herkyleese/status/879391497396899841
3062,ABetter Kayleigh McEnany,@MissElllly,2017-06-26T20:55:27.000Z,$SPY $XLV $IBB $XHE $BBP $IHI $PTH $XBI $GILD $MRK $GSK $JNJ $HUM $ANTH $AET $PFE $MMM $GE #Healthcarebill #Healthcare #Healthsector,"$SPY $XLV $IBB $XHE $BBP $IHI $PTH $XBI $GILD $MRK $GSK $JNJ $HUM $ANTH $AET $PFE $MMM $GE #Healthcarebill #Healthcare #Healthsector
ABetter Kayleigh McEnany
@MissElllly
 ¬∑ 23 Jun 2017
$SPY $PFE $GSK $AMD $GILD #Healthcarebill  less federal money for health insurance/greater likelihood that more Americans will be uninsured",,,,,['https://pbs.twimg.com/profile_images/1123937992618409984/2rzzFs3G_mini.png'],https://twitter.com/MissElllly/status/879443011175948290
3063,Eti,@Eti8888,2017-06-26T17:26:52.000Z,Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023 http://businesswire.com/news/home/20170626005474/en/Global-Dendritic-Cell-Cancer-Vaccine-Market-Clinical‚Ä¶ $NWBO $ARGS $MRK $IMUC #CANCER #VACCINE,"Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023 http://businesswire.com/news/home/20170626005474/en/Global-Dendritic-Cell-Cancer-Vaccine-Market-Clinical‚Ä¶ $NWBO $ARGS $MRK $IMUC #CANCER #VACCINE
businesswire.com
Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2017-2023 - Research and...
Research and Markets has announced the addition of the
1
5",,,1,5,[],https://twitter.com/Eti8888/status/879390517758488578
3064,Finbox,@FinboxIO,2017-06-26T13:30:10.000Z,Check out the discounted P/E multiple of Bristol-Myers Squibb Company $BMY vs comps: $LLY $MRK $AZN $PFE $ABBV http://ow.ly/7ATh30cOohv,Check out the discounted P/E multiple of Bristol-Myers Squibb Company $BMY vs comps: $LLY $MRK $AZN $PFE $ABBV http://ow.ly/7ATh30cOohv,,,,,['https://pbs.twimg.com/media/DDQC1uHXYAAT83w?format=jpg&name=small'],https://twitter.com/FinboxIO/status/879330951586885632
3065,Muathe,@muathe,2017-06-24T14:33:20.000Z,"[Wkend] U.S. Market Technical Analysis June 24, 2017 $ATVI $RIG $AMAT $HPQ $MRK $UNP $STAY $MRO $CX $KBR $AMGN $ECA","[Wkend] U.S. Market Technical Analysis June 24, 2017 $ATVI $RIG $AMAT $HPQ $MRK $UNP $STAY $MRO $CX $KBR $AMGN $ECA
youtube.com
[ Part 1 ] U.S. Market Technical Analysis June 24-25, 2017
Ôº¨Ôº©Ôº´Ôº• | Ôº£ÔºØÔº≠Ôº≠Ôº•ÔºÆÔº¥ | Ôº≥Ôº®Ôº°Ôº≤Ôº• | Ôº≥ÔºµÔº¢Ôº≥Ôº£Ôº≤Ôº©Ôº¢Ôº•My Website; http://www.muathe.com/Original Muathe.com Concepts!Daily 2-Minute Chart Study #497: ""World-Wide"" Single Line Ro...",,,,,['https://pbs.twimg.com/card_img/1496135872135282706/O5heAlBI?format=jpg&name=240x240'],https://twitter.com/muathe/status/878622073341562880
3066,Dr. Mark JS Miller,@docmmiller,2017-06-25T22:27:28.000Z,"The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK https://fool.com/investing/2017/06/25/the-fda-has-never-approved-a-drug-like-this-in-its.aspx?source=isafpbcs0000001‚Ä¶ 
@Connealy_MD","The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK https://fool.com/investing/2017/06/25/the-fda-has-never-approved-a-drug-like-this-in-its.aspx?source=isafpbcs0000001‚Ä¶ 
@Connealy_MD
fool.com
The FDA Has Never Approved a Drug Like This in Its 111-Year History @themotleyfool #stocks $MRK
This cancer drug produced data so incredible that the FDA approved it immediately for a specific genetic mutation, regardless of cancer location.
3
2",,,3,2,[],https://twitter.com/docmmiller/status/879103780188545025
3067,SF Education,@SFEducation,2017-06-26T18:27:50.000Z,The FDA Has Never Approved a Drug Like This in Its 111-Year History https://aff.whotrades.com/t/b/n6cv2/ $MRK,The FDA Has Never Approved a Drug Like This in Its 111-Year History https://aff.whotrades.com/t/b/n6cv2/ $MRK,,,,,['https://pbs.twimg.com/media/DDRG-FcWsAEcGdh?format=png&name=900x900'],https://twitter.com/SFEducation/status/879405861898203136
3068,Fluid,@Fluidinvest,2017-06-26T20:59:04.000Z,Biotech Boom!: Overview And Company-By-Company Review https://seekingalpha.com/article/4083947-biotech-boom-overview-company-company-review?source=tweet‚Ä¶ $ABT $AMGN $BIIB $BMY $GILD $IBB $MRK $NVS $PFE $REGN $RHHBY,Biotech Boom!: Overview And Company-By-Company Review https://seekingalpha.com/article/4083947-biotech-boom-overview-company-company-review?source=tweet‚Ä¶ $ABT $AMGN $BIIB $BMY $GILD $IBB $MRK $NVS $PFE $REGN $RHHBY,,,,,[],https://twitter.com/Fluidinvest/status/879443918844301312
3069,Trade Academy,@TradeAcademyCo,2017-06-26T12:26:47.000Z,6/26 52-Week Hi Watch List: $NXPI $NTES $GLW $MGM $SVXY $BA $MBLY $EXPE $XBI $GRUB $HLF $WYNN $HRB $KITE $CLVS $FB $ZNGA $RH $MRK #trading,6/26 52-Week Hi Watch List: $NXPI $NTES $GLW $MGM $SVXY $BA $MBLY $EXPE $XBI $GRUB $HLF $WYNN $HRB $KITE $CLVS $FB $ZNGA $RH $MRK #trading,,,,,[],https://twitter.com/TradeAcademyCo/status/879315000967516160
3070,StockSpotter,@StockSpotter,2017-06-26T14:47:57.000Z,Closed $MRK for a 4.4% gain in 6 days. Forecast remains slightly bullish.  #stocks  #trading http://bit.ly/1fug5ZK,Closed $MRK for a 4.4% gain in 6 days. Forecast remains slightly bullish.  #stocks  #trading http://bit.ly/1fug5ZK,,,,,[],https://twitter.com/StockSpotter/status/879350527145852928
3071,Prop_Trader,@Prop_Trader,2017-06-26T02:26:50.000Z,How is a drug company even allowed to exist after withholding health risk from $VIOXX drug in 2004 for 5 years. $MRK,How is a drug company even allowed to exist after withholding health risk from $VIOXX drug in 2004 for 5 years. $MRK,,,,,[],https://twitter.com/Prop_Trader/status/879164017515909120
3072,Prop_Trader,@Prop_Trader,2017-06-26T20:56:13.000Z,Vioxx drug only killed 60k people media is quick to remember the 6k 911 victims but hush hush no remembrance from $MRK,Vioxx drug only killed 60k people media is quick to remember the 6k 911 victims but hush hush no remembrance from $MRK,,,,,[],https://twitter.com/Prop_Trader/status/879443204810182658
3073,Prop_Trader,@Prop_Trader,2017-06-26T02:38:52.000Z,"VIOXX was the most prescribed drug in History back in 1999 to treat arthritis, over 80 million prescribed. $MRK took it off market in 2004","VIOXX was the most prescribed drug in History back in 1999 to treat arthritis, over 80 million prescribed. $MRK took it off market in 2004",,,,,[],https://twitter.com/Prop_Trader/status/879167046939852800
3074,"Kwame Osei-Sarfo, PhD",@smokinscientist,2017-06-26T12:36:54.000Z,"Great article about a top I-O drug #fda #ImmunoOncology #keytruda 
@themotleyfool
 #stocks $MRK","Great article about a top I-O drug #fda #ImmunoOncology #keytruda 
@themotleyfool
 #stocks $MRK
fool.com
The FDA Has Never Approved a Drug Like This in Its 111-Year History @themotleyfool #stocks $MRK
This cancer drug produced data so incredible that the FDA approved it immediately for a specific genetic mutation, regardless of cancer location.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1500370507899842564/DH8HlVpt?format=jpg&name=small'],https://twitter.com/smokinscientist/status/879317545366560769
3075,ABetter Kayleigh McEnany,@MissElllly,2017-06-26T17:36:51.000Z,$Spy #CBO Score expected today #HealthcareBill $PFE $AET $JNJ $MRK $UNH $AMGN $BMY $CELG $GILD $XLV $IBB $PTH $XBI,$Spy #CBO Score expected today #HealthcareBill $PFE $AET $JNJ $MRK $UNH $AMGN $BMY $CELG $GILD $XLV $IBB $PTH $XBI,,,,,[],https://twitter.com/MissElllly/status/879393030578610182
3076,StockMarketVideo.com,@stockmarketvide,2017-06-26T00:51:23.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/879139998175547392
3077,Sweet Platform,@SweetPlatform,2017-06-26T14:48:21.000Z,"MRK Top news - Jun 26th, 2017 $MRK http://https://goo.gl/FXTDjd","MRK Top news - Jun 26th, 2017 $MRK http://https://goo.gl/FXTDjd",,,,,[],https://twitter.com/SweetPlatform/status/879350626160967682
3078,FinInvTr,@FinInvTr,2017-06-26T02:17:41.000Z,Which Cancer-Killing Drug Companies Are Set To Fly Up?  http://buff.ly/2s1aCWg $KITE $BLUE $PFE $INCY $MRK,"Which Cancer-Killing Drug Companies Are Set To Fly Up?  http://buff.ly/2s1aCWg $KITE $BLUE $PFE $INCY $MRK
whotrades.com
Will These Cutting-Edge Cancer Killers Reignite The Biotech Rally?
Shutterstock photo The biotech industry, always a highly technical conundrum for investors, might currently pose an even greater challenge - and offer even greater opportunities - than‚Ä¶",,,,,[],https://twitter.com/FinInvTr/status/879161714473828352
3079,Hottest Stocks Now,@HottestStockNow,2017-06-26T12:26:32.000Z,"Highlights on $PFE, $MRK, $ABBV, $JNJ http://crweworld.com/newsroom/prnewswire?rkey=20170626enUK201706266495&filter=10284‚Ä¶","Highlights on $PFE, $MRK, $ABBV, $JNJ http://crweworld.com/newsroom/prnewswire?rkey=20170626enUK201706266495&filter=10284‚Ä¶",,,,,[],https://twitter.com/HottestStockNow/status/879314936404430849
3080,Prudent Biotech,@PrudentBiotech,2017-06-24T14:30:09.000Z,"Biotech's Best Chance Gets Even Better
http://buff.ly/2sMcNdv
$nvcr $fmi $akba $loxo $insy $glyc $tgtx $xlf $labu $labd $mrk $jnj $pfe $bmy","Biotech's Best Chance Gets Even Better
http://buff.ly/2sMcNdv
$nvcr $fmi $akba $loxo $insy $glyc $tgtx $xlf $labu $labd $mrk $jnj $pfe $bmy
1",,1,,,[],https://twitter.com/PrudentBiotech/status/878621272103669760
3081,IECONOMICS,@iECONOMICS,2017-06-26T14:15:41.000Z,Merck & Co $MRK market alert: 16-week high @ 66.39 https://ieconomics.com/merck,Merck & Co $MRK market alert: 16-week high @ 66.39 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/879342403332734978
3082,Stockflare US Page,@StockflareUS,2017-06-24T09:32:32.000Z,"$MRK: Merck & Co., Inc. has lost a star, now a 3 star stock. (https://stockflare.com/stock/MRK)","$MRK: Merck & Co., Inc. has lost a star, now a 3 star stock. (https://stockflare.com/stock/MRK)",,,,,[],https://twitter.com/StockflareUS/status/878546371971878916
3083,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-06-24T14:00:40.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/8ZGU06kEw,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live... http://fb.me/8ZGU06kEw,,,,,[],https://twitter.com/gem_2014/status/878613852035981313
3084,1 min Stock Insights,@1MinuteStock,2017-06-26T04:02:02.000Z,Not sure what to do with $MRK? Explore our #fundamental pros and cons.  https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=notsureproscons&utm_source=twitter‚Ä¶,Not sure what to do with $MRK? Explore our #fundamental pros and cons.  https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=notsureproscons&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/1MinuteStock/status/879187974415691776
3085,BioPharma Dive,@BioPharmaDive,2017-06-24T16:59:00.000Z,#ICYMI Here's how $MRK hopes to win in I/O combos,"#ICYMI Here's how $MRK hopes to win in I/O combos
biopharmadive.com
How Merck hopes to win in I/O combos: Q&A with Roy Baynes
Combinations are pegged as the next step forward in immuno-oncology. Speaking with BioPharma Dive at ASCO, Merck's Roy Baynes cautioned how little is known about the best pairing and explained why...",,,,,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/878658730409078784
3086,US Banking News,@AmericanBanking,2017-06-26T12:14:16.000Z,Merck KGaA given ‚Ç¨115.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2rSZpTw $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2rSZpTw $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/879311849854029824
3087,Tim Reller,@TraderGuruNY,2017-06-26T00:56:52.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/879141376100900864
3088,Limex,@LimexMe,2017-06-26T13:51:25.000Z,The 3 Top Stocks for Your IRA in June http://bit.ly/260617CAKE $CAKE $MRK $CLR,The 3 Top Stocks for Your IRA in June http://bit.ly/260617CAKE $CAKE $MRK $CLR,,,,,[],https://twitter.com/LimexMe/status/879336299290923012
3089,Transcript Daily,@TranscriptDaily,2017-06-26T11:49:39.000Z,"Nationwide Fund Advisors Sells 423,780 Shares of Merck & Company, Inc. $MRK http://ift.tt/2ta95g7","Nationwide Fund Advisors Sells 423,780 Shares of Merck & Company, Inc. $MRK http://ift.tt/2ta95g7",,,,,[],https://twitter.com/TranscriptDaily/status/879305655248728064
3090,Dakota Financial,@dakotafinancial,2017-06-26T17:23:37.000Z,"BidaskClub Upgrades Merck & Company, Inc. $MRK to Hold http://ift.tt/2sJyL2i","BidaskClub Upgrades Merck & Company, Inc. $MRK to Hold http://ift.tt/2sJyL2i",,,,,[],https://twitter.com/dakotafinancial/status/879389702176083968
3091,Daily Political,@dailypoliticaln,2017-06-24T08:28:36.000Z,"V Wealth Management LLC Purchases 2,838 Shares of Merck & Company, Inc. $MRK http://ift.tt/2sBkpRp","V Wealth Management LLC Purchases 2,838 Shares of Merck & Company, Inc. $MRK http://ift.tt/2sBkpRp",,,,,[],https://twitter.com/dailypoliticaln/status/878530282185527296
3092,$E,@25k_Trading,2017-06-26T17:29:40.000Z,Shorted closed on drop towards $80 $XBI a nice little scalp! $IBB $CELG $LABU $LABD $BMY $MRK $GILD LiveChat,"Shorted closed on drop towards $80 $XBI a nice little scalp! $IBB $CELG $LABU $LABD $BMY $MRK $GILD LiveChat
youtube.com
All Time Highs with 25kTrading [Pilot]
Want to see more? Hit subscribe and get notified when I'm on! Join us in the free YouTube LIVE chat room where hundreds of online day traders discuss trading...",,,,,['https://pbs.twimg.com/card_img/1501252352812085249/MuOjfNzR?format=jpg&name=240x240'],https://twitter.com/25k_Trading/status/879391223789867008
3093,$E,@25k_Trading,2017-06-26T16:46:34.000Z,Shorted bio on afternoon pop just now trading within open 5m. $IBB $XBI $CELG $LABU $LABD $BMY $MRK $GILD LiveChat,"Shorted bio on afternoon pop just now trading within open 5m. $IBB $XBI $CELG $LABU $LABD $BMY $MRK $GILD LiveChat
youtube.com
All Time Highs with 25kTrading [Pilot]
Want to see more? Hit subscribe and get notified when I'm on! Join us in the free YouTube LIVE chat room where hundreds of online day traders discuss trading...",,,,,['https://pbs.twimg.com/card_img/1501252352812085249/MuOjfNzR?format=jpg&name=240x240'],https://twitter.com/25k_Trading/status/879380375742668800
3094,Dakota Financial,@dakotafinancial,2017-06-26T12:53:26.000Z,"Country Trust Bank Has $29.57 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2s8Gp7M","Country Trust Bank Has $29.57 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2s8Gp7M",,,,,[],https://twitter.com/dakotafinancial/status/879321705818312704
3095,1 min Stock Insights,@1MinuteStock,2017-06-26T04:19:03.000Z,Wondering about risks of $MRK? The 21-day volatility is 4.12%,"Wondering about risks of $MRK? The 21-day volatility is 4.12%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/879192259740266500
3096,Zenect,@zenect,2017-06-25T07:00:58.000Z,Which one would you pick? http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,Which one would you pick? http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V,,,,,[],https://twitter.com/zenect/status/878870616337678336
3097,Watchlist News,@WatchlistN,2017-06-26T08:41:25.000Z,"Merck & Company, Inc. $MRK Position Reduced by Hollencrest Securities LLC http://ift.tt/2u6b4yX","Merck & Company, Inc. $MRK Position Reduced by Hollencrest Securities LLC http://ift.tt/2u6b4yX",,,,,[],https://twitter.com/WatchlistN/status/879258284284403712
3098,Watchlist News,@WatchlistN,2017-06-25T08:11:19.000Z,"Merck & Company, Inc. $MRK Shares Bought by CAPROCK Group Inc. http://ift.tt/2s4qzeu","Merck & Company, Inc. $MRK Shares Bought by CAPROCK Group Inc. http://ift.tt/2s4qzeu",,,,,[],https://twitter.com/WatchlistN/status/878888323367960580
3099,Ticker Report,@TickerReport,2017-06-24T08:30:45.000Z,"Murphy Pohlad Asset Management LLC Sells 1,781 Shares of Merck & Company, Inc. $MRK http://ift.tt/2tF0I9U","Murphy Pohlad Asset Management LLC Sells 1,781 Shares of Merck & Company, Inc. $MRK http://ift.tt/2tF0I9U",,,,,[],https://twitter.com/TickerReport/status/878530824177676288
3100,$peedyCalls,@SpeedyCalls,2017-06-26T15:11:15.000Z,"$MRK 62.5 Calls SELLING Activity expiring on 19th Jan, Vol 4049","$MRK 62.5 Calls SELLING Activity expiring on 19th Jan, Vol 4049",,,,,[],https://twitter.com/SpeedyCalls/status/879356388669091845
3101,$E,@25k_Trading,2017-06-24T21:58:14.000Z,"Quick trade on friday for fast profit, looking to keep shorting on mon $IBB $XBI $CELG $LABU $LABD $BMY $MRK $GILD https://youtu.be/K6-xYtpgm5M","Quick trade on friday for fast profit, looking to keep shorting on mon $IBB $XBI $CELG $LABU $LABD $BMY $MRK $GILD https://youtu.be/K6-xYtpgm5M
1",,1,,,[],https://twitter.com/25k_Trading/status/878734032250580992
3102,Bursatil Biotech,@BursatilBiotech,2017-06-25T20:23:56.000Z,"This week's $MRSN's IPO
Highlights:Takeda owns a stake since last yr & $MRK also gave them $12M as upfront+ $2M for ADC $BMY $AZN $PFE $SGEN","This week's $MRSN's IPO
Highlights:Takeda owns a stake since last yr & $MRK also gave them $12M as upfront+ $2M for ADC $BMY $AZN $PFE $SGEN",,,,,[],https://twitter.com/BursatilBiotech/status/879072690899955715
3103,MarketBeat,@MarketBeatCom,2017-06-25T11:19:21.000Z,"Northern Capital Management LLC Has $453,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2rQ11xe","Northern Capital Management LLC Has $453,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2rQ11xe",,,,,[],https://twitter.com/MarketBeatCom/status/878935641337323520
3104,Dakota Financial,@dakotafinancial,2017-06-25T11:27:24.000Z,"Northern Capital Management LLC Has $453,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2rQ11xe","Northern Capital Management LLC Has $453,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2rQ11xe",,,,,[],https://twitter.com/dakotafinancial/status/878937666468941828
3105,US Banking News,@AmericanBanking,2017-06-26T08:19:07.000Z,Merck KGaA given ‚Ç¨112.00 PT by equinet AG. neutral rating. http://ift.tt/2tLtpC6 $MRK #MRK,Merck KGaA given ‚Ç¨112.00 PT by equinet AG. neutral rating. http://ift.tt/2tLtpC6 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/879252674046300160
3106,Watchlist News,@WatchlistN,2017-06-24T08:27:33.000Z,"Merck & Company, Inc. $MRK Position Cut by Diversified Trust Co http://ift.tt/2rMUK5q","Merck & Company, Inc. $MRK Position Cut by Diversified Trust Co http://ift.tt/2rMUK5q",,,,,[],https://twitter.com/WatchlistN/status/878530020985253888
3107,DDELabs,@DrugDeliveryExp,2017-06-26T16:39:33.000Z,"The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK","The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK
fool.com
The FDA Has Never Approved a Drug Like This in Its 111-Year History @themotleyfool #stocks $MRK
This cancer drug produced data so incredible that the FDA approved it immediately for a specific genetic mutation, regardless of cancer location.",,,,,['https://pbs.twimg.com/card_img/1500370507899842564/DH8HlVpt?format=jpg&name=small'],https://twitter.com/DrugDeliveryExp/status/879378611672723456
3108,BooRad,@atticusMB,2017-06-26T14:52:48.000Z,"Better Buy: Merck & Co. Inc. vs. AbbVie Inc. 
@themotleyfool
 #stocks $MRK, $ABBV","Better Buy: Merck & Co. Inc. vs. AbbVie Inc. 
@themotleyfool
 #stocks $MRK, $ABBV
fool.com
Better Buy: Merck & Co. Inc. vs. AbbVie Inc. @themotleyfool #stocks $ABBV $MRK
Which drug stock can make investors more money over the long run -- Merck or AbbVie?",,,,,[],https://twitter.com/atticusMB/status/879351745138315264
3109,Volker Schulz,@portefeuillefun,2017-06-26T22:06:53.000Z,"Replying to 
@RNAiAnalyst","Replying to 
@RNAiAnalyst
Convenience & probably a touch of patent protection I suppose. They are basically saying it might be the new (better?) #Vytorin. $ESPR $MRK
1
1",,1,,1,[],https://twitter.com/portefeuillefun/status/879460986658447360
3110,stockassassin,@stockassassin74,2017-06-25T20:11:18.000Z,"Replying to 
@bio_2022
 and 
@Robohogs","Replying to 
@bio_2022
 and 
@Robohogs
Buyouts change everything $xbi $ibb $labu now where are they?!? Cmon $gild $pfe $biib $amgn $mrk
1
1",,1,1,,[],https://twitter.com/stockassassin74/status/879069509641846784
3111,Benzinga,@Benzinga,2017-06-26T19:20:00.000Z,"A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside https://benzinga.com/z/9653648 $PTLA $BMY $MRK $PFE","A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside https://benzinga.com/z/9653648 $PTLA $BMY $MRK $PFE",,,,,[],https://twitter.com/Benzinga/status/879418990031851520
3112,Limex,@LimexMe,2017-06-26T13:55:25.000Z,Better Buy: Merck & Co. Inc. vs. AbbVie Inc. http://bit.ly/260617ABBV $ABBV $MRK,"Better Buy: Merck & Co. Inc. vs. AbbVie Inc. http://bit.ly/260617ABBV $ABBV $MRK
whotrades.com
Better Buy: Merck & Co. Inc. vs. AbbVie Inc.
Similarities between Merck & Co. Inc. (NYSE: MRK) and AbbVie Inc. (NYSE: ABBV) are easy to find. Both are big pharma companies with promising cancer drugs on the market. Both‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/879337303315034113
3113,MarketBeat,@MarketBeatCom,2017-06-26T08:22:10.000Z,Merck KGaA given ‚Ç¨112.00 PT by equinet AG. neutral rating. http://ift.tt/2tLtpC6 $MRK #MRK,Merck KGaA given ‚Ç¨112.00 PT by equinet AG. neutral rating. http://ift.tt/2tLtpC6 $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/879253439699709952
3114,Michael Hamboussi,@mikehamboussi,2017-06-26T02:05:34.000Z,"The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK","The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK
fool.com
The FDA Has Never Approved a Drug Like This in Its 111-Year History @themotleyfool #stocks $MRK
This cancer drug produced data so incredible that the FDA approved it immediately for a specific genetic mutation, regardless of cancer location.
1",,,,1,['https://pbs.twimg.com/card_img/1500370507899842564/DH8HlVpt?format=jpg&name=small'],https://twitter.com/mikehamboussi/status/879158664405364737
3115,Matthew Herper,@matthewherper,2017-06-27T13:27:24.000Z,Because I feel it's getting lost in my stream: my look at the history of CETP drugs in light of $MRK's surprise win:,"Because I feel it's getting lost in my stream: my look at the history of CETP drugs in light of $MRK's surprise win:
forbes.com
Shocker: Merck Cholesterol Drug Yields Benefit Where Rivals Failed
Merck announced this morning that anacetrapib, a cholesterol-lowering medicine, reduced heart problems and strokes in a 30,000-patient clinical trial, giving the drug giant a success where Pfizer,...
2
16
25",,2,16,25,[],https://twitter.com/matthewherper/status/879692644162584576
3116,Andy Biotech,@AndyBiotech,2017-06-27T10:58:23.000Z,"Wow!  $MRK CETPi anacetrapib CVOT met its primary endpoint, significantly reducing major coronary events.  Full data at #ESC17. -> $ESPR","Wow!  $MRK CETPi anacetrapib CVOT met its primary endpoint, significantly reducing major coronary events.  Full data at #ESC17. -> $ESPR
4
33
29",,4,33,29,[],https://twitter.com/AndyBiotech/status/879655142626406400
3117,Brad Loncar,@bradloncar,2017-06-29T13:06:48.000Z,$MRK CMO Roy Baynes says Keytruda has been studied in over 500 trials. Plus a cool slide showing monotherapy waterfall plots by cancer type.,"$MRK CMO Roy Baynes says Keytruda has been studied in over 500 trials. Plus a cool slide showing monotherapy waterfall plots by cancer type.
10
23",,,10,23,"['https://pbs.twimg.com/media/DDfaOJyXYAQI55D?format=jpg&name=small', 'https://pbs.twimg.com/media/DDfaOJ1XsAAyZuu?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DDfaOJwXUAI_0Qh?format=jpg&name=360x360']",https://twitter.com/bradloncar/status/880412233733459968
3118,Matthew Herper,@matthewherper,2017-06-27T13:04:24.000Z,"Shocker: Merck Cholesterol Drug Yields Benefit Where Rivals Failed 
$MRK $PFE $LLY","Shocker: Merck Cholesterol Drug Yields Benefit Where Rivals Failed 
$MRK $PFE $LLY
forbes.com
Shocker: Merck Cholesterol Drug Yields Benefit Where Rivals Failed
Merck announced this morning that anacetrapib, a cholesterol-lowering medicine, reduced heart problems and strokes in a 30,000-patient clinical trial, giving the drug giant a success where Pfizer,...
1
8
8",,1,8,8,[],https://twitter.com/matthewherper/status/879686852881653760
3119,Vista Partners LLC,@VistaPResearch,2017-06-29T12:02:58.000Z,Merck says new type of cholesterol drug worked in big study https://lnkd.in/ghrvpiQ $MRK #biotech #healthcare $DIA,"Merck says new type of cholesterol drug worked in big study https://lnkd.in/ghrvpiQ $MRK #biotech #healthcare $DIA
3
2",,,3,2,[],https://twitter.com/VistaPResearch/status/880396171520352256
3120,pharmalot,@pharmalot,2017-06-27T16:09:52.000Z,"A Merck #cholesterol drug surprises, but is it really a game changer? What the wags say.. https://statnews.com/pharmalot/2017/06/27/merck-cholesterol-surprise-pfizer-lilly/‚Ä¶ #pharma $MRK $LLY $PFE","A Merck #cholesterol drug surprises, but is it really a game changer? What the wags say.. https://statnews.com/pharmalot/2017/06/27/merck-cholesterol-surprise-pfizer-lilly/‚Ä¶ #pharma $MRK $LLY $PFE
statnews.com
A Merck cholesterol drug trial surprises, but is it really a game changer?
The reason the results are a surprise is that the type of medicine being studied has repeatedly failed when other drug makers pursued their own versions.
10
3",,,10,3,[],https://twitter.com/pharmalot/status/879733528661041152
3121,David Shaywitz,@DShaywitz,2017-06-29T14:21:00.000Z,This is a remarkable statistic: ~500 clinical trials of Keytruda. $MRK essentially betting everything on this one drug. wow.,"This is a remarkable statistic: ~500 clinical trials of Keytruda. $MRK essentially betting everything on this one drug. wow.
5
7
9",,5,7,9,['https://pbs.twimg.com/media/DDfq6qGVoAILFLS?format=jpg&name=900x900'],https://twitter.com/DShaywitz/status/880430906514616320
3122,Brad Loncar,@bradloncar,2017-06-29T13:23:01.000Z,"$MRK CMO Roy Baynes is going over their IO/Chemo combo work. Highlights lung (OS curves starting to separate), H&N, and breast.","$MRK CMO Roy Baynes is going over their IO/Chemo combo work. Highlights lung (OS curves starting to separate), H&N, and breast.
1
2
10",,1,2,10,"['https://pbs.twimg.com/media/DDfd7ToWAAAB65P?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DDfd7ToXUAA6fjy?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DDfd7TqXkAAkD1q?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DDfd7TrWsAQPNbb?format=jpg&name=360x360']",https://twitter.com/bradloncar/status/880416313843359745
3123,pharmalot,@pharmalot,2017-06-27T13:06:27.000Z,Pharmalot.. Pharmalittle.. Good Morning.. #Shkreli is 'evil' and a Merck trial surprises.. https://statnews.com/pharmalot/2017/06/27/shkreli-merck-cholesterol-fda/‚Ä¶ #pharma $MRK $VRX $REGN,"Pharmalot.. Pharmalittle.. Good Morning.. #Shkreli is 'evil' and a Merck trial surprises.. https://statnews.com/pharmalot/2017/06/27/shkreli-merck-cholesterol-fda/‚Ä¶ #pharma $MRK $VRX $REGN
statnews.com
Pharmalittle: Shkreli is called 'evil' and a 'snake'; Merck surprises with a positive trial result
Prosecutors and defense lawyers failed to find a juror to sit and judge Martin Shkreli, with many calling him a ‚Äúsnake,‚Äù ‚Äúevil,‚Äù and a ‚Äúd‚Äìk.‚Äù
1",,,1,,[],https://twitter.com/pharmalot/status/879687369158520832
3124,Brad Loncar,@bradloncar,2017-06-29T13:27:53.000Z,"$MRK's early stage IO pipeline includes STING, TIGIT, GITR, and the 
@moderna_tx
 mRNA vaccines.","$MRK's early stage IO pipeline includes STING, TIGIT, GITR, and the 
@moderna_tx
 mRNA vaccines.
2
9
15",,2,9,15,"['https://pbs.twimg.com/media/DDffEpdWsAAPhzL?format=jpg&name=small', 'https://pbs.twimg.com/media/DDffEpjXkAEfzJL?format=jpg&name=360x360']",https://twitter.com/bradloncar/status/880417537942573056
3125,Peter Chang,@BMTPeterC,2017-06-27T15:41:37.000Z,"$MRK anacetrapib CVOT longer and larger than evacetrapib, and will be interesting to see if it did not raise BP, as others did.","$MRK anacetrapib CVOT longer and larger than evacetrapib, and will be interesting to see if it did not raise BP, as others did.
2
3",,,2,3,[],https://twitter.com/BMTPeterC/status/879726418266963968
3126,Volker Schulz,@portefeuillefun,2017-06-27T14:19:55.000Z,There's a debate breaking out over how much $MRK's new cholesterol drug will help the stock http://cnbc.com/2017/06/27/merck-shares-rise-after-saying-cholesterol-drug-met-primary-goal-in-study.html‚Ä¶. #anacetrapib,"There's a debate breaking out over how much $MRK's new cholesterol drug will help the stock http://cnbc.com/2017/06/27/merck-shares-rise-after-saying-cholesterol-drug-met-primary-goal-in-study.html‚Ä¶. #anacetrapib
cnbc.com
There's a debate breaking out over how much Merck's new cholesterol drug will help the stock
Merck said Tuesday its cholesterol drug anacetrapib met its primary goal in significantly reducing coronary heart disease.
1",,,,1,['https://pbs.twimg.com/card_img/1499574034002022402/aYAW3Mwu?format=jpg&name=small'],https://twitter.com/portefeuillefun/status/879705857138847749
3127,Kara Jill Stancell,@kjilly,2017-06-28T14:37:38.000Z,"#Mystic Study Success Could Put $AZN Ahead in #Cancer Revolution #biotech #pharma $MRK $RHHBY $BMY https://bloomberg.com/news/articles/2017-06-28/mystic-study-success-could-put-astra-ahead-in-cancer-revolution‚Ä¶ via 
@business","#Mystic Study Success Could Put $AZN Ahead in #Cancer Revolution #biotech #pharma $MRK $RHHBY $BMY https://bloomberg.com/news/articles/2017-06-28/mystic-study-success-could-put-astra-ahead-in-cancer-revolution‚Ä¶ via 
@business
bloomberg.com
Mystic Study Success Could Put Astra Ahead in Cancer Revolution
Test results for AstraZeneca Plc‚Äôs next-generation cancer therapy -- among the most anticipated in the pharmaceutical industry this year -- stand to reorder of dominance in a field led by Merck & Co.
3",,,3,,[],https://twitter.com/kjilly/status/880072706200264704
3128,Peter Chang,@BMTPeterC,2017-06-27T16:05:50.000Z,"$MRK anacetrapib REVEAL had enough primary events, that could meet p of 0.05 with only a 9% reduction(# planned primary events < IMPROVE-IT)","$MRK anacetrapib REVEAL had enough primary events, that could meet p of 0.05 with only a 9% reduction(# planned primary events < IMPROVE-IT)
1
2
3",,1,2,3,[],https://twitter.com/BMTPeterC/status/879732514599784448
3129,Kevin Shannon,@kj_shannon15,2017-06-28T13:50:39.000Z,"Post #ADA2017 podcast featuring 
@BMTPeterC
 @CitelineJakeM
 and myself. Check out our analysis on $MRK $NVO $JNJ $LXRX","Post #ADA2017 podcast featuring 
@BMTPeterC
 @CitelineJakeM
 and myself. Check out our analysis on $MRK $NVO $JNJ $LXRX
soundcloud.com
Biomedtracker
Listen to Biomedtracker | SoundCloud is an audio platform that lets you listen to what you love and share the sounds you create.
9
6",,,9,6,[],https://twitter.com/kj_shannon15/status/880060879592542208
3130,Trader Silver,@TraderSilver1,2017-06-28T19:28:37.000Z,Who's next?? $BIIB $GILD $LLY $CELG $AZN $MRK oh don't forget $NVS  was yesterday last day for Shorts to cover?? $SGMO ,"Who's next?? $BIIB $GILD $LLY $CELG $AZN $MRK oh don't forget $NVS  was yesterday last day for Shorts to cover?? $SGMO 
üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR
@_B_I_O_T_E_C_H_
 ¬∑ 31 May 2017
$SGMO updated their partnership site implementing recent $PFE deal nice placeholder for $NVS $CELG CAR-T or $GSK $GILD HIV or $BIIB TAU deal
Show this thread
2
4",ü§ì üòé üÖ± üÖæ,,2,4,"['https://pbs.twimg.com/profile_images/1490073125391937538/WdkRt7E4_mini.jpg', 'https://pbs.twimg.com/media/DBKoCiKWsAELTFB?format=jpg&name=small']",https://twitter.com/TraderSilver1/status/880145935082426372
3131,WLST.com,@wlstcom,2017-06-29T20:59:29.000Z,Merck says new type of cholesterol drug worked in big study #biotech #healthcare $MRK $DIA https://yahoo.com/news/merck-says-type-cholesterol-drug-152500829.html‚Ä¶,"Merck says new type of cholesterol drug worked in big study #biotech #healthcare $MRK $DIA https://yahoo.com/news/merck-says-type-cholesterol-drug-152500829.html‚Ä¶
1",,,1,,['https://pbs.twimg.com/media/DDhGcg7XgAABTnb?format=jpg&name=small'],https://twitter.com/wlstcom/status/880531186656956419
3132,Meg Tirrell,@megtirrell,2017-06-27T11:05:00.000Z,"$MRK +1.6% pre-mkt as CETP inhibitor anacetrapib meets goals of outcome study, reducing major coronary events http://mrknewsroom.com/news-release/research-and-development-news/merck-provides-update-reveal-outcomes-study-anacetrapib‚Ä¶","$MRK +1.6% pre-mkt as CETP inhibitor anacetrapib meets goals of outcome study, reducing major coronary events http://mrknewsroom.com/news-release/research-and-development-news/merck-provides-update-reveal-outcomes-study-anacetrapib‚Ä¶
4
13
11",,4,13,11,[],https://twitter.com/megtirrell/status/879656804967383040
3133,Evaluate Vantage,@evaluatevantage,2017-06-29T11:35:28.000Z,Vantage Snippet - Bioclin flop sends an early warning for combination trials $MRK,"Vantage Snippet - Bioclin flop sends an early warning for combination trials $MRK
1",,,1,,['https://pbs.twimg.com/media/DDfEtNXXcAA27Zt?format=jpg&name=medium'],https://twitter.com/evaluatevantage/status/880389247374589953
3134,Arsalan Arif,@AKAarsalan,2017-06-29T16:29:12.000Z,"Per 
@Merck
 source not authorized to speak to media, employees being told co isnt a target but a bystander from Russian hack on Ukraine $MRK","Per 
@Merck
 source not authorized to speak to media, employees being told co isnt a target but a bystander from Russian hack on Ukraine $MRK
1
5
2",,1,5,2,[],https://twitter.com/AKAarsalan/status/880463168337850368
3135,Vk,@biotechinvstr,2017-06-27T11:24:38.000Z,Hmmm $MRK hedged language in PR over filing reflective of strength of CETP dataset?,"Hmmm $MRK hedged language in PR over filing reflective of strength of CETP dataset?
2
1
1",,2,1,1,['https://pbs.twimg.com/media/DDUvp7GUAAAGJzN?format=jpg&name=small'],https://twitter.com/biotechinvstr/status/879661748567068672
3136,BioSpace,@biospace,2017-06-27T21:40:10.000Z,Merck & Co. $MRK's Midas Touch Continues as Heart Drug Succeeds Where Others Failed http://ow.ly/4rm230cWReu,"Merck & Co. $MRK's Midas Touch Continues as Heart Drug Succeeds Where Others Failed http://ow.ly/4rm230cWReu
2
1",,,2,1,['https://pbs.twimg.com/media/DDW8lD8XUAE3mDx?format=jpg&name=small'],https://twitter.com/biospace/status/879816649557389313
3137,Vk,@biotechinvstr,2017-06-27T11:29:55.000Z,"Yes, I looked at other $MRK data PRs, almost always see some sort of endorsement/comment if data unequivocal","Yes, I looked at other $MRK data PRs, almost always see some sort of endorsement/comment if data unequivocal
Brad Loncar
@bradloncar
 ¬∑ 27 Jun 2017
Replying to @biotechinvstr
If this was a smaller biotech company we'd be very cautious on this. Plus, no quote from Roger or anyone.
1
2",,,1,2,['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg'],https://twitter.com/biotechinvstr/status/879663075158306816
3138,Jack Allen,@JohnK_Allen,2017-06-27T14:48:06.000Z,"Wonder if increased hypertension seen in evacetrapib $LLY trial, was also observed in anacetrapib REVEAL this may have lead to $MRK caution","Wonder if increased hypertension seen in evacetrapib $LLY trial, was also observed in anacetrapib REVEAL this may have lead to $MRK caution
Jack Allen
@JohnK_Allen
 ¬∑ 27 Jun 2017
$MRK REVEAL outcomes study of anacetrapib (CETP inhibitor) surprisingly meets primary endpoint, still cautious about filing in press release
1",,,,1,"['https://pbs.twimg.com/profile_images/894566706651078657/pw0zVPjN_mini.jpg', 'https://pbs.twimg.com/media/DDUvMOAXUAQfeS1?format=jpg&name=900x900']",https://twitter.com/JohnK_Allen/status/879712950751301632
3139,Breaking News,@MarketCurrents,2017-06-27T12:25:14.000Z,Merck's anacetrapib reduced incidence of major coronary events in high-risk patients in large-sca... https://seekingalpha.com/news/3275700-mercks-anacetrapib-reduced-incidence-major-coronary-events-high-risk-patients-large-scale?source=feed_f‚Ä¶ #premarket $MRK,"Merck's anacetrapib reduced incidence of major coronary events in high-risk patients in large-sca... https://seekingalpha.com/news/3275700-mercks-anacetrapib-reduced-incidence-major-coronary-events-high-risk-patients-large-scale?source=feed_f‚Ä¶ #premarket $MRK
seekingalpha.com
Merck's anacetrapib reduced incidence of major coronary events in high-risk patients in large-scale...
Merck (NYSE:MRK) is up 2% premarket on increased volume in response to its announcement of positive results from a Phase 3 clinical trial, REVEAL, assessing anacetrapib for...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/879676998905249793
3140,dough,@semodough,2017-06-29T13:35:00.000Z,Good news for $LPTX to see GITR top of $MRK list https://twitter.com/tgtxdough/status/873234543200940032‚Ä¶,"Good news for $LPTX to see GITR top of $MRK list https://twitter.com/tgtxdough/status/873234543200940032‚Ä¶
Brad Loncar
@bradloncar
 ¬∑ 29 Jun 2017
$MRK's early stage IO pipeline includes STING, TIGIT, GITR, and the @moderna_tx mRNA vaccines.
2
9",,,2,9,"['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg', 'https://pbs.twimg.com/media/DDffEpdWsAAPhzL?format=jpg&name=small', 'https://pbs.twimg.com/media/DDffEpjXkAEfzJL?format=jpg&name=360x360']",https://twitter.com/semodough/status/880419332429414400
3141,Seeking Alpha,@SeekingAlpha,2017-06-29T21:49:28.000Z,"Hold On, Merck's CETP Inhibitor Actually Works? https://seekingalpha.com/article/4084982-hold-mercks-cetp-inhibitor-actually-works?source=feed_f‚Ä¶ $MRK","Hold On, Merck's CETP Inhibitor Actually Works? https://seekingalpha.com/article/4084982-hold-mercks-cetp-inhibitor-actually-works?source=feed_f‚Ä¶ $MRK",,,,,[],https://twitter.com/SeekingAlpha/status/880543767538786304
3142,Michael Goodman,@mikegoodma,2017-06-29T10:38:05.000Z,When $MRK bought $CBST in 2014 it got Sivextro 4 gram+ skin infect incl caused by MRSA. It bombed. Zerbaxa gram- cephalosp'n did much better,"When $MRK bought $CBST in 2014 it got Sivextro 4 gram+ skin infect incl caused by MRSA. It bombed. Zerbaxa gram- cephalosp'n did much better
1",,,,1,[],https://twitter.com/mikegoodma/status/880374806784483328
3143,Limex,@LimexMe,2017-06-28T15:47:40.000Z,Esperion's Combo Cholesterol Candidate Enters Phase III http://bit.ly/2smpF8m $ESPR $REGN $MRK,"Esperion's Combo Cholesterol Candidate Enters Phase III http://bit.ly/2smpF8m $ESPR $REGN $MRK
whotrades.com
Esperion's Combo Cholesterol Candidate Enters Phase III
Esperion Therapeutics, Inc. ESPR received positive feedback from the FDA for initiation of a phase III bridging study, evaluating the combination of bempedoic acid (180 mg) and‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/880090329466195968
3144,The Fly,@theflynews,2017-06-27T20:32:05.000Z,On The Fly: Top stock stories for Tuesday $S $TMUS $CMCSA $CHTR $VZ $T $GOOG $GOOGL $MRK $MDLZ $WPPGY $FDX $CBI‚Ä¶,"On The Fly: Top stock stories for Tuesday $S $TMUS $CMCSA $CHTR $VZ $T $GOOG $GOOGL $MRK $MDLZ $WPPGY $FDX $CBI‚Ä¶
thefly.com
On The Fly: Top stock stories for Tuesday
Stocks moved in a very na... S, TMUS, CMCSA, CHTR, VZ, T, GOOG, GOOGL, MRK, MDLZ, WPPGY, FDX, CBI, DRI, WDC, STX, RARX
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501757230848249864/L6iEUcw8?format=jpg&name=small'],https://twitter.com/theflynews/status/879799516949565441
3145,Streetinsider.com,@Street_Insider,2017-06-27T11:00:57.000Z,Merck $MRK REVEAL Study of Anacetrapib Met Primary Endpoint of Reducing Major Coronary Events,"Merck $MRK REVEAL Study of Anacetrapib Met Primary Endpoint of Reducing Major Coronary Events
streetinsider.com
Merck (MRK) REVEAL Study of Anacetrapib Met Primary Endpoint of Reducing Major Coronary Events
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the REVEAL (Randomized EValuation of the Effects of Anacetrapib through Lipid modification)...
1",,,,1,[],https://twitter.com/Street_Insider/status/879655787802611712
3146,David Shaywitz,@DShaywitz,2017-06-27T13:10:44.000Z,"Pretty impressive- my brother 
@adamjshay
 tweet from 2013 anticipating ANA success! $MRK 
@matthewherper
 @AndyBiotech
 @adamfeuerstein","Pretty impressive- my brother 
@adamjshay
 tweet from 2013 anticipating ANA success! $MRK 
@matthewherper
 @AndyBiotech
 @adamfeuerstein
Adam Shaywitz
@adamjshay
 ¬∑ 13 Dec 2013
Replying to @adamjshay
@sciencescanner @DShaywitz so bottom line is that genetics DO support giant $MRK ph3 w ANA - far from a ""loser"" that should've been killed
1
1
6",,1,1,6,['https://pbs.twimg.com/profile_images/872660718142668801/x97QG0Rj_mini.jpg'],https://twitter.com/DShaywitz/status/879688448294100992
3147,BioWorld,@BioWorld,2017-06-27T18:20:54.000Z,".
@Cortellis
 data: 17 CETP inhibitors stalled in discovery, 10 others halted. Will $MRK's anacetrapib buoy the class?",".
@Cortellis
 data: 17 CETP inhibitors stalled in discovery, 10 others halted. Will $MRK's anacetrapib buoy the class?",,,,,[],https://twitter.com/BioWorld/status/879766504090341376
3148,Aniu Student,@AniuStudent,2017-06-27T12:54:12.000Z,"Replying to 
@Lin_ling_88","Replying to 
@Lin_ling_88
...unless of course there r significant side effects. Yet if no NDA, $ESPR becomes an immediate target 4 $MRK w/ an LDL hole n its pipeline.
1
1
3",,1,1,3,[],https://twitter.com/AniuStudent/status/879684286206627840
3149,Volker Schulz,@portefeuillefun,2017-06-27T11:26:34.000Z,"Replying to 
@portefeuillefun","Replying to 
@portefeuillefun
Mostly because I think the $MRK CETPi news will drown yesterday's $ESPR news. #ohwell
1
1",,1,,1,[],https://twitter.com/portefeuillefun/status/879662232854024196
3150,MedTechMonday,@MedTechMonday,2017-06-27T06:35:58.000Z,The FDA Has Never Approved a Drug Like This in Its 111-Year History #medtech #pharma  #stocks $MRK https://fool.com/investing/2017/06/25/the-fda-has-never-approved-a-drug-like-this-in-its.aspx‚Ä¶ Cancer Fighter,"The FDA Has Never Approved a Drug Like This in Its 111-Year History #medtech #pharma  #stocks $MRK https://fool.com/investing/2017/06/25/the-fda-has-never-approved-a-drug-like-this-in-its.aspx‚Ä¶ Cancer Fighter
1",,,1,,[],https://twitter.com/MedTechMonday/status/879589101854269440
3151,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-06-28T20:42:07.000Z,Merck's Cautious Statement Suggests Slim Chances Of Anacetrapib Success $LLY $PFE $RHHBY $MRK http://dlvr.it/PQp353 #Investing #Stocks,Merck's Cautious Statement Suggests Slim Chances Of Anacetrapib Success $LLY $PFE $RHHBY $MRK http://dlvr.it/PQp353 #Investing #Stocks,,,,,[],https://twitter.com/AlertTrade/status/880164431384109057
3152,EarlyBird,@mktearlybird,2017-06-28T15:15:08.000Z,"Merck targeted in global ransomware attack: http://ow.ly/KWUr30d0Jng | Via 
@FiercePharma
 #Merck $MRK #Pharma","Merck targeted in global ransomware attack: http://ow.ly/KWUr30d0Jng | Via 
@FiercePharma
 #Merck $MRK #Pharma
fiercepharma.com
Merck targeted in global ransomware attack
Merck & Co. | Merck & Co. was among those affected by a massive ransomware attack Tuesday that infiltrated the computer systems of companies around the world as well as government ministries in...
1",,,1,,['https://pbs.twimg.com/card_img/1500025938716803073/yiwYVF5o?format=jpg&name=small'],https://twitter.com/mktearlybird/status/880082142729994245
3153,Endpoints News,@endpts,2017-06-28T15:01:47.000Z,Merck was hit hard by a vicious #cyberattack yesterday. Here is what we know. $MRK https://endpts.com/merck-was-hit-hard-by-a-vicious-cyberattack-yesterday-here-is-what-we-know/‚Ä¶ #biotech #pharma,"Merck was hit hard by a vicious #cyberattack yesterday. Here is what we know. $MRK https://endpts.com/merck-was-hit-hard-by-a-vicious-cyberattack-yesterday-here-is-what-we-know/‚Ä¶ #biotech #pharma
1",,,1,,[],https://twitter.com/endpts/status/880078780739596288
3154,StockNews.com,@stocknewsdotcom,2017-06-27T11:04:21.000Z,$MRK Announces that the REVEAL outcomes study of anacetrapib met its primary endpoint significantly reducing major‚Ä¶ https://stocknews.com/news/mrk-announces-that-the-reveal-outcomes-study-of-anacetrapib-met-its/‚Ä¶,$MRK Announces that the REVEAL outcomes study of anacetrapib met its primary endpoint significantly reducing major‚Ä¶ https://stocknews.com/news/mrk-announces-that-the-reveal-outcomes-study-of-anacetrapib-met-its/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/879656643813924864
3155,The Fly,@theflynews,2017-06-27T16:48:04.000Z,On The Fly: Top stock stories at midday $S $TMUS $CMCSA $CHTR $VZ $T $GOOGL $GOOG $MRK $MDLZ $WPPGY $CBI $DRI $WDC‚Ä¶,"On The Fly: Top stock stories at midday $S $TMUS $CMCSA $CHTR $VZ $T $GOOGL $GOOG $MRK $MDLZ $WPPGY $CBI $DRI $WDC‚Ä¶
thefly.com
On The Fly: Top stock stories at midday
The major averages are mi... S, TMUS, CMCSA, CHTR, VZ, T, GOOGL, GOOG, MRK, MDLZ, WPPGY, CBI, DRI, WDC, STX, RARX
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501757230848249864/L6iEUcw8?format=jpg&name=small'],https://twitter.com/theflynews/status/879743141892337664
3156,Dennis M Winters,@m_denniswinters,2017-06-27T11:08:53.000Z,"Replying to 
@adamfeuerstein","Replying to 
@adamfeuerstein
$mrk is firing on all cylinders.  Would like to see them step it up with $auph.  Looks like they could spare some change to lock up LN.
2",,,,2,[],https://twitter.com/m_denniswinters/status/879657785474068481
3157,Jonathan Rockoff,@jonathanrockoff,2017-06-27T13:42:56.000Z,ICYMI here is the $MRK news release on its CETP inhibitor anaceptrapib meeting its primary endpoint: http://bit.ly/2rX5kXJ,ICYMI here is the $MRK news release on its CETP inhibitor anaceptrapib meeting its primary endpoint: http://bit.ly/2rX5kXJ,,,,,[],https://twitter.com/jonathanrockoff/status/879696552167649280
3158,Damian Garde,@damiangarde,2017-06-27T12:15:57.000Z,"CETP saga
Big Data: doesn't work https://statnews.com/2016/10/31/hdl-cholesterol/‚Ä¶

Genetics: could work http://circres.ahajournals.org/content/early/2017/05/15/CIRCRESAHA.117.311145?ijkey=1KO1QK13DzOwgiv&keytype=ref‚Ä¶

$MRK: works!","CETP saga
Big Data: doesn't work https://statnews.com/2016/10/31/hdl-cholesterol/‚Ä¶

Genetics: could work http://circres.ahajournals.org/content/early/2017/05/15/CIRCRESAHA.117.311145?ijkey=1KO1QK13DzOwgiv&keytype=ref‚Ä¶

$MRK: works!
statnews.com
Merck shocks with CETP cholesterol study win; Ra Pharma's scant PNH data
News, analysis and market chatter from the corner of biotech and Wall Street.
2",,,,2,['https://pbs.twimg.com/card_img/1498071732237787140/9CUWY7Vr?format=png&name=small'],https://twitter.com/damiangarde/status/879674660874575872
3159,Benzinga,@Benzinga,2017-06-27T18:34:06.000Z,Ransomware Rears Its Head Again As 150 Countries Hit By New Virus https://benzinga.com/z/9660113 $MRK,Ransomware Rears Its Head Again As 150 Countries Hit By New Virus https://benzinga.com/z/9660113 $MRK,,,,,[],https://twitter.com/Benzinga/status/879769826075582464
3160,gmt999,@gmt9992,2017-06-27T12:27:23.000Z,"Replying to 
@matthewherper","Replying to 
@matthewherper
Or was the $MRK study powered to show a tiny difference where others failed? It was by far the largest of those trials I think
2",,,,2,[],https://twitter.com/gmt9992/status/879677539790336000
3161,David Grainger,@sciencescanner,2017-06-27T11:40:49.000Z,"Replying to 
@JohnCendpts","Replying to 
@JohnCendpts
BUT will the effect be large enough to be clinically (and commercially) relevant? Guess not. Hence $MRK hesitancy
1",,,,1,[],https://twitter.com/sciencescanner/status/879665819617198080
3162,Amit V. Khera,@amitvkhera,2017-06-27T11:49:12.000Z,"Replying to 
@skathire
 and 
@escardio","Replying to 
@skathire
 and 
@escardio
Regardless of clinical impact, credit to $MRK for testing anacetrapib hypothesis to completion - many suggested giving up on CETPi.
1",,,,1,[],https://twitter.com/amitvkhera/status/879667929599668227
3163,Jacob Plieth,@JacobPlieth,2017-06-29T17:43:30.000Z,"Replying to 
@jq1234t","Replying to 
@jq1234t
Right. Option for patients unable to tolerate chemo? But then could they tolerate tremelimumab? $AZN $MRK
1
1",,1,,1,[],https://twitter.com/JacobPlieth/status/880481869611061248
3164,Christian Fromhertz,@cfromhertz,2017-06-30T15:11:05.000Z,"Midday #Option Update:
calls: $TTWO $HAIN $PVH $NVO $JCI $NPTN $AAOI $JACK $BMY $LVS $SLV $AMLP 
puts: $ETH $MRK $GILD","Midday #Option Update:
calls: $TTWO $HAIN $PVH $NVO $JCI $NPTN $AAOI $JACK $BMY $LVS $SLV $AMLP 
puts: $ETH $MRK $GILD
2
2
5",,2,2,5,['https://pbs.twimg.com/media/DDlARnEUAAAUdma?format=jpg&name=small'],https://twitter.com/cfromhertz/status/880805897274093568
3165,WLST.com,@wlstcom,2017-06-30T04:18:41.000Z,"What to Watch in the Markets Friday, June 30 #FridayFeeling #investing $CVX $XOM $MCD $MRK https://finance.yahoo.com/video/watch-markets-friday-june-30-210420726.html‚Ä¶","What to Watch in the Markets Friday, June 30 #FridayFeeling #investing $CVX $XOM $MCD $MRK https://finance.yahoo.com/video/watch-markets-friday-june-30-210420726.html‚Ä¶",,,,,['https://pbs.twimg.com/media/DDiq-THW0AAlJ7O?format=jpg&name=small'],https://twitter.com/wlstcom/status/880641716835037184
3166,Stockrow,@stockrow1,2017-07-02T16:45:12.000Z,"Here's how much big pharma spends on R&D, Merck and $JNJ lead the way #stocks #investing $AMGN $CELG $GILD $MRK #Biotech","Here's how much big pharma spends on R&D, Merck and $JNJ lead the way #stocks #investing $AMGN $CELG $GILD $MRK #Biotech
1
1",,,1,1,['https://pbs.twimg.com/media/DDvo9fvXoAE4WGZ?format=jpg&name=small'],https://twitter.com/stockrow1/status/881554357766037505
3167,SF Education,@SFEducation,2017-06-30T20:56:15.000Z,Russia In The Spotlight As Second Wave Of Ransomware Grips Globe https://aff.whotrades.com/t/b/bcuyg/ $MSFT $MRK,Russia In The Spotlight As Second Wave Of Ransomware Grips Globe https://aff.whotrades.com/t/b/bcuyg/ $MSFT $MRK,,,,,['https://pbs.twimg.com/media/DDmPTF8XkAAHGbq?format=jpg&name=small'],https://twitter.com/SFEducation/status/880892762496921602
3168,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-06-30T10:32:08.000Z,$ADAP Adaptimmune Multiple Myeloma blood cancer study together with Merck Keytruda is open for patients $GSK $MRK https://clinicaltrials.gov/ct2/show/NCT03168438?term=Adaptimmune+Merck&rank=1‚Ä¶,"$ADAP Adaptimmune Multiple Myeloma blood cancer study together with Merck Keytruda is open for patients $GSK $MRK https://clinicaltrials.gov/ct2/show/NCT03168438?term=Adaptimmune+Merck&rank=1‚Ä¶
1
1",,,1,1,"['https://pbs.twimg.com/media/DDj_kTKXgAAHwwl?format=jpg&name=small', 'https://pbs.twimg.com/media/DDkAZbNXoAEwF0P?format=jpg&name=360x360']",https://twitter.com/dhovekamp42/status/880735697514233856
3169,Jack Allen,@JohnK_Allen,2017-06-30T15:46:44.000Z,"New 
@Datamonitor_HC
 podcast - $MRK REVEAL trial -0:52, $CLVS ARIEL3 trial-6:07, $PTLA Bevyxxa approval-13:56","New 
@Datamonitor_HC
 podcast - $MRK REVEAL trial -0:52, $CLVS ARIEL3 trial-6:07, $PTLA Bevyxxa approval-13:56
soundcloud.com
Informa Pharma Intelligence Podcast
Round table discussion format focusing on recent events in the healthcare space, published monthly by thought leaders at Informa Pharma Intelligence. https://pharmaintelligence.informa.com/
3
5",,,3,5,['https://pbs.twimg.com/card_img/1499968131678482437/V6ETNoUC?format=jpg&name=240x240'],https://twitter.com/JohnK_Allen/status/880814869246877696
3170,Donna Young,@DonnaYoungDC,2017-07-02T15:21:37.000Z,"#WHO declares an end to #Ebola outbreak in the Democratic Republic of the Congo http://afro.who.int/en/media-centre/pressreleases/item/9744-who-declares-an-end-to-the-ebola-outbreak-in-the-democratic-republic-of-the-congo.html‚Ä¶ 
#NIH #NIAID $MRK #pharma #DRCongo","#WHO declares an end to #Ebola outbreak in the Democratic Republic of the Congo http://afro.who.int/en/media-centre/pressreleases/item/9744-who-declares-an-end-to-the-ebola-outbreak-in-the-democratic-republic-of-the-congo.html‚Ä¶ 
#NIH #NIAID $MRK #pharma #DRCongo
2
1",üì∞,,2,1,[],https://twitter.com/DonnaYoungDC/status/881533324526833664
3171,Donna Young,@DonnaYoungDC,2017-07-02T15:26:58.000Z,"But latest #Ebola outbreak a reminder of continued need for vaccines, drugs
http://snl.com/web/client?auth=inherit#news/article?id=40917568&cdid=A-40917568-9522‚Ä¶
$MRK $JNJ $REGN $GSK $GILD #NIH #pharma","But latest #Ebola outbreak a reminder of continued need for vaccines, drugs
http://snl.com/web/client?auth=inherit#news/article?id=40917568&cdid=A-40917568-9522‚Ä¶
$MRK $JNJ $REGN $GSK $GILD #NIH #pharma
Donna Young
@DonnaYoungDC
 ¬∑ 2 Jul 2017
#WHO declares an end to #Ebola outbreak in the Democratic Republic of the Congo http://afro.who.int/en/media-centre/pressreleases/item/9744-who-declares-an-end-to-the-ebola-outbreak-in-the-democratic-republic-of-the-congo.html‚Ä¶ 
#NIH #NIAID $MRK #pharma #DRCongo
1
2",üì∞ üì∞,,1,2,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/881534670093111296
3172,Vista Partners LLC,@VistaPResearch,2017-07-02T22:08:55.000Z,@DigitalMediaCEO thanks for follow! See Vista Partners #InvestingForLife #technology #biotech http://vistapglobal.com $AAPL $DGLT $MRK $UTX,"@DigitalMediaCEO thanks for follow! See Vista Partners #InvestingForLife #technology #biotech http://vistapglobal.com $AAPL $DGLT $MRK $UTX
GIF
1
7
1",,1,7,1,[],https://twitter.com/VistaPResearch/status/881635826966212608
3173,TickWatcher,@MITickWatcher,2017-06-30T20:05:03.000Z,"Top #moneyflow for #sp500 today
$LLY $NKE $NVDA $GE $JNJ $MO $KO $ORCL $MRK $KR ...","Top #moneyflow for #sp500 today
$LLY $NKE $NVDA $GE $JNJ $MO $KO $ORCL $MRK $KR ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/880879879708913664
3174,John Carroll,@JohnCendpts,2017-06-30T14:48:03.000Z,"Merck left the door open to a devastating cyberattack, missing two chances to raise a defense
$MRK 
@AKAarsalan","Merck left the door open to a devastating cyberattack, missing two chances to raise a defense
$MRK 
@AKAarsalan
endpts.com
Merck left the door open to a devastating cyberattack, missing two chances to raise a defense
Merck missed two critical opportunities earlier this year to inoculate themselves from the vicious cyberattack they suffered this week, roiling operations and raising questions about their lack of...
4
4",,,4,4,[],https://twitter.com/JohnCendpts/status/880800101156913152
3175,Seeking Alpha,@SeekingAlpha,2017-07-02T13:00:06.000Z,"3 Things In Biotech You Should Learn Today: July 2, 2017 https://seekingalpha.com/article/4085236-3-things-biotech-learn-today-july-2-2017?source=feed_f‚Ä¶ $ABBV $MRK $REGN $TEVA $XENE","3 Things In Biotech You Should Learn Today: July 2, 2017 https://seekingalpha.com/article/4085236-3-things-biotech-learn-today-july-2-2017?source=feed_f‚Ä¶ $ABBV $MRK $REGN $TEVA $XENE",,,,,[],https://twitter.com/SeekingAlpha/status/881497713488965634
3176,Margin Hunt,@MarginHunt,2017-06-30T11:00:14.000Z,"Stocks w/ expensive P/E multiples vs peers: Merck & Company, $MRK $BMY $PFE $LLY $SNY $GSK http://ow.ly/BUGH30cVFy8","Stocks w/ expensive P/E multiples vs peers: Merck & Company, $MRK $BMY $PFE $LLY $SNY $GSK http://ow.ly/BUGH30cVFy8",,,,,['https://pbs.twimg.com/media/DDkG4ZPXgAAeZn0?format=jpg&name=small'],https://twitter.com/MarginHunt/status/880742770918514690
3177,Margin Hunt,@MarginHunt,2017-06-30T12:30:08.000Z,LTM P/E multiple of Novartis AG $NVS is trading above peer group median: $GSK $SNY $BAYRY $AZN $MRK http://ow.ly/vFx930cVFyh,LTM P/E multiple of Novartis AG $NVS is trading above peer group median: $GSK $SNY $BAYRY $AZN $MRK http://ow.ly/vFx930cVFyh,,,,,['https://pbs.twimg.com/media/DDkbdZaXUAAY5Kg?format=jpg&name=small'],https://twitter.com/MarginHunt/status/880765396399398912
3178,Pharmaceutical News,@pharma_sector,2017-07-02T16:33:30.000Z,"#Merck Drug maker MSD hit by ransomware, Indian website down. Read more: http://owler.us/acX0NA $MRK","#Merck Drug maker MSD hit by ransomware, Indian website down. Read more: http://owler.us/acX0NA $MRK",,,,,[],https://twitter.com/pharma_sector/status/881551416900206592
3179,ŒìŒπœéœÅŒ≥ŒøœÇ ŒúŒ¨œÅŒ∫ŒøŒ≤ŒπœÑœÇ,@gem_2014,2017-07-01T12:45:18.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,,,,,[],https://twitter.com/gem_2014/status/881131597000581120
3180,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-06-30T01:17:12.000Z,Commented on The Merck Malware Attack https://seekingalpha.com/article/4084984-merck-malware-attack?source=tweet‚Ä¶ $MRK,Commented on The Merck Malware Attack https://seekingalpha.com/article/4084984-merck-malware-attack?source=tweet‚Ä¶ $MRK,,,,,[],https://twitter.com/dhovekamp42/status/880596044890873856
3181,StockMarketVideo.com,@stockmarketvide,2017-06-30T14:47:53.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/880800059717234688
3182,Market Realist,@MarketRealist,2017-07-01T02:32:45.000Z,Johnson &amp; Johnson‚Äôs Recent Developments and Valuations http://marketrealist.com/?p=2178801 $JNJ $XLV $MDT $MRK,"Johnson &amp; Johnson‚Äôs Recent Developments and Valuations http://marketrealist.com/?p=2178801 $JNJ $XLV $MDT $MRK
1
1",,,1,1,[],https://twitter.com/MarketRealist/status/880977445402411009
3183,Traderific,@Traderific,2017-06-30T20:25:59.000Z,"COVER $MAT 21.50, SHORT $MRK 64.11, COVER $NKE 57.71, SELL $PCLN 1873.32. More stock tips & details at: http://traderific.com/?date=2017-06-30‚Ä¶","COVER $MAT 21.50, SHORT $MRK 64.11, COVER $NKE 57.71, SELL $PCLN 1873.32. More stock tips & details at: http://traderific.com/?date=2017-06-30‚Ä¶",,,,,[],https://twitter.com/Traderific/status/880885144713928704
3184,BioPharma Dive,@BioPharmaDive,2017-07-01T13:00:01.000Z,"$MRK succeeds where others failed, but skepticism abounds","$MRK succeeds where others failed, but skepticism abounds
biopharmadive.com
Merck succeeds where others failed, but skepticism abounds
The big pharma reported positive data for its CETP inhibitor; a class plagued by a string of failures. Yet, prospects for the drug are still unclear.
1",,,,1,['https://pbs.twimg.com/card_img/1501937254045941765/gyCzFnU-?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/881135302387138562
3185,Sweet Platform,@SweetPlatform,2017-06-30T14:48:29.000Z,"MRK Top news - Jun 30th, 2017 $MRK http://https://goo.gl/PJtQP9","MRK Top news - Jun 30th, 2017 $MRK http://https://goo.gl/PJtQP9",,,,,[],https://twitter.com/SweetPlatform/status/880800213014917120
3186,Pharmaceutical News,@pharma_sector,2017-07-02T16:32:53.000Z,#Merck's CETP inhibitor Anacetrapib meets primary end point in REVEAL study. Read more: http://owler.us/acX0NF $MRK,#Merck's CETP inhibitor Anacetrapib meets primary end point in REVEAL study. Read more: http://owler.us/acX0NF $MRK,,,,,[],https://twitter.com/pharma_sector/status/881551261488762881
3187,Pharmaceutical News,@pharma_sector,2017-07-02T16:32:16.000Z,"#Merck, Novartis pipeline stunners headline surprisingly good month for CV agents. Read more: http://owler.us/acX0NC $MRK","#Merck, Novartis pipeline stunners headline surprisingly good month for CV agents. Read more: http://owler.us/acX0NC $MRK",,,,,[],https://twitter.com/pharma_sector/status/881551105896833025
3188,Tim Reller,@TraderGuruNY,2017-06-30T01:18:37.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/880596400819580929
3189,Endpoints News,@endpts,2017-06-30T14:48:14.000Z,"Merck left the door open to a devastating cyberattack, missing two chances to raise a defense https://endpts.com/merck-left-the-door-open-to-a-devastating-cyberattack-missing-two-chances-to-raise-a-defense/‚Ä¶ $MRK #merck","Merck left the door open to a devastating cyberattack, missing two chances to raise a defense https://endpts.com/merck-left-the-door-open-to-a-devastating-cyberattack-missing-two-chances-to-raise-a-defense/‚Ä¶ $MRK #merck
endpts.com
Merck left the door open to a devastating cyberattack, missing two chances to raise a defense
Merck missed two critical opportunities earlier this year to inoculate themselves from the vicious cyberattack they suffered this week, roiling operations and raising questions about their lack of...
1
1",,1,1,,['https://pbs.twimg.com/card_img/1501988968530776079/-3RcCR7J?format=jpg&name=small'],https://twitter.com/endpts/status/880800147210481664
3190,Ben Silverberg,@silverjet2,2017-07-02T14:03:44.000Z,"Stocks with a Bearish MACD, Price>20.00, below 21-dMA, Vol>500K: $EDR $IMAX $DRI $O $SNY $GBX $MRK $HOG $FDS $ILMN $CTXS","Stocks with a Bearish MACD, Price>20.00, below 21-dMA, Vol>500K: $EDR $IMAX $DRI $O $SNY $GBX $MRK $HOG $FDS $ILMN $CTXS
1",,,,1,[],https://twitter.com/silverjet2/status/881513723365658624
3191,Zenect,@zenect,2017-06-30T12:42:26.000Z,I assume you‚Äôre going to buy this dividend #stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V and hold it forever‚Ä¶,I assume you‚Äôre going to buy this dividend #stock http://bit.ly/1sQ7Crl $BUD $CL $GE $HD $JNJ $KHC $MRK $PG $WFC $V and hold it forever‚Ä¶,,,,,[],https://twitter.com/zenect/status/880768489132347392
3192,MarketBeat,@MarketBeatCom,2017-07-02T11:32:18.000Z,"Short Interest in Merck & Company, Inc. $MRK Declines By 20.5% http://ift.tt/2tAir4V #acn","Short Interest in Merck & Company, Inc. $MRK Declines By 20.5% http://ift.tt/2tAir4V #acn",,,,,[],https://twitter.com/MarketBeatCom/status/881475617786658816
3193,FiercePharma,@FiercePharma,2017-06-30T14:31:44.000Z,$MRK moves up sales rankings in vaccine industry projection,"$MRK moves up sales rankings in vaccine industry projection
fiercepharma.com
Merck moves up sales rankings in vaccine industry projection
Last year, life science commercial intelligence firm Evaluate released a vaccine market projection stating that GlaxoSmithKline would top the industry by 2022, with Sanofi, Pfizer and Merck trailin |...
1
1",,,1,1,['https://pbs.twimg.com/card_img/1500025938716803073/yiwYVF5o?format=jpg&name=small'],https://twitter.com/FiercePharma/status/880795997429014528
3194,$peedyCalls,@SpeedyCalls,2017-06-30T13:49:18.000Z,"$MRK 63 Puts BUYING Activity expiring on 21st Jul, Vol 3488","$MRK 63 Puts BUYING Activity expiring on 21st Jul, Vol 3488",,,,,[],https://twitter.com/SpeedyCalls/status/880785318437412864
3195,Market Realist,@MarketRealist,2017-06-30T21:21:07.000Z,Should We Be Interested in AstraZeneca in 2017? http://marketrealist.com/?p=2171909 $AZN $BMY $MRK $PFE,Should We Be Interested in AstraZeneca in 2017? http://marketrealist.com/?p=2171909 $AZN $BMY $MRK $PFE,,,,,[],https://twitter.com/MarketRealist/status/880899019874197504
3196,US Banking News,@AmericanBanking,2017-06-30T17:26:56.000Z,Traders Purchase Large Volume of Put Options on Merck & Co. $MRK http://ift.tt/2s9Oc1f,Traders Purchase Large Volume of Put Options on Merck & Co. $MRK http://ift.tt/2s9Oc1f,,,,,[],https://twitter.com/AmericanBanking/status/880840087734542340
3197,MarketBeat,@MarketBeatCom,2017-07-01T13:23:34.000Z,"Rehmann Capital Advisory Group Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2tvB5uV","Rehmann Capital Advisory Group Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2tvB5uV",,,,,[],https://twitter.com/MarketBeatCom/status/881141229638926336
3198,On My Mind,@OnMyMind54,2017-07-01T11:05:01.000Z,"The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK https://fool.com/investing/2017/06/25/the-fda-has-never-approved-a-drug-like-this-in-its.aspx‚Ä¶","The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK https://fool.com/investing/2017/06/25/the-fda-has-never-approved-a-drug-like-this-in-its.aspx‚Ä¶",,,,,[],https://twitter.com/OnMyMind54/status/881106361706270720
3199,Jacob Bell,@realJacobBell,2017-06-30T17:56:22.000Z,Prescribed Reading: Charges come down on ex-$ARIA execs; $CHRS cuts staff; $MRK wows with CETP data,"Prescribed Reading: Charges come down on ex-$ARIA execs; $CHRS cuts staff; $MRK wows with CETP data
biopharmadive.com
Prescribed Reading: Gottlieb pushes for efficiency at FDA
The Chief is trying to fulfill promises, while deal activity continues to stagnate in the sector as the industry waits on news from Washington. ",,,,,['https://pbs.twimg.com/card_img/1494367869919977481/aek3Y8jJ?format=jpg&name=small'],https://twitter.com/realJacobBell/status/880847492195201024
3200,Art,@mRNAdisrupts,2017-06-30T20:56:10.000Z,"Replying to 
@mRNAdisrupts
 and 
@IPODave","Replying to 
@mRNAdisrupts
 and 
@IPODave
$AKCA $IONS $NVS $REGN $AMGN $SFY $MRK $LLY #AkceaTx #cardiology #Stroke  http://lipoproteinafoundation.org/?utm_source=HVD%20Awareness%20Day&utm_campaign=Lp(a)%20and%20Aortic%20Stenosis%202-21&utm_medium=Social%20Media‚Ä¶",,,,,[],https://twitter.com/mRNAdisrupts/status/880892741747703809
3201,dough,@semodough,2017-07-01T16:37:10.000Z,"Replying to 
@JacobPlieth
 and 
@EPVantage","Replying to 
@JacobPlieth
 and 
@EPVantage
CS Possible stock moves coming on mystic data $AZN $MRK $BMY",,,,,['https://pbs.twimg.com/media/DDqdkubXgAAuc16?format=jpg&name=small'],https://twitter.com/semodough/status/881189952079482881
3202,Kara Jill Stancell,@kjilly,2017-06-30T17:27:31.000Z,"$MRK left the door open to a devastating #cyberattack, missing two chances to raise a defense #biotech #pharma","$MRK left the door open to a devastating #cyberattack, missing two chances to raise a defense #biotech #pharma
endpts.com
Merck left the door open to a devastating cyberattack, missing two chances to raise a defense
Merck missed two critical opportunities earlier this year to inoculate themselves from the vicious cyberattack they suffered this week, roiling operations and raising questions about their lack of...
2",,,2,,['https://pbs.twimg.com/card_img/1501988968530776079/-3RcCR7J?format=jpg&name=small'],https://twitter.com/kjilly/status/880840233008283649
3203,Dakota Financial,@dakotafinancial,2017-07-01T13:25:18.000Z,"Rehmann Capital Advisory Group Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2tvB5uV","Rehmann Capital Advisory Group Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2tvB5uV",,,,,[],https://twitter.com/dakotafinancial/status/881141664647180288
3204,Ticker Report,@TickerReport,2017-07-02T08:15:31.000Z,"Merck & Company, Inc. $MRK Position Increased by Foster & Motley Inc. http://ift.tt/2te11Zs","Merck & Company, Inc. $MRK Position Increased by Foster & Motley Inc. http://ift.tt/2te11Zs",,,,,[],https://twitter.com/TickerReport/status/881426095714783233
3205,Eric Sagonowsky,@EricSFierce,2017-06-30T14:31:44.000Z,$MRK moves up sales rankings in vaccine industry projection http://fiercepharma.com/vaccines/merck-moves-up-sales-rankings-firm-s-vaccine-industry-projection‚Ä¶,"$MRK moves up sales rankings in vaccine industry projection http://fiercepharma.com/vaccines/merck-moves-up-sales-rankings-firm-s-vaccine-industry-projection‚Ä¶
1",,,,1,[],https://twitter.com/EricSFierce/status/880795997366104064
3206,MarketBeat,@MarketBeatCom,2017-07-02T13:16:19.000Z,"Short Interest in Merck & Company, Inc. $MRK Declines By 20.5% http://ift.tt/2sfJEpX","Short Interest in Merck & Company, Inc. $MRK Declines By 20.5% http://ift.tt/2sfJEpX",,,,,[],https://twitter.com/MarketBeatCom/status/881501790545600512
3207,BioPharma Dive,@BioPharmaDive,2017-06-30T17:56:22.000Z,Prescribed Reading: Charges come down on ex-$ARIA execs; $CHRS cuts staff; $MRK wows with CETP data,"Prescribed Reading: Charges come down on ex-$ARIA execs; $CHRS cuts staff; $MRK wows with CETP data
biopharmadive.com
Prescribed Reading: Gottlieb pushes for efficiency at FDA
The Chief is trying to fulfill promises, while deal activity continues to stagnate in the sector as the industry waits on news from Washington. ",,,,,['https://pbs.twimg.com/card_img/1501983579286372354/UUFlIgZv?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/880847492069416960
3208,The Fly,@theflynews,2017-06-30T21:09:04.000Z,"S&P, Dow finish week slightly lower as Nasdaq falls sharply $GOOGL $AMZN $NKE $MRK $FDX $COF $C $JPM $WFC $BAC $MS‚Ä¶","S&P, Dow finish week slightly lower as Nasdaq falls sharply $GOOGL $AMZN $NKE $MRK $FDX $COF $C $JPM $WFC $BAC $MS‚Ä¶
thefly.com
S&P, Dow finish week slightly lower as Nasdaq falls sharply
The major averages all de... GOOGL, AMZN, NKE, MRK, FDX, COF, C, JPM, WFC, BAC, MS, GS, NSRGY, HTZ, CAR, S, TMUS, CMCSA, CHTR, VZ, T, GOOG, MDLZ, WPPGY, CBI, DRI, WDC, MU, SPNC, PHG, GOV, FPO, RAD,...
2
1",,,2,1,['https://pbs.twimg.com/card_img/1501757230848249864/L6iEUcw8?format=jpg&name=small'],https://twitter.com/theflynews/status/880895986477826050
3209,TradingView,@tradingview,2017-07-01T01:00:00.000Z,$MRK - MRK: Low risk long opportunity - https://tradingview.com/chart/MRK/jh3XmTEC-MRK-Low-risk-long-opportunity/‚Ä¶,$MRK - MRK: Low risk long opportunity - https://tradingview.com/chart/MRK/jh3XmTEC-MRK-Low-risk-long-opportunity/‚Ä¶,,,,,[],https://twitter.com/tradingview/status/880954102913445888
3210,Peter Blood,@ptrbld,2017-06-30T15:49:59.000Z,"Replying to 
@cfromhertz","Replying to 
@cfromhertz
Soothsayer "" calls $BMY  puts $MRK could be a merger arbitrage or #Opdiva vs #Keydura clinical trails """,,,,,[],https://twitter.com/ptrbld/status/880815689715650563
3211,JQ,@jq1234t,2017-07-01T19:15:47.000Z,"Replying to 
@jq1234t
 @Asthika
  and 2 others","Replying to 
@jq1234t
 @Asthika
  and 2 others
If $AZN did stratify PD-L1‚â•25% and ‚â•50%, they would have greater foresight than $BMY since MYSTIC started in 2015 before $MRK KN024 result.
1
1
2",,1,1,2,[],https://twitter.com/jq1234t/status/881229865416101888
3212,Jacob Plieth,@JacobPlieth,2017-07-01T08:17:57.000Z,"Replying to 
@Asthika
 and 
@EPVantage","Replying to 
@Asthika
 and 
@EPVantage
Hmm. I just think after KN-021 this battle for 25 percentage points of PD-L1 expression is looking like a bit of a side show $AZN $MRK $BMY
1
1",,1,,1,[],https://twitter.com/JacobPlieth/status/881064317197701120
3213,Jacob Plieth,@JacobPlieth,2017-06-30T21:42:16.000Z,"Replying to 
@Asthika
 and 
@EPVantage","Replying to 
@Asthika
 and 
@EPVantage
>50% cut is already on $MRK Keytruda label, so wouldn't that be a bit meh for $AZN Imfinzi monotherapy?
1
1",,1,,1,[],https://twitter.com/JacobPlieth/status/880904342676570113
3214,Dakota Financial,@dakotafinancial,2017-07-02T13:20:28.000Z,"Short Interest in Merck & Company, Inc. $MRK Declines By 20.5% http://ift.tt/2sfJEpX","Short Interest in Merck & Company, Inc. $MRK Declines By 20.5% http://ift.tt/2sfJEpX",,,,,[],https://twitter.com/dakotafinancial/status/881502836986662913
3215,Crypto Trader Pro,@CryptoTraderPro,2017-07-01T01:06:06.000Z,‚ñ∫ http://bit.do/BestTradeSetups $MRK - MRK: Low risk long opportunity -,‚ñ∫ http://bit.do/BestTradeSetups $MRK - MRK: Low risk long opportunity -,,,,,[],https://twitter.com/CryptoTraderPro/status/880955639425519616
3216,TradingView Ideas,@TradingViewAlt,2017-07-01T00:55:02.000Z,MRK: Low risk long opportunity $MRK http://tradingview.com/chart/MRK/jh3XmTEC-MRK-Low-risk-long-opportunity/‚Ä¶,MRK: Low risk long opportunity $MRK http://tradingview.com/chart/MRK/jh3XmTEC-MRK-Low-risk-long-opportunity/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/880952854302740480
3217,Buy Cryptocurrency,@cryptosbuy,2017-07-01T00:56:23.000Z,MRK: Low risk long opportunity $MRK http://tradingview.com/chart/MRK/jh3XmTEC-MRK-Low-risk-long-opportunity/‚Ä¶ TV_TradingIdeas,MRK: Low risk long opportunity $MRK http://tradingview.com/chart/MRK/jh3XmTEC-MRK-Low-risk-long-opportunity/‚Ä¶ TV_TradingIdeas,,,,,[],https://twitter.com/cryptosbuy/status/880953196050612225
3218,pharmalot,@pharmalot,2017-07-05T18:00:42.000Z,"For doctors down under, there are no free lunches when pharma pays.. new analysis here.. https://statnews.com/pharmalot/2017/07/05/doctors-free-lunches-pharma/‚Ä¶ #pharma $AZN $MRK $NVS $MRK","For doctors down under, there are no free lunches when pharma pays.. new analysis here.. https://statnews.com/pharmalot/2017/07/05/doctors-free-lunches-pharma/‚Ä¶ #pharma $AZN $MRK $NVS $MRK
statnews.com
For doctors 'down under,' there are no free lunches when pharma pays
A study is reviving a debate in Australia over financial ties between doctors and drug makers, underscoring about unduly influencing medical practice.
11
6",,,11,6,['https://pbs.twimg.com/card_img/1497582776060633096/8T8YUaN8?format=jpg&name=small'],https://twitter.com/pharmalot/status/882660521815793664
3219,Ozmosi,@OzmosiHealth,2017-07-04T16:02:00.000Z,We're fans of #AI. Glad to see big #pharma is using it more to speed drug discovery.  http://reut.rs/2tEF34m $GSK $MRK $JNJ,"We're fans of #AI. Glad to see big #pharma is using it more to speed drug discovery.  http://reut.rs/2tEF34m $GSK $MRK $JNJ
2",,,2,,['https://pbs.twimg.com/media/DD5yTpkXcAExwxa?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/882268261915742209
3220,Divya Grover,@thegirlshewasnt,2017-07-05T21:14:50.000Z,U.S. #FDA places clinical hold on 3 combo #studies testing Merck's #Keytruda in multiple #myeloma #patients $MRK,"U.S. #FDA places clinical hold on 3 combo #studies testing Merck's #Keytruda in multiple #myeloma #patients $MRK
reuters.com
FDA puts hold on Merck multiple myeloma trials after deaths
Merck & Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood...
2",,,2,,[],https://twitter.com/thegirlshewasnt/status/882709379811688448
3221,Sentiment Stocks,@sentimentstock,2017-07-03T03:34:41.000Z,"$NWBO $KITE $MRK $BMY $CLDX $JUNO BlockChain meets Stock Market. Say hello to TRANSPARENCY. Say goodby to the DTCC.
http://visualcapitalist.com/blockchain-backbone-stock-market/‚Ä¶","$NWBO $KITE $MRK $BMY $CLDX $JUNO BlockChain meets Stock Market. Say hello to TRANSPARENCY. Say goodby to the DTCC.
http://visualcapitalist.com/blockchain-backbone-stock-market/‚Ä¶
10
15",,,10,15,[],https://twitter.com/sentimentstock/status/881717808022798336
3222,Jacob Plieth,@JacobPlieth,2017-07-05T21:04:48.000Z,"Most shocking thing about $MRK clinical holds is that anyone thought Keytruda had potential in multiple myeloma. Via 
@evaluatepharma","Most shocking thing about $MRK clinical holds is that anyone thought Keytruda had potential in multiple myeloma. Via 
@evaluatepharma
3
10
26",,3,10,26,['https://pbs.twimg.com/media/DEABJ0_XUAAZyIw?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/882706853200842752
3223,c lark,@7LadyQ,2017-07-05T20:57:28.000Z,$MRK Merck shares slip as 3 blood-cancer drug studies halted by FDA,"$MRK Merck shares slip as 3 blood-cancer drug studies halted by FDA
marketwatch.com
Merck shares slip as 3 blood-cancer drug studies halted by FDA
Merck & Co. undefined shares declined in the extended session Wednesday after the drugmaker said the Food and Drug Administration halted three clinical...",,,,,['https://pbs.twimg.com/card_img/1474864754590162951/kxP9MxLz?format=jpg&name=small'],https://twitter.com/7LadyQ/status/882705006654357505
3224,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-07-04T20:44:54.000Z,Commented on The Merck Malware Attack https://seekingalpha.com/article/4084984-merck-malware-attack?source=tweet‚Ä¶ $MRK,"Commented on The Merck Malware Attack https://seekingalpha.com/article/4084984-merck-malware-attack?source=tweet‚Ä¶ $MRK
seekingalpha.com
The Merck Malware Attack (NYSE:MRK)
As everyone will have seen, the last few days have brought news of yet another ‚Äúransomware‚Äù attack, this time from a piece of malware known most often as Petya.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/dhovekamp42/status/882339458317725697
3225,Meg Tirrell,@megtirrell,2017-07-05T20:44:41.000Z,"FDA puts clinical hold on 3 $MRK Keytruda trials in multiple myeloma, citing greater potential for risk than benefit http://mrknewsroom.com/news-release/prescription-medicine-news/merck-provides-further-update-three-multiple-myeloma-studies‚Ä¶","FDA puts clinical hold on 3 $MRK Keytruda trials in multiple myeloma, citing greater potential for risk than benefit http://mrknewsroom.com/news-release/prescription-medicine-news/merck-provides-further-update-three-multiple-myeloma-studies‚Ä¶
1
22
21",,1,22,21,[],https://twitter.com/megtirrell/status/882701791376363521
3226,"Dennis Dick, CFA",@TripleDTrader,2017-07-03T13:03:30.000Z,"It's early but seeing some huge opening imbalances: $MRK -235K, $PFE -427K, $VZ -214K, $XOM -177K, $CVX -142K, $CAT -69K, $IBM -93K","It's early but seeing some huge opening imbalances: $MRK -235K, $PFE -427K, $VZ -214K, $XOM -177K, $CVX -142K, $CAT -69K, $IBM -93K
2
3
4",,2,3,4,[],https://twitter.com/TripleDTrader/status/881860955814154240
3227,Ro Patel,@Ro_Patel,2017-07-04T02:14:31.000Z,1H Non-Dogs of the Dow vs Dogs of the Dow Performance: $VZ $PFE $CVX $BA $CSCO $KO $IBM $XOM $CAT $MRK,"1H Non-Dogs of the Dow vs Dogs of the Dow Performance: $VZ $PFE $CVX $BA $CSCO $KO $IBM $XOM $CAT $MRK
1",,,1,,['https://pbs.twimg.com/media/DD206VZW0AEvl4i?format=jpg&name=small'],https://twitter.com/Ro_Patel/status/882060019377819653
3228,Matthew Herper,@matthewherper,2017-07-05T20:42:53.000Z,$MRK: FDA has determined that now the risks of Keytruda plus pomalidomide or lenalidomide outweigh any potential benefit in multiple myeloma,"$MRK: FDA has determined that now the risks of Keytruda plus pomalidomide or lenalidomide outweigh any potential benefit in multiple myeloma
1
6
3",,1,6,3,[],https://twitter.com/matthewherper/status/882701340119629825
3229,Brandon,@bran_chem,2017-07-03T04:40:21.000Z,$MRK tops list for 2016 R&D spenders by a long shot... encouraging things to come,"$MRK tops list for 2016 R&D spenders by a long shot... encouraging things to come
David Shaywitz
@DShaywitz
 ¬∑ 3 Jul 2017
Interesting. http://pharmexec.com/pharm-execs-top-50-companies-2017‚Ä¶
1
1",,,1,1,"['https://pbs.twimg.com/profile_images/1474396883925798917/QT5Wk8dB_mini.jpg', 'https://pbs.twimg.com/media/DDx6LHvUwAAtmEa?format=jpg&name=small']",https://twitter.com/bran_chem/status/881734331844218880
3230,Charles Gordon,@princetongb,2017-07-05T20:50:11.000Z,"$MRK has placed a clinical hold on KEYNOTE-183, KEYNOTE-185 + KEYNOTE-023, 3 combination studies in MM. http://mrknewsroom.com/news-release/prescription-medicine-news/merck-provides-further-update-three-multiple-myeloma-studies‚Ä¶","$MRK has placed a clinical hold on KEYNOTE-183, KEYNOTE-185 + KEYNOTE-023, 3 combination studies in MM. http://mrknewsroom.com/news-release/prescription-medicine-news/merck-provides-further-update-three-multiple-myeloma-studies‚Ä¶
1
2
1",,1,2,1,['https://pbs.twimg.com/media/DD_9S-lXsAAnm6g?format=jpg&name=small'],https://twitter.com/princetongb/status/882703174234198018
3231,John Carroll,@JohnCendpts,2017-07-05T20:24:16.000Z,"Top story --
Bristol-Myers‚Äô tarnished checkpoint star Opdivo beats out Yervoy in surprise PhIII
$BMY $MRK","Top story --
Bristol-Myers‚Äô tarnished checkpoint star Opdivo beats out Yervoy in surprise PhIII
$BMY $MRK
endpts.com
Bristol-Myers‚Äô tarnished checkpoint star Opdivo beats out Yervoy in surprise PhIII
Bristol-Myers got a much-needed boost with the earlier-than-expected news that Opdivo beat out Yervoy in a Phase III study focused on a particular niche for adjuvant melanoma therapy. And an analyst...
2
2",,,2,2,[],https://twitter.com/JohnCendpts/status/882696652104110081
3232,WLST.com,@wlstcom,2017-07-03T19:33:22.000Z,3 Top High-Yield Pharmaceutical Stocks to Buy Now --  The Motley Fool #stocks $MRK $GSK https://fool.com/investing/2017/07/03/3-top-high-yield-pharmaceutical-stocks-to-buy-now.aspx‚Ä¶,3 Top High-Yield Pharmaceutical Stocks to Buy Now --  The Motley Fool #stocks $MRK $GSK https://fool.com/investing/2017/07/03/3-top-high-yield-pharmaceutical-stocks-to-buy-now.aspx‚Ä¶,,,,,['https://pbs.twimg.com/media/DD1ZGVDXkAEfddh?format=jpg&name=small'],https://twitter.com/wlstcom/status/881959069677912066
3233,Tuan Pham,@15minofPham,2017-07-03T04:29:42.000Z,Weekly MACD bearish crossover: $AAOI $AMAT $AVGO $CARA $CMCSA $CDNS $CRM $D $LRCX $MAR $MCHP $MRK $MSFT $MU $NUAN $QQQ $SBUX $SMH $WEN $XLK,Weekly MACD bearish crossover: $AAOI $AMAT $AVGO $CARA $CMCSA $CDNS $CRM $D $LRCX $MAR $MCHP $MRK $MSFT $MU $NUAN $QQQ $SBUX $SMH $WEN $XLK,,,,,[],https://twitter.com/15minofPham/status/881731652724174848
3234,Vista Partners LLC,@VistaPResearch,2017-07-05T04:02:34.000Z,"@CashorTrade
 thanks for follow! See Vista Partners #InvestingForLife #biotech #healthcare http://vistapglobal.com $MRK $HIIQ $JNJ $IBB $PFE","@CashorTrade
 thanks for follow! See Vista Partners #InvestingForLife #biotech #healthcare http://vistapglobal.com $MRK $HIIQ $JNJ $IBB $PFE
GIF
1",,,1,,['https://pbs.twimg.com/tweet_video_thumb/DD8XOwZVwAAYJXk.jpg'],https://twitter.com/VistaPResearch/status/882449599704604673
3235,Margin Hunt,@MarginHunt,2017-07-05T20:25:07.000Z,BMO Capital reiterated Merck & $MRK at Sell. This Dividend Discount Model implies stock's trading above fair value http://ow.ly/s7hS30dmAh7,BMO Capital reiterated Merck & $MRK at Sell. This Dividend Discount Model implies stock's trading above fair value http://ow.ly/s7hS30dmAh7,,,,,['https://pbs.twimg.com/media/DD_4HzSWsAAkxaX?format=jpg&name=small'],https://twitter.com/MarginHunt/status/882696867724873729
3236,Margin Hunt,@MarginHunt,2017-07-03T00:45:03.000Z,The market values Zoetis $ZTS @ a premium vs most peers. Expensive? $MRK $PRGO $LLY $PFE $BMY http://ow.ly/p6nQ30cVFCn,The market values Zoetis $ZTS @ a premium vs most peers. Expensive? $MRK $PRGO $LLY $PFE $BMY http://ow.ly/p6nQ30cVFCn,,,,,['https://pbs.twimg.com/media/DDxW2PzXoAAHIOj?format=jpg&name=small'],https://twitter.com/MarginHunt/status/881675119915085825
3237,John Carroll,@JohnCendpts,2017-07-05T21:01:54.000Z,"Troubled by deaths, FDA orders Merck to slam the brakes on three Keytruda studies
$MRK -1% $BMY","Troubled by deaths, FDA orders Merck to slam the brakes on three Keytruda studies
$MRK -1% $BMY
endpts.com
Troubled by deaths, FDA orders Merck to slam the brakes on three Keytruda studies
A month after Merck flagged a higher risk of death in two combo studies using its flagship drug Keytruda, the FDA has followed up with a clinical hold that will slam the brakes on further treatment...
9
7",,,9,7,['https://pbs.twimg.com/card_img/1501989092988358668/lj65Ad_e?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/882706124193091587
3238,Vista Partners LLC,@VistaPResearch,2017-07-05T22:12:47.000Z,"@LaraWhitten
 thanks for follow! See Vista Partners #InvestingForLife #Growth #biotech http://vistapglobal.com $PFE $MRK $IBB $JNJ","@LaraWhitten
 thanks for follow! See Vista Partners #InvestingForLife #Growth #biotech http://vistapglobal.com $PFE $MRK $IBB $JNJ
GIF
1
1
1",,1,1,1,['https://pbs.twimg.com/tweet_video_thumb/DEAQwbXU0AAUxKF.jpg'],https://twitter.com/VistaPResearch/status/882723963780055041
3239,Ben Hirschler,@reutersBenHir,2017-07-05T20:53:39.000Z,#Merck shares fall 2% after the bell as #FDA places clinical hold on  combo therapy for multiple #myeloma http://reut.rs/2sHgVOV $MRK,"#Merck shares fall 2% after the bell as #FDA places clinical hold on  combo therapy for multiple #myeloma http://reut.rs/2sHgVOV $MRK
reuters.com
FDA places clinical hold on Merck's combo therapy for multiple myeloma
Merck & Co Inc said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its immunotherapy drug, Keytruda, in combination with other...",,,,,['https://pbs.twimg.com/card_img/1501782971220512769/gWB9KIZe?format=png&name=small'],https://twitter.com/reutersBenHir/status/882704045823201280
3240,MarketBeat,@MarketBeatCom,2017-07-05T18:56:17.000Z,Merck & Company given $65.00 PT by Citigroup Inc.. hold rating. http://ift.tt/2tRQLJM $MRK #MRK,Merck & Company given $65.00 PT by Citigroup Inc.. hold rating. http://ift.tt/2tRQLJM $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/882674513497948160
3241,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-07-05T21:59:53.000Z,"Replying to 
@JacobPlieth
 and 
@evaluatepharma","Replying to 
@JacobPlieth
 and 
@evaluatepharma
Not all $MRK Keytruda in multiple myeloma trials are on hold - e.g. $ADAP $GSK NY-ESO-1 KEYNOTE-487 still recruiting
clinicaltrials.gov
Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1...
Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma - Full Text View.
1
2
2",,1,2,2,['https://pbs.twimg.com/card_img/1499578112115363861/JaVVFVxw?format=png&name=240x240'],https://twitter.com/dhovekamp42/status/882720716038303747
3242,bake mcbride,@ITRADEVOL,2017-07-05T21:44:36.000Z,Decliners in After Hours Trading $FFIN $YUMC $PSMT $JMP $PKG $MRK $ONCE $NCR $AWH $HTZ $CNSL $ODP $CACQ $SCO https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,Decliners in After Hours Trading $FFIN $YUMC $PSMT $JMP $PKG $MRK $ONCE $NCR $AWH $HTZ $CNSL $ODP $CACQ $SCO https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/882716869211410432
3243,Ticker Report,@TickerReport,2017-07-05T08:28:32.000Z,"Merck & Company, Inc. $MRK is Excalibur Management Corp‚Äôs 6th Largest Position http://ift.tt/2tPDEsy","Merck & Company, Inc. $MRK is Excalibur Management Corp‚Äôs 6th Largest Position http://ift.tt/2tPDEsy",,,,,[],https://twitter.com/TickerReport/status/882516531070021632
3244,Daily Political,@dailypoliticaln,2017-07-05T08:24:49.000Z,"Headinvest LLC Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2tHyH4k","Headinvest LLC Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2tHyH4k",,,,,[],https://twitter.com/dailypoliticaln/status/882515595966763008
3245,Dakota Financial,@dakotafinancial,2017-07-04T21:27:13.000Z,"Merck & Company $MRK Receiving Somewhat Favorable Media Coverage, Study Shows http://ift.tt/2tJCL3B","Merck & Company $MRK Receiving Somewhat Favorable Media Coverage, Study Shows http://ift.tt/2tJCL3B",,,,,[],https://twitter.com/dakotafinancial/status/882350108981047296
3246,Transcript Daily,@TranscriptDaily,2017-07-05T21:01:17.000Z,"Analysts Expect Merck & Company, Inc. $MRK Will Announce Earnings of $0.87 Per Share http://ift.tt/2tS7GMm","Analysts Expect Merck & Company, Inc. $MRK Will Announce Earnings of $0.87 Per Share http://ift.tt/2tS7GMm",,,,,[],https://twitter.com/TranscriptDaily/status/882705969498787842
3247,Pharmacutical Daily,@PharmacDaily,2017-07-04T07:37:04.000Z,"First patients get NOX-A12 combined with Keytruda in certain cancers
$ALNOX $MRK","First patients get NOX-A12 combined with Keytruda in certain cancers
$ALNOX $MRK
pharmaceuticaldaily.com
First patients get NOX-A12 combined with Keytruda in certain cancers
NOXXON Pharma, a biotechnology company whose core focus is on improving cancer treatment by targeting the tumor microenvironment, has treated first patients in its Phase 1/2 clinical trial in patie‚Ä¶",,,,,[],https://twitter.com/PharmacDaily/status/882141195069247489
3248,Watchlist News,@WatchlistN,2017-07-03T08:41:32.000Z,"Merck & Company, Inc. $MRK Stake Boosted by Buckhead Capital Management LLC http://ift.tt/2sxsQ1H","Merck & Company, Inc. $MRK Stake Boosted by Buckhead Capital Management LLC http://ift.tt/2sxsQ1H",,,,,[],https://twitter.com/WatchlistN/status/881795029706182657
3249,SwingTradeBot,@SwingTradeBot,2017-07-03T13:22:06.000Z,"Recent $MRK technical alerts: Non-ADX 1,2,3,4 Bullish plus 3 more alerts...","Recent $MRK technical alerts: Non-ADX 1,2,3,4 Bullish plus 3 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/881865635596296193
3250,US Banking News,@AmericanBanking,2017-07-05T20:09:41.000Z,Merck & Company Gets Average Rating of Hold from Analysts $MRK http://ift.tt/2qbDsRN,Merck & Company Gets Average Rating of Hold from Analysts $MRK http://ift.tt/2qbDsRN,,,,,[],https://twitter.com/AmericanBanking/status/882692984323571714
3251,US Banking News,@AmericanBanking,2017-07-05T20:25:43.000Z,"Analysts Expect Merck & Company, Inc. $MRK Will Announce Earnings of $0.87 Per Share http://ift.tt/2tNeXMo","Analysts Expect Merck & Company, Inc. $MRK Will Announce Earnings of $0.87 Per Share http://ift.tt/2tNeXMo",,,,,[],https://twitter.com/AmericanBanking/status/882697019982307330
3252,Hottest Stocks Now,@HottestStockNow,2017-07-05T11:31:46.000Z,"$MRK ‚Äôs Keytruda, $LLY ‚Äôs Lartruvo Available via Cancer Drugs Fund for Sarcoma Patients in UK http://crweworld.com/article/pharma-biotech/113982/mercks-keytruda-lillys-lartruvo-available-via-cdf‚Ä¶","$MRK ‚Äôs Keytruda, $LLY ‚Äôs Lartruvo Available via Cancer Drugs Fund for Sarcoma Patients in UK http://crweworld.com/article/pharma-biotech/113982/mercks-keytruda-lillys-lartruvo-available-via-cdf‚Ä¶",,,,,[],https://twitter.com/HottestStockNow/status/882562644531597312
3253,Allison Gatlin,@IBD_AGatlin,2017-07-05T15:52:00.000Z,Bristol beats itself in cancer test; can it conquer Dow's Merck? $BMY $MRK,"Bristol beats itself in cancer test; can it conquer Dow's Merck? $BMY $MRK
investors.com
Bristol Beats Itself In Cancer Test; Can It Conquer Dow's Merck?
Bristol could add $1 billion in sales after a study showed its Opdivo was better than another of its drugs, Yervoy, in treating melanoma.",,,,,[],https://twitter.com/IBD_AGatlin/status/882628135958794244
3254,MarketBeat,@MarketBeatCom,2017-07-04T11:36:27.000Z,"Research Analysts Set Expectations for Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2uFMaqs","Research Analysts Set Expectations for Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2uFMaqs",,,,,[],https://twitter.com/MarketBeatCom/status/882201437312344064
3255,BioPharma Dive,@BioPharmaDive,2017-07-04T19:00:02.000Z,"Rx Reading: $TEVA, $XENE report mid-stage failure; $SRPT appoints new CEO; $MRK wows with CETP data","Rx Reading: $TEVA, $XENE report mid-stage failure; $SRPT appoints new CEO; $MRK wows with CETP data
biopharmadive.com
Prescribed Reading: Gottlieb pushes for efficiency at FDA
The Chief is trying to fulfill promises, while deal activity continues to stagnate in the sector as the industry waits on news from Washington. 
1",,,,1,['https://pbs.twimg.com/card_img/1501983579286372354/UUFlIgZv?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/882313068008660995
3256,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-07-03T13:28:09.000Z,"#SwingTradeAlert Recent $MRK technical alerts: Non-ADX 1,2,3,4 Bullish plus 3 more‚Ä¶ http://dlvr.it/PRtrdk via ‚Üí http://bit.do/FreeTradingRoom","#SwingTradeAlert Recent $MRK technical alerts: Non-ADX 1,2,3,4 Bullish plus 3 more‚Ä¶ http://dlvr.it/PRtrdk via ‚Üí http://bit.do/FreeTradingRoom",,,,,[],https://twitter.com/AlertTrade/status/881867159906861057
3257,Dakota Financial,@dakotafinancial,2017-07-04T14:47:33.000Z,"Manchester Capital Management LLC Maintains Stake in Merck & Company, Inc. $MRK http://ift.tt/2tIpJnj","Manchester Capital Management LLC Maintains Stake in Merck & Company, Inc. $MRK http://ift.tt/2tIpJnj",,,,,[],https://twitter.com/dakotafinancial/status/882249527088087041
3258,Watchlist News,@WatchlistN,2017-07-04T06:30:46.000Z,"Research Analysts Set Expectations for Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2tbM4ZK","Research Analysts Set Expectations for Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2tbM4ZK",,,,,[],https://twitter.com/WatchlistN/status/882124509431693312
3259,Carly Helfand,@CarlyHFierce,2017-07-05T18:24:53.000Z,"Can Merck knock Glaxo off its HIV perch? Maybe so, one analyst says: http://bit.ly/2sMQiUc $GSK $MRK #pharma","Can Merck knock Glaxo off its HIV perch? Maybe so, one analyst says: http://bit.ly/2sMQiUc $GSK $MRK #pharma",,,,,[],https://twitter.com/CarlyHFierce/status/882666610334552069
3260,US Banking News,@AmericanBanking,2017-07-05T20:09:42.000Z,Analysts Give Average Rating of Hold to Merck & Company $MRK http://ift.tt/2qbDsRN,Analysts Give Average Rating of Hold to Merck & Company $MRK http://ift.tt/2qbDsRN,,,,,[],https://twitter.com/AmericanBanking/status/882692987700080640
3261,Jacob Plieth,@JacobPlieth,2017-07-05T21:09:46.000Z,"Replying to 
@adamfeuerstein
 and 
@evaluatepharma","Replying to 
@adamfeuerstein
 and 
@evaluatepharma
Multiple myeloma accounts for $193m out of total $9,448m 2022e Keytruda sales $MRK
1
4",,,1,4,[],https://twitter.com/JacobPlieth/status/882708103938101249
3262,Siti van der Meij,@sitivandermeij,2017-07-05T20:56:18.000Z,Merck announces Keytruda clinical holds after patient deaths https://seekingalpha.com/news/3277112-merck-announces-keytruda-clinical-holds-patient-deaths?source=feed_f‚Ä¶ $MRK #sitifatimah #malaysia #financialplanning,Merck announces Keytruda clinical holds after patient deaths https://seekingalpha.com/news/3277112-merck-announces-keytruda-clinical-holds-patient-deaths?source=feed_f‚Ä¶ $MRK #sitifatimah #malaysia #financialplanning,,,,,[],https://twitter.com/sitivandermeij/status/882704716345561088
3263,Donna Young,@DonnaYoungDC,2017-07-05T20:57:42.000Z,#FDA slaps clinical hold on $MRK trials testing #Keytruda in multiple myeloma; risks outweigh any potential benefit http://mrknewsroom.com/news-release/prescription-medicine-news/merck-provides-further-update-three-multiple-myeloma-studies‚Ä¶,"#FDA slaps clinical hold on $MRK trials testing #Keytruda in multiple myeloma; risks outweigh any potential benefit http://mrknewsroom.com/news-release/prescription-medicine-news/merck-provides-further-update-three-multiple-myeloma-studies‚Ä¶
1",üì∞,,,1,[],https://twitter.com/DonnaYoungDC/status/882705067878617088
3264,Benzinga,@Benzinga,2017-07-05T16:45:00.000Z,"Healthcare Repeal Bad For GlaxoSmithKline, Other HIV Treatment Stocks https://benzinga.com/z/9739632 $GSK $MRK $PFE","Healthcare Repeal Bad For GlaxoSmithKline, Other HIV Treatment Stocks https://benzinga.com/z/9739632 $GSK $MRK $PFE",,,,,[],https://twitter.com/Benzinga/status/882641473971171328
3265,dough,@semodough,2017-07-05T11:17:16.000Z,"Replying to 
@_B_I_O_T_E_C_H_","Replying to 
@_B_I_O_T_E_C_H_
$MRK potential to dominate both therapeutic&prevention setting (PrEP)novel NRTI EFdA.
1
1",,1,,1,[],https://twitter.com/semodough/status/882558997030719488
3266,dough,@semodough,2017-07-05T11:27:13.000Z,"Replying to 
@_B_I_O_T_E_C_H_","Replying to 
@_B_I_O_T_E_C_H_
CITI $MRK EFdA not in consensus but has category-killer potential for both treatment-na√Øve&PrEP (HIV prevention)impressive efficacy, $GILD",,,,,[],https://twitter.com/semodough/status/882561499935502336
3267,Ticker Report,@TickerReport,2017-07-05T06:53:32.000Z,"Research Analysts Set Expectations for Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2soFV9D","Research Analysts Set Expectations for Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2soFV9D",,,,,[],https://twitter.com/TickerReport/status/882492626661978112
3268,SwingTradeBot,@SwingTradeBot,2017-07-05T16:52:18.000Z,"Recent $MRK technical alerts: Non-ADX 1,2,3,4 Bullish...","Recent $MRK technical alerts: Non-ADX 1,2,3,4 Bullish...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/882643309080059904
3269,Anirban Maitra,@Aiims1742,2017-07-06T13:58:47.000Z,"Endogenous or induced DNA repair defects in cancer & responses to checkpoint #Immunotherapy 
http://cancerdiscovery.aacrjournals.org/content/7/7/675?utm_source=ETOC+Master&utm_campaign=5d47adebdd-CD+July+2017+eTOC&utm_medium=email&utm_term=0_aae0ec8d4d-5d47adebdd-160576873‚Ä¶
$BMY $AZN $MRK $CELG","Endogenous or induced DNA repair defects in cancer & responses to checkpoint #Immunotherapy 
http://cancerdiscovery.aacrjournals.org/content/7/7/675?utm_source=ETOC+Master&utm_campaign=5d47adebdd-CD+July+2017+eTOC&utm_medium=email&utm_term=0_aae0ec8d4d-5d47adebdd-160576873‚Ä¶
$BMY $AZN $MRK $CELG
19
26",,,19,26,"['https://pbs.twimg.com/media/DEDpSErUQAA3aIp?format=jpg&name=small', 'https://pbs.twimg.com/media/DEDpSEpUIAAMT2i?format=jpg&name=small']",https://twitter.com/Aiims1742/status/882962031334346752
3270,nolter,@nolter,2017-07-07T15:40:25.000Z,"$MDLZ  feels #PETYA's pain, but shares don't suffer Friday. http://bit.ly/2tQpEyk A good sign for $FDX, $WPPGY, $MRK?","$MDLZ  feels #PETYA's pain, but shares don't suffer Friday. http://bit.ly/2tQpEyk A good sign for $FDX, $WPPGY, $MRK?
1
1",,,1,1,[],https://twitter.com/nolter/status/883349994291556353
3271,pharmalot,@pharmalot,2017-07-06T13:17:22.000Z,Pharmalot.. Pharmalittle.. Good Morning.. FDA suspends $MRK trials; $VRTX raises price for CF drug.. https://statnews.com/pharmalot/2017/07/06/merck-fda-deaths-vertex-pfizer/‚Ä¶ #pharma $CELG,"Pharmalot.. Pharmalittle.. Good Morning.. FDA suspends $MRK trials; $VRTX raises price for CF drug.. https://statnews.com/pharmalot/2017/07/06/merck-fda-deaths-vertex-pfizer/‚Ä¶ #pharma $CELG
statnews.com
Pharmalittle: Three Merck trials are suspended; Vertex hikes CF drug price; Pfizer sells a unit for...
The FDA suspended three trials for Merck's Keytruda, which was being tested with two Celgene drugs, due to patient deaths reported.
2
1",,,2,1,[],https://twitter.com/pharmalot/status/882951609235505152
3272,Peter Schacknow,@peterschack,2017-07-06T12:19:09.000Z,"FDA hands Merck a bitter pill, and RBC less energetic on big oil - today's stocks to watch: $MRK $XOM $CVX","FDA hands Merck a bitter pill, and RBC less energetic on big oil - today's stocks to watch: $MRK $XOM $CVX
cnbc.com
Early movers: TSLA, INTC, COST, YUMC, P, F, PSMT & more
These are the stocks posting the largest moves before the bell.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1499763967476047881/tg-Sw3iD?format=jpg&name=small'],https://twitter.com/peterschack/status/882936958166675457
3273,David Moadel,@davidmoadel,2017-07-06T16:25:40.000Z,$MRK #Merck: Good Long-Term Despite Major Setback https://seekingalpha.com/article/4086073-merck-good-long-term-despite-major-setback‚Ä¶ $XLV $IBB $PFE #stockmarket #stocks #investing #finance $SPY $QQQ,"$MRK #Merck: Good Long-Term Despite Major Setback https://seekingalpha.com/article/4086073-merck-good-long-term-despite-major-setback‚Ä¶ $XLV $IBB $PFE #stockmarket #stocks #investing #finance $SPY $QQQ
seekingalpha.com
Merck: Good Long-Term Despite Major Setback (NYSE:MRK)
The FDA has placed Keytruda multiple myeloma combination studies on a clinical hold. Keytruda had been selling remarkably well to date.",,,,,['https://pbs.twimg.com/card_img/1494733840761245699/ntVQbPBr?format=png&name=240x240'],https://twitter.com/davidmoadel/status/882998997086064640
3274,TA Scilab Ichimoku,@tasciccac,2017-07-07T22:00:10.000Z,"Replying to 
@tasciccac","Replying to 
@tasciccac
$DJIA WKLY Best performing $JPM $BA $MCD $DD $GS $UNH $MSFT $MMM  Worst $GE $DIS $NKE $MRK $VZ $KO $CVX $HD $PFE $XOM #Ichimoku #Dashboard
1
2",,,1,2,['https://pbs.twimg.com/media/DEKg2W1XsAA87tt?format=jpg&name=small'],https://twitter.com/tasciccac/status/883445564884619266
3275,Money Morning,@moneymorning,2017-07-06T13:25:01.000Z,Three #Stocks to Watch Today: $TSLA #$PSMT $MRK https://mney.co/2tLBPwe #StockMarket #StocksToWatch,"Three #Stocks to Watch Today: $TSLA #$PSMT $MRK https://mney.co/2tLBPwe #StockMarket #StocksToWatch
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DEDhjT0XgAAlJrp.jpg'],https://twitter.com/moneymorning/status/882953533066280961
3276,Tim Reller,@TraderGuruNY,2017-07-06T20:17:58.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶  #stocks,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶  #stocks,,,,,['https://pbs.twimg.com/media/DEFAEtZXYAAREAw?format=jpg&name=small'],https://twitter.com/TraderGuruNY/status/883057453725822976
3277,Sentiment Stocks,@sentimentstock,2017-07-06T15:32:44.000Z,"$NWBO $MRK $BMY $KITE $AZN Neuro-Oncologists & patient advocates ask for conditional approvals 4 GBM treatments.
https://virtualtrials.com/PDF2017/FDAProposal_v40.pdf‚Ä¶","$NWBO $MRK $BMY $KITE $AZN Neuro-Oncologists & patient advocates ask for conditional approvals 4 GBM treatments.
https://virtualtrials.com/PDF2017/FDAProposal_v40.pdf‚Ä¶
1
3
8",,1,3,8,[],https://twitter.com/sentimentstock/status/882985675284295681
3278,Russo Partners,@russopartners,2017-07-06T14:46:52.000Z,"FDA puts hold on Merck $MRK multiple myeloma trials after deaths http://reut.rs/2tSpDdJ via 
@Reuters
 #pharma #news","FDA puts hold on Merck $MRK multiple myeloma trials after deaths http://reut.rs/2tSpDdJ via 
@Reuters
 #pharma #news
reuters.com
FDA puts hold on Merck multiple myeloma trials after deaths
Merck & Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood...
1",,,,1,[],https://twitter.com/russopartners/status/882974133176479745
3279,FinInvTr,@FinInvTr,2017-07-06T21:07:02.000Z,"The Top Holdings In Market's Best Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2sKNBah","The Top Holdings In Market's Best Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2sKNBah
1",,,1,,['https://pbs.twimg.com/media/DEFLTczW0AAuPnk?format=jpg&name=small'],https://twitter.com/FinInvTr/status/883069803472330752
3280,MM+M Magazine,@MMMnews,2017-07-06T21:30:00.000Z,"5 things for #pharma #marketers to know: Thu., July 6 $MRK #MultipleMyeloma $BMY #Oncology $NVS #opioidepidemic  http://bit.ly/2uOnAU9","5 things for #pharma #marketers to know: Thu., July 6 $MRK #MultipleMyeloma $BMY #Oncology $NVS #opioidepidemic  http://bit.ly/2uOnAU9
2",,,,2,['https://pbs.twimg.com/media/DEDw0gBWsAAtToM?format=jpg&name=small'],https://twitter.com/MMMnews/status/883075584019922945
3281,Vista Partners LLC,@VistaPResearch,2017-07-08T05:40:28.000Z,"@boxticker
 thanks for follow! See Vista Partners #Investing #tech #biotech http://vistapglobal.com $MMM $UTX $ATOS $MRK $DGLT","@boxticker
 thanks for follow! See Vista Partners #Investing #tech #biotech http://vistapglobal.com $MMM $UTX $ATOS $MRK $DGLT
GIF
4
2",,,4,2,['https://pbs.twimg.com/tweet_video_thumb/DEMKZiXV0AE3G-W.jpg'],https://twitter.com/VistaPResearch/status/883561400303366144
3282,George Marcovits,@GemsBot,2017-07-08T16:40:10.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,,,,,['https://pbs.twimg.com/media/DEOhZ7RXcAEy9Vi?format=jpg&name=small'],https://twitter.com/GemsBot/status/883727421421367296
3283,GuruFocus,@gurufocus,2017-07-06T22:17:19.000Z,US Market Indexes Lower on Thursday https://gurufocus.com/news/537537 $GE $INTC $MRK,US Market Indexes Lower on Thursday https://gurufocus.com/news/537537 $GE $INTC $MRK,,,,,['https://pbs.twimg.com/media/DEFbYaLVwAAmGwW?format=jpg&name=small'],https://twitter.com/gurufocus/status/883087490055376896
3284,John Carroll,@JohnCendpts,2017-07-06T11:50:35.000Z,"The PM bureau:
Troubled by deaths, FDA orders Merck to slam the brakes on three Keytruda studies
$MRK -1%","The PM bureau:
Troubled by deaths, FDA orders Merck to slam the brakes on three Keytruda studies
$MRK -1%
endpts.com
Troubled by deaths, FDA orders Merck to slam the brakes on three Keytruda studies
A month after Merck flagged a higher risk of death in two combo studies using its flagship drug Keytruda, the FDA has followed up with a clinical hold that will slam the brakes on further treatment...
1
4",,,1,4,['https://pbs.twimg.com/card_img/1501989092988358668/lj65Ad_e?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/882929767221260289
3285,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-07-06T06:40:15.000Z,$CELG $JNJ $MRK Barclays: Thoughts on Keytruda MM FDA #clinicalholds FDA places clinical hold on Keytruda (cont) http://tl.gd/n_1sq0o85,"$CELG $JNJ $MRK Barclays: Thoughts on Keytruda MM FDA #clinicalholds FDA places clinical hold on Keytruda (cont) http://tl.gd/n_1sq0o85
1",üÖ± üÖæ,,,1,[],https://twitter.com/_B_I_O_T_E_C_H_/status/882851672074092545
3286,Open Outcrier,@OpenOutcrier,2017-07-06T13:00:41.000Z,"$MRK (-0.7% pre) FDA puts hold on Merck multiple myeloma trials after deaths - Reuters

http://ooc.bz/l/13635","$MRK (-0.7% pre) FDA puts hold on Merck multiple myeloma trials after deaths - Reuters

http://ooc.bz/l/13635
2
2",,,2,2,[],https://twitter.com/OpenOutcrier/status/882947408551976961
3287,Jacob Bell,@realJacobBell,2017-07-06T16:18:01.000Z,3 Keytruda studies put on clinical hold after deaths http://bit.ly/2tustCg $MRK $CELG $BMY $AZN,"3 Keytruda studies put on clinical hold after deaths http://bit.ly/2tustCg $MRK $CELG $BMY $AZN
biopharmadive.com
3 Keytruda studies put on clinical hold after deaths
The FDA halt comes three weeks after Merck paused enrollment in the trials, which pair Keytruda with Celgene's Revlimid or Pomalyst in multiple myeloma.
1",,,,1,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/realJacobBell/status/882997068360450051
3288,BioPharma Dive,@BioPharmaDive,2017-07-06T21:41:00.000Z,A review of the studies found more deaths had occurred in the treatment arms http://bit.ly/2tustCg $MRK $CELG $AZN $BMY,"A review of the studies found more deaths had occurred in the treatment arms http://bit.ly/2tustCg $MRK $CELG $AZN $BMY
biopharmadive.com
3 Keytruda studies put on clinical hold after deaths
The FDA halt comes three weeks after Merck paused enrollment in the trials, which pair Keytruda with Celgene's Revlimid or Pomalyst in multiple myeloma.
1",,,1,,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/883078352398991360
3289,Pharmaceutical News,@pharma_sector,2017-07-08T11:52:37.000Z,"Analysts Expect #Merck & Company, Inc. Will Announce Earnings of $0.87 Per Share. Read more: http://owler.us/acZCUw $MRK","Analysts Expect #Merck & Company, Inc. Will Announce Earnings of $0.87 Per Share. Read more: http://owler.us/acZCUw $MRK",,,,,[],https://twitter.com/pharma_sector/status/883655054804172800
3290,Pharmaceutical News,@pharma_sector,2017-07-07T15:16:56.000Z,#Merck & Co. To Hold Second-Quarter 2017 Sales And Earnings Conference Call On July 28  . Read more: http://owler.us/acZsyG $MRK,#Merck & Co. To Hold Second-Quarter 2017 Sales And Earnings Conference Call On July 28  . Read more: http://owler.us/acZsyG $MRK,,,,,[],https://twitter.com/pharma_sector/status/883344086320545793
3291,Pharmaceutical News,@pharma_sector,2017-07-07T14:27:23.000Z,"#Merck Pharma Stock Roundup: 's Keytruda MM Combo Studies on Clinical Hold, Bayer to Revise ... Read more: http://owler.us/acZrTP $MRK","#Merck Pharma Stock Roundup: 's Keytruda MM Combo Studies on Clinical Hold, Bayer to Revise ... Read more: http://owler.us/acZrTP $MRK",,,,,[],https://twitter.com/pharma_sector/status/883331616981917696
3292,Biotech2050,@Biotech2050,2017-07-06T03:39:43.000Z,So now will $MRK consider buying $KPTI or will $CELG pull the trigger before?,"So now will $MRK consider buying $KPTI or will $CELG pull the trigger before?
Meg Tirrell
@megtirrell
 ¬∑ 6 Jul 2017
FDA puts clinical hold on 3 $MRK Keytruda trials in multiple myeloma, citing greater potential for risk than benefit http://mrknewsroom.com/news-release/prescription-medicine-news/merck-provides-further-update-three-multiple-myeloma-studies‚Ä¶",,,,,['https://pbs.twimg.com/profile_images/791618485621325824/wBeu2-6V_mini.jpg'],https://twitter.com/Biotech2050/status/882806235862622208
3293,WLST.com,@wlstcom,2017-07-06T10:10:15.000Z,"Charges over misleading merger info #CAJ #Canon,Inc. $MRK $SIAL $GE $CAJ http://wlst.com","Charges over misleading merger info #CAJ #Canon,Inc. $MRK $SIAL $GE $CAJ http://wlst.com
seekingalpha.com
Charges over misleading merger info (OTCMKTS:MKGAY)
EU antitrust regulators are charging Merck KGaA (OTCPK:MKGAY), Sigma-Aldrich (NASDAQ:SIAL), General Electric (NYSE:GE) and Canon (NYSE:CAJ) for providing misleading information during their...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/wlstcom/status/882904517116928001
3294,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-07-08T09:08:08.000Z,"#SwingTradeAlert $MRK technical alerts: MACD Bearish Centerline Cross, Doji -‚Ä¶ http://dlvr.it/PT599X via ‚Üí http://bit.do/FreeTradingRoom","#SwingTradeAlert $MRK technical alerts: MACD Bearish Centerline Cross, Doji -‚Ä¶ http://dlvr.it/PT599X via ‚Üí http://bit.do/FreeTradingRoom",,,,,[],https://twitter.com/AlertTrade/status/883613661280915456
3295,MarketBeat,@MarketBeatCom,2017-07-07T14:31:31.000Z,Merck KGaA given ‚Ç¨116.00 PT by Warburg Research. neutral rating. http://ift.tt/2sxKoHb $MRK #MRK,Merck KGaA given ‚Ç¨116.00 PT by Warburg Research. neutral rating. http://ift.tt/2sxKoHb $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/883332654954942464
3296,Ro Patel,@Ro_Patel,2017-07-06T13:37:57.000Z,EU antitrust regulators are charging $MRK $SIAL $GE & $CAJ for providing misleading info during their merger deals,EU antitrust regulators are charging $MRK $SIAL $GE & $CAJ for providing misleading info during their merger deals,,,,,[],https://twitter.com/Ro_Patel/status/882956787443433472
3297,Ronnie Matrix Mukiibi.,@RonnieMatrix,2017-07-06T19:23:28.000Z,"Pfizer $PFE,biotech play with agood 3.86% yield that could provide you with protection from any market downturn. Merck $MRK has a2.95% yield","Pfizer $PFE,biotech play with agood 3.86% yield that could provide you with protection from any market downturn. Merck $MRK has a2.95% yield",,,,,[],https://twitter.com/RonnieMatrix/status/883043741325557764
3298,bake mcbride,@ITRADEVOL,2017-07-06T11:32:41.000Z,$MRK The 07-Jul-17 option ATM straddle implied a move of ¬±1.0% by expiration https://marketchameleon.com/Overview/MRK/OptionChain/‚Ä¶,$MRK The 07-Jul-17 option ATM straddle implied a move of ¬±1.0% by expiration https://marketchameleon.com/Overview/MRK/OptionChain/‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/882925264048726016
3299,bake mcbride,@ITRADEVOL,2017-07-06T20:33:35.000Z,AfterHoursTrading $FTR $GDX $SPY $XLF $OKE $BAC $IWM $CSCO $KO $RAD $GE $EEM $HYG $MRK $GDXJ $SRC $F $CHK $ETP $APC https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,AfterHoursTrading $FTR $GDX $SPY $XLF $OKE $BAC $IWM $CSCO $KO $RAD $GE $EEM $HYG $MRK $GDXJ $SRC $F $CHK $ETP $APC https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/883061385458065409
3300,Ticker Report,@TickerReport,2017-07-08T08:17:13.000Z,"Merck & Company, Inc. $MRK Stake Increased by Baystate Wealth Management LLC http://ift.tt/2tSRPN6","Merck & Company, Inc. $MRK Stake Increased by Baystate Wealth Management LLC http://ift.tt/2tSRPN6",,,,,[],https://twitter.com/TickerReport/status/883600848944869376
3301,Dakota Financial,@dakotafinancial,2017-07-06T11:57:49.000Z,"First Quadrant L P CA Purchases 206,301 Shares of Merck & Company, Inc. $MRK http://ift.tt/2tUyqM2","First Quadrant L P CA Purchases 206,301 Shares of Merck & Company, Inc. $MRK http://ift.tt/2tUyqM2",,,,,[],https://twitter.com/dakotafinancial/status/882931589654687744
3302,Watchlist News,@WatchlistN,2017-07-06T21:07:42.000Z,"Merck & Company, Inc. $MRK Given a $65.00 Price Target at Citigroup Inc. http://ift.tt/2tmhzQJ","Merck & Company, Inc. $MRK Given a $65.00 Price Target at Citigroup Inc. http://ift.tt/2tmhzQJ",,,,,[],https://twitter.com/WatchlistN/status/883069971991023616
3303,Limex,@LimexMe,2017-07-06T16:22:12.000Z,Merck Falls as FDA Puts Hold on 3 Keytruda Myeloma Studies http://bit.ly/060717MRK $MRK $CELG $LLY,"Merck Falls as FDA Puts Hold on 3 Keytruda Myeloma Studies http://bit.ly/060717MRK $MRK $CELG $LLY
whotrades.com
Merck Falls as FDA Puts Hold on 3 Keytruda Myeloma Studies
Merck & Co., Inc. MRK shares were down more than 1% in after-hours trading on Wednesday after the company announced that the FDA has placed a clinical hold on three‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/882998123311845376
3304,Kara Jill Stancell,@kjilly,2017-07-06T13:09:35.000Z,"Troubled by deaths, #FDA orders $MRK to slam the brakes on three #Keytruda studies #pharma #biotech #biopharma https://endpts.com/troubled-by-deaths-fda-orders-merck-to-slam-the-brakes-on-three-keytruda-studies‚Ä¶","Troubled by deaths, #FDA orders $MRK to slam the brakes on three #Keytruda studies #pharma #biotech #biopharma https://endpts.com/troubled-by-deaths-fda-orders-merck-to-slam-the-brakes-on-three-keytruda-studies‚Ä¶
1",,,1,,[],https://twitter.com/kjilly/status/882949651250397184
3305,Frank Vinluan,@frankvinluan,2017-07-06T00:34:08.000Z,"FDA Halts Merck‚Äôs #MultipleMyeloma Trials After Patient Deaths http://xconomy.com/new-york/2017/07/05/fda-halts-mercks-multiple-myeloma-trials-after-patient-deaths/‚Ä¶ via 
@xconomy
 #cancer $MRK","FDA Halts Merck‚Äôs #MultipleMyeloma Trials After Patient Deaths http://xconomy.com/new-york/2017/07/05/fda-halts-mercks-multiple-myeloma-trials-after-patient-deaths/‚Ä¶ via 
@xconomy
 #cancer $MRK
xconomy.com
Xconomy: FDA Halts Merck‚Äôs Multiple Myeloma Trials After Patient Deaths
Nearly a month after Merck paused enrollment in three clinical trials in multiple myeloma to gather more information about patient deaths, the FDA has now
1",,,,1,[],https://twitter.com/frankvinluan/status/882759534313340928
3306,Stockboard Media Inc,@stockboardinc,2017-07-06T21:50:37.000Z,$MRK Merck to Hold Second-Quarter 2017 Sales and Earnings Conference Call on July 28... - http://sbml.co/d89c5330,$MRK Merck to Hold Second-Quarter 2017 Sales and Earnings Conference Call on July 28... - http://sbml.co/d89c5330,,,,,[],https://twitter.com/stockboardinc/status/883080771065573377
3307,Ticker Report,@TickerReport,2017-07-07T10:37:21.000Z,Somewhat Critical Press Coverage Extremely Unlikely to Affect Merck & Company $MRK Share Price http://ift.tt/2tPDIrJ,Somewhat Critical Press Coverage Extremely Unlikely to Affect Merck & Company $MRK Share Price http://ift.tt/2tPDIrJ,,,,,[],https://twitter.com/TickerReport/status/883273728444051456
3308,StockNews.com,@stocknewsdotcom,2017-07-06T11:17:18.000Z,$MRK Announces that new data from the company's HIV portfolio and pipeline are scheduled to be presented at the 9‚Ä¶ https://stocknews.com/news/mrk-announces-that-new-data-from-the-companys-hiv-portfolio-and/‚Ä¶,$MRK Announces that new data from the company's HIV portfolio and pipeline are scheduled to be presented at the 9‚Ä¶ https://stocknews.com/news/mrk-announces-that-new-data-from-the-companys-hiv-portfolio-and/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/882921393544986624
3309,Hottest Stocks Now,@HottestStockNow,2017-07-06T13:24:30.000Z,FDA puts hold on Certain Clinical Trials of $MRK ‚Äôs Keytruda after deaths,"FDA puts hold on Certain Clinical Trials of $MRK ‚Äôs Keytruda after deaths
crweworld.com
FDA puts on hold Keytruda studies
US regulators have placed on clinical hold three studies testing the immunotherapy Keytruda in combination with other therapies for multiple myeloma because of patient deaths. Source: PharmaTimes",,,,,['https://pbs.twimg.com/card_img/1499816442249629696/ZyoDobPa?format=jpg&name=240x240'],https://twitter.com/HottestStockNow/status/882953402912616450
3310,Market Realist,@MarketRealist,2017-07-06T22:59:00.000Z,Who's Watching Bristol-Myers Squibb Now? http://marketrealist.com/?p=2186995 $BMY $MRK $JNJ $PFE,Who's Watching Bristol-Myers Squibb Now? http://marketrealist.com/?p=2186995 $BMY $MRK $JNJ $PFE,,,,,[],https://twitter.com/MarketRealist/status/883097980177350656
3311,MarketBeat,@MarketBeatCom,2017-07-07T12:20:08.000Z,"Merck & Company, Inc. $MRK Stake Increased by Cubic Asset Management LLC http://ift.tt/2sNAxBn","Merck & Company, Inc. $MRK Stake Increased by Cubic Asset Management LLC http://ift.tt/2sNAxBn",,,,,[],https://twitter.com/MarketBeatCom/status/883299592116228101
3312,US Banking News,@AmericanBanking,2017-07-06T00:30:51.000Z,Weekly Investment Analysts‚Äô Ratings Changes for Merck & Company $MRK http://ift.tt/2uLRyYQ,Weekly Investment Analysts‚Äô Ratings Changes for Merck & Company $MRK http://ift.tt/2uLRyYQ,,,,,[],https://twitter.com/AmericanBanking/status/882758707318325248
3313,Dakota Financial,@dakotafinancial,2017-07-07T12:17:35.000Z,"Merck & Company, Inc. $MRK Stake Increased by Cubic Asset Management LLC http://ift.tt/2sNAxBn","Merck & Company, Inc. $MRK Stake Increased by Cubic Asset Management LLC http://ift.tt/2sNAxBn",,,,,[],https://twitter.com/dakotafinancial/status/883298951033651200
3314,US Banking News,@AmericanBanking,2017-07-07T16:51:09.000Z,"$9.70 Billion in Sales Expected for Merck & Company, Inc. $MRK This Quarter http://ift.tt/2uyEA1B","$9.70 Billion in Sales Expected for Merck & Company, Inc. $MRK This Quarter http://ift.tt/2uyEA1B",,,,,[],https://twitter.com/AmericanBanking/status/883367795098087424
3315,SwingTradeBot,@SwingTradeBot,2017-07-08T09:03:24.000Z,"$MRK technical alerts: MACD Bearish Centerline Cross, Doji - Bullish?, and NR7","$MRK technical alerts: MACD Bearish Centerline Cross, Doji - Bullish?, and NR7
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/883612471893909504
3316,Insider Monkey,@insidermonkey,2017-07-06T16:01:44.000Z,"15 Biggest #Healthcare Companies in USA
$AMGN $ABBV $GILD $CI $MRK $CNC $HCA $PFE $HUM $AET $JNJ $ANTM $ESRX $CVS...","15 Biggest #Healthcare Companies in USA
$AMGN $ABBV $GILD $CI $MRK $CNC $HCA $PFE $HUM $AET $JNJ $ANTM $ESRX $CVS...
insidermonkey.com
15 Biggest Healthcare Companies in USA
If you're seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the 15 biggest healthcare companies in USA are probably...",,,,,[],https://twitter.com/insidermonkey/status/882992974199738368
3317,AJMC,@AJMC_Journal,2017-07-08T20:35:00.000Z,".
@US_FDA
 places 3 trials of #Keytruda for #multiplemyeloma on hold due to patient deaths, $MRK announces http://bit.ly/2sPfbn4",".
@US_FDA
 places 3 trials of #Keytruda for #multiplemyeloma on hold due to patient deaths, $MRK announces http://bit.ly/2sPfbn4
1",,,1,,['https://pbs.twimg.com/media/DEJ5XLvUIAAcLdV?format=jpg&name=small'],https://twitter.com/AJMC_Journal/status/883786517969125376
3318,Allison Gatlin,@IBD_AGatlin,2017-07-07T18:03:26.000Z,Why Celgene's $413 million gamble helps this small biotech more $CELG $BGNE $MRK $BMY $AZN,"Why Celgene's $413 million gamble helps this small biotech more $CELG $BGNE $MRK $BMY $AZN
investors.com
Why Celgene's $413 Million Gamble Helps This Small Biotech More
Chinese biotech BeiGene is the strongest beneficiary of Celgene's $413 million gamble in immuno-oncology, an analyst said Friday.",,,,,[],https://twitter.com/IBD_AGatlin/status/883385985114963970
3319,BioPharma Dive,@BioPharmaDive,2017-07-07T23:44:00.000Z,"Rx Reading: $CELG expands oncology pipeline; $RHHBY, $PTCT reveal topline results; FDA hits $MRK with clinical holds","Rx Reading: $CELG expands oncology pipeline; $RHHBY, $PTCT reveal topline results; FDA hits $MRK with clinical holds
biopharmadive.com
Prescribed Reading: I/O is the only game in town
Immuno-oncology dominates dealmaking, clinical trial data and regulatory action. ",,,,,['https://pbs.twimg.com/card_img/1500049809826369538/mq3I7xko?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/883471694404272128
3320,Day Trading Academy,@DTradingAcademy,2017-07-06T11:51:00.000Z,EU antitrust regulators charge $MRK $SIAL $GE & $CAJ for providing misleading information during their merger deals.,"EU antitrust regulators charge $MRK $SIAL $GE & $CAJ for providing misleading information during their merger deals.
daytradingacademy.com
Day Trading Academy: Investing & Trading Education
Market leading day trading education, trading coaching, and investing company offering a true path to becoming a professional day trader.",,,,,['https://pbs.twimg.com/card_img/1499767849774166016/qCYqbOO-?format=png&name=medium'],https://twitter.com/DTradingAcademy/status/882929874716901376
3321,FiercePharma,@FiercePharma,2017-07-06T07:30:01.000Z,"Can Merck knock Glaxo off its HIV perch? Maybe so, one analyst says http://fiercepharma.com/pharma/can-merck-knock-glaxo-off-its-hiv-perch-maybe-so-one-analyst-says‚Ä¶ $GSK $MRK","Can Merck knock Glaxo off its HIV perch? Maybe so, one analyst says http://fiercepharma.com/pharma/can-merck-knock-glaxo-off-its-hiv-perch-maybe-so-one-analyst-says‚Ä¶ $GSK $MRK",,,,,[],https://twitter.com/FiercePharma/status/882864193782730752
3322,dough,@semodough,2017-07-09T03:08:53.000Z,Market cap top 25 pharma biotech $IBB $JNJ $MRK $CELG $GILD $BMY $INCY $SPY,"Market cap top 25 pharma biotech $IBB $JNJ $MRK $CELG $GILD $BMY $INCY $SPY
1
5
11",,1,5,11,['https://pbs.twimg.com/media/DEQxS6EWAAAtUpm?format=jpg&name=small'],https://twitter.com/semodough/status/883885643738296320
3323,Seeking Alpha,@SeekingAlpha,2017-07-11T21:01:47.000Z,AC Immune: A Compelling Speculative Investment https://seekingalpha.com/article/4087044-ac-immune-compelling-speculative-investment?source=feed_f‚Ä¶ $BIIB $JNJ $LLY $MRK $ACIU,"AC Immune: A Compelling Speculative Investment https://seekingalpha.com/article/4087044-ac-immune-compelling-speculative-investment?source=feed_f‚Ä¶ $BIIB $JNJ $LLY $MRK $ACIU
seekingalpha.com
AC Immune: A Compelling Speculative Investment (NASDAQ:ACIU)
The amyloid hypothesis is the leading hypothesis for understanding and treating Alzheimer's disease, but it has lost some support following several high profile phase 3 failures.
1
2",,,1,2,[],https://twitter.com/SeekingAlpha/status/884880423544684544
3324,"Larry Tentarelli, Blue Chip Daily",@LMT978,2017-07-11T23:58:21.000Z,"$MRK
Oversold daily nearing 200d","$MRK
Oversold daily nearing 200d
1
24",,1,,24,['https://pbs.twimg.com/media/DEfidjmXsAEezaN?format=jpg&name=small'],https://twitter.com/LMT978/status/884924857556905985
3325,FinInvTr,@FinInvTr,2017-07-10T13:58:02.000Z,"10 Stocks = 64% Of Market's Top Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo","10 Stocks = 64% Of Market's Top Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2t35HQo
2
1",,,2,1,['https://pbs.twimg.com/media/DEYPeWTXkAAF-EZ?format=jpg&name=small'],https://twitter.com/FinInvTr/status/884411393570738176
3326,Herkyleese,@herkyleese,2017-07-10T13:57:36.000Z,Which of these would you want to align your technolgy with if you were trying to get approval for a rare disease?  $nwbo $bmy $mrk $kite,"Which of these would you want to align your technolgy with if you were trying to get approval for a rare disease?  $nwbo $bmy $mrk $kite
Linda Liau ucla oncology
46.2%
Kings college top 25
0%
Dr Mac Cheever (CITN)
3.8%
All of the above
50%
26 votes
¬∑
Final results
3
5",,,3,5,[],https://twitter.com/herkyleese/status/884411283075989505
3327,John Baresky Healthcare And Content Marketing Guy,,2017-07-10T01:05:15.000Z,".
@US_FDA
 places 3 trials of #Keytruda for #multiplemyeloma on hold due to patient deaths, $MRK announces http://crwd.fr/2uWuOFW #merck #FDA",".
@US_FDA
 places 3 trials of #Keytruda for #multiplemyeloma on hold due to patient deaths, $MRK announces http://crwd.fr/2uWuOFW #merck #FDA",,,,,['https://pbs.twimg.com/media/DEVemORXkAAtitT?format=jpg&name=360x360'],https://twitter.com/JohnGBaresky/status/884216914842718209
3328,MomoprtnrsLLC,@MomentumPtrsLLC,2017-07-10T19:23:51.000Z,$mrk starter long via calls on megaphone tl tag,$mrk starter long via calls on megaphone tl tag,,,,,[],https://twitter.com/MomentumPtrsLLC/status/884493389785444352
3329,FinInvTr,@FinInvTr,2017-07-10T23:05:57.000Z,#CyberSecurity #Stocks Gain as #Mondelez Loses Sales to #Petya  http://buff.ly/2tHJ0TE  $FTNT $MANT $SYMC $FDX $MRK $MDLZ $CUDA $PANW $FEYE,"#CyberSecurity #Stocks Gain as #Mondelez Loses Sales to #Petya  http://buff.ly/2tHJ0TE  $FTNT $MANT $SYMC $FDX $MRK $MDLZ $CUDA $PANW $FEYE
whotrades.com
Cybersecurity Stocks Gain as Mondelez Loses Sales to Petya
Cybersecurity stocks were seen soaring on Jul 7, after Mondelez International, Inc. MDLZ revealed that its second-quarter 2017 revenues were hit by the global ransomware‚Ä¶",,,,,[],https://twitter.com/FinInvTr/status/884549281084002304
3330,Keith Speights,@keithspeights,2017-07-11T23:40:23.000Z,"Biggest cancer drugs of 2022 #stocks $PFE, $MRK, $JNJ, $BMY, $CELG, $ABBV","Biggest cancer drugs of 2022 #stocks $PFE, $MRK, $JNJ, $BMY, $CELG, $ABBV
fool.com
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now @themotleyfool #stocks $CELG $PFE...
Five cancer drugs that are already successful will become even bigger winners by 2022.",,,,,[],https://twitter.com/keithspeights/status/884920336587919361
3331,Ted Wooley,@TedWooley,2017-07-10T19:41:57.000Z,$mrk buying at the 200m a has been working well since Dec. Here we are again,$mrk buying at the 200m a has been working well since Dec. Here we are again,,,,,[],https://twitter.com/TedWooley/status/884497943218335745
3332,Sweet Platform,@SweetPlatform,2017-07-11T14:48:29.000Z,"MRK Top news - Jul 11th, 2017 $MRK http://https://goo.gl/9SefRd","MRK Top news - Jul 11th, 2017 $MRK http://https://goo.gl/9SefRd",,,,,[],https://twitter.com/SweetPlatform/status/884786479813230593
3333,Tuan Pham,@15minofPham,2017-07-10T17:31:01.000Z,Mid-day GREEN to RED: $CAR $DBD $DUST $HTZ $IYR $LOW $MO $MRK $OPK $PEP,Mid-day GREEN to RED: $CAR $DBD $DUST $HTZ $IYR $LOW $MO $MRK $OPK $PEP,,,,,[],https://twitter.com/15minofPham/status/884464991893692417
3334,Vista Partners LLC,@VistaPResearch,2017-07-11T17:02:12.000Z,"@CallRespiratory
 thanks for RT! See Vista Partners #InvestingForLife #Healthcare http://vistapglobal.com $HIIQ $ATOS $MRK #TuesdayThoughts","@CallRespiratory
 thanks for RT! See Vista Partners #InvestingForLife #Healthcare http://vistapglobal.com $HIIQ $ATOS $MRK #TuesdayThoughts
GIF
1
1",,,1,1,[],https://twitter.com/VistaPResearch/status/884820128310845440
3335,Sujit Mardhani,@sujit_mardhani,2017-07-11T06:55:56.000Z,RT VistaPResearch: Ten40One thanks for follow! See Vista Partners #tech #biotech #fintech http://vistapglobal.com $AAPL $MRK $V http://,RT VistaPResearch: Ten40One thanks for follow! See Vista Partners #tech #biotech #fintech http://vistapglobal.com $AAPL $MRK $V http://,,,,,[],https://twitter.com/sujit_mardhani/status/884667555247509505
3336,bake mcbride,@ITRADEVOL,2017-07-10T20:47:05.000Z,Buy Side Closing Order Imbalances $T $GM $IBM $MRK $RAI $DVN $MET $CVX $EGN $EXC $LB $UNP $WEC $XYL $XOM $JNPR $OKE https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,"Buy Side Closing Order Imbalances $T $GM $IBM $MRK $RAI $DVN $MET $CVX $EGN $EXC $LB $UNP $WEC $XYL $XOM $JNPR $OKE https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶
1",,,1,,[],https://twitter.com/ITRADEVOL/status/884514333547524096
3337,IECONOMICS,@iECONOMICS,2017-07-11T17:33:46.000Z,Merck & Co $MRK market alert: 10-week low @ 62.26 https://ieconomics.com/merck,Merck & Co $MRK market alert: 10-week low @ 62.26 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/884828071643230208
3338,StockMarketVideo.com,@stockmarketvide,2017-07-11T16:20:08.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/884809544127447041
3339,Analyst Ratings,@ARatings,2017-07-09T11:48:13.000Z,Merck & Company Receives a Buy from BMO Capital $MRK http://analystratings.com/2017/07/04/merck-company-receives-a-sell-from-bmo-capital/490115/‚Ä¶,Merck & Company Receives a Buy from BMO Capital $MRK http://analystratings.com/2017/07/04/merck-company-receives-a-sell-from-bmo-capital/490115/‚Ä¶,,,,,[],https://twitter.com/ARatings/status/884016335558201344
3340,FinInvTr,@FinInvTr,2017-07-11T11:52:00.000Z,Cybersecurity Stocks Gain as Mondelez Loses Sales to Petya  http://buff.ly/2sJpkxv  $FTNT $MANT $SYMC $FDX $MRK $MDLZ $CUDA $PANW $FEYE,"Cybersecurity Stocks Gain as Mondelez Loses Sales to Petya  http://buff.ly/2sJpkxv  $FTNT $MANT $SYMC $FDX $MRK $MDLZ $CUDA $PANW $FEYE
whotrades.com
Cybersecurity Stocks Gain as Mondelez Loses Sales to Petya
Cybersecurity stocks were seen soaring on Jul 7, after Mondelez International, Inc. MDLZ revealed that its second-quarter 2017 revenues were hit by the global ransomware‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1501720022733008901/2fOjYsqX?format=jpg&name=small'],https://twitter.com/FinInvTr/status/884742065447370754
3341,MarketBeat,@MarketBeatCom,2017-07-11T02:54:12.000Z,"Merck & Company, Inc. $MRK Receives Average Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2uck1Lo #acn","Merck & Company, Inc. $MRK Receives Average Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2uck1Lo #acn",,,,,[],https://twitter.com/MarketBeatCom/status/884606723587272705
3342,CBPartners,@CBPartners,2017-07-10T17:05:17.000Z,Patient fatalities cause #FDA to place a hold on $MRK KEYTRUDA & $CELG POMALYST / REVLIMID combination drug trials,"Patient fatalities cause #FDA to place a hold on $MRK KEYTRUDA & $CELG POMALYST / REVLIMID combination drug trials
fiercepharma.com
Trial deaths frustrate Merck's bid to pair Keytruda with Celgene's myeloma stars
After reviewing deaths in two Keytruda trials, the FDA put both Merck studies on clinical hold and stopped Keytruda dosing in a third, thwarting Merck's hopes for combining | After reviewing deaths...",,,,,['https://pbs.twimg.com/card_img/1501989258327822348/xoErhbKG?format=jpg&name=small'],https://twitter.com/CBPartners/status/884458516232187905
3343,MarketBeat,@MarketBeatCom,2017-07-09T22:02:53.000Z,"Merck & Company, Inc. $MRK Given a $65.00 Price Target at Citigroup Inc. http://ift.tt/2tEfcas #acn","Merck & Company, Inc. $MRK Given a $65.00 Price Target at Citigroup Inc. http://ift.tt/2tEfcas #acn",,,,,[],https://twitter.com/MarketBeatCom/status/884171023683289090
3344,Amit Jolly,@amitkjolly,2017-07-11T17:59:09.000Z,"$MRK -6% in the past 2.5 weeks. Sector hit, or has it been adjusting for positive $AZN MYSTIC data?","$MRK -6% in the past 2.5 weeks. Sector hit, or has it been adjusting for positive $AZN MYSTIC data?
Sector hit, AZN -5% too
53.8%
MRK adj 2L NSCLC runup
15.4%
MYSTIC +
30.8%
13 votes
¬∑
Final results",,,,,[],https://twitter.com/amitkjolly/status/884834459136266240
3345,Ticker Report,@TickerReport,2017-07-11T06:00:24.000Z,Merck & Company‚Äôs $MRK ‚ÄúSell‚Äù Rating Reiterated at BMO Capital Markets http://ift.tt/2sKlyUB,Merck & Company‚Äôs $MRK ‚ÄúSell‚Äù Rating Reiterated at BMO Capital Markets http://ift.tt/2sKlyUB,,,,,[],https://twitter.com/TickerReport/status/884653581969784832
3346,Daily Political,@dailypoliticaln,2017-07-11T08:21:41.000Z,"Merck & Company, Inc. $MRK Stake Raised by HM Capital Management LLC http://ift.tt/2uMdvrU","Merck & Company, Inc. $MRK Stake Raised by HM Capital Management LLC http://ift.tt/2uMdvrU",,,,,[],https://twitter.com/dailypoliticaln/status/884689134899613696
3347,Limex,@LimexMe,2017-07-10T20:44:49.000Z,These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now http://bit.ly/100717CELG $CELG $PFE $MRK $BMY,"These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now http://bit.ly/100717CELG $CELG $PFE $MRK $BMY
whotrades.com
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Five years fly by quickly. In 2022, the landscape for cancer drugs will be different from today ‚Äî but with some familiar players. Pharmaceutical market analysis firm EvaluatePharma‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/884513763818446855
3348,Watchlist News,@WatchlistN,2017-07-09T08:22:15.000Z,"Merck & Company, Inc. $MRK Shares Sold by Baker Ellis Asset Management LLC http://ift.tt/2sT5V0Z","Merck & Company, Inc. $MRK Shares Sold by Baker Ellis Asset Management LLC http://ift.tt/2sT5V0Z",,,,,[],https://twitter.com/WatchlistN/status/883964504056442880
3349,Tim Reller,@TraderGuruNY,2017-07-11T15:45:44.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/884800886974951425
3350,Ticker Report,@TickerReport,2017-07-09T08:17:19.000Z,"Merck & Company, Inc. $MRK Shares Bought by Clear Harbor Asset Management LLC http://ift.tt/2t0LESD","Merck & Company, Inc. $MRK Shares Bought by Clear Harbor Asset Management LLC http://ift.tt/2t0LESD",,,,,[],https://twitter.com/TickerReport/status/883963259879084033
3351,Daily Political,@dailypoliticaln,2017-07-10T17:36:31.000Z,Merck & Company‚Äôs $MRK Sell Rating Reiterated at BMO Capital Markets http://ift.tt/2uaA8ZF,Merck & Company‚Äôs $MRK Sell Rating Reiterated at BMO Capital Markets http://ift.tt/2uaA8ZF,,,,,[],https://twitter.com/dailypoliticaln/status/884466376378920961
3352,Limex,@LimexMe,2017-07-11T20:11:59.000Z,3 Dividend Stocks in Healthcare http://bit.ly/110717AMGN $AMGN $CHRS $AZN $MDT $MRK $MBY,"3 Dividend Stocks in Healthcare http://bit.ly/110717AMGN $AMGN $CHRS $AZN $MDT $MRK $MBY
whotrades.com
3 Dividend Stocks in Healthcare
No one gets to choose when they get sick. That's a big reason the demand for healthcare tends to remain stable even during periods of economic stress. For income investors, this means some‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/884867889517514753
3353,Watchlist News,@WatchlistN,2017-07-11T00:57:19.000Z,"Merck & Company, Inc. $MRK Expected to Announce Quarterly Sales of $9.70 Billion http://ift.tt/2tBIGaA","Merck & Company, Inc. $MRK Expected to Announce Quarterly Sales of $9.70 Billion http://ift.tt/2tBIGaA",,,,,[],https://twitter.com/WatchlistN/status/884577307012333569
3354,Daily Political,@dailypoliticaln,2017-07-10T16:07:20.000Z,Positive Media Coverage Extremely Unlikely to Affect Merck & Company $MRK Share Price http://ift.tt/2uap3rQ,Positive Media Coverage Extremely Unlikely to Affect Merck & Company $MRK Share Price http://ift.tt/2uap3rQ,,,,,[],https://twitter.com/dailypoliticaln/status/884443932993753088
3355,US Banking News,@AmericanBanking,2017-07-09T22:11:12.000Z,"Merck & Company, Inc. $MRK Given a $65.00 Price Target at Citigroup Inc. http://ift.tt/2uZG1Fu","Merck & Company, Inc. $MRK Given a $65.00 Price Target at Citigroup Inc. http://ift.tt/2uZG1Fu",,,,,[],https://twitter.com/AmericanBanking/status/884173113705082885
3356,US Banking News,@AmericanBanking,2017-07-11T02:56:12.000Z,"Merck & Company, Inc. $MRK Receives Average Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2uLd6pq","Merck & Company, Inc. $MRK Receives Average Rating of ‚ÄúHold‚Äù from Analysts http://ift.tt/2uLd6pq",,,,,[],https://twitter.com/AmericanBanking/status/884607223812501505
3357,Hottest Stocks Now,@HottestStockNow,2017-07-10T13:38:19.000Z,"PDS Biotechnology, $MRK to Evaluate Combo of Versamune/KEYTRUDA for Metastatic Head and Neck Cancer http://crweworld.com/newsroom/prnewswire?rkey=20170710CL34563&filter=10284‚Ä¶","PDS Biotechnology, $MRK to Evaluate Combo of Versamune/KEYTRUDA for Metastatic Head and Neck Cancer http://crweworld.com/newsroom/prnewswire?rkey=20170710CL34563&filter=10284‚Ä¶",,,,,[],https://twitter.com/HottestStockNow/status/884406431151046657
3358,avidresearch,@avidresearch,2017-07-11T02:59:06.000Z,"Replying to 
@JohnK_Allen","Replying to 
@JohnK_Allen
How much do u think $MRK falls if MYSTIC hits?
1
1",,1,,1,[],https://twitter.com/avidresearch/status/884607955773075456
3359,YASHIRA GOUCHA,@YGOUCHA,2017-07-11T13:37:48.000Z,"Replying to 
@YGOUCHA
 and 
@OpenOutcrier","Replying to 
@YGOUCHA
 and 
@OpenOutcrier
$ACAD - Here we go again - been there done that. This time $MRK/$JNJ battling it out
1",,1,,,[],https://twitter.com/YGOUCHA/status/884768691241594880
3360,subu,@sububoston,2017-07-10T17:26:56.000Z,"Replying to 
@Amylucio2009","Replying to 
@Amylucio2009
Also $LPTX, $FPRX, $MRK, $BMY",,,,,[],https://twitter.com/sububoston/status/884463965987758081
3361,Mark Balson,@mark_balson,2017-07-11T17:11:23.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/mark_balson/status/884822438122582016
3362,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-07-14T12:35:26.000Z,Options Market Positioning Block Trade Volume 7/3-7/12 in $AZN $BMY $MRK bearish bias in PD1/L1 + CTLA4 companies bullish/neutral PD1+chemo,"Options Market Positioning Block Trade Volume 7/3-7/12 in $AZN $BMY $MRK bearish bias in PD1/L1 + CTLA4 companies bullish/neutral PD1+chemo
1
2
4",,1,2,4,['https://pbs.twimg.com/media/DEsi6uhVYAAmbNt?format=jpg&name=small'],https://twitter.com/DrPaulyDeSantis/status/885840159484383233
3363,Andy Biotech,@AndyBiotech,2017-07-12T23:06:41.000Z,"Whoa that's a nice side effect to have!
https://twitter.com/JAMADerm/status/885257464702173184‚Ä¶

But anti-PD1 also causes vitiligo? hmm...
http://jamanetwork.com/journals/jamadermatology/fullarticle/2464931‚Ä¶
$BMY $MRK","Whoa that's a nice side effect to have!
https://twitter.com/JAMADerm/status/885257464702173184‚Ä¶

But anti-PD1 also causes vitiligo? hmm...
http://jamanetwork.com/journals/jamadermatology/fullarticle/2464931‚Ä¶
$BMY $MRK
JAMA Dermatology
@JAMADerm
 ¬∑ 13 Jul 2017
14 patients in anti-PD-1/anti-PD-L1 therapy for #lungcancer have shown hair repigmentation during Tx http://ja.ma/2ujoa0c #LCSM
5
38
55",,5,38,55,"['https://pbs.twimg.com/profile_images/1117842762320228353/Zxb24jfo_mini.png', 'https://pbs.twimg.com/media/DEkQ-LMWAAEqI8M?format=jpg&name=small']",https://twitter.com/AndyBiotech/status/885274241213583360
3364,Seeking Alpha,@SeekingAlpha,2017-07-13T13:14:54.000Z,Merck's Constant Struggle With Leverage https://seekingalpha.com/article/4087473-mercks-constant-struggle-leverage?source=feed_f‚Ä¶ $MRK,"Merck's Constant Struggle With Leverage https://seekingalpha.com/article/4087473-mercks-constant-struggle-leverage?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Merck's Constant Struggle With Leverage (NYSE:MRK)
Merck has issued billions of dollars in new debt in recent years. This comes on top of its already significant debt pile from a few years ago.
1",,,,1,[],https://twitter.com/SeekingAlpha/status/885487700618354688
3365,Seeking Alpha,@SeekingAlpha,2017-07-13T13:16:46.000Z,Amgen Receives FDA Approval For BLINCYTO https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto?source=feed_f‚Ä¶ $MRK $AMGN,"Amgen Receives FDA Approval For BLINCYTO https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto?source=feed_f‚Ä¶ $MRK $AMGN
1",,,,1,[],https://twitter.com/SeekingAlpha/status/885488173408632832
3366,ABetter Kayleigh McEnany,@MissElllly,2017-07-13T13:19:09.000Z,$SPY $XLV $PFE $HUM $CI $GILD $UNH $MRK $ABBV Doctors make last-ditch effort to sink GOP health-care bill,"$SPY $XLV $PFE $HUM $CI $GILD $UNH $MRK $ABBV Doctors make last-ditch effort to sink GOP health-care bill
washingtonpost.com
Analysis | The Health 202: Doctors make last-ditch effort to sink GOP health-care bill
Today is the day the Senate bill will be unveiled.",,,,,[],https://twitter.com/MissElllly/status/885488772489637889
3367,Vista Partners LLC,@VistaPResearch,2017-07-14T15:25:19.000Z,See 1/yr Chart $HIIQ Health Insurance Innovations !New all time today! learn more at Vista Partners http://vistapglobal.com/vp-coverage/health-insurance-innovations-inc/‚Ä¶ $DGLT $ATOS $MRK,"See 1/yr Chart $HIIQ Health Insurance Innovations !New all time today! learn more at Vista Partners http://vistapglobal.com/vp-coverage/health-insurance-innovations-inc/‚Ä¶ $DGLT $ATOS $MRK
1
1",,,1,1,['https://pbs.twimg.com/media/DEtJzxzVYAI9IPW?format=jpg&name=900x900'],https://twitter.com/VistaPResearch/status/885882909642465280
3368,StockMarketVideo.com,@stockmarketvide,2017-07-14T13:44:29.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/885857535525355525
3369,Tuan Pham,@15minofPham,2017-07-13T03:40:18.000Z,"Highest Call-Put ratio vs OI. CALL: $FCAU $MRK $FB $PYPL $HOLX $QRVO $ENDP. PUT: $XLV $IWM $GLD $XBI $NRG $CLR 
 http://tinyurl.com/ls6vzw7","Highest Call-Put ratio vs OI. CALL: $FCAU $MRK $FB $PYPL $HOLX $QRVO $ENDP. PUT: $XLV $IWM $GLD $XBI $NRG $CLR 
 http://tinyurl.com/ls6vzw7",‚û° ‚û° ‚û°,,,,['https://pbs.twimg.com/media/DEldgtkVoAAMM_g?format=jpg&name=small'],https://twitter.com/15minofPham/status/885343099056214016
3370,Zero Filter,@zerofiltertruth,2017-07-14T12:38:23.000Z,"Our #biotech wild-ones $PPHM / $DRRX going for more this early AM 

$NVS $MRK $GILD $AMGN $CELG $SHPG $BIIB

$IBB $XBI","Our #biotech wild-ones $PPHM / $DRRX going for more this early AM 

$NVS $MRK $GILD $AMGN $CELG $SHPG $BIIB

$IBB $XBI",,,,,[],https://twitter.com/zerofiltertruth/status/885840900416565248
3371,Vagabond Quas,@CthruHD,2017-07-14T19:26:26.000Z,Increased $BUD and $MRK,"Increased $BUD and $MRK
1",,,1,,[],https://twitter.com/CthruHD/status/885943589104234496
3372,Fearlessgirl,@Trader_gurl,2017-07-12T16:33:35.000Z,$MRK CALL $63.50 EXP 21/07/17 BUYING,$MRK CALL $63.50 EXP 21/07/17 BUYING,,,,,[],https://twitter.com/Trader_gurl/status/885175315412258817
3373,AMEGI,@AMEGI_MX,2017-07-14T22:22:59.000Z,Amgen Receives FDA Approval For BLINCYTO https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto?source=tweet‚Ä¶ $MRK $AMGN https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto‚Ä¶,"Amgen Receives FDA Approval For BLINCYTO https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto?source=tweet‚Ä¶ $MRK $AMGN https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto‚Ä¶
seekingalpha.com
Amgen Receives FDA Approval For BLINCYTO (NASDAQ:AMGN)
BLINCYTO scores FDA approval for patients with relasped or refractory B-cell precursor acute lymphoblastic leukemia in adults and Children. Market potential for BLINCYTO will expand.
1",,,1,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/AMEGI_MX/status/885988021660602368
3374,JustTradingHoy,@JustTradingHoy,2017-07-13T18:55:12.000Z,Must have leaked out of US Senate. $IBB flying. Shorts are going to scramble in the last hour. If going UP $2-$4 each: $NVS $MRK $BMY $PFE,"Must have leaked out of US Senate. $IBB flying. Shorts are going to scramble in the last hour. If going UP $2-$4 each: $NVS $MRK $BMY $PFE
1",,,,1,[],https://twitter.com/JustTradingHoy/status/885573340525711361
3375,Odi Bruckman,@odibro,2017-07-13T12:07:06.000Z,$ADRO: $2M Milestone Achieved Relating to Collaboration with $MRK for Development of Anti-CD27 Antibody,"$ADRO: $2M Milestone Achieved Relating to Collaboration with $MRK for Development of Anti-CD27 Antibody
globenewswire.com
Aduro Announces Milestone Achieved Relating to Collaboration with Merck for Development of Anti-C...
Investigational Immunotherapy on Track to Enter Clinical Development in 2018...
2
2",,,2,2,[],https://twitter.com/odibro/status/885470641566232576
3376,Tim Reller,@TraderGuruNY,2017-07-12T15:44:41.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/885163008753905672
3377,MakeTrades,@MakeTrades,2017-07-13T17:48:41.000Z,"$MRK if it touches $62, I will load up on Call options....","$MRK if it touches $62, I will load up on Call options....",,,,,[],https://twitter.com/MakeTrades/status/885556602711019520
3378,MakeTrades,@MakeTrades,2017-07-13T17:45:58.000Z,$MRK looking attractive here if $IBB breaks higher....,$MRK looking attractive here if $IBB breaks higher....,,,,,[],https://twitter.com/MakeTrades/status/885555919681183744
3379,Vista Partners LLC,@VistaPResearch,2017-07-12T17:16:24.000Z,"@DroneFlo
 thanks for follow! See Vista Partners #InvestingForGrowth #Biotech http://vistapglobal.com $MRK $ATOS $JNJ $IBB #breastcancer","@DroneFlo
 thanks for follow! See Vista Partners #InvestingForGrowth #Biotech http://vistapglobal.com $MRK $ATOS $JNJ $IBB #breastcancer
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DEjQC6xV0AAony2.jpg'],https://twitter.com/VistaPResearch/status/885186089148755968
3380,Art,@mRNAdisrupts,2017-07-13T01:02:21.000Z,"$IONS $AMGN $MRK  #antisense #RNAi Interview with Paul Burke http://oligotherapeutics.org/interview-paul-burke/‚Ä¶ via 
@OTSociety","$IONS $AMGN $MRK  #antisense #RNAi Interview with Paul Burke http://oligotherapeutics.org/interview-paul-burke/‚Ä¶ via 
@OTSociety
oligotherapeutics.org
Interview with Paul Burke - Oligonucleotide Therapeutics Society
Paul Burke, PhD Principal, Burke Bioventures LLC How did you become interested in the field of oligonucleotides? I first became interested in",,,,,['https://pbs.twimg.com/card_img/1500360297906851842/uCOMFGAx?format=jpg&name=360x360'],https://twitter.com/mRNAdisrupts/status/885303349431738369
3381,FinInvTr,@FinInvTr,2017-07-14T21:07:03.000Z,#Gilead $GILD Application for #HIV Drug Validated in EU  http://buff.ly/2to9A2i $ENZ $GSK $MRK #Biotech #Pharma,"#Gilead $GILD Application for #HIV Drug Validated in EU  http://buff.ly/2to9A2i $ENZ $GSK $MRK #Biotech #Pharma
whotrades.com
Gilead (GILD) Application for HIV Drug Validated in EU
Gilead Sciences, Inc. GILD announced that the company‚Äôs Marketing Authorization Application (MAA) for a once-daily single tablet regimen containing bictegravir (50 mg; BIC) and‚Ä¶",,,,,[],https://twitter.com/FinInvTr/status/885968908720713728
3382,FinInvTr,@FinInvTr,2017-07-14T22:16:35.000Z,"Highlights On #Merck, #Celgene, #Gilead, Seattle Genetics and #Vanda Pharmaceuticals  http://buff.ly/2tS8BuQ $MRK $CELG $GILD $SGEN $VNDA","Highlights On #Merck, #Celgene, #Gilead, Seattle Genetics and #Vanda Pharmaceuticals  http://buff.ly/2tS8BuQ $MRK $CELG $GILD $SGEN $VNDA",,,,,[],https://twitter.com/FinInvTr/status/885986410272092160
3383,Dow Stocks,@Top_Dow_Stocks,2017-07-14T07:16:57.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/885760009228869633
3384,Trade Academy,@TradeAcademyCo,2017-07-13T12:20:41.000Z,7/13 200D MA Watch List: $CF $MYL $LOW $FOXA $GRPN $LYB $DBA $CARA $MRK $LULU $AMGN $ETE $BMY $NUE $AIG $POT $CBS $SRPT $IEF $SHAK #trading,7/13 200D MA Watch List: $CF $MYL $LOW $FOXA $GRPN $LYB $DBA $CARA $MRK $LULU $AMGN $ETE $BMY $NUE $AIG $POT $CBS $SRPT $IEF $SHAK #trading,,,,,[],https://twitter.com/TradeAcademyCo/status/885474059047358464
3385,$peedyCalls,@SpeedyCalls,2017-07-12T19:25:42.000Z,"$MRK 64 Calls BUYING Activity expiring on 21st Jul, Vol 2499","$MRK 64 Calls BUYING Activity expiring on 21st Jul, Vol 2499",,,,,[],https://twitter.com/SpeedyCalls/status/885218630501371905
3386,Zero Filter,@zerofiltertruth,2017-07-12T17:03:03.000Z,"$DRRX m/c $0.242 Billion 

$NVS m/c  $218 Billion 

Thus, #Novartis is literally 900x size #Durect which it has collab agree with lol 

$MRK","$DRRX m/c $0.242 Billion 

$NVS m/c  $218 Billion 

Thus, #Novartis is literally 900x size #Durect which it has collab agree with lol 

$MRK
1",,,1,,[],https://twitter.com/zerofiltertruth/status/885182731944173568
3387,JustTradingHoy,@JustTradingHoy,2017-07-14T13:00:04.000Z,$IBB let's see if banks weekness give bios rotation inflows. This market is all about stepping on a wave just b4 it crests. $BMY $MRK $NVS,$IBB let's see if banks weekness give bios rotation inflows. This market is all about stepping on a wave just b4 it crests. $BMY $MRK $NVS,,,,,[],https://twitter.com/JustTradingHoy/status/885846356589518850
3388,ABetter Kayleigh McEnany,@MissElllly,2017-07-13T17:49:20.000Z,$SPY #Healthcare didnt get done...... $XLV $XBI $UNH $PFE $MRK $ABBV $ABT $HUM $CI,$SPY #Healthcare didnt get done...... $XLV $XBI $UNH $PFE $MRK $ABBV $ABT $HUM $CI,,,,,[],https://twitter.com/MissElllly/status/885556764304953348
3389,cowenresearch,@CowenResearch,2017-07-14T14:18:59.000Z,Quiz on Monday... Steve Scala publishes 782-page #Pharma Pulse sector update $ABBV $BMY $LLY $JNJ $MRK $PFE $AZN $GSK $NVS $SNY $RHHBY $ZTS,"Quiz on Monday... Steve Scala publishes 782-page #Pharma Pulse sector update $ABBV $BMY $LLY $JNJ $MRK $PFE $AZN $GSK $NVS $SNY $RHHBY $ZTS
1",,,,1,[],https://twitter.com/CowenResearch/status/885866216056905728
3390,Sweet Platform,@SweetPlatform,2017-07-13T14:48:38.000Z,"MRK Top news - Jul 13th, 2017 $MRK http://https://goo.gl/hcZgG4","MRK Top news - Jul 13th, 2017 $MRK http://https://goo.gl/hcZgG4",,,,,[],https://twitter.com/SweetPlatform/status/885511292689104896
3391,TalkMarkets,@TalkMarkets,2017-07-13T15:05:38.000Z,5 #Pharma & #Biotech #Stocks That Could Be Big Winners In Q2 Earnings $MRK $GILD $LLY $CELG $SHPG https://goo.gl/k2Ykm7,5 #Pharma & #Biotech #Stocks That Could Be Big Winners In Q2 Earnings $MRK $GILD $LLY $CELG $SHPG https://goo.gl/k2Ykm7,,,,,[],https://twitter.com/TalkMarkets/status/885515567721050112
3392,EdisonHealthcare,@EdisonHealth,2017-07-13T12:34:27.000Z,"Aduro receives $2m Milestone from 
@Merck
 for Development of Anti-CD27 Antibody for the Treatment of Cancer $ADRO $MRK","Aduro receives $2m Milestone from 
@Merck
 for Development of Anti-CD27 Antibody for the Treatment of Cancer $ADRO $MRK
1
2",,,1,2,[],https://twitter.com/EdisonHealth/status/885477524033216512
3393,Mark Balson,@mark_balson,2017-07-14T14:02:33.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/mark_balson/status/885862079860756481
3394,Sweet Platform,@SweetPlatform,2017-07-14T14:48:35.000Z,"MRK Top news - Jul 14th, 2017 $MRK http://https://goo.gl/FVkfwm","MRK Top news - Jul 14th, 2017 $MRK http://https://goo.gl/FVkfwm",,,,,[],https://twitter.com/SweetPlatform/status/885873664675246080
3395,bake mcbride,@ITRADEVOL,2017-07-14T20:20:00.000Z,Buy Side Closing Order Imbalances $MCD $$WRK $LLY $MPC $DLR $MRK $ETP $CNX $HD $USB $VTR $KSS $MET $VNO $DD $HCN $SO https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,Buy Side Closing Order Imbalances $MCD $$WRK $LLY $MPC $DLR $MRK $ETP $CNX $HD $USB $VTR $KSS $MET $VNO $DD $HCN $SO https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/885957068657766400
3396,Limex,@LimexMe,2017-07-13T15:56:06.000Z,5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings http://bit.ly/2umFhxW $GILD $CELG $MRK $LLY,"5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings http://bit.ly/2umFhxW $GILD $CELG $MRK $LLY
whotrades.com
5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings
Drug stocks have bounced back this year with the NASDAQ Biotechnology Index and the NYSE ARCA Pharmaceutical Index gaining 18.6% and 10.8%, respectively, year-to-date (YTD). There‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/885528269940039680
3397,Limex,@LimexMe,2017-07-13T16:00:06.000Z,Lilly Settles Patent Litigation on Cialis with Generic Firms http://bit.ly/2sU5BeI $LLY $AZN $MRK $SNY,"Lilly Settles Patent Litigation on Cialis with Generic Firms http://bit.ly/2sU5BeI $LLY $AZN $MRK $SNY
whotrades.com
Lilly Settles Patent Litigation on Cialis with Generic Firms
Eli Lilly & Company LLY announced that it has entered into an agreement with generic companies to settle a patent related to its erectile dysfunction drug Cialis‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/885529277944516609
3398,Watchlist News,@WatchlistN,2017-07-14T08:18:27.000Z,"Merck & Company, Inc. $MRK Position Cut by State of New Jersey Common Pension Fund D http://ift.tt/2tQcDE5","Merck & Company, Inc. $MRK Position Cut by State of New Jersey Common Pension Fund D http://ift.tt/2tQcDE5",,,,,[],https://twitter.com/WatchlistN/status/885775484541444096
3399,Hottest Stocks Now,@HottestStockNow,2017-07-12T07:39:51.000Z,"Report Sees Adult Vaccines Market Reaching $20B by 2022 - $GSK, $MRK, $SNY, $PFE http://crweworld.com/newsroom/prnewswire?rkey=20170711IO38827&filter=10284‚Ä¶","Report Sees Adult Vaccines Market Reaching $20B by 2022 - $GSK, $MRK, $SNY, $PFE http://crweworld.com/newsroom/prnewswire?rkey=20170711IO38827&filter=10284‚Ä¶",,,,,[],https://twitter.com/HottestStockNow/status/885040995154448385
3400,Hottest Stocks Now,@HottestStockNow,2017-07-13T14:17:27.000Z,$ADRO Earns $2.0M milestone payment under its worldwide licensing deal with $MRK,"$ADRO Earns $2.0M milestone payment under its worldwide licensing deal with $MRK
crweworld.com
Aduro Announces Milestone Achieved Relating to Collaboration with Merck for Development of Anti-C...
BERKELEY, Calif., July 13, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the company has...",,,,,[],https://twitter.com/HottestStockNow/status/885503443724410881
3401,$peedyCalls,@SpeedyCalls,2017-07-12T19:48:32.000Z,"$MRK 65 Calls BUYING Activity expiring on 18th Aug, Vol 1554","$MRK 65 Calls BUYING Activity expiring on 18th Aug, Vol 1554
1
1",,,1,1,[],https://twitter.com/SpeedyCalls/status/885224374554513408
3402,MarketBeat,@MarketBeatCom,2017-07-12T12:13:56.000Z,"Strs Ohio Lowers Stake in Merck & Company, Inc. $MRK http://ift.tt/2t3a9TP","Strs Ohio Lowers Stake in Merck & Company, Inc. $MRK http://ift.tt/2t3a9TP",,,,,[],https://twitter.com/MarketBeatCom/status/885109972497043456
3403,Buy Cryptocurrency,@cryptosbuy,2017-07-13T23:51:27.000Z,on watch $MRK http://tradingview.com/chart/MRK/L9xukLSn-on-watch/‚Ä¶ TV_TradingIdeas,"on watch $MRK http://tradingview.com/chart/MRK/L9xukLSn-on-watch/‚Ä¶ TV_TradingIdeas
tradingview.com
on watch for NYSE:MRK by VC_Trader
.",,,,,['https://pbs.twimg.com/card_img/1501989468420509697/oxQax47e?format=png&name=small'],https://twitter.com/cryptosbuy/status/885647897429237761
3404,Dakota Financial,@dakotafinancial,2017-07-12T12:05:44.000Z,"Strs Ohio Lowers Stake in Merck & Company, Inc. $MRK http://ift.tt/2t3a9TP","Strs Ohio Lowers Stake in Merck & Company, Inc. $MRK http://ift.tt/2t3a9TP",,,,,[],https://twitter.com/dakotafinancial/status/885107910120001536
3405,Dakota Financial,@dakotafinancial,2017-07-13T15:24:14.000Z,"Parsec Financial Management Inc. Sells 2,837 Shares of Merck & Company, Inc. $MRK http://ift.tt/2umXtHS","Parsec Financial Management Inc. Sells 2,837 Shares of Merck & Company, Inc. $MRK http://ift.tt/2umXtHS",,,,,[],https://twitter.com/dakotafinancial/status/885520250137194500
3406,Watchlist News,@WatchlistN,2017-07-12T21:33:35.000Z,"Merck & Company, Inc. $MRK Lowered to ‚ÄúSell‚Äù at BidaskClub http://ift.tt/2uSDyO4","Merck & Company, Inc. $MRK Lowered to ‚ÄúSell‚Äù at BidaskClub http://ift.tt/2uSDyO4",,,,,[],https://twitter.com/WatchlistN/status/885250813953703936
3407,Watchlist News,@WatchlistN,2017-07-13T03:08:08.000Z,"$0.87 EPS Expected for Merck & Company, Inc. $MRK This Quarter http://ift.tt/2sSslvy","$0.87 EPS Expected for Merck & Company, Inc. $MRK This Quarter http://ift.tt/2sSslvy",,,,,[],https://twitter.com/WatchlistN/status/885335003105812480
3408,Market Realist,@MarketRealist,2017-07-14T14:14:52.000Z,What to Expect from Johnson &amp; Johnson‚Äôs 2Q17 Earnings http://marketrealist.com/?p=2202034 $JNJ $XLV $GILD $MRK,What to Expect from Johnson &amp; Johnson‚Äôs 2Q17 Earnings http://marketrealist.com/?p=2202034 $JNJ $XLV $GILD $MRK,,,,,[],https://twitter.com/MarketRealist/status/885865180982325249
3409,US Banking News,@AmericanBanking,2017-07-13T12:34:27.000Z,"Merck & Company, Inc. $MRK Expected to Post Q2 2017 Earnings of $0.86 Per Share http://ift.tt/2vg82bX","Merck & Company, Inc. $MRK Expected to Post Q2 2017 Earnings of $0.86 Per Share http://ift.tt/2vg82bX",,,,,[],https://twitter.com/AmericanBanking/status/885477524289007618
3410,US Banking News,@AmericanBanking,2017-07-14T20:04:48.000Z,"Jefferies Group Weighs in on Merck & Company, Inc.‚Äôs FY2020 Earnings $MRK http://ift.tt/2v0BUdl","Jefferies Group Weighs in on Merck & Company, Inc.‚Äôs FY2020 Earnings $MRK http://ift.tt/2v0BUdl",,,,,[],https://twitter.com/AmericanBanking/status/885953244270297088
3411,TalkMarkets,@TalkMarkets,2017-07-13T20:58:46.000Z,5 Drug Stocks Well Poised to Beat Q2 Earnings Estimates $MRK $SGEN $VNDA $CELG $GILD https://goo.gl/Ftr8Qy,5 Drug Stocks Well Poised to Beat Q2 Earnings Estimates $MRK $SGEN $VNDA $CELG $GILD https://goo.gl/Ftr8Qy,,,,,[],https://twitter.com/TalkMarkets/status/885604436634107905
3412,Allison Gatlin,@IBD_AGatlin,2017-07-14T19:03:02.000Z,AstraZeneca pops on report CEO won't just ship for Teva $AZN $TEVA $BMY $MRK,"AstraZeneca pops on report CEO won't just ship for Teva $AZN $TEVA $BMY $MRK
investors.com
AstraZeneca Pops On Report CEO Won't Jump Ship For Teva Pharma
AstraZeneca stock rallied Friday on reports CEO Pascal Soriot will remain on board, defying rumors he would leave to take the top job at Teva Pharmaceutical.",,,,,[],https://twitter.com/IBD_AGatlin/status/885937701932994560
3413,MarketBeat,@MarketBeatCom,2017-07-14T16:05:01.000Z,"Equities Analysts Issue Forecasts for Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2tnnL7R","Equities Analysts Issue Forecasts for Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2tnnL7R",,,,,[],https://twitter.com/MarketBeatCom/status/885892899895955457
3414,Allison Gatlin,@IBD_AGatlin,2017-07-14T19:06:18.000Z,Could Q2 surprise spike this beleaguered biotech's stock? $GILD $TSRO $INCY $CLVS $KITE $VRTX $AMGN $BIIB $MRK $BMY,"Could Q2 surprise spike this beleaguered biotech's stock? $GILD $TSRO $INCY $CLVS $KITE $VRTX $AMGN $BIIB $MRK $BMY
investors.com
Could Q2 Surprise Spike This Beleaguered Biotech's Stock?
A key hepatitis C drug from Gilead could top Wall Street's Q2 expectations, but investors want to hear more about potential M&A activity.
1
1",,,1,1,[],https://twitter.com/IBD_AGatlin/status/885938524264026113
3415,tanwarskis,@tanwar84,2017-07-14T00:57:46.000Z,"Replying to 
@sjwcpa
 and 
@JMVala_Trades","Replying to 
@sjwcpa
 and 
@JMVala_Trades
In $REGN & $MRK calls next week exp.
2",,,,2,[],https://twitter.com/tanwar84/status/885664583020670976
3416,JQ,@jq1234t,2017-07-14T22:05:01.000Z,"Replying to 
@bio_clouseau","Replying to 
@bio_clouseau
Other possibility: 8/9 ph3 $MRK $BMY combo with epacadostat are in 1st line, Roche had many ongoing combo with chemo/targeted therapy in 1L.
1
4",,1,,4,[],https://twitter.com/jq1234t/status/885983499492220929
3417,Clark Joseph Kent,@JorelLaraKalel,2017-07-13T16:52:31.000Z,"5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings http://bit.ly/2tNaMQt $LLY $GILD $CELG $MRK $SHPG 
@zacks","5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings http://bit.ly/2tNaMQt $LLY $GILD $CELG $MRK $SHPG 
@zacks",,,,,[],https://twitter.com/JorelLaraKalel/status/885542466451066882
3418,Binnur Aydogan Temel,@baydtemel,2017-07-15T09:25:34.000Z,Amgen Receives FDA Approval For BLINCYTO https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto?source=tweet‚Ä¶ $MRK $AMGN https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto‚Ä¶,"Amgen Receives FDA Approval For BLINCYTO https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto?source=tweet‚Ä¶ $MRK $AMGN https://seekingalpha.com/article/4087466-amgen-receives-fda-approval-blincyto‚Ä¶
seekingalpha.com
Amgen Receives FDA Approval For BLINCYTO (NASDAQ:AMGN)
BLINCYTO scores FDA approval for patients with relasped or refractory B-cell precursor acute lymphoblastic leukemia in adults and Children. Market potential for BLINCYTO will expand.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/baydtemel/status/886154764643336192
3419,Vista Partners LLC,@VistaPResearch,2017-07-17T10:22:50.000Z,Scared of #tech stocks? #Healthcare shares are rallying http://marketwatch.com/story/scared-of-tech-stocks-health-care-shares-are-cheaper-and-rallying-2017-07-12?siteid=yhoof2&yptr=yahoo‚Ä¶ $IBB $HIIQ $ATOS $UNH $MRK #invest http://vistapglobal.com,"Scared of #tech stocks? #Healthcare shares are rallying http://marketwatch.com/story/scared-of-tech-stocks-health-care-shares-are-cheaper-and-rallying-2017-07-12?siteid=yhoof2&yptr=yahoo‚Ä¶ $IBB $HIIQ $ATOS $UNH $MRK #invest http://vistapglobal.com
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DE7hVuHUQAAmHrU.jpg'],https://twitter.com/VistaPResearch/status/886893950027431936
3420,Seeking Alpha,@SeekingAlpha,2017-07-17T18:22:10.000Z,Betting On The CAR-T Race https://seekingalpha.com/article/4088181-betting-car-t-race?source=feed_f‚Ä¶ $BMY $JUNO $MRK $BGNE $BLUE $CELG $KITE $NVS,Betting On The CAR-T Race https://seekingalpha.com/article/4088181-betting-car-t-race?source=feed_f‚Ä¶ $BMY $JUNO $MRK $BGNE $BLUE $CELG $KITE $NVS,,,,,[],https://twitter.com/SeekingAlpha/status/887014579913465858
3421,Seeking Alpha,@SeekingAlpha,2017-07-17T19:55:50.000Z,Quintiles IMS: A Novel Way To Invest In Biopharma https://seekingalpha.com/article/4088218-quintiles-ims-novel-way-invest-biopharma?source=feed_f‚Ä¶ $ARNA $BMY $CVS $JNJ $LLY $MRK $OREX $PFE $VRTX $VVUS $WBA $Q,"Quintiles IMS: A Novel Way To Invest In Biopharma https://seekingalpha.com/article/4088218-quintiles-ims-novel-way-invest-biopharma?source=feed_f‚Ä¶ $ARNA $BMY $CVS $JNJ $LLY $MRK $OREX $PFE $VRTX $VVUS $WBA $Q
seekingalpha.com
Quintiles IMS: A Novel Way To Invest In Biopharma (NYSE:IQV)
Can investors ride the coat-tails of a successful Biotech/Pharma sector while mitigating inherent risks? How does Quintiles IMS Holdings help usher new drugs from research through clinical...",,,,,[],https://twitter.com/SeekingAlpha/status/887038152476475393
3422,ABetter Kayleigh McEnany,@MissElllly,2017-07-17T17:32:42.000Z,"$Spy $XLV $XBI $GILD $JNJ $MRK MORE uncertainty! #CBO report on health care bill not expected Monday 
@CNNPolitics","$Spy $XLV $XBI $GILD $JNJ $MRK MORE uncertainty! #CBO report on health care bill not expected Monday 
@CNNPolitics
cnn.com
Source: CBO report on health care bill not expected Monday | CNN Politics
The Congressional Budget Office is not expected to release its analysis of the revised Republican health care bill Monday, a Senate GOP aide tells CNN.
1",,,,1,[],https://twitter.com/MissElllly/status/887002130350972928
3423,Herkyleese,@herkyleese,2017-07-15T02:34:28.000Z,"Replying to 
@sentimentstock
 and 
@RichFairgrieve","Replying to 
@sentimentstock
 and 
@RichFairgrieve
PIG, you shorted at $.16?  Whap!!!   $nwbo $fgen $icpt $bmy $mrk $kite $fb $celg $gild $agio $blue $exel You could have at least done $juno
GIF
2
5",,,2,5,['https://pbs.twimg.com/tweet_video_thumb/DEvi9uGVoAAoew2.jpg'],https://twitter.com/herkyleese/status/886051309736022016
3424,Quantcha Trade Ideas,@QuantchaIdeas,2017-07-17T15:19:57.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/07/17/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-3/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/07/17/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-3/‚Ä¶,,,,,['https://pbs.twimg.com/media/DE8lWnrVoAEgbrP?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/886968724753960960
3425,Vista Partners LLC,@VistaPResearch,2017-07-17T18:45:22.000Z,"@VeganYogaDude
 tx for follow! See Vista Partners #Investingforlife #emergingGrowth #Healthcare http://vistapglobal.com $MRK $JNJ $ATOS $HIIQ","@VeganYogaDude
 tx for follow! See Vista Partners #Investingforlife #emergingGrowth #Healthcare http://vistapglobal.com $MRK $JNJ $ATOS $HIIQ
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DE9UXXxVwAACPhs.jpg'],https://twitter.com/VistaPResearch/status/887020418216869888
3426,Vista Partners LLC,@VistaPResearch,2017-07-17T22:01:08.000Z,"@AskTheEagle
 thanks for follow! See Vista Partners #InvestingForLife #Biotech #Tech http://vistapglobal.com $MMM $ATOS $IBB $MRK $DGLT","@AskTheEagle
 thanks for follow! See Vista Partners #InvestingForLife #Biotech #Tech http://vistapglobal.com $MMM $ATOS $IBB $MRK $DGLT
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DE-BKVhUQAAmlD3.jpg'],https://twitter.com/VistaPResearch/status/887069683739836417
3427,FiercePharma,@FiercePharma,2017-07-17T17:16:34.000Z,Merck's new Keytruda flat dose could add $1B each year to U.S. healthcare spending http://fiercepharma.com/pharma/keytruda-flat-dose-could-cost-extra-1b-each-year-for-u-s-healthcare-system-experts-say‚Ä¶ $MRK,"Merck's new Keytruda flat dose could add $1B each year to U.S. healthcare spending http://fiercepharma.com/pharma/keytruda-flat-dose-could-cost-extra-1b-each-year-for-u-s-healthcare-system-experts-say‚Ä¶ $MRK
fiercepharma.com
Merck's new Keytruda flat dose could add $1B each year to U.S. healthcare spending
While some drug price hikes in the hundreds or thousands of percentages appear to be purely about profit and generate plenty o | Merck & Co.'s move to introduce Keytruda as a flat-dose med in...
4
1",,,4,1,[],https://twitter.com/FiercePharma/status/886998070562623489
3428,jim rogers,@jollyaz,2017-07-17T20:13:54.000Z,$prtk Are you listening/watching $MRK,"$prtk Are you listening/watching $MRK
1
2
2",,1,2,2,[],https://twitter.com/jollyaz/status/887042697206300673
3429,The Stock Table,@thestocktable,2017-07-17T18:47:21.000Z,MERCK $MRK new cholesterol drug may hold huge impact on price of stock,MERCK $MRK new cholesterol drug may hold huge impact on price of stock,,,,,[],https://twitter.com/thestocktable/status/887020917834088449
3430,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-07-17T15:22:43.000Z,$MGNX posted Ph1 PD1xLAG3 bsp (MGD013) in Pts w/Unresectable or MetastaticNeoplasms $TSRO $INCY $BMY $MRK $NVS $PBMD,"$MGNX posted Ph1 PD1xLAG3 bsp (MGD013) in Pts w/Unresectable or MetastaticNeoplasms $TSRO $INCY $BMY $MRK $NVS $PBMD
clinicaltrials.gov
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms - Full Text View - Clinic...
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms - Full Text View.
1
4",,1,,4,['https://pbs.twimg.com/card_img/1499934075531907072/UYy6jAXC?format=png&name=240x240'],https://twitter.com/DrPaulyDeSantis/status/886969421897625600
3431,bake mcbride,@ITRADEVOL,2017-07-17T12:15:38.000Z,Fridays Buy Side Closing Order Imbalances $WRK $LLY $MPC $DLR $MRK $ETP $CNX $HD $USB $VTR $KSS $MET $VNO  $DD $HCN https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,"Fridays Buy Side Closing Order Imbalances $WRK $LLY $MPC $DLR $MRK $ETP $CNX $HD $USB $VTR $KSS $MET $VNO  $DD $HCN https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶
1",,,,1,[],https://twitter.com/ITRADEVOL/status/886922338788397057
3432,9/11 No Planer,@911NoPlaner,2017-07-16T11:30:49.000Z,"#Gardasil #Vaccine Injured Baby Medically Kidnapped From Mother http://yournewswire.com/gardasil-vaccine-baby-kidnapped/‚Ä¶ via 
@yournewswire
 #HPVvaccine #hpv #merck $mrk","#Gardasil #Vaccine Injured Baby Medically Kidnapped From Mother http://yournewswire.com/gardasil-vaccine-baby-kidnapped/‚Ä¶ via 
@yournewswire
 #HPVvaccine #hpv #merck $mrk
1",ü•∂,,,1,[],https://twitter.com/911NoPlaner/status/886548671499730945
3433,FinInvTr,@FinInvTr,2017-07-15T18:15:08.000Z,"Small Cancer #Biotech Space in Focus, 3 #Stocks Up 100%+ - http://buff.ly/2tWJ7ej 

$AMGN $CELG $INCY $PFE $MRK $PBYI $BLUE $KITE $CLVS","Small Cancer #Biotech Space in Focus, 3 #Stocks Up 100%+ - http://buff.ly/2tWJ7ej 

$AMGN $CELG $INCY $PFE $MRK $PBYI $BLUE $KITE $CLVS",,,,,[],https://twitter.com/FinInvTr/status/886288032407662592
3434,Beverly A. Pekala,@PekalaLaw,2017-07-16T13:02:10.000Z,Chicago now requires pharma reps to be licensed. $750 yr fee. #ChaChing #twill $GSK $MRK $PFE $NVS $ABBV #stocks,"Chicago now requires pharma reps to be licensed. $750 yr fee. #ChaChing #twill $GSK $MRK $PFE $NVS $ABBV #stocks
dnainfo.com
Pharmaceutical Reps Must Get Licensed To Work In Chicago Now
The $750-a-year license is part of an effort to curb an epidemic of heroin and opiate deaths.
1
1",,1,1,,[],https://twitter.com/PekalaLaw/status/886571660777836545
3435,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-07-17T19:09:57.000Z,Commented on Betting On The CAR-T Race https://seekingalpha.com/article/4088181-betting-car-t-race?source=tweet‚Ä¶ $BMY $JUNO $MRK $BGNE $BLUE $CELG $KITE $NVS,"Commented on Betting On The CAR-T Race https://seekingalpha.com/article/4088181-betting-car-t-race?source=tweet‚Ä¶ $BMY $JUNO $MRK $BGNE $BLUE $CELG $KITE $NVS
seekingalpha.com
Betting On The CAR-T Race (NASDAQ:CELG)
CAR-T dominance is not dependent on being first. More operational challenges/competitive advantages to consider in this next generation of immuno-oncology therapy.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/dhovekamp42/status/887026606635491328
3436,tbirdman,@ChickenReaper,2017-07-17T12:56:32.000Z,$MRLA - Israeli #skincancer detention #appstock at all time lows / may be worth a flyer here with $MRK partnership and patents pending,"$MRLA - Israeli #skincancer detention #appstock at all time lows / may be worth a flyer here with $MRK partnership and patents pending
1",,,1,,[],https://twitter.com/ChickenReaper/status/886932633485103104
3437,Limex,@LimexMe,2017-07-17T15:58:16.000Z,Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA http://bit.ly/170717AMGN $AMGN $CELG $MRK,"Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA http://bit.ly/170717AMGN $AMGN $CELG $MRK
whotrades.com
Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA
Amgen Inc. AMGN and partner UCB SA UCBJF announced that the FDA has issued a complete response letter (CRL) for the biologics license application (BLA) for Evenity‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/886978367815376896
3438,1 min Stock Insights,@1MinuteStock,2017-07-16T18:06:02.000Z,We calculated 63-day Expected Return of $MRK for you: 1.71%,"We calculated 63-day Expected Return of $MRK for you: 1.71%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/886648131638575104
3439,Watchlist News,@WatchlistN,2017-07-17T19:39:50.000Z,"Merck & Company, Inc. $MRK Shares Sold by Cape Cod Five Cents Savings Bank http://ift.tt/2u2wZtJ","Merck & Company, Inc. $MRK Shares Sold by Cape Cod Five Cents Savings Bank http://ift.tt/2u2wZtJ",,,,,[],https://twitter.com/WatchlistN/status/887034125974208514
3440,Watchlist News,@WatchlistN,2017-07-16T08:34:22.000Z,"Leavell Investment Management Inc. Buys 1,459 Shares of Merck & Company, Inc. $MRK http://ift.tt/2ttAQwi","Leavell Investment Management Inc. Buys 1,459 Shares of Merck & Company, Inc. $MRK http://ift.tt/2ttAQwi",,,,,[],https://twitter.com/WatchlistN/status/886504269079343105
3441,FinInvTr,@FinInvTr,2017-07-16T07:07:03.000Z,"10 Top Holdings In Market's Best #Healthcare Fund  http://buff.ly/2tWxu8A

$JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD #stocks","10 Top Holdings In Market's Best #Healthcare Fund  http://buff.ly/2tWxu8A

$JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD #stocks",,,,,[],https://twitter.com/FinInvTr/status/886482292079812608
3442,Tim Reller,@TraderGuruNY,2017-07-17T16:21:16.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/886984156206510080
3443,Ticker Report,@TickerReport,2017-07-16T08:31:00.000Z,"First Midwest Bank Trust Division Purchases 153 Shares of Merck & Company, Inc. $MRK http://ift.tt/2uwDarl","First Midwest Bank Trust Division Purchases 153 Shares of Merck & Company, Inc. $MRK http://ift.tt/2uwDarl",,,,,[],https://twitter.com/TickerReport/status/886503419724345344
3444,ThinkingProfit.com,@TPCMG,2017-07-17T21:14:18.000Z,"$MRK: 3 open, suited signals indicate continued price decrease beyond average holding times. http://thinkingprofit.com/equity/?s=MRK","$MRK: 3 open, suited signals indicate continued price decrease beyond average holding times. http://thinkingprofit.com/equity/?s=MRK",,,,,[],https://twitter.com/TPCMG/status/887057900480454656
3445,Daily Political,@dailypoliticaln,2017-07-15T08:12:36.000Z,"Jefferies Group Weighs in on Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2t1rN6k","Jefferies Group Weighs in on Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2t1rN6k",,,,,[],https://twitter.com/dailypoliticaln/status/886136402001440768
3446,TradingView Ideas,@TradingViewAlt,2017-07-16T10:05:19.000Z,Big Pharma MERCK & CO in SERIOUS TROUBLE ! $MRK http://tradingview.com/chart/MRK/XlalmQw2-Big-Pharma-MERCK-CO-in-SERIOUS-TROUBLE/‚Ä¶,Big Pharma MERCK & CO in SERIOUS TROUBLE ! $MRK http://tradingview.com/chart/MRK/XlalmQw2-Big-Pharma-MERCK-CO-in-SERIOUS-TROUBLE/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/886527155395477504
3447,Daily Political,@dailypoliticaln,2017-07-15T08:22:21.000Z,"Rand Wealth LLC Has $277,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2tTNY1w","Rand Wealth LLC Has $277,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2tTNY1w",,,,,[],https://twitter.com/dailypoliticaln/status/886138854721429504
3448,Watchlist News,@WatchlistN,2017-07-17T08:24:48.000Z,"Schmidt P J Investment Management Inc. Decreases Position in Merck & Company, Inc. $MRK http://ift.tt/2twa1aQ","Schmidt P J Investment Management Inc. Decreases Position in Merck & Company, Inc. $MRK http://ift.tt/2twa1aQ",,,,,[],https://twitter.com/WatchlistN/status/886864248747565056
3449,Ticker Report,@TickerReport,2017-07-15T14:35:52.000Z,"Jefferies Group Analysts Decrease Earnings Estimates for Merck & Company, Inc. $MRK http://ift.tt/2vo4HaX","Jefferies Group Analysts Decrease Earnings Estimates for Merck & Company, Inc. $MRK http://ift.tt/2vo4HaX",,,,,[],https://twitter.com/TickerReport/status/886232855373860865
3450,Eric Sagonowsky,@EricSFierce,2017-07-17T17:16:34.000Z,Merck's new Keytruda flat dose could add $1B each year to U.S. healthcare spending http://fiercepharma.com/pharma/keytruda-flat-dose-could-cost-extra-1b-each-year-for-u-s-healthcare-system-experts-say‚Ä¶ $MRK,"Merck's new Keytruda flat dose could add $1B each year to U.S. healthcare spending http://fiercepharma.com/pharma/keytruda-flat-dose-could-cost-extra-1b-each-year-for-u-s-healthcare-system-experts-say‚Ä¶ $MRK
1",,,,1,[],https://twitter.com/EricSFierce/status/886998070424154112
3451,InTheMoneyStocks.com,@ITMS,2017-07-17T15:42:44.000Z,Stalking The Institutional Trade Level...  http://bit.ly/MRKLevel  $MRK,Stalking The Institutional Trade Level...  http://bit.ly/MRKLevel  $MRK,,,,,[],https://twitter.com/ITMS/status/886974458304581634
3452,MarketBeat,@MarketBeatCom,2017-07-16T16:55:27.000Z,Merck & Company $MRK Receives News Impact Rating of 0.19 http://ift.tt/2unG4i0,Merck & Company $MRK Receives News Impact Rating of 0.19 http://ift.tt/2unG4i0,,,,,[],https://twitter.com/MarketBeatCom/status/886630368295735296
3453,MarketBeat,@MarketBeatCom,2017-07-16T11:29:52.000Z,"Merck & Company, Inc. $MRK Stake Raised by IFP Advisors Inc http://ift.tt/2unUzlQ","Merck & Company, Inc. $MRK Stake Raised by IFP Advisors Inc http://ift.tt/2unUzlQ",,,,,[],https://twitter.com/MarketBeatCom/status/886548432776830976
3454,Insider Monkey,@insidermonkey,2017-07-17T19:50:13.000Z,"Top 75 Healthcare #Dividend Stocks To Invest In
$AGN $MRK $PFE $GILD $UNH $JNJ $BMY $ABBV $AMGN $ANTM $CI $AET $MCK","Top 75 Healthcare #Dividend Stocks To Invest In
$AGN $MRK $PFE $GILD $UNH $JNJ $BMY $ABBV $AMGN $ANTM $CI $AET $MCK
insidermonkey.com
Top 75 Healthcare Dividend Stocks To Invest In
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.",,,,,[],https://twitter.com/insidermonkey/status/887036737515659264
3455,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-07-17T18:45:45.000Z,"Replying to 
@doritmi
 @DocMeehan
  and 36 others","Replying to 
@doritmi
 @DocMeehan
  and 36 others
Drug-funded, trust fund baby 
@doritmi
 runs cover for her bank accnt! Japan rejects $MRK MMR shot for encephalitis/ autism adverse effects 
3
1
1",ü§¢,3,1,1,[],https://twitter.com/ZimJay/status/887020513121447937
3456,US Banking News,@AmericanBanking,2017-07-15T11:19:13.000Z,Investors Purchase High Volume of Merck & Company Call Options $MRK http://ift.tt/2vnFrl9,Investors Purchase High Volume of Merck & Company Call Options $MRK http://ift.tt/2vnFrl9,,,,,[],https://twitter.com/AmericanBanking/status/886183363547209728
3457,MarketBeat,@MarketBeatCom,2017-07-15T19:04:13.000Z,"Merck & Company, Inc. $MRK Receives $68.00 Consensus Target Price from Analysts http://ift.tt/2ulGaq0","Merck & Company, Inc. $MRK Receives $68.00 Consensus Target Price from Analysts http://ift.tt/2ulGaq0",,,,,[],https://twitter.com/MarketBeatCom/status/886300385320816640
3458,cowenresearch,@CowenResearch,2017-07-17T10:13:29.000Z,Steve Scala previews 2Q17 #pharma. Sees sector EPS +5% & revenue +2%. $ABBV $BMY $LLY $JNJ $MRK $PFE $AZN $GSK $NVS $SNY $RHHBY $ZTS,Steve Scala previews 2Q17 #pharma. Sees sector EPS +5% & revenue +2%. $ABBV $BMY $LLY $JNJ $MRK $PFE $AZN $GSK $NVS $SNY $RHHBY $ZTS,,,,,[],https://twitter.com/CowenResearch/status/886891598499516418
3459,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-07-17T23:33:13.000Z,"Replying to 
@EmmaGPaley","Replying to 
@EmmaGPaley
Scientists Sue $MRK Merck: allege fraud, mislabeling, and **false certification of #MMR #Vaccine. ** 
http://vaccinationcouncil.org/2012/06/25/scientists-sue-merck-allege-fraud-mislabeling-and-false-certificaion-of-mmr-vaccine-suzanne-humphries-md/‚Ä¶
1",ü§¢,1,,,[],https://twitter.com/ZimJay/status/887092857592590337
3460,Buy Cryptocurrency,@cryptosbuy,2017-07-16T10:08:18.000Z,Big Pharma MERCK & CO in SERIOUS TROUBLE ! $MRK http://tradingview.com/chart/MRK/XlalmQw2-Big-Pharma-MERCK-CO-in-SERIOUS-TROUBLE/‚Ä¶ TV_TradingIdeas,Big Pharma MERCK & CO in SERIOUS TROUBLE ! $MRK http://tradingview.com/chart/MRK/XlalmQw2-Big-Pharma-MERCK-CO-in-SERIOUS-TROUBLE/‚Ä¶ TV_TradingIdeas,,,,,[],https://twitter.com/cryptosbuy/status/886527907417530373
3461,Daily Political,@dailypoliticaln,2017-07-16T08:30:45.000Z,"Merck & Company, Inc. $MRK Stake Raised by IFP Advisors Inc http://ift.tt/2uwObZM","Merck & Company, Inc. $MRK Stake Raised by IFP Advisors Inc http://ift.tt/2uwObZM",,,,,[],https://twitter.com/dailypoliticaln/status/886503358164602881
3462,Dakota Financial,@dakotafinancial,2017-07-17T11:56:21.000Z,"Schmidt P J Investment Management Inc. Decreases Position in Merck & Company, Inc. $MRK http://ift.tt/2u1gfl4","Schmidt P J Investment Management Inc. Decreases Position in Merck & Company, Inc. $MRK http://ift.tt/2u1gfl4",,,,,[],https://twitter.com/dakotafinancial/status/886917485609529344
3463,Benzinga,@Benzinga,2017-07-17T15:15:01.000Z,5 Biggest Price Target Changes For Monday https://benzinga.com/z/9783412 $C $MRK $MSFT $RH $NFLX,"5 Biggest Price Target Changes For Monday https://benzinga.com/z/9783412 $C $MRK $MSFT $RH $NFLX
benzinga.com
5 Biggest Price Target Changes For Monday
Deutsche Bank raised Merck & Co., Inc. (NYSE: MRK) price target from $64 to $66. Merck shares closed at $63.06 on Friday. Credit Suisse boosted the price target for...",,,,,['https://pbs.twimg.com/card_img/1499875349303205890/mxn4g2w2?format=png&name=240x240'],https://twitter.com/Benzinga/status/886967480480026624
3464,Sarah Owermohle,@owermohle,2017-07-17T16:08:23.000Z,New drugs steer earnings: here's what to expect in the upcoming Q2'17 calls $AMGN $GILD $PFE $JNJ $BMY $MRK $ROG  http://bit.ly/2vu6cnZ,New drugs steer earnings: here's what to expect in the upcoming Q2'17 calls $AMGN $GILD $PFE $JNJ $BMY $MRK $ROG  http://bit.ly/2vu6cnZ,,,,,[],https://twitter.com/owermohle/status/886980911639785472
3465,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-07-17T17:51:14.000Z,"Replying to 
@RenoHemonc","Replying to 
@RenoHemonc
All the ones tagged on the first tweet are the ones I know of + $MRK",,,,,[],https://twitter.com/DrPaulyDeSantis/status/887006796476432384
3466,JQ,@jq1234t,2017-07-15T05:25:47.000Z,"Replying to 
@Miljenkoz
 and 
@bio_clouseau","Replying to 
@Miljenkoz
 and 
@bio_clouseau
My alternative explanation exactly pointed to ""Roche know business"". 9 ph3 combo trials announced by $INCY $MRK $BMY so far.
1
1",,1,,1,[],https://twitter.com/jq1234t/status/886094420596097024
3467,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-07-17T22:46:30.000Z,"Replying to 
@EmmaGPaley
 @doritmi
  and 36 others","Replying to 
@EmmaGPaley
 @doritmi
  and 36 others
Japan stopped $MRK 's sketchy mmr #vaccine bc of side effects like brain infections - Many studies link encephalitis w/ the onset of autism.
2",,2,,,[],https://twitter.com/ZimJay/status/887081102678085632
3468,Dakota Financial,@dakotafinancial,2017-07-16T11:33:26.000Z,"Merck & Company, Inc. $MRK Stake Raised by IFP Advisors Inc http://ift.tt/2unUzlQ","Merck & Company, Inc. $MRK Stake Raised by IFP Advisors Inc http://ift.tt/2unUzlQ
1",,,1,,[],https://twitter.com/dakotafinancial/status/886549332429860864
3469,Jonathan Rockoff,@jonathanrockoff,2017-07-19T18:46:34.000Z,Leerink's Fernandez says $MRK's Keytruda's gains against $BMY's Opdivo are accelerating,"Leerink's Fernandez says $MRK's Keytruda's gains against $BMY's Opdivo are accelerating
9
7",,,9,7,['https://pbs.twimg.com/media/DFHnsDEUIAAixQR?format=jpg&name=small'],https://twitter.com/jonathanrockoff/status/887745495476703233
3470,Vista Partners LLC,@VistaPResearch,2017-07-18T18:51:56.000Z,Merck Announces Presentations of Clinical & Real-World Data at The #Alzheimers Association https://finance.yahoo.com/news/merck-announces-presentations-clinical-real-110000268.html?soc_src=social-sh&soc_trk=tw‚Ä¶ $MRK $IBB $DIA #biotech,"Merck Announces Presentations of Clinical & Real-World Data at The #Alzheimers Association https://finance.yahoo.com/news/merck-announces-presentations-clinical-real-110000268.html?soc_src=social-sh&soc_trk=tw‚Ä¶ $MRK $IBB $DIA #biotech
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DFCfdDHV0AE_qCy.jpg'],https://twitter.com/VistaPResearch/status/887384457572786176
3471,pharmalot,@pharmalot,2017-07-20T10:44:18.000Z,Should drug makers be banned from buying back stock? A contentious notion. Take our reader poll.. https://statnews.com/pharmalot/2017/07/19/buybacks-shareholders-research/‚Ä¶ #pharma $GILD $MRK,"Should drug makers be banned from buying back stock? A contentious notion. Take our reader poll.. https://statnews.com/pharmalot/2017/07/19/buybacks-shareholders-research/‚Ä¶ #pharma $GILD $MRK
statnews.com
Should drug makers be banned from buying back stock? Take our reader poll
A new analysis finds many drug makers spent more on buying back stock and paying dividends than on research and development.
2",,,,2,[],https://twitter.com/pharmalot/status/887986517704048641
3472,FiercePharma,@FiercePharma,2017-07-19T14:15:00.000Z,$MRK sifts ideas for turning Alexa into a diabetes aide,"$MRK sifts ideas for turning Alexa into a diabetes aide
fiercepharma.com
'Alexa, help manage my diabetes.' That's what Merck and its contest finalists envision for the...
What can Amazon Alexa can do for people with diabetes? | What can Alexa do for diabetes patients? A virtual coach might sense a patient's mood. An AI platform could detect risky behavior. Or the...
6
4",,,6,4,['https://pbs.twimg.com/card_img/1499130153011752962/Nty8iSqG?format=jpg&name=small'],https://twitter.com/FiercePharma/status/887677155684962306
3473,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-07-18T09:08:37.000Z,"Jefferies New $GILD, $GSK, $MRK HIV data next week at #IAS17 Conf...**DOC CALL on Wednesday**","Jefferies New $GILD, $GSK, $MRK HIV data next week at #IAS17 Conf...**DOC CALL on Wednesday**
2
3",üÖ± üÖæ,,2,3,[],https://twitter.com/_B_I_O_T_E_C_H_/status/887237663304159232
3474,Jack Allen,@JohnK_Allen,2017-07-20T20:16:38.000Z,"$AZN MYSTIC results were due mid year last I head, could it be a Friday announcement tomorrow (implying poor results)?

$BMY $MRK $PFE","$AZN MYSTIC results were due mid year last I head, could it be a Friday announcement tomorrow (implying poor results)?

$BMY $MRK $PFE
Yes and poor results
50%
Yes, but good results
20%
No
30%
40 votes
¬∑
Final results
1
1",,1,1,,[],https://twitter.com/JohnK_Allen/status/888130550573154304
3475,tobias hildebrandt,@timeout2575,2017-07-18T16:54:08.000Z,BREAKING: $MRK is going to buy $prtk ;) ... like that?,"BREAKING: $MRK is going to buy $prtk ;) ... like that?
1
3",,1,,3,[],https://twitter.com/timeout2575/status/887354813557747712
3476,jim rogers,@jollyaz,2017-07-18T11:56:25.000Z,$prtk It's time $MRK...start accumulating in big blocks!,"$prtk It's time $MRK...start accumulating in big blocks!
1",,,,1,[],https://twitter.com/jollyaz/status/887279891003125761
3477,Drugdoctor1,@Drugdoctor2014,2017-07-19T15:46:49.000Z,$LVVV.0035-LIVEWIRE-ON FIRE! - MMJ STOCK NEWS-HOT CBD CREAM $KSHB $LAGBF $LXRP $MPEFF $MSRT  $BUDZ $VAPI $MRK $MYL,"$LVVV.0035-LIVEWIRE-ON FIRE! - MMJ STOCK NEWS-HOT CBD CREAM $KSHB $LAGBF $LXRP $MPEFF $MSRT  $BUDZ $VAPI $MRK $MYL
youtube.com
LiveWire Topical Lotion Development
LiveWire Ergogenics Product development: CBD lotion with Olive Oil, Jojoba Oil and Vitamin E. One of the samples contains all of the above plus Capsaicin pow...
3",,,,3,['https://pbs.twimg.com/card_img/1501988916894699524/nOeILLMI?format=jpg&name=240x240'],https://twitter.com/Drugdoctor2014/status/887700259182452737
3478,WLST.com,@wlstcom,2017-07-18T11:58:49.000Z,Nasdaq posts 7-day win streak ahead of key earnings due this week $MRK http://wlst.com,"Nasdaq posts 7-day win streak ahead of key earnings due this week $MRK http://wlst.com
finance.yahoo.com
Nasdaq posts 7-day win streak ahead of key earnings due this week
Investing.com ‚Äì U.S. stocks closed roughly flat on Monday, as investors looked ahead to a raft of corporate earnings reports slated for later this week.",,,,,['https://pbs.twimg.com/card_img/1500327801228046337/mkG_xSeN?format=jpg&name=small'],https://twitter.com/wlstcom/status/887280492881612800
3479,AustinBizJournal,@MyABJ,2017-07-18T17:05:03.000Z,"With $6M state grant secured, 
@Merck
 $MRK moves ahead with IT hub in Austin http://bizj.us/1p8wln ","With $6M state grant secured, 
@Merck
 $MRK moves ahead with IT hub in Austin http://bizj.us/1p8wln 
1
2
3",üîí,1,2,3,[],https://twitter.com/MyABJ/status/887357560952586240
3480,FinInvTr,@FinInvTr,2017-07-19T04:57:06.000Z,"Market's Top Large/Mid Cap Fund Up 14% In Past Year http://buff.ly/2tEoKAE

$VZ $PM $CMCSA $UNH $MRK $V $KO $PEP $DIS $INTC $CSCO $ORCL $MO","Market's Top Large/Mid Cap Fund Up 14% In Past Year http://buff.ly/2tEoKAE

$VZ $PM $CMCSA $UNH $MRK $V $KO $PEP $DIS $INTC $CSCO $ORCL $MO
whotrades.com
Large/Mid Cap Fund Makes Another All-Time High ‚Äì Overvalued Or More To Come?
US large and mid caps keep making all-time highs as earnings growth improves even while liquidity is taken away gradually in the US economy. It is generally taken that small cap stocks‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1500352070825570306/61rgPd0e?format=jpg&name=small'],https://twitter.com/FinInvTr/status/887536753594302465
3481,BioPharma Dive,@BioPharmaDive,2017-07-20T17:06:00.000Z,"What do we know about the amyloid theory for Alzheimer's?
 http://bit.ly/2tjto7O $LLY $BIIB $AZN $RHHBY $MRK $JNJ","What do we know about the amyloid theory for Alzheimer's?
 http://bit.ly/2tjto7O $LLY $BIIB $AZN $RHHBY $MRK $JNJ
biopharmadive.com
What do we know about the amyloid theory for Alzheimer's?
A growing knowledge of the science behind the disease is allowing researchers to better test potential therapies.
1",,,,1,[],https://twitter.com/BioPharmaDive/status/888082577055039488
3482,BioPharma Dive,@BioPharmaDive,2017-07-19T23:50:01.000Z,Here are the biggest factors weighing on the drugmakers targeting Alzheimer's disease http://bit.ly/2vjjXqx $AGN $BIIB $LLY $MRK,"Here are the biggest factors weighing on the drugmakers targeting Alzheimer's disease http://bit.ly/2vjjXqx $AGN $BIIB $LLY $MRK
1
2",,,1,2,[],https://twitter.com/BioPharmaDive/status/887821860800475137
3483,Drug Delivery Business News,@DrugDeliveryNow,2017-07-20T15:00:54.000Z,Lawsuit stalls approval of Merck‚Äôs #insulin injection. $MRK,"Lawsuit stalls approval of Merck‚Äôs #insulin injection. $MRK
drugdeliverybusiness.com
Lawsuit stalls approval of Merck‚Äôs insulin injection
Merck (NYSE:MRK) said today that the FDA granted tentative approval for its Lusduna Nexvue insulin glargine injection. The biologic basal insulin met regulatory standards, the company said, but a...
1",,,1,,[],https://twitter.com/DrugDeliveryNow/status/888051093154004995
3484,Pharmaceutical News,@pharma_sector,2017-07-20T22:51:08.000Z,Corning Incorporated : #Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutica... Read more: http://owler.us/ac4dBh $MRK,Corning Incorporated : #Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutica... Read more: http://owler.us/ac4dBh $MRK,,,,,[],https://twitter.com/pharma_sector/status/888169430349357056
3485,Breaking News,@MarketCurrents,2017-07-20T20:06:11.000Z,Big Pharma and Corning lead initiative to manufacture pharmaceutical glass in U.S. https://seekingalpha.com/news/3280019-big-pharma-corning-lead-initiative-manufacture-pharmaceutical-glass-u-s?source=feed_f‚Ä¶ $MRK $PFE $GLW,Big Pharma and Corning lead initiative to manufacture pharmaceutical glass in U.S. https://seekingalpha.com/news/3280019-big-pharma-corning-lead-initiative-manufacture-pharmaceutical-glass-u-s?source=feed_f‚Ä¶ $MRK $PFE $GLW,,,,,[],https://twitter.com/MarketCurrents/status/888127920555741185
3486,Jacob Bell,@realJacobBell,2017-07-20T17:06:01.000Z,"What do we know about the amyloid theory for Alzheimer's?
 http://bit.ly/2tjto7O $LLY $BIIB $AZN $RHHBY $MRK $JNJ","What do we know about the amyloid theory for Alzheimer's?
 http://bit.ly/2tjto7O $LLY $BIIB $AZN $RHHBY $MRK $JNJ
biopharmadive.com
What do we know about the amyloid theory for Alzheimer's?
A growing knowledge of the science behind the disease is allowing researchers to better test potential therapies.
1",,,1,,['https://pbs.twimg.com/card_img/1501989716425510944/L7zznzOn?format=jpg&name=small'],https://twitter.com/realJacobBell/status/888082578774872064
3487,Tim Reller,@TraderGuruNY,2017-07-20T00:44:49.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/887835651185532928
3488,kyookine,@kyookine,2017-07-20T22:58:48.000Z,Gilead Has Another Ace Up Its Sleeve https://seekingalpha.com/article/4089210-gilead-another-ace-sleeve?source=tweet‚Ä¶ $ABBV $MRK $GILD,"Gilead Has Another Ace Up Its Sleeve https://seekingalpha.com/article/4089210-gilead-another-ace-sleeve?source=tweet‚Ä¶ $ABBV $MRK $GILD
seekingalpha.com
Gilead Has Another Ace Up Its Sleeve (NASDAQ:GILD)
Approval of Vosevi should help the company produce more sales in Hep C space. Two phase 3 studies show that Vosevi can be a contender.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/kyookine/status/888171358856691712
3489,Pharmaceutical News,@pharma_sector,2017-07-20T22:50:31.000Z,#Merck and : Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging. Read more: http://owler.us/ac4dBj $MRK,#Merck and : Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging. Read more: http://owler.us/ac4dBj $MRK,,,,,[],https://twitter.com/pharma_sector/status/888169274484727808
3490,TalkMarkets,@TalkMarkets,2017-07-20T17:59:47.000Z,"Credit Suisse Cuts #Pfizer To Hold, Prefers Merck, J&J $PFE Also $JNJ $MRK https://goo.gl/DcZyTL","Credit Suisse Cuts #Pfizer To Hold, Prefers Merck, J&J $PFE Also $JNJ $MRK https://goo.gl/DcZyTL",,,,,[],https://twitter.com/TalkMarkets/status/888096109255680002
3491,Zero Filter,@zerofiltertruth,2017-07-18T18:58:38.000Z,"We're happy with $DRRX recovery but be thrilled when pierces $3 or if $NVS outright buys during collaboration 

$CELG $MRK $AMGN $SHPG $BIIB","We're happy with $DRRX recovery but be thrilled when pierces $3 or if $NVS outright buys during collaboration 

$CELG $MRK $AMGN $SHPG $BIIB",,,,,[],https://twitter.com/zerofiltertruth/status/887386144220086274
3492,McGriddle Connoisseur,@CloisterRes,2017-07-19T12:03:05.000Z,"Folks, after what I've heard about  pharma ($mrk $pfe $nvs) I wouldn't invest in any. Particularly $MRK. Horror stories abound at this conf","Folks, after what I've heard about  pharma ($mrk $pfe $nvs) I wouldn't invest in any. Particularly $MRK. Horror stories abound at this conf
2",,2,,,[],https://twitter.com/CloisterRes/status/887643955936014337
3493,Watchlist News,@WatchlistN,2017-07-19T15:33:31.000Z,"Merck & Company, Inc. $MRK Stock Rating Reaffirmed by Deutsche Bank AG http://ift.tt/2tGTfpB","Merck & Company, Inc. $MRK Stock Rating Reaffirmed by Deutsche Bank AG http://ift.tt/2tGTfpB",,,,,[],https://twitter.com/WatchlistN/status/887696913772027909
3494,Daily Political,@dailypoliticaln,2017-07-19T13:43:58.000Z,"Norway Savings Bank Has $167,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2uzjAdR","Norway Savings Bank Has $167,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2uzjAdR",,,,,[],https://twitter.com/dailypoliticaln/status/887669343600955392
3495,Dakota Financial,@dakotafinancial,2017-07-20T21:54:45.000Z,"American National Insurance Co. TX Maintains Stake in Merck & Company, Inc. $MRK http://ift.tt/2ufaFf8","American National Insurance Co. TX Maintains Stake in Merck & Company, Inc. $MRK http://ift.tt/2ufaFf8",,,,,[],https://twitter.com/dakotafinancial/status/888155240587034624
3496,Watchlist News,@WatchlistN,2017-07-19T08:23:47.000Z,"Merck & Company, Inc. $MRK Shares Bought by Whittier Trust Co. of Nevada Inc. http://ift.tt/2uBAS9K","Merck & Company, Inc. $MRK Shares Bought by Whittier Trust Co. of Nevada Inc. http://ift.tt/2uBAS9K",,,,,[],https://twitter.com/WatchlistN/status/887588765895675905
3497,bake mcbride,@ITRADEVOL,2017-07-20T11:53:35.000Z,Early Press Releases $STBA $ONCE $PRIM $MNRO $SPH $ADS $AAXN $MRK $USAT $ARAY $INCY $VPG $DYN $PGR $AMT $RNST $BAC  https://marketchameleon.com/PressReleases,"Early Press Releases $STBA $ONCE $PRIM $MNRO $SPH $ADS $AAXN $MRK $USAT $ARAY $INCY $VPG $DYN $PGR $AMT $RNST $BAC  https://marketchameleon.com/PressReleases
1
1",,,1,1,[],https://twitter.com/ITRADEVOL/status/888003952868024320
3498,Ticker Report,@TickerReport,2017-07-20T12:05:30.000Z,"WealthTrust Axiom LLC Has $3.30 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2uCmAGk","WealthTrust Axiom LLC Has $3.30 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2uCmAGk",,,,,[],https://twitter.com/TickerReport/status/888006951975743490
3499,Watchlist News,@WatchlistN,2017-07-19T13:43:34.000Z,"Lowe Wealth Advisors LLC Has $141,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2tGiN6t","Lowe Wealth Advisors LLC Has $141,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2tGiN6t",,,,,[],https://twitter.com/WatchlistN/status/887669244628013056
3500,Ticker Report,@TickerReport,2017-07-20T11:57:20.000Z,"SunTrust Banks Comments on Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2vmXgBB","SunTrust Banks Comments on Merck & Company, Inc.‚Äôs Q2 2017 Earnings $MRK http://ift.tt/2vmXgBB",,,,,[],https://twitter.com/TickerReport/status/888004897731432448
3501,Stockboard Media Inc,@stockboardinc,2017-07-20T11:37:29.000Z,$MRK Merck Announces U.S. FDA Grants Tentative Approval for LUSDUNA‚Ñ¢ Nexvue‚Ñ¢ (insulin glargine inject... - http://sbml.co/3bcf2dfb,$MRK Merck Announces U.S. FDA Grants Tentative Approval for LUSDUNA‚Ñ¢ Nexvue‚Ñ¢ (insulin glargine inject... - http://sbml.co/3bcf2dfb,,,,,[],https://twitter.com/stockboardinc/status/887999903812784128
3502,Daily Political,@dailypoliticaln,2017-07-20T12:03:51.000Z,"Merck & Company, Inc. $MRK is NJ State Employees Deferred Compensation Plan‚Äôs 8th Largest Position http://ift.tt/2uFC3F1","Merck & Company, Inc. $MRK is NJ State Employees Deferred Compensation Plan‚Äôs 8th Largest Position http://ift.tt/2uFC3F1",,,,,[],https://twitter.com/dailypoliticaln/status/888006538463506434
3503,Jacob Bell,@realJacobBell,2017-07-19T18:08:01.000Z,5 trends shaping Alzheimer's drug development http://bit.ly/2vjjXqx $AGN $BIIB $LLY $MRK,5 trends shaping Alzheimer's drug development http://bit.ly/2vjjXqx $AGN $BIIB $LLY $MRK,,,,,[],https://twitter.com/realJacobBell/status/887735793019760644
3504,Market Realist,@MarketRealist,2017-07-18T19:44:09.000Z,An In-Depth Look into Merck in July 2017 http://marketrealist.com/?p=2202598 $MRK $AMGN $NVS $PFE,An In-Depth Look into Merck in July 2017 http://marketrealist.com/?p=2202598 $MRK $AMGN $NVS $PFE,,,,,[],https://twitter.com/MarketRealist/status/887397598977552388
3505,Allison Gatlin,@IBD_AGatlin,2017-07-19T18:33:17.000Z,How AbbVie could hammer Gilead's Hepatitis C franchise $GILD $ABBV $MRK,"How AbbVie could hammer Gilead's Hepatitis C franchise $GILD $ABBV $MRK
investors.com
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
AbbVie is likely to swipe significant hepatitis C drug share from Gilead Sciences with an eight-week regimen, an analyst said Wednesday.",,,,,[],https://twitter.com/IBD_AGatlin/status/887742155141382144
3506,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-07-20T18:05:08.000Z,"I don‚Äôt know PMBCL well, but this Keytruda data $MRK look good, curious others views compared to $KITE KTEC19 http://bloodjournal.org/content/130/3/267?sso-checked=true‚Ä¶","I don‚Äôt know PMBCL well, but this Keytruda data $MRK look good, curious others views compared to $KITE KTEC19 http://bloodjournal.org/content/130/3/267?sso-checked=true‚Ä¶",,,,,[],https://twitter.com/DrPaulyDeSantis/status/888097455408947200
3507,Hans,@WartenbergHans,2017-07-20T22:30:22.000Z,"Replying to 
@Lizardjb3","Replying to 
@Lizardjb3
Luckily $MRK not on the list.
1
2",,1,,2,[],https://twitter.com/WartenbergHans/status/888164204787769347
3508,Zero Filter,@zerofiltertruth,2017-07-18T21:13:53.000Z,"Wow our #biotech lotto tickets on roll - Even traditional laughing stock $AEZS - 

$MRK $CELG $AMGN $BIIB 
@CNBC
  http://ir.aezsinc.com/press-release/aeternazentaris/nda-macrilen-evaluation-growth-hormone-deficiency-adults-granted‚Ä¶","Wow our #biotech lotto tickets on roll - Even traditional laughing stock $AEZS - 

$MRK $CELG $AMGN $BIIB 
@CNBC
  http://ir.aezsinc.com/press-release/aeternazentaris/nda-macrilen-evaluation-growth-hormone-deficiency-adults-granted‚Ä¶",üî• ‚Üó üî•,,,,[],https://twitter.com/zerofiltertruth/status/887420182628618241
3509,dough,@semodough,2017-07-20T12:27:48.000Z,LR $MRK  continues to gain share at expense of $BMY June's data suggesting a greater m/m improvement for Keytruda than in months past.,LR $MRK  continues to gain share at expense of $BMY June's data suggesting a greater m/m improvement for Keytruda than in months past.,,,,,[],https://twitter.com/semodough/status/888012563748966401
3510,The Fly,@theflynews,2017-07-20T14:54:07.000Z,"Credit Suisse cuts Pfizer to hold, prefers Merck, J&J $PFE $MRK $JNJ","Credit Suisse cuts Pfizer to hold, prefers Merck, J&J $PFE $MRK $JNJ
thefly.com
Credit Suisse cuts Pfizer to hold, prefers Merck, J&J
Credit Suisse downgraded ... PFE, MRK, JNJ",,,,,[],https://twitter.com/theflynews/status/888049384499273729
3511,Zain Raj,@ZAIN_RAJ,2017-07-19T16:22:17.000Z,"RT 
@donnayoungdc
: Hey forget about #MadeInAmerica. $MRK Reichert says #MadeInSpace will be big opportunities for #pharma #biotech
#NASA","RT 
@donnayoungdc
: Hey forget about #MadeInAmerica. $MRK Reichert says #MadeInSpace will be big opportunities for #pharma #biotech
#NASA",,,,,[],https://twitter.com/ZAIN_RAJ/status/887709185852547072
3512,Hans,@WartenbergHans,2017-07-20T22:56:08.000Z,"Replying to 
@WartenbergHans
 and 
@Lizardjb3","Replying to 
@WartenbergHans
 and 
@Lizardjb3
Target price for $MRK is between 70-90. $EBIX has a similar price target.
1",,,,1,[],https://twitter.com/WartenbergHans/status/888170690431651840
3513,MarketBeat,@MarketBeatCom,2017-07-20T00:41:25.000Z,"Merck & Company, Inc. $MRK Rating Lowered to Strong Sell at BidaskClub http://ift.tt/2vl8I0Q #acn","Merck & Company, Inc. $MRK Rating Lowered to Strong Sell at BidaskClub http://ift.tt/2vl8I0Q #acn",,,,,[],https://twitter.com/MarketBeatCom/status/887834795761381376
3514,TradingView Ideas,@TradingViewAlt,2017-07-19T19:58:26.000Z,Merck - interesting to long after\u2026 $MRK http://tradingview.com/chart/MRK/7chsnQzp-Merck-interesting-to-long-after-earnings-28-July/‚Ä¶,Merck - interesting to long after\u2026 $MRK http://tradingview.com/chart/MRK/7chsnQzp-Merck-interesting-to-long-after-earnings-28-July/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/887763583223734272
3515,TradeTheNews.com,@Trade_The_News,2017-07-20T11:35:07.000Z,$MRK U.S. FDA Grants Tentative Approval for LUSDUNA Nexvue,$MRK U.S. FDA Grants Tentative Approval for LUSDUNA Nexvue,,,,,[],https://twitter.com/Trade_The_News/status/887999308309696512
3516,Barchart,@Barchart,2017-07-20T14:47:46.000Z,"US stocks waver as earnings and central banks dominate https://barchart.com/social/share?t=US%20stocks%20waver%20as%20earnings%20and%20central%20banks%20dominate&d=NEW%20YORK%20(AP)%20%E2%80%94%20U.S%20stocks%20are%20wavering%20between%20small%20gains%20and%20losses%20in%20early%20trading%20on%20Wall%20Street%20Thursday.&i=https%3A%2F%2Fs3.amazonaws.com%2Fbarchart-news-media%2Fap%2F41b418d67b684b9897b662d89cec009c%2F370b0ee2dec441688d0f7acb0f1d098d_financial_markets_wall_street_61637.jpg&r=https%3A%2F%2Fwww.barchart.com%2F%23%2Fnews%2F3341588%2Fus-stocks-waver-as-earnings-and-central-banks-dominate&du=false‚Ä¶ via 
@Barchart
 $SHW $SHLD $MRK $AMZN $ABT $PM","US stocks waver as earnings and central banks dominate https://barchart.com/social/share?t=US%20stocks%20waver%20as%20earnings%20and%20central%20banks%20dominate&d=NEW%20YORK%20(AP)%20%E2%80%94%20U.S%20stocks%20are%20wavering%20between%20small%20gains%20and%20losses%20in%20early%20trading%20on%20Wall%20Street%20Thursday.&i=https%3A%2F%2Fs3.amazonaws.com%2Fbarchart-news-media%2Fap%2F41b418d67b684b9897b662d89cec009c%2F370b0ee2dec441688d0f7acb0f1d098d_financial_markets_wall_street_61637.jpg&r=https%3A%2F%2Fwww.barchart.com%2F%23%2Fnews%2F3341588%2Fus-stocks-waver-as-earnings-and-central-banks-dominate&du=false‚Ä¶ via 
@Barchart
 $SHW $SHLD $MRK $AMZN $ABT $PM
barchart.com
US stocks waver as earnings and central banks dominate
NEW YORK (AP) ‚Äî U.S stocks are wavering between small gains and losses in early trading on Wall Street Thursday.",,,,,[],https://twitter.com/Barchart/status/888047787069382656
3517,Buy Cryptocurrency,@cryptosbuy,2017-07-19T20:02:28.000Z,Merck - interesting to long after\u2026 $MRK http://tradingview.com/chart/MRK/7chsnQzp-Merck-interesting-to-long-after-earnings-28-July/‚Ä¶ TV_TradingIdeas,Merck - interesting to long after\u2026 $MRK http://tradingview.com/chart/MRK/7chsnQzp-Merck-interesting-to-long-after-earnings-28-July/‚Ä¶ TV_TradingIdeas,,,,,[],https://twitter.com/cryptosbuy/status/887764596643254272
3518,Dakota Financial,@dakotafinancial,2017-07-20T23:39:34.000Z,"Merck & Company, Inc. $MRK Downgraded to ‚ÄúStrong Sell‚Äù at BidaskClub http://ift.tt/2uNHZgf","Merck & Company, Inc. $MRK Downgraded to ‚ÄúStrong Sell‚Äù at BidaskClub http://ift.tt/2uNHZgf",,,,,[],https://twitter.com/dakotafinancial/status/888181620636868608
3519,Brad Loncar,@bradloncar,2017-07-23T20:00:02.000Z,"Huge earnings week.

M: -
T: $AMGN $BIIB $LLY
W: $GILD $GSK $VRTX
T: $ALXN $AZN $BMY $CELG
F: $ABBV $MRK

Full list: http://loncarblog.com/july-24-healthcare-earnings‚Ä¶","Huge earnings week.

M: -
T: $AMGN $BIIB $LLY
W: $GILD $GSK $VRTX
T: $ALXN $AZN $BMY $CELG
F: $ABBV $MRK

Full list: http://loncarblog.com/july-24-healthcare-earnings‚Ä¶
1
16
27",,1,16,27,['https://pbs.twimg.com/media/DFT7Nr1UwAE56pg?format=jpg&name=small'],https://twitter.com/bradloncar/status/889213536873857024
3520,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-07-21T12:13:56.000Z,"Gottlieb:""I dont want to create unintended consequences for investors where capital leaves the sector"" $GILD $IBB $XBI $CELG $MRK $BMY ","Gottlieb:""I dont want to create unintended consequences for investors where capital leaves the sector"" $GILD $IBB $XBI $CELG $MRK $BMY 
5
11",üëå,,5,11,[],https://twitter.com/DrPaulyDeSantis/status/888371463706869760
3521,David Shaywitz,@DShaywitz,2017-07-22T13:49:48.000Z,"Today, $MRK lauded 4 biomarker strategy 4Keytruda - but as recently as March 2016, opposite seemed true... https://wsj.com/articles/bristol-bucks-trend-toward-precision-medicine-1457912801‚Ä¶","Today, $MRK lauded 4 biomarker strategy 4Keytruda - but as recently as March 2016, opposite seemed true... https://wsj.com/articles/bristol-bucks-trend-toward-precision-medicine-1457912801‚Ä¶
1
1",,,1,1,['https://pbs.twimg.com/media/DFWAowZUQAAVFbA?format=jpg&name=900x900'],https://twitter.com/DShaywitz/status/888757976948809728
3522,Seeking Alpha,@SeekingAlpha,2017-07-23T13:00:03.000Z,"3 Things In Biotech You Should Learn Today: July 23, 2017 https://seekingalpha.com/article/4089596-3-things-biotech-learn-today-july-23-2017?source=feed_f‚Ä¶ $BMY $KITE $MRK $NVS $SNY","3 Things In Biotech You Should Learn Today: July 23, 2017 https://seekingalpha.com/article/4089596-3-things-biotech-learn-today-july-23-2017?source=feed_f‚Ä¶ $BMY $KITE $MRK $NVS $SNY
1
2",,,1,2,[],https://twitter.com/SeekingAlpha/status/889107843483279361
3523,Seeking Alpha,@SeekingAlpha,2017-07-21T11:04:44.000Z,Wall Street Breakfast: Confidence In Bitcoin Is Back https://seekingalpha.com/article/4089324-wall-street-breakfast-confidence-bitcoin-back?source=feed_f‚Ä¶ $SPY $QQQ $ABT $AMZN $BX $CMG $COF $DAL $EBAY $FB $GLW $MRK,Wall Street Breakfast: Confidence In Bitcoin Is Back https://seekingalpha.com/article/4089324-wall-street-breakfast-confidence-bitcoin-back?source=feed_f‚Ä¶ $SPY $QQQ $ABT $AMZN $BX $CMG $COF $DAL $EBAY $FB $GLW $MRK,,,,,[],https://twitter.com/SeekingAlpha/status/888354049224986624
3524,Breaking News,@MarketCurrents,2017-07-21T13:44:53.000Z,European advisory group backs approval of 11 new meds https://seekingalpha.com/news/3280298-european-advisory-group-backs-approval-11-new-meds?source=feed_f‚Ä¶ $MRK $AAAP $NVS $IPSEY,"European advisory group backs approval of 11 new meds https://seekingalpha.com/news/3280298-european-advisory-group-backs-approval-11-new-meds?source=feed_f‚Ä¶ $MRK $AAAP $NVS $IPSEY
seekingalpha.com
European advisory group backs approval of 11 new meds (NASDAQ:AAAP)
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopts positive opinions backing the approval of 11 new therapies, including five Orphan...",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/888394352493383682
3525,Sean Hyman,@Sean_Hyman,2017-07-21T15:28:32.000Z,Big Pharma and Corning lead initiative to manufacture pharmaceutical glass in U.S. https://seekingalpha.com/news/3280019-big-pharma-corning-lead-initiative-manufacture-pharmaceutical-glass-u-s?source=tweet‚Ä¶ $MRK $PFE $GLW,"Big Pharma and Corning lead initiative to manufacture pharmaceutical glass in U.S. https://seekingalpha.com/news/3280019-big-pharma-corning-lead-initiative-manufacture-pharmaceutical-glass-u-s?source=tweet‚Ä¶ $MRK $PFE $GLW
seekingalpha.com
Big Pharma and Corning lead initiative to manufacture pharmaceutical glass in U.S. (NYSE:MRK)
President Trump announces an initiative led by Merck (NYSE:MRK), Pfizer (NYSE:PFE) and Corning (NYSE:GLW) to manufacture pharmaceutical glass packaging in the U.S.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/Sean_Hyman/status/888420436278730753
3526,Jason Gilmore,@Jason_g26272,2017-07-23T17:32:30.000Z,$dcth what happenes to our shares if $mrk were to buy out $dcth,"$dcth what happenes to our shares if $mrk were to buy out $dcth
4
2",,4,,2,[],https://twitter.com/Jason_g26272/status/889176410031611909
3527,FinInvTr,@FinInvTr,2017-07-21T09:51:01.000Z,"14 Top Holdings In Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2ufF3pv","14 Top Holdings In Leading Dividend Fund $MSFT $JNJ $XOM $JPM $WFC $GE $T $PG $PFE $CVX $VZ $KO $PM $MRK

http://buff.ly/2ufF3pv",,,,,['https://pbs.twimg.com/media/DFQAbPjW0AAT4tP?format=jpg&name=small'],https://twitter.com/FinInvTr/status/888335496337928192
3528,BoardCentral,@BoardCentral,2017-07-22T18:34:51.000Z,Web Stock buzz: $AMZN $AAPL $INTC $MRK (02:34 pm) #stocks #finance #stockmarket #StockPicks,"Web Stock buzz: $AMZN $AAPL $INTC $MRK (02:34 pm) #stocks #finance #stockmarket #StockPicks
2",,,,2,[],https://twitter.com/BoardCentral/status/888829709768937472
3529,The Midas Touch,@MysteryMan_777,2017-07-21T14:17:53.000Z,$OPGN In 36's for swing. To much good news going in with $MRK and $PFE to pass up.,"$OPGN In 36's for swing. To much good news going in with $MRK and $PFE to pass up.
2
2",„ÄΩ „ÄΩ,2,,2,[],https://twitter.com/MysteryMan_777/status/888402656988983298
3530,Nathan Michaud,@InvestorsLive,2017-07-21T16:34:28.000Z,$MRK slow & steady,"$MRK slow & steady
1",,,1,,[],https://twitter.com/InvestorsLive/status/888437027661860864
3531,Tizz Taylor,@Here2TradeHey,2017-07-23T14:11:38.000Z,"Bio earnings/ present next week:
M: $GILD P3 HIV Data
T: $BIOG $AMGN ; $MRK P3 HIV Data
W: $GILD $VRTX
R: $CELG $BMY
F: $ABBV $MRK","Bio earnings/ present next week:
M: $GILD P3 HIV Data
T: $BIOG $AMGN ; $MRK P3 HIV Data
W: $GILD $VRTX
R: $CELG $BMY
F: $ABBV $MRK
1",,,1,,[],https://twitter.com/Here2TradeHey/status/889125860451790848
3532,FiercePharma,@FiercePharma,2017-07-21T15:16:28.000Z,Merck‚Äôs Zostavax draws new litigation from patients alleging they contracted shingles http://fiercepharma.com/legal/more-patients-allege-they-suffered-injuries-from-merck-s-zostavax‚Ä¶ $MRK,"Merck‚Äôs Zostavax draws new litigation from patients alleging they contracted shingles http://fiercepharma.com/legal/more-patients-allege-they-suffered-injuries-from-merck-s-zostavax‚Ä¶ $MRK
fiercepharma.com
Merck‚Äôs Zostavax draws new litigation from patients alleging they contracted shingles
Even as Merck & Co. | Eighteen patients have filed a liability lawsuit against Merck & Co., alleging Zostavax is an ‚Äúunreasonably dangerous vaccine‚Äù that caused injuries.
1
3",,,1,3,['https://pbs.twimg.com/card_img/1500028598643834885/046z2TuJ?format=jpg&name=small'],https://twitter.com/FiercePharma/status/888417397757149184
3533,Dow Stocks,@Top_Dow_Stocks,2017-07-21T07:16:57.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/888296725273657344
3534,BioPharma Dive,@BioPharmaDive,2017-07-21T22:44:00.000Z,FDA grants tentative approval for $MRK's Lusduna Nexvue,"FDA grants tentative approval for $MRK's Lusduna Nexvue
biopharmadive.com
Merck's Lantus follow-on gets tentative thumb's up
A second follow-on biologic of Sanofi's blockbuster insulin Lantus has now gotten approval from the FDA, dealing another blow to the French drugmaker.  
1",,,,1,['https://pbs.twimg.com/card_img/1491141785426571270/IAohpzFi?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/888530024541954049
3535,BioPharma Dive,@BioPharmaDive,2017-07-22T00:33:00.000Z,5 trends shaping Alzheimer's drug development http://bit.ly/2vjjXqx $AGN $BIIB $LLY $MRK,"5 trends shaping Alzheimer's drug development http://bit.ly/2vjjXqx $AGN $BIIB $LLY $MRK
biopharmadive.com
5 trends shaping Alzheimer's drug development
Almost all Alzheimer‚Äôs drugs have failed. But pharma continues to invest millions in hopes of finding a hit, motivated by market opportunity and armed with lessons learned.
2",,,,2,['https://pbs.twimg.com/card_img/1501590850073153541/xlr-QWtB?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/888557455050891264
3536,Dakota Financial,@dakotafinancial,2017-07-22T01:24:45.000Z,"BidaskClub Upgrades Merck & Company, Inc. $MRK to ‚ÄúHold‚Äù http://ift.tt/2ty93Qp","BidaskClub Upgrades Merck & Company, Inc. $MRK to ‚ÄúHold‚Äù http://ift.tt/2ty93Qp",,,,,[],https://twitter.com/dakotafinancial/status/888570478247464961
3537,Drug Delivery Business News,@DrugDeliveryNow,2017-07-21T16:42:04.000Z,Trump pushes ‚ÄòAmerica First‚Äô policy with #pharmaceutical #packaging industry. $MRK $PFE $GLW,"Trump pushes ‚ÄòAmerica First‚Äô policy with #pharmaceutical #packaging industry. $MRK $PFE $GLW
drugdeliverybusiness.com
Trump pushes ‚ÄòAmerica First‚Äô policy with pharmaceutical packaging industry
Donald Trump yesterday revealed an initiative to bring jobs and investment into the U.S. drug packaging industry, spearheaded by Corning Inc. (NYSE:GLW), Merck (NYSE:MRK) and Pfizer (NYSE:PFE). At...",,,,,[],https://twitter.com/DrugDeliveryNow/status/888438940113436672
3538,ExileOnBaySt,@ExileOnBaySt,2017-07-23T16:53:46.000Z,"Earnings
M $GOOGL
T $AMGN $CAT $DD $ESRX $LLY $MNLZ
W $BA $FB $F $KO $GLW 
T $AMZN $TWTR $BMY $COP $PG $INTC $UPS $SBUX $MC
F $MRK $CVX $XOM","Earnings
M $GOOGL
T $AMGN $CAT $DD $ESRX $LLY $MNLZ
W $BA $FB $F $KO $GLW 
T $AMZN $TWTR $BMY $COP $PG $INTC $UPS $SBUX $MC
F $MRK $CVX $XOM",,,,,[],https://twitter.com/ExileOnBaySt/status/889166659046584320
3539,MomoTrader 007,@MomoTrader007,2017-07-21T17:25:42.000Z,$scyx -- need a flawless execution or this will be $0.40 RIP -- why did $MRK abandon their drug mk-3118 ; they must know something....,$scyx -- need a flawless execution or this will be $0.40 RIP -- why did $MRK abandon their drug mk-3118 ; they must know something....,,,,,[],https://twitter.com/MomoTrader007/status/888449919396311040
3540,MAISA,@MaisaCorp,2017-07-22T00:26:42.000Z,$MRK  CHMP has adopted a positive opinion recommending approval of KEYTRUDA (pembrolizumab),$MRK  CHMP has adopted a positive opinion recommending approval of KEYTRUDA (pembrolizumab),,,,,[],https://twitter.com/MaisaCorp/status/888555871457996800
3541,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-07-22T13:05:18.000Z,"3 Things In Biotech You Should Learn Today: July 22, 2017 $CSLLY $INCY $MRK http://dlvr.it/PXcFdT #Investing #Stocks","3 Things In Biotech You Should Learn Today: July 22, 2017 $CSLLY $INCY $MRK http://dlvr.it/PXcFdT #Investing #Stocks
seekingalpha.com
3 Things In Biotech You Should Learn Today: July 22, 2017
Merck grabs approval in Europe for bladder cancer drug. Incyte marches on in GVHD.",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/AlertTrade/status/888746775669989376
3542,Tim Reller,@TraderGuruNY,2017-07-21T01:02:13.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/888202418474889218
3543,Pharmaceutical News,@pharma_sector,2017-07-22T00:03:01.000Z,#Merck Vineland facility to be major beneficiary of Corning's multibillion-dollar pharma gla... Read more: http://owler.us/ac4IN1 $MRK,#Merck Vineland facility to be major beneficiary of Corning's multibillion-dollar pharma gla... Read more: http://owler.us/ac4IN1 $MRK,,,,,[],https://twitter.com/pharma_sector/status/888549909590196224
3544,Hannibal Hamlin,@HHamlinVP,2017-07-21T11:06:35.000Z,Wall Street Breakfast: Confidence In Bitcoin Is Back https://seekingalpha.com/article/4089324-wall-street-breakfast-confidence-bitcoin-back?source=tweet‚Ä¶ $SPY $QQQ $ABT $AMZN $BX $CMG $COF $DAL $EBAY $FB $GLW $MRK,Wall Street Breakfast: Confidence In Bitcoin Is Back https://seekingalpha.com/article/4089324-wall-street-breakfast-confidence-bitcoin-back?source=tweet‚Ä¶ $SPY $QQQ $ABT $AMZN $BX $CMG $COF $DAL $EBAY $FB $GLW $MRK,,,,,[],https://twitter.com/HHamlinVP/status/888354511940669440
3545,Randy Morris,@investmorris,2017-07-21T13:54:53.000Z,European advisory group backs approval of 11 new meds $MRK $AAAP $NVS $IPSEY $SNY $JNJ $RHHBY $MYL,"European advisory group backs approval of 11 new meds $MRK $AAAP $NVS $IPSEY $SNY $JNJ $RHHBY $MYL
seekingalpha.com
European advisory group backs approval of 11 new meds (NASDAQ:AAAP)
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopts positive opinions backing the approval of 11 new therapies, including five Orphan...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/investmorris/status/888396867633111040
3546,Ticker Report,@TickerReport,2017-07-21T19:46:30.000Z,"Merck & Company, Inc. $MRK Rating Lowered to Strong Sell at BidaskClub http://ift.tt/2txsR6A","Merck & Company, Inc. $MRK Rating Lowered to Strong Sell at BidaskClub http://ift.tt/2txsR6A",,,,,[],https://twitter.com/TickerReport/status/888485356496203776
3547,Limex,@LimexMe,2017-07-21T17:01:40.000Z,"What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings?
 http://bit.ly/210717BMY $BMY $GILD $MRK $VRTX","What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings?
 http://bit.ly/210717BMY $BMY $GILD $MRK $VRTX",,,,,[],https://twitter.com/LimexMe/status/888443874141712384
3548,WallStreetGangsta,@WallStGangsta,2017-07-21T12:50:49.000Z,$PTLF Petlife Pharmaceuticals inc The Next buyout Candidate https://wallstreetpr.com/is-petlife-pharmaceuticals-inc-ptlf-a-real-opportunity-right-now-39919‚Ä¶ ‚Ä¶ $IBB $JNJ $GILD $VRTX $NVS $MRK $BMY $AMGN $BSX $VRX,$PTLF Petlife Pharmaceuticals inc The Next buyout Candidate https://wallstreetpr.com/is-petlife-pharmaceuticals-inc-ptlf-a-real-opportunity-right-now-39919‚Ä¶ ‚Ä¶ $IBB $JNJ $GILD $VRTX $NVS $MRK $BMY $AMGN $BSX $VRX,,,,,[],https://twitter.com/WallStGangsta/status/888380743667388416
3549,Eric Sagonowsky,@EricSFierce,2017-07-21T15:16:28.000Z,Merck‚Äôs Zostavax draws new litigation from patients alleging they contracted shingles http://fiercepharma.com/legal/more-patients-allege-they-suffered-injuries-from-merck-s-zostavax‚Ä¶ $MRK,"Merck‚Äôs Zostavax draws new litigation from patients alleging they contracted shingles http://fiercepharma.com/legal/more-patients-allege-they-suffered-injuries-from-merck-s-zostavax‚Ä¶ $MRK
fiercepharma.com
Merck‚Äôs Zostavax draws new litigation from patients alleging they contracted shingles
Even as Merck & Co. | Eighteen patients have filed a liability lawsuit against Merck & Co., alleging Zostavax is an ‚Äúunreasonably dangerous vaccine‚Äù that caused injuries.
2",,,,2,['https://pbs.twimg.com/card_img/1500028598643834885/046z2TuJ?format=jpg&name=small'],https://twitter.com/EricSFierce/status/888417397715107841
3550,Michael Hamboussi,@mikehamboussi,2017-07-21T14:10:37.000Z,"The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK","The FDA Has Never Approved a Drug Like This in Its 111-Year History 
@themotleyfool
 #stocks $MRK
fool.com
The FDA Has Never Approved a Drug Like This in Its 111-Year History @themotleyfool #stocks $MRK
This cancer drug produced data so incredible that the FDA approved it immediately for a specific genetic mutation, regardless of cancer location.
1",,,,1,['https://pbs.twimg.com/card_img/1500370507899842564/DH8HlVpt?format=jpg&name=small'],https://twitter.com/mikehamboussi/status/888400825395142656
3551,MarketBeat,@MarketBeatCom,2017-07-21T12:29:22.000Z,"Merck & Company, Inc. $MRK Stake Raised by First Bank & Trust http://ift.tt/2vI2eIt","Merck & Company, Inc. $MRK Stake Raised by First Bank & Trust http://ift.tt/2vI2eIt",,,,,[],https://twitter.com/MarketBeatCom/status/888375348542492672
3552,$peedyCalls,@SpeedyCalls,2017-07-21T18:37:36.000Z,"$MRK 60 Puts BUYING Activity expiring on 18th Aug, Vol 1590","$MRK 60 Puts BUYING Activity expiring on 18th Aug, Vol 1590",,,,,[],https://twitter.com/SpeedyCalls/status/888468015330844672
3553,Mark Balson,@mark_balson,2017-07-21T01:13:15.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/mark_balson/status/888205194957344768
3554,Pharmaceutical News,@pharma_sector,2017-07-22T00:02:24.000Z,#Merck's Biosimilar Insulin Gets Tentative FDA Approval . Read more: http://owler.us/ac4IN3 $MRK,#Merck's Biosimilar Insulin Gets Tentative FDA Approval . Read more: http://owler.us/ac4IN3 $MRK,,,,,[],https://twitter.com/pharma_sector/status/888549753876762624
3555,Siti van der Meij,@sitivandermeij,2017-07-21T13:48:24.000Z,European advisory group backs approval of 11 new meds https://seekingalpha.com/news/3280298-european-advisory-group-backs-approval-11-new-meds?source=feed_f‚Ä¶ $MRK $AAAP $NVS $IPSEY #sitifatimah #malaysia #financialplan‚Ä¶,"European advisory group backs approval of 11 new meds https://seekingalpha.com/news/3280298-european-advisory-group-backs-approval-11-new-meds?source=feed_f‚Ä¶ $MRK $AAAP $NVS $IPSEY #sitifatimah #malaysia #financialplan‚Ä¶
seekingalpha.com
European advisory group backs approval of 11 new meds (NASDAQ:AAAP)
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopts positive opinions backing the approval of 11 new therapies, including five Orphan...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/888395234450788353
3556,Ticker Report,@TickerReport,2017-07-23T15:26:40.000Z,"Merck & Company, Inc. $MRK Position Boosted by Watch Point Trust Co http://ift.tt/2tB2sov","Merck & Company, Inc. $MRK Position Boosted by Watch Point Trust Co http://ift.tt/2tB2sov",,,,,[],https://twitter.com/TickerReport/status/889144742369472512
3557,Daily Political,@dailypoliticaln,2017-07-22T12:01:39.000Z,"Northstar Asset Management LLC Continues to Hold Position in Merck & Company, Inc. $MRK http://ift.tt/2uklRsB","Northstar Asset Management LLC Continues to Hold Position in Merck & Company, Inc. $MRK http://ift.tt/2uklRsB",,,,,[],https://twitter.com/dailypoliticaln/status/888730761351888897
3558,MarketBeat,@MarketBeatCom,2017-07-23T12:08:10.000Z,"Bourgeon Capital Management LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2tRoXAD","Bourgeon Capital Management LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2tRoXAD",,,,,[],https://twitter.com/MarketBeatCom/status/889094788645101568
3559,MarketBeat,@MarketBeatCom,2017-07-22T13:04:15.000Z,"Shine Investment Advisory Services Inc. Buys Shares of 5,676 Merck & Company, Inc. $MRK http://ift.tt/2uSM2I1","Shine Investment Advisory Services Inc. Buys Shares of 5,676 Merck & Company, Inc. $MRK http://ift.tt/2uSM2I1",,,,,[],https://twitter.com/MarketBeatCom/status/888746511500288001
3560,Day Trading Academy,@DTradingAcademy,2017-07-21T17:19:05.000Z,"Prez Trump announces an initiative led by $MRK, $PFE & $GLW to manufacture pharmaceutical glass packaging in U.S.","Prez Trump announces an initiative led by $MRK, $PFE & $GLW to manufacture pharmaceutical glass packaging in U.S.
daytradingacademy.com
Day Trading Academy: Investing & Trading Education
Market leading day trading education, trading coaching, and investing company offering a true path to becoming a professional day trader.",,,,,['https://pbs.twimg.com/card_img/1499767849774166016/qCYqbOO-?format=png&name=medium'],https://twitter.com/DTradingAcademy/status/888448257948393472
3561,Briefing.com,@Briefingcom,2017-07-21T13:36:42.000Z,$MRK: Merck confirms that the CHMP has adopted a positive opinion recommending approval of KEYTRUDA... http://bit.ly/2uG0L8M,$MRK: Merck confirms that the CHMP has adopted a positive opinion recommending approval of KEYTRUDA... http://bit.ly/2uG0L8M,,,,,[],https://twitter.com/Briefingcom/status/888392290514882561
3562,The Fly,@theflynews,2017-07-22T11:41:03.000Z,Week in review: How Trump's policies moved stocks $BCC $CAT $CPB $LVB $GLW $MRK $PFE $AMZN $AET $ANTM $CNC $CI $HNT‚Ä¶,"Week in review: How Trump's policies moved stocks $BCC $CAT $CPB $LVB $GLW $MRK $PFE $AMZN $AET $ANTM $CNC $CI $HNT‚Ä¶
thefly.com
Week in review: How Trump's policies moved stocks
Catch up on the top indus... BCC, CAT, CPB, LVB, GLW, MRK, PFE, AMZN, AET, ANTM, CNC, CI, HNT, HUM, MOH, UNH, WCG, X, STLD, NUE, CYH, HCA, LPNT, THC, UHS
1",,,,1,[],https://twitter.com/theflynews/status/888725574343983104
3563,$PENNY KING,@groman100,2017-07-21T18:46:01.000Z,"$FBIO up 8% after fox&friends TV spot 4 mustang bio & 
@johnmachan
 brain cancer $kite $juno $clls $pfe $mrk $Vrtx $auph $cala $cara $ew $ziop","$FBIO up 8% after fox&friends TV spot 4 mustang bio & 
@johnmachan
 brain cancer $kite $juno $clls $pfe $mrk $Vrtx $auph $cala $cara $ew $ziop",,,,,[],https://twitter.com/groman100/status/888470133227765760
3564,BioWorld,@BioWorld,2017-07-21T21:38:00.000Z,"Coming Monday in 
@BioWorld
 Insight: CETP inhibitor class may rebound from graveyard status with $MRK win","Coming Monday in 
@BioWorld
 Insight: CETP inhibitor class may rebound from graveyard status with $MRK win
1",,,,1,[],https://twitter.com/BioWorld/status/888513416242929664
3565,Floyd Jenks,@JenksFloyd,2017-07-21T15:27:45.000Z,"President Trump announced $4 billion investment & 4,000 Jobs from $MRK, $PFE & $GLW. http://alph.st/b9ead2cc 
@realDonaldTrump
 @WhiteHouse","President Trump announced $4 billion investment & 4,000 Jobs from $MRK, $PFE & $GLW. http://alph.st/b9ead2cc 
@realDonaldTrump
 @WhiteHouse",,,,,[],https://twitter.com/JenksFloyd/status/888420236193480704
3566,Ronnie Matrix Mukiibi.,@RonnieMatrix,2017-07-23T20:23:36.000Z,"Replying to 
@TheStreet","Replying to 
@TheStreet
Big week coming up with large-caps $GOOGL $KO $DFS $FB $AMZN $GSK $BSX $BTI $INTC $VZ $ABBV $MRK & energy names like $XOM $VLP reporting",,,,,[],https://twitter.com/RonnieMatrix/status/889219465367474176
3567,Will Purdy,@WillPurdyCO,2017-07-21T06:46:33.000Z,"I can find no evidence of that large a $MRK stake. Please, where are you seeing that number?","I can find no evidence of that large a $MRK stake. Please, where are you seeing that number?
1",,1,,,[],https://twitter.com/WillPurdyCO/status/888289073885962240
3568,Dakota Financial,@dakotafinancial,2017-07-23T12:07:58.000Z,"Bourgeon Capital Management LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2tRoXAD","Bourgeon Capital Management LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2tRoXAD",,,,,[],https://twitter.com/dakotafinancial/status/889094736719597569
3569,StockNews.com,@stocknewsdotcom,2017-07-21T11:45:31.000Z,$MRK Company confirms that the CHMP has adopted a positive opinion recommending approval of KEYTRUDA (pembrolizuma‚Ä¶ https://stocknews.com/news/mrk-company-confirms-that-the-chmp-has-adopted-a-positive-opinion/‚Ä¶,$MRK Company confirms that the CHMP has adopted a positive opinion recommending approval of KEYTRUDA (pembrolizuma‚Ä¶ https://stocknews.com/news/mrk-company-confirms-that-the-chmp-has-adopted-a-positive-opinion/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/888364309574758401
3570,Andy Biotech,@AndyBiotech,2017-07-26T12:03:38.000Z,"Excellent story by 
@DShaywitz
 on the remarkable history of $MRK Keytruda development 

https://forbes.com/sites/davidshaywitz/2017/07/26/the-startling-history-behind-mercks-new-cancer-blockbuster/‚Ä¶","Excellent story by 
@DShaywitz
 on the remarkable history of $MRK Keytruda development 

https://forbes.com/sites/davidshaywitz/2017/07/26/the-startling-history-behind-mercks-new-cancer-blockbuster/‚Ä¶
1
36
57",,1,36,57,[],https://twitter.com/AndyBiotech/status/890180811357552640
3571,Andy Biotech,@AndyBiotech,2017-07-24T21:01:12.000Z,"$MRK Keytruda Ph3 HNSCC trial did not meet pre-specified primary endpoint of OS (HR, 0.82 [95% CI, 0.67-1.01]; p = 0.03 [one-sided]).","$MRK Keytruda Ph3 HNSCC trial did not meet pre-specified primary endpoint of OS (HR, 0.82 [95% CI, 0.67-1.01]; p = 0.03 [one-sided]).
2
22
23",,2,22,23,[],https://twitter.com/AndyBiotech/status/889591316727951360
3572,Adam Feuerstein,@adamfeuerstein,2017-07-24T22:03:38.000Z,"$MRK Keytruda trial comes up short in head and neck cancer, but FDA approval stays, company says ‚Äî> https://statnews.com/2017/07/24/merck-tk/‚Ä¶ Bad decision!","$MRK Keytruda trial comes up short in head and neck cancer, but FDA approval stays, company says ‚Äî> https://statnews.com/2017/07/24/merck-tk/‚Ä¶ Bad decision!
statnews.com
Merck: Keytruda trial comes up short in head and neck cancer, but FDA approval stays
Merck‚Äôs Keytruda doesn‚Äôt help patients with advanced head-and-neck cancer live longer, but the failed clinical trial won‚Äôt compel FDA to rescind approval
3
10
13",,3,10,13,['https://pbs.twimg.com/card_img/1498409748437295111/FW2nNPHT?format=jpg&name=small'],https://twitter.com/adamfeuerstein/status/889607027776991233
3573,pharmalot,@pharmalot,2017-07-25T16:37:37.000Z,Can Merck and Samsung really win market share from $JNJ w/ their new biosimilar? https://statnews.com/pharmalot/2017/07/25/merck-samsung-biosimilar-pfizer-johnson/‚Ä¶ #pharma $MRK $PFE $JNJ #biosimilar,"Can Merck and Samsung really win market share from $JNJ w/ their new biosimilar? https://statnews.com/pharmalot/2017/07/25/merck-samsung-biosimilar-pfizer-johnson/‚Ä¶ #pharma $MRK $PFE $JNJ #biosimilar
statnews.com
J&J now has two competitors for a pricey blockbuster. Will that finally drive down prices?
For the first time, a pricey biologic now has more than one lower-cost biosimilar to fend off, a development that should usher in long-awaited savings for
1",,,1,,['https://pbs.twimg.com/card_img/1500957895067766785/UjfOc-Vy?format=jpg&name=small'],https://twitter.com/pharmalot/status/889887370715295751
3574,Bio Stocks‚Ñ¢,@BioStocks,2017-07-25T13:07:11.000Z,"$MRK Doravirine Meets Primary Efficacy Endpoint in Pivotal Ph.3 Trial for Treatment of HIV-1 Infection. NDA in Q4
https://finance.yahoo.com/news/merck-investigational-nnrti-doravirine-meets-123500361.html‚Ä¶","$MRK Doravirine Meets Primary Efficacy Endpoint in Pivotal Ph.3 Trial for Treatment of HIV-1 Infection. NDA in Q4
https://finance.yahoo.com/news/merck-investigational-nnrti-doravirine-meets-123500361.html‚Ä¶
1",,,1,,[],https://twitter.com/BioStocks/status/889834414674497536
3575,Breaking News,@MarketCurrents,2017-07-24T11:42:42.000Z,Merck's once-daily HIV med Isentress HD on par with twice-daily formulation https://seekingalpha.com/news/3280485-mercks-daily-hiv-med-isentress-hd-par-twice-daily-formulation?source=feed_f‚Ä¶ #premarket $MRK,Merck's once-daily HIV med Isentress HD on par with twice-daily formulation https://seekingalpha.com/news/3280485-mercks-daily-hiv-med-isentress-hd-par-twice-daily-formulation?source=feed_f‚Ä¶ #premarket $MRK,,,,,[],https://twitter.com/MarketCurrents/status/889450768029278209
3576,Seeking Alpha,@SeekingAlpha,2017-07-26T16:46:46.000Z,"3 Things In Biotech You Should Learn Today: July 26, 2017 https://seekingalpha.com/article/4090730-3-things-biotech-learn-today-july-26-2017?source=feed_f‚Ä¶ $BMY $CUR $MRK $RHHBF $SGIOF","3 Things In Biotech You Should Learn Today: July 26, 2017 https://seekingalpha.com/article/4090730-3-things-biotech-learn-today-july-26-2017?source=feed_f‚Ä¶ $BMY $CUR $MRK $RHHBF $SGIOF",,,,,[],https://twitter.com/SeekingAlpha/status/890252062738440192
3577,Breaking News,@MarketCurrents,2017-07-25T20:10:36.000Z,Merck declares $0.47 dividend https://seekingalpha.com/news/3281073-merck-declares-0_47-dividend?source=feed_f‚Ä¶ $MRK,"Merck declares $0.47 dividend https://seekingalpha.com/news/3281073-merck-declares-0_47-dividend?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Merck declares $0.47 dividend (NYSE:MRK)
Merck (NYSE:MRK) declares $0.47/share quarterly dividend, in line with previous.Forward yield 3.02%Payable Oct. 6; for shareholders of record Sept. 15; ex-div Sept.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/889940971298750464
3578,Seeking Alpha,@SeekingAlpha,2017-07-25T19:56:47.000Z,Aralez: A Quick Overview Of The Investment Thesis https://seekingalpha.com/article/4090375-aralez-quick-overview-investment-thesis?source=feed_f‚Ä¶ $AZN $MRK $ARLZ,"Aralez: A Quick Overview Of The Investment Thesis https://seekingalpha.com/article/4090375-aralez-quick-overview-investment-thesis?source=feed_f‚Ä¶ $AZN $MRK $ARLZ
seekingalpha.com
Aralez: A Quick Overview Of The Investment Thesis (NASDAQ:ARLZ-OLD)
Aralez has multiple revenue generating products. It also has a huge debt and a cash flow problem.",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/889937492509458432
3579,Herkyleese,@herkyleese,2017-07-24T15:48:29.000Z,It is sad that Mr #McCain  has to be the one to spark awareness about #gbm  $nwbo #dcvax soon!  $nvcr $bmy $mrk $nvs,"It is sad that Mr #McCain  has to be the one to spark awareness about #gbm  $nwbo #dcvax soon!  $nvcr $bmy $mrk $nvs
braintumor.org
Understanding Brain Tumors
While it is normal to feel scared, insecure, or angry about a brain tumor diagnosis, you can empower yourself to cope by taking this one step at a time. Start gathering information. Talk to everyone...
5
9",,,5,9,[],https://twitter.com/herkyleese/status/889512621031948288
3580,Stockrow,@stockrow1,2017-07-26T17:54:19.000Z,"$GILD P/S of 3.3 is still the lowest among peers, more upside ahead #stocks #valueinvesting #biotech $AMGN $JNJ $PFE $MRK","$GILD P/S of 3.3 is still the lowest among peers, more upside ahead #stocks #valueinvesting #biotech $AMGN $JNJ $PFE $MRK",,,,,['https://pbs.twimg.com/media/DFre-bqWAAQrfi8?format=jpg&name=small'],https://twitter.com/stockrow1/status/890269060914696192
3581,The Midas Touch,@MysteryMan_777,2017-07-24T16:34:25.000Z,$OPGN adding here. Director and CEO bought a boatload on open market at .40 I'm calling this a SALE. $MRK also big pc of pie and $PFE in mix,"$OPGN adding here. Director and CEO bought a boatload on open market at .40 I'm calling this a SALE. $MRK also big pc of pie and $PFE in mix
2
3
10",„ÄΩ „ÄΩ,2,3,10,['https://pbs.twimg.com/media/DFg5g4mXUAAggFr?format=jpg&name=small'],https://twitter.com/MysteryMan_777/status/889524178474414081
3582,BioSpace,@biospace,2017-07-26T21:20:11.000Z,Merck & Co. $MRK Plans to File NDA for HIV Treatment Doravirine Based on Phase III Results http://ow.ly/NUZq30dW9A7,"Merck & Co. $MRK Plans to File NDA for HIV Treatment Doravirine Based on Phase III Results http://ow.ly/NUZq30dW9A7
3
3",,,3,3,['https://pbs.twimg.com/media/DFsOHLwW0AAKSRx?format=jpg&name=small'],https://twitter.com/biospace/status/890320869909725184
3583,Gi McMurray,@GiMcMurray,2017-07-24T22:15:51.000Z,$MRK down 0.9% after hrs as Keytruda phase 3 failed to meet overall survival goal in head & neck cancer.,"$MRK down 0.9% after hrs as Keytruda phase 3 failed to meet overall survival goal in head & neck cancer.
1",,,1,,['https://pbs.twimg.com/media/DFiHq1KWAAE2YRs?format=jpg&name=900x900'],https://twitter.com/GiMcMurray/status/889610102755520514
3584,Wall Street Horizon,@WallStHorizon,2017-07-24T15:28:45.000Z,"Busy week in #biotech $BIIB $AMGN $BAX $GILD $BAYRY $BMY $CELG $ABBV $MRK announce #earnings, Contact 
@WallStHorizon
 for corp. event updates","Busy week in #biotech $BIIB $AMGN $BAX $GILD $BAYRY $BMY $CELG $ABBV $MRK announce #earnings, Contact 
@WallStHorizon
 for corp. event updates",,,,,['https://pbs.twimg.com/media/DFgpsNSXkAEs3k1?format=jpg&name=small'],https://twitter.com/WallStHorizon/status/889507652245630978
3585,Lisa LaMotta,@lisalamotta,2017-07-24T12:50:23.000Z,"Samsung Bioepis, $MRK launch Remicade #biosimilar Renflexis today after April approval. Priced at 35% discount $JNJ #drugpricing","Samsung Bioepis, $MRK launch Remicade #biosimilar Renflexis today after April approval. Priced at 35% discount $JNJ #drugpricing
1
4",,,1,4,[],https://twitter.com/lisalamotta/status/889467799390826496
3586,dough,@semodough,2017-07-26T17:21:16.000Z,"Replying to 
@megtirrell","Replying to 
@megtirrell
BMO Nice comments on $MRK $AZN $BMY
1
1",,,1,1,['https://pbs.twimg.com/media/DFrXadmUAAEzYLQ?format=jpg&name=small'],https://twitter.com/semodough/status/890260744830320640
3587,Meg Tirrell,@megtirrell,2017-07-26T16:33:40.000Z,BMO's Alex Arfaei says there's a good chance $AZN will release MYSTIC top-line results tomorrow with earnings $BMY $MRK,"BMO's Alex Arfaei says there's a good chance $AZN will release MYSTIC top-line results tomorrow with earnings $BMY $MRK
2
3
10",,2,3,10,[],https://twitter.com/megtirrell/status/890248767110352896
3588,Sarah Karlin-Smith,@SarahKarlin,2017-07-24T16:33:23.000Z,$mrk to launch biosimilar of remicade at 35% discount to brand. Who wants to tell me how it compares 2price of Remicade when 1st launched?,"$mrk to launch biosimilar of remicade at 35% discount to brand. Who wants to tell me how it compares 2price of Remicade when 1st launched?
3
1
3",,3,1,3,[],https://twitter.com/SarahKarlin/status/889523919887245313
3589,cp,@cparisi94,2017-07-25T11:49:18.000Z,$dcth heard today through source $mrk will be announcing something with $dcth,"$dcth heard today through source $mrk will be announcing something with $dcth
4
2",,4,,2,[],https://twitter.com/cparisi94/status/889814814142476288
3590,BioSpace,@biospace,2017-07-25T12:49:42.000Z,"Texas Officials Lure Life Sciences Companies Like Merck & Co. $MRK, Which is Expected to Employ 600 http://ow.ly/RiOu30dTwtw","Texas Officials Lure Life Sciences Companies Like Merck & Co. $MRK, Which is Expected to Employ 600 http://ow.ly/RiOu30dTwtw
1",,,,1,['https://pbs.twimg.com/media/DFlPrkzXcAA39Rm?format=jpg&name=small'],https://twitter.com/biospace/status/889830013796847616
3591,John Carroll,@JohnCendpts,2017-07-24T21:42:09.000Z,"Checkpoint barriers? 
Merck hit with another late-stage setback on checkpoint star Keytruda
$MRK","Checkpoint barriers? 
Merck hit with another late-stage setback on checkpoint star Keytruda
$MRK
endpts.com
Trading places with Bristol-Myers, Merck hit with another late-stage setback on checkpoint star...
Close to a year after Merck $MRK won an accelerated FDA OK to use its PD-1 checkpoint star Keytruda for treating second-line cases head and neck squamous cell carcinoma in combination with platinum...
7
3",,,7,3,['https://pbs.twimg.com/card_img/1500378907417083907/qVXQBuMV?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/889601623269486598
3592,Stanton Mehr,@StanMehr,2017-07-24T15:06:09.000Z,$MRK launches Its biosimilar #Infliximab at big discount. Will $PFZ or  $Janssen match the net cost? http://wp.me/p7gt6c-b2 #biosimilars,"$MRK launches Its biosimilar #Infliximab at big discount. Will $PFZ or  $Janssen match the net cost? http://wp.me/p7gt6c-b2 #biosimilars
1",,,,1,[],https://twitter.com/StanMehr/status/889501967134990336
3593,Paul D. Rennert,@PDRennert,2017-07-25T19:41:50.000Z,"Replying to 
@PDRennert","Replying to 
@PDRennert
bet $MRK steps up, maybe $NVS, both with programs in this space
1
2",,,1,2,[],https://twitter.com/PDRennert/status/889933731145945089
3594,StockMarketVideo.com,@stockmarketvide,2017-07-26T20:34:31.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/890309377789489152
3595,Roy Friedman,@DewDiligence,2017-07-24T21:09:57.000Z,"Replying to 
@adamfeuerstein","Replying to 
@adamfeuerstein
Doubt that AA will be rescinded based on OS HR=0.82 w 95% CI [0.67-1.01]. Not gonna happen with current FDA, IMO. $MRK
2
1
3",,2,1,3,[],https://twitter.com/DewDiligence/status/889593520293629954
3596,Finbox,@FinboxIO,2017-07-24T15:01:08.000Z,"Merck & Company, $MRK trading at a 6% discount to Fair Value before earnings Friday http://ow.ly/Bnde30dNiFI","Merck & Company, $MRK trading at a 6% discount to Fair Value before earnings Friday http://ow.ly/Bnde30dNiFI",,,,,['https://pbs.twimg.com/media/DFgkLKGXYAAdEj-?format=jpg&name=small'],https://twitter.com/FinboxIO/status/889500703550574593
3597,Evaluate Pharma,@evaluatepharma,2017-07-25T16:12:20.000Z,"#Merck‚Äôs Keynote falls flat, and that‚Äôs just fine http://ow.ly/va4o30dTXCj via 
@JacobPlieth
 @EPVantage
 $MRK $BMY","#Merck‚Äôs Keynote falls flat, and that‚Äôs just fine http://ow.ly/va4o30dTXCj via 
@JacobPlieth
 @EPVantage
 $MRK $BMY",,,,,['https://pbs.twimg.com/media/DFl-D6-XkAQMSX2?format=jpg&name=small'],https://twitter.com/evaluatepharma/status/889881010141360135
3598,BioPharma Dive,@BioPharmaDive,2017-07-25T17:04:00.000Z,Keytruda failure another setback for PD-1/L1 class http://bit.ly/2tGI0CH $MRK,"Keytruda failure another setback for PD-1/L1 class http://bit.ly/2tGI0CH $MRK
biopharmadive.com
Keytruda failure another setback for PD-1/L1 class
Merck's flagship immunotherapy didn't significantly improve overall survival for some head and neck cancer patients ‚Äî adding to a string of recent setbacks for the anti-PD-1 class.
1",,,1,,['https://pbs.twimg.com/card_img/1501937254045941765/gyCzFnU-?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/889894013238509568
3599,Bio Stocks‚Ñ¢,@BioStocks,2017-07-24T12:05:35.000Z,$MRK RENFLEXIS to Be Introduced in U.S. at Wholesaler Acquisition Cost of $753.39,"$MRK RENFLEXIS to Be Introduced in U.S. at Wholesaler Acquisition Cost of $753.39
Andy Biotech
@AndyBiotech
 ¬∑ 24 Jul 2017
$MRK U.S. Launch of RENFLEXIS, second #biosimilar of Remicade at 35% discount. ($PFE 1st Remicade #biosimilar launched at 15% discount)
1",,,,1,['https://pbs.twimg.com/profile_images/378800000074240482/d961ebeb9f4fe6b084a68663b9a36738_mini.png'],https://twitter.com/BioStocks/status/889456523788914688
3600,Meg Tirrell,@megtirrell,2017-07-26T14:47:08.000Z,"Alt heds for 
@DShaywitz
 fantastic read on $MRK Keytruda:
""Pembro's Perilous Path""
""Peter Kim: Unsung Biomarker Hero""","Alt heds for 
@DShaywitz
 fantastic read on $MRK Keytruda:
""Pembro's Perilous Path""
""Peter Kim: Unsung Biomarker Hero""
David Shaywitz
@DShaywitz
 ¬∑ 26 Jul 2017
Latest @forbes, and a bit of a long read: ""The Startling History Behind Merck's New Cancer Blockbuster."" https://forbes.com/sites/davidshaywitz/2017/07/26/the-startling-history-behind-mercks-new-cancer-blockbuster/#4ffe0493948d‚Ä¶
1
6
5",,1,6,5,['https://pbs.twimg.com/profile_images/1474396883925798917/QT5Wk8dB_mini.jpg'],https://twitter.com/megtirrell/status/890221957580558336
3601,The Fly,@theflynews,2017-07-24T23:24:41.000Z,On The Fly: After Hours Movers $CE $RMBS $CDNS $SWFT $ACC $HSII $SANM $APC $GOOG $GOOGL $TISI $QEP $MRK,"On The Fly: After Hours Movers $CE $RMBS $CDNS $SWFT $ACC $HSII $SANM $APC $GOOG $GOOGL $TISI $QEP $MRK
thefly.com
On The Fly: After Hours Movers
UP AFTER EARNINGS: Celane... CE, RMBS, CDNS, SWFT, ACC, HSII, SANM, APC, GOOG, GOOGL, TISI, QEP, MRK
3",,,,3,['https://pbs.twimg.com/card_img/1498862396328361986/Tgq1_DRq?format=jpg&name=small'],https://twitter.com/theflynews/status/889627427965501440
3602,Tim Reller,@TraderGuruNY,2017-07-25T01:19:08.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/889656228686831616
3603,dough,@semodough,2017-07-26T17:04:21.000Z,$PRTK Nice sign CEO & CMO exercised & held about 60K shares. $AGN $MRK most likely longterm http://services.corporate-ir.net/SEC.Enhanced/SecCapsule.aspx?c=253770&fid=15120513‚Ä¶ http://services.corporate-ir.net/SEC.Enhanced/SecCapsule.aspx?c=253770&fid=15120476‚Ä¶,"$PRTK Nice sign CEO & CMO exercised & held about 60K shares. $AGN $MRK most likely longterm http://services.corporate-ir.net/SEC.Enhanced/SecCapsule.aspx?c=253770&fid=15120513‚Ä¶ http://services.corporate-ir.net/SEC.Enhanced/SecCapsule.aspx?c=253770&fid=15120476‚Ä¶
2
1
5",,2,1,5,[],https://twitter.com/semodough/status/890256486580006912
3604,1 min Stock Insights,@1MinuteStock,2017-07-24T02:58:02.000Z,"Btw, Estimated #Earnings Per Share for $MRK is $1.07 it's 1.71% of the current price","Btw, Estimated #Earnings Per Share for $MRK is $1.07 it's 1.71% of the current price
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/889318729703596032
3605,Frank Vinluan,@frankvinluan,2017-07-24T23:57:58.000Z,"Merck #immunotherapy drug fails key clinical trial in head-and-neck #cancer http://xconomy.com/boston/2017/07/24/merck-drug-shows-no-life-extending-benefit-in-head-and-neck-cancer/‚Ä¶ via 
@xconomy
 $MRK","Merck #immunotherapy drug fails key clinical trial in head-and-neck #cancer http://xconomy.com/boston/2017/07/24/merck-drug-shows-no-life-extending-benefit-in-head-and-neck-cancer/‚Ä¶ via 
@xconomy
 $MRK
xconomy.com
Xconomy: Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer
The first immunotherapy approved in the U.S. to treat head and neck cancer has failed a big test, but it's unclear if the FDA will exercise its right to
1",,,,1,[],https://twitter.com/frankvinluan/status/889635800866062338
3606,Allison Gatlin,@IBD_AGatlin,2017-07-25T19:01:14.000Z,How Bristol could put the hurt on Dow's Merck in immuno-oncology $BMY $MRK $RHHBY $LLY,"How Bristol could put the hurt on Dow's Merck in immuno-oncology $BMY $MRK $RHHBY $LLY
investors.com
How Bristol Could Put The Hurt On Dow's Merck In Immuno-Oncology
Bristol could put the hurt on Dow component Merck, an analyst said Tuesday, after Merck's flagship immuno-oncology drug missed its goal in a key trial.",,,,,['https://pbs.twimg.com/card_img/1501718569566056454/XD6dGkCL?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/889923513267740673
3607,Eric Sagonowsky,@EricSFierce,2017-07-24T15:47:51.000Z,"Targeting a $5B brand, Samsung and Merck launch Remicade biosim at 35% discount http://fiercepharma.com/pharma/samsung-merck-launch-remicade-biosim-at-35-discount‚Ä¶ $MRK $JNJ","Targeting a $5B brand, Samsung and Merck launch Remicade biosim at 35% discount http://fiercepharma.com/pharma/samsung-merck-launch-remicade-biosim-at-35-discount‚Ä¶ $MRK $JNJ
1",,,,1,[],https://twitter.com/EricSFierce/status/889512460843188225
3608,MarketBeat,@MarketBeatCom,2017-07-26T11:07:14.000Z,Investors Purchase High Volume of Put Options on Merck & $MRK http://ift.tt/2vZKZml,Investors Purchase High Volume of Put Options on Merck & $MRK http://ift.tt/2vZKZml,,,,,[],https://twitter.com/MarketBeatCom/status/890166614544568320
3609,Market Realist,@MarketRealist,2017-07-26T19:39:26.000Z,Expect Lower Revenue from AstraZeneca in 2Q17 http://marketrealist.com/?p=2228123 $AZN $MRK $SNY $JNJ,Expect Lower Revenue from AstraZeneca in 2Q17 http://marketrealist.com/?p=2228123 $AZN $MRK $SNY $JNJ,,,,,[],https://twitter.com/MarketRealist/status/890295516139065345
3610,Market Realist,@MarketRealist,2017-07-25T20:55:41.000Z,GlaxoSmithKline's 2Q17 Earnings: What to Expect http://marketrealist.com/?p=2225113 $GSK $PPH $MRK $TEVA,"GlaxoSmithKline's 2Q17 Earnings: What to Expect http://marketrealist.com/?p=2225113 $GSK $PPH $MRK $TEVA
1",,,1,,[],https://twitter.com/MarketRealist/status/889952316501221378
3611,Market Realist,@MarketRealist,2017-07-26T19:08:52.000Z,Bristol-Myers Squibb‚Äôs 2Q17 Estimates: Expect Growth! http://marketrealist.com/?p=2227771 $BMY $IHE $JNJ $MRK,Bristol-Myers Squibb‚Äôs 2Q17 Estimates: Expect Growth! http://marketrealist.com/?p=2227771 $BMY $IHE $JNJ $MRK,,,,,[],https://twitter.com/MarketRealist/status/890287822757875712
3612,Stephanie Simon,@StephanieSimon_,2017-07-25T11:30:36.000Z,ICYMI: FDA OK'd cancer drug on condition further study showed it worked. It didn't. But FDA approval will stand $MRK,"ICYMI: FDA OK'd cancer drug on condition further study showed it worked. It didn't. But FDA approval will stand $MRK
statnews.com
Merck: Keytruda trial comes up short in head and neck cancer, but FDA approval stays
Merck‚Äôs Keytruda doesn‚Äôt help patients with advanced head-and-neck cancer live longer, but the failed clinical trial won‚Äôt compel FDA to rescind approval
1
1",,,1,1,['https://pbs.twimg.com/card_img/1498409748437295111/FW2nNPHT?format=jpg&name=small'],https://twitter.com/StephanieSimon_/status/889810109739794432
3613,avidresearch,@avidresearch,2017-07-25T00:20:32.000Z,$MRK showed 18% reduction in risk of death. Too bad p-value was 0.03 and not 0.025 coz 0.03 makes the 18% benefit completely worthless,$MRK showed 18% reduction in risk of death. Too bad p-value was 0.03 and not 0.025 coz 0.03 makes the 18% benefit completely worthless,,,,,[],https://twitter.com/avidresearch/status/889641482004680704
3614,Peter Suzman,@Biomaven,2017-07-26T13:42:50.000Z,"Great article in 
@Forbes
 on history of $MRK's PD-1 drug:
https://forbes.com/sites/davidshaywitz/2017/07/26/the-startling-history-behind-mercks-new-cancer-blockbuster/#1bd20d8e948d‚Ä¶","Great article in 
@Forbes
 on history of $MRK's PD-1 drug:
https://forbes.com/sites/davidshaywitz/2017/07/26/the-startling-history-behind-mercks-new-cancer-blockbuster/#1bd20d8e948d‚Ä¶
1
1",,,1,1,[],https://twitter.com/Biomaven/status/890205773875359746
3615,MarketBeat,@MarketBeatCom,2017-07-26T11:11:12.000Z,Merck KGaA given ‚Ç¨106.00 PT by Credit Suisse Group. neutral rating. http://ift.tt/2uYzPko $MRK #MRK,Merck KGaA given ‚Ç¨106.00 PT by Credit Suisse Group. neutral rating. http://ift.tt/2uYzPko $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/890167614881902592
3616,Stanton Mehr,@StanMehr,2017-07-26T19:20:40.000Z,This update from @DanJamesStanton: $MRK and $PFZ biosimilars both now at 35% discount to Remicade. #Biosimilars price wars!,"This update from @DanJamesStanton: $MRK and $PFZ biosimilars both now at 35% discount to Remicade. #Biosimilars price wars!
Dan Stanton
@Dan5tanton
 ¬∑ 26 Jul 2017
#Biosimilars: @pfizer Inflectra and @Merck rival both at 35% discount to Remicade in US http://biopharma-reporter.com/Markets-Regulations/Pfizer-cuts-biosimilar-price-to-match-Merck-s-new-infliximab-rival?utm_source=AddThis_twitter&utm_medium=twitter&utm_campaign=SocialMedia#.WXiic0y4zUg.twitter‚Ä¶ via @BioPharmaReport",,,,,['https://pbs.twimg.com/profile_images/3180665132/4ec32ade4d9fc64a0baec0f0bbf6f83c_mini.jpeg'],https://twitter.com/StanMehr/status/890290791716970497
3617,TradeTheNews.com,@Trade_The_News,2017-07-25T12:37:38.000Z,"$MRK Investigational NNRTI, Doravirine, Meets Primary Efficacy Endpoint of Non-Inferiority to Efavirenz,","$MRK Investigational NNRTI, Doravirine, Meets Primary Efficacy Endpoint of Non-Inferiority to Efavirenz,",,,,,[],https://twitter.com/Trade_The_News/status/889826979226296321
3618,Sir Biosimilarz,@biosimilarz,2017-07-25T16:07:51.000Z,"I find it slightly concerning that in all of the chat about $MRK's launch of Renflexis in the US, very few have mentioned $MRK also... (1/n)","I find it slightly concerning that in all of the chat about $MRK's launch of Renflexis in the US, very few have mentioned $MRK also... (1/n)
2
1",,2,1,,[],https://twitter.com/biosimilarz/status/889879881311543300
3619,Sarah Karlin-Smith,@SarahKarlin,2017-07-24T17:00:51.000Z,Re $mrk plan to sell remicade biosimilar at 35% discount. Looks close to 2012 remicade price,"Re $mrk plan to sell remicade biosimilar at 35% discount. Looks close to 2012 remicade price
Walid Gellad, MD MPH
@walidgellad
 ¬∑ 24 Jul 2017
Replying to @SarahKarlin
I had been wondering the same thing earlier today. basing estimate on this chart.
http://npr.org/sections/health-shots/2016/10/19/498559386/small-savings-for-drugs-made-to-mimic-biotech-blockbusters‚Ä¶
1",,,1,,"['https://pbs.twimg.com/profile_images/1291468546493550594/9QTRMQIi_mini.jpg', 'https://pbs.twimg.com/media/DFg8WF7XYAA0lwc?format=jpg&name=small']",https://twitter.com/SarahKarlin/status/889530832540643333
3620,EarlyBird,@mktearlybird,2017-07-25T13:55:09.000Z,"Targeting a $5B brand, Samsung and Merck launch Remicade biosim at 35% discount: http://ow.ly/vSqV30dTbgk #Pharma $MRK | Via 
@FiercePharma","Targeting a $5B brand, Samsung and Merck launch Remicade biosim at 35% discount: http://ow.ly/vSqV30dTbgk #Pharma $MRK | Via 
@FiercePharma",,,,,[],https://twitter.com/mktearlybird/status/889846484207902721
3621,Bret Jensen,@bret_jensen,2017-07-26T11:57:21.000Z,"$MRK  The Startling History Behind Merck's New Cancer Blockbuster via 
@forbes
 http://forbes.com/sites/davidshaywitz/2017/07/26/the-startling-history-behind-mercks-new-cancer-blockbuster/#7291ebb6948d‚Ä¶","$MRK  The Startling History Behind Merck's New Cancer Blockbuster via 
@forbes
 http://forbes.com/sites/davidshaywitz/2017/07/26/the-startling-history-behind-mercks-new-cancer-blockbuster/#7291ebb6948d‚Ä¶
1",,,,1,[],https://twitter.com/bret_jensen/status/890179228943216641
3622,FirstWord Pharma,@fwpharma,2017-07-25T08:02:32.000Z,Merck & Co.'s Keytruda fails to improve overall survival in head and neck cancer study https://firstwordpharma.com/node/1490692 $MRK,"Merck & Co.'s Keytruda fails to improve overall survival in head and neck cancer study https://firstwordpharma.com/node/1490692 $MRK
old.firstwordpharma.com
Merck & Co.'s Keytruda fails to improve overall survival in head and neck cancer study
Merck & Co. announced that the Phase III KEYNOTE-040 study of Keytruda (pembrolizumab) in previously treated patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) failed...
1
1",,,1,1,[],https://twitter.com/fwpharma/status/889757748522622976
3623,jim rogers,@jollyaz,2017-07-26T15:49:22.000Z,"Replying to 
@TheSimArchitect","Replying to 
@TheSimArchitect
Not rumors...if they have a approval-able antibiotic..they all sell out $MRK is a player in this area!
1
1",,1,,1,[],https://twitter.com/jollyaz/status/890237618532864005
3624,Meg Tirrell,@megtirrell,2017-07-26T14:48:30.000Z,"But even as 
@DShaywitz
 points out Kim's crucial emphasis on biomarkers, his description of Perlmutter's role feels especially inspiring $MRK","But even as 
@DShaywitz
 points out Kim's crucial emphasis on biomarkers, his description of Perlmutter's role feels especially inspiring $MRK
Meg Tirrell
@megtirrell
 ¬∑ 26 Jul 2017
Alt heds for @DShaywitz fantastic read on $MRK Keytruda:
""Pembro's Perilous Path""
""Peter Kim: Unsung Biomarker Hero""
https://twitter.com/DShaywitz/status/890105598389481472‚Ä¶
1
2
2",,1,2,2,['https://pbs.twimg.com/profile_images/791618485621325824/wBeu2-6V_mini.jpg'],https://twitter.com/megtirrell/status/890222300624191489
3625,Benzinga,@Benzinga,2017-07-24T21:30:00.000Z,Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers https://benzinga.com/z/9812288 $BMY $MRK,Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers https://benzinga.com/z/9812288 $BMY $MRK,,,,,[],https://twitter.com/Benzinga/status/889598566766960641
3626,Ronnie Matrix Mukiibi.,@RonnieMatrix,2017-07-24T13:08:10.000Z,"Replying to 
@CNNMoneyInvest
 and 
@Google","Replying to 
@CNNMoneyInvest
 and 
@Google
Big week, i will be closely watching earnings reports from $ABBV $DFS $GSK $KO $MRK $GOOGL $FB $AMZN $XOM $INTC & $VLP.
1",,,,1,[],https://twitter.com/RonnieMatrix/status/889472275677941760
3627,MarketBeat,@MarketBeatCom,2017-07-26T08:16:29.000Z,Merck KGaA given ‚Ç¨106.00 PT by Deutsche Bank AG. neutral rating. http://ift.tt/2uW3pHv $MRK #MRK,Merck KGaA given ‚Ç¨106.00 PT by Deutsche Bank AG. neutral rating. http://ift.tt/2uW3pHv $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/890123646831910914
3628,StockNews.com,@stocknewsdotcom,2017-07-24T11:16:30.000Z,$MRK Presents Week 96 results from the pivotal Phase 3 ONCEMRK study evaluating the efficacy and safety of ISENTRE‚Ä¶ https://stocknews.com/news/mrk-presents-week-96-results-from-the-pivotal-phase-3-oncemrk/‚Ä¶,$MRK Presents Week 96 results from the pivotal Phase 3 ONCEMRK study evaluating the efficacy and safety of ISENTRE‚Ä¶ https://stocknews.com/news/mrk-presents-week-96-results-from-the-pivotal-phase-3-oncemrk/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/889444173920837636
3629,The Midas Touch,@MysteryMan_777,2017-07-25T15:35:17.000Z,"Replying to 
@three_rs","Replying to 
@three_rs
$OPGN A gift here imo 33's lol. Grabbed more actually avg'd down now. Well below CEO's large open market purchase and $MRK $PZE
1
1",„ÄΩ „ÄΩ,,1,1,['https://pbs.twimg.com/media/DFl1k_ZXgAAOSZK?format=jpg&name=small'],https://twitter.com/MysteryMan_777/status/889871684941094912
3630,Andy Biotech,@AndyBiotech,2017-07-27T15:37:45.000Z,"I/O recap this week

$AZN MYSTIC fail in 1L NSCLC
$MRK KN-040 fail in HNSCC
$RHHBY axing OX40 and IDO
$AMGN ""too many PD1/PD-L1 around""","I/O recap this week

$AZN MYSTIC fail in 1L NSCLC
$MRK KN-040 fail in HNSCC
$RHHBY axing OX40 and IDO
$AMGN ""too many PD1/PD-L1 around""
3
52
42",,3,52,42,[],https://twitter.com/AndyBiotech/status/890597081303351296
3631,Merck,@Merck,2017-07-28T13:32:46.000Z,A word from Ken Frazier on our 2Q financial results. $MRK,"A word from Ken Frazier on our 2Q financial results. $MRK
5
13
50",,5,13,50,['https://pbs.twimg.com/media/DF02JbKUIAAEPJI?format=png&name=small'],https://twitter.com/Merck/status/890928015512883204
3632,Adam Feuerstein,@adamfeuerstein,2017-07-27T10:50:42.000Z,"$AZN lung cancer immunotherapy trial failure sends shares plunging ‚Äî> https://statnews.com/2017/07/27/astrazeneca-lung-cancer-immunotherapy-trial-failure-sends-shares-plunging/‚Ä¶

no doubt, you heard this already. $BMY $MRK","$AZN lung cancer immunotherapy trial failure sends shares plunging ‚Äî> https://statnews.com/2017/07/27/astrazeneca-lung-cancer-immunotherapy-trial-failure-sends-shares-plunging/‚Ä¶

no doubt, you heard this already. $BMY $MRK
statnews.com
AstraZeneca lung cancer immunotherapy trial failure sends shares plunging
A highly anticipated clinical trial combining two immunotherapy drugs failed to delay tumor growth in patients with newly diagnosed lung cancer.
1
8
15",,1,8,15,['https://pbs.twimg.com/card_img/1500878583220166656/pe4qroBn?format=jpg&name=small'],https://twitter.com/adamfeuerstein/status/890524843346624512
3633,Peter Loftus,@Loftus,2017-07-28T19:03:03.000Z,"Drug maker Merck says cyberattack hit production, will hurt profit $MRK  https://wsj.com/articles/merck-earnings-rise-on-cancer-drug-sales-1501243195‚Ä¶ via 
@WSJ","Drug maker Merck says cyberattack hit production, will hurt profit $MRK  https://wsj.com/articles/merck-earnings-rise-on-cancer-drug-sales-1501243195‚Ä¶ via 
@WSJ
wsj.com
Merck Says Cyberattack Hit Production, Will Hurt Profit
Merck said its second-quarter earnings rose as the drugmaker recorded blockbuster growth for its cancer drug Keytruda.
1
13
5",,1,13,5,['https://pbs.twimg.com/card_img/1499718498678886400/iMFUw41b?format=jpg&name=small'],https://twitter.com/Loftus/status/891011133779398658
3634,Divya Grover,@thegirlshewasnt,2017-07-28T12:08:47.000Z,"$MRK Q2 profit blew past estimates as demand surged for its key immuno-oncology drug, #Keytruda, and expenses drop
http://reuters.com/article/us-merck-co-results-idUSKBN1AD1AO‚Ä¶","$MRK Q2 profit blew past estimates as demand surged for its key immuno-oncology drug, #Keytruda, and expenses drop
http://reuters.com/article/us-merck-co-results-idUSKBN1AD1AO‚Ä¶
1
1",,,1,1,[],https://twitter.com/thegirlshewasnt/status/890906881958395905
3635,Forbes Health,@forbeshealth,2017-07-27T17:10:02.000Z,"How $MRK's cancer blockbuster went from lab bench (to lab bench, to lab bench) to market: http://on.forbes.com/60118svpJ by 
@DShaywitz","How $MRK's cancer blockbuster went from lab bench (to lab bench, to lab bench) to market: http://on.forbes.com/60118svpJ by 
@DShaywitz
1
1",,,1,1,['https://pbs.twimg.com/media/DFwecgTV0AArtq7?format=jpg&name=small'],https://twitter.com/forbeshealth/status/890620304635985922
3636,Breaking News,@MarketCurrents,2017-07-28T17:19:17.000Z,"Merck hacked, says profits impacted for remainder of year https://seekingalpha.com/news/3283060-merck-hacked-says-profits-impacted-remainder-year?source=feed_f‚Ä¶ $MRK","Merck hacked, says profits impacted for remainder of year https://seekingalpha.com/news/3283060-merck-hacked-says-profits-impacted-remainder-year?source=feed_f‚Ä¶ $MRK
1",,,,1,[],https://twitter.com/MarketCurrents/status/890985023137959936
3637,SnakeEyez,@TheMercOfWallSt,2017-07-27T18:57:39.000Z,$VZ $MRK $DIS $BA keeping the Dow green. despite market selloff.,"$VZ $MRK $DIS $BA keeping the Dow green. despite market selloff.
1",üé≤ üé≤,,,1,['https://pbs.twimg.com/media/DFw21iKUQAI5v_h?format=jpg&name=small'],https://twitter.com/TheMercOfWallSt/status/890647389416980481
3638,Seeking Alpha,@SeekingAlpha,2017-07-27T19:55:44.000Z,AstraZeneca Muddies The Water As Mystic Fails https://seekingalpha.com/article/4091492-astrazeneca-muddies-water-mystic-fails?source=feed_f‚Ä¶ $MRK $AZN,"AstraZeneca Muddies The Water As Mystic Fails https://seekingalpha.com/article/4091492-astrazeneca-muddies-water-mystic-fails?source=feed_f‚Ä¶ $MRK $AZN
seekingalpha.com
AstraZeneca Muddies The Water As Mystic Fails (NASDAQ:AZN)
The honorable intentions of chief executive Pascal Soriot seemed destined to dominate AstraZeneca's (NASDAQ:AZN) second-quarter earnings today.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1485040309126012929/Npe6H9LZ?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/890662003823345664
3639,Seeking Alpha,@SeekingAlpha,2017-07-29T13:00:05.000Z,"3 Things In Biotech You Should Learn Today: July 29, 2017 https://seekingalpha.com/article/4091847-3-things-biotech-learn-today-july-29-2017?source=feed_f‚Ä¶ $ABLYF $AZN $EGRX $MRK","3 Things In Biotech You Should Learn Today: July 29, 2017 https://seekingalpha.com/article/4091847-3-things-biotech-learn-today-july-29-2017?source=feed_f‚Ä¶ $ABLYF $AZN $EGRX $MRK",,,,,[],https://twitter.com/SeekingAlpha/status/891282180277641216
3640,John Carroll,@JohnCendpts,2017-07-28T12:47:07.000Z,"CheckMate-227: Bristol-Myers Squibb has a MYSTIC problem
$BMY $AZN $MRK","CheckMate-227: Bristol-Myers Squibb has a MYSTIC problem
$BMY $AZN $MRK
endpts.com
CheckMate-227: Bristol-Myers Squibb has a MYSTIC-sized problem on its hands
Nobody knows how to put a top exec on the spot quite like Goldman Sach‚Äôs Jami Rubin. The high-profile analyst has a well-earned rep for going straight for the jugular, and that was on full display...
8
6",,,8,6,[],https://twitter.com/JohnCendpts/status/890916530397085696
3641,Cboe,@CBOE,2017-07-27T16:11:42.000Z,"#FANGS options heavy action: $FB, $AMZN, $AAPL  
@AngieMiles
 w 
@FreeboardCap
 $MRK & $BMY http://bit.ly/2h639jB","#FANGS options heavy action: $FB, $AMZN, $AAPL  
@AngieMiles
 w 
@FreeboardCap
 $MRK & $BMY http://bit.ly/2h639jB
1
5
6",,1,5,6,['https://pbs.twimg.com/ext_tw_video_thumb/890605238167719936/pu/img/S-8h4YiUxA8be9r1.jpg'],https://twitter.com/CBOE/status/890605625171890179
3642,SpeakToMe,@SpeakToMe,2017-07-28T19:07:46.000Z,$DVAX adcom votes 11-1 in favor. So upsetting. No way in my mind that the FDA was not influenced previously by big money from $MRK and $GSK.,"$DVAX adcom votes 11-1 in favor. So upsetting. No way in my mind that the FDA was not influenced previously by big money from $MRK and $GSK.
2",,,,2,[],https://twitter.com/SpeakToMe/status/891012323397304321
3643,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-07-27T12:25:37.000Z,$TSRO $CLVS $AZN $MRK CS Thoughts on PARP space announcements ‚ñ† Interesting news this morning in the PARP (cont) http://tl.gd/n_1sq2hq2,"$TSRO $CLVS $AZN $MRK CS Thoughts on PARP space announcements ‚ñ† Interesting news this morning in the PARP (cont) http://tl.gd/n_1sq2hq2
3
4",üÖ± üÖæ,,3,4,[],https://twitter.com/_B_I_O_T_E_C_H_/status/890548728439898113
3644,jim rogers,@jollyaz,2017-07-28T19:51:20.000Z,$dvax Take out by $MRK $750 would put the stk near $15.  Not bad for hepB vac said to be wth $500m. Throw in the pipeline for O ?,"$dvax Take out by $MRK $750 would put the stk near $15.  Not bad for hepB vac said to be wth $500m. Throw in the pipeline for O ?
2",,,,2,[],https://twitter.com/jollyaz/status/891023288260067328
3645,SpoiledrottenBrat,@TaxHavens,2017-07-28T12:37:37.000Z,$GILD so HCV of $2.9B compared with $MRK Zap at $517M - 6 times in favor of GILD. Just last Q GILD HCV jumped $400M from $2.5B in Q1 2017.,"$GILD so HCV of $2.9B compared with $MRK Zap at $517M - 6 times in favor of GILD. Just last Q GILD HCV jumped $400M from $2.5B in Q1 2017.
1
2",,1,,2,[],https://twitter.com/TaxHavens/status/890914135952818176
3646,MM+M Magazine,@MMMnews,2017-07-28T03:15:00.000Z,"5 things for #pharma #marketers to know: Thu., July 27 #FDA $GSK #hiv #oncology $AZN $MRK $LLY http://bit.ly/2v0Ae6g","5 things for #pharma #marketers to know: Thu., July 27 #FDA $GSK #hiv #oncology $AZN $MRK $LLY http://bit.ly/2v0Ae6g
2",,,,2,['https://pbs.twimg.com/media/DFv2DJ_XgAEBKfa?format=jpg&name=small'],https://twitter.com/MMMnews/status/890772551126863873
3647,Cboe,@CBOE,2017-07-27T16:39:02.000Z,$AAL $CVX $XOM $MRK and more report before the market open tomorrow - get the 3 year stock price reaction histories http://bit.ly/2eFnDil,"$AAL $CVX $XOM $MRK and more report before the market open tomorrow - get the 3 year stock price reaction histories http://bit.ly/2eFnDil
2
4",,,2,4,['https://pbs.twimg.com/media/DFwXWiCUQAA2GzG?format=jpg&name=small'],https://twitter.com/CBOE/status/890612505004965888
3648,BioWorld,@BioWorld,2017-07-28T16:48:01.000Z,"More gyrations in tumultuous week for #biopharma with $AZN ph 3 dud, $8.5B $MRK arrangement #biopharma http://bit.ly/2eTm9RM","More gyrations in tumultuous week for #biopharma with $AZN ph 3 dud, $8.5B $MRK arrangement #biopharma http://bit.ly/2eTm9RM
2
2",,,2,2,[],https://twitter.com/BioWorld/status/890977152228884480
3649,Selerity,@Selerity,2017-07-28T10:45:35.000Z,"#BREAKING: Merck $MRK Q2 Non-GAAP Earnings Per Share (EPS), $1.01 vs. $0.87 expected","#BREAKING: Merck $MRK Q2 Non-GAAP Earnings Per Share (EPS), $1.01 vs. $0.87 expected
1
2",,,1,2,[],https://twitter.com/Selerity/status/890885944445980672
3650,Stock Horizon LLC,@StockHorizon,2017-07-28T13:32:01.000Z,Sonar top 10 NYSE @ open: $AKS $BA $BCC $CMG $GNC $HOG $MRK $SNAP $TWTR $X See them ranked http://sonar.stockhorizon.com/?open=1,"Sonar top 10 NYSE @ open: $AKS $BA $BCC $CMG $GNC $HOG $MRK $SNAP $TWTR $X See them ranked http://sonar.stockhorizon.com/?open=1
1
1
1",,1,1,1,[],https://twitter.com/StockHorizon/status/890927828367282176
3651,"Clair Lee, M.S.",@clair520,2017-07-27T12:25:32.000Z,"Looked like 2 $XLV ( $ALXN, $MRK ) R up & 2 $XLV ( $BMY, $WST ) R down premarket today! Thx Coach for on time 8@8 again! Travel Safe Home!","Looked like 2 $XLV ( $ALXN, $MRK ) R up & 2 $XLV ( $BMY, $WST ) R down premarket today! Thx Coach for on time 8@8 again! Travel Safe Home!
3
4",‚úà,,3,4,[],https://twitter.com/clair520/status/890548707741118468
3652,ADayTRading,@ADaytrading,2017-07-27T13:23:19.000Z,"Watchlist: $FB $TWTR $NVDA $MRK $CAPR $TOO $NUGT 
#daytrading #beatrader #StocksToWatch #StockTrading","Watchlist: $FB $TWTR $NVDA $MRK $CAPR $TOO $NUGT 
#daytrading #beatrader #StocksToWatch #StockTrading
1
1",,1,,1,[],https://twitter.com/ADaytrading/status/890563250051579904
3653,Joanne Fagg,@ByJoFagg,2017-07-28T10:05:30.000Z,"Ahead of the $MRK financial call later, a look at its biggest products by 2022 via 
@evaluatepharma
 more info: http://evaluategroup.com/public/Evaluate-Media-Kit.aspx‚Ä¶","Ahead of the $MRK financial call later, a look at its biggest products by 2022 via 
@evaluatepharma
 more info: http://evaluategroup.com/public/Evaluate-Media-Kit.aspx‚Ä¶
2
1",,,2,1,['https://pbs.twimg.com/media/DF0G0ojXkAAzB2-?format=jpg&name=small'],https://twitter.com/ByJoFagg/status/890875856398286851
3654,BioSpace,@biospace,2017-07-27T21:55:07.000Z,AstraZeneca PLC $AZN Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co. $MRK http://ow.ly/uBIO30dXWMr,"AstraZeneca PLC $AZN Seals a $8.5 Billion R&D Cancer Tie-Up With Merck & Co. $MRK http://ow.ly/uBIO30dXWMr
1",,,,1,['https://pbs.twimg.com/media/DFxfspHVoAAHVtJ?format=jpg&name=small'],https://twitter.com/biospace/status/890692050647216129
3655,Helen Ong,@Lin_ling_88,2017-07-28T05:51:18.000Z,"Calling time on the #immunotherapy gold rush - The Lancet Oncology

$KITE $JUNO $BLUE $MRK $AZN http://thelancet.com/journals/lanonc/article/PIIS1470-2045%2817%2930521-1/fulltext#.WXppC2AEYQw.twitter‚Ä¶","Calling time on the #immunotherapy gold rush - The Lancet Oncology

$KITE $JUNO $BLUE $MRK $AZN http://thelancet.com/journals/lanonc/article/PIIS1470-2045%2817%2930521-1/fulltext#.WXppC2AEYQw.twitter‚Ä¶
2",,,,2,[],https://twitter.com/Lin_ling_88/status/890811884726767617
3656,Ankur Banerjee,@AnkurBanerjee17,2017-07-27T09:16:48.000Z,And some billions to be added to $MRK market cap,"And some billions to be added to $MRK market cap
Thyagu Adinarayan
@Thyagu
 ¬∑ 27 Jul 2017
$13 billion market cap loss; $AZN in bullets",,,,,"['https://pbs.twimg.com/profile_images/1479582966909177856/E0Nhq7aw_mini.jpg', 'https://pbs.twimg.com/media/DFuxL7uUIAAaU_-?format=jpg&name=large']",https://twitter.com/AnkurBanerjee17/status/890501210721013760
3657,John Carroll,@JohnCendpts,2017-07-27T17:16:37.000Z,"Blowout --
UPDATED: $AZN inks $8.4B pact with $MRK as crucial MYSTIC study fails and shares plunge
$BMY","Blowout --
UPDATED: $AZN inks $8.4B pact with $MRK as crucial MYSTIC study fails and shares plunge
$BMY
endpts.com
AstraZeneca inks $8.4B pact with Merck as crucial MYSTIC study fails and shares plunge
AstraZeneca's crucial combination trial of durvalumab (Imfinzi) and tremelimumab has failed the primary endpoint on progression-free survival as a first-line therapy for non-small cell lung cancer....
2
1",,,2,1,['https://pbs.twimg.com/card_img/1501985063109644293/8WanqS9I?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/890621964062048266
3658,Mavis Nye Dr (hon) BEM. BCAh,@Grandmamavis,2017-07-28T18:50:54.000Z,"Merck hacked, says profits impacted for remainder of year #mesothelioma #NHS https://seekingalpha.com/news/3283060-merck-hacked-says-profits-impacted-remainder-year?source=tweet‚Ä¶ $MRK","Merck hacked, says profits impacted for remainder of year #mesothelioma #NHS https://seekingalpha.com/news/3283060-merck-hacked-says-profits-impacted-remainder-year?source=tweet‚Ä¶ $MRK
seekingalpha.com
Merck hacked, says profits impacted for remainder of year (NYSE:MRK)
Reuters reports that Merck (MRK +0.5%) was the target of an international cyberattack last month that disrupted its global operations, halting the production of its drugs.
1",,,1,,['https://pbs.twimg.com/card_img/1499883144031641600/6nYXB84Y?format=png&name=240x240'],https://twitter.com/Grandmamavis/status/891008079491366912
3659,BioWorld,@BioWorld,2017-07-29T02:39:00.000Z,"Updated: $AZN ph 3 dud, $8.5B $MRK arrangement cause more ripples in #biopharma http://bit.ly/2eTm9RM","Updated: $AZN ph 3 dud, $8.5B $MRK arrangement cause more ripples in #biopharma http://bit.ly/2eTm9RM
1
1",,,1,1,[],https://twitter.com/BioWorld/status/891125880210292736
3660,Amy Brown,@ByAmyBrown,2017-07-27T06:26:29.000Z,"$AZN hits the wires (burying news?) with PR onslaught as Mystic fails at 1st cut - Tagrisso Flaura P3 hit, $MRK onc collab, Q2 results.","$AZN hits the wires (burying news?) with PR onslaught as Mystic fails at 1st cut - Tagrisso Flaura P3 hit, $MRK onc collab, Q2 results.
1",,,1,,[],https://twitter.com/ByAmyBrown/status/890458353218052098
3661,$peedyCalls,@SpeedyCalls,2017-07-27T19:15:59.000Z,"$MRK 62 Puts BUYING Activity expiring on 28th Jul, Vol 5549","$MRK 62 Puts BUYING Activity expiring on 28th Jul, Vol 5549",,,,,[],https://twitter.com/SpeedyCalls/status/890652000148348932
3662,Thyagu Adinarayan,@Thyagu,2017-07-27T11:01:11.000Z,"Replying to 
@Thyagu","Replying to 
@Thyagu
Merck $MRK +5 pct; $BMY -5 pct in light premarket trade; 
@AnkurBanerjee17
, Sort of understood the connection, I'm bad at this
1
1",,1,,1,['https://pbs.twimg.com/media/DFvJoPRXUAA752r?format=jpg&name=900x900'],https://twitter.com/Thyagu/status/890527482365059072
3663,Sean McGrath,@sean_uk,2017-07-28T19:25:00.000Z,AstraZeneca Shows the Peril of Going All-In https://shar.es/1TdIbE #cancer #oncology #immunotherapy $AZN $MRK $BMS #lungcancer,"AstraZeneca Shows the Peril of Going All-In https://shar.es/1TdIbE #cancer #oncology #immunotherapy $AZN $MRK $BMS #lungcancer
1
1",,,1,1,[],https://twitter.com/sean_uk/status/891016659229650945
3664,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-07-27T09:59:53.000Z,"$MRK $AZN  Establish Strategic Oncology Collaboration

Wow... I did not see this coming at all... http://investors.merck.com/news/press-release-details/2017/AstraZeneca-and-Merck-Establish-Strategic-Oncology-Collaboration/default.aspx‚Ä¶","$MRK $AZN  Establish Strategic Oncology Collaboration

Wow... I did not see this coming at all... http://investors.merck.com/news/press-release-details/2017/AstraZeneca-and-Merck-Establish-Strategic-Oncology-Collaboration/default.aspx‚Ä¶
3",,,,3,[],https://twitter.com/DrPaulyDeSantis/status/890512053026168832
3665,Brad Loncar,@bradloncar,2017-07-28T12:16:53.000Z,This emphasis of this $MRK call is all about the cyber attack.,"This emphasis of this $MRK call is all about the cyber attack.
1
1",,,1,1,[],https://twitter.com/bradloncar/status/890908920855879681
3666,Vista Partners LLC,@VistaPResearch,2017-07-27T04:20:40.000Z,"@freecozymyster1
 thanks for follow! See Vista Partners #InvestingForLife #Dow30 http://vistapglobal.com $V $MSFT $DIS $ATOS $MRK #biotech","@freecozymyster1
 thanks for follow! See Vista Partners #InvestingForLife #Dow30 http://vistapglobal.com $V $MSFT $DIS $ATOS $MRK #biotech
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DFtuWCdUMAA8t0L.jpg'],https://twitter.com/VistaPResearch/status/890426686327500802
3667,Lisa LaMotta,@lisalamotta,2017-07-27T13:42:00.000Z,"Hedging its bets after MYSTIC fail, $AZN inks $8.5B #oncology deal with $MRK http://biopharmadive.com/news/astrazeneca-merck-billion-cancer-deal-lynparza-mystic-miss/447998/‚Ä¶","Hedging its bets after MYSTIC fail, $AZN inks $8.5B #oncology deal with $MRK http://biopharmadive.com/news/astrazeneca-merck-billion-cancer-deal-lynparza-mystic-miss/447998/‚Ä¶
1",,,,1,[],https://twitter.com/lisalamotta/status/890567953174757377
3668,Selerity,@Selerity,2017-07-28T10:45:35.000Z,"#BREAKING: Merck $MRK Q2 Revenue, $9.93B vs. $9.75B expected","#BREAKING: Merck $MRK Q2 Revenue, $9.93B vs. $9.75B expected
1",,,,1,[],https://twitter.com/Selerity/status/890885945351917568
3669,MarkFuccio,@markfuccio,2017-07-28T19:44:07.000Z,"FYI 
@SGgrc
: NotPetya  cyber attack hurting production and revenue. Thus this disclosure by $MRK.","FYI 
@SGgrc
: NotPetya  cyber attack hurting production and revenue. Thus this disclosure by $MRK.
Reuters
@Reuters
 ¬∑ 29 Jul 2017
Merck says cyber attack halted production, will hurt profits http://reut.rs/2w7kTxC
1",,,,1,"['https://pbs.twimg.com/profile_images/1194751949821939712/3VBu4_Sa_mini.jpg', 'https://pbs.twimg.com/media/DF2IG5SXkAA6x6K?format=jpg&name=small']",https://twitter.com/markfuccio/status/891021470125522944
3670,Merck,@Merck,2017-07-28T13:05:37.000Z,Thank you to our investors for following & joining our $MRK conversation this morning. Have a great day.,"Thank you to our investors for following & joining our $MRK conversation this morning. Have a great day.
6",,,,6,[],https://twitter.com/Merck/status/890921185676054528
3671,Sir Biosimilarz,@biosimilarz,2017-07-28T15:03:29.000Z,Nice to see someone take my advice and mention $MRK's dual personality in relation to #biosimilars and branded biologics :),"Nice to see someone take my advice and mention $MRK's dual personality in relation to #biosimilars and branded biologics :)
Stanton Mehr
@StanMehr
 ¬∑ 28 Jul 2017
Please see the erratum on my recent post regarding #Inflectra, #Renflexis, and #Remicade. http://wp.me/p7gt6c-b2  #biosimilars",,,,,['https://pbs.twimg.com/profile_images/780039368824221696/XbUwDROw_mini.jpg'],https://twitter.com/biosimilarz/status/890950846992797696
3672,Jeff Buchanan,@_jeffbuchanan,2017-07-28T23:52:08.000Z,"Invenra Signs On With Merck in Antibody Discovery Partnership $MRK http://xconomy.com/wisconsin/2017/07/28/invenra-signs-on-with-merck-in-antibody-discovery-partnership/‚Ä¶ 
@Xconomy","Invenra Signs On With Merck in Antibody Discovery Partnership $MRK http://xconomy.com/wisconsin/2017/07/28/invenra-signs-on-with-merck-in-antibody-discovery-partnership/‚Ä¶ 
@Xconomy
1
2",,,1,2,[],https://twitter.com/_jeffbuchanan/status/891083884628193280
3673,The Fly,@theflynews,2017-07-27T14:53:06.000Z,AstraZeneca plunges following failed lung cancer study $AZN $BMY $MRK $TEVA http://dlvr.it/PYwc0L,"AstraZeneca plunges following failed lung cancer study $AZN $BMY $MRK $TEVA http://dlvr.it/PYwc0L
1",,,,1,[],https://twitter.com/theflynews/status/890585846805479425
3674,The Fly,@theflynews,2017-07-28T13:49:04.000Z,On The Fly: Pre-market Movers $BIDU $ALGN $NLNK $INTC $MRK $COL $ABBV $SBUX $WDC $EA $KLAC $FLS $AAL $XOM $OZRK http://dlvr.it/PZ8jmh,On The Fly: Pre-market Movers $BIDU $ALGN $NLNK $INTC $MRK $COL $ABBV $SBUX $WDC $EA $KLAC $FLS $AAL $XOM $OZRK http://dlvr.it/PZ8jmh,,,,,[],https://twitter.com/theflynews/status/890932117852397569
3675,John Carroll,@JohnCendpts,2017-07-27T19:05:16.000Z,Insightful remarks on Lynparza deal with $MRK. $AZN is selling future revenue for temp gains. Not smart.,"Insightful remarks on Lynparza deal with $MRK. $AZN is selling future revenue for temp gains. Not smart.
Max Nisen
@MaxNisen
 ¬∑ 28 Jul 2017
AstraZeneca shows the perils of going all-in https://bloomberg.com/gadfly/articles/2017-07-27/astrazeneca-mystic-failure-shows-the-peril-of-going-all-in‚Ä¶
3",,,,3,['https://pbs.twimg.com/profile_images/1451176535969484801/QZABl675_mini.jpg'],https://twitter.com/JohnCendpts/status/890649303500206080
3676,Ron Leuty,@rleuty_biotech,2017-07-27T17:57:14.000Z,"$AZN, $MRK have big So SF real estate plans -> AstraZeneca inks $8.4B pact w Merck as key study fails, shares plunge","$AZN, $MRK have big So SF real estate plans -> AstraZeneca inks $8.4B pact w Merck as key study fails, shares plunge
endpts.com
AstraZeneca inks $8.4B pact with Merck as crucial MYSTIC study fails and shares plunge
AstraZeneca's crucial combination trial of durvalumab (Imfinzi) and tremelimumab has failed the primary endpoint on progression-free survival as a first-line therapy for non-small cell lung cancer....
1",,,1,,['https://pbs.twimg.com/card_img/1501985063109644293/8WanqS9I?format=jpg&name=small'],https://twitter.com/rleuty_biotech/status/890632184205164544
3677,FirstWord Pharma,@fwpharma,2017-07-27T09:21:01.000Z,"AstraZeneca, Merck & Co. enter cancer drug development deal focused on PARP inhibitor Lynparza https://firstwordpharma.com/node/1491567 $AZN $MRK","AstraZeneca, Merck & Co. enter cancer drug development deal focused on PARP inhibitor Lynparza https://firstwordpharma.com/node/1491567 $AZN $MRK
old.firstwordpharma.com
AstraZeneca, Merck & Co. enter cancer drug development deal focused on PARP inhibitor Lynparza
AstraZeneca and Merck & Co. entered a deal potentially worth up to $8.5 billion to jointly develop and market the UK drugmaker's PARP inhibitor Lynparza (olaparib) for multiple cancer types, includ...
1
1",,,1,1,[],https://twitter.com/fwpharma/status/890502273356398592
3678,Benzinga,@Benzinga,2017-07-28T11:15:01.000Z,"10 Stocks To Watch For July 28, 2017 https://benzinga.com/z/9838195 $AAL $AMZN $CVX $MRK $GT $INTC $SBUX $PEG $WDC $XOM","10 Stocks To Watch For July 28, 2017 https://benzinga.com/z/9838195 $AAL $AMZN $CVX $MRK $GT $INTC $SBUX $PEG $WDC $XOM
benzinga.com
10 Stocks To Watch For July 28, 2017
Some of the stocks that may grab investor focus today are: Wall Street expects Chevron Corporation (NYSE: CVX) to report quarterly earnings at $0.87 per share on revenue of $...
2",,,2,,[],https://twitter.com/Benzinga/status/890893348889698304
3679,Bursatil Biotech,@BursatilBiotech,2017-07-28T11:23:01.000Z,"Replying to 
@BursatilBiotech","Replying to 
@BursatilBiotech
Cute Caforio $BMY $MRK
Bio Stocks‚Ñ¢
@BioStocks
 ¬∑ 28 Jul 2017
$BMY 'we expect a significant slowdown for Opdivo in the U.S' - BMO 
Reiterates Underperform. PT lowered to $49
1",,,,1,['https://pbs.twimg.com/profile_images/1345176821185306624/4OaDT_lb_mini.jpg'],https://twitter.com/BursatilBiotech/status/890895362851995648
3680,Mandy Jackson,@ScripMandy,2017-07-27T06:13:55.000Z,$AZN Also announcing oncology collaboration with $MRK to jointly develop & commercialize PARP inhibitor Lynparza & MEK inhibitor selumetinib,"$AZN Also announcing oncology collaboration with $MRK to jointly develop & commercialize PARP inhibitor Lynparza & MEK inhibitor selumetinib
AstraZeneca
@AstraZeneca
 ¬∑ 27 Jul 2017
AstraZeneca publishes H1 2017 financial results $AZN http://bit.ly/2tLfoIu",,,,,['https://pbs.twimg.com/profile_images/837494857/AZTwitter_mini.png'],https://twitter.com/ScripMandy/status/890455186887458816
3681,$PENNY KING,@groman100,2017-07-28T17:32:13.000Z,"Study Demonstrating NT-219 Enhanced Efficacy of Keytruda¬Æ in Immune-On... https://finance.yahoo.com/news/kitov-announces-results-study-demonstrating-123600596.html?soc_src=social-sh&soc_trk=tw‚Ä¶ via 
@YahooFinance
 $MRK $KTOV","Study Demonstrating NT-219 Enhanced Efficacy of Keytruda¬Æ in Immune-On... https://finance.yahoo.com/news/kitov-announces-results-study-demonstrating-123600596.html?soc_src=social-sh&soc_trk=tw‚Ä¶ via 
@YahooFinance
 $MRK $KTOV
1",,,,1,[],https://twitter.com/groman100/status/890988275996872704
3682,Lisa LaMotta,@lisalamotta,2017-07-27T10:38:31.000Z,$AZN tapping $MRK to develop/commercialize Lynparza and selumetinib with Keytruda https://astrazeneca.com/content/astraz/media-centre/press-releases/2017/astrazeneca-and-merck-establish-strategic-oncology-collaboration-27072017.html‚Ä¶,$AZN tapping $MRK to develop/commercialize Lynparza and selumetinib with Keytruda https://astrazeneca.com/content/astraz/media-centre/press-releases/2017/astrazeneca-and-merck-establish-strategic-oncology-collaboration-27072017.html‚Ä¶,,,,,[],https://twitter.com/lisalamotta/status/890521779374051328
3683,Dennis M Winters,@m_denniswinters,2017-07-29T00:55:19.000Z,"Replying to 
@zybrestat","Replying to 
@zybrestat
2x sales + 500m for io pipeline is still over $33 per share.  This is super cheap!  $dvax $Mrk 
@bradloncar
1
9",,1,,9,[],https://twitter.com/m_denniswinters/status/891099786027380736
3684,Imani,@MoiseNoise,2017-07-28T12:21:55.000Z,Merck is playing both sides of the brand name vs. generic battle $MRK https://wsj.com/articles/merck-earnings-rise-on-cancer-drug-sales-1501243195‚Ä¶,Merck is playing both sides of the brand name vs. generic battle $MRK https://wsj.com/articles/merck-earnings-rise-on-cancer-drug-sales-1501243195‚Ä¶,,,,,[],https://twitter.com/MoiseNoise/status/890910186310971393
3685,Cynthia Koons,@CynthiaLKoons,2017-07-27T12:08:34.000Z,"AstraZeneca's immune therapy combo for lung cancer fails, rewriting the cancer drug landscape: https://bloom.bg/2ePn6dG $AZN $BMY $MRK","AstraZeneca's immune therapy combo for lung cancer fails, rewriting the cancer drug landscape: https://bloom.bg/2ePn6dG $AZN $BMY $MRK
2",,,2,,[],https://twitter.com/CynthiaLKoons/status/890544440800104448
3686,avidresearch,@avidresearch,2017-07-28T12:26:47.000Z,"Replying to 
@bradloncar","Replying to 
@bradloncar
an incredible drug that almost got shelved. $MRK
2",,,,2,[],https://twitter.com/avidresearch/status/890911412779974656
3687,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-07-28T18:23:24.000Z,"Replying to 
@popastock","Replying to 
@popastock
Should be - if $MRK Keytruda was unaffected by the Cyberattack ;)
1
3",,1,,3,[],https://twitter.com/dhovekamp42/status/891001155182096390
3688,Earnings News,@EPSGUID,2017-07-27T18:31:49.000Z,"Options are priced for bigger-than-average #earnings move for $MRK reporting 7/28/2017 via 
@eWhispers
 #volatility","Options are priced for bigger-than-average #earnings move for $MRK reporting 7/28/2017 via 
@eWhispers
 #volatility
earningswhispers.com
Merck & (MRK) Reports Earnings on May 5
Merck & (MRK) reports earnings on 5/5/2022. Shares are down 5.8% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings.",,,,,['https://pbs.twimg.com/card_img/1501679964579831808/vvCng05m?format=png&name=240x240'],https://twitter.com/EPSGUID/status/890640887931256835
3689,Earnings News,@EPSGUID,2017-07-28T10:46:56.000Z,"$MRK reported earnings of $1.01, consensus was $0.87, Earnings Whisper was $0.89 via 
@eWhispers
 #whisperbeat http://eps.sh/d/mrk","$MRK reported earnings of $1.01, consensus was $0.87, Earnings Whisper was $0.89 via 
@eWhispers
 #whisperbeat http://eps.sh/d/mrk",,,,,[],https://twitter.com/EPSGUID/status/890886284629213184
3690,Estimize,@Estimize,2017-07-28T11:03:22.000Z,Well done Guido_Coenen beating 42 other analysts and the Wall Street Consensus to take the win for $MRK - http://estimize.com/mrk/fq2-2017?utm_content=release_winner&utm_medium=tweet&utm_source=twitter‚Ä¶,Well done Guido_Coenen beating 42 other analysts and the Wall Street Consensus to take the win for $MRK - http://estimize.com/mrk/fq2-2017?utm_content=release_winner&utm_medium=tweet&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/Estimize/status/890890417436315648
3691,JQ,@jq1234t,2017-07-27T08:08:13.000Z,"Replying to 
@jq1234t
, 
@JacobPlieth
 and 
@Asthika","Replying to 
@jq1234t
, 
@JacobPlieth
 and 
@Asthika
What's the point of having PD-L1/CTLA4 combo if they can't expand PD-L1>=50% to 25%? Durvalumab failed at 25% too, $MRK chose perfect cutoff
1
1",,1,,1,[],https://twitter.com/jq1234t/status/890483954960224257
3692,Dennis M Winters,@m_denniswinters,2017-07-29T12:27:48.000Z,"They are testing io assets with $mrk.  Would not surprise me to see them team up again on this.  But again, I think they should be acquired.","They are testing io assets with $mrk.  Would not surprise me to see them team up again on this.  But again, I think they should be acquired.
1",,,,1,[],https://twitter.com/m_denniswinters/status/891274053381758977
3693,Benzinga,@Benzinga,2017-07-28T12:00:03.000Z,A Peek Into The Markets: U.S. Stock Futures Down; Amazon Earnings Miss Views https://benzinga.com/news/17/07/9839103/a-peek-into-the-markets-u-s-stock-futures-down-amazon-earnings-miss-views‚Ä¶ $SAVE $AMZN $MRK $INTC $SBUX,"A Peek Into The Markets: U.S. Stock Futures Down; Amazon Earnings Miss Views https://benzinga.com/news/17/07/9839103/a-peek-into-the-markets-u-s-stock-futures-down-amazon-earnings-miss-views‚Ä¶ $SAVE $AMZN $MRK $INTC $SBUX
benzinga.com
A Peek Into The Markets: U.S. Stock Futures Down; Amazon Earnings Miss Views
Pre-open movers U.S. stock futures traded lower in early pre-market trade, ahead of earnings from several companies. Data on Gross Domestic Product growth for the second quarter...",,,,,[],https://twitter.com/Benzinga/status/890904684625502208
3694,stockassassin,@stockassassin74,2017-07-29T18:30:20.000Z,"Replying to 
@BigBullCap
 @skaushi
  and 2 others","Replying to 
@BigBullCap
 @skaushi
  and 2 others
¬Ø\_(„ÉÑ)_/¬Ø but how does $mrk not buy $dvax now? vaccine and IO - sorry $gsk!
2
1",,2,,1,[],https://twitter.com/stockassassin74/status/891365289350242304
3695,Jacob Plieth,@JacobPlieth,2017-07-27T15:19:19.000Z,"Replying to 
@PDRennert","Replying to 
@PDRennert
@BursatilBiotech
 Very hard to compare across trials. 2L setting different vs 1L. Design differences/crossover/duration of PFS $AZN $BMY $MRK
1
1",,1,,1,[],https://twitter.com/JacobPlieth/status/890592441363042305
3696,Brad Loncar,@bradloncar,2017-07-28T12:37:30.000Z,Something that all companies like $BMY $MRK have talked about is how hard it will be to show an OS benefit in lung due to crossover. $AZN,"Something that all companies like $BMY $MRK have talked about is how hard it will be to show an OS benefit in lung due to crossover. $AZN
2
2",,2,,2,[],https://twitter.com/bradloncar/status/890914106609414144
3697,Herkyleese,@herkyleese,2017-07-31T09:10:28.000Z,If one antigen is worth $Billions imagine what multiple antigens are worth. $mrk $bmy $nwbo $rbbhy $kite $juno   #Dcvax-L  (Thanks Brad),"If one antigen is worth $Billions imagine what multiple antigens are worth. $mrk $bmy $nwbo $rbbhy $kite $juno   #Dcvax-L  (Thanks Brad)
7
10",,,7,10,['https://pbs.twimg.com/media/DGDXBvQVYAACypD?format=jpg&name=small'],https://twitter.com/herkyleese/status/891949171409915905
3698,pharmalot,@pharmalot,2017-07-31T13:18:25.000Z,Pharmalot.. Pharmalittle.. Good Morning.. Merck admits cyberattack hurts & more news.. https://statnews.com/pharmalot/2017/07/31/merck-cyberattack-amgen-regeneron/‚Ä¶ #pharma $MRK $AMGN $REGN $AZN,"Pharmalot.. Pharmalittle.. Good Morning.. Merck admits cyberattack hurts & more news.. https://statnews.com/pharmalot/2017/07/31/merck-cyberattack-amgen-regeneron/‚Ä¶ #pharma $MRK $AMGN $REGN $AZN
statnews.com
Pharmalittle: Merck admits cyberattack hurts; Amgen hopes for Repatha label update
Merck disclosed profits will be hit by a June 27 cyberattack and is still restoring active pharmaceutical ingredient operations.
2
2",,,2,2,['https://pbs.twimg.com/card_img/1500534343600644098/wAHXYJa7?format=jpg&name=small'],https://twitter.com/pharmalot/status/892011570724831232
3699,Bio Stocks‚Ñ¢,@BioStocks,2017-07-31T13:34:40.000Z,"$GNBT $MRK Collaboration to Evaluate KEYTRUDA in Combination with AE37 in Patients with Breast Cancer
https://finance.yahoo.com/news/generex-announces-collaboration-merck-evaluate-133000182.html‚Ä¶","$GNBT $MRK Collaboration to Evaluate KEYTRUDA in Combination with AE37 in Patients with Breast Cancer
https://finance.yahoo.com/news/generex-announces-collaboration-merck-evaluate-133000182.html‚Ä¶
2",,,2,,[],https://twitter.com/BioStocks/status/892015658132799488
3700,Hawkeye Advisory Services LLC,@AlaLongleaf,2017-07-31T20:05:02.000Z,"#Dynavax stock skyrockets 72% after rollercoaster ride toward #vaccine approval 
http://marketwatch.com/story/the-rollercoaster-ride-that-led-to-dynavax-stock-skyrocketing-74-2017-07-31‚Ä¶ $MRK $DVAX $GKS #ShortSqueeze","#Dynavax stock skyrockets 72% after rollercoaster ride toward #vaccine approval 
http://marketwatch.com/story/the-rollercoaster-ride-that-led-to-dynavax-stock-skyrocketing-74-2017-07-31‚Ä¶ $MRK $DVAX $GKS #ShortSqueeze",,,,,['https://pbs.twimg.com/media/DGFsclRVYAAApa-?format=jpg&name=small'],https://twitter.com/AlaLongleaf/status/892113898563874817
3701,Tom Silver,@TomSilver39,2017-07-30T01:32:22.000Z,"$BMY $MRK $AZN Immune checkpoint inhibitors
for advanced NSCLC: emerging sequencing for new treatment targets http://esmoopen.bmj.com/content/esmoopen/2/3/e000200.full.pdf‚Ä¶","$BMY $MRK $AZN Immune checkpoint inhibitors
for advanced NSCLC: emerging sequencing for new treatment targets http://esmoopen.bmj.com/content/esmoopen/2/3/e000200.full.pdf‚Ä¶
5
4",,,5,4,"['https://pbs.twimg.com/media/DF8kkGeVwAAjXz7?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DF8kkfOUMAAkByV?format=jpg&name=small', 'https://pbs.twimg.com/media/DF8kk_3VYAAX0LE?format=jpg&name=small']",https://twitter.com/TomSilver39/status/891471498459926530
3702,MM+M Magazine,@MMMnews,2017-08-01T11:30:02.000Z,Missed yesterday's news? Here's what to know: #pharma #Marketers #hcmktg $JNJ #Arthritis $AZN #oncology $MRK $CAH http://bit.ly/2vXEhy3,"Missed yesterday's news? Here's what to know: #pharma #Marketers #hcmktg $JNJ #Arthritis $AZN #oncology $MRK $CAH http://bit.ly/2vXEhy3
1
1",,,1,1,['https://pbs.twimg.com/media/DGEkPe3XsAEO9RL?format=jpg&name=small'],https://twitter.com/MMMnews/status/892346679671828480
3703,Make Black Swans Great AGAIN,@RuniteDragon,2017-08-01T05:51:02.000Z,$IBB $XBI $PFE $MRK $LLY Atleast Trump & Scott G. want to push drug to market faster w less regulations.,"$IBB $XBI $PFE $MRK $LLY Atleast Trump & Scott G. want to push drug to market faster w less regulations.
marketwatch.com
Biotech companies lose $21 billion in research funds amid political squabbling
Michael Brush does the math and says that could have funded the development of 15 to 20 drugs.",üßä üß® üê≥ ‚ùÑ,,,,['https://pbs.twimg.com/card_img/1499990437691633666/HfMSAW3O?format=jpg&name=small'],https://twitter.com/RuniteDragon/status/892261368388132866
3704,jim rogers,@jollyaz,2017-08-01T15:50:45.000Z,$dvax $MRK this shld be a fit...move!!,"$dvax $MRK this shld be a fit...move!!
3",,,,3,[],https://twitter.com/jollyaz/status/892412293287469056
3705,Evaluate Vantage,@evaluatevantage,2017-07-31T15:51:32.000Z,Dynavax gets new injection of life http://epvantage.com/Universal/View.aspx?type=Story&id=722464&isEPVantage=yes‚Ä¶ $DVAX $MRK $AZN,"Dynavax gets new injection of life http://epvantage.com/Universal/View.aspx?type=Story&id=722464&isEPVantage=yes‚Ä¶ $DVAX $MRK $AZN
2
2",,,2,2,[],https://twitter.com/evaluatevantage/status/892050100863873026
3706,Hawkeye Advisory Services LLC,@AlaLongleaf,2017-08-01T08:34:16.000Z,"Dynavax makes a good showing
https://fool.com/investing/2017/07/31/why-dynavax-technologies-alliance-holdings-and-soh.aspx‚Ä¶ #HeplisavB #Vaccine #FDAapproval $DVAX is a takeover target! $MRK $GKS $PFE #Innovation","Dynavax makes a good showing
https://fool.com/investing/2017/07/31/why-dynavax-technologies-alliance-holdings-and-soh.aspx‚Ä¶ #HeplisavB #Vaccine #FDAapproval $DVAX is a takeover target! $MRK $GKS $PFE #Innovation
3",,,,3,['https://pbs.twimg.com/media/DGIYSy7UAAA9S1i?format=jpg&name=small'],https://twitter.com/AlaLongleaf/status/892302448882266112
3707,The Midas Touch,@MysteryMan_777,2017-07-31T17:20:57.000Z,$MRK nice lower gap to fill. Grabbed some $62.50P's this wk at .09,"$MRK nice lower gap to fill. Grabbed some $62.50P's this wk at .09
1",„ÄΩ „ÄΩ,,,1,"['https://pbs.twimg.com/media/DGFHS3iXgAAacNk?format=jpg&name=small', 'https://pbs.twimg.com/media/DGFHS3fWsAA6vr3?format=jpg&name=small']",https://twitter.com/MysteryMan_777/status/892072604378550273
3708,Bio&TechWebinar,@BioTechWebinar,2017-08-01T19:30:45.000Z,$SAN $REGN believe their PD-1 drug can quickly start by leapfrogging PD-L1s from  $MRK $ROG https://pbs.twimg.com/media/DF0R2bhU0AALuhe.jpg‚Ä¶,"$SAN $REGN believe their PD-1 drug can quickly start by leapfrogging PD-L1s from  $MRK $ROG https://pbs.twimg.com/media/DF0R2bhU0AALuhe.jpg‚Ä¶
endpts.com
Looking for an oncology reboot, Sanofi, Regeneron shoot for a fast and flashy FDA OK of a promising...
There‚Äôs another PD-1 drug headed toward the market. And this fast-moving ‚Äî and often overlooked ‚Äî program is due to arrive at the FDA for marketing review in just a matter of months. In an outline of...
1",,,,1,['https://pbs.twimg.com/card_img/1501276194293133322/dRpEMyDg?format=jpg&name=small'],https://twitter.com/BioTechWebinar/status/892467656741326855
3709,1stOncology,@1stOncology,2017-07-31T14:00:44.000Z,#Merck&Co World-Wide Sales for #GARDASIL/#GARDASIL9 was 469m USD in Q2 2017 (Up 19%) $MRK http://1stoncology.com/blog/merck-announces-second-quarter-2017-financial-results‚Ä¶,"#Merck&Co World-Wide Sales for #GARDASIL/#GARDASIL9 was 469m USD in Q2 2017 (Up 19%) $MRK http://1stoncology.com/blog/merck-announces-second-quarter-2017-financial-results‚Ä¶
1",,,1,,[],https://twitter.com/1stOncology/status/892022217780998144
3710,Oscar Gould o7,@realoscargould,2017-08-01T23:41:13.000Z,"*Pharma execs rub hands together and glance furtively at one another*

$PFE $BMY $MRK","*Pharma execs rub hands together and glance furtively at one another*

$PFE $BMY $MRK
PBS NewsHour
@NewsHour
 ¬∑ 2 Aug 2017
Should we treat drug abuse with more drugs? Gov. Roy Cooper of North Carolina says yes, ""if it helps them.""
1",,,,1,"['https://pbs.twimg.com/profile_images/875456540450443265/W5yKx8um_mini.jpg', 'https://pbs.twimg.com/media/DGLaRw2UIAAsZKl.jpg']",https://twitter.com/realoscargould/status/892530689912037376
3711,Trade Academy,@TradeAcademyCo,2017-08-01T12:08:37.000Z,8/1 50D MA Watch List: $SPLK $OPK $HL $VIAB $AMRN $WFC $AAPL $REGN $SPG $RIG $MRK $ETP $CIT $HES $FTR $CHK $DOW $DLTR $XLI $STLD #trading,8/1 50D MA Watch List: $SPLK $OPK $HL $VIAB $AMRN $WFC $AAPL $REGN $SPG $RIG $MRK $ETP $CIT $HES $FTR $CHK $DOW $DLTR $XLI $STLD #trading,,,,,[],https://twitter.com/TradeAcademyCo/status/892356390257385472
3712,Trade Academy,@TradeAcademyCo,2017-07-31T12:13:12.000Z,7/31 50D MA Watch List: $WBA $MRO $SPLK $JNJ $STLD $RIG $ABBV $PANW $MON $MYL $CIEN $MAR $SLV $AMGN $XLU $CSCO $WFT $HL $MRK $TSM #trading,7/31 50D MA Watch List: $WBA $MRO $SPLK $JNJ $STLD $RIG $ABBV $PANW $MON $MYL $CIEN $MAR $SLV $AMGN $XLU $CSCO $WFT $HL $MRK $TSM #trading,,,,,[],https://twitter.com/TradeAcademyCo/status/891995158337781760
3713,The Midas Touch,@MysteryMan_777,2017-08-01T17:06:18.000Z,Was just thinking the same thing started about an hour or so after open $OPGN $MRK https://twitter.com/drsmanian/status/892430912473804801‚Ä¶,"Was just thinking the same thing started about an hour or so after open $OPGN $MRK https://twitter.com/drsmanian/status/892430912473804801‚Ä¶
This Tweet is unavailable.
1",„ÄΩ „ÄΩ,,,1,[],https://twitter.com/MysteryMan_777/status/892431303571886080
3714,StockSpotter,@StockSpotter,2017-08-01T14:17:54.000Z,Closed $MRK for a 2.3% gain in 15 days. Forecast remains slightly bullish.  #stocks  #trading http://bit.ly/1fug5ZK,Closed $MRK for a 2.3% gain in 15 days. Forecast remains slightly bullish.  #stocks  #trading http://bit.ly/1fug5ZK,,,,,[],https://twitter.com/StockSpotter/status/892388927411068928
3715,Biwen Tao,@TaoBiwen,2017-08-01T20:16:29.000Z,"These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now #stocks $PFE, $MRK, $JNJ, $BMY, $CELG, $ABBV","These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now #stocks $PFE, $MRK, $JNJ, $BMY, $CELG, $ABBV
fool.com
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now @themotleyfool #stocks $CELG $PFE...
Five cancer drugs that are already successful will become even bigger winners by 2022.",,,,,['https://pbs.twimg.com/card_img/1501471175691718658/l2jVLv9r?format=jpg&name=small'],https://twitter.com/TaoBiwen/status/892479166288932865
3716,FiercePharma,@FiercePharma,2017-08-01T12:11:22.000Z,"Vaccines provide a boost for GlaxoSmithKline, Sanofi and Merck in second-quarter financials http://fiercepharma.com/vaccines/vaccines-provide-a-boost-for-gsk-sanofi-and-merck-second-quarter-financials‚Ä¶ $GSK $SNY $MRK","Vaccines provide a boost for GlaxoSmithKline, Sanofi and Merck in second-quarter financials http://fiercepharma.com/vaccines/vaccines-provide-a-boost-for-gsk-sanofi-and-merck-second-quarter-financials‚Ä¶ $GSK $SNY $MRK
1",,,1,,[],https://twitter.com/FiercePharma/status/892357082191626242
3717,Pharmaceutical News,@pharma_sector,2017-08-01T04:34:15.000Z,#Merck warns of drug delays after 'NotPetya' cyberattack: 3 things to know. Read more: http://owler.us/ac7gzJ $MRK,#Merck warns of drug delays after 'NotPetya' cyberattack: 3 things to know. Read more: http://owler.us/ac7gzJ $MRK,,,,,[],https://twitter.com/pharma_sector/status/892242046538326016
3718,Magnolia Gallery,@MagnoliaG2012,2017-07-31T16:32:09.000Z,The Black Hole https://seekingalpha.com/article/4092744-black-hole?source=tweet‚Ä¶ $BMY $BRK.A $BRK.B $C $CSCO $GE $IBM $INTC $JNJ $JPM $KO $MO $MRK $PG $RDS.A $SPY $T $WFC $WMT $XOM,"The Black Hole https://seekingalpha.com/article/4092744-black-hole?source=tweet‚Ä¶ $BMY $BRK.A $BRK.B $C $CSCO $GE $IBM $INTC $JNJ $JPM $KO $MO $MRK $PG $RDS.A $SPY $T $WFC $WMT $XOM
seekingalpha.com
The Black Hole (NASDAQ:AAPL)
Apple, Alphabet, Microsoft, Facebook, and Amazon are now the five largest U.S. market capitalization equities.",,,,,['https://pbs.twimg.com/card_img/1501718269027401728/bwE64fAH?format=jpg&name=240x240'],https://twitter.com/MagnoliaG2012/status/892060322256834560
3719,Jeffrey Weber,@jjjinvesting,2017-07-30T16:23:39.000Z,"3 Things In Biotech You Should Learn Today: July 29, 2017 https://seekingalpha.com/article/4091847-3-things-biotech-learn-today-july-29-2017?source=tweet‚Ä¶ $ABLYF $AZN $EGRX $MRK","3 Things In Biotech You Should Learn Today: July 29, 2017 https://seekingalpha.com/article/4091847-3-things-biotech-learn-today-july-29-2017?source=tweet‚Ä¶ $ABLYF $AZN $EGRX $MRK",,,,,[],https://twitter.com/jjjinvesting/status/891695795925393409
3720,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-07-31T16:33:17.000Z,#Upgrades #Downgrades ‚Äï $MRK: UBS reits Buy http://dlvr.it/PZqC51 via ‚Üí http://bit.do/BestTradeSetups,#Upgrades #Downgrades ‚Äï $MRK: UBS reits Buy http://dlvr.it/PZqC51 via ‚Üí http://bit.do/BestTradeSetups,,,,,[],https://twitter.com/AlertTrade/status/892060608568279041
3721,BioPharma Dive,@BioPharmaDive,2017-08-01T15:41:39.000Z,"$PFE still mum on BD, frustrated by biosimilar market http://bit.ly/2f4MfBt $JNJ $MRK","$PFE still mum on BD, frustrated by biosimilar market http://bit.ly/2f4MfBt $JNJ $MRK
biopharmadive.com
Pfizer still mum on BD, frustrated by biosimilar market
Second quarter earnings for the big pharma were uneventful, but commentary on business development and the biosimilar market were illuminating.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1499882689679310851/PXhQbqF7?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/892410003486855168
3722,BioPharma Dive,@BioPharmaDive,2017-07-30T16:50:00.000Z,"$AZN, $MRK team up on cancer combos","$AZN, $MRK team up on cancer combos
biopharmadive.com
After MYSTIC miss, AstraZeneca taps Merck in $8.5B cancer deal
On the heels of its MYSTIC failure, the British pharma has teamed up with Merck to jointly develop and commercialize two of its oncology drugs.
1
2",,,1,2,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/891702429816848384
3723,Sweet Platform,@SweetPlatform,2017-07-31T14:48:30.000Z,"MRK Top news - Jul 31st, 2017 $MRK http://https://goo.gl/TUJvLa","MRK Top news - Jul 31st, 2017 $MRK http://https://goo.gl/TUJvLa",,,,,[],https://twitter.com/SweetPlatform/status/892034239201521665
3724,Pharmaceutical News,@pharma_sector,2017-07-31T23:22:09.000Z,#Merck & Co API operations hit by cyberattack yet to restart production. Read more: http://owler.us/ac7dbc $MRK,#Merck & Co API operations hit by cyberattack yet to restart production. Read more: http://owler.us/ac7dbc $MRK,,,,,[],https://twitter.com/pharma_sector/status/892163501640212481
3725,GREEN STOCK NEWS,@greenstocknews,2017-07-31T17:56:30.000Z,AbbVie Drops; Getting Bullish: Part 1 - Focus On Q2 And Humira https://seekingalpha.com/article/4092768-abbvie-drops-getting-bullish-part-1-focus-q2-humira?source=feed_f‚Ä¶ $ABT $AMGN $MRK $ABBV,AbbVie Drops; Getting Bullish: Part 1 - Focus On Q2 And Humira https://seekingalpha.com/article/4092768-abbvie-drops-getting-bullish-part-1-focus-q2-humira?source=feed_f‚Ä¶ $ABT $AMGN $MRK $ABBV,,,,,[],https://twitter.com/greenstocknews/status/892081552930353153
3726,Stock Snapshots,@stocksnapshots,2017-07-30T00:58:56.000Z,"$MRK  http://stocksnapshots.org/2017/07/stock-snapshot-of-merck-co-mrk.html‚Ä¶ Stock snapshot of Merck & Co. (MRK) $64.11 (+0.66%), 07-29-2017","$MRK  http://stocksnapshots.org/2017/07/stock-snapshot-of-merck-co-mrk.html‚Ä¶ Stock snapshot of Merck & Co. (MRK) $64.11 (+0.66%), 07-29-2017",,,,,[],https://twitter.com/stocksnapshots/status/891463083998277632
3727,StockMarketVideo.com,@stockmarketvide,2017-07-31T23:28:30.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,,,,,[],https://twitter.com/stockmarketvide/status/892165100395679744
3728,carlos jorge martins,@2013martins28j1,2017-07-31T18:07:22.000Z,4 Drug Stocks in Focus this World Hepatitis Day  $GILD  $MRK  $ABBV  $ENTA https://goo.gl/1muRao,4 Drug Stocks in Focus this World Hepatitis Day  $GILD  $MRK  $ABBV  $ENTA https://goo.gl/1muRao,,,,,[],https://twitter.com/2013martins28j1/status/892084284521160708
3729,Allison Gatlin,@IBD_AGatlin,2017-08-01T18:54:10.000Z,Will Pfizer's cancer drugs help it grow without a merger? $PFE $BMY $MRK $AZN $RHHBY,"Will Pfizer's cancer drugs help it grow without a merger? $PFE $BMY $MRK $AZN $RHHBY
investors.com
Why Sanofi Earnings Spooked Regeneron Shares To A 6-Week Low
Regeneron tanked to a six-week low Tuesday after partner Sanofi reported lagging sales of eczema drug Dupixent.",,,,,[],https://twitter.com/IBD_AGatlin/status/892458452064378881
3730,Pharmaceutical News,@pharma_sector,2017-08-01T16:24:23.000Z,#Merck Biosimilar Renflexis PBS listing brings potential for health budget savings for Austr... Read more: http://owler.us/ac7yBl $MRK,#Merck Biosimilar Renflexis PBS listing brings potential for health budget savings for Austr... Read more: http://owler.us/ac7yBl $MRK,,,,,[],https://twitter.com/pharma_sector/status/892420756667211776
3731,Scott Gillam,@mallig,2017-07-31T11:01:16.000Z,"7/31 Triple Cross (5/20 EMA, RSI, MACD): 
bullish - $ABC, $BBY, $BXP, $CVS, $HST, $MAA, $MRK.","7/31 Triple Cross (5/20 EMA, RSI, MACD): 
bullish - $ABC, $BBY, $BXP, $CVS, $HST, $MAA, $MRK.",,,,,[],https://twitter.com/mallig/status/891977054312386560
3732,US Banking News,@AmericanBanking,2017-07-30T15:07:37.000Z,Merck & Company given $70.00 PT by Piper Jaffray Companies. buy rating. http://ift.tt/2viXi0z $MRK #MRK,Merck & Company given $70.00 PT by Piper Jaffray Companies. buy rating. http://ift.tt/2viXi0z $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/891676660885590016
3733,US Banking News,@AmericanBanking,2017-07-31T17:12:22.000Z,Merck & Company's PT raised by UBS AG to $72.00. buy rating. http://ift.tt/2vg6vWE $MRK #MRK,Merck & Company's PT raised by UBS AG to $72.00. buy rating. http://ift.tt/2vg6vWE $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/892070442688811008
3734,StockNews.com,@stocknewsdotcom,2017-07-31T16:27:51.000Z,$MRK UBS raises PT to $72 from $70 https://stocknews.com/news/mrk-ubs-raises-pt-to-72-from-70/‚Ä¶,$MRK UBS raises PT to $72 from $70 https://stocknews.com/news/mrk-ubs-raises-pt-to-72-from-70/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/892059243045629952
3735,BitSpec,@bitspec,2017-07-31T16:39:01.000Z,The Black Hole https://seekingalpha.com/article/4092744-black-hole?source=tweet‚Ä¶ $BMY $BRK.A $BRK.B $C $CSCO $GE $IBM $INTC $JNJ $JPM $KO $MO $MRK $PG $RDS.A $SPY $T $WFC $WMT $XOM,"The Black Hole https://seekingalpha.com/article/4092744-black-hole?source=tweet‚Ä¶ $BMY $BRK.A $BRK.B $C $CSCO $GE $IBM $INTC $JNJ $JPM $KO $MO $MRK $PG $RDS.A $SPY $T $WFC $WMT $XOM
seekingalpha.com
The Black Hole (NASDAQ:AAPL)
Apple, Alphabet, Microsoft, Facebook, and Amazon are now the five largest U.S. market capitalization equities.
1",,1,,,['https://pbs.twimg.com/card_img/1501718269027401728/bwE64fAH?format=jpg&name=240x240'],https://twitter.com/bitspec/status/892062050503053313
3736,FinInvTr,@FinInvTr,2017-08-01T18:15:01.000Z,"What All Top Market Performers Have In Common http://buff.ly/2w2PFsq

$MMC $MMI $MMM $MMS $MN $MNST $MO $MOMO $MON $MRK $MSB $MSFT $MSGN","What All Top Market Performers Have In Common http://buff.ly/2w2PFsq

$MMC $MMI $MMM $MMS $MN $MNST $MO $MOMO $MON $MRK $MSB $MSFT $MSGN
1",,,,1,[],https://twitter.com/FinInvTr/status/892448597886873600
3737,Daily Political,@dailypoliticaln,2017-08-01T12:19:31.000Z,"Trust Co. of Vermont Maintains Position in Merck & Company, Inc. $MRK http://ift.tt/2w1MWzu","Trust Co. of Vermont Maintains Position in Merck & Company, Inc. $MRK http://ift.tt/2w1MWzu",,,,,[],https://twitter.com/dailypoliticaln/status/892359135995596802
3738,Daily Political,@dailypoliticaln,2017-07-31T18:54:20.000Z,"Merck & Company, Inc. $MRK Shares Sold by Cribstone Capital Management LLC http://ift.tt/2weBGz3","Merck & Company, Inc. $MRK Shares Sold by Cribstone Capital Management LLC http://ift.tt/2weBGz3",,,,,[],https://twitter.com/dailypoliticaln/status/892096103667167232
3739,Tim Reller,@TraderGuruNY,2017-07-31T23:30:47.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/892165677599137793
3740,Sweet Platform,@SweetPlatform,2017-08-01T14:48:30.000Z,"MRK Top news - Aug 1st, 2017 $MRK http://https://goo.gl/prx4MG","MRK Top news - Aug 1st, 2017 $MRK http://https://goo.gl/prx4MG",,,,,[],https://twitter.com/SweetPlatform/status/892396626513408005
3741,Dakota Financial,@dakotafinancial,2017-08-01T22:00:46.000Z,"Merck & Company, Inc. $MRK Shares Bought by Busey Trust CO http://ift.tt/2hkV7DF","Merck & Company, Inc. $MRK Shares Bought by Busey Trust CO http://ift.tt/2hkV7DF",,,,,[],https://twitter.com/dakotafinancial/status/892505409017319424
3742,BioPharma Dive,@BioPharmaDive,2017-08-01T21:34:20.000Z,$PFE's Inflectra continues to have mixed reimbursement http://bit.ly/2f4MfBt $JNJ $MRK,"$PFE's Inflectra continues to have mixed reimbursement http://bit.ly/2f4MfBt $JNJ $MRK
biopharmadive.com
Pfizer still mum on BD, frustrated by biosimilar market
Second quarter earnings for the big pharma were uneventful, but commentary on business development and the biosimilar market were illuminating.
1",,,,1,['https://pbs.twimg.com/card_img/1499882689679310851/PXhQbqF7?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/892498757031514116
3743,Allison Gatlin,@IBD_AGatlin,2017-08-01T18:13:11.000Z,Why Sanofi earnings spooked Regeneron stock to a 6-week low $SNY $REGN $MRK $BMY,"Why Sanofi earnings spooked Regeneron stock to a 6-week low $SNY $REGN $MRK $BMY
investors.com
Why Sanofi Earnings Spooked Regeneron Shares To A 6-Week Low
Regeneron tanked to a six-week low Tuesday after partner Sanofi reported lagging sales of eczema drug Dupixent.",,,,,['https://pbs.twimg.com/card_img/1501718275000086529/JzODbLH4?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/892448135771025408
3744,Allison Gatlin,@IBD_AGatlin,2017-08-01T18:10:05.000Z,"Generics chip away at Dow stock Pfizer, but cancer unit 'stabilizing' $PFE $MRK","Generics chip away at Dow stock Pfizer, but cancer unit 'stabilizing' $PFE $MRK
investors.com
Generics Chip Away At Dow Stock Pfizer, But Cancer Unit 'Stabilizing'
Pfizer reported better-than-expected second-quarter earnings early Tuesday, but revenue came up short.",,,,,[],https://twitter.com/IBD_AGatlin/status/892447357551484929
3745,ABN Newswire,@ABN_Newswire,2017-07-31T13:59:06.000Z,"Moleculin Biotech, Inc. (NASDAQ:MBRX) is ""One to Watch"" $MBRX $RHHBY $PDII $MRK $DRAD 
@NNWMedia","Moleculin Biotech, Inc. (NASDAQ:MBRX) is ""One to Watch"" $MBRX $RHHBY $PDII $MRK $DRAD 
@NNWMedia
abnnewswire.net
Moleculin Biotech, Inc. (NASDAQ:MBRX) is
(NetworkNewsWire) For preclinical oncology biopharma Moleculin Biotech, Inc. (NASDAQ:MBRX), the quest to deliver potentially revolutionary anti-cancer drugs to the market is enkindled by a close...",,,,,[],https://twitter.com/ABN_Newswire/status/892021806680256512
3746,Flattening,@flattening,2017-07-31T14:59:31.000Z,"Replying to 
@adamfeuerstein
 and 
@ty17rr","Replying to 
@adamfeuerstein
 and 
@ty17rr
obvious retort is that $DVAX won't sell Heplisav, a partner or acquirer will($GILD? $MRK?).Meanwhile  $DVAX shareholders shall laugh + point
1
2",,1,,2,[],https://twitter.com/flattening/status/892037011841757185
3747,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-07-31T19:27:45.000Z,"Replying to 
@Gabapentin_Awar
 and 
@US_FDA","Replying to 
@Gabapentin_Awar
 and 
@US_FDA
$PFE $JNJ $MRK These drug companies kill more #Americans than ANY enemy, foreign or domestic. I applaud your effort - thanks for the info. 
1
1",ü§ì,1,,1,[],https://twitter.com/ZimJay/status/892104515893309440
3748,Dakota Financial,@dakotafinancial,2017-08-01T11:35:24.000Z,"Merck & Company, Inc. $MRK Rating Increased to Hold at BidaskClub http://ift.tt/2voUBuE","Merck & Company, Inc. $MRK Rating Increased to Hold at BidaskClub http://ift.tt/2voUBuE",,,,,[],https://twitter.com/dakotafinancial/status/892348030866915328
3749,Dakota Financial,@dakotafinancial,2017-08-01T16:55:29.000Z,"Merck & Company, Inc. $MRK Position Maintained by Fruth Investment Management http://ift.tt/2tW4R9d","Merck & Company, Inc. $MRK Position Maintained by Fruth Investment Management http://ift.tt/2tW4R9d",,,,,[],https://twitter.com/dakotafinancial/status/892428583758594048
3750,Dennis M Winters,@m_denniswinters,2017-07-30T13:51:05.000Z,"Replying to 
@TRADINGFOOL1","Replying to 
@TRADINGFOOL1
Likely after approval on Aug 10th.  Offering at 25-30 per share is smart move....or partnership with $mrk.  Betting they are already talking",,,,,[],https://twitter.com/m_denniswinters/status/891657401086214145
3751,The Midas Touch,@MysteryMan_777,2017-08-01T18:54:40.000Z,Yeah might be. I'm thinking bigger picture on this w/ $MRK & it being a M&A candidate. Same w/ $MBVX who verbally annnounced it & Frost $OPK,Yeah might be. I'm thinking bigger picture on this w/ $MRK & it being a M&A candidate. Same w/ $MBVX who verbally annnounced it & Frost $OPK,„ÄΩ „ÄΩ,,,,[],https://twitter.com/MysteryMan_777/status/892458576861593600
3752,Brad Loncar,@bradloncar,2017-07-31T11:04:13.000Z,"Replying to 
@JohnsHopkins2","Replying to 
@JohnsHopkins2
Yes, very different from the $MRK $AZN deal on Thursday.
1",,1,,,[],https://twitter.com/bradloncar/status/891977794649034752
3753,dough,@semodough,2017-08-04T11:56:17.000Z,$MRK $LPTX #GITR,"$MRK $LPTX #GITR
Anirban Maitra
@Aiims1742
 ¬∑ 4 Aug 2017
$MRK #openaccess paper on its agonistic GITR antibody MK-4166 
#cancer #Immunotherapy 
http://cancerres.aacrjournals.org/content/canres/early/2017/08/02/0008-5472.CAN-16-1439.full.pdf‚Ä¶
4
5",,,4,5,['https://pbs.twimg.com/profile_images/1378426780684587012/IU5zJk2E_mini.jpg'],https://twitter.com/semodough/status/893440452862595072
3754,dough,@semodough,2017-08-03T13:44:50.000Z,CS Prefers $MRK $JNJ    SMID Likes $ALKS $AIMT $MYOK,"CS Prefers $MRK $JNJ    SMID Likes $ALKS $AIMT $MYOK
1
2
7",,1,2,7,['https://pbs.twimg.com/media/DGTymocUMAARXwY?format=jpg&name=small'],https://twitter.com/semodough/status/893105382138236929
3755,Jacob Plieth,@JacobPlieth,2017-08-02T08:51:46.000Z,$BMY Opdivo approval in MSI-H/MMRd limited to colorectal cancer bc that was setting of CM-142. $MRK Keytruda approval based on these trials,"$BMY Opdivo approval in MSI-H/MMRd limited to colorectal cancer bc that was setting of CM-142. $MRK Keytruda approval based on these trials
3
9",,,3,9,['https://pbs.twimg.com/media/DGNl6LKWAAEMdYs?format=jpg&name=900x900'],https://twitter.com/JacobPlieth/status/892669241790525440
3756,Seeking Alpha,@SeekingAlpha,2017-08-03T14:33:25.000Z,"After AstraZeneca's 'Disaster', What's In Store For Their Immune Checkpoint Program? https://seekingalpha.com/article/4094242-astrazenecas-disaster-store-immune-checkpoint-program?source=feed_f‚Ä¶ $BMY $MRK $AZN","After AstraZeneca's 'Disaster', What's In Store For Their Immune Checkpoint Program? https://seekingalpha.com/article/4094242-astrazenecas-disaster-store-immune-checkpoint-program?source=feed_f‚Ä¶ $BMY $MRK $AZN
1",,,,1,[],https://twitter.com/SeekingAlpha/status/893117605925371904
3757,Christine McKenzie,@CMcKenzie77,2017-08-02T13:00:57.000Z,#Merck - The story behind the company's IO success https://seekingalpha.com/article/4093565-keytruda-story?source=tweet‚Ä¶ $MRK,#Merck - The story behind the company's IO success https://seekingalpha.com/article/4093565-keytruda-story?source=tweet‚Ä¶ $MRK,,,,,[],https://twitter.com/CMcKenzie77/status/892731950238183425
3758,Seeking Alpha,@SeekingAlpha,2017-08-04T19:20:44.000Z,Why Stocks Could Soar Into Year End https://seekingalpha.com/article/4095091-stocks-soar-year-end?source=feed_f‚Ä¶ $AAPL #APPLE $CSCO $DIA $GE $GOOG $GOOGL $IBM $IVV $JNJ $MRK $MSFT $PFE $QQQ,Why Stocks Could Soar Into Year End https://seekingalpha.com/article/4095091-stocks-soar-year-end?source=feed_f‚Ä¶ $AAPL #APPLE $CSCO $DIA $GE $GOOG $GOOGL $IBM $IVV $JNJ $MRK $MSFT $PFE $QQQ,,,,,[],https://twitter.com/SeekingAlpha/status/893552299645190144
3759,BullsBearsOfBuckhead,@bwmbearsbulls,2017-08-03T15:57:11.000Z,"Check out our new article on 
@SeekingAlpha
 https://seekingalpha.com/article/4094186-skys-limit-ziopharm?v=1501773799&comments=show‚Ä¶ $ZIOP $xon $MRK","Check out our new article on 
@SeekingAlpha
 https://seekingalpha.com/article/4094186-skys-limit-ziopharm?v=1501773799&comments=show‚Ä¶ $ZIOP $xon $MRK
1
1",,,1,1,[],https://twitter.com/bwmbearsbulls/status/893138688603041792
3760,The Midas Touch,@MysteryMan_777,2017-08-03T19:04:04.000Z,Taking a long weekend $MBVX looks great shopping the Co let's see what they come up with. $OPGN your next w/ $MRK 40% ownership for a #M&A,"Taking a long weekend $MBVX looks great shopping the Co let's see what they come up with. $OPGN your next w/ $MRK 40% ownership for a #M&A
1
2
3",„ÄΩ „ÄΩ,1,2,3,['https://pbs.twimg.com/media/DGU7q-JVoAAFQJ9?format=jpg&name=900x900'],https://twitter.com/MysteryMan_777/status/893185719480573952
3761,Evaluate Vantage,@evaluatevantage,2017-08-02T11:31:28.000Z,Vantage Snippet - Mismatch between Opdivo and Keytruda approvals could be a moot point $BMY $MRK,"Vantage Snippet - Mismatch between Opdivo and Keytruda approvals could be a moot point $BMY $MRK
2",,,,2,['https://pbs.twimg.com/media/DGOKQK8WAAEuhQ5?format=jpg&name=small'],https://twitter.com/evaluatevantage/status/892709430936166401
3762,Ozmosi,@OzmosiHealth,2017-08-04T16:02:13.000Z,How #pharma companies add value for #cancer patients  http://bit.ly/2uRE8xn $MRK $CELG,How #pharma companies add value for #cancer patients  http://bit.ly/2uRE8xn $MRK $CELG,,,,,['https://pbs.twimg.com/media/DGZbpUqXoAENP_D?format=jpg&name=small'],https://twitter.com/OzmosiHealth/status/893502343534317569
3763,The Midas Touch,@MysteryMan_777,2017-08-02T13:42:13.000Z,$OPGN looking good out of the gate of double bottom. #M&A play $MRK,"$OPGN looking good out of the gate of double bottom. #M&A play $MRK
1",„ÄΩ „ÄΩ,,,1,"['https://pbs.twimg.com/media/DGOoapbWsAAHmCe?format=jpg&name=small', 'https://pbs.twimg.com/media/DGOoapeXsAEZ3ec?format=jpg&name=small']",https://twitter.com/MysteryMan_777/status/892742332323426304
3764,M,@bio_clouseau,2017-08-03T21:21:35.000Z,Mavyret 1st HCV regimen to have 8wk tx label for naive and exp. Without a nuc http://rxabbvie.com/pdf/mavyret_pi.pdf‚Ä¶ $ABBV $ENTA $GILD $MRK,"Mavyret 1st HCV regimen to have 8wk tx label for naive and exp. Without a nuc http://rxabbvie.com/pdf/mavyret_pi.pdf‚Ä¶ $ABBV $ENTA $GILD $MRK
3
6",,,3,6,[],https://twitter.com/bio_clouseau/status/893220327169413120
3765,"Jordan Alexander (,)",@JD4for4,2017-08-03T21:00:23.000Z,Who is going to bid $30-40 for $DVAX first?  $MRK or $SNY ?????,"Who is going to bid $30-40 for $DVAX first?  $MRK or $SNY ?????
3",üìú üìú,,,3,[],https://twitter.com/JD4for4/status/893214989754007552
3766,SpoiledrottenBrat,@TaxHavens,2017-08-04T20:28:01.000Z,$GILD 's Harvonu sold over $9B in its first year out dare! $ABBV $MRK $JNJ $BMY,"$GILD 's Harvonu sold over $9B in its first year out dare! $ABBV $MRK $JNJ $BMY
1",,,,1,[],https://twitter.com/TaxHavens/status/893569232453206016
3767,GREEN STOCK NEWS,@greenstocknews,2017-08-04T19:23:30.000Z,Why Stocks Could Soar Into Year End https://seekingalpha.com/article/4095091-stocks-soar-year-end?source=feed_f‚Ä¶ $AAPL #APPLE $CSCO $DIA $GE $GOOG $GOOGL $IBM $IVV $JNJ $MRK $MSFT $PFE $QQQ,Why Stocks Could Soar Into Year End https://seekingalpha.com/article/4095091-stocks-soar-year-end?source=feed_f‚Ä¶ $AAPL #APPLE $CSCO $DIA $GE $GOOG $GOOGL $IBM $IVV $JNJ $MRK $MSFT $PFE $QQQ,,,,,[],https://twitter.com/greenstocknews/status/893552998655213568
3768,Pharmaceutical News,@pharma_sector,2017-08-03T18:13:39.000Z,"AstraZeneca, #Merck in $8.5B Oncology Pact. Read more: http://owler.us/ac79Fq $MRK","AstraZeneca, #Merck in $8.5B Oncology Pact. Read more: http://owler.us/ac79Fq $MRK",,,,,[],https://twitter.com/pharma_sector/status/893173030905552896
3769,James Sikes,@wosaikeneriki,2017-08-03T14:38:51.000Z,Brookside Capital Management Holding in Merck & Co $Call $MRK Has Increased by $16.02 Million ...,Brookside Capital Management Holding in Merck & Co $Call $MRK Has Increased by $16.02 Million ...,,,,,[],https://twitter.com/wosaikeneriki/status/893118973134462976
3770,Bosco,@wboscoho,2017-08-04T15:04:25.000Z,$BMY willingness to buy IFM ($NVS has a stake) for $300M + $1B milestone means 1) it is losing to $MRK and 2) #immunooncology  is still open,$BMY willingness to buy IFM ($NVS has a stake) for $300M + $1B milestone means 1) it is losing to $MRK and 2) #immunooncology  is still open,,,,,[],https://twitter.com/wboscoho/status/893487794940768256
3771,Pharmaceutical News,@pharma_sector,2017-08-04T11:20:32.000Z,#Merck Biosimilar Renflexis PBS listing brings potential for health budget savings for Austr... Read more: http://owler.us/ac8vEh $MRK,#Merck Biosimilar Renflexis PBS listing brings potential for health budget savings for Austr... Read more: http://owler.us/ac8vEh $MRK,,,,,[],https://twitter.com/pharma_sector/status/893431454620831744
3772,US Banking News,@AmericanBanking,2017-08-03T10:17:24.000Z,Merck KGaA given ‚Ç¨116.00 PT by Warburg Research. neutral rating. http://ift.tt/2umMQR2 $MRK #MRK,Merck KGaA given ‚Ç¨116.00 PT by Warburg Research. neutral rating. http://ift.tt/2umMQR2 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/893053176584306688
3773,US Banking News,@AmericanBanking,2017-08-04T06:27:28.000Z,"Merck KGaA given ‚Ç¨110.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2fdAbOg $MRK #MRK","Merck KGaA given ‚Ç¨110.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2fdAbOg $MRK #MRK",,,,,[],https://twitter.com/AmericanBanking/status/893357700859428865
3774,GREEN STOCK NEWS,@greenstocknews,2017-08-04T18:49:06.000Z,"Snippet Roundup: Two Approvals, Two Setbacks And A Price War https://seekingalpha.com/article/4095059-snippet-roundup-two-approvals-two-setbacks-price-war?source=feed_f‚Ä¶ $BMY $ABBV $JNJ $AGIO $BSX $KITE $NVS $ONCE $MRK","Snippet Roundup: Two Approvals, Two Setbacks And A Price War https://seekingalpha.com/article/4095059-snippet-roundup-two-approvals-two-setbacks-price-war?source=feed_f‚Ä¶ $BMY $ABBV $JNJ $AGIO $BSX $KITE $NVS $ONCE $MRK
seekingalpha.com
Snippet Roundup: Two Approvals, Two Setbacks And A Price War
Welcome to your weekly roundup of EP Vantage's snippets - short takes on smaller news items.",,,,,['https://pbs.twimg.com/card_img/1501718241256869889/RsA544pX?format=jpg&name=240x240'],https://twitter.com/greenstocknews/status/893544340424761344
3775,Stocks Pastor,@stockspastor,2017-08-03T14:38:18.000Z,Did you get them yesterday? $MRK especially. http://bit.ly/1PSG79Z,"Did you get them yesterday? $MRK especially. http://bit.ly/1PSG79Z
Stocks Pastor
@stockspastor
 ¬∑ 3 Aug 2017
Swing trades given to my subs: $MRK took off at 63.20 when alerted. $JNPR took off also.  $HOG gapper potential  http://bit.ly/1PSG79Z",,,,,['https://pbs.twimg.com/profile_images/1331139608/one_billion_dollars2_mini.jpg'],https://twitter.com/stockspastor/status/893118836878307328
3776,Transcript Daily,@TranscriptDaily,2017-08-02T16:24:47.000Z,"Glenview State Bank Trust DEPT. Decreases Position in Merck & Company, Inc. $MRK http://ift.tt/2w6PP27","Glenview State Bank Trust DEPT. Decreases Position in Merck & Company, Inc. $MRK http://ift.tt/2w6PP27",,,,,[],https://twitter.com/TranscriptDaily/status/892783243698868228
3777,Daily Political,@dailypoliticaln,2017-08-03T20:08:03.000Z,"Merck & Company, Inc. $MRK Rating Increased to Hold at BidaskClub http://ift.tt/2vtYOfV","Merck & Company, Inc. $MRK Rating Increased to Hold at BidaskClub http://ift.tt/2vtYOfV",,,,,[],https://twitter.com/dailypoliticaln/status/893201820851597312
3778,Daily Political,@dailypoliticaln,2017-08-04T02:02:28.000Z,"Merck & Company, Inc. $MRK Downgraded by Zacks Investment Research to Hold http://ift.tt/2vnPs5C","Merck & Company, Inc. $MRK Downgraded by Zacks Investment Research to Hold http://ift.tt/2vnPs5C",,,,,[],https://twitter.com/dailypoliticaln/status/893291010247323648
3779,Limex,@LimexMe,2017-08-04T21:11:45.000Z,"Celgene vs. Gilead Sciences: Who Reported Better Earnings?
 http://bit.ly/040817GILD $GILD $CELG $MRK $BMY","Celgene vs. Gilead Sciences: Who Reported Better Earnings?
 http://bit.ly/040817GILD $GILD $CELG $MRK $BMY
whotrades.com
Celgene vs. Gilead Sciences: Who Reported Better Earnings?
Celgene Corp. (NASDAQ: CELG) and Gilead Sciences (NASDAQ: GILD) reported second-quarter earnings that were better than industry-watchers' forecasts, but these two giants' circumstances are‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/893580240148201473
3780,Dakota Financial,@dakotafinancial,2017-08-03T13:01:00.000Z,"Warren Averett Asset Management LLC Acquires Shares of 20,648 Merck & Company, Inc. $MRK http://ift.tt/2fba8XZ","Warren Averett Asset Management LLC Acquires Shares of 20,648 Merck & Company, Inc. $MRK http://ift.tt/2fba8XZ",,,,,[],https://twitter.com/dakotafinancial/status/893094349747171329
3781,Ticker Report,@TickerReport,2017-08-02T12:10:18.000Z,"Merck & Company, Inc. $MRK Given a $70.00 Price Target at Piper Jaffray Companies http://ift.tt/2vhUTmE","Merck & Company, Inc. $MRK Given a $70.00 Price Target at Piper Jaffray Companies http://ift.tt/2vhUTmE",,,,,[],https://twitter.com/TickerReport/status/892719202154446849
3782,Ticker Report,@TickerReport,2017-08-04T18:05:40.000Z,"UBS AG Increases Merck & Company, Inc. $MRK Price Target to $72.00 http://ift.tt/2urtytA","UBS AG Increases Merck & Company, Inc. $MRK Price Target to $72.00 http://ift.tt/2urtytA",,,,,[],https://twitter.com/TickerReport/status/893533410400063488
3783,Stocks Pastor,@stockspastor,2017-08-02T20:36:10.000Z,Swing trades given to my subs: $MRK took off at 63.20 when alerted. $JNPR took off also.  $HOG gapper potential  http://bit.ly/1PSG79Z,"Swing trades given to my subs: $MRK took off at 63.20 when alerted. $JNPR took off also.  $HOG gapper potential  http://bit.ly/1PSG79Z
1",,,1,,[],https://twitter.com/stockspastor/status/892846509905002497
3784,Transcript Daily,@TranscriptDaily,2017-08-02T15:30:34.000Z,"UBS AG Increases Merck & Company, Inc. $MRK Price Target to $72.00 http://ift.tt/2f7Z7Xw","UBS AG Increases Merck & Company, Inc. $MRK Price Target to $72.00 http://ift.tt/2f7Z7Xw",,,,,[],https://twitter.com/TranscriptDaily/status/892769601330794496
3785,MarketBeat,@MarketBeatCom,2017-08-03T10:12:16.000Z,Merck KGaA given ‚Ç¨116.00 PT by Warburg Research. neutral rating. http://ift.tt/2umMQR2 $MRK #MRK,Merck KGaA given ‚Ç¨116.00 PT by Warburg Research. neutral rating. http://ift.tt/2umMQR2 $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/893051886718341121
3786,MarketBeat,@MarketBeatCom,2017-08-04T06:22:05.000Z,"Merck KGaA given ‚Ç¨110.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2fdAbOg $MRK #MRK","Merck KGaA given ‚Ç¨110.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2fdAbOg $MRK #MRK",,,,,[],https://twitter.com/MarketBeatCom/status/893356346321645569
3787,Markman Advisors LLC,@MarkmanAdvisors,2017-08-04T12:49:11.000Z,$GILD $MRK Large (14mm) award of attorney's fees in $GILD favor (pending appeal) after failed $MRK bid to earn royalty on ISIS patents.,$GILD $MRK Large (14mm) award of attorney's fees in $GILD favor (pending appeal) after failed $MRK bid to earn royalty on ISIS patents.,,,,,[],https://twitter.com/MarkmanAdvisors/status/893453763402399744
3788,Market Realist,@MarketRealist,2017-08-04T15:09:49.000Z,How Is AbbVie Positioned after 2Q17? http://marketrealist.com/?p=2251581 $MRK $GILD $JNJ $ABBV,How Is AbbVie Positioned after 2Q17? http://marketrealist.com/?p=2251581 $MRK $GILD $JNJ $ABBV,,,,,[],https://twitter.com/MarketRealist/status/893489156621578240
3789,TalkMarkets,@TalkMarkets,2017-08-02T02:42:07.000Z,"Large Cap Biopharma Earnings Boost Stocks: Update Thursday, Aug 1 $BMY $MBI $MRK $RHHBY $ALXN $IBB $REGN $AMGN ... https://goo.gl/2t2q24","Large Cap Biopharma Earnings Boost Stocks: Update Thursday, Aug 1 $BMY $MBI $MRK $RHHBY $ALXN $IBB $REGN $AMGN ... https://goo.gl/2t2q24",,,,,[],https://twitter.com/TalkMarkets/status/892576216078790661
3790,Allison Gatlin,@IBD_AGatlin,2017-08-04T20:50:15.000Z,Why biotechs outperformed their pharma brethren in June quarter $VRTX $BIIB $GILD $ALXN $LLY $MRK $PFE $JNJ $BMY,"Why biotechs outperformed their pharma brethren in June quarter $VRTX $BIIB $GILD $ALXN $LLY $MRK $PFE $JNJ $BMY
investors.com
Biotechs Are Popping Today On The Backs Of These Small Players
The biotech sector popped thanks to Cara, Sage and Neurocrine, which had strong earnings or offered promising updates.
2
1",,,2,1,['https://pbs.twimg.com/card_img/1499460513880813568/cBRC9_lY?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/893574829294718977
3791,Allison Gatlin,@IBD_AGatlin,2017-08-04T18:22:25.000Z,"How AbbVie's ""gauntlet"" could squeeze Gilead's drugs in hepatitis C $ABBV $GILD $MRK $JNJ $BMY http://ow.ly/IDhU30eaWXC","How AbbVie's ""gauntlet"" could squeeze Gilead's drugs in hepatitis C $ABBV $GILD $MRK $JNJ $BMY http://ow.ly/IDhU30eaWXC
1",,,,1,[],https://twitter.com/IBD_AGatlin/status/893537624358617088
3792,Todd Campbell,@ebcapital,2017-08-02T11:23:49.000Z,"Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo 
@themotleyfool
 #stocks $PFE, $MRK, $BMY, $RHHBY, $AZN","Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo 
@themotleyfool
 #stocks $PFE, $MRK, $BMY, $RHHBY, $AZN
fool.com
Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo @themotleyfool #stocks $MRK $PFE $BMY...
The two biopharma giants PD-1 inhibitors are facing off against each other in cancer indications that are worth billions of dollars in annual sales.",,,,,[],https://twitter.com/ebcapital/status/892707502974017543
3793,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-08-03T14:53:00.000Z,"Interesting PD1 trial at NCI opening up withTetrahydrouridine $MRK $BMY 
@jasonlukemd","Interesting PD1 trial at NCI opening up withTetrahydrouridine $MRK $BMY 
@jasonlukemd
clinicaltrials.gov
Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for, Pembrolizumab-Mediated Immune...
Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for, Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Sm...",,,,,['https://pbs.twimg.com/card_img/1489783320023994368/48CnaOr2?format=png&name=240x240'],https://twitter.com/DrPaulyDeSantis/status/893122533934813184
3794,Dennis M Winters,@m_denniswinters,2017-08-04T12:23:19.000Z,"Replying to 
@stockassassin74
 and 
@skaushi","Replying to 
@stockassassin74
 and 
@skaushi
$dvax would like to see partnership with $mrk again over offering.  Could happen at any time after this news.  Expect we will hear soon.
1
2",,1,,2,[],https://twitter.com/m_denniswinters/status/893447253658042368
3795,tobias hildebrandt,@timeout2575,2017-08-03T13:06:56.000Z,"Replying to 
@DallinFoxdal
 and 
@princetongb","Replying to 
@DallinFoxdal
 and 
@princetongb
$MRK is going to buy $SGMO .... there :)
2
1",,,2,1,[],https://twitter.com/timeout2575/status/893095841275269121
3796,JQ,@jq1234t,2017-08-04T16:54:21.000Z,"Replying to 
@C_Garthwaite
, 
@matthewherper
 and 
@Clarksterh","Replying to 
@C_Garthwaite
, 
@matthewherper
 and 
@Clarksterh
Don't agree. Both $MRK $ABBV priced mainly for government healthcare programs, they said so explicitly.
1
2",,1,,2,[],https://twitter.com/jq1234t/status/893515462163787776
3797,Prudent Perspective,@prudentperspect,2017-08-02T19:44:42.000Z,"Replying to 
@AP","Replying to 
@AP
Let me guess He's going hard after $MRK $FOR $ABT and $BMY too riiight?",,,,,[],https://twitter.com/prudentperspect/status/892833557672071170
3798,Sarah Owermohle,@owermohle,2017-08-02T21:20:44.000Z,"Replying to 
@owermohle","Replying to 
@owermohle
Also: $INCY forges on with $MRK Merck, $BMY cancer combos amid $AZN doubts

http://bit.ly/2u5L77n",,,,,[],https://twitter.com/owermohle/status/892857721971716096
3799,Prudent Perspective,@prudentperspect,2017-08-02T19:45:55.000Z,"Replying to 
@creeknation01
 and 
@AP","Replying to 
@creeknation01
 and 
@AP
$ABT $MRK $BMY $ABT.  Perhaps?",,,,,[],https://twitter.com/prudentperspect/status/892833863478718468
3800,US Banking News,@AmericanBanking,2017-08-03T14:27:25.000Z,Merck KGaA given ‚Ç¨100.00 PT by Nord/LB. neutral rating. http://ift.tt/2u4gCKT $MRK #MRK,Merck KGaA given ‚Ç¨100.00 PT by Nord/LB. neutral rating. http://ift.tt/2u4gCKT $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/893116095426678784
3801,dough,@semodough,2017-08-05T02:42:44.000Z,UPCOMING PDUFA dates $IBB $DVAX now nivember. $ATRS $PTCT $MRK $TSRO $ADMS $NEOS $FLXN $BMY,"UPCOMING PDUFA dates $IBB $DVAX now nivember. $ATRS $PTCT $MRK $TSRO $ADMS $NEOS $FLXN $BMY
4
14
33",,4,14,33,['https://pbs.twimg.com/media/DGbuPWuXcAEUo_r?format=jpg&name=small'],https://twitter.com/semodough/status/893663534135083008
3802,RAS Life Science Solutions,@raslss,2017-08-06T06:04:39.000Z,"Luck, Time and Grit - the Keytruda Story: https://seekingalpha.com/article/4093565-keytruda-story?source=tweet‚Ä¶ $MRK","Luck, Time and Grit - the Keytruda Story: https://seekingalpha.com/article/4093565-keytruda-story?source=tweet‚Ä¶ $MRK
seekingalpha.com
The Keytruda Story (NYSE:MRK)
This is a good history of Keytruda, the Merck (NYSE:MRK) immuno-oncology blockbuster, from David Shaywitz.
6
2",,,6,2,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/raslss/status/894076735490326528
3803,Seeking Alpha,@SeekingAlpha,2017-08-05T13:00:06.000Z,"3 Things In Biotech You Should Learn Today: August 5, 2017 https://seekingalpha.com/article/4094223-3-things-biotech-learn-today-august-5-2017?source=feed_f‚Ä¶ $ABBV $ABT $AGIO $BMY $CELG $JNJ $MRK","3 Things In Biotech You Should Learn Today: August 5, 2017 https://seekingalpha.com/article/4094223-3-things-biotech-learn-today-august-5-2017?source=feed_f‚Ä¶ $ABBV $ABT $AGIO $BMY $CELG $JNJ $MRK
seekingalpha.com
3 Things In Biotech You Should Learn Today: August 5, 2017
Bristol-Myers jumps in the colorectal cancer market with accelerated approval. Surprise! Celgene has a new approval in AML.
1",,,1,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/893818899145179136
3804,The Midas Touch,@MysteryMan_777,2017-08-07T22:56:35.000Z,$OPGN $MBVX still holding ALL my shares. 60min charts ehh but  catalysts are my end game here. MBVX verbally Co $OPK / Frost? OPGN --> $MRK,"$OPGN $MBVX still holding ALL my shares. 60min charts ehh but  catalysts are my end game here. MBVX verbally Co $OPK / Frost? OPGN --> $MRK
1
3
5",„ÄΩ „ÄΩ üõí,1,3,5,"['https://pbs.twimg.com/media/DGqXPAHXUAAUkOg?format=jpg&name=small', 'https://pbs.twimg.com/media/DGqXPALXkAAYtqZ?format=jpg&name=small']",https://twitter.com/MysteryMan_777/status/894693783861948416
3805,Breaking News,@MarketCurrents,2017-08-07T17:36:37.000Z,"Always buy a generic for lower price? Now, not so much https://seekingalpha.com/news/3286336-always-buy-generic-lower-price-now-much?source=feed_f‚Ä¶ $MRK $ENDP $SHPG $MCK","Always buy a generic for lower price? Now, not so much https://seekingalpha.com/news/3286336-always-buy-generic-lower-price-now-much?source=feed_f‚Ä¶ $MRK $ENDP $SHPG $MCK",,,,,[],https://twitter.com/MarketCurrents/status/894613262397980672
3806,Jeffrey Weber,@jjjinvesting,2017-08-06T16:13:42.000Z,Why Stocks Could Soar Into Year End https://seekingalpha.com/article/4095091-stocks-soar-year-end?source=tweet‚Ä¶ $AAPL $CSCO $DIA $GE $GOOG $GOOGL $IBM $IVV $JNJ $MRK $MSFT $PFE $QQQ $SPY,"Why Stocks Could Soar Into Year End https://seekingalpha.com/article/4095091-stocks-soar-year-end?source=tweet‚Ä¶ $AAPL $CSCO $DIA $GE $GOOG $GOOGL $IBM $IVV $JNJ $MRK $MSFT $PFE $QQQ $SPY
1",,,1,,[],https://twitter.com/jjjinvesting/status/894230007014445057
3807,mrd2upls,@mrd2upls,2017-08-07T06:37:47.000Z,Afm13 + #keytruda trial is kinda small. What y'all think? $afmd $mrk #biotech,Afm13 + #keytruda trial is kinda small. What y'all think? $afmd $mrk #biotech,,,,,['https://pbs.twimg.com/media/DGm3OG5UIAAFnYp?format=jpg&name=900x900'],https://twitter.com/mrd2upls/status/894447460034134016
3808,Vista Partners LLC,@VistaPResearch,2017-08-05T06:11:52.000Z,"@BakerEvalina
 thanks for follow! Vista Partners #InvestingForLife http://vistapglobal.com #tech #biotech $MRK $ATOS $AAPL $UTX","@BakerEvalina
 thanks for follow! Vista Partners #InvestingForLife http://vistapglobal.com #tech #biotech $MRK $ATOS $AAPL $UTX
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DGceG71UIAA4JIz.jpg'],https://twitter.com/VistaPResearch/status/893716165549187075
3809,dough,@semodough,2017-08-07T10:38:56.000Z,$MRK AUG 29 MRK plans to reveal data on REVEAL STUDY Anacetracib at ESC,"$MRK AUG 29 MRK plans to reveal data on REVEAL STUDY Anacetracib at ESC
1
1",,,1,1,[],https://twitter.com/semodough/status/894508148731633664
3810,TickWatcher,@MITickWatcher,2017-08-07T20:05:05.000Z,"Top #moneyflow for #sp500 today
$FIS $MRK $COL $AIG $CMCSA $C $MSFT $CSCO $LOW $ORCL ...","Top #moneyflow for #sp500 today
$FIS $MRK $COL $AIG $CMCSA $C $MSFT $CSCO $LOW $ORCL ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.4672/5.0 stars ‚Äì 5,625 ratings",,,,,[],https://twitter.com/MITickWatcher/status/894650623777308672
3811,bake mcbride,@ITRADEVOL,2017-08-07T22:49:15.000Z,BuySideClosing Imbalances $GM $CL $VSH $CNP $MRK $BK $UPS $MPLX $APC $POR $CLF $AA $PEP $BWA $TWX $MOR $SYY $NYCB  https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,"BuySideClosing Imbalances $GM $CL $VSH $CNP $MRK $BK $UPS $MPLX $APC $POR $CLF $AA $PEP $BWA $TWX $MOR $SYY $NYCB  https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶
1",,,,1,[],https://twitter.com/ITRADEVOL/status/894691939383209984
3812,Sean McGrath,@sean_uk,2017-08-07T12:34:00.000Z,AstraZeneca Takes a Long Shot on Lung #Cancer Drug Study https://shar.es/1TQNz3 $AZN $MRK #oncology #NSCLC #lungcancer #immunotherapy,AstraZeneca Takes a Long Shot on Lung #Cancer Drug Study https://shar.es/1TQNz3 $AZN $MRK #oncology #NSCLC #lungcancer #immunotherapy,,,,,[],https://twitter.com/sean_uk/status/894537105107554305
3813,TickWatcher,@MITickWatcher,2017-08-07T20:05:01.000Z,"Top #moneyflow for whole #market today
$WFC $SYMC $IWD $USMV $CHTR $TSLA $LQD $XBI $FIS $MRK ...","Top #moneyflow for whole #market today
$WFC $SYMC $IWD $USMV $CHTR $TSLA $LQD $XBI $FIS $MRK ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/894650606413074432
3814,CBPartners,@CBPartners,2017-08-07T16:40:18.000Z,New #HCV treatment $ABBV MAVYRET undercuts prices of direct competitors $GILD and $MRK - will this be the start of a pricing war?,"New #HCV treatment $ABBV MAVYRET undercuts prices of direct competitors $GILD and $MRK - will this be the start of a pricing war?
FirstWord Pharma
@fwpharma
 ¬∑ 28 Jul 2017
AbbVie's second-quarter revenue up 8 percent, with Humira sales beating forecasts https://firstwordpharma.com/node/1492061 $ABBV",,,,,['https://pbs.twimg.com/profile_images/1436380429846777862/OE8ntEaR_mini.jpg'],https://twitter.com/CBPartners/status/894599089060446209
3815,Sweet Platform,@SweetPlatform,2017-08-07T13:12:59.000Z,"MRK Top news - Aug 7th, 2017 $MRK http://https://goo.gl/PXrR86","MRK Top news - Aug 7th, 2017 $MRK http://https://goo.gl/PXrR86",,,,,[],https://twitter.com/SweetPlatform/status/894546916834516993
3816,Siti van der Meij,@sitivandermeij,2017-08-07T17:46:11.000Z,"Always buy a generic for lower price? Now, not so much https://seekingalpha.com/news/3286336-always-buy-generic-lower-price-now-much?source=feed_f‚Ä¶ $MRK $ENDP $SHPG $MCK #sitifatimah #malaysia #financialplan‚Ä¶","Always buy a generic for lower price? Now, not so much https://seekingalpha.com/news/3286336-always-buy-generic-lower-price-now-much?source=feed_f‚Ä¶ $MRK $ENDP $SHPG $MCK #sitifatimah #malaysia #financialplan‚Ä¶
seekingalpha.com
Always buy a generic for lower price? Now, not so much (NYSE:MRK)
The New York Times reports that there is a growing trend among health insurers specifying branded drugs over generics, driven by more attractive margins for pharmacy benefit managers...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/894615668083109888
3817,Alessandro viva l‚Äô#Ucraina,@pelias01,2017-08-07T12:33:24.000Z,Why Stocks Could Soar Into Year End https://seekingalpha.com/article/4095091-stocks-soar-year-end?source=tweet‚Ä¶ $AAPL $CSCO $DIA $GE $GOOG $GOOGL $IBM $IVV $JNJ $MRK $MSFT $PFE $QQQ $SPY,Why Stocks Could Soar Into Year End https://seekingalpha.com/article/4095091-stocks-soar-year-end?source=tweet‚Ä¶ $AAPL $CSCO $DIA $GE $GOOG $GOOGL $IBM $IVV $JNJ $MRK $MSFT $PFE $QQQ $SPY,,,,,[],https://twitter.com/pelias01/status/894536955282821120
3818,Jeffrey Weber,@jjjinvesting,2017-08-06T16:04:43.000Z,"3 Things In Biotech You Should Learn Today: August 5, 2017 https://seekingalpha.com/article/4094223-3-things-biotech-learn-today-august-5-2017?source=tweet‚Ä¶ $ABBV $ABT $AGIO $BMY $CELG $JNJ $MRK","3 Things In Biotech You Should Learn Today: August 5, 2017 https://seekingalpha.com/article/4094223-3-things-biotech-learn-today-august-5-2017?source=tweet‚Ä¶ $ABBV $ABT $AGIO $BMY $CELG $JNJ $MRK
seekingalpha.com
3 Things In Biotech You Should Learn Today: August 5, 2017
Bristol-Myers jumps in the colorectal cancer market with accelerated approval. Surprise! Celgene has a new approval in AML.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/jjjinvesting/status/894227745768648704
3819,Daily Political,@dailypoliticaln,2017-08-06T16:21:53.000Z,"Mogy Joel R Investment Counsel Inc. Holds Stake in Merck & Company, Inc. $MRK http://ift.tt/2wjAScV","Mogy Joel R Investment Counsel Inc. Holds Stake in Merck & Company, Inc. $MRK http://ift.tt/2wjAScV",,,,,[],https://twitter.com/dailypoliticaln/status/894232065633390592
3820,MarketBeat,@MarketBeatCom,2017-08-07T21:21:08.000Z,"Merck & Company, Inc. $MRK Shares Sold by First National Bank of Omaha http://ift.tt/2uiJr6f","Merck & Company, Inc. $MRK Shares Sold by First National Bank of Omaha http://ift.tt/2uiJr6f",,,,,[],https://twitter.com/MarketBeatCom/status/894669763674333184
3821,TalkMarkets,@TalkMarkets,2017-08-07T20:47:49.000Z,Q2 Earnings Fail to Impress Pharma ETF $IHE $PJP $XPH $PPH Also $BMY $JNJ $LLY $MRK $PFE https://goo.gl/R9N4j1,Q2 Earnings Fail to Impress Pharma ETF $IHE $PJP $XPH $PPH Also $BMY $JNJ $LLY $MRK $PFE https://goo.gl/R9N4j1,,,,,[],https://twitter.com/TalkMarkets/status/894661381206814720
3822,BioPharma Dive,@BioPharmaDive,2017-08-05T15:01:00.000Z,$PFE's Inflectra continues to have mixed reimbursement http://bit.ly/2f4MfBt $JNJ $MRK,"$PFE's Inflectra continues to have mixed reimbursement http://bit.ly/2f4MfBt $JNJ $MRK
biopharmadive.com
Pfizer still mum on BD, frustrated by biosimilar market
Second quarter earnings for the big pharma were uneventful, but commentary on business development and the biosimilar market were illuminating.",,,,,['https://pbs.twimg.com/card_img/1499882689679310851/PXhQbqF7?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/893849325125722112
3823,US Banking News,@AmericanBanking,2017-08-05T02:47:13.000Z,"Merck & Company, Inc. $MRK Given Consensus Recommendation of ‚ÄúHold‚Äù by Brokerages http://ift.tt/2v7gDPk","Merck & Company, Inc. $MRK Given Consensus Recommendation of ‚ÄúHold‚Äù by Brokerages http://ift.tt/2v7gDPk",,,,,[],https://twitter.com/AmericanBanking/status/893664662109159425
3824,cowenresearch,@CowenResearch,2017-08-07T11:49:18.000Z,Steve Scala publishes takeaways from Cowen's Hot Wheels Tour - meetings with managements of $AZN $BMY $LLY $GSK $MRK $NVS $PFE $RHHBY,"Steve Scala publishes takeaways from Cowen's Hot Wheels Tour - meetings with managements of $AZN $BMY $LLY $GSK $MRK $NVS $PFE $RHHBY
1",,,1,,[],https://twitter.com/CowenResearch/status/894525857888444417
3825,Todd Campbell,@ebcapital,2017-08-06T13:44:37.000Z,"Celgene vs. Gilead Sciences: Who Reported Better Earnings? 
@themotleyfool
 #stocks $MRK, $BMY, $CELG, $GILD","Celgene vs. Gilead Sciences: Who Reported Better Earnings? 
@themotleyfool
 #stocks $MRK, $BMY, $CELG, $GILD
fool.com
Celgene vs. Gilead Sciences: Who Reported Better Earnings? @themotleyfool #stocks $CELG $GILD $MRK...
Celgene's and Gilead Sciences‚Äô Q2 2017 results are fueling gains in their stock prices, but is one of these stocks doing better than the other?",,,,,[],https://twitter.com/ebcapital/status/894192491108462592
3826,GREEN STOCK NEWS,@greenstocknews,2017-08-05T13:01:12.000Z,"3 Things In Biotech You Should Learn Today: August 5, 2017 https://seekingalpha.com/article/4094223-3-things-biotech-learn-today-august-5-2017?source=feed_f‚Ä¶ $ABBV $ABT $AGIO $BMY $CELG $JNJ $MRK","3 Things In Biotech You Should Learn Today: August 5, 2017 https://seekingalpha.com/article/4094223-3-things-biotech-learn-today-august-5-2017?source=feed_f‚Ä¶ $ABBV $ABT $AGIO $BMY $CELG $JNJ $MRK
seekingalpha.com
3 Things In Biotech You Should Learn Today: August 5, 2017
Bristol-Myers jumps in the colorectal cancer market with accelerated approval. Surprise! Celgene has a new approval in AML.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/greenstocknews/status/893819173951987712
3827,MarketBeat,@MarketBeatCom,2017-08-05T02:43:49.000Z,"Merck & Company, Inc. $MRK Given Consensus Recommendation of ‚ÄúHold‚Äù by Brokerages http://ift.tt/2v55D6I #acn","Merck & Company, Inc. $MRK Given Consensus Recommendation of ‚ÄúHold‚Äù by Brokerages http://ift.tt/2v55D6I #acn",,,,,[],https://twitter.com/MarketBeatCom/status/893663807406579713
3828,Limex,@LimexMe,2017-08-07T14:37:58.000Z,Q2 Earnings Fail to Impress Pharma ETF http://bit.ly/070817PFE $PFE $JNJ $LLY $MRK $BMY,"Q2 Earnings Fail to Impress Pharma ETF http://bit.ly/070817PFE $PFE $JNJ $LLY $MRK $BMY
whotrades.com
Q2 Earnings Fail to Impress Pharma ETF
Total earnings for 83.3% of the total healthcare market capitalization are up 6% on revenue growth of 4.1%. Though earnings growth is weak compared with many other sectors,‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/894568305004077056
3829,MarketBeat,@MarketBeatCom,2017-08-05T19:43:29.000Z,"Merck & Company, Inc. $MRK Shares Sold by Blue Chip Partners Inc. http://ift.tt/2wiohXl","Merck & Company, Inc. $MRK Shares Sold by Blue Chip Partners Inc. http://ift.tt/2wiohXl",,,,,[],https://twitter.com/MarketBeatCom/status/893920414690418689
3830,Dakota Financial,@dakotafinancial,2017-08-07T21:20:43.000Z,"Merck & Company, Inc. $MRK Shares Sold by First National Bank of Omaha http://ift.tt/2uiJr6f","Merck & Company, Inc. $MRK Shares Sold by First National Bank of Omaha http://ift.tt/2uiJr6f",,,,,[],https://twitter.com/dakotafinancial/status/894669659731111941
3831,Dakota Financial,@dakotafinancial,2017-08-05T19:43:12.000Z,"Merck & Company, Inc. $MRK Shares Sold by Blue Chip Partners Inc. http://ift.tt/2wiohXl","Merck & Company, Inc. $MRK Shares Sold by Blue Chip Partners Inc. http://ift.tt/2wiohXl",,,,,[],https://twitter.com/dakotafinancial/status/893920342900604928
3832,Seeking Alpha,@SeekingAlpha,2017-08-10T06:20:53.000Z,Valeant Pharmaceuticals: A Lesson In Value Traps https://seekingalpha.com/article/4097208-valeant-pharmaceuticals-lesson-value-traps?source=feed_f‚Ä¶ $JNJ $MRK $PFE $VRX,"Valeant Pharmaceuticals: A Lesson In Value Traps https://seekingalpha.com/article/4097208-valeant-pharmaceuticals-lesson-value-traps?source=feed_f‚Ä¶ $JNJ $MRK $PFE $VRX
3",,,,3,[],https://twitter.com/SeekingAlpha/status/895530371067949056
3833,haodongvli,@haodongvli,2017-08-09T20:25:33.000Z,Esperion's Triple Combo Hits A Home Run https://seekingalpha.com/article/4096984-esperions-triple-combo-hits-home-run?source=tweet‚Ä¶ $AMGN $LDL $LLY $MRK $PFE $REGN $SNY $ESPR,"Esperion's Triple Combo Hits A Home Run https://seekingalpha.com/article/4096984-esperions-triple-combo-hits-home-run?source=tweet‚Ä¶ $AMGN $LDL $LLY $MRK $PFE $REGN $SNY $ESPR
seekingalpha.com
Esperion's Triple Combo Hits A Home Run (NASDAQ:ESPR)
Triple combo therapy with bempedoic paves the way for clinical success in the high-cholesterol market.
1",,,,1,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/haodongvli/status/895380551376437250
3834,Seeking Alpha,@SeekingAlpha,2017-08-09T13:51:55.000Z,What AbbVie's Mavyret Approval Means To Gilead https://seekingalpha.com/article/4096805-abbvies-mavyret-approval-means-gilead?source=feed_f‚Ä¶ $ESRX $MRK $GILD $ABBV,"What AbbVie's Mavyret Approval Means To Gilead https://seekingalpha.com/article/4096805-abbvies-mavyret-approval-means-gilead?source=feed_f‚Ä¶ $ESRX $MRK $GILD $ABBV
1",,,,1,[],https://twitter.com/SeekingAlpha/status/895281490518392832
3835,Activist Stocks,@activiststocks,2017-08-08T18:50:15.000Z,Gilead: Obsolete By 2020? http://ow.ly/wqjG30efyEB $GILD $ABBV $MRK,"Gilead: Obsolete By 2020? http://ow.ly/wqjG30efyEB $GILD $ABBV $MRK
seekingalpha.com
Gilead: Obsolete By 2020? (NASDAQ:GILD)
Gilead is craving an activist investor. However, what it really needs is a little faith.
1",,,,1,[],https://twitter.com/activiststocks/status/894994180606484480
3836,WLST.com,@wlstcom,2017-08-08T16:11:23.000Z,DelMar Pharmaceuticals: Where We Are Headed #MRK #RHHBY #DMPI #DelMarPharma #Canada #DrugRelatedProducts $MRK $DMPI https://seekingalpha.com/article/4096311-delmar-pharmaceuticals-headed‚Ä¶,DelMar Pharmaceuticals: Where We Are Headed #MRK #RHHBY #DMPI #DelMarPharma #Canada #DrugRelatedProducts $MRK $DMPI https://seekingalpha.com/article/4096311-delmar-pharmaceuticals-headed‚Ä¶,,,,,[],https://twitter.com/wlstcom/status/894954201759051777
3837,pharmalot,@pharmalot,2017-08-08T13:20:02.000Z,Pharmalot.. Pharmalittle.. Good Morning.. hot headlines & hot coffee are served.. https://statnews.com/pharmalot/2017/08/08/india-clinical-trials-epipen-pbm/‚Ä¶ #pharma $MYL $MRK $PFE $ENDP,"Pharmalot.. Pharmalittle.. Good Morning.. hot headlines & hot coffee are served.. https://statnews.com/pharmalot/2017/08/08/india-clinical-trials-epipen-pbm/‚Ä¶ #pharma $MYL $MRK $PFE $ENDP
statnews.com
Pharmalittle: Why EpiPen pricing is so strange; India may waive trials for some drugs
India's health ministry recommended waiving clinical trials for critical drugs to treat such diseases as HIV, hepatitis, and tuberculosis.
1",,,,1,[],https://twitter.com/pharmalot/status/894911080195121153
3838,Colley Cibber,@situate,2017-08-08T19:54:21.000Z,$SNY suing $MRK https://seekingalpha.com/pr/16910275-sanofi-files-suit-u-s-defend-patent-rights-lantus‚Ä¶,$SNY suing $MRK https://seekingalpha.com/pr/16910275-sanofi-files-suit-u-s-defend-patent-rights-lantus‚Ä¶,,,,,[],https://twitter.com/situate/status/895010310683324416
3839,Clark Joseph Kent,@JorelLaraKalel,2017-08-10T16:54:43.000Z,Dynavax Gets Ready To Go It Alone With Heplisav-B $DVAX http://bit.ly/2fw3eNc $MRK $GSK,"Dynavax Gets Ready To Go It Alone With Heplisav-B $DVAX http://bit.ly/2fw3eNc $MRK $GSK
seekingalpha.com
Dynavax Gets Ready To Go It Alone With Heplisav-B (NASDAQ:DVAX)
DVAX has stated its intention to raise $75 million through a stock offering. Approval of Heplisav-B appears to be nearly certain despite PDUFA delay.
1",,,,1,['https://pbs.twimg.com/card_img/1497724725002448899/2TZ3O23_?format=png&name=240x240'],https://twitter.com/JorelLaraKalel/status/895689880893890562
3840,Odi Bruckman,@odibro,2017-08-08T10:09:02.000Z,$MRK says NICE recommends Erbitux/platinum-based chemotherapy combination as first line treatment for #SCCHN  http://pharmafile.com/news/514833/mercks-scores-expanded-nice-recommendation-head-neck-and-oral-cancer‚Ä¶,"$MRK says NICE recommends Erbitux/platinum-based chemotherapy combination as first line treatment for #SCCHN  http://pharmafile.com/news/514833/mercks-scores-expanded-nice-recommendation-head-neck-and-oral-cancer‚Ä¶
2
5",,,2,5,[],https://twitter.com/odibro/status/894863013714558976
3841,The Midas Touch,@MysteryMan_777,2017-08-08T17:31:00.000Z,$OPGN shares still selling 17% cheaper than CEO/CBOD's 1.9 mill market purchase at .40 ~ ER/Conf Call AMC today. Any $MRK comm would be nice,"$OPGN shares still selling 17% cheaper than CEO/CBOD's 1.9 mill market purchase at .40 ~ ER/Conf Call AMC today. Any $MRK comm would be nice
4",„ÄΩ „ÄΩ,,,4,"['https://pbs.twimg.com/media/DGuWUS6VoAAA_97?format=jpg&name=small', 'https://pbs.twimg.com/media/DGuWUS4VoAAKx4-?format=jpg&name=360x360']",https://twitter.com/MysteryMan_777/status/894974235109711874
3842,Kara Jill Stancell,@kjilly,2017-08-08T13:21:45.000Z,"$SNY is trying to catch up on the next generation of #cancerdrugs #lungcancer #pharma $MRK $AZN $BMY https://bloomberg.com/news/articles/2017-08-08/an-also-ran-in-cancer-drugs-sanofi-sees-chance-to-close-the-gap‚Ä¶ via 
@business","$SNY is trying to catch up on the next generation of #cancerdrugs #lungcancer #pharma $MRK $AZN $BMY https://bloomberg.com/news/articles/2017-08-08/an-also-ran-in-cancer-drugs-sanofi-sees-chance-to-close-the-gap‚Ä¶ via 
@business
bloomberg.com
An Also-Ran in Cancer Drugs, Sanofi Sees Chance to Close the Gap
Sanofi, the French drugmaker that‚Äôs been a laggard in the race to develop a new generation of cancer drugs, sees an opportunity to close the gap after key contenders including AstraZeneca Plc and...",,,,,['https://pbs.twimg.com/card_img/1501469380198244353/rwMAvPR8?format=jpg&name=small'],https://twitter.com/kjilly/status/894911509712613377
3843,dough,@semodough,2017-08-09T19:53:03.000Z,"Replying to 
@semodough","Replying to 
@semodough
$LPTX interesting comments on GITR -also $MRK $BMY $NVS all involved
1
1",,,1,1,['https://pbs.twimg.com/media/DG0AbH_V0AAPxrP?format=jpg&name=small'],https://twitter.com/semodough/status/895372372857016320
3844,Maria Chaudhry,@mchaudhry82,2017-08-09T16:58:13.000Z,"Upgrades, Downgrades, Initiations & More: $MRK $AZN $RL $NVAX $GTS $ESPR $AA $SAGE $ZG $KORS $ACHN $DIS $PCLN $CYRX","Upgrades, Downgrades, Initiations & More: $MRK $AZN $RL $NVAX $GTS $ESPR $AA $SAGE $ZG $KORS $ACHN $DIS $PCLN $CYRX",,,,,['https://pbs.twimg.com/media/DGzYaLqUQAAsjdt?format=jpg&name=small'],https://twitter.com/mchaudhry82/status/895328373974618113
3845,Kara Jill Stancell,@kjilly,2017-08-09T13:26:30.000Z,"$ESPR hits goal in #LDL trial, pulls forward #NDA target date #biotech  #cholesteroldrugs #cholesterol $MRK $PFE","$ESPR hits goal in #LDL trial, pulls forward #NDA target date #biotech  #cholesteroldrugs #cholesterol $MRK $PFE
fiercebiotech.com
Esperion hits goal in LDL trial, pulls forward NDA target date
A phase 2 trial combining Esperion Therapeutics‚Äô bempedoic acid with the active ingredients in Merck‚Äôs Zetia and Pfizer‚Äôs Lipitor has
1",,,,1,['https://pbs.twimg.com/card_img/1501717821520289793/caZJDiYZ?format=jpg&name=small'],https://twitter.com/kjilly/status/895275093328240641
3846,FinInvTr,@FinInvTr,2017-08-08T11:53:02.000Z,"Market's Top Large/Mid Cap Fund Up 14% In Past Year https://buff.ly/2woeqiX

$VZ $PM $CMCSA $UNH $MRK $V $KO $PEP $DIS $INTC $CSCO $ORCL $MO","Market's Top Large/Mid Cap Fund Up 14% In Past Year https://buff.ly/2woeqiX

$VZ $PM $CMCSA $UNH $MRK $V $KO $PEP $DIS $INTC $CSCO $ORCL $MO",,,,,['https://pbs.twimg.com/media/DGtI-H3WAAAp8Y_?format=jpg&name=small'],https://twitter.com/FinInvTr/status/894889185139609600
3847,Vista Partners LLC,@VistaPResearch,2017-08-08T19:45:42.000Z,@OutfitsGrids thanks for follow! Vista Partners #InvestingForLife #healthcare http://vistapglobal.com $DIA $IBB $HIIQ $ATOS $MRK,"@OutfitsGrids thanks for follow! Vista Partners #InvestingForLife #healthcare http://vistapglobal.com $DIA $IBB $HIIQ $ATOS $MRK
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DGu1JTxU0AAnMXq.jpg'],https://twitter.com/VistaPResearch/status/895008135911424000
3848,Dow Stocks,@Top_Dow_Stocks,2017-08-10T07:16:58.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/895544485886566400
3849,Jack Allen,@JohnK_Allen,2017-08-09T13:26:23.000Z,"In your opinion which major pharma is most likely to partner with $MDCO for inclisiran?

Please RT to expand reach

$PFE $AZN $MRK $ALNY","In your opinion which major pharma is most likely to partner with $MDCO for inclisiran?

Please RT to expand reach

$PFE $AZN $MRK $ALNY
$PFE
52.2%
$AZN
17.4%
$MRK
21.7%
Other please comment
8.7%
23 votes
¬∑
Final results
1
1
1",,1,1,1,[],https://twitter.com/JohnK_Allen/status/895275065075478528
3850,Pharmaceutical News,@pharma_sector,2017-08-10T09:40:37.000Z,"EOD Risers: #Merck & Co., Inc., Nike Inc, Pfizer Inc. Read more: http://owler.us/ac93I1 $MRK","EOD Risers: #Merck & Co., Inc., Nike Inc, Pfizer Inc. Read more: http://owler.us/ac93I1 $MRK",,,,,[],https://twitter.com/pharma_sector/status/895580638312407040
3851,CBPartners,@CBPartners,2017-08-10T22:10:09.000Z,"$SNY files #PatentInfringement suit against $MRK in NJ, USA over alleged infringement of two LANTUS #insulin patents http://bit.ly/2wLnrly","$SNY files #PatentInfringement suit against $MRK in NJ, USA over alleged infringement of two LANTUS #insulin patents http://bit.ly/2wLnrly",,,,,[],https://twitter.com/CBPartners/status/895769264405315588
3852,BioPharma Dive,@BioPharmaDive,2017-08-10T22:05:22.000Z,England starts prioritizing patients amid global hep B vaccine shortage http://bit.ly/2vTuyLk $MRK $GSK,"England starts prioritizing patients amid global hep B vaccine shortage http://bit.ly/2vTuyLk $MRK $GSK
biopharmadive.com
England starts prioritizing patients amid global hep B vaccine shortage
The decision comes as Merck and GSK work to restore vaccine supplies.
1",,,,1,[],https://twitter.com/BioPharmaDive/status/895768060166107136
3853,Traderific,@Traderific,2017-08-08T20:25:34.000Z,"COVER $LRCX 156.15, SELL $MCHP 84.58, SHORT $MRK 62.33, SELL $S 8.41. More stock tips & details at: http://traderific.com/?date=2017-08-08‚Ä¶","COVER $LRCX 156.15, SELL $MCHP 84.58, SHORT $MRK 62.33, SELL $S 8.41. More stock tips & details at: http://traderific.com/?date=2017-08-08‚Ä¶",,,,,[],https://twitter.com/Traderific/status/895018167076048896
3854,MR QA Env,@mr_env_qa,2017-08-09T18:05:52.000Z,Can Pfizer Report Growth in 4Q16 Earnings? - Partner Voice Test http://qa.aws.marketrealist.com/?p=1888851 $PFE $MRK $IXJ $LLY,Can Pfizer Report Growth in 4Q16 Earnings? - Partner Voice Test http://qa.aws.marketrealist.com/?p=1888851 $PFE $MRK $IXJ $LLY,,,,,[],https://twitter.com/mr_env_qa/status/895345398327455744
3855,Limex,@LimexMe,2017-08-09T16:11:49.000Z,Why BeiGene Soared 56.6% In July http://bit.ly/2vmSwwc $BGNE $MRK $BMY,"Why BeiGene Soared 56.6% In July http://bit.ly/2vmSwwc $BGNE $MRK $BMY
whotrades.com
Why BeiGene Soared 56.6% In July
What happened After inking a collaboration agreement with biotech powerhouse Celgene (NASDAQ: CELG) , shares in BeiGene Ltd. (NASDAQ: BGNE) rocketed 56.6% higher last month,‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/895316697787138048
3856,StockMarketVideo.com,@stockmarketvide,2017-08-10T00:54:49.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,,,,,[],https://twitter.com/stockmarketvide/status/895448316435091456
3857,Bridgewater,@fourifbyair,2017-08-08T18:55:10.000Z,Gilead: Obsolete By 2020? http://ow.ly/wqjG30efyEB $GILD $ABBV $MRK,"Gilead: Obsolete By 2020? http://ow.ly/wqjG30efyEB $GILD $ABBV $MRK
seekingalpha.com
Gilead: Obsolete By 2020? (NASDAQ:GILD)
Gilead is craving an activist investor. However, what it really needs is a little faith.",,,,,['https://pbs.twimg.com/card_img/1501990534524518401/6EVYgUJ9?format=png&name=360x360'],https://twitter.com/fourifbyair/status/894995418404327424
3858,Pharmaceutical News,@pharma_sector,2017-08-10T15:17:46.000Z,#Merck and : Hep B vaccine supply issues at Merck & Co and GSK prompt UK to prioritize access . Read more: http://owler.us/ac97Dc $MRK,#Merck and : Hep B vaccine supply issues at Merck & Co and GSK prompt UK to prioritize access . Read more: http://owler.us/ac97Dc $MRK,,,,,[],https://twitter.com/pharma_sector/status/895665484208627712
3859,Pharmaceutical News,@pharma_sector,2017-08-10T19:25:17.000Z,Researchers from #Merck & Company Report Details of New Studies and Findings in the Area of ... Read more: http://owler.us/ac90eH $MRK,Researchers from #Merck & Company Report Details of New Studies and Findings in the Area of ... Read more: http://owler.us/ac90eH $MRK,,,,,[],https://twitter.com/pharma_sector/status/895727774752686080
3860,Daily Political,@dailypoliticaln,2017-08-09T15:23:43.000Z,"PNC Financial Services Group Inc. Has $624.06 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2vOrDU6","PNC Financial Services Group Inc. Has $624.06 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2vOrDU6",,,,,[],https://twitter.com/dailypoliticaln/status/895304592270995456
3861,US Banking News,@AmericanBanking,2017-08-09T07:14:17.000Z,Merck KGaA given ‚Ç¨94.00 PT by HSBC Holdings plc. neutral rating. http://ift.tt/2vNsN3n $MRK #MRK,Merck KGaA given ‚Ç¨94.00 PT by HSBC Holdings plc. neutral rating. http://ift.tt/2vNsN3n $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/895181423191220224
3862,bake mcbride,@ITRADEVOL,2017-08-10T23:21:20.000Z,SellSideClosing Imbalances $JNJ $TWX $MRK $WFC $PFE $JPM $BCR $UNH $TMO $BTI $COL $DAL $MO $K $UNP $HON $NRG $CRM https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,"SellSideClosing Imbalances $JNJ $TWX $MRK $WFC $PFE $JPM $BCR $UNH $TMO $BTI $COL $DAL $MO $K $UNP $HON $NRG $CRM https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶
1",,,,1,[],https://twitter.com/ITRADEVOL/status/895787177052962818
3863,MarketBeat,@MarketBeatCom,2017-08-09T16:13:32.000Z,"Merck & Company, Inc. $MRK Forecasted to Earn Q4 2017 Earnings of $0.98 Per Share http://ift.tt/2hLpZxw","Merck & Company, Inc. $MRK Forecasted to Earn Q4 2017 Earnings of $0.98 Per Share http://ift.tt/2hLpZxw",,,,,[],https://twitter.com/MarketBeatCom/status/895317128005406720
3864,StockNews.com,@stocknewsdotcom,2017-08-08T19:34:22.000Z,$MRK Sanofi files a patent infringement suit against Merck alleging infringement of two patents https://stocknews.com/news/mrk-sanofi-files-a-patent-infringement-suit-against-merck-alleging-infringement/‚Ä¶,$MRK Sanofi files a patent infringement suit against Merck alleging infringement of two patents https://stocknews.com/news/mrk-sanofi-files-a-patent-infringement-suit-against-merck-alleging-infringement/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/895005281935118336
3865,Limex,@LimexMe,2017-08-09T16:12:16.000Z,"Celldex Therapeutics, Inc. Finishes Second Quarter With Plenty of Cash and Clinical Momentum http://bit.ly/2uGf74U $CLDX $MRK $BMY","Celldex Therapeutics, Inc. Finishes Second Quarter With Plenty of Cash and Clinical Momentum http://bit.ly/2uGf74U $CLDX $MRK $BMY
whotrades.com
Celldex Therapeutics, Inc. Finishes Second Quarter With Plenty of Cash and Clinical Momentum
Investors view quarterly updates from clinical-stage biotechs in a much different way from how they view those of other companies. When Celldex Therapeutics (NASDAQ: CLDX) reported‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/895316809137639424
3866,StockNews.com,@stocknewsdotcom,2017-08-08T21:43:54.000Z,$MRK 10-Q discloses that it recently received an investigative subpoena from the California Insurance Commissioner‚Ä¶ https://stocknews.com/news/mrk-10-q-discloses-that-it-recently-received-an-investigative-subpoena-from/‚Ä¶,$MRK 10-Q discloses that it recently received an investigative subpoena from the California Insurance Commissioner‚Ä¶ https://stocknews.com/news/mrk-10-q-discloses-that-it-recently-received-an-investigative-subpoena-from/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/895037881789685761
3867,US Banking News,@AmericanBanking,2017-08-08T11:15:25.000Z,"SunTrust Banks Research Analysts Lower Earnings Estimates for Merck & Company, Inc. $MRK http://ift.tt/2fpidsa","SunTrust Banks Research Analysts Lower Earnings Estimates for Merck & Company, Inc. $MRK http://ift.tt/2fpidsa",,,,,[],https://twitter.com/AmericanBanking/status/894879719518240768
3868,Todd Campbell,@ebcapital,2017-08-09T15:21:23.000Z,"Why BeiGene Soared 56.6% In July 
@themotleyfool
 #stocks $MRK, $CELG, $BMY, $BGNE","Why BeiGene Soared 56.6% In July 
@themotleyfool
 #stocks $MRK, $CELG, $BMY, $BGNE
fool.com
Why BeiGene Soared 56.6% In July @themotleyfool #stocks $BGNE $MRK $CELG $BMY
The company inked a trans-formative deal with biotech behemoth Celgene last month.",,,,,['https://pbs.twimg.com/card_img/1501717765077487621/FP3V26P3?format=jpg&name=small'],https://twitter.com/ebcapital/status/895304006700081153
3869,StockNews.com,@stocknewsdotcom,2017-08-09T12:53:06.000Z,$MRK HSBC raises to a hold from a reduce https://stocknews.com/news/mrk-hsbc-raises-to-a-hold-from-a-reduce/‚Ä¶,$MRK HSBC raises to a hold from a reduce https://stocknews.com/news/mrk-hsbc-raises-to-a-hold-from-a-reduce/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/895266690702995456
3870,Dakota Financial,@dakotafinancial,2017-08-10T03:58:41.000Z,"Douglas Lane & Associates LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2vPXcgw","Douglas Lane & Associates LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2vPXcgw",,,,,[],https://twitter.com/dakotafinancial/status/895494587468447744
3871,BooRad,@atticusMB,2017-08-09T16:21:25.000Z,"Why BeiGene Soared 56.6% In July 
@themotleyfool
 #stocks $MRK, $CELG, $BMY, $BGNE","Why BeiGene Soared 56.6% In July 
@themotleyfool
 #stocks $MRK, $CELG, $BMY, $BGNE
fool.com
Why BeiGene Soared 56.6% In July @themotleyfool #stocks $BGNE $MRK $CELG $BMY
The company inked a trans-formative deal with biotech behemoth Celgene last month.",,,,,['https://pbs.twimg.com/card_img/1501717765077487621/FP3V26P3?format=jpg&name=small'],https://twitter.com/atticusMB/status/895319113764970496
3872,Zero Filter,@zerofiltertruth,2017-08-09T12:10:19.000Z,"#Zica - schmica $NVAX all about #flu virus now 

$IBB $XBI $FBT $MRK $CELG $GILD $AMGN $NVS $SHPG

#Biotech insanity 
@petenajarian
 @GuyAdami","#Zica - schmica $NVAX all about #flu virus now 

$IBB $XBI $FBT $MRK $CELG $GILD $AMGN $NVS $SHPG

#Biotech insanity 
@petenajarian
 @GuyAdami
Zero Filter
@zerofiltertruth
 ¬∑ 9 Aug 2017
#Biotech bonanza:

Epic-failure $NVAX upgraded to Buy at Ladenburg with $1.60pt post print / call 

$IBB $XBI $FBT $GILD $AMGN $SHPG $NVS",,,,,['https://pbs.twimg.com/profile_images/497038230823649280/gsfC9L1V_mini.jpeg'],https://twitter.com/zerofiltertruth/status/895255920430678016
3873,The Midas Touch,@MysteryMan_777,2017-08-08T20:36:04.000Z,"Replying to 
@MACDcurlingup","Replying to 
@MACDcurlingup
Still got $MRK lingering as well 40% ownership
1",„ÄΩ „ÄΩ,1,,,[],https://twitter.com/MysteryMan_777/status/895020811760930816
3874,The Capitolist,@CapitolistPig,2017-08-08T02:02:22.000Z,"Replying to 
@CapitolistPig
, 
@jonathanrockoff
 and 
@pcmanet","Replying to 
@CapitolistPig
, 
@jonathanrockoff
 and 
@pcmanet
What is the difference between $MRK owning Medco and a limited distribution network agreement at $ESRX?",,,,,[],https://twitter.com/CapitolistPig/status/894740539140079616
3875,MarketBeat,@MarketBeatCom,2017-08-09T07:15:50.000Z,Merck KGaA given ‚Ç¨94.00 PT by HSBC Holdings plc. neutral rating. http://ift.tt/2vNsN3n $MRK #MRK,Merck KGaA given ‚Ç¨94.00 PT by HSBC Holdings plc. neutral rating. http://ift.tt/2vNsN3n $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/895181812225499139
3876,Arnab,@arnabch01,2017-08-13T03:28:16.000Z,#AI #robotics #BigData #genomics #stemcell advances wil grtly enhance #health #wellness $GOOG $MSFT $IBM $JNJ $PFE $NVS $GSK $SNY $MRK  $AZN,"#AI #robotics #BigData #genomics #stemcell advances wil grtly enhance #health #wellness $GOOG $MSFT $IBM $JNJ $PFE $NVS $GSK $SNY $MRK  $AZN
125
99",,,125,99,['https://pbs.twimg.com/media/DHFFUd4UwAI1Mxk?format=jpg&name=small'],https://twitter.com/arnabch01/status/896574095885647874
3877,Drugdoctor1,@Drugdoctor2014,2017-08-13T04:29:34.000Z,$SLDC.043 NEW MINN.-MMJ-Stock-only-43.5M-Outstand $PMCB $GYOG $MMEG $DRYS $DCTH $ELED $FRZT $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG,"$SLDC.043 NEW MINN.-MMJ-Stock-only-43.5M-Outstand $PMCB $GYOG $MMEG $DRYS $DCTH $ELED $FRZT $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG
3
4",,,3,4,"['https://pbs.twimg.com/media/DHFTF8UVoAECKl-?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DHFTF8TUAAEv6E2?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DHFTF8UVwAEYOov?format=jpg&name=360x360']",https://twitter.com/Drugdoctor2014/status/896589522510774277
3878,Buckhead Wealth Management,@BheadWealthmgmt,2017-08-13T17:14:23.000Z,"https://bloomberg.com/quicktake/cancer-coup‚Ä¶
$BMY $MRK #Immunotherapy","https://bloomberg.com/quicktake/cancer-coup‚Ä¶
$BMY $MRK #Immunotherapy",,,,,[],https://twitter.com/BheadWealthmgmt/status/896781995572953089
3879,dough,@semodough,2017-08-12T17:48:04.000Z,"Replying to 
@semodough","Replying to 
@semodough
M&A Deals from 2017 -can this list really stay this small $DERM $ARIA   I see no $MRK $AMGN $GILD $NVS $JNJ $NVS $BMY ETC all who needs to
5
4
10",,5,4,10,['https://pbs.twimg.com/media/DHDAlhmXUAArJiI?format=jpg&name=small'],https://twitter.com/semodough/status/896428083665940480
3880,John Guerriero,@vulken17,2017-08-12T18:30:42.000Z,"$NPHC
Must research biotech STOCK Cloned cobra VENOM Gene reverseS multiple sclerosis $NVS $AMGN $LLY $TEVA $MRK $GSK $GILD $ABBV $PFE $BAYN","$NPHC
Must research biotech STOCK Cloned cobra VENOM Gene reverseS multiple sclerosis $NVS $AMGN $LLY $TEVA $MRK $GSK $GILD $ABBV $PFE $BAYN
Ticker Trend
@TickerTrend
 ¬∑ 12 Aug 2017
RT @vulken17: $NPHC big pharma will be all over this  phase 2 trials led by Dr. Vanderputten Reverses MULTIPLE SCLEROSIS
Wind Fall
S.H. Let‚Ä¶
2
2",,,2,2,['https://pbs.twimg.com/profile_images/842996515752820736/V-lWUjG7_mini.jpg'],https://twitter.com/vulken17/status/896438811412049920
3881,Donna Young,@DonnaYoungDC,2017-08-13T19:59:36.000Z,".
@MichaelJFoxOrg
 Marco Baptista: LRRK2 is very druggable; it's low-hanging fruit to go after it.
#CRS12 #Dragon #Parkinsons #pharma $MRK",".
@MichaelJFoxOrg
 Marco Baptista: LRRK2 is very druggable; it's low-hanging fruit to go after it.
#CRS12 #Dragon #Parkinsons #pharma $MRK
Donna Young
@DonnaYoungDC
 ¬∑ 14 Aug 2017
.@MichaelJFoxOrg Marco Baptista is hoping to improve the crystallization of #Parkinsons protein LRRK2 on @Space_Station 
#CRS12 #Dragon $MRK https://twitter.com/DonnaYoungDC/status/896798878799974400‚Ä¶
3",üì∞ üì∞,,3,,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/896823574341849089
3882,Dow Stocks,@Top_Dow_Stocks,2017-08-11T07:16:58.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/895906873995444225
3883,James Sikes,@wosaikeneriki,2017-08-11T17:37:37.000Z,"As Merck & Co $MRK Market Value Declined, Haverford Trust Company Has Increased Its Position by $826,500 ...","As Merck & Co $MRK Market Value Declined, Haverford Trust Company Has Increased Its Position by $826,500 ...",,,,,[],https://twitter.com/wosaikeneriki/status/896063066571395074
3884,James Sikes,@wosaikeneriki,2017-08-11T16:07:14.000Z,"As Merck & Co $MRK Market Valuation Declined, Cordasco Financial Network Has Decreased Its Position by $304...","As Merck & Co $MRK Market Valuation Declined, Cordasco Financial Network Has Decreased Its Position by $304...",,,,,[],https://twitter.com/wosaikeneriki/status/896040318092574721
3885,Sweet Platform,@SweetPlatform,2017-08-11T15:44:24.000Z,"MRK Top news - Aug 11th, 2017 $MRK http://https://goo.gl/jyCLxu","MRK Top news - Aug 11th, 2017 $MRK http://https://goo.gl/jyCLxu",,,,,[],https://twitter.com/SweetPlatform/status/896034571900387328
3886,Daily Stock Forecast,@Stock_Forecast,2017-08-11T01:54:16.000Z,"Top 5 forecasted #stocks for Aug, Fri 11: $HD - Short, $DIS - Long, $ORCL - Long, $MRK - Long, $MMM - Long. http://daily-stock-forecast.com","Top 5 forecasted #stocks for Aug, Fri 11: $HD - Short, $DIS - Long, $ORCL - Long, $MRK - Long, $MMM - Long. http://daily-stock-forecast.com",,,,,[],https://twitter.com/Stock_Forecast/status/895825661725638657
3887,Tim Reller,@TraderGuruNY,2017-08-11T00:36:25.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/895806072501530624
3888,Donna Young,@DonnaYoungDC,2017-08-13T19:50:23.000Z,".
@ISS_CASIS
 Ken Shields: There's never been a better time to go & have access to space & do research
#CRS12 #Dragon #Parkinsons $LLY $MRK",".
@ISS_CASIS
 Ken Shields: There's never been a better time to go & have access to space & do research
#CRS12 #Dragon #Parkinsons $LLY $MRK
Donna Young
@DonnaYoungDC
 ¬∑ 14 Aug 2017
.@NASA Pete Hasbrook: @AstroPeggy's extended time on @Space_Station puts here in same duration category as @StationCDRKelly 
#TwinsStudy https://twitter.com/DonnaYoungDC/status/896819752961814530‚Ä¶",üì∞ üì∞,,,,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/896821253557940229
3889,FinInvTr,@FinInvTr,2017-08-12T13:21:00.000Z,"10 Top Holdings In Market's Best Healthcare Fund -- https://buff.ly/2vNsTr9

$JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD","10 Top Holdings In Market's Best Healthcare Fund -- https://buff.ly/2vNsTr9

$JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD
whotrades.com
The Market‚Äôs Top Healthcare ETF
Of any sector in the market, along with the tech market, healthcare and biotechnology may be the one with the highest growth trajectory over time. Populations in developing countries are‚Ä¶",,,,,[],https://twitter.com/FinInvTr/status/896360873912127489
3890,James Sikes,@wosaikeneriki,2017-08-11T19:42:16.000Z,"As Merck & Co $MRK Shares Declined, Veritas Investment Management Llp Has Cut Position http://bzweekly.com/as-merck-p2-capital-partners-increases-stake-in-netscout-sys-ntct/‚Ä¶","As Merck & Co $MRK Shares Declined, Veritas Investment Management Llp Has Cut Position http://bzweekly.com/as-merck-p2-capital-partners-increases-stake-in-netscout-sys-ntct/‚Ä¶",,,,,[],https://twitter.com/wosaikeneriki/status/896094435389259776
3891,Daily Political,@dailypoliticaln,2017-08-11T22:55:33.000Z,"Reilly Financial Advisors LLC Buys 316 Shares of Merck & Company, Inc. $MRK http://ift.tt/2fynfmp","Reilly Financial Advisors LLC Buys 316 Shares of Merck & Company, Inc. $MRK http://ift.tt/2fynfmp",,,,,[],https://twitter.com/dailypoliticaln/status/896143074161639424
3892,Watchlist News,@WatchlistN,2017-08-12T18:58:13.000Z,"Level Four Advisory Services LLC Buys 3,726 Shares of Merck & Company, Inc. $MRK http://ift.tt/2fAZKc8","Level Four Advisory Services LLC Buys 3,726 Shares of Merck & Company, Inc. $MRK http://ift.tt/2fAZKc8",,,,,[],https://twitter.com/WatchlistN/status/896445737827012609
3893,Ticker Report,@TickerReport,2017-08-13T15:50:21.000Z,"Farmhouse Investment Management LLC Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2uS2O5R","Farmhouse Investment Management LLC Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2uS2O5R",,,,,[],https://twitter.com/TickerReport/status/896760845375504385
3894,Margin Hunt,@MarginHunt,2017-08-11T19:00:33.000Z,"At 18.5x EV / EBITDA, Eli Lilly and $LLY is above all comps: $BMY $MRK $AZN $PFE $TEVA http://ow.ly/FIuF30eicqu","At 18.5x EV / EBITDA, Eli Lilly and $LLY is above all comps: $BMY $MRK $AZN $PFE $TEVA http://ow.ly/FIuF30eicqu",,,,,[],https://twitter.com/MarginHunt/status/896083935037239296
3895,MarketBeat,@MarketBeatCom,2017-08-12T01:53:15.000Z,"Merck & Company, Inc. $MRK Stake Decreased by Mitchell Sinkler & Starr PA http://ift.tt/2vrChzJ","Merck & Company, Inc. $MRK Stake Decreased by Mitchell Sinkler & Starr PA http://ift.tt/2vrChzJ",,,,,[],https://twitter.com/MarketBeatCom/status/896187796184072192
3896,MarketBeat,@MarketBeatCom,2017-08-12T21:17:31.000Z,"Sii Investments Inc. WI Cuts Stake in Merck & Company, Inc. $MRK http://ift.tt/2vZCwDJ","Sii Investments Inc. WI Cuts Stake in Merck & Company, Inc. $MRK http://ift.tt/2vZCwDJ",,,,,[],https://twitter.com/MarketBeatCom/status/896480793849200642
3897,US Banking News,@AmericanBanking,2017-08-11T17:04:05.000Z,Merck & $MRK ‚Äì Investment Analysts‚Äô Weekly Ratings Updates http://ift.tt/2wPyD0w,Merck & $MRK ‚Äì Investment Analysts‚Äô Weekly Ratings Updates http://ift.tt/2wPyD0w,,,,,[],https://twitter.com/AmericanBanking/status/896054627363282944
3898,MarketBeat,@MarketBeatCom,2017-08-13T23:37:17.000Z,"Stellar Capital Management LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2vA0jqT","Stellar Capital Management LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2vA0jqT",,,,,[],https://twitter.com/MarketBeatCom/status/896878354040619008
3899,InvestorPlace,@InvestorPlace,2017-08-11T15:06:43.000Z,3 Big Stock Charts for Friday: $IWM $GS and $MRK - http://investorplace.com/2017/08/3-big-stock-charts-for-friday-ishares-russell-2000-index-etf-iwm-goldman-sachs-group-inc-gs-and-merck-co-inc-mrk/‚Ä¶,3 Big Stock Charts for Friday: $IWM $GS and $MRK - http://investorplace.com/2017/08/3-big-stock-charts-for-friday-ishares-russell-2000-index-etf-iwm-goldman-sachs-group-inc-gs-and-merck-co-inc-mrk/‚Ä¶,,,,,[],https://twitter.com/InvestorPlace/status/896025088348311552
3900,Donna Young,@DonnaYoungDC,2017-08-13T19:57:38.000Z,".
@MichaelJFoxOrg
 Marco Baptista is hoping to improve the crystallization of #Parkinsons protein LRRK2 on 
@Space_Station
 
#CRS12 #Dragon $MRK",".
@MichaelJFoxOrg
 Marco Baptista is hoping to improve the crystallization of #Parkinsons protein LRRK2 on 
@Space_Station
 
#CRS12 #Dragon $MRK
Donna Young
@DonnaYoungDC
 ¬∑ 13 Aug 2017
Also on board @SpaceX #CRS12 #Dragon is an experiment from @MichaelJFoxOrg to study a key #Parkinsons protein LRRK2 in microgravity
#pharma https://twitter.com/DonnaYoungDC/status/896795736947515392‚Ä¶
1",üì∞ üì∞,,1,,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/896823078034038784
3901,Andrew McCreath,@forgefirst,2017-08-11T17:51:19.000Z,"Tonight on 
@BNN
 'Weekly' I talk immuno #oncology w Tony Butler 
@GuggenheimPtnrs
 $MRK $AZN $BMY @ 5,7 &9pm ET + as always my #markets wrap","Tonight on 
@BNN
 'Weekly' I talk immuno #oncology w Tony Butler 
@GuggenheimPtnrs
 $MRK $AZN $BMY @ 5,7 &9pm ET + as always my #markets wrap
1",,,,1,[],https://twitter.com/forgefirst/status/896066513450409985
3902,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-08-13T14:44:12.000Z,"Replying to 
@kidoctr","Replying to 
@kidoctr
How much corruption in $MRK 
@Merck
 / 
@CDCgov
 #vaccinescience do you have to see before you stop trusting them?
https://twitter.com/GingerTaylor/status/892535504469733377‚Ä¶
This Tweet is unavailable.
1",,1,,,[],https://twitter.com/ZimJay/status/896744200284368897
3903,JB,@jbMacro,2017-08-11T21:17:54.000Z,"Replying to 
@SuperMugatu
 and 
@MugatuCapital","Replying to 
@SuperMugatu
 and 
@MugatuCapital
Maybe buy $BMY or $MRK",,,,,[],https://twitter.com/jbMacro/status/896118501294854144
3904,Dakota Financial,@dakotafinancial,2017-08-12T01:58:23.000Z,"Merck & Company, Inc. $MRK Stake Decreased by Mitchell Sinkler & Starr PA http://ift.tt/2vrChzJ","Merck & Company, Inc. $MRK Stake Decreased by Mitchell Sinkler & Starr PA http://ift.tt/2vrChzJ",,,,,[],https://twitter.com/dakotafinancial/status/896189087073415170
3905,Daily Political,@dailypoliticaln,2017-08-12T20:25:20.000Z,"Viking Fund Management LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2uQptQ3","Viking Fund Management LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2uQptQ3",,,,,[],https://twitter.com/dailypoliticaln/status/896467660346490880
3906,Ticker Report,@TickerReport,2017-08-13T15:30:13.000Z,"Stellar Capital Management LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2w3tR28","Stellar Capital Management LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2w3tR28",,,,,[],https://twitter.com/TickerReport/status/896755779981725696
3907,Daily Political,@dailypoliticaln,2017-08-11T22:25:41.000Z,Merck & $MRK ‚Äì Investment Analysts‚Äô Weekly Ratings Updates http://ift.tt/2vNcMtu,Merck & $MRK ‚Äì Investment Analysts‚Äô Weekly Ratings Updates http://ift.tt/2vNcMtu,,,,,[],https://twitter.com/dailypoliticaln/status/896135559952818176
3908,Dakota Financial,@dakotafinancial,2017-08-13T23:40:09.000Z,"Stellar Capital Management LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2vA0jqT","Stellar Capital Management LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2vA0jqT",,,,,[],https://twitter.com/dakotafinancial/status/896879076853522433
3909,Ross Gerber,@GerberKawasaki,2017-08-14T14:01:22.000Z,Proud of CEO of Merck for resigning from racist Trumps council. We call on all CEOs to resign! Stand up to hate $MRK,"Proud of CEO of Merck for resigning from racist Trumps council. We call on all CEOs to resign! Stand up to hate $MRK
bloomberg.com
Intel CEO Becomes Third Chief to Quit Trump Council After Riots
Intel Corp.‚Äôs Brian Krzanich joined Under Armour Inc.‚Äôs Kevin Plank in becoming the latest chief executives to quit President Donald Trump‚Äôs council of U.S. business leaders, as membership on the...
32
186
656",,32,186,656,['https://pbs.twimg.com/card_img/1500627560329220099/CxQ_C33F?format=jpg&name=small'],https://twitter.com/GerberKawasaki/status/897095809568694273
3910,Carl Quintanilla,@carlquintanilla,2017-08-14T13:54:13.000Z,"Best day for shares of #Merck since July 27.
@CNBC
 $MRK","Best day for shares of #Merck since July 27.
@CNBC
 $MRK
18
153
248",,18,153,248,['https://pbs.twimg.com/media/DHMePhKWsAAJ_FW?format=jpg&name=small'],https://twitter.com/carlquintanilla/status/897094008702464000
3911,Rebecca Jarvis,@RebeccaJarvis,2017-08-14T13:55:40.000Z,"#Merck & biotech stocks open fractionally higher across the board after $MRK CEO steps down from President's Advisory Council, Trump tweet","#Merck & biotech stocks open fractionally higher across the board after $MRK CEO steps down from President's Advisory Council, Trump tweet
11
38
58",,11,38,58,"['https://pbs.twimg.com/media/DHMek0HUIAAYQLp?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DHMek0FV0AAjn8E?format=jpg&name=small']",https://twitter.com/RebeccaJarvis/status/897094374055714816
3912,Meg Tirrell,@megtirrell,2017-08-16T19:51:57.000Z,"First analyst note I've seen on $MRK CEO's move, from BMO. ""We believe most (investors) respect Mr. Frazier's decision""","First analyst note I've seen on $MRK CEO's move, from BMO. ""We believe most (investors) respect Mr. Frazier's decision""
7
21
30",,7,21,30,['https://pbs.twimg.com/media/DHYDTC9XUAEXOxy?format=jpg&name=small'],https://twitter.com/megtirrell/status/897908811251560448
3913,Rebecca Robbins,@RebeccaDRobbins,2017-08-15T19:14:29.000Z,"$JNJ CEO Alex Gorsky breaks his silence; will stay on Trump's advisory group after $MRK CEO, others quit in protest","$JNJ CEO Alex Gorsky breaks his silence; will stay on Trump's advisory group after $MRK CEO, others quit in protest
statnews.com
J&J CEO to stay on Trump's advisory group amid executive exodus
CEO Alex Gorsky will stay on a presidential advisory panel, declining to join an exodus of executives that began with his counterpart at Merck.
5
16
4",,5,16,4,['https://pbs.twimg.com/card_img/1499658849623625729/aXoCmd8w?format=jpg&name=small'],https://twitter.com/RebeccaDRobbins/status/897536994183655425
3914,Stocktwits,@Stocktwits,2017-08-16T13:20:09.000Z,"Somone just captioned this "" $MRK, $UAA, and $INTC CEOs be like... ""  

-> https://stocktwits.com/StockJester/message/92123850‚Ä¶","Somone just captioned this "" $MRK, $UAA, and $INTC CEOs be like... ""  

-> https://stocktwits.com/StockJester/message/92123850‚Ä¶
GIF
20
15",üòÇ üò≠,,20,15,['https://pbs.twimg.com/tweet_video_thumb/DHWncI_XcAATat9.jpg'],https://twitter.com/Stocktwits/status/897810210223513601
3915,Mike Dorning,@MikeDorning,2017-08-14T16:03:27.000Z,Merck stock best day since July 28 as CEO quits Trump manufacturing group over failure to call out supremacists https://bloomberg.com/news/articles/2017-08-14/merck-ceo-quits-trump-council-as-matter-of-personal-conscience‚Ä¶ $MRK,"Merck stock best day since July 28 as CEO quits Trump manufacturing group over failure to call out supremacists https://bloomberg.com/news/articles/2017-08-14/merck-ceo-quits-trump-council-as-matter-of-personal-conscience‚Ä¶ $MRK
2
3",,,2,3,['https://pbs.twimg.com/media/DHM7PVbXgAIpoX9?format=jpg&name=small'],https://twitter.com/MikeDorning/status/897126529225895936
3916,Bio Stocks‚Ñ¢,@BioStocks,2017-08-16T11:11:37.000Z,What's harder than making copycat #biotech drugs? Selling them https://bloomberg.com/news/articles/2017-08-15/what-s-harder-than-making-copycat-biotech-drugs-selling-them‚Ä¶ $PFE $MRK $AMGN,"What's harder than making copycat #biotech drugs? Selling them https://bloomberg.com/news/articles/2017-08-15/what-s-harder-than-making-copycat-biotech-drugs-selling-them‚Ä¶ $PFE $MRK $AMGN
1
2",,,1,2,[],https://twitter.com/BioStocks/status/897777862668832768
3917,Jonathan Rockoff,@jonathanrockoff,2017-08-14T13:35:51.000Z,Here's the statement from $MRK CEO Frazier announcing his departure from President's manufacturing council,"Here's the statement from $MRK CEO Frazier announcing his departure from President's manufacturing council
Merck
@Merck
 ¬∑ 14 Aug 2017
7
6",,,7,6,"['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg', 'https://pbs.twimg.com/media/DHMDjhqUwAAgoHl?format=jpg&name=small']",https://twitter.com/jonathanrockoff/status/897089387116326914
3918,Rebecca Jarvis,@RebeccaJarvis,2017-08-14T13:59:03.000Z,"Merck stock this morning. Investors shrugging off 
@realDonaldTrump
 tweet $MRK","Merck stock this morning. Investors shrugging off 
@realDonaldTrump
 tweet $MRK
3
11",,,3,11,['https://pbs.twimg.com/media/DHMfWUfU0AA3wvY?format=jpg&name=small'],https://twitter.com/RebeccaJarvis/status/897095225281327105
3919,Dougie Kass,@DougKass,2017-08-14T15:31:01.000Z,"I am buying $MRK just on principle.  
@maddow
 @msnbc
 @carlquintanilla
 @jimcramer
 @tomkeene
 @andrewrsorkin
 @BeckyQuick","I am buying $MRK just on principle.  
@maddow
 @msnbc
 @carlquintanilla
 @jimcramer
 @tomkeene
 @andrewrsorkin
 @BeckyQuick
14
11
85",,14,11,85,[],https://twitter.com/DougKass/status/897118371061411840
3920,AndrewFactor,@AndrewFactor,2017-08-14T12:53:25.000Z,That's a big statement $MRK.,"That's a big statement $MRK.
Merck
@Merck
 ¬∑ 14 Aug 2017
1",,,,1,"['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg', 'https://pbs.twimg.com/media/DHMDjhqUwAAgoHl?format=jpg&name=small']",https://twitter.com/AndrewFactor/status/897078708036653058
3921,Pranav Ghai,@pragha,2017-08-14T13:10:55.000Z,"Replying to 
@kylegriffin1","Replying to 
@kylegriffin1
Those who are able should buy a little Merck stock today. $MRK.
1
3",,,1,3,[],https://twitter.com/pragha/status/897083111565123584
3922,Mario Roa,@mariohroa,2017-08-15T03:56:48.000Z,"Quit 
@POTUS
' manufacturing council:

$INTC CEO
$UAA CEO
$MRK CEO
$TSLA CEO (June)
$DIS CEO (June)
$UBER CEO (February)","Quit 
@POTUS
' manufacturing council:

$INTC CEO
$UAA CEO
$MRK CEO
$TSLA CEO (June)
$DIS CEO (June)
$UBER CEO (February)
1
1",,,1,1,[],https://twitter.com/mariohroa/status/897306052823314432
3923,Samantha LaDuc,@SamanthaLaDuc,2017-08-14T16:34:55.000Z,"Forbes defending Ken Frazier $MRK

Silence helps the aggressor, never the victim. 

https://forbes.com/sites/matthewherper/2017/08/14/what-you-should-know-about-ken-frazier-the-ceo-who-just-resigned-from-trumps-council/#6625c1707e01‚Ä¶","Forbes defending Ken Frazier $MRK

Silence helps the aggressor, never the victim. 

https://forbes.com/sites/matthewherper/2017/08/14/what-you-should-know-about-ken-frazier-the-ceo-who-just-resigned-from-trumps-council/#6625c1707e01‚Ä¶
1
1
2",,1,1,2,[],https://twitter.com/SamanthaLaDuc/status/897134449560875010
3924,Cindy Kent,@CindyRKent,2017-08-14T13:00:46.000Z,"Kudos 
@Merck
 for leadership Merck chief quits  Manufacturing Council on ""intolerance"" and ""extremism"" $MRK http://seekingalpha.com/news/3288970","Kudos 
@Merck
 for leadership Merck chief quits  Manufacturing Council on ""intolerance"" and ""extremism"" $MRK http://seekingalpha.com/news/3288970
1
12",,,1,12,[],https://twitter.com/CindyRKent/status/897080555686297600
3925,dough,@semodough,2017-08-16T10:45:35.000Z,"Replying to 
@semodough","Replying to 
@semodough
$PRTK a ORAL CUTI would GIVE $PRTK a huge TRIPLE ORAL DRUG in #CABP #ABSSSI #CUTI  -hard for $MRK $AGN to ignore
2",,,,2,['https://pbs.twimg.com/media/DHWGPzGUIAATD1j?format=jpg&name=small'],https://twitter.com/semodough/status/897771311778459648
3926,Ivan the K‚Ñ¢,@IvanTheK,2017-08-16T20:51:01.000Z,"KUDOS TO KEN FRAZIER

$MRK","KUDOS TO KEN FRAZIER

$MRK
1
1
27",,1,1,27,[],https://twitter.com/IvanTheK/status/897923673369317376
3927,Douglas K. Chia,@dougchia,2017-08-16T19:48:36.000Z,Timing isn't important. What is is that Ken Frazier of $MRK was the one who had the spine to start the chain reaction. He's the real hero.,"Timing isn't important. What is is that Ken Frazier of $MRK was the one who had the spine to start the chain reaction. He's the real hero.
Charles Gasparino
@CGasparino
 ¬∑ 17 Aug 2017
lets be clear: the advisory council resigned before he could fire them according to @jpmorgan jamie dimon https://twitter.com/thatbillokeefe/status/897891764756860928‚Ä¶
3
5",,3,,5,['https://pbs.twimg.com/profile_images/661650693565120512/rX5z4_Zv_mini.jpg'],https://twitter.com/dougchia/status/897907967961571329
3928,Matthew Herper,@matthewherper,2017-08-14T14:29:53.000Z,"Now, will anything Trump does on drug pricing look like retaliation? Does this help pharma politically? $mrk","Now, will anything Trump does on drug pricing look like retaliation? Does this help pharma politically? $mrk
8
5
3",,8,5,3,[],https://twitter.com/matthewherper/status/897102983321833472
3929,Leilani Pips‚Ñ¢,@PipsToDollars,2017-08-14T12:58:58.000Z,The stock symbol for Merck is $MRK btw. ,"The stock symbol for Merck is $MRK btw. 
1
3",ü§£,1,,3,[],https://twitter.com/PipsToDollars/status/897080103498166272
3930,Helen Ong,@Lin_ling_88,2017-08-14T19:46:25.000Z,$MRK: Mr. Frazier should never have accepted the invitation to serve on the council in the first place. https://twitter.com/armstrongdrew/status/897181097393614852‚Ä¶,"$MRK: Mr. Frazier should never have accepted the invitation to serve on the council in the first place. https://twitter.com/armstrongdrew/status/897181097393614852‚Ä¶
This Tweet is unavailable.
5",,,,5,[],https://twitter.com/Lin_ling_88/status/897182642940125184
3931,Joe,@GantosJ,2017-08-16T16:27:53.000Z,"Now $MMM CEO resigning. So who's left beside $JNJ CEO at Trump's manufacturing council!!!
Hat tip to $MRK's CEO to start this important step","Now $MMM CEO resigning. So who's left beside $JNJ CEO at Trump's manufacturing council!!!
Hat tip to $MRK's CEO to start this important step
CNBC
@CNBC
 ¬∑ 16 Aug 2017
BREAKING: 3M's CEO resigns from Trump's manufacturing council. http://cnbc.com/id/104653387
7",,,,7,['https://pbs.twimg.com/profile_images/1451346007594315779/fJq985Yf_mini.png'],https://twitter.com/GantosJ/status/897857455161577472
3932,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-08-15T17:39:09.000Z,Anyone know this $MRK asset? MK-2118 intratumoral inj‚Ä¶is it STING agonist? Or what??? $ADRO $NVS,"Anyone know this $MRK asset? MK-2118 intratumoral inj‚Ä¶is it STING agonist? Or what??? $ADRO $NVS
clinicaltrials.gov
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With...
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment...
3
1
4",,3,1,4,['https://pbs.twimg.com/card_img/1499934075531907072/UYy6jAXC?format=png&name=240x240'],https://twitter.com/DrPaulyDeSantis/status/897513004027191296
3933,BioPharm Insight,@BioPharmInsight,2017-08-15T13:27:10.000Z,What do $MRK‚Äôs #Keytruda deaths in multiple myeloma mean for other checkpoint inhibitors? @AlaricJDeArment http://bit.ly/2uL22rW,"What do $MRK‚Äôs #Keytruda deaths in multiple myeloma mean for other checkpoint inhibitors? @AlaricJDeArment http://bit.ly/2uL22rW
2",,,2,,[],https://twitter.com/BioPharmInsight/status/897449590827307008
3934,VexTrades,@VexTrades,2017-08-14T13:15:29.000Z,"Quick, someone prank-call Trump and tell him that the KKK is $MRK's largest shareholder.","Quick, someone prank-call Trump and tell him that the KKK is $MRK's largest shareholder.
2
4",,2,,4,[],https://twitter.com/VexTrades/status/897084262838611968
3935,Charley Grant,@CGrantWSJ,2017-08-14T14:10:57.000Z,"Just FYI: If you're new to pharma stock watching, checking every 2 minutes to see how $MRK is doing will make you very bored.","Just FYI: If you're new to pharma stock watching, checking every 2 minutes to see how $MRK is doing will make you very bored.
1
26",,1,,26,[],https://twitter.com/CGrantWSJ/status/897098218512764929
3936,Rare Disease Report,@RareDR,2017-08-14T14:25:30.000Z,"#BreakingNews: 
@Merck
 / $MRK CEO Ken Frazier resigns from council after 
@realDonaldTrump
 refuses to denounce racism http://raredr.com/link/2523","#BreakingNews: 
@Merck
 / $MRK CEO Ken Frazier resigns from council after 
@realDonaldTrump
 refuses to denounce racism http://raredr.com/link/2523
5",,,,5,['https://pbs.twimg.com/media/DHMlZIsUwAATzCc?format=jpg&name=small'],https://twitter.com/RareDR/status/897101879922102272
3937,Ben Fidler,@BentheFidler,2017-08-16T12:59:35.000Z,Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer http://xconomy.com/new-york/2017/08/16/latest-immunotherapy-slip-up-bristol-drugs-stumble-in-kidney-cancer/‚Ä¶ $BMY $AZN $MRK,"Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer http://xconomy.com/new-york/2017/08/16/latest-immunotherapy-slip-up-bristol-drugs-stumble-in-kidney-cancer/‚Ä¶ $BMY $AZN $MRK
1
1",,,1,1,[],https://twitter.com/BentheFidler/status/897805034049679361
3938,Lisa LaMotta,@lisalamotta,2017-08-14T17:16:18.000Z,I applaud $MRK's Ken Frazier for leaving Trump's Manufacturing Council. And I'm wondering why other CEOs aren't following suit?,"I applaud $MRK's Ken Frazier for leaving Trump's Manufacturing Council. And I'm wondering why other CEOs aren't following suit?
1
1",,1,,1,[],https://twitter.com/lisalamotta/status/897144864000835586
3939,Joe W.,@w_biltmore85,2017-08-15T01:22:11.000Z,"While I completely denounce all the KKK, hatred, & bigotry I don't think quitting is the right choice. U guys should work together $UA $MRK","While I completely denounce all the KKK, hatred, & bigotry I don't think quitting is the right choice. U guys should work together $UA $MRK
Under Armour
@UnderArmour
 ¬∑ 15 Aug 2017
I love our country & company. I am stepping down from the council to focus on inspiring & uniting through power of sport. - CEO Kevin Plank
2
3",,2,,3,"['https://pbs.twimg.com/profile_images/1217113524532654081/kPJNPGc4_mini.jpg', 'https://pbs.twimg.com/media/DHOr6qvXgAEnOVt?format=jpg&name=small']",https://twitter.com/w_biltmore85/status/897267140943908864
3940,Benzinga,@Benzinga,2017-08-15T11:31:01.000Z,"Last night, Under Armour and Intel CEOs joined Merck and resigned from Trump's Manufacturing Council https://benzinga.com/news/17/01/8959545/a-ceo-whos-who-of-trumps-manufacturing-council‚Ä¶ $UAA $INTC $MRK","Last night, Under Armour and Intel CEOs joined Merck and resigned from Trump's Manufacturing Council https://benzinga.com/news/17/01/8959545/a-ceo-whos-who-of-trumps-manufacturing-council‚Ä¶ $UAA $INTC $MRK
benzinga.com
A CEO Who's Who Of Trump's Manufacturing Council
A group of more than two dozen CEOs have been tapped by President Donald Trump to create recommendations to grow the American manufacturing sector. The group convenes at a time...
2
2",,,2,2,[],https://twitter.com/Benzinga/status/897420358306992128
3941,Paul R. La Monica,@LaMonicaBuzz,2017-08-16T17:04:42.000Z,This would be ETF for companies whose CEOs have left Trump's manufacturing council. $MRK $UA $INTC $MMM $CPB. I suspect there will be more.,"This would be ETF for companies whose CEOs have left Trump's manufacturing council. $MRK $UA $INTC $MMM $CPB. I suspect there will be more.
1
3",,,1,3,[],https://twitter.com/LaMonicaBuzz/status/897866719150178304
3942,Anirban Maitra,@Aiims1742,2017-08-14T13:01:10.000Z,"Replying to 
@Aiims1742","Replying to 
@Aiims1742
Strongest anti-PD1 (anti-President DONALD 1) yet from $MRK CEO meets with immediate treatment resistance
2
1
14",,2,1,14,[],https://twitter.com/Aiims1742/status/897080656710205440
3943,Roy Friedman,@DewDiligence,2017-08-14T15:12:19.000Z,"Replying to 
@adamfeuerstein","Replying to 
@adamfeuerstein
I doubt it. $MRK is 1of America's great companies &Frazier probably the top Big Pharma CEO in the industry. This row will blow over, IMO.
1
1
4",,1,1,4,[],https://twitter.com/DewDiligence/status/897113662539870208
3944,Open Outcrier,@OpenOutcrier,2017-08-14T20:01:36.000Z,"RECAP 8/14 TRUMPWATCH:
$MRK LOWER RIPOFF DRUG PRICES

Full Detailed Recap available at http://openoutcrier.com","RECAP 8/14 TRUMPWATCH:
$MRK LOWER RIPOFF DRUG PRICES

Full Detailed Recap available at http://openoutcrier.com
1
1",,,1,1,[],https://twitter.com/OpenOutcrier/status/897186463003144193
3945,Samantha LaDuc,@SamanthaLaDuc,2017-08-14T16:16:32.000Z,$MRK CEO then $GDDY stepped up/into it and will ban the neo-nazi site it hosted. https://twitter.com/godaddy/status/896935462622957573‚Ä¶ #BraveNewSouls,"$MRK CEO then $GDDY stepped up/into it and will ban the neo-nazi site it hosted. https://twitter.com/godaddy/status/896935462622957573‚Ä¶ #BraveNewSouls
George Takei
@GeorgeTakei
 ¬∑ 14 Aug 2017
Time to delete your account, Donald. http://qklnk.co/KytwUB
1
1",,,1,1,['https://pbs.twimg.com/profile_images/1395773050881196032/yCpIyKBt_mini.jpg'],https://twitter.com/SamanthaLaDuc/status/897129823964975104
3946,Allison Gatlin,@IBD_AGatlin,2017-08-14T18:18:58.000Z,Trump blasts Dow's Merck after CEO resigns from manufacturing council $MRK $JNJ $TSLA $BA $DIS $DOW $NVO,"Trump blasts Dow's Merck after CEO resigns from manufacturing council $MRK $JNJ $TSLA $BA $DIS $DOW $NVO
investors.com
Trump Blasts Dow's Merck After CEO Resigns From Manufacturing Council
Merck's chief executive Kenneth Frazier resigned from a Trump's council early Monday.
2",,,,2,['https://pbs.twimg.com/card_img/1501941670161498123/apPRCv0e?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/897160634076450817
3947,Peter Bornstein,@spidadoc1,2017-08-14T13:14:11.000Z,"I hope the $MRK BOD supports the CEO. ""Trump attacks Merck CEO for stepping down from mfg council in protest"" https://cnbc.com/2017/08/14/merck-ceo-resigns-from-trumps-american-manufacturing-council.html‚Ä¶","I hope the $MRK BOD supports the CEO. ""Trump attacks Merck CEO for stepping down from mfg council in protest"" https://cnbc.com/2017/08/14/merck-ceo-resigns-from-trumps-american-manufacturing-council.html‚Ä¶
2",,,,2,[],https://twitter.com/spidadoc1/status/897083932621103104
3948,John Carroll,@JohnCendpts,2017-08-16T18:06:44.000Z,"J&J‚Äôs Alex Gorsky reverses course and jumps ship ‚Äî just as Trump scuttles top CEO groups
$JNJ $MRK","J&J‚Äôs Alex Gorsky reverses course and jumps ship ‚Äî just as Trump scuttles top CEO groups
$JNJ $MRK
endpts.com
J&J's Alex Gorsky reverses course and jumps ship ‚Äî just as Trump scuttles top CEO groups
One day after J&J CEO Alex Gorsky publicly committed to staying on President Donald Trump's manufacturing council, he abruptly reversed course ‚Äî just as a sudden exodus of executives forced the...
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501166467047325698/_jIR-csO?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/897882330257346563
3949,Jane King,@MarketJane,2017-08-15T11:58:23.000Z,"North Korea Dials Down Tensions With United States, Stocks Higher https://thestreet.com/video/14271586/north-korea-dials-down-tensions-with-united-states-stocks-higher.html‚Ä¶ via 
@TheStreet
 $MRK $HD $INTC $UAA","North Korea Dials Down Tensions With United States, Stocks Higher https://thestreet.com/video/14271586/north-korea-dials-down-tensions-with-united-states-stocks-higher.html‚Ä¶ via 
@TheStreet
 $MRK $HD $INTC $UAA
thestreet.com
North Korea Dials Down Tensions With United States, Stocks Higher
North Korea says it will delay a decision on attacking Guam.
2",,,,2,[],https://twitter.com/MarketJane/status/897427247921078277
3950,jodi gralnick,@jodigralnick,2017-08-14T12:45:13.000Z,"$MRK CEO resigns from 
@POTUS
 manufacturing council","$MRK CEO resigns from 
@POTUS
 manufacturing council
Merck
@Merck
 ¬∑ 14 Aug 2017
1",,,,1,"['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg', 'https://pbs.twimg.com/media/DHMDjhqUwAAgoHl?format=jpg&name=small']",https://twitter.com/jodigralnick/status/897076645105938432
3951,John Carroll,@JohnCendpts,2017-08-15T20:22:41.000Z,"Breaking his silence, J&J‚Äôs Alex Gorsky says he‚Äôs not abandoning Trump‚Äôs council
$JNJ $MRK","Breaking his silence, J&J‚Äôs Alex Gorsky says he‚Äôs not abandoning Trump‚Äôs council
$JNJ $MRK
endpts.com
As Trump lashes out at Frazier again, J&J's Alex Gorsky says he's not abandoning president's council
See the latest update here. J&J CEO Alex Gorsky isn't joining any exodus off of the president's manufacturing council. And he offered his reasons why just before Trump unleashed a new attack on Merck...
1
1",,,1,1,[],https://twitter.com/JohnCendpts/status/897554159288930305
3952,Roy Friedman,@DewDiligence,2017-08-14T16:37:11.000Z,"Replying to 
@adamfeuerstein","Replying to 
@adamfeuerstein
How can you top the story of how Frazier saved $MRK from extinction when he was General Counsel overseeing Vioxx litigation?
1
4",,1,,4,[],https://twitter.com/DewDiligence/status/897135018518208512
3953,Timmy O' Toole,@timmyotoole23,2017-08-14T13:10:06.000Z,"Replying to 
@michaelbatnick","Replying to 
@michaelbatnick
Hope $MRK rallys hard today not just because I own it .. this is so surreal a president with a temper of a 3 year old ..
1
2",,1,,2,[],https://twitter.com/timmyotoole23/status/897082904752381954
3954,Tom Graff,@tdgraff,2017-08-14T18:44:56.000Z,"Replying to 
@carlquintanilla","Replying to 
@carlquintanilla
$MRK stock price is up today. What are people afraid of?
3",,,,3,[],https://twitter.com/tdgraff/status/897167169649340417
3955,Sentiment Stocks,@sentimentstock,2017-08-17T19:00:48.000Z,"$NWBO $KITE $MRK $AZN $JUNO $CLDX $BMY $PFE $GSK If DCVax-L is approved, w/9k annual cases, w/450m shares - share price estimate $33.25.","$NWBO $KITE $MRK $AZN $JUNO $CLDX $BMY $PFE $GSK If DCVax-L is approved, w/9k annual cases, w/450m shares - share price estimate $33.25.
1
14
21",,1,14,21,['https://pbs.twimg.com/media/DHc_r6UUQAAG5tU?format=jpg&name=small'],https://twitter.com/sentimentstock/status/898258327930511360
3956,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-08-17T20:19:28.000Z,"Replying to 
@DrPaulyDeSantis","Replying to 
@DrPaulyDeSantis
Taking a Victory Lap on $TSRO, now down -43% since my call on it's ABSURD valuation on Feb-8, 2017...Fundamentals Matter
$CLVS $AZN $MRK
5
6
33",,5,6,33,['https://pbs.twimg.com/media/DHdTFT3UMAAitLT?format=jpg&name=small'],https://twitter.com/DrPaulyDeSantis/status/898278124474867713
3957,Bio Stocks‚Ñ¢,@BioStocks,2017-08-18T12:33:13.000Z,"Scientists, Out $12 Million, Sue Delaware Over Seizure of Their Idenix Pharma Stock https://wsj.com/articles/scientists-out-12-million-sue-delaware-over-seizure-of-their-stock-1503054001‚Ä¶ $MRK","Scientists, Out $12 Million, Sue Delaware Over Seizure of Their Idenix Pharma Stock https://wsj.com/articles/scientists-out-12-million-sue-delaware-over-seizure-of-their-stock-1503054001‚Ä¶ $MRK
5",,,5,,[],https://twitter.com/BioStocks/status/898523176736481280
3958,SF Education,@SFEducation,2017-08-17T17:36:33.000Z,Complete List of CEOs https://aff.whotrades.com/t/b/rytrs/ $INTC $BA $GE $TSLA $DKS $MRK $F $TWTR,Complete List of CEOs https://aff.whotrades.com/t/b/rytrs/ $INTC $BA $GE $TSLA $DKS $MRK $F $TWTR,,,,,['https://pbs.twimg.com/media/DHct5u8XsAE3ntE?format=jpg&name=small'],https://twitter.com/SFEducation/status/898237123551211520
3959,Focus on Dividends,@Focus_on_Dvds,2017-08-19T18:48:03.000Z,"Notable Analyst Upgrades and Downgrades for Week of August 7, 2017 https://buff.ly/2v1BzX8 $CMI $CVX $DE $FL $KSS $MRK  $SBUX $UL $UPS $VOD","Notable Analyst Upgrades and Downgrades for Week of August 7, 2017 https://buff.ly/2v1BzX8 $CMI $CVX $DE $FL $KSS $MRK  $SBUX $UL $UPS $VOD",,,,,['https://pbs.twimg.com/media/DHnRclVWsAAdM0U?format=jpg&name=360x360'],https://twitter.com/Focus_on_Dvds/status/898979891697381376
3960,Quantcha Trade Ideas,@QuantchaIdeas,2017-08-17T14:28:24.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/08/17/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-2/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/08/17/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-2/‚Ä¶,,,,,['https://pbs.twimg.com/media/DHcC1tTUMA0EcMe?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/898189774418309123
3961,BioPharma Dive,@BioPharmaDive,2017-08-18T16:27:41.000Z,Expanded label boosts $AZN and $MRK's Lynparza,"Expanded label boosts $AZN and $MRK's Lynparza
biopharmadive.com
Expanded label boosts AstraZeneca and Merck's Lynparza
Securing a broader indication for earlier treatment of ovarian cancer should help Lynparza fend off competition from rival PARP inhibitors.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1491440467032084489/i_IDp2SJ?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/898582183174168577
3962,Kristen Hallam,@kristen_hallam,2017-08-18T13:17:00.000Z,$AZN's failed Mystic trial casts a long shadow: http://bit.ly/2fPrKJg $PFE $BMY $MRK,"$AZN's failed Mystic trial casts a long shadow: http://bit.ly/2fPrKJg $PFE $BMY $MRK
1
1",,1,,1,['https://pbs.twimg.com/media/DHdb4tmXgAE8EZ0?format=jpg&name=small'],https://twitter.com/kristen_hallam/status/898534195005464577
3963,Kara Jill Stancell,@kjilly,2017-08-18T13:23:44.000Z,"Watch out $TSRO, $AZN and $MRK get #FDA OK for broad use of #Lynparza #ovariancancer #pharma #biotech","Watch out $TSRO, $AZN and $MRK get #FDA OK for broad use of #Lynparza #ovariancancer #pharma #biotech
endpts.com
Watch out Tesaro, AstraZeneca and Merck get FDA OK for broad use of Lynparza
AstraZeneca and its new Big Pharma partner Merck have picked up the FDA‚Äôs approval for the broad use of Lynparza, which will put it directly in the marketing path being blazed by Tesaro. Like...
1",,,1,,[],https://twitter.com/kjilly/status/898535889994825729
3964,Charles Zinnel,@charles_zinnel,2017-08-18T20:38:35.000Z,Vote NO! I'm voting NO to the newly proposed r/s and so should you. $pfe $jnj $mrk $gsk $cytr,"Vote NO! I'm voting NO to the newly proposed r/s and so should you. $pfe $jnj $mrk $gsk $cytr
Charles Zinnel
@charles_zinnel
 ¬∑ 19 Aug 2017
Vote NO!!!!!!! I'm voting NO to the newly proposed r/s and so should you. $pfe $jnj $mrk $gsk $cytr https://twitter.com/greenpenny2016/status/898638991490252801‚Ä¶",,,,,['https://pbs.twimg.com/profile_images/892823376678572033/shdIsi7L_mini.jpg'],https://twitter.com/charles_zinnel/status/898645323345571840
3965,Vista Partners LLC,@VistaPResearch,2017-08-19T12:01:20.000Z,"@ICAP11
 thx or follow! #SaturdayThoughts Hell from #SanFrancisco! Vista Partners #InvestingForLife http://vistapglobal.com $AAPL $MRK $HIIQ","@ICAP11
 thx or follow! #SaturdayThoughts Hell from #SanFrancisco! Vista Partners #InvestingForLife http://vistapglobal.com $AAPL $MRK $HIIQ
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DHl0WUGVoAIIbTW.jpg'],https://twitter.com/VistaPResearch/status/898877540890066945
3966,Vista Partners LLC,@VistaPResearch,2017-08-18T08:30:49.000Z,"@bowenjoe_fx
 thank for follow! see Vista Partners #InvestingForLife http://vistapglobal.com #biotech $ATOS $MRK $PFE $IBB $JNJ  #fridayfunny","@bowenjoe_fx
 thank for follow! see Vista Partners #InvestingForLife http://vistapglobal.com #biotech $ATOS $MRK $PFE $IBB $JNJ  #fridayfunny
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DHf6kz_UAAAuSJT.jpg'],https://twitter.com/VistaPResearch/status/898462175496347648
3967,Ben Fidler,@BentheFidler,2017-08-18T12:09:36.000Z,"#Biotech Roundup: Frazier v. Trump, Data Dumps, New York Steps & More http://xconomy.com/national/2017/08/18/bio-roundup-frazier-v-trump-data-dumps-new-york-steps-more/‚Ä¶ $MRK $BMY $AZN $REGN $NVO","#Biotech Roundup: Frazier v. Trump, Data Dumps, New York Steps & More http://xconomy.com/national/2017/08/18/bio-roundup-frazier-v-trump-data-dumps-new-york-steps-more/‚Ä¶ $MRK $BMY $AZN $REGN $NVO
2",,,,2,[],https://twitter.com/BentheFidler/status/898517234439475200
3968,biotechnicality,@biotechnicality,2017-08-18T17:46:31.000Z,Ok I think I am getting on the mavyret train now $abbv $gild $mrk,"Ok I think I am getting on the mavyret train now $abbv $gild $mrk
1
2",,,1,2,[],https://twitter.com/biotechnicality/status/898602020256575489
3969,Juan Bobo,@objuanquenove,2017-08-17T15:49:37.000Z,Commented on Boeing: Money Over Morals https://seekingalpha.com/article/4099739-boeing-money-morals?source=tweet‚Ä¶ $BDRAF $EADSF $GE $INTC $MMM $MRK $UAA $UTX $BA,"Commented on Boeing: Money Over Morals https://seekingalpha.com/article/4099739-boeing-money-morals?source=tweet‚Ä¶ $BDRAF $EADSF $GE $INTC $MMM $MRK $UAA $UTX $BA
seekingalpha.com
Boeing: Money Over Morals (NYSE:BA)
Boeing's seat on the council served purposes other than supporting 'American jobs'.",,,,,['https://pbs.twimg.com/card_img/1501716146957033476/lZaKTPCW?format=jpg&name=240x240'],https://twitter.com/objuanquenove/status/898210215459303424
3970,James Sikes,@wosaikeneriki,2017-08-17T16:00:02.000Z,"As Merck & Co.  $MRK Share Price Declined, Wafra Investment Advisory Group Upped Holding by $7.77 Million ...","As Merck & Co.  $MRK Share Price Declined, Wafra Investment Advisory Group Upped Holding by $7.77 Million ...",,,,,[],https://twitter.com/wosaikeneriki/status/898212835095961600
3971,James Sikes,@wosaikeneriki,2017-08-17T15:44:34.000Z,"Reliance Trust Has Cut Its Merck & Co $MRK Holding by $338,662 http://bzweekly.com/reliance-trust-has-cut-its-merck-ksa-capital-management-cut-aep-inds-aepi-position-by-3-09-million-as-stock-price-were-volatile/‚Ä¶","Reliance Trust Has Cut Its Merck & Co $MRK Holding by $338,662 http://bzweekly.com/reliance-trust-has-cut-its-merck-ksa-capital-management-cut-aep-inds-aepi-position-by-3-09-million-as-stock-price-were-volatile/‚Ä¶",,,,,[],https://twitter.com/wosaikeneriki/status/898208943717134336
3972,GREEN STOCK NEWS,@greenstocknews,2017-08-19T13:04:35.000Z,"3 Things In Biotech You Should Learn Today: August 19, 2017 https://seekingalpha.com/article/4100389-3-things-biotech-learn-today-august-19-2017?source=feed_f‚Ä¶ $AZN $CLVS $MRK $PFE $SGEN $TSRO","3 Things In Biotech You Should Learn Today: August 19, 2017 https://seekingalpha.com/article/4100389-3-things-biotech-learn-today-august-19-2017?source=feed_f‚Ä¶ $AZN $CLVS $MRK $PFE $SGEN $TSRO",,,,,[],https://twitter.com/greenstocknews/status/898893456273096704
3973,GREEN STOCK NEWS,@greenstocknews,2017-08-18T12:03:26.000Z,"AstraZeneca, Time To Expand The Operation https://seekingalpha.com/article/4100024-astrazeneca-time-expand-operation?source=feed_f‚Ä¶ $CLVS $MRK $TSRO $AZN","AstraZeneca, Time To Expand The Operation https://seekingalpha.com/article/4100024-astrazeneca-time-expand-operation?source=feed_f‚Ä¶ $CLVS $MRK $TSRO $AZN",,,,,[],https://twitter.com/greenstocknews/status/898515678423990272
3974,Alex Washington,@alexwdc,2017-08-17T14:40:06.000Z,"$JPM $mrk #federalreserve #OMWI The daily acceptance of covert insults--""#colorblindness""--> bigger tragedies. |","$JPM $mrk #federalreserve #OMWI The daily acceptance of covert insults--""#colorblindness""--> bigger tragedies. |
alexwdc.wordpress.com
Futility of ‚ÄúColorblindness‚Äù & White Hegemony: Mere CEO Repudiations of the 45th President‚Äôs...
While the words of POTUS Donald Trump were hard to hear, they are the result of covertly practiced & rampant systemic discrimination.
1",,1,,,[],https://twitter.com/alexwdc/status/898192718467407873
3975,FinInvTr,@FinInvTr,2017-08-19T05:50:15.000Z,"10 Top Holdings In Market's Best Healthcare Fund 

https://buff.ly/2w9BFjs

$JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD","10 Top Holdings In Market's Best Healthcare Fund 

https://buff.ly/2w9BFjs

$JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD",,,,,[],https://twitter.com/FinInvTr/status/898784152274653185
3976,Alex Washington,@alexwdc,2017-08-17T14:22:27.000Z,$JPM $Mrk $UA $mmm #ibm $INTC $cpb Mere denunciation of POTUS words insufficient. #dickgrote #rankandyank has to go. https://alexwdc.wordpress.com/?s=dick+grote,$JPM $Mrk $UA $mmm #ibm $INTC $cpb Mere denunciation of POTUS words insufficient. #dickgrote #rankandyank has to go. https://alexwdc.wordpress.com/?s=dick+grote,,,,,[],https://twitter.com/alexwdc/status/898188277844398080
3977,SAC Tracker,@FDAadcomm,2017-08-17T18:04:28.000Z,Background Analysis: US #FDA Advisory Committee to Review Shingles #Vaccine Proposed by GlaxoSmithKline $GSK $MRK http://sac-tracker.com/vrbpac-20170913-ba‚Ä¶,"Background Analysis: US #FDA Advisory Committee to Review Shingles #Vaccine Proposed by GlaxoSmithKline $GSK $MRK http://sac-tracker.com/vrbpac-20170913-ba‚Ä¶
1",,,1,,[],https://twitter.com/FDAadcomm/status/898244150457511936
3978,Benzinga,@Benzinga,2017-08-17T01:01:00.000Z,"You Can't Quit, Because You're Fired! Trump Disbands Manufacturing Council, Policy Forum https://benzinga.com/z/9940520 $CPB $MMM $INTC $MRK $UAA","You Can't Quit, Because You're Fired! Trump Disbands Manufacturing Council, Policy Forum https://benzinga.com/z/9940520 $CPB $MMM $INTC $MRK $UAA
3
1",,,3,1,[],https://twitter.com/Benzinga/status/897986587258003456
3979,MAISA,@MaisaCorp,2017-08-17T21:03:54.000Z,$MRK $AZN  FDA approves expanded use of AstraZeneca ovarian cancer  drug,$MRK $AZN  FDA approves expanded use of AstraZeneca ovarian cancer  drug,,,,,[],https://twitter.com/MaisaCorp/status/898289306946609153
3980,Pharmaceutical News,@pharma_sector,2017-08-19T06:48:51.000Z,#Merck Fellowship for Global Health PNRI Partner to Advance Promising Antifungal. Read more: http://owler.us/adbOqf $MRK,#Merck Fellowship for Global Health PNRI Partner to Advance Promising Antifungal. Read more: http://owler.us/adbOqf $MRK,,,,,[],https://twitter.com/pharma_sector/status/898798900139573248
3981,Donna Young,@DonnaYoungDC,2017-08-18T23:03:13.000Z,"And the exodus of the business community from backing Trump, starting w/ $MRK","And the exodus of the business community from backing Trump, starting w/ $MRK
Jordan Fabian
@Jordanfabian
 ¬∑ 19 Aug 2017
Trump vacation: 
 
McConnell feud
  standoff
 mil option
Charlottesville 
 trade probe
TT presser
Barcelona
 meet
Bannon ouster",üì∞ ‚õ≥ üì∑,,,,['https://pbs.twimg.com/profile_images/662284365171421184/6TjjtC-n_mini.jpg'],https://twitter.com/DonnaYoungDC/status/898681718734864384
3982,Allison Gatlin,@IBD_AGatlin,2017-08-18T19:39:48.000Z,"All eyes will be on this Dow component's ""star"" drug next week $JNJ $BAYRY $MRK $NVS","All eyes will be on this Dow component's ""star"" drug next week $JNJ $BAYRY $MRK $NVS
investors.com
All Eyes Will Be On This Dow Component's 'Star' Drug Next Week
J&J and Bayer's Xarelto will likely be the star of next week's European Society of Cardiology conference, an analyst says.
1",,,1,,[],https://twitter.com/IBD_AGatlin/status/898630530224185344
3983,Andrew terzis,@Agterzis,2017-08-17T23:25:59.000Z,"Replying to 
@PaulBorisPraemo
 and 
@SethPatin","Replying to 
@PaulBorisPraemo
 and 
@SethPatin
manufacturer level big pharma i.e. $mrk , $jnj , $abt ,  but inside local pharmacies too, error reduction #roi $cvs  $wba 
@cvspharmacy
 $vuzi
1
4",,,1,4,[],https://twitter.com/Agterzis/status/898325061030903808
3984,Trapperpk,@trapperpk,2017-08-18T19:19:12.000Z,Commented on Boeing: Money Over Morals https://seekingalpha.com/article/4099739-boeing-money-morals?source=tweet‚Ä¶ $BDRAF $EADSF $GE $INTC $MMM $MRK $UAA $UTX $BA $LMT,Commented on Boeing: Money Over Morals https://seekingalpha.com/article/4099739-boeing-money-morals?source=tweet‚Ä¶ $BDRAF $EADSF $GE $INTC $MMM $MRK $UAA $UTX $BA $LMT,,,,,[],https://twitter.com/trapperpk/status/898625345066160128
3985,TalkMarkets,@TalkMarkets,2017-08-17T16:59:34.000Z,Can #Pfizer Bank On New Immunotherapy Bavencio For Growth? $PFE Also $AZN $MRK $NVS https://goo.gl/p34vPa,Can #Pfizer Bank On New Immunotherapy Bavencio For Growth? $PFE Also $AZN $MRK $NVS https://goo.gl/p34vPa,,,,,[],https://twitter.com/TalkMarkets/status/898227816873021440
3986,leahanne,@leahanneta,2017-08-18T15:14:56.000Z,"10:45 ET Volume Leader #78 - MRK 11,169,597 Merck & Company $MRK 61.27 -1.43 -2.28% High today of 63.02 day lo","10:45 ET Volume Leader #78 - MRK 11,169,597 Merck & Company $MRK 61.27 -1.43 -2.28% High today of 63.02 day lo
investorshangout.com
10:45 ET Volume Leader #78 - MRK - The Hot Zone #4704432 - Investors Hangout
The Hot Zone: 10:45 ET Volume Leader #78 - MRK 11,169,597 Merck Company $MRK 61.27 -1.43 -2.28% High today of 63 - #4704432",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/898563872528883712
3987,US Banking News,@AmericanBanking,2017-08-17T06:18:34.000Z,"Merck KGaA given ‚Ç¨105.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2wcoHBN $MRK #MRK","Merck KGaA given ‚Ç¨105.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2wcoHBN $MRK #MRK",,,,,[],https://twitter.com/AmericanBanking/status/898066503303667712
3988,MarketBeat,@MarketBeatCom,2017-08-18T05:57:23.000Z,"$10.45 Billion in Sales Expected for Merck & Co., Inc. $MRK This Quarter http://ift.tt/2vOajww #acn","$10.45 Billion in Sales Expected for Merck & Co., Inc. $MRK This Quarter http://ift.tt/2vOajww #acn",,,,,[],https://twitter.com/MarketBeatCom/status/898423559931936769
3989,Josh Berlin,@BioPharmaJosh,2017-08-18T21:47:41.000Z,Former CEO of $MDT on $MRK CEO Ken Frazier -> A Courageous Leader Triggers a Moral Revolt Among CEOs https://linkedin.com/pulse/courageous-leader-triggers-moral-revolt-among-ceos-bill-george‚Ä¶,"Former CEO of $MDT on $MRK CEO Ken Frazier -> A Courageous Leader Triggers a Moral Revolt Among CEOs https://linkedin.com/pulse/courageous-leader-triggers-moral-revolt-among-ceos-bill-george‚Ä¶
1",,,1,,[],https://twitter.com/BioPharmaJosh/status/898662713550807040
3990,Limex,@LimexMe,2017-08-18T15:12:46.000Z,Gilead (GILD) HCV Drug Vosevi Receives Approval in Canada http://bit.ly/2wo8Y1Q $GILD $MRK $BMY $ABBV,Gilead (GILD) HCV Drug Vosevi Receives Approval in Canada http://bit.ly/2wo8Y1Q $GILD $MRK $BMY $ABBV,,,,,[],https://twitter.com/LimexMe/status/898563328624250880
3991,Pharmaceutical News,@pharma_sector,2017-08-18T21:42:01.000Z,FDA expands use of AZ#Mercks Lynparza in the US. Read more: http://owler.us/adbCvY $MRK,FDA expands use of AZ#Mercks Lynparza in the US. Read more: http://owler.us/adbCvY $MRK,,,,,[],https://twitter.com/pharma_sector/status/898661287323811840
3992,Limex,@LimexMe,2017-08-18T15:33:00.000Z,AbbVie's HCV Combo Drug Mavyret Clinches Approval in Canada http://bit.ly/180817ABBV $ABBV $MRK $GILD,AbbVie's HCV Combo Drug Mavyret Clinches Approval in Canada http://bit.ly/180817ABBV $ABBV $MRK $GILD,,,,,[],https://twitter.com/LimexMe/status/898568421520150528
3993,Limex,@LimexMe,2017-08-18T15:29:58.000Z,"AstraZeneca/Merck's Lynparza Gets FDA Nod for Label Expansion 
 http://bit.ly/2w9ekhT $AZN $PFE $MRK","AstraZeneca/Merck's Lynparza Gets FDA Nod for Label Expansion 
 http://bit.ly/2w9ekhT $AZN $PFE $MRK
whotrades.com
AstraZeneca/Merck's Lynparza Gets FDA Nod for Label Expansion
AstraZeneca, plc AZN and partner Merck & Co., Inc. MRK announced that the FDA has approved a new tablet formulation for ovarian cancer drug, Lynparza while also broadening‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/898567657112313856
3994,Watchlist News,@WatchlistN,2017-08-18T17:27:18.000Z,"Dubuque Bank & Trust Co. Has $3.60 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2fSnIQy","Dubuque Bank & Trust Co. Has $3.60 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2fSnIQy",,,,,[],https://twitter.com/WatchlistN/status/898597183657832448
3995,Watchlist News,@WatchlistN,2017-08-19T16:17:53.000Z,"Aua Capital Management LLC Has $129,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2x0L7TT","Aua Capital Management LLC Has $129,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2x0L7TT",,,,,[],https://twitter.com/WatchlistN/status/898942104830963712
3996,Watchlist News,@WatchlistN,2017-08-19T16:58:55.000Z,"BLB&B Advisors LLC Continues to Hold Stake in Merck & Company, Inc. $MRK http://ift.tt/2xelm1Q","BLB&B Advisors LLC Continues to Hold Stake in Merck & Company, Inc. $MRK http://ift.tt/2xelm1Q",,,,,[],https://twitter.com/WatchlistN/status/898952430318223361
3997,Ticker Report,@TickerReport,2017-08-19T16:10:56.000Z,"Merck & Company, Inc. $MRK Stake Raised by Piedmont Investment Advisors LLC http://ift.tt/2xdQmii","Merck & Company, Inc. $MRK Stake Raised by Piedmont Investment Advisors LLC http://ift.tt/2xdQmii",,,,,[],https://twitter.com/TickerReport/status/898940351683100672
3998,Wolfe,@everytimeicash,2017-08-17T17:44:55.000Z,Bout to snap - $MRK chart,"Bout to snap - $MRK chart
tradingview.com
Bout to snap for NYSE:MRK by everytimeicash
@1simpletrader #STFR",,,,,[],https://twitter.com/everytimeicash/status/898239230895243264
3999,ThinkingProfit.com,@TPCMG,2017-08-17T18:21:10.000Z,"$MRK: 3 open, suited signals indicate continued price decrease beyond average holding times. http://thinkingprofit.com/equity/?s=MRK","$MRK: 3 open, suited signals indicate continued price decrease beyond average holding times. http://thinkingprofit.com/equity/?s=MRK",,,,,[],https://twitter.com/TPCMG/status/898248350297989126
4000,Stockboard Media Inc,@stockboardinc,2017-08-17T19:40:25.000Z,$MRK LYNPARZA Receives Additional and Broad Approval in the U.S. for Ovarian Cancer... - http://sbml.co/a577b9eb,$MRK LYNPARZA Receives Additional and Broad Approval in the U.S. for Ovarian Cancer... - http://sbml.co/a577b9eb,,,,,[],https://twitter.com/stockboardinc/status/898268296864178176
4001,EdisonHealthcare,@EdisonHealth,2017-08-18T07:37:42.000Z,".
@BGenBio
 reports Q217 results. Raised NOK400m in IPO; #BGB324 in 4 Ph II trials. Collab w/ 
@Merck
. Pres & webcast at 10am CET. $BGBIO $MRK",".
@BGenBio
 reports Q217 results. Raised NOK400m in IPO; #BGB324 in 4 Ph II trials. Collab w/ 
@Merck
. Pres & webcast at 10am CET. $BGBIO $MRK
1",,,1,,[],https://twitter.com/EdisonHealth/status/898448807377195008
4002,Jonathan Faison,@jfais20,2017-08-17T21:58:05.000Z,"$AZN $MRK $CLVS $TSRO FDA grants additional, broad approval for LYNPARZA in the U.S","$AZN $MRK $CLVS $TSRO FDA grants additional, broad approval for LYNPARZA in the U.S",,,,,[],https://twitter.com/jfais20/status/898302942926831616
4003,Helen Ong,@Lin_ling_88,2017-08-17T14:54:40.000Z,"Immunotherapy in Cancer: Hits and Misses, but Charging Ahead

$MRK $BMY $RHHBY","Immunotherapy in Cancer: Hits and Misses, but Charging Ahead

$MRK $BMY $RHHBY
medscape.com
Immunotherapy in Cancer: Hits and Misses, but Charging Ahead
Immunotherapy in cancer care has taken off, but recent negative trials and limited success have raised some criticism and concern.",,,,,[],https://twitter.com/Lin_ling_88/status/898196386252034048
4004,MarketBeat,@MarketBeatCom,2017-08-17T21:25:19.000Z,"Merck & Company, Inc. $MRK Stake Raised by Lynch & Associates IN http://ift.tt/2wf2GSV","Merck & Company, Inc. $MRK Stake Raised by Lynch & Associates IN http://ift.tt/2wf2GSV",,,,,[],https://twitter.com/MarketBeatCom/status/898294695469752320
4005,US Banking News,@AmericanBanking,2017-08-17T04:08:44.000Z,Analysts Give Average Rating of Hold to Merck & Company $MRK http://ift.tt/2qbDsRN,Analysts Give Average Rating of Hold to Merck & Company $MRK http://ift.tt/2qbDsRN,,,,,[],https://twitter.com/AmericanBanking/status/898033830929543168
4006,Briefing.com,@Briefingcom,2017-08-17T21:38:07.000Z,"$MRK: Merck and AstraZeneca (AZN) granted FDA approval for the PARP inhibitor, LYNPARZA http://bit.ly/2uUpFi4","$MRK: Merck and AstraZeneca (AZN) granted FDA approval for the PARP inhibitor, LYNPARZA http://bit.ly/2uUpFi4",,,,,[],https://twitter.com/Briefingcom/status/898297914895683584
4007,APM Health Europe,@apmhealtheurope,2017-08-18T14:01:00.000Z,"#FDA approves $AZN $MRK 's new Lynparza formulation in ovarian cancer, full story 
@apmhealtheurope
 via 
@tmeek87","#FDA approves $AZN $MRK 's new Lynparza formulation in ovarian cancer, full story 
@apmhealtheurope
 via 
@tmeek87",,,,,[],https://twitter.com/apmhealtheurope/status/898545268836184065
4008,The Fly,@theflynews,2017-08-19T19:25:03.000Z,Week in review: How Trump's policies moved stocks $MRK $INTC $UA $UAA $CPB $JNJ $UTX $BX $JPM $GM $WMT $TSLA $DIS‚Ä¶ http://dlvr.it/PgD298,"Week in review: How Trump's policies moved stocks $MRK $INTC $UA $UAA $CPB $JNJ $UTX $BX $JPM $GM $WMT $TSLA $DIS‚Ä¶ http://dlvr.it/PgD298
1
1",,,1,1,[],https://twitter.com/theflynews/status/898989204411080705
4009,FierceBiotech,@FierceBiotech,2017-08-17T08:11:13.000Z,J&J CEO Alex Gorsky leaves Trump council as president breaks it up: http://ow.ly/YOhy30etiIA $JNJ $IBB $XBI $MRK,"J&J CEO Alex Gorsky leaves Trump council as president breaks it up: http://ow.ly/YOhy30etiIA $JNJ $IBB $XBI $MRK
fiercepharma.com
Johnson & Johnson CEO Alex Gorsky leaves Trump council as president breaks it up
One day after committing to remain on President Donald Trump's manufacturing council, Johnson & Johnson CEO Alex Gorsky on | One day after committing to remain on President Donald Trump's manufactu...
1
3",,1,3,,['https://pbs.twimg.com/card_img/1501631587175178244/demaE6p3?format=jpg&name=small'],https://twitter.com/FierceBiotech/status/898094854433116160
4010,Sir Biosimilarz,@biosimilarz,2017-08-18T14:00:16.000Z,"Replying to 
@StanMehr","Replying to 
@StanMehr
Very surprising that someone from the 
@safebiologics
 thinks $MRK's infliximab #biosimilar was the first in the US. Very surprising...
3",,,,3,[],https://twitter.com/biosimilarz/status/898545082680451073
4011,MarketSmith,@MarketSmith,2017-08-18T22:09:37.000Z,All Eyes Will Be On This Dow Component's 'Star' Drug Next Week: http://ow.ly/Z3eI30ewn6E $JNJ $BAYRY $MRK $NVS,"All Eyes Will Be On This Dow Component's 'Star' Drug Next Week: http://ow.ly/Z3eI30ewn6E $JNJ $BAYRY $MRK $NVS
investors.com
All Eyes Will Be On This Dow Component's 'Star' Drug Next Week
J&J and Bayer's Xarelto will likely be the star of next week's European Society of Cardiology conference, an analyst says.",,,,,['https://pbs.twimg.com/card_img/1501990859998261248/NQaIlNkL?format=jpg&name=small'],https://twitter.com/MarketSmith/status/898668230767591424
4012,Kristen Hallam,@kristen_hallam,2017-08-17T20:39:27.000Z,ICYMI: Our take on the end of the CEO advisory groups $JNJ $MRK http://bit.ly/2i92WwC,ICYMI: Our take on the end of the CEO advisory groups $JNJ $MRK http://bit.ly/2i92WwC,,,,,[],https://twitter.com/kristen_hallam/status/898283150480097280
4013,Daily Political,@dailypoliticaln,2017-08-18T16:16:10.000Z,"Ballentine Partners LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2v89kVW","Ballentine Partners LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2v89kVW",,,,,[],https://twitter.com/dailypoliticaln/status/898579281751678977
4014,Daily Political,@dailypoliticaln,2017-08-19T17:03:07.000Z,"Merck & Company, Inc. $MRK Stake Cut by Bourne Lent Asset Management Inc. http://ift.tt/2vbDIPk","Merck & Company, Inc. $MRK Stake Cut by Bourne Lent Asset Management Inc. http://ift.tt/2vbDIPk",,,,,[],https://twitter.com/dailypoliticaln/status/898953484887871489
4015,Daily Political,@dailypoliticaln,2017-08-18T16:16:05.000Z,"Merck & Company, Inc. $MRK Shares Sold by Palisades Hudson Asset Management L.P. http://ift.tt/2uPbhLJ","Merck & Company, Inc. $MRK Shares Sold by Palisades Hudson Asset Management L.P. http://ift.tt/2uPbhLJ",,,,,[],https://twitter.com/dailypoliticaln/status/898579263783292928
4016,StockNews.com,@stocknewsdotcom,2017-08-17T19:38:43.000Z,"$MRK Merck and AstraZeneca granted FDA approval for the PARP inhibitor, LYNPARZA https://stocknews.com/news/mrk-merck-and-astrazeneca-granted-fda-approval-for-the-parp-inhibitor/‚Ä¶","$MRK Merck and AstraZeneca granted FDA approval for the PARP inhibitor, LYNPARZA https://stocknews.com/news/mrk-merck-and-astrazeneca-granted-fda-approval-for-the-parp-inhibitor/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/898267868248387585
4017,Dakota Financial,@dakotafinancial,2017-08-17T21:22:55.000Z,"Merck & Company, Inc. $MRK Stake Raised by Lynch & Associates IN http://ift.tt/2wf2GSV","Merck & Company, Inc. $MRK Stake Raised by Lynch & Associates IN http://ift.tt/2wf2GSV",,,,,[],https://twitter.com/dakotafinancial/status/898294090181341184
4018,Dakota Financial,@dakotafinancial,2017-08-18T19:49:35.000Z,"Merck & Company, Inc. $MRK Shares Bought by Ballentine Partners LLC http://ift.tt/2wY6Xax","Merck & Company, Inc. $MRK Shares Bought by Ballentine Partners LLC http://ift.tt/2wY6Xax",,,,,[],https://twitter.com/dakotafinancial/status/898632988946186240
4019,c lark,@7LadyQ,2017-08-17T21:39:23.000Z,"$MRK: Merck and AstraZeneca (AZN) granted FDA approval for the PARP inhibitor, LYNPARZA http://bit.ly/2uUpFi4","$MRK: Merck and AstraZeneca (AZN) granted FDA approval for the PARP inhibitor, LYNPARZA http://bit.ly/2uUpFi4",,,,,[],https://twitter.com/7LadyQ/status/898298236603170816
4020,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-08-22T10:50:57.000Z,13.5% of NSCLC Medicare pts have autoimmune dz C/I for ICI with PD1 +/- CTLA4 $MRK $BMY $AZN $ROG $INCY  https://ncbi.nlm.nih.gov/pubmed/28241095,"13.5% of NSCLC Medicare pts have autoimmune dz C/I for ICI with PD1 +/- CTLA4 $MRK $BMY $AZN $ROG $INCY  https://ncbi.nlm.nih.gov/pubmed/28241095
2
1
3",,2,1,3,['https://pbs.twimg.com/media/DH1AsOYUIAADZBx?format=jpg&name=small'],https://twitter.com/DrPaulyDeSantis/status/899946992217899008
4021,Adri√°n Hern√°ndez,@adrivalue,2017-08-21T07:34:28.000Z,"Top #10 Gain ""Safer"" Dividend DOW Dogs https://seekingalpha.com/article/4100371-dow-safer-dividend-dogs-hound-ibm-pfizer-home-depot-top-gainers-per-august-broker-targets‚Ä¶ $IBM $PFE $HD $INTC $MRK $CSCO $DIS $MSFT $XOM $UTX #DividendGrowth","Top #10 Gain ""Safer"" Dividend DOW Dogs https://seekingalpha.com/article/4100371-dow-safer-dividend-dogs-hound-ibm-pfizer-home-depot-top-gainers-per-august-broker-targets‚Ä¶ $IBM $PFE $HD $INTC $MRK $CSCO $DIS $MSFT $XOM $UTX #DividendGrowth
1",,,,1,['https://pbs.twimg.com/media/DHvKMVdXkAAjRPt?format=jpg&name=small'],https://twitter.com/adrivalue/status/899535158445002752
4022,dough,@semodough,2017-08-21T02:37:43.000Z,"Replying to 
@semodough","Replying to 
@semodough
$MRK $INCY #ESMO17
1
1",,,1,1,['https://pbs.twimg.com/media/DHuGh4ZUwAA2BPV?format=jpg&name=900x900'],https://twitter.com/semodough/status/899460475720790017
4023,PrevInvest,@PrevInvest_Adv,2017-08-22T19:57:03.000Z,"The 10 stocks America's biggest #hedgefunds are selling 
$PFE $PEP $MDT $GOOGL $MRK $JPM $JNJ $LLY $AAPL $K","The 10 stocks America's biggest #hedgefunds are selling 
$PFE $PEP $MDT $GOOGL $MRK $JPM $JNJ $LLY $AAPL $K
thestreet.com
The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy
America's biggest hedge funds are worth over $6 trillion combined, and here are the most common stocks they're selling.
1",,,1,,[],https://twitter.com/PrevInvest_Adv/status/900084420383846400
4024,Vista Partners LLC,@VistaPResearch,2017-08-21T17:53:15.000Z,#StreetArt #SanFrancisco Vista Partners #InvestingForLife http://vistapglobal.com $ATOS $HIIQ $AAPL $MRK,"#StreetArt #SanFrancisco Vista Partners #InvestingForLife http://vistapglobal.com $ATOS $HIIQ $AAPL $MRK
2
1",,,2,1,['https://pbs.twimg.com/media/DHxYFf1UMAA6Vxi?format=jpg&name=small'],https://twitter.com/VistaPResearch/status/899690879992057857
4025,Financhill,@financhill,2017-08-22T08:02:12.000Z,Seasonality for $MRK could surprise traders. http://bit.ly/2o9D6K3,Seasonality for $MRK could surprise traders. http://bit.ly/2o9D6K3,,,,,['https://pbs.twimg.com/media/DH0aZQ8XUAEB7Z6?format=jpg&name=small'],https://twitter.com/financhill/status/899904524671954944
4026,Vista Partners LLC,@VistaPResearch,2017-08-20T17:59:29.000Z,"@MsCapitalMarket
 thanks for follow! #SundayFunday Vista Partners #Investing #technology http://vistapglobal.com $AAPL $BA $ATOS $CSCO $MRK","@MsCapitalMarket
 thanks for follow! #SundayFunday Vista Partners #Investing #technology http://vistapglobal.com $AAPL $BA $ATOS $CSCO $MRK
GIF
1
2",,,1,2,['https://pbs.twimg.com/tweet_video_thumb/DHsP6aaV0AAubcV.jpg'],https://twitter.com/VistaPResearch/status/899330057511895041
4027,CBPartners,@CBPartners,2017-08-22T07:40:05.000Z,#FDA approves $MRK #PARPinhibitor LYNPARZA as maintenance treatment for some #FemaleCancers including #OvarianCancer http://bit.ly/2ij7eBA,"#FDA approves $MRK #PARPinhibitor LYNPARZA as maintenance treatment for some #FemaleCancers including #OvarianCancer http://bit.ly/2ij7eBA
2",,,2,,[],https://twitter.com/CBPartners/status/899898957849079808
4028,Focus on Dividends,@Focus_on_Dvds,2017-08-20T05:35:41.000Z,"Notable Analyst Upgrades and Downgrades for Week of August 7, 2017 https://buff.ly/2x2bM2s $CMI $CVX $DE $FL $KSS $MRK  $SBUX $UL $UPS $VOD","Notable Analyst Upgrades and Downgrades for Week of August 7, 2017 https://buff.ly/2x2bM2s $CMI $CVX $DE $FL $KSS $MRK  $SBUX $UL $UPS $VOD",,,,,['https://pbs.twimg.com/media/DHplrc9XkAAJXcq?format=jpg&name=360x360'],https://twitter.com/Focus_on_Dvds/status/899142875002306560
4029,Maximum Pain,@themaxpain,2017-08-21T12:30:47.000Z,"$MRK $61.49 ($65) $COP $43.11 ($45) $F $10.56 ($11) max pain trades for Aug 25, 2017 exp. #MaxPain #Options","$MRK $61.49 ($65) $COP $43.11 ($45) $F $10.56 ($11) max pain trades for Aug 25, 2017 exp. #MaxPain #Options",,,,,[],https://twitter.com/themaxpain/status/899609727323312129
4030,Charles Zinnel,@charles_zinnel,2017-08-22T18:03:29.000Z,$dxtr surging should be trading $2+ $pfe $jnj $mrk $gsk $wmgi,$dxtr surging should be trading $2+ $pfe $jnj $mrk $gsk $wmgi,,,,,[],https://twitter.com/charles_zinnel/status/900055843554701313
4031,Charles Zinnel,@charles_zinnel,2017-08-22T21:13:42.000Z,Expecting $imuc partnership news tomorrow before CC IMO. $pfe $jnj $mrk $gsk $cytr $dcth $dxtr,"Expecting $imuc partnership news tomorrow before CC IMO. $pfe $jnj $mrk $gsk $cytr $dcth $dxtr
1",,,,1,[],https://twitter.com/charles_zinnel/status/900103712131104769
4032,Charles Zinnel,@charles_zinnel,2017-08-22T21:07:03.000Z,adding more $imuc into conference call tomorrow. Expecting positive news. $pfe $jnj $mrk $gsk,"adding more $imuc into conference call tomorrow. Expecting positive news. $pfe $jnj $mrk $gsk
1",,,,1,[],https://twitter.com/charles_zinnel/status/900102038243098624
4033,Obi,@aaaamhim,2017-08-21T09:08:38.000Z,$SLDC MUST READ Free money? https://insiderfinancial.com/solid-controls-inc-com-stk-usd0-05-otcmktssldc-oversold-and-due-for-a-bounce/152677/‚Ä¶ $PMCB $GYOG $MMEG $DRYS $DCTH $ELED $FRZT $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG,"$SLDC MUST READ Free money? https://insiderfinancial.com/solid-controls-inc-com-stk-usd0-05-otcmktssldc-oversold-and-due-for-a-bounce/152677/‚Ä¶ $PMCB $GYOG $MMEG $DRYS $DCTH $ELED $FRZT $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG
1",,,,1,[],https://twitter.com/aaaamhim/status/899558852617793537
4034,Vista Partners LLC,@VistaPResearch,2017-08-22T16:58:17.000Z,"@AndroidApps010
 thanks for follow! #TuesdayTip See Vista Partners #Investing #biotech http://vistapglobal.com $ATOS $MMM $MRK $PFE","@AndroidApps010
 thanks for follow! #TuesdayTip See Vista Partners #Investing #biotech http://vistapglobal.com $ATOS $MMM $MRK $PFE
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DH2VFuEVoAAYvwY.jpg'],https://twitter.com/VistaPResearch/status/900039432539062272
4035,Dow Stocks,@Top_Dow_Stocks,2017-08-22T07:16:57.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/899893136092053504
4036,StockMarketVideo.com,@stockmarketvide,2017-08-22T20:49:53.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/900097718378532864
4037,BioPharma Dive,@BioPharmaDive,2017-08-21T22:07:00.000Z,ICYMI: $AZN and $MRK win broader label for PARP inhibitor Lynparza,"ICYMI: $AZN and $MRK win broader label for PARP inhibitor Lynparza
biopharmadive.com
Expanded label boosts AstraZeneca and Merck's Lynparza
Securing a broader indication for earlier treatment of ovarian cancer should help Lynparza fend off competition from rival PARP inhibitors.
1",,,,1,['https://pbs.twimg.com/card_img/1501985636869234688/L2DYeo-q?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/899754736680751104
4038,Donna Young,@DonnaYoungDC,2017-08-20T21:17:06.000Z,"Former #FDA chief praises 
@TonyColesMD
 op-ed on $MRK CEO exit Trump manufacturing council, says 'Leadership needed in this country'
#pharma","Former #FDA chief praises 
@TonyColesMD
 op-ed on $MRK CEO exit Trump manufacturing council, says 'Leadership needed in this country'
#pharma
Robert M Califf
@califf001
 ¬∑ 20 Aug 2017
Wisdom from colleague @TonyColesMD.  Leadership needed in this country. https://statnews.com/2017/08/15/ken-frazier-right-call/?utm_source=STAT+Newsletters&utm_campaign=41977c743b-First_Opinion&utm_medium=email&utm_term=0_8cab1d7961-41977c743b-150034209‚Ä¶
2",üì∞,,,2,['https://pbs.twimg.com/profile_images/419058001907941376/xT-QVwXz_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/899379790465183744
4039,Pharmaceutical News,@pharma_sector,2017-08-22T17:19:27.000Z,#Merck FDAlist celebrities Why Mandy Moore is the latest Big Pharma recruit. Read more: http://owler.us/adcmYO $MRK,#Merck FDAlist celebrities Why Mandy Moore is the latest Big Pharma recruit. Read more: http://owler.us/adcmYO $MRK,,,,,[],https://twitter.com/pharma_sector/status/900044760252989440
4040,MarketBeat,@MarketBeatCom,2017-08-20T05:25:26.000Z,Merck & Company's sell rating reiterated at Jefferies Group LLC. $52.00 PT. http://ift.tt/2wkTFYt $MRK #MRK,Merck & Company's sell rating reiterated at Jefferies Group LLC. $52.00 PT. http://ift.tt/2wkTFYt $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/899140296906338304
4041,Daily Political,@dailypoliticaln,2017-08-22T15:06:16.000Z,"Merck & Company, Inc. $MRK Stake Maintained by Adams Diversified Equity Fund Inc. http://ift.tt/2x9CiXW","Merck & Company, Inc. $MRK Stake Maintained by Adams Diversified Equity Fund Inc. http://ift.tt/2x9CiXW",,,,,[],https://twitter.com/dailypoliticaln/status/900011242391302144
4042,Analyst Ratings,@ARatings,2017-08-20T05:05:11.000Z,Jefferies Keeps Their Sell Rating on Merck & Company $MRK http://analystratings.com/articles/jefferies-keeps-their-sell-rating-on-merck-company/‚Ä¶,Jefferies Keeps Their Sell Rating on Merck & Company $MRK http://analystratings.com/articles/jefferies-keeps-their-sell-rating-on-merck-company/‚Ä¶,,,,,[],https://twitter.com/ARatings/status/899135201858781184
4043,Ticker Report,@TickerReport,2017-08-20T05:16:26.000Z,"Merck & Company, Inc. $MRK Receives ‚ÄúSell‚Äù Rating from Jefferies Group LLC http://ift.tt/2v2Aoaa","Merck & Company, Inc. $MRK Receives ‚ÄúSell‚Äù Rating from Jefferies Group LLC http://ift.tt/2v2Aoaa",,,,,[],https://twitter.com/TickerReport/status/899138030249926656
4044,Daily Political,@dailypoliticaln,2017-08-21T23:25:28.000Z,"Investors Sell Shares of Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2vYtIeB","Investors Sell Shares of Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2vYtIeB",,,,,[],https://twitter.com/dailypoliticaln/status/899774481928929281
4045,Watchlist News,@WatchlistN,2017-08-21T16:49:06.000Z,"Doyle Wealth Management Purchases 3,516 Shares of Merck & Company, Inc. $MRK http://ift.tt/2wqQWwR","Doyle Wealth Management Purchases 3,516 Shares of Merck & Company, Inc. $MRK http://ift.tt/2wqQWwR",,,,,[],https://twitter.com/WatchlistN/status/899674732961902593
4046,Sweet Platform,@SweetPlatform,2017-08-22T15:25:33.000Z,"MRK Top news - Aug 22nd, 2017 $MRK http://https://goo.gl/8oznSb","MRK Top news - Aug 22nd, 2017 $MRK http://https://goo.gl/8oznSb",,,,,[],https://twitter.com/SweetPlatform/status/900016094752239616
4047,BioPharma Dive,@BioPharmaDive,2017-08-22T22:08:00.000Z,"With rights in hand, ALK plans to push up North American launch date for Odactra to Q4 http://bit.ly/2w0rScT $MRK","With rights in hand, ALK plans to push up North American launch date for Odactra to Q4 http://bit.ly/2w0rScT $MRK
biopharmadive.com
ALK readies Odactra launch after Merck exit
The Danish drugmaker is ready to launch its house dust mite treatment after its big pharma partner pulled out of the collaboration in 2016.
1",,,,1,['https://pbs.twimg.com/card_img/1501942548989841413/GSzK7LFw?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/900117377064603650
4048,Igor Lokot,@Lokot_Igor,2017-08-21T20:00:55.000Z,The Troubles Never End For Teva https://seekingalpha.com/article/4100694-troubles-never-end-teva?source=tweet‚Ä¶ $BIIB $MNTA $MRK $NVS $RHHBY $SNY $BAYZF $TEVA,"The Troubles Never End For Teva https://seekingalpha.com/article/4100694-troubles-never-end-teva?source=tweet‚Ä¶ $BIIB $MNTA $MRK $NVS $RHHBY $SNY $BAYZF $TEVA
1",,,,1,[],https://twitter.com/Lokot_Igor/status/899723005974241286
4049,US Banking News,@AmericanBanking,2017-08-20T05:18:12.000Z,Merck & Company's sell rating reiterated at Jefferies Group LLC. $52.00 PT. http://ift.tt/2wkTFYt $MRK #MRK,Merck & Company's sell rating reiterated at Jefferies Group LLC. $52.00 PT. http://ift.tt/2wkTFYt $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/899138475219398656
4050,FinInvTr,@FinInvTr,2017-08-22T19:28:00.000Z,The 10 Stocks America's Biggest Hedge Funds Are Selling: https://buff.ly/2vbtEqk  $AAPL $JPM $PEP $PFE $MDT $LLY $MRK $JNJ $K $GOOG,"The 10 Stocks America's Biggest Hedge Funds Are Selling: https://buff.ly/2vbtEqk  $AAPL $JPM $PEP $PFE $MDT $LLY $MRK $JNJ $K $GOOG
whotrades.com
The 10 Stocks America's Biggest Hedge Funds Are Selling
Hedge funds make, hold and spend an enormous amount of money. According to Barron's , the largest 50 funds in America manage more in assets than the combined value of the entire‚Ä¶",,,,,[],https://twitter.com/FinInvTr/status/900077110408204288
4051,MarketBeat,@MarketBeatCom,2017-08-20T01:30:37.000Z,Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Merck & $MRK Share Price http://ift.tt/2vcymn8,Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Merck & $MRK Share Price http://ift.tt/2vcymn8,,,,,[],https://twitter.com/MarketBeatCom/status/899081203319549952
4052,Novateur Ventures,@NovateurBio,2017-08-21T19:58:06.000Z,"Will more pharmas defy #Trump after $MRK Merck CEO's council exit? Don't count on it http://fiercepharma.com/pharma/other-drugmakers-stay-mum-after-merck-ceo-s-exit-from-trump-panel‚Ä¶ via 
@FiercePharma","Will more pharmas defy #Trump after $MRK Merck CEO's council exit? Don't count on it http://fiercepharma.com/pharma/other-drugmakers-stay-mum-after-merck-ceo-s-exit-from-trump-panel‚Ä¶ via 
@FiercePharma
fiercepharma.com
Will more pharmas defy Trump after Merck CEO's council exit? Don't count on it
Merck CEO Ken Frazier made waves far beyond the pharma industry when he stepped down from President Donald Trump‚Äôs manufacturing panel Monday, taking a stand against ‚Äúintolerance and extremism.‚Äù...",,,,,[],https://twitter.com/NovateurBio/status/899722296574697472
4053,Miljenko Zuanic,@Miljenkoz,2017-08-22T23:15:03.000Z,"Replying to 
@Ogut_Ozgur
 and 
@PRB51","Replying to 
@Ogut_Ozgur
 and 
@PRB51
Sometimes premature (OR/PFR) report on IO treatment data, one way or another, may be simple wrong for ultimate OS benefit! $INCY $BMY $MRK
2",,,,2,[],https://twitter.com/Miljenkoz/status/900134250204192769
4054,Donna Young,@DonnaYoungDC,2017-08-22T23:45:50.000Z,".
@andrewrsorkin
: Don't expect business to walk away from Washington b/c of the Trump exodus b/c that's where the money is. 
$MRK #pharma",".
@andrewrsorkin
: Don't expect business to walk away from Washington b/c of the Trump exodus b/c that's where the money is. 
$MRK #pharma
PBS NewsHour
@NewsHour
 ¬∑ 23 Aug 2017
For some CEOs serving on Pres. Trump's advisory councils, it became both moral + commercial issue after Charlottesville, says @andrewrsorkin",üì∞,,,,"['https://pbs.twimg.com/profile_images/875456540450443265/W5yKx8um_mini.jpg', 'https://pbs.twimg.com/media/DH3utMcUQAArKVp.jpg']",https://twitter.com/DonnaYoungDC/status/900141997851369473
4055,AustinBizJournal,@MyABJ,2017-08-22T21:15:01.000Z,"@Merck
 already has openings for software jobs & more in Austin http://bizj.us/1pahzu  $MRK","@Merck
 already has openings for software jobs & more in Austin http://bizj.us/1pahzu  $MRK
bizjournals.com
Merck starts search for tech minds to staff $29M Austin office
The company needs people skilled in data science, analytics, machine learning, cybersecurity, agile software development and architecture. It has agreed to create up to 600 jobs at an average wage of...",üîí,,,,[],https://twitter.com/MyABJ/status/900104043128926209
4056,AustinBizJournal,@MyABJ,2017-08-22T17:07:01.000Z,"@Merck
 is hiring tech minds for future IT hub in Austin http://bizj.us/1pahzu  
@DellMedSchool
 $MRK","@Merck
 is hiring tech minds for future IT hub in Austin http://bizj.us/1pahzu  
@DellMedSchool
 $MRK
bizjournals.com
Merck starts search for tech minds to staff $29M Austin office
The company needs people skilled in data science, analytics, machine learning, cybersecurity, agile software development and architecture. It has agreed to create up to 600 jobs at an average wage of...",üîí,,,,[],https://twitter.com/MyABJ/status/900041630039900161
4057,Dakota Financial,@dakotafinancial,2017-08-20T01:34:23.000Z,Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Merck & $MRK Share Price http://ift.tt/2vcymn8,Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Merck & $MRK Share Price http://ift.tt/2vcymn8,,,,,[],https://twitter.com/dakotafinancial/status/899082152083681282
4058,MarketBeat,@MarketBeatCom,2017-08-20T10:34:38.000Z,"Merck & Company, Inc. $MRK Given ‚ÄúSell‚Äù Rating at Jefferies Group LLC http://ift.tt/2vPe4DQ #acn","Merck & Company, Inc. $MRK Given ‚ÄúSell‚Äù Rating at Jefferies Group LLC http://ift.tt/2vPe4DQ #acn",,,,,[],https://twitter.com/MarketBeatCom/status/899218108342292480
4059,BioPharma Dive,@BioPharmaDive,2017-08-22T18:28:00.000Z,ALK readies Odactra launch after $MRK exit,"ALK readies Odactra launch after $MRK exit
biopharmadive.com
ALK readies Odactra launch after Merck exit
The Danish drugmaker is ready to launch its house dust mite treatment after its big pharma partner pulled out of the collaboration in 2016.",,,,,['https://pbs.twimg.com/card_img/1501942548989841413/GSzK7LFw?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/900062013333876741
4060,US Banking News,@AmericanBanking,2017-08-20T10:30:35.000Z,"Merck & Company, Inc. $MRK Given ‚ÄúSell‚Äù Rating at Jefferies Group LLC http://ift.tt/2xfCaoZ","Merck & Company, Inc. $MRK Given ‚ÄúSell‚Äù Rating at Jefferies Group LLC http://ift.tt/2xfCaoZ",,,,,[],https://twitter.com/AmericanBanking/status/899217090984509442
4061,Herkyleese,@herkyleese,2017-08-23T12:57:57.000Z,Key players:  $nwbo $mrk $gsk $immu most are phase I/II.  $nwbo phase III dcvax-l readout very soon  O.S. may crush anything we've ever seen,"Key players:  $nwbo $mrk $gsk $immu most are phase I/II.  $nwbo phase III dcvax-l readout very soon  O.S. may crush anything we've ever seen
1
10
18",,1,10,18,"['https://pbs.twimg.com/media/DH6nolaUQAARvhn?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DH6npQwV0AEaaSI?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DH6nqDOV0AEShXT?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DH6nq07VoAAOCGG?format=jpg&name=small']",https://twitter.com/herkyleese/status/900341340256387072
4062,Herkyleese,@herkyleese,2017-08-24T13:14:33.000Z,Players: $mrk $sny $adro $nwbo $gsk $csl $azn with on lookers $bmy $exel $fgen $agio $celg $blue $gild.  Many are late to the party= buyouts,"Players: $mrk $sny $adro $nwbo $gsk $csl $azn with on lookers $bmy $exel $fgen $agio $celg $blue $gild.  Many are late to the party= buyouts
4
8",,,4,8,"['https://pbs.twimg.com/media/DH_1BqYUQAARJQS?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DH_1CMeVYAI7TUL?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DH_1C4GUAAAneHk?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DH_1DmOV0AELa7F?format=jpg&name=360x360']",https://twitter.com/herkyleese/status/900707904696614912
4063,Seeking Alpha,@SeekingAlpha,2017-08-25T19:55:20.000Z,Merck: Shareholders will fail to be rewarded here https://seekingalpha.com/article/4102006-merck-shareholders-will-fail-rewarded?source=feed_f‚Ä¶ $MRK,"Merck: Shareholders will fail to be rewarded here https://seekingalpha.com/article/4102006-merck-shareholders-will-fail-rewarded?source=feed_f‚Ä¶ $MRK
1
1",,,1,1,[],https://twitter.com/SeekingAlpha/status/901171155028951040
4064,WLST.com,@wlstcom,2017-08-24T18:33:39.000Z,Options say these three stocks are ready to break out $MRK http://wlst.com https://finance.yahoo.com/video/options-three-stocks-ready-break-173900659.html‚Ä¶,Options say these three stocks are ready to break out $MRK http://wlst.com https://finance.yahoo.com/video/options-three-stocks-ready-break-173900659.html‚Ä¶,,,,,['https://pbs.twimg.com/media/DIA-GiXXoAAba92?format=jpg&name=small'],https://twitter.com/wlstcom/status/900788209864626176
4065,Christian Fromhertz,@cfromhertz,2017-08-24T14:27:42.000Z,$MRK +5k of Sep 63 calls trading,"$MRK +5k of Sep 63 calls trading
1
2",,,1,2,[],https://twitter.com/cfromhertz/status/900726311756464132
4066,max pain,@optioncharts,2017-08-25T17:20:39.000Z,$MRK high OI range is 62.50 to 65.00 for option expiration 09/01/2017 #maxpain #options http://maximum-pain.com/options/open-interest?s=MRK&e=09%2f01%2f2017‚Ä¶,$MRK high OI range is 62.50 to 65.00 for option expiration 09/01/2017 #maxpain #options http://maximum-pain.com/options/open-interest?s=MRK&e=09%2f01%2f2017‚Ä¶,,,,,['https://pbs.twimg.com/media/DIF2-1XXUAAQc4D?format=jpg&name=small'],https://twitter.com/optioncharts/status/901132225055469569
4067,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-08-23T10:41:08.000Z,$MRK $BMY $AZN $LLY IO Market is +1% (adj) MoM in July; Keytruda Market Share Rises from 37% to 39% Keytruda (cont) http://tl.gd/n_1sq4osg,"$MRK $BMY $AZN $LLY IO Market is +1% (adj) MoM in July; Keytruda Market Share Rises from 37% to 39% Keytruda (cont) http://tl.gd/n_1sq4osg
1
3
1",üÖ± üÖæ,1,3,1,[],https://twitter.com/_B_I_O_T_E_C_H_/status/900306907050672128
4068,Œûlian D. Alvarez,@eliandalvarez,2017-08-24T03:50:48.000Z,"The ten stocks that America's biggest #HedgeFund are unloading right now.
$PFE 
$PEP 
$MDT
$GOOGL
$MRK
$JPM
$JNJ
$LLY
$AAPL
$K","The ten stocks that America's biggest #HedgeFund are unloading right now.
$PFE 
$PEP 
$MDT
$GOOGL
$MRK
$JPM
$JNJ
$LLY
$AAPL
$K
TheStreet
@TheStreet
 ¬∑ 24 Aug 2017
America's biggest hedge funds are worth over $6 trillion combined https://buff.ly/2wFWzGI
1
1
3",ü¶á üîä,1,1,3,['https://pbs.twimg.com/profile_images/1438558308164644866/JLxN88qJ_mini.jpg'],https://twitter.com/eliandalvarez/status/900566030946369536
4069,StocksCrypto_Analyst,@Taarriqq,2017-08-25T13:39:16.000Z,"$mrk squizzing here, sept 63 7000+ calls added in oi  yestrday #follow #volume","$mrk squizzing here, sept 63 7000+ calls added in oi  yestrday #follow #volume
1
1",,1,,1,[],https://twitter.com/Taarriqq/status/901076512794869760
4070,MarketSmith,@MarketSmith,2017-08-24T15:53:24.000Z,Early Stock Rally Fades; These Two Leaders On Tap After The Bell: http://ow.ly/4acO30eEt7G $MRK $AAPL $AMZN $PLNT $BABA $NFLX $AVGO,"Early Stock Rally Fades; These Two Leaders On Tap After The Bell: http://ow.ly/4acO30eEt7G $MRK $AAPL $AMZN $PLNT $BABA $NFLX $AVGO
1",,,1,,['https://pbs.twimg.com/media/DIAZa8fXcAEgKcC?format=jpg&name=small'],https://twitter.com/MarketSmith/status/900747879496781825
4071,Hans,@WartenbergHans,2017-08-24T11:30:16.000Z,$MRK 12 month price target for $90. We'll see if they hit it or surpass it.,"$MRK 12 month price target for $90. We'll see if they hit it or surpass it.
WSJ Markets
@WSJmarkets
 ¬∑ 24 Aug 2017
Merck gives investors exposure to most promising cancer drug on the market at a good price    https://wsj.com/articles/merck-is-good-for-your-portfolios-health-1503567000‚Ä¶ via @WSJ",,,,,['https://pbs.twimg.com/profile_images/954404826212904960/TnG97-_8_mini.jpg'],https://twitter.com/WartenbergHans/status/900681661708464129
4072,James Sikes,@wosaikeneriki,2017-08-25T19:37:00.000Z,"As Merck & Co $MRK Market Value Declined, Healthcor Management LP Has Decreased Position by $13.49 Million ...","As Merck & Co $MRK Market Value Declined, Healthcor Management LP Has Decreased Position by $13.49 Million ...",,,,,[],https://twitter.com/wosaikeneriki/status/901166540325867520
4073,Jon Najarian,@NajarianTV,2017-08-24T18:29:42.000Z,"Podcast: The 
@LouFerrigno
 Hurricane  Hulk Trade $MPC $CZR $MRK $ADBE https://youtu.be/qXrhJegyPNw","Podcast: The 
@LouFerrigno
 Hurricane  Hulk Trade $MPC $CZR $MRK $ADBE https://youtu.be/qXrhJegyPNw",,,,,['https://pbs.twimg.com/media/DIA9K5OW0AED1gV?format=jpg&name=small'],https://twitter.com/NajarianTV/status/900787216842199040
4074,The Fly,@theflynews,2017-08-23T17:35:01.000Z,"Raymond James says Paratek takeover speculation ""seems plausible"": http://bit.ly/2w3BTWJ $PRTK $AGN $MRK $PFE","Raymond James says Paratek takeover speculation ""seems plausible"": http://bit.ly/2w3BTWJ $PRTK $AGN $MRK $PFE
2",,,,2,['https://pbs.twimg.com/media/DH7feLZUAAEYH7h?format=jpg&name=small'],https://twitter.com/theflynews/status/900411064369778688
4075,James Sikes,@wosaikeneriki,2017-08-23T13:28:23.000Z,Sphera Funds Management LTD Lifted Merck & Co INC $MRK Position by $8.70 Million http://bzweekly.com/sphera-funds-management-ltd-lifted-merck-stock-price-declined/‚Ä¶,Sphera Funds Management LTD Lifted Merck & Co INC $MRK Position by $8.70 Million http://bzweekly.com/sphera-funds-management-ltd-lifted-merck-stock-price-declined/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/900348999248498688
4076,FinInvTr,@FinInvTr,2017-08-25T18:13:00.000Z,10 Top Holdings In Market's Best Healthcare Fund - https://buff.ly/2wvqH7Y - $JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD,10 Top Holdings In Market's Best Healthcare Fund - https://buff.ly/2wvqH7Y - $JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD,,,,,[],https://twitter.com/FinInvTr/status/901145400673021952
4077,Mike DeSenne,@mdesenne,2017-08-24T14:48:01.000Z,Greatest stocks of all time: http://kiplinger.com/slideshow/investing/T052-S001-30-great-stocks-of-all-time/index.html‚Ä¶ $XOM $PG $KO $AAPL $MSFT $IBM $INTC $MRK $DIS $PFE $PEP $JNJ $GE $GM $WFC $GOOGL $AMZN,"Greatest stocks of all time: http://kiplinger.com/slideshow/investing/T052-S001-30-great-stocks-of-all-time/index.html‚Ä¶ $XOM $PG $KO $AAPL $MSFT $IBM $INTC $MRK $DIS $PFE $PEP $JNJ $GE $GM $WFC $GOOGL $AMZN
kiplinger.com
The 30 Best Stocks of the Past 30 Years | Kiplinger
This elite group of global equities created the most wealth for shareholders over the past three decades.",,,,,['https://pbs.twimg.com/card_img/1501163192940212225/uvMaMEd5?format=jpg&name=small'],https://twitter.com/mdesenne/status/900731425560956930
4078,Limex,@LimexMe,2017-08-24T15:42:16.000Z,4 of the Highest-Growth Stocks in Biotech Today http://bit.ly/240817CORT $CORT $EXEL $INCY $VRTX $MRK,4 of the Highest-Growth Stocks in Biotech Today http://bit.ly/240817CORT $CORT $EXEL $INCY $VRTX $MRK,,,,,[],https://twitter.com/LimexMe/status/900745076825108480
4079,Insider Monkey News,@insidermonkey_n,2017-08-25T19:56:20.000Z,"Opus Point Partners‚Äô AUM, History and Investments
$MRK $BMY $AZN $RXDX $LOXO $KPTI","Opus Point Partners‚Äô AUM, History and Investments
$MRK $BMY $AZN $RXDX $LOXO $KPTI
insidermonkey.com
Opus Point Partners‚Äô AUM, History and Investments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr.",,,,,['https://pbs.twimg.com/card_img/1500383826748612608/GWG5m8ei?format=jpg&name=240x240'],https://twitter.com/insidermonkey_n/status/901171403927560194
4080,Ticker Report,@TickerReport,2017-08-25T01:48:16.000Z,Merck & $MRK Earns Media Sentiment Rating of 0.11 http://ift.tt/2w96DWy,Merck & $MRK Earns Media Sentiment Rating of 0.11 http://ift.tt/2w96DWy,,,,,[],https://twitter.com/TickerReport/status/900897585589780480
4081,Watchlist News,@WatchlistN,2017-08-24T16:22:36.000Z,"Merck & Company, Inc. $MRK Stake Increased by Ariel Capital Advisors LLC http://ift.tt/2itYQiH","Merck & Company, Inc. $MRK Stake Increased by Ariel Capital Advisors LLC http://ift.tt/2itYQiH",,,,,[],https://twitter.com/WatchlistN/status/900755229339209729
4082,Watchlist News,@WatchlistN,2017-08-24T18:37:14.000Z,"Investment House LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2vaJ81V","Investment House LLC Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2vaJ81V",,,,,[],https://twitter.com/WatchlistN/status/900789110545186816
4083,bake mcbride,@ITRADEVOL,2017-08-24T20:32:38.000Z,After Hours  Most Active $GEN $GDX $CSCO $MSFT $SPY $LYG $BAC $GE $EZU $BABA $MU $XOM $TGT $DAL $MRK $WFC $PFE $IWM https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,After Hours  Most Active $GEN $GDX $CSCO $MSFT $SPY $LYG $BAC $GE $EZU $BABA $MU $XOM $TGT $DAL $MRK $WFC $PFE $IWM https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/900818153818796032
4084,Daily Political,@dailypoliticaln,2017-08-24T10:30:30.000Z,"Investors Sell Shares of Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2vrFVX5","Investors Sell Shares of Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2vrFVX5",,,,,[],https://twitter.com/dailypoliticaln/status/900666618442899457
4085,Ticker Report,@TickerReport,2017-08-25T17:19:49.000Z,"Farmers & Merchants Investments Inc. Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2w4AOj8","Farmers & Merchants Investments Inc. Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2w4AOj8",,,,,[],https://twitter.com/TickerReport/status/901132014962827264
4086,Obi,@aaaamhim,2017-08-23T02:05:43.000Z,$ELED 2000% RUN COMING https://insiderfinancial.com/exeled-holding  $MSFT $NVDA $VZ $ORCL $KR $TGT $JPM $CVX $FCX $DISCA $THC $DISCA $AMAT $MRK $RIG $HPQ $AKS,$ELED 2000% RUN COMING https://insiderfinancial.com/exeled-holding  $MSFT $NVDA $VZ $ORCL $KR $TGT $JPM $CVX $FCX $DISCA $THC $DISCA $AMAT $MRK $RIG $HPQ $AKS,üí∏ üí∞,,,,[],https://twitter.com/aaaamhim/status/900177199210401793
4087,Daily Political,@dailypoliticaln,2017-08-23T15:45:53.000Z,"Merck & Company, Inc. $MRK Position Lowered by Arrow Financial Corp http://ift.tt/2xsR7UW","Merck & Company, Inc. $MRK Position Lowered by Arrow Financial Corp http://ift.tt/2xsR7UW",,,,,[],https://twitter.com/dailypoliticaln/status/900383601887465473
4088,Siti van der Meij,@sitivandermeij,2017-08-24T16:46:34.000Z,Michigan the latest state to act on high drug prices https://seekingalpha.com/news/3291612-michigan-latest-state-act-high-drug-prices?source=feed_f‚Ä¶ $MRK $PFE $NVS $LLY #sitifatimah #malaysia #financialplanning,Michigan the latest state to act on high drug prices https://seekingalpha.com/news/3291612-michigan-latest-state-act-high-drug-prices?source=feed_f‚Ä¶ $MRK $PFE $NVS $LLY #sitifatimah #malaysia #financialplanning,,,,,[],https://twitter.com/sitivandermeij/status/900761262514204672
4089,Daily Political,@dailypoliticaln,2017-08-23T09:01:20.000Z,"Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2xbPAmy","Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2xbPAmy",,,,,[],https://twitter.com/dailypoliticaln/status/900281794217607168
4090,$peedyCalls,@SpeedyCalls,2017-08-24T15:20:50.000Z,"$MRK 62 Puts BUYING Activity expiring on 15th Sep, Vol 1746","$MRK 62 Puts BUYING Activity expiring on 15th Sep, Vol 1746",,,,,[],https://twitter.com/SpeedyCalls/status/900739683352801280
4091,Robert Lee,@roberee,2017-08-23T16:39:33.000Z,$MRK Merck got the biggest boost in positive consumer perception.,"$MRK Merck got the biggest boost in positive consumer perception.
fortune.com
Tons of Companies Ditched Trump After Charlottesville. But Merck Got the Biggest Boost
Ken Frazier's strong words gave his company a big word-of-mouth bump.",,,,,[],https://twitter.com/roberee/status/900397107118473218
4092,Ozgur Ogut,@Ogut_Ozgur,2017-08-24T14:29:04.000Z,"Have to admit, I didn‚Äôt think RCC would be the next epacadostat phase 3 that would be up and running $INCY $MRK","Have to admit, I didn‚Äôt think RCC would be the next epacadostat phase 3 that would be up and running $INCY $MRK
clinicaltrials.gov
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) - Full...
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) - Full Text View.
2",,,,2,['https://pbs.twimg.com/card_img/1499578112115363861/JaVVFVxw?format=png&name=240x240'],https://twitter.com/Ogut_Ozgur/status/900726656108593152
4093,Helen Ong,@Lin_ling_88,2017-08-24T10:46:23.000Z,"Replying to 
@Lin_ling_88","Replying to 
@Lin_ling_88
$MRK has yet2 see a profit, doubt it wud pick up another Gram+ve ABX. The Cubist deal was one of the WORST M&A http://fiercepharma.com/pharma/which-m-a-deals-made-our-best-and-worst-ballot-vote-for-deals-decade‚Ä¶ $PRTK
fiercepharma.com
Which M&A made our best-and-worst ballot? Vote for the deals of the decade
The word ‚Äúdeal‚Äù has a curiously apt set of meanings when it comes to M&A. It‚Äôs the hook-up of two companies, of course. | The word ""deal"" doesn't just mean the hook-up of two companies. It's also...
4
1",,4,,1,['https://pbs.twimg.com/card_img/1500298092339412992/xj6dAJlm?format=jpg&name=small'],https://twitter.com/Lin_ling_88/status/900670617619505153
4094,Donna Young,@DonnaYoungDC,2017-08-24T15:03:16.000Z,"Speaking of #NASA: Parkinson's, cancer drug developers look to space to solve big questions  https://snl.com/web/client?auth=inherit#news/article?id=41751277&cdid=A-41751277-11313‚Ä¶ $MRK #pharma #biotech","Speaking of #NASA: Parkinson's, cancer drug developers look to space to solve big questions  https://snl.com/web/client?auth=inherit#news/article?id=41751277&cdid=A-41751277-11313‚Ä¶ $MRK #pharma #biotech
Donna Young
@DonnaYoungDC
 ¬∑ 24 Aug 2017
.@theNASEM: #NASA Should Continue its Large Strategic Missions to Maintain United States‚Äô Global Leadership in Space https://nap.edu/catalog/24857/powering-science-nasas-large-strategic-science-missions‚Ä¶
1",üì∞ üì∞,,1,,['https://pbs.twimg.com/profile_images/474939099648778240/Ug76s07w_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/900735265651793921
4095,Insider Monkey,@insidermonkey,2017-08-25T19:55:54.000Z,"Opus Point Partners‚Äô AUM, History and Investments
$MRK $BMY $AZN $RXDX $LOXO $KPTI","Opus Point Partners‚Äô AUM, History and Investments
$MRK $BMY $AZN $RXDX $LOXO $KPTI
insidermonkey.com
Opus Point Partners‚Äô AUM, History and Investments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr.",,,,,['https://pbs.twimg.com/card_img/1500383826748612608/GWG5m8ei?format=jpg&name=240x240'],https://twitter.com/insidermonkey/status/901171295802576900
4096,CNBC Republican,@CNBCrepublican,2017-08-24T16:52:21.000Z,"Thanks to 
@jonnajarian
 for delivering the Trifecta Options Activity on 
@HalftimeReport
  $MPC $CZR $MRK #UnusualOptionActivity #GiddyUp","Thanks to 
@jonnajarian
 for delivering the Trifecta Options Activity on 
@HalftimeReport
  $MPC $CZR $MRK #UnusualOptionActivity #GiddyUp
1",,,1,,[],https://twitter.com/CNBCrepublican/status/900762714276024321
4097,&Sons,@CCphernow,2017-08-24T10:20:34.000Z,"Merck gives investors exposure to most promising cancer drug on the market at a good price    https://wsj.com/articles/merck-is-good-for-your-portfolios-health-1503567000‚Ä¶ via 
@WSJ
 $MRK","Merck gives investors exposure to most promising cancer drug on the market at a good price    https://wsj.com/articles/merck-is-good-for-your-portfolios-health-1503567000‚Ä¶ via 
@WSJ
 $MRK",,,,,[],https://twitter.com/CCphernow/status/900664120852262920
4098,Dakota Financial,@dakotafinancial,2017-08-24T16:21:08.000Z,"Merck & Company, Inc. $MRK Stake Cut by Greenleaf Trust http://ift.tt/2va4fl4","Merck & Company, Inc. $MRK Stake Cut by Greenleaf Trust http://ift.tt/2va4fl4",,,,,[],https://twitter.com/dakotafinancial/status/900754859611258881
4099,Dakota Financial,@dakotafinancial,2017-08-23T16:25:17.000Z,"Merck & Company, Inc. $MRK Shares Bought by Camelot Portfolios LLC http://ift.tt/2voBRqB","Merck & Company, Inc. $MRK Shares Bought by Camelot Portfolios LLC http://ift.tt/2voBRqB",,,,,[],https://twitter.com/dakotafinancial/status/900393517893246976
4100,bake mcbride,@ITRADEVOL,2017-08-23T20:22:44.000Z,BUY Stock Closing Order Imbalances $GIS $CVX $MRK $DOW $EQT $BBY $CTL $DXC $BDX $MPC $NEE $TAL $MCK $EIX $CRM $VIPS  https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,"BUY Stock Closing Order Imbalances $GIS $CVX $MRK $DOW $EQT $BBY $CTL $DXC $BDX $MPC $NEE $TAL $MCK $EIX $CRM $VIPS  https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶
1",,,1,,[],https://twitter.com/ITRADEVOL/status/900453271944429568
4101,Donna Young,@DonnaYoungDC,2017-08-24T20:01:05.000Z,"ICYMI: Parkinson's, cancer drug developers look to space to solve big questions  https://snl.com/web/client?auth=inherit#news/article?id=41751277&cdid=A-41751277-11313‚Ä¶ #Parkinsons $MRK #pharma #NASA","ICYMI: Parkinson's, cancer drug developers look to space to solve big questions  https://snl.com/web/client?auth=inherit#news/article?id=41751277&cdid=A-41751277-11313‚Ä¶ #Parkinsons $MRK #pharma #NASA",üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/900810211627347972
4102,Donna Young,@DonnaYoungDC,2017-08-24T20:30:09.000Z,"ICYMI: 
@MichaelJFoxOrg
, $MRK & others use 
@NASA
 @Space_Station
 microgravity environment to explore better ways to design drugs
#pharma #NASA","ICYMI: 
@MichaelJFoxOrg
, $MRK & others use 
@NASA
 @Space_Station
 microgravity environment to explore better ways to design drugs
#pharma #NASA
S&P Global Market Intelligence
@SPGMarketIntel
 ¬∑ 25 Aug 2017
Parkinson's, cancer drug developers look to space to solve big questions http://bit.ly/2wKhkRz #healthcare",üì∞,,,,"['https://pbs.twimg.com/profile_images/1498410518897385473/JURni4SV_mini.png', 'https://pbs.twimg.com/media/DIBU7UIXUAEyb-l?format=jpg&name=small']",https://twitter.com/DonnaYoungDC/status/900817528611643393
4103,AustinBizJournal,@MyABJ,2017-08-23T20:55:25.000Z,"@utsystem
 regents to vote tomorrow on 22K-sq-ft lease for 
@Merck
 at 
@DellMedSchool
 http://bizj.us/1paktz  $MRK","@utsystem
 regents to vote tomorrow on 22K-sq-ft lease for 
@Merck
 at 
@DellMedSchool
 http://bizj.us/1paktz  $MRK",üîí,,,,['https://pbs.twimg.com/media/DH8U9U-UMAAXswU?format=jpg&name=small'],https://twitter.com/MyABJ/status/900461498153267202
4104,dough,@semodough,2017-08-25T19:35:00.000Z,"Replying to 
@AjayAjhooda
 and 
@haodongvli","Replying to 
@AjayAjhooda
 and 
@haodongvli
$PRTK not heard that-but I fill strongly $AGN is there&how can they not be as partner on2ND drug.  Throw in $MRK 15B cash&sometime it happen
3",,,,3,[],https://twitter.com/semodough/status/901166037525254145
4105,Herkyleese,@herkyleese,2017-08-27T00:58:12.000Z,#MayweathervMcgregor   maybe not the fight you wanted but  #Dcvax-L vs. #cancer is bigger.  #fda approve!  $nwbo $bmy $mrk $fgen $exel $kite,"#MayweathervMcgregor   maybe not the fight you wanted but  #Dcvax-L vs. #cancer is bigger.  #fda approve!  $nwbo $bmy $mrk $fgen $exel $kite
10
12",,,10,12,"['https://pbs.twimg.com/media/DIMpQFcVoAA68RO?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DIMpQ3TV4AABP7s?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DIMpRuJV4AApDRt?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DIMpScQVYAA1uK3?format=jpg&name=360x360']",https://twitter.com/herkyleese/status/901609758716715008
4106,Seeking Alpha,@SeekingAlpha,2017-08-27T19:33:33.000Z,"3 Things In Biotech You Should Learn Today: August 27, 2017 https://seekingalpha.com/article/4102162-3-things-biotech-learn-today-august-27-2017?source=feed_f‚Ä¶ $CELG $KMDA $MRK $SHPG","3 Things In Biotech You Should Learn Today: August 27, 2017 https://seekingalpha.com/article/4102162-3-things-biotech-learn-today-august-27-2017?source=feed_f‚Ä¶ $CELG $KMDA $MRK $SHPG
2",,,,2,[],https://twitter.com/SeekingAlpha/status/901890447814955008
4107,Vista Partners LLC,@VistaPResearch,2017-08-26T03:14:24.000Z,"This #biotech #stock is about to take off?: #Trader
https://finance.yahoo.com/video/biotech-stock-off-trader-214300695.html‚Ä¶ $ABBV $ATOS $IBB $MRK Vista Partners http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶","This #biotech #stock is about to take off?: #Trader
https://finance.yahoo.com/video/biotech-stock-off-trader-214300695.html‚Ä¶ $ABBV $ATOS $IBB $MRK Vista Partners http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DIH-3ulVwAAzBS3.jpg'],https://twitter.com/VistaPResearch/status/901281649404411904
4108,Heather Swift Morrison,@heatherswifty,2017-08-26T03:57:05.000Z,Michigan the latest state to act on high drug prices https://seekingalpha.com/news/3291612-michigan-latest-state-act-high-drug-prices?source=tweet‚Ä¶ $MRK $PFE $NVS $LLY,"Michigan the latest state to act on high drug prices https://seekingalpha.com/news/3291612-michigan-latest-state-act-high-drug-prices?source=tweet‚Ä¶ $MRK $PFE $NVS $LLY
seekingalpha.com
Michigan the latest state to act on high drug prices (NYSE:MRK)
Saying they are tired of waiting for Congress to act, Michigan state legislators have introduced a bill that would require drug makers to justify price hikes greater than 10% in one year...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/heatherswifty/status/901292387481341953
4109,FAHAD,@alfahadf10,2017-08-26T16:13:29.000Z,$MRK BROKE THE TREND,"$MRK BROKE THE TREND
2",,2,,,['https://pbs.twimg.com/media/DIKxMumWsAAVL4o?format=jpg&name=small'],https://twitter.com/alfahadf10/status/901477709867601920
4110,Dow Stocks,@Top_Dow_Stocks,2017-08-28T07:16:59.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/902067469698732032
4111,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-08-26T18:46:47.000Z,"Replying to 
@marcf17443245","Replying to 
@marcf17443245
That was cut off date March - $ADAP should get even better CR & PFS with its own TCRs and next generation T-Cells alone or with $BLCM $MRK
1
4",,1,,4,"['https://pbs.twimg.com/media/DILT0J0XoAAmck4?format=jpg&name=small', 'https://pbs.twimg.com/media/DILUOcuWAAE7MjV?format=jpg&name=small']",https://twitter.com/dhovekamp42/status/901516288509583360
4112,James Sikes,@wosaikeneriki,2017-08-26T13:33:08.000Z,"Merck & Co $MRK Market Valuation Declined While Manchester Capital Management Cut Its Holding by $451,588 ...","Merck & Co $MRK Market Valuation Declined While Manchester Capital Management Cut Its Holding by $451,588 ...",,,,,[],https://twitter.com/wosaikeneriki/status/901437357991350272
4113,James Sikes,@wosaikeneriki,2017-08-27T10:05:09.000Z,Merck & Co $MRK Stock Value Declined While Altavista Wealth Management Has Cut Its Position by $50.22 Million ...,Merck & Co $MRK Stock Value Declined While Altavista Wealth Management Has Cut Its Position by $50.22 Million ...,,,,,[],https://twitter.com/wosaikeneriki/status/901747402532675584
4114,Trade Academy,@TradeAcademyCo,2017-08-28T12:25:10.000Z,8/28 200D MA Watch List: $USB $UTX $CAR $OKE $S $DDS $SLV $CL $SFM $TIF $ABX $MRK $VZ $IWM $VRX $CMI $HTZ $ANF $COH $GPS $CBS $YPF #trading,8/28 200D MA Watch List: $USB $UTX $CAR $OKE $S $DDS $SLV $CL $SFM $TIF $ABX $MRK $VZ $IWM $VRX $CMI $HTZ $ANF $COH $GPS $CBS $YPF #trading,,,,,[],https://twitter.com/TradeAcademyCo/status/902145026624544770
4115,ChinaBio¬Æ Group,@ChinaBio,2017-08-26T16:49:12.000Z,Week In Review: Columbia China Building $150 Million Hospital In Jiaxing $GSK $MRK $PFE $BIIB $ADRO https://goo.gl/B5cvyU,"Week In Review: Columbia China Building $150 Million Hospital In Jiaxing $GSK $MRK $PFE $BIIB $ADRO https://goo.gl/B5cvyU
1",,,,1,[],https://twitter.com/ChinaBio/status/901486697921343489
4116,Barchart,@Barchart,2017-08-26T00:00:01.000Z,"Unusual #Options Activity $JD $JNJ $MPC $JD $MU $CBL $DIS $GNRC $ADBE $MRK
See full list at http://Barchart.com
https://barchart.com/options/unusual-activity‚Ä¶","Unusual #Options Activity $JD $JNJ $MPC $JD $MU $CBL $DIS $GNRC $ADBE $MRK
See full list at http://Barchart.com
https://barchart.com/options/unusual-activity‚Ä¶",,,,,['https://pbs.twimg.com/media/DIFMWWkXUAAs3N3?format=jpg&name=900x900'],https://twitter.com/Barchart/status/901232729311793153
4117,Sweet Platform,@SweetPlatform,2017-08-28T15:33:45.000Z,"MRK Top news - Aug 28th, 2017 $MRK http://https://goo.gl/xDzWbz","MRK Top news - Aug 28th, 2017 $MRK http://https://goo.gl/xDzWbz",,,,,[],https://twitter.com/SweetPlatform/status/902192487577649153
4118,Pharmaceutical News,@pharma_sector,2017-08-28T08:08:16.000Z,Pharma Giant #Merck Opens Startup Incubator In Israel. Read more: http://owler.us/addG5X $MRK,Pharma Giant #Merck Opens Startup Incubator In Israel. Read more: http://owler.us/addG5X $MRK,,,,,[],https://twitter.com/pharma_sector/status/902080377262563329
4119,James Sikes,@wosaikeneriki,2017-08-28T19:02:06.000Z,Cullen Capital Management Lowered Merck & Co.  $MRK Position by $9.01 Million http://bzweekly.com/cullen-capital-management-lowered-merck-stock-declined-intercontinental-exchange-in-ice-valuation-rose-while-kohlberg-kravis-roberts-company-lp-raised-hold/‚Ä¶,Cullen Capital Management Lowered Merck & Co.  $MRK Position by $9.01 Million http://bzweekly.com/cullen-capital-management-lowered-merck-stock-declined-intercontinental-exchange-in-ice-valuation-rose-while-kohlberg-kravis-roberts-company-lp-raised-hold/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/902244920102199297
4120,McGriddle Connoisseur,@CloisterRes,2017-08-28T13:05:26.000Z,"The 
@CGrantWSJ
 portfolio:

Long:
$KR
$GILD
$MRK

Short: 
$TSLA

I intend to update and track. We must keep the fake news wsj accountable!","The 
@CGrantWSJ
 portfolio:

Long:
$KR
$GILD
$MRK

Short: 
$TSLA

I intend to update and track. We must keep the fake news wsj accountable!
1
4",,1,,4,[],https://twitter.com/CloisterRes/status/902155162038525954
4121,Seeking Alpha,@SeekingAlpha,2017-08-27T12:56:25.000Z,Week In Review: Columbia China Building $150 Million Hospital In Jiaxing https://seekingalpha.com/article/4102129-week-review-columbia-china-building-150-million-hospital-jiaxing?source=feed_f‚Ä¶ $BIIB $TKPYY $ADRO $MRK $PFE $GSK,"Week In Review: Columbia China Building $150 Million Hospital In Jiaxing https://seekingalpha.com/article/4102129-week-review-columbia-china-building-150-million-hospital-jiaxing?source=feed_f‚Ä¶ $BIIB $TKPYY $ADRO $MRK $PFE $GSK
seekingalpha.com
Week In Review: Columbia China Building $150 Million Hospital In Jiaxing
Deals and Financings Columbia China has begun construction on a $150 million 500-bed multi-specialty hospital in Jiaxing, Zhejiang Province.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/901790503267471361
4122,JustTradingHoy,@JustTradingHoy,2017-08-28T12:10:11.000Z,$GILD made 1st move last call for $NVS $BMY $PFE $MRK $AMGN to wake up or they will end with the crumbs of the $XBI & $IBB companies.,$GILD made 1st move last call for $NVS $BMY $PFE $MRK $AMGN to wake up or they will end with the crumbs of the $XBI & $IBB companies.,,,,,[],https://twitter.com/JustTradingHoy/status/902141259476860928
4123,Sara Elizabeth Siegler,@sesiegler,2017-08-26T11:40:29.000Z,She's apparently very rude to people she feels aren't on her level.  How you treat people you don't know says a lot about you. $MRK,"She's apparently very rude to people she feels aren't on her level.  How you treat people you don't know says a lot about you. $MRK
Pharmaceutical News
@pharma_sector
 ¬∑ 26 Aug 2017
#Merck FDAlist celebrities Why Mandy Moore is the latest Big Pharma recruit. Read more: http://owler.us/addotn $MRK
1",,1,,,['https://pbs.twimg.com/profile_images/692277803270672384/HtVpv2md_mini.jpg'],https://twitter.com/sesiegler/status/901409006740279296
4124,Deep Dive,@deepxdive,2017-08-28T23:29:05.000Z,"$MRK ETFs with exposure to Merck & Co., Inc.   August 28, 2017 https://online.capitalcube.com/#!/stock/US/exchange/MRK/investment-analysis/ETF%20Alternatives‚Ä¶","$MRK ETFs with exposure to Merck & Co., Inc.   August 28, 2017 https://online.capitalcube.com/#!/stock/US/exchange/MRK/investment-analysis/ETF%20Alternatives‚Ä¶",,,,,[],https://twitter.com/deepxdive/status/902312110008524800
4125,FinInvTr,@FinInvTr,2017-08-28T23:52:55.000Z,Billionaire Former Soros Sidekick's Current Stock Holdings https://buff.ly/2x8EtLb  | $CMCSA $CTRP $EA $JD $PYPL $MRK $EXPE,Billionaire Former Soros Sidekick's Current Stock Holdings https://buff.ly/2x8EtLb  | $CMCSA $CTRP $EA $JD $PYPL $MRK $EXPE,,,,,[],https://twitter.com/FinInvTr/status/902318107632574465
4126,Pharmaceutical News,@pharma_sector,2017-08-28T05:18:46.000Z,#Merck Lynparza approval sets up tighter bout with PARP rivals. Read more: http://owler.us/addFg7 $MRK,#Merck Lynparza approval sets up tighter bout with PARP rivals. Read more: http://owler.us/addFg7 $MRK,,,,,[],https://twitter.com/pharma_sector/status/902037722142916608
4127,MarketBeat,@MarketBeatCom,2017-08-28T09:44:25.000Z,Merck KGaA given ‚Ç¨105.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2giAI1L $MRK #MRK,Merck KGaA given ‚Ç¨105.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2giAI1L $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/902104576102461440
4128,MarketBeat,@MarketBeatCom,2017-08-27T07:17:20.000Z,Investors Purchase Large Volume of Call Options on Merck & $MRK http://ift.tt/2wfyKTY #acn,Investors Purchase Large Volume of Call Options on Merck & $MRK http://ift.tt/2wfyKTY #acn,,,,,[],https://twitter.com/MarketBeatCom/status/901705171729862656
4129,Dakota Financial,@dakotafinancial,2017-08-27T08:05:21.000Z,Merck & Sees Unusually High Options Volume $MRK http://ift.tt/2wStBn2,Merck & Sees Unusually High Options Volume $MRK http://ift.tt/2wStBn2,,,,,[],https://twitter.com/dakotafinancial/status/901717257193185280
4130,stockeye,@stockeye1,2017-08-26T18:21:33.000Z,$ATHX $MRK $NVS $BILL I think $BIIB for takeover.  They have a stroke platform evolving.,"$ATHX $MRK $NVS $BILL I think $BIIB for takeover.  They have a stroke platform evolving.
stocktwits.com
stockeye (@stockeye) | Stocktwits
$ATHX $MRK $NVS $BILL I think $BIIB for takeover. They have a stroke platform evolving.",,,,,[],https://twitter.com/stockeye1/status/901509939302199297
4131,Daily Political,@dailypoliticaln,2017-08-27T15:25:27.000Z,"OLD National Bancorp IN Boosts Stake in Merck & Company, Inc. $MRK http://ift.tt/2xEc67n","OLD National Bancorp IN Boosts Stake in Merck & Company, Inc. $MRK http://ift.tt/2xEc67n",,,,,[],https://twitter.com/dailypoliticaln/status/901828011397451776
4132,Watchlist News,@WatchlistN,2017-08-28T15:13:54.000Z,"Merck & Company, Inc. $MRK Shares Sold by Wedge Capital Management L L P NC http://ift.tt/2vx81RC","Merck & Company, Inc. $MRK Shares Sold by Wedge Capital Management L L P NC http://ift.tt/2vx81RC",,,,,[],https://twitter.com/WatchlistN/status/902187493151440897
4133,Ticker Report,@TickerReport,2017-08-27T17:10:34.000Z,"Merck & Company, Inc. $MRK Shares Bought by Private Bank & Trust Co. http://ift.tt/2visHko","Merck & Company, Inc. $MRK Shares Bought by Private Bank & Trust Co. http://ift.tt/2visHko",,,,,[],https://twitter.com/TickerReport/status/901854465308884994
4134,Daily Political,@dailypoliticaln,2017-08-28T23:55:15.000Z,"Investors Sell Shares of Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2vlSHv4","Investors Sell Shares of Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2vlSHv4",,,,,[],https://twitter.com/dailypoliticaln/status/902318691638968320
4135,Ticker Report,@TickerReport,2017-08-28T16:55:13.000Z,"Bridges Investment Counsel Inc. Has $2.78 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2vCZLyP","Bridges Investment Counsel Inc. Has $2.78 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2vCZLyP",,,,,[],https://twitter.com/TickerReport/status/902212990216364032
4136,Stocks Pastor,@stockspastor,2017-08-28T17:38:27.000Z,"Today's bulls: $AKS, $HFC, $PAA $MCD $F $THC $AMD $MGM $PYPL $RRC $SFM $VIAB $BMY $PAGP $NEM $AABA $WPM $MRK $AVGO http://bit.ly/1PSG79Z","Today's bulls: $AKS, $HFC, $PAA $MCD $F $THC $AMD $MGM $PYPL $RRC $SFM $VIAB $BMY $PAGP $NEM $AABA $WPM $MRK $AVGO http://bit.ly/1PSG79Z",,,,,[],https://twitter.com/stockspastor/status/902223870232592385
4137,US Banking News,@AmericanBanking,2017-08-26T12:30:36.000Z,Financial Analysis: Merck & $MRK and Novartis AG $NVS http://ift.tt/2gdNizB,Financial Analysis: Merck & $MRK and Novartis AG $NVS http://ift.tt/2gdNizB,,,,,[],https://twitter.com/AmericanBanking/status/901421621226897409
4138,John Guerriero,@vulken17,2017-08-27T16:18:38.000Z,"$NPHC
 NYLOXIN pain reliever products on Amazon $AMZN

https://amazon.com/gp/aw/s/ref=is_s_ss_i_1_8?k=nyloxin+chronic+pain+relief&sprefix=Nyloxin‚Ä¶+
@ShareThis
 @twitter
$BMY $MRK $GSK $GILD $ABBV $PFE $TEVA","$NPHC
 NYLOXIN pain reliever products on Amazon $AMZN

https://amazon.com/gp/aw/s/ref=is_s_ss_i_1_8?k=nyloxin+chronic+pain+relief&sprefix=Nyloxin‚Ä¶+
@ShareThis
 @twitter
$BMY $MRK $GSK $GILD $ABBV $PFE $TEVA
John Guerriero
@vulken17
 ¬∑ 24 Aug 2017
Replying to @vulken17
$NPHC
NYLOXIN pain reliever products selling on Amazon 
$OTTV $BVTK $RMRK $AZFL $CBIS $MJNA $ERBB $USMJ $FB $TSLA $NVDA $MSFT $IBM $GDX $USO
1
1",,,1,1,"['https://pbs.twimg.com/profile_images/1631196038/white-tiger-abstract-image_mini.jpg', 'https://pbs.twimg.com/media/DIAEzbWUMAAMZf_?format=jpg&name=900x900']",https://twitter.com/vulken17/status/901841396470042624
4139,US Banking News,@AmericanBanking,2017-08-28T09:42:19.000Z,Merck KGaA given ‚Ç¨105.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2giAI1L $MRK #MRK,Merck KGaA given ‚Ç¨105.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2giAI1L $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/902104044633772032
4140,Daily Political,@dailypoliticaln,2017-08-27T17:00:45.000Z,"Merck & Company, Inc. $MRK Position Boosted by Altfest L J & Co. Inc. http://ift.tt/2wJZm2j","Merck & Company, Inc. $MRK Position Boosted by Altfest L J & Co. Inc. http://ift.tt/2wJZm2j",,,,,[],https://twitter.com/dailypoliticaln/status/901851991743369217
4141,Science Agora,@AgoraScience,2017-08-28T05:21:56.000Z,"Here Are the Big Pharma Stocks to Own Based on R&D Spending 
@themotleyfool
 #stocks $MRK, $PFE, $JNJ, $RHHBY, $NVS","Here Are the Big Pharma Stocks to Own Based on R&D Spending 
@themotleyfool
 #stocks $MRK, $PFE, $JNJ, $RHHBY, $NVS
fool.com
Here Are the Big Pharma Stocks to Own Based on R&D Spending @themotleyfool #stocks $MRK $PFE $JNJ...
Roche, Novartis, Pfizer, Johnson & Johnson, and Merck are investing the heaviest in R&D. That could bode well for these big pharma stocks.",,,,,[],https://twitter.com/AgoraScience/status/902038516812709888
4142,Vista Partners LLC,@VistaPResearch,2017-08-26T05:08:12.000Z,"@mysteryfreebook
 thanks for follow! see Vista Partners #Investing #tech http://vistapglobal.com $MRK $MSFT $PFE $UTX #FridayNight","@mysteryfreebook
 thanks for follow! see Vista Partners #Investing #tech http://vistapglobal.com $MRK $MSFT $PFE $UTX #FridayNight
GIF",,,,,['https://pbs.twimg.com/tweet_video_thumb/DIIY7CUVYAAVi4o.jpg'],https://twitter.com/VistaPResearch/status/901310285457244160
4143,US Banking News,@AmericanBanking,2017-08-27T07:12:52.000Z,Investors Purchase Large Volume of Call Options on Merck & $MRK http://ift.tt/2vsnpyJ,"Investors Purchase Large Volume of Call Options on Merck & $MRK http://ift.tt/2vsnpyJ
1",,,,1,[],https://twitter.com/AmericanBanking/status/901704047933181952
4144,Chameleon,@MarketChmln,2017-08-28T20:45:46.000Z,Largest $Notional Buy On Close Order Imbalances $BABA $TGT $GE $ANTM $UNP $MRK $ALL $JPM $C $LMT http://tinyurl.com/y8jo8mjb,Largest $Notional Buy On Close Order Imbalances $BABA $TGT $GE $ANTM $UNP $MRK $ALL $JPM $C $LMT http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/902271007855128578
4145,MarketBeat,@MarketBeatCom,2017-08-27T15:28:25.000Z,"Sfmg LLC Has $1.37 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2wJOhyf","Sfmg LLC Has $1.37 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2wJOhyf",,,,,[],https://twitter.com/MarketBeatCom/status/901828758495211521
4146,Market Realist,@MarketRealist,2017-08-28T19:29:08.000Z,What's Driving Johnson &amp; Johnson's Post-2Q17 Valuation http://marketrealist.com/?p=2294949 $JNJ $XLV $MRK $LLY,What's Driving Johnson &amp; Johnson's Post-2Q17 Valuation http://marketrealist.com/?p=2294949 $JNJ $XLV $MRK $LLY,,,,,[],https://twitter.com/MarketRealist/status/902251723112239105
4147,SwingTradeBot,@SwingTradeBot,2017-08-26T09:23:20.000Z,"$MRK technical alerts: Non-ADX 1,2,3,4 Bearish, Shooting Star Candlestick, and 50 DMA Resistance","$MRK technical alerts: Non-ADX 1,2,3,4 Bearish, Shooting Star Candlestick, and 50 DMA Resistance
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/901374492315975680
4148,TalkMarkets,@TalkMarkets,2017-08-26T16:49:12.000Z,Week In Review: Columbia China Building $150 Million Hospital In Jiaxing $GSK $MRK $PFE $BIIB $ADRO https://goo.gl/B5cvyU,Week In Review: Columbia China Building $150 Million Hospital In Jiaxing $GSK $MRK $PFE $BIIB $ADRO https://goo.gl/B5cvyU,,,,,[],https://twitter.com/TalkMarkets/status/901486696893698049
4149,Dakota Financial,@dakotafinancial,2017-08-27T15:25:07.000Z,"Sfmg LLC Has $1.37 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2wJOhyf","Sfmg LLC Has $1.37 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2wJOhyf",,,,,[],https://twitter.com/dakotafinancial/status/901827925191864320
4150,bake mcbride,@ITRADEVOL,2017-08-28T20:31:32.000Z,Buy On Close Stock Order Imbalances $BABA $TGT $GE $ANTM $UNP $MRK $ALL $JPM $C $LMT $XOM $PNC $AGN $D $LYV $WRK https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,Buy On Close Stock Order Imbalances $BABA $TGT $GE $ANTM $UNP $MRK $ALL $JPM $C $LMT $XOM $PNC $AGN $D $LYV $WRK https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/902267425151954945
4151,Andy Biotech,@AndyBiotech,2017-08-30T23:02:27.000Z,"#ESMO17 $INCY $MRK IDOi + PD1 combo data update

mPFS has not been reached in treatment-na√Øve pts;
PFS rates at 6, 12, 18‚Äâmo: 68%, 52%, 52%","#ESMO17 $INCY $MRK IDOi + PD1 combo data update

mPFS has not been reached in treatment-na√Øve pts;
PFS rates at 6, 12, 18‚Äâmo: 68%, 52%, 52%
5
18
28",,5,18,28,['https://pbs.twimg.com/media/DIg0qszXkAEk2mC?format=jpg&name=medium'],https://twitter.com/AndyBiotech/status/903030182281433089
4152,Joe,@Drchik23,2017-08-30T03:48:24.000Z,"Lot of #bios ripe with cash. $mrk $amgn $jnj

https://yahoo.com/finance/news/chart-shows-17-us-companies-143911797.html‚Ä¶","Lot of #bios ripe with cash. $mrk $amgn $jnj

https://yahoo.com/finance/news/chart-shows-17-us-companies-143911797.html‚Ä¶
1
8
7",,1,8,7,[],https://twitter.com/Drchik23/status/902739757536608256
4153,Adam Feuerstein,@adamfeuerstein,2017-08-30T23:45:30.000Z,$INCY $MRK epacadostat/Keytruda melanoma (ECHO-202 study) update looks good ‚Äî>,"$INCY $MRK epacadostat/Keytruda melanoma (ECHO-202 study) update looks good ‚Äî>
statnews.com
New Incyte, Merck skin cancer immunotherapy study results disclosed, and they look promising
A big slice of Incyte‚Äôs $26 billion market value is based on the presumed success of epacadostat, an immunotherapy. Crucial data will be released tonight.
1
13
19",,1,13,19,['https://pbs.twimg.com/card_img/1498934986816344064/5tvuqdPe?format=jpg&name=small'],https://twitter.com/adamfeuerstein/status/903041015682138112
4154,Adam Feuerstein,@adamfeuerstein,2017-08-30T14:00:32.000Z,What to look for tonight when $INCY $MRK disclose new skin cancer immunotherapy study results https://statnews.com/2017/08/30/incyte-merck-melanoma-esmo/‚Ä¶ #ESMO17 IDO-latry,"What to look for tonight when $INCY $MRK disclose new skin cancer immunotherapy study results https://statnews.com/2017/08/30/incyte-merck-melanoma-esmo/‚Ä¶ #ESMO17 IDO-latry
statnews.com
New Incyte, Merck skin cancer immunotherapy study results disclosed, and they look promising
A big slice of Incyte‚Äôs $26 billion market value is based on the presumed success of epacadostat, an immunotherapy. Crucial data will be released tonight.
1
7
8",,1,7,8,['https://pbs.twimg.com/card_img/1498934986816344064/5tvuqdPe?format=jpg&name=small'],https://twitter.com/adamfeuerstein/status/902893804499415041
4155,Helen Ong,@Lin_ling_88,2017-08-29T21:43:05.000Z,"$MRK cholesterol drug cuts heart risk only 9%, future unclear

$ESPR: BempedoicA coming 
#Death of CETP inhibitors","$MRK cholesterol drug cuts heart risk only 9%, future unclear

$ESPR: BempedoicA coming 
#Death of CETP inhibitors
finance.yahoo.com
Merck cholesterol drug cuts heart risk only 9 pct, future unclear
A large study of a new type of cholesterol medicine from Merck & Co Inc found it cut the risk of heart attack and death by a modest 9 percent, while causing a build up of the drug in fat tissue,...
1
2
7",,1,2,7,['https://pbs.twimg.com/card_img/1490180682299097091/gYGu8ety?format=jpg&name=small'],https://twitter.com/Lin_ling_88/status/902647820968235013
4156,Breaking News,@MarketCurrents,2017-08-29T11:18:13.000Z,Merck's anacetrapib lowers CV risk in large-scale study in high-risk patients; regulatory applica... https://seekingalpha.com/news/3292296-mercks-anacetrapib-lowers-cv-risk-large-scale-study-high-risk-patients-regulatory?source=feed_f‚Ä¶ #premarket $MRK,"Merck's anacetrapib lowers CV risk in large-scale study in high-risk patients; regulatory applica... https://seekingalpha.com/news/3292296-mercks-anacetrapib-lowers-cv-risk-large-scale-study-high-risk-patients-regulatory?source=feed_f‚Ä¶ #premarket $MRK
seekingalpha.com
Merck's anacetrapib lowers CV risk in large-scale study in high-risk patients; regulatory applica...
Results from the 30,449-subject REVEAL study assessing the ability of Merck's (NYSE:MRK) anacetrapib to lower the risk of major coronary events (MCEs) in patients with atherosclerotic...",,,,,['https://pbs.twimg.com/card_img/1485040309126012929/Npe6H9LZ?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/902490567338147840
4157,Seeking Alpha,@SeekingAlpha,2017-08-31T17:31:46.000Z,Gilead's Competition: Other Stocks To Watch In Immunotherapy https://seekingalpha.com/article/4103397-gileads-competition-stocks-watch-immunotherapy?source=feed_f‚Ä¶ $INCY $MRK $GILD $KITE $NVS $ROG,Gilead's Competition: Other Stocks To Watch In Immunotherapy https://seekingalpha.com/article/4103397-gileads-competition-stocks-watch-immunotherapy?source=feed_f‚Ä¶ $INCY $MRK $GILD $KITE $NVS $ROG,,,,,[],https://twitter.com/SeekingAlpha/status/903309349178589185
4158,Clark Joseph Kent,@JorelLaraKalel,2017-08-31T23:16:23.000Z,Investors are betting on a cancer cure with these stocks http://cnb.cx/2gsMpTE $JUNO $KITE $IBB $XBI $BLUE $MRK $NKTR $GILD,"Investors are betting on a cancer cure with these stocks http://cnb.cx/2gsMpTE $JUNO $KITE $IBB $XBI $BLUE $MRK $NKTR $GILD
1",,,,1,[],https://twitter.com/JorelLaraKalel/status/903396074462818305
4159,TeresaTrades,@TeresaTrades,2017-08-31T21:24:28.000Z,$SQ $OLED $NXPI $RIO $MU $GILD $PBF $SLB $DG $BMY $MRK $LVS $WYNN $T $PAH $THC $AAPL-Today's unusual options actvy,"$SQ $OLED $NXPI $RIO $MU $GILD $PBF $SLB $DG $BMY $MRK $LVS $WYNN $T $PAH $THC $AAPL-Today's unusual options actvy
2",,,,2,['https://pbs.twimg.com/media/DIloUymXcAA_fV4?format=jpg&name=small'],https://twitter.com/TeresaTrades/status/903367909363384320
4160,Breaking News,@MarketCurrents,2017-08-31T15:58:25.000Z,New data on combo of Incyte's epacadostat and Merck's Keytruda show positive benefit in melanoma patients https://seekingalpha.com/news/3292985-new-data-combo-incytes-epacadostat-mercks-keytruda-show-positive-benefit-melanoma-patients?source=feed_f‚Ä¶ $INCY $MRK,"New data on combo of Incyte's epacadostat and Merck's Keytruda show positive benefit in melanoma patients https://seekingalpha.com/news/3292985-new-data-combo-incytes-epacadostat-mercks-keytruda-show-positive-benefit-melanoma-patients?source=feed_f‚Ä¶ $INCY $MRK
seekingalpha.com
New data on combo of Incyte's epacadostat and Merck's Keytruda show positive benefit in melanoma...
Updated results from the Phase 1/2 ECHO-202 study evaluating the combination of Incyte's (INCY -2.4%) epacadostat and Merck's (MRK +0.5%) KEYTRUDA (pembrolizumab) in patients with advanced...",,,,,['https://pbs.twimg.com/card_img/1494733840761245699/ntVQbPBr?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/903285857418846209
4161,Tom Silver,@TomSilver39,2017-08-29T04:49:20.000Z,$AZN $BMY $MRK $GSK $GILD $CELG $ABBV Oncology Meets Immunology: The Cancer-Immunity Cycle http://sciencedirect.com/science/article/pii/S1074761313002963‚Ä¶,"$AZN $BMY $MRK $GSK $GILD $CELG $ABBV Oncology Meets Immunology: The Cancer-Immunity Cycle http://sciencedirect.com/science/article/pii/S1074761313002963‚Ä¶
3
8",,,3,8,['https://pbs.twimg.com/media/DIXw3-LUMAAst2Y?format=jpg&name=small'],https://twitter.com/TomSilver39/status/902392704176275458
4162,David Grainger,@sciencescanner,2017-08-29T10:10:20.000Z,From #DrugBaron in 2012 the prediction that $MRK CETPi program would end in tears: http://drugbaron.com/mercks-880m-bet-on-sir-austin-bradford-hill/‚Ä¶,"From #DrugBaron in 2012 the prediction that $MRK CETPi program would end in tears: http://drugbaron.com/mercks-880m-bet-on-sir-austin-bradford-hill/‚Ä¶
2
7
8",,2,7,8,[],https://twitter.com/sciencescanner/status/902473485687160834
4163,·îïTEI·ëé·ó∑E·ñáG ·ó∞·ó™,@DrSteinberg,2017-08-31T12:50:40.000Z,"$MRK $BMY
2 year OS data for NIVO/IPI
US pt's tend do better than EU
Full 3 year OS data to be presented at #ESMO17 
https://cslide.ctimeetingtech.com/library/esmo/browse/search/2fuG#2Bb4L02bE‚Ä¶","$MRK $BMY
2 year OS data for NIVO/IPI
US pt's tend do better than EU
Full 3 year OS data to be presented at #ESMO17 
https://cslide.ctimeetingtech.com/library/esmo/browse/search/2fuG#2Bb4L02bE‚Ä¶
3
3",üî¨,,3,3,['https://pbs.twimg.com/media/DIjxxk6VAAIRQ7a?format=jpg&name=small'],https://twitter.com/DrSteinberg/status/903238609121288193
4164,Drugdoctor1,@Drugdoctor2014,2017-08-29T11:17:37.000Z,$ICNB.0038- $PAOG.0164- Wine & Weed-Buy the dips? $GEVO $PPHM $PMCB $GYOG $MMEG $DRYS $DCTH $ELED $FRZT $PG $MRK $MYL $VRX $VRTX $BIIB,"$ICNB.0038- $PAOG.0164- Wine & Weed-Buy the dips? $GEVO $PPHM $PMCB $GYOG $MMEG $DRYS $DCTH $ELED $FRZT $PG $MRK $MYL $VRX $VRTX $BIIB
1
1",,,1,1,"['https://pbs.twimg.com/media/DIZKNUtVoAAAhsQ?format=jpg&name=small', 'https://pbs.twimg.com/media/DIZKNUsVoAQoYn3?format=jpg&name=small']",https://twitter.com/Drugdoctor2014/status/902490416318210049
4165,Lisa LaMotta,@lisalamotta,2017-08-31T15:51:40.000Z,".
@US_FDA
 put out an alert abt $MRK's #Keytruda in multiple myeloma - not much new, but this struck me--> looking closely at other PD-1/L1s",".
@US_FDA
 put out an alert abt $MRK's #Keytruda in multiple myeloma - not much new, but this struck me--> looking closely at other PD-1/L1s
3
1",,,3,1,['https://pbs.twimg.com/media/DIkb9PDXcAgGqyE?format=jpg&name=small'],https://twitter.com/lisalamotta/status/903284157840855040
4166,David Grainger,@sciencescanner,2017-08-29T10:09:03.000Z,CETPi story is a perfect example of what happens when you don‚Äôt kill programs early when all the datas you should $MRK,"CETPi story is a perfect example of what happens when you don‚Äôt kill programs early when all the datas you should $MRK
1
3",,,1,3,[],https://twitter.com/sciencescanner/status/902473162373419008
4167,Trade Academy,@TradeAcademyCo,2017-08-30T12:40:42.000Z,8/30 200D MA Watch List: $TSN $AMD $MRK $IWM $PANW $IP $VZ $CLF $AMBA $THC $TWTR $FLEX $COH $CL $NAK $TIF $URI $EQT $RH $CS $OKE #trading,"8/30 200D MA Watch List: $TSN $AMD $MRK $IWM $PANW $IP $VZ $CLF $AMBA $THC $TWTR $FLEX $COH $CL $NAK $TIF $URI $EQT $RH $CS $OKE #trading
1",,,,1,[],https://twitter.com/TradeAcademyCo/status/902873713812672517
4168,dough,@semodough,2017-08-31T11:27:30.000Z,$INCY  BIG pharma or $GILD -bad news price to acquire $INCY going up significantly-very encouraging data for $MRK $INCY combo moving forward,"$INCY  BIG pharma or $GILD -bad news price to acquire $INCY going up significantly-very encouraging data for $MRK $INCY combo moving forward
Dr. Paul DeSantis, PharmD
@DrPaulyDeSantis
 ¬∑ 31 Aug 2017
Replying to @semodough and @jasonlukemd
This is the key differentiator of PD1/IDO vs PD1/CTLA4: leas tox, pts stay on trx longer, fewer d/c=better disease control $INCY $MRK $BMY
1
1
7",,1,1,7,"['https://pbs.twimg.com/profile_images/1457582344005513217/hpfLYXJ-_mini.jpg', 'https://pbs.twimg.com/media/DIjczakUMAAAOGn?format=jpg&name=small']",https://twitter.com/semodough/status/903217679351328768
4169,Madeleine Armstrong,@ByMadeleineA,2017-08-29T10:11:30.000Z,"#ESCcongress: $MRK still won‚Äôt Reveal its hand - but surely a filing for anacetrapib is now unlikely, via 
@EPVantage","#ESCcongress: $MRK still won‚Äôt Reveal its hand - but surely a filing for anacetrapib is now unlikely, via 
@EPVantage
evaluate.com
ESC 2017 ‚Äì Merck still won‚Äôt Reveal its hand
3
1",,,3,1,[],https://twitter.com/ByMadeleineA/status/902473778705432577
4170,Keith Speights,@keithspeights,2017-08-29T20:18:40.000Z,"This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier #diabetes  $MRK, $JNJ, $VRX, $ESRX","This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier #diabetes  $MRK, $JNJ, $VRX, $ESRX
fool.com
This Simple Step Can Make Diabetes Patients Healthier -- and Possibly Wealthier @themotleyfool...
A study by Express Scripts points to how diabetes patients can avoid ER visits and hospital stays while potentially keeping more money in their pockets.
1",,1,,,[],https://twitter.com/keithspeights/status/902626578613592065
4171,Aniu Student,@AniuStudent,2017-08-29T12:06:38.000Z,"Effect  than #PCSK9s, a small  in BP & analysts still concerned about $MRK's tissue accumulation of ( #CETP) #anacetrapib.

$ESPR","Effect  than #PCSK9s, a small  in BP & analysts still concerned about $MRK's tissue accumulation of ( #CETP) #anacetrapib.

$ESPR
2
1",‚¨á ‚¨Ü,2,,1,[],https://twitter.com/AniuStudent/status/902502753909563392
4172,MM+M Magazine,@MMMnews,2017-08-31T13:00:02.000Z,"Here are the top 25 #vaccine products in 2016, based on U.S. sales. #pharma #hcmktg $PFE $MRK $SNY 
@evaluatepharma
 http://bit.ly/2vEUKq4","Here are the top 25 #vaccine products in 2016, based on U.S. sales. #pharma #hcmktg $PFE $MRK $SNY 
@evaluatepharma
 http://bit.ly/2vEUKq4
1
1",,,1,1,['https://pbs.twimg.com/media/DIfP7biVoAEU85-?format=png&name=120x120'],https://twitter.com/MMMnews/status/903240968572243969
4173,zach,@zbiotech,2017-08-31T19:12:02.000Z,"after falling $60 to mid $40s in jan after $MRK priority review for all comers 1st-line NSCLC, $BMY back above $60 into CM-227 interim","after falling $60 to mid $40s in jan after $MRK priority review for all comers 1st-line NSCLC, $BMY back above $60 into CM-227 interim
1
5",,1,,5,[],https://twitter.com/zbiotech/status/903334584930193410
4174,MM+M Magazine,@MMMnews,2017-08-30T11:30:02.000Z,Missed yesterday's news? Here's what to know #pharma #hcmktg $MRK $BMY #cancer $AZN #Parkinsons $GOOGL #HealthTech http://bit.ly/2voKiH9,"Missed yesterday's news? Here's what to know #pharma #hcmktg $MRK $BMY #cancer $AZN #Parkinsons $GOOGL #HealthTech http://bit.ly/2voKiH9
1",,,,1,['https://pbs.twimg.com/media/DIZ9zbgXYAAhkee?format=jpg&name=small'],https://twitter.com/MMMnews/status/902855927933673472
4175,Sports_Bios,@Sports_bios,2017-08-29T09:55:47.000Z,$MRK REVEAL data PR http://investors.merck.com/news/press-release-details/2017/Merck-Announces-Results-of-REVEAL-Outcomes-Study-of-Anacetrapib-Investigational-Medicine-for-Cardiovascular-Disease/default.aspx‚Ä¶ - just 9% bene..,"$MRK REVEAL data PR http://investors.merck.com/news/press-release-details/2017/Merck-Announces-Results-of-REVEAL-Outcomes-Study-of-Anacetrapib-Investigational-Medicine-for-Cardiovascular-Disease/default.aspx‚Ä¶ - just 9% bene..
1
2",,1,,2,[],https://twitter.com/Sports_bios/status/902469821195018240
4176,Jon Ogg,@jonogg,2017-08-30T13:17:03.000Z,"#investing #daytrading Wednesday's Top Analyst Upgrades and Downgrades $BX $CIEN $MRK $TPX $PANL  
http://247wallst.com/investing/2017/08/30/top-analyst-upgrades-and-downgrades-blackstone-ciena-merck-tempur-sealy-universal-display-and-more/‚Ä¶","#investing #daytrading Wednesday's Top Analyst Upgrades and Downgrades $BX $CIEN $MRK $TPX $PANL  
http://247wallst.com/investing/2017/08/30/top-analyst-upgrades-and-downgrades-blackstone-ciena-merck-tempur-sealy-universal-display-and-more/‚Ä¶",,,,,['https://pbs.twimg.com/media/DIevJpqVwAE5y98?format=jpg&name=360x360'],https://twitter.com/jonogg/status/902882861065412608
4177,BioPharma Dive,@BioPharmaDive,2017-08-29T16:01:00.000Z,$MRK's REVEAL results could spell end to CETP class,"$MRK's REVEAL results could spell end to CETP class
biopharmadive.com
Merck's REVEAL results could spell end to CETP class
While mildly positive, the cardiovascular outcomes study for the CETP inhibitor was underwhelming, leaving Merck uncertain of whether to file for approval.
2",,,2,,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/902561734501601281
4178,Aniu Student,@AniuStudent,2017-08-29T12:19:35.000Z,"Replying to 
@AniuStudent","Replying to 
@AniuStudent
... $MRK now appears to have a GIGANTIC CV therapy hole in its drug development pipeline, which $ESPR can, quite nicely, fill for it.
1
2",,1,,2,[],https://twitter.com/AniuStudent/status/902506011885543426
4179,Vista Partners LLC,@VistaPResearch,2017-08-30T11:21:20.000Z,"@grocerydeals3
 thanks for follow! See Vista Partners #InvestingForLife http://vistapglobal.com $MRK $PFE $JNJ $ATOS $HIIQ $IBB #healthcare","@grocerydeals3
 thanks for follow! See Vista Partners #InvestingForLife http://vistapglobal.com $MRK $PFE $JNJ $ATOS $HIIQ $IBB #healthcare
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DIeUsAMUEAEQ10q.jpg'],https://twitter.com/VistaPResearch/status/902853740864069632
4180,Peter Loftus,@Loftus,2017-08-29T12:17:00.000Z,"Merck cholesterol drug cuts risk of heart problems, but modestly and with potential safety concern $MRK ‚Äî NEJM","Merck cholesterol drug cuts risk of heart problems, but modestly and with potential safety concern $MRK ‚Äî NEJM
nejm.org
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease | NEJM
Original Article from The New England Journal of Medicine ‚Äî Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
1
3
1",,1,3,1,['https://pbs.twimg.com/card_img/1499425972290007047/X9L4ZYIP?format=jpg&name=240x240'],https://twitter.com/Loftus/status/902505362640785408
4181,Advera Health,@AdveraHealth,2017-08-30T15:08:24.000Z,"New Evidex Alert analyzing new additions of AEs to $MRK Keytruda label (incl. SJS, TEN). https://hubs.ly/H08vwy80","New Evidex Alert analyzing new additions of AEs to $MRK Keytruda label (incl. SJS, TEN). https://hubs.ly/H08vwy80
1",,,1,,[],https://twitter.com/AdveraHealth/status/902910883948572672
4182,John Carroll,@JohnCendpts,2017-08-29T17:19:30.000Z,"Top story:
Merck hits a bloop single in an epic PhIII CETP cardio contest. Now what?
$MRK","Top story:
Merck hits a bloop single in an epic PhIII CETP cardio contest. Now what?
$MRK
endpts.com
Merck hits a bloop single in an epic PhIII CETP cardio contest. Now what?
Merck $MRK has an interesting dilemma on its hands. The drug's enormous Phase III study of its CETP drug anacetrapib came through on the key endpoint ‚Äî but it was at best a base hit for an enormous...
3
1",,,3,1,['https://pbs.twimg.com/card_img/1501166467047325698/_jIR-csO?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/902581489824620544
4183,Art,@mRNAdisrupts,2017-08-29T21:46:51.000Z,"Replying to 
@Lin_ling_88","Replying to 
@Lin_ling_88
No surprise here. Insanity is doing the same thing over and over again and expecting a different result.  $mrk
1",,,,1,[],https://twitter.com/mRNAdisrupts/status/902648766741839873
4184,1 min Stock Insights,@1MinuteStock,2017-08-29T12:03:02.000Z,"Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.52% of the current price","Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.52% of the current price
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/902501847276990465
4185,Bobby Axelrod,@BobbyAxelrod__,2017-08-29T16:12:51.000Z,"Replying to 
@Karon0000
 @stockassassin74
  and 2 others","Replying to 
@Karon0000
 @stockassassin74
  and 2 others
$MRK & $PFE will be in a bidding war for $ESPR. Merck doesn't want to miss out on the next Lipator to Pfizer like last time. Going over $100
2
2
4",,2,2,4,[],https://twitter.com/BobbyAxelrod__/status/902564716215758848
4186,BioWorld,@BioWorld,2017-08-29T17:05:00.000Z,"Whither $MRK on anacetrapib? As expected, REVEAL CV outcomes study confirms low benefit for CETP inhibitor, dimming commercial prospects","Whither $MRK on anacetrapib? As expected, REVEAL CV outcomes study confirms low benefit for CETP inhibitor, dimming commercial prospects",,,,,[],https://twitter.com/BioWorld/status/902577840692047872
4187,Ben Fidler,@BentheFidler,2017-08-29T20:07:58.000Z,ICYMI earlier: Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? http://xconomy.com/new-york/2017/08/29/will-merck-seek-fda-filing-for-heart-drug-after-lackluster-results/‚Ä¶ $MRK,"ICYMI earlier: Will Merck Seek FDA Filing For Heart Drug After Lackluster Results? http://xconomy.com/new-york/2017/08/29/will-merck-seek-fda-filing-for-heart-drug-after-lackluster-results/‚Ä¶ $MRK
1",,,,1,[],https://twitter.com/BentheFidler/status/902623883462881281
4188,dough,@semodough,2017-08-31T11:28:28.000Z,Remind everyone just $INCY $MRK catalysts alone,"Remind everyone just $INCY $MRK catalysts alone
dough
@semodough
 ¬∑ 31 Aug 2017
Replying to @semodough
$INCY just epacadostat catalysts $MRK
3",,,,3,"['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg', 'https://pbs.twimg.com/media/DIf3mNUUwAAHLVX?format=jpg&name=small']",https://twitter.com/semodough/status/903217924051279872
4189,SwingTradeBot,@SwingTradeBot,2017-08-29T13:21:26.000Z,Recent $MRK technical alerts: Crossed Above 50 DMA plus 5 more alerts...,"Recent $MRK technical alerts: Crossed Above 50 DMA plus 5 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/902521576301760513
4190,SwingTradeBot,@SwingTradeBot,2017-08-31T21:23:00.000Z,Scan results - Crossed Above 50 DMA today: $NVS $RLJ $XHR $ARE $SWK $BCC $HCN $KEYS $MRK $ECL ...,"Scan results - Crossed Above 50 DMA today: $NVS $RLJ $XHR $ARE $SWK $BCC $HCN $KEYS $MRK $ECL ...
swingtradebot.com
Crossed Above 50 DMA on 03/09/2022 Stock Screen Results
Stock Screen: Price rose above the 50-day moving average for 03/09/2022",,,,,['https://pbs.twimg.com/card_img/1501587861375619072/ci4Gtlmm?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/903367541829095424
4191,US Banking News,@AmericanBanking,2017-08-30T17:15:42.000Z,"Credit Suisse Group Cuts Merck & Company, Inc. $MRK Price Target to $74.00 http://ift.tt/2wT7sWO","Credit Suisse Group Cuts Merck & Company, Inc. $MRK Price Target to $74.00 http://ift.tt/2wT7sWO",,,,,[],https://twitter.com/AmericanBanking/status/902942919719563264
4192,Frank Vinluan,@frankvinluan,2017-08-31T16:12:54.000Z,Patient deaths in clinical trials prompted FDA review of $MRK's Keytruda in combo w/ other drugs in multiple myeloma,"Patient deaths in clinical trials prompted FDA review of $MRK's Keytruda in combo w/ other drugs in multiple myeloma
Media Affairs
@FDAMedia
 ¬∑ 31 Aug 2017
FDA statement regarding safety concerns related to investigational use of Keytruda in multiple myeloma: http://go.usa.gov/xRsgf",,,,,['https://pbs.twimg.com/profile_images/773147745263742976/r2yFT64P_mini.jpg'],https://twitter.com/frankvinluan/status/903289501631512576
4193,Market Realist,@MarketRealist,2017-08-30T19:24:22.000Z,This Is Driving Novartis‚Äôs Valuation after 2Q17 http://marketrealist.com/?p=2301307 $NVS $MRK $GSK $PFE,This Is Driving Novartis‚Äôs Valuation after 2Q17 http://marketrealist.com/?p=2301307 $NVS $MRK $GSK $PFE,,,,,[],https://twitter.com/MarketRealist/status/902975299348041729
4194,Zach Brennan,@ZacharyBrennan,2017-08-31T15:27:32.000Z,FDA Alerts on Risks From $MRK Keytruda in Multiple Myeloma Following Halted Trials http://raps.org/Regulatory-Focus/News/2017/08/31/28372/FDA-Alerts-on-Risks-From-Merck%E2%80%99s-Keytruda-in-Multiple-Myeloma-Following-Halted-Trials/‚Ä¶,"FDA Alerts on Risks From $MRK Keytruda in Multiple Myeloma Following Halted Trials http://raps.org/Regulatory-Focus/News/2017/08/31/28372/FDA-Alerts-on-Risks-From-Merck%E2%80%99s-Keytruda-in-Multiple-Myeloma-Following-Halted-Trials/‚Ä¶
4
1",,,4,1,[],https://twitter.com/ZacharyBrennan/status/903278084408975361
4195,Evaluate Pharma,@evaluatepharma,2017-08-29T15:49:15.000Z,"#ESCCongress 2017 ‚Äì #Merck still won‚Äôt Reveal its hand http://ow.ly/kvBm30eL867 via 
@ByMadeleineA
 @EPVantage
 $MRK $RHHBY $PFE","#ESCCongress 2017 ‚Äì #Merck still won‚Äôt Reveal its hand http://ow.ly/kvBm30eL867 via 
@ByMadeleineA
 @EPVantage
 $MRK $RHHBY $PFE
1
1",,,1,1,[],https://twitter.com/evaluatepharma/status/902558776670257152
4196,Barron's,@barronsonline,2017-08-30T16:45:05.000Z,Merck: Heartbreak Over a Cholesterol Drug http://on.barrons.com/2goQYP4 $MRK,"Merck: Heartbreak Over a Cholesterol Drug http://on.barrons.com/2goQYP4 $MRK
barrons.com
Merck: Heartbreak Over A Cholesterol Drug
Clinical trial results for Merck‚Äôs experimental cholesterol-lowering drug proved underwhelming.
1
1
2",,1,1,2,['https://pbs.twimg.com/card_img/1499837323823190017/7WBMdyMR?format=jpg&name=small'],https://twitter.com/barronsonline/status/902935215412269056
4197,24/7 Wall St.,@247WallSt,2017-08-30T13:32:53.000Z,Wednesday's Top Analyst Upgrades and Downgrades $BX $CIEN $MRK $TPX $PANL,"Wednesday's Top Analyst Upgrades and Downgrades $BX $CIEN $MRK $TPX $PANL
247wallst.com
Top Analyst Upgrades and Downgrades: Blackstone, Ciena, Merck, Tempur Sealy, Universal Display and...
The top analyst upgrades, downgrades and other research calls from Wednesday include Blackstone, Ciena, Merck, Tempur Sealy and Universal Display.",,,,,['https://pbs.twimg.com/card_img/1500325555404636162/-23lEZE-?format=jpg&name=small'],https://twitter.com/247WallSt/status/902886844182011904
4198,Sports_Bios,@Sports_bios,2017-08-29T09:58:20.000Z,"Replying to 
@Sports_bios","Replying to 
@Sports_bios
Just for comp $AMGN PCSK9 CVOT had about 15% bene w/ 2-yrs followup vs this $MRK CVOT at 9% w/4-yrs followup.. let's crank the NNTs.. Ha!
1
1",,1,,1,[],https://twitter.com/Sports_bios/status/902470463141629953
4199,Sports_Bios,@Sports_bios,2017-08-29T10:11:40.000Z,"Replying to 
@Sports_bios","Replying to 
@Sports_bios
Not a surprise given the composite bene is just 9%.. that the prevention of MI, stroke, and CV deaths 2nd ep not hitting stats sign  $MRK -
1",,,,1,[],https://twitter.com/Sports_bios/status/902473819234988032
4200,CR,@CashRocket,2017-08-30T18:31:25.000Z,"Replying to 
@semodough","Replying to 
@semodough
can you imagine the bidding war between $MRK and $BMY for this one? The Baker Bros would just back and laaaaaaaaugh :)
3",,,,3,[],https://twitter.com/CashRocket/status/902961974157336576
4201,Benzinga,@Benzinga,2017-08-31T00:31:00.000Z,Born On The Battlefield: AcelRx Awaits Ruling On Device That Delivers Potent Opioid To Wounded Soldiers https://benzinga.com/z/9991447 $ACRX $MRK,Born On The Battlefield: AcelRx Awaits Ruling On Device That Delivers Potent Opioid To Wounded Soldiers https://benzinga.com/z/9991447 $ACRX $MRK,,,,,[],https://twitter.com/Benzinga/status/903052467671244801
4202,StockNews.com,@stocknewsdotcom,2017-08-31T14:57:48.000Z,$MRK FDA Alerts Healthcare Professionals and Oncology Clinical Investigators about Two Clinical Trials on Hold Eva‚Ä¶ https://stocknews.com/news/mrk-fda-alerts-healthcare-professionals-and-oncology-clinical-investigators-about-two/‚Ä¶,$MRK FDA Alerts Healthcare Professionals and Oncology Clinical Investigators about Two Clinical Trials on Hold Eva‚Ä¶ https://stocknews.com/news/mrk-fda-alerts-healthcare-professionals-and-oncology-clinical-investigators-about-two/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/903270605419622400
4203,dough,@semodough,2017-09-02T14:09:31.000Z,Key FDA/EMA regulatory catalysts next 2 months sept/oct $MRK $PTCT $TSRO $FLXN $ALXN $ACRX $IBB,"Key FDA/EMA regulatory catalysts next 2 months sept/oct $MRK $PTCT $TSRO $FLXN $ALXN $ACRX $IBB
2
10
15",,2,10,15,['https://pbs.twimg.com/media/DIuX8y9XYAEBMSr?format=jpg&name=small'],https://twitter.com/semodough/status/903983229681750016
4204,Advera Health,@AdveraHealth,2017-09-01T18:07:15.000Z,"$MRK #cholesterol drug cuts heart risk only 9 percent, future unclear | #anacetrapib https://hubs.ly/H08vWvc0 by 
@Reuters","$MRK #cholesterol drug cuts heart risk only 9 percent, future unclear | #anacetrapib https://hubs.ly/H08vWvc0 by 
@Reuters",,,,,['https://pbs.twimg.com/media/DIqExsXUwAAp2MV?format=jpg&name=small'],https://twitter.com/AdveraHealth/status/903680666939875330
4205,Seeking Alpha,@SeekingAlpha,2017-09-02T12:00:07.000Z,"3 Things In Biotech You Should Learn Today: September 2, 2017 https://seekingalpha.com/article/4103748-3-things-biotech-learn-today-september-2-2017?source=feed_f‚Ä¶ $ABEO $BMRN $MRK","3 Things In Biotech You Should Learn Today: September 2, 2017 https://seekingalpha.com/article/4103748-3-things-biotech-learn-today-september-2-2017?source=feed_f‚Ä¶ $ABEO $BMRN $MRK",,,,,[],https://twitter.com/SeekingAlpha/status/903950664627191808
4206,Seeking Alpha,@SeekingAlpha,2017-09-03T10:33:57.000Z,Week In Review: This Week's China Pharma Deals Top $1 Billion https://seekingalpha.com/article/4103810-week-review-weeks-china-pharma-deals-top-1-billion?source=feed_f‚Ä¶ $BLRX $LIFE $MRK $ICAD,"Week In Review: This Week's China Pharma Deals Top $1 Billion https://seekingalpha.com/article/4103810-week-review-weeks-china-pharma-deals-top-1-billion?source=feed_f‚Ä¶ $BLRX $LIFE $MRK $ICAD
seekingalpha.com
Week In Review: This Week's China Pharma Deals Top $1 Billion
Deals and Financings Berry Genomics (SHZ: 000710), a Beijing diagnostics and sequencing company, completed its $648 million reverse merger that lists the company on the Shenzhen exchange.",,,,,['https://pbs.twimg.com/card_img/1497724725002448899/2TZ3O23_?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/904291369006489600
4207,Seeking Alpha,@SeekingAlpha,2017-09-01T13:24:56.000Z,"And Then There Was One: NewLink Genetics Refocuses Efforts On Indoximod, Its Remaining, Und... https://seekingalpha.com/article/4103585-one-newlink-genetics-refocuses-efforts-indoximod-remaining-undervalued-late-stage-asset?source=feed_f‚Ä¶ $BMY $INCY $MRK","And Then There Was One: NewLink Genetics Refocuses Efforts On Indoximod, Its Remaining, Und... https://seekingalpha.com/article/4103585-one-newlink-genetics-refocuses-efforts-indoximod-remaining-undervalued-late-stage-asset?source=feed_f‚Ä¶ $BMY $INCY $MRK",,,,,[],https://twitter.com/SeekingAlpha/status/903609620517629952
4208,Vista Partners LLC,@VistaPResearch,2017-09-01T19:57:55.000Z,Atossa Genetics $ATOS bumping +4.9% up too!!! #biotech #FridayFeeling Vista Partners http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ #TradingView $IBB $MRK,"Atossa Genetics $ATOS bumping +4.9% up too!!! #biotech #FridayFeeling Vista Partners http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ #TradingView $IBB $MRK
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DIqeCvTUEAA1npt.jpg'],https://twitter.com/VistaPResearch/status/903708518569566208
4209,Jacob Plieth,@JacobPlieth,2017-09-01T10:48:47.000Z,"As $MRK KN-183 & KN-185 go on clinical hold, here are some other PD-(L)1/multiple myeloma studies worth watching. Via 
@ByAmyBrown
 $BMY $AZN","As $MRK KN-183 & KN-185 go on clinical hold, here are some other PD-(L)1/multiple myeloma studies worth watching. Via 
@ByAmyBrown
 $BMY $AZN
2
6",,2,,6,['https://pbs.twimg.com/media/DIogGe_WsAA8NuD?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/903570326348591104
4210,Evaluate Vantage,@evaluatevantage,2017-09-01T14:51:28.000Z,Upcoming events ‚Äì Approval firsts for Keytruda and Opdivo http://epvantage.com/Universal/View.aspx?type=Story&id=728325&isEPVantage=yes‚Ä¶ $MRK $BMY,"Upcoming events ‚Äì Approval firsts for Keytruda and Opdivo http://epvantage.com/Universal/View.aspx?type=Story&id=728325&isEPVantage=yes‚Ä¶ $MRK $BMY
evaluate.com
Upcoming events ‚Äì Approval firsts for Keytruda and Opdivo
4",,,4,,[],https://twitter.com/evaluatevantage/status/903631398208188419
4211,BioPharma Dive,@BioPharmaDive,2017-09-03T16:24:00.000Z,Full data from the study showed the drug reduced the risk of major coronary events by 9% compared with placebo http://bit.ly/2vGIgO5 $MRK,"Full data from the study showed the drug reduced the risk of major coronary events by 9% compared with placebo http://bit.ly/2vGIgO5 $MRK
biopharmadive.com
Merck's REVEAL results could spell end to CETP class
While mildly positive, the cardiovascular outcomes study for the CETP inhibitor was underwhelming, leaving Merck uncertain of whether to file for approval.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/904379460136321025
4212,Maximum Pain,@themaxpain,2017-09-01T13:10:32.000Z,$MRK $AMGN $MXIM $AMAT $CELG $SYMC $CA $INCY $CSCO Bullish MACD crossover,$MRK $AMGN $MXIM $AMAT $CELG $SYMC $CA $INCY $CSCO Bullish MACD crossover,,,,,[],https://twitter.com/themaxpain/status/903605998958645248
4213,James Sikes,@wosaikeneriki,2017-09-01T19:25:03.000Z,"As Merck & Co $MRK Stock Declined, Holder Buckingham Asset Management Decreased Its Holding ...","As Merck & Co $MRK Stock Declined, Holder Buckingham Asset Management Decreased Its Holding ...",,,,,[],https://twitter.com/wosaikeneriki/status/903700246315880450
4214,James Sikes,@wosaikeneriki,2017-09-02T12:30:36.000Z,"Merck & Co $MRK Market Valuation Declined While Stanley-Laman Group LTD Trimmed Position by $308,270 ...","Merck & Co $MRK Market Valuation Declined While Stanley-Laman Group LTD Trimmed Position by $308,270 ...",,,,,[],https://twitter.com/wosaikeneriki/status/903958334457470976
4215,Peter Blood,@ptrbld,2017-09-03T21:12:22.000Z,"... Soothsayer "" 20170901 executions -> Dogs of the DOW $XOM $GE $MRK other dogs $MOS $CCJ // tight STOPS in place"" ...","... Soothsayer "" 20170901 executions -> Dogs of the DOW $XOM $GE $MRK other dogs $MOS $CCJ // tight STOPS in place"" ...",,,,,[],https://twitter.com/ptrbld/status/904452030172946432
4216,Evaluate Pharma,@evaluatepharma,2017-09-01T16:44:45.000Z,"Upcoming events ‚Äì Approval firsts for #Keytruda & #Opdivo http://ow.ly/pjer30eQHBQ via 
@ByJoFagg
 @EPVantage
  $MRK $BMY","Upcoming events ‚Äì Approval firsts for #Keytruda & #Opdivo http://ow.ly/pjer30eQHBQ via 
@ByJoFagg
 @EPVantage
  $MRK $BMY",,,,,['https://pbs.twimg.com/media/DIpx5WYXcAACJFt?format=jpg&name=small'],https://twitter.com/evaluatepharma/status/903659907655884800
4217,SADIF - Analytics,@SADIFAnalytics,2017-09-01T13:07:43.000Z,Rating Update for Merck KGaA $MRK https://sadifanalytics.com/reports/find/MRK-37865‚Ä¶,Rating Update for Merck KGaA $MRK https://sadifanalytics.com/reports/find/MRK-37865‚Ä¶,,,,,[],https://twitter.com/SADIFAnalytics/status/903605287071993861
4218,FinInvTr,@FinInvTr,2017-09-01T13:58:01.000Z,What Stocks Does Billionaire Stanley Druckenmiller Own? https://buff.ly/2eKZ80w  $EA $PYPL $MRK $ATVI $ADSK,What Stocks Does Billionaire Stanley Druckenmiller Own? https://buff.ly/2eKZ80w  $EA $PYPL $MRK $ATVI $ADSK,,,,,[],https://twitter.com/FinInvTr/status/903617947016593408
4219,FinInvTr,@FinInvTr,2017-09-01T20:03:02.000Z,What $ESRX $VRX $MRK $JNJ Are Doing For Diabetes Patients,"What $ESRX $VRX $MRK $JNJ Are Doing For Diabetes Patients
whotrades.com
This Simple Step Can Make Diabetes Patients Healthier ‚Äî and Possibly Wealthier
If you're one of the millions of Americans diagnosed with diabetes, large pharmacy benefits manager (PBM) Express Scripts (NASDAQ: ESRX) has good news for you. There's something you can‚Ä¶",,,,,[],https://twitter.com/FinInvTr/status/903709804719431680
4220,IECONOMICS,@iECONOMICS,2017-09-01T14:59:00.000Z,Merck & Co $MRK market alert: 4-week high @ 63.93 https://ieconomics.com/merck,Merck & Co $MRK market alert: 4-week high @ 63.93 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/903633291781296128
4221,James Sikes,@wosaikeneriki,2017-09-02T11:35:50.000Z,Cordasco Financial Network Lowered Merck & Co $MRK Holding as Market Value Declined http://bzweekly.com/cordasco-financial-network-lowered-merck-neumeier-poma-investment-counsel-decreased-its-nautilus-nls-holding-as-market-valuation-rose/‚Ä¶,Cordasco Financial Network Lowered Merck & Co $MRK Holding as Market Value Declined http://bzweekly.com/cordasco-financial-network-lowered-merck-neumeier-poma-investment-counsel-decreased-its-nautilus-nls-holding-as-market-valuation-rose/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/903944550946885634
4222,Sweet Platform,@SweetPlatform,2017-09-01T15:56:38.000Z,"MRK Top news - Sep 1st, 2017 $MRK http://https://goo.gl/hQQUD1","MRK Top news - Sep 1st, 2017 $MRK http://https://goo.gl/hQQUD1",,,,,[],https://twitter.com/SweetPlatform/status/903647798561792001
4223,Tim Reller,@TraderGuruNY,2017-09-01T14:40:22.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/903628605498040320
4224,Limex,@LimexMe,2017-09-01T22:16:35.000Z,Incyte (INCY) Reports Positive Data on Epacadostat/Keytruda http://bit.ly/010917INCY1 $INCY $MRK $BMY,"Incyte (INCY) Reports Positive Data on Epacadostat/Keytruda http://bit.ly/010917INCY1 $INCY $MRK $BMY
whotrades.com
Incyte (INCY) Reports Positive Data on Epacadostat/Keytruda
Incyte Corporation INCY announced that the European Society for Medical Oncology (ESMO) published an abstract containing new and updated data from the ongoing phase I/II‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/903743415271161856
4225,Ticker Report,@TickerReport,2017-09-01T09:39:42.000Z,"Merck & Company, Inc. $MRK Price Target Cut to $74.00 http://ift.tt/2wo7yE0","Merck & Company, Inc. $MRK Price Target Cut to $74.00 http://ift.tt/2wo7yE0",,,,,[],https://twitter.com/TickerReport/status/903552937712082944
4226,Analyst Ratings,@ARatings,2017-09-01T06:52:09.000Z,Cowen & Co. Sticks to Its Hold Rating for Merck & Company $MRK http://analystratings.com/articles/cowen-co-sticks-to-its-hold-rating-for-merck-company/‚Ä¶,Cowen & Co. Sticks to Its Hold Rating for Merck & Company $MRK http://analystratings.com/articles/cowen-co-sticks-to-its-hold-rating-for-merck-company/‚Ä¶,,,,,[],https://twitter.com/ARatings/status/903510771694530564
4227,AlpacaAlerts,@AlpacaAlerts,2017-09-02T00:31:00.000Z,$MRK is in Ichimoku Golden Cross winning 66.67% in the past. https://goo.gl/TcfYoZ,$MRK is in Ichimoku Golden Cross winning 66.67% in the past. https://goo.gl/TcfYoZ,,,,,[],https://twitter.com/AlpacaAlerts/status/903777240948887552
4228,Watchlist News,@WatchlistN,2017-09-03T15:37:19.000Z,"Mutual of America Capital Management LLC Buys 14,161 Shares of Merck & Company, Inc. $MRK http://ift.tt/2xHqV9J","Mutual of America Capital Management LLC Buys 14,161 Shares of Merck & Company, Inc. $MRK http://ift.tt/2xHqV9J",,,,,[],https://twitter.com/WatchlistN/status/904367712067051523
4229,BioPharma Dive,@BioPharmaDive,2017-09-01T18:06:00.000Z,Prescribed Reading: $CELG extends Forma deal; $MRK REVEALs new data; CAR-T has a monumental week $NVS $KITE $GILD http://bit.ly/2wYbHQS,"Prescribed Reading: $CELG extends Forma deal; $MRK REVEALs new data; CAR-T has a monumental week $NVS $KITE $GILD http://bit.ly/2wYbHQS
1",,,,1,[],https://twitter.com/BioPharmaDive/status/903680355370246145
4230,Sarah Karlin-Smith,@SarahKarlin,2017-09-01T00:31:47.000Z,Some pharma / healthcare companies on this list including $mrk $lly and McKesson,"Some pharma / healthcare companies on this list including $mrk $lly and McKesson
Carrie Budoff Brown
@cbudoffbrown
 ¬∑ 1 Sep 2017
NEW @politico interactive: Trump wants to slash corp tax rate. Here are 100 companies that prove that rate is a myth http://politi.co/2xBS66a
2",,,,2,['https://pbs.twimg.com/profile_images/1295203854259290112/379CykpD_mini.jpg'],https://twitter.com/SarahKarlin/status/903415052388192257
4231,MarketBeat,@MarketBeatCom,2017-09-03T09:51:15.000Z,"Merck & Company, Inc. $MRK PT Lowered to $74.00 at Credit Suisse Group http://ift.tt/2eRDI1G","Merck & Company, Inc. $MRK PT Lowered to $74.00 at Credit Suisse Group http://ift.tt/2eRDI1G",,,,,[],https://twitter.com/MarketBeatCom/status/904280620377010176
4232,US Banking News,@AmericanBanking,2017-09-03T07:19:00.000Z,Traders Buy Large Volume of Merck & Put Options $MRK http://ift.tt/2vC8VjR,Traders Buy Large Volume of Merck & Put Options $MRK http://ift.tt/2vC8VjR,,,,,[],https://twitter.com/AmericanBanking/status/904242306043260928
4233,MarketBeat,@MarketBeatCom,2017-09-03T07:21:19.000Z,Traders Buy Large Volume of Merck & Put Options $MRK http://ift.tt/2eRk1r1 #acn,Traders Buy Large Volume of Merck & Put Options $MRK http://ift.tt/2eRk1r1 #acn,,,,,[],https://twitter.com/MarketBeatCom/status/904242891291283460
4234,Dakota Financial,@dakotafinancial,2017-09-01T09:33:35.000Z,Merck &‚Äôs $MRK Hold Rating Reiterated at Cowen and Company http://ift.tt/2vwLc4x,Merck &‚Äôs $MRK Hold Rating Reiterated at Cowen and Company http://ift.tt/2vwLc4x,,,,,[],https://twitter.com/dakotafinancial/status/903551401103687680
4235,Watchlist News,@WatchlistN,2017-09-02T14:12:52.000Z,"Merck & Company, Inc. $MRK PT Lowered to $74.00 at Credit Suisse Group http://ift.tt/2iRDYC7","Merck & Company, Inc. $MRK PT Lowered to $74.00 at Credit Suisse Group http://ift.tt/2iRDYC7",,,,,[],https://twitter.com/WatchlistN/status/903984070035726337
4236,Jacq,@Tiny_Dancr1,2017-09-01T01:03:25.000Z,"$APOP
Business model, sci-fi explanation/ scheduled trials and some financials.
Hired frmr $MRK Exec 4marketing.

 http://cellect.co/assets/cellect---corporate-presentation-jan-2017.pdf‚Ä¶","$APOP
Business model, sci-fi explanation/ scheduled trials and some financials.
Hired frmr $MRK Exec 4marketing.

 http://cellect.co/assets/cellect---corporate-presentation-jan-2017.pdf‚Ä¶",,,,,[],https://twitter.com/Tiny_Dancr1/status/903423012220923909
4237,"Juan P. Serrate, DVM",@JPZaragoza1,2017-09-01T12:32:09.000Z,"Fresenius & 
@merckgroup
's complete biosimilars sale transaction. ‚Ç¨156m u/f + ‚Ç¨500m+roy earnout. $FRE $MRK","Fresenius & 
@merckgroup
's complete biosimilars sale transaction. ‚Ç¨156m u/f + ‚Ç¨500m+roy earnout. $FRE $MRK
2",,,,2,[],https://twitter.com/JPZaragoza1/status/903596339229057024
4238,Donna Young,@DonnaYoungDC,2017-09-01T10:55:45.000Z,ICYMI: FDA issues warning about testing Merck's Keytruda in multiple myeloma https://snl.com/web/client?auth=inherit#news/article?id=41844777&cdid=A-41844777-10285‚Ä¶ $MRK #cancer  #Keytruda #FDA #pharma,ICYMI: FDA issues warning about testing Merck's Keytruda in multiple myeloma https://snl.com/web/client?auth=inherit#news/article?id=41844777&cdid=A-41844777-10285‚Ä¶ $MRK #cancer  #Keytruda #FDA #pharma,üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/903572076619075584
4239,Market Realist,@MarketRealist,2017-09-02T03:58:31.000Z,What Drives AstraZeneca‚Äôs Valuation after Its 2Q17 Earnings? http://marketrealist.com/?p=2306865 $AZN $LLY $MRK $PFE,"What Drives AstraZeneca‚Äôs Valuation after Its 2Q17 Earnings? http://marketrealist.com/?p=2306865 $AZN $LLY $MRK $PFE
1",,,1,,[],https://twitter.com/MarketRealist/status/903829465360465920
4240,Options Trading IQ,@OptiontradinIQ,2017-09-03T12:23:11.000Z,"Dogs of the Dow 2017 Update
http://optionstradingiq.com/dogs-of-the-dow-2017-update/‚Ä¶
$SPY, $VZ, $PFE, $CVX, $BA, $CSCO, $KO, $IBM, $XOM, $MRK, $CAT, $SPX","Dogs of the Dow 2017 Update
http://optionstradingiq.com/dogs-of-the-dow-2017-update/‚Ä¶
$SPY, $VZ, $PFE, $CVX, $BA, $CSCO, $KO, $IBM, $XOM, $MRK, $CAT, $SPX
optionstradingiq.com
Dogs of the Dow 2017 Update
Each year, I like to take a look at the Dogs of the Dow. Given we are fast approaching the end of 2017, I thought it would be a good time to take another look at how
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501715607150075904/Mv5tWwFi?format=png&name=360x360'],https://twitter.com/OptiontradinIQ/status/904318856952414208
4241,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-09-02T13:00:40.000Z,"@Merck
 $MRK  #vaccineswork to destroy health #MMR #Parenting #babies
#Merck sued by own employees over bad #science","@Merck
 $MRK  #vaccineswork to destroy health #MMR #Parenting #babies
#Merck sued by own employees over bad #science
Children's Health Defense
@ChildrensHD
 ¬∑ 2 Sep 2017
Thanks to Epoch Times for covering this important issue! http://fb.me/3K4xCyRbw",,,,,['https://pbs.twimg.com/profile_images/1326262820195987456/6VhfzkpD_mini.png'],https://twitter.com/ZimJay/status/903965900143034369
4242,Oscar Gould o7,@realoscargould,2017-09-03T22:24:11.000Z,"Replying to 
@TIME","Replying to 
@TIME
Because it doesn't help the pharmaceutical industry?

$PFE $MRK $BMY $LLY",,,,,[],https://twitter.com/realoscargould/status/904470102057332737
4243,Ronnie Matrix Mukiibi.,@RonnieMatrix,2017-09-03T11:43:04.000Z,"Replying to 
@Kiplinger","Replying to 
@Kiplinger
Some of my favorite picks in the healthcare space are $PFE $ABT $JNJ & $MRK. I believe those companies are poised for long-term growth.",,,,,[],https://twitter.com/RonnieMatrix/status/904308761791254528
4244,StockNews.com,@stocknewsdotcom,2017-09-01T13:07:47.000Z,"$MRK Cowen & Company reiterates Hold rating, $70 PT https://stocknews.com/news/mrk-cowen-company-reiterates-hold-rating-70-pt/‚Ä¶","$MRK Cowen & Company reiterates Hold rating, $70 PT https://stocknews.com/news/mrk-cowen-company-reiterates-hold-rating-70-pt/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/903605303131996160
4245,Dakota Financial,@dakotafinancial,2017-09-03T09:43:36.000Z,"Merck & Company, Inc. $MRK PT Lowered to $74.00 at Credit Suisse Group http://ift.tt/2eRDI1G","Merck & Company, Inc. $MRK PT Lowered to $74.00 at Credit Suisse Group http://ift.tt/2eRDI1G",,,,,[],https://twitter.com/dakotafinancial/status/904278695799611396
4246,Watchlist News,@WatchlistN,2017-09-03T07:22:16.000Z,Traders Buy Large Volume of Merck & Put Options $MRK http://ift.tt/2ezciAR,Traders Buy Large Volume of Merck & Put Options $MRK http://ift.tt/2ezciAR,,,,,[],https://twitter.com/WatchlistN/status/904243127489265664
4247,Vista Partners LLC,@VistaPResearch,2017-09-05T21:11:07.000Z,"""Meeting Or Exceeding Expectations""
https://finance.yahoo.com/news/meeting-exceeding-expectations-132000271.html‚Ä¶ Vista Partners #Investing #healthcare #stocks $ATOS $HIIQ $IBB $MRK","""Meeting Or Exceeding Expectations""
https://finance.yahoo.com/news/meeting-exceeding-expectations-132000271.html‚Ä¶ Vista Partners #Investing #healthcare #stocks $ATOS $HIIQ $IBB $MRK
GIF
1
2",,,1,2,[],https://twitter.com/VistaPResearch/status/905176491431936000
4248,Siti van der Meij,@sitivandermeij,2017-09-06T11:02:33.000Z,Merck to acquire cancer immunotherapy innovator Rigontec for up to ‚Ç¨464M https://seekingalpha.com/news/3293750-merck-acquire-cancer-immunotherapy-innovator-rigontec-464m?source=feed_f‚Ä¶ #premarket $MRK #sitifatimah #malaysia #f‚Ä¶,"Merck to acquire cancer immunotherapy innovator Rigontec for up to ‚Ç¨464M https://seekingalpha.com/news/3293750-merck-acquire-cancer-immunotherapy-innovator-rigontec-464m?source=feed_f‚Ä¶ #premarket $MRK #sitifatimah #malaysia #f‚Ä¶
seekingalpha.com
Merck to acquire cancer immunotherapy innovator Rigontec for up to ‚Ç¨464M (NYSE:MRK)
Merck (NYSE:MRK) agrees to acquire Rigontech GmbH for an upfront cash payment of ‚Ç¨115M plus up to ‚Ç¨349M in milestones.
2
1",,,2,1,['https://pbs.twimg.com/card_img/1488926688029581312/IaROcXV3?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/905385727118233602
4249,pharmalot,@pharmalot,2017-09-06T13:25:50.000Z,Pharmalot.. Pharmalittle.. Good Morning..  Sarepta data cheers investors.. https://statnews.com/pharmalot/2017/09/06/pharmalittle-sarepta-cancer/‚Ä¶ #pharma $SRPT $MRK $TEVA $JNJ #opioids,"Pharmalot.. Pharmalittle.. Good Morning..  Sarepta data cheers investors.. https://statnews.com/pharmalot/2017/09/06/pharmalittle-sarepta-cancer/‚Ä¶ #pharma $SRPT $MRK $TEVA $JNJ #opioids
statnews.com
Pharmalittle: Cancer drug costs still vex patients; Sarepta data cheers investors
The percentage of U.S. adults under age 65 who skip essential medicines due to price has declined, but cancer survivors still have problems affording drugs.
1",,,,1,['https://pbs.twimg.com/card_img/1501064820937822212/YW68E-Ya?format=jpg&name=small'],https://twitter.com/pharmalot/status/905421788439597057
4250,Bursatil Biotech,@BursatilBiotech,2017-09-05T10:42:11.000Z,"Dont forget about these couple of upcoming events 
$MYL $ARRY $TEVA $MRK $ADXS","Dont forget about these couple of upcoming events 
$MYL $ARRY $TEVA $MRK $ADXS
1
4
4",,1,4,4,['https://pbs.twimg.com/media/DI9FLqnW4AEsfr0?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/905018216493219840
4251,Breaking News,@MarketCurrents,2017-09-05T11:39:28.000Z,Merck's Keytruda OK'd in Europe for certain bladder cancer patients https://seekingalpha.com/news/3293455-mercks-keytruda-okd-europe-certain-bladder-cancer-patients?source=feed_f‚Ä¶ #premarket $MRK,"Merck's Keytruda OK'd in Europe for certain bladder cancer patients https://seekingalpha.com/news/3293455-mercks-keytruda-okd-europe-certain-bladder-cancer-patients?source=feed_f‚Ä¶ #premarket $MRK
seekingalpha.com
Merck's Keytruda OK'd in Europe for certain bladder cancer patients (NYSE:MRK)
The European Commission approves Merck's (NYSE:MRK) KEYTRUDA (pembrolizumab) as monotherapy for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma...",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/905032631682711553
4252,John Carroll,@JohnCendpts,2017-09-06T22:26:53.000Z,"FDA orders $BMY's Opdivo to the sidelines on 3 studies as regulators explore dangers of checkpoint combos
$MRK","FDA orders $BMY's Opdivo to the sidelines on 3 studies as regulators explore dangers of checkpoint combos
$MRK
endpts.com
Safety fears spur FDA to pause checkpoint combo studies by Bristol-Myers, Celgene
Two months after the FDA ordered Merck to slam the brakes on three Keytruda combo studies targeting multiple myeloma, alarmed regulators have followed up by posting a stop sign on enrolling any new...
11
5",,,11,5,['https://pbs.twimg.com/card_img/1499901336023928835/vuIyN4N_?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/905557945148211202
4253,Wall Street Wires,@WallStreetWires,2017-09-06T12:11:57.000Z,"$MRK to #Acquire Rigontec | 
@BusinessWire
 | http://bit.ly/2f1XLuj #MnA","$MRK to #Acquire Rigontec | 
@BusinessWire
 | http://bit.ly/2f1XLuj #MnA
1",,,1,,['https://pbs.twimg.com/media/DJCjZCdUIAA9itN?format=jpg&name=small'],https://twitter.com/WallStreetWires/status/905403194016022529
4254,Bursatil Biotech,@BursatilBiotech,2017-09-05T10:40:40.000Z,"GOOOOOOOD morning, Biotwitter! 
News so far:
$CLLS - Deja v√∫ (-30%) 1Gr5 PT
$MRK - Keytruda fully approved
$PTLA update on Betrixaban launch","GOOOOOOOD morning, Biotwitter! 
News so far:
$CLLS - Deja v√∫ (-30%) 1Gr5 PT
$MRK - Keytruda fully approved
$PTLA update on Betrixaban launch
GIF
3",,,,3,['https://pbs.twimg.com/tweet_video_thumb/DI9Ej9ZWsAA2wO0.jpg'],https://twitter.com/BursatilBiotech/status/905017832513167360
4255,"Sam Shrivastava, BS, MS, HI-Cancer Research HMS.",,2017-09-06T12:40:58.000Z,RIG-I a cousin of STING. Nice to see more deals in innate pathway.   $MRK,"RIG-I a cousin of STING. Nice to see more deals in innate pathway.   $MRK
3",,,,3,[],https://twitter.com/shrivastava_sam/status/905410497578770432
4256,MomentumBeast,@momentumbeast,2017-09-06T13:56:30.000Z,"$GWPH GW Pharma plans UK expansion, Alternate Health Corp $AHGIF Q2 Revenue of $7.2M up 87% From Q1 http://damngoodpennystocks.com/news-press-releases/gw-pharmaceuticals-nasdaqgwph-plans-uk-expansion-alternate-health-corp-otcahgif-q2-revenue-of-7-2-million-up-87-from-q1/‚Ä¶ ‚Ä¶ $MRK $BMY $VRX","$GWPH GW Pharma plans UK expansion, Alternate Health Corp $AHGIF Q2 Revenue of $7.2M up 87% From Q1 http://damngoodpennystocks.com/news-press-releases/gw-pharmaceuticals-nasdaqgwph-plans-uk-expansion-alternate-health-corp-otcahgif-q2-revenue-of-7-2-million-up-87-from-q1/‚Ä¶ ‚Ä¶ $MRK $BMY $VRX
1",,,,1,[],https://twitter.com/momentumbeast/status/905429502662148097
4257,John Carroll,@JohnCendpts,2017-09-06T11:21:51.000Z,"Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal
$MRK","Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal
$MRK
endpts.com
Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal
Munich-based Rigontec is delivering a solid return for its venture backers. Merck $MRK has struck a rare deal to buy the biotech for $150 million in cash and another $453 million in milestones,...
9
9",,,9,9,['https://pbs.twimg.com/card_img/1500484000040763393/1cW9auNn?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/905390586181582853
4258,MomentumBeast,@momentumbeast,2017-09-06T13:55:16.000Z,$AHGIF Multi Million $ Revenues Cannabis Biotech with 300% Upside Potential $IBB $GILD $GWPH $MRK $NVS $BMY $JNJ http://damngoodpennystocks.com/news-press-releases/gw-pharmaceuticals-nasdaqgwph-plans-uk-expansion-alternate-health-corp-otcahgif-q2-revenue-of-7-2-million-up-87-from-q1/‚Ä¶ ‚Ä¶,"$AHGIF Multi Million $ Revenues Cannabis Biotech with 300% Upside Potential $IBB $GILD $GWPH $MRK $NVS $BMY $JNJ http://damngoodpennystocks.com/news-press-releases/gw-pharmaceuticals-nasdaqgwph-plans-uk-expansion-alternate-health-corp-otcahgif-q2-revenue-of-7-2-million-up-87-from-q1/‚Ä¶ ‚Ä¶
1",,,,1,[],https://twitter.com/momentumbeast/status/905429193500057602
4259,Bio Stocks‚Ñ¢,@BioStocks,2017-09-05T10:31:14.000Z,$MRK European Commission Approves KEYTRUDA for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma,"$MRK European Commission Approves KEYTRUDA for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
2
3",,,2,3,[],https://twitter.com/BioStocks/status/905015460298678272
4260,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-09-06T10:31:43.000Z,"$MRK Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology     #CARTCR","$MRK Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology     #CARTCR
1
2
4",üÖ± üÖæ,1,2,4,[],https://twitter.com/_B_I_O_T_E_C_H_/status/905377969966915585
4261,FinInvTr,@FinInvTr,2017-09-05T00:41:54.000Z,10 Top Holdings In Market's Best Healthcare Fund  https://buff.ly/2gA89JE  $JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD,"10 Top Holdings In Market's Best Healthcare Fund  https://buff.ly/2gA89JE  $JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD
1",,,,1,[],https://twitter.com/FinInvTr/status/904867147469422592
4262,Roy Friedman,@DewDiligence,2017-09-05T22:16:51.000Z,"$PTLA ‚ÄîMany small biotech cos r arrogant in thinking they can devlp/launch a product solo.If $MRK were still on board,this probably averted.","$PTLA ‚ÄîMany small biotech cos r arrogant in thinking they can devlp/launch a product solo.If $MRK were still on board,this probably averted.
hugg
@d_hugg
 ¬∑ 6 Sep 2017
Replying to @DewDiligence
So $PTLA has screwed the pooch twice now when it comes to CMC.  Yikes.  Hard head makes a soft behind.
1
3",,1,,3,['https://pbs.twimg.com/profile_images/1493428994389200901/Xhn9vFJ5_mini.jpg'],https://twitter.com/DewDiligence/status/905193032433242112
4263,Ozgur Ogut,@Ogut_Ozgur,2017-09-06T15:53:13.000Z,ECHO-301 closed to enrollment. Start your spreadsheets. $MRK $INCY,"ECHO-301 closed to enrollment. Start your spreadsheets. $MRK $INCY
clinicaltrials.gov
A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metast...
A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301) - Full Text View.
1
4",,1,,4,['https://pbs.twimg.com/card_img/1499578112115363861/JaVVFVxw?format=png&name=240x240'],https://twitter.com/Ogut_Ozgur/status/905458876446785538
4264,Chameleon Options,@MC_OptionTrades,2017-09-06T00:40:29.000Z,Price Moves vs Expected Moves $INSM $CVS $CELG $KITE $BMY $LLY $MRK $PFE $JNJ $GILD $VRX $TEVA http://tinyurl.com/y7zbwhgq,"Price Moves vs Expected Moves $INSM $CVS $CELG $KITE $BMY $LLY $MRK $PFE $JNJ $GILD $VRX $TEVA http://tinyurl.com/y7zbwhgq
1",ü¶é,,,1,['https://pbs.twimg.com/media/DJAFJD_UEAA2Yxc?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/905229180769587202
4265,Carly Helfand,@CarlyHFierce,2017-09-06T19:07:01.000Z,#ICYMI Friday: FDA warns public over Keytruda myeloma combo risks in wake of Merck trial deaths http://bit.ly/2vKTDcR $MRK #pharma,"#ICYMI Friday: FDA warns public over Keytruda myeloma combo risks in wake of Merck trial deaths http://bit.ly/2vKTDcR $MRK #pharma
fiercepharma.com
FDA warns public over Keytruda myeloma combo risks in wake of Merck trial deaths
Last month, following deaths in two Keytruda trials, the FDA halted the pair of Merck studies. | Last month, following deaths in two Keytruda trials, the FDA halted the pair of Merck studies. And...
1",,,,1,['https://pbs.twimg.com/card_img/1501991521809141764/nzBP-w8C?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/905507649600593925
4266,Donna Young,@DonnaYoungDC,2017-09-05T20:15:42.000Z,"$BIIB came out pretty quickly on #travelban.
In the case of Trump's manufacturing council & #Charlottesville, that time, it was $MRK. https://twitter.com/CarolineYLChen/status/905147757676994560‚Ä¶","$BIIB came out pretty quickly on #travelban.
In the case of Trump's manufacturing council & #Charlottesville, that time, it was $MRK. https://twitter.com/CarolineYLChen/status/905147757676994560‚Ä¶
This Tweet is unavailable.",üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/905162545023115264
4267,FierceBiotech,@FierceBiotech,2017-09-06T10:45:28.000Z,"Merck, looking to build on cancer success, buys IO biotech Rigontec: http://ow.ly/KwEu30eWNWn $MRK","Merck, looking to build on cancer success, buys IO biotech Rigontec: http://ow.ly/KwEu30eWNWn $MRK
fiercebiotech.com
Merck, looking to build on cancer success, buys I-O biotech Rigontec
Merck is spending ‚Ç¨115 million ($137 million) up front and up to ‚Ç¨349 million in future payments to
3
2",,,3,2,['https://pbs.twimg.com/card_img/1499456441912016899/810FZb5k?format=jpg&name=small'],https://twitter.com/FierceBiotech/status/905381430657773568
4268,"Jordan Alexander (,)",@JD4for4,2017-09-06T17:20:10.000Z,$DVAX back to pre-offering levels!  Hep approval coming?  Onco progress? Takeover?  $MRK $SNY,"$DVAX back to pre-offering levels!  Hep approval coming?  Onco progress? Takeover?  $MRK $SNY
1",üìú üìú,,,1,[],https://twitter.com/JD4for4/status/905480759686950912
4269,Amanda Micklus,@amandamicklus,2017-09-06T14:29:38.000Z,"$MRK making acquisition in innate immune system #immunoOncology focus w/ Rigontec; $BMY bought IFM Therapeutics, different mechanisms","$MRK making acquisition in innate immune system #immunoOncology focus w/ Rigontec; $BMY bought IFM Therapeutics, different mechanisms
Ben Thorner
@thorner_ben
 ¬∑ 6 Sep 2017
#Merck announced our acquisition of Rigontec today.  See our website for more info.",,,,,['https://pbs.twimg.com/profile_images/735202150087823360/euOxLSi0_mini.jpg'],https://twitter.com/amandamicklus/status/905437842989608961
4270,Options Trading IQ,@OptiontradinIQ,2017-09-04T07:30:22.000Z,"Dogs of the Dow 2017 Update
http://optionstradingiq.com/dogs-of-the-dow-2017-update/‚Ä¶
$SPX, $SPY, $VZ, $PFE, $CVX, $BA, $CSCO, $KO, $IBM, $XOM, $CAT, $MRK","Dogs of the Dow 2017 Update
http://optionstradingiq.com/dogs-of-the-dow-2017-update/‚Ä¶
$SPX, $SPY, $VZ, $PFE, $CVX, $BA, $CSCO, $KO, $IBM, $XOM, $CAT, $MRK
optionstradingiq.com
Dogs of the Dow 2017 Update
Each year, I like to take a look at the Dogs of the Dow. Given we are fast approaching the end of 2017, I thought it would be a good time to take another look at how
3",,,,3,['https://pbs.twimg.com/card_img/1501715607150075904/Mv5tWwFi?format=png&name=360x360'],https://twitter.com/OptiontradinIQ/status/904607556756271104
4271,Bio Stocks‚Ñ¢,@BioStocks,2017-09-06T10:33:25.000Z,"$MRK to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology https://finance.yahoo.com/news/merck-acquire-rigontec-rig-therapeutics-103000725.html?soc_src=social-sh&soc_trk=tw‚Ä¶","$MRK to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology https://finance.yahoo.com/news/merck-acquire-rigontec-rig-therapeutics-103000725.html?soc_src=social-sh&soc_trk=tw‚Ä¶
2
1",,,2,1,[],https://twitter.com/BioStocks/status/905378395948802048
4272,FinInvTr,@FinInvTr,2017-09-05T01:08:03.000Z,10 Top Holdings In Market's Best #Healthcare Fund  https://buff.ly/2iX3Bl6  $JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD #stocks,"10 Top Holdings In Market's Best #Healthcare Fund  https://buff.ly/2iX3Bl6  $JNJ $PFE $MRK $UNH $MDT $AMGN $ABBV $BMY $CELG $GILD #stocks
1",,,,1,[],https://twitter.com/FinInvTr/status/904873728043081728
4273,Sean McGrath,@sean_uk,2017-09-06T11:44:38.000Z,Merck snaps up German immuno-oncology upstart in a $603M bolt-on deal - https://endpts.com/merck-snaps-up-a-german-immuno-oncology-upstart-in-a-603m-bolt-on-deal‚Ä¶ $MRK #Immunotherapy #cancer #oncology,"Merck snaps up German immuno-oncology upstart in a $603M bolt-on deal - https://endpts.com/merck-snaps-up-a-german-immuno-oncology-upstart-in-a-603m-bolt-on-deal‚Ä¶ $MRK #Immunotherapy #cancer #oncology
1",,,1,,[],https://twitter.com/sean_uk/status/905396317630992385
4274,WLST.com,@wlstcom,2017-09-06T11:02:09.000Z,Merck to acquire cancer immunotherapy innovator Rigontec for up to ‚Ç¨464M #premarket #MRK #Merck&amp;CoInc. $MRK https://seekingalpha.com/news/3293750-merck-acquire-cancer-immunotherapy-innovator-rigontec-464m‚Ä¶,Merck to acquire cancer immunotherapy innovator Rigontec for up to ‚Ç¨464M #premarket #MRK #Merck&amp;CoInc. $MRK https://seekingalpha.com/news/3293750-merck-acquire-cancer-immunotherapy-innovator-rigontec-464m‚Ä¶,,,,,[],https://twitter.com/wlstcom/status/905385626173927424
4275,ChimeraResearchGroup,@ChimeraResearch,2017-09-06T14:52:19.000Z,September 6 Biotech Update $MRK $SRPT https://goo.gl/nUarsn,"September 6 Biotech Update $MRK $SRPT https://goo.gl/nUarsn
1",,,,1,[],https://twitter.com/ChimeraResearch/status/905443552150335488
4276,1 min Stock Insights,@1MinuteStock,2017-09-06T11:38:02.000Z,Wondering about #sentiment indicator for $MRK? The Short Ratio is 1.79%,"Wondering about #sentiment indicator for $MRK? The Short Ratio is 1.79%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/905394659165331456
4277,1 min Stock Insights,@1MinuteStock,2017-09-05T03:58:02.000Z,"Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.5% of the current price","Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.5% of the current price
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/904916506965712897
4278,US Banking News,@AmericanBanking,2017-09-06T11:16:13.000Z,Merck KGaA's neutral rating reiterated at J P Morgan Chase & Co. http://ift.tt/2vLq0YO $MRK #MRK,Merck KGaA's neutral rating reiterated at J P Morgan Chase & Co. http://ift.tt/2vLq0YO $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/905389165914845184
4279,US Banking News,@AmericanBanking,2017-09-06T10:15:57.000Z,Merck KGaA given ‚Ç¨105.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2wFBfAV $MRK #MRK,Merck KGaA given ‚Ç¨105.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2wFBfAV $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/905374001928777728
4280,APM Health Europe,@apmhealtheurope,2017-09-05T11:55:01.000Z,"New approval in Europe for 
@Merck
's cancer immunotherapy Keytruda http://bit.ly/2wByctk $MRK #pharma","New approval in Europe for 
@Merck
's cancer immunotherapy Keytruda http://bit.ly/2wByctk $MRK #pharma
1",,,1,,[],https://twitter.com/apmhealtheurope/status/905036542003089408
4281,Bosco,@wboscoho,2017-09-06T14:32:03.000Z,$MRK willing to acquire Rigontec bodes very well some of the early stage,$MRK willing to acquire Rigontec bodes very well some of the early stage,,,,,[],https://twitter.com/wboscoho/status/905438452166131712
4282,The Banker's Tribune,@bankerstribune,2017-09-05T22:25:03.000Z,Credit Suisse reiterated Merck & $MRK at Outperform. Cashflow models imply stocks undervalued http://ow.ly/9k4G30eVJWN,Credit Suisse reiterated Merck & $MRK at Outperform. Cashflow models imply stocks undervalued http://ow.ly/9k4G30eVJWN,,,,,[],https://twitter.com/bankerstribune/status/905195096127229952
4283,Stephanie May,@StephAmaSing,2017-09-06T12:17:59.000Z,"#Rigontec & 
@Merck
 deal is 2nd innate immunity acquisition within a month, hot field in oncology $MRK $BMS http://bit.ly/2xa1mRF","#Rigontec & 
@Merck
 deal is 2nd innate immunity acquisition within a month, hot field in oncology $MRK $BMS http://bit.ly/2xa1mRF
FierceBiotech
@FierceBiotech
 ¬∑ 6 Sep 2017
Merck, looking to build on cancer success, buys IO biotech Rigontec: http://ow.ly/KwEu30eWNWn $MRK
1",,,1,,['https://pbs.twimg.com/profile_images/1270578068701224962/2YHKa3mX_mini.jpg'],https://twitter.com/StephAmaSing/status/905404710504497153
4284,Daily Political,@dailypoliticaln,2017-09-06T02:49:24.000Z,"Traders Buy Shares of Merck & Company, Inc. $MRK on Weakness http://ift.tt/2f2cF3P","Traders Buy Shares of Merck & Company, Inc. $MRK on Weakness http://ift.tt/2f2cF3P",,,,,[],https://twitter.com/dailypoliticaln/status/905261623199375361
4285,Dakota Financial,@dakotafinancial,2017-09-04T15:58:16.000Z,"Stevens Capital Management LP Invests $15.13 Million in Merck & Company, Inc. $MRK http://ift.tt/2wyDwh8","Stevens Capital Management LP Invests $15.13 Million in Merck & Company, Inc. $MRK http://ift.tt/2wyDwh8",,,,,[],https://twitter.com/dakotafinancial/status/904735370797076481
4286,Limex,@LimexMe,2017-09-06T15:57:07.000Z,Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer http://bit.ly/060917MRK $MRK $AMGN $PFE $LLY,"Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer http://bit.ly/060917MRK $MRK $AMGN $PFE $LLY
whotrades.com
Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer
Merck & Co., Inc. MRK announced that its anti-PD-1 therapy, Keytruda has received approval from the European Commission (EC) for the first and second line treatment of‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/905459856861274112
4287,Watchlist News,@WatchlistN,2017-09-04T14:11:07.000Z,"Merck & Company, Inc. $MRK Earns ‚ÄúHold‚Äù Rating from Cowen and Company http://ift.tt/2gE18v8","Merck & Company, Inc. $MRK Earns ‚ÄúHold‚Äù Rating from Cowen and Company http://ift.tt/2gE18v8",,,,,[],https://twitter.com/WatchlistN/status/904708405981581312
4288,WallStreetGangsta,@WallStGangsta,2017-09-05T10:14:11.000Z,"$GWPH GW Pharma plans UK expansion, Alternate Health Corp $AHGIF Q2 Revenue of $7.2M up 87% From Q1 http://damngoodpennystocks.com/news-press-releases/gw-pharmaceuticals-nasdaqgwph-plans-uk-expansion-alternate-health-corp-otcahgif-q2-revenue-of-7-2-million-up-87-from-q1/‚Ä¶ ‚Ä¶ $MRK $BMY $VRX","$GWPH GW Pharma plans UK expansion, Alternate Health Corp $AHGIF Q2 Revenue of $7.2M up 87% From Q1 http://damngoodpennystocks.com/news-press-releases/gw-pharmaceuticals-nasdaqgwph-plans-uk-expansion-alternate-health-corp-otcahgif-q2-revenue-of-7-2-million-up-87-from-q1/‚Ä¶ ‚Ä¶ $MRK $BMY $VRX",,,,,[],https://twitter.com/WallStGangsta/status/905011167160127488
4289,Stockboard Media Inc,@stockboardinc,2017-09-05T15:19:47.000Z,$MRK European Commission Approves Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) for the Treatment of Certain Patie... - http://sbml.co/99d63e33,$MRK European Commission Approves Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) for the Treatment of Certain Patie... - http://sbml.co/99d63e33,,,,,[],https://twitter.com/stockboardinc/status/905088073297518593
4290,MarketBeat,@MarketBeatCom,2017-09-06T11:18:36.000Z,Merck KGaA's neutral rating reiterated at J P Morgan Chase & Co. http://ift.tt/2vLq0YO $MRK #MRK,Merck KGaA's neutral rating reiterated at J P Morgan Chase & Co. http://ift.tt/2vLq0YO $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/905389767059222528
4291,MarketBeat,@MarketBeatCom,2017-09-06T10:18:42.000Z,Merck KGaA given ‚Ç¨105.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2wFBfAV $MRK #MRK,Merck KGaA given ‚Ç¨105.00 PT by Independent Research GmbH. neutral rating. http://ift.tt/2wFBfAV $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/905374691120091136
4292,TalkMarkets,@TalkMarkets,2017-09-05T15:32:45.000Z,"#Biotech Digest - $INSM Reports Positive Data, $MRK Gets EC Approval, LCI Receives FDA Approval $CYH $TFX $LCI https://goo.gl/BUWDBw","#Biotech Digest - $INSM Reports Positive Data, $MRK Gets EC Approval, LCI Receives FDA Approval $CYH $TFX $LCI https://goo.gl/BUWDBw",,,,,[],https://twitter.com/TalkMarkets/status/905091337661317120
4293,Ticker Report,@TickerReport,2017-09-06T17:41:41.000Z,"Merck & Company, Inc. $MRK Shares Sold by Miller Howard Investments Inc. NY http://ift.tt/2eGbjes","Merck & Company, Inc. $MRK Shares Sold by Miller Howard Investments Inc. NY http://ift.tt/2eGbjes",,,,,[],https://twitter.com/TickerReport/status/905486175238062082
4294,Watchlist News,@WatchlistN,2017-09-04T03:42:31.000Z,"Merck & $MRK Receiving Somewhat Favorable News Coverage, Analysis Finds http://ift.tt/2xI3Unh","Merck & $MRK Receiving Somewhat Favorable News Coverage, Analysis Finds http://ift.tt/2xI3Unh",,,,,[],https://twitter.com/WatchlistN/status/904550213930680320
4295,Fluid,@Fluidinvest,2017-09-06T13:26:51.000Z,Merck to acquire cancer immunotherapy innovator Rigontec for up to ‚Ç¨464M https://seekingalpha.com/news/3293750-merck-acquire-cancer-immunotherapy-innovator-rigontec-464m?source=tweet‚Ä¶ $MRK,"Merck to acquire cancer immunotherapy innovator Rigontec for up to ‚Ç¨464M https://seekingalpha.com/news/3293750-merck-acquire-cancer-immunotherapy-innovator-rigontec-464m?source=tweet‚Ä¶ $MRK
seekingalpha.com
Merck to acquire cancer immunotherapy innovator Rigontec for up to ‚Ç¨464M (NYSE:MRK)
Merck (NYSE:MRK) agrees to acquire Rigontech GmbH for an upfront cash payment of ‚Ç¨115M plus up to ‚Ç¨349M in milestones.
1",,,1,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/Fluidinvest/status/905422041528053760
4296,Open Outcrier,@OpenOutcrier,2017-09-06T12:47:47.000Z,"$MRK (+0.0% pre) Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology

http://ooc.bz/l/15566","$MRK (+0.0% pre) Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology

http://ooc.bz/l/15566
1
2",,,1,2,[],https://twitter.com/OpenOutcrier/status/905412209777545217
4297,CR,@CashRocket,2017-09-05T03:45:23.000Z,Do PD-1 and PD-L1 Checkpoint Inhibitors Live Up to Their Hype? http://labiotech.eu/pd-1-pd-l1-checkpoint-inhibitors/‚Ä¶ $MRK $BMY $RHHBY $PFE $AZN,Do PD-1 and PD-L1 Checkpoint Inhibitors Live Up to Their Hype? http://labiotech.eu/pd-1-pd-l1-checkpoint-inhibitors/‚Ä¶ $MRK $BMY $RHHBY $PFE $AZN,,,,,[],https://twitter.com/CashRocket/status/904913322000056320
4298,U.S. News Investing,@USNewsInvesting,2017-09-05T19:59:05.000Z,".
@merck
 investors have high hopes for this drug: http://trib.al/utqiCFg $MRK",".
@merck
 investors have high hopes for this drug: http://trib.al/utqiCFg $MRK",,,,,['https://pbs.twimg.com/media/DI_Eu1KXYAABzrK?format=jpg&name=small'],https://twitter.com/USNewsInvesting/status/905158361464918020
4299,Donna Young,@DonnaYoungDC,2017-09-06T21:56:31.000Z,"#FDA places partial clinical hold on $BMY #Opdivo multiple myeloma trials [recall, warning $MRK #Keytruda studies]","#FDA places partial clinical hold on $BMY #Opdivo multiple myeloma trials [recall, warning $MRK #Keytruda studies]
investors.bms.com
Bristol-Myers Squibb Provides an Update on Three Opdivo-based Combination Clinical Studies in...
The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on CA209602 (CheckMate -602), CA209039 (CheckMate -039) and CA204142, three clinical trials investigating Opdivo...",üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/905550303960948736
4300,dough,@semodough,2017-09-05T14:34:30.000Z,ARGUS $MRK Growth Stock: Merck & Co. Inc.: Reiterating BUY and $80 target (David Toung),ARGUS $MRK Growth Stock: Merck & Co. Inc.: Reiterating BUY and $80 target (David Toung),,,,,[],https://twitter.com/semodough/status/905076680573820928
4301,Briefing.com,@Briefingcom,2017-09-05T12:35:50.000Z,$MRK: Merck: EC approved KEYTRUDA for the treatment of certain patients with locally advanced or metastatic... http://bit.ly/2w2kpbK,"$MRK: Merck: EC approved KEYTRUDA for the treatment of certain patients with locally advanced or metastatic... http://bit.ly/2w2kpbK
2",,,2,,[],https://twitter.com/Briefingcom/status/905046815698952193
4302,Briefing.com,@Briefingcom,2017-09-06T12:36:02.000Z,$MRK: Merck will acquire Rigontec for an upfront cash payment of EUR 115 million plus potentially EUR 349 mln in... http://bit.ly/2w5Vkwt,"$MRK: Merck will acquire Rigontec for an upfront cash payment of EUR 115 million plus potentially EUR 349 mln in... http://bit.ly/2w5Vkwt
1",,1,,,[],https://twitter.com/Briefingcom/status/905409253027962881
4303,Jacob Bell,@realJacobBell,2017-09-06T18:15:00.000Z,"#ICYMI 
@NedPagliarulo
 takes us through big biopharma trends in M&A, immuno-oncology and biosimilars http://bit.ly/2eKZ9Vx $MRK $BMY $AZN","#ICYMI 
@NedPagliarulo
 takes us through big biopharma trends in M&A, immuno-oncology and biosimilars http://bit.ly/2eKZ9Vx $MRK $BMY $AZN",,,,,[],https://twitter.com/realJacobBell/status/905494558317752320
4304,Ro Patel,@Ro_Patel,2017-09-06T12:58:05.000Z,"$MRK to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology","$MRK to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology",,,,,[],https://twitter.com/Ro_Patel/status/905414801010159617
4305,US Banking News,@AmericanBanking,2017-09-06T10:15:59.000Z,Merck KGaA given ‚Ç¨109.00 PT by Commerzbank Ag. neutral rating. http://ift.tt/2wFl7zm $MRK #MRK,Merck KGaA given ‚Ç¨109.00 PT by Commerzbank Ag. neutral rating. http://ift.tt/2wFl7zm $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/905374009281339392
4306,Ticker Report,@TickerReport,2017-09-05T15:27:25.000Z,"Merck & Company, Inc. $MRK Shares Bought by Trexquant Investment LP http://ift.tt/2eBUKR0","Merck & Company, Inc. $MRK Shares Bought by Trexquant Investment LP http://ift.tt/2eBUKR0",,,,,[],https://twitter.com/TickerReport/status/905089995538665472
4307,WallStreetGangsta,@WallStGangsta,2017-09-05T10:13:26.000Z,$AHGIF Multi Million $ Revenues Cannabis Biotech with 300% Upside Potential $IBB $GILD $GWPH $MRK $NVS $BMY $JNJ http://damngoodpennystocks.com/news-press-releases/gw-pharmaceuticals-nasdaqgwph-plans-uk-expansion-alternate-health-corp-otcahgif-q2-revenue-of-7-2-million-up-87-from-q1/‚Ä¶ ‚Ä¶,$AHGIF Multi Million $ Revenues Cannabis Biotech with 300% Upside Potential $IBB $GILD $GWPH $MRK $NVS $BMY $JNJ http://damngoodpennystocks.com/news-press-releases/gw-pharmaceuticals-nasdaqgwph-plans-uk-expansion-alternate-health-corp-otcahgif-q2-revenue-of-7-2-million-up-87-from-q1/‚Ä¶ ‚Ä¶,,,,,[],https://twitter.com/WallStGangsta/status/905010977585983493
4308,StockNews.com,@stocknewsdotcom,2017-09-05T10:57:13.000Z,$MRK EC approved KEYTRUDA for the treatment of certain patients with locally advanced or metastatic urothelial car‚Ä¶ https://stocknews.com/news/mrk-ec-approved-keytruda-for-the-treatment-of-certain-patients-with/‚Ä¶,$MRK EC approved KEYTRUDA for the treatment of certain patients with locally advanced or metastatic urothelial car‚Ä¶ https://stocknews.com/news/mrk-ec-approved-keytruda-for-the-treatment-of-certain-patients-with/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/905021998283280384
4309,StockNews.com,@stocknewsdotcom,2017-09-06T10:54:52.000Z,$MRK Merck will acquire Rigontec for an upfront cash payment of EUR 115 million plus potentially EUR 349 mln in co‚Ä¶ https://stocknews.com/news/mrk-merck-will-acquire-rigontec-for-an-upfront-cash-payment-of/‚Ä¶,$MRK Merck will acquire Rigontec for an upfront cash payment of EUR 115 million plus potentially EUR 349 mln in co‚Ä¶ https://stocknews.com/news/mrk-merck-will-acquire-rigontec-for-an-upfront-cash-payment-of/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/905383796178071553
4310,BioPharma Dive,@BioPharmaDive,2017-09-06T18:15:01.000Z,"#ICYMI 
@NedPagliarulo
 takes us through big biopharma trends in M&A, immuno-oncology and biosimilars http://bit.ly/2eKZ9Vx $MRK $BMY $AZN","#ICYMI 
@NedPagliarulo
 takes us through big biopharma trends in M&A, immuno-oncology and biosimilars http://bit.ly/2eKZ9Vx $MRK $BMY $AZN",,,,,[],https://twitter.com/BioPharmaDive/status/905494561425895425
4311,Mike Dzikowski,@MikeDzikowski,2017-09-05T21:18:25.000Z,"@CarlODonnell26
 Carl, have you heard any rumors of a Palatin $PTN - $AMAG Merck $MRK deal?","@CarlODonnell26
 Carl, have you heard any rumors of a Palatin $PTN - $AMAG Merck $MRK deal?
2",,,,2,[],https://twitter.com/MikeDzikowski/status/905178328834781184
4312,Jacob Plieth,@JacobPlieth,2017-09-06T21:34:58.000Z,Here we go: more PD1 multiple myeloma studies on hold. Now it's Opdivo's turn $BMY CM-602 CM-039 $MRK,"Here we go: more PD1 multiple myeloma studies on hold. Now it's Opdivo's turn $BMY CM-602 CM-039 $MRK
1
1
2",,1,1,2,[],https://twitter.com/JacobPlieth/status/905544879975038976
4313,MarketBeat,@MarketBeatCom,2017-09-06T10:18:44.000Z,Merck KGaA given ‚Ç¨109.00 PT by Commerzbank Ag. neutral rating. http://ift.tt/2wFl7zm $MRK #MRK,Merck KGaA given ‚Ç¨109.00 PT by Commerzbank Ag. neutral rating. http://ift.tt/2wFl7zm $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/905374701161152513
4314,Daily Political,@dailypoliticaln,2017-09-05T17:00:06.000Z,"Merck & Company, Inc. $MRK Shares Bought by Breton Hill Capital Ltd. http://ift.tt/2gJssIF","Merck & Company, Inc. $MRK Shares Bought by Breton Hill Capital Ltd. http://ift.tt/2gJssIF",,,,,[],https://twitter.com/dailypoliticaln/status/905113320763650048
4315,Stockboard Media Inc,@stockboardinc,2017-09-06T10:35:13.000Z,"$MRK Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology... - http://sbml.co/ba5789b6","$MRK Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology... - http://sbml.co/ba5789b6",,,,,[],https://twitter.com/stockboardinc/status/905378850372292609
4316,Watchlist News,@WatchlistN,2017-09-05T17:01:43.000Z,"Merck & Company, Inc. $MRK Shares Sold by Carl Domino Inc http://ift.tt/2iYOt6S","Merck & Company, Inc. $MRK Shares Sold by Carl Domino Inc http://ift.tt/2iYOt6S",,,,,[],https://twitter.com/WatchlistN/status/905113728651321344
4317,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-09-09T13:24:03.000Z,Great melanoma IO vs targeted therapy table $INCY $ARRY $BMY $MRK,"Great melanoma IO vs targeted therapy table $INCY $ARRY $BMY $MRK
1
11
24",,1,11,24,['https://pbs.twimg.com/media/DJSQqyrW0AAvVbU?format=jpg&name=small'],https://twitter.com/DrPaulyDeSantis/status/906508500901224448
4318,Vista Partners LLC,@VistaPResearch,2017-09-08T21:29:55.000Z,"Updated Data for Merck‚Äôs KEYTRUDA in Patients with Advanced Gastric #Cancer #earthquake ESMO2017
https://finance.yahoo.com/news/updated-data-merck-keytruda-pembrolizumab-120000094.html‚Ä¶ $MRK $IBB $ATOS","Updated Data for Merck‚Äôs KEYTRUDA in Patients with Advanced Gastric #Cancer #earthquake ESMO2017
https://finance.yahoo.com/news/updated-data-merck-keytruda-pembrolizumab-120000094.html‚Ä¶ $MRK $IBB $ATOS
GIF
1
2",,,1,2,['https://pbs.twimg.com/tweet_video_thumb/DJO2SMsUMAEFaZV.jpg'],https://twitter.com/VistaPResearch/status/906268386673307648
4319,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-09-08T15:31:23.000Z,Best Commercial Slide on PD1/L1 in NSCLC $BMY $MRK,"Best Commercial Slide on PD1/L1 in NSCLC $BMY $MRK
1
2
6",,1,2,6,['https://pbs.twimg.com/media/DJNkOVkW0AEOUA3?format=jpg&name=small'],https://twitter.com/DrPaulyDeSantis/status/906178157681803264
4320,Siti van der Meij,@sitivandermeij,2017-09-08T13:26:36.000Z,Merck's Keytruda shows treatment effect in mid-stage gastric cancer study https://seekingalpha.com/news/3294400-mercks-keytruda-shows-treatment-effect-mid-stage-gastric-cancer-study?source=feed_f‚Ä¶ #premarket $MRK #sitifatimah #malaysia #‚Ä¶,"Merck's Keytruda shows treatment effect in mid-stage gastric cancer study https://seekingalpha.com/news/3294400-mercks-keytruda-shows-treatment-effect-mid-stage-gastric-cancer-study?source=feed_f‚Ä¶ #premarket $MRK #sitifatimah #malaysia #‚Ä¶
seekingalpha.com
Merck's Keytruda shows treatment effect in mid-stage gastric cancer study (NYSE:MRK)
Updated results from a registrational Phase 2 study, KEYNOTE-059, evaluating Merck's (NYSE:MRK) KEYTRUDA (pembrolizumab) in patients with advanced gastric or gastroesophageal junction...
1
1",,,1,1,['https://pbs.twimg.com/card_img/1494733840761245699/ntVQbPBr?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/906146756752179206
4321,dough,@semodough,2017-09-09T20:07:09.000Z,#esmo2017 Sunday lot to go $MRK $ARRY $FPRX $ARQL $EXEL $KITE $IBB,"#esmo2017 Sunday lot to go $MRK $ARRY $FPRX $ARQL $EXEL $KITE $IBB
1
6
8",,1,6,8,['https://pbs.twimg.com/media/DJTs7yrXkAEqyBR?format=jpg&name=900x900'],https://twitter.com/semodough/status/906609945180811265
4322,Tom Silver,@TomSilver39,2017-09-09T17:43:45.000Z,$INCY $MRK #ESMO17 PFS Data from ECHO-202 Trial of Epacadostat in Combination with KEYTRUDA¬Æ (pembrolizumab)  in Patients with AM,"$INCY $MRK #ESMO17 PFS Data from ECHO-202 Trial of Epacadostat in Combination with KEYTRUDA¬Æ (pembrolizumab)  in Patients with AM
3",,,,3,"['https://pbs.twimg.com/media/DJTMGl8UMAACVCT?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DJTMG8sV4AAm9XY?format=jpg&name=large']",https://twitter.com/TomSilver39/status/906573857540030464
4323,Breaking News,@MarketCurrents,2017-09-07T12:21:04.000Z,FDA halts patient recruitment in three Opdivo combo studies in MM after safety signal observ... https://seekingalpha.com/news/3294086-fda-halts-patient-recruitment-three-opdivo-combo-studies-mm-safety-signal-observed-related?source=feed_f‚Ä¶ #premarket $BMY $MRK,"FDA halts patient recruitment in three Opdivo combo studies in MM after safety signal observ... https://seekingalpha.com/news/3294086-fda-halts-patient-recruitment-three-opdivo-combo-studies-mm-safety-signal-observed-related?source=feed_f‚Ä¶ #premarket $BMY $MRK
seekingalpha.com
FDA halts patient recruitment in three Opdivo combo studies in MM after safety signal observed...
Bristol-Myers Squibb (NYSE:BMY) announces that the FDA has placed a partial clinical hold suspending patient recruitment in three studies of Opdivo (nivolumab) combinations in multiple...",,,,,['https://pbs.twimg.com/card_img/1489660067628519424/VfYFJfDz?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/905767877378138113
4324,Vista Partners LLC,@VistaPResearch,2017-09-09T03:02:37.000Z,"AstraZeneca shares tick higher on lung #cancer drug study results
http://on.mktw.net/2faoiG1 $AZN $IBB $MRK $ATOS http://vistapglobal.com","AstraZeneca shares tick higher on lung #cancer drug study results
http://on.mktw.net/2faoiG1 $AZN $IBB $MRK $ATOS http://vistapglobal.com
GIF
1
2",,,1,2,['https://pbs.twimg.com/tweet_video_thumb/DJQCb1BVYAAA-fT.jpg'],https://twitter.com/VistaPResearch/status/906352113600446464
4325,Divya Grover,@thegirlshewasnt,2017-09-07T13:13:22.000Z,Success of $BMY combo therapy in improving overall survival in #kidneycancer #patients helps it end trial early $MRK,"Success of $BMY combo therapy in improving overall survival in #kidneycancer #patients helps it end trial early $MRK
reuters.com
Bristol-Myers stops kidney cancer drug test after early success
Bristol-Myers Squibb Co said on Thursday the success of its combination therapy to improve overall survival in kidney cancer patients helped it end the trial well ahead of schedule, despite earlier...",,,,,['https://pbs.twimg.com/card_img/1489661867526017024/ZUuUrqwR?format=png&name=small'],https://twitter.com/thegirlshewasnt/status/905781035593375744
4326,BioSpace,@biospace,2017-09-07T13:52:30.000Z,Merck & Co. $MRK Takes Out Immuno-Oncology Startup in $603 Million Deal http://ow.ly/BNLG30eYV39,"Merck & Co. $MRK Takes Out Immuno-Oncology Startup in $603 Million Deal http://ow.ly/BNLG30eYV39
1
5",,,1,5,['https://pbs.twimg.com/media/DJIEAevV4AQCJ5-?format=jpg&name=small'],https://twitter.com/biospace/status/905790884041687040
4327,WallStreetGangsta,@WallStGangsta,2017-09-07T16:34:14.000Z,"$AHGIF revenues stem mostly from its clinical lab subsidiary, Alternate Health Labs. $AAPL $SPY $GILD $GWPH $JNJ $IBB $MRK $BMY $NVS $BSX","$AHGIF revenues stem mostly from its clinical lab subsidiary, Alternate Health Labs. $AAPL $SPY $GILD $GWPH $JNJ $IBB $MRK $BMY $NVS $BSX
2
1",,,2,1,['https://pbs.twimg.com/media/DJIpBSSUMAAAdt6?format=jpg&name=small'],https://twitter.com/WallStGangsta/status/905831587161530368
4328,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-09-07T18:07:34.000Z,"Replying to 
@FierceBiotech","Replying to 
@FierceBiotech
$GSK $ADAP TCR NY-ESO-1 $MRK Keytruda combo in multiple myeloma #MM is scientific sound & on-going
1
2",,,1,2,"['https://pbs.twimg.com/media/DJI9-rEXcAMjFjv?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DJI-EP2WsAE7Snh?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DJI-Xy9WsAApGQP?format=jpg&name=360x360']",https://twitter.com/dhovekamp42/status/905855075578511365
4329,John Carroll,@JohnCendpts,2017-09-08T12:03:33.000Z,"#ESMO17 ROUNDUP: Merck‚Äôs data on Keytruda/chemo combo for lung cancer takes early spotlight at ESMO
$MRK","#ESMO17 ROUNDUP: Merck‚Äôs data on Keytruda/chemo combo for lung cancer takes early spotlight at ESMO
$MRK
endpts.com
#ESMO17 ROUNDUP: Merck‚Äôs data on Keytruda/chemo combo for lung cancer takes early spotlight at ESMO
MADRID ‚Äî Merck‚Äôs abstract $MRK on its big study of Keytruda (pembrolizumab) combined with chemo hit early at ESMO, attracting considerable attention for the impressive progression-free survival data...
6
10",,,6,10,[],https://twitter.com/JohnCendpts/status/906125855646244864
4330,Herkyleese,@herkyleese,2017-09-07T13:01:25.000Z,"$mrk clinical hold on enrollment for deaths
$bmy clincal hold enrollment also / no firetrucks / $nwbo had same 98.5% stock hit #overreaction","$mrk clinical hold on enrollment for deaths
$bmy clincal hold enrollment also / no firetrucks / $nwbo had same 98.5% stock hit #overreaction
1",,,,1,[],https://twitter.com/herkyleese/status/905778029581934592
4331,Behavioral Finance,@BehaviorFin,2017-09-08T07:06:37.000Z,"Please Rt
After last M&A in Car-T, which #biotech sector will be next?
$GILD $MRK $LLY $SNY $PFE $JNJ $MRK $NVS $GSK $BMY $KITE $BLUE $JUNO","Please Rt
After last M&A in Car-T, which #biotech sector will be next?
$GILD $MRK $LLY $SNY $PFE $JNJ $MRK $NVS $GSK $BMY $KITE $BLUE $JUNO
Car-T again
28.6%
T-cell, NK-cell,...
0%
#geneediting
35.7%
Alzheimer and CNS
35.7%
14 votes
¬∑
Final results
1
2",,,1,2,[],https://twitter.com/BehaviorFin/status/906051128999247872
4332,Sports_Bios,@Sports_bios,2017-09-07T11:36:03.000Z,"Clearly FDA is doing a blanket hold on these IO combos on MM - be honest, it sickens me the $MRK data was allowed to mature to get to HR 2.0","Clearly FDA is doing a blanket hold on these IO combos on MM - be honest, it sickens me the $MRK data was allowed to mature to get to HR 2.0
4",,,,4,[],https://twitter.com/Sports_bios/status/905756545560039425
4333,Madeleine Armstrong,@ByMadeleineA,2017-09-07T15:19:24.000Z,"Interview ‚Äì $MRK's Rigontec buy primes another IO combo, via 
@EPVantage
. Not many other RIG-I assets around http://epvantage.com/Universal/View.aspx?type=Story&id=729882&isEPVantage=yes‚Ä¶","Interview ‚Äì $MRK's Rigontec buy primes another IO combo, via 
@EPVantage
. Not many other RIG-I assets around http://epvantage.com/Universal/View.aspx?type=Story&id=729882&isEPVantage=yes‚Ä¶
1
1",,,1,1,['https://pbs.twimg.com/media/DJIX2ckXcAQx9HM?format=jpg&name=medium'],https://twitter.com/ByMadeleineA/status/905812753423749121
4334,Breaking News,@MarketCurrents,2017-09-08T13:25:31.000Z,Merck's Keytruda shows treatment effect in mid-stage gastric cancer study https://seekingalpha.com/news/3294400-mercks-keytruda-shows-treatment-effect-mid-stage-gastric-cancer-study?source=feed_f‚Ä¶ #premarket $MRK,"Merck's Keytruda shows treatment effect in mid-stage gastric cancer study https://seekingalpha.com/news/3294400-mercks-keytruda-shows-treatment-effect-mid-stage-gastric-cancer-study?source=feed_f‚Ä¶ #premarket $MRK
seekingalpha.com
Merck's Keytruda shows treatment effect in mid-stage gastric cancer study (NYSE:MRK)
Updated results from a registrational Phase 2 study, KEYNOTE-059, evaluating Merck's (NYSE:MRK) KEYTRUDA (pembrolizumab) in patients with advanced gastric or gastroesophageal junction...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/906146483304415232
4335,Evaluate Pharma,@evaluatepharma,2017-09-07T16:40:26.000Z,".
@EPVantage
 Interview ‚Äì Merck's Rigontec buy primes another #immuno-oncology combo #pharma $MRK http://ow.ly/ymcM30eZfK8",".
@EPVantage
 Interview ‚Äì Merck's Rigontec buy primes another #immuno-oncology combo #pharma $MRK http://ow.ly/ymcM30eZfK8",,,,,['https://pbs.twimg.com/media/DJIqcedW0AY5odH?format=jpg&name=small'],https://twitter.com/evaluatepharma/status/905833147597717508
4336,Margin Hunt,@MarginHunt,2017-09-07T16:01:07.000Z,Check out the discounted P/E multiple of Sanofi $SNY vs comps: $GSK $AZN $BAYRY $NVS $MRK http://ow.ly/lLNB30eVzL2,Check out the discounted P/E multiple of Sanofi $SNY vs comps: $GSK $AZN $BAYRY $NVS $MRK http://ow.ly/lLNB30eVzL2,,,,,['https://pbs.twimg.com/media/DJIhchyWsAE7zyR?format=jpg&name=small'],https://twitter.com/MarginHunt/status/905823252420984835
4337,Lisa LaMotta,@lisalamotta,2017-09-07T12:18:10.000Z,$AZN/ $CELG PD-1 combo trial put on clinical hold by #FDA after the deaths in the $MRK #Keytruda trials,"$AZN/ $CELG PD-1 combo trial put on clinical hold by #FDA after the deaths in the $MRK #Keytruda trials
astrazeneca.com
Celgene and AstraZeneca provide update on the FUSION clinical trial programme
2",,,2,,[],https://twitter.com/lisalamotta/status/905767146566942720
4338,dough,@semodough,2017-09-08T21:49:42.000Z,"ISI Tomorrow‚Äôs key trials are:
 $AZN PACIFIC. & $MRK $INCY ECHO-202 melanoma cohort update","ISI Tomorrow‚Äôs key trials are:
 $AZN PACIFIC. & $MRK $INCY ECHO-202 melanoma cohort update
2",,,,2,[],https://twitter.com/semodough/status/906273365773692928
4339,Ben Fidler,@BentheFidler,2017-09-07T18:43:40.000Z,"Immunotherapy Safety Worries Halt Celgene Myeloma Study, Slow 5 Others http://xconomy.com/new-york/2017/09/07/immunotherapy-safety-worries-halt-celgene-myeloma-study-slow-5-others/‚Ä¶ by 
@alexlash
 $CELG $MRK $BMY $AZN","Immunotherapy Safety Worries Halt Celgene Myeloma Study, Slow 5 Others http://xconomy.com/new-york/2017/09/07/immunotherapy-safety-worries-halt-celgene-myeloma-study-slow-5-others/‚Ä¶ by 
@alexlash
 $CELG $MRK $BMY $AZN
2
2",,,2,2,[],https://twitter.com/BentheFidler/status/905864157853081600
4340,CBPartners,@CBPartners,2017-09-07T16:35:05.000Z,#EU_Commission approves $MRK KEYTRUDA as treatment for some patient groups with LA / metastatic #UrothelialCarcinoma http://bit.ly/2gC2gMb,#EU_Commission approves $MRK KEYTRUDA as treatment for some patient groups with LA / metastatic #UrothelialCarcinoma http://bit.ly/2gC2gMb,,,,,[],https://twitter.com/CBPartners/status/905831799682732033
4341,Jacob Plieth,@JacobPlieth,2017-09-09T06:30:18.000Z,"L Paz-Ares did not display an OS slide from Pacific, just said OS was not mature $AZN #ESMO17 $BMY $MRK $RHHBY","L Paz-Ares did not display an OS slide from Pacific, just said OS was not mature $AZN #ESMO17 $BMY $MRK $RHHBY
4
1",,,4,1,[],https://twitter.com/JacobPlieth/status/906404379682582528
4342,AJMC-Diabetes Mgt,@EBDiabetes,2017-09-09T20:28:13.000Z,"ICYMI: Phase 3 Results for #Ertugliflozin Are Published, With #FDA Action Pending $MRK $PFE https://shar.es/1SVMKY via 
@ajmc_journal","ICYMI: Phase 3 Results for #Ertugliflozin Are Published, With #FDA Action Pending $MRK $PFE https://shar.es/1SVMKY via 
@ajmc_journal
1",,,,1,[],https://twitter.com/EBDiabetes/status/906615247498334208
4343,1stOncology,@1stOncology,2017-09-07T14:52:34.000Z,"MSD to Acquire #Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in #ImmunoOncology $MRK http://1stoncology.com/blog/msd-to-acquire-rigontec-rig-i-therapeutics-pioneer-advancing-leadership-in-immuno-oncology‚Ä¶","MSD to Acquire #Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in #ImmunoOncology $MRK http://1stoncology.com/blog/msd-to-acquire-rigontec-rig-i-therapeutics-pioneer-advancing-leadership-in-immuno-oncology‚Ä¶
2",,,2,,[],https://twitter.com/1stOncology/status/905806000866897924
4344,Heath Care News,@hc_equipment,2017-09-09T18:42:24.000Z,"Phosplatin Therapeutics Announces Collaboration with Pfizer and #Merck KGaA, Darmstadt, Germ... Read more: http://owler.us/adgOCc $MRK","Phosplatin Therapeutics Announces Collaboration with Pfizer and #Merck KGaA, Darmstadt, Germ... Read more: http://owler.us/adgOCc $MRK",,,,,[],https://twitter.com/hc_equipment/status/906588618872954880
4345,Ben Fidler,@BentheFidler,2017-09-08T11:50:03.000Z,"#Biotech Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More http://xconomy.com/national/2017/09/08/bio-roundup-rnai-drama-immunotherapy-data-lasker-winners-more/‚Ä¶ $BMY $MRK $ALNY $CLLS $VYGR","#Biotech Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More http://xconomy.com/national/2017/09/08/bio-roundup-rnai-drama-immunotherapy-data-lasker-winners-more/‚Ä¶ $BMY $MRK $ALNY $CLLS $VYGR
1
1",,,1,1,[],https://twitter.com/BentheFidler/status/906122455844040705
4346,Pharmaceutical News,@pharma_sector,2017-09-09T18:07:24.000Z,#Merck Progression-Free Survival Data from ECHO-202 Trial of Incyte's Epacadostat in Combina... Read more: http://owler.us/adgOpq $MRK,#Merck Progression-Free Survival Data from ECHO-202 Trial of Incyte's Epacadostat in Combina... Read more: http://owler.us/adgOpq $MRK,,,,,[],https://twitter.com/pharma_sector/status/906579809228120069
4347,biotechnicality,@biotechnicality,2017-09-08T20:54:42.000Z,"Still ordering mostly Zepatier (twice today) as that is still formulary for most plans I see, epclusa for the 2/3s #hcv $gild $mrk $abbv","Still ordering mostly Zepatier (twice today) as that is still formulary for most plans I see, epclusa for the 2/3s #hcv $gild $mrk $abbv",,,,,[],https://twitter.com/biotechnicality/status/906259521236021250
4348,bake mcbride,@ITRADEVOL,2017-09-08T21:32:52.000Z,Most Active  #AfterHours $SPY $GDX $KNX $GDXJ $AAPL $BAC $GE $T $IUSG $MU $USO $MSFT $VZ $F $VIPS $MRK $QQQ $HAL https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,Most Active  #AfterHours $SPY $GDX $KNX $GDXJ $AAPL $BAC $GE $T $IUSG $MU $USO $MSFT $VZ $F $VIPS $MRK $QQQ $HAL https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/906269129564454917
4349,Mavis Nye Dr (hon) BEM. BCAh,@Grandmamavis,2017-09-07T12:29:05.000Z,FDA halts patient recruitment in three Opdivo combo studies in MM after safety signal observed related ... https://seekingalpha.com/news/3294086-fda-halts-patient-recruitment-three-opdivo-combo-studies-mm-safety-signal-observed-related?source=tweet‚Ä¶ $BMY $MRK,"FDA halts patient recruitment in three Opdivo combo studies in MM after safety signal observed related ... https://seekingalpha.com/news/3294086-fda-halts-patient-recruitment-three-opdivo-combo-studies-mm-safety-signal-observed-related?source=tweet‚Ä¶ $BMY $MRK
seekingalpha.com
FDA halts patient recruitment in three Opdivo combo studies in MM after safety signal observed...
Bristol-Myers Squibb (NYSE:BMY) announces that the FDA has placed a partial clinical hold suspending patient recruitment in three studies of Opdivo (nivolumab) combinations in multiple...
1",,,1,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/Grandmamavis/status/905769892791582721
4350,MAISA,@MaisaCorp,2017-09-07T20:06:52.000Z,$NLNK Data from an ongoing phase 2 study of indoximod in combination with $MRK Keytruda showed improved response rate for patients,"$NLNK Data from an ongoing phase 2 study of indoximod in combination with $MRK Keytruda showed improved response rate for patients
1",,,,1,[],https://twitter.com/MaisaCorp/status/905885098972774401
4351,US Banking News,@AmericanBanking,2017-09-08T17:10:12.000Z,Merck & Company's buy rating reiterated at BMO Capital Markets. $72.00 PT. http://ift.tt/2wOrTmn $MRK #MRK,Merck & Company's buy rating reiterated at BMO Capital Markets. $72.00 PT. http://ift.tt/2wOrTmn $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/906203025278210048
4352,MarketBeat,@MarketBeatCom,2017-09-08T18:00:15.000Z,"Merck & Company, Inc. $MRK Earns ‚ÄúBuy‚Äù Rating from BMO Capital Markets http://ift.tt/2f8RIUO #acn","Merck & Company, Inc. $MRK Earns ‚ÄúBuy‚Äù Rating from BMO Capital Markets http://ift.tt/2f8RIUO #acn",,,,,[],https://twitter.com/MarketBeatCom/status/906215622413082624
4353,Pharmaceutical News,@pharma_sector,2017-09-09T18:05:32.000Z,#Merck Incyte : Progression-Free Survival Data from ECHO-202 Trial of Incyte's Epacadostat i... Read more: http://owler.us/adgOps $MRK,#Merck Incyte : Progression-Free Survival Data from ECHO-202 Trial of Incyte's Epacadostat i... Read more: http://owler.us/adgOps $MRK,,,,,[],https://twitter.com/pharma_sector/status/906579337725460480
4354,Dakota Financial,@dakotafinancial,2017-09-09T17:26:07.000Z,"Merck & Company, Inc. $MRK Position Boosted by Gotham Asset Management LLC http://ift.tt/2jd2U7n","Merck & Company, Inc. $MRK Position Boosted by Gotham Asset Management LLC http://ift.tt/2jd2U7n",,,,,[],https://twitter.com/dakotafinancial/status/906569420331470849
4355,Daily Political,@dailypoliticaln,2017-09-09T17:44:38.000Z,"Merck & Company, Inc. $MRK Stake Lessened by Cambridge Advisors Inc. http://ift.tt/2jd6kHf","Merck & Company, Inc. $MRK Stake Lessened by Cambridge Advisors Inc. http://ift.tt/2jd6kHf",,,,,[],https://twitter.com/dailypoliticaln/status/906574081008525312
4356,Stockboard Media Inc,@stockboardinc,2017-09-08T12:07:17.000Z,$MRK Updated Data for Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) in Patients with Advanced Gastric Cancer Acros... - http://sbml.co/852cac00,$MRK Updated Data for Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) in Patients with Advanced Gastric Cancer Acros... - http://sbml.co/852cac00,,,,,[],https://twitter.com/stockboardinc/status/906126795367440384
4357,bake mcbride,@ITRADEVOL,2017-09-08T12:07:28.000Z,8am Press Releases $DEO $AGN $VVUS $HURC $ADK $QUIK $AMPE $ARCI $CVS $MRK $KHC $TRTN $C $GNRX $THHY $AKR $CTR https://marketchameleon.com/PressReleases,8am Press Releases $DEO $AGN $VVUS $HURC $ADK $QUIK $AMPE $ARCI $CVS $MRK $KHC $TRTN $C $GNRX $THHY $AKR $CTR https://marketchameleon.com/PressReleases,,,,,[],https://twitter.com/ITRADEVOL/status/906126839181127684
4358,bake mcbride,@ITRADEVOL,2017-09-08T15:24:13.000Z,11am PressReleases $ANTM $STM $T $deo $ABBV $WMT $PCG $JE $WIT $PEO $ADX $AET $NTEC $PAYX $MRK $BNS $AON $WERN $CIA  https://marketchameleon.com/PressReleases,11am PressReleases $ANTM $STM $T $deo $ABBV $WMT $PCG $JE $WIT $PEO $ADX $AET $NTEC $PAYX $MRK $BNS $AON $WERN $CIA  https://marketchameleon.com/PressReleases,,,,,[],https://twitter.com/ITRADEVOL/status/906176355188002816
4359,Limex,@LimexMe,2017-09-08T15:22:54.000Z,"Bristol-Myers' Opdivo Study Meets Early Success, Stock Up http://bit.ly/080917BMY $BMY $SGEN $PFE $MRK","Bristol-Myers' Opdivo Study Meets Early Success, Stock Up http://bit.ly/080917BMY $BMY $SGEN $PFE $MRK
whotrades.com
Bristol-Myers' Opdivo Study Meets Early Success, Stock Up
Shares of Bristol-Myers Squibb Company BMY gained about 5% after the company ended its phase III combination study, CheckMate-214, earlier than expected after it met its co-‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/906176023246594049
4360,Ticker Report,@TickerReport,2017-09-07T08:52:07.000Z,Financial Survey: Pernix Therapeutics Holdings $PTX versus Merck & $MRK http://ift.tt/2wKvXlP,Financial Survey: Pernix Therapeutics Holdings $PTX versus Merck & $MRK http://ift.tt/2wKvXlP,,,,,[],https://twitter.com/TickerReport/status/905715290255880192
4361,Watchlist News,@WatchlistN,2017-09-08T16:45:41.000Z,"Merck & Company, Inc. $MRK Shares Bought by Investec Asset Management LTD http://ift.tt/2xbllyJ","Merck & Company, Inc. $MRK Shares Bought by Investec Asset Management LTD http://ift.tt/2xbllyJ",,,,,[],https://twitter.com/WatchlistN/status/906196855402500096
4362,StockNews.com,@stocknewsdotcom,2017-09-08T12:09:58.000Z,$MRK Presents data from all 3 cohorts of the phase 2 KEYNOTE-059 trial investigating the use of KEYTRUDA in patien‚Ä¶ https://stocknews.com/news/mrk-presents-data-from-all-3-cohorts-of-the-phase-2/‚Ä¶,$MRK Presents data from all 3 cohorts of the phase 2 KEYNOTE-059 trial investigating the use of KEYTRUDA in patien‚Ä¶ https://stocknews.com/news/mrk-presents-data-from-all-3-cohorts-of-the-phase-2/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/906127469618622464
4363,StockNews.com,@stocknewsdotcom,2017-09-08T15:04:57.000Z,"$MRK Presents Five Months of Additional Data from KEYNOTE-021, Cohort G, Including Updated Overall Survival, to be‚Ä¶ https://stocknews.com/news/mrk-presents-five-months-of-additional-data-from-keynote-021-cohort-g/‚Ä¶","$MRK Presents Five Months of Additional Data from KEYNOTE-021, Cohort G, Including Updated Overall Survival, to be‚Ä¶ https://stocknews.com/news/mrk-presents-five-months-of-additional-data-from-keynote-021-cohort-g/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/906171505591111680
4364,BioPharma Dive,@BioPharmaDive,2017-09-09T23:21:00.000Z,$MRK buys German biotech Rigontec for ‚Ç¨115 million,"$MRK buys German biotech Rigontec for ‚Ç¨115 million
biopharmadive.com
Merck picks up new I/O approach
The big pharma is further growing its I/O portfolio by acquiring RIG-I targeting therapeutics startup Rigontec.",,,,,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/906658729009053697
4365,Jacob Bell,@realJacobBell,2017-09-07T15:49:10.000Z,New PD-1 clinical holds raise more concerns for class http://bit.ly/2wbKLbe $MRK $BMY $AZN $CELG,New PD-1 clinical holds raise more concerns for class http://bit.ly/2wbKLbe $MRK $BMY $AZN $CELG,,,,,[],https://twitter.com/realJacobBell/status/905820246531088385
4366,Watchlist News,@WatchlistN,2017-09-09T17:20:24.000Z,"Partners Capital Investment Group Holdings LLC Has $748,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2vVNYAx","Partners Capital Investment Group Holdings LLC Has $748,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2vVNYAx",,,,,[],https://twitter.com/WatchlistN/status/906567980468895744
4367,US Banking News,@AmericanBanking,2017-09-08T17:58:29.000Z,"Merck & Company, Inc. $MRK Earns ‚ÄúBuy‚Äù Rating from BMO Capital Markets http://ift.tt/2gPL4mC","Merck & Company, Inc. $MRK Earns ‚ÄúBuy‚Äù Rating from BMO Capital Markets http://ift.tt/2gPL4mC",,,,,[],https://twitter.com/AmericanBanking/status/906215176273317888
4368,Limex,@LimexMe,2017-09-08T14:10:24.000Z,Good News for Opdivo Shows Why You Shouldn't Give Up on Bristol-Myers Squibb Stock http://bit.ly/080917CLDX $CLDX $EXEL $SGEN $MRK,"Good News for Opdivo Shows Why You Shouldn't Give Up on Bristol-Myers Squibb Stock http://bit.ly/080917CLDX $CLDX $EXEL $SGEN $MRK
whotrades.com
Good News for Opdivo Shows Why You Shouldn't Give Up on Bristol-Myers Squibb Stock
Bristol-Myers Squibb (NYSE: BMY) investors might have been just a bit worried on Wednesday. After all, the U.S. Food and Drug Administration (FDA) had just placed a partial clinical‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/906157776317157376
4369,BioPharma Dive,@BioPharmaDive,2017-09-09T19:41:01.000Z,FDA halts more immunotherapy trials http://bit.ly/2wbKLbe $AZN $BMY $CELG $MRK,"FDA halts more immunotherapy trials http://bit.ly/2wbKLbe $AZN $BMY $CELG $MRK
biopharmadive.com
New PD-1 clinical holds raise more concerns for class
The FDA halted several trials from Bristol-Myers, AstraZeneca and Celgene after the deaths in Merck's Keytruda trials.
1",,,,1,[],https://twitter.com/BioPharmaDive/status/906603367602024450
4370,MarketBeat,@MarketBeatCom,2017-09-09T12:46:17.000Z,"Merck & Company, Inc. $MRK Stock Rating Reaffirmed by Credit Suisse Group http://ift.tt/2eUzE4b","Merck & Company, Inc. $MRK Stock Rating Reaffirmed by Credit Suisse Group http://ift.tt/2eUzE4b",,,,,[],https://twitter.com/MarketBeatCom/status/906498997203939330
4371,US Banking News,@AmericanBanking,2017-09-07T09:59:34.000Z,Merck & $MRK ‚Äì Investment Analysts‚Äô Recent Ratings Changes http://ift.tt/2vOx1Io,Merck & $MRK ‚Äì Investment Analysts‚Äô Recent Ratings Changes http://ift.tt/2vOx1Io,,,,,[],https://twitter.com/AmericanBanking/status/905732265371684865
4372,Market Realist,@MarketRealist,2017-09-07T23:35:09.000Z,This Could Be Driving Merck's Valuation after 2Q17 http://marketrealist.com/?p=2316438 $MRK $PFE $LLY $NVS,This Could Be Driving Merck's Valuation after 2Q17 http://marketrealist.com/?p=2316438 $MRK $PFE $LLY $NVS,,,,,[],https://twitter.com/MarketRealist/status/905937514497757185
4373,TalkMarkets,@TalkMarkets,2017-09-08T16:35:43.000Z,"70 Firms Going Ex-Dividend: Coca-Cola, Merck And T. Rowe Price $BCE $DPS $EMN $HES $KO $MRK $TROW https://goo.gl/BNvbMD","70 Firms Going Ex-Dividend: Coca-Cola, Merck And T. Rowe Price $BCE $DPS $EMN $HES $KO $MRK $TROW https://goo.gl/BNvbMD",,,,,[],https://twitter.com/TalkMarkets/status/906194349972697088
4374,Allison Gatlin,@IBD_AGatlin,2017-09-07T20:21:04.000Z,How Bristol-Myers' cancer win helped boost this rival $BMY $AZN $RHHBY $MRK $PFE,"How Bristol-Myers' cancer win helped boost this rival $BMY $AZN $RHHBY $MRK $PFE
investors.com
How Bristol-Myers' Cancer Win Helped Boost This Rival
Bristol popped to a 13-month high Thursday after its immuno-oncology combination proved successful vs. chemotherapy in advanced kidney cancer.",,,,,[],https://twitter.com/IBD_AGatlin/status/905888669608890369
4375,Options Trading IQ,@OptiontradinIQ,2017-09-08T03:45:05.000Z,"Dogs of the Dow 2017 Update
http://optionstradingiq.com/dogs-of-the-dow-2017-update/‚Ä¶
$PFE, $CVX, $BA, $CSCO, $KO, $IBM, $XOM, $CAT, $MRK, $SPX, $SPY, $VZ","Dogs of the Dow 2017 Update
http://optionstradingiq.com/dogs-of-the-dow-2017-update/‚Ä¶
$PFE, $CVX, $BA, $CSCO, $KO, $IBM, $XOM, $CAT, $MRK, $SPX, $SPY, $VZ
optionstradingiq.com
Dogs of the Dow 2017 Update
Each year, I like to take a look at the Dogs of the Dow. Given we are fast approaching the end of 2017, I thought it would be a good time to take another look at how",,,,,['https://pbs.twimg.com/card_img/1501715607150075904/Mv5tWwFi?format=png&name=360x360'],https://twitter.com/OptiontradinIQ/status/906000413585002496
4376,Jacob Bell,@realJacobBell,2017-09-08T18:34:00.000Z,Prescribed Reading: $MRK acquires Rigontec for $140M; $VSTM reports positive Ph. 3 data; FDA pauses PD-1/L1 trials,"Prescribed Reading: $MRK acquires Rigontec for $140M; $VSTM reports positive Ph. 3 data; FDA pauses PD-1/L1 trials
biopharmadive.com
Prescribed Reading: PD-1, CAR-T threatened by clinical holds
Highly innovative oncology technologies may be life-saving, but they have also raised major safety concerns.",,,,,['https://pbs.twimg.com/card_img/1501983579286372354/UUFlIgZv?format=jpg&name=small'],https://twitter.com/realJacobBell/status/906224116029579264
4377,Transcript Daily,@TranscriptDaily,2017-09-07T08:53:38.000Z,"Credit Suisse Group Reiterates Outperform Rating for Merck & Company, Inc. $MRK http://ift.tt/2gJy9m5","Credit Suisse Group Reiterates Outperform Rating for Merck & Company, Inc. $MRK http://ift.tt/2gJy9m5",,,,,[],https://twitter.com/TranscriptDaily/status/905715672386347008
4378,Options Trading IQ,@OptiontradinIQ,2017-09-08T22:45:11.000Z,"Dogs of the Dow Update 2017
http://optionstradingiq.com/dogs-of-the-dow-2017-update/‚Ä¶
$CSCO, $KO, $IBM, $XOM, $CAT, $MRK, $SPX, $SPY, $VZ, $PFE, $CVX, $BA","Dogs of the Dow Update 2017
http://optionstradingiq.com/dogs-of-the-dow-2017-update/‚Ä¶
$CSCO, $KO, $IBM, $XOM, $CAT, $MRK, $SPX, $SPY, $VZ, $PFE, $CVX, $BA
optionstradingiq.com
Dogs of the Dow 2017 Update
Each year, I like to take a look at the Dogs of the Dow. Given we are fast approaching the end of 2017, I thought it would be a good time to take another look at how",,,,,['https://pbs.twimg.com/card_img/1501715607150075904/Mv5tWwFi?format=png&name=360x360'],https://twitter.com/OptiontradinIQ/status/906287325264707584
4379,Dakota Financial,@dakotafinancial,2017-09-09T12:45:55.000Z,"Merck & Company, Inc. $MRK Stock Rating Reaffirmed by Credit Suisse Group http://ift.tt/2eUzE4b","Merck & Company, Inc. $MRK Stock Rating Reaffirmed by Credit Suisse Group http://ift.tt/2eUzE4b",,,,,[],https://twitter.com/dakotafinancial/status/906498904824401920
4380,Jay Kyle,@JayIKyle,2017-09-12T11:32:47.000Z,"Some Open Interest Changes featured in today's First Read

$CCL $CFX $GEF $FMC $HAS $JD $LOW $MRK","Some Open Interest Changes featured in today's First Read

$CCL $CFX $GEF $FMC $HAS $JD $LOW $MRK
6
5",,,6,5,['https://pbs.twimg.com/media/DJhT6wrXkAAAo8X?format=jpg&name=small'],https://twitter.com/JayIKyle/status/907567662917615616
4381,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-09-11T15:01:08.000Z,"Winners in Melanoma $BMY $ARRY $NVS $MRK $INCY 
@BayAreaBiotechI","Winners in Melanoma $BMY $ARRY $NVS $MRK $INCY 
@BayAreaBiotechI
4
12",,,4,12,['https://pbs.twimg.com/media/DJc6D9zWsAAbpOo?format=jpg&name=small'],https://twitter.com/DrPaulyDeSantis/status/907257710583918592
4382,Helen Ong,@Lin_ling_88,2017-09-10T05:00:32.000Z,"Lilly Breast Cancer Drug Results May Challenge Pfizer Pill 

$LLY #abemacicli (46% progression) =
$MRK #Ibrance","Lilly Breast Cancer Drug Results May Challenge Pfizer Pill 

$LLY #abemacicli (46% progression) =
$MRK #Ibrance
bloomberg.com
Lilly Breast Cancer Drug Results May Challenge Pfizer Pill
Eli Lilly & Co.‚Äôs experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of the tumor in patients with an advanced form of the disease.
1
1",‚¨á,,1,1,[],https://twitter.com/Lin_ling_88/status/906744175504363520
4383,Vista Partners LLC,@VistaPResearch,2017-09-11T12:45:38.000Z,What Are the Risk Factors for #BreastCancer in Men? https://cancer.org/cancer/breast-cancer-in-men/causes-risks-prevention/risk-factors.html#.WbaE4l8Gamg.twitter‚Ä¶ $ATOS Atossa Genetics http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK $PFE,"What Are the Risk Factors for #BreastCancer in Men? https://cancer.org/cancer/breast-cancer-in-men/causes-risks-prevention/risk-factors.html#.WbaE4l8Gamg.twitter‚Ä¶ $ATOS Atossa Genetics http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK $PFE
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DJcbDVHXgAEytnq.jpg'],https://twitter.com/VistaPResearch/status/907223610036772865
4384,Greg5thTrad,@Greg5thTrad,2017-09-10T00:17:13.000Z,"$ Flows: Buying on Weakness: Among stocks that were down FRI, these had the largest net inflows of money $SPY $EEM $GDXJ $MRK $AMZN $JBGB","$ Flows: Buying on Weakness: Among stocks that were down FRI, these had the largest net inflows of money $SPY $EEM $GDXJ $MRK $AMZN $JBGB",,,,,['https://pbs.twimg.com/media/DJUmKtuXkAEwhuS?format=jpg&name=small'],https://twitter.com/Greg5thTrad/status/906672875163340800
4385,kyookine,@kyookine,2017-09-10T05:14:19.000Z,"Bristol-Myers Squibb Gets Huge Boost In Oncology Program After Trial Stoppage
https://seekingalpha.com/article/4105430-bristol-myers-squibb-gets-huge-boost-oncology-program-trial-stoppage?source=tweet‚Ä¶ $CELG $MRK $PFE $BMY","Bristol-Myers Squibb Gets Huge Boost In Oncology Program After Trial Stoppage
https://seekingalpha.com/article/4105430-bristol-myers-squibb-gets-huge-boost-oncology-program-trial-stoppage?source=tweet‚Ä¶ $CELG $MRK $PFE $BMY
kyookine
@kyookine
 ¬∑ 10 Sep 2017
9/8ÔΩû9/12
Bristol-Myers :BMY and AstraZeneca :AZN are presenters at the European Society for Medical Oncology this week.
Show this thread
1",,1,,,['https://pbs.twimg.com/profile_images/464266705313615872/PpryEcou_mini.jpeg'],https://twitter.com/kyookine/status/906747643694505984
4386,Christian Fromhertz,@cfromhertz,2017-09-11T14:43:01.000Z,"Midday Option activity:  underperformers from last week catch up quickly... 
calls: $AAPL $NFLX $BABA $VRX $TDOC $MRK $AMAT $SRCL $RRC","Midday Option activity:  underperformers from last week catch up quickly... 
calls: $AAPL $NFLX $BABA $VRX $TDOC $MRK $AMAT $SRCL $RRC
1
2",,1,,2,['https://pbs.twimg.com/media/DJc17MPXkAAMMAs?format=jpg&name=small'],https://twitter.com/cfromhertz/status/907253148678574081
4387,Finbox,@FinboxIO,2017-09-11T12:30:29.000Z,Merck $MRK racks up a 8 out of 9 on Piotroski's F-Score calculation http://ow.ly/GSK030eYTb8,Merck $MRK racks up a 8 out of 9 on Piotroski's F-Score calculation http://ow.ly/GSK030eYTb8,,,,,['https://pbs.twimg.com/media/DJcXmNNVYAA3P5l?format=jpg&name=small'],https://twitter.com/FinboxIO/status/907219797582245888
4388,M,@bio_clouseau,2017-09-11T08:29:47.000Z,$MRK should have used >50 for its H&N primary endpoint similar to NSCLC http://esmo.org/Press-Office/Press-Releases/KEYNOTE-040-Evaluates-Pembrolizumab-in-Head-and-Neck-Cancer‚Ä¶,$MRK should have used >50 for its H&N primary endpoint similar to NSCLC http://esmo.org/Press-Office/Press-Releases/KEYNOTE-040-Evaluates-Pembrolizumab-in-Head-and-Neck-Cancer‚Ä¶,,,,,['https://pbs.twimg.com/media/DJbgeBPXkAEpoH-?format=jpg&name=900x900'],https://twitter.com/bio_clouseau/status/907159221187248128
4389,Chameleon Options,@MC_OptionTrades,2017-09-12T21:34:07.000Z,Price Returns vs Expected Daily Move $MNKD $TEVA $CVS $PFE $AMGN $VRX $ABBV $CELG $MRK $BMY $GILD $ICPT http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $MNKD $TEVA $CVS $PFE $AMGN $VRX $ABBV $CELG $MRK $BMY $GILD $ICPT http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DJjdnQwUEAE5m94?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/907718993636724736
4390,Pharmaceutical News,@pharma_sector,2017-09-12T18:24:22.000Z,US drug giant #Merck brings blockbuster drug Keytruda to India. Read more: http://owler.us/adhkZn $MRK,"US drug giant #Merck brings blockbuster drug Keytruda to India. Read more: http://owler.us/adhkZn $MRK
1",,,1,,[],https://twitter.com/pharma_sector/status/907671244199178240
4391,Recall Propecia,@RecallPropecia,2017-09-11T09:35:42.000Z,"#NeverForget911 and those who died in the attacks, both by al-Qaeda, and #Merck's ongoing chemical attacks using #VIOXX. #NeverForget $MRK","#NeverForget911 and those who died in the attacks, both by al-Qaeda, and #Merck's ongoing chemical attacks using #VIOXX. #NeverForget $MRK
3",,,,3,[],https://twitter.com/RecallPropecia/status/907175809500065792
4392,Equity Clock,@EquityClock,2017-09-11T14:22:07.000Z,Techs by S&P 500 stocks to 10:00:Bullish. Breakouts: $LLY $MRK $MTD $WAT $DE $NSC $TXT $MMM $APD $AWK $KO $EQR $FTV $INFO. Breakdown: $REGN,"Techs by S&P 500 stocks to 10:00:Bullish. Breakouts: $LLY $MRK $MTD $WAT $DE $NSC $TXT $MMM $APD $AWK $KO $EQR $FTV $INFO. Breakdown: $REGN
1",,,,1,[],https://twitter.com/EquityClock/status/907247891831554048
4393,IECONOMICS,@iECONOMICS,2017-09-12T13:30:20.000Z,Merck & Co $MRK market alert: 10-week high @ 65.31 https://ieconomics.com/merck,Merck & Co $MRK market alert: 10-week high @ 65.31 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/907597246820225024
4394,James Sikes,@wosaikeneriki,2017-09-10T10:14:11.000Z,"Afam Capital Has Lifted Merck & Co. $MRK Holding by $326,250 http://bzweekly.com/afam-capital-has-lifted-merck-thomaspartners-cut-its-illinois-tool-wks-itw-holding-by-176-00-million/‚Ä¶","Afam Capital Has Lifted Merck & Co. $MRK Holding by $326,250 http://bzweekly.com/afam-capital-has-lifted-merck-thomaspartners-cut-its-illinois-tool-wks-itw-holding-by-176-00-million/‚Ä¶",,,,,[],https://twitter.com/wosaikeneriki/status/906823108581056512
4395,Community Financial,@CFinancialNews,2017-09-10T08:14:27.000Z,Comparing Merck & $MRK & Amphastar Pharmaceuticals $AMPH http://ift.tt/2eOAyvp,Comparing Merck & $MRK & Amphastar Pharmaceuticals $AMPH http://ift.tt/2eOAyvp,,,,,[],https://twitter.com/CFinancialNews/status/906792975174389760
4396,MySmallCap,@tzack16,2017-09-12T18:10:08.000Z,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h2xCMi $MRK,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h2xCMi $MRK,,,,,['https://pbs.twimg.com/media/DJiu7BgW0AENHDn?format=jpg&name=small'],https://twitter.com/tzack16/status/907667658665086976
4397,Buy Cryptocurrency,@cryptosbuy,2017-09-11T15:14:28.000Z,Merck $MRK http://tradingview.com/chart/MRK/DMoqyrim-Merck/‚Ä¶ TV_TradingIdeas,Merck $MRK http://tradingview.com/chart/MRK/DMoqyrim-Merck/‚Ä¶ TV_TradingIdeas,,,,,[],https://twitter.com/cryptosbuy/status/907261062835326976
4398,Sweet Platform,@SweetPlatform,2017-09-12T15:16:21.000Z,"MRK Top news - Sep 12th, 2017 $MRK http://https://goo.gl/4R3gMK","MRK Top news - Sep 12th, 2017 $MRK http://https://goo.gl/4R3gMK",,,,,[],https://twitter.com/SweetPlatform/status/907623925080883205
4399,Carly Helfand,@CarlyHFierce,2017-09-12T16:08:01.000Z,ICYMI at #ESMO17 $MRK Keytruda-chemo combo spurs big response in new stomach cancer patients across the PD-L1 board,"ICYMI at #ESMO17 $MRK Keytruda-chemo combo spurs big response in new stomach cancer patients across the PD-L1 board
fiercepharma.com
ESMO: Merck's Keytruda-chemo combo spurs big response in new stomach cancer patients across the...
MADRID, Spain‚ÄîMerck immuno-oncology star Keytruda has posted updated, longer-term positive data in previously untreated stomach cancer patients‚Äî< | Merck immuno-oncology star Keytruda has posted...
1",,,,1,['https://pbs.twimg.com/card_img/1501241110705983490/FVdcfatv?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/907636927607734272
4400,Buy Cryptocurrency,@cryptosbuy,2017-09-12T01:59:38.000Z,MRK DOW 30 Weekly Trend  $MRK http://tradingview.com/chart/MRK/rbxLCjOw-MRK-DOW-30-Weekly-Trend/‚Ä¶ TV_TradingIdeas,MRK DOW 30 Weekly Trend  $MRK http://tradingview.com/chart/MRK/rbxLCjOw-MRK-DOW-30-Weekly-Trend/‚Ä¶ TV_TradingIdeas,,,,,[],https://twitter.com/cryptosbuy/status/907423425211371520
4401,Carly Helfand,@CarlyHFierce,2017-09-11T09:03:28.000Z,#ICYMI: Merck's Keytruda extends survival edge on its bladder cancer rivals http://bit.ly/2gTAej4 $MRK #pharma #ESMO17,"#ICYMI: Merck's Keytruda extends survival edge on its bladder cancer rivals http://bit.ly/2gTAej4 $MRK #pharma #ESMO17
fiercepharma.com
ESMO: Merck's Keytruda extends survival edge on its bladder cancer rivals
MADRID, Spain‚ÄîRight now, Merck‚Äôs Keytruda is the only PD-1/PD-L1 med with data to show it can improve | Right now, Merck‚Äôs Keytruda is the only PD-1/PD-L1 med with data to show it can improve overall...
2",,,,2,['https://pbs.twimg.com/card_img/1499650296905093121/OAackR36?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/907167698072809473
4402,CBPartners,@CBPartners,2017-09-12T22:30:08.000Z,$MRK & PROJECT DATA SPHERE expand trial data platform to advance understanding of #cancer treatment  http://bit.ly/2ePv6rO,$MRK & PROJECT DATA SPHERE expand trial data platform to advance understanding of #cancer treatment  http://bit.ly/2ePv6rO,,,,,[],https://twitter.com/CBPartners/status/907733090373685254
4403,bake mcbride,@ITRADEVOL,2017-09-12T13:47:59.000Z,"#TRADEIDEAS w/Company Events Calendar $JPM $WFC $T $CMCSA $MRK $CSCO $ABBV $AMGN $CHTR $LLY $NFLX $AXP $CAT $CRM 
 https://marketchameleon.com/Calendar/CompanyEvents‚Ä¶","#TRADEIDEAS w/Company Events Calendar $JPM $WFC $T $CMCSA $MRK $CSCO $ABBV $AMGN $CHTR $LLY $NFLX $AXP $CAT $CRM 
 https://marketchameleon.com/Calendar/CompanyEvents‚Ä¶",,,,,[],https://twitter.com/ITRADEVOL/status/907601687631851520
4404,Regen BioPharma News,@RegenBioPharm,2017-09-11T21:16:01.000Z,Congrats Rigontec - $MRK buys German #immuno-oncology company in deal valued at up to $554M https://buff.ly/2xsmwL5,"Congrats Rigontec - $MRK buys German #immuno-oncology company in deal valued at up to $554M https://buff.ly/2xsmwL5
1
1",,,1,1,[],https://twitter.com/RegenBioPharm/status/907352050006216705
4405,MarketBeat,@MarketBeatCom,2017-09-11T19:03:09.000Z,Head to Head Analysis: Pernix Therapeutics Holdings $PTX vs. Merck & $MRK http://ift.tt/2xrSzLp #acn,Head to Head Analysis: Pernix Therapeutics Holdings $PTX vs. Merck & $MRK http://ift.tt/2xrSzLp #acn,,,,,[],https://twitter.com/MarketBeatCom/status/907318614784606208
4406,Dakota Financial,@dakotafinancial,2017-09-12T16:49:29.000Z,"Macquarie Group Ltd. Sells 209,905 Shares of Merck & Co., Inc. $MRK http://ift.tt/2vRC1YH","Macquarie Group Ltd. Sells 209,905 Shares of Merck & Co., Inc. $MRK http://ift.tt/2vRC1YH",,,,,[],https://twitter.com/dakotafinancial/status/907647365376626688
4407,Limex,@LimexMe,2017-09-12T17:02:21.000Z,"Here's Why Advaxis, Inc. Stock Is Getting Pummeled Today http://bit.ly/120917MRK $MRK $BMY $ADXS","Here's Why Advaxis, Inc. Stock Is Getting Pummeled Today http://bit.ly/120917MRK $MRK $BMY $ADXS
whotrades.com
Here's Why Advaxis, Inc. Stock Is Getting Pummeled Today
What happened Shares of Advaxis, Inc. (NASDAQ: ADXS) , a clinical-stage biotech developing novel cancer immunotherapies, are sinking after the company provided a business update along‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1501714909209448450/xrIFEk94?format=jpg&name=small'],https://twitter.com/LimexMe/status/907650601965772802
4408,Watchlist News,@WatchlistN,2017-09-12T17:50:23.000Z,"Merck & Co., Inc. $MRK Stake Lessened by Clear Harbor Asset Management LLC http://ift.tt/2wXULHp","Merck & Co., Inc. $MRK Stake Lessened by Clear Harbor Asset Management LLC http://ift.tt/2wXULHp",,,,,[],https://twitter.com/WatchlistN/status/907662691971555328
4409,Daily Political,@dailypoliticaln,2017-09-11T16:40:52.000Z,"Aveo Capital Partners LLC Has $201,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2eR1ri4","Aveo Capital Partners LLC Has $201,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2eR1ri4",,,,,[],https://twitter.com/dailypoliticaln/status/907282808619651073
4410,Limex,@LimexMe,2017-09-11T21:40:49.000Z,"AstraZeneca's Lung Cancer Study Data Promising, Shares Spike http://bit.ly/110917AZN $AZN $REGN $MRK","AstraZeneca's Lung Cancer Study Data Promising, Shares Spike http://bit.ly/110917AZN $AZN $REGN $MRK",,,,,[],https://twitter.com/LimexMe/status/907358293940740102
4411,Ticker Report,@TickerReport,2017-09-12T17:45:30.000Z,"Acadian Asset Management LLC Purchases 498 Shares of Merck & Co., Inc. $MRK http://ift.tt/2xXUXp8","Acadian Asset Management LLC Purchases 498 Shares of Merck & Co., Inc. $MRK http://ift.tt/2xXUXp8",,,,,[],https://twitter.com/TickerReport/status/907661461975171073
4412,Limex,@LimexMe,2017-09-12T22:35:56.000Z,Bristol-Myers Reports Positive Results from Melanoma Study http://bit.ly/120917BMY $BMY $AZN $PFE $MRK,"Bristol-Myers Reports Positive Results from Melanoma Study http://bit.ly/120917BMY $BMY $AZN $PFE $MRK
whotrades.com
Bristol-Myers Reports Positive Results from Melanoma Study
Bristol-Myers Squibb Company BMY announced encouraging results from a phase III study, CheckMate -238, on Opdivo. CheckMate 238 is an ongoing phase III, randomized double-blind‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/907734551065178112
4413,marketexclusive,@marketexclusive,2017-09-11T12:52:47.000Z,"$MRK Merck & Co., Inc. (NYSE:MRK) Strengthens Immuno-Oncology Portfolio With Rigontec Acquisition","$MRK Merck & Co., Inc. (NYSE:MRK) Strengthens Immuno-Oncology Portfolio With Rigontec Acquisition
marketexclusive.com
Did Merck Overpay For Rigontec
Merck has reached an agreement for the acquisition of Rigontec in a deal worth $137 million in cash
1",,,1,,[],https://twitter.com/marketexclusive/status/907225410206756864
4414,Portfolio Penny,@PortfolioPenny,2017-09-11T16:50:08.000Z,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2wTEp2a $MRK,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2wTEp2a $MRK,,,,,['https://pbs.twimg.com/media/DJdTBfKW4AAm3I6?format=jpg&name=small'],https://twitter.com/PortfolioPenny/status/907285138228342785
4415,Dakota Financial,@dakotafinancial,2017-09-11T20:59:17.000Z,Head to Head Review: Pernix Therapeutics Holdings $PTX and Merck & $MRK http://ift.tt/2wlcoPo,Head to Head Review: Pernix Therapeutics Holdings $PTX and Merck & $MRK http://ift.tt/2wlcoPo,,,,,[],https://twitter.com/dakotafinancial/status/907347839457644546
4416,TradingView Ideas,@TradingViewAlt,2017-09-12T01:58:37.000Z,MRK DOW 30 Weekly Trend  $MRK http://tradingview.com/chart/MRK/rbxLCjOw-MRK-DOW-30-Weekly-Trend/‚Ä¶,MRK DOW 30 Weekly Trend  $MRK http://tradingview.com/chart/MRK/rbxLCjOw-MRK-DOW-30-Weekly-Trend/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/907423167945175041
4417,Stockboard Media Inc,@stockboardinc,2017-09-10T12:50:11.000Z,$MRK Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) Continues to Show Overall Survival Benefit Over Chemotherapy wi... - http://sbml.co/fa507ac8,$MRK Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) Continues to Show Overall Survival Benefit Over Chemotherapy wi... - http://sbml.co/fa507ac8,,,,,[],https://twitter.com/stockboardinc/status/906862364783513600
4418,FiercePharma,@FiercePharma,2017-09-12T13:55:51.000Z,ESMO: $MRK details Keytruda's narrow head and neck cancer miss in phase 3,"ESMO: $MRK details Keytruda's narrow head and neck cancer miss in phase 3
fiercepharma.com
ESMO: Merck details Keytruda's narrow head and neck cancer miss in phase 3
MADRID, Spain‚ÄîIn July, Merck‚Äôs Keytruda narrowly missed the mark in a head and neck cancer trial, failing to show it could significantly extend overall survival. | In July, Merck‚Äôs Keytruda narrowly...
1",,,1,,['https://pbs.twimg.com/card_img/1501714913693163523/6PW-_WgP?format=jpg&name=small'],https://twitter.com/FiercePharma/status/907603668027019265
4419,HealthInnovSAS,@HealthInnovSAS,2017-09-11T11:08:31.000Z,"$MRK Merck : Darmstadt, Germany, Set to Join Forces with Project Data Sphere to Pioneer Global Oncology Big Data ...","$MRK Merck : Darmstadt, Germany, Set to Join Forces with Project Data Sphere to Pioneer Global Oncology Big Data ...
marketscreener.com
Merck : Darmstadt, Germany, Set to Join Forces with Project Data Sphere to Pioneer Global Oncology...
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or... | February...",,,,,['https://pbs.twimg.com/card_img/1490118236725252099/N0WCsHb_?format=png&name=small'],https://twitter.com/HealthInnovSAS/status/907199170959769601
4420,MarketBeat,@MarketBeatCom,2017-09-10T16:26:27.000Z,"Investment Centers of America Inc. Has $4.45 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2xUza1H","Investment Centers of America Inc. Has $4.45 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2xUza1H",,,,,[],https://twitter.com/MarketBeatCom/status/906916792316067843
4421,cowenresearch,@CowenResearch,2017-09-11T11:24:44.000Z,Steve Scala publishes #pharma highlights from #ESMO2017 $AZN $BMY $LLY $MRK $INCY,Steve Scala publishes #pharma highlights from #ESMO2017 $AZN $BMY $LLY $MRK $INCY,,,,,[],https://twitter.com/CowenResearch/status/907203251313004544
4422,Vista Partners LLC,@VistaPResearch,2017-09-11T23:09:11.000Z,@psrkr0 thxfor follow! Visit Vista Partners to learn more $ATOS Atossa Genetics http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK $PFE $JNJ #breastcancer,"@psrkr0 thxfor follow! Visit Vista Partners to learn more $ATOS Atossa Genetics http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK $PFE $JNJ #breastcancer
GIF
1
1",,1,,1,['https://pbs.twimg.com/tweet_video_thumb/DJepxoTXcAA7GjG.jpg'],https://twitter.com/VistaPResearch/status/907380531297484802
4423,"Social Market Analytics, Inc. (SMA)",@SMA_alpha,2017-09-11T12:20:02.000Z,"$MRK Negative investor sentiment Sep 11, 8:19 AM ET, see chart at https://socialmarketanalytics.com #sentiment #trading #stocks","$MRK Negative investor sentiment Sep 11, 8:19 AM ET, see chart at https://socialmarketanalytics.com #sentiment #trading #stocks",,,,,[],https://twitter.com/SMA_alpha/status/907217165434200064
4424,Briefing.com,@Briefingcom,2017-09-11T11:52:01.000Z,$MRK: Merck announces updated results from the phase 3 KEYNOTE-045 trial evaluating KEYTRUDA in patients with... http://bit.ly/2xVglLU,$MRK: Merck announces updated results from the phase 3 KEYNOTE-045 trial evaluating KEYTRUDA in patients with... http://bit.ly/2xVglLU,,,,,[],https://twitter.com/Briefingcom/status/907210117036175361
4425,ZoZoTrader,@ZoZoStockwatch,2017-09-10T13:24:54.000Z,$FDX $NKE $GE $MRK $AMZN $VIX $AAPL $DIS and more Let's Get Ready for The Week Ahead 9/11 to 9/15,"$FDX $NKE $GE $MRK $AMZN $VIX $AAPL $DIS and more Let's Get Ready for The Week Ahead 9/11 to 9/15
youtube.com
Let's Get Ready for The Week Ahead 9/11 to 9/15
Markets Stocks News Information for 9/11 to 9/15 ZoZoStockWatch.com https://www.zozostockwatch.com/https://www.zozostockwatch.com/day-trading-swing-trading-...
1
1",,,1,1,[],https://twitter.com/ZoZoStockwatch/status/906871103066341377
4426,Piggy Bank People,@PiggyBankPeople,2017-09-11T19:50:15.000Z,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2wTEoeC $MRK,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2wTEoeC $MRK,,,,,['https://pbs.twimg.com/media/DJd8QBMW4AYDoRG?format=jpg&name=small'],https://twitter.com/PiggyBankPeople/status/907330468114202624
4427,Pharmaceutical News,@pharma_sector,2017-09-12T19:28:14.000Z,ESMO: #Merck details Keytruda's narrow head and neck cancer miss in phase 3. Read more: http://owler.us/adhlP4 $MRK,ESMO: #Merck details Keytruda's narrow head and neck cancer miss in phase 3. Read more: http://owler.us/adhlP4 $MRK,,,,,[],https://twitter.com/pharma_sector/status/907687316742742016
4428,c lark,@7LadyQ,2017-09-11T00:34:34.000Z,$MRK - Merck Keytruda continues to show overall survival benefit over chemotherapy,$MRK - Merck Keytruda continues to show overall survival benefit over chemotherapy,,,,,[],https://twitter.com/7LadyQ/status/907039631283286018
4429,StockNews.com,@stocknewsdotcom,2017-09-11T11:08:56.000Z,$MRK Announces updated results from the phase 3 KEYNOTE-045 trial evaluating KEYTRUDA in patients with locally adv‚Ä¶ https://stocknews.com/news/mrk-announces-updated-results-from-the-phase-3-keynote-045-trial-evaluating/‚Ä¶,$MRK Announces updated results from the phase 3 KEYNOTE-045 trial evaluating KEYTRUDA in patients with locally adv‚Ä¶ https://stocknews.com/news/mrk-announces-updated-results-from-the-phase-3-keynote-045-trial-evaluating/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/907199273456062464
4430,Ticker Report,@TickerReport,2017-09-11T17:01:32.000Z,"Teachers Insurance & Annuity Association of America Has $10,014,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2wUxk1p","Teachers Insurance & Annuity Association of America Has $10,014,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2wUxk1p",,,,,[],https://twitter.com/TickerReport/status/907288008218509312
4431,Dakota Financial,@dakotafinancial,2017-09-10T16:30:28.000Z,"Investment Centers of America Inc. Has $4.45 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2xUza1H","Investment Centers of America Inc. Has $4.45 Million Position in Merck & Company, Inc. $MRK http://ift.tt/2xUza1H",,,,,[],https://twitter.com/dakotafinancial/status/906917804586270722
4432,Herkyleese,@herkyleese,2017-09-15T11:49:13.000Z,http://mobile.reuters.com/article/amp/idUSKCN1BI1JZ‚Ä¶. Partial hold $nwbo the sky was falling.  #crickets $bmy $mrk $azn  #pdl #bloodcancers $kite sold poor $gild T-Cell,"http://mobile.reuters.com/article/amp/idUSKCN1BI1JZ‚Ä¶. Partial hold $nwbo the sky was falling.  #crickets $bmy $mrk $azn  #pdl #bloodcancers $kite sold poor $gild T-Cell
1
1
2",,1,1,2,"['https://pbs.twimg.com/media/DJw0dANVoAEP6ak?format=jpg&name=small', 'https://pbs.twimg.com/media/DJw0d3nUIAE8EQh?format=jpg&name=small', 'https://pbs.twimg.com/media/DJw0fA9V4AAx2wB?format=jpg&name=small', 'https://pbs.twimg.com/media/DJw0gKWV4AAF9Hq?format=jpg&name=small']",https://twitter.com/herkyleese/status/908658963935309825
4433,FlowAlgo +Ai,@flowalgoapp,2017-09-13T22:06:41.000Z,Top Options Bull Flow Today - $NVDA $GILD $JD $TRGP $SBUX $BAC $AAPL $NXPI $MU $MRK $BABA $KO $IWM $M $AVGO $MS $T,"Top Options Bull Flow Today - $NVDA $GILD $JD $TRGP $SBUX $BAC $AAPL $NXPI $MU $MRK $BABA $KO $IWM $M $AVGO $MS $T
4
3",,,4,3,['https://pbs.twimg.com/media/DJoum9QUEAAZgSy?format=jpg&name=small'],https://twitter.com/flowalgoapp/status/908089577935593472
4434,Bespoke,@bespokeinvest,2017-09-13T14:18:46.000Z,Average Dow stock now up 10% YTD.  Here's a look at where the 30 Dow stocks stand: $AAPL $GS $MRK $PFE $MCD $DIS $JPM $NKE $XOM,"Average Dow stock now up 10% YTD.  Here's a look at where the 30 Dow stocks stand: $AAPL $GS $MRK $PFE $MCD $DIS $JPM $NKE $XOM
3
3",,,3,3,['https://pbs.twimg.com/media/DJnDa4xVYAAMcGm?format=jpg&name=small'],https://twitter.com/bespokeinvest/status/907971823828180992
4435,Seeking Alpha,@SeekingAlpha,2017-09-14T16:48:22.000Z,https://seekingalpha.com/article/4106966-achillion-crushed-johnson-and-johnson-heads-exit?source=feed_f‚Ä¶ $ABBV $ALXN $GILD $JNJ $MRK $ACHN,https://seekingalpha.com/article/4106966-achillion-crushed-johnson-and-johnson-heads-exit?source=feed_f‚Ä¶ $ABBV $ALXN $GILD $JNJ $MRK $ACHN,,,,,[],https://twitter.com/SeekingAlpha/status/908371859824984064
4436,TA Scilab Ichimoku,@tasciccac,2017-09-15T22:01:12.000Z,$DJIA WKLY Best performance $DWDP $INTC $BA $VZ $MMM $PFE $GS $MRK $JPM Worst $MCD $HD $GE $PG $KO $UNH $AAPL $V $TRV #Ichimoku #Dashboard,"$DJIA WKLY Best performance $DWDP $INTC $BA $VZ $MMM $PFE $GS $MRK $JPM Worst $MCD $HD $GE $PG $KO $UNH $AAPL $V $TRV #Ichimoku #Dashboard
1",,,1,,['https://pbs.twimg.com/media/DJzAUKxXoAIAFs2?format=jpg&name=small'],https://twitter.com/tasciccac/status/908812974718177280
4437,John Carroll,@JohnCendpts,2017-09-14T10:08:02.000Z,"GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on
$GSK $MRK","GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on
$GSK $MRK
endpts.com
GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on
New GlaxoSmithKline CEO Emma Walmsley is one big step closer to taking a shot at a blockbuster marketing program today after an FDA panel review ended with a unanimous thumbs up for their new...
9
6",,,9,6,['https://pbs.twimg.com/card_img/1499192556282089472/HgvbFoAD?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/908271110063640576
4438,bake mcbride,@ITRADEVOL,2017-09-14T12:49:40.000Z,$MRK Large Decrease in Open Interest https://marketchameleon.com/Overview/MRK/OptionSummary/OpenInterest/‚Ä¶,"$MRK Large Decrease in Open Interest https://marketchameleon.com/Overview/MRK/OptionSummary/OpenInterest/‚Ä¶
2",,,2,,['https://pbs.twimg.com/media/DJr4wgZXoAAayXa?format=jpg&name=small'],https://twitter.com/ITRADEVOL/status/908311789728931841
4439,Financial Carnivores,@HowieRegay,2017-09-13T01:50:18.000Z,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h1OgeY $MRK,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h1OgeY $MRK,,,,,['https://pbs.twimg.com/media/DJkYP8UWsAAgdN7?format=jpg&name=small'],https://twitter.com/HowieRegay/status/907783465369849856
4440,@Stockhoot,@Stockhoot,2017-09-13T05:05:50.000Z,$QQQ $TQQQ $MRK $AMZN $GOOG  - New recommendations from Marc M at  https://stockhoot.com/ExtAnalyst.aspx?id=37857611-085c-4708-a242-58084ec7cd63&srid=c13efeb6-651b-4c58-b610-4057c1013e96&from=StockTwits‚Ä¶,"$QQQ $TQQQ $MRK $AMZN $GOOG  - New recommendations from Marc M at  https://stockhoot.com/ExtAnalyst.aspx?id=37857611-085c-4708-a242-58084ec7cd63&srid=c13efeb6-651b-4c58-b610-4057c1013e96&from=StockTwits‚Ä¶
1",,,,1,[],https://twitter.com/stockhoot/status/907832670494892032
4441,SAC Tracker,@FDAadcomm,2017-09-13T18:11:34.000Z,"SAFETY VOTE #shingrix $GSK $MRK
11-Yes
0-No
0-Abstain","SAFETY VOTE #shingrix $GSK $MRK
11-Yes
0-No
0-Abstain
2",,,,2,['https://pbs.twimg.com/media/DJn2mc5WsAoPGpW?format=jpg&name=small'],https://twitter.com/FDAadcomm/status/908030410302640130
4442,FancyFinancy,@FancyFinancy,2017-09-14T13:10:10.000Z,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h2flP8 $MRK,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h2flP8 $MRK,,,,,['https://pbs.twimg.com/media/DJr9cmmU8AE17rP?format=jpg&name=small'],https://twitter.com/FancyFinancy/status/908316946587844609
4443,Charles Zinnel,@charles_zinnel,2017-09-13T20:51:41.000Z,$imuc surging AHs on SEC news- will remain listed until 12/31/18! buyout or partnership likely IMO $pfe $jnj $mrk $gsk $alxn,$imuc surging AHs on SEC news- will remain listed until 12/31/18! buyout or partnership likely IMO $pfe $jnj $mrk $gsk $alxn,,,,,[],https://twitter.com/charles_zinnel/status/908070701978062850
4444,Evaluate Vantage,@evaluatevantage,2017-09-13T15:11:01.000Z,Event ‚Äì The next showdown in first-line lung cancer http://epvantage.com/Universal/View.aspx?type=Story&id=731193&isEPVantage=yes‚Ä¶ $RHHBY $BMY $MRK $AZN,"Event ‚Äì The next showdown in first-line lung cancer http://epvantage.com/Universal/View.aspx?type=Story&id=731193&isEPVantage=yes‚Ä¶ $RHHBY $BMY $MRK $AZN
evaluate.com
Event ‚Äì The next showdown in first-line lung cancer
3
1",,,3,1,[],https://twitter.com/evaluatevantage/status/907984973474516992
4445,Margin Hunt,@MarginHunt,2017-09-14T01:45:07.000Z,"Ray Dalio owns Merck & Company, $MRK. Should you? Stock has nice upside http://ow.ly/j9os30f4BeR","Ray Dalio owns Merck & Company, $MRK. Should you? Stock has nice upside http://ow.ly/j9os30f4BeR",,,,,['https://pbs.twimg.com/media/DJpgp2kX0AAtyjo?format=jpg&name=small'],https://twitter.com/MarginHunt/status/908144549868003329
4446,Kara Jill Stancell,@kjilly,2017-09-14T20:29:58.000Z,$GSK lines up a shot at a blockbuster market as new CEO prepares to tackle $MRK rival head on #pharma #biotech -,"$GSK lines up a shot at a blockbuster market as new CEO prepares to tackle $MRK rival head on #pharma #biotech -
endpts.com
GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on
New GlaxoSmithKline CEO Emma Walmsley is one big step closer to taking a shot at a blockbuster marketing program today after an FDA panel review ended with a unanimous thumbs up for their new...",,,,,['https://pbs.twimg.com/card_img/1499192556282089472/HgvbFoAD?format=jpg&name=small'],https://twitter.com/kjilly/status/908427626255048704
4447,Heath Care News,@hc_equipment,2017-09-14T17:22:58.000Z,Germany's #Merck hires JP Morgan to sell consumer health. Read more: http://owler.us/adhQd8 $MRK,Germany's #Merck hires JP Morgan to sell consumer health. Read more: http://owler.us/adhQd8 $MRK,,,,,[],https://twitter.com/hc_equipment/status/908380567867031552
4448,BidaskClubOnTheirOwn,@BACOnTheirOwn,2017-09-13T12:00:05.000Z,BidaskClub top 50 #OntheirOwn $MRK $SNCR $ROK $HCLP $INFO $CMCSA $HMC $MKC $TRU $KEYS $MAN $JCOM $LECO $XRAY $BGCP http://bidaskclub.com/news/company-news/on-their-own/2017/09/the-on-their-own-companies-in-the-us-equity-market-50/‚Ä¶,BidaskClub top 50 #OntheirOwn $MRK $SNCR $ROK $HCLP $INFO $CMCSA $HMC $MKC $TRU $KEYS $MAN $JCOM $LECO $XRAY $BGCP http://bidaskclub.com/news/company-news/on-their-own/2017/09/the-on-their-own-companies-in-the-us-equity-market-50/‚Ä¶,,,,,[],https://twitter.com/BACOnTheirOwn/status/907936920898035714
4449,Heath Care News,@hc_equipment,2017-09-14T17:22:21.000Z,"#Merck KGaA, Darmstadt, Germany, Celebrates Successful Premiere at IAA. Read more: http://owler.us/adhQd9 $MRK","#Merck KGaA, Darmstadt, Germany, Celebrates Successful Premiere at IAA. Read more: http://owler.us/adhQd9 $MRK",,,,,[],https://twitter.com/hc_equipment/status/908380412505759744
4450,Pharmaceutical News,@pharma_sector,2017-09-15T11:00:42.000Z,"EOD Risers: Johnson & Johnson, #Merck & Co., Inc. Nike Inc. Read more: http://owler.us/adh166 $MRK","EOD Risers: Johnson & Johnson, #Merck & Co., Inc. Nike Inc. Read more: http://owler.us/adh166 $MRK",,,,,[],https://twitter.com/pharma_sector/status/908646751678095360
4451,Chameleon Options,@MC_OptionTrades,2017-09-13T21:31:42.000Z,Price Returns vs Expected Daily Move $JUNO $FOLD $ABBV $MRK $ABT $CELG $AMGN $BMY $PFE $GILD $VRX $TEVA http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $JUNO $FOLD $ABBV $MRK $ABT $CELG $AMGN $BMY $PFE $GILD $VRX $TEVA http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DJompp0XoAEvJ_s?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/908080774464905217
4452,James Sikes,@wosaikeneriki,2017-09-15T10:46:07.000Z,Merck And Co $MRK Share Value Declined While Picton Mahoney Asset Management Boosted Position by $14.04 Mil...,Merck And Co $MRK Share Value Declined While Picton Mahoney Asset Management Boosted Position by $14.04 Mil...,,,,,[],https://twitter.com/wosaikeneriki/status/908643085390958592
4453,IECONOMICS,@iECONOMICS,2017-09-15T13:45:32.000Z,Merck & Co $MRK market alert: 11-week high @ 66.17 https://ieconomics.com/merck,Merck & Co $MRK market alert: 11-week high @ 66.17 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/908688233021759488
4454,James Sikes,@wosaikeneriki,2017-09-15T20:39:26.000Z,Merck & Co $MRK Position Has Boosted by Kelly Lawrence W & Associates Inc http://bzweekly.com/merck-schlumberger-ltd-slb-stock-price-declined-while-rmb-capital-management-has-cut-holding-by-1-16-million/‚Ä¶,Merck & Co $MRK Position Has Boosted by Kelly Lawrence W & Associates Inc http://bzweekly.com/merck-schlumberger-ltd-slb-stock-price-declined-while-rmb-capital-management-has-cut-holding-by-1-16-million/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/908792394476396544
4455,James Sikes,@wosaikeneriki,2017-09-15T15:22:20.000Z,"Merck & Co $MRK Holder Manchester Capital Management Has Cut Holding by $451,588 http://bzweekly.com/merck-alphabet-goog-shareholder-robshaw-julian-associates-has-increased-its-holding-by-813405/‚Ä¶","Merck & Co $MRK Holder Manchester Capital Management Has Cut Holding by $451,588 http://bzweekly.com/merck-alphabet-goog-shareholder-robshaw-julian-associates-has-increased-its-holding-by-813405/‚Ä¶",,,,,[],https://twitter.com/wosaikeneriki/status/908712597544894465
4456,Hedge of Hedgies,@hedgeofhedgies,2017-09-13T18:50:09.000Z,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h0Xbgy $MRK,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h0Xbgy $MRK,,,,,['https://pbs.twimg.com/media/DJoBrK8XcAA_66z?format=jpg&name=small'],https://twitter.com/hedgeofhedgies/status/908040119931850755
4457,Chameleon Options,@MC_OptionTrades,2017-09-14T21:30:57.000Z,Price Returns vs Expected Daily Move $HALO $THC $PFE $MRK $JNJ $ABBV $BMY $CELG $FOLD $VRX $GILD $TEVA http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $HALO $THC $PFE $MRK $JNJ $ABBV $BMY $CELG $FOLD $VRX $GILD $TEVA http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DJtwEQhXkAMQAJ_?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/908442971032424449
4458,Charles Zinnel,@charles_zinnel,2017-09-13T20:33:48.000Z,$imuc surging AHs on SEC news buyout or partnership likely IMO $pfe $jnj $mrk $gsk $alxn,$imuc surging AHs on SEC news buyout or partnership likely IMO $pfe $jnj $mrk $gsk $alxn,,,,,[],https://twitter.com/charles_zinnel/status/908066202144174080
4459,Heath Care News,@hc_equipment,2017-09-15T19:16:26.000Z,#Merck KGaA Celebrates Successful Premiere at the IAA. Read more: http://owler.us/adh8yw $MRK,#Merck KGaA Celebrates Successful Premiere at the IAA. Read more: http://owler.us/adh8yw $MRK,,,,,[],https://twitter.com/hc_equipment/status/908771507165290496
4460,max pain,@optioncharts,2017-09-13T18:46:31.000Z,$MRK open interest for maturity 09/15/2017. High put=57.50 High call=65.00 #maxpain #options http://maximum-pain.com/options/open-interest?s=MRK&e=09%2f15%2f2017‚Ä¶,$MRK open interest for maturity 09/15/2017. High put=57.50 High call=65.00 #maxpain #options http://maximum-pain.com/options/open-interest?s=MRK&e=09%2f15%2f2017‚Ä¶,,,,,[],https://twitter.com/optioncharts/status/908039203103047681
4461,@Stockhoot,@Stockhoot,2017-09-13T16:56:12.000Z,$XHB $MRK $GOOG  - New recommendations from Marc M at  https://stockhoot.com/ExtAnalyst.aspx?id=37857611-085c-4708-a242-58084ec7cd63&srid=ac7f5185-55b4-4cbc-b707-432af9a12f2a&from=StockTwits‚Ä¶,$XHB $MRK $GOOG  - New recommendations from Marc M at  https://stockhoot.com/ExtAnalyst.aspx?id=37857611-085c-4708-a242-58084ec7cd63&srid=ac7f5185-55b4-4cbc-b707-432af9a12f2a&from=StockTwits‚Ä¶,,,,,[],https://twitter.com/stockhoot/status/908011441961291779
4462,Sweet Platform,@SweetPlatform,2017-09-14T15:46:54.000Z,"MRK Top news - Sep 14th, 2017 $MRK http://https://goo.gl/MkqhLf","MRK Top news - Sep 14th, 2017 $MRK http://https://goo.gl/MkqhLf",,,,,[],https://twitter.com/SweetPlatform/status/908356388895817730
4463,StockMarketVideo.com,@stockmarketvide,2017-09-15T14:50:34.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/908704599967780865
4464,Pharmaceutical News,@pharma_sector,2017-09-14T23:06:48.000Z,"#Merck & Co., Inc. Strengthens Immuno-Oncology Portfolio With Rigontec Acquisition. Read more: http://owler.us/adhUcZ $MRK","#Merck & Co., Inc. Strengthens Immuno-Oncology Portfolio With Rigontec Acquisition. Read more: http://owler.us/adhUcZ $MRK",,,,,[],https://twitter.com/pharma_sector/status/908467096509595648
4465,Pharmaceutical News,@pharma_sector,2017-09-14T23:06:11.000Z,Investigators at #Merck & Company Describe Findings in Nephrology (Pharmacokinetics of sugam... Read more: http://owler.us/adhUc3 $MRK,Investigators at #Merck & Company Describe Findings in Nephrology (Pharmacokinetics of sugam... Read more: http://owler.us/adhUc3 $MRK,,,,,[],https://twitter.com/pharma_sector/status/908466940980506625
4466,ChartMill,@ChartMill,2017-09-15T17:08:01.000Z,$MRK showing a nice technical picture. Check out the full analysis http://stockcharts.chartmill.com/u/rJeqltYYcZ #maya #indie,$MRK showing a nice technical picture. Check out the full analysis http://stockcharts.chartmill.com/u/rJeqltYYcZ #maya #indie,,,,,[],https://twitter.com/ChartMill/status/908739192490004480
4467,Gambiste,@GambisteFinance,2017-09-15T20:22:59.000Z,"Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $WFC $JNJ $WMT $WBA $VZ $MRK $XOM $GOOG $MSFT $KO http://gambiste.com/index.php/2017/09/15/gambiste-top-10-afternoon-most-tweeted-big-caps-45/‚Ä¶","Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $WFC $JNJ $WMT $WBA $VZ $MRK $XOM $GOOG $MSFT $KO http://gambiste.com/index.php/2017/09/15/gambiste-top-10-afternoon-most-tweeted-big-caps-45/‚Ä¶",,,,,[],https://twitter.com/GambisteFinance/status/908788258393481221
4468,LargeVoid Bot,@LargeVoidBot,2017-09-15T13:37:22.000Z,09:37 New 52wk Highs: $MON $MRK $MRVL $MTG $MTGE $MTOR $MYCC $NEE $NKTR,09:37 New 52wk Highs: $MON $MRK $MRVL $MTG $MTGE $MTOR $MYCC $NEE $NKTR,,,,,[],https://twitter.com/LargeVoidBot/status/908686181172371456
4469,FinInvTr,@FinInvTr,2017-09-14T19:26:04.000Z,"Stanley Druckenmiller's Current Stock Holdings -- https://buff.ly/2y2eipf

$CMCSA $CTRP $EA $JD $PYPL $MRK $EXPE","Stanley Druckenmiller's Current Stock Holdings -- https://buff.ly/2y2eipf

$CMCSA $CTRP $EA $JD $PYPL $MRK $EXPE",,,,,[],https://twitter.com/FinInvTr/status/908411545406836737
4470,US Banking News,@AmericanBanking,2017-09-13T12:14:33.000Z,Merck KGaA given ‚Ç¨123.00 PT by Citigroup Inc.. buy rating. http://ift.tt/2xy0Nl9 $MRK #MRK,Merck KGaA given ‚Ç¨123.00 PT by Citigroup Inc.. buy rating. http://ift.tt/2xy0Nl9 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/907940563776929792
4471,Bring Back The BTK (the index),@BioWino,2017-09-15T13:52:35.000Z,$mrk $pfe $gild $bmy pharma names still red hot.. maybe they are ready to put money to work.,$mrk $pfe $gild $bmy pharma names still red hot.. maybe they are ready to put money to work.,,,,,[],https://twitter.com/BioWino/status/908690008466427910
4472,Bring Back The BTK (the index),@BioWino,2017-09-14T17:16:17.000Z,"Couple of deaths can't stop $clls. 
$kite $juno $pfe $nvs $mrk $abbv
which one of these pharma names will step up and purchase?","Couple of deaths can't stop $clls. 
$kite $juno $pfe $nvs $mrk $abbv
which one of these pharma names will step up and purchase?",,,,,[],https://twitter.com/BioWino/status/908378884273565697
4473,Dakota Financial,@dakotafinancial,2017-09-15T09:50:33.000Z,"Investors Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2weyWpz","Investors Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2weyWpz",,,,,[],https://twitter.com/dakotafinancial/status/908629099576479744
4474,Multivalent Dirk Haussecker,@RNAiAnalyst,2017-09-14T11:25:24.000Z,The next shoe to drop will be from $MRK's CV program.,"The next shoe to drop will be from $MRK's CV program.
Moderna
@moderna_tx
 ¬∑ 14 Sep 2017
Our updated development pipeline: 16 #mRNA medicines; 7 Phase 1 studies
1
1",,1,,1,"['https://pbs.twimg.com/profile_images/1410575625350488064/2ywfTawX_mini.jpg', 'https://pbs.twimg.com/media/DJrgk7jVwAAGh1S?format=jpg&name=small']",https://twitter.com/RNAiAnalyst/status/908290581566312448
4475,Evaluate Pharma,@evaluatepharma,2017-09-13T16:11:29.000Z,"Event ‚Äì The next showdown in first-line lung cancer http://ow.ly/a63630f7XdL via 
@JacobPlieth
 @EPVantage
 $RHHBY $BMY $MRK $AZN","Event ‚Äì The next showdown in first-line lung cancer http://ow.ly/a63630f7XdL via 
@JacobPlieth
 @EPVantage
 $RHHBY $BMY $MRK $AZN
2",,,,2,['https://pbs.twimg.com/media/DJndWyJUQAAKfF3?format=png&name=small'],https://twitter.com/evaluatepharma/status/908000186823266305
4476,Olderpreneurs,@Olderpreneurs,2017-09-13T17:04:05.000Z,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h1wKaR $MRK,Merck snaps up a German immuno-oncology upstart in a $603M bolt-on deal https://buff.ly/2h1wKaR $MRK,,,,,['https://pbs.twimg.com/media/DJnpZXZVwAA9rwf?format=jpg&name=small'],https://twitter.com/Olderpreneurs/status/908013425565073408
4477,MarketBeat,@MarketBeatCom,2017-09-15T17:14:23.000Z,"First American Trust FSB Invests $242,000 in Merck & Company, Inc. $MRK Stock http://ift.tt/2fogxfz","First American Trust FSB Invests $242,000 in Merck & Company, Inc. $MRK Stock http://ift.tt/2fogxfz",,,,,[],https://twitter.com/MarketBeatCom/status/908740795099963392
4478,ABG Analytics,@ABG_Analytics,2017-09-15T22:01:05.000Z,All weekly stock reports now updated. Oversold: $CMCSA $MO Overbought: $AMGN $CELG $CVS $FMR $F $MRK $NSC $UNP $UPS http://abg-analytics.com/overbought-oversold.shtml‚Ä¶,All weekly stock reports now updated. Oversold: $CMCSA $MO Overbought: $AMGN $CELG $CVS $FMR $F $MRK $NSC $UNP $UPS http://abg-analytics.com/overbought-oversold.shtml‚Ä¶,,,,,[],https://twitter.com/ABG_Analytics/status/908812944045219840
4479,Watchlist News,@WatchlistN,2017-09-14T23:49:05.000Z,"Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2wtcmF2","Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2wtcmF2",,,,,[],https://twitter.com/WatchlistN/status/908477734116085761
4480,Ticker Report,@TickerReport,2017-09-15T17:04:30.000Z,"Indiana Trust & Investment Management CO Maintains Holdings in Merck & Company, Inc. $MRK http://ift.tt/2x81boY","Indiana Trust & Investment Management CO Maintains Holdings in Merck & Company, Inc. $MRK http://ift.tt/2x81boY",,,,,[],https://twitter.com/TickerReport/status/908738307495989248
4481,John Carroll,@JohnCendpts,2017-09-15T18:20:47.000Z,"FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths
$RHHBY $MRK","FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths
$RHHBY $MRK
endpts.com
FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths
Alarmed that an imbalance in deaths among patients taking a combination of Keytruda with Celgene‚Äôs Pomalyst and Revlimid could represent a threat in that whole class of checkpoint combos, the FDA has...
1
2",,,1,2,['https://pbs.twimg.com/card_img/1500753080698441728/cxPNMeBy?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/908757505576185857
4482,Chameleon Options,@MC_OptionTrades,2017-09-14T18:15:51.000Z,$MRK 27-Oct-17 ATM Implied Volatility is up +3.4% to 16.7. Straddle Implies a Move of ¬±4.7%. Earnings Oct 27 BMO. http://tinyurl.com/yczj7dce,$MRK 27-Oct-17 ATM Implied Volatility is up +3.4% to 16.7. Straddle Implies a Move of ¬±4.7%. Earnings Oct 27 BMO. http://tinyurl.com/yczj7dce,ü¶é,,,,[],https://twitter.com/MC_OptionTrades/status/908393874737057792
4483,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-09-14T10:25:46.000Z,"@JohnCendpts
: ""Big changes may be coming soon at $GSK, in a followup to its Adaptimmune pact""? $ADAP $MRK head on -","@JohnCendpts
: ""Big changes may be coming soon at $GSK, in a followup to its Adaptimmune pact""? $ADAP $MRK head on -
endpts.com
GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on
New GlaxoSmithKline CEO Emma Walmsley is one big step closer to taking a shot at a blockbuster marketing program today after an FDA panel review ended with a unanimous thumbs up for their new...
1
1
2",,1,1,2,['https://pbs.twimg.com/card_img/1499192556282089472/HgvbFoAD?format=jpg&name=small'],https://twitter.com/dhovekamp42/status/908275572773703680
4484,Dakota Financial,@dakotafinancial,2017-09-15T17:15:31.000Z,"First American Trust FSB Invests $242,000 in Merck & Company, Inc. $MRK Stock http://ift.tt/2fogxfz","First American Trust FSB Invests $242,000 in Merck & Company, Inc. $MRK Stock http://ift.tt/2fogxfz",,,,,[],https://twitter.com/dakotafinancial/status/908741080228810752
4485,MarketBeat,@MarketBeatCom,2017-09-15T09:49:32.000Z,"Investors Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2weyWpz","Investors Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2weyWpz",,,,,[],https://twitter.com/MarketBeatCom/status/908628844575383553
4486,BioWorld,@BioWorld,2017-09-13T18:25:01.000Z,FDA #adcom still parsing $GSK shingles vaccine Shingrix; could go up against $MRK's Zostavax,FDA #adcom still parsing $GSK shingles vaccine Shingrix; could go up against $MRK's Zostavax,,,,,[],https://twitter.com/BioWorld/status/908033792400658433
4487,Allison Gatlin,@IBD_AGatlin,2017-09-15T19:11:04.000Z,Abbvie's new hepatitis C drug chipping away at Gilead's share $GILD $ABBV $MRK $KITE $NVS $BLUE $JUNO $CELG http://ow.ly/vY1F30fbSiw,Abbvie's new hepatitis C drug chipping away at Gilead's share $GILD $ABBV $MRK $KITE $NVS $BLUE $JUNO $CELG http://ow.ly/vY1F30fbSiw,,,,,[],https://twitter.com/IBD_AGatlin/status/908770156863684608
4488,dough,@semodough,2017-09-15T17:45:12.000Z,"ISI per latest IMS data, $GILD competitor Hep C launch (ABBV‚Äôs Mavyret) is now tracking at 7% of total HCV NRx $ENTA $MRK","ISI per latest IMS data, $GILD competitor Hep C launch (ABBV‚Äôs Mavyret) is now tracking at 7% of total HCV NRx $ENTA $MRK
1",,,,1,[],https://twitter.com/semodough/status/908748548543479808
4489,BioWorld,@BioWorld,2017-09-13T17:58:42.000Z,"FDA adcom ""impressed"" with $GSK's shingles vaccine efficacy over $MRK's Zostavax though wants more diverse population studied","FDA adcom ""impressed"" with $GSK's shingles vaccine efficacy over $MRK's Zostavax though wants more diverse population studied",,,,,[],https://twitter.com/BioWorld/status/908027172643893248
4490,Seeking Alpha,@SeekingAlpha,2017-09-16T12:00:05.000Z,https://seekingalpha.com/article/4107437-3-things-biotech-learn-today-september-16-2017?source=feed_f‚Ä¶ $BMY $JNJ $MRK $MRTX $RHHBF,"https://seekingalpha.com/article/4107437-3-things-biotech-learn-today-september-16-2017?source=feed_f‚Ä¶ $BMY $JNJ $MRK $MRTX $RHHBF
seekingalpha.com
3 Things In Biotech You Should Learn Today: September 16, 2017
Roche is the next in line to feel the FDA hammer. Johnson & Johnson tries to move toward the front of the line in advanced prostate cancer.",,,,,['https://pbs.twimg.com/card_img/1489660067628519424/VfYFJfDz?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/909024083588792321
4491,BioSpace,@biospace,2017-09-18T19:05:06.000Z,Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist $MRK Exec http://ow.ly/xpjN30ffgn2,"Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist $MRK Exec http://ow.ly/xpjN30ffgn2
4
4",,,4,4,['https://pbs.twimg.com/media/DKB1C4AWAAYLllF?format=jpg&name=small'],https://twitter.com/biospace/status/909855820199940098
4492,Afurakan Emporium,@AfrakanEmporium,2017-09-18T17:32:55.000Z,$MRTX holding within a nice daily channel... MAKE $MRTX $MRK $DCTH $NVCN $ITUS $NETE GREAT AGAIN,"$MRTX holding within a nice daily channel... MAKE $MRTX $MRK $DCTH $NVCN $ITUS $NETE GREAT AGAIN
2",ü§£ ü§£ ü§£,,,2,['https://pbs.twimg.com/media/DKBf8kxWAAE4HEq?format=jpg&name=small'],https://twitter.com/AfrakanEmporium/status/909832621441605632
4493,1 min Stock Insights,@1MinuteStock,2017-09-16T10:45:02.000Z,Do you know that #WallStreet price for $MRK is $69.85,"Do you know that #WallStreet price for $MRK is $69.85
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/909005198294605825
4494,IECONOMICS,@iECONOMICS,2017-09-18T13:41:31.000Z,Merck & Co $MRK market alert: 12-week high @ 66.35 https://ieconomics.com/merck,Merck & Co $MRK market alert: 12-week high @ 66.35 https://ieconomics.com/merck,,,,,[],https://twitter.com/iECONOMICS/status/909774389218091008
4495,leahanne,@leahanneta,2017-09-18T16:16:40.000Z,"11:42 ET Volume Leader #92 - MRK 2,618,693 Merck & Company $MRK 66.04 -0.12 -0.18% High today of 66.41 day low","11:42 ET Volume Leader #92 - MRK 2,618,693 Merck & Company $MRK 66.04 -0.12 -0.18% High today of 66.41 day low
investorshangout.com
11:42 ET Volume Leader #92 - MRK - ALERTS, HOT STOCKS & CHARTS #4739899 - Investors Hangout
ALERTS, HOT STOCKS & CHARTS: 11:42 ET Volume Leader #92 - MRK 2,618,693 Merck Company $MRK 66.04 -0.12 -0.18% High today of 66. - #4739899",,,,,['https://pbs.twimg.com/card_img/1489662400739565568/VIdpQtc3?format=png&name=240x240'],https://twitter.com/leahanneta/status/909813434333777920
4496,Beverly A. Pekala,@PekalaLaw,2017-09-18T17:26:53.000Z,Chicago now requires every #pharma rep be licensed. $750 fee. Per year. $PFE $NVS $JNJ $MRK #stocks,"Chicago now requires every #pharma rep be licensed. $750 fee. Per year. $PFE $NVS $JNJ $MRK #stocks
dnainfo.com
1,000 Licensed Pharmaceutical Reps Means $700K To Treat Opioid Addicts
City officials have touted the license requirement as the toughest in the nation.
2",,2,,,[],https://twitter.com/PekalaLaw/status/909831101337817088
4497,FinInvTr,@FinInvTr,2017-09-18T05:50:03.000Z,"Top Companies In America ‚Äì Who's In The 2nd Tier? https://buff.ly/2x7A268

$AMGN $TM $CSCO $KO $INTC $PG $PEP $JNJ $MRK $CVX $WMT","Top Companies In America ‚Äì Who's In The 2nd Tier? https://buff.ly/2x7A268

$AMGN $TM $CSCO $KO $INTC $PG $PEP $JNJ $MRK $CVX $WMT
longshortinv.whotrades.com
Top 50 Companies In America ‚Äì Who‚Äôs Leading The Charge?
The following presents a list of the 50 top companies on the major US stock exchanges, with each column going by (in order) (1) market capitalization rank, (2) market cap (in billions), (3)‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1501264698255237121/a36mlk3Y?format=jpg&name=small'],https://twitter.com/FinInvTr/status/909655741371437056
4498,Pharmaceutical News,@pharma_sector,2017-09-18T23:32:42.000Z,#Merck FDA slaps enrollment hold on 2 Tecentriq studies after Keytruda myeloma trial deaths. Read more: http://owler.us/adiKRi $MRK,#Merck FDA slaps enrollment hold on 2 Tecentriq studies after Keytruda myeloma trial deaths. Read more: http://owler.us/adiKRi $MRK,,,,,[],https://twitter.com/pharma_sector/status/909923164053938179
4499,Daily Political,@dailypoliticaln,2017-09-17T17:07:38.000Z,"Merck & Company, Inc. $MRK Shares Bought by Trust Co http://ift.tt/2yhN5jc","Merck & Company, Inc. $MRK Shares Bought by Trust Co http://ift.tt/2yhN5jc",,,,,[],https://twitter.com/dailypoliticaln/status/909463872599412736
4500,Krypto Cop,@KryptoCop,2017-09-16T12:18:37.000Z,https://seekingalpha.com/article/4107437-3-things-biotech-learn-today-september-16-2017?source=tweet‚Ä¶ $BMY $JNJ $MRK $MRTX $RHHBF $IDXG,"https://seekingalpha.com/article/4107437-3-things-biotech-learn-today-september-16-2017?source=tweet‚Ä¶ $BMY $JNJ $MRK $MRTX $RHHBF $IDXG
seekingalpha.com
3 Things In Biotech You Should Learn Today: September 16, 2017
Roche is the next in line to feel the FDA hammer. Johnson & Johnson tries to move toward the front of the line in advanced prostate cancer.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/KryptoCop/status/909028751413010432
4501,FinInvTr,@FinInvTr,2017-09-18T19:16:05.000Z,"Stocks That Outperform The Market Have This One Trait In Common - https://buff.ly/2xgLE6s

$MMM $MNST $MO $MOMO $MON $MRK $MSFT","Stocks That Outperform The Market Have This One Trait In Common - https://buff.ly/2xgLE6s

$MMM $MNST $MO $MOMO $MON $MRK $MSFT",,,,,[],https://twitter.com/FinInvTr/status/909858584661553153
4502,1 min Stock Insights,@1MinuteStock,2017-09-16T10:26:02.000Z,"Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.45% of the current price","Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.45% of the current price
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/909000417719107584
4503,vnmaster gupta,@Gupta_Calling,2017-09-17T21:04:44.000Z,"$MRK $PFE $NVO anybody have a comparison article DPP4, SGLT2, GLP1, any others? for Diabetes Mellitus?","$MRK $PFE $NVO anybody have a comparison article DPP4, SGLT2, GLP1, any others? for Diabetes Mellitus?",,,,,[],https://twitter.com/Gupta_Calling/status/909523540407459840
4504,Gambiste,@GambisteFinance,2017-09-18T20:32:35.000Z,"Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $CELG $MRK $GOOG $GOOGL $NVS $AMGN $MO $JPM $MSFT $HD http://gambiste.com/index.php/2017/09/18/gambiste-top-10-afternoon-most-tweeted-big-caps-50/‚Ä¶","Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $CELG $MRK $GOOG $GOOGL $NVS $AMGN $MO $JPM $MSFT $HD http://gambiste.com/index.php/2017/09/18/gambiste-top-10-afternoon-most-tweeted-big-caps-50/‚Ä¶",,,,,[],https://twitter.com/GambisteFinance/status/909877835405434880
4505,bake mcbride,@ITRADEVOL,2017-09-18T20:35:48.000Z,After Hours Tradin Most Active $GDX $BAC $MSFT $GE $MU $AAPL $CERN $GDXJ $PFE $LC $FDC $BABA $MRK $SQ $SPY $GM $WFC https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,After Hours Tradin Most Active $GDX $BAC $MSFT $GE $MU $AAPL $CERN $GDXJ $PFE $LC $FDC $BABA $MRK $SQ $SPY $GM $WFC https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/909878646827036672
4506,Daily Political,@dailypoliticaln,2017-09-17T17:07:35.000Z,"Merck & Company, Inc. $MRK Shares Sold by Xact Kapitalforvaltning AB http://ift.tt/2yhN0Mq","Merck & Company, Inc. $MRK Shares Sold by Xact Kapitalforvaltning AB http://ift.tt/2yhN0Mq",,,,,[],https://twitter.com/dailypoliticaln/status/909463858053615616
4507,SwingTradeBot,@SwingTradeBot,2017-09-16T09:13:14.000Z,$MRK technical alerts: New Uptrend and Doji - Bearish?,"$MRK technical alerts: New Uptrend and Doji - Bearish?
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/908982098391961600
4508,Vista Partners LLC,@VistaPResearch,2017-09-18T08:14:54.000Z,"@RamonWickham
 Thanks for follow! #MondayMotivaton See Vista Partners #InvestingForLife #Biotech http://vistapglobal.com $ATOS $MRK $PFE","@RamonWickham
 Thanks for follow! #MondayMotivaton See Vista Partners #InvestingForLife #Biotech http://vistapglobal.com $ATOS $MRK $PFE
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DJ_gL_EUEAAIwp5.jpg'],https://twitter.com/VistaPResearch/status/909692193576673281
4509,OncologyInfo,@OncologyInfo,2017-09-18T17:11:29.000Z,"The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017 
@themotleyfool
 #stocks $MRK, $BMY","The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017 
@themotleyfool
 #stocks $MRK, $BMY
fool.com
The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017 @themotleyfool #stocks...
These next-generation medicines are quickly becoming the foundation for advanced cancer treatments.",,,,,[],https://twitter.com/OncologyInfo/status/909827228866838528
4510,Biotech2050,@Biotech2050,2017-09-17T04:17:02.000Z,"Replying to 
@semodough
, 
@srqstockpicker
 and 
@anthonymatomd","Replying to 
@semodough
, 
@srqstockpicker
 and 
@anthonymatomd
Also a week ago this trial was initiated https://clinicaltrials.gov/show/NCT03283137‚Ä¶ $TGTX $MRK combo
clinicaltrials.gov
Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL...
Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL - Full Text View.
1
2",,,1,2,['https://pbs.twimg.com/card_img/1499578112115363861/JaVVFVxw?format=png&name=240x240'],https://twitter.com/Biotech2050/status/909269941483950080
4511,Mr. Breakout,@sharptraders,2017-09-17T12:53:00.000Z,"Friday's ALL TIME NEW HIGHS, Over $1.00, Closed Up on at least 1.50x  ADV(50) ‚ñ∫‚ñ∫‚ñ∫ http://sharptraders.com/AllTimeNewHighs.html‚Ä¶  including 
$UCTT $MRK $NVDA  etc","Friday's ALL TIME NEW HIGHS, Over $1.00, Closed Up on at least 1.50x  ADV(50) ‚ñ∫‚ñ∫‚ñ∫ http://sharptraders.com/AllTimeNewHighs.html‚Ä¶  including 
$UCTT $MRK $NVDA  etc
2",,,,2,[],https://twitter.com/sharptraders/status/909399790211010561
4512,Helen Larsen,@Pro_Larsen,2017-09-18T19:37:31.000Z,Commented on https://seekingalpha.com/article/4107437-3-things-biotech-learn-today-september-16-2017?source=tweet#comment-76247044‚Ä¶ $BMY $JNJ $MRK $MRTX $RHHBF,Commented on https://seekingalpha.com/article/4107437-3-things-biotech-learn-today-september-16-2017?source=tweet#comment-76247044‚Ä¶ $BMY $JNJ $MRK $MRTX $RHHBF,,,,,[],https://twitter.com/Pro_Larsen/status/909863976174891008
4513,Gambiste,@GambisteFinance,2017-09-18T23:21:59.000Z,"Evening Most Tweeted Big Caps, check out Gambiste Top 10: $PM $PG $MRK $AMGN $TSM $MO $NVS $MSFT $MMM $CMCSA http://gambiste.com/index.php/2017/09/18/gambiste-top-10-evening-most-tweeted-big-caps-47/‚Ä¶","Evening Most Tweeted Big Caps, check out Gambiste Top 10: $PM $PG $MRK $AMGN $TSM $MO $NVS $MSFT $MMM $CMCSA http://gambiste.com/index.php/2017/09/18/gambiste-top-10-evening-most-tweeted-big-caps-47/‚Ä¶",,,,,[],https://twitter.com/GambisteFinance/status/909920467385020416
4514,MarketBeat,@MarketBeatCom,2017-09-18T06:59:41.000Z,"Merck & Company, Inc. $MRK Short Interest Up 27.3% in August http://ift.tt/2yiUC1t #acn","Merck & Company, Inc. $MRK Short Interest Up 27.3% in August http://ift.tt/2yiUC1t #acn",,,,,[],https://twitter.com/MarketBeatCom/status/909673262761865221
4515,Dakota Financial,@dakotafinancial,2017-09-16T16:55:10.000Z,"Pioneer Trust Bank N A OR Purchases 320 Shares of Merck & Company, Inc. $MRK http://ift.tt/2x7iSmO","Pioneer Trust Bank N A OR Purchases 320 Shares of Merck & Company, Inc. $MRK http://ift.tt/2x7iSmO",,,,,[],https://twitter.com/dakotafinancial/status/909098344500416517
4516,Dakota Financial,@dakotafinancial,2017-09-18T17:23:35.000Z,"Merck & Company, Inc. $MRK Stake Lifted by Cornerstone Advisors Inc. http://ift.tt/2hbzUfK","Merck & Company, Inc. $MRK Stake Lifted by Cornerstone Advisors Inc. http://ift.tt/2hbzUfK",,,,,[],https://twitter.com/dakotafinancial/status/909830272287461382
4517,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-09-16T14:46:26.000Z,"Replying to 
@doritmi","Replying to 
@doritmi
FU two 
@doritmi
 @Voices4Vaccines
 
@Merck
 employees sue $MRK over their faulty #MMR shot.
#vaccineswork for #WallSt 
https://youtube.com/watch?v=dLwfDr5OKlI&sns=tw‚Ä¶
2
1",,2,1,,[],https://twitter.com/ZimJay/status/909065950187720704
4518,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-09-17T01:44:59.000Z,"Replying to 
@MackayIM","Replying to 
@MackayIM
$MRK Faulty #MMR  
Lolz ...   Shorter Mac: "" I ain't never birthed no baby Miss Scarlet .""
https://youtube.com/watch?v=dLwfDr5OKlI&sns=tw‚Ä¶ via 
@youtube
1",,1,,,[],https://twitter.com/ZimJay/status/909231677964193794
4519,Transcript Daily,@TranscriptDaily,2017-09-18T07:04:41.000Z,"Merck & Company, Inc. $MRK Short Interest Up 27.3% in August http://ift.tt/2wAX0OY","Merck & Company, Inc. $MRK Short Interest Up 27.3% in August http://ift.tt/2wAX0OY",,,,,[],https://twitter.com/TranscriptDaily/status/909674522177097728
4520,Herkyleese,@herkyleese,2017-09-19T01:32:20.000Z,"no body goes after solid tumors, yet #ucla $nwbo use #dcvax for operable and inoperable solid tumors. Targeting most cancers$$$$ $bmy $mrk","no body goes after solid tumors, yet #ucla $nwbo use #dcvax for operable and inoperable solid tumors. Targeting most cancers$$$$ $bmy $mrk
0:45
483 views
4
11",,,4,11,['https://pbs.twimg.com/ext_tw_video_thumb/909947277136904192/pu/img/FZEuUnErnDyjR9-a.jpg'],https://twitter.com/herkyleese/status/909953271221112832
4521,Seeking Alpha,@SeekingAlpha,2017-09-21T13:03:48.000Z,https://seekingalpha.com/article/4108514-hold-zoetis-2017?source=feed_f‚Ä¶ $LLY $MRK $ZTS,https://seekingalpha.com/article/4108514-hold-zoetis-2017?source=feed_f‚Ä¶ $LLY $MRK $ZTS,,,,,[],https://twitter.com/SeekingAlpha/status/910852060463038465
4522,Vista Partners LLC,@VistaPResearch,2017-09-19T21:01:16.000Z,#KateWalsh on #BrainTumor Removal: ‚ÄòIt Was a Really Big Wake-Up Call‚Äô https://yahoo.com/entertainment/kate-walsh-brain-tumor-removal-really-big-wake-174647154.html?soc_src=social-sh&soc_trk=tw‚Ä¶ $DIA $MRK $PFE $ATOS http://vistapglobal.com,"#KateWalsh on #BrainTumor Removal: ‚ÄòIt Was a Really Big Wake-Up Call‚Äô https://yahoo.com/entertainment/kate-walsh-brain-tumor-removal-really-big-wake-174647154.html?soc_src=social-sh&soc_trk=tw‚Ä¶ $DIA $MRK $PFE $ATOS http://vistapglobal.com
GIF
1
3",,,1,3,['https://pbs.twimg.com/tweet_video_thumb/DKHZMRkVoAAT1bK.jpg'],https://twitter.com/VistaPResearch/status/910247440514613249
4523,Vista Partners LLC,@VistaPResearch,2017-09-20T15:33:15.000Z,Got to love the simplicity!  #NationalPepperoniPizzaDay #WednesdayWisdom Vista Partners #Investing http://vistapglobal.com $HIIQ $ATOS $MRK,"Got to love the simplicity!  #NationalPepperoniPizzaDay #WednesdayWisdom Vista Partners #Investing http://vistapglobal.com $HIIQ $ATOS $MRK
GIF
2
3",,,2,3,['https://pbs.twimg.com/tweet_video_thumb/DKLXu9cVAAAlq-K.jpg'],https://twitter.com/VistaPResearch/status/910527283718373377
4524,Drugdoctor1,@Drugdoctor2014,2017-09-19T16:22:10.000Z,$KAYS.15-4500 lb TOP SHELF WEED-NEWS! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS,"$KAYS.15-4500 lb TOP SHELF WEED-NEWS! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
1",,,,1,['https://pbs.twimg.com/media/DKGZFjrUIAAxfjr?format=jpg&name=small'],https://twitter.com/Drugdoctor2014/status/910177203001929730
4525,Antonio Costa,@ACInvestorBlog,2017-09-19T10:08:23.000Z,$MRK $ZYME Merck to Advance Bispecific Antibody Drug Candidate Developed Using Zymeworks‚Äô Azymetric Platform,"$MRK $ZYME Merck to Advance Bispecific Antibody Drug Candidate Developed Using Zymeworks‚Äô Azymetric Platform
businesswire.com
Merck to Advance Bispecific Antibody Drug Candidate Developed Using Zymeworks‚Äô Azymetric‚Ñ¢ Platform...
Zymeworks Inc. (‚ÄúZymeworks‚Äù), (NYSE: ZYME; TSX: ZYME) a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercia
2
3",,,2,3,['https://pbs.twimg.com/card_img/1500311540649574401/QBwXfKbG?format=png&name=240x240'],https://twitter.com/ACInvestorBlog/status/910083136918315008
4526,Dow Stocks,@Top_Dow_Stocks,2017-09-21T07:16:58.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/910764777290399745
4527,Chameleon Options,@MC_OptionTrades,2017-09-19T00:38:43.000Z,Price Moves vs Expected Moves $AXON $GILD $JNJ $AGN $CELG $PFE $BMY $MDT $MRK $VRX $ABBV $TEVA http://tinyurl.com/y7zbwhgq,Price Moves vs Expected Moves $AXON $GILD $JNJ $AGN $CELG $PFE $BMY $MDT $MRK $VRX $ABBV $TEVA http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DKDBZ1KVAAEf-8g?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/909939776362598401
4528,Stockboard Media Inc,@stockboardinc,2017-09-19T11:05:24.000Z,"$MRK Pro Baseball Hall of Famer and Cancer Survivor Mike Schmidt Joins Merck, Jim Kelly and Leading Cance... - http://sbml.co/ae0e8919","$MRK Pro Baseball Hall of Famer and Cancer Survivor Mike Schmidt Joins Merck, Jim Kelly and Leading Cance... - http://sbml.co/ae0e8919",,,,,[],https://twitter.com/stockboardinc/status/910097486408273921
4529,TickWatcher,@MITickWatcher,2017-09-20T20:05:04.000Z,"Top #moneyflow for #sp500 today
$AAPL $ORCL $NVDA $AMZN $CMCSA $JNJ $MMM $AGN $MAR $MRK ...","Top #moneyflow for #sp500 today
$AAPL $ORCL $NVDA $AMZN $CMCSA $JNJ $MMM $AGN $MAR $MRK ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/910595685946454016
4530,Sweet Platform,@SweetPlatform,2017-09-21T15:44:38.000Z,"MRK Top news - Sep 21st, 2017 $MRK http://https://goo.gl/edYMm9","MRK Top news - Sep 21st, 2017 $MRK http://https://goo.gl/edYMm9",,,,,[],https://twitter.com/SweetPlatform/status/910892532871122945
4531,CBPartners,@CBPartners,2017-09-19T19:40:09.000Z,NZL #PHARMAC proposes to fund $MRK ZOSTAVAX as #vaccine against #HerpesZoster for patients aged between 66 and 80 http://bit.ly/2wv9Bbq,NZL #PHARMAC proposes to fund $MRK ZOSTAVAX as #vaccine against #HerpesZoster for patients aged between 66 and 80 http://bit.ly/2wv9Bbq,,,,,[],https://twitter.com/CBPartners/status/910227027105648640
4532,MomoTrader 007,@MomoTrader007,2017-09-19T14:24:47.000Z,"$RXDX hope it closes red today so it will breakout HOY once for good, see u @ $1Billion mcap - oct data catalyst - $LOXO $MRTX $MRK","$RXDX hope it closes red today so it will breakout HOY once for good, see u @ $1Billion mcap - oct data catalyst - $LOXO $MRTX $MRK",,,,,[],https://twitter.com/MomoTrader007/status/910147666146988032
4533,Jerome,@HarryWanger,2017-09-19T16:43:53.000Z,"$AMGN, $ABBV, $BMY, $MRK, $PFE, $LLY, among others. 11 of top 20 prescription meds sold in the US are manufactured in Puerto Rico #Maria","$AMGN, $ABBV, $BMY, $MRK, $PFE, $LLY, among others. 11 of top 20 prescription meds sold in the US are manufactured in Puerto Rico #Maria",,,,,[],https://twitter.com/HarryWanger/status/910182669069164544
4534,CheckRare,@CheckRare,2017-09-21T12:46:11.000Z,2 Important Dates for Big Pharma $MRK $BMY,"2 Important Dates for Big Pharma $MRK $BMY
gurufocus.com
2 Important Dates for Big Pharma
Big PDUFA dates to watch for at the end of September",,,,,[],https://twitter.com/CheckRare/status/910847624995098625
4535,Dakota Financial,@dakotafinancial,2017-09-21T16:52:36.000Z,"Merck & Company, Inc. $MRK Shares Bought by Country Club Trust Company n.a. http://ift.tt/2wJkzFp","Merck & Company, Inc. $MRK Shares Bought by Country Club Trust Company n.a. http://ift.tt/2wJkzFp",,,,,[],https://twitter.com/dakotafinancial/status/910909638362697728
4536,Dakota Financial,@dakotafinancial,2017-09-21T16:42:50.000Z,"Dynamic Advisors Solutions LLC Has $549,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2hlpuXi","Dynamic Advisors Solutions LLC Has $549,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2hlpuXi",,,,,[],https://twitter.com/dakotafinancial/status/910907183000367104
4537,Daily Political,@dailypoliticaln,2017-09-20T17:44:04.000Z,"Howland Capital Management LLC Reduces Stake in Merck & Company, Inc. $MRK http://ift.tt/2w7NoLZ","Howland Capital Management LLC Reduces Stake in Merck & Company, Inc. $MRK http://ift.tt/2w7NoLZ",,,,,[],https://twitter.com/dailypoliticaln/status/910560203120300033
4538,1 min Stock Insights,@1MinuteStock,2017-09-19T11:17:02.000Z,We calculated 21-day Expected Return of $MRK for you: 6.81%,"We calculated 21-day Expected Return of $MRK for you: 6.81%
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/910100415332487170
4539,Daily Political,@dailypoliticaln,2017-09-21T16:48:25.000Z,"City Holding Co. Has $510,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2wJJokk","City Holding Co. Has $510,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2wJJokk",,,,,[],https://twitter.com/dailypoliticaln/status/910908586364203008
4540,Ticker Report,@TickerReport,2017-09-21T06:18:40.000Z,"Short Interest in Merck & Company, Inc. $MRK Expands By 27.3% http://ift.tt/2xSHva6","Short Interest in Merck & Company, Inc. $MRK Expands By 27.3% http://ift.tt/2xSHva6",,,,,[],https://twitter.com/TickerReport/status/910750102972661760
4541,Watchlist News,@WatchlistN,2017-09-19T17:59:01.000Z,"Merck & Company, Inc. $MRK Holdings Trimmed by Hartford Investment Management Co. http://ift.tt/2xcGmJY","Merck & Company, Inc. $MRK Holdings Trimmed by Hartford Investment Management Co. http://ift.tt/2xcGmJY",,,,,[],https://twitter.com/WatchlistN/status/910201579059515392
4542,Pharmaceutical News,@pharma_sector,2017-09-19T16:04:47.000Z,"Pro Baseball Hall Of Famer And Cancer Survivor Joins #Merck & Co., And Leading Cancer Organi... Read more: http://owler.us/adiYB9 $MRK","Pro Baseball Hall Of Famer And Cancer Survivor Joins #Merck & Co., And Leading Cancer Organi... Read more: http://owler.us/adiYB9 $MRK",,,,,[],https://twitter.com/pharma_sector/status/910172829466763264
4543,MarketBeat,@MarketBeatCom,2017-09-21T13:13:32.000Z,Merck KGaA given ‚Ç¨119.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2fCXRcj $MRK #MRK,Merck KGaA given ‚Ç¨119.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2fCXRcj $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/910854510205177856
4544,Dakota Financial,@dakotafinancial,2017-09-19T17:45:08.000Z,"Merck & Company, Inc. $MRK Holdings Trimmed by Aviance Capital Partners LLC http://ift.tt/2ybu41b","Merck & Company, Inc. $MRK Holdings Trimmed by Aviance Capital Partners LLC http://ift.tt/2ybu41b",,,,,[],https://twitter.com/dakotafinancial/status/910198085745303554
4545,Watchlist News,@WatchlistN,2017-09-20T17:58:17.000Z,"Mechanics Bank Trust Department Maintains Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xS14PU","Mechanics Bank Trust Department Maintains Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xS14PU",,,,,[],https://twitter.com/WatchlistN/status/910563781230686212
4546,US Banking News,@AmericanBanking,2017-09-20T20:41:44.000Z,Investment Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2yqsqto,Investment Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2yqsqto,,,,,[],https://twitter.com/AmericanBanking/status/910604916250562563
4547,US Banking News,@AmericanBanking,2017-09-21T06:21:41.000Z,Head to Head Contrast: Novo Nordisk A/S $NVO & Merck & $MRK http://ift.tt/2xSYdGl,Head to Head Contrast: Novo Nordisk A/S $NVO & Merck & $MRK http://ift.tt/2xSYdGl,,,,,[],https://twitter.com/AmericanBanking/status/910750862481510401
4548,Market Realist,@MarketRealist,2017-09-21T17:30:37.000Z,"Roche's Drugs, Trials, and FDA Approvals after 1H17 http://marketrealist.com/?p=2343543 $VEU $RHHBY $BMY $MRK","Roche's Drugs, Trials, and FDA Approvals after 1H17 http://marketrealist.com/?p=2343543 $VEU $RHHBY $BMY $MRK",,,,,[],https://twitter.com/MarketRealist/status/910919205498867713
4549,Market Realist,@MarketRealist,2017-09-20T16:50:09.000Z,Novo Nordisk and How It's Positioned after the 1st Half of 2017 http://marketrealist.com/?p=2339490 $LLY $MRK $NVO $SNY,Novo Nordisk and How It's Positioned after the 1st Half of 2017 http://marketrealist.com/?p=2339490 $LLY $MRK $NVO $SNY,,,,,[],https://twitter.com/MarketRealist/status/910546635901587458
4550,Market Realist,@MarketRealist,2017-09-20T11:20:09.000Z,Should Investors Consider Zoetis in September 2017? http://marketrealist.com/?p=2339769 $ZTS $LLY $MRK $REGN,Should Investors Consider Zoetis in September 2017? http://marketrealist.com/?p=2339769 $ZTS $LLY $MRK $REGN,,,,,[],https://twitter.com/MarketRealist/status/910463588137144320
4551,Chameleon,@MarketChmln,2017-09-19T20:35:54.000Z,Largest $Notional Sell On Close Order Imbalances $MRK $JPM $GM $JNJ $C $UNH $PFE $CVX $ETE $XOM http://tinyurl.com/y8jo8mjb,Largest $Notional Sell On Close Order Imbalances $MRK $JPM $GM $JNJ $C $UNH $PFE $CVX $ETE $XOM http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/910241059007025155
4552,EdisonHealthcare,@EdisonHealth,2017-09-19T15:53:54.000Z,".
@TransgeneSA
 1st Patient Treated in Phase Ib/II Trial of TG4001 + Avelumab 
in HPV+ Cancers. Collab. w 
@merckgroup
 & 
@pfizer
 $TNG $PFE $MRK",".
@TransgeneSA
 1st Patient Treated in Phase Ib/II Trial of TG4001 + Avelumab 
in HPV+ Cancers. Collab. w 
@merckgroup
 & 
@pfizer
 $TNG $PFE $MRK
1",,,,1,[],https://twitter.com/EdisonHealth/status/910170092226400256
4553,Trader Dave,@DNev47,2017-09-21T12:19:54.000Z,"3 Small-Cap Biotech Stocks to Buy This Fall 
@themotleyfool
 #stocks $MRK, $CLDX, $CELG, $INCY, $NLNK, $IDRA","3 Small-Cap Biotech Stocks to Buy This Fall 
@themotleyfool
 #stocks $MRK, $CLDX, $CELG, $INCY, $NLNK, $IDRA
fool.com
3 Small-Cap Biotech Stocks to Buy This Fall @themotleyfool #stocks $NLNK $MRK $CLDX $CELG $INCY...
Why small-cap biotechs Celldex Therapeutics, Idera Pharmaceuticals, and NewLink Genetics could be big winners.
1
1",,,1,1,[],https://twitter.com/DNev47/status/910841013635371008
4554,MarketBeat,@MarketBeatCom,2017-09-21T06:18:32.000Z,Head to Head Contrast: Novo Nordisk A/S $NVO & Merck & $MRK http://ift.tt/2hkO2Qm #acn,Head to Head Contrast: Novo Nordisk A/S $NVO & Merck & $MRK http://ift.tt/2hkO2Qm #acn,,,,,[],https://twitter.com/MarketBeatCom/status/910750069799911427
4555,MarketBeat,@MarketBeatCom,2017-09-20T20:43:38.000Z,Investment Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2xnYVdm #acn,Investment Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2xnYVdm #acn,,,,,[],https://twitter.com/MarketBeatCom/status/910605391419052032
4556,Ticker Report,@TickerReport,2017-09-20T20:52:39.000Z,Investment Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2wxLEQG,Investment Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2wxLEQG,,,,,[],https://twitter.com/TickerReport/status/910607662722711552
4557,Tom Silver,@TomSilver39,2017-09-24T16:57:50.000Z,European Society of Gene &Cell Therapy Berlin 17-20 October Schedule: $SGMO $BLUE $ONCE $BIIB $MRK $AVXS $EDIT $QURE https://esgct.eu/home/ESGCT_Berlin2017_MainCongress.pdf‚Ä¶,"European Society of Gene &Cell Therapy Berlin 17-20 October Schedule: $SGMO $BLUE $ONCE $BIIB $MRK $AVXS $EDIT $QURE https://esgct.eu/home/ESGCT_Berlin2017_MainCongress.pdf‚Ä¶
15
23",,,15,23,"['https://pbs.twimg.com/media/DKgRX3IUMAAT9JQ?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DKgRYOwVYAAzGBP?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DKgRYmsV4AAfjQF?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DKgRY6AU8AAPAx5?format=jpg&name=360x360']",https://twitter.com/TomSilver39/status/911998118954024961
4558,Anirban Maitra,@Aiims1742,2017-09-23T13:05:29.000Z,"ICYMI $MRK Keytruda launched in India against melanoma at 30% lower prices 
Still unaffordable for many families 
http://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/msd-launches-blockbuster-cancer-drug-keytruda-in-india/articleshow/60487138.cms‚Ä¶","ICYMI $MRK Keytruda launched in India against melanoma at 30% lower prices 
Still unaffordable for many families 
http://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/msd-launches-blockbuster-cancer-drug-keytruda-in-india/articleshow/60487138.cms‚Ä¶
4
10
9",,4,10,9,['https://pbs.twimg.com/media/DKaSrxFU8AYCtRo?format=jpg&name=small'],https://twitter.com/Aiims1742/status/911577260129488896
4559,Seeking Alpha,@SeekingAlpha,2017-09-23T12:00:05.000Z,https://seekingalpha.com/article/4108964-3-things-biotech-learn-today-september-23-2017?source=feed_f‚Ä¶ $MRK $RHHBF,https://seekingalpha.com/article/4108964-3-things-biotech-learn-today-september-23-2017?source=feed_f‚Ä¶ $MRK $RHHBF,,,,,[],https://twitter.com/SeekingAlpha/status/911560800686374912
4560,Brad Loncar,@bradloncar,2017-09-22T20:30:16.000Z,Added $MRK's gastric cancer approval to the tally of FDA approved immunotherapies. Congrats to them! http://loncarblog.com/immunotherapy-approvals-timeline‚Ä¶,"Added $MRK's gastric cancer approval to the tally of FDA approved immunotherapies. Congrats to them! http://loncarblog.com/immunotherapy-approvals-timeline‚Ä¶
1
4
10",,1,4,10,['https://pbs.twimg.com/media/DKWusaWW4AIzNlj?format=jpg&name=small'],https://twitter.com/bradloncar/status/911326805575036930
4561,Charles Zinnel,@charles_zinnel,2017-09-22T03:29:04.000Z,Email response I got from CYTRs proxy agent. What a joke! $cytr this needs investigated $pfe $jnj $mrk $gsk,"Email response I got from CYTRs proxy agent. What a joke! $cytr this needs investigated $pfe $jnj $mrk $gsk
1",,1,,,['https://pbs.twimg.com/media/DKTFKO3UMAEuYFh?format=jpg&name=900x900'],https://twitter.com/charles_zinnel/status/911069810611621889
4562,Margin Hunt,@MarginHunt,2017-09-23T09:45:06.000Z,Stocks w/ discounted EBITDA multiples vs peers: Biogen Inc. $BIIB $LLY $ABBV $SHPG $MRK $CELG http://ow.ly/Dd2330fhBru,Stocks w/ discounted EBITDA multiples vs peers: Biogen Inc. $BIIB $LLY $ABBV $SHPG $MRK $CELG http://ow.ly/Dd2330fhBru,,,,,['https://pbs.twimg.com/media/DKZk0pZW0AANoVr?format=jpg&name=small'],https://twitter.com/MarginHunt/status/911526832079597568
4563,Kara Jill Stancell,@kjilly,2017-09-22T19:01:18.000Z,Chutes & Ladders‚ÄîEx-$GSK CEO Witty joins #VC #biotech #pharma #managementchanges $AERI $MRK,"Chutes & Ladders‚ÄîEx-$GSK CEO Witty joins #VC #biotech #pharma #managementchanges $AERI $MRK
fiercebiotech.com
Chutes & Ladders‚ÄîEx-GlaxoSmithKline CEO Witty joins venture capital
GlaxoSmithKline's former CEO Andrew Witty and former R&D head Moncef Slaoui jumped into biotech venture capital, Aerie poached yet another executive from Novartis' Alcon unit, Roivant Sciences hired...",,,,,[],https://twitter.com/kjilly/status/911304415427969024
4564,Dow Stocks,@Top_Dow_Stocks,2017-09-22T07:16:58.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/911127164627513344
4565,James Sikes,@wosaikeneriki,2017-09-23T10:50:41.000Z,Merck & Co $MRK Holder Birchview Capital LP Has Decreased Its Holding as Market Value Declined ...,Merck & Co $MRK Holder Birchview Capital LP Has Decreased Its Holding as Market Value Declined ...,,,,,[],https://twitter.com/wosaikeneriki/status/911543337353703425
4566,James Sikes,@wosaikeneriki,2017-09-24T10:19:42.000Z,"As Merck & Co $MRK Market Valuation Declined, Holder Gateway Investment Advisers Upped Its Stake ...","As Merck & Co $MRK Market Valuation Declined, Holder Gateway Investment Advisers Upped Its Stake ...",,,,,[],https://twitter.com/wosaikeneriki/status/911897927592873984
4567,FinInvTr,@FinInvTr,2017-09-24T19:26:01.000Z,"Large/Mid Cap Fund Keeps Making All-Time Highs ‚Äì Overvalued Or More To Come? https://buff.ly/2xyyl1e

$VZ $PM $CMCSA $UNH $MRK $V $KO $PEP","Large/Mid Cap Fund Keeps Making All-Time Highs ‚Äì Overvalued Or More To Come? https://buff.ly/2xyyl1e

$VZ $PM $CMCSA $UNH $MRK $V $KO $PEP",,,,,[],https://twitter.com/FinInvTr/status/912035411433807872
4568,James Sikes,@wosaikeneriki,2017-09-22T16:26:01.000Z,"As Merck & Co $MRK Market Valuation Declined, Howland Capital Management Has Decreased Holding by $356,800 ...","As Merck & Co $MRK Market Valuation Declined, Howland Capital Management Has Decreased Holding by $356,800 ...",,,,,[],https://twitter.com/wosaikeneriki/status/911265335994699777
4569,Ticker Report,@TickerReport,2017-09-24T16:58:55.000Z,"Merck & Company, Inc. $MRK is Bonness Enterprises Inc.‚Äôs 9th Largest Position http://ift.tt/2fiLAJs","Merck & Company, Inc. $MRK is Bonness Enterprises Inc.‚Äôs 9th Largest Position http://ift.tt/2fiLAJs
1",,,,1,[],https://twitter.com/TickerReport/status/911998391038640128
4570,CBPartners,@CBPartners,2017-09-22T19:15:06.000Z,$MRK and $PZE #BAVENCIO receives EU green light as treatment for #MerkelCellCarcinoma patients #SkinCancer,"$MRK and $PZE #BAVENCIO receives EU green light as treatment for #MerkelCellCarcinoma patients #SkinCancer
pharmatimes.com
EU green light for Merck, Pfizer‚Äôs Bavencio
Adult patients with metastatic Merkel cell carcinoma (mMCC) in Europe stand to gain access to the first immunotherapy to treat the disease following regulatory approval of Merck and Pfizer‚Äôs Bavencio.",,,,,[],https://twitter.com/CBPartners/status/911307886671859713
4571,Sweet Platform,@SweetPlatform,2017-09-22T15:43:04.000Z,"MRK Top news - Sep 22nd, 2017 $MRK http://https://goo.gl/AqPBVr","MRK Top news - Sep 22nd, 2017 $MRK http://https://goo.gl/AqPBVr",,,,,[],https://twitter.com/SweetPlatform/status/911254528833572864
4572,FinInvTr,@FinInvTr,2017-09-23T23:21:04.000Z,"Top 50 US Companies: Who's Leading The Pack Performance-Wise?  https://buff.ly/2fIQMqH 

$V $TSM $MSFT $DIS $WFC $WMT $CVX $MRK $JNJ","Top 50 US Companies: Who's Leading The Pack Performance-Wise?  https://buff.ly/2fIQMqH 

$V $TSM $MSFT $DIS $WFC $WMT $CVX $MRK $JNJ",,,,,[],https://twitter.com/FinInvTr/status/911732175795613696
4573,John Carroll,@JohnCendpts,2017-09-22T10:48:17.000Z,"House committee wants to know a lot more about the cyberattack that damaged Merck
$MRK","House committee wants to know a lot more about the cyberattack that damaged Merck
$MRK
endpts.com
House committee wants to know a lot more about the cyberattack that damaged Merck
Up to now, Merck has been reluctant to go into much detail regarding just how damaging a recent cyberattack has been to operations. Now, though, it‚Äôs going to have to as the House Committee on Energy...
2
2",,,2,2,[],https://twitter.com/JohnCendpts/status/911180345269215233
4574,US Banking News,@AmericanBanking,2017-09-24T21:32:57.000Z,"$The, $MRK - Goldman Sachs Group, Inc. #The Analysts Give Merck KGaA #MRK a &euro;105.00 Price Target https://goo.gl/fb/aU4rsW","$The, $MRK - Goldman Sachs Group, Inc. #The Analysts Give Merck KGaA #MRK a &euro;105.00 Price Target https://goo.gl/fb/aU4rsW",,,,,[],https://twitter.com/AmericanBanking/status/912067353743118337
4575,1 min Stock Insights,@1MinuteStock,2017-09-22T20:04:02.000Z,Explore #fundamental numbers and pros and cons for $MRK,"Explore #fundamental numbers and pros and cons for $MRK
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/911320202360397824
4576,LargeVoid Bot,@LargeVoidBot,2017-09-22T13:34:22.000Z,09:34 New 52wk Highs: $MMM $MOMO $MRK $MSFT $MU $NFLX $NOBL $NRZ $NTIP,09:34 New 52wk Highs: $MMM $MOMO $MRK $MSFT $MU $NFLX $NOBL $NRZ $NTIP,,,,,[],https://twitter.com/LargeVoidBot/status/911222139591593985
4577,MarketBeat,@MarketBeatCom,2017-09-24T03:01:05.000Z,"Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Brokerages http://ift.tt/2xnE6zD #acn","Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Brokerages http://ift.tt/2xnE6zD #acn",,,,,[],https://twitter.com/MarketBeatCom/status/911787545578614784
4578,CBPartners,@CBPartners,2017-09-22T18:44:53.000Z,"#MS therapy $MRK MAVENCLAD launches in GBR and IRL, boasting lowest treatment burden of all available MS DMTs","#MS therapy $MRK MAVENCLAD launches in GBR and IRL, boasting lowest treatment burden of all available MS DMTs
pharmatimes.com
Merck‚Äôs MS pill Mavenclad launched in the UK and Ireland
Merck‚Äôs Mavenclad is now available in the UK and Ireland to treat highly active relapsing multiple sclerosis in adults.
1",,,1,,[],https://twitter.com/CBPartners/status/911300283585777667
4579,Gambiste,@GambisteFinance,2017-09-22T20:21:22.000Z,"Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $NVS $XOM $KO $V $PFE $CMCSA $GOOG $MRK $PG $INTC http://gambiste.com/index.php/2017/09/22/gambiste-top-10-afternoon-most-tweeted-big-caps-54/‚Ä¶","Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $NVS $XOM $KO $V $PFE $CMCSA $GOOG $MRK $PG $INTC http://gambiste.com/index.php/2017/09/22/gambiste-top-10-afternoon-most-tweeted-big-caps-54/‚Ä¶",,,,,[],https://twitter.com/GambisteFinance/status/911324565669912576
4580,TradeHawk,@TradeHawk,2017-09-22T19:12:22.000Z,$MRK Merck receives FDA approval for Keytruda for Treatment of Gastro Adenocarcinoma https://accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514‚Ä¶,"$MRK Merck receives FDA approval for Keytruda for Treatment of Gastro Adenocarcinoma https://accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514‚Ä¶
2
1",,,2,1,[],https://twitter.com/TradeHawk/status/911307199502196736
4581,Dakota Financial,@dakotafinancial,2017-09-22T17:12:54.000Z,"Iberiabank Corp Has $4.51 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xWRYRU","Iberiabank Corp Has $4.51 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xWRYRU",,,,,[],https://twitter.com/dakotafinancial/status/911277135955980288
4582,Daily Political,@dailypoliticaln,2017-09-23T07:29:13.000Z,"Merck & Company, Inc. $MRK Short Interest Update http://ift.tt/2xpKHqT","Merck & Company, Inc. $MRK Short Interest Update http://ift.tt/2xpKHqT",,,,,[],https://twitter.com/dailypoliticaln/status/911492635478683648
4583,Timothy L. Fortin,@fortint,2017-09-23T12:04:07.000Z,$MRK pembrolizumab approved in 3rd line gastric cancer (PD-L1 positive) http://mrknewsroom.com/news-release/prescription-medicine-news/fda-approves-mercks-keytruda-pembrolizumab-previously-treate‚Ä¶,$MRK pembrolizumab approved in 3rd line gastric cancer (PD-L1 positive) http://mrknewsroom.com/news-release/prescription-medicine-news/fda-approves-mercks-keytruda-pembrolizumab-previously-treate‚Ä¶,,,,,[],https://twitter.com/fortint/status/911561814701461504
4584,Dakota Financial,@dakotafinancial,2017-09-23T08:22:45.000Z,"Perkins Capital Management Inc. Has $590,000 Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xqufGS","Perkins Capital Management Inc. Has $590,000 Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xqufGS",,,,,[],https://twitter.com/dakotafinancial/status/911506107931283456
4585,Limex,@LimexMe,2017-09-22T17:58:24.000Z,AstraZeneca Stock Upgraded: What You Need to Know http://bit.ly/220917AZN $AZN $PFE $MRK $LLY,"AstraZeneca Stock Upgraded: What You Need to Know http://bit.ly/220917AZN $AZN $PFE $MRK $LLY
whotrades.com
AstraZeneca Stock Upgraded: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and ""initiate coverage"" on a few more. But do these analysts even know what they're talking about? Today, we're‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/911288584065478657
4586,Limex,@LimexMe,2017-09-22T18:19:22.000Z,"Cancer Space Update: Mixed Week for Pfizer, Roche Falters http://bit.ly/2xA5RV8 $PFE $RHHBY $TEVA $MRK","Cancer Space Update: Mixed Week for Pfizer, Roche Falters http://bit.ly/2xA5RV8 $PFE $RHHBY $TEVA $MRK
whotrades.com
Cancer Space Update: Mixed Week for Pfizer, Roche Falters
While last week was eventful with European Society for Medical Oncology (‚ÄúESMO‚Äù) congress taking place, this week saw the approval of Pfizer Inc.‚Äôs PFE Bavencio in Europe. On‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/911293863452663809
4587,Ticker Report,@TickerReport,2017-09-24T08:29:15.000Z,"Merck & Company, Inc. $MRK Shares Sold by Congress Asset Management Co. MA http://ift.tt/2jWRHse","Merck & Company, Inc. $MRK Shares Sold by Congress Asset Management Co. MA http://ift.tt/2jWRHse",,,,,[],https://twitter.com/TickerReport/status/911870130392567808
4588,SwingTradeBot,@SwingTradeBot,2017-09-22T18:42:37.000Z,"Recent $MRK technical alerts: 1,2,3 Pullback Bullish plus 5 more alerts...","Recent $MRK technical alerts: 1,2,3 Pullback Bullish plus 5 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/911299713059770374
4589,US Banking News,@AmericanBanking,2017-09-24T02:05:16.000Z,Analysts Give Average Rating of Hold to Merck & Company $MRK http://ift.tt/2qbDsRN,Analysts Give Average Rating of Hold to Merck & Company $MRK http://ift.tt/2qbDsRN,,,,,[],https://twitter.com/AmericanBanking/status/911773497491382272
4590,MarketBeat,@MarketBeatCom,2017-09-23T08:26:27.000Z,"Perkins Capital Management Inc. Has $590,000 Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xqufGS","Perkins Capital Management Inc. Has $590,000 Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xqufGS",,,,,[],https://twitter.com/MarketBeatCom/status/911507039855226880
4591,US Banking News,@AmericanBanking,2017-09-24T02:56:49.000Z,"Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Brokerages http://ift.tt/2hrfBqX","Merck & Company, Inc. $MRK Receives Consensus Rating of ‚ÄúHold‚Äù from Brokerages http://ift.tt/2hrfBqX",,,,,[],https://twitter.com/AmericanBanking/status/911786472461803521
4592,MarketBeat,@MarketBeatCom,2017-09-24T08:23:35.000Z,"Northeast Financial Consultants Inc Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2xruyB1","Northeast Financial Consultants Inc Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2xruyB1",,,,,[],https://twitter.com/MarketBeatCom/status/911868703310049280
4593,Market Realist,@MarketRealist,2017-09-22T23:10:22.000Z,What Allergan's Latest Developments Tell Us http://marketrealist.com/?p=2346569 $AGN $PFE $BMY $MRK,What Allergan's Latest Developments Tell Us http://marketrealist.com/?p=2346569 $AGN $PFE $BMY $MRK,,,,,[],https://twitter.com/MarketRealist/status/911367094725484546
4594,ECM Capital LLC,@ECMCapital,2017-09-22T17:40:15.000Z,"Retweeted Daily Political (
@DPolitical
):

$MRK - Merck KGaA #MRK Given a &euro;119.00 Price Target by Kepler... http://fb.me/2UofY0LMa","Retweeted Daily Political (
@DPolitical
):

$MRK - Merck KGaA #MRK Given a &euro;119.00 Price Target by Kepler... http://fb.me/2UofY0LMa",,,,,[],https://twitter.com/ECMCapital/status/911284017114185728
4595,TalkMarkets,@TalkMarkets,2017-09-23T21:03:49.000Z,Week In Review: Zai Lab Completes $150 Million US IPO; Investors Push Valuation To $1.4 Billion $MRK $ZLAB $DMPI https://goo.gl/jfeR3f,Week In Review: Zai Lab Completes $150 Million US IPO; Investors Push Valuation To $1.4 Billion $MRK $ZLAB $DMPI https://goo.gl/jfeR3f,,,,,[],https://twitter.com/TalkMarkets/status/911697635081408513
4596,Dakota Financial,@dakotafinancial,2017-09-24T08:24:29.000Z,"Northeast Financial Consultants Inc Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2xruyB1","Northeast Financial Consultants Inc Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2xruyB1",,,,,[],https://twitter.com/dakotafinancial/status/911868931048173568
4597,Daily Political,@dailypoliticaln,2017-09-22T17:14:00.000Z,"Waverton Investment Management Ltd Has $1,041,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2xoq1zc","Waverton Investment Management Ltd Has $1,041,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2xoq1zc",,,,,[],https://twitter.com/dailypoliticaln/status/911277413337792512
4598,Watchlist News,@WatchlistN,2017-09-24T17:06:33.000Z,"Central Bank & Trust Co. Reduces Stake in Merck & Company, Inc. $MRK http://ift.tt/2jXAj6H","Central Bank & Trust Co. Reduces Stake in Merck & Company, Inc. $MRK http://ift.tt/2jXAj6H",,,,,[],https://twitter.com/WatchlistN/status/912000312264855552
4599,Briefing.com,@Briefingcom,2017-09-22T21:35:51.000Z,$MRK: Merck announces that the FDA has approved KEYTRUDA for the treatment of patients with recurrent locally... http://bit.ly/2yvEf1q,$MRK: Merck announces that the FDA has approved KEYTRUDA for the treatment of patients with recurrent locally... http://bit.ly/2yvEf1q,,,,,[],https://twitter.com/Briefingcom/status/911343307690672131
4600,Arsalan Arif,@AKAarsalan,2017-09-22T10:46:56.000Z,House committee wants to know a lot more about the cyberattack that damaged Merck $MRK,"House committee wants to know a lot more about the cyberattack that damaged Merck $MRK
endpts.com
House committee wants to know a lot more about the cyberattack that damaged Merck
Up to now, Merck has been reluctant to go into much detail regarding just how damaging a recent cyberattack has been to operations. Now, though, it‚Äôs going to have to as the House Committee on Energy...",,,,,['https://pbs.twimg.com/card_img/1501992221553266698/EcXD5CEs?format=jpg&name=small'],https://twitter.com/AKAarsalan/status/911180002649104384
4601,Benzinga,@Benzinga,2017-09-23T13:23:00.000Z,Cramer's Guide To Profit From Market Rotations https://benzinga.com/z/10069482 $JNJ $MRK $PFE,"Cramer's Guide To Profit From Market Rotations https://benzinga.com/z/10069482 $JNJ $MRK $PFE
benzinga.com
Cramer's Guide To Profit From Market Rotations - Benzinga
1",,,,1,[],https://twitter.com/Benzinga/status/911581668888203264
4602,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-09-24T15:45:32.000Z,"Replying to 
@alexkasprak
 @gorskon
  and 2 others","Replying to 
@alexkasprak
 @gorskon
  and 2 others
Didn't take the #clickbait but imagine Paul Proffit doesn't mention his earnings from faulty #mmr maker & US defendant 
@Merck
 $MRK
#MedFraud",,,,,[],https://twitter.com/ZimJay/status/911979924357025792
4603,Vista Partners LLC,@VistaPResearch,2017-09-27T13:30:06.000Z,"""Keeps On Keepin' On""
https://finance.yahoo.com/news/keeps-keepin-130500652.html‚Ä¶ $UNH $MRK $ATOS $FSNN $HIIQ #healthcare  #investing #WednesdayMotivation","""Keeps On Keepin' On""
https://finance.yahoo.com/news/keeps-keepin-130500652.html‚Ä¶ $UNH $MRK $ATOS $FSNN $HIIQ #healthcare  #investing #WednesdayMotivation
GIF
1
2",,,1,2,[],https://twitter.com/VistaPResearch/status/913033005001666561
4604,Herkyleese,@herkyleese,2017-09-27T12:30:44.000Z,"http://Statnew.com/2017/07/21/mcc7/21/mccain-glioblastoma-treatments‚Ä¶  very informative article.  There is an unmet need in #GBM #Car-t #dcvax-l $nwbo 
@US_FDA
 @SGottliebFDA $bmy $mrk","http://Statnew.com/2017/07/21/mcc7/21/mccain-glioblastoma-treatments‚Ä¶  very informative article.  There is an unmet need in #GBM #Car-t #dcvax-l $nwbo 
@US_FDA
 @SGottliebFDA $bmy $mrk
1
5
10",,1,5,10,['https://pbs.twimg.com/ext_tw_video_thumb/913017551327715329/pu/img/4ln_W6JSvE-NnAUp.jpg'],https://twitter.com/herkyleese/status/913018063422967808
4605,Vista Partners LLC,@VistaPResearch,2017-09-27T06:01:37.000Z,9 symptoms of #breastcancer http://bit.ly/2yBCNuE Atossa Genetics clinical stage trials http://vistapglobal.com/2017/09/leading-breast-cancer-researcher-spearheading-atossa-genetics-atoss-topical-endoxifen-phase-2-trial-mbd/‚Ä¶ #biotech #stocks $IBB $MRK,"9 symptoms of #breastcancer http://bit.ly/2yBCNuE Atossa Genetics clinical stage trials http://vistapglobal.com/2017/09/leading-breast-cancer-researcher-spearheading-atossa-genetics-atoss-topical-endoxifen-phase-2-trial-mbd/‚Ä¶ #biotech #stocks $IBB $MRK
GIF
1
1
1",,1,1,1,['https://pbs.twimg.com/tweet_video_thumb/DKtYBH-XUAAVmlg.jpg'],https://twitter.com/VistaPResearch/status/912920139984785408
4606,Bret Jensen,@bret_jensen,2017-09-27T18:10:13.000Z,Commented on https://seekingalpha.com/article/4109817-biotech-forum-daily-digest-still-gains-ahead-dynavax?source=tweet&sht=owyah1&shu=aozs#comment-76333666‚Ä¶ $AXON $CORI $DVAX $GNCA $ICPT $KITE $MRK $PTCT $VCYT,Commented on https://seekingalpha.com/article/4109817-biotech-forum-daily-digest-still-gains-ahead-dynavax?source=tweet&sht=owyah1&shu=aozs#comment-76333666‚Ä¶ $AXON $CORI $DVAX $GNCA $ICPT $KITE $MRK $PTCT $VCYT,,,,,[],https://twitter.com/bret_jensen/status/913103498983620609
4607,The Biotech Forum,@thebiotechforum,2017-09-27T17:45:34.000Z,Biotech Forum Daily Digest: Still Gains Ahead For Dynavax https://seekingalpha.com/article/4109817-biotech-forum-daily-digest-still-gains-ahead-dynavax?source=tweet‚Ä¶ $AXON $CORI $DVAX $GNCA $ICPT $KITE $MRK $PTCT $VCYT,Biotech Forum Daily Digest: Still Gains Ahead For Dynavax https://seekingalpha.com/article/4109817-biotech-forum-daily-digest-still-gains-ahead-dynavax?source=tweet‚Ä¶ $AXON $CORI $DVAX $GNCA $ICPT $KITE $MRK $PTCT $VCYT,,,,,[],https://twitter.com/thebiotechforum/status/913097296346275841
4608,Margin Hunt,@MarginHunt,2017-09-26T15:30:23.000Z,The market is valuing Eli Lilly and $LLY at a premium vs peers. Sell? $BMY $MRK $AZN $PFE $TEVA http://ow.ly/21HB30fkvNt,The market is valuing Eli Lilly and $LLY at a premium vs peers. Sell? $BMY $MRK $AZN $PFE $TEVA http://ow.ly/21HB30fkvNt,,,,,['https://pbs.twimg.com/media/DKqQnnXWkAIKoE4?format=jpg&name=small'],https://twitter.com/MarginHunt/status/912700887193329664
4609,Vista Partners LLC,@VistaPResearch,2017-09-27T02:29:04.000Z,@DroneRacingMag thanks for follow! #TuesdayThoughts See Vista Partners #Trading #biotech http://vistapglobal.com $ATOS $MRK $PFE $JNJ $HIIQ,"@DroneRacingMag thanks for follow! #TuesdayThoughts See Vista Partners #Trading #biotech http://vistapglobal.com $ATOS $MRK $PFE $JNJ $HIIQ
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DKsnXkgVwAAwSpt.jpg'],https://twitter.com/VistaPResearch/status/912866648943497216
4610,Peter Blood,@ptrbld,2017-09-26T14:43:15.000Z,"#Soothsayer  (#AI #ML) "" $APC $MRK coming to life via Call Options -> probability function signaling end of their dog days  ""","#Soothsayer  (#AI #ML) "" $APC $MRK coming to life via Call Options -> probability function signaling end of their dog days  """,,,,,[],https://twitter.com/ptrbld/status/912689025550516224
4611,Dow Stocks,@Top_Dow_Stocks,2017-09-27T07:16:58.000Z,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.90% Weekly:-1.25% YTD:4.89% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/912939103515156480
4612,Jon Gardner,@ByJonGardner,2017-09-27T14:54:18.000Z,The Curious Case of the Well Timed Drug Price Increases: http://ow.ly/v4Rl30fsRVC $PFE $MRK $ABBV $AMGN $BMY $LLY,"The Curious Case of the Well Timed Drug Price Increases: http://ow.ly/v4Rl30fsRVC $PFE $MRK $ABBV $AMGN $BMY $LLY
evaluate.com
How politics has affected the timing of drug price rises
Data show that prices hardly budged in the first few months of 2017.
4",,,4,,[],https://twitter.com/ByJonGardner/status/913054193371553792
4613,Jacob Plieth,@JacobPlieth,2017-09-26T07:53:39.000Z,"How valid are those surrogate endpoints in immuno-oncology? US & EU regulators disagree. Via 
@EPVantage
 http://bit.ly/2yE7cIw $BMY $MRK","How valid are those surrogate endpoints in immuno-oncology? US & EU regulators disagree. Via 
@EPVantage
 http://bit.ly/2yE7cIw $BMY $MRK
evaluate.com
Immuno-oncology approval conflict in the firing line
7
9",,,7,9,[],https://twitter.com/JacobPlieth/status/912585947287576576
4614,FinInvTr,@FinInvTr,2017-09-25T22:07:00.000Z,"Duquesne Capital's Current Stock Holdings -- https://buff.ly/2fv2vfI

$CTRP $EA $JD $PYPL $MRK $EXPE","Duquesne Capital's Current Stock Holdings -- https://buff.ly/2fv2vfI

$CTRP $EA $JD $PYPL $MRK $EXPE",,,,,[],https://twitter.com/FinInvTr/status/912438312375345152
4615,Avisol Capital,@AvisolCapital,2017-09-25T13:02:50.000Z,"Daily Pharma Scoop 2017-09-25: $GILD at mid-80s, $MRK Keytruda new label, $ASND positive trial - http://avisolcapital.com/daily-pharma-scoop-2017-09-25-gild-at-mid-80s-mrk-keytruda-new-label-asnd-positive-trial/‚Ä¶","Daily Pharma Scoop 2017-09-25: $GILD at mid-80s, $MRK Keytruda new label, $ASND positive trial - http://avisolcapital.com/daily-pharma-scoop-2017-09-25-gild-at-mid-80s-mrk-keytruda-new-label-asnd-positive-trial/‚Ä¶",,,,,[],https://twitter.com/AvisolCapital/status/912301369675124737
4616,Sweet Platform,@SweetPlatform,2017-09-27T15:34:51.000Z,"MRK Top news - Sep 27th, 2017 $MRK http://https://goo.gl/L1TF9s","MRK Top news - Sep 27th, 2017 $MRK http://https://goo.gl/L1TF9s",,,,,[],https://twitter.com/SweetPlatform/status/913064400822652933
4617,Jon Gardner,@ByJonGardner,2017-09-25T20:24:44.000Z,"The ""Big Six"" tax plan comes out this week. Here's where biopharma taxes stood in 2016. $PFE $BMY $MRK $JNJ $AMGN http://bit.ly/2huqTPf","The ""Big Six"" tax plan comes out this week. Here's where biopharma taxes stood in 2016. $PFE $BMY $MRK $JNJ $AMGN http://bit.ly/2huqTPf
2
2",,,2,2,['https://pbs.twimg.com/media/DKmKRf7XoAE6o1O?format=jpg&name=small'],https://twitter.com/ByJonGardner/status/912412573642915842
4618,Mark Bottas,@MBottas27,2017-09-27T18:26:46.000Z,"I highly recommend checking this out for discovering good stocks to trade http://bit.ly/2wgCWSt
$KORS $MRK $MCD","I highly recommend checking this out for discovering good stocks to trade http://bit.ly/2wgCWSt
$KORS $MRK $MCD",,,,,[],https://twitter.com/MBottas27/status/913107664036667404
4619,MarketBeat,@MarketBeatCom,2017-09-26T13:12:34.000Z,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2wibHXO $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2wibHXO $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/912666204439040001
4620,TalkMarkets,@TalkMarkets,2017-09-26T17:10:41.000Z,3 Heart Disease Focused #Stocks To Buy Ahead Of World Heart Day $BEAT $EW $NVS Also $MRK $NVO $LLY https://goo.gl/1txJuh,3 Heart Disease Focused #Stocks To Buy Ahead Of World Heart Day $BEAT $EW $NVS Also $MRK $NVO $LLY https://goo.gl/1txJuh,,,,,[],https://twitter.com/TalkMarkets/status/912726128292499457
4621,Transcript Daily,@TranscriptDaily,2017-09-26T08:21:19.000Z,"Investors Asset Management of Georgia Inc. GA ADV Sells 936 Shares of Merck & Company, Inc. $MRK http://ift.tt/2y4foop","Investors Asset Management of Georgia Inc. GA ADV Sells 936 Shares of Merck & Company, Inc. $MRK http://ift.tt/2y4foop",,,,,[],https://twitter.com/TranscriptDaily/status/912592907705765889
4622,Stockflare US Page,@StockflareUS,2017-09-27T09:02:43.000Z,"$MRK: The MACD technical indicator for Merck & Co., Inc. has just fallen below zero indicating a negative signal. (https://stockflare.com/stock/MRK)","$MRK: The MACD technical indicator for Merck & Co., Inc. has just fallen below zero indicating a negative signal. (https://stockflare.com/stock/MRK)",,,,,[],https://twitter.com/StockflareUS/status/912965714251862016
4623,Gambiste,@GambisteFinance,2017-09-26T20:23:22.000Z,"Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $VZ $HD $CVX $GSK $V $MRK $MA $PG $UNH $BUD http://gambiste.com/index.php/2017/09/26/gambiste-top-10-afternoon-most-tweeted-big-caps-58/‚Ä¶","Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $VZ $HD $CVX $GSK $V $MRK $MA $PG $UNH $BUD http://gambiste.com/index.php/2017/09/26/gambiste-top-10-afternoon-most-tweeted-big-caps-58/‚Ä¶",,,,,[],https://twitter.com/GambisteFinance/status/912774621195390976
4624,Gambiste,@GambisteFinance,2017-09-25T23:23:13.000Z,"Evening Most Tweeted Big Caps, check out Gambiste Top 10: $MRK $CMCSA $JPM $PM $WMT $MDT $CSCO $BP $GOOGL $SNY http://gambiste.com/index.php/2017/09/25/gambiste-top-10-evening-most-tweeted-big-caps-54/‚Ä¶","Evening Most Tweeted Big Caps, check out Gambiste Top 10: $MRK $CMCSA $JPM $PM $WMT $MDT $CSCO $BP $GOOGL $SNY http://gambiste.com/index.php/2017/09/25/gambiste-top-10-evening-most-tweeted-big-caps-54/‚Ä¶",,,,,[],https://twitter.com/GambisteFinance/status/912457492105490432
4625,US Banking News,@AmericanBanking,2017-09-25T13:11:36.000Z,Merck KGaA given ‚Ç¨123.00 PT by Citigroup Inc.. buy rating. http://ift.tt/2ftuuMw $MRK #MRK,Merck KGaA given ‚Ç¨123.00 PT by Citigroup Inc.. buy rating. http://ift.tt/2ftuuMw $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/912303574864072704
4626,Ro Patel,@Ro_Patel,2017-09-25T17:23:02.000Z,US District in rules that $GILD conduct didn't warrant enhanced damages for willful infringement in $2.5B patent fight w/ $MRK sub Idenix,US District in rules that $GILD conduct didn't warrant enhanced damages for willful infringement in $2.5B patent fight w/ $MRK sub Idenix,,,,,[],https://twitter.com/Ro_Patel/status/912366848389402624
4627,clayton,@clayton_dd,2017-09-26T15:06:47.000Z,MRK 65.28 Merck & Company $MRK Std Dev +0.64. MRK Trading at 65.28 Day High 65.28 & Day Low 65.40 Change +0.10,"MRK 65.28 Merck & Company $MRK Std Dev +0.64. MRK Trading at 65.28 Day High 65.28 & Day Low 65.40 Change +0.10
investorshangout.com
MRK 65.28 Merck & Company $MRK - The Launch Pad #4758620 - Investors Hangout
The Launch Pad: MRK 65.28 Merck Company $MRK Std Dev +0.64. MRK Trading at 65.28 Day High 65.28 Day Low 65.40 - #4758620",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/clayton_dd/status/912694949212229632
4628,Dakota Financial,@dakotafinancial,2017-09-25T16:54:20.000Z,"Merck & Company, Inc. $MRK Holdings Lifted by Bank of Montreal Can http://ift.tt/2ht2Mwk","Merck & Company, Inc. $MRK Holdings Lifted by Bank of Montreal Can http://ift.tt/2ht2Mwk",,,,,[],https://twitter.com/dakotafinancial/status/912359625017774081
4629,Limex,@LimexMe,2017-09-26T20:31:25.000Z,Axovant Sciences (AXON) Stock Crashed Over 70%: Here's Why http://bit.ly/260917AXON1 $AXON $MRK $LLY,"Axovant Sciences (AXON) Stock Crashed Over 70%: Here's Why http://bit.ly/260917AXON1 $AXON $MRK $LLY
whotrades.com
Axovant Sciences (AXON) Stock Crashed Over 70%: Here's Why
On Tuesday, shares of biopharmaceutical company Axovant Sciences Ltd. AXON have crashed, and the stock is currently down over 70% to $6.72 per share in late-morning trading after it said‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/912776646964469760
4630,Transcript Daily,@TranscriptDaily,2017-09-27T08:21:49.000Z,"Steinberg Global Asset Management Reduces Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xvISLv","Steinberg Global Asset Management Reduces Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xvISLv",,,,,[],https://twitter.com/TranscriptDaily/status/912955423623401473
4631,Limex,@LimexMe,2017-09-26T18:18:23.000Z,3 Heart Disease Focused Stocks to Buy Ahead of World Heart Day http://bit.ly/260917NVO $NVO $BEAT $LLY $MRK,"3 Heart Disease Focused Stocks to Buy Ahead of World Heart Day http://bit.ly/260917NVO $NVO $BEAT $LLY $MRK
whotrades.com
3 Heart Disease Focused Stocks to Buy Ahead of World Heart Day
World Heart Day is observed every year on September 29 to raise awareness across the world about cardiovascular (CV) diseases. CV diseases, more commonly known as heart disease or‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/912743167069491201
4632,Daily Political,@dailypoliticaln,2017-09-25T08:09:22.000Z,"Strs Ohio Sells 371,775 Shares of Merck & Company, Inc. $MRK http://ift.tt/2wNirkW","Strs Ohio Sells 371,775 Shares of Merck & Company, Inc. $MRK http://ift.tt/2wNirkW",,,,,[],https://twitter.com/dailypoliticaln/status/912227514193530880
4633,Ticker Report,@TickerReport,2017-09-26T17:14:30.000Z,"Cornerstone Investment Partners LLC Sells 52 Shares of Merck & Company, Inc. $MRK http://ift.tt/2wRY5H2","Cornerstone Investment Partners LLC Sells 52 Shares of Merck & Company, Inc. $MRK http://ift.tt/2wRY5H2",,,,,[],https://twitter.com/TickerReport/status/912727088939102208
4634,Watchlist News,@WatchlistN,2017-09-25T16:54:08.000Z,"Appleton Partners Inc. MA Cuts Stake in Merck & Company, Inc. $MRK http://ift.tt/2xvnpzQ","Appleton Partners Inc. MA Cuts Stake in Merck & Company, Inc. $MRK http://ift.tt/2xvnpzQ",,,,,[],https://twitter.com/WatchlistN/status/912359574803550208
4635,Stockboard Media Inc,@stockboardinc,2017-09-27T10:50:13.000Z,$MRK Merck to Hold Third-Quarter 2017 Sales and Earnings Conference Call on October 27... - http://sbml.co/dc9406d1,$MRK Merck to Hold Third-Quarter 2017 Sales and Earnings Conference Call on October 27... - http://sbml.co/dc9406d1,,,,,[],https://twitter.com/stockboardinc/status/912992767483301889
4636,Watchlist News,@WatchlistN,2017-09-26T17:13:56.000Z,"Hays Advisory LLC Increases Holdings in Merck & Company, Inc. $MRK http://ift.tt/2hxtog2","Hays Advisory LLC Increases Holdings in Merck & Company, Inc. $MRK http://ift.tt/2hxtog2",,,,,[],https://twitter.com/WatchlistN/status/912726946454351873
4637,Watchlist News,@WatchlistN,2017-09-26T17:04:52.000Z,"Merck & Company, Inc. $MRK Shares Bought by GW&K Investment Management LLC http://ift.tt/2yr48P4","Merck & Company, Inc. $MRK Shares Bought by GW&K Investment Management LLC http://ift.tt/2yr48P4",,,,,[],https://twitter.com/WatchlistN/status/912724665130455040
4638,bake mcbride,@ITRADEVOL,2017-09-26T14:39:35.000Z,Option Trades Screener for Trade IDEAS $SPY $SNAP $BAC $MGM $GDX $ASML $QQQ $RAD $NVDA $XLF $FB $MRK $BABA $BP $VXX https://marketchameleon.com/Screeners/OptionTrades‚Ä¶,Option Trades Screener for Trade IDEAS $SPY $SNAP $BAC $MGM $GDX $ASML $QQQ $RAD $NVDA $XLF $FB $MRK $BABA $BP $VXX https://marketchameleon.com/Screeners/OptionTrades‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/912688104024231936
4639,TalkMarkets,@TalkMarkets,2017-09-27T15:55:06.000Z,#Aldeyra Raises Additional Capital To Fund Dry Eye Treatment $ALDX Also $AGN $SHPG $GILD $MRK https://goo.gl/xkD9AP,#Aldeyra Raises Additional Capital To Fund Dry Eye Treatment $ALDX Also $AGN $SHPG $GILD $MRK https://goo.gl/xkD9AP,,,,,[],https://twitter.com/TalkMarkets/status/913069495283060736
4640,Michael Goodman,@mikegoodma,2017-09-25T13:42:14.000Z,"$EXEL has a few other partnered assets: a pan-PI3k w $SNY in P2, a PI3k-delta in preclinic licensed to $MRK, & a RORgamma licensed to $BMY","$EXEL has a few other partnered assets: a pan-PI3k w $SNY in P2, a PI3k-delta in preclinic licensed to $MRK, & a RORgamma licensed to $BMY
1
1",,,1,1,[],https://twitter.com/mikegoodma/status/912311282325434368
4641,US Banking News,@AmericanBanking,2017-09-26T07:15:14.000Z,Merck KGaA given ‚Ç¨120.00 PT by UBS AG. buy rating. http://ift.tt/2fNH3PY $MRK #MRK,Merck KGaA given ‚Ç¨120.00 PT by UBS AG. buy rating. http://ift.tt/2fNH3PY $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/912576280356323328
4642,Ticker Report,@TickerReport,2017-09-26T08:28:16.000Z,"Merck & Company, Inc. $MRK Shares Sold by Beck Mack & Oliver LLC http://ift.tt/2jXa7c0","Merck & Company, Inc. $MRK Shares Sold by Beck Mack & Oliver LLC http://ift.tt/2jXa7c0",,,,,[],https://twitter.com/TickerReport/status/912594659578400769
4643,US Banking News,@AmericanBanking,2017-09-25T11:31:35.000Z,"$10.45 Billion in Sales Expected for Merck & Company, Inc. $MRK This Quarter http://ift.tt/2xzVdx7","$10.45 Billion in Sales Expected for Merck & Company, Inc. $MRK This Quarter http://ift.tt/2xzVdx7",,,,,[],https://twitter.com/AmericanBanking/status/912278403314802688
4644,MarketBeat,@MarketBeatCom,2017-09-26T17:10:12.000Z,"Banced Corp Has $361,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2y6v2zA","Banced Corp Has $361,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2y6v2zA",,,,,[],https://twitter.com/MarketBeatCom/status/912726007320326144
4645,Market Realist,@MarketRealist,2017-09-27T12:03:06.000Z,Investor Update: A Look at Johnson &amp; Johnson's Key Developments http://marketrealist.com/?p=2352536 $JNJ $PFE $MRK $AMGN,Investor Update: A Look at Johnson &amp; Johnson's Key Developments http://marketrealist.com/?p=2352536 $JNJ $PFE $MRK $AMGN,,,,,[],https://twitter.com/MarketRealist/status/913011111028457472
4646,Bio&TechWebinar,@BioTechWebinar,2017-09-27T08:21:48.000Z,"Antibacterial products pipeline 
@WHO
 $GSK $NVS 
@Spero_Tx
 $MRK ... #AntibioticResistance #AMR #pharma #biotech http://who.int/entity/research-observatory/monitoring/processes/gohrd_antibacterial_products.xls?ua=1‚Ä¶","Antibacterial products pipeline 
@WHO
 $GSK $NVS 
@Spero_Tx
 $MRK ... #AntibioticResistance #AMR #pharma #biotech http://who.int/entity/research-observatory/monitoring/processes/gohrd_antibacterial_products.xls?ua=1‚Ä¶",,,,,[],https://twitter.com/BioTechWebinar/status/912955417583587328
4647,cowenresearch,@CowenResearch,2017-09-26T17:10:01.000Z,"Steve Scala publishes 790-page quarterly overview, #Pharma Pulse $LLY $BMY $PFE $RHHBY $SNY $MRK $GSK $NVS $AZN $ABBV $ZTS #CowenHealthCare","Steve Scala publishes 790-page quarterly overview, #Pharma Pulse $LLY $BMY $PFE $RHHBY $SNY $MRK $GSK $NVS $AZN $ABBV $ZTS #CowenHealthCare
1",,,,1,[],https://twitter.com/CowenResearch/status/912725962319646721
4648,Muathe,@muathe,2017-09-25T10:33:49.000Z,"[REPOST] U.S. Market Technical Analysis Sept 24, 2017 $M $ABX $CPN $SCHW $COP $OPK $LB $MRK $CVE $NTNX $CCC $KEY","[REPOST] U.S. Market Technical Analysis Sept 24, 2017 $M $ABX $CPN $SCHW $COP $OPK $LB $MRK $CVE $NTNX $CCC $KEY
youtube.com
[ Public Version ] U.S. Market Technical Analysis Sept 22nd - 24th,...
Ôº¨Ôº©Ôº´Ôº• | Ôº£ÔºØÔº≠Ôº≠Ôº•ÔºÆÔº¥ | Ôº≥Ôº®Ôº°Ôº≤Ôº• | Ôº≥ÔºµÔº¢Ôº≥Ôº£Ôº≤Ôº©Ôº¢Ôº•My Website; http://www.muathe.com/Original Muathe.com Concepts!LOG ON TO WWW.MUATHE.COM FOR THE EXCLUSIVE PART TWO VIDEO OF...",,,,,['https://pbs.twimg.com/card_img/1501714330416517120/2yJm0v-2?format=jpg&name=240x240'],https://twitter.com/muathe/status/912263865743826945
4649,Zacks.com,@ZacksResearch,2017-09-26T21:11:26.000Z,Kevin Matras takes a look at the top stocks with big potential catch-up moves. $MRK $LKQ $HON $HAE $EMN,"Kevin Matras takes a look at the top stocks with big potential catch-up moves. $MRK $LKQ $HON $HAE $EMN
zacks.com
Top Stocks with Big Potential Catch-Up Moves
Given the recent run-up in the market, here's a screen I've been using recently. Highlighted stocks include MRK, HAE, LKQ, EMN and HON.
1",,,,1,[],https://twitter.com/ZacksResearch/status/912786718033670149
4650,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-09-25T14:17:57.000Z,"Replying to 
@LotusOak
 and 
@Vimeo","Replying to 
@LotusOak
 and 
@Vimeo
The #CDCWhistleblower tells how 
@Merck
 's faulty #MMR shot effects AA babies -
@CDC
 dumped data in the trash. $MRK #Lawsuit",,,,,[],https://twitter.com/ZimJay/status/912320273529163776
4651,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-09-25T18:41:33.000Z,"Replying to 
@pharmagossip","Replying to 
@pharmagossip
We're in this mess bc the 
@US_FDA
 doesn't regulate them - dirty $MRK $PFE $GSK #PerduePharma 
WeThePeople = Pill eating ATM machines",,,,,[],https://twitter.com/ZimJay/status/912386609663938560
4652,MarketBeat,@MarketBeatCom,2017-09-26T07:17:28.000Z,Merck KGaA given ‚Ç¨120.00 PT by UBS AG. buy rating. http://ift.tt/2fNH3PY $MRK #MRK,Merck KGaA given ‚Ç¨120.00 PT by UBS AG. buy rating. http://ift.tt/2fNH3PY $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/912576841629749248
4653,Dakota Financial,@dakotafinancial,2017-09-26T17:10:16.000Z,"Banced Corp Has $361,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2y6v2zA","Banced Corp Has $361,000 Position in Merck & Company, Inc. $MRK http://ift.tt/2y6v2zA",,,,,[],https://twitter.com/dakotafinancial/status/912726026240786432
4654,Clark Joseph Kent,@JorelLaraKalel,2017-09-26T21:52:31.000Z,"Top Stocks with Big Potential Catch-Up Moves $HON $EMN $HAE $LKQ $MRK http://bit.ly/2xAWDpO 
@zacks","Top Stocks with Big Potential Catch-Up Moves $HON $EMN $HAE $LKQ $MRK http://bit.ly/2xAWDpO 
@zacks
zacks.com
Top Stocks with Big Potential Catch-Up Moves
Given the recent run-up in the market, here's a screen I've been using recently. Highlighted stocks include MRK, HAE, LKQ, EMN and HON.",,,,,[],https://twitter.com/JorelLaraKalel/status/912797055042686976
4655,Branko Krstevski,@KrstevskiBranko,2017-09-28T01:14:22.000Z,"Dr Linda Liau promoted to chair at UCLA.
She is the creator of $NWBO DCVax-L GBM cancer vaccine @ Ph3.
$BMY $MRK 

http://newsroom.ucla.edu/dept/faculty/neurosurgeon-scientist-takes-helm-of-ucla-neurosurgery‚Ä¶","Dr Linda Liau promoted to chair at UCLA.
She is the creator of $NWBO DCVax-L GBM cancer vaccine @ Ph3.
$BMY $MRK 

http://newsroom.ucla.edu/dept/faculty/neurosurgeon-scientist-takes-helm-of-ucla-neurosurgery‚Ä¶
2
18
27",,2,18,27,['https://pbs.twimg.com/media/DKxf3kdV4AAoaQp?format=jpg&name=small'],https://twitter.com/KrstevskiBranko/status/913210239591186433
4656,Vista Partners LLC,@VistaPResearch,2017-09-28T14:03:53.000Z,"""Keeps On Keepin' On"" https://finance.yahoo.com/news/keeps-keepin-130500652.html‚Ä¶ 
$UNH $MRK $ATOS $FSNN $HIIQ #biotech #StockMarket  #ThursdayMotivation","""Keeps On Keepin' On"" https://finance.yahoo.com/news/keeps-keepin-130500652.html‚Ä¶ 
$UNH $MRK $ATOS $FSNN $HIIQ #biotech #StockMarket  #ThursdayMotivation
GIF
1
3",,,1,3,['https://pbs.twimg.com/tweet_video_thumb/DK0P_k9UQAM1X8b.jpg'],https://twitter.com/VistaPResearch/status/913403894935412737
4657,Seeking Alpha,@SeekingAlpha,2017-09-29T02:59:53.000Z,https://seekingalpha.com/article/4110476-safer-dividend-dow-dogs-go-apple-disney-ibm-gains-per-broker-september-estimates?source=feed_f‚Ä¶ $AAPL #APPLE $CAT $CSCO $DIS $IBM $INTC $JNJ $MCD $MRK $MSFT $PFE $PG $UNH $UTX $WMT $XOM,"https://seekingalpha.com/article/4110476-safer-dividend-dow-dogs-go-apple-disney-ibm-gains-per-broker-september-estimates?source=feed_f‚Ä¶ $AAPL #APPLE $CAT $CSCO $DIS $IBM $INTC $JNJ $MCD $MRK $MSFT $PFE $PG $UNH $UTX $WMT $XOM
1
2",,,1,2,[],https://twitter.com/SeekingAlpha/status/913599180857163776
4658,Gery DIVRY,@GeryDIVRY,2017-09-30T10:26:08.000Z,Commented on https://seekingalpha.com/article/4110628-intercept-runs-trouble-nash-developers-like-galectin-gain-value?source=tweet&sht=ox38zk&shu=l8mmr#comment-76361641‚Ä¶ $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT,"Commented on https://seekingalpha.com/article/4110628-intercept-runs-trouble-nash-developers-like-galectin-gain-value?source=tweet&sht=ox38zk&shu=l8mmr#comment-76361641‚Ä¶ $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT
1",,,1,,[],https://twitter.com/GeryDIVRY/status/914073873997426688
4659,Henry E. Chang,@HenryEChang,2017-09-29T13:41:43.000Z,"#BREAKING | 
@Merck
 discontinues development of MK-3682B (GZR/RZR/UPR) & MK-3682C (RZR/UPR) for #HCV treatment‚Üíhttp://ow.ly/GLsm30fwfkw $MRK","#BREAKING | 
@Merck
 discontinues development of MK-3682B (GZR/RZR/UPR) & MK-3682C (RZR/UPR) for #HCV treatment‚Üíhttp://ow.ly/GLsm30fwfkw $MRK
1
18
4",,1,18,4,[],https://twitter.com/HenryEChang/status/913760704922030086
4660,Hotpage News,@Hotpage_News,2017-09-29T13:26:07.000Z,EARLY MOVERS: $KBH $MRK $MA $V $AIG $AMZN $VLKAY $WMT $GOOGL $SNE $IVZ $TSN $TWTR $AAPL - CNBC,"EARLY MOVERS: $KBH $MRK $MA $V $AIG $AMZN $VLKAY $WMT $GOOGL $SNE $IVZ $TSN $TWTR $AAPL - CNBC
cnbc.com
Early Movers: KBH, MRK, MA, V, AIG, AMZN, VLKAY & more
These are the stocks posting the largest moves before the bell.
1",,,,1,['https://pbs.twimg.com/card_img/1501706790660190211/LMJOlwr7?format=jpg&name=small'],https://twitter.com/Hotpage_News/status/913756778571223041
4661,Greg5thTrad,@Greg5thTrad,2017-09-30T02:00:51.000Z,"$ Flows: Buying on Weakness: Among stocks that were down FRI, these had the largest net inflows of money $STL $BAC $MCD $BA $MRK $CVX $UNH","$ Flows: Buying on Weakness: Among stocks that were down FRI, these had the largest net inflows of money $STL $BAC $MCD $BA $MRK $CVX $UNH",,,,,['https://pbs.twimg.com/media/DK79sBrWsAAbKUg?format=jpg&name=small'],https://twitter.com/Greg5thTrad/status/913946714758877184
4662,George Marcovits,@GemsBot,2017-09-30T11:05:46.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,,,,,['https://pbs.twimg.com/media/DK96adKXcAAfcC9?format=jpg&name=small'],https://twitter.com/GemsBot/status/914083846374686722
4663,Christian Fromhertz,@cfromhertz,2017-09-29T12:09:54.000Z,"$PPH Pharma ETF posts rare inflow of +$34M
top weights: $JNJ $NVS $ABBV $NVO $BMY $PFE $MRK $SNY $AZN $LLY","$PPH Pharma ETF posts rare inflow of +$34M
top weights: $JNJ $NVS $ABBV $NVO $BMY $PFE $MRK $SNY $AZN $LLY
1",,,,1,['https://pbs.twimg.com/media/DK4_VSoWkAAzzJU?format=jpg&name=small'],https://twitter.com/cfromhertz/status/913737597939257345
4664,Brad Bailey,@BradBailey3331,2017-09-30T00:54:21.000Z,"has anyone else used this? i've been getting in on some amazing trades because of it http://bit.ly/2w790s7
$MRK $MTL $MCD","has anyone else used this? i've been getting in on some amazing trades because of it http://bit.ly/2w790s7
$MRK $MTL $MCD",,,,,['https://pbs.twimg.com/media/DK7ueCJU8AEa6cN?format=jpg&name=small'],https://twitter.com/BradBailey3331/status/913929976491249664
4665,Logan Horner,@LoganHorner93,2017-09-30T17:14:35.000Z,"I highly recommend checking this out for finding good stocks to trade http://bit.ly/2ypWZzz
$MTH $MRK $MDT","I highly recommend checking this out for finding good stocks to trade http://bit.ly/2ypWZzz
$MTH $MRK $MDT",,,,,['https://pbs.twimg.com/media/DK_O09LXUAIuH-F?format=jpg&name=small'],https://twitter.com/LoganHorner93/status/914176661834346496
4666,Ethan Allen,@ethanallen2013,2017-09-29T11:33:06.000Z,$INCY. $BMY or $MRK should just buy them. Perfect sense at this price. Else atleast take a big stake in them. Like $ CELG does. Very bullish,$INCY. $BMY or $MRK should just buy them. Perfect sense at this price. Else atleast take a big stake in them. Like $ CELG does. Very bullish,,,,,[],https://twitter.com/ethanallen2013/status/913728336865742848
4667,BoardCentral,@BoardCentral,2017-09-30T14:30:21.000Z,Top Stock searches on message boards and Twitter: $MRK $CZR $ZGNX $TSLA $AAPL (10:30 am) #stocks #finance #stockmarket #StockPicks,Top Stock searches on message boards and Twitter: $MRK $CZR $ZGNX $TSLA $AAPL (10:30 am) #stocks #finance #stockmarket #StockPicks,,,,,[],https://twitter.com/BoardCentral/status/914135331049545728
4668,Odi Bruckman,@odibro,2017-09-29T10:57:13.000Z,$MRK Discontinues MK-3682B and MK-3682C Development Programs,"$MRK Discontinues MK-3682B and MK-3682C Development Programs
businesswire.com
Merck Discontinues MK-3682B and MK-3682C Development Programs
Merck Discontinues MK-3682B and MK-3682C Development Programs
2
1",,,2,1,[],https://twitter.com/odibro/status/913719306428588033
4669,Paul,@BWUIC,2017-09-29T14:53:50.000Z,Merck bails on future HCV drugs; shares down 1% https://seekingalpha.com/news/3298427-merck-bails-future-hcv-drugs-shares-1-percent?source=tweet‚Ä¶ $MRK $JNJ $GILD $ABBV,Merck bails on future HCV drugs; shares down 1% https://seekingalpha.com/news/3298427-merck-bails-future-hcv-drugs-shares-1-percent?source=tweet‚Ä¶ $MRK $JNJ $GILD $ABBV,,,,,[],https://twitter.com/BWUIC/status/913778853310496768
4670,MarketGlance,@MarketGlance,2017-09-29T11:33:18.000Z,Merck discontinues development program for a Hep-C treatment $MRK - MarketWatch -,"Merck discontinues development program for a Hep-C treatment $MRK - MarketWatch -
marketwatch.com
Merck discontinues development program for a Hep-C treatment
Merck & Co. undefined said Friday it would discontinue the development of the investigational combination regimens MK-3682B and MK-3682C for the treatment of...",,,,,['https://pbs.twimg.com/card_img/1501020535399931905/F60ICdjx?format=jpg&name=small'],https://twitter.com/MarketGlance/status/913728387725893634
4671,FinInvTr,@FinInvTr,2017-09-28T18:13:06.000Z,"Companies w/ The Largest Positive Changes In Shares Short  https://buff.ly/2xAI7Ax

$XLV $LUV $MRK","Companies w/ The Largest Positive Changes In Shares Short  https://buff.ly/2xAI7Ax

$XLV $LUV $MRK",,,,,[],https://twitter.com/FinInvTr/status/913466613277581315
4672,Bryan Love,@blove_usc,2017-09-30T01:09:32.000Z,"$MRK stops development of combo regimens MK-3682B and MK-3682C for chronic #HCV, after a review of available Phase 2 efficacy data.","$MRK stops development of combo regimens MK-3682B and MK-3682C for chronic #HCV, after a review of available Phase 2 efficacy data.",,,,,[],https://twitter.com/blove_usc/status/913933801138655232
4673,Tom Silver,@TomSilver39,2017-09-28T02:37:53.000Z,"EASL-AASLD meeting on Alcohol related Liver Disease, London 30 Sep to 01 Oct, 2017, $GILD $VTL $MRK $ABBV abstracts: http://easloffice.eu/events/2017_london/Full-abstract-listPDF.pdf‚Ä¶","EASL-AASLD meeting on Alcohol related Liver Disease, London 30 Sep to 01 Oct, 2017, $GILD $VTL $MRK $ABBV abstracts: http://easloffice.eu/events/2017_london/Full-abstract-listPDF.pdf‚Ä¶
2",,,,2,[],https://twitter.com/TomSilver39/status/913231258036998145
4674,FirstWord Pharma,@fwpharma,2017-09-29T10:58:28.000Z,$MRK Discontinues MK-3682B and MK-3682C Development Programs,"$MRK Discontinues MK-3682B and MK-3682C Development Programs
Merck
@Merck
 ¬∑ 29 Sep 2017
Click here for our latest news: http://bit.ly/2fEgqjs
1",,,1,,['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg'],https://twitter.com/fwpharma/status/913719620061814784
4675,Chameleon,@MarketChmln,2017-09-28T20:35:27.000Z,Largest $Notional Sell On Close Order Imbalances $PEP $MO $CVX $GM $ABBV $AIG $NEM $JPM $MRK $PGR http://tinyurl.com/y8jo8mjb,"Largest $Notional Sell On Close Order Imbalances $PEP $MO $CVX $GM $ABBV $AIG $NEM $JPM $MRK $PGR http://tinyurl.com/y8jo8mjb
1",ü¶é,,1,,[],https://twitter.com/MarketChmln/status/913502437146841088
4676,BoardCentral,@BoardCentral,2017-09-30T18:30:48.000Z,Top Stock searches on message boards and Twitter: $MRK $AAPL $TSLA $AMZN $GDX (02:30 pm) #stocks #finance #stockmarket #StockPicks,Top Stock searches on message boards and Twitter: $MRK $AAPL $TSLA $AMZN $GDX (02:30 pm) #stocks #finance #stockmarket #StockPicks,,,,,[],https://twitter.com/BoardCentral/status/914195843682578432
4677,US Banking News,@AmericanBanking,2017-09-29T13:22:46.000Z,Merck KGaA given ‚Ç¨125.00 PT by Oddo Bhf. buy rating. http://ift.tt/2x23whJ $MRK #MRK,Merck KGaA given ‚Ç¨125.00 PT by Oddo Bhf. buy rating. http://ift.tt/2x23whJ $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/913755935310479366
4678,US Banking News,@AmericanBanking,2017-09-29T13:22:47.000Z,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2yxSpyi $MRK #MRK,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2yxSpyi $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/913755941270679557
4679,marketexclusive,@marketexclusive,2017-09-29T10:50:44.000Z,$GILD‚Äôs Sovaldi Gets The Approval Of Chinese Regulators https://marketexclusive.com/gilead-sciences-inc-nasdaqgilds-sovaldi-gets-approval-chinese-regulators/2017/09/‚Ä¶ $ABBV $MRK,"$GILD‚Äôs Sovaldi Gets The Approval Of Chinese Regulators https://marketexclusive.com/gilead-sciences-inc-nasdaqgilds-sovaldi-gets-approval-chinese-regulators/2017/09/‚Ä¶ $ABBV $MRK
marketexclusive.com
Gilead‚Äôs Sovaldi Gets The Approval Of Chinese Regulators
Gilead Sciences has announced that Sovaldi, its blockbuster drug used in the treatment of hepatitis C virus, has received the approval of the CFDA ‚Äì China Food and Drug Administration.
4
1",,,4,1,['https://pbs.twimg.com/card_img/1501713821181911040/0w6BnpAA?format=jpg&name=small'],https://twitter.com/marketexclusive/status/913717676068954114
4680,MAISA,@MaisaCorp,2017-09-29T20:30:35.000Z,"$JNJ Janssen Sciences Ireland UC, a unit $JNJ, said  it would discontinue further development of its hepatitis C research $MRK $GILD","$JNJ Janssen Sciences Ireland UC, a unit $JNJ, said  it would discontinue further development of its hepatitis C research $MRK $GILD",,,,,[],https://twitter.com/MaisaCorp/status/913863598107168769
4681,MAISA,@MaisaCorp,2017-09-29T20:29:51.000Z,"$MRK discontinue developing an experimental drug combination for chronic  hepatitis C, as competition rises & patient population shrinks.","$MRK discontinue developing an experimental drug combination for chronic  hepatitis C, as competition rises & patient population shrinks.",,,,,[],https://twitter.com/MaisaCorp/status/913863416342831110
4682,Bosco,@wboscoho,2017-09-29T13:50:50.000Z,Sold $ACHN after seeing $MRK ending its HCV program. So $JNJ Janssen ending its deal with $ACHN is based on biz considerations...,Sold $ACHN after seeing $MRK ending its HCV program. So $JNJ Janssen ending its deal with $ACHN is based on biz considerations...,,,,,[],https://twitter.com/wboscoho/status/913762999323680768
4683,leahanne,@leahanneta,2017-09-30T20:22:44.000Z,"09/29/17 Volume Leader #55 - MRK 11,449,600 Merck & Company $MRK 64.03 -0.26 -0.40% High today of 64.53 day lo","09/29/17 Volume Leader #55 - MRK 11,449,600 Merck & Company $MRK 64.03 -0.26 -0.40% High today of 64.53 day lo
investorshangout.com
09/29/17 Volume Leader #55 - MRK - Most Active Stocks #4770737 - Investors Hangout
Most Active Stocks: 09/29/17 Volume Leader #55 - MRK 11,449,600 Merck Company $MRK 64.03 -0.26 -0.40% High today of 64 - #4770737",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/914224012821221376
4684,Dakota Financial,@dakotafinancial,2017-09-30T17:36:18.000Z,"Trust Co. of Vermont Has $5.93 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2yego9C","Trust Co. of Vermont Has $5.93 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2yego9C",,,,,[],https://twitter.com/dakotafinancial/status/914182129021591552
4685,Daily Political,@dailypoliticaln,2017-09-29T17:34:10.000Z,"Merck & Company, Inc. $MRK Shares Bought by Private Capital Advisors Inc. http://ift.tt/2fWWvsY","Merck & Company, Inc. $MRK Shares Bought by Private Capital Advisors Inc. http://ift.tt/2fWWvsY",,,,,[],https://twitter.com/dailypoliticaln/status/913819202276007936
4686,Ticker Report,@TickerReport,2017-09-29T01:38:18.000Z,"Merck & Company, Inc. $MRK Expected to Post Quarterly Sales of $10.45 Billion http://ift.tt/2x1tm5G","Merck & Company, Inc. $MRK Expected to Post Quarterly Sales of $10.45 Billion http://ift.tt/2x1tm5G",,,,,[],https://twitter.com/TickerReport/status/913578649307271168
4687,Limex,@LimexMe,2017-09-29T16:02:25.000Z,1 Great Biotech Stock You Have Never Heard Of http://bit.ly/290917CELG $CELG $HALO $MRK $LLY $BMY $JNJ,"1 Great Biotech Stock You Have Never Heard Of http://bit.ly/290917CELG $CELG $HALO $MRK $LLY $BMY $JNJ
whotrades.com
1 Great Biotech Stock You Have Never Heard Of
About 90% of drug candidates that enter clinical trials never make it to market. That brutal fact makes the small-cap biotech sector a tough place for investors to put their money to work.‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/913796113634938880
4688,Watchlist News,@WatchlistN,2017-09-29T23:12:29.000Z,"Investors Buy Shares of Merck & Company, Inc. $MRK on Weakness http://ift.tt/2xDMZoE","Investors Buy Shares of Merck & Company, Inc. $MRK on Weakness http://ift.tt/2xDMZoE",,,,,[],https://twitter.com/WatchlistN/status/913904344013078528
4689,Stockboard Media Inc,@stockboardinc,2017-09-29T11:00:25.000Z,$MRK New and Updated Clinical Data on Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) to Be Presented at 18th World ... - http://sbml.co/d8e922bb,$MRK New and Updated Clinical Data on Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) to Be Presented at 18th World ... - http://sbml.co/d8e922bb,,,,,[],https://twitter.com/stockboardinc/status/913720113685200898
4690,Stockboard Media Inc,@stockboardinc,2017-09-28T13:06:49.000Z,$MRK Merck Animal Health Extends Commitment to Fighting Rabies in the World‚Äôs Most At-Risk Regions... - http://sbml.co/f941baa5,$MRK Merck Animal Health Extends Commitment to Fighting Rabies in the World‚Äôs Most At-Risk Regions... - http://sbml.co/f941baa5,,,,,[],https://twitter.com/stockboardinc/status/913389532577398785
4691,Zak Mir,@ZaksTradersCafe,2017-09-28T15:36:21.000Z,"Novartis and Advanced Accelerator negotiating $85 a share https://voxmarkets.co.uk/blogs/novartis-and-advanced-accelerator-negotiating-85-a-share/‚Ä¶ via 
@voxmarkets
 $MRK #NOVARTIS $AAAP","Novartis and Advanced Accelerator negotiating $85 a share https://voxmarkets.co.uk/blogs/novartis-and-advanced-accelerator-negotiating-85-a-share/‚Ä¶ via 
@voxmarkets
 $MRK #NOVARTIS $AAAP
3
3",,,3,3,[],https://twitter.com/ZaksTradersCafe/status/913427166607667203
4692,Ticker Report,@TickerReport,2017-09-29T14:15:53.000Z,"Traders Buy Shares of Merck & Company, Inc. $MRK on Weakness http://ift.tt/2k8HJnB","Traders Buy Shares of Merck & Company, Inc. $MRK on Weakness http://ift.tt/2k8HJnB",,,,,[],https://twitter.com/TickerReport/status/913769304063184902
4693,Watchlist News,@WatchlistN,2017-09-29T17:42:19.000Z,"Swedbank Has $233.32 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2xCY5dH","Swedbank Has $233.32 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2xCY5dH",,,,,[],https://twitter.com/WatchlistN/status/913821253290602496
4694,Clark Joseph Kent,@JorelLaraKalel,2017-09-28T12:19:41.000Z,5 Stocks That May Win Big From Tax Reform http://bit.ly/2k8eukW http://bit.ly/AAPL912 $AAPL $GE $AMGN $MRK $RL,"5 Stocks That May Win Big From Tax Reform http://bit.ly/2k8eukW http://bit.ly/AAPL912 $AAPL $GE $AMGN $MRK $RL
youtube.com
Apple Event (September 12th) Winners
Apple (AAPL) had its big event September 12th.Apple's stock has gone down 3 out of the 4 trading days since the September 12th event.The iPhone 8 is availabl...",,,,,['https://pbs.twimg.com/card_img/1501526192905920519/94fenNI7?format=jpg&name=240x240'],https://twitter.com/JorelLaraKalel/status/913377674512535552
4695,Watchlist News,@WatchlistN,2017-09-30T08:17:45.000Z,"Merck & Company, Inc. $MRK Holdings Maintained by Capital Advisors Ltd. LLC http://ift.tt/2x4k4WC","Merck & Company, Inc. $MRK Holdings Maintained by Capital Advisors Ltd. LLC http://ift.tt/2x4k4WC",,,,,[],https://twitter.com/WatchlistN/status/914041563432521728
4696,NH,@navelhunt,2017-09-29T22:18:42.000Z,"$MRK MK-3682 killed, $IDIX 3.9bn in smoke, $8bn $CBST what came out of that with Cubicin generic? that's $12bn...some quality M&A there!!","$MRK MK-3682 killed, $IDIX 3.9bn in smoke, $8bn $CBST what came out of that with Cubicin generic? that's $12bn...some quality M&A there!!
2",,2,,,[],https://twitter.com/navelhunt/status/913890807328976896
4697,SwingTradeBot,@SwingTradeBot,2017-09-30T09:04:23.000Z,"$MRK technical alerts: Non-ADX 1,2,3,4 Bullish, Stochastic Reached Oversold, and 50 DMA Support","$MRK technical alerts: Non-ADX 1,2,3,4 Bullish, Stochastic Reached Oversold, and 50 DMA Support
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/914053300709990400
4698,TradeTheNews.com,@Trade_The_News,2017-09-29T10:56:40.000Z,$MRK Discontinues MK-3682B and MK-3682C Development Programs (Merck & Co Inc),$MRK Discontinues MK-3682B and MK-3682C Development Programs (Merck & Co Inc),,,,,[],https://twitter.com/Trade_The_News/status/913719168154898432
4699,Clark Joseph Kent,@JorelLaraKalel,2017-09-29T12:47:44.000Z,Early Movers: $KBH $MRK $V $MA $AIG $AMZN $VLKAY $AAPL $TWTR $SNE $GOOGL $WMT $TSN $IVZ http://cnb.cx/2xL2n1L,"Early Movers: $KBH $MRK $V $MA $AIG $AMZN $VLKAY $AAPL $TWTR $SNE $GOOGL $WMT $TSN $IVZ http://cnb.cx/2xL2n1L
youtube.com
Apple Event (September 12th) Winners
Apple (AAPL) had its big event September 12th.Apple's stock has gone down 3 out of the 4 trading days since the September 12th event.The iPhone 8 is availabl...",,,,,['https://pbs.twimg.com/card_img/1501526192905920519/94fenNI7?format=jpg&name=240x240'],https://twitter.com/JorelLaraKalel/status/913747120573812736
4700,Berkeley Lovelace Jr.,@BerkeleyJr,2017-09-29T11:32:57.000Z,"Merck $MRK has discontinued development of certain experimental hepatitis C treatments.

(h/t 
@peterschack
)","Merck $MRK has discontinued development of certain experimental hepatitis C treatments.

(h/t 
@peterschack
)
1",,,1,,[],https://twitter.com/BerkeleyJr/status/913728298450132993
4701,Donna Young,@DonnaYoungDC,2017-09-29T15:43:51.000Z,"Trump now at 
@ShopFloorNAM
. Reminder, $MRK CEO Frazier 1st to leave Trump's manufacturing panel, which then disbanded
#Charlottesville","Trump now at 
@ShopFloorNAM
. Reminder, $MRK CEO Frazier 1st to leave Trump's manufacturing panel, which then disbanded
#Charlottesville",üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/913791440941088768
4702,Matthew Herper,@matthewherper,2017-09-29T11:05:46.000Z,$MRK is discontinuing development of two mid-stage Hep C drugs.,$MRK is discontinuing development of two mid-stage Hep C drugs.,,,,,[],https://twitter.com/matthewherper/status/913721457775177728
4703,Jing Liang,@AppleHelix,2017-09-29T12:24:28.000Z,"Replying to 
@PRB51","Replying to 
@PRB51
Vivek Rameswamy made his name on the $IDIX trade. If $MRK didn't buy $IDIX for the fear of missing out, Roivant may not exist today
3",,,,3,[],https://twitter.com/AppleHelix/status/913741261978374145
4704,Stockboard Media Inc,@stockboardinc,2017-09-29T11:00:14.000Z,$MRK Merck Discontinues MK-3682B and MK-3682C Development Programs... - http://sbml.co/bf60d0ba,$MRK Merck Discontinues MK-3682B and MK-3682C Development Programs... - http://sbml.co/bf60d0ba,,,,,[],https://twitter.com/stockboardinc/status/913720064377049090
4705,Daily Political,@dailypoliticaln,2017-09-29T17:34:06.000Z,"Merck & Company, Inc. $MRK Holdings Held by Trust Department MB Financial Bank N A http://ift.tt/2xDBX2B","Merck & Company, Inc. $MRK Holdings Held by Trust Department MB Financial Bank N A http://ift.tt/2xDBX2B",,,,,[],https://twitter.com/dailypoliticaln/status/913819187402899461
4706,MarketBeat,@MarketBeatCom,2017-09-30T20:29:44.000Z,Comparing Merck & $MRK and Teva Pharmaceutical Industries Limited $TEVA http://ift.tt/2xRgSlc,Comparing Merck & $MRK and Teva Pharmaceutical Industries Limited $TEVA http://ift.tt/2xRgSlc,,,,,[],https://twitter.com/MarketBeatCom/status/914225771526475779
4707,Seeking Alpha,@SeekingAlpha,2017-10-03T11:30:06.000Z,https://seekingalpha.com/article/4110766-ono-pharmaceutical-needs-reinvest-windfall?source=feed_f‚Ä¶ $ARRY $BMY $MRK $OPHLY,https://seekingalpha.com/article/4110766-ono-pharmaceutical-needs-reinvest-windfall?source=feed_f‚Ä¶ $ARRY $BMY $MRK $OPHLY,,,,,[],https://twitter.com/SeekingAlpha/status/915177131994365953
4708,Seeking Alpha,@SeekingAlpha,2017-10-03T19:32:22.000Z,https://seekingalpha.com/article/4111437-johnson-and-johnson-best-breed-healthcare?source=feed_f‚Ä¶ $ABBV $BMY $LLY $MRK $PFE $JNJ,https://seekingalpha.com/article/4111437-johnson-and-johnson-best-breed-healthcare?source=feed_f‚Ä¶ $ABBV $BMY $LLY $MRK $PFE $JNJ,,,,,[],https://twitter.com/SeekingAlpha/status/915298499893256192
4709,Igor Lokot,@Lokot_Igor,2017-10-02T20:52:31.000Z,#Bigpharma has Big #debt https://seekingalpha.com/article/4110964-starting-point-big-pharma-novartis-sanofi-clear-hurdles?source=tweet‚Ä¶ $BAYRY $BAYZF $BMY $GSK $LLY $MRK $PFE $JNJ $NVO $NVS $RHHBF $RHHBY $SNY #medtech #biotech,"#Bigpharma has Big #debt https://seekingalpha.com/article/4110964-starting-point-big-pharma-novartis-sanofi-clear-hurdles?source=tweet‚Ä¶ $BAYRY $BAYZF $BMY $GSK $LLY $MRK $PFE $JNJ $NVO $NVS $RHHBF $RHHBY $SNY #medtech #biotech
seekingalpha.com
A Starting Point For Big Pharma: Do Novartis And Sanofi Clear The Hurdles? (NASDAQ:SNY)
Novartis and Sanofi may lack the quality to compete with the best of big pharmaceutical companies.
1",,,1,,[],https://twitter.com/Lokot_Igor/status/914956283815632898
4710,Gery DIVRY,@GeryDIVRY,2017-10-01T08:28:33.000Z,Commented on https://seekingalpha.com/article/4110628-intercept-runs-trouble-nash-developers-like-galectin-gain-value?source=tweet&sht=ox4y7l&shu=l8mmr#comment-76366151‚Ä¶ $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT,"Commented on https://seekingalpha.com/article/4110628-intercept-runs-trouble-nash-developers-like-galectin-gain-value?source=tweet&sht=ox4y7l&shu=l8mmr#comment-76366151‚Ä¶ $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT
2",,,2,,[],https://twitter.com/GeryDIVRY/status/914406668460425216
4711,Seeking Alpha,@SeekingAlpha,2017-10-03T09:59:42.000Z,https://seekingalpha.com/article/4111254-tax-reform-effect-small-cap-high-cash-flow-stocks-part-2?source=feed_f‚Ä¶ $AAPL #APPLE $APLP $CALF $CSCO $GE $GOOG $IWN $JNJ $MRK $MSFT $OFS $PEP $PFE,https://seekingalpha.com/article/4111254-tax-reform-effect-small-cap-high-cash-flow-stocks-part-2?source=feed_f‚Ä¶ $AAPL #APPLE $APLP $CALF $CSCO $GE $GOOG $IWN $JNJ $MRK $MSFT $OFS $PEP $PFE,,,,,[],https://twitter.com/SeekingAlpha/status/915154381942558720
4712,Vista Partners LLC,@VistaPResearch,2017-10-02T19:29:53.000Z,The drug-maker's guide to the galaxy http://nature.com/news/the-drug-maker-s-guide-to-the-galaxy-1.22683‚Ä¶ #healthcare #biotech Vista Partners http://vistapglobal.com $ATOS $MRK $PFE,"The drug-maker's guide to the galaxy http://nature.com/news/the-drug-maker-s-guide-to-the-galaxy-1.22683‚Ä¶ #healthcare #biotech Vista Partners http://vistapglobal.com $ATOS $MRK $PFE
GIF
1
2",,,1,2,['https://pbs.twimg.com/tweet_video_thumb/DLKA9lmUIAAl8Ho.jpg'],https://twitter.com/VistaPResearch/status/914935488053522432
4713,FalconStocks.com,@FalconStocks,2017-10-02T16:13:06.000Z,".
NYSE Sextuple!
.
94% Avg Gain
100% Unbiased
Family-Run Newsletter
.
http://FalconStocks.com  .
.
.
$AZFL $MRK $XOM $JPM $JNJ $SRPT $ORCL",".
NYSE Sextuple!
.
94% Avg Gain
100% Unbiased
Family-Run Newsletter
.
http://FalconStocks.com  .
.
.
$AZFL $MRK $XOM $JPM $JNJ $SRPT $ORCL
1",,,1,,['https://pbs.twimg.com/media/DLJT7TAUQAA4crM?format=jpg&name=900x900'],https://twitter.com/FalconStocks/status/914885964148957184
4714,Gibbs,@Gibbs4608,2017-10-02T17:25:42.000Z,"I really recommend trying this out for discovering great stocks to trade http://bit.ly/2w8T20q
$MCO $MGM $MRK","I really recommend trying this out for discovering great stocks to trade http://bit.ly/2w8T20q
$MCO $MGM $MRK",,,,,['https://pbs.twimg.com/media/DLJkjUjW0AAfdht?format=jpg&name=small'],https://twitter.com/Gibbs4608/status/914904234855985152
4715,Danny Holmes,@HolmesTrader21,2017-10-01T17:32:04.000Z,"I highly recommend everyone check this out for finding good stocks to trade http://bit.ly/2yscRSe
$MRK $MTL $MCK","I highly recommend everyone check this out for finding good stocks to trade http://bit.ly/2yscRSe
$MRK $MTL $MCK",,,,,['https://pbs.twimg.com/media/DLEcaz4XkAAx_8W?format=jpg&name=small'],https://twitter.com/HolmesTrader21/status/914543449067663360
4716,Vista Partners LLC,@VistaPResearch,2017-10-02T15:46:59.000Z,"""Keeps On Keepin' On"" Vista's Monthly Newsletter http://vistapglobal.com/2017/09/keeps-on-keepin-on/‚Ä¶ 
$UNH $MRK $ATOS $FSNN $HIIQ #healthcare #Stocks #MondayMotivation","""Keeps On Keepin' On"" Vista's Monthly Newsletter http://vistapglobal.com/2017/09/keeps-on-keepin-on/‚Ä¶ 
$UNH $MRK $ATOS $FSNN $HIIQ #healthcare #Stocks #MondayMotivation
1
2",,,1,2,[],https://twitter.com/VistaPResearch/status/914879394404896774
4717,Vista Partners LLC,@VistaPResearch,2017-10-02T19:07:58.000Z,"@BionxHoldings
 thanks for RT! #BreastCancerAwareness $ATOS Atossa Genetics http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK","@BionxHoldings
 thanks for RT! #BreastCancerAwareness $ATOS Atossa Genetics http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK
GIF
1
3",,,1,3,[],https://twitter.com/VistaPResearch/status/914929970790535168
4718,James Sikes,@wosaikeneriki,2017-10-03T15:26:06.000Z,"Baltimore-Washington Financial Advisors Has Increased Merck & Co  Com $MRK Holding by $763,328 ...","Baltimore-Washington Financial Advisors Has Increased Merck & Co  Com $MRK Holding by $763,328 ...",,,,,[],https://twitter.com/wosaikeneriki/status/915236524521861121
4719,AMEGI,@AMEGI_MX,2017-10-03T00:53:13.000Z,https://seekingalpha.com/article/4110964-starting-point-big-pharma-novartis-sanofi-clear-hurdles?source=tweet‚Ä¶ $BAYRY $BAYZF $BMY $GSK $LLY $MRK $PFE $JNJ $NVO $NVS $RHHBF $RHHBY $SNY https://seekingalpha.com/article/4110964-starting-point-big-pharma-novartis-sanofi-clear-hurdles‚Ä¶,"https://seekingalpha.com/article/4110964-starting-point-big-pharma-novartis-sanofi-clear-hurdles?source=tweet‚Ä¶ $BAYRY $BAYZF $BMY $GSK $LLY $MRK $PFE $JNJ $NVO $NVS $RHHBF $RHHBY $SNY https://seekingalpha.com/article/4110964-starting-point-big-pharma-novartis-sanofi-clear-hurdles‚Ä¶
seekingalpha.com
A Starting Point For Big Pharma: Do Novartis And Sanofi Clear The Hurdles? (NASDAQ:SNY)
Novartis and Sanofi may lack the quality to compete with the best of big pharmaceutical companies.",,,,,['https://pbs.twimg.com/card_img/1499515715614908417/faitQJFq?format=png&name=small'],https://twitter.com/AMEGI_MX/status/915016858654449665
4720,BoardCentral,@BoardCentral,2017-10-01T14:30:22.000Z,Top Stock searches on message boards and Twitter: $AMZN $AAPL $TOL $MRK $ETH (10:30 am) #stocks #finance #stockmarket #StockPicks,Top Stock searches on message boards and Twitter: $AMZN $AAPL $TOL $MRK $ETH (10:30 am) #stocks #finance #stockmarket #StockPicks,,,,,[],https://twitter.com/BoardCentral/status/914497724686454785
4721,Daily Political,@DPolitical,2017-10-01T16:54:48.000Z,"$MRK - State of Alaska Department of Revenue Reduces Holdings in Merck & Company, Inc. #MRK https://goo.gl/fb/iECWrJ","$MRK - State of Alaska Department of Revenue Reduces Holdings in Merck & Company, Inc. #MRK https://goo.gl/fb/iECWrJ",,,,,[],https://twitter.com/DPolitical/status/914534070457110528
4722,FiercePharma,@FiercePharma,2017-10-03T13:00:01.000Z,"Promising Ebola vaccines from Merck, Johnson & Johnson win BARDA funding http://fiercepharma.com/vaccines/promising-ebola-vaccines-from-merck-j-j-win-barda-funding‚Ä¶ $MRK $JNJ","Promising Ebola vaccines from Merck, Johnson & Johnson win BARDA funding http://fiercepharma.com/vaccines/promising-ebola-vaccines-from-merck-j-j-win-barda-funding‚Ä¶ $MRK $JNJ
fiercepharma.com
Promising Ebola vaccines from Merck, Johnson & Johnson win BARDA funding
Even though the devastating Ebola outbreak in West Africa has ended, U.S. | The U.S. government is committing millions of dollars in support for leading Ebola vaccine programs at Merck and Johnson &...
1
2",,,1,2,['https://pbs.twimg.com/card_img/1501992565192593478/1PAk-cpd?format=jpg&name=small'],https://twitter.com/FiercePharma/status/915199760088186880
4723,Siera Xray,@orion659,2017-10-02T19:50:25.000Z,SELLAS Life Sciences to collaborate with Merck on clinical trial assessing combo treatment for... $MRK $GALE http://seekingalpha.com/news/3298813,SELLAS Life Sciences to collaborate with Merck on clinical trial assessing combo treatment for... $MRK $GALE http://seekingalpha.com/news/3298813,‚úà,,,,[],https://twitter.com/orion659/status/914940654794485761
4724,James Sikes,@wosaikeneriki,2017-10-01T16:19:24.000Z,Merck & Co $MRK Shareholder Prospector Partners Raised Position http://bzweekly.com/merck-beddow-capital-management-position-in-autoliv-alv-upped-as-market-valuation-declined/‚Ä¶,Merck & Co $MRK Shareholder Prospector Partners Raised Position http://bzweekly.com/merck-beddow-capital-management-position-in-autoliv-alv-upped-as-market-valuation-declined/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/914525161105354753
4725,Amy Brown,@ByAmyBrown,2017-10-03T15:36:29.000Z,Another slow quarter for biopharma takeovers: http://ow.ly/bdtn30fBPjL $GILD $BMY $MRK,"Another slow quarter for biopharma takeovers: http://ow.ly/bdtn30fBPjL $GILD $BMY $MRK
evaluate.com
Another slow quarter for biopharma takeovers
The summer lull proved even quieter than normal in 2017, as transaction volumes slumped to a decade low.
1",,,1,,[],https://twitter.com/ByAmyBrown/status/915239139540295680
4726,ABS News & Research,@AlphaBetaStock,2017-10-03T14:10:04.000Z,Hot Stock Breaking: Merck & Co Inc $MRK http://alphabetastock.com/technical-indicators-in-focus-merck-co-inc-nysemrk/‚Ä¶,Hot Stock Breaking: Merck & Co Inc $MRK http://alphabetastock.com/technical-indicators-in-focus-merck-co-inc-nysemrk/‚Ä¶,,,,,[],https://twitter.com/AlphaBetaStock/status/915217392623652864
4727,NASDAQ,@NASDAQODUK,2017-10-01T13:10:22.000Z,$MRK Merck Abandons New Hepatitis C Drugs Amid Crowded Market‚Ä¶,"$MRK Merck Abandons New Hepatitis C Drugs Amid Crowded Market‚Ä¶
uk.advfn.com
Merck Abandons New Hepatitis C Drugs Amid Crowded Market
By Cara Lombardo Merck & Co. is halting development of new hepatitis C treatments after reviewing their effectiveness and...",,,,,['https://pbs.twimg.com/card_img/1500753754672418822/vwOyl4Ul?format=png&name=small'],https://twitter.com/NASDAQODUK/status/914477589355532289
4728,WallStreetGangsta,@WallStGangsta,2017-10-02T19:36:46.000Z,$ITUS ITUS Corp (NASDAQ:ITUS) : The Patent Behind The Huge Momentum http://nasdaqreporter.com/itus-corp-nasdaqitus-the-patent-behind-the-huge-momentum/‚Ä¶ ‚Ä¶ $IBB $GILD $NVS $BSX $MRK $BMY $JNJ $PFE,$ITUS ITUS Corp (NASDAQ:ITUS) : The Patent Behind The Huge Momentum http://nasdaqreporter.com/itus-corp-nasdaqitus-the-patent-behind-the-huge-momentum/‚Ä¶ ‚Ä¶ $IBB $GILD $NVS $BSX $MRK $BMY $JNJ $PFE,,,,,[],https://twitter.com/WallStGangsta/status/914937217772085248
4729,Transcript Daily,@TranscriptDaily,2017-10-02T08:31:35.000Z,"Merck & Company, Inc. $MRK Position Trimmed by Boston Financial Mangement LLC http://ift.tt/2g31Z5C","Merck & Company, Inc. $MRK Position Trimmed by Boston Financial Mangement LLC http://ift.tt/2g31Z5C",,,,,[],https://twitter.com/TranscriptDaily/status/914769822004781056
4730,Limex,@LimexMe,2017-10-03T16:53:17.000Z,Johnson & Johnson Files sNDA for Label Expansion of Invokana http://bit.ly/031017JNJ $JNJ $NVO $MRK $LLY,"Johnson & Johnson Files sNDA for Label Expansion of Invokana http://bit.ly/031017JNJ $JNJ $NVO $MRK $LLY
whotrades.com
Johnson & Johnson Files sNDA for Label Expansion of Invokana
Johnson & Johnson ‚Äôs JNJ announced that it has submitted a supplemental new drug application (sNDA) to the FDA for the label expansion of its diabetes drug Invokana (to‚Ä¶
1",,1,,,[],https://twitter.com/LimexMe/status/915258466628972546
4731,Daily Political,@dailypoliticaln,2017-10-02T17:48:22.000Z,"Professional Advisory Services Inc. Has $472,000 Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xPji1G","Professional Advisory Services Inc. Has $472,000 Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xPji1G",,,,,[],https://twitter.com/dailypoliticaln/status/914909937918185473
4732,Limex,@LimexMe,2017-10-03T17:06:14.000Z,Seattle Genetics' Adcetris Gets Breakthrough Therapy Status http://bit.ly/031017SGEN $SGEN $REGN $MRK $BMY,"Seattle Genetics' Adcetris Gets Breakthrough Therapy Status http://bit.ly/031017SGEN $SGEN $REGN $MRK $BMY
whotrades.com
Seattle Genetics' Adcetris Gets Breakthrough Therapy Status
Seattle Genetics, Inc. SGEN announced that the FDA has granted Breakthrough Therapy Designation status to its lymphoma drug, Adcetris, as frontline treatment for advanced‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/915261724743409664
4733,Watchlist News,@WatchlistN,2017-10-02T17:47:31.000Z,"First Financial Corp IN Sells 200 Shares of Merck & Company, Inc. $MRK http://ift.tt/2hK5GRu","First Financial Corp IN Sells 200 Shares of Merck & Company, Inc. $MRK http://ift.tt/2hK5GRu",,,,,[],https://twitter.com/WatchlistN/status/914909725669634048
4734,Watchlist News,@WatchlistN,2017-10-03T08:22:25.000Z,"Mraz Amerine & Associates Inc. Has $312,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2ylC6bR","Mraz Amerine & Associates Inc. Has $312,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2ylC6bR",,,,,[],https://twitter.com/WatchlistN/status/915129899844857856
4735,Stockboard Media Inc,@stockboardinc,2017-10-03T11:00:11.000Z,$MRK Merck to Present New Data on ZEPATIER¬Æ (elbasvir and grazoprevir) for the Treatment of Chronic Hepa... - http://sbml.co/9b8672f0,$MRK Merck to Present New Data on ZEPATIER¬Æ (elbasvir and grazoprevir) for the Treatment of Chronic Hepa... - http://sbml.co/9b8672f0,,,,,[],https://twitter.com/stockboardinc/status/915169603197788160
4736,Watchlist News,@WatchlistN,2017-10-02T17:47:30.000Z,"Baldwin Brothers Inc. MA Has $14.47 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2khdsTx","Baldwin Brothers Inc. MA Has $14.47 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2khdsTx",,,,,[],https://twitter.com/WatchlistN/status/914909723232817152
4737,Limex,@LimexMe,2017-10-03T16:59:40.000Z,Will Gilead & AbbVie Benefit from Merck's Decision to Drop Two HCV Programs? http://bit.ly/031017GILD1 $GILD $NVS $MRK $ABBV,Will Gilead & AbbVie Benefit from Merck's Decision to Drop Two HCV Programs? http://bit.ly/031017GILD1 $GILD $NVS $MRK $ABBV,,,,,[],https://twitter.com/LimexMe/status/915260072753860608
4738,New World Strategies,@raysnewworld,2017-10-02T01:53:10.000Z,"Extend your trading years by extending your #Telomeres....Easier than you think, get on board > http://tinyurl.com/josocez  $PFE $MRK $SPY","Extend your trading years by extending your #Telomeres....Easier than you think, get on board > http://tinyurl.com/josocez  $PFE $MRK $SPY",,,,,[],https://twitter.com/raysnewworld/status/914669554009219072
4739,Gambiste,@GambisteFinance,2017-10-02T23:21:58.000Z,"Evening Most Tweeted Big Caps, check out Gambiste Top 10: $VZ $GOOGL $WFC $MRK $IBM $JNJ $HD $T $LVS $CMCSA http://gambiste.com/index.php/2017/10/02/gambiste-top-10-evening-most-tweeted-big-caps-61/‚Ä¶","Evening Most Tweeted Big Caps, check out Gambiste Top 10: $VZ $GOOGL $WFC $MRK $IBM $JNJ $HD $T $LVS $CMCSA http://gambiste.com/index.php/2017/10/02/gambiste-top-10-evening-most-tweeted-big-caps-61/‚Ä¶",,,,,[],https://twitter.com/GambisteFinance/status/914993893199970304
4740,EarlyBird,@mktearlybird,2017-10-02T10:10:04.000Z,"#Merck discontinues HCV programmes: http://ow.ly/h8GU30fz9Es | Via 
@PharmaTimes
 $MRK #Pharma #Health","#Merck discontinues HCV programmes: http://ow.ly/h8GU30fz9Es | Via 
@PharmaTimes
 $MRK #Pharma #Health
pharmatimes.com
Merck discontinues HCV programmes
Company will focus on existing HCV drug ZEPATIER",,,,,['https://pbs.twimg.com/card_img/1500614348036739073/mJQXZ8S_?format=jpg&name=240x240'],https://twitter.com/mktearlybird/status/914794605077549056
4741,Daily Political,@dailypoliticaln,2017-10-01T16:54:58.000Z,"State of Alaska Department of Revenue Reduces Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xPrujY","State of Alaska Department of Revenue Reduces Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xPrujY",,,,,[],https://twitter.com/dailypoliticaln/status/914534112974852097
4742,Jacob Bell,@realJacobBell,2017-10-02T16:24:00.000Z,$MRK drops hep C programs in 'strategic decision' http://bit.ly/2kpAWRL $GILD,"$MRK drops hep C programs in 'strategic decision' http://bit.ly/2kpAWRL $GILD
biopharmadive.com
Why biosimilars could be market disruptors
The biologic copies are just now entering the U.S. market and could mean a shift in several major therapeutic indications. ",,,,,['https://pbs.twimg.com/card_img/1499060731777593346/qyMSl5mL?format=jpg&name=small'],https://twitter.com/realJacobBell/status/914888709488623617
4743,Jon Ogg,@jonogg,2017-10-03T18:11:12.000Z,Credit Suisse top big-mid biotech/pharma stock picks right now -- $MRK $AGN $JNJ $ALKS $AIMT $MYOK,"Credit Suisse top big-mid biotech/pharma stock picks right now -- $MRK $AGN $JNJ $ALKS $AIMT $MYOK
247wallst.com
Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside
U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of the market has not come without controversy in the past year and a half.",,,,,['https://pbs.twimg.com/card_img/1501724285500465152/K9SkoBGY?format=jpg&name=small'],https://twitter.com/jonogg/status/915278073288953856
4744,Â°©„Åò„ÇÉ„Åå„ÅÑ„ÇÇ,@ShioJyagaimo,2017-10-03T13:01:52.000Z,"Good News and Bad News for Gilead Sciences: Which Carries More Weight? 
@themotleyfool
 #stocks $MRK, $GILD, $ABBV","Good News and Bad News for Gilead Sciences: Which Carries More Weight? 
@themotleyfool
 #stocks $MRK, $GILD, $ABBV
fool.com
Good News and Bad News for Gilead Sciences: Which Carries More Weight? @themotleyfool #stocks $GILD...
Investors seem to be worried more about recent negative developments for the big biotech. But are they right?",,,,,[],https://twitter.com/ShioJyagaimo/status/915200228789182464
4745,Siti van der Meij,@sitivandermeij,2017-10-02T19:50:50.000Z,SELLAS Life Sciences to collaborate with Merck on clinical trial assessing combo treatment for range o... https://seekingalpha.com/news/3298813-sellas-life-sciences-collaborate-merck-clinical-trial-assessing-combo-treatment-range-cancers?source=feed_f‚Ä¶ $MRK $GA‚Ä¶,"SELLAS Life Sciences to collaborate with Merck on clinical trial assessing combo treatment for range o... https://seekingalpha.com/news/3298813-sellas-life-sciences-collaborate-merck-clinical-trial-assessing-combo-treatment-range-cancers?source=feed_f‚Ä¶ $MRK $GA‚Ä¶
seekingalpha.com
SELLAS Life Sciences to collaborate with Merck on clinical trial assessing combo treatment for...
Privately held SELLAS Life Sciences Group inks a clinical trial collaboration agreement with Merck (MRK +0.8%) evaluating the combination of galinpepimut-S and Keytruda (pembrolizumab)...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/914940760549707776
4746,dough,@semodough,2017-10-02T11:17:27.000Z,#SITC17 Society for Immunotherapy of Cancer late-breaker abstracts are expected next week. $IBB $FPRX $BMY $MRK,"#SITC17 Society for Immunotherapy of Cancer late-breaker abstracts are expected next week. $IBB $FPRX $BMY $MRK
1",,,,1,[],https://twitter.com/semodough/status/914811562354987008
4747,Allison Gatlin,@IBD_AGatlin,2017-10-02T18:29:49.000Z,"AbbVie's patent deal staves off Amgen competition, but others lurk $ABBV $AMGN $MRK $PFE $NVS $CHRS $MNTA","AbbVie's patent deal staves off Amgen competition, but others lurk $ABBV $AMGN $MRK $PFE $NVS $CHRS $MNTA
investors.com
AbbVie's Humira Safe From Competition Until 2023, But Merck, Pfizer, Novartis Are Closing In |...
AbbVie's Humira franchise is safe through 2023 after a patent settlement with Amgen, an analyst said Monday.",,,,,['https://pbs.twimg.com/card_img/1499844644972032002/fxgUH3Wl?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/914920372323192843
4748,c lark,@7LadyQ,2017-10-02T20:11:10.000Z,"$MRK
SELLAS Life Sciences to collaborate with Merck on clinical trial assessing combo treatment for range of cancers; merger partner Galena","$MRK
SELLAS Life Sciences to collaborate with Merck on clinical trial assessing combo treatment for range of cancers; merger partner Galena",,,,,[],https://twitter.com/7LadyQ/status/914945878506524672
4749,dough,@semodough,2017-10-06T11:32:11.000Z,CS Top healthcare pics $CELG $PBYI $WBA $ZTS $MRK,"CS Top healthcare pics $CELG $PBYI $WBA $ZTS $MRK
1
3
5",,1,3,5,['https://pbs.twimg.com/media/DLc5_qTVAAAzjh8?format=jpg&name=900x900'],https://twitter.com/semodough/status/916264820671963136
4750,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-10-05T16:30:13.000Z,"Fascinating Commercial/Investor Dynamic to Closely Watch in '18 $GILD $ABBV $MRK Docs say +10%+ HCV volume growth, <10% investors agree","Fascinating Commercial/Investor Dynamic to Closely Watch in '18 $GILD $ABBV $MRK Docs say +10%+ HCV volume growth, <10% investors agree
1
4
2",,1,4,2,['https://pbs.twimg.com/media/DLY0es7U8AAfinR?format=jpg&name=900x900'],https://twitter.com/DrPaulyDeSantis/status/915977435702628353
4751,Vista Partners LLC,@VistaPResearch,2017-10-06T15:12:15.000Z,#WorldSmileDay #BreastCancerAwareness #FridayFeeling http://vistapglobal.com/2017/10/fda-approves-eli-lilly-breast-cancer-drug-verzenio/‚Ä¶ $ATOS $MRK $RHHBY $JNJ $PFE,"#WorldSmileDay #BreastCancerAwareness #FridayFeeling http://vistapglobal.com/2017/10/fda-approves-eli-lilly-breast-cancer-drug-verzenio/‚Ä¶ $ATOS $MRK $RHHBY $JNJ $PFE
GIF
1
2",,,1,2,['https://pbs.twimg.com/tweet_video_thumb/DLdsXVmVwAMCPNE.jpg'],https://twitter.com/VistaPResearch/status/916320204933574656
4752,Greg5thTrad,@Greg5thTrad,2017-10-06T11:06:36.000Z,U.S. Orphan Drug tally from #FDA -  $EPZM $JUNO $TROV $MRK $OVID $TKPYY $BLUE http://seekingalpha.com/news/3299706,U.S. Orphan Drug tally from #FDA -  $EPZM $JUNO $TROV $MRK $OVID $TKPYY $BLUE http://seekingalpha.com/news/3299706,,,,,[],https://twitter.com/Greg5thTrad/status/916258382503432192
4753,Breaking News,@MarketCurrents,2017-10-06T12:06:36.000Z,Roche bladder cancer drug struggles as medics focus on survival https://seekingalpha.com/news/3299722-roche-bladder-cancer-drug-struggles-medics-focus-survival?source=feed_f‚Ä¶ #premarket $RHHBY $MRK $RHHBF,"Roche bladder cancer drug struggles as medics focus on survival https://seekingalpha.com/news/3299722-roche-bladder-cancer-drug-struggles-medics-focus-survival?source=feed_f‚Ä¶ #premarket $RHHBY $MRK $RHHBF
seekingalpha.com
Roche bladder cancer drug struggles as medics focus on survival (OTCMKTS:RHHBY)
Roche Holding's (OTCQX:RHHBY) immunotherapy drug Tecentriq (atezolizumab) has lost market share to Merck's (NYSE:MRK) Keytruda (pembrolizumab) since a clinical trial showed the Swiss...",,,,,['https://pbs.twimg.com/card_img/1479966849626480640/cLosLnr_?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/916273483302105088
4754,Vista Partners LLC,@VistaPResearch,2017-10-05T16:07:04.000Z,"#BreastCancer Innovator Atossa Genetics Presenting in #NewYorkCity TODAY! Oct 5, 2017 http://vistapglobal.com/2017/09/breast-cancer-innovator-atossa-genetics-atos-presenting-new-york-city-october-5-2017/‚Ä¶ $ATOS $IBB $MRK $PFE #biotech","#BreastCancer Innovator Atossa Genetics Presenting in #NewYorkCity TODAY! Oct 5, 2017 http://vistapglobal.com/2017/09/breast-cancer-innovator-atossa-genetics-atos-presenting-new-york-city-october-5-2017/‚Ä¶ $ATOS $IBB $MRK $PFE #biotech
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DLYvUdKVYAAOv1k.jpg'],https://twitter.com/VistaPResearch/status/915971608849768449
4755,Market Participant,@AnInvestorGuy,2017-10-06T15:35:03.000Z,Today's dividend: $0.47 from $MRK. I've been paid a combined 15 #dividends so far this month ... at least one on all six days.,"Today's dividend: $0.47 from $MRK. I've been paid a combined 15 #dividends so far this month ... at least one on all six days.
3",,,,3,[],https://twitter.com/AnInvestorGuy/status/916325942225788928
4756,M,@bio_clouseau,2017-10-05T14:44:26.000Z,This $NLNK IDO trial may help compare prembro vs Nivo in Melanoma FWIW https://clinicaltrials.gov/ct2/show/NCT03301636‚Ä¶ $INCY $MRK $BMY,"This $NLNK IDO trial may help compare prembro vs Nivo in Melanoma FWIW https://clinicaltrials.gov/ct2/show/NCT03301636‚Ä¶ $INCY $MRK $BMY
clinicaltrials.gov
A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or...
A Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab for Subjects With Unresectable or Metastatic Melanoma - Full Text View.
4
3
3",,4,3,3,['https://pbs.twimg.com/card_img/1494503800215851014/RNyMRpjM?format=png&name=240x240'],https://twitter.com/bio_clouseau/status/915950814069510144
4757,reem,@kafinancialLLC,2017-10-05T17:24:56.000Z,$MRK setting up for a breakout imo,$MRK setting up for a breakout imo,,,,,['https://pbs.twimg.com/media/DLZBJN8XoAATsmD?format=jpg&name=small'],https://twitter.com/kafinancialLLC/status/915991205162491905
4758,Matthew Herper,@matthewherper,2017-10-05T22:15:00.000Z,Bam! $MRK started a trial combining Keytruda w/ Yervoy. via Tim Anderson at Bernstein.,"Bam! $MRK started a trial combining Keytruda w/ Yervoy. via Tim Anderson at Bernstein.
clinicaltrials.gov
Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic...
Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598) - Full Text View.
5
7",,,5,7,['https://pbs.twimg.com/card_img/1494503800215851014/RNyMRpjM?format=png&name=240x240'],https://twitter.com/matthewherper/status/916064204322426880
4759,James Sikes,@wosaikeneriki,2017-10-06T13:31:25.000Z,"Merck & Co $MRK Share Value Declined While Alethea Capital Management Lowered Its Stake by $615,616 ...","Merck & Co $MRK Share Value Declined While Alethea Capital Management Lowered Its Stake by $615,616 ...",,,,,[],https://twitter.com/wosaikeneriki/status/916294827800780802
4760,James Sikes,@wosaikeneriki,2017-10-06T12:43:38.000Z,"As Merck & Co $MRK Stock Price Declined, Shareholder Semper Augustus Investments Group Trimmed Its Holding ...","As Merck & Co $MRK Stock Price Declined, Shareholder Semper Augustus Investments Group Trimmed Its Holding ...",,,,,[],https://twitter.com/wosaikeneriki/status/916282802555023360
4761,Pete Stock,@PeteStock11,2017-10-05T18:45:27.000Z,"$OPGN lost compliance in May so imo will be afforded another 6 months by Naz, so anything can happen with $MRK. Stay tuned on algo machines","$OPGN lost compliance in May so imo will be afforded another 6 months by Naz, so anything can happen with $MRK. Stay tuned on algo machines
Pete Stock
@PeteStock11
 ¬∑ 6 Oct 2017
$BSTG traders if u sold fast .29-.30 on delisting alert and down for the day may I suggest $OPGN .28-.29 to .35-.40, pressure mounting imo
2",,,,2,['https://pbs.twimg.com/profile_images/1479124146181312515/8j23cdfR_mini.jpg'],https://twitter.com/PeteStock11/status/916011466876125184
4762,1BestTrader.com,@1BestTrader,2017-10-05T20:40:36.000Z,"Replying to 
@jimcramer","Replying to 
@jimcramer
There is still more gold in Eli Lily before the 2017 ends: Target $91.55

$PFE $MRK $SNY $GSK $USDJPY $TOL $TLT 
@dastrader
 #Selflove #Fatima
1
1",,,1,1,['https://pbs.twimg.com/media/DLZtnfhVYAAHlhO?format=jpg&name=small'],https://twitter.com/1BestTrader/status/916040445637156866
4763,ABS News & Research,@AlphaBetaStock,2017-10-04T14:33:59.000Z,Hot Stock Alert: Merck & Co Inc $MRK http://alphabetastock.com/featured-volatile-stock-merck-co-inc-nyse-mrk/‚Ä¶,Hot Stock Alert: Merck & Co Inc $MRK http://alphabetastock.com/featured-volatile-stock-merck-co-inc-nyse-mrk/‚Ä¶,,,,,[],https://twitter.com/AlphaBetaStock/status/915585796744388608
4764,FinInvTr,@FinInvTr,2017-10-04T16:35:08.000Z,Stanley Druckenmiller's Stock Portfolio - https://buff.ly/2ganYHO  $CRM $JD $MRK $EXPE $ATVI $IBB $DAL $UAL $AAL,"Stanley Druckenmiller's Stock Portfolio - https://buff.ly/2ganYHO  $CRM $JD $MRK $EXPE $ATVI $IBB $DAL $UAL $AAL
whotrades.com
Stanley Druckenmiller ‚Äì Equity Holdings
Duquesne Family Office is run by billionaire Stanley Druckenmiller, formerly of two of the top performing hedge funds of all time ‚Äì George Soros‚Äôs Quantum Fund, which he headed from 1988‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1501264601077338114/aQ895T72?format=jpg&name=small'],https://twitter.com/FinInvTr/status/915616285886763008
4765,FinInvTr,@FinInvTr,2017-10-05T21:07:00.000Z,"Top 10 Russell 1000 Companies With Most Cash Abroad: https://buff.ly/2y2UmWe

$MSFT $AAPL $PFE $GE $IBM $CSCO $JNJ $MRK $GOOG $XOM","Top 10 Russell 1000 Companies With Most Cash Abroad: https://buff.ly/2y2UmWe

$MSFT $AAPL $PFE $GE $IBM $CSCO $JNJ $MRK $GOOG $XOM",,,,,[],https://twitter.com/FinInvTr/status/916047089792159749
4766,Blake Higgins,@BHiggins663,2017-10-06T14:05:12.000Z,"have you used this? i've been getting in on some great trades from it http://bit.ly/2whDszU
$MRK $MCD $M","have you used this? i've been getting in on some great trades from it http://bit.ly/2whDszU
$MRK $MCD $M",,,,,['https://pbs.twimg.com/media/DLddBOtUMAAWa2N?format=jpg&name=small'],https://twitter.com/BHiggins663/status/916303328560152576
4767,Patrick Byrd,@PByrd112,2017-10-06T02:07:43.000Z,"I highly recommend everyone check this out for discovering good stocks to trade http://bit.ly/2w7Zy7z
$MEI $MTOR $MRK","I highly recommend everyone check this out for discovering good stocks to trade http://bit.ly/2w7Zy7z
$MEI $MTOR $MRK",,,,,['https://pbs.twimg.com/media/DLa4zVPVwAAeWr6?format=jpg&name=small'],https://twitter.com/PByrd112/status/916122769519149056
4768,Kara Jill Stancell,@kjilly,2017-10-06T19:17:55.000Z,'Going big': $MRK launches frontline PhIII #lungcancer study for #Keytruda/Yervoy combo - #biotech #pharma $AZN,"'Going big': $MRK launches frontline PhIII #lungcancer study for #Keytruda/Yervoy combo - #biotech #pharma $AZN
endpts.com
'Going big': Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo
Merck took a dominant position in frontline lung cancer with the approval of a combination of Keytruda and chemo. And it isn‚Äôt just waiting around to see if any combination of a PD-(L)1 with a CTLA4...",,,,,[],https://twitter.com/kjilly/status/916382025241653248
4769,James Sikes,@wosaikeneriki,2017-10-06T18:09:29.000Z,Hall Laurie J Trustee Has Trimmed Position in Merck And Co $MRK as Share Value Declined ...,Hall Laurie J Trustee Has Trimmed Position in Merck And Co $MRK as Share Value Declined ...,,,,,[],https://twitter.com/wosaikeneriki/status/916364806856368128
4770,Sweet Platform,@SweetPlatform,2017-10-04T15:23:13.000Z,"MRK Top news - Oct 4th, 2017 $MRK http://https://goo.gl/XyEm7j","MRK Top news - Oct 4th, 2017 $MRK http://https://goo.gl/XyEm7j",,,,,[],https://twitter.com/SweetPlatform/status/915598186957492224
4771,Buy Cryptocurrency,@cryptosbuy,2017-10-04T06:14:42.000Z,Long setup $MRK http://tradingview.com/chart/MRK/b6GQfLp9-Long-setup/‚Ä¶ TV_TradingIdeas,Long setup $MRK http://tradingview.com/chart/MRK/b6GQfLp9-Long-setup/‚Ä¶ TV_TradingIdeas,,,,,[],https://twitter.com/cryptosbuy/status/915460150345043968
4772,StockMarketVideo.com,@stockmarketvide,2017-10-06T01:28:34.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/916112915471749120
4773,Gambiste,@GambisteFinance,2017-10-05T20:23:15.000Z,"Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $JPM $BABA $ABBV $WFC $BAC $WMT $GOOG $BUD $MRK $KO http://gambiste.com/index.php/2017/10/05/gambiste-top-10-afternoon-most-tweeted-big-caps-67/‚Ä¶","Afternoon Most Tweeted Big Caps, check out Gambiste Top 10: $JPM $BABA $ABBV $WFC $BAC $WMT $GOOG $BUD $MRK $KO http://gambiste.com/index.php/2017/10/05/gambiste-top-10-afternoon-most-tweeted-big-caps-67/‚Ä¶",,,,,[],https://twitter.com/GambisteFinance/status/916036079219761152
4774,US Banking News,@AmericanBanking,2017-10-06T15:15:54.000Z,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2xYvkrP $MRK #MRK,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2xYvkrP $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/916321123029090305
4775,US Banking News,@AmericanBanking,2017-10-04T13:17:14.000Z,Merck KGaA given ‚Ç¨115.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2xYalVi $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2xYalVi $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/915566480523251713
4776,New World Strategies,@raysnewworld,2017-10-06T21:00:16.000Z,"This Biotechnology cohort has made up a lot of lost ground....Read "" $IBB - A Clearer Runway Ahead"" > http://tinyurl.com/y8zzmnou $MRK $BMY","This Biotechnology cohort has made up a lot of lost ground....Read "" $IBB - A Clearer Runway Ahead"" > http://tinyurl.com/y8zzmnou $MRK $BMY
ino.com
IBB - A Clearer Runway Ahead - INO.com Trader's Blog
iShares Biotechnology Index ETF (NASDAQ:IBB) has finally made up much of the lost ground it suffered during the 2016 presidential race.",,,,,['https://pbs.twimg.com/card_img/1500820693079838720/6X1lUujj?format=png&name=360x360'],https://twitter.com/raysnewworld/status/916407785562054656
4777,Dakota Financial,@dakotafinancial,2017-10-04T17:55:33.000Z,"Iowa State Bank Raises Holdings in Merck & Company, Inc. $MRK http://ift.tt/2kn84OP","Iowa State Bank Raises Holdings in Merck & Company, Inc. $MRK http://ift.tt/2kn84OP",,,,,[],https://twitter.com/dakotafinancial/status/915636522325626880
4778,stockassassin,@stockassassin74,2017-10-06T08:51:26.000Z,... $zgnx incredible data should be 1.5b soon and buyout candidate $alny new ath coming nice pause and basing $dvax will be bought by $mrk,"... $zgnx incredible data should be 1.5b soon and buyout candidate $alny new ath coming nice pause and basing $dvax will be bought by $mrk
1
2",,1,,2,[],https://twitter.com/stockassassin74/status/916224367888973824
4779,bake mcbride,@ITRADEVOL,2017-10-05T20:54:00.000Z,After Hours MostActive $ESV $ATW $GDX $PLAB $SPY $BAC $PARR $GE $EEM $MSFT $MRK $CSCO $PFE $GM $EWP $AZN $USB $AAPL https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,After Hours MostActive $ESV $ATW $GDX $PLAB $SPY $BAC $PARR $GE $EEM $MSFT $MRK $CSCO $PFE $GM $EWP $AZN $USB $AAPL https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/916043818423734272
4780,Transcript Daily,@TranscriptDaily,2017-10-05T20:18:28.000Z,"Merck & Company, Inc. $MRK Position Lifted by BTR Capital Management Inc. http://ift.tt/2gfg93E","Merck & Company, Inc. $MRK Position Lifted by BTR Capital Management Inc. http://ift.tt/2gfg93E",,,,,[],https://twitter.com/TranscriptDaily/status/916034875953602561
4781,Limex,@LimexMe,2017-10-06T21:17:34.000Z,Here's What's Has Happened in the HCV Space Lately http://bit.ly/061017GILD $GILD $ABBV $MRK $BMY $JNJ,Here's What's Has Happened in the HCV Space Lately http://bit.ly/061017GILD $GILD $ABBV $MRK $BMY $JNJ,,,,,[],https://twitter.com/LimexMe/status/916412139300114432
4782,Dakota Financial,@dakotafinancial,2017-10-04T08:08:30.000Z,"Merck & Company, Inc. $MRK Stake Decreased by Oakwood Capital Management LLC CA http://ift.tt/2xQwTbx","Merck & Company, Inc. $MRK Stake Decreased by Oakwood Capital Management LLC CA http://ift.tt/2xQwTbx",,,,,[],https://twitter.com/dakotafinancial/status/915488787458875393
4783,Daily Political,@DPolitical,2017-10-04T17:52:59.000Z,"$MRK - St. Johns Investment Management Company LLC Boosts Stake in Merck & Company, Inc‚Ä¶ https://goo.gl/fb/XgRFXK","$MRK - St. Johns Investment Management Company LLC Boosts Stake in Merck & Company, Inc‚Ä¶ https://goo.gl/fb/XgRFXK",,,,,[],https://twitter.com/DPolitical/status/915635879003160588
4784,Stockboard Media Inc,@stockboardinc,2017-10-04T12:07:29.000Z,$MRK Merck Highlights Ongoing Commitment to Fighting Infectious Diseases With 40 Data Presentations at ID... - http://sbml.co/ceaa57d1,$MRK Merck Highlights Ongoing Commitment to Fighting Infectious Diseases With 40 Data Presentations at ID... - http://sbml.co/ceaa57d1,,,,,[],https://twitter.com/stockboardinc/status/915548930489962496
4785,US Banking News,@AmericanBanking,2017-10-04T08:36:19.000Z,Reviewing Merck & $MRK & Its Peers http://ift.tt/2g9kCVy,Reviewing Merck & $MRK & Its Peers http://ift.tt/2g9kCVy,,,,,[],https://twitter.com/AmericanBanking/status/915495787282534400
4786,Tim Reller,@TraderGuruNY,2017-10-06T01:22:39.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/916111426569359365
4787,Sweet Platform,@SweetPlatform,2017-10-06T15:38:51.000Z,"MRK Top news - Oct 6th, 2017 $MRK http://https://goo.gl/PjTu9P","MRK Top news - Oct 6th, 2017 $MRK http://https://goo.gl/PjTu9P",,,,,[],https://twitter.com/SweetPlatform/status/916326896576729088
4788,MarketBeat,@MarketBeatCom,2017-10-04T08:47:18.000Z,Reviewing Merck & $MRK & Its Peers http://ift.tt/2ww1Spd #acn,Reviewing Merck & $MRK & Its Peers http://ift.tt/2ww1Spd #acn,,,,,[],https://twitter.com/MarketBeatCom/status/915498550045310976
4789,StockNews.com,@stocknewsdotcom,2017-10-06T10:28:19.000Z,$MRK Granted orphan drug designation by the FDA for Keytruda for the treatment of Small Cell Lung Cancer excluding‚Ä¶ https://stocknews.com/news/mrk-granted-orphan-drug-designation-by-the-fda-for-keytruda-for/‚Ä¶,$MRK Granted orphan drug designation by the FDA for Keytruda for the treatment of Small Cell Lung Cancer excluding‚Ä¶ https://stocknews.com/news/mrk-granted-orphan-drug-designation-by-the-fda-for-keytruda-for/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/916248748191375361
4790,Ticker Report,@TickerReport,2017-10-05T18:38:19.000Z,"Town & Country Bank & Trust CO dba First Bankers Trust CO Sells 35 Shares of Merck & Company, Inc. $MRK http://ift.tt/2fNGgOE","Town & Country Bank & Trust CO dba First Bankers Trust CO Sells 35 Shares of Merck & Company, Inc. $MRK http://ift.tt/2fNGgOE",,,,,[],https://twitter.com/TickerReport/status/916009672582270977
4791,Limex,@LimexMe,2017-10-06T14:27:26.000Z,Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now? http://bit.ly/061017AMGN $AMGN $GILD $CELG $MRK $ABBV,"Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now? http://bit.ly/061017AMGN $AMGN $GILD $CELG $MRK $ABBV
whotrades.com
Everything Is Going Right for AbbVie: Is It the Best Biotech Stock to Buy Right Now?
Have you ever had one of those days where everything seems to fall into place for you? AbbVie (NYSE: ABBV) is having one of those kinds of years.  The big biotech's stock is up more‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/916308923870859265
4792,Daily Political,@dailypoliticaln,2017-10-04T18:00:40.000Z,"St. Johns Investment Management Company LLC Boosts Stake in Merck & Company, Inc. $MRK http://ift.tt/2fS2Zg7","St. Johns Investment Management Company LLC Boosts Stake in Merck & Company, Inc. $MRK http://ift.tt/2fS2Zg7",,,,,[],https://twitter.com/dailypoliticaln/status/915637809729372161
4793,Margin Hunt,@MarginHunt,2017-10-04T13:35:05.000Z,"Ray Dalio did his homework on Merck & Company, $MRK. Stock's trading below fair value http://ow.ly/TfSn30fzFl4","Ray Dalio did his homework on Merck & Company, $MRK. Stock's trading below fair value http://ow.ly/TfSn30fzFl4",,,,,[],https://twitter.com/MarginHunt/status/915570975613300736
4794,CBPartners,@CBPartners,2017-10-06T22:05:08.000Z,"$MRK invests EUR 35m in new production line at ITA manufacturing site, with aim to be fully operational in 2022","$MRK invests EUR 35m in new production line at ITA manufacturing site, with aim to be fully operational in 2022
medianet.com.au
News Hub Post",,,,,[],https://twitter.com/CBPartners/status/916424107125821441
4795,MarketSmith,@MarketSmith,2017-10-06T21:08:09.000Z,"Delta, Top Banks To Begin Q3 Earnings Season: Investing Action Plan http://ow.ly/q13I30fHEE9 $DAL $JPM $C $WFC $BAC $WMT $CSCO $UTX $COL $MRK","Delta, Top Banks To Begin Q3 Earnings Season: Investing Action Plan http://ow.ly/q13I30fHEE9 $DAL $JPM $C $WFC $BAC $WMT $CSCO $UTX $COL $MRK
investors.com
Delta, JPMorgan, Citigroup, BofA, Wells Fargo To Report: Investing Action Plan | Stock News & Stock...
The reporting season for Q3 results is about to begin, with Delta Air Lines, JPMorgan Chase, Citigroup, Bank of America and Wells Fargo leading the charge.
1",,,,1,[],https://twitter.com/MarketSmith/status/916409767286976512
4796,Donna Young,@DonnaYoungDC,2017-10-06T22:46:47.000Z,"ICYMI: US faces dire drug shortages if Puerto Rico plants not restored, FDA chief warns  https://snl.com/web/client?auth=inherit#news/article?id=42172852&cdid=A-42172852-13101‚Ä¶ $LLY $PFE $AMGN $JNJ $MRK https://twitter.com/SGottliebFDA/status/916400016196960257‚Ä¶","ICYMI: US faces dire drug shortages if Puerto Rico plants not restored, FDA chief warns  https://snl.com/web/client?auth=inherit#news/article?id=42172852&cdid=A-42172852-13101‚Ä¶ $LLY $PFE $AMGN $JNJ $MRK https://twitter.com/SGottliebFDA/status/916400016196960257‚Ä¶
This Tweet is unavailable.",üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/916434592080519168
4797,BioPharm Insight,@BioPharmInsight,2017-10-06T12:30:02.000Z,"@ManasiVaidya22
 gets the update on $PFE $MRK #Bavencio trial in 1L #RCC http://bit.ly/2yu5D3i #BPINews","@ManasiVaidya22
 gets the update on $PFE $MRK #Bavencio trial in 1L #RCC http://bit.ly/2yu5D3i #BPINews
1",,,,1,[],https://twitter.com/BioPharmInsight/status/916279378862133249
4798,BenjiMax,@BenjiMax2,2017-10-05T18:57:52.000Z,"Replying to 
@PeteStock11","Replying to 
@PeteStock11
Still expect $MRK to buy out $OPGN
1
1",,,1,1,[],https://twitter.com/BenjiMax2/status/916014592605777921
4799,dough,@semodough,2017-10-07T13:02:01.000Z,25 largest pharma/biotech PE not expensive going forward here $IBB $BTK $NBI $MRK $JNJ $GILD $CELG,"25 largest pharma/biotech PE not expensive going forward here $IBB $BTK $NBI $MRK $JNJ $GILD $CELG
1
11
21",,1,11,21,['https://pbs.twimg.com/media/DLiYHixXkAERPAb?format=jpg&name=small'],https://twitter.com/semodough/status/916649816276504576
4800,Gery DIVRY,@GeryDIVRY,2017-10-09T13:52:18.000Z,Commented on https://seekingalpha.com/article/4110628-intercept-runs-trouble-nash-developers-like-galectin-gain-value?source=tweet&sht=oxk6j6&shu=l8mmr#comment-76434817‚Ä¶ $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT,"Commented on https://seekingalpha.com/article/4110628-intercept-runs-trouble-nash-developers-like-galectin-gain-value?source=tweet&sht=oxk6j6&shu=l8mmr#comment-76434817‚Ä¶ $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT
1
5",,1,5,,[],https://twitter.com/GeryDIVRY/status/917387247338397697
4801,Art,@mRNAdisrupts,2017-10-07T19:11:05.000Z,Commented on https://seekingalpha.com/article/4112225-3-things-biotech-learn-today-october-7-2017?source=tweet&sht=oxgvyh&shu=8elm#comment-76426304‚Ä¶ $AMGN $BIIB $BMY $IONS $MRK,"Commented on https://seekingalpha.com/article/4112225-3-things-biotech-learn-today-october-7-2017?source=tweet&sht=oxgvyh&shu=8elm#comment-76426304‚Ä¶ $AMGN $BIIB $BMY $IONS $MRK
seekingalpha.com
3 Things In Biotech You Should Learn Today: October 7, 2017
Merck goes big in new combo trial for lung cancer. New T-VEC pub bodes well for patients with melanoma.
1",,,,1,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/mRNAdisrupts/status/916742697313955840
4802,Seeking Alpha,@SeekingAlpha,2017-10-09T20:05:04.000Z,https://seekingalpha.com/article/4112544-agenus-loads-impressive-new-pipeline?source=feed_f‚Ä¶ $BMY $GSK $INCY $MRK $AGEN,"https://seekingalpha.com/article/4112544-agenus-loads-impressive-new-pipeline?source=feed_f‚Ä¶ $BMY $GSK $INCY $MRK $AGEN
1",,,,1,[],https://twitter.com/SeekingAlpha/status/917481058555199493
4803,dough,@semodough,2017-10-07T13:21:05.000Z,Great slide by Leerink porgess on HCV revenue thru 2021 $ENTA $GILD $ABBV $MRK $IBB $BMY,"Great slide by Leerink porgess on HCV revenue thru 2021 $ENTA $GILD $ABBV $MRK $IBB $BMY
2
9
7",,2,9,7,['https://pbs.twimg.com/media/DLicgk3WsAASZcg?format=jpg&name=small'],https://twitter.com/semodough/status/916654616741400583
4804,dough,@semodough,2017-10-07T13:30:32.000Z,Biotech earnings week away $JNJ $UNH $ABT $ISRG $GILD $CELG $MRK   Also investor meetings $PRTK $AUPH upcoming,"Biotech earnings week away $JNJ $UNH $ABT $ISRG $GILD $CELG $MRK   Also investor meetings $PRTK $AUPH upcoming
4
12",,,4,12,['https://pbs.twimg.com/media/DLieq5sXkAAl_Fs?format=jpg&name=small'],https://twitter.com/semodough/status/916656993292767235
4805,Eric Cunningham,@TopFlightTrades,2017-10-08T16:14:52.000Z,These 5 Dow Stocks Are Courting Buy Zones As Earnings Season Begins $SPY $WMT $UTX $MRK $CSCO $PFE http://bit.ly/2wFyBZn,These 5 Dow Stocks Are Courting Buy Zones As Earnings Season Begins $SPY $WMT $UTX $MRK $CSCO $PFE http://bit.ly/2wFyBZn,,,,,['https://pbs.twimg.com/media/DLoN4VnVoAAj2MS?format=jpg&name=small'],https://twitter.com/TopFlightTrades/status/917060738010710018
4806,Finbox,@FinboxIO,2017-10-09T06:15:04.000Z,Value investors may want to look at Merck & $MRK. Jeremy Grantham is http://ow.ly/v9BT30fE0iE,Value investors may want to look at Merck & $MRK. Jeremy Grantham is http://ow.ly/v9BT30fE0iE,,,,,['https://pbs.twimg.com/media/DLrOLyyXUAA5czA?format=jpg&name=small'],https://twitter.com/FinboxIO/status/917272178894221312
4807,James Sikes,@wosaikeneriki,2017-10-07T20:52:38.000Z,"As Merck & Co $MRK Market Valuation Declined, Holder Alethea Capital Management Trimmed by $615,616 Its Hol...","As Merck & Co $MRK Market Valuation Declined, Holder Alethea Capital Management Trimmed by $615,616 Its Hol...",,,,,[],https://twitter.com/wosaikeneriki/status/916768249785798656
4808,James Sikes,@wosaikeneriki,2017-10-09T09:15:47.000Z,"Investment Centers Of America Raised Merck & Co $MRK Holding by $404,082 http://bzweekly.com/investment-centers-of-america-raised-merck-share-value-declined-amazon-com-amzn-shareholder-steadfast-capital-management-lp-has-trimmed-holding-as-share-value-rose/‚Ä¶","Investment Centers Of America Raised Merck & Co $MRK Holding by $404,082 http://bzweekly.com/investment-centers-of-america-raised-merck-share-value-declined-amazon-com-amzn-shareholder-steadfast-capital-management-lp-has-trimmed-holding-as-share-value-rose/‚Ä¶",,,,,[],https://twitter.com/wosaikeneriki/status/917317660299362305
4809,Sweet Platform,@SweetPlatform,2017-10-09T15:37:24.000Z,"MRK Top news - Oct 9th, 2017 $MRK http://https://goo.gl/L3yZBF","MRK Top news - Oct 9th, 2017 $MRK http://https://goo.gl/L3yZBF",,,,,[],https://twitter.com/SweetPlatform/status/917413696657293313
4810,BioPharma Dive,@BioPharmaDive,2017-10-08T18:45:01.000Z,$MRK drops hep C programs in 'strategic decision' http://bit.ly/2xaWyXL,"$MRK drops hep C programs in 'strategic decision' http://bit.ly/2xaWyXL
2",,,,2,[],https://twitter.com/BioPharmaDive/status/917098524231204864
4811,James Sikes,@wosaikeneriki,2017-10-09T15:52:19.000Z,Botty Investors Lowered Stake in Merck & Co $MRK as Stock Price Declined http://bzweekly.com/botty-investors-lowered-stake-in-merck-bbt-securities-holding-in-crown-castle-intl-new-cci-has-cut-by-20-65-million-as-market-value-rose/‚Ä¶,Botty Investors Lowered Stake in Merck & Co $MRK as Stock Price Declined http://bzweekly.com/botty-investors-lowered-stake-in-merck-bbt-securities-holding-in-crown-castle-intl-new-cci-has-cut-by-20-65-million-as-market-value-rose/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/917417450756562946
4812,Clark Joseph Kent,@JorelLaraKalel,2017-10-09T16:00:04.000Z,These 5 Dow Stocks Are Courting Buy Zones As Earnings Season Begins $DJIA http://bit.ly/2yb2IuJ $WMT $UTX $MRK $CSCO $PFE,"These 5 Dow Stocks Are Courting Buy Zones As Earnings Season Begins $DJIA http://bit.ly/2yb2IuJ $WMT $UTX $MRK $CSCO $PFE
investors.com
Dow Stocks Wal-Mart, Cisco, Pfizer Are Courting Buy Zones As Earnings Season Begins | Stock News &...
The Dow has been setting record highs, but there are still possible buying opportunities for some top blue chips, including Wal-Mart, Cisco and Pfizer.",,,,,[],https://twitter.com/JorelLaraKalel/status/917419401963548677
4813,TalkMarkets,@TalkMarkets,2017-10-08T22:08:44.000Z,Here's What's Has Happened In The HCV Space Lately $JNJ $GILD $ABBV $MRK Also $BMY https://goo.gl/53zkK1,Here's What's Has Happened In The HCV Space Lately $JNJ $GILD $ABBV $MRK Also $BMY https://goo.gl/53zkK1,,,,,[],https://twitter.com/TalkMarkets/status/917149791855022080
4814,MarketBeat,@MarketBeatCom,2017-10-09T08:25:15.000Z,"Moody National Bank Trust Division Continues to Hold Holdings in Merck & Company, Inc. $MRK http://ift.tt/2yA4Ldw","Moody National Bank Trust Division Continues to Hold Holdings in Merck & Company, Inc. $MRK http://ift.tt/2yA4Ldw",,,,,[],https://twitter.com/MarketBeatCom/status/917304940388855809
4815,FiercePharma,@FiercePharma,2017-10-09T15:35:02.000Z,Goodbye to Belsomra's furry mascots. Merck's focusing on sleepless patients instead http://fiercepharma.com/marketing/good-bye-sleep-cat-and-wake-dog-merck-s-belsomra-new-marketing-direction-built-patient‚Ä¶ $MRK,"Goodbye to Belsomra's furry mascots. Merck's focusing on sleepless patients instead http://fiercepharma.com/marketing/good-bye-sleep-cat-and-wake-dog-merck-s-belsomra-new-marketing-direction-built-patient‚Ä¶ $MRK
fiercepharma.com
Goodbye to Belsomra's furry mascots. Merck's focusing on sleepless patients instead
Belsomra's furry word creatures have officially retired. | Belsomra's furry word creatures have officially retired. Merck & Co.'s ""sleep"" cat and ""wake"" dog in the insomnia drug's first wave of TV...",,,,,['https://pbs.twimg.com/card_img/1499740394107584522/kcx8Uc5B?format=jpg&name=small'],https://twitter.com/FiercePharma/status/917413100634169344
4816,Peeptrade,@peeptrade,2017-10-09T20:25:50.000Z,"The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September 
@themotleyfool
 #stocks $MRK, $BMY, $NLNK","The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September 
@themotleyfool
 #stocks $MRK, $BMY, $NLNK
fool.com
The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September @themotleyfool #stocks...
New data on NewLink's lead drug puts some pep in this clinical-stage drug developers' step.",,,,,[],https://twitter.com/peeptrade/status/917486282275778560
4817,nj.com reader,@NjdotcomReader,2017-10-07T13:37:29.000Z,"@jimcramer
 For portfolio covering 11 sectors, how to choose ONE buy & hold from $utx $hon $ge $mmm $emr or $mrk $pfe $lly or $ko $pep $dps?","@jimcramer
 For portfolio covering 11 sectors, how to choose ONE buy & hold from $utx $hon $ge $mmm $emr or $mrk $pfe $lly or $ko $pep $dps?",,,,,[],https://twitter.com/NjdotcomReader/status/916658742195867648
4818,Dakota Financial,@dakotafinancial,2017-10-09T08:32:24.000Z,"Moody National Bank Trust Division Continues to Hold Holdings in Merck & Company, Inc. $MRK http://ift.tt/2yA4Ldw","Moody National Bank Trust Division Continues to Hold Holdings in Merck & Company, Inc. $MRK http://ift.tt/2yA4Ldw",,,,,[],https://twitter.com/dakotafinancial/status/917306741137772545
4819,Limex,@LimexMe,2017-10-09T16:16:18.000Z,The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September http://bit.ly/091017MRK $MRK $BMY $NLNK,"The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September http://bit.ly/091017MRK $MRK $BMY $NLNK
whotrades.com
The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September
What happened Shares of NewLink Genetics (NASDAQ: NLNK) , a small-cap clinical-stage drug developer focused on therapies to treat cancer, skyrocketed by 25% in September, according to‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/917423484086685697
4820,Biotech2050,@Biotech2050,2017-10-09T04:53:11.000Z,"Replying to 
@Biotech2050
 @fezziwig2008
  and 2 others","Replying to 
@Biotech2050
 @fezziwig2008
  and 2 others
so $HALO could end up getting a piece of the cake by either way of royalties for #enhanze SC or revenues from PEGPH20 combo
$MRK $BMY 
@roche
1
1",,1,,1,[],https://twitter.com/Biotech2050/status/917251574354890752
4821,Biotech2050,@Biotech2050,2017-10-09T04:38:53.000Z,"Replying to 
@fezziwig2008
 and 
@Forbes","Replying to 
@fezziwig2008
 and 
@Forbes
So effectively $HALO will win with both #KEYTRUDA & #OPDIVO if #pegph20 & #subcutaneous combos are successful 
$BMY $MRK
2",,2,,,[],https://twitter.com/Biotech2050/status/917247974861885441
4822,David Crow,@bydavidcrow,2017-10-10T16:51:03.000Z,Decoding cancer: the four trends that are turning precision medicine into a reality https://ft.com/content/9e02a064-a9d1-11e7-93c5-648314d2c72c‚Ä¶ $LOXO $MRK $FMI $TMO,"Decoding cancer: the four trends that are turning precision medicine into a reality https://ft.com/content/9e02a064-a9d1-11e7-93c5-648314d2c72c‚Ä¶ $LOXO $MRK $FMI $TMO
2
32
42",,2,32,42,['https://pbs.twimg.com/media/DLypJprXcAEfXgJ?format=jpg&name=small'],https://twitter.com/bydavidcrow/status/917794617743069184
4823,Bio Stocks‚Ñ¢,@BioStocks,2017-10-10T11:32:34.000Z,"$KALV Announces Collaboration With $MRK.  $37M Upfront. $MRK Acquires 9.9% Stake. 
http://marketwatch.com/story/kalvista-pharmaceuticals-announces-collaboration-with-merck-2017-10-10‚Ä¶","$KALV Announces Collaboration With $MRK.  $37M Upfront. $MRK Acquires 9.9% Stake. 
http://marketwatch.com/story/kalvista-pharmaceuticals-announces-collaboration-with-merck-2017-10-10‚Ä¶
15
11",,,15,11,[],https://twitter.com/BioStocks/status/917714469664559105
4824,Jacob Plieth,@JacobPlieth,2017-10-10T08:56:58.000Z,Updating my list of anti-CTLA4 assets. Any obvious omissions? $ADRO $AGEN $MRK $XNCR $BMY $AZN #SITC17,"Updating my list of anti-CTLA4 assets. Any obvious omissions? $ADRO $AGEN $MRK $XNCR $BMY $AZN #SITC17
6
16
30",,6,16,30,['https://pbs.twimg.com/media/DLw8svkWsAEmqTL?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/917675310577078272
4825,Andy Biotech,@AndyBiotech,2017-10-12T16:18:25.000Z,"Tumor and Microenvironment Evolution during #Immunotherapy with Nivolumab

http://cell.com/cell/fulltext/S0092-8674(17)31122-4‚Ä¶
$BMY $MRK $AZN $PFE","Tumor and Microenvironment Evolution during #Immunotherapy with Nivolumab

http://cell.com/cell/fulltext/S0092-8674(17)31122-4‚Ä¶
$BMY $MRK $AZN $PFE
1
39
62",,1,39,62,['https://pbs.twimg.com/media/DL80IMXXkAIcltY?format=jpg&name=small'],https://twitter.com/AndyBiotech/status/918511180171366400
4826,Matthew Herper,@matthewherper,2017-10-10T11:43:05.000Z,Investors may be interested in this quote about $incy from $mrk's Roger Perlmutter. https://forbes.com/sites/matthewherper/2017/10/10/incyte-pharmaceuticals-finds-the-right-chemistry-for-success/#79c4e08a51bb‚Ä¶,"Investors may be interested in this quote about $incy from $mrk's Roger Perlmutter. https://forbes.com/sites/matthewherper/2017/10/10/incyte-pharmaceuticals-finds-the-right-chemistry-for-success/#79c4e08a51bb‚Ä¶
1
4
16",,1,4,16,['https://pbs.twimg.com/media/DLxi2PpUMAAIRp4?format=jpg&name=small'],https://twitter.com/matthewherper/status/917717114764648450
4827,M,@bio_clouseau,2017-10-10T11:32:19.000Z,$KALV MC ~ 70M. U/F from $MRK 37M + biobucks totalling ~715M + royalties,"$KALV MC ~ 70M. U/F from $MRK 37M + biobucks totalling ~715M + royalties
9
9",,,9,9,[],https://twitter.com/bio_clouseau/status/917714404577292288
4828,Divya Grover,@thegirlshewasnt,2017-10-12T09:57:13.000Z,$MRK to not seek #FDA approval for its #cholesterol drug as its clinical profile does not support regulatory filings,"$MRK to not seek #FDA approval for its #cholesterol drug as its clinical profile does not support regulatory filings
reuters.com
Merck says will not seek approval of cholesterol treatment
Merck & Co Inc said on Wednesday it will not seek regulatory approval for its experimental cholesterol drug, anacetrapib, as the clinical profile of the treatment does not support regulatory filings.
2",,,,2,[],https://twitter.com/thegirlshewasnt/status/918415248075382784
4829,dough,@semodough,2017-10-10T14:19:44.000Z,"AASLD conference on liver diseases (October 20‚Äì24) in Washington, D.C.  $CBAY $ICPT $GILD $ENTA $ABUS $MRK","AASLD conference on liver diseases (October 20‚Äì24) in Washington, D.C.  $CBAY $ICPT $GILD $ENTA $ABUS $MRK
7
8",,,7,8,[],https://twitter.com/semodough/status/917756538680479744
4830,Donna Young,@DonnaYoungDC,2017-10-11T21:36:19.000Z,#NIH: Experimental #Ebola #vaccines elicit year-long immune response https://nih.gov/news-events/news-releases/experimental-ebola-vaccines-elicit-year-long-immune-response‚Ä¶ #pharma #biotech $MRK $GSK $NLNK #NIAID,#NIH: Experimental #Ebola #vaccines elicit year-long immune response https://nih.gov/news-events/news-releases/experimental-ebola-vaccines-elicit-year-long-immune-response‚Ä¶ #pharma #biotech $MRK $GSK $NLNK #NIAID,üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/918228797446676481
4831,pharmalot,@pharmalot,2017-10-12T13:13:58.000Z,Pharmalot.. Pharmalittle.. Good Morning.. Merck dumps a cholesterol drug & more news.. https://statnews.com/pharmalot/2017/10/12/merck-cholesterol-novartis-roche/‚Ä¶ #pharma $MRK $NVS $PFE $JNJ,"Pharmalot.. Pharmalittle.. Good Morning.. Merck dumps a cholesterol drug & more news.. https://statnews.com/pharmalot/2017/10/12/merck-cholesterol-novartis-roche/‚Ä¶ #pharma $MRK $NVS $PFE $JNJ
statnews.com
Pharmalittle: Merck dumps a cholesterol drug; Novartis to keep its stake in Roche
Merck is not seeking regulatory approval for a type of cholesterol-lowering medicine that has vexed other drug makers.
1",,,,1,[],https://twitter.com/pharmalot/status/918464765021782016
4832,Seeking Alpha,@SeekingAlpha,2017-10-12T17:07:33.000Z,https://seekingalpha.com/article/4113175-lower-volatility-stock-portfolio-retirees-others?source=feed_f‚Ä¶ $ABBV $ABT $AMGN $BCR $BDX $BMY $CL $COST $CVS $EL $GILD $GIS $JNJ $KHC $KMB $KO $LLY $MDLZ $MDT $MRK,"https://seekingalpha.com/article/4113175-lower-volatility-stock-portfolio-retirees-others?source=feed_f‚Ä¶ $ABBV $ABT $AMGN $BCR $BDX $BMY $CL $COST $CVS $EL $GILD $GIS $JNJ $KHC $KMB $KO $LLY $MDLZ $MDT $MRK
seekingalpha.com
The Lower Volatility Stock Portfolio For Retirees And Others
I recently had a look at the SPDR sectors through the last two major market corrections in search of lower volatility or drawdown.",,,,,[],https://twitter.com/SeekingAlpha/status/918523544773959680
4833,Meg Tirrell,@megtirrell,2017-10-11T20:47:55.000Z,"$MRK says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $MRK -0.8% after hrs","$MRK says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $MRK -0.8% after hrs
9
15",,,9,15,[],https://twitter.com/megtirrell/status/918216614536974336
4834,Hotpage News,@Hotpage_News,2017-10-12T13:26:35.000Z,STOCKS MAKING BIGGEST MOVES PREMARKET: $JPM $HLF $DPZ $GOOGL $WSM $SQ $T $MRK $DIS $TM $JILL $AMZN - CNBC,"STOCKS MAKING BIGGEST MOVES PREMARKET: $JPM $HLF $DPZ $GOOGL $WSM $SQ $T $MRK $DIS $TM $JILL $AMZN - CNBC
cnbc.com
Stocks making the biggest moves premarket: JPM, HLF, DPZ, GOOGL & more
These are the stocks posting the largest moves before the bell.",,,,,[],https://twitter.com/Hotpage_News/status/918467938625212419
4835,Diane Askwyth,@dianerocks52,2017-10-11T18:21:13.000Z,Hurricane-related damage could cause shortages of 40 drugs - FDA https://seekingalpha.com/news/3300468-hurricane-related-damage-cause-shortages-40-drugs-fda?source=tweet‚Ä¶ $BMY $MRK $PFE $AGN,"Hurricane-related damage could cause shortages of 40 drugs - FDA https://seekingalpha.com/news/3300468-hurricane-related-damage-cause-shortages-40-drugs-fda?source=tweet‚Ä¶ $BMY $MRK $PFE $AGN
seekingalpha.com
Hurricane-related damage could cause shortages of 40 drugs - FDA (NYSE:BMY)
FDA Commissioner Scott Gottlieb, M.D. says damages to drug makers' Puerto Rico manufacturing operations could result in shortages of as many as 40 medicines before companies regain full...
1",,,1,,['https://pbs.twimg.com/card_img/1492650956311474182/Znmq8Lz7?format=png&name=240x240'],https://twitter.com/dianerocks52/status/918179698139578368
4836,MM+M Magazine,@MMMnews,2017-10-12T14:45:01.000Z,"5 things for #pharma #marketers to know: Thurs., Oct. 12 $MRK #clinicaltrials #FDA #oncology #DTC #hcmktg $ARDX #IBS http://bit.ly/2geNIpM","5 things for #pharma #marketers to know: Thurs., Oct. 12 $MRK #clinicaltrials #FDA #oncology #DTC #hcmktg $ARDX #IBS http://bit.ly/2geNIpM
1
2",,,1,2,['https://pbs.twimg.com/media/DL8dDlQX4AAYhIz?format=jpg&name=small'],https://twitter.com/MMMnews/status/918487677590167552
4837,John Carroll,@JohnCendpts,2017-10-11T21:06:35.000Z,"Breaking-
Positive PhIII can‚Äôt salvage Merck‚Äôs anacetrapib, now relegated to the scrap heap
$MRK","Breaking-
Positive PhIII can‚Äôt salvage Merck‚Äôs anacetrapib, now relegated to the scrap heap
$MRK
endpts.com
Positive PhIII can't salvage Merck's anacetrapib, now relegated to the scrap heap
There will be no CETP heart drug miracle in the works at Merck. The pharma giant looked over a set of positive but troublesome Phase III data for its drug anacetrapib and concluded today that they...
1
12
9",,1,12,9,['https://pbs.twimg.com/card_img/1501187304265863173/CWThvcdQ?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/918221313961021448
4838,Vista Partners LLC,@VistaPResearch,2017-10-12T16:54:11.000Z,"Have you read ""Keeps On Keepin' On"" Vista's Monthly Newsletter http://vistapglobal.com/2017/09/keeps-on-keepin-on/‚Ä¶
$MRK $ATOS $FSNN $HIIQ #biotech #ThursdayMotivation","Have you read ""Keeps On Keepin' On"" Vista's Monthly Newsletter http://vistapglobal.com/2017/09/keeps-on-keepin-on/‚Ä¶
$MRK $ATOS $FSNN $HIIQ #biotech #ThursdayMotivation
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DL89Ot0UMAA9s3j.jpg'],https://twitter.com/VistaPResearch/status/918520181785108480
4839,John Carroll,@JohnCendpts,2017-10-10T12:41:34.000Z,"Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal
$KALV
wowza +106% $MRK","Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal
$KALV
wowza +106% $MRK
endpts.com
Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal
Pharma giant Merck $MRK is buying into micro cap biotech player KalVista $KALV, bagging an option on a lead drug and outlining a rich potential future for the company if all goes according to plan....
1
3
4",,1,3,4,['https://pbs.twimg.com/card_img/1497735447149260806/FscISuUI?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/917731833172955138
4840,Matthew Herper,@matthewherper,2017-10-11T20:51:01.000Z,"Replying to 
@ethanjweiss","Replying to 
@ethanjweiss
Total costs must exceed $5 billion for $MRK, $PFE, $RHBBY...
4
8",,,4,8,[],https://twitter.com/matthewherper/status/918217394186870785
4841,Evaluate Vantage,@evaluatevantage,2017-10-12T14:41:04.000Z,Vantage Snippet - Merck ignores call of history and shelves anacetrapib $MRK,"Vantage Snippet - Merck ignores call of history and shelves anacetrapib $MRK
1",,,1,,['https://pbs.twimg.com/media/DL8ed4JWkAAW-FO?format=jpg&name=small'],https://twitter.com/evaluatevantage/status/918486683980566534
4842,Deep Dive,@deepxdive,2017-10-12T12:38:57.000Z,"$MRK Merck & Co., Inc. breached its 50 day moving average in a Bearish Manner   MRK-US   October 12, 2017 https://online.capitalcube.com/#!/stock/US/exchange/MRK‚Ä¶","$MRK Merck & Co., Inc. breached its 50 day moving average in a Bearish Manner   MRK-US   October 12, 2017 https://online.capitalcube.com/#!/stock/US/exchange/MRK‚Ä¶",,,,,['https://pbs.twimg.com/media/DL8C0faXUAA-SNo?format=jpg&name=small'],https://twitter.com/deepxdive/status/918455952713633792
4843,Peter Loftus,@Loftus,2017-10-11T21:08:10.000Z,"Merck $MRK won't seek regulatory approval for cholesterol-modifying drug anacetrapib, cites 'clinical profile' http://mrknewsroom.com/news-release/corporate-news/merck-provides-update-anacetrapib-development-program‚Ä¶","Merck $MRK won't seek regulatory approval for cholesterol-modifying drug anacetrapib, cites 'clinical profile' http://mrknewsroom.com/news-release/corporate-news/merck-provides-update-anacetrapib-development-program‚Ä¶
1
2
2",,1,2,2,[],https://twitter.com/Loftus/status/918221712973496320
4844,Tim Reller,@TraderGuruNY,2017-10-12T18:13:41.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/918540187931742208
4845,Vista Partners LLC,@VistaPResearch,2017-10-10T02:19:41.000Z,"@AgadiaSystems
 thanks for Follow! #MondayMotivaton See Vista Partners #Investing #Healthcare http://vistapglobal.com $HIIQ $ATOS $MRK $JNJ","@AgadiaSystems
 thanks for Follow! #MondayMotivaton See Vista Partners #Investing #Healthcare http://vistapglobal.com $HIIQ $ATOS $MRK $JNJ
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DLvh5VBVoAEc4ev.jpg'],https://twitter.com/VistaPResearch/status/917575330646212608
4846,Aniu Student,@AniuStudent,2017-10-12T13:34:13.000Z,"Replying to 
@AniuStudent","Replying to 
@AniuStudent
$MRK now has a clear cardiovascular drug candidate void in its pipeline & with MRK‚Äôs #Zetia, $ESPR is the logical drug candidate 2 fill it.
1",,,,1,[],https://twitter.com/AniuStudent/status/918469860161703936
4847,BioWorld,@BioWorld,2017-10-12T17:45:00.000Z,CETP inhibitor class still seeking salvation after $MRK drops anacetrapib program,CETP inhibitor class still seeking salvation after $MRK drops anacetrapib program,,,,,[],https://twitter.com/BioWorld/status/918532972545900545
4848,Jack Allen,@JohnK_Allen,2017-10-11T21:58:47.000Z,After running expensive CVOT and hitting PE $MRK cans anacetrapib,"After running expensive CVOT and hitting PE $MRK cans anacetrapib
Meg Tirrell
@megtirrell
 ¬∑ 12 Oct 2017
$MRK says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $MRK -0.8% after hrs",,,,,['https://pbs.twimg.com/profile_images/791618485621325824/wBeu2-6V_mini.jpg'],https://twitter.com/JohnK_Allen/status/918234450005299200
4849,PharmaCentra,@PharmaCentra,2017-10-10T13:24:15.000Z,"Growth Trajectory Ready For Launch 
@pfizer
 https://seekingalpha.com/article/4112318-pfizer-growth-trajectory-locked-ready-launch?source=tweet‚Ä¶ $ABBV $AGN $AMGN $AZN $BAYZF $BMY $CELG $GILD $JNJ $LLY $MRK $NVS $PFE","Growth Trajectory Ready For Launch 
@pfizer
 https://seekingalpha.com/article/4112318-pfizer-growth-trajectory-locked-ready-launch?source=tweet‚Ä¶ $ABBV $AGN $AMGN $AZN $BAYZF $BMY $CELG $GILD $JNJ $LLY $MRK $NVS $PFE",,,,,['https://pbs.twimg.com/media/DLx6AJ8VwAAF3Kn?format=jpg&name=small'],https://twitter.com/PharmaCentra/status/917742574491897857
4850,Robin Davison,@RobinDavison2,2017-10-10T15:39:39.000Z,"Great article. Key question for me is why $MRK has designed study only in PDL-1 high pts, scientific or commercial rationale?","Great article. Key question for me is why $MRK has designed study only in PDL-1 high pts, scientific or commercial rationale?
Jacob Plieth
@JacobPlieth
 ¬∑ 10 Oct 2017
A look at possible reasons why $MRK just started a Keytruda + Yervoy 1L NSCLC trial, via @EPVantage http://bit.ly/2g01g4M $BM& $AZN",,,,,['https://pbs.twimg.com/profile_images/453547761401462784/a2Lp0d3m_mini.jpeg'],https://twitter.com/RobinDavison2/status/917776650183553024
4851,MarketBeat,@MarketBeatCom,2017-10-11T22:08:16.000Z,Merck & Company given $70.00 PT by BMO Capital Markets. buy rating. http://ift.tt/2xzlihy $MRK #MRK,Merck & Company given $70.00 PT by BMO Capital Markets. buy rating. http://ift.tt/2xzlihy $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/918236836442591233
4852,Kshitiz Goliya,@KGoliya,2017-10-11T21:15:55.000Z,"Merck $MRK dumps cholesterol drug anacetrapib, shortly after shelving hepatitis C program; focus shifts back to cancer & diabetes portfolio","Merck $MRK dumps cholesterol drug anacetrapib, shortly after shelving hepatitis C program; focus shifts back to cancer & diabetes portfolio
1",,,,1,[],https://twitter.com/KGoliya/status/918223663635111936
4853,US Banking News,@AmericanBanking,2017-10-12T14:41:34.000Z,Merck & Company's outperform rating reiterated at BMO Capital Markets. $72.00 PT. http://ift.tt/2wRBeHH $MRK #MRK,Merck & Company's outperform rating reiterated at BMO Capital Markets. $72.00 PT. http://ift.tt/2wRBeHH $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/918486807398027264
4854,BioPharma Dive,@BioPharmaDive,2017-10-12T21:44:00.000Z,The decision isn't surprising given previous letdowns across the class of cholesterol-lowering drugs http://bit.ly/2z19ReQ $MRK $PFE $LLY,"The decision isn't surprising given previous letdowns across the class of cholesterol-lowering drugs http://bit.ly/2z19ReQ $MRK $PFE $LLY
biopharmadive.com
CETP class shelved as Merck pulls out
Development of the last major CETP inhibitor has now ceased, ending a decade of pharma setbacks. 
1",,,1,,[],https://twitter.com/BioPharmaDive/status/918593118861176832
4855,Jacob Bell,@realJacobBell,2017-10-11T15:45:01.000Z,$MRK invests in diabetes through KalVista deal http://bit.ly/2yDSAMA $KALV,"$MRK invests in diabetes through KalVista deal http://bit.ly/2yDSAMA $KALV
biopharmadive.com
Merck invests in diabetes through KalVista deal
By taking a stake in KalVista, the big pharma aims to buffer its diabetes franchise with related therapies. ",,,,,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/realJacobBell/status/918140389365829634
4856,MarketBeat,@MarketBeatCom,2017-10-10T08:10:12.000Z,"Tokio Marine Asset Management Co. Ltd. Acquires 35,119 Shares of Merck & Company, Inc. $MRK http://ift.tt/2xw6DPc","Tokio Marine Asset Management Co. Ltd. Acquires 35,119 Shares of Merck & Company, Inc. $MRK http://ift.tt/2xw6DPc",,,,,[],https://twitter.com/MarketBeatCom/status/917663542534463488
4857,dough,@semodough,2017-10-10T14:53:53.000Z,Best part of $KALV $MRK news was nobody knew about it yesterday.  $KALV 5000 shares traded yesterday.Thanks @JSTBiotech for pointing thatout,"Best part of $KALV $MRK news was nobody knew about it yesterday.  $KALV 5000 shares traded yesterday.Thanks @JSTBiotech for pointing thatout
2",,,,2,[],https://twitter.com/semodough/status/917765130519220224
4858,Open Outcrier,@OpenOutcrier,2017-10-10T12:54:00.000Z,"$KALV (+127.2% pre) Giant Merck $MRK buddies up with little KalVista on lead drug, igniting stock w $760M deal

http://ooc.bz/l/16608","$KALV (+127.2% pre) Giant Merck $MRK buddies up with little KalVista on lead drug, igniting stock w $760M deal

http://ooc.bz/l/16608
2
1",,,2,1,[],https://twitter.com/OpenOutcrier/status/917734961679040512
4859,Allison Gatlin,@IBD_AGatlin,2017-10-10T20:13:56.000Z,Small-cap biotech rockets after Dow's Merck buys 10% stake $KALV $MRK http://ow.ly/fk9t30fMFDD,Small-cap biotech rockets after Dow's Merck buys 10% stake $KALV $MRK http://ow.ly/fk9t30fMFDD,,,,,[],https://twitter.com/IBD_AGatlin/status/917845677002063873
4860,SwingTradeBot,@SwingTradeBot,2017-10-12T13:33:03.000Z,Recent $MRK technical alerts: Fell Below 50 DMA plus 4 more alerts...,"Recent $MRK technical alerts: Fell Below 50 DMA plus 4 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/918469565193089024
4861,SwingTradeBot,@SwingTradeBot,2017-10-11T21:26:51.000Z,Scan results - Fell Below 50 DMA today: $CUDA $XPER $IPG $KW $MRK $RL $TWNK $GIII $AMAG $TGTX ...,"Scan results - Fell Below 50 DMA today: $CUDA $XPER $IPG $KW $MRK $RL $TWNK $GIII $AMAG $TGTX ...
swingtradebot.com
Fell Below 50 DMA on 03/09/2022 Stock Screen Results
Stock Screen: Price dropped below the 50-day moving average for 03/09/2022",,,,,['https://pbs.twimg.com/card_img/1500886800889524226/AD5QHDJO?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/918226413240684545
4862,Zack Capp,@zackcapp,2017-10-10T11:50:01.000Z,'Going big': Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo https://buff.ly/2ybw9NO $MRK,'Going big': Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo https://buff.ly/2ybw9NO $MRK,,,,,['https://pbs.twimg.com/media/DLxkcMwX4AEDx43?format=jpg&name=small'],https://twitter.com/zackcapp/status/917718862375866368
4863,Streetinsider.com,@Street_Insider,2017-10-10T11:35:51.000Z,KalVista Pharmaceuticals $KALV Reports Collaboration with Merck $MRK on Continuing Development of KVD001,"KalVista Pharmaceuticals $KALV Reports Collaboration with Merck $MRK on Continuing Development of KVD001
streetinsider.com
KalVista Pharmaceuticals (KALV) Reports Collaboration with Merck (MRK) on Continuing Development of...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced that it has entered into a collaboration agreement with Merck (NYSE: MRK), known as MSD outside...
1",,,1,,['https://pbs.twimg.com/card_img/1500594891948105729/ysEeMunp?format=png&name=240x240'],https://twitter.com/Street_Insider/status/917715296579878913
4864,David Grainger,@sciencescanner,2017-10-12T07:14:33.000Z,Right decision by $MRK - and quite brave. Would have been ‚Äúeasier‚Äù to seek approval and then win little or no sales,"Right decision by $MRK - and quite brave. Would have been ‚Äúeasier‚Äù to seek approval and then win little or no sales
Ben Hirschler
@reutersBenHir
 ¬∑ 12 Oct 2017
Bye-bye #anacetrapib...#Merck says will not seek approval of #cholesterol treatment https://reut.rs/2i6TfPx
1
1",,1,,1,['https://pbs.twimg.com/profile_images/668968842/Venice_pic_mini.jpg'],https://twitter.com/sciencescanner/status/918374312683495425
4865,Frank Vinluan,@frankvinluan,2017-10-11T22:38:20.000Z,"Merck bails on regulatory plans 4 its CETP-inhibitor, the last of a once-promising class of cholesterol drugs http://xconomy.com/new-york/2017/10/11/merck-abandons-plans-to-seek-fda-approval-of-cholesterol-drug/‚Ä¶ $MRK","Merck bails on regulatory plans 4 its CETP-inhibitor, the last of a once-promising class of cholesterol drugs http://xconomy.com/new-york/2017/10/11/merck-abandons-plans-to-seek-fda-approval-of-cholesterol-drug/‚Ä¶ $MRK
xconomy.com
Xconomy: Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug
Merck is pulling the plug on a cholesterol-lowering drug that met its main goal in a clinical trial but still raised questions about whether it would",,,,,[],https://twitter.com/frankvinluan/status/918244403612930048
4866,dough,@semodough,2017-10-12T11:00:18.000Z,"BMO $MRK 3Q Keytruda Should Be Solid, Survey Suggests ~45% Share; IO Execution Paramount PT 70","BMO $MRK 3Q Keytruda Should Be Solid, Survey Suggests ~45% Share; IO Execution Paramount PT 70",,,,,[],https://twitter.com/semodough/status/918431127077040128
4867,SwingTradeBot,@SwingTradeBot,2017-10-11T21:35:02.000Z,Scan results - MACD Bearish Centerline Cross today: $JNPR $FNF $BHGE $REGN $AXTA $EA $MRK $WM $QVCA $COST ...,"Scan results - MACD Bearish Centerline Cross today: $JNPR $FNF $BHGE $REGN $AXTA $EA $MRK $WM $QVCA $COST ...
swingtradebot.com
MACD Bearish Centerline Cross on 03/08/2022 Stock Screen Results
Stock Screen: The MACD Line has moved below the zero line to turn negative. This happens when the 12-day EMA of the stock moves below the 26-day EMA. for 03/08/2022",,,,,['https://pbs.twimg.com/card_img/1499039987701981190/b97cw9IH?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/918228473507917824
4868,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-10-12T00:47:29.000Z,"@sitcancer
 #SitC2017 Just went through all the titles, very exciting stuff this year. $JUNO $GILD $BMY $MRK $AZN $INCY","@sitcancer
 #SitC2017 Just went through all the titles, very exciting stuff this year. $JUNO $GILD $BMY $MRK $AZN $INCY
2",,,,2,[],https://twitter.com/DrPaulyDeSantis/status/918276905622683648
4869,Briefing.com,@Briefingcom,2017-10-11T22:56:37.000Z,$MRK: Merck will not submit applications for regulatory approval for anacetrapib - investigational cholesteryl... http://bit.ly/2ycAwsB,"$MRK: Merck will not submit applications for regulatory approval for anacetrapib - investigational cholesteryl... http://bit.ly/2ycAwsB
1",,,1,,[],https://twitter.com/Briefingcom/status/918249003346624512
4870,Evaluate Pharma,@evaluatepharma,2017-10-10T16:36:21.000Z,"Merck‚Äôs CTLA4 move ‚Äì insurance policy or knockout bid? http://ow.ly/EAMs30fMkZX via 
@JacobPlieth
 @EPVantage
 $MRK","Merck‚Äôs CTLA4 move ‚Äì insurance policy or knockout bid? http://ow.ly/EAMs30fMkZX via 
@JacobPlieth
 @EPVantage
 $MRK
2",,,,2,[],https://twitter.com/evaluatepharma/status/917790920359268353
4871,BioWorld,@BioWorld,2017-10-10T16:33:44.000Z,"$KALV shares peak at highest level since last yr's reverse merger with Carbylan on potential $752M $MRK deal, holding 50+% gain","$KALV shares peak at highest level since last yr's reverse merger with Carbylan on potential $752M $MRK deal, holding 50+% gain",,,,,[],https://twitter.com/BioWorld/status/917790261111132161
4872,Open Outcrier,@OpenOutcrier,2017-10-12T12:49:50.000Z,"$MRK (+0.0% pre) Positive PhIII can‚Äôt salvage Merck‚Äôs anacetrapib, now relegated to the scrap heap - ENDPTS

http://ooc.bz/l/16687","$MRK (+0.0% pre) Positive PhIII can‚Äôt salvage Merck‚Äôs anacetrapib, now relegated to the scrap heap - ENDPTS

http://ooc.bz/l/16687",,,,,[],https://twitter.com/OpenOutcrier/status/918458689618669568
4873,MC Trader,@MC_Trader1,2017-10-10T21:47:22.000Z,$KALV BTIG initiated with a Buy and $18 price target recently.  Wondering if other analysts might initiate coverage after this $MRK news,"$KALV BTIG initiated with a Buy and $18 price target recently.  Wondering if other analysts might initiate coverage after this $MRK news
1",,,1,,[],https://twitter.com/MC_Trader1/status/917869189892857857
4874,FDR Investment Group,@FDRInvestments,2017-10-10T11:36:23.000Z,KalVista Pharmaceuticals $KALV Reports Collaboration with Merck $MRK on Continuing Development of KVD001,"KalVista Pharmaceuticals $KALV Reports Collaboration with Merck $MRK on Continuing Development of KVD001
streetinsider.com
KalVista Pharmaceuticals (KALV) Reports Collaboration with Merck (MRK) on Continuing Development of...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced that it has entered into a collaboration agreement with Merck (NYSE: MRK), known as MSD outside...",,,,,['https://pbs.twimg.com/card_img/1500594891948105729/ysEeMunp?format=png&name=240x240'],https://twitter.com/FDRInvestments/status/917715430407593984
4875,StockNews.com,@stocknewsdotcom,2017-10-11T21:04:14.000Z,$MRK Company will not submit applications for regulatory approval for anacetrapib - investigational cholesteryl es‚Ä¶ https://stocknews.com/news/mrk-company-will-not-submit-applications-for-regulatory-approval-for-anacetrapib/‚Ä¶,$MRK Company will not submit applications for regulatory approval for anacetrapib - investigational cholesteryl es‚Ä¶ https://stocknews.com/news/mrk-company-will-not-submit-applications-for-regulatory-approval-for-anacetrapib/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/918220721947635714
4876,Zack Capp,@zackcapp,2017-10-15T18:50:07.000Z,"Positive PhIII can't salvage Merck's anacetrapib, now relegated to the scrap heap https://buff.ly/2yrDxoz $MRK #CETP","Positive PhIII can't salvage Merck's anacetrapib, now relegated to the scrap heap https://buff.ly/2yrDxoz $MRK #CETP
3",,,3,,['https://pbs.twimg.com/media/DMM0iqFUEAASxNE?format=jpg&name=small'],https://twitter.com/zackcapp/status/919636521380171778
4877,Breaking News,@MarketCurrents,2017-10-13T19:19:55.000Z,Glaxo shingles vaccine OK'd in Canada https://seekingalpha.com/news/3301010-glaxo-shingles-vaccine-okd-canada?source=feed_f‚Ä¶ $GSK $MRK,"Glaxo shingles vaccine OK'd in Canada https://seekingalpha.com/news/3301010-glaxo-shingles-vaccine-okd-canada?source=feed_f‚Ä¶ $GSK $MRK
seekingalpha.com
Glaxo shingles vaccine OK'd in Canada (NYSE:GSK)
Health Canada approves GlaxoSmithKline's (GSK) Shingrix [Zoster Vaccine (Adjuvanted)] shingles vaccine, the first approval for the expected blockbuster.Marketing applications are currently...",,,,,['https://pbs.twimg.com/card_img/1479966849626480640/cLosLnr_?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/918919244762431488
4878,Gery DIVRY,@GeryDIVRY,2017-10-13T18:03:01.000Z,Commented on https://seekingalpha.com/article/4110628-intercept-runs-trouble-nash-developers-like-galectin-gain-value?source=tweet&sht=oxrwt1&shu=l8mmr#comment-76482225‚Ä¶ $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT,"Commented on https://seekingalpha.com/article/4110628-intercept-runs-trouble-nash-developers-like-galectin-gain-value?source=tweet&sht=oxrwt1&shu=l8mmr#comment-76482225‚Ä¶ $AGN $BMY $CNAT $GALT $GNFTF $MRK $ICPT
1",,,1,,[],https://twitter.com/GeryDIVRY/status/918899893086822402
4879,"Jason Luke, MD, FACP",@jasonlukemd,2017-10-15T01:57:03.000Z,"IDO (Indoleamine-2,3-dioxygenase) drama $INCY #flexus $BMY $MRK 
@sitcancer
 via 
@PDRennert
 #immunotherapy","IDO (Indoleamine-2,3-dioxygenase) drama $INCY #flexus $BMY $MRK 
@sitcancer
 via 
@PDRennert
 #immunotherapy
delawareonline.com
Incyte seeks billions after worker allegedly walks off with cancer drug secrets
Delaware drugmaker Incyte is battling the founders of pharma startup Flexus Biosciences in a corporate espionage lawsuit.
1
12
17",,1,12,17,['https://pbs.twimg.com/card_img/1500811771711475724/Cy8h2vJ2?format=jpg&name=small'],https://twitter.com/jasonlukemd/status/919381576722546689
4880,Alan Robert Ross,@alanrobertross,2017-10-15T05:59:07.000Z,"$PVCT #PV10 + $MRK #Keytruda combo in #melanoma poster abstract 2B presented in #9thWorldCongressofMelanoma Oct. 18
http://trustintelligence.com/forum/viewtopic.php?pid=151243#p151243‚Ä¶","$PVCT #PV10 + $MRK #Keytruda combo in #melanoma poster abstract 2B presented in #9thWorldCongressofMelanoma Oct. 18
http://trustintelligence.com/forum/viewtopic.php?pid=151243#p151243‚Ä¶
2
1",,,2,1,[],https://twitter.com/alanrobertross/status/919442494810722304
4881,Fractaurean,@Fractaurean,2017-10-13T14:23:36.000Z,https://seekingalpha.com/article/4113175-lower-volatility-stock-portfolio-retirees-others?source=tweet‚Ä¶ $ABBV $ABT $AMGN $BCR $BDX $BMY $CL $COST $CVS $EL $GILD $GIS $JNJ $KHC $KMB $KO $LLY $MDLZ $MDT $MRK,"https://seekingalpha.com/article/4113175-lower-volatility-stock-portfolio-retirees-others?source=tweet‚Ä¶ $ABBV $ABT $AMGN $BCR $BDX $BMY $CL $COST $CVS $EL $GILD $GIS $JNJ $KHC $KMB $KO $LLY $MDLZ $MDT $MRK
seekingalpha.com
The Lower Volatility Stock Portfolio For Retirees And Others
I recently had a look at the SPDR sectors through the last two major market corrections in search of lower volatility or drawdown.",,,,,['https://pbs.twimg.com/card_img/1501992853353861124/KbHbR1zS?format=png&name=240x240'],https://twitter.com/Fractaurean/status/918844673229287424
4882,Allen Howard,@AllenHoward66,2017-10-13T12:29:44.000Z,"has anyone else used this? i've been getting in on some amazing trades through it http://bit.ly/2yr97QH
$MS $MTH $MRK","has anyone else used this? i've been getting in on some amazing trades through it http://bit.ly/2yr97QH
$MS $MTH $MRK",,,,,['https://pbs.twimg.com/media/DMBKTQTV4AAJx7R?format=jpg&name=small'],https://twitter.com/AllenHoward66/status/918816021179453441
4883,Financial Carnivores,@HowieRegay,2017-10-13T05:10:09.000Z,'Going big': Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo https://buff.ly/2ycymJp $MRK,'Going big': Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo https://buff.ly/2ycymJp $MRK,,,,,['https://pbs.twimg.com/media/DL_lry-UIAAoSi0?format=jpg&name=small'],https://twitter.com/HowieRegay/status/918705393571741698
4884,Donna Young,@DonnaYoungDC,2017-10-13T11:57:22.000Z,"I was told yesterday $MRK included in design phase, but elected not to join #NIH #PACT, which was a 
@BarackObama
 @JoeBiden
 initiative","I was told yesterday $MRK included in design phase, but elected not to join #NIH #PACT, which was a 
@BarackObama
 @JoeBiden
 initiative
John Carroll
@JohnCendpts
 ¬∑ 13 Oct 2017
And what about Merck? https://twitter.com/JohnCendpts/status/918794042883833856‚Ä¶
1
3
3",üì∞,1,3,3,['https://pbs.twimg.com/profile_images/558676395597889536/0J3-iJDB_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/918807874939379712
4885,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-10-14T09:34:26.000Z,"SWING TRADE ALERT: $MRK technical alerts: New Downtrend, Stochastic Reached Oversold,‚Ä¶ http://dlvr.it/PvVHV9 via ‚Üí http://bit.do/FreeTradingRoom","SWING TRADE ALERT: $MRK technical alerts: New Downtrend, Stochastic Reached Oversold,‚Ä¶ http://dlvr.it/PvVHV9 via ‚Üí http://bit.do/FreeTradingRoom",,,,,['https://pbs.twimg.com/media/DMFrxA3UQAUopr2?format=jpg&name=small'],https://twitter.com/AlertTrade/status/919134290973093888
4886,Kristjan Kullam√§gi,@Qullamaggie,2017-10-13T12:08:22.000Z,$KALV Post $MRK tie-up selloff b/c $NVO sold 2.3M shares past 3 sessions. Could grind back to low-mid teens over weeks-months. Good r/r here,"$KALV Post $MRK tie-up selloff b/c $NVO sold 2.3M shares past 3 sessions. Could grind back to low-mid teens over weeks-months. Good r/r here
1
1",,1,,1,[],https://twitter.com/Qullamaggie/status/918810642034909184
4887,James Sikes,@wosaikeneriki,2017-10-15T17:13:00.000Z,Schafer Cullen Capital Management Has Cut Merck & Co.  $MRK Position by $3.90 Million http://bzweekly.com/schafer-cullen-capital-management-has-cut-merck-disney-walt-co-dis-market-value-declined-while-heathbridge-capital-management-ltd-lifted-holding/‚Ä¶,Schafer Cullen Capital Management Has Cut Merck & Co.  $MRK Position by $3.90 Million http://bzweekly.com/schafer-cullen-capital-management-has-cut-merck-disney-walt-co-dis-market-value-declined-while-heathbridge-capital-management-ltd-lifted-holding/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/919612080986173440
4888,Sweet Platform,@SweetPlatform,2017-10-13T14:56:32.000Z,"MRK Top news - Oct 13th, 2017 $MRK http://https://goo.gl/GGc8rQ","MRK Top news - Oct 13th, 2017 $MRK http://https://goo.gl/GGc8rQ",,,,,[],https://twitter.com/SweetPlatform/status/918852961043968001
4889,StockMarketVideo.com,@stockmarketvide,2017-10-13T01:39:26.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/918652366152519680
4890,Dakota Financial,@dakotafinancial,2017-10-13T12:40:07.000Z,"Traders Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2iba9MX","Traders Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2iba9MX",,,,,[],https://twitter.com/dakotafinancial/status/918818631642943488
4891,Evaluate Pharma,@evaluatepharma,2017-10-13T15:46:26.000Z,"Snippet roundup: The #FDA says no to Acelrx whereas Merck decides not to ask  http://ow.ly/omjz30fRevO via 
@EPVantage
 $ACRX $MRK","Snippet roundup: The #FDA says no to Acelrx whereas Merck decides not to ask  http://ow.ly/omjz30fRevO via 
@EPVantage
 $ACRX $MRK",,,,,['https://pbs.twimg.com/media/DMB3Un2W0AElBsx?format=jpg&name=small'],https://twitter.com/evaluatepharma/status/918865522816462848
4892,MarketBeat,@MarketBeatCom,2017-10-14T23:14:26.000Z,"BMO Capital Markets Reiterates Outperform Rating for Merck & Company, Inc. $MRK http://ift.tt/2yLhGJF #acn","BMO Capital Markets Reiterates Outperform Rating for Merck & Company, Inc. $MRK http://ift.tt/2yLhGJF #acn",,,,,[],https://twitter.com/MarketBeatCom/status/919340651057242114
4893,Antonio Costa,@ACInvestorBlog,2017-10-13T14:09:34.000Z,$KALV is a low float stock (can run fast). Don‚Äôt forget $MRK Merck Acquired 9.9% Stake in KalVista in Private Placement. Double digits soon,"$KALV is a low float stock (can run fast). Don‚Äôt forget $MRK Merck Acquired 9.9% Stake in KalVista in Private Placement. Double digits soon
3",,,,3,[],https://twitter.com/ACInvestorBlog/status/918841145542705152
4894,Portfolio Penny,@PortfolioPenny,2017-10-15T18:30:14.000Z,"Positive PhIII can't salvage Merck's anacetrapib, now relegated to the scrap heap https://buff.ly/2yqkg6R $MRK #CETP","Positive PhIII can't salvage Merck's anacetrapib, now relegated to the scrap heap https://buff.ly/2yqkg6R $MRK #CETP
1",,,1,,['https://pbs.twimg.com/media/DMMv_Z3WkAYmy7T?format=jpg&name=small'],https://twitter.com/PortfolioPenny/status/919631517537767426
4895,MySmallCap,@tzack16,2017-10-13T13:50:11.000Z,'Going big': Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo https://buff.ly/2ydHUUA $MRK,'Going big': Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo https://buff.ly/2ydHUUA $MRK,,,,,['https://pbs.twimg.com/media/DMBctmPWkAEmkXE?format=jpg&name=small'],https://twitter.com/tzack16/status/918836265616846851
4896,Gambiste,@GambisteFinance,2017-10-13T16:22:59.000Z,"Midday Most Tweeted Big Caps, check out Gambiste Top 10: $GE $MU $MRK $RIO $ABEV $PYPL $VALE $NUE $INTC $PFE http://gambiste.com/index.php/2017/10/13/gambiste-top-10-midday-most-tweeted-big-caps-74/‚Ä¶","Midday Most Tweeted Big Caps, check out Gambiste Top 10: $GE $MU $MRK $RIO $ABEV $PYPL $VALE $NUE $INTC $PFE http://gambiste.com/index.php/2017/10/13/gambiste-top-10-midday-most-tweeted-big-caps-74/‚Ä¶",,,,,[],https://twitter.com/GambisteFinance/status/918874719360872448
4897,Dakota Financial,@dakotafinancial,2017-10-13T08:30:41.000Z,"Cadence Bank NA Sells 5,276 Shares of Merck & Company, Inc. $MRK http://ift.tt/2ggub8a","Cadence Bank NA Sells 5,276 Shares of Merck & Company, Inc. $MRK http://ift.tt/2ggub8a",,,,,[],https://twitter.com/dakotafinancial/status/918755860570103808
4898,Transcript Daily,@TranscriptDaily,2017-10-14T19:44:30.000Z,"BMO Capital Markets Analysts Give Merck & Company, Inc. $MRK a $70.00 Price Target http://ift.tt/2ykizrM","BMO Capital Markets Analysts Give Merck & Company, Inc. $MRK a $70.00 Price Target http://ift.tt/2ykizrM",,,,,[],https://twitter.com/TranscriptDaily/status/919287821214633985
4899,Transcript Daily,@TranscriptDaily,2017-10-15T08:39:31.000Z,"Barry Investment Advisors LLC Acquires 369 Shares of Merck & Company, Inc. $MRK http://ift.tt/2zoxgrv","Barry Investment Advisors LLC Acquires 369 Shares of Merck & Company, Inc. $MRK http://ift.tt/2zoxgrv",,,,,[],https://twitter.com/TranscriptDaily/status/919482858493939712
4900,Ticker Report,@TickerReport,2017-10-15T13:49:40.000Z,"Merck & Company, Inc. $MRK Stock Rating Lowered by Zacks Investment Research http://ift.tt/2hJzF86","Merck & Company, Inc. $MRK Stock Rating Lowered by Zacks Investment Research http://ift.tt/2hJzF86",,,,,[],https://twitter.com/TickerReport/status/919560913019076608
4901,Stock Charts,@stockcharts247,2017-10-15T15:36:14.000Z,MRK 63.39   -  Updated: 10-15-2017 $MRK Last Trade: 10/13/2017 Last 63.39   -  Open 63.95 Previous Clo,"MRK 63.39   -  Updated: 10-15-2017 $MRK Last Trade: 10/13/2017 Last 63.39   -  Open 63.95 Previous Clo
investorshangout.com
MRK 63.39   -  Updated: 10-15-2017 - Stock Charts & Historical Trade Data #4796042 - Investors...
Stock Charts & Historical Trade Data: MRK 63.39   -  Updated: 10-15-2017 $MRK Last Trade: 10/13/2017 Last 63.39   -  Open 63.95 Pre",,,,,['https://pbs.twimg.com/card_img/1499224644112498691/uNNWn6ac?format=png&name=240x240'],https://twitter.com/stockcharts247/status/919587728702009344
4902,BoardCentral,@BoardCentral,2017-10-15T23:00:03.000Z,"$MRK ""VDRM VIABECLINE/TETRASTEM USES"" on ADFN InvestorsHub message boards: http://bit.ly/2yLPerb","$MRK ""VDRM VIABECLINE/TETRASTEM USES"" on ADFN InvestorsHub message boards: http://bit.ly/2yLPerb",,,,,[],https://twitter.com/BoardCentral/status/919699418013581312
4903,Eric Sagonowsky,@EricSFierce,2017-10-13T17:15:36.000Z,"Ebola vaccines from $GSK, $MRK elicit yearlong response","Ebola vaccines from $GSK, $MRK elicit yearlong response
fiercepharma.com
Ebola vaccines from GlaxoSmithKline, Merck elicit yearlong response, study finds
After initially setting out to test two vaccines on 28,000 volunteers during West Africa's deadly Ebol | Ebola vaccines from GlaxoSmithKline and Merck elicited antibody responses that lasted one year...
2",,,,2,['https://pbs.twimg.com/card_img/1501992984954343452/O_PXtPWV?format=jpg&name=small'],https://twitter.com/EricSFierce/status/918887961470566406
4904,MarketBeat,@MarketBeatCom,2017-10-13T12:44:26.000Z,"Traders Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2iba9MX","Traders Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2iba9MX",,,,,[],https://twitter.com/MarketBeatCom/status/918819720471728129
4905,Watchlist News,@WatchlistN,2017-10-13T08:23:18.000Z,"State of New Jersey Common Pension Fund D Sells 130,000 Shares of Merck & Company, Inc. $MRK http://ift.tt/2hEwoak","State of New Jersey Common Pension Fund D Sells 130,000 Shares of Merck & Company, Inc. $MRK http://ift.tt/2hEwoak",,,,,[],https://twitter.com/WatchlistN/status/918754001138708480
4906,MarketBeat,@MarketBeatCom,2017-10-14T08:14:19.000Z,"River Wealth Advisors LLC Trims Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xEvJvF","River Wealth Advisors LLC Trims Holdings in Merck & Company, Inc. $MRK http://ift.tt/2xEvJvF",,,,,[],https://twitter.com/MarketBeatCom/status/919114129868316672
4907,Hottest Stocks Now,@HottestStockNow,2017-10-13T05:13:57.000Z,$MRK Joins with the American Liver Foundation to Educate U.S. Veterans on Chronic Hepatitis C Virus Infection http://crweworld.com/article/news-provided-by-business-wire/154975/merck-joins-with-the-american-liver-foundation-to-educate-us-veterans-on-chronic-hepatitis-c-virus-hcv-infection‚Ä¶,$MRK Joins with the American Liver Foundation to Educate U.S. Veterans on Chronic Hepatitis C Virus Infection http://crweworld.com/article/news-provided-by-business-wire/154975/merck-joins-with-the-american-liver-foundation-to-educate-us-veterans-on-chronic-hepatitis-c-virus-hcv-infection‚Ä¶,,,,,[],https://twitter.com/HottestStockNow/status/918706350179287040
4908,US Banking News,@AmericanBanking,2017-10-14T23:06:30.000Z,"BMO Capital Markets Reiterates Outperform Rating for Merck & Company, Inc. $MRK http://ift.tt/2z9jiZB","BMO Capital Markets Reiterates Outperform Rating for Merck & Company, Inc. $MRK http://ift.tt/2z9jiZB",,,,,[],https://twitter.com/AmericanBanking/status/919338656908955649
4909,US Banking News,@AmericanBanking,2017-10-13T08:45:14.000Z,"Analysts Expect Merck & Company, Inc. $MRK Will Post Quarterly Sales of $10.44 Billion http://ift.tt/2ylbXst","Analysts Expect Merck & Company, Inc. $MRK Will Post Quarterly Sales of $10.44 Billion http://ift.tt/2ylbXst",,,,,[],https://twitter.com/AmericanBanking/status/918759524277858304
4910,BioPharma Dive,@BioPharmaDive,2017-10-13T21:11:00.000Z,Rx Reading: $MRK shelves its CETP dreams; $ARDX sees success with IBS drug; California passes drug pricing law,"Rx Reading: $MRK shelves its CETP dreams; $ARDX sees success with IBS drug; California passes drug pricing law
biopharmadive.com
Prescribed Reading: A week of game-changers in pharma
A new gene therapy is poised to hit the market; one dose of Anaptysbio's drug is all it took to clear some patients' skin; and a late-stage failure is hurting Lilly's oncology prospects.
1",,,1,,['https://pbs.twimg.com/card_img/1500049809826369538/mq3I7xko?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/918947202336247808
4911,Muathe,@muathe,2017-10-15T16:27:47.000Z,"[REPOST] U.S. Market Technical Oct 15, 2017 $MS $DAL $MRK $GLUU $KMI $GPS $GPS $NRG $NE $HST $SYF  $JNPR $BBRY $M","[REPOST] U.S. Market Technical Oct 15, 2017 $MS $DAL $MRK $GLUU $KMI $GPS $GPS $NRG $NE $HST $SYF  $JNPR $BBRY $M
youtube.com
[ Public Version ] U.S. Market Technical Analysis Oct 13 - 15, 2017
Ôº¨Ôº©Ôº´Ôº• | Ôº£ÔºØÔº≠Ôº≠Ôº•ÔºÆÔº¥ | Ôº≥Ôº®Ôº°Ôº≤Ôº• | Ôº≥ÔºµÔº¢Ôº≥Ôº£Ôº≤Ôº©Ôº¢Ôº•A Muathe.com Original Concept!Using Mostly Original Muathe.com Concepts!Charts discussed include: NASDAQ weekly , NASDAQ da...",,,,,[],https://twitter.com/muathe/status/919600701809967104
4912,Barron's,@barronsonline,2017-10-13T14:30:52.000Z,Pfizer: Could a Big Merger Move the Needle? http://on.barrons.com/2kLC4UU $PFE $MRK,"Pfizer: Could a Big Merger Move the Needle? http://on.barrons.com/2kLC4UU $PFE $MRK
barrons.com
Pfizer: Could a Big Merger Move the Needle?
Pfizer's decision hangs on a number of factors.
1",,,,1,['https://pbs.twimg.com/card_img/1499837106520477696/g2Psl_Dg?format=jpg&name=small'],https://twitter.com/barronsonline/status/918846503296348162
4913,tjguy,@tjguy500,2017-10-15T11:06:44.000Z,"Replying to 
@fezziwig2008","Replying to 
@fezziwig2008
What do you think of $MRK's  recent partnership announcement with $ONCS?
gurufocus.com
Merck Collaborates With OncoSec Medical to Unlock Untapped Market for Keytruda
The cancer immunotherapy may already be blockbuster, but most melanoma patients still don't respond to it",,,,,[],https://twitter.com/tjguy500/status/919519906789441536
4914,Volker Schulz,@portefeuillefun,2017-10-13T14:14:41.000Z,"... distant future. Mostly based on the recent $MRK deal, but there is also the HAE indication.","... distant future. Mostly based on the recent $MRK deal, but there is also the HAE indication.
1",,1,,,[],https://twitter.com/portefeuillefun/status/918842432082661376
4915,Bios_n_Techs,@Bios_n_Techs,2017-10-13T14:22:56.000Z,"Replying to 
@portefeuillefun","Replying to 
@portefeuillefun
Agree but let‚Äôs not forget DME too ! $KALV $MRK",,,,,[],https://twitter.com/Bios_n_Techs/status/918844507948544000
4916,Lloren√ß Martin,@lorenzomarca,2017-10-18T13:43:29.000Z,Merck's #Keytruda doubles survival over chemo in lung cancer study $MRK #InventingForLife #goodnews http://seekingalpha.com/news/3301718,"Merck's #Keytruda doubles survival over chemo in lung cancer study $MRK #InventingForLife #goodnews http://seekingalpha.com/news/3301718
8
2",,,8,2,[],https://twitter.com/lorenzomarca/status/920646520424329217
4917,Bursatil Biotech,@BursatilBiotech,2017-10-16T13:26:43.000Z,"Some of the biggest movers (based on 2012-2016's sales) over Biotech Industry.
HIV & Anti TNF-Agents remain on top. 
$GILD $ABBV $MRK $BMY","Some of the biggest movers (based on 2012-2016's sales) over Biotech Industry.
HIV & Anti TNF-Agents remain on top. 
$GILD $ABBV $MRK $BMY
1
1
3",,1,1,3,['https://pbs.twimg.com/media/DMQyg7SWAAEKbY1?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/919917524719988736
4918,Zack Capp,@zackcapp,2017-10-17T20:10:18.000Z,"Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2yv1VUl $MRK $KALV","Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2yv1VUl $MRK $KALV
1
2",,,1,2,['https://pbs.twimg.com/media/DMXaEtiW0AIyQmc?format=jpg&name=small'],https://twitter.com/zackcapp/status/920381476440629253
4919,Hotpage News,@Hotpage_News,2017-10-18T13:19:55.000Z,STOCKS MOVING PREMARKET:  $CVX $MGM $ANTM $IBM $AMZN $ULTA $SCSS $MSFT $TSLA $VZ $JPM $VIAB $ADP $MCD $MRK  - CNBC,"STOCKS MOVING PREMARKET:  $CVX $MGM $ANTM $IBM $AMZN $ULTA $SCSS $MSFT $TSLA $VZ $JPM $VIAB $ADP $MCD $MRK  - CNBC
cnbc.com
Stocks making the biggest moves premarket: CVX, MGM, ANTM, IBM, CREE, AMZN & more
These are the stocks posting the largest moves before the bell.
1",,,1,,['https://pbs.twimg.com/card_img/1501527049344716802/VGq3Nio7?format=jpg&name=small'],https://twitter.com/Hotpage_News/status/920640587778416640
4920,dough,@semodough,2017-10-18T17:27:15.000Z,CITI $MRK BUY for first time-increased DCF- derived price target from $65 to $72.increased our 2025 Keytruda forecasts from $9bn to$15bn,"CITI $MRK BUY for first time-increased DCF- derived price target from $65 to $72.increased our 2025 Keytruda forecasts from $9bn to$15bn
1
3
2",üò≥,1,3,2,[],https://twitter.com/semodough/status/920702829697929217
4921,Bursatil Biotech,@BursatilBiotech,2017-10-16T15:16:21.000Z,"Upcoming dates  $PFE $MRK/ $CELG, $IONS $LOXO $ARRY
 BTW $BAYN was supposed to release data on PFS over its Ph2 along w/ $IMGN
Where is it?","Upcoming dates  $PFE $MRK/ $CELG, $IONS $LOXO $ARRY
 BTW $BAYN was supposed to release data on PFS over its Ph2 along w/ $IMGN
Where is it?
1
2",,1,,2,['https://pbs.twimg.com/media/DMRNGKWXcAES6M_?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/919945114331635712
4922,Option Runners,@OptionRunners,2017-10-16T15:59:36.000Z,"$BMY $MRK $LLY $PFE $NVS $GSK $AZN Trump calls prescription drug prices 'out of control,' CBS reports","$BMY $MRK $LLY $PFE $NVS $GSK $AZN Trump calls prescription drug prices 'out of control,' CBS reports
1
1",,,1,1,[],https://twitter.com/OptionRunners/status/919955996784676864
4923,Odi Bruckman,@odibro,2017-10-18T07:28:21.000Z,$AZN $MRK FDA accepts regulatory submission for Lynparza in metastatic breast cancer and grants Priority Review,"$AZN $MRK FDA accepts regulatory submission for Lynparza in metastatic breast cancer and grants Priority Review
astrazeneca.com
US FDA accepts regulatory submission for Lynparza in metastatic breast cancer and grants Priority...
2
3",,,2,3,[],https://twitter.com/odibro/status/920552112131575808
4924,Volker Schulz,@portefeuillefun,2017-10-17T14:08:50.000Z,"$KALV. We all know how these things develop, don't we? My PT is $12, but it could well go much higher on $MRK deal alone. #RoundingBottom","$KALV. We all know how these things develop, don't we? My PT is $12, but it could well go much higher on $MRK deal alone. #RoundingBottom
2
1",,,2,1,['https://pbs.twimg.com/media/DMWHCgdWAAATyC2?format=jpg&name=small'],https://twitter.com/portefeuillefun/status/920290509733711872
4925,FirstWord Pharma,@fwpharma,2017-10-18T08:17:34.000Z,"FDA grants priority review to AstraZeneca, Merck & Co.'s filing for Lynparza in breast cancer https://firstwordpharma.com/node/1514560 $AZN $MRK","FDA grants priority review to AstraZeneca, Merck & Co.'s filing for Lynparza in breast cancer https://firstwordpharma.com/node/1514560 $AZN $MRK
old.firstwordpharma.com
FDA grants priority review to AstraZeneca, Merck & Co.'s filing for Lynparza in breast cancer
AstraZeneca and Merck & Co. announced Wednesday that the FDA granted priority review to a marketing application seeking approval of Lynparza (olaparib) in patients with germline BRCA-mutated,...
6
1",,,6,1,[],https://twitter.com/fwpharma/status/920564497466773505
4926,Truth Studio,@TheTruthStudio,2017-10-17T10:03:21.000Z,"Positive PhIII can't salvage Merck's anacetrapib, now relegated to the scrap heap https://buff.ly/2yrDBoj $MRK #CETP","Positive PhIII can't salvage Merck's anacetrapib, now relegated to the scrap heap https://buff.ly/2yrDBoj $MRK #CETP
4",,,4,,['https://pbs.twimg.com/media/DMVPJ9GWAAAUWhW?format=jpg&name=small'],https://twitter.com/TheTruthStudio/status/920228733650395136
4927,Java Diva,@diva_java,2017-10-18T15:55:02.000Z,"Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2ymJnIa $MRK #biotech #diabetic 
@Merck","Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2ymJnIa $MRK #biotech #diabetic 
@Merck
1",,,1,,['https://pbs.twimg.com/media/DMbpPUMX4AAKorr?format=jpg&name=small'],https://twitter.com/diva_java/status/920679626208407552
4928,Portfolio Penny,@PortfolioPenny,2017-10-17T19:30:19.000Z,"Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2yu3Mso $MRK $KALV","Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2yu3Mso $MRK $KALV
1",,,1,,['https://pbs.twimg.com/media/DMXQ7LBX4AcLq5y?format=jpg&name=small'],https://twitter.com/PortfolioPenny/status/920371416041709568
4929,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-10-18T13:25:28.000Z,SWING TRADE ALERT: Recent $MRK technical alerts: Lizard Bullish plus 4 more alerts... http://dlvr.it/PwLDBD via ‚Üí http://bit.do/FreeTradingRoom,"SWING TRADE ALERT: Recent $MRK technical alerts: Lizard Bullish plus 4 more alerts... http://dlvr.it/PwLDBD via ‚Üí http://bit.do/FreeTradingRoom
1",,,,1,['https://pbs.twimg.com/media/DMbHANpUQAAspuE?format=jpg&name=small'],https://twitter.com/AlertTrade/status/920641983504269312
4930,Vista Partners LLC,@VistaPResearch,2017-10-18T22:24:09.000Z,Learn more about #biotech #breastcancer focused Atossa Genetics at Vista Partners http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $ATOS $IBB $HIIQ $MRK $JNJ #stocks,"Learn more about #biotech #breastcancer focused Atossa Genetics at Vista Partners http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $ATOS $IBB $HIIQ $MRK $JNJ #stocks
1
1",,,1,1,[],https://twitter.com/VistaPResearch/status/920777548308422657
4931,Philip Calrissian,@Trading_Sunset,2017-10-17T23:52:16.000Z,"Merck $MRK remains weak from mid Sept'. F' PE 15s, yield 3.0%. There are better alternatives. I favour $GILD PE 10s. 
@peterfarahani","Merck $MRK remains weak from mid Sept'. F' PE 15s, yield 3.0%. There are better alternatives. I favour $GILD PE 10s. 
@peterfarahani",,,,,['https://pbs.twimg.com/media/DMYMglAXkAE0J5H?format=jpg&name=small'],https://twitter.com/Trading_Sunset/status/920437334084063232
4932,Christian Fromhertz,@cfromhertz,2017-10-17T14:32:03.000Z,"$XLV calls up to 38k  bought.  
note largest weights in XLV @ $JNJ $PFE $UNH $MRK $ABBV $AMGN $CELG","$XLV calls up to 38k  bought.  
note largest weights in XLV @ $JNJ $PFE $UNH $MRK $ABBV $AMGN $CELG
3",,,,3,[],https://twitter.com/cfromhertz/status/920296351816175617
4933,Clark Joseph Kent,@JorelLaraKalel,2017-10-18T12:00:12.000Z,Premarket movers: $CVX $MGM $ANTN $IBM $CREE $AMZN $SCSS $MCD $ADP $MSFT $ULTA $TSLA $VZ $JPM $VIA $MRK $AZN http://cnb.cx/2il78Ke,Premarket movers: $CVX $MGM $ANTN $IBM $CREE $AMZN $SCSS $MCD $ADP $MSFT $ULTA $TSLA $VZ $JPM $VIA $MRK $AZN http://cnb.cx/2il78Ke,,,,,[],https://twitter.com/JorelLaraKalel/status/920620527852621824
4934,CBPartners,@CBPartners,2017-10-16T12:10:09.000Z,Can recent launches by PDx #DrugManufacturers compete with $BMY and $MRK? Read about the emerging secrets to success http://bit.ly/2yAl61V,Can recent launches by PDx #DrugManufacturers compete with $BMY and $MRK? Read about the emerging secrets to success http://bit.ly/2yAl61V,,,,,[],https://twitter.com/CBPartners/status/919898254476763136
4935,US Banking News,@AmericanBanking,2017-10-18T11:24:35.000Z,Merck & Company upgraded by Citigroup Inc. to buy. http://ift.tt/2gPhLBB $MRK #MRK,Merck & Company upgraded by Citigroup Inc. to buy. http://ift.tt/2gPhLBB $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/920611564692168704
4936,TalkMarkets,@TalkMarkets,2017-10-18T10:45:46.000Z,#Merck Upgraded To Buy From Neutral At Citi $MRK Also $LLY $RHHBY https://goo.gl/QTNrKW,#Merck Upgraded To Buy From Neutral At Citi $MRK Also $LLY $RHHBY https://goo.gl/QTNrKW,,,,,[],https://twitter.com/TalkMarkets/status/920601794891436032
4937,Open Outcrier,@OpenOutcrier,2017-10-18T13:17:37.000Z,"$MRK (+1.6% pre) Citi Upgrades Merck to Buy, $72 PT

http://ooc.bz/l/16935","$MRK (+1.6% pre) Citi Upgrades Merck to Buy, $72 PT

http://ooc.bz/l/16935
1",,,1,,[],https://twitter.com/OpenOutcrier/status/920640008872177664
4938,BioPharma Dive,@BioPharmaDive,2017-10-16T00:02:00.000Z,"Rx Reading: Biocon, $MYL face biosimilar setback; $MRK shelves its CETP dreams; $ARDX sees success with IBS drug","Rx Reading: Biocon, $MYL face biosimilar setback; $MRK shelves its CETP dreams; $ARDX sees success with IBS drug
biopharmadive.com
Prescribed Reading: A week of game-changers in pharma
A new gene therapy is poised to hit the market; one dose of Anaptysbio's drug is all it took to clear some patients' skin; and a late-stage failure is hurting Lilly's oncology prospects.
2",,,,2,['https://pbs.twimg.com/card_img/1500049809826369538/mq3I7xko?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/919715011404087296
4939,bake mcbride,@ITRADEVOL,2017-10-18T12:48:49.000Z,Gainers Premarket $RXDX $SPPI $HCLP $IBM $GPRO $NVO $DUST $MRK $JDST $ERIC $TNA $DGAZ $MT $ABT https://marketchameleon.com/Reports/PremarketTrading‚Ä¶,Gainers Premarket $RXDX $SPPI $HCLP $IBM $GPRO $NVO $DUST $MRK $JDST $ERIC $TNA $DGAZ $MT $ABT https://marketchameleon.com/Reports/PremarketTrading‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/920632760548712448
4940,The Fly,@theflynews,2017-10-18T13:57:41.000Z,On The Fly: Pre-market Movers $IBM $CTBI $ABT $NTRS $SVU $MRK $PLX $CVS $ANTM $MTB $SCSS $CREE $ULTA http://dlvr.it/PwLV3h,On The Fly: Pre-market Movers $IBM $CTBI $ABT $NTRS $SVU $MRK $PLX $CVS $ANTM $MTB $SCSS $CREE $ULTA http://dlvr.it/PwLV3h,,,,,[],https://twitter.com/theflynews/status/920650094319362048
4941,Ani Anirudhan,@pnani456,2017-10-18T11:37:25.000Z,$MRK D1 multiple +ve news today after hammer candle - could gap n go > 200SMA   https://tradingview.com/x/yL5TY8yI/ via https://tradingview.com,$MRK D1 multiple +ve news today after hammer candle - could gap n go > 200SMA   https://tradingview.com/x/yL5TY8yI/ via https://tradingview.com,,,,,[],https://twitter.com/pnani456/status/920614793492488192
4942,StockCharts.com,@StockCharts,2017-10-18T12:41:01.000Z,Arthur Hill: Three Pullbacks for Three Healthcare Stocks $GILD $AMGN $MRK http://scharts.co/2inm0rG,"Arthur Hill: Three Pullbacks for Three Healthcare Stocks $GILD $AMGN $MRK http://scharts.co/2inm0rG
1",,,,1,[],https://twitter.com/StockCharts/status/920630799120048128
4943,Limex,@LimexMe,2017-10-17T14:41:20.000Z,Bristol-Myers Gets Priority Review for Opdivo Label Expansion http://bit.ly/171017BMY $BMY $AZN $NVO $MRK,"Bristol-Myers Gets Priority Review for Opdivo Label Expansion http://bit.ly/171017BMY $BMY $AZN $NVO $MRK
whotrades.com
Bristol-Myers Gets Priority Review for Opdivo Label Expansion
Bristol-Myers Squibb Company BMY announced that that the FDA has granted priority review to the supplemental Biologics License Application (sBLA) for the label expansion of‚Ä¶",,,,,[],https://twitter.com/LimexMe/status/920298687536001027
4944,Ticker Report,@TickerReport,2017-10-18T10:02:27.000Z,"Research Analysts Offer Predictions for Merck & Company, Inc.‚Äôs FY2017 Earnings $MRK http://ift.tt/2yuBmhN","Research Analysts Offer Predictions for Merck & Company, Inc.‚Äôs FY2017 Earnings $MRK http://ift.tt/2yuBmhN",,,,,[],https://twitter.com/TickerReport/status/920590895698927616
4945,BiotechBioPharma,@Regencells,2017-10-18T04:05:01.000Z,"Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2ymoHzS $MRK #biotech #diabetic 
@Merck","Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2ymoHzS $MRK #biotech #diabetic 
@Merck
1
1",,,1,1,['https://pbs.twimg.com/media/DMZGukXXUAAvsZ2?format=jpg&name=small'],https://twitter.com/Regencells/status/920500941954191363
4946,FancyFinancy,@FancyFinancy,2017-10-18T03:30:08.000Z,"Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2yv22PL $MRK $KALV","Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2yv22PL $MRK $KALV",,,,,['https://pbs.twimg.com/media/DMY-vlKWAAE23SY?format=jpg&name=small'],https://twitter.com/FancyFinancy/status/920492163317641216
4947,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-10-18T12:46:14.000Z,"Arthur Hill: Three Pullbacks for Three Healthcare Stocks $GILD $AMGN $MRK http://dlvr.it/PwKvxP ‚Üí via 
@AlertTrade","Arthur Hill: Three Pullbacks for Three Healthcare Stocks $GILD $AMGN $MRK http://dlvr.it/PwKvxP ‚Üí via 
@AlertTrade",,,,,['https://pbs.twimg.com/media/DMa-BrqUMAIZXKY?format=jpg&name=small'],https://twitter.com/AlertTrade/status/920632113090592768
4948,Carly Helfand,@CarlyHFierce,2017-10-18T15:45:57.000Z,"Padding its lung cancer lead, Merck's Keytruda helped PD-L1 patients live 30 months longer: http://bit.ly/2yxlSeD $MRK #pharma","Padding its lung cancer lead, Merck's Keytruda helped PD-L1 patients live 30 months longer: http://bit.ly/2yxlSeD $MRK #pharma
fiercepharma.com
Padding its lung cancer lead, Merck's Keytruda helped PD-L1 patients live 30 months longer
Merck‚Äôs immuno-oncology medication Keytruda has built up an imposing lead in lung cancer, and the company is touting more positive survival data to keep that lead intact. | Merck‚Äôs Keytruda has built...",,,,,['https://pbs.twimg.com/card_img/1501993121512517633/May6h3nF?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/920677339901644800
4949,Chameleon,@MarketChmln,2017-10-18T12:34:43.000Z,"$MRK stock increases 1.8% in premarket, company press release at 6:55 AM http://tinyurl.com/y8wvyets","$MRK stock increases 1.8% in premarket, company press release at 6:55 AM http://tinyurl.com/y8wvyets
1
1",ü¶é,,1,1,[],https://twitter.com/MarketChmln/status/920629212247150593
4950,Antonio Costa,@ACInvestorBlog,2017-10-18T12:31:29.000Z,"""
@wuzupwidat
: 
@ACInvestorBlog
 Maybe $MRK collaboration about to go to the next level ? $OPGN https://pic.twitter.com/BZDwNxP34T"" great point of view","""
@wuzupwidat
: 
@ACInvestorBlog
 Maybe $MRK collaboration about to go to the next level ? $OPGN https://pic.twitter.com/BZDwNxP34T"" great point of view
1",,,,1,[],https://twitter.com/ACInvestorBlog/status/920628398833139713
4951,SwingTradeBot,@SwingTradeBot,2017-10-18T13:22:54.000Z,Recent $MRK technical alerts: Lizard Bullish plus 4 more alerts...,"Recent $MRK technical alerts: Lizard Bullish plus 4 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/920641337975824384
4952,Inelegant Investor,@inelegantinvest,2017-10-18T12:05:55.000Z,Take An Advil? Pfizer Looking At Options For Consumer Health Business http://stockspinoffs.com/2017/10/18/take-advil-pfizer-looking-options-consumer-health-business/‚Ä¶ $PFE $AGN $MRK $ZTS,Take An Advil? Pfizer Looking At Options For Consumer Health Business http://stockspinoffs.com/2017/10/18/take-advil-pfizer-looking-options-consumer-health-business/‚Ä¶ $PFE $AGN $MRK $ZTS,,,,,[],https://twitter.com/inelegantinvest/status/920621967329423362
4953,Helen Ong,@Lin_ling_88,2017-10-18T15:08:21.000Z,"Replying to 
@AndyBiotech","Replying to 
@AndyBiotech
Sexy I/O is now old tech. 

$RXDX $LOXO $MRTX vs $MRK $BMY
2",,,,2,[],https://twitter.com/Lin_ling_88/status/920667875915988992
4954,Chameleon Options,@MC_OptionTrades,2017-10-17T21:31:43.000Z,$MRK 27-Oct-17 ATM Implied Volatility is up +5.9% to 16.7. Straddle Implies a Move of ¬±2.4%. Earnings Oct 27 BMO. http://tinyurl.com/yczj7dce,$MRK 27-Oct-17 ATM Implied Volatility is up +5.9% to 16.7. Straddle Implies a Move of ¬±2.4%. Earnings Oct 27 BMO. http://tinyurl.com/yczj7dce,ü¶é,,,,[],https://twitter.com/MC_OptionTrades/status/920401966022516736
4955,Piggy Bank People,@PiggyBankPeople,2017-10-17T19:30:22.000Z,"Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2yv1UQh $MRK $KALV","Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2yv1UQh $MRK $KALV",,,,,['https://pbs.twimg.com/media/DMXQ7yMW4AcQlkb?format=jpg&name=small'],https://twitter.com/PiggyBankPeople/status/920371427592802304
4956,BioPharmaDevice,@OneMedWorld,2017-10-17T15:01:14.000Z,"Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2ymoEnG $MRK #biotech #diabetic 
@Merck","Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2ymoEnG $MRK #biotech #diabetic 
@Merck",,,,,['https://pbs.twimg.com/media/DMWTVhxUEAA4Yjf?format=jpg&name=small'],https://twitter.com/OneMedWorld/status/920303699137843200
4957,Watchlist News,@WatchlistN,2017-10-18T08:29:17.000Z,"Merck & Company, Inc. $MRK Stake Lowered by Lucas Capital Management http://ift.tt/2x3LOvl","Merck & Company, Inc. $MRK Stake Lowered by Lucas Capital Management http://ift.tt/2x3LOvl",,,,,[],https://twitter.com/WatchlistN/status/920567446339248128
4958,24/7 Wall St.,@247WallSt,2017-10-18T13:28:12.000Z,"#investing #daytrading Wed's Top Analyst Up & Downgrades PT1
$CVX $CMG $XOM $GS $GPRO $IBM $MRK $PBR $UNH $V $ZNGA","#investing #daytrading Wed's Top Analyst Up & Downgrades PT1
$CVX $CMG $XOM $GS $GPRO $IBM $MRK $PBR $UNH $V $ZNGA
247wallst.com
Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck,...
The top analyst upgrades, downgrades and other research calls from Wednesday include Chevron, Chipotle Mexican Grill, Exxon Mobil, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa and...",,,,,['https://pbs.twimg.com/card_img/1499692876258680836/3fciU-Zp?format=jpg&name=small'],https://twitter.com/247WallSt/status/920642674369138688
4959,Allison Gatlin,@IBD_AGatlin,2017-10-16T16:09:03.000Z,Cure is a strong word; why some biotech analysts are ready to use it $CELG $BIIB $REGN $GILD $INCY $LOXO $MRK $BMY,"Cure is a strong word; why some biotech analysts are ready to use it $CELG $BIIB $REGN $GILD $INCY $LOXO $MRK $BMY
investors.com
Top Biotech Companies In Innovation: 6 Biotech Stocks Recognized In Fast-Growing U.S. Industry |...
Cancer. Alzheimer‚Äôs. MS. Treatments from the fast-growing U.S. biotech industry provide new hope for patients. What are the top biotech companies in innovation?
1",,,1,,['https://pbs.twimg.com/card_img/1501712115979235335/WHsxc6p9?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/919958377127694336
4960,Briefing.com,@Briefingcom,2017-10-18T12:49:17.000Z,$MRK: Merck presents updated overall survival findings from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA in... http://bit.ly/2zxI7zz,"$MRK: Merck presents updated overall survival findings from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA in... http://bit.ly/2zxI7zz
1
1",,,1,1,[],https://twitter.com/Briefingcom/status/920632877858955265
4961,FiercePharma,@FiercePharma,2017-10-16T14:14:00.000Z,$MRK targets high-risk military veterans for hepatitis C lessons,"$MRK targets high-risk military veterans for hepatitis C lessons
fiercepharma.com
Merck targets high-risk military veterans for hepatitis C lessons
Veterans are three times more likely to have hepatitis C than the general po | Veterans are three times more likely to have hepatitis C than the general population‚Äîand antiviral drugmaker Merck & Co....",,,,,['https://pbs.twimg.com/card_img/1501993102214500375/BA-W7XV1?format=jpg&name=small'],https://twitter.com/FiercePharma/status/919929423247241217
4962,Open Outcrier,@OpenOutcrier,2017-10-18T12:27:57.000Z,"$AZN (-0.3% pre) Astra and Merck $MRK win speedy review for Lynparza in breast cancer - NAsdaq

http://ooc.bz/l/16908","$AZN (-0.3% pre) Astra and Merck $MRK win speedy review for Lynparza in breast cancer - NAsdaq

http://ooc.bz/l/16908
1
1",,,1,1,[],https://twitter.com/OpenOutcrier/status/920627509942784001
4963,Benzinga,@Benzinga,2017-10-18T14:20:01.000Z,"Boosted By Keytruda, Citi Upgrades Merck To Buy For The First Time Ever https://benzinga.com/z/10192709 $MRK $AZN","Boosted By Keytruda, Citi Upgrades Merck To Buy For The First Time Ever https://benzinga.com/z/10192709 $MRK $AZN
benzinga.com
Boosted By Keytruda, Citi Upgrades Merck To Buy For The First Time Ever
Analysts at Citi hold a bullish rating on Merck & Co., Inc. (NYSE: MRK). The firm's Andrew Baum upgraded Merck's stock from Neutral to Buy ""for the first time,...",,,,,[],https://twitter.com/Benzinga/status/920655712417546240
4964,Jon Ogg,@jonogg,2017-10-18T13:23:16.000Z,"#investing #daytrading 
Wednesday's Top Analyst Upgrades and Downgrades PT1 
$CVX $CMG $XOM $GS $GPRO $IBM $MRK $PBR $UNH $V $ZNGA","#investing #daytrading 
Wednesday's Top Analyst Upgrades and Downgrades PT1 
$CVX $CMG $XOM $GS $GPRO $IBM $MRK $PBR $UNH $V $ZNGA
247wallst.com
Top Analyst Upgrades and Downgrades: Chevron, Chipotle, Exxon, Goldman Sachs, GoPro, IBM, Merck,...
The top analyst upgrades, downgrades and other research calls from Wednesday include Chevron, Chipotle Mexican Grill, Exxon Mobil, Goldman Sachs, GoPro, IBM, Merck, Petrobras, UnitedHealth, Visa and...",,,,,['https://pbs.twimg.com/card_img/1499692876258680836/3fciU-Zp?format=jpg&name=small'],https://twitter.com/jonogg/status/920641429541548033
4965,Carly Helfand,@CarlyHFierce,2017-10-17T20:33:02.000Z,Merck targets high-risk military veterans for hepatitis C lessons: http://bit.ly/2ijlwTn $MRK #pharma #marketing,"Merck targets high-risk military veterans for hepatitis C lessons: http://bit.ly/2ijlwTn $MRK #pharma #marketing
fiercepharma.com
Merck targets high-risk military veterans for hepatitis C lessons
Veterans are three times more likely to have hepatitis C than the general po | Veterans are three times more likely to have hepatitis C than the general population‚Äîand antiviral drugmaker Merck & Co....",,,,,['https://pbs.twimg.com/card_img/1501993102214500375/BA-W7XV1?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/920387195667697664
4966,StockNews.com,@stocknewsdotcom,2017-10-18T10:57:57.000Z,$MRK Presents updated overall survival findings from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA in patients‚Ä¶ https://stocknews.com/news/mrk-presents-updated-overall-survival-findings-from-the-phase-3-keynote-024/‚Ä¶,$MRK Presents updated overall survival findings from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA in patients‚Ä¶ https://stocknews.com/news/mrk-presents-updated-overall-survival-findings-from-the-phase-3-keynote-024/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/920604861057691648
4967,pharmalot,@pharmalot,2017-10-20T18:05:21.000Z,UK regulator opens four new probes into generic drug competition.. https://statnews.com/pharmalot/2017/10/20/uk-antitrust-probes-generics/‚Ä¶ #pharma $MRK $PFE,"UK regulator opens four new probes into generic drug competition.. https://statnews.com/pharmalot/2017/10/20/uk-antitrust-probes-generics/‚Ä¶ #pharma $MRK $PFE
statnews.com
U.K. antitrust regulator opens new probes into generic drug competition
U.K. authorities are investigating an unspecified number of drug makers over potential violations of anti-competitive laws concerning generic drugs.
1
3",,,1,3,[],https://twitter.com/pharmalot/status/921437195579351040
4968,pharmalot,@pharmalot,2017-10-20T15:41:29.000Z,"Merck is cutting 1,800 U.S. sales reps from its primary care force over the next two months.. https://statnews.com/pharmalot/2017/10/20/merck-layoff-sales-reps/‚Ä¶ #pharma $MRK $LLY","Merck is cutting 1,800 U.S. sales reps from its primary care force over the next two months.. https://statnews.com/pharmalot/2017/10/20/merck-layoff-sales-reps/‚Ä¶ #pharma $MRK $LLY
statnews.com
Merck lays off 1,800 U.S. sales reps to overhaul its primary care marketing
A Merck spokeswoman confirmed the move, which was disclosed to Merck employees on Thursday and is expected to be completed by early January.
3
2",,,3,2,['https://pbs.twimg.com/card_img/1501645406932979717/l8FvzIQw?format=jpg&name=small'],https://twitter.com/pharmalot/status/921400990863110144
4969,Breaking News,@MarketCurrents,2017-10-20T16:18:22.000Z,"Merck to lay off 1,800 sales reps https://seekingalpha.com/news/3302684-merck-lay-1800-sales-reps?source=feed_f‚Ä¶ $MRK","Merck to lay off 1,800 sales reps https://seekingalpha.com/news/3302684-merck-lay-1800-sales-reps?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Merck to lay off 1,800 sales reps (NYSE:MRK)
STAT reports that Merck (MRK) will cut 1,800 jobs from its sales organization, expected to be completed in early January.
1",,,1,,['https://pbs.twimg.com/card_img/1491463678931398657/umyv7Cbr?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/921410271435833346
4970,pharmalot,@pharmalot,2017-10-20T13:08:02.000Z,"Pharmalot.. Pharmalot.. Good Morning.. coffee, headlines & weekend daydreams are served.. https://statnews.com/pharmalot/2017/10/20/teva-opioids-astrazeneca-korea-avanir/‚Ä¶ #pharma $TEVA $AZN $MRK","Pharmalot.. Pharmalot.. Good Morning.. coffee, headlines & weekend daydreams are served.. https://statnews.com/pharmalot/2017/10/20/teva-opioids-astrazeneca-korea-avanir/‚Ä¶ #pharma $TEVA $AZN $MRK
statnews.com
Pharmalittle: Ontario probes Teva over opioids; Is AstraZeneca playing hardball in Korea?
The Ontario government is investigating allegations that Teva Pharmaceuticals offered pharmacies ‚Äúillegal‚Äù payments to stock its opioid medications.
1",,,,1,[],https://twitter.com/pharmalot/status/921362371859361792
4971,MM+M Magazine,@MMMnews,2017-10-20T20:30:00.000Z,"5 things for #pharma #marketers to know: Fri, Oct 20 $MRK $CELG #crohnsdisease #clinicaltrials #PBM #drugprices http://bit.ly/2yXbC0O","5 things for #pharma #marketers to know: Fri, Oct 20 $MRK $CELG #crohnsdisease #clinicaltrials #PBM #drugprices http://bit.ly/2yXbC0O
2
2",,,2,2,['https://pbs.twimg.com/media/DMlxNDSW4AAvtHY?format=jpg&name=small'],https://twitter.com/MMMnews/status/921473598077804544
4972,reem,@kafinancialLLC,2017-10-19T14:25:00.000Z,$MRK holding some calls. Thinking a move to 64-65 region soon,$MRK holding some calls. Thinking a move to 64-65 region soon,,,,,['https://pbs.twimg.com/media/DMgeNo7W0AA1QvZ?format=jpg&name=small'],https://twitter.com/kafinancialLLC/status/921019354971557888
4973,Ani Anirudhan,@pnani456,2017-10-21T18:08:59.000Z,$MRK MN bull flag above 63.50 breakout level into earnings (Fri BMO),$MRK MN bull flag above 63.50 breakout level into earnings (Fri BMO),,,,,['https://pbs.twimg.com/media/DMrkqmFXcAUUkXh?format=jpg&name=small'],https://twitter.com/pnani456/status/921800497174077441
4974,Greg5thTrad,@Greg5thTrad,2017-10-19T22:57:02.000Z,"$ Flows: Selling on Strength: Among stocks that were THR, these had the largest net outflows of money $MRK $JNJ $SPY $DWDP $AGN $PFE $GE","$ Flows: Selling on Strength: Among stocks that were THR, these had the largest net outflows of money $MRK $JNJ $SPY $DWDP $AGN $PFE $GE
1",üìà,,1,,['https://pbs.twimg.com/media/DMiTYMjWAAEP98n?format=jpg&name=small'],https://twitter.com/Greg5thTrad/status/921148211095535618
4975,FiercePharma,@FiercePharma,2017-10-20T17:46:03.000Z,"Trending: $MRK plots 1,800 sales layoffs and a new chronic care team","Trending: $MRK plots 1,800 sales layoffs and a new chronic care team
fiercepharma.com
Merck, citing 'ebb and flow' in priorities, plots 1,800 sales layoffs and new chronic care focus
In a nationwide shakeup, Merck & Co. plans to cut 1,800 U.S. | Merck & Co. plans to jettison three U.S. sales teams and 1,800 associated staffers while creating a new, 960-employee chronic care force.
1
2",,,1,2,['https://pbs.twimg.com/card_img/1499515720899739654/2A1_L_b7?format=jpg&name=small'],https://twitter.com/FiercePharma/status/921432339821088769
4976,Mike Richardson,@RFIMike,2017-10-20T17:00:18.000Z,"$MRK will cut 1,800 #jobs from its sales organization, expected to be completed in early January. The company notified employees yesterday.","$MRK will cut 1,800 #jobs from its sales organization, expected to be completed in early January. The company notified employees yesterday.",,,,,[],https://twitter.com/RFIMike/status/921420826771107840
4977,FonsieTrader,@FonsieTrader,2017-10-20T16:39:56.000Z,"$ONCS at current levels and based on the recent news, the company is now a great aquisition for $MRK","$ONCS at current levels and based on the recent news, the company is now a great aquisition for $MRK
3",,,,3,[],https://twitter.com/FonsieTrader/status/921415699570003968
4978,Carly Helfand,@CarlyHFierce,2017-10-19T11:02:01.000Z,Roche's Tecentriq cedes bladder-cancer share to Keytruda in wake of trial misfire: http://bit.ly/2xLlRQP $RHHBY $MRK #pharma #marketing,"Roche's Tecentriq cedes bladder-cancer share to Keytruda in wake of trial misfire: http://bit.ly/2xLlRQP $RHHBY $MRK #pharma #marketing
fiercepharma.com
Roche's Tecentriq cedes bladder-cancer share to Keytruda in wake of trial misfire
Roche may be able to keep its bladder cancer nod for Tecentriq despite its phase 3 failure to improve overall survival. But that doesn‚Äôt mean it can keep its market share.
1
1",,,1,1,[],https://twitter.com/CarlyHFierce/status/920968273532928001
4979,Option Runners,@OptionRunners,2017-10-19T14:17:01.000Z,"$MRK $TEVA Merck wins appeal to revive NuvaRing patent case against Teva, Bloomberg says","$MRK $TEVA Merck wins appeal to revive NuvaRing patent case against Teva, Bloomberg says
1",,,1,,[],https://twitter.com/OptionRunners/status/921017345350488064
4980,trading.jeff,@trading_jeff,2017-10-19T18:11:09.000Z,"OncoSec Medical Inc. ($ONCS): $ONCS, $MRK a ""significant incentive"" for Merck to","OncoSec Medical Inc. ($ONCS): $ONCS, $MRK a ""significant incentive"" for Merck to
investorshub.advfn.com
OncoSec Medical Inc. ONCS Post # 40409
1",,,,1,['https://pbs.twimg.com/card_img/1501887901210087429/pRQPrjCX?format=png&name=240x240'],https://twitter.com/trading_jeff/status/921076266903752705
4981,Community Financial,@CFinancialNews,2017-10-19T05:12:48.000Z,"Merck & Company, Inc. $MRK Receives Average Rating of ‚ÄúHold‚Äù from Brokerages http://ift.tt/2xPGJGF","Merck & Company, Inc. $MRK Receives Average Rating of ‚ÄúHold‚Äù from Brokerages http://ift.tt/2xPGJGF",,,,,[],https://twitter.com/CFinancialNews/status/920880386820988929
4982,Host_Master_Guardian,@imtiaz_gold,2017-10-21T03:30:35.000Z,$DVA $MRK $UTX $ALB $MAA $END $SHLO $CIE $PCCC $HP $VAR #Bitcoin Charts Posted.  90 days FREE. https://buff.ly/2yBXRS1,$DVA $MRK $UTX $ALB $MAA $END $SHLO $CIE $PCCC $HP $VAR #Bitcoin Charts Posted.  90 days FREE. https://buff.ly/2yBXRS1,,,,,[],https://twitter.com/imtiaz_gold/status/921579440194408448
4983,baha,@bahabusiness,2017-10-20T17:56:29.000Z,Downsizing to take effect on January 2. $MRK #Merck #pharma https://news.teletrader.com/merck-to-focus-on-chronic-care-cut-us-sales-jobs/news/details/40767021‚Ä¶,Downsizing to take effect on January 2. $MRK #Merck #pharma https://news.teletrader.com/merck-to-focus-on-chronic-care-cut-us-sales-jobs/news/details/40767021‚Ä¶,,,,,[],https://twitter.com/bahabusiness/status/921434965065261057
4984,1 min Stock Insights,@1MinuteStock,2017-10-21T08:23:02.000Z,"Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.5% of the current price","Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.5% of the current price
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/921653039093522432
4985,US Banking News,@AmericanBanking,2017-10-21T21:19:55.000Z,Merck & Company's sell rating reiterated at Jefferies Group LLC. $55.00 PT. http://ift.tt/2hVqTEa $MRK #MRK,Merck & Company's sell rating reiterated at Jefferies Group LLC. $55.00 PT. http://ift.tt/2hVqTEa $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/921848548622258176
4986,MarketBeat,@MarketBeatCom,2017-10-21T21:32:03.000Z,"Jefferies Group LLC Reiterates Sell Rating for Merck & Company, Inc. $MRK http://ift.tt/2xVkgN3 #acn","Jefferies Group LLC Reiterates Sell Rating for Merck & Company, Inc. $MRK http://ift.tt/2xVkgN3 #acn",,,,,[],https://twitter.com/MarketBeatCom/status/921851600297185280
4987,Transcript Daily,@TranscriptDaily,2017-10-20T08:37:19.000Z,"Merck & Company, Inc. $MRK Stake Boosted by Honeywell International Inc. http://ift.tt/2x9wuNH","Merck & Company, Inc. $MRK Stake Boosted by Honeywell International Inc. http://ift.tt/2x9wuNH",,,,,[],https://twitter.com/TranscriptDaily/status/921294245570457600
4988,Dakota Financial,@dakotafinancial,2017-10-19T08:33:17.000Z,"Perennial Advisors LLC Acquires 157 Shares of Merck & Company, Inc. $MRK http://ift.tt/2zjz1FT","Perennial Advisors LLC Acquires 157 Shares of Merck & Company, Inc. $MRK http://ift.tt/2zjz1FT",,,,,[],https://twitter.com/dakotafinancial/status/920930840850427904
4989,StockNews.com,@stocknewsdotcom,2017-10-21T13:37:47.000Z,$MRK Cautious commentary on Mad Money show https://stocknews.com/news/mrk-cautious-commentary-on-mad-money-show-58777662/‚Ä¶,$MRK Cautious commentary on Mad Money show https://stocknews.com/news/mrk-cautious-commentary-on-mad-money-show-58777662/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/921732245827792896
4990,Stockboard Media Inc,@stockboardinc,2017-10-21T18:05:14.000Z,$MRK Real-World Study Shows ZEPATIER¬Æ (Elbasvir and Grazoprevir) Resulted in High Rates of Sustained Vir... - http://sbml.co/932f1311,$MRK Real-World Study Shows ZEPATIER¬Æ (Elbasvir and Grazoprevir) Resulted in High Rates of Sustained Vir... - http://sbml.co/932f1311,,,,,[],https://twitter.com/stockboardinc/status/921799552667144194
4991,1 min Stock Insights,@1MinuteStock,2017-10-21T08:22:01.000Z,Unicorn Bay rating for $MRK is 2.88 out of 5.,"Unicorn Bay rating for $MRK is 2.88 out of 5.
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/921652783584985088
4992,Watchlist News,@WatchlistN,2017-10-21T08:36:17.000Z,"Davis R M Inc. Has $16.35 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zrV11b","Davis R M Inc. Has $16.35 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zrV11b",,,,,[],https://twitter.com/WatchlistN/status/921656374060310528
4993,Ticker Report,@TickerReport,2017-10-20T08:43:16.000Z,"Peak Asset Management LLC Boosts Stake in Merck & Company, Inc. $MRK http://ift.tt/2l2X8Gq","Peak Asset Management LLC Boosts Stake in Merck & Company, Inc. $MRK http://ift.tt/2l2X8Gq",,,,,[],https://twitter.com/TickerReport/status/921295740546273280
4994,Dakota Financial,@dakotafinancial,2017-10-21T17:50:30.000Z,"BMO Capital Markets Reiterates $70.00 Price Target for Merck & Company, Inc. $MRK http://ift.tt/2guGdrl","BMO Capital Markets Reiterates $70.00 Price Target for Merck & Company, Inc. $MRK http://ift.tt/2guGdrl",,,,,[],https://twitter.com/dakotafinancial/status/921795845095387136
4995,StockNews.com,@stocknewsdotcom,2017-10-20T15:35:51.000Z,"$MRK Company said to be cutting 1,800 US sales reps, according to Stat News https://stocknews.com/news/mrk-company-said-to-be-cutting-1800-us-sales-reps-according/‚Ä¶","$MRK Company said to be cutting 1,800 US sales reps, according to Stat News https://stocknews.com/news/mrk-company-said-to-be-cutting-1800-us-sales-reps-according/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/921399573347741697
4996,Eric Sagonowsky,@EricSFierce,2017-10-20T13:43:19.000Z,"Breaking: $MRK cutting 1,800 sales staffers 'across all states' http://fiercepharma.com/pharma/citing-ebb-and-flow-pharma-merck-says-it-s-cutting-1-800-sales-staffers‚Ä¶","Breaking: $MRK cutting 1,800 sales staffers 'across all states' http://fiercepharma.com/pharma/citing-ebb-and-flow-pharma-merck-says-it-s-cutting-1-800-sales-staffers‚Ä¶
1
1",,,1,1,[],https://twitter.com/EricSFierce/status/921371250546659328
4997,Watchlist News,@WatchlistN,2017-10-21T19:11:49.000Z,"Merck & Company, Inc. $MRK Lifted to Buy at Citigroup Inc. http://ift.tt/2xdImhR","Merck & Company, Inc. $MRK Lifted to Buy at Citigroup Inc. http://ift.tt/2xdImhR",,,,,[],https://twitter.com/WatchlistN/status/921816308479557632
4998,MySmallCap,@tzack16,2017-10-20T17:50:06.000Z,"Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2xarrfX $MRK $KALV","Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2xarrfX $MRK $KALV",,,,,['https://pbs.twimg.com/media/DMmWwVVW0AAyjtE?format=jpg&name=small'],https://twitter.com/tzack16/status/921433359309529088
4999,Crown Equity CRWE,@CRWECrownEquity,2017-10-20T05:17:34.000Z,$PBMD to present findings from study evaluating its IMP321 + $MRK 's KEYTRUDA in metastatic melanoma patients http://crweworld.com/article/news-provided-by-globenewswire/159513/dr-frederic-triebel-presenting-at-the-world-immunotherapy-congress-2017‚Ä¶,$PBMD to present findings from study evaluating its IMP321 + $MRK 's KEYTRUDA in metastatic melanoma patients http://crweworld.com/article/news-provided-by-globenewswire/159513/dr-frederic-triebel-presenting-at-the-world-immunotherapy-congress-2017‚Ä¶,,,,,[],https://twitter.com/CRWECrownEquity/status/921243975737995266
5000,UnicornBay,@TheUnicornBay,2017-10-21T05:26:01.000Z,We calculated 63-day Expected Return of $MRK for you: 3.15% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=expreturn&utm_source=twitter‚Ä¶,We calculated 63-day Expected Return of $MRK for you: 3.15% https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=expreturn&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/TheUnicornBay/status/921608492233900032
5001,FonsieTrader,@FonsieTrader,2017-10-19T15:41:17.000Z,Great presentation today !! $MRK owns a lot of shares of $OPGN something is up guys.,"Great presentation today !! $MRK owns a lot of shares of $OPGN something is up guys.
1",,,,1,[],https://twitter.com/FonsieTrader/status/921038551097192449
5002,Chameleon,@MarketChmln,2017-10-19T20:46:04.000Z,Largest $Notional Buy On Close Order Imbalances $GM $DWDP $MRK $FDX $EPD $ANTM $CVX $JPM $BA $C http://tinyurl.com/y8jo8mjb,Largest $Notional Buy On Close Order Imbalances $GM $DWDP $MRK $FDX $EPD $ANTM $CVX $JPM $BA $C http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/921115251457761280
5003,SwingTradeBot,@SwingTradeBot,2017-10-19T15:52:08.000Z,Recent $MRK technical alerts: Upside 200 DMA Break plus 7 more alerts...,"Recent $MRK technical alerts: Upside 200 DMA Break plus 7 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/921041281979207684
5004,Antonio Costa,@ACInvestorBlog,2017-10-19T15:35:52.000Z,"$OPGN $MRK correct......and insiders have been buying like crazy. So, $MRK and insiders know something....","$OPGN $MRK correct......and insiders have been buying like crazy. So, $MRK and insiders know something....
stocktwits.com
Antonio Costa (@ACInvestorBlog) | Stocktwits
$OPGN $MRK correct......and insiders have been buying like crazy. So, $MRK and insiders know something....
4",,,,4,[],https://twitter.com/ACInvestorBlog/status/921037188686589953
5005,The Fly,@theflynews,2017-10-19T15:17:38.000Z,REPORT: Merck wins appeal to revive NuvaRing patent case against Teva: http://bit.ly/2yB3FeN $MRK $TEVA,REPORT: Merck wins appeal to revive NuvaRing patent case against Teva: http://bit.ly/2yB3FeN $MRK $TEVA,,,,,[],https://twitter.com/theflynews/status/921032598717022211
5006,BioPharma Dive,@BioPharmaDive,2017-10-20T20:14:00.000Z,"Eliquis, Yescarta, Ozanimod and more will be on investors' radars as Q3 earnings continue http://bit.ly/2yC8ndy $BMY $CELG $GSK $GILD $MRK","Eliquis, Yescarta, Ozanimod and more will be on investors' radars as Q3 earnings continue http://bit.ly/2yC8ndy $BMY $CELG $GSK $GILD $MRK
biopharmadive.com
What's next for biopharma Q3 earnings
Bristol-Myers, AbbVie, Merck, Gilead and several other notable names will all host third quarter earnings calls this week.
1",,,,1,['https://pbs.twimg.com/card_img/1500520448324427785/5kgGmSp4?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/921469571663413248
5007,Olderpreneurs,@Olderpreneurs,2017-10-20T19:02:06.000Z,"Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2x9DsSJ $MRK $KALV","Giant Merck buddies up with little KalVista on lead drug, igniting stock with a $760M deal https://buff.ly/2x9DsSJ $MRK $KALV",,,,,['https://pbs.twimg.com/media/DMmnPF-UIAENCWI?format=jpg&name=small'],https://twitter.com/Olderpreneurs/status/921451479021604865
5008,Transcript Daily,@TranscriptDaily,2017-10-21T08:37:34.000Z,"Merck & Company, Inc. $MRK Shares Sold by TD Asset Management Inc. http://ift.tt/2l50jO1","Merck & Company, Inc. $MRK Shares Sold by TD Asset Management Inc. http://ift.tt/2l50jO1",,,,,[],https://twitter.com/TranscriptDaily/status/921656694731628544
5009,Chameleon,@MarketChmln,2017-10-20T20:46:38.000Z,Largest $Notional Buy On Close Order Imbalances $V $GM $MRK $PG $CCI-A $IBM $PPG $USB $EPD $VLO http://tinyurl.com/y8jo8mjb,Largest $Notional Buy On Close Order Imbalances $V $GM $MRK $PG $CCI-A $IBM $PPG $USB $EPD $VLO http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/921477782898606080
5010,Tony Ashcraft,@ashcraft_tony,2017-10-23T11:42:55.000Z,Corr: $AGEN $1Billion rev. est. by 2022; superior to $MRK leading Zostavax; 52/high (5.98) b4 FDA approval; buyout?,"Corr: $AGEN $1Billion rev. est. by 2022; superior to $MRK leading Zostavax; 52/high (5.98) b4 FDA approval; buyout?
statnews.com
FDA approves a new vaccine for shingles that provides broad protection
In trials, the vaccine offered 98 percent protection in the first year and that protection remained at 85 percent or higher three years after vaccination.
3
4",,,3,4,['https://pbs.twimg.com/card_img/1500100923053551620/RF4bvJSY?format=jpg&name=small'],https://twitter.com/ashcraft_tony/status/922428116311699457
5011,pharmalot,@pharmalot,2017-10-23T13:02:01.000Z,Pharmalot.. Pharmalittle.. Good Morning.. coffee & headlines are served.. https://statnews.com/pharmalot/2017/10/23/white-house-drug-prices-jnj/‚Ä¶ #pharma $GSK $JNJ $MRK $INSY,"Pharmalot.. Pharmalittle.. Good Morning.. coffee & headlines are served.. https://statnews.com/pharmalot/2017/10/23/white-house-drug-prices-jnj/‚Ä¶ #pharma $GSK $JNJ $MRK $INSY
statnews.com
Pharmalittle: White House eyes drug price task force; J&J talcum powder verdict tossed
White House officials asked members of Congress to form a bi-partisan task force on prescription drug pricing, but Republicans are pushing back.
1
3",,,1,3,['https://pbs.twimg.com/card_img/1500534343600644098/wAHXYJa7?format=jpg&name=small'],https://twitter.com/pharmalot/status/922448022713323522
5012,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-10-24T17:53:25.000Z,Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer. - $MRK $AZN $BMY $ROG,"Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer. - $MRK $AZN $BMY $ROG
pubmed.ncbi.nlm.nih.gov
Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer - PubMed
Recently, a firmer understanding of tumor immunology and tumor escape mechanisms has led to the development of immune checkpoint inhibitors, antibodies against programmed death-1 (PD-1) and its...
2
2",,,2,2,['https://pbs.twimg.com/card_img/1489644136395206658/iqjcILC3?format=jpg&name=240x240'],https://twitter.com/DrPaulyDeSantis/status/922883742934421505
5013,Tom Wrigley,@WrigleyTom,2017-10-23T12:04:04.000Z,"Pre-mkt Movers + News | via CNBC
$HAS $HIG $HAL $ROKU $VFC $GE
$CSCO $BSFT $AZN $JPM $AAPL
$TSLA $PCH $NOW $GSK $MRK","Pre-mkt Movers + News | via CNBC
$HAS $HIG $HAL $ROKU $VFC $GE
$CSCO $BSFT $AZN $JPM $AAPL
$TSLA $PCH $NOW $GSK $MRK
cnbc.com
Stocks making the biggest moves premarket: HAS, HIG, HAL, ROKU, VFC, GE, CSCO & more
These are the stocks posting the largest moves before the bell.
2
3",,,2,3,['https://pbs.twimg.com/card_img/1499386693866115074/s_7_93Hx?format=jpg&name=small'],https://twitter.com/WrigleyTom/status/922433437184745477
5014,Optionsonar,@Optionsonar1,2017-10-23T15:09:11.000Z,"$575,824.00 of bullish unusual option activity detected for $MRK http://optionsonar.com/unusual-option-activity/mrk/latest-trades‚Ä¶","$575,824.00 of bullish unusual option activity detected for $MRK http://optionsonar.com/unusual-option-activity/mrk/latest-trades‚Ä¶
1
1",,,1,1,['https://pbs.twimg.com/media/DM1OscRWsAE_l_v?format=jpg&name=small'],https://twitter.com/Optionsonar1/status/922480027077414912
5015,Hawkeye Advisory Services LLC,@AlaLongleaf,2017-10-23T17:02:02.000Z,$GOVX is breaking out due to major breakthrough on #HIV development https://wallstreet-online.de/nachricht/9965753-geovax-reports-significant-advance-hiv-vaccine-development‚Ä¶ #AID  #biotechnology $GILD $BMY $MRK #innovation,"$GOVX is breaking out due to major breakthrough on #HIV development https://wallstreet-online.de/nachricht/9965753-geovax-reports-significant-advance-hiv-vaccine-development‚Ä¶ #AID  #biotechnology $GILD $BMY $MRK #innovation
1
1",,,1,1,['https://pbs.twimg.com/media/DM1nntbVQAM4LNv?format=jpg&name=small'],https://twitter.com/AlaLongleaf/status/922508425707257856
5016,Corbin Travels,@corbintravel,2017-10-23T01:21:10.000Z,"Merck $MRK to lay off about 1,800 U.S. sales reps in cost-cutting move     https://wsj.com/articles/merck-to-lay-off-about-1-800-u-s-sales-reps-in-cost-cutting-move-1508532828‚Ä¶ via 
@WSJ","Merck $MRK to lay off about 1,800 U.S. sales reps in cost-cutting move     https://wsj.com/articles/merck-to-lay-off-about-1-800-u-s-sales-reps-in-cost-cutting-move-1508532828‚Ä¶ via 
@WSJ
wsj.com
Merck to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
Merck & Co. said it is laying off nearly 7% of its U.S. workforce in a reorganization the company says will cut costs and shift focus to products with growth potential.",,,,,[],https://twitter.com/corbintravel/status/922271646907600896
5017,John Carroll,@JohnCendpts,2017-10-23T09:51:44.000Z,"GSK grabs FDA OK for new shingles vaccine, which will now tackle a key Merck franchise
$GSK $MRK","GSK grabs FDA OK for new shingles vaccine, which will now tackle a key Merck franchise
$GSK $MRK
endpts.com
GSK grabs FDA OK for new shingles vaccine, which will now tackle a key Merck franchise
Watch out Merck. GlaxoSmithKline is coming for a chunk of your shingles vaccine franchise. Late on Friday the FDA announced that it had green-lighted Shingrix, one of its biggest development programs...
1
6
8",,1,6,8,['https://pbs.twimg.com/card_img/1498584609684135940/MF4drHmS?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/922400136155844608
5018,Counter Hedge,@counter_hedge,2017-10-23T23:20:27.000Z,"Bearish engulfing that takes out the range of the previous 3 candles, a rare occurrence. $MRK $SPY $INDU $RUT $QQQ","Bearish engulfing that takes out the range of the previous 3 candles, a rare occurrence. $MRK $SPY $INDU $RUT $QQQ",,,,,['https://pbs.twimg.com/media/DM2_IsOXcAAlkcI?format=jpg&name=small'],https://twitter.com/counter_hedge/status/922603657878573056
5019,G,@smokiemahoney,2017-10-24T15:05:44.000Z,"$OPGN Yes, a $900k contract and a CEO and CFO whom bought $1.8mil worth @.40 (open market buys). Discount shopping here..Oh and $MRK ties  https://twitter.com/petedoom/status/922840767227420673‚Ä¶","$OPGN Yes, a $900k contract and a CEO and CFO whom bought $1.8mil worth @.40 (open market buys). Discount shopping here..Oh and $MRK ties  https://twitter.com/petedoom/status/922840767227420673‚Ä¶
This Tweet is unavailable.
2",üìà,,,2,[],https://twitter.com/smokiemahoney/status/922841544067026947
5020,Vista Partners LLC,@VistaPResearch,2017-10-24T23:26:20.000Z,#NationalFoodDay #TuesdayThoughts See Vista Partners investing in #Biotech http://vistapglobal.com $ATOS $MRK $JNJ #PFE $IBB,"#NationalFoodDay #TuesdayThoughts See Vista Partners investing in #Biotech http://vistapglobal.com $ATOS $MRK $JNJ #PFE $IBB
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DM8KEJrVwAA4IRE.jpg'],https://twitter.com/VistaPResearch/status/922967526069346304
5021,Vista Partners LLC,@VistaPResearch,2017-10-23T14:51:12.000Z,Learn more about Atossa Genetics $ATOS at Vista Partners Coverage Pages http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK $JNJ $PFE #biotech #breastcancer,"Learn more about Atossa Genetics $ATOS at Vista Partners Coverage Pages http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK $JNJ $PFE #biotech #breastcancer
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DM1KkYaVwAAFlp_.jpg'],https://twitter.com/VistaPResearch/status/922475497434497024
5022,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-10-23T15:48:34.000Z,SWING TRADE ALERT: Recent $MRK technical alerts: 50 DMA Resistance plus 2 more‚Ä¶ http://dlvr.it/Px9sMn via ‚Üí http://bit.do/FreeTradingRoom,SWING TRADE ALERT: Recent $MRK technical alerts: 50 DMA Resistance plus 2 more‚Ä¶ http://dlvr.it/Px9sMn via ‚Üí http://bit.do/FreeTradingRoom,,,,,['https://pbs.twimg.com/media/DM1XtPwVoAAT8q7?format=jpg&name=small'],https://twitter.com/AlertTrade/status/922489936334356480
5023,Margin Hunt,@MarginHunt,2017-10-22T22:00:13.000Z,"Our fundamental analysis implies Merck & Company, Inc. $MRK is 10% undervalued before earnings next Friday http://ow.ly/13RI30fYajM","Our fundamental analysis implies Merck & Company, Inc. $MRK is 10% undervalued before earnings next Friday http://ow.ly/13RI30fYajM",,,,,['https://pbs.twimg.com/media/DMxjLeiX0AEy9rN?format=jpg&name=small'],https://twitter.com/MarginHunt/status/922221075316035585
5024,Chameleon Options,@MC_OptionTrades,2017-10-24T22:13:42.000Z,Price Moves vs Expected Moves $VRX $GILD $PFE $MRK $JNJ $CELG $TEVA $MNKD $AGN $ABBV $BIIB $MDXG http://tinyurl.com/y7zbwhgq,Price Moves vs Expected Moves $VRX $GILD $PFE $MRK $JNJ $CELG $TEVA $MNKD $AGN $ABBV $BIIB $MDXG http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DM75cdqXkAAenj1?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/922949244302057472
5025,Chuck Carnevale,@MarketsUpChuck,2017-10-24T13:46:57.000Z,"$TRV $MRK $AXP $GE $PFE $JPM
Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶","$TRV $MRK $AXP $GE $PFE $JPM
Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶",,,,,['https://pbs.twimg.com/media/DM6FdIAW4AE8bw4?format=jpg&name=medium'],https://twitter.com/MarketsUpChuck/status/922821717998923777
5026,Bio Stocks‚Ñ¢,@BioStocks,2017-10-23T10:48:30.000Z,What's next for #biopharma Q3 earnings http://biopharmadive.com/news/whats-next-for-biopharma-q3-earnings/507703/‚Ä¶ $BMY $CELG $GILD $ABBV $MRK,"What's next for #biopharma Q3 earnings http://biopharmadive.com/news/whats-next-for-biopharma-q3-earnings/507703/‚Ä¶ $BMY $CELG $GILD $ABBV $MRK
biopharmadive.com
What's next for biopharma Q3 earnings
Bristol-Myers, AbbVie, Merck, Gilead and several other notable names will all host third quarter earnings calls this week.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1500520448324427785/5kgGmSp4?format=jpg&name=small'],https://twitter.com/BioStocks/status/922414423838359553
5027,Stock Market Picks,@StockWebTrading,2017-10-24T19:38:34.000Z,DowStockTip's Results: $MRK opened SHORT on 10/19 at $64.00 and closed today at $62.50 +2.34% (http://dowstocktips.com) $QQQ $SPY $DIA,DowStockTip's Results: $MRK opened SHORT on 10/19 at $64.00 and closed today at $62.50 +2.34% (http://dowstocktips.com) $QQQ $SPY $DIA,,,,,['https://pbs.twimg.com/media/DM7V7BRXkAAtn05?format=jpg&name=small'],https://twitter.com/StockWebTrading/status/922910205159133184
5028,Bursatil Biotech,@BursatilBiotech,2017-10-23T10:51:36.000Z,"Its Earnings' week! Here's the Morning Session - 
Based on 
@bradloncar
  & 
@TomMathies
 's data base 
$NVS $BIIB $LLY $CELG $MRK $BMY $ABBV","Its Earnings' week! Here's the Morning Session - 
Based on 
@bradloncar
  & 
@TomMathies
 's data base 
$NVS $BIIB $LLY $CELG $MRK $BMY $ABBV
1
2",,1,,2,['https://pbs.twimg.com/media/DM0TZKsXcAEoYrr?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/922415200468430849
5029,Market Realist,@MarketRealist,2017-10-24T20:39:45.000Z,What Investors Can Expect from Merck‚Äôs 3Q17 Earnings Release http://marketrealist.com/?p=2404321 $MRK $FHLC $ABT $GILD,What Investors Can Expect from Merck‚Äôs 3Q17 Earnings Release http://marketrealist.com/?p=2404321 $MRK $FHLC $ABT $GILD,,,,,[],https://twitter.com/MarketRealist/status/922925602356674560
5030,StockMarketVideo.com,@stockmarketvide,2017-10-24T01:01:05.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/922628980032851968
5031,Ira Cohen,@MeyersCohen,2017-10-23T13:11:09.000Z,$AGEN: AH NEWS GlaxoSmithKline adult shingles vaccine wins U.S. FDA approval  http://businessinsider.com/r-glaxosmithkline-adult-shingles-vaccine-wins-us-approval-2017-10‚Ä¶ $GBX $GSK $AZN $MRK $PFE $AAPL,$AGEN: AH NEWS GlaxoSmithKline adult shingles vaccine wins U.S. FDA approval  http://businessinsider.com/r-glaxosmithkline-adult-shingles-vaccine-wins-us-approval-2017-10‚Ä¶ $GBX $GSK $AZN $MRK $PFE $AAPL,,,,,[],https://twitter.com/MeyersCohen/status/922450322659954688
5032,1 min Stock Insights,@1MinuteStock,2017-10-24T01:37:02.000Z,Do you know that #Book Value for $MRK is $14.47,"Do you know that #Book Value for $MRK is $14.47
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/922638028446646272
5033,MarketBeat,@MarketBeatCom,2017-10-23T15:20:35.000Z,Merck KGaA given ‚Ç¨120.00 PT by UBS AG. buy rating. http://ift.tt/2hZ2FJv $MRK #MRK,Merck KGaA given ‚Ç¨120.00 PT by UBS AG. buy rating. http://ift.tt/2hZ2FJv $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/922482895486414850
5034,MarketBeat,@MarketBeatCom,2017-10-23T18:10:18.000Z,Merck & Company's PT raised by Leerink Swann to $70.00. market perform rating. http://ift.tt/2hZ4Igp $MRK #MRK,Merck & Company's PT raised by Leerink Swann to $70.00. market perform rating. http://ift.tt/2hZ4Igp $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/922525604762832896
5035,Verified Investing,@InvestVerified,2017-10-23T13:48:47.000Z,"Are you following the Verified Trader Chatter this morning: https://verifiedinvesting.com/pro-traders/chatter‚Ä¶. 
Trades $STX $GILD $VRTX $SRPT $MRK $CELG $BIIB $AMGN","Are you following the Verified Trader Chatter this morning: https://verifiedinvesting.com/pro-traders/chatter‚Ä¶. 
Trades $STX $GILD $VRTX $SRPT $MRK $CELG $BIIB $AMGN",,,,,[],https://twitter.com/InvestVerified/status/922459791561314306
5036,Jack Allen,@JohnK_Allen,2017-10-23T13:44:34.000Z,"$MRK earnings prediction, Keytruda sales continue strong growth, 1097m, expect lots of conversation about Lynparza deal/potential $AZN","$MRK earnings prediction, Keytruda sales continue strong growth, 1097m, expect lots of conversation about Lynparza deal/potential $AZN",,,,,[],https://twitter.com/JohnK_Allen/status/922458731065069569
5037,Crown Equity CRWE,@CRWECrownEquity,2017-10-23T05:14:30.000Z,"Week Ahead (Oct 23 - 27) Market Strategies $SCO, $MOS, $BMY, $G, $AGX, $MRK, $VFC, $FCAU, $WRB, $AMGN, $RTN, $WDC http://crweworld.com/article/markets/160206/oct-23-27-2017-weekly-market-strategies‚Ä¶","Week Ahead (Oct 23 - 27) Market Strategies $SCO, $MOS, $BMY, $G, $AGX, $MRK, $VFC, $FCAU, $WRB, $AMGN, $RTN, $WDC http://crweworld.com/article/markets/160206/oct-23-27-2017-weekly-market-strategies‚Ä¶",,,,,[],https://twitter.com/CRWECrownEquity/status/922330368107261953
5038,Antonio Costa,@ACInvestorBlog,2017-10-23T11:02:44.000Z,$MRK $AZN AstraZeneca and Merck Rapidly Advance LYNPARZA¬Æ (olaparib) in Japan With a Second Regulatory Submission http://businesswire.com/news/home/20171023005473/en/AstraZeneca-Merck-Rapidly-Advance-LYNPARZA%C2%AE-olaparib-Japan‚Ä¶,"$MRK $AZN AstraZeneca and Merck Rapidly Advance LYNPARZA¬Æ (olaparib) in Japan With a Second Regulatory Submission http://businesswire.com/news/home/20171023005473/en/AstraZeneca-Merck-Rapidly-Advance-LYNPARZA%C2%AE-olaparib-Japan‚Ä¶
2",,,,2,[],https://twitter.com/ACInvestorBlog/status/922418004398346241
5039,Daily Political,@dailypoliticaln,2017-10-24T08:45:27.000Z,"Aveo Capital Partners LLC Sells 29 Shares of Merck & Company, Inc. $MRK http://ift.tt/2yFHsyh","Aveo Capital Partners LLC Sells 29 Shares of Merck & Company, Inc. $MRK http://ift.tt/2yFHsyh",,,,,[],https://twitter.com/dailypoliticaln/status/922745842834001920
5040,Ticker Report,@TickerReport,2017-10-23T08:32:37.000Z,"Rockland Trust Co. Has $3.77 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2yClZX9","Rockland Trust Co. Has $3.77 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2yClZX9",,,,,[],https://twitter.com/TickerReport/status/922380227858313216
5041,Dakota Financial,@dakotafinancial,2017-10-22T08:40:24.000Z,"Merck & Company, Inc. $MRK Holdings Lifted by Barrett Asset Management LLC http://ift.tt/2gZ68rR","Merck & Company, Inc. $MRK Holdings Lifted by Barrett Asset Management LLC http://ift.tt/2gZ68rR",,,,,[],https://twitter.com/dakotafinancial/status/922019797335990273
5042,SwingTradeBot,@SwingTradeBot,2017-10-23T15:42:28.000Z,Recent $MRK technical alerts: 50 DMA Resistance plus 2 more alerts...,"Recent $MRK technical alerts: 50 DMA Resistance plus 2 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/922488402469183488
5043,US Banking News,@AmericanBanking,2017-10-24T12:36:48.000Z,"Leerink Swann Comments on Merck & Company, Inc.‚Äôs FY2017 Earnings $MRK http://ift.tt/2lbEQmp","Leerink Swann Comments on Merck & Company, Inc.‚Äôs FY2017 Earnings $MRK http://ift.tt/2lbEQmp",,,,,[],https://twitter.com/AmericanBanking/status/922804064999571456
5044,Hottest Stocks Now,@HottestStockNow,2017-10-23T19:49:17.000Z,"$AZN, $MRK Submit NDA to Japan‚Äôs PMDA for use of LYNPARZA (olaparib) tablets in BRCA-mutated breast cancer patients http://crweworld.com/article/news-provided-by-business-wire/160384/astrazeneca-and-merck-rapidly-advance-lynparza-olaparib-in-japan-with-a-second-regulatory-submission‚Ä¶","$AZN, $MRK Submit NDA to Japan‚Äôs PMDA for use of LYNPARZA (olaparib) tablets in BRCA-mutated breast cancer patients http://crweworld.com/article/news-provided-by-business-wire/160384/astrazeneca-and-merck-rapidly-advance-lynparza-olaparib-in-japan-with-a-second-regulatory-submission‚Ä¶",,,,,[],https://twitter.com/HottestStockNow/status/922550514109304833
5045,Chameleon Options,@MC_OptionTrades,2017-10-24T23:28:45.000Z,$MRK 27-Oct-17 ATM Implied Volatility is up +32.3%. Straddle Implies a Move of ¬±2.4%. Earnings Oct 27 BMO. http://tinyurl.com/yczj7dce,"$MRK 27-Oct-17 ATM Implied Volatility is up +32.3%. Straddle Implies a Move of ¬±2.4%. Earnings Oct 27 BMO. http://tinyurl.com/yczj7dce
1",ü¶é,1,,,[],https://twitter.com/MC_OptionTrades/status/922968133102645249
5046,Rishesh Singh,@androsForm,2017-10-24T17:12:25.000Z,Top Buy Flow Money -- $SPY $JNK $MRK $WHR $IWM $NFLX $GOOGL $IBM $VEEV,Top Buy Flow Money -- $SPY $JNK $MRK $WHR $IWM $NFLX $GOOGL $IBM $VEEV,,,,,[],https://twitter.com/androsForm/status/922873424741060609
5047,Chameleon,@MarketChmln,2017-10-24T01:32:31.000Z,Largest $Notional Sell On Close Order Imbalances $IBM $JNJ $BRK.B $MRK $HD $CVX $XOM $BX $PSX $PFE http://tinyurl.com/y8jo8mjb,Largest $Notional Sell On Close Order Imbalances $IBM $JNJ $BRK.B $MRK $HD $CVX $XOM $BX $PSX $PFE http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/922636891903746048
5048,Jacob Bell,@realJacobBell,2017-10-23T21:20:01.000Z,$GSK believes Shingrix could become the company's top-selling vaccine http://bit.ly/2xhTBFI $MRK,"$GSK believes Shingrix could become the company's top-selling vaccine http://bit.ly/2xhTBFI $MRK
biopharmadive.com
Vaccine approval buoys GSK new drug push
An FDA OK for GSK's shingles vaccine puts the British drugmaker in direct competition with Merck's Zostavax franchise.",,,,,[],https://twitter.com/realJacobBell/status/922573349766737926
5049,Calcbench,@Calcbench,2017-10-24T20:09:17.000Z,"@Calcbench
 Study:  Corporate Income #Tax Reconciling.    $spy #earnings $aapl $fb $wfc $msft $jnj $csco $mrk   https://linkedin.com/feed/update/urn:li:activity:6328677752094494720‚Ä¶","@Calcbench
 Study:  Corporate Income #Tax Reconciling.    $spy #earnings $aapl $fb $wfc $msft $jnj $csco $mrk   https://linkedin.com/feed/update/urn:li:activity:6328677752094494720‚Ä¶
1",,,,1,[],https://twitter.com/Calcbench/status/922917933604413440
5050,BioPharma Dive,@BioPharmaDive,2017-10-23T16:55:00.000Z,What's next for biopharma Q3 earnings http://bit.ly/2yC8ndy $AMGN $GSK $BMY $CELG $GILD $ABBV $MRK $SHPG #pharma #biotech,"What's next for biopharma Q3 earnings http://bit.ly/2yC8ndy $AMGN $GSK $BMY $CELG $GILD $ABBV $MRK $SHPG #pharma #biotech
biopharmadive.com
What's next for biopharma Q3 earnings
Bristol-Myers, AbbVie, Merck, Gilead and several other notable names will all host third quarter earnings calls this week.",,,,,['https://pbs.twimg.com/card_img/1500520448324427785/5kgGmSp4?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/922506654226071552
5051,Watchlist News,@WatchlistN,2017-10-24T08:56:15.000Z,"Merck & Company, Inc. $MRK Position Boosted by Solaris Asset Management LLC http://ift.tt/2gAxNym","Merck & Company, Inc. $MRK Position Boosted by Solaris Asset Management LLC http://ift.tt/2gAxNym",,,,,[],https://twitter.com/WatchlistN/status/922748561665740800
5052,US Banking News,@AmericanBanking,2017-10-23T19:41:49.000Z,"Merck & Company, Inc. $MRK PT Raised to $70.00 at Leerink Swann http://ift.tt/2gDNYyP","Merck & Company, Inc. $MRK PT Raised to $70.00 at Leerink Swann http://ift.tt/2gDNYyP",,,,,[],https://twitter.com/AmericanBanking/status/922548635233071104
5053,BioPharma Dive,@BioPharmaDive,2017-10-23T21:20:00.000Z,$GSK believes Shingrix could become the company's top-selling vaccine http://bit.ly/2xhTBFI $MRK,"$GSK believes Shingrix could become the company's top-selling vaccine http://bit.ly/2xhTBFI $MRK
biopharmadive.com
Vaccine approval buoys GSK new drug push
An FDA OK for GSK's shingles vaccine puts the British drugmaker in direct competition with Merck's Zostavax franchise.
1",,,,1,['https://pbs.twimg.com/card_img/1499454196394962954/ZuRLeYHG?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/922573345522151424
5054,Briefing.com,@Briefingcom,2017-10-23T10:39:15.000Z,$MRK: Merck presents study data for ZEPATIER resulted in high rates of sustained virologic response http://bit.ly/2h2inE2,$MRK: Merck presents study data for ZEPATIER resulted in high rates of sustained virologic response http://bit.ly/2h2inE2,,,,,[],https://twitter.com/Briefingcom/status/922412094443491328
5055,cowenresearch,@CowenResearch,2017-10-23T10:19:11.000Z,"In new report, Steve Scala looks at how adjuvant use of immune oncology could transform cancer treatment $AZN $BMY $MRK $PFE $RHHBY","In new report, Steve Scala looks at how adjuvant use of immune oncology could transform cancer treatment $AZN $BMY $MRK $PFE $RHHBY
1",,1,,,[],https://twitter.com/CowenResearch/status/922407042555568128
5056,Wolfer,@TheWolferNY,2017-10-24T02:05:21.000Z,"Replying to 
@immunooncnews","Replying to 
@immunooncnews
Il-12 + Keytruda $ONCS + $MRK = cancer cure
2",,,,2,[],https://twitter.com/TheWolferNY/status/922645153059237893
5057,StockNews.com,@stocknewsdotcom,2017-10-23T10:27:06.000Z,$MRK Presents study data for ZEPATIER resulted in high rates of sustained virologic response https://stocknews.com/news/mrk-presents-study-data-for-zepatier-resulted-in-high-rates-of/‚Ä¶,$MRK Presents study data for ZEPATIER resulted in high rates of sustained virologic response https://stocknews.com/news/mrk-presents-study-data-for-zepatier-resulted-in-high-rates-of/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/922409036531879936
5058,Investment U,@InvestmentU,2017-10-23T16:00:06.000Z,"Merck stock is underperforming the market. So is it a good time to buy? $MRK
http://bit.ly/2ieXJ72","Merck stock is underperforming the market. So is it a good time to buy? $MRK
http://bit.ly/2ieXJ72",,,,,[],https://twitter.com/InvestmentU/status/922492838297956353
5059,Andy Biotech,@AndyBiotech,2017-10-27T20:20:26.000Z,"When it rains, it pours...

$MRK has withdrawn its European application for Keytruda + chemo combo in 1L NSCLC.","When it rains, it pours...

$MRK has withdrawn its European application for Keytruda + chemo combo in 1L NSCLC.
6
20
31",,6,20,31,[],https://twitter.com/AndyBiotech/status/924007903685677057
5060,Merck,@Merck,2017-10-27T13:01:12.000Z,A closing word from Ken Frazier on our 3Q financial results. $MRK,"A closing word from Ken Frazier on our 3Q financial results. $MRK
1
18
59",,1,18,59,['https://pbs.twimg.com/media/DNJQbGYUIAAE3mZ?format=jpg&name=small'],https://twitter.com/Merck/status/923897370408046592
5061,Divya Grover,@thegirlshewasnt,2017-10-27T21:13:19.000Z,$MRK withdraws European application for #Keytruda as a combo treatment for advanced non-small cell #lungcancer,"$MRK withdraws European application for #Keytruda as a combo treatment for advanced non-small cell #lungcancer
reuters.com
Merck withdraws marketing application for Keytruda in Europe
Merck & Co Inc said on Friday it had withdrawn its European application for Keytruda as a combination treatment for patients with an advanced stage of non-small cell lung cancer.
1
2
2",,1,2,2,['https://pbs.twimg.com/card_img/1494735728793640961/ImYEZdpO?format=png&name=small'],https://twitter.com/thegirlshewasnt/status/924021214686806016
5062,Earnings Whispers,@eWhispers,2017-10-26T16:38:39.000Z,Fri #earnings $XOM $ABBV $CVX $MRK $PSX $CL $COL $SHPG $COG $PDS $GT $NRZ $MDXG $GBX $WY $HUN $LYB $CCJ $TRU $B $AAN http://eps.sh/cal,"Fri #earnings $XOM $ABBV $CVX $MRK $PSX $CL $COL $SHPG $COG $PDS $GT $NRZ $MDXG $GBX $WY $HUN $LYB $CCJ $TRU $B $AAN http://eps.sh/cal
22
23",,,22,23,['https://pbs.twimg.com/media/DNE_D1wVoAAMv0K?format=jpg&name=small'],https://twitter.com/eWhispers/status/923589704439738368
5063,Bursatil Biotech,@BursatilBiotech,2017-10-27T11:03:22.000Z,"$MRK 
Much better","$MRK 
Much better
2
3",,,2,3,['https://pbs.twimg.com/media/DNI8vkfW0AAIv2s?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/923867716032876545
5064,Brad Loncar,@bradloncar,2017-10-27T20:32:00.000Z,Flashback to this morning: the change $MRK made to KEYNOTE-189.,"Flashback to this morning: the change $MRK made to KEYNOTE-189.
3
8",,,3,8,['https://pbs.twimg.com/media/DNK-twsUQAANthm?format=jpg&name=900x900'],https://twitter.com/bradloncar/status/924010816822759426
5065,Breaking News,@MarketCurrents,2017-10-27T11:35:37.000Z,Merck Q3 revenues off 2%; non-GAAP EPS up 4%; updates guidance https://seekingalpha.com/news/3305169-merck-q3-revenues-2-percent-non-gaap-eps-4-percent-updates-guidance?source=feed_f‚Ä¶ #premarket $MRK,Merck Q3 revenues off 2%; non-GAAP EPS up 4%; updates guidance https://seekingalpha.com/news/3305169-merck-q3-revenues-2-percent-non-gaap-eps-4-percent-updates-guidance?source=feed_f‚Ä¶ #premarket $MRK,,,,,[],https://twitter.com/MarketCurrents/status/923875829406343168
5066,Ram Levi,@ramlevi,2017-10-27T11:06:01.000Z,Merck reports #NotPetya caused reduced sales by $240m and ‚Äútemporary production shutdown‚Äù $MRK,"Merck reports #NotPetya caused reduced sales by $240m and ‚Äútemporary production shutdown‚Äù $MRK
1",‚öú,,1,,['https://pbs.twimg.com/media/DNI9YCCWkAAvWjp?format=jpg&name=small'],https://twitter.com/ramlevi/status/923868381559877632
5067,Kananda Barrons,@KanandaBarrons,2017-10-25T15:41:17.000Z,"$AGEN ACIP votes 8-7 to prefer $GSK's shingles vaccine #Shingrix with 
@Agenus_Bio
' #QS21 over $MRK 's Zostavax http://markets.businessinsider.com/news/stocks/r-brief-acip-votes-8-7-to-prefer-gsks-shingles-vaccine-shingrix-over-mercks-zostavax-2017-10-1005587456‚Ä¶","$AGEN ACIP votes 8-7 to prefer $GSK's shingles vaccine #Shingrix with 
@Agenus_Bio
' #QS21 over $MRK 's Zostavax http://markets.businessinsider.com/news/stocks/r-brief-acip-votes-8-7-to-prefer-gsks-shingles-vaccine-shingrix-over-mercks-zostavax-2017-10-1005587456‚Ä¶
1
4",,,1,4,[],https://twitter.com/KanandaBarrons/status/923212878647300096
5068,Dan Rosenblum,@sharkbiotech,2017-10-27T20:50:42.000Z,$MRK is now below where it was the day before the Opdivo failure gap up in August 2016,"$MRK is now below where it was the day before the Opdivo failure gap up in August 2016
1
2
5",,1,2,5,[],https://twitter.com/sharkbiotech/status/924015523804930048
5069,David Crow,@bydavidcrow,2017-10-27T20:51:13.000Z,Bonkers that EMA approved PTC's DMD dud but knocks back combo of two proven cancer drugs because of small(ish) data set $MRK $PTCT,"Bonkers that EMA approved PTC's DMD dud but knocks back combo of two proven cancer drugs because of small(ish) data set $MRK $PTCT
2
5
20",,2,5,20,[],https://twitter.com/bydavidcrow/status/924015651752161280
5070,dough,@semodough,2017-10-27T19:16:54.000Z,$MRK M&A  YES $CELG for sure $AMGN been looking $GILD no way done $PFE way past due    - $AGN LLY $AZN $BMY over/under before #JPM2018,"$MRK M&A  YES $CELG for sure $AMGN been looking $GILD no way done $PFE way past due    - $AGN LLY $AZN $BMY over/under before #JPM2018
Endpoints News
@endpts
 ¬∑ 27 Oct 2017
In a switch, Merck CEO signals he‚Äôs in a deal-making frame of mind https://endpts.com/in-a-switch-merck-ceo-signals-hes-in-a-deal-making-frame-of-mind/‚Ä¶ #biopharma >subscribe> http://endpts.com/subscribe
1
2
9",,1,2,9,['https://pbs.twimg.com/profile_images/1139555869262274561/e-ncz5WD_mini.png'],https://twitter.com/semodough/status/923991918094225409
5071,Christoph McLee,@ChristophMcLee,2017-10-27T12:32:08.000Z,"Tyre maker $GT's #earnings fell about 60% in 3Q17 to $129MM, or 50 cents per share... http://alph.st/b1ca2bd4
#trading #stock $XOM $MRK $CVS","Tyre maker $GT's #earnings fell about 60% in 3Q17 to $129MM, or 50 cents per share... http://alph.st/b1ca2bd4
#trading #stock $XOM $MRK $CVS",,,,,['https://pbs.twimg.com/media/DNJRCewU8AAKP5n?format=jpg&name=small'],https://twitter.com/ChristophMcLee/status/923890053524348928
5072,Brenda Sandburg,@brendasandburg,2017-10-25T15:01:06.000Z,"CDC ACIP votes 8 yes, 7 no to recommend $GSK Shingrix shingles vaccine preference over $MRK's Zostavax vaccine","CDC ACIP votes 8 yes, 7 no to recommend $GSK Shingrix shingles vaccine preference over $MRK's Zostavax vaccine
2",,,2,,[],https://twitter.com/brendasandburg/status/923202768554348544
5073,Investors.com,@IBDinvestors,2017-10-27T13:47:26.000Z,"Friday's biggest business headlines in a minute or less. For the latest market news/ analysis, go to http://ow.ly/SsTe30gaJDI 
$XOM $MRK $JCP","Friday's biggest business headlines in a minute or less. For the latest market news/ analysis, go to http://ow.ly/SsTe30gaJDI 
$XOM $MRK $JCP
1
3",,,1,3,['https://pbs.twimg.com/ext_tw_video_thumb/923908889107730432/pu/img/n4dkmb6J-CYOnNCP.jpg'],https://twitter.com/IBDinvestors/status/923909002102296576
5074,GuruFocus,@gurufocus,2017-10-27T16:46:32.000Z,"Despite Profit Beat, Merck Shares Fall Due to Impact of NotPetya Attack https://gurufocus.com/news/585674 $MRK $AZN","Despite Profit Beat, Merck Shares Fall Due to Impact of NotPetya Attack https://gurufocus.com/news/585674 $MRK $AZN
1
1",,,1,1,['https://pbs.twimg.com/media/DNKLTrRVwAA3WWv?format=jpg&name=small'],https://twitter.com/gurufocus/status/923954073447084032
5075,John Carroll,@JohnCendpts,2017-10-27T13:13:14.000Z,"In a switch, Merck CEO signals he‚Äôs in a deal-making frame of mind
$MRK
https://endpts.com/in-a-switch-merck-ceo-signals-hes-in-a-deal-making-frame-of-mind/‚Ä¶","In a switch, Merck CEO signals he‚Äôs in a deal-making frame of mind
$MRK
https://endpts.com/in-a-switch-merck-ceo-signals-hes-in-a-deal-making-frame-of-mind/‚Ä¶
3
6",,,3,6,[],https://twitter.com/JohnCendpts/status/923900396158021633
5076,Jacob Plieth,@JacobPlieth,2017-10-27T12:50:44.000Z,"$MRK also highlighting need to look across trials to compare Keytruda vs Opdivo+Yervoy in 1L NSCLC, because of the tox that Yervoy adds","$MRK also highlighting need to look across trials to compare Keytruda vs Opdivo+Yervoy in 1L NSCLC, because of the tox that Yervoy adds
4
3",,,4,3,[],https://twitter.com/JacobPlieth/status/923894734296375297
5077,Vista Partners LLC,@VistaPResearch,2017-10-27T21:45:23.000Z,A Progressive Week for #BreastCancer Focused #Biotech Atossa Genetics $ATOS http://vistapglobal.com/2017/10/progressive-week-breast-cancer-focused-biotech-atossa-genetics-atos/‚Ä¶ $IBB $MRK $PFE #investing,"A Progressive Week for #BreastCancer Focused #Biotech Atossa Genetics $ATOS http://vistapglobal.com/2017/10/progressive-week-breast-cancer-focused-biotech-atossa-genetics-atos/‚Ä¶ $IBB $MRK $PFE #investing
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DNLPukxV4AAK4XA.jpg'],https://twitter.com/VistaPResearch/status/924029282942312449
5078,ICEMAN,@IcemanTrading,2017-10-27T10:15:29.000Z,$AAN $ABBV $CL $COG $COL $CPLP $CVX $CYOU $DORM $GT $GVA $HUN $LECO $LPNT $LYB $MDXG $MRK $PSX $PSXP $SC $SHPG $SOHU $SPG $TEN $WY $XOM,"$AAN $ABBV $CL $COG $COL $CPLP $CVX $CYOU $DORM $GT $GVA $HUN $LECO $LPNT $LYB $MDXG $MRK $PSX $PSXP $SC $SHPG $SOHU $SPG $TEN $WY $XOM
1",,,,1,['https://pbs.twimg.com/media/DNIxzx1UEAAT2KO?format=jpg&name=small'],https://twitter.com/IcemanTrading/status/923855662978826240
5079,Demy Colton,@demycolton,2017-10-25T18:52:04.000Z,"Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2yK103S $MRK #biotech #diabetic 
@Merck","Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2yK103S $MRK #biotech #diabetic 
@Merck
2",,,2,,['https://pbs.twimg.com/media/DNAU4pvW0AMcCIa?format=jpg&name=small'],https://twitter.com/demycolton/status/923260889280778240
5080,Mr. Profit,@ProfitTradeRoom,2017-10-27T21:38:29.000Z,Biggest Market Losers $PETZ $EFII $CLSN $VSAR $EXPE $JCP $TRXC $JP $ENDP $NBR $SRAX $TEN $MAT $XXII $BIDU $UVXY $TVIX $UGAZ $M $MRK $CVS,"Biggest Market Losers $PETZ $EFII $CLSN $VSAR $EXPE $JCP $TRXC $JP $ENDP $NBR $SRAX $TEN $MAT $XXII $BIDU $UVXY $TVIX $UGAZ $M $MRK $CVS
1",üí∞,,,1,['https://pbs.twimg.com/media/DNLOIHtXkAULuKF?format=jpg&name=small'],https://twitter.com/ProfitTradeRoom/status/924027546399846400
5081,MM+M Magazine,@MMMnews,2017-10-27T14:58:52.000Z,"5 things for #pharma #marketers to know: Fri., Oct. 27 $CVS $AET $AMZN #pharmacy $MRK #CyberSecurity $PFE $GSK $RB http://bit.ly/2gOIv8r","5 things for #pharma #marketers to know: Fri., Oct. 27 $CVS $AET $AMZN #pharmacy $MRK #CyberSecurity $PFE $GSK $RB http://bit.ly/2gOIv8r
1
1",,,1,1,['https://pbs.twimg.com/media/DNJxXOHVoAEZSiS?format=jpg&name=small'],https://twitter.com/MMMnews/status/923926980130721793
5082,Sara Jane Demy,@demy_sara,2017-10-25T14:07:16.000Z,"Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2yK0YJi $MRK #biotech #diabetic 
@Merck","Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2yK0YJi $MRK #biotech #diabetic 
@Merck
1",,,1,,['https://pbs.twimg.com/media/DM_Ts3LVwAAzEUC?format=jpg&name=small'],https://twitter.com/demy_sara/status/923189218490413058
5083,kyookine,@kyookine,2017-10-27T23:07:21.000Z,Merck logs ugliest day in over six years after Q3 revenue miss; shares down 6% https://seekingalpha.com/news/3305367-merck-logs-ugliest-day-six-years-q3-revenue-miss-shares-6-percent?source=tweet‚Ä¶ $MRK,"Merck logs ugliest day in over six years after Q3 revenue miss; shares down 6% https://seekingalpha.com/news/3305367-merck-logs-ugliest-day-six-years-q3-revenue-miss-shares-6-percent?source=tweet‚Ä¶ $MRK
seekingalpha.com
Merck logs ugliest day in over six years after Q3 revenue miss; shares down 6% (NYSE:MRK)
Merck's (MRK -6.3%) Q3 revenue miss, though modest at 2.1%, is weighing on the stock.
1",,,1,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/kyookine/status/924049912144175104
5084,Open Outcrier,@OpenOutcrier,2017-10-27T13:19:43.000Z,"$MRK In a switch, Merck CEO signals he‚Äôs in a deal-making frame of mind - ENDPTS

http://ooc.bz/l/17364","$MRK In a switch, Merck CEO signals he‚Äôs in a deal-making frame of mind - ENDPTS

http://ooc.bz/l/17364
1
2
2",,1,2,2,[],https://twitter.com/OpenOutcrier/status/923902027343769605
5085,Ty,@HCanalyst,2017-10-27T12:01:15.000Z,"Seems that everyone is pushing back trials this quarter $CELG Ozanimod in UC, $ABBV Rova-T, $MRK KN-189, etc","Seems that everyone is pushing back trials this quarter $CELG Ozanimod in UC, $ABBV Rova-T, $MRK KN-189, etc
1",,,,1,[],https://twitter.com/HCanalyst/status/923882281705590784
5086,Jack Allen,@JohnK_Allen,2017-10-27T12:49:12.000Z,"$MRK Keytruda breakdown -55% NSCLC, 20% melanoma, 10% head and neck, 10% bladder, 5% other,I believe this is right but will check transcript","$MRK Keytruda breakdown -55% NSCLC, 20% melanoma, 10% head and neck, 10% bladder, 5% other,I believe this is right but will check transcript
1",,,,1,[],https://twitter.com/JohnK_Allen/status/923894349674565632
5087,Hotpage News,@Hotpage_News,2017-10-27T13:28:18.000Z,STOCKS MAKING MOVES  $MRK $JCP $ABBV $CL $AMZN $GOOGL $ALGN $DECK $WDC $TSLA $HUN $MAT $WYNN $EXPE $INTC $AET $CVS,"STOCKS MAKING MOVES  $MRK $JCP $ABBV $CL $AMZN $GOOGL $ALGN $DECK $WDC $TSLA $HUN $MAT $WYNN $EXPE $INTC $AET $CVS
cnbc.com
Stocks making the biggest moves premarket: MRK, JCP, ABBV, CL, AMZN, GOOGL & more
These are the stocks posting the largest moves before the bell.
1",,,,1,['https://pbs.twimg.com/card_img/1500719368681840640/dWPvJBvb?format=jpg&name=small'],https://twitter.com/Hotpage_News/status/923904188874182656
5088,Jacob Plieth,@JacobPlieth,2017-10-27T12:47:29.000Z,"$MRK noted good survival data in KN-021G despite crossover, but in that case crossover rate was 60-70%","$MRK noted good survival data in KN-021G despite crossover, but in that case crossover rate was 60-70%
Emily
@emilykatehayes
 ¬∑ 27 Oct 2017
Merck call?: Is there a risk of 100% crossover in KEYNOTE 189? Merck says it's important to know value of Keytruda early vs. late.
1
1",,,1,1,['https://pbs.twimg.com/profile_images/888122236434907136/t1Da8F7y_mini.jpg'],https://twitter.com/JacobPlieth/status/923893918235811843
5089,Open Outcrier,@OpenOutcrier,2017-10-27T12:30:06.000Z,"$MRK (-0.5% pre) Merck Swings to 3Q Loss on Big Charge but Raises Forecast - US News

http://ooc.bz/l/17350","$MRK (-0.5% pre) Merck Swings to 3Q Loss on Big Charge but Raises Forecast - US News

http://ooc.bz/l/17350
1
1",,,1,1,[],https://twitter.com/OpenOutcrier/status/923889541668392961
5090,Java Diva,@diva_java,2017-10-25T20:42:01.000Z,"Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2yJKm4t $MRK #biotech #diabetic 
@Merck","Merck pays $760M to buy into KalVista drug for diabetic eye disease https://buff.ly/2yJKm4t $MRK #biotech #diabetic 
@Merck
1",,,1,,['https://pbs.twimg.com/media/DNAuDXKWkAI6YhM?format=jpg&name=small'],https://twitter.com/diva_java/status/923288562644242434
5091,Melissa Lee,@MelissaLeeCNBC,2017-10-27T11:40:23.000Z,$MRK $BMY,"$MRK $BMY
Brad Loncar
@bradloncar
 ¬∑ 27 Oct 2017
Keytruda vs Opdivo sales
2
3",,2,,3,"['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg', 'https://pbs.twimg.com/media/DNJEhfXUQAAtCL1?format=jpg&name=small']",https://twitter.com/MelissaLeeCNBC/status/923877031082938368
5092,Gillian Rich,@GillianRich_,2017-10-26T16:19:06.000Z,Friday's #investing action plan features 3 Dow stocks http://ow.ly/PwLk30g9jLs $XOM $CVX $MRK,"Friday's #investing action plan features 3 Dow stocks http://ow.ly/PwLk30g9jLs $XOM $CVX $MRK
investors.com
Dow's Exxon Mobil, Chevron, Merck Earnings Lead Friday's Investing Action Plan | Stock News & Stock...
Earnings from Exxon Mobil, Chevron, Merck and AbbVie are expected before the market opens Friday.
1
2",,,1,2,['https://pbs.twimg.com/card_img/1500573530982813698/IUi2E6OS?format=jpg&name=small'],https://twitter.com/GillianRich_/status/923584783564800000
5093,Antonio Costa,@ACInvestorBlog,2017-10-27T08:42:10.000Z,Companies reporting earnings b4 the open $XOM $CVX $MRK $ABBV $CL $PSX $COL $COG $TRU $GT,"Companies reporting earnings b4 the open $XOM $CVX $MRK $ABBV $CL $PSX $COL $COG $TRU $GT
2",,,,2,[],https://twitter.com/ACInvestorBlog/status/923832182635974656
5094,The Fly,@theflynews,2017-10-27T13:44:03.000Z,On The Fly: Pre-market Movers $AMZN $ABBV $GOOG $GOOGL $MSFT $ALGN $COG $SYK $INTC $GILD $MRK $CVX $EXPE $XOM $GT‚Ä¶,"On The Fly: Pre-market Movers $AMZN $ABBV $GOOG $GOOGL $MSFT $ALGN $COG $SYK $INTC $GILD $MRK $CVX $EXPE $XOM $GT‚Ä¶
thefly.com
On The Fly: Pre-market Movers
UP AFTER EARNINGS: Amazon... AMZN, ABBV, GOOG, GOOGL, MSFT, ALGN, COG, SYK, INTC, GILD, MRK, CVX, EXPE, XOM, GT, JCP
1",,,,1,['https://pbs.twimg.com/card_img/1501512941245726722/XKsmyV75?format=jpg&name=small'],https://twitter.com/theflynews/status/923908152784863232
5095,FirstWord Pharma,@fwpharma,2017-10-27T11:07:44.000Z,Merck & Co. raises annual guidance as Keytruda sales pass $1 billion in third quarter https://firstwordpharma.com/node/1517315 $MRK,"Merck & Co. raises annual guidance as Keytruda sales pass $1 billion in third quarter https://firstwordpharma.com/node/1517315 $MRK
old.firstwordpharma.com
Merck & Co. raises annual guidance as Keytruda sales pass $1 billion in third quarter
Merck & Co. announced Friday that third-quarter sales of Keytruda surged 194 percent year-over-year to $1 billion, broadly in line with analyst expectations, with the company noting that the product...
1",,,1,,['https://pbs.twimg.com/card_img/1501945360222019595/MaHaAd3b?format=jpg&name=240x240'],https://twitter.com/fwpharma/status/923868812272984064
5096,Ozgur Ogut,@Ogut_Ozgur,2017-10-26T19:04:45.000Z,"7 Enrolled, 3 responses, 2 Not Evaluable at ASCO. Either the NE became responses, or they‚Äôre insane. $INCY $MRK","7 Enrolled, 3 responses, 2 Not Evaluable at ASCO. Either the NE became responses, or they‚Äôre insane. $INCY $MRK
Dr. Paul DeSantis, PharmD
@DrPaulyDeSantis
 ¬∑ 26 Oct 2017
$INCY $MRK 2nd Phase 3 1L NSCLC PDL1 >50% PD1 vs PD1 + IDO https://clinicaltrials.gov/ct2/show/NCT03322540?term=INCB024360&lupd_s=10%2F12%2F2017&lupd_d=14‚Ä¶
1
2",,1,,2,['https://pbs.twimg.com/profile_images/1457582344005513217/hpfLYXJ-_mini.jpg'],https://twitter.com/Ogut_Ozgur/status/923626472417329152
5097,David Crow,@bydavidcrow,2017-10-27T20:32:15.000Z,Wonder if Merck knew about withdrawal when they did the call this morning... $MRK,"Wonder if Merck knew about withdrawal when they did the call this morning... $MRK
1",,,,1,[],https://twitter.com/bydavidcrow/status/924010877325594631
5098,SharpShooter,@SharpShooter090,2017-10-25T20:30:14.000Z,"Replying to 
@pennystocksusa","Replying to 
@pennystocksusa
$ONCS he did say they are working with $MRK. that's a big plus
1
1",,1,,1,[],https://twitter.com/SharpShooter090/status/923285594851151873
5099,Chameleon,@MarketChmln,2017-10-26T20:36:08.000Z,Largest $Notional Sell On Close Order Imbalances $MRK $GPN $HPQ $LLL $FDX $RTN $UNP $EMN $HON $CNC http://tinyurl.com/y8jo8mjb,Largest $Notional Sell On Close Order Imbalances $MRK $GPN $HPQ $LLL $FDX $RTN $UNP $EMN $HON $CNC http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/923649467475210240
5100,Roy Friedman,@DewDiligence,2017-10-27T20:44:44.000Z,"Replying to 
@bradloncar","Replying to 
@bradloncar
Did news leak? Between 6% loss in reg trading session & 3% loss in AH, $MRK -10% vs Thursday close. Worst day for MRK since Vioxx?
1
1
1",,1,1,1,[],https://twitter.com/DewDiligence/status/924014020008513536
5101,dough,@semodough,2017-10-27T20:59:00.000Z,$MRK sorry for first line lung CANCER patients EU Imho KEYTRUDA clearly works&worjs well unfortunate for them  ultimately will get approved,"$MRK sorry for first line lung CANCER patients EU Imho KEYTRUDA clearly works&worjs well unfortunate for them  ultimately will get approved
Andy Biotech
@AndyBiotech
 ¬∑ 28 Oct 2017
$MRK Keytruda+chemo combo marks 2nd time EMA CHMP held a tougher standard for I/O than FDA after $BMY Opdivo in HCC
https://twitter.com/AndyBiotech/status/911334550118260747‚Ä¶
1",,1,,,['https://pbs.twimg.com/profile_images/378800000074240482/d961ebeb9f4fe6b084a68663b9a36738_mini.png'],https://twitter.com/semodough/status/924017612559970304
5102,Earnings News,@EPSGUID,2017-10-26T18:32:16.000Z,"Options are priced for bigger-than-average #earnings move for $MRK reporting 10/27/2017 via 
@eWhispers
 #volatility http://eps.sh/s/mrk","Options are priced for bigger-than-average #earnings move for $MRK reporting 10/27/2017 via 
@eWhispers
 #volatility http://eps.sh/s/mrk",,,,,[],https://twitter.com/EPSGUID/status/923618296834019328
5103,Sarah Owermohle,@owermohle,2017-10-27T12:05:01.000Z,$MRK took a big revenue miss on Gardasil and Zepatier but came in better than expected on Remicade and the Animal Health unit,$MRK took a big revenue miss on Gardasil and Zepatier but came in better than expected on Remicade and the Animal Health unit,,,,,[],https://twitter.com/owermohle/status/923883229991587840
5104,Adam Feuerstein,@adamfeuerstein,2017-10-27T21:20:07.000Z,"Replying to 
@MaverickNY
 and 
@AndyBiotech","Replying to 
@MaverickNY
 and 
@AndyBiotech
No, $MRK knew, decided not to say anything this morning, then changed its mind and announced tonight. See my prior tweet.
2
1
4",,2,1,4,[],https://twitter.com/adamfeuerstein/status/924022925178671107
5105,D,@d_voted_1,2017-10-27T19:35:29.000Z,"Replying to 
@semodough","Replying to 
@semodough
After $MRK scrapped its bone drug Odanacatib, why wouldnt it go after $RDUS? Small transactions adds up. #ideas. Stop the $SHPG rumor! TY D!
2
4",,2,,4,[],https://twitter.com/d_voted_1/status/923996593325457408
5106,Ethan Allen,@ethanallen2013,2017-10-27T21:00:04.000Z,"@DrPaulyDeSantis
 After the EMEA debacle & earnings today, does $MRK jump into M&A full throttle. Thinking $INCY might be the one. Thoughts?","@DrPaulyDeSantis
 After the EMEA debacle & earnings today, does $MRK jump into M&A full throttle. Thinking $INCY might be the one. Thoughts?
2",,,,2,[],https://twitter.com/ethanallen2013/status/924017880840245248
5107,Matthew Herper,@matthewherper,2017-10-25T20:18:46.000Z,Trip down memory lane: one of my favorite stories when $PFE's CETP inhibitor failed. $AMGN $MRK,"Trip down memory lane: one of my favorite stories when $PFE's CETP inhibitor failed. $AMGN $MRK
1",,1,,,[],https://twitter.com/matthewherper/status/923282709702725632
5108,Estimize,@Estimize,2017-10-27T10:50:15.000Z,$MRK beats the Estimize EPS Consensus by 6c and misses the Estimize Revenue Consensus by $204.22M - http://estimize.com/mrk/fq3-2017?utm_content=beat_or_miss&utm_medium=tweet&utm_source=twitter‚Ä¶,$MRK beats the Estimize EPS Consensus by 6c and misses the Estimize Revenue Consensus by $204.22M - http://estimize.com/mrk/fq3-2017?utm_content=beat_or_miss&utm_medium=tweet&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/Estimize/status/923864412070600704
5109,Estimize,@Estimize,2017-10-27T10:50:15.000Z,Well done Analyst_8245669 beating 30 other analysts and the Wall Street Consensus to take the win for $MRK - http://estimize.com/mrk/fq3-2017?utm_content=release_winner&utm_medium=tweet&utm_source=twitter‚Ä¶,Well done Analyst_8245669 beating 30 other analysts and the Wall Street Consensus to take the win for $MRK - http://estimize.com/mrk/fq3-2017?utm_content=release_winner&utm_medium=tweet&utm_source=twitter‚Ä¶,,,,,[],https://twitter.com/Estimize/status/923864413987377152
5110,"Jordan Alexander (,)",@JD4for4,2017-10-27T13:58:02.000Z,"Replying to 
@sharkbiotech","Replying to 
@sharkbiotech
$IBB weakness due to big cap $CELG $GILD $MRK weakness, but should lead to much more M&A of small caps!  $DVAX $SGMO $TGTX $TRIL $LPTX
1",üìú üìú,,,1,[],https://twitter.com/JD4for4/status/923911671013310464
5111,Sarah Owermohle,@owermohle,2017-10-27T12:24:42.000Z,"Echoing $GILD's troubles, $MRK expects significant pressure in hep C/Zepatier in Q4 and 2018. Gilead story here: 

http://bit.ly/2yPAUgI","Echoing $GILD's troubles, $MRK expects significant pressure in hep C/Zepatier in Q4 and 2018. Gilead story here: 

http://bit.ly/2yPAUgI
1",,1,,,[],https://twitter.com/owermohle/status/923888182038532096
5112,Sally Church,@MaverickNY,2017-10-25T15:44:06.000Z,"Replying to 
@Frank_S_David
, 
@adamfeuerstein
 and 
@bradloncar","Replying to 
@Frank_S_David
, 
@adamfeuerstein
 and 
@bradloncar
Finally, there is a matter of pride - not everyone want to go to $BMY $MRK $AZN $PFE and beg to do a joint study, it‚Äôs considered unseemly
1",,,,1,[],https://twitter.com/MaverickNY/status/923213586612260866
5113,Briefing.com,@Briefingcom,2017-10-27T22:23:12.000Z,$MRK: Merck withdrew its European application for KEYTRUDA (pembrolizumab) in combination with pemetrexed and... http://bit.ly/2ljVfFo,"$MRK: Merck withdrew its European application for KEYTRUDA (pembrolizumab) in combination with pemetrexed and... http://bit.ly/2ljVfFo
1",,,,1,[],https://twitter.com/Briefingcom/status/924038799859990530
5114,Sicarius,@is_matrix,2017-10-30T13:29:31.000Z,$MRK shareholder...,"$MRK shareholder...
4
10",üòç üòç üòç üòç,,4,10,['https://pbs.twimg.com/media/DNY6_6mVAAAlQBO?format=jpg&name=small'],https://twitter.com/is_matrix/status/924991657031995392
5115,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-10-30T18:30:30.000Z,IO Monthly IMS Sales Figures: $MRK catching $BMY rapidly $AZN and $PFE far far behind...,"IO Monthly IMS Sales Figures: $MRK catching $BMY rapidly $AZN and $PFE far far behind...
2
12
12",,2,12,12,['https://pbs.twimg.com/media/DNZ_4zsVwAAR8sT?format=jpg&name=small'],https://twitter.com/DrPaulyDeSantis/status/925067401351249920
5116,Reuters Business,@ReutersBiz,2017-10-30T17:20:04.000Z,Cancer-drug setback sends Merck shares down again http://reut.rs/2zQxiIo $MRK,"Cancer-drug setback sends Merck shares down again http://reut.rs/2zQxiIo $MRK
1
5
2",,1,5,2,['https://pbs.twimg.com/media/DNZvx-MW0AAsrbW?format=jpg&name=small'],https://twitter.com/ReutersBiz/status/925049679989133312
5117,Evaluate Vantage,@evaluatevantage,2017-10-30T11:33:05.000Z,Vantage Snippet - Second Keytruda delay ‚Äì embarrassment rather than catastrophe? $MRK,"Vantage Snippet - Second Keytruda delay ‚Äì embarrassment rather than catastrophe? $MRK
1
7
3",,1,7,3,['https://pbs.twimg.com/media/DNYgAP7WAAEbHTP?format=jpg&name=small'],https://twitter.com/evaluatevantage/status/924962358581252096
5118,Yahoo Finance,@YahooFinance,2017-10-30T20:04:38.000Z,"LIVE: Today's losers $S $MRK $GM
WATCH: https://yhoo.it/2yZibwW","LIVE: Today's losers $S $MRK $GM
WATCH: https://yhoo.it/2yZibwW
1
2
2",,1,2,2,"['https://pbs.twimg.com/media/DNaVRE1VQAA-D7A?format=jpg&name=small', 'https://pbs.twimg.com/media/DNaVUzPVAAAqmlV?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DNaVUzOVoAExpli?format=jpg&name=360x360']",https://twitter.com/YahooFinance/status/925091093070467074
5119,Hotpage News,@Hotpage_News,2017-10-30T13:29:45.000Z,STOCKS MAKING MOVES PREMARKET:  $LEN $AAPL $STRA $DYN $GM $AMD $MRK $HBC $CVS $AET $CVX $STZ $GE $INSY $WFC $AXTA -,"STOCKS MAKING MOVES PREMARKET:  $LEN $AAPL $STRA $DYN $GM $AMD $MRK $HBC $CVS $AET $CVX $STZ $GE $INSY $WFC $AXTA -
cnbc.com
Stocks making the biggest moves premarket: LEN, AAPL, STRA, DYN, GM, AMD & more
These are the stocks posting the largest moves before the bell.
1",,,,1,['https://pbs.twimg.com/card_img/1499462359651340290/krO2nyPp?format=jpg&name=small'],https://twitter.com/Hotpage_News/status/924991718369452038
5120,Breaking News,@MarketCurrents,2017-10-30T12:26:26.000Z,Merck down 5% premarket on withdrawal of European marketing application for Keytruda in NSCLC https://seekingalpha.com/news/3305544-merck-5-percent-premarket-withdrawal-european-marketing-application-keytruda-nsclc?source=feed_f‚Ä¶ #premarket $MRK,"Merck down 5% premarket on withdrawal of European marketing application for Keytruda in NSCLC https://seekingalpha.com/news/3305544-merck-5-percent-premarket-withdrawal-european-marketing-application-keytruda-nsclc?source=feed_f‚Ä¶ #premarket $MRK
1",,,1,,[],https://twitter.com/MarketCurrents/status/924975783625482242
5121,Open Outcrier,@OpenOutcrier,2017-10-30T13:15:13.000Z,$MRK (-3% pre) weak after withdrawing European Keytruda app http://ooc.bz/l/17376,$MRK (-3% pre) weak after withdrawing European Keytruda app http://ooc.bz/l/17376,,,,,[],https://twitter.com/OpenOutcrier/status/924988061288751104
5122,Lewis Krauskopf,@LKrauskopf,2017-10-30T16:48:53.000Z,"Cancer-drug setback sends Merck shares down again https://reut.rs/2yYX6CK $MRK down 11% over past two days, worst two-day swoon in 8+ years","Cancer-drug setback sends Merck shares down again https://reut.rs/2yYX6CK $MRK down 11% over past two days, worst two-day swoon in 8+ years
reuters.com
Cancer-drug setback sends Merck shares down again
A setback for Merck & Co's key cancer drug sent the drugmaker's stock swooning on Monday for a second straight session, putting the shares on track for their biggest two-day decline in more than...
1",,,,1,['https://pbs.twimg.com/card_img/1501710767304974338/mtGrFVIM?format=jpg&name=small'],https://twitter.com/LKrauskopf/status/925041830772670464
5123,Breaking News,@MarketCurrents,2017-10-30T18:45:44.000Z,Merck begins sale process of consumer unit - FT https://seekingalpha.com/news/3305686-merck-begins-sale-process-consumer-unit-ft?source=feed_f‚Ä¶ $MRK,Merck begins sale process of consumer unit - FT https://seekingalpha.com/news/3305686-merck-begins-sale-process-consumer-unit-ft?source=feed_f‚Ä¶ $MRK,,,,,[],https://twitter.com/MarketCurrents/status/925071235385458688
5124,Equity Clock,@EquityClock,2017-10-30T19:04:16.000Z,"Merck $MRK, a Dow Jones Industrial stock broke more support levels at $$57.30 and $56.60","Merck $MRK, a Dow Jones Industrial stock broke more support levels at $$57.30 and $56.60
1
1",,,1,1,['https://pbs.twimg.com/media/DNaHoR8XcAAOb_J?format=jpg&name=small'],https://twitter.com/EquityClock/status/925075902752489474
5125,Kermit ‚ÄúCOVID/Cancer Scientist & $IONS Investor‚Äù,,2017-10-30T19:23:27.000Z,"$MRK Best Time To Buy Is When There's Blood On The Street 
Merck suffers biggest 2-day selloff since February 2009","$MRK Best Time To Buy Is When There's Blood On The Street 
Merck suffers biggest 2-day selloff since February 2009
marketwatch.com
Merck's stock suffering biggest 2-day selloff since February 2009
Shares of Merck & Co. Inc. undefined tumbled 5.8% in active afternoon trade Monday, putting them on track for a sixth straight loss to a 5 1/2-month low,...
1",üß¨,,,1,['https://pbs.twimg.com/card_img/1500234875353325570/RmEQ0urJ?format=jpg&name=small'],https://twitter.com/BatScientist/status/925080727149932544
5126,4üÖ≥üÜÄ,@4DQuest,2017-10-30T13:02:20.000Z,#TRADING US Pre-Market Movers Gap Up / Down  $CAA $ADMS $SHPG $BABA $AET $SOHU $SHOP $OSTK $RACE $BMY $CELG $GOOGL $AMZN $MRK $LEN $TSLA $GM,"#TRADING US Pre-Market Movers Gap Up / Down  $CAA $ADMS $SHPG $BABA $AET $SOHU $SHOP $OSTK $RACE $BMY $CELG $GOOGL $AMZN $MRK $LEN $TSLA $GM
1",,,,1,['https://pbs.twimg.com/media/DNY0yBgXUAAivk0?format=png&name=small'],https://twitter.com/4DQuest/status/924984818164781056
5127,TeresaTrades,@TeresaTrades,2017-10-30T23:23:03.000Z,$RCII $ABBV $SQ $M $NVDA $AMD $GE $RDC $PFE $ZION $MCEP $HUN $UAA $SBUX $ESIO $MRK - 10/30 Unusual options activity,"$RCII $ABBV $SQ $M $NVDA $AMD $GE $RDC $PFE $ZION $MCEP $HUN $UAA $SBUX $ESIO $MRK - 10/30 Unusual options activity
1",,,,1,['https://pbs.twimg.com/media/DNbC3BtXkAAJQ2T?format=jpg&name=small'],https://twitter.com/TeresaTrades/status/925141026838282240
5128,CarnivoresHealth,@HealthierIT,2017-10-30T20:30:12.000Z,"Petya cyberattack cost Merck $135 million in revenue https://buff.ly/2xzdCIf $MRK #cyberattack 
@Merck","Petya cyberattack cost Merck $135 million in revenue https://buff.ly/2xzdCIf $MRK #cyberattack 
@Merck
1",,,1,,['https://pbs.twimg.com/media/DNabS-wU8AEiWFY?format=jpg&name=small'],https://twitter.com/HealthierIT/status/925097525949890560
5129,Evil Speculator,@evilspeculator,2017-10-29T13:29:45.000Z,Top And Bottom Performing Stocks For Week 44 http://evilspeculator.com/top-and-bottom-performing-stocks-for-week-44-2017/‚Ä¶ $AEM $BMY $CLF $CSCO $CSX $CVA $INTC $KO $MRK $ORCL $PBT $SJT $SPA,"Top And Bottom Performing Stocks For Week 44 http://evilspeculator.com/top-and-bottom-performing-stocks-for-week-44-2017/‚Ä¶ $AEM $BMY $CLF $CSCO $CSX $CVA $INTC $KO $MRK $ORCL $PBT $SJT $SPA
1
1",,,1,1,[],https://twitter.com/evilspeculator/status/924629328327053314
5130,John Carroll,@JohnCendpts,2017-10-29T13:21:35.000Z,#NotPetya attack on $MRK is going to end up costing more than a billion dollars. Puts the fire wall in perspective.,"#NotPetya attack on $MRK is going to end up costing more than a billion dollars. Puts the fire wall in perspective.
endpts.com
Merck‚Äôs bad day: $310M for NotPetya, franchise drugs take a hit and now the EMA pushes back on...
Merck $MRK took a series of hits on Friday, capped by news after the market closed that its European application for its Keytruda/chemo combo for frontline non-small cell lung cancer was being...
1
2
7",,1,2,7,[],https://twitter.com/JohnCendpts/status/924627275286540288
5131,Armando Monsalve,@AJMonsalveR,2017-10-30T17:02:44.000Z,Started red on the day but ended up breakeven. Nice reads on $MRK and $LEN on those stuffs and wash below support. Think I've found my edge.,"Started red on the day but ended up breakeven. Nice reads on $MRK and $LEN on those stuffs and wash below support. Think I've found my edge.
1",,,,1,[],https://twitter.com/AJMonsalveR/status/925045316998631427
5132,Bart,@BartVanTrading,2017-10-30T13:17:32.000Z,watchlist: $ADMS $CTB $MRK $LEN $TWTR $MACK,"watchlist: $ADMS $CTB $MRK $LEN $TWTR $MACK
1",,,,1,[],https://twitter.com/BartVanTrading/status/924988643944665089
5133,Intensity Stock Watch,@IntensityStocks,2017-10-30T13:15:23.000Z,Top Gainers Pre-Mkt: $CAA $ENDP $ADMS $DYN $ANY Losers: $PSTI $HMNY $AMD $MRK $LEN Active: $AMD $AVIR $AAAP $DYN $SPI,"Top Gainers Pre-Mkt: $CAA $ENDP $ADMS $DYN $ANY Losers: $PSTI $HMNY $AMD $MRK $LEN Active: $AMD $AVIR $AAAP $DYN $SPI
1",,,,1,[],https://twitter.com/IntensityStocks/status/924988100668899328
5134,Clark Joseph Kent,@JorelLaraKalel,2017-10-30T13:15:50.000Z,Pre-market movers http://cnb.cx/2ydOTNL  $LEN $AAPL $STRA $DYN $GM $AMD $MRK $CVS $AET $STZ $WFC $GE $NTDOY,"Pre-market movers http://cnb.cx/2ydOTNL  $LEN $AAPL $STRA $DYN $GM $AMD $MRK $CVS $AET $STZ $WFC $GE $NTDOY
1",,,,1,[],https://twitter.com/JorelLaraKalel/status/924988213848166400
5135,MM+M Magazine,@MMMnews,2017-10-30T11:30:01.000Z,Missed Friday's news? Here's what to know #pharma $CVS $AET $AMZN #pharmacy $MRK #CyberSecurity $PFE $GSK $RB #hcsm http://bit.ly/2gOIv8r,"Missed Friday's news? Here's what to know #pharma $CVS $AET $AMZN #pharmacy $MRK #CyberSecurity $PFE $GSK $RB #hcsm http://bit.ly/2gOIv8r
1",,,,1,['https://pbs.twimg.com/media/DNJ1QazW4AEsqi2?format=jpg&name=small'],https://twitter.com/MMMnews/status/924961586988462080
5136,Dominic Chu,@TheDomino,2017-10-30T14:32:15.000Z,"S&P 500 52-wk lows so far today
Advance Auto Parts $AAP
$DISH Network
Macy's $M
Under Armour $UAA
General Electric $GE
Merck $MRK
Etc
@cnbc","S&P 500 52-wk lows so far today
Advance Auto Parts $AAP
$DISH Network
Macy's $M
Under Armour $UAA
General Electric $GE
Merck $MRK
Etc
@cnbc
3
7",,,3,7,[],https://twitter.com/TheDomino/status/925007447357497344
5137,Ken Lloyd,@KenLloyd67,2017-10-30T16:42:29.000Z,"I highly recommend checking this out for finding good stocks to trade http://bit.ly/2yqn9lE
$SID $MOD $MRK","I highly recommend checking this out for finding good stocks to trade http://bit.ly/2yqn9lE
$SID $MOD $MRK
1",,,,1,['https://pbs.twimg.com/media/DNZnLT7UEAEn_Cw?format=jpg&name=small'],https://twitter.com/KenLloyd67/status/925040220541784064
5138,PHILOSOPHY,@WSJticks,2017-10-30T16:18:57.000Z,$mrk at or below $54.41.. = #sell,"$mrk at or below $54.41.. = #sell
1",,,,1,[],https://twitter.com/WSJticks/status/925034299199492096
5139,Intensity Stock Watch,@IntensityStocks,2017-10-30T12:45:25.000Z,Pre-Mkt Top Gainers: $CAA $ADMS $ENDP $DYN $ANY Losers: $PSTI $MRK $AMD $LEN $GM Active: $AMD $AVIR $AAAP $SPI $UGAZ,"Pre-Mkt Top Gainers: $CAA $ADMS $ENDP $DYN $ANY Losers: $PSTI $MRK $AMD $LEN $GM Active: $AMD $AVIR $AAAP $SPI $UGAZ
1",,,,1,[],https://twitter.com/IntensityStocks/status/924980559016628224
5140,stocklock,@zoomlivetrading,2017-10-30T16:12:56.000Z,$MRK puke. Some serious gains here on 2k shares,"$MRK puke. Some serious gains here on 2k shares
1
2",,1,,2,[],https://twitter.com/zoomlivetrading/status/925032782111404033
5141,InTheMoneyStocks.com,@ITMS,2017-10-30T15:55:50.000Z,"Hardcore Analysis On Why These 2 Day Trades Made Members $1,000 In Minutes...  http://bit.ly/2DayTrades  $MRK $AAPL","Hardcore Analysis On Why These 2 Day Trades Made Members $1,000 In Minutes...  http://bit.ly/2DayTrades  $MRK $AAPL
1",,,,1,[],https://twitter.com/ITMS/status/925028480353558531
5142,Justin Pulitzer,@JustinPulitzer,2017-10-30T16:47:57.000Z,As discussed in the Weekend Video‚Ä¶ not sure why $MRK didn‚Äôt give the news on their earnings‚Ä¶ instead thought putting it out Friday was better? Shady dummies IMHO.,"As discussed in the Weekend Video‚Ä¶ not sure why $MRK didn‚Äôt give the news on their earnings‚Ä¶ instead thought putting it out Friday was better? Shady dummies IMHO.
1
4",üçä,1,,4,[],https://twitter.com/JustinPulitzer/status/925041594742517760
5143,Ticker Report,@TickerReport,2017-10-29T14:32:00.000Z,"Merck & Company, Inc. $MRK Updates FY17 Earnings Guidance http://ift.tt/2yVSXli","Merck & Company, Inc. $MRK Updates FY17 Earnings Guidance http://ift.tt/2yVSXli
1",,,,1,[],https://twitter.com/TickerReport/status/924644995851841536
5144,c lark,@7LadyQ,2017-10-30T13:17:03.000Z,Pre-market movers http://cnbc.com/2017/10/30/stocks-‚Ä¶... $LEN $AAPL $STRA $DYN $GM $AMD $MRK $CVS $AET $STZ $WFC $GE $NTDOY,"Pre-market movers http://cnbc.com/2017/10/30/stocks-‚Ä¶... $LEN $AAPL $STRA $DYN $GM $AMD $MRK $CVS $AET $STZ $WFC $GE $NTDOY
1",,,,1,[],https://twitter.com/7LadyQ/status/924988522108542976
5145,Bio Stocks‚Ñ¢,@BioStocks,2017-10-30T09:53:01.000Z,$MRK downgraded to Hold from Buy at SunTrust. PT $54 from $73,"$MRK downgraded to Hold from Buy at SunTrust. PT $54 from $73
1",,,1,,[],https://twitter.com/BioStocks/status/924937174692200448
5146,Mr Connected,@SellSideSource,2017-10-30T11:12:23.000Z,$MRK downgraded at Morgan Stanley Suntrust and Barclays this morning.,"$MRK downgraded at Morgan Stanley Suntrust and Barclays this morning.
1",,,1,,[],https://twitter.com/SellSideSource/status/924957149448503298
5147,Meg Tirrell,@megtirrell,2017-10-30T17:32:06.000Z,"Umer on 
@PowerLunch
 right now talking $MRK, biopharma performance","Umer on 
@PowerLunch
 right now talking $MRK, biopharma performance
5",,,,5,['https://pbs.twimg.com/media/DNZyiMrXUAE4V_x?format=jpg&name=small'],https://twitter.com/megtirrell/status/925052707861385217
5148,Jim Sultan,@sultanofstocks,2017-10-30T16:35:57.000Z,".
@petenajarian
 - $MRK at 16 month low. #Merck has traded 50 MIL shares last day and a half v. normal 10 million shares a day. Bought today.",".
@petenajarian
 - $MRK at 16 month low. #Merck has traded 50 MIL shares last day and a half v. normal 10 million shares a day. Bought today.
Pete Najarian
@petenajarian
 ¬∑ 30 Oct 2017
Long term hold, not added yet https://twitter.com/bostonshane666/status/924992919077052416‚Ä¶
1",,,,1,['https://pbs.twimg.com/profile_images/846471207348137984/JLF7SMhN_mini.jpg'],https://twitter.com/sultanofstocks/status/925038576349405184
5149,Odi Bruckman,@odibro,2017-10-30T09:14:36.000Z,$MRK downgraded to Equal Weight from Overweight at Barclays. PT $62 from $72,"$MRK downgraded to Equal Weight from Overweight at Barclays. PT $62 from $72
4",,,,4,[],https://twitter.com/odibro/status/924927505273847809
5150,Spartan,@SpartanTrading,2017-10-30T13:17:40.000Z,pre market tickers on watch $CAA $ENDP $ADMS $CTB $DYN $MRK,"pre market tickers on watch $CAA $ENDP $ADMS $CTB $DYN $MRK
3",,,,3,[],https://twitter.com/SpartanTrading/status/924988677872271360
5151,avidresearch,@avidresearch,2017-10-30T12:53:16.000Z,$MRK $CELG trip from 52 week highs to lows didn‚Äôt take that long,"$MRK $CELG trip from 52 week highs to lows didn‚Äôt take that long
2",,,,2,[],https://twitter.com/avidresearch/status/924982537193246720
5152,Marc Harper,@MarcHarper8472,2017-10-30T21:31:25.000Z,"I highly recommend trying this out for discovering great stocks to trade http://bit.ly/2w7Kmrk
$NAV $MOD $MRK","I highly recommend trying this out for discovering great stocks to trade http://bit.ly/2w7Kmrk
$NAV $MOD $MRK
1",,,,1,['https://pbs.twimg.com/media/DNapTtFVAAAzUAe?format=jpg&name=small'],https://twitter.com/MarcHarper8472/status/925112933146914817
5153,Bio Stocks‚Ñ¢,@BioStocks,2017-10-30T09:39:24.000Z,$MRK downgraded to Equal-weight from Overweight at Barclays. PT $62 from $72,"$MRK downgraded to Equal-weight from Overweight at Barclays. PT $62 from $72
1
1",,,1,1,[],https://twitter.com/BioStocks/status/924933748025540608
5154,Michelle Fay Cortez,@FayCortez,2017-10-30T14:53:02.000Z,So Merck is Mystic-sizing its Keytruda trial? Overall survival is back! $MRK $AZN,"So Merck is Mystic-sizing its Keytruda trial? Overall survival is back! $MRK $AZN
1
1",,,1,1,[],https://twitter.com/FayCortez/status/925012676060893184
5155,SIAnalystWire,@AnalystWire,2017-10-30T09:26:08.000Z,SunTrust Robinson Humphrey Downgrades Merck $MRK to Hold,"SunTrust Robinson Humphrey Downgrades Merck $MRK to Hold
streetinsider.com
SunTrust Robinson Humphrey Downgrades Merck (MRK) to Hold
SunTrust Robinson Humphrey downgraded Merck (NYSE: MRK) from Buy to Hold with a price target of $54.00 (from $73.00).Analyst John Boris adjusts his model to account for Keytruda...
1",,,,1,[],https://twitter.com/AnalystWire/status/924930406843117568
5156,Brad Loncar,@bradloncar,2017-10-30T17:36:29.000Z,Umer left out an entire angle that's really important....competition. Delay doesn't just set back $MRK but gives others like Roche a window.,"Umer left out an entire angle that's really important....competition. Delay doesn't just set back $MRK but gives others like Roche a window.
2
2
7",,2,2,7,[],https://twitter.com/bradloncar/status/925053807570116608
5157,Home Day Trading,@HomeDayTrading,2017-10-30T13:05:22.000Z,"Acciones activas lunes 30 de octubre 2017 
$AAPL $BABA $FB $SYN $MRK $BP $GM $AAAP $ADMS $ENDP $LEN
Mas... http://fb.me/AozpnUP8","Acciones activas lunes 30 de octubre 2017 
$AAPL $BABA $FB $SYN $MRK $BP $GM $AAAP $ADMS $ENDP $LEN
Mas... http://fb.me/AozpnUP8
1",,,,1,[],https://twitter.com/HomeDayTrading/status/924985579095379968
5158,John Beagle,@johnbeagle,2017-10-30T15:18:11.000Z,Picked up $MRK @$55/sh adding The 10.5 percent two-day decline for Merck shares is an overreaction over-correction buying opp.,"Picked up $MRK @$55/sh adding The 10.5 percent two-day decline for Merck shares is an overreaction over-correction buying opp.
1",,,,1,[],https://twitter.com/johnbeagle/status/925019005710143488
5159,Sean McGrath,@sean_uk,2017-10-30T20:03:36.000Z,"Keytruda sales forecasts take a hit after Merck's 'awkward' EU app withdrawal http://fiercepharma.com/pharma/analysts-slash-merck-targets-after-awkward-eu-keytruda-combo-withdrawal‚Ä¶ A disaster, or merely a delay? $MRK","Keytruda sales forecasts take a hit after Merck's 'awkward' EU app withdrawal http://fiercepharma.com/pharma/analysts-slash-merck-targets-after-awkward-eu-keytruda-combo-withdrawal‚Ä¶ A disaster, or merely a delay? $MRK
fiercepharma.com
Keytruda sales forecasts take a hit after Merck's 'awkward' EU app withdrawal
Merck & Co. | Merck & Co. surprised investors and analysts Friday with news that it had pulled its European application for a new Keytruda combo in non-small cell lung cancer. They haven‚Äôt taken it...
1",,,,1,['https://pbs.twimg.com/card_img/1501993601659637760/feR-tX97?format=jpg&name=small'],https://twitter.com/sean_uk/status/925090830641180674
5160,"H. Jack West, MD",@JackWestMD,2017-10-28T15:53:42.000Z,Either bec $MRK knows their ph3 data will weaken case for immunoRx or EMA has indicated ph2 KN-21G trial w/N of 123 pts will be insufficient,"Either bec $MRK knows their ph3 data will weaken case for immunoRx or EMA has indicated ph2 KN-21G trial w/N of 123 pts will be insufficient
Adam Feuerstein
@adamfeuerstein
 ¬∑ 28 Oct 2017
Why did $MRK release bad news on withdrawing KN-021 EMA filing tonight, instead of mentioning it on this morning‚Äôs call? Merck spox:
2",,,,2,"['https://pbs.twimg.com/profile_images/1387730248394059779/dhhPgaLD_mini.jpg', 'https://pbs.twimg.com/media/DNLHHTMUMAAfhzR?format=jpg&name=small']",https://twitter.com/JackWestMD/status/924303169240354816
5161,"Trade Ideas, LLC",@TradeIdeas,2017-10-30T13:37:59.000Z,"More certain than a 3-2 lead in the WS, Or indictment outcomes: $AAAP $ADMS $AMD $CAA $CENX $GM $GT $HMNY $MRK","More certain than a 3-2 lead in the WS, Or indictment outcomes: $AAAP $ADMS $AMD $CAA $CENX $GM $GT $HMNY $MRK
stocktwits.com
Dave Mabe (@davemabe) | Stocktwits
Here's my watchlist for the day: $AAAP, $ADMS, $AMD, $CAA, $CENX, $GM, $GT, $HMNY, $MRK powered by @TradeIdeas1 @TradeIdeas
1
2",,,1,2,['https://pbs.twimg.com/card_img/1499660898155347972/UNHdU749?format=png&name=240x240'],https://twitter.com/TradeIdeas/status/924993787243397120
5162,Ian Tobin,@iangtobin,2017-10-28T13:56:44.000Z,That almost looks like a a Legacy Pharma sales effort getting into its rhythm at $MRK,"That almost looks like a a Legacy Pharma sales effort getting into its rhythm at $MRK
Brad Loncar
@bradloncar
 ¬∑ 27 Oct 2017
Keytruda vs Opdivo sales",,,,,"['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg', 'https://pbs.twimg.com/media/DNJEhfXUQAAtCL1?format=jpg&name=small']",https://twitter.com/iangtobin/status/924273731794378752
5163,MedicalQuack,@MedicalQuack,2017-10-28T00:36:48.000Z,"RT 
@kyookine
: Merck logs ugliest day in over six years after Q3 revenue miss; shares down 6% https://seekingalpha.com/news/3305367-merck-logs-ugliest-day-six-years-q3-revenue-miss-shares-6-percent?source=tweet‚Ä¶ $MRK","RT 
@kyookine
: Merck logs ugliest day in over six years after Q3 revenue miss; shares down 6% https://seekingalpha.com/news/3305367-merck-logs-ugliest-day-six-years-q3-revenue-miss-shares-6-percent?source=tweet‚Ä¶ $MRK
seekingalpha.com
Merck logs ugliest day in over six years after Q3 revenue miss; shares down 6% (NYSE:MRK)
Merck's (MRK -6.3%) Q3 revenue miss, though modest at 2.1%, is weighing on the stock.",,,,,['https://pbs.twimg.com/card_img/1479966849626480640/cLosLnr_?format=png&name=240x240'],https://twitter.com/MedicalQuack/status/924072422088654848
5164,Chameleon,@MarketChmln,2017-10-30T20:46:12.000Z,Largest $Notional Buy On Close Order Imbalances $MS $LOW $HUM $MRK $VZ $PM $GE $CCI $PSX $EOG http://tinyurl.com/y8jo8mjb,Largest $Notional Buy On Close Order Imbalances $MS $LOW $HUM $MRK $VZ $PM $GE $CCI $PSX $EOG http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/925101553270378496
5165,Justin Pulitzer,@JustinPulitzer,2017-10-29T06:30:25.000Z,"√Ä La Carte - Weekend Review VIDEO 10/29: https://vimeo.com/ondemand/jptrades/240336332‚Ä¶

$VIX $FXE $UUP $GLD $TLT $HYG $CL_F $XLE $XOM $FXI $BABA $BIDU $IBB $CELG $GILD $GSK $MRK $BMY $PFE $IYT $HG_F $XLF $JPM $SPY $IWM $QQQ $AAPL $AMZN $GOOGL $MSFT $FB $EXPE $PCLN $NFLX $TSLA $CMG $BWLD $FSLR $AVGO","√Ä La Carte - Weekend Review VIDEO 10/29: https://vimeo.com/ondemand/jptrades/240336332‚Ä¶

$VIX $FXE $UUP $GLD $TLT $HYG $CL_F $XLE $XOM $FXI $BABA $BIDU $IBB $CELG $GILD $GSK $MRK $BMY $PFE $IYT $HG_F $XLF $JPM $SPY $IWM $QQQ $AAPL $AMZN $GOOGL $MSFT $FB $EXPE $PCLN $NFLX $TSLA $CMG $BWLD $FSLR $AVGO
vimeo.com
Watch Justin Pulitzer Trades Online | Vimeo On Demand
Monthly Subscribers have access to ALL of my Weekend Review, Mid Week Review & Special Edition Videos for $69.99/mo. New Subscribers have a 5 day trial period‚Ä¶
2
3",üçä,,2,3,['https://pbs.twimg.com/card_img/1501306835760001034/z0pNC36o?format=jpg&name=360x360'],https://twitter.com/JustinPulitzer/status/924523798627606529
5166,Carly Helfand,@CarlyHFierce,2017-10-30T16:35:11.000Z,Keytruda sales forecasts take a hit after Merck's 'awkward' EU app withdrawal: http://bit.ly/2gWNvYt $MRK #pharma,"Keytruda sales forecasts take a hit after Merck's 'awkward' EU app withdrawal: http://bit.ly/2gWNvYt $MRK #pharma
fiercepharma.com
Keytruda sales forecasts take a hit after Merck's 'awkward' EU app withdrawal
Merck & Co. | Merck & Co. surprised investors and analysts Friday with news that it had pulled its European application for a new Keytruda combo in non-small cell lung cancer. They haven‚Äôt taken it...",,,,,['https://pbs.twimg.com/card_img/1501993601659637760/feR-tX97?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/925038381268168706
5167,SwingTradeBot,@SwingTradeBot,2017-10-28T09:30:30.000Z,"$MRK technical alerts: Expansion Breakdown, Lower Bollinger Band Walk, New Downtrend, Wide Range B...","$MRK technical alerts: Expansion Breakdown, Lower Bollinger Band Walk, New Downtrend, Wide Range B...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/924206731453960192
5168,The Fly,@theflynews,2017-10-30T16:35:03.000Z,On The Fly: Top stock stories at midday $LEN $CAA $VST $DYN $AAAP $NVS $MRK $ADMS $ENDP $AMD,"On The Fly: Top stock stories at midday $LEN $CAA $VST $DYN $AAAP $NVS $MRK $ADMS $ENDP $AMD
thefly.com
On The Fly: Top stock stories at midday
The S&P opened in neg... LEN, CAA, VST, DYN, AAAP, NVS, MRK, ADMS, ENDP, AMD",,,,,['https://pbs.twimg.com/card_img/1501514587010650114/lIQrNwpv?format=jpg&name=small'],https://twitter.com/theflynews/status/925038350183972865
5169,24/7 Wall St.,@247WallSt,2017-10-30T13:17:41.000Z,Monday's Top Analyst Upgrades & Downgrades $AMD $CVX $GM $INTC $MRK $NOK $UAA $UA,"Monday's Top Analyst Upgrades & Downgrades $AMD $CVX $GM $INTC $MRK $NOK $UAA $UA
247wallst.com
Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More
The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under Armour.",,,,,['https://pbs.twimg.com/card_img/1499663127130091521/NOlVeNVt?format=jpg&name=240x240'],https://twitter.com/247WallSt/status/924988678929297410
5170,Benzinga,@Benzinga,2017-10-30T12:35:01.000Z,30 Stocks Moving In Monday's Pre-Market Session https://benzinga.com/z/10246939 $AVIR $MICT $ADMS $DO $CAA $MACK $SPWR $ACHC $JCP $MRK $UAA $AMD $M,"30 Stocks Moving In Monday's Pre-Market Session https://benzinga.com/z/10246939 $AVIR $MICT $ADMS $DO $CAA $MACK $SPWR $ACHC $JCP $MRK $UAA $AMD $M
benzinga.com
30 Stocks Moving In Monday's Pre-Market Session
Gainers Aviragen Therapeutics Inc (NASDAQ: AVIR) shares rose 60.3 percent to $1.330 in pre-market trading. Aviragen Therapeutics and Vaxart entered into a merger agreement...
1
1",,,1,1,['https://pbs.twimg.com/card_img/1499224544283877377/6ijvwYCi?format=png&name=240x240'],https://twitter.com/Benzinga/status/924977941766950912
5171,Streetinsider.com,@Street_Insider,2017-10-30T10:23:09.000Z,Merck $MRK down 5% after it withdraws European Application for KEYTRUDA for NSCLS,"Merck $MRK down 5% after it withdraws European Application for KEYTRUDA for NSCLS
streetinsider.com
Merck (MRK) Withdraws European Application for KEYTRUDA in Combination with Pemetrexed and Carbop...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it has withdrawn its European application for KEYTRUDA√Ç¬Æ (pembrolizumab) in combination with pemetrexed...
1",,,1,,[],https://twitter.com/Street_Insider/status/924944757327122433
5172,Aniu Student,@AniuStudent,2017-10-30T13:51:44.000Z,"Replying to 
@neddyj0608","Replying to 
@neddyj0608
#Zetia is part of the combo&trio (w/ low dose aspirin still needed in the quartet), so $MRK has always been the logical $ESPR partner to me.
2",,,,2,[],https://twitter.com/AniuStudent/status/924997250803208192
5173,DrStrangeLove,@Tauschhandel,2017-10-30T20:20:21.000Z,"Replying to 
@WavePattTraders","Replying to 
@WavePattTraders
You really targeting $40 for $MRK, is this a real money trade?",,,,,[],https://twitter.com/Tauschhandel/status/925095046566817794
5174,Sports_Bios,@Sports_bios,2017-10-30T11:40:44.000Z,"Replying to 
@semodough","Replying to 
@semodough
At least they get the drug thru, a lot more than $MRK can say.. Ha!
1",,,,1,[],https://twitter.com/Sports_bios/status/924964282772664320
5175,Benzinga,@Benzinga,2017-10-30T17:20:01.000Z,35 Stocks Moving In Monday's Mid-Day Session https://benzinga.com/z/10249218 $SPCB $CPLA $MICT $ADMS $TRXC $AAAP $ICON $GRVY $PSTI $MRK $JCP $AMD $M,35 Stocks Moving In Monday's Mid-Day Session https://benzinga.com/z/10249218 $SPCB $CPLA $MICT $ADMS $TRXC $AAAP $ICON $GRVY $PSTI $MRK $JCP $AMD $M,,,,,[],https://twitter.com/Benzinga/status/925049666743418880
5176,Barron's,@barronsonline,2017-10-30T16:14:53.000Z,Why What's Bad for Merck Is Good For Bristol-Myers http://on.barrons.com/2yXDx04 $MRK $BMY,"Why What's Bad for Merck Is Good For Bristol-Myers http://on.barrons.com/2yXDx04 $MRK $BMY
barrons.com
Why What‚Äôs Bad for Merck Is Good For Bristol-Myers
With a Merck cancer drug application in Europe on hold, shares are tumbling as analysts cut estimates.",,,,,['https://pbs.twimg.com/card_img/1499836900466913280/5wZQQtvn?format=jpg&name=small'],https://twitter.com/barronsonline/status/925033274807914496
5177,David Grainger,@sciencescanner,2017-10-30T17:39:23.000Z,"Replying to 
@bradloncar","Replying to 
@bradloncar
Recent data may suggest $MRK lead is diminished, as $BMS suffered before it, but doesn‚Äôt fundamentally change global I/O potential
1",,,,1,[],https://twitter.com/sciencescanner/status/925054538037460994
5178,TalkMarkets,@TalkMarkets,2017-10-30T17:49:47.000Z,Bristol-Myers Rises After #Merck Pulls Cancer Drug Combo Filing In Europe $BMY Also $MRK $PFE $RHHBY https://goo.gl/QzG2GK,Bristol-Myers Rises After #Merck Pulls Cancer Drug Combo Filing In Europe $BMY Also $MRK $PFE $RHHBY https://goo.gl/QzG2GK,,,,,[],https://twitter.com/TalkMarkets/status/925057158512865280
5179,Andy Biotech,@AndyBiotech,2017-11-02T13:11:10.000Z,"$MRK US Product Portfolio took 9.6% list price increase --> 5.5% net price gain, which is about ~$1 billion easy peasy free growth","$MRK US Product Portfolio took 9.6% list price increase --> 5.5% net price gain, which is about ~$1 billion easy peasy free growth
1
12
17",,1,12,17,['https://pbs.twimg.com/media/DNoTkZzXcAEsACm?format=jpg&name=small'],https://twitter.com/AndyBiotech/status/926074202997784576
5180,dough,@semodough,2017-11-01T10:06:19.000Z,$PRTK  for SALE.  $AGN $MRK These Pharma Executives Are Showing Their Cards - Bloomberg Gadfly https://bloomberg.com/gadfly/amp/articles/2017-10-27/pharma-takeover-target-paratek-is-being-too-obvious‚Ä¶,"$PRTK  for SALE.  $AGN $MRK These Pharma Executives Are Showing Their Cards - Bloomberg Gadfly https://bloomberg.com/gadfly/amp/articles/2017-10-27/pharma-takeover-target-paratek-is-being-too-obvious‚Ä¶
2
6
10",,2,6,10,[],https://twitter.com/semodough/status/925665298518282240
5181,Seeking Alpha,@SeekingAlpha,2017-11-02T08:01:18.000Z,https://seekingalpha.com/article/4119430-microsoft-apple-visa-top-gain-safer-dividend-dow-dogs-per-broker-october-estimates?source=feed_f‚Ä¶ $AAPL #APPLE $CSCO $DIS $IBM $INTC $JNJ $MCD $MMM $MRK $MSFT $PFE $PG $UNH $UTX $V $XOM,"https://seekingalpha.com/article/4119430-microsoft-apple-visa-top-gain-safer-dividend-dow-dogs-per-broker-october-estimates?source=feed_f‚Ä¶ $AAPL #APPLE $CSCO $DIS $IBM $INTC $JNJ $MCD $MMM $MRK $MSFT $PFE $PG $UNH $UTX $V $XOM
1",,,1,,[],https://twitter.com/SeekingAlpha/status/925996222669668352
5182,Eti,@Eti8888,2017-10-31T03:54:18.000Z,"Biotech Forum: Why M&A Will Pick Up In 2018 https://seekingalpha.com/article/4118103?source=ansh‚Ä¶ $ABBV, $AMGN, $CELG, $GILD, $KITE, $MRK could impact $NWBO  eventually","Biotech Forum: Why M&A Will Pick Up In 2018 https://seekingalpha.com/article/4118103?source=ansh‚Ä¶ $ABBV, $AMGN, $CELG, $GILD, $KITE, $MRK could impact $NWBO  eventually
1
2",,,1,2,[],https://twitter.com/Eti8888/status/925209286447456256
5183,Seeking Alpha,@SeekingAlpha,2017-11-01T11:18:11.000Z,https://seekingalpha.com/article/4118958-buying-merck-52-week-lows?source=feed_f‚Ä¶ $BMY $CELG $GILD $RHHBY $MRK,"https://seekingalpha.com/article/4118958-buying-merck-52-week-lows?source=feed_f‚Ä¶ $BMY $CELG $GILD $RHHBY $MRK
seekingalpha.com
I'm Buying Merck At 52-Week Lows (NYSE:MRK)
It's rare to find high quality names like Merck trading at 52-week lows. Down double digits last week alone, I added to my position.",,,,,[],https://twitter.com/SeekingAlpha/status/925683384495382528
5184,Dana Lyons,@JLyonsFundMgmt,2017-11-02T13:22:06.000Z,Merck $MRK Testing Post-2009 Up Trendline #TrendlineWednesday,"Merck $MRK Testing Post-2009 Up Trendline #TrendlineWednesday
1
3",,,1,3,['https://pbs.twimg.com/media/DNoWFICX0AAX92s?format=jpg&name=small'],https://twitter.com/JLyonsFundMgmt/status/926076953320415233
5185,Lance Roberts,@LanceRoberts,2017-11-01T14:00:05.000Z,"Do you own one of these companies: $PEP, $KO, $G, $BBY, $MRK, $GE? They've all checked into the ""Roach Motel"" https://realinvestmentadvice.com/the-roach-motel/‚Ä¶","Do you own one of these companies: $PEP, $KO, $G, $BBY, $MRK, $GE? They've all checked into the ""Roach Motel"" https://realinvestmentadvice.com/the-roach-motel/‚Ä¶
1
5
5",,1,5,5,['https://pbs.twimg.com/media/DNiolTwVoAA2vHH?format=jpg&name=small'],https://twitter.com/LanceRoberts/status/925724124348956673
5186,Stocktwits,@Stocktwits,2017-10-31T12:44:02.000Z,"The 5 WORST Dow stocks of the year

$GE -35%
$VZ -10%
$IBM -9.4%
$DIS -8.7%
$MRK -7.7%","The 5 WORST Dow stocks of the year

$GE -35%
$VZ -10%
$IBM -9.4%
$DIS -8.7%
$MRK -7.7%
stocktwits.com
Suri Duddella (@suriNotes) | Stocktwits
$STUDY Dow30 YTD%, Top Performing Stocks: $BA $CAT $AAPL, Worst performing stocks: $GE $VZ $IBM
4
18
16",,4,18,16,['https://pbs.twimg.com/card_img/1501527625344323584/AqixgPFK?format=png&name=small'],https://twitter.com/Stocktwits/status/925342601838055428
5187,Vista Partners LLC,@VistaPResearch,2017-10-31T22:10:11.000Z,A Progressive Week for #BreastCancer Focused #Biotech Atossa Genetics $ATOS   http://vistapglobal.com/2017/10/progressive-week-breast-cancer-focused-biotech-atossa-genetics-atos/‚Ä¶ $IBB $MRK $PFE #TuesdayMotivation,"A Progressive Week for #BreastCancer Focused #Biotech Atossa Genetics $ATOS   http://vistapglobal.com/2017/10/progressive-week-breast-cancer-focused-biotech-atossa-genetics-atos/‚Ä¶ $IBB $MRK $PFE #TuesdayMotivation
GIF
1
2",,,1,2,['https://pbs.twimg.com/tweet_video_thumb/DNf7wxHVoAA1gIv.jpg'],https://twitter.com/VistaPResearch/status/925485075285684224
5188,Alex,@pablodesaavedra,2017-10-31T17:53:56.000Z,"Oncosec Monotherapy and Combination Therapy Studies with ImmunoPulse¬Æ IL-12 at the #SITC 
$oncs $mrk O35 & P524 https://sitcancer.org/2017/abstracts/titles/late-breaking‚Ä¶","Oncosec Monotherapy and Combination Therapy Studies with ImmunoPulse¬Æ IL-12 at the #SITC 
$oncs $mrk O35 & P524 https://sitcancer.org/2017/abstracts/titles/late-breaking‚Ä¶
1
4",,,1,4,[],https://twitter.com/pablodesaavedra/status/925420587668959232
5189,ICEMAN,@IcemanTrading,2017-10-31T10:26:11.000Z,"$MRK u/g Hold @ Jefferies $55
$ADRO int @ Oppenheimer $15
$HRTX int @ Oppenheimer $27
$JUNO pt > 59 @ Citi 
$EXAS pt > $54 @ Stephens","$MRK u/g Hold @ Jefferies $55
$ADRO int @ Oppenheimer $15
$HRTX int @ Oppenheimer $27
$JUNO pt > 59 @ Citi 
$EXAS pt > $54 @ Stephens
2
3",,,2,3,['https://pbs.twimg.com/media/DNdaoC2VoAAWDUt?format=jpg&name=small'],https://twitter.com/IcemanTrading/status/925307908115623936
5190,Limex,@LimexMe,2017-11-02T18:26:37.000Z,"Merck: A Slow And Steady Dividend Grower, But Do Better Alternatives Exist? $MRK $PFE $JNJ More on WhoTrades","Merck: A Slow And Steady Dividend Grower, But Do Better Alternatives Exist? $MRK $PFE $JNJ More on WhoTrades
1",,,,1,['https://pbs.twimg.com/media/DNpbyCeW4AAQEkE?format=jpg&name=small'],https://twitter.com/LimexMe/status/926153591374655488
5191,Chelli Miller,@cmiller1225,2017-11-02T21:05:02.000Z,"Petya cyberattack cost Merck $135 million in revenue https://buff.ly/2A4q0kZ $MRK #cyberattack 
@Merck","Petya cyberattack cost Merck $135 million in revenue https://buff.ly/2A4q0kZ $MRK #cyberattack 
@Merck
3",,,3,,['https://pbs.twimg.com/media/DNqACXRVQAAn-cO?format=jpg&name=small'],https://twitter.com/cmiller1225/status/926193454820020224
5192,Jesse Colombo,@TheBubbleBubble,2017-11-01T14:46:44.000Z,"Do you own $PEP, $KO, $G, $BBY, $MRK, or $GE? They've all checked into the ""Roach Motel"": https://realinvestmentadvice.com/the-roach-motel/‚Ä¶ by 
@michaellebowitz","Do you own $PEP, $KO, $G, $BBY, $MRK, or $GE? They've all checked into the ""Roach Motel"": https://realinvestmentadvice.com/the-roach-motel/‚Ä¶ by 
@michaellebowitz
1
6
6",,1,6,6,['https://pbs.twimg.com/media/DNjfvVwWsAAMPPg?format=jpg&name=small'],https://twitter.com/TheBubbleBubble/status/925735864331841536
5193,Jonathan Faison,@jfais20,2017-11-01T05:14:33.000Z,Interesting case study for $PBMD IMP321 + $MRK's Keytruda,"Interesting case study for $PBMD IMP321 + $MRK's Keytruda
1
1",,1,,1,['https://pbs.twimg.com/media/DNhc2dcWAAAVB5E?format=jpg&name=small'],https://twitter.com/jfais20/status/925591873011535873
5194,Veteran Market Timer,@3Xtraders,2017-11-02T20:12:56.000Z,"I was a little early on this one, but it's the bulls who got it wrong. $MRK breaks support, gives back all the gains for the year. lol","I was a little early on this one, but it's the bulls who got it wrong. $MRK breaks support, gives back all the gains for the year. lol
1",,1,,,['https://pbs.twimg.com/media/DNpz_vQW0AAroZC?format=jpg&name=small'],https://twitter.com/3Xtraders/status/926180344142934016
5195,Maria Chaudhry,@mchaudhry82,2017-10-31T18:18:30.000Z,"Upgrades, Downgrades, Initiations & More: $MSFT $zbra $mrk $COG $payc $wday $CRM $VYGR $swch $UAA $LYB $baba $EXAS #StayGreen ","Upgrades, Downgrades, Initiations & More: $MSFT $zbra $mrk $COG $payc $wday $CRM $VYGR $swch $UAA $LYB $baba $EXAS #StayGreen ",‚ò∫ üòò,,,,['https://pbs.twimg.com/media/DNfGYZOUMAAyy-G?format=jpg&name=small'],https://twitter.com/mchaudhry82/status/925426770022715399
5196,biogemfinder,@biogemfinder,2017-10-31T16:37:42.000Z,Other likely bidders for $EXEL are $BMY $MRK $GILD $RHHB $PFE Either way within next 6-12 months exel will be bought for 50-70 a share. $IBB,"Other likely bidders for $EXEL are $BMY $MRK $GILD $RHHB $PFE Either way within next 6-12 months exel will be bought for 50-70 a share. $IBB
1",,,1,,[],https://twitter.com/biogemfinder/status/925401404470059008
5197,Trade Academy,@TradeAcademyCo,2017-10-31T13:05:27.000Z,10/31 52-Week Lo Watch List: $BBBY $CMG $KHC $K $DBVT $MDLZ $MRK $T $SCO $GE $AXON $VIPS $M $GGP $AAP $QID $SQQQ $TEVA $SHLD $COTY #trading,"10/31 52-Week Lo Watch List: $BBBY $CMG $KHC $K $DBVT $MDLZ $MRK $T $SCO $GE $AXON $VIPS $M $GGP $AAP $QID $SQQQ $TEVA $SHLD $COTY #trading
1",,,,1,[],https://twitter.com/TradeAcademyCo/status/925347991023771649
5198,Kylan Hodson{Heavily Redacted},@KylanHodson,2017-11-01T02:11:07.000Z,$MRK unusual buyer of Jan 57.5 strike calls hitting the ask with about 200K right before the closing bell. Looking for more unusual,"$MRK unusual buyer of Jan 57.5 strike calls hitting the ask with about 200K right before the closing bell. Looking for more unusual
1",üî• üçí,,,1,[],https://twitter.com/KylanHodson/status/925545707649449984
5199,SIAnalystWire,@AnalystWire,2017-10-31T07:51:24.000Z,Jefferies Upgrades Merck $MRK to Hold,"Jefferies Upgrades Merck $MRK to Hold
streetinsider.com
Jefferies Upgrades Merck (MRK) to Hold
Jefferies upgraded Merck (NYSE: MRK) from Underperform to Hold with a price target of $55.00 (from $54.00).Analyst Jeffery Holford believes the sharp move lower recently has removed much of the...
1",,,,1,[],https://twitter.com/AnalystWire/status/925268955450761216
5200,Jared Wesley,@ScalpMaster1,2017-11-01T14:28:14.000Z,$MRK watch for a move higher here,"$MRK watch for a move higher here
1
2",,,1,2,[],https://twitter.com/ScalpMaster1/status/925731209384284160
5201,CNBC's Closing Bell,@CNBCClosingBell,2017-10-31T20:01:46.000Z,"Closing out the month, worst Dow stocks in October:
$GE down 16.63%
$MRK down 14.01%
$PG down 5.11%
$VZ down 3.27%
$PFE down 1.79%","Closing out the month, worst Dow stocks in October:
$GE down 16.63%
$MRK down 14.01%
$PG down 5.11%
$VZ down 3.27%
$PFE down 1.79%
1
2",,,1,2,[],https://twitter.com/CNBCClosingBell/status/925452760643928066
5202,BioPharmaDevice,@OneMedWorld,2017-11-02T14:40:03.000Z,"Petya cyberattack cost Merck $135 million in revenue https://buff.ly/2A6uGHg $MRK #cyberattack 
@Merck","Petya cyberattack cost Merck $135 million in revenue https://buff.ly/2A6uGHg $MRK #cyberattack 
@Merck",,,,,['https://pbs.twimg.com/media/DNon7H7XkAAgdxh?format=jpg&name=small'],https://twitter.com/OneMedWorld/status/926096573070761984
5203,Tim,@tstamm7002,2017-10-31T14:50:17.000Z,"& just like $GILD, $MRK will need to make a panic buy to add immediate revenue.  Who will it be?","& just like $GILD, $MRK will need to make a panic buy to add immediate revenue.  Who will it be?
Tim
@tstamm7002
 ¬∑ 31 Oct 2017
$ABBV‚Äôs Mavyret will pressure $GILD but it could wipe out $MRK‚Äôs Zepatier‚Ä¶  just Zepatier wiped out $ABBV‚Äôs Viekira.  payback‚Äôs a bitch",,,,,['https://pbs.twimg.com/profile_images/1498445865803030528/L6fhgqL0_mini.jpg'],https://twitter.com/tstamm7002/status/925374373422301184
5204,Jon Ogg,@jonogg,2017-10-31T13:13:57.000Z,"#investing #daytrading 
Tuesday Top Analyst Upgrades & Downgrades 
$AXTA $BIDU $CY $MRK $MSFT $SWCH","#investing #daytrading 
Tuesday Top Analyst Upgrades & Downgrades 
$AXTA $BIDU $CY $MRK $MSFT $SWCH
247wallst.com
Top Analyst Upgrades and Downgrades: Axalta, Baidu, Cypress Semi, Merck, Microsoft, Switch and More
The include Axalta, Baidu, Cypress Semi, Merck, Microsoft, Switch top analyst upgrades, downgrades and other research calls from Tuesday.",,,,,['https://pbs.twimg.com/card_img/1500008865206652933/APQiMH5r?format=jpg&name=240x240'],https://twitter.com/jonogg/status/925350128860454913
5205,Chameleon Options,@MC_OptionTrades,2017-11-01T22:51:34.000Z,Price Returns vs Expected Daily Move $AGN $ABBV $VRX $TEVA $BMY $PFE $MRK $GILD $CELG $REGN $INCY $CYH http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $AGN $ABBV $VRX $TEVA $BMY $PFE $MRK $GILD $CELG $REGN $INCY $CYH http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DNlO1S_WkAAe4L7?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/925857878594015232
5206,Barron's,@barronsonline,2017-10-31T19:08:09.000Z,"Big Pharma: Win Some, Lose Some http://on.barrons.com/2z1E5lP $MRK $PFE","Big Pharma: Win Some, Lose Some http://on.barrons.com/2z1E5lP $MRK $PFE
1
1",,,1,1,[],https://twitter.com/barronsonline/status/925439267459010560
5207,TalkMarkets,@TalkMarkets,2017-11-02T15:52:19.000Z,"#Sanofi Q3 #Earnings In Line, Sales Lag, Diabetes Weak $SNY Also $MRK $REGN $AMGN https://goo.gl/rhCJG7","#Sanofi Q3 #Earnings In Line, Sales Lag, Diabetes Weak $SNY Also $MRK $REGN $AMGN https://goo.gl/rhCJG7",,,,,[],https://twitter.com/TalkMarkets/status/926114758679519232
5208,David Crow,@bydavidcrow,2017-10-31T14:26:14.000Z,"Lots of variability in immuno-oncology, says Pfizer CEO. Have to wait for readout on trials before deciding what to do. $PFE $BMY $MRK $AZN","Lots of variability in immuno-oncology, says Pfizer CEO. Have to wait for readout on trials before deciding what to do. $PFE $BMY $MRK $AZN
1
2",,1,,2,[],https://twitter.com/bydavidcrow/status/925368319477239808
5209,MarketBeat,@MarketBeatCom,2017-11-02T07:39:41.000Z,Research Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2iUeXH0 #acn,Research Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2iUeXH0 #acn,,,,,[],https://twitter.com/MarketBeatCom/status/925990782049406976
5210,MarketBeat,@MarketBeatCom,2017-11-01T09:21:29.000Z,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2z3FqWB $MRK #MRK,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2z3FqWB $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/925654014469033984
5211,Daily Political,@dailypoliticaln,2017-11-02T08:38:20.000Z,"Trillium Asset Management LLC Buys 6,376 Shares of Merck & Company, Inc. $MRK http://ift.tt/2z722Fy","Trillium Asset Management LLC Buys 6,376 Shares of Merck & Company, Inc. $MRK http://ift.tt/2z722Fy",,,,,[],https://twitter.com/dailypoliticaln/status/926005544867057670
5212,marketexclusive,@marketexclusive,2017-11-01T10:26:33.000Z,Analyst Activity ‚Äì Berenberg Bank Reiterates Hold on Merck & Company (NYSE:MRK) https://marketexclusive.com/analyst-activity-berenberg-bank-reiterates-hold-on-merck-company-nysemrk/2017/11/‚Ä¶ $MRK,"Analyst Activity ‚Äì Berenberg Bank Reiterates Hold on Merck & Company (NYSE:MRK) https://marketexclusive.com/analyst-activity-berenberg-bank-reiterates-hold-on-merck-company-nysemrk/2017/11/‚Ä¶ $MRK
marketexclusive.com
Analyst Activity ‚Äì Berenberg Bank Reiterates Hold on Merck & Company (NYSE:MRK) - Market Exclusive
Analyst Ratings For Merck & Company (NYSE:MRK) Today, Berenberg Bank reiterated its Hold rating on Merck & Company (NYSE:MRK). There are 1 sell rating, 10 hold ratings, 7 buy ratings on the stock....",,,,,[],https://twitter.com/marketexclusive/status/925670388763209728
5213,US Banking News,@AmericanBanking,2017-11-01T10:27:28.000Z,Merck & Company's hold rating reiterated at Berenberg Bank. http://ift.tt/2lC15Cd $MRK #MRK,Merck & Company's hold rating reiterated at Berenberg Bank. http://ift.tt/2lC15Cd $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/925670621203304448
5214,Host_Master_Guardian,@imtiaz_gold,2017-11-02T13:03:14.000Z,$MRK $CDNS $INTC $RCL $BBBB $MSG $FNLC $SVU $COBZ $PPS $INTU $WINA $NUGT Charts Posted.  90 days FREE. https://buff.ly/2A3WR9x,$MRK $CDNS $INTC $RCL $BBBB $MSG $FNLC $SVU $COBZ $PPS $INTU $WINA $NUGT Charts Posted.  90 days FREE. https://buff.ly/2A3WR9x,,,,,[],https://twitter.com/imtiaz_gold/status/926072207700320256
5215,Stockflare US Page,@StockflareUS,2017-10-31T09:39:18.000Z,"$MRK: Merck & Co., Inc.'s price is -14.6% but the forecast earnings moved 0.0% over the last month. (https://stockflare.com/stock/MRK)","$MRK: Merck & Co., Inc.'s price is -14.6% but the forecast earnings moved 0.0% over the last month. (https://stockflare.com/stock/MRK)",,,,,[],https://twitter.com/StockflareUS/status/925296110268309504
5216,TalkMarkets,@TalkMarkets,2017-10-31T08:07:50.000Z,"#Merck: A Slow And Steady #Dividend Grower, But Do Better Alternatives Exist? $MRK Also $JNJ $PFE https://goo.gl/yZSBk3","#Merck: A Slow And Steady #Dividend Grower, But Do Better Alternatives Exist? $MRK Also $JNJ $PFE https://goo.gl/yZSBk3",,,,,[],https://twitter.com/TalkMarkets/status/925273093198753792
5217,Optionsonar,@Optionsonar1,2017-11-02T17:30:46.000Z,"Big bullish unusual option activity detected: $NYLDA, $JUNO, $AAPL, $BABA - big bearish: $C, $MRK, $CBS, $TEVA","Big bullish unusual option activity detected: $NYLDA, $JUNO, $AAPL, $BABA - big bearish: $C, $MRK, $CBS, $TEVA",,,,,[],https://twitter.com/Optionsonar1/status/926139536098447361
5218,Jon Ogg,@jonogg,2017-10-31T16:35:56.000Z,"Feels like more drug price negotiation pressure, societal overhang (opioids), and political risk ahead to weigh further on Drug/Bio stocks. In last week:
$AMGN -3%
$BIIB -4%
$CELG -17%
$GILD -5%
$MRK -13%
$PFE -3%","Feels like more drug price negotiation pressure, societal overhang (opioids), and political risk ahead to weigh further on Drug/Bio stocks. In last week:
$AMGN -3%
$BIIB -4%
$CELG -17%
$GILD -5%
$MRK -13%
$PFE -3%
1
1",,,1,1,[],https://twitter.com/jonogg/status/925400960326930432
5219,bake mcbride,@ITRADEVOL,2017-10-31T18:00:23.000Z,Selling Naked Puts 2 Improve Portfolio Performance $TRXC $MSFT $S $ABEV $GRPN $CZR $MRK $NOK $SWN $ITUN $CTL $JD $FB https://marketchameleon.com/Blog/post/2017/10/09/selling-naked-puts-to-improve-portfolio-performance‚Ä¶,Selling Naked Puts 2 Improve Portfolio Performance $TRXC $MSFT $S $ABEV $GRPN $CZR $MRK $NOK $SWN $ITUN $CTL $JD $FB https://marketchameleon.com/Blog/post/2017/10/09/selling-naked-puts-to-improve-portfolio-performance‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/925422213880336384
5220,Watchlist News,@WatchlistN,2017-11-02T22:38:16.000Z,"Merck & Company, Inc. $MRK Lowered to ‚ÄúUnderperform‚Äù at Jefferies Group LLC http://ift.tt/2zr2Tnz","Merck & Company, Inc. $MRK Lowered to ‚ÄúUnderperform‚Äù at Jefferies Group LLC http://ift.tt/2zr2Tnz",,,,,[],https://twitter.com/WatchlistN/status/926216918482214912
5221,Watchlist News,@WatchlistN,2017-11-02T08:38:35.000Z,"Premier Asset Management LLC Decreases Position in Merck & Company, Inc. $MRK http://ift.tt/2h5UlLw","Premier Asset Management LLC Decreases Position in Merck & Company, Inc. $MRK http://ift.tt/2h5UlLw",,,,,[],https://twitter.com/WatchlistN/status/926005607743873024
5222,Watchlist News,@WatchlistN,2017-11-02T05:43:10.000Z,"Merck & Company, Inc. $MRK Given a $70.00 Price Target by J P Morgan Chase & Co Analysts http://ift.tt/2hyDlL0","Merck & Company, Inc. $MRK Given a $70.00 Price Target by J P Morgan Chase & Co Analysts http://ift.tt/2hyDlL0",,,,,[],https://twitter.com/WatchlistN/status/925961461356224512
5223,Chameleon Options,@MC_OptionTrades,2017-10-31T04:25:24.000Z,$MRK 03-Nov-17 ATM Implied Vol Increases +77.5%. Straddle Implies a Move of ¬±2.7% http://tinyurl.com/yczj7dce,$MRK 03-Nov-17 ATM Implied Vol Increases +77.5%. Straddle Implies a Move of ¬±2.7% http://tinyurl.com/yczj7dce,ü¶é,,,,[],https://twitter.com/MC_OptionTrades/status/925217113308106752
5224,Chuck Carnevale,@MarketsUpChuck,2017-11-02T14:03:55.000Z,"$TRV $MRK $AXP $GE $PFE $JPM
Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶","$TRV $MRK $AXP $GE $PFE $JPM
Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶",,,,,[],https://twitter.com/MarketsUpChuck/status/926087477202432000
5225,US Banking News,@AmericanBanking,2017-11-02T07:38:05.000Z,$MRK - Research Analysts' Weekly Ratings Changes for Merck & #MRK https://goo.gl/fb/aKgNEd,$MRK - Research Analysts' Weekly Ratings Changes for Merck & #MRK https://goo.gl/fb/aKgNEd,,,,,[],https://twitter.com/AmericanBanking/status/925990381388554240
5226,MarketBeat,@MarketBeatCom,2017-11-01T08:39:20.000Z,"Merck & Company, Inc. $MRK Holdings Trimmed by Accredited Investors Inc. http://ift.tt/2huIrHQ","Merck & Company, Inc. $MRK Holdings Trimmed by Accredited Investors Inc. http://ift.tt/2huIrHQ",,,,,[],https://twitter.com/MarketBeatCom/status/925643407099383808
5227,Investing.com Stocks,@InvestingStockz,2017-10-31T17:23:20.000Z,Edited Transcript of $MRK earnings conference call or presentation 27-Oct-17 12:00pm GMT - https://invst.ly/5n42m,Edited Transcript of $MRK earnings conference call or presentation 27-Oct-17 12:00pm GMT - https://invst.ly/5n42m,,,,,[],https://twitter.com/InvestingStockz/status/925412887467880449
5228,Sarah Owermohle,@owermohle,2017-10-31T14:10:47.000Z,"What happens next for $MRK's lung cancer goals depends in no small part on data from $BMY, $AZN and $ROG

http://bit.ly/2h0bEO9","What happens next for $MRK's lung cancer goals depends in no small part on data from $BMY, $AZN and $ROG

http://bit.ly/2h0bEO9",,,,,['https://pbs.twimg.com/media/DNeN8kLWsAA7zu7?format=jpg&name=small'],https://twitter.com/owermohle/status/925364432531845121
5229,FiercePharma,@FiercePharma,2017-11-01T15:26:41.000Z,"$MRK borrows Gardasil doses from CDC stockpile due to hack, hitting Q3 sales","$MRK borrows Gardasil doses from CDC stockpile due to hack, hitting Q3 sales
fiercepharma.com
Hack forces Merck to borrow Gardasil doses from CDC stockpile, slamming Q3 sales
Working to recover from a damaging cyberattack, Merck reported that its star HPV vaccine miss | Working to recover from a damaging cyberattack, Merck reported that its star HPV vaccine missed sales...",,,,,['https://pbs.twimg.com/card_img/1499864326366244866/ISe0Glh8?format=jpg&name=small'],https://twitter.com/FiercePharma/status/925745921543024640
5230,24/7 Wall St.,@247WallSt,2017-10-31T13:16:54.000Z,Tuesday Top Analyst Upgrades & Downgrades $AXTA $BIDU $CY $MRK $MSFT $SWCH,"Tuesday Top Analyst Upgrades & Downgrades $AXTA $BIDU $CY $MRK $MSFT $SWCH
247wallst.com
Top Analyst Upgrades and Downgrades: Axalta, Baidu, Cypress Semi, Merck, Microsoft, Switch and More
The include Axalta, Baidu, Cypress Semi, Merck, Microsoft, Switch top analyst upgrades, downgrades and other research calls from Tuesday.",,,,,['https://pbs.twimg.com/card_img/1500008865206652933/APQiMH5r?format=jpg&name=240x240'],https://twitter.com/247WallSt/status/925350871365509121
5231,avidresearch,@avidresearch,2017-10-31T04:55:21.000Z,"$MRK while delayed till early 2019 could still stop early 
@interim
 analysis in 2018","$MRK while delayed till early 2019 could still stop early 
@interim
 analysis in 2018
Brad Loncar
@bradloncar
 ¬∑ 28 Oct 2017
Flashback to this morning: the change $MRK made to KEYNOTE-189.
Show this thread",,,,,"['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg', 'https://pbs.twimg.com/media/DNK-twsUQAANthm?format=jpg&name=900x900']",https://twitter.com/avidresearch/status/925224653819346944
5232,John Vandermosten,@vanjohn10,2017-11-02T15:10:31.000Z,$HTBX $SCLP $CKPT $ONC $RXII $MRK $BMY $GILD $NVS See our discussion of trends in the cancer immunotherapy space: https://youtube.com/watch?v=acKPtGd2bbA‚Ä¶,$HTBX $SCLP $CKPT $ONC $RXII $MRK $BMY $GILD $NVS See our discussion of trends in the cancer immunotherapy space: https://youtube.com/watch?v=acKPtGd2bbA‚Ä¶,,,,,[],https://twitter.com/vanjohn10/status/926104237473435649
5233,US Banking News,@AmericanBanking,2017-11-02T07:43:45.000Z,Research Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2hwZCsz,Research Analysts‚Äô Weekly Ratings Changes for Merck & $MRK http://ift.tt/2hwZCsz,,,,,[],https://twitter.com/AmericanBanking/status/925991804792696832
5234,Bursatil Biotech,@BursatilBiotech,2017-11-04T11:09:10.000Z,"Withing the next 3 years, 7 US Patent from Large Pharma within oncology's field will expire. Including Rituxan from $RHHBY (2018)
$MRK $JNJ","Withing the next 3 years, 7 US Patent from Large Pharma within oncology's field will expire. Including Rituxan from $RHHBY (2018)
$MRK $JNJ
2
7
6",,2,7,6,['https://pbs.twimg.com/media/DNyKSJ7V4AALJyO?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/926768277329608706
5235,Drugdoctor1,@Drugdoctor2014,2017-11-03T01:59:39.000Z,"$ICNB.0063  HUGE REVENUE increase NEWS 
 $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS","$ICNB.0063  HUGE REVENUE increase NEWS 
 $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
1
2",,,1,2,['https://pbs.twimg.com/media/DNrDdk6VAAEu2SA?format=jpg&name=small'],https://twitter.com/Drugdoctor2014/status/926267597355651072
5236,Dana Lyons,@JLyonsFundMgmt,2017-11-04T13:14:43.000Z,Merck $MRK Testing Post-2009 Up Trendline,"Merck $MRK Testing Post-2009 Up Trendline
2
4",,,2,4,['https://pbs.twimg.com/media/DNynkeBUEAA2mSl?format=jpg&name=small'],https://twitter.com/JLyonsFundMgmt/status/926799871754977282
5237,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-11-04T22:36:43.000Z,LAG-3 ranks #1 then TIGIT #2 as most promising Checkpoint Inh's after PD1/L1 $BMY $PBMD $MRK $ROG $NVS,"LAG-3 ranks #1 then TIGIT #2 as most promising Checkpoint Inh's after PD1/L1 $BMY $PBMD $MRK $ROG $NVS
1
1
3",,1,1,3,['https://pbs.twimg.com/media/DN0oMM3VoAASaUv?format=jpg&name=medium'],https://twitter.com/DrPaulyDeSantis/status/926941304814157824
5238,Bursatil Biotech,@BursatilBiotech,2017-11-04T19:42:05.000Z,"Total US Patent Expiries from 2017-2026
$PFE $BAYN $NVS $JNJ $ABBV $MRK $LLY $BMY","Total US Patent Expiries from 2017-2026
$PFE $BAYN $NVS $JNJ $ABBV $MRK $LLY $BMY
1
1
2",,1,1,2,['https://pbs.twimg.com/media/DNz_9emW0AEmnEF?format=jpg&name=small'],https://twitter.com/BursatilBiotech/status/926897355328245763
5239,max pain,@optioncharts,2017-11-03T16:29:00.000Z,$MRK open interest for maturity 11/10/2017. High put=60.00 High call=64.50 #maxpain #options http://bit.ly/2irRsRQ,$MRK open interest for maturity 11/10/2017. High put=60.00 High call=64.50 #maxpain #options http://bit.ly/2irRsRQ,,,,,['https://pbs.twimg.com/media/DNuKc1CX4AIg3I0?format=jpg&name=small'],https://twitter.com/optioncharts/status/926486378216554497
5240,Limex,@LimexMe,2017-11-03T20:22:14.000Z,Top Analyst Upgrades and Downgrades: $AMD $CVX $GM $INTC $MRK $NOK $UA $UAA,Top Analyst Upgrades and Downgrades: $AMD $CVX $GM $INTC $MRK $NOK $UA $UAA,,,,,['https://pbs.twimg.com/media/DNu_1MjUMAAeVk2?format=jpg&name=small'],https://twitter.com/LimexMe/status/926545071796838402
5241,suriNotes,@surinotes,2017-11-03T16:58:32.000Z,$MRK 2nd Target zone in Rect. channel break down,$MRK 2nd Target zone in Rect. channel break down,,,,,['https://pbs.twimg.com/media/DNuRNbQV4AALcgN?format=jpg&name=small'],https://twitter.com/surinotes/status/926493810472910848
5242,tradewithjoe,@tradewithjoe,2017-11-05T15:03:34.000Z,Bracket trade. Can go long stock with stop below 54.50 $MRK,Bracket trade. Can go long stock with stop below 54.50 $MRK,,,,,['https://pbs.twimg.com/media/DN4KEwIWsAEX33U?format=jpg&name=small'],https://twitter.com/tradewithjoe/status/927189651839954944
5243,George Marcovits,@GemsBot,2017-11-04T15:56:57.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,,,,,['https://pbs.twimg.com/media/DNzMtEOX0AACASM?format=jpg&name=small'],https://twitter.com/GemsBot/status/926840700896989184
5244,Drugdoctor1,@Drugdoctor2014,2017-11-05T17:14:40.000Z,$ICNB.0074-Red-hot CHART-More NEWS This Wk! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO,"$ICNB.0074-Red-hot CHART-More NEWS This Wk! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO
1",,,,1,"['https://pbs.twimg.com/media/DN4n9uTUIAECbFL?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DN4oBQvVwAA1p9J?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DN4oBQzVoAIxhmk?format=jpg&name=360x360']",https://twitter.com/Drugdoctor2014/status/927222646671994880
5245,Kylan Hodson{Heavily Redacted},@KylanHodson,2017-11-04T22:21:33.000Z,$MRK they're back for more! Now unusual buyer of the Nov 17th 57.5 strike calls for 100K.... 15 times OI expansion,"$MRK they're back for more! Now unusual buyer of the Nov 17th 57.5 strike calls for 100K.... 15 times OI expansion
Kylan Hodson{Heavily Redacted}
@KylanHodson
 ¬∑ 3 Nov 2017
$MRK yeah that was 5 million....Chug a lug https://twitter.com/KylanHodson/status/926172916059815936‚Ä¶
1",üî• üçí üî• üçí,,,1,['https://pbs.twimg.com/profile_images/1151677346954399745/jTQ9I0NB_mini.jpg'],https://twitter.com/KylanHodson/status/926937488144220160
5246,Nick Hewitt,@NHewitt84,2017-11-03T19:56:08.000Z,"I highly recommend everyone check this out for finding good stocks to trade http://bit.ly/2whOu82
$PAY $PG $MRK","I highly recommend everyone check this out for finding good stocks to trade http://bit.ly/2whOu82
$PAY $PG $MRK",,,,,['https://pbs.twimg.com/media/DNu521QUIAAqs5z?format=jpg&name=small'],https://twitter.com/NHewitt84/status/926538502946377728
5247,SRPTloving_Scientist,@SRPT_Fan,2017-11-03T13:17:55.000Z,"Biopharma investors perfectly ok with this but triggered by Len S's ""tone?"" $REGN $MRK","Biopharma investors perfectly ok with this but triggered by Len S's ""tone?"" $REGN $MRK
Andy Biotech
@AndyBiotech
 ¬∑ 2 Nov 2017
$MRK US Product Portfolio took 9.6% list price increase --> 5.5% net price gain, which is about ~$1 billion easy peasy free growth",,,,,"['https://pbs.twimg.com/profile_images/378800000074240482/d961ebeb9f4fe6b084a68663b9a36738_mini.png', 'https://pbs.twimg.com/media/DNoTkZzXcAEsACm?format=jpg&name=small']",https://twitter.com/SRPT_Fan/status/926438291909595136
5248,James Sikes,@wosaikeneriki,2017-11-04T15:50:00.000Z,"Merck & Co $MRK Holder Walter & Keenan Financial Consulting Company Has Decreased Holding by $338,432 ...","Merck & Co $MRK Holder Walter & Keenan Financial Consulting Company Has Decreased Holding by $338,432 ...
1",,,,1,[],https://twitter.com/wosaikeneriki/status/926838951050137607
5249,James Sikes,@wosaikeneriki,2017-11-05T10:24:26.000Z,Merck & Co $MRK Shareholder Continental Advisors Has Lowered Position as Stock Price Declined ...,Merck & Co $MRK Shareholder Continental Advisors Has Lowered Position as Stock Price Declined ...,,,,,[],https://twitter.com/wosaikeneriki/status/927119409742794752
5250,FinInvTr,@FinInvTr,2017-11-03T11:53:05.000Z,"3 Stocks for Warren Buffett Fans - https://buff.ly/2Ae9dfi

$AAPL $O $MRK","3 Stocks for Warren Buffett Fans - https://buff.ly/2Ae9dfi

$AAPL $O $MRK",,,,,[],https://twitter.com/FinInvTr/status/926416941425840129
5251,James Sikes,@wosaikeneriki,2017-11-04T17:24:15.000Z,"Alethea Capital Management Decreased Its Merck & Co $MRK Stake by $615,616 http://bzweekly.com/alethea-capital-management-decreased-its-merck-as-d-r-horton-dhi-market-value-rose-horizon-investment-services-lifted-holding-by-1-18-million/‚Ä¶","Alethea Capital Management Decreased Its Merck & Co $MRK Stake by $615,616 http://bzweekly.com/alethea-capital-management-decreased-its-merck-as-d-r-horton-dhi-market-value-rose-horizon-investment-services-lifted-holding-by-1-18-million/‚Ä¶",,,,,[],https://twitter.com/wosaikeneriki/status/926862671986790401
5252,David York,@DavidYork918,2017-11-05T14:54:40.000Z,"I highly recommend everyone check this out for discovering great stocks to trade http://bit.ly/2yrxVrP
$MAA $MEI $MRK","I highly recommend everyone check this out for discovering great stocks to trade http://bit.ly/2yrxVrP
$MAA $MEI $MRK",,,,,['https://pbs.twimg.com/media/DN4ICfGUEAEWNv8?format=jpg&name=small'],https://twitter.com/DavidYork918/status/927187415013478400
5253,MicroCapOwl,@MicroCapOwl,2017-11-03T16:46:47.000Z,"Take Advantage of $CURR current Undervalued stock price ,  Phase 1 #FDA #biotech $IBB $GILD $NVS $JNJ $MRK $BMY $AMGN $BSX $PFE","Take Advantage of $CURR current Undervalued stock price ,  Phase 1 #FDA #biotech $IBB $GILD $NVS $JNJ $MRK $BMY $AMGN $BSX $PFE",,,,,[],https://twitter.com/MicroCapOwl/status/926490851777409024
5254,CarnivoresHealth,@HealthierIT,2017-11-03T17:00:47.000Z,"Petya cyberattack cost Merck $135 million in revenue https://buff.ly/2A779pk $MRK #cyberattack 
@Merck","Petya cyberattack cost Merck $135 million in revenue https://buff.ly/2A779pk $MRK #cyberattack 
@Merck",,,,,['https://pbs.twimg.com/media/DNuRuQsXUAADEG6?format=jpg&name=small'],https://twitter.com/HealthierIT/status/926494374879514624
5255,Sweet Platform,@SweetPlatform,2017-11-03T23:47:42.000Z,"MRK Top news - Nov 3rd, 2017 $MRK http://https://goo.gl/tEJan5","MRK Top news - Nov 3rd, 2017 $MRK http://https://goo.gl/tEJan5",,,,,[],https://twitter.com/SweetPlatform/status/926596781064048641
5256,Paul D. Rennert,@PDRennert,2017-11-05T13:02:35.000Z,"interested to know when this will impact dose regimen in practice

http://blogs.shu.edu/cancer/2017/11/01/early-discontinuation-of-checkpoint-inhibitors-due-to-immune-related-side-effects-does-not-have-a-significant-impact-on-treatment-outcome/‚Ä¶

$MRK $BMY $AZN etc etc","interested to know when this will impact dose regimen in practice

http://blogs.shu.edu/cancer/2017/11/01/early-discontinuation-of-checkpoint-inhibitors-due-to-immune-related-side-effects-does-not-have-a-significant-impact-on-treatment-outcome/‚Ä¶

$MRK $BMY $AZN etc etc
2",,,,2,[],https://twitter.com/PDRennert/status/927159209317322753
5257,StockMarketVideo.com,@stockmarketvide,2017-11-03T00:08:05.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/926239522249232385
5258,Dakota Financial,@dakotafinancial,2017-11-04T16:27:48.000Z,Merck &‚Äôs $MRK Hold Rating Reiterated at Berenberg Bank http://ift.tt/2zwg7PZ,Merck &‚Äôs $MRK Hold Rating Reiterated at Berenberg Bank http://ift.tt/2zwg7PZ,,,,,[],https://twitter.com/dakotafinancial/status/926848465937879041
5259,MarketBeat,@MarketBeatCom,2017-11-03T22:32:37.000Z,Merck & Company's hold rating reiterated at Cowen and Company. $70.00 PT. http://ift.tt/2h3jCSU $MRK #MRK,Merck & Company's hold rating reiterated at Cowen and Company. $70.00 PT. http://ift.tt/2h3jCSU $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/926577884210266112
5260,FinInvTr,@FinInvTr,2017-11-04T17:15:41.000Z,"Cash Repatriation: Which Companies Will Benefit Most? https://buff.ly/2hdbxPn

$MSFT $AAPL $PFE $GE $IBM $CSCO $JNJ $MRK $GOOG $XOM","Cash Repatriation: Which Companies Will Benefit Most? https://buff.ly/2hdbxPn

$MSFT $AAPL $PFE $GE $IBM $CSCO $JNJ $MRK $GOOG $XOM",,,,,[],https://twitter.com/FinInvTr/status/926860514248052737
5261,Analyst Ratings,@ARatings,2017-11-03T22:14:04.000Z,Merck & Company Gets a Hold Rating from Cowen & Co. $MRK http://analystratings.com/articles/merck-company-gets-a-hold-rating-from-cowen-co/‚Ä¶,Merck & Company Gets a Hold Rating from Cowen & Co. $MRK http://analystratings.com/articles/merck-company-gets-a-hold-rating-from-cowen-co/‚Ä¶,,,,,[],https://twitter.com/ARatings/status/926573216230989824
5262,Transcript Daily,@TranscriptDaily,2017-11-04T08:38:27.000Z,"Merck & Company, Inc. $MRK Stake Increased by Alps Advisors Inc. http://ift.tt/2yuFZvE","Merck & Company, Inc. $MRK Stake Increased by Alps Advisors Inc. http://ift.tt/2yuFZvE",,,,,[],https://twitter.com/TranscriptDaily/status/926730347898957825
5263,StockNews.com,@stocknewsdotcom,2017-11-05T16:16:41.000Z,"$MRK Cowen & Company reiterates Hold rating, $70 PT https://stocknews.com/news/mrk-cowen-company-reiterates-hold-rating-70-pt-65424588/‚Ä¶","$MRK Cowen & Company reiterates Hold rating, $70 PT https://stocknews.com/news/mrk-cowen-company-reiterates-hold-rating-70-pt-65424588/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/927208053560217600
5264,Dakota Financial,@dakotafinancial,2017-11-03T08:41:50.000Z,"Merck & Company, Inc. $MRK Position Boosted by Denver Investment Advisors LLC http://ift.tt/2za16R1","Merck & Company, Inc. $MRK Position Boosted by Denver Investment Advisors LLC http://ift.tt/2za16R1",,,,,[],https://twitter.com/dakotafinancial/status/926368811158245376
5265,Ticker Report,@TickerReport,2017-11-05T09:38:24.000Z,"Stelac Advisory Services LLC Buys New Holdings in Merck & Company, Inc. $MRK http://ift.tt/2lTRXJq","Stelac Advisory Services LLC Buys New Holdings in Merck & Company, Inc. $MRK http://ift.tt/2lTRXJq",,,,,[],https://twitter.com/TickerReport/status/927107824479604736
5266,bake mcbride,@ITRADEVOL,2017-11-03T16:35:53.000Z,Stock Option TradesScreener $GE $SPY  $DBC $EEM $GDX $MU $TWX $T $CSCO $UNG $EXPE $HD $RF $C $ATVI $HIMX $MRK $NVDA  https://marketchameleon.com/Blog/post/2017/10/25/will-u-s-indices-be-able-to-push-through-earnings-and-extend-the-bullish-streak‚Ä¶,Stock Option TradesScreener $GE $SPY  $DBC $EEM $GDX $MU $TWX $T $CSCO $UNG $EXPE $HD $RF $C $ATVI $HIMX $MRK $NVDA  https://marketchameleon.com/Blog/post/2017/10/25/will-u-s-indices-be-able-to-push-through-earnings-and-extend-the-bullish-streak‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/926488108790636544
5267,Ticker Report,@TickerReport,2017-11-04T08:38:40.000Z,"Merck & Company, Inc. $MRK Stake Lessened by LLBH Private Wealth Management LLC http://ift.tt/2hGzQCi","Merck & Company, Inc. $MRK Stake Lessened by LLBH Private Wealth Management LLC http://ift.tt/2hGzQCi",,,,,[],https://twitter.com/TickerReport/status/926730401716072449
5268,Watchlist News,@WatchlistN,2017-11-05T09:33:36.000Z,"Camden National Bank Has $9.25 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2zjF9Rr","Camden National Bank Has $9.25 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2zjF9Rr",,,,,[],https://twitter.com/WatchlistN/status/927106615098200066
5269,Watchlist News,@WatchlistN,2017-11-04T16:28:08.000Z,"Jefferies Group LLC Upgrades Merck & Company, Inc. $MRK to Hold http://ift.tt/2AjEEVx","Jefferies Group LLC Upgrades Merck & Company, Inc. $MRK to Hold http://ift.tt/2AjEEVx",,,,,[],https://twitter.com/WatchlistN/status/926848547441594368
5270,Tim Reller,@TraderGuruNY,2017-11-03T00:09:39.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/926239917700677632
5271,Transcript Daily,@TranscriptDaily,2017-11-03T22:43:27.000Z,"Cowen and Company Reaffirms Hold Rating for Merck & Company, Inc. $MRK http://ift.tt/2lNQbcA","Cowen and Company Reaffirms Hold Rating for Merck & Company, Inc. $MRK http://ift.tt/2lNQbcA",,,,,[],https://twitter.com/TranscriptDaily/status/926580612722458624
5272,BioPharma Dive,@BioPharmaDive,2017-11-04T13:00:04.000Z,$MRK's hold on 1st line NSCLC market looks a little shakier,"$MRK's hold on 1st line NSCLC market looks a little shakier
biopharmadive.com
Merck pulls Keytruda lung combo application in Europe
Withdrawal of an EU submission for approval of the Keytruda chemo combo in first-line lung could open up a window for Merck's I/O competitors. 
1",,,,1,['https://pbs.twimg.com/card_img/1500746074922889221/bGXqLNdY?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/926796184479522817
5273,Chameleon,@MarketChmln,2017-11-03T20:36:28.000Z,Largest $Notional Sell On Close Order Imbalances $RICE $SLB $GE $IPG $XOM $MRK $ITW $MAC $CLX $PRGO http://tinyurl.com/y8jo8mjb,Largest $Notional Sell On Close Order Imbalances $RICE $SLB $GE $IPG $XOM $MRK $ITW $MAC $CLX $PRGO http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/926548653879250944
5274,dough,@semodough,2017-11-04T23:05:49.000Z,"Replying to 
@biosleuth","Replying to 
@biosleuth
$MRK 24 billioncash.+Deal http://coming.Deals $INCY $AZN.Plus 4% divy $MRK not for everyone.oversold here at 55
Joe
@Drchik23
 ¬∑ 30 Aug 2017
Lot of #bios ripe with cash. $mrk $amgn $jnj

https://yahoo.com/finance/news/chart-shows-17-us-companies-143911797.html‚Ä¶
2
1
3",,2,1,3,['https://pbs.twimg.com/profile_images/807662692932714496/rpRUyI_L_mini.jpg'],https://twitter.com/semodough/status/926948627825733633
5275,Dana Lyons,@JLyonsFundMgmt,2017-11-03T12:17:53.000Z,"(PREMIUM) The Lyons Share Daily Strategy video for 11/3/17 is up: https://lyonssharepro.com/2017/11/daily-strategy-session-1132017-premium/‚Ä¶
Among mkts covered:$RZG $XLY $EWZ $ACWI $MRK $TBT","(PREMIUM) The Lyons Share Daily Strategy video for 11/3/17 is up: https://lyonssharepro.com/2017/11/daily-strategy-session-1132017-premium/‚Ä¶
Among mkts covered:$RZG $XLY $EWZ $ACWI $MRK $TBT",,,,,[],https://twitter.com/JLyonsFundMgmt/status/926423182990544896
5276,Mark Paris,@geneman10,2017-11-03T21:20:51.000Z,"Replying to 
@bradloncar","Replying to 
@bradloncar
$NSTG is because $MRK walked away from a comp diag deal for Pembro.  Not sure about the others.

In contrast, $FMI had a great week.
1",,1,,,[],https://twitter.com/geneman10/status/926559822832721920
5277,Dan Cohen,@biosleuth,2017-11-04T22:50:25.000Z,"Replying to 
@semodough","Replying to 
@semodough
$MRK pipeline doesnt exactly inspire confidence in the valuation, very few in-house keytruda combos & PD-1 axis rapidly being commoditized
2",,2,,,[],https://twitter.com/biosleuth/status/926944753014407168
5278,Daily Political,@dailypoliticaln,2017-11-05T04:47:24.000Z,Merck &‚Äôs $MRK Hold Rating Reaffirmed at Cowen and Company http://ift.tt/2zed7EX,Merck &‚Äôs $MRK Hold Rating Reaffirmed at Cowen and Company http://ift.tt/2zed7EX,,,,,[],https://twitter.com/dailypoliticaln/status/927034592380547073
5279,Daily Political,@dailypoliticaln,2017-11-03T13:33:08.000Z,"Jefferies Group LLC Downgrades Merck & Company, Inc. $MRK to Underperform http://ift.tt/2ztHslU","Jefferies Group LLC Downgrades Merck & Company, Inc. $MRK to Underperform http://ift.tt/2ztHslU",,,,,[],https://twitter.com/dailypoliticaln/status/926442121179123714
5280,Transcript Daily,@TranscriptDaily,2017-11-05T09:48:25.000Z,"Murphy Pohlad Asset Management LLC Has $707,000 Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zfuPrQ","Murphy Pohlad Asset Management LLC Has $707,000 Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zfuPrQ",,,,,[],https://twitter.com/TranscriptDaily/status/927110342475382784
5281,Dakota Financial,@dakotafinancial,2017-11-04T13:11:10.000Z,"Merck & Company, Inc. $MRK Downgraded by Jefferies Group LLC http://ift.tt/2yv1T1W","Merck & Company, Inc. $MRK Downgraded by Jefferies Group LLC http://ift.tt/2yv1T1W",,,,,[],https://twitter.com/dakotafinancial/status/926798979576184835
5282,Wolfmetric,@Wolfmetric,2017-11-07T12:14:50.000Z,"$MRK March $57.50 call open interest climbs from 8,070 to 13,216","$MRK March $57.50 call open interest climbs from 8,070 to 13,216
4
6",,,4,6,[],https://twitter.com/Wolfmetric/status/927871965507063808
5283,Seeking Alpha,@SeekingAlpha,2017-11-06T17:02:53.000Z,https://seekingalpha.com/article/4121120-comments-q3-results-merck-pfizer-bristol-myers-novo-nordisk?source=feed_f‚Ä¶ $AZN $BMY $GILD $LLY $NVO $NVS $PFE $MRK,https://seekingalpha.com/article/4121120-comments-q3-results-merck-pfizer-bristol-myers-novo-nordisk?source=feed_f‚Ä¶ $AZN $BMY $GILD $LLY $NVO $NVS $PFE $MRK,,,,,[],https://twitter.com/SeekingAlpha/status/927582066929123328
5284,dough,@semodough,2017-11-07T02:45:21.000Z,$TRIL nice to see old tweet -still very much in the game - $TRIL partner coming $ROG $CELG $PFE $MRK,"$TRIL nice to see old tweet -still very much in the game - $TRIL partner coming $ROG $CELG $PFE $MRK
dough
@semodough
 ¬∑ 17 Aug 2016
Laden $TRIL differentiated anti-CD47 asset TTI-621 best-inclass potential&high potential to attract partnership with potential upfront $200m
3
16",,,3,16,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/927728650321039361
5285,pharmalot,@pharmalot,2017-11-07T14:10:11.000Z,Pharmalot.. Pharmalittle.. Good Morning.. Fitch rates Teva as junk & more news.. https://statnews.com/pharmalot/2017/11/07/defense-drug-approvals-teva-junk/‚Ä¶ #pharma $TEVA $MRK $LLY $AGN $CVS,"Pharmalot.. Pharmalittle.. Good Morning.. Fitch rates Teva as junk & more news.. https://statnews.com/pharmalot/2017/11/07/defense-drug-approvals-teva-junk/‚Ä¶ #pharma $TEVA $MRK $LLY $AGN $CVS
statnews.com
Pharmalittle: The Defense Department would approve drugs? Teva gets a junk rating
The U.S. Department of Defense ‚Äî and not the FDA ‚Äî would have the power to approve drugs and medical devices under a defense policy bill.",,,,,['https://pbs.twimg.com/card_img/1500534343600644098/wAHXYJa7?format=jpg&name=small'],https://twitter.com/pharmalot/status/927900996390543360
5286,Breaking News,@MarketCurrents,2017-11-08T14:10:07.000Z,OncoSec's ImmunoPulse shows durable treatment effect in mid-stage melanoma study; shares ah... https://seekingalpha.com/news/3309815-oncosecs-immunopulse-shows-durable-treatment-effect-mid-stage-melanoma-study-shares-ahead-81?source=feed_f‚Ä¶ #premarket $ONCS $MRK,OncoSec's ImmunoPulse shows durable treatment effect in mid-stage melanoma study; shares ah... https://seekingalpha.com/news/3309815-oncosecs-immunopulse-shows-durable-treatment-effect-mid-stage-melanoma-study-shares-ahead-81?source=feed_f‚Ä¶ #premarket $ONCS $MRK,,,,,[],https://twitter.com/MarketCurrents/status/928263365750767616
5287,Drugdoctor1,@Drugdoctor2014,2017-11-07T14:17:43.000Z,$ICNB.0079-Bellissima-Wine-Now-in-PUBLIX! Stock-Soaring! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT,"$ICNB.0079-Bellissima-Wine-Now-in-PUBLIX! Stock-Soaring! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT
2",,,,2,"['https://pbs.twimg.com/media/DOCSnVNVwAA-iSd?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DOCSo8gUEAANhwb?format=jpg&name=small']",https://twitter.com/Drugdoctor2014/status/927902891548999680
5288,Bret Jensen,@bret_jensen,2017-11-08T14:30:20.000Z,Commented on https://seekingalpha.com/article/4121331-biotech-forum-daily-digest-adamas-soaring?source=tweet&sht=oz3sak&shu=aozs#comment-76742449‚Ä¶ $ADMS $DVAX $KERX $MRK $NEOS $PDLI $PODD $SBPH $TXMD,Commented on https://seekingalpha.com/article/4121331-biotech-forum-daily-digest-adamas-soaring?source=tweet&sht=oz3sak&shu=aozs#comment-76742449‚Ä¶ $ADMS $DVAX $KERX $MRK $NEOS $PDLI $PODD $SBPH $TXMD,,,,,[],https://twitter.com/bret_jensen/status/928268453609291776
5289,Vista Partners LLC,@VistaPResearch,2017-11-06T19:40:14.000Z,Intriguing Federal Legislation Introduced Regarding Breast Density Masking #BreastCancer http://vistapglobal.com/2017/11/intriguing-federal-legislation-introduced-regarding-breast-density-masking-breast-cancer/‚Ä¶ $ATOS $IBB $MRK $JNJ $PFE,"Intriguing Federal Legislation Introduced Regarding Breast Density Masking #BreastCancer http://vistapglobal.com/2017/11/intriguing-federal-legislation-introduced-regarding-breast-density-masking-breast-cancer/‚Ä¶ $ATOS $IBB $MRK $JNJ $PFE
GIF
1
2",,,1,2,['https://pbs.twimg.com/tweet_video_thumb/DN-S9HEUQAAFFgt.jpg'],https://twitter.com/VistaPResearch/status/927621667907497985
5290,George Papadopoulos,@Emerald_CG,2017-11-08T23:50:01.000Z,#PREVYMIS (letermovir) from $MRK for prophylaxis of #CMV,"#PREVYMIS (letermovir) from $MRK for prophylaxis of #CMV
FDA Drug Information
@FDA_Drug_Info
 ¬∑ 9 Nov 2017
#FDAapproves first drug for prophylaxis of cytomegalovirus infection and disease in bone marrow transplant patients: https://go.usa.gov/xnjAB
1
1",,,1,1,"['https://pbs.twimg.com/profile_images/774289732582903808/kU8p7iWI_mini.jpg', 'https://pbs.twimg.com/media/DOJN7gAW0AAI4oD?format=jpg&name=small']",https://twitter.com/Emerald_CG/status/928409304151068672
5291,Kylan Hodson{Heavily Redacted},@KylanHodson,2017-11-06T16:15:53.000Z,$MRK R/G confirmation,"$MRK R/G confirmation
$peedyCalls
@SpeedyCalls
 ¬∑ 6 Nov 2017
$MRK 57.5 Calls BUYING Activity expiring on 16th Mar, Vol 4493 @ IS
1",üî• üçí,,,1,['https://pbs.twimg.com/profile_images/1123868529948876800/SbbCxnzG_mini.png'],https://twitter.com/KylanHodson/status/927570241852289024
5292,Anton,@Anton_A9,2017-11-07T20:30:00.000Z,added to $MRK,"added to $MRK
1",,,,1,[],https://twitter.com/Anton_A9/status/927996579621036032
5293,SAC Tracker,@FDAadcomm,2017-11-07T14:25:53.000Z,"FDA notes past failed #StaphVaccine trials by Nabi and Merck, which should be gleaned for any learnings #VRBPAC $PFE $MRK","FDA notes past failed #StaphVaccine trials by Nabi and Merck, which should be gleaned for any learnings #VRBPAC $PFE $MRK",,,,,['https://pbs.twimg.com/media/DOCUmW_X0AAJETv?format=jpg&name=small'],https://twitter.com/FDAadcomm/status/927904946141491200
5294,Nick Smith,@lilnickysmith,2017-11-08T19:14:40.000Z,$MRK vol spike,"$MRK vol spike
1",,,,1,[],https://twitter.com/lilnickysmith/status/928340008804732929
5295,TheTradingNinja,@TradeWithNinja,2017-11-08T17:21:34.000Z,$MRK time stamped... love the setup over $56 and holding will continue higher (WE ARE LONG) W.A.L,$MRK time stamped... love the setup over $56 and holding will continue higher (WE ARE LONG) W.A.L,,,,,['https://pbs.twimg.com/media/DOIGbhTXcAIdSBO?format=jpg&name=medium'],https://twitter.com/TradeWithNinja/status/928311545179856897
5296,M,@bio_clouseau,2017-11-08T14:53:54.000Z,$AZN $MRK PARP deal on 7/27 deal thus far looking smart by $AZN and like peak-parp moment. $CLVS $TSRO each down down ~ 30% since,"$AZN $MRK PARP deal on 7/27 deal thus far looking smart by $AZN and like peak-parp moment. $CLVS $TSRO each down down ~ 30% since
4",,,,4,[],https://twitter.com/bio_clouseau/status/928274385303166976
5297,Derek,@SFoptionTrader,2017-11-08T17:49:58.000Z,Sold to open 57.5/55 strangle in $MRK for $1.40 will close at 37.5% of credit received because I sold the closer to the money 30 delta options instead of further out options- A100k,Sold to open 57.5/55 strangle in $MRK for $1.40 will close at 37.5% of credit received because I sold the closer to the money 30 delta options instead of further out options- A100k,,,,,[],https://twitter.com/SFoptionTrader/status/928318692877840386
5298,Focus on Dividends,@Focus_on_Dvds,2017-11-08T21:20:02.000Z,Notable Upgrades and Downgrades for Week of October 30 $ABB $AMGN $GM $INTC $KMB $MRK $NOK $RDS $STO $TEVA $UAA https://buff.ly/2zsABZp,Notable Upgrades and Downgrades for Week of October 30 $ABB $AMGN $GM $INTC $KMB $MRK $NOK $RDS $STO $TEVA $UAA https://buff.ly/2zsABZp,,,,,['https://pbs.twimg.com/media/DOI9ApvX0AAVm__?format=jpg&name=360x360'],https://twitter.com/Focus_on_Dvds/status/928371557004660736
5299,Chameleon Options,@MC_OptionTrades,2017-11-07T01:48:38.000Z,Price Moves vs Expected Moves $TXMD $TEVA $VRX $MYL $CELG $HZNP $MRK $AGN $PFE $BMY $GILD $CVS http://tinyurl.com/y7zbwhgq,Price Moves vs Expected Moves $TXMD $TEVA $VRX $MYL $CELG $HZNP $MRK $AGN $PFE $BMY $GILD $CVS http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DN_nTtoUQAAVG91?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/927714376924188674
5300,Chameleon Options,@MC_OptionTrades,2017-11-08T22:33:35.000Z,Price Returns vs Expected Daily Move $VRX $REGN $MRK $TEVA $JNJ $PFE $GILD $MDT $MNK $CELG $AZN $HZNP http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $VRX $REGN $MRK $TEVA $JNJ $PFE $GILD $MDT $MNK $CELG $AZN $HZNP http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DOJN2IsXcAAazz2?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/928390068825481222
5301,Steven Huff,@SHuff27,2017-11-06T17:03:19.000Z,"have you tried this? i've been getting in on some great trades from it http://bit.ly/2yr7BOE
$KORS $MRK $BMA","have you tried this? i've been getting in on some great trades from it http://bit.ly/2yr7BOE
$KORS $MRK $BMA",,,,,['https://pbs.twimg.com/media/DN9vEywVAAAfasn?format=jpg&name=small'],https://twitter.com/SHuff27/status/927582179206541312
5302,Dow Stocks,@Top_Dow_Stocks,2017-11-08T08:16:57.000Z,#Dow #stocks $MRK Merck  Daily:0.45% Weekly:-11.39% YTD:-6% Trend:100 / 100  http://12Stocks.com/MRK,#Dow #stocks $MRK Merck  Daily:0.45% Weekly:-11.39% YTD:-6% Trend:100 / 100  http://12Stocks.com/MRK,,,,,[],https://twitter.com/Top_Dow_Stocks/status/928174491003379713
5303,$peedyCalls,@SpeedyCalls,2017-11-06T15:00:01.000Z,"$MRK 57.5 Calls BUYING Activity expiring on 16th Mar, Vol 4493 @ IS","$MRK 57.5 Calls BUYING Activity expiring on 16th Mar, Vol 4493 @ IS
1
1",,,1,1,[],https://twitter.com/SpeedyCalls/status/927551146637647872
5304,The_Real_Fly,@The_Real_Fly,2017-11-07T22:19:48.000Z,Here Are High Probability Oversold Plays in Exodus Right Now - Dr. Fly $MRK $PCLN,"Here Are High Probability Oversold Plays in Exodus Right Now - Dr. Fly $MRK $PCLN
ibankcoin.com
Here Are High Probability Oversold Plays in Exodus Right Now
Using the sublime harmony of mathematical precision (SHOMP), Exodus provides users with a discernible edge in analyzing the market. Here are 23 large cap stocks that were flagged as oversold on the pr
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501710109386366978/F6QLsu9o?format=jpg&name=240x240'],https://twitter.com/The_Real_Fly/status/928024211326726145
5305,Sift Stock,@SiftStock,2017-11-08T11:30:05.000Z,$MRK $55.59 (-0.52%) being heavily traded.  Our #sentiment analysis tool gives you a pulse on the #market.  http://siftstock.com,$MRK $55.59 (-0.52%) being heavily traded.  Our #sentiment analysis tool gives you a pulse on the #market.  http://siftstock.com,,,,,[],https://twitter.com/SiftStock/status/928223091486023681
5306,Siti van der Meij,@sitivandermeij,2017-11-08T15:56:09.000Z,Immunovaccine on go with mid-stage study of triplet therapy in DLBCL; shares up 2% https://seekingalpha.com/news/3309869-immunovaccine-go-mid-stage-study-triplet-therapy-dlbcl-shares-2-percent?source=feed_f‚Ä¶ $IMMVF $MRK #sitifatimah #malay‚Ä¶,"Immunovaccine on go with mid-stage study of triplet therapy in DLBCL; shares up 2% https://seekingalpha.com/news/3309869-immunovaccine-go-mid-stage-study-triplet-therapy-dlbcl-shares-2-percent?source=feed_f‚Ä¶ $IMMVF $MRK #sitifatimah #malay‚Ä¶
seekingalpha.com
Immunovaccine on go with mid-stage study of triplet therapy in DLBCL; shares up 2% (OTCMKTS:IMMVF)
Health Canada has signed off on a Phase 2 clinical trial assessing Immunovaccine's (OTCQX:IMMVF +2.4%) DPX-Survivac, in combination with Merck's (MRK +0.7%) KEYTRUDA (pembrolizumab) and...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/928290048805691392
5307,CSIMarket.com,@CSIMarket,2017-11-08T18:40:21.000Z,"#Merck $MRK #stock  #investing  From preceding quarter,  eps fell  from $0.71 per share and Sales increased  by 3.98 % from  $9.93 billions‚Ä¶","#Merck $MRK #stock  #investing  From preceding quarter,  eps fell  from $0.71 per share and Sales increased  by 3.98 % from  $9.93 billions‚Ä¶",,,,,[],https://twitter.com/CSIMarket/status/928331371071836160
5308,StockMarketVideo.com,@stockmarketvide,2017-11-08T21:37:48.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/928376030057975816
5309,Daily Political,@dailypoliticaln,2017-11-06T19:12:14.000Z,Financial Survey: Merck & $MRK versus Its Peers http://ift.tt/2yCzpmG,Financial Survey: Merck & $MRK versus Its Peers http://ift.tt/2yCzpmG,,,,,[],https://twitter.com/dailypoliticaln/status/927614622311571457
5310,Zeus Stock,@MadeinBorsacom,2017-11-07T12:50:42.000Z,Monitor on: $PG and $MRK. Waiting for $IBM at prox $147 before buying,"Monitor on: $PG and $MRK. Waiting for $IBM at prox $147 before buying
2",,,,2,[],https://twitter.com/MadeinBorsacom/status/927880994245545984
5311,US Banking News,@AmericanBanking,2017-11-06T10:44:16.000Z,Merck KGaA given ‚Ç¨115.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2yz5RGG $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Kepler Capital Markets. buy rating. http://ift.tt/2yz5RGG $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/927486787282489344
5312,Dakota Financial,@dakotafinancial,2017-11-06T19:02:28.000Z,"Cowen and Company Reaffirms Hold Rating for Merck & Company, Inc. $MRK http://ift.tt/2AfBQYK","Cowen and Company Reaffirms Hold Rating for Merck & Company, Inc. $MRK http://ift.tt/2AfBQYK",,,,,[],https://twitter.com/dakotafinancial/status/927612162964639744
5313,US Banking News,@AmericanBanking,2017-11-08T13:18:36.000Z,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2AtbJP2 $MRK #MRK,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2AtbJP2 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/928250401002020864
5314,Chameleon,@MarketChmln,2017-11-08T21:35:44.000Z,Largest $Notional Sell On Close Order Imbalances $EW $PFE $UNP $MCD $ORCL $DHR $MRK $ABBV $LVS $UNH http://tinyurl.com/y8jo8mjb,"Largest $Notional Sell On Close Order Imbalances $EW $PFE $UNP $MCD $ORCL $DHR $MRK $ABBV $LVS $UNH http://tinyurl.com/y8jo8mjb
1",ü¶é,,,1,[],https://twitter.com/MarketChmln/status/928375511499362309
5315,FinInvTr,@FinInvTr,2017-11-08T20:00:01.000Z,"Top Stock Held by the World's 4th Most Influential Central Bank  https://buff.ly/2zGJI9C

$UNH $KO $CMCSA $MRK $PEP $AAPL $GOOG","Top Stock Held by the World's 4th Most Influential Central Bank  https://buff.ly/2zGJI9C

$UNH $KO $CMCSA $MRK $PEP $AAPL $GOOG
whotrades.com
The Swiss National Bank Now Owns A Record $88 Billion In US Stocks
In the third quarter of 2017, one in which the global economy was supposedly undergoing an unprecedented ""coordinated growth spurt"", and in which central banks were preparing to unveil‚Ä¶",,,,,[],https://twitter.com/FinInvTr/status/928351420994277376
5316,MarketBeat,@MarketBeatCom,2017-11-07T09:59:16.000Z,"First Personal Financial Services Buys 413 Shares of Merck & Company, Inc. $MRK http://ift.tt/2yDbrrE","First Personal Financial Services Buys 413 Shares of Merck & Company, Inc. $MRK http://ift.tt/2yDbrrE",,,,,[],https://twitter.com/MarketBeatCom/status/927837851701608448
5317,Daily Political,@dailypoliticaln,2017-11-08T09:48:06.000Z,"First Eagle Investment Management LLC Maintains Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zllJwd","First Eagle Investment Management LLC Maintains Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zllJwd",,,,,[],https://twitter.com/dailypoliticaln/status/928197429798809600
5318,Chameleon Options,@MC_OptionTrades,2017-11-08T20:45:35.000Z,$MRK Merck Option Order Flow Sentiment is 73.6% Bullish. http://tinyurl.com/ydxxcwh5,$MRK Merck Option Order Flow Sentiment is 73.6% Bullish. http://tinyurl.com/ydxxcwh5,ü¶é,,,,[],https://twitter.com/MC_OptionTrades/status/928362889601306625
5319,Market Realist,@MarketRealist,2017-11-06T21:20:37.000Z,The Truth behind Pfizer's 3Q17 Earnings http://marketrealist.com/?p=2427439 $PFE $IHE $MRK $MYL,The Truth behind Pfizer's 3Q17 Earnings http://marketrealist.com/?p=2427439 $PFE $IHE $MRK $MYL,,,,,[],https://twitter.com/MarketRealist/status/927646930146156546
5320,Nick,@realNick1st,2017-11-08T19:03:52.000Z,"#Breaking Department of Justice DOJ demands AT&T $T sell CNN 
@cnnbrk
 for Time Warner $TWX acquisition approval $AAPL $GS $JPM $MS $BX $AVGO $QCOM $WTI $GOOGL $AMZN $WFC $BAC $PHK $BLK $WMT $JNJ $MRK $PG $HD $C $V $BA $KO #ThankYouHillary #WednesdayWisdom #MAGA #WallStreet #NYC","#Breaking Department of Justice DOJ demands AT&T $T sell CNN 
@cnnbrk
 for Time Warner $TWX acquisition approval $AAPL $GS $JPM $MS $BX $AVGO $QCOM $WTI $GOOGL $AMZN $WFC $BAC $PHK $BLK $WMT $JNJ $MRK $PG $HD $C $V $BA $KO #ThankYouHillary #WednesdayWisdom #MAGA #WallStreet #NYC
1",,,,1,[],https://twitter.com/realNick1st/status/928337292565106688
5321,Michelle Fay Cortez,@FayCortez,2017-11-07T17:01:17.000Z,"Last time Bloomberg used ""unprecedented"" wrt study result, by myself & 
@ArmstrongDrew
, was in 2013. Sadly supports thesis: $MRK #alzheimers","Last time Bloomberg used ""unprecedented"" wrt study result, by myself & 
@ArmstrongDrew
, was in 2013. Sadly supports thesis: $MRK #alzheimers
3",,,,3,['https://pbs.twimg.com/media/DOC3z5MWsAISSjz?format=jpg&name=medium'],https://twitter.com/FayCortez/status/927944053085401088
5322,dough,@semodough,2017-11-06T17:31:58.000Z,$BMY has primary endpoint of PFS only  (recall $MRK $INCY  are using PFS & OS co-primary endpoint),"$BMY has primary endpoint of PFS only  (recall $MRK $INCY  are using PFS & OS co-primary endpoint)
2",,,,2,[],https://twitter.com/semodough/status/927589386807578624
5323,BooRad,@atticusMB,2017-11-08T16:58:25.000Z,"Here's Why Merck & Co., Inc. Tanked 14% in October 
@themotleyfool
 #stocks $MRK","Here's Why Merck & Co., Inc. Tanked 14% in October 
@themotleyfool
 #stocks $MRK
fool.com
Here's Why Merck & Co., Inc. Tanked 14% in October @themotleyfool #stocks $MRK
Keytruda just wasn't strong enough to overcome stiff headwinds that made Merck's third-quarter report one investors would like to forget.",,,,,[],https://twitter.com/atticusMB/status/928305722030424065
5324,Transcript Daily,@TranscriptDaily,2017-11-08T04:29:26.000Z,"Investors Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2hkydxd","Investors Buy Merck & Company, Inc. $MRK on Weakness http://ift.tt/2hkydxd",,,,,[],https://twitter.com/TranscriptDaily/status/928117233468964864
5325,Dakota Financial,@dakotafinancial,2017-11-07T09:58:27.000Z,"First Personal Financial Services Buys 413 Shares of Merck & Company, Inc. $MRK http://ift.tt/2yDbrrE","First Personal Financial Services Buys 413 Shares of Merck & Company, Inc. $MRK http://ift.tt/2yDbrrE",,,,,[],https://twitter.com/dakotafinancial/status/927837645174165505
5326,Siti van der Meij,@sitivandermeij,2017-11-08T15:01:29.000Z,Seattle Genetics and Astellas launch early-stage study of enfortumab vedotin in urotheli... https://seekingalpha.com/news/3309842-seattle-genetics-astellas-launch-early-stage-study-enfortumab-vedotin-urothelial-cancer?source=feed_f‚Ä¶ $SGEN $ALPMF $MRK $RHH‚Ä¶,"Seattle Genetics and Astellas launch early-stage study of enfortumab vedotin in urotheli... https://seekingalpha.com/news/3309842-seattle-genetics-astellas-launch-early-stage-study-enfortumab-vedotin-urothelial-cancer?source=feed_f‚Ä¶ $SGEN $ALPMF $MRK $RHH‚Ä¶
seekingalpha.com
Seattle Genetics and Astellas launch early-stage study of enfortumab vedotin in urothelial cancer...
Seattle Genetics (SGEN -1.1%) and development partner Astellas Pharma (OTCPK:ALPMF) announce that the first patient has been dosed in a Phase 1b clinical trial, EV-103, assessing the safety...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/928276294210609152
5327,@ZimJay Expand The Court,@ZimJay Expand The Court,2017-11-08T17:13:49.000Z,"Tell 
@pfizer
 @JNJCares
 @Merck
 we're coming for you now. 
Divest! $JNJ $MRK $PFE $GSK $NVS $ABBV $SNY
Educate before you medicate.","Tell 
@pfizer
 @JNJCares
 @Merck
 we're coming for you now. 
Divest! $JNJ $MRK $PFE $GSK $NVS $ABBV $SNY
Educate before you medicate.
#MedicareForAll Mike Hersh
@MikeHersh
 ¬∑ 7 Nov 2017
Replying to @JeffRicksDude
End profiteering in healthcare #MedicareForAll @DrBillH @RoseAnnDeMoro @donnasicko @pdamerica @SenSanders @RepJohnConyers @USProgressives",‚ò† üò∑,,,,"['https://pbs.twimg.com/profile_images/904023535110299648/FYcY_Md3_mini.jpg', 'https://pbs.twimg.com/media/DOB7LTCW0AA77-k?format=jpg&name=small']",https://twitter.com/ZimJay/status/928309594237145088
5328,Andy Biotech,@AndyBiotech,2017-11-10T13:26:17.000Z,"I/O Q3 sales recap:
$BMY Opdivo $1265M
Ono Opdivo $184M
$MRK Keytruda $1047M
$RHHBY Tecentriq $120M
$AZN Imfinzi $0
$PFE Bavencio n/a

Anti-PD-(L)1 class officially above $10B run rate WW only 3yrs after first approval!

(and yes 4th 5th late comers are struggling to gain shares)","I/O Q3 sales recap:
$BMY Opdivo $1265M
Ono Opdivo $184M
$MRK Keytruda $1047M
$RHHBY Tecentriq $120M
$AZN Imfinzi $0
$PFE Bavencio n/a

Anti-PD-(L)1 class officially above $10B run rate WW only 3yrs after first approval!

(and yes 4th 5th late comers are struggling to gain shares)
3
26
48",,3,26,48,[],https://twitter.com/AndyBiotech/status/928977111414640641
5329,trading.jeff,@trading_jeff,2017-11-09T14:06:18.000Z,$ONCS https://seekingalpha.com/article/4122712-oncosec-presses-forward-positive-melanoma-combo-study?source=tweet‚Ä¶ $MRK $ONCS,"$ONCS https://seekingalpha.com/article/4122712-oncosec-presses-forward-positive-melanoma-combo-study?source=tweet‚Ä¶ $MRK $ONCS
seekingalpha.com
OncoSec Presses Forward With Positive Melanoma Combo Study (NASDAQ:ONCS)
Positive Phase 2 data using OncoSec's IL-12 ImmunoPulse and Keytruda combo shows a lot of promise. The melanoma market is expected to reach $12.4 billion by 2025.
1",,,,1,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/trading_jeff/status/928624792223305728
5330,Andy Biotech,@AndyBiotech,2017-11-10T12:37:25.000Z,"$MRK Here is EMA doc on MAA withdrawal of Keytruda+chemo combo in 1L NSCLC based on KN-21G
http://ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2017/11/WC500238047.pdf‚Ä¶

http://ema.europa.eu/docs/en_GB/document_library/Withdrawal_letter/2017/11/WC500238007.pdf‚Ä¶","$MRK Here is EMA doc on MAA withdrawal of Keytruda+chemo combo in 1L NSCLC based on KN-21G
http://ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2017/11/WC500238047.pdf‚Ä¶

http://ema.europa.eu/docs/en_GB/document_library/Withdrawal_letter/2017/11/WC500238007.pdf‚Ä¶
2
9
13",,2,9,13,['https://pbs.twimg.com/media/DORYhs0W0AAe0wT?format=jpg&name=small'],https://twitter.com/AndyBiotech/status/928964813270765568
5331,pharmalot,@pharmalot,2017-11-10T14:18:19.000Z,"Pharmalot.. Pharmalittle.. Good Morning.. Coffee, headlines & weekend daydreams.. https://statnews.com/pharmalot/2017/11/10/valeant-sec-fda-generics/‚Ä¶ #pharma #FDA $VRX $SNY $MRK $DVAX","Pharmalot.. Pharmalittle.. Good Morning.. Coffee, headlines & weekend daydreams.. https://statnews.com/pharmalot/2017/11/10/valeant-sec-fda-generics/‚Ä¶ #pharma #FDA $VRX $SNY $MRK $DVAX
statnews.com
Pharmalittle: Is Valeant defying SEC with earnings numbers? FDA to speed generic reviews
The Food and Drug Administration plans to expand which generic drug applications will be given faster reviews.
1",,,1,,[],https://twitter.com/pharmalot/status/928990204953878529
5332,Hawkeye Advisory Services LLC,@AlaLongleaf,2017-11-10T16:33:20.000Z,#Dynvax Reaches The Final Point On Its Journey: #FDA Approval Achieved For #HepatitisB Vaccine https://seekingalpha.com/article/4123158-dynvax-reaches-final-point-journey-fda-approval-achieved-hepatitis-b-vaccine‚Ä¶ $DVAX #GlaxoSmithKline $GSK #ENGERIXB #ShortSqueeze #TakeoverTarget $MRK $SNY $GLID $ABBV $ENTA,"#Dynvax Reaches The Final Point On Its Journey: #FDA Approval Achieved For #HepatitisB Vaccine https://seekingalpha.com/article/4123158-dynvax-reaches-final-point-journey-fda-approval-achieved-hepatitis-b-vaccine‚Ä¶ $DVAX #GlaxoSmithKline $GSK #ENGERIXB #ShortSqueeze #TakeoverTarget $MRK $SNY $GLID $ABBV $ENTA
seekingalpha.com
Dynavax Reaches The Final Point On Its Journey: FDA Approval Achieved For Hepatitis B Vaccine...
Dynavax Receives FDA Approval for HEPLISAV-B for preventing Hepatitis B. Prior safety issues were put to rest, making approval of HEPLISAV-B an almost sure thing.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/AlaLongleaf/status/929024183245398016
5333,Jaxon Longfellow,@JaxonLongfellow,2017-11-09T11:11:54.000Z,"OncoSec Presses Forward With Positive Melanoma Combo Study https://seekingalpha.com/article/4122712?source=ansh‚Ä¶ $ONCS, $MRK","OncoSec Presses Forward With Positive Melanoma Combo Study https://seekingalpha.com/article/4122712?source=ansh‚Ä¶ $ONCS, $MRK
seekingalpha.com
OncoSec Presses Forward With Positive Melanoma Combo Study (NASDAQ:ONCS)
Positive Phase 2 data using OncoSec's IL-12 ImmunoPulse and Keytruda combo shows a lot of promise. The melanoma market is expected to reach $12.4 billion by 2025.
3
1",,,3,1,['https://pbs.twimg.com/card_img/1499245929144090626/Es7NFtun?format=png&name=240x240'],https://twitter.com/JaxonLongfellow/status/928580903785385984
5334,John Carroll,@JohnCendpts,2017-11-09T12:47:44.000Z,"Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
$MRK","Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
$MRK
endpts.com
Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
Five years after bagging the CMV drug letermovir in a $500 million-plus deal with AiCuris, Merck says the FDA has come through with an approval. While not a blockbuster by most accounts, the drug ‚Äî...
4
6",,,4,6,[],https://twitter.com/JohnCendpts/status/928605022916575232
5335,MM+M Magazine,@MMMnews,2017-11-09T15:40:00.000Z,"5 things for #pharma #marketers to know: Thurs, Nov 9 $GSK $GOOGL $MRK #FDA $LLY #HHS #Trump $AGN #hcmktg http://bit.ly/2hhN4Vk","5 things for #pharma #marketers to know: Thurs, Nov 9 $GSK $GOOGL $MRK #FDA $LLY #HHS #Trump $AGN #hcmktg http://bit.ly/2hhN4Vk
3",,,,3,['https://pbs.twimg.com/media/DOM37cYXcAEJSLW?format=jpg&name=small'],https://twitter.com/MMMnews/status/928648376203268098
5336,Vista Partners LLC,@VistaPResearch,2017-11-09T03:50:15.000Z,Intriguing Federal Legislation Introduced Regarding Breast Density Masking #BreastCancer http://vistapglobal.com/intriguing-federal-legislation-introduced-regarding-breast-density-masking-breast-cancer/‚Ä¶ #biotech $ATOS $IBB $MRK,"Intriguing Federal Legislation Introduced Regarding Breast Density Masking #BreastCancer http://vistapglobal.com/intriguing-federal-legislation-introduced-regarding-breast-density-masking-breast-cancer/‚Ä¶ #biotech $ATOS $IBB $MRK
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DOKWUdoU8AAAaLo.jpg'],https://twitter.com/VistaPResearch/status/928469759431020544
5337,max pain,@optioncharts,2017-11-09T21:17:22.000Z,$MRK high OI range is 64.50 to 57.00 for option expiration 11/10/2017 #maxpain #options http://bit.ly/2irRsRQ,$MRK high OI range is 64.50 to 57.00 for option expiration 11/10/2017 #maxpain #options http://bit.ly/2irRsRQ,,,,,['https://pbs.twimg.com/media/DOOF_gaWkAYKOil?format=jpg&name=small'],https://twitter.com/optioncharts/status/928733275983695872
5338,$tocks Follower,@EL_MarketWatch,2017-11-10T11:40:31.000Z,"$GALE reports loss in-line with analyst estimates.  Awesome! Would have loved beat, but I'll take this and holding, given $MRK agreement.","$GALE reports loss in-line with analyst estimates.  Awesome! Would have loved beat, but I'll take this and holding, given $MRK agreement.",,,,,['https://pbs.twimg.com/media/DORLizSUQAIFnsO?format=jpg&name=small'],https://twitter.com/EL_MarketWatch/status/928950493849833472
5339,Drugdoctor1,@Drugdoctor2014,2017-11-09T11:47:05.000Z,"$ICNB.0075 Incredible - Bellissima Wine sales EXCEED CEO Expectations!  $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TEVA $RDY $MNK $ASMB $TCK $CC $CRBP $EXEL $HL $FNSR $AMD $OCLR $FMSA","$ICNB.0075 Incredible - Bellissima Wine sales EXCEED CEO Expectations!  $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TEVA $RDY $MNK $ASMB $TCK $CC $CRBP $EXEL $HL $FNSR $AMD $OCLR $FMSA
2",,,,2,['https://pbs.twimg.com/media/DOMDdG_VwAAJIxP?format=jpg&name=small'],https://twitter.com/Drugdoctor2014/status/928589758858715137
5340,ADAPLONG,@LONGADAP,2017-11-10T20:28:52.000Z,"I just sold all my $ADAP, and went all in $AFMD

$TRIL $PIRS $NTLA $EDIT $CRSP $CLLS $BLUE $XON $ZIOP $SGMO $NK $ONCE $FATE $INO $BLCM $JUNO $GILD $GSK $NVS $MRK $BGNE $HCM $BYSI $CALA $GWPH $BMY $CELG $REGN $BIIB $LLY $SNY $PFE $BAYRY $RHHBY $ABBV $NH $FMI $MRNS $MGNX $QURE","I just sold all my $ADAP, and went all in $AFMD

$TRIL $PIRS $NTLA $EDIT $CRSP $CLLS $BLUE $XON $ZIOP $SGMO $NK $ONCE $FATE $INO $BLCM $JUNO $GILD $GSK $NVS $MRK $BGNE $HCM $BYSI $CALA $GWPH $BMY $CELG $REGN $BIIB $LLY $SNY $PFE $BAYRY $RHHBY $ABBV $NH $FMI $MRNS $MGNX $QURE
4
4",,4,,4,[],https://twitter.com/LONGADAP/status/929083457912934406
5341,goldmask,@goldmask123,2017-11-11T20:06:55.000Z,"Replying to 
@DrSteinberg","Replying to 
@DrSteinberg
$INCY bladder cancer IDOi+PD1i has about 10% CR and 35% ORR, but $MRK PD1i mono also has 10% CR and 20% ORR. It is bizarre that $BMY IDOi+PD1i has no CR at all.
1
2",,1,,2,['https://pbs.twimg.com/media/DOYIXwMWsAAjdga?format=jpg&name=small'],https://twitter.com/goldmask123/status/929440321154449408
5342,Wolfe,@everytimeicash,2017-11-09T04:49:23.000Z,Forgot to post this last week @1simpletrader: $PFE $MRK $GILD $AMGN $CELG $BMY $BIIB $IBB $XBI,"Forgot to post this last week @1simpletrader: $PFE $MRK $GILD $AMGN $CELG $BMY $BIIB $IBB $XBI
1",,,,1,['https://pbs.twimg.com/media/DOKj28tWsAAqsf1?format=jpg&name=small'],https://twitter.com/everytimeicash/status/928484639802646528
5343,Contagion,@Contagion_Live,2017-11-10T17:24:55.000Z,"Dr Roy F. Chemaly, MD, MPH 
@MDAndersonNews
 discusses the background behind $MRK‚Äôs #letermovir & what it brings to the table. #CMV http://contagionlive.com/videos/mercks-letermovir-for-cmv-prevention-approved-by-fda‚Ä¶","Dr Roy F. Chemaly, MD, MPH 
@MDAndersonNews
 discusses the background behind $MRK‚Äôs #letermovir & what it brings to the table. #CMV http://contagionlive.com/videos/mercks-letermovir-for-cmv-prevention-approved-by-fda‚Ä¶
1",,,,1,['https://pbs.twimg.com/media/DOSaV2gW0AAor62?format=jpg&name=small'],https://twitter.com/Contagion_Live/status/929037164679135232
5344,"Jordan Alexander (,)",@JD4for4,2017-11-09T22:43:24.000Z,"If potential $DVAX partner was waiting for approval and clean label, $DVAX delivered on both! $MRK $SNY","If potential $DVAX partner was waiting for approval and clean label, $DVAX delivered on both! $MRK $SNY
1",üìú üìú,,,1,[],https://twitter.com/JD4for4/status/928754925248663555
5345,Hurstcourt Bolen,@SpyjodyBolen,2017-11-10T16:35:34.000Z,"$MRK more FDA approvals on strong pipeline, triple Keytruda sales quarter over quarter seems to only keep growing with new indications.","$MRK more FDA approvals on strong pipeline, triple Keytruda sales quarter over quarter seems to only keep growing with new indications.",,,,,[],https://twitter.com/SpyjodyBolen/status/929024747219902464
5346,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-11-11T08:12:57.000Z,"Replying to 
@techwhitepapers","Replying to 
@techwhitepapers
SCCHN should give a very good target indication 4 $AFMD AFM-24 and may profit from a $MRK #Keytruda combo and Anti-KIR 2",,,,,['https://pbs.twimg.com/media/DOVlV1HW0AAdj41?format=jpg&name=small'],https://twitter.com/dhovekamp42/status/929260644758630400
5347,StockMarketVideo.com,@stockmarketvide,2017-11-10T02:53:07.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/928817767951798272
5348,Drugdoctor1,@Drugdoctor2014,2017-11-10T11:02:50.000Z,"$ICNB.0086 - COSTCO - WINE Tasting-TODAY! Riverhead- Long Island- NEW YORK - Meet Christie Brinkley! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS $WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TEVA $RDY $MNK $ASMB
$TCK $CC $CRBP $EXEL","$ICNB.0086 - COSTCO - WINE Tasting-TODAY! Riverhead- Long Island- NEW YORK - Meet Christie Brinkley! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS $WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TEVA $RDY $MNK $ASMB
$TCK $CC $CRBP $EXEL
1
1
2",,1,1,2,"['https://pbs.twimg.com/media/DORC5qPV4AAvgNg?format=jpg&name=small', 'https://pbs.twimg.com/media/DORC5qXUQAAaZKz?format=jpg&name=small']",https://twitter.com/Drugdoctor2014/status/928941009333080064
5349,Gary Kinney,@GKinney36,2017-11-10T21:20:52.000Z,"I highly recommend checking this out for discovering good stocks to trade http://bit.ly/2yCvvXo
$MCO $MRK $MCD","I highly recommend checking this out for discovering good stocks to trade http://bit.ly/2yCvvXo
$MCO $MRK $MCD",,,,,['https://pbs.twimg.com/media/DOTQYfTVwAEoqFI?format=jpg&name=small'],https://twitter.com/GKinney36/status/929096544959238145
5350,BioWorld,@BioWorld,2017-11-11T03:24:00.000Z,UPDATED: Aicuris banks $122M on #FDA nod for $MRK's letermovir http://bit.ly/2AzhLxK,"UPDATED: Aicuris banks $122M on #FDA nod for $MRK's letermovir http://bit.ly/2AzhLxK
1
1",,,1,1,[],https://twitter.com/BioWorld/status/929187930769444864
5351,Tim Reller,@TraderGuruNY,2017-11-10T02:56:11.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/928818540072853504
5352,Hawkeye Advisory Services LLC,@AlaLongleaf,2017-11-09T15:03:45.000Z,Will $DVAX gets the approval for #HeptitisB #Vaccine based on the data or will it be politics as usual?  https://benzinga.com/news/17/11/10746246/dynavax-awaits-fda-verdict-on-hepatitis-b-vaccine‚Ä¶ $MRK $LLY $GSK,"Will $DVAX gets the approval for #HeptitisB #Vaccine based on the data or will it be politics as usual?  https://benzinga.com/news/17/11/10746246/dynavax-awaits-fda-verdict-on-hepatitis-b-vaccine‚Ä¶ $MRK $LLY $GSK
benzinga.com
Dynavax Awaits FDA Verdict On Hepatitis B Vaccine
Undaunted by two earlier FDA snubs, Dynavax Technologies Corporation (NASDAQ: DVAX) is trying again with its hepatitis B vaccine, Heplisav. Will it successfully scale the hurdle...
2
1",,,2,1,[],https://twitter.com/AlaLongleaf/status/928639250333126656
5353,US Banking News,@AmericanBanking,2017-11-10T11:27:18.000Z,Merck KGaA given ‚Ç¨125.00 PT by Oddo Bhf. buy rating. http://ift.tt/2zKThED $MRK #MRK,Merck KGaA given ‚Ç¨125.00 PT by Oddo Bhf. buy rating. http://ift.tt/2zKThED $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/928947167850614784
5354,c lark,@7LadyQ,2017-11-09T14:12:47.000Z,"$MRK (+0.0% pre) Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris","$MRK (+0.0% pre) Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris",,,,,[],https://twitter.com/7LadyQ/status/928626427368493056
5355,US Banking News,@AmericanBanking,2017-11-10T09:17:26.000Z,Merck KGaA given ‚Ç¨99.00 PT by Deutsche Bank AG. neutral rating. http://ift.tt/2zsl0t2 $MRK #MRK,Merck KGaA given ‚Ç¨99.00 PT by Deutsche Bank AG. neutral rating. http://ift.tt/2zsl0t2 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/928914487507341312
5356,TalkMarkets,@TalkMarkets,2017-11-09T21:21:21.000Z,Pharma #ETFs Down Post Q3 Earnings $PJP $IHE $XPH $PPH Also $JNJ $LLY $PFE $MRK $BMY https://goo.gl/u2P3xY,Pharma #ETFs Down Post Q3 Earnings $PJP $IHE $XPH $PPH Also $JNJ $LLY $PFE $MRK $BMY https://goo.gl/u2P3xY,,,,,[],https://twitter.com/TalkMarkets/status/928734275771555840
5357,Watchlist News,@WatchlistN,2017-11-11T09:44:24.000Z,"Merck & Company, Inc. $MRK Holdings Increased by Truepoint Inc. http://ift.tt/2zvNCl0","Merck & Company, Inc. $MRK Holdings Increased by Truepoint Inc. http://ift.tt/2zvNCl0",,,,,[],https://twitter.com/WatchlistN/status/929283660511174656
5358,Transcript Daily,@TranscriptDaily,2017-11-09T09:29:26.000Z,"Merck & Company, Inc. $MRK Stake Lowered by Jennison Associates LLC http://ift.tt/2yJYeNE","Merck & Company, Inc. $MRK Stake Lowered by Jennison Associates LLC http://ift.tt/2yJYeNE",,,,,[],https://twitter.com/TranscriptDaily/status/928555117246369792
5359,Ticker Report,@TickerReport,2017-11-10T09:32:51.000Z,"Wayne Hummer Investments L.L.C. Sells 140 Shares of Merck & Company, Inc. $MRK http://ift.tt/2i0gMPr","Wayne Hummer Investments L.L.C. Sells 140 Shares of Merck & Company, Inc. $MRK http://ift.tt/2i0gMPr",,,,,[],https://twitter.com/TickerReport/status/928918365363720192
5360,Ticker Report,@TickerReport,2017-11-11T09:42:31.000Z,"Cadence Capital Management LLC Reduces Stake in Merck & Company, Inc. $MRK http://ift.tt/2iM69zm","Cadence Capital Management LLC Reduces Stake in Merck & Company, Inc. $MRK http://ift.tt/2iM69zm",,,,,[],https://twitter.com/TickerReport/status/929283184931549185
5361,Watchlist News,@WatchlistN,2017-11-10T09:34:23.000Z,"Knowledge Leaders Capital LLC Has $5.46 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2zxgffm","Knowledge Leaders Capital LLC Has $5.46 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2zxgffm",,,,,[],https://twitter.com/WatchlistN/status/928918751168417793
5362,Daily Political,@dailypoliticaln,2017-11-10T09:40:10.000Z,"Sicart Associates LLC Maintains Position in Merck & Company, Inc. $MRK http://ift.tt/2yO4R1q","Sicart Associates LLC Maintains Position in Merck & Company, Inc. $MRK http://ift.tt/2yO4R1q",,,,,[],https://twitter.com/dailypoliticaln/status/928920207401410561
5363,Daily Political,@dailypoliticaln,2017-11-11T09:45:38.000Z,"Apriem Advisors Has $522,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2yPDzrr","Apriem Advisors Has $522,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2yPDzrr",,,,,[],https://twitter.com/dailypoliticaln/status/929283969383727104
5364,The Market is Open,@themarketisopen,2017-11-09T12:41:25.000Z,$MRK Merck Receives FDA Approval of PREVYMIS‚Ñ¢ (letermovir) for Prevention of ... http://ift.tt/2AoafoD,$MRK Merck Receives FDA Approval of PREVYMIS‚Ñ¢ (letermovir) for Prevention of ... http://ift.tt/2AoafoD,,,,,[],https://twitter.com/themarketisopen/status/928603431845101568
5365,Daily Political,@dailypoliticaln,2017-11-09T09:23:31.000Z,"Northeast Investment Management Has $1.86 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2iHCAPe","Northeast Investment Management Has $1.86 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2iHCAPe",,,,,[],https://twitter.com/dailypoliticaln/status/928553629870673921
5366,bake mcbride,@ITRADEVOL,2017-11-10T19:18:36.000Z,Option Implied Volatility Movers Report $CSCO $GE $ORCL $TEVA $MET $SPY $ROKU $TLT $XLU $BX $MSFT $FL $SPY $BX $MRK https://marketchameleon.com/volReports/topImpliedVolMovers‚Ä¶,Option Implied Volatility Movers Report $CSCO $GE $ORCL $TEVA $MET $SPY $ROKU $TLT $XLU $BX $MSFT $FL $SPY $BX $MRK https://marketchameleon.com/volReports/topImpliedVolMovers‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/929065773468999681
5367,Transcript Daily,@TranscriptDaily,2017-11-10T09:33:29.000Z,"William Blair Investment Management LLC Trims Holdings in Merck & Company, Inc. $MRK http://ift.tt/2ApRpNJ","William Blair Investment Management LLC Trims Holdings in Merck & Company, Inc. $MRK http://ift.tt/2ApRpNJ",,,,,[],https://twitter.com/TranscriptDaily/status/928918523379929088
5368,MarketBeat,@MarketBeatCom,2017-11-10T11:21:26.000Z,Merck KGaA given ‚Ç¨125.00 PT by Oddo Bhf. buy rating. http://ift.tt/2zKThED $MRK #MRK,Merck KGaA given ‚Ç¨125.00 PT by Oddo Bhf. buy rating. http://ift.tt/2zKThED $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/928945692093108225
5369,Briefing.com,@Briefingcom,2017-11-09T13:49:44.000Z,$MRK: Merck receives approval of PREVYMIS from FDA http://bit.ly/2zqocp3,$MRK: Merck receives approval of PREVYMIS from FDA http://bit.ly/2zqocp3,,,,,[],https://twitter.com/Briefingcom/status/928620623756115968
5370,Rishesh Singh,@androsForm,2017-11-10T17:50:27.000Z,"$EEM, $LQD, $IWN, $BBT, $ABCO, $BABA, $IWM, $NFLX, $VZ, $MRK that shoud read bearish obv","$EEM, $LQD, $IWN, $BBT, $ABCO, $BABA, $IWM, $NFLX, $VZ, $MRK that shoud read bearish obv
stocktwits.com
Rishesh Singh (@androsForm) | Stocktwits
$EEM, $LQD, $IWN, $BBT, $ABCO, $BABA, $IWM, $NFLX, $VZ, $MRK that shoud read bearish obv",,,,,[],https://twitter.com/androsForm/status/929043592739516417
5371,stockassassin,@stockassassin74,2017-11-10T17:40:50.000Z,"Replying to 
@drip_aristocrat
 and 
@yungsoundclout","Replying to 
@drip_aristocrat
 and 
@yungsoundclout
$dvax because $mrk wants to buy it much cheaper ¬Ø\_(„ÉÑ)_/¬Ø
1",,,,1,[],https://twitter.com/stockassassin74/status/929041169115373568
5372,Kristen Hallam,@kristen_hallam,2017-11-10T15:33:00.000Z,"Avastin biosimilar, 9 other new drugs recommended for EU approval http://bit.ly/2m9uDY0 $RHHBY $AMGN $AGN $MRK","Avastin biosimilar, 9 other new drugs recommended for EU approval http://bit.ly/2m9uDY0 $RHHBY $AMGN $AGN $MRK
1
1",,,1,1,[],https://twitter.com/kristen_hallam/status/929009002016661504
5373,David Sobek,@dsobek,2017-11-10T16:18:34.000Z,"You could add $AMGN, $CELG, $PFE, $MRK, $BMY, and so on","You could add $AMGN, $CELG, $PFE, $MRK, $BMY, and so on
2",,,,2,[],https://twitter.com/dsobek/status/929020468421636096
5374,Dakota Financial,@dakotafinancial,2017-11-09T18:19:27.000Z,"Traders Buy Shares of Merck & Company, Inc. $MRK on Weakness http://ift.tt/2zv1r34","Traders Buy Shares of Merck & Company, Inc. $MRK on Weakness http://ift.tt/2zv1r34",,,,,[],https://twitter.com/dakotafinancial/status/928688500756635650
5375,US Banking News,@AmericanBanking,2017-11-09T17:22:22.000Z,Merck KGaA given ‚Ç¨98.00 PT by Nord/LB. neutral rating. http://ift.tt/2Ap3KBV $MRK #MRK,Merck KGaA given ‚Ç¨98.00 PT by Nord/LB. neutral rating. http://ift.tt/2Ap3KBV $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/928674133818437633
5376,Rishesh Singh,@androsForm,2017-11-10T17:48:23.000Z,Top Sell Flow Money - $EEM $LQD $IWN $BBT $ABCO $BABA $IWM $NFLX $VZ $MRK,Top Sell Flow Money - $EEM $LQD $IWN $BBT $ABCO $BABA $IWM $NFLX $VZ $MRK,,,,,[],https://twitter.com/androsForm/status/929043071052009479
5377,Open Outcrier,@OpenOutcrier,2017-11-10T13:07:34.000Z,"$MRK (+0.3% pre) Watch out Merck: Heron $HRTX snagged FDA approval on Emend competitor - ENDPTS

http://ooc.bz/l/17872","$MRK (+0.3% pre) Watch out Merck: Heron $HRTX snagged FDA approval on Emend competitor - ENDPTS

http://ooc.bz/l/17872
1
1",,,1,1,[],https://twitter.com/OpenOutcrier/status/928972401639030784
5378,Open Outcrier,@OpenOutcrier,2017-11-09T13:30:23.000Z,"$MRK (+0.0% pre) Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris - Endpts

http://ooc.bz/l/17808","$MRK (+0.0% pre) Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris - Endpts

http://ooc.bz/l/17808",,,,,[],https://twitter.com/OpenOutcrier/status/928615753816866816
5379,Peter Loftus,@Loftus,2017-11-10T15:43:42.000Z,EU drug regulator: results from studies of Merck's Keytruda-chemo combination in lung cancer patients 'did not allow firm conclusions on the effectiveness and safety of Keytruda in these patients.' Merck is running bigger study to shore up data $MRK http://ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003820/wapp/Post-authorisation/human_wapp_000242.jsp&mid=WC0b01ac058001d128‚Ä¶,"EU drug regulator: results from studies of Merck's Keytruda-chemo combination in lung cancer patients 'did not allow firm conclusions on the effectiveness and safety of Keytruda in these patients.' Merck is running bigger study to shore up data $MRK http://ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003820/wapp/Post-authorisation/human_wapp_000242.jsp&mid=WC0b01ac058001d128‚Ä¶
1",,,1,,[],https://twitter.com/Loftus/status/929011691794391040
5380,"Jordan Alexander (,)",@JD4for4,2017-11-10T11:34:28.000Z,"Replying to 
@princetongb","Replying to 
@princetongb
Heplisav worth $1.5-2b & oncology portfolio $500m, maybe not today but soon.  $MRK & $GSK must be pleased with strong label.
1",üìú üìú,,,1,[],https://twitter.com/JD4for4/status/928948969849413632
5381,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-11-10T17:40:13.000Z,"Replying to 
@cornel6m","Replying to 
@cornel6m
The big picture - AFAIK the only Keytruda combination trial in #MM multiple myeloma not being halted by FDA - and recruiting NCT03168438
http://fiercepharma.com/pharma/fda-warns-public-over-keytruda-myeloma-combo-risks-wake-merck-trial-deaths‚Ä¶ $MRK $ADAP $BMS
fiercepharma.com
FDA warns public over Keytruda myeloma combo risks in wake of Merck trial deaths
Last month, following deaths in two Keytruda trials, the FDA halted the pair of Merck studies. | Last month, following deaths in two Keytruda trials, the FDA halted the pair of Merck studies. And...
1",,,,1,['https://pbs.twimg.com/card_img/1501991521809141764/nzBP-w8C?format=jpg&name=small'],https://twitter.com/dhovekamp42/status/929041015654240257
5382,Bursatil Biotech,@BursatilBiotech,2017-11-13T20:18:55.000Z,"Saving this graph.
IDO responses
$INCY $MRK","Saving this graph.
IDO responses
$INCY $MRK
2
6
8",,2,6,8,['https://pbs.twimg.com/media/DOie0mWX4AMV5iX?format=jpg&name=900x900'],https://twitter.com/BursatilBiotech/status/930168116688146432
5383,"David Settle, CMT",@davidsettle42,2017-11-14T19:49:07.000Z,There are 16 bullish & 16 bearish clusters today within $SPX. One is below. See what the rest are by joining our email newsletter list: http://eepurl.com/c-rgZD $MRK,"There are 16 bullish & 16 bearish clusters today within $SPX. One is below. See what the rest are by joining our email newsletter list: http://eepurl.com/c-rgZD $MRK
2
3
13",,2,3,13,['https://pbs.twimg.com/media/DOnhIyGW4AIn1Qx?format=jpg&name=small'],https://twitter.com/davidsettle42/status/930523005335121920
5384,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-11-12T13:55:47.000Z,"Mackall:""CAR + Nivo marginally effective, ‚Äúin no way compares to on/off car‚Äù $JUNO $KITE $GILD $NVS $BMY $AZN $MRK","Mackall:""CAR + Nivo marginally effective, ‚Äúin no way compares to on/off car‚Äù $JUNO $KITE $GILD $NVS $BMY $AZN $MRK
1
5
5",,1,5,5,[],https://twitter.com/DrPaulyDeSantis/status/929709310908747778
5385,BQ Invest,@BQInvstTraining,2017-11-14T14:07:49.000Z,"Test your knowledge of the Dow Jones Industrial Average

30 Constituents of the #DJIA:
 
$GE $CAT $DD $DIS $CVX $XOM $GS $MSFT $WMT $CSCO 
$JNJ $VZ $NKE $MMM $PFE $JPM $INTC $KO $AAPL $V
$AXP $IBM $BA $MRK $UNH $HD $UTX $PG $MCD $TRV
 
@VenturelyNet
 
http://bit.ly/DJIA-Tidbits","Test your knowledge of the Dow Jones Industrial Average

30 Constituents of the #DJIA:
 
$GE $CAT $DD $DIS $CVX $XOM $GS $MSFT $WMT $CSCO 
$JNJ $VZ $NKE $MMM $PFE $JPM $INTC $KO $AAPL $V
$AXP $IBM $BA $MRK $UNH $HD $UTX $PG $MCD $TRV
 
@VenturelyNet
 
http://bit.ly/DJIA-Tidbits
1",,,,1,"['https://pbs.twimg.com/media/DOmR5Q8WkAAup4N?format=jpg&name=small', 'https://pbs.twimg.com/media/DOmR_iVXkAAYYt3?format=jpg&name=small']",https://twitter.com/BQInvstTraining/status/930437114520518656
5386,Olivia Voz,@TheVoz4Real,2017-11-14T18:27:04.000Z,"Wall Street bloodier than my November mani

 #wallstreet #nyse $GE $AAPL $V $MSFT $INTC $KO $PFE $MRK","Wall Street bloodier than my November mani

 #wallstreet #nyse $GE $AAPL $V $MSFT $INTC $KO $PFE $MRK
2
2
3",üåª,2,2,3,['https://pbs.twimg.com/media/DOnO9RGWkAAEa9c?format=jpg&name=small'],https://twitter.com/TheVoz4Real/status/930502356130762752
5387,GuruFocus,@gurufocus,2017-11-13T17:48:42.000Z,Jeff Auxier Establishes 6 Positions in 3rd Quarter https://gurufocus.com/news/594588 $DWDP $AON $GOOG $GVA $TSM $BCCLF $AIG $MRK $WFC $CVS,"Jeff Auxier Establishes 6 Positions in 3rd Quarter https://gurufocus.com/news/594588 $DWDP $AON $GOOG $GVA $TSM $BCCLF $AIG $MRK $WFC $CVS
1
1",,,1,1,['https://pbs.twimg.com/media/DOh8km7VQAANRu7?format=jpg&name=small'],https://twitter.com/gurufocus/status/930130312897748992
5388,Tech Savvy,@harekrishna2025,2017-11-13T12:22:48.000Z,$MRK buying   $ACAD?,"$MRK buying   $ACAD?
Merck
@Merck
 ¬∑ 13 Nov 2017
Thank you @BillGates for joining the fight against Alzheimer's disease and your continued partnership: http://bit.ly/2zzWDJS. We will continue to push the boundaries of science and invest in critical research to address this devastating disease. #InventingForLife
2",,,,2,['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg'],https://twitter.com/harekrishna2025/status/930048297812791297
5389,Scanz Alerts,@ScanzAlerts,2017-11-13T15:25:45.000Z,"BLOCK TRADE: $MRK 500,000 shares @ $55.40 [10:25:44]","BLOCK TRADE: $MRK 500,000 shares @ $55.40 [10:25:44]
2",,,2,,[],https://twitter.com/ScanzAlerts/status/930094337916133378
5390,Titan V,@titan_v16,2017-11-12T23:59:03.000Z,"Merck & Co.'s Patent Cliff In 2017 https://fool.com/investing/2016/10/27/merck-cos-patent-cliff-in-2017.aspx‚Ä¶ 

$MRK needs Keytruda to over-deliver but Keytruda only works in ~30% of patients.

$ONCS EP + Tavo can help turn cold tumors with  low TILs into hot and make majority of Keytruda non-responders respond. 

#SITC2017","Merck & Co.'s Patent Cliff In 2017 https://fool.com/investing/2016/10/27/merck-cos-patent-cliff-in-2017.aspx‚Ä¶ 

$MRK needs Keytruda to over-deliver but Keytruda only works in ~30% of patients.

$ONCS EP + Tavo can help turn cold tumors with  low TILs into hot and make majority of Keytruda non-responders respond. 

#SITC2017
fool.com
Merck & Co.'s Patent Cliff In 2017 @themotleyfool #stocks $MRK
The expiration of patents on some of the company's top-selling drugs poses big headwinds for investors.
2
1
12",,2,1,12,[],https://twitter.com/titan_v16/status/929861126229291009
5391,Zach Brennan,@ZacharyBrennan,2017-11-14T14:56:20.000Z,"On Q of whether FDA should only rely on user fees (as Trump wanted)? Unanimous no. $MRK SVP says: it‚Äôs not the money, it‚Äôs the balance #BPC3","On Q of whether FDA should only rely on user fees (as Trump wanted)? Unanimous no. $MRK SVP says: it‚Äôs not the money, it‚Äôs the balance #BPC3
2
2",,,2,2,[],https://twitter.com/ZacharyBrennan/status/930449323619430405
5392,Jack Allen,@JohnK_Allen,2017-11-13T14:07:45.000Z,"For perspective see Keytruda $MRK label melanoma data below, very early phase but if these results continue GR-MD-02 $GALT may have a place in melanoma 

$GALT P1 results - http://investor.galectintherapeutics.com/news-releases/news-release-details/combination-immunotherapy-pembrolizumab-galectin-3-inhibitor-gr‚Ä¶","For perspective see Keytruda $MRK label melanoma data below, very early phase but if these results continue GR-MD-02 $GALT may have a place in melanoma 

$GALT P1 results - http://investor.galectintherapeutics.com/news-releases/news-release-details/combination-immunotherapy-pembrolizumab-galectin-3-inhibitor-gr‚Ä¶
1",,,1,,['https://pbs.twimg.com/media/DOhKAtBXkAAlxav?format=jpg&name=small'],https://twitter.com/JohnK_Allen/status/930074708200083456
5393,John Carroll,@JohnCendpts,2017-11-13T13:09:12.000Z,"J&J antes $50M to get Zymeworks‚Äô 6th big bispecifics alliance underway, with $6B in total milestones on the table
$JNJ $ZYME $MRK etc","J&J antes $50M to get Zymeworks‚Äô 6th big bispecifics alliance underway, with $6B in total milestones on the table
$JNJ $ZYME $MRK etc
endpts.com
J&J antes $50M to get Zymeworks' 6th big bispecifics alliance underway, with $6B in total milesto...
Newly public Zymeworks $ZYME has just lined up its 6th major biopharma discovery alliance, this time bringing J&J $JNJ into a fold that already includes such big players as Merck, Eli Lilly, Celgene,...
6
5",,,6,5,['https://pbs.twimg.com/card_img/1500933418158284803/bln_xHdY?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/930059976764219392
5394,StockMarketVideo.com,@stockmarketvide,2017-11-14T01:43:12.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/930249727161131008
5395,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-11-13T10:49:42.000Z,"Replying to 
@odibro","Replying to 
@odibro
Great list of $ZYME partnerships now 5.5b Biotech$ from $MRK $LLY $CELG $GSK $JNJ 
http://ir.zymeworks.com/~/media/Files/Z/ZymeWorks-IR/documents/171113-zymeworks-corporate-deck.pdf‚Ä¶
-- this & more is what $AFMD investors expect
3
1
3",,3,1,3,"['https://pbs.twimg.com/media/DOgbwcGW0AA0qci?format=jpg&name=small', 'https://pbs.twimg.com/media/DOgcVr0X4AAuJMu?format=png&name=small']",https://twitter.com/dhovekamp42/status/930024871228211200
5396,FinInvTr,@FinInvTr,2017-11-13T21:05:19.000Z,"$NKTR / $BMY Combo Trial Positive in Phase I/II - https://buff.ly/2yx44Oj

PROPEL Study Designed to Confirm Efficacy Alongside $MRK $RHHBY Products","$NKTR / $BMY Combo Trial Positive in Phase I/II - https://buff.ly/2yx44Oj

PROPEL Study Designed to Confirm Efficacy Alongside $MRK $RHHBY Products
whotrades.com
Nektar/Bristol-Myers' Combo Trial Positive in Phase I/II
Nektar Therapeutics NKTR along with partner Bristol-Myers Squibb BMY announced positive interim data from dose-escalation part of a phase I/II study, evaluating the safety and‚Ä¶",,,,,[],https://twitter.com/FinInvTr/status/930179794234413056
5397,TalkMarkets,@TalkMarkets,2017-11-13T19:16:18.000Z,BMO Argues For #Biogen As Most Logical Takeover Target For #Pfizer $PFE $BIIB Also $BMY $MRK $AZN $LLY https://goo.gl/7QVY9S,BMO Argues For #Biogen As Most Logical Takeover Target For #Pfizer $PFE $BIIB Also $BMY $MRK $AZN $LLY https://goo.gl/7QVY9S,,,,,[],https://twitter.com/TalkMarkets/status/930152358453104640
5398,Siti van der Meij,@sitivandermeij,2017-11-13T18:35:20.000Z,"Syndax Pharma reports study results that support treatment benefit of entinostat, investors u... https://seekingalpha.com/news/3311543-syndax-pharma-reports-study-results-support-treatment-benefit-entinostat-investors-unmoved?source=feed_f‚Ä¶ $SNDX $MRK $L $NK‚Ä¶","Syndax Pharma reports study results that support treatment benefit of entinostat, investors u... https://seekingalpha.com/news/3311543-syndax-pharma-reports-study-results-support-treatment-benefit-entinostat-investors-unmoved?source=feed_f‚Ä¶ $SNDX $MRK $L $NK‚Ä¶
seekingalpha.com
Syndax Pharma reports study results that support treatment benefit of entinostat, investors unmoved...
Thinly traded micro cap Syndax Pharmaceuticals (SNDX -10.9%) slumps on 50% higher volume, albeit on turnover of only 153K shares, on the heels of its announcement of results from an...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/930142049785073664
5399,US Banking News,@AmericanBanking,2017-11-13T03:43:46.000Z,"$MRK - Merck & Company, Inc. #MRK Given Consensus Recommendation of ""Hold"" by Brokerages https://goo.gl/fb/WhkyL4","$MRK - Merck & Company, Inc. #MRK Given Consensus Recommendation of ""Hold"" by Brokerages https://goo.gl/fb/WhkyL4",,,,,[],https://twitter.com/AmericanBanking/status/929917677497470977
5400,Gooser,@gooser_fol,2017-11-13T07:22:46.000Z,Merck $MRK has an offer on the table for the purchase of Synergy Pharmaceuticals $SGYP https://investorwire.blogspot.it/2017/11/merck-mrk-has-offer-on-table-for.html?m=1‚Ä¶,"Merck $MRK has an offer on the table for the purchase of Synergy Pharmaceuticals $SGYP https://investorwire.blogspot.it/2017/11/merck-mrk-has-offer-on-table-for.html?m=1‚Ä¶
1",,1,,,[],https://twitter.com/gooser_fol/status/929972791885160448
5401,Stockboard Media Inc,@stockboardinc,2017-11-13T13:05:57.000Z,$MRK Merck Receives Positive CHMP Opinion for PREVYMIS‚Ñ¢ (letermovir) in the European Union... - http://sbml.co/b901b6f8,$MRK Merck Receives Positive CHMP Opinion for PREVYMIS‚Ñ¢ (letermovir) in the European Union... - http://sbml.co/b901b6f8,,,,,[],https://twitter.com/stockboardinc/status/930059156916178945
5402,Daily Political,@dailypoliticaln,2017-11-12T09:45:23.000Z,"Edgemoor Investment Advisors Inc. Cuts Stake in Merck & Company, Inc. $MRK http://ift.tt/2jlKfXn","Edgemoor Investment Advisors Inc. Cuts Stake in Merck & Company, Inc. $MRK http://ift.tt/2jlKfXn",,,,,[],https://twitter.com/dailypoliticaln/status/929646293911302145
5403,SpeculatingStocks.com Social Network for Investors,,2017-11-14T10:26:19.000Z,"Research $MRK with social data, financial data and a wealth of other data. No login required! http://speculatingstocks.com/pulse/pulse-portal/symbol-details.php?id=1287‚Ä¶","Research $MRK with social data, financial data and a wealth of other data. No login required! http://speculatingstocks.com/pulse/pulse-portal/symbol-details.php?id=1287‚Ä¶",,,,,[],https://twitter.com/specstockspulse/status/930381370542530560
5404,Sydnee R. Gatewood,@gurusydneerg,2017-11-13T17:47:49.000Z,Jeff Auxier Establishes 6 Positions in 3rd Quarter https://gurufocus.com/news/594588 $DWDP $AON $GOOG $GVA $TSM $BCCLF $AIG $MRK $WFC $CVS,"Jeff Auxier Establishes 6 Positions in 3rd Quarter https://gurufocus.com/news/594588 $DWDP $AON $GOOG $GVA $TSM $BCCLF $AIG $MRK $WFC $CVS
gurufocus.com
Jeff Auxier Establishes 6 Positions in 3rd Quarter
Guru releases quarterly portfolio",,,,,[],https://twitter.com/gurusydneerg/status/930130092566687744
5405,Titan V,@titan_v16,2017-11-14T01:30:56.000Z,I would be surprised if $MRK does not do a formal collaboration with $ONCS with upfront payment in coming months.,"I would be surprised if $MRK does not do a formal collaboration with $ONCS with upfront payment in coming months.
4",,,,4,[],https://twitter.com/titan_v16/status/930246639239008256
5406,Merck,@Merck,2017-11-13T13:08:41.000Z,Check out our latest news: http://bit.ly/2iRD0Tc $MRK,"Check out our latest news: http://bit.ly/2iRD0Tc $MRK
1
1
6",,1,1,6,[],https://twitter.com/Merck/status/930059847332188160
5407,Carly Helfand,@CarlyHFierce,2017-11-14T14:55:00.000Z,#ICYMI: Heron takes on Merck's Emend with FDA win for antinausea drug Cinvanti http://bit.ly/2mpXkQM $MRK #pharma,"#ICYMI: Heron takes on Merck's Emend with FDA win for antinausea drug Cinvanti http://bit.ly/2mpXkQM $MRK #pharma
fiercepharma.com
Heron takes on Merck's Emend with FDA win for antinausea drug Cinvanti
Merck‚Äôs drug for chemo-induced nausea and vomiting has some new competition. On Thursday, the FDA approved Cinvanti from California‚Äôs Heron Therapeutics, and it‚Äôll go up against the New Jersey pharma...",,,,,[],https://twitter.com/CarlyHFierce/status/930448988465020928
5408,Drugdoctor1,@Drugdoctor2014,2017-11-14T02:47:08.000Z,"$ICNB.0066 - Seriously? Penny stock has Top 5 rated Prosecco. Bellissima! 
@BellissimaByCB
 $TSCO $LVNTA $ILMN $SHPG $COST $MNST $MDLZ $WFM $SBAC  $VOD $TMUS $FAST $DAL $AAL $WFM $CERN $HSIC 
 $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ","$ICNB.0066 - Seriously? Penny stock has Top 5 rated Prosecco. Bellissima! 
@BellissimaByCB
 $TSCO $LVNTA $ILMN $SHPG $COST $MNST $MDLZ $WFM $SBAC  $VOD $TMUS $FAST $DAL $AAL $WFM $CERN $HSIC 
 $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ
vinepair.com
Popping Off: The Most Popular Prosecco Brands of 2017
It's the bubbliest time of the year, and we've got the info you need to get the best Prosecco out there for your end-of-year festivities.
2",,,,2,['https://pbs.twimg.com/card_img/1501956154993397767/445sjhVG?format=jpg&name=small'],https://twitter.com/Drugdoctor2014/status/930265814472720384
5409,FiercePharma,@FiercePharma,2017-11-14T20:04:15.000Z,"Amid deadly U.S. outbreaks, $MRK, $GSK face hep A vaccine shortage","Amid deadly U.S. outbreaks, $MRK, $GSK face hep A vaccine shortage
fiercepharma.com
Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid U.S. outbreaks
It was only August when Merck and GlaxoSmithKline had to deal with a global shortage of their hepatitis B vaccines, and now unexpected demand in the U.S. | It was only August when Merck and GlaxoSm...
2",,,2,,[],https://twitter.com/FiercePharma/status/930526814933585926
5410,Stockboard Media Inc,@stockboardinc,2017-11-13T19:05:12.000Z,$MRK Merck Announces Pricing of Any and All Tender Offers... - http://sbml.co/0ef726e6,$MRK Merck Announces Pricing of Any and All Tender Offers... - http://sbml.co/0ef726e6,,,,,[],https://twitter.com/stockboardinc/status/930149567600918529
5411,Ticker Report,@TickerReport,2017-11-14T09:32:11.000Z,"Ifrah Financial Services Inc. Trims Stake in Merck & Company, Inc. $MRK http://ift.tt/2AFu5vI","Ifrah Financial Services Inc. Trims Stake in Merck & Company, Inc. $MRK http://ift.tt/2AFu5vI",,,,,[],https://twitter.com/TickerReport/status/930367747686653954
5412,ValueTrades,@StockTradePicks,2017-11-13T18:24:03.000Z,MUST READ: Improved financials and insider buying: http://nasdaqnewsreports.blogspot.com/2017/11/rlog-improved-financials-and-insider.html‚Ä¶ $GOOG $F $CMCSA $KO $BRK.B $MO $MRK $CMG $NVDA $EBAY,MUST READ: Improved financials and insider buying: http://nasdaqnewsreports.blogspot.com/2017/11/rlog-improved-financials-and-insider.html‚Ä¶ $GOOG $F $CMCSA $KO $BRK.B $MO $MRK $CMG $NVDA $EBAY,,,,,[],https://twitter.com/StockTradePicks/status/930139208311758848
5413,Watchlist News,@WatchlistN,2017-11-12T09:39:27.000Z,"Alethea Capital Management LLC Has $1.31 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2ht4ouo","Alethea Capital Management LLC Has $1.31 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2ht4ouo",,,,,[],https://twitter.com/WatchlistN/status/929644800990744576
5414,Chuck Carnevale,@MarketsUpChuck,2017-11-13T17:21:21.000Z,"$TRV $MRK $AXP $GE $PFE $JPM
Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶","$TRV $MRK $AXP $GE $PFE $JPM
Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶",,,,,[],https://twitter.com/MarketsUpChuck/status/930123431210897408
5415,MarketBeat,@MarketBeatCom,2017-11-13T09:43:23.000Z,"Strategy Asset Managers LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2jkTmYx","Strategy Asset Managers LLC Decreases Stake in Merck & Company, Inc. $MRK http://ift.tt/2jkTmYx",,,,,[],https://twitter.com/MarketBeatCom/status/930008180293292032
5416,The Fly,@theflynews,2017-11-13T12:52:59.000Z,BMO says Pfizer buying Biogen makes more sense than deal for Bristol-Myers $BIIB $PFE $BMY $MRK $AZN $LLY,"BMO says Pfizer buying Biogen makes more sense than deal for Bristol-Myers $BIIB $PFE $BMY $MRK $AZN $LLY
thefly.com
BMO says Pfizer buying Biogen makes more sense than deal for Bristol-Myers
BMO Capital analyst Alex ... BIIB, PFE, BMY, MRK, AZN, LLY
1",,,1,,[],https://twitter.com/theflynews/status/930055894011805704
5417,Briefing.com,@Briefingcom,2017-11-13T15:01:33.000Z,$MRK: Merck: CHMP of the EMA has adopted a positive opinion recommending approval of PREVYMIS for prophylaxis of... http://bit.ly/2zyulzt,$MRK: Merck: CHMP of the EMA has adopted a positive opinion recommending approval of PREVYMIS for prophylaxis of... http://bit.ly/2zyulzt,,,,,[],https://twitter.com/Briefingcom/status/930088247950155777
5418,Merck,@Merck,2017-11-13T20:02:47.000Z,Click here for our latest news: http://bit.ly/2yYpyry $MRK,"Click here for our latest news: http://bit.ly/2yYpyry $MRK
1
1
3",,1,1,3,[],https://twitter.com/Merck/status/930164055398109185
5419,The Fly,@theflynews,2017-11-13T16:08:02.000Z,BMO argues for Biogen as most logical takeover target for Pfizer $PFE $BIIB $BMY $MRK $AZN $LLY,"BMO argues for Biogen as most logical takeover target for Pfizer $PFE $BIIB $BMY $MRK $AZN $LLY
thefly.com
BMO argues for Biogen as most logical takeover target for Pfizer
Commenting on ""signi... PFE, BIIB, BMY, MRK, AZN, LLY
1",,1,,,[],https://twitter.com/theflynews/status/930104979322413057
5420,Zach Brennan,@ZacharyBrennan,2017-11-14T14:22:55.000Z,"$MRK SVP says risks are high to using real world data, still believe randomized controlled trials are gold standard","$MRK SVP says risks are high to using real world data, still believe randomized controlled trials are gold standard
1
1",,1,1,,[],https://twitter.com/ZacharyBrennan/status/930440913897316352
5421,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-11-14T13:11:25.000Z,"Replying to 
@cornel6m","Replying to 
@cornel6m
Well since $GSK took the NY-ESO option in September early ;) --  and $MRK didn't halt the only remaining Keytruda combo trial in multiple #myeloma ...
1",,,,1,[],https://twitter.com/dhovekamp42/status/930422922510000129
5422,Merck,@Merck,2017-11-14T12:18:20.000Z,Take a look at our latest news: http://bit.ly/2jpw1oy $MRK,"Take a look at our latest news: http://bit.ly/2jpw1oy $MRK
1
2",,,1,2,[],https://twitter.com/Merck/status/930409563253329920
5423,LeConte Wealth,@lecontewealth,2017-11-13T22:10:17.000Z,"Replying to 
@87Spider","Replying to 
@87Spider
Here's a fun story about $JDSU addition to the S&P 500 in July 2000. 
http://on.mktw.net/2hwPkvs

You are right about blue chips. $KO was something like 70x eps. $MRK was crazy too. You couldn't talk anyone into selling though!",,,,,[],https://twitter.com/lecontewealth/status/930196144877113344
5424,MarketBeat,@MarketBeatCom,2017-11-13T03:47:21.000Z,"Merck & Company, Inc. $MRK Given Consensus Recommendation of ‚ÄúHold‚Äù by Brokerages http://ift.tt/2zxfTaZ #acn","Merck & Company, Inc. $MRK Given Consensus Recommendation of ‚ÄúHold‚Äù by Brokerages http://ift.tt/2zxfTaZ #acn",,,,,[],https://twitter.com/MarketBeatCom/status/929918581294485504
5425,Transcript Daily,@TranscriptDaily,2017-11-13T09:43:36.000Z,"Merck & Company, Inc. $MRK Holdings Lifted by Victory Capital Management Inc. http://ift.tt/2i8Angv","Merck & Company, Inc. $MRK Holdings Lifted by Victory Capital Management Inc. http://ift.tt/2i8Angv",,,,,[],https://twitter.com/TranscriptDaily/status/930008236161486849
5426,StockNews.com,@stocknewsdotcom,2017-11-13T13:01:29.000Z,$MRK CHMP of the EMA has adopted a positive opinion recommending approval of PREVYMIS for prophylaxis of cytomegal‚Ä¶ https://stocknews.com/news/mrk-chmp-of-the-ema-has-adopted-a-positive-opinion-recommending/‚Ä¶,$MRK CHMP of the EMA has adopted a positive opinion recommending approval of PREVYMIS for prophylaxis of cytomegal‚Ä¶ https://stocknews.com/news/mrk-chmp-of-the-ema-has-adopted-a-positive-opinion-recommending/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/930058034482765825
5427,Robert Langreth,@RobertLangreth,2017-11-15T14:01:24.000Z,"A $5 billion startup. Its totally personalized cancer vaccine to teach the body to fight cancer. Can it finally succeed when every other company that tried has failed?  http://ow.ly/gEYF30gATFT $MRK 
@CarolineYLChen","A $5 billion startup. Its totally personalized cancer vaccine to teach the body to fight cancer. Can it finally succeed when every other company that tried has failed?  http://ow.ly/gEYF30gATFT $MRK 
@CarolineYLChen
bloomberg.com
This $5 Billion Startup Made Its First Cancer Vaccine‚ÄîFor Just One Person
Moderna claims it can upend how drugs are made.
1
4
4",,1,4,4,[],https://twitter.com/RobertLangreth/status/930797887843422209
5428,Jacob Plieth,@JacobPlieth,2017-11-15T11:33:06.000Z,"$BMY stresses that 1L  NSCLC strategy is 4 studies, not 1. I've attempted to summarise is here #Jefferies17 $MRK $RHHBY $AZN","$BMY stresses that 1L  NSCLC strategy is 4 studies, not 1. I've attempted to summarise is here #Jefferies17 $MRK $RHHBY $AZN
2
8
12",,2,8,12,['https://pbs.twimg.com/media/DOq5tWLW4AA1Aac?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/930760567161344000
5429,dough,@semodough,2017-11-16T20:29:11.000Z,"Replying to 
@BioValues","Replying to 
@BioValues
$LPTX catalyst page busy 2018 coming Mcap 70 million.   #GITR #DKN $MRK $LLY $NVS
1
8
10",,1,8,10,['https://pbs.twimg.com/media/DOx-FrcXkAEPpjK?format=jpg&name=small'],https://twitter.com/semodough/status/931257865767129088
5430,Breaking News,@MarketCurrents,2017-11-15T14:46:22.000Z,Agenus receives $4M from Merck for advancement of antibody https://seekingalpha.com/news/3312474-agenus-receives-4m-merck-advancement-antibody?source=feed_f‚Ä¶ $MRK $AGEN,"Agenus receives $4M from Merck for advancement of antibody https://seekingalpha.com/news/3312474-agenus-receives-4m-merck-advancement-antibody?source=feed_f‚Ä¶ $MRK $AGEN
seekingalpha.com
Agenus receives $4M from Merck for advancement of antibody (NYSE:MRK)
Merck (MRK -0.1%) has paid collaboration partner Agenus (AGEN) $4M for the advancement of an undisclosed candidate under their April 2014 agreement aimed at developing therapeutic...",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/930809202838142976
5431,Sicarius,@is_matrix,2017-11-15T20:39:40.000Z,Adding some $MRK at 54.45 today...,"Adding some $MRK at 54.45 today...
1",üò≥ üò≥ üò≥,,,1,['https://pbs.twimg.com/media/DOs25S9U8AASX4m?format=jpg&name=small'],https://twitter.com/is_matrix/status/930898113841303558
5432,Cavalli Picks,@cavallimedia1,2017-11-17T21:00:33.000Z,My followers bought $JUNO at $17 recently and now they are buying $NWBO at $.23 #cnbc #wsj $GILD $MRK $BMY - BIG NEWS SOON!,"My followers bought $JUNO at $17 recently and now they are buying $NWBO at $.23 #cnbc #wsj $GILD $MRK $BMY - BIG NEWS SOON!
1
1
7",,1,1,7,[],https://twitter.com/cavallimedia1/status/931628145932886016
5433,Vista Partners LLC,@VistaPResearch,2017-11-16T16:19:33.000Z,#BreastCancer Innovative Firm Atossa Genetics $ATOS Publishes Q3 Results http://vistapglobal.com/2017/11/breast-cancer-innovative-firm-atossa-genetics-atos-publishes-q3-results/‚Ä¶ #biotech #stocks $IBB $MRK $JNJ $UNH,"#BreastCancer Innovative Firm Atossa Genetics $ATOS Publishes Q3 Results http://vistapglobal.com/2017/11/breast-cancer-innovative-firm-atossa-genetics-atos-publishes-q3-results/‚Ä¶ #biotech #stocks $IBB $MRK $JNJ $UNH
GIF
2
2",,,2,2,['https://pbs.twimg.com/tweet_video_thumb/DOxE81rVAAAb-bQ.jpg'],https://twitter.com/VistaPResearch/status/931195043020337152
5434,OptionsPro MaxPain,@OptionsMaxPain,2017-11-15T16:59:10.000Z,#Options #maxpain chart for $MRK. Free options app http://mystockstation.com,#Options #maxpain chart for $MRK. Free options app http://mystockstation.com,,,,,['https://pbs.twimg.com/media/DOsEbojW0AA3TkU?format=jpg&name=small'],https://twitter.com/OptionsMaxPain/status/930842623069380609
5435,Michael Goodman,@mikegoodma,2017-11-15T20:10:57.000Z,$AUPH deal gives $MRK animal health WW rights to VOS for dry eye in dogs. MRK developed/sells Optimmune for dry eye in dogs; it is the equivalent of Restasis in humans.,"$AUPH deal gives $MRK animal health WW rights to VOS for dry eye in dogs. MRK developed/sells Optimmune for dry eye in dogs; it is the equivalent of Restasis in humans.
3
7",,,3,7,[],https://twitter.com/mikegoodma/status/930890887789514754
5436,max pain,@optioncharts,2017-11-15T21:03:31.000Z,$MRK high OI range is 55.00 to 65.00 for option expiration 11/17/2017 #maxpain #options http://bit.ly/2iIh4Kt,$MRK high OI range is 55.00 to 65.00 for option expiration 11/17/2017 #maxpain #options http://bit.ly/2iIh4Kt,,,,,['https://pbs.twimg.com/media/DOs8XARXkAAJPCC?format=jpg&name=small'],https://twitter.com/optioncharts/status/930904117018578946
5437,max pain,@optioncharts,2017-11-15T01:13:58.000Z,$MRK open interest for maturity 11/17/2017. High put=55.00 High call=65.00 #maxpain #options http://bit.ly/2iIh4Kt,$MRK open interest for maturity 11/17/2017. High put=55.00 High call=65.00 #maxpain #options http://bit.ly/2iIh4Kt,,,,,['https://pbs.twimg.com/media/DOosGA0WkAAjEr2?format=jpg&name=small'],https://twitter.com/optioncharts/status/930604756577538049
5438,Kananda Barrons,@KanandaBarrons,2017-11-15T15:24:36.000Z,"$AGEN 
@Agenus_Bio
 Receives License Fee of $4 Million USD from $MRK, and it's  entitled up to an additional $99 Million USD in success milestones plus Royalties on sales. http://investor.agenusbio.com/2017-11-15-Agenus-Receives-License-Fee-of-4-Million-USD-from-Merck#.WgxSkKtnyO8.twitter‚Ä¶","$AGEN 
@Agenus_Bio
 Receives License Fee of $4 Million USD from $MRK, and it's  entitled up to an additional $99 Million USD in success milestones plus Royalties on sales. http://investor.agenusbio.com/2017-11-15-Agenus-Receives-License-Fee-of-4-Million-USD-from-Merck#.WgxSkKtnyO8.twitter‚Ä¶
1
2
4",,1,2,4,[],https://twitter.com/KanandaBarrons/status/930818824655593472
5439,Cavalli Picks,@cavallimedia1,2017-11-17T21:15:26.000Z,$NWBO mkt spread just increased to 2 cents. Supply is fading fast! #cnbc #wsj $GILD $MRK $BMY,"$NWBO mkt spread just increased to 2 cents. Supply is fading fast! #cnbc #wsj $GILD $MRK $BMY
1
3",,,1,3,[],https://twitter.com/cavallimedia1/status/931631891949563904
5440,Chuck Carnevale,@MarketsUpChuck,2017-11-17T20:12:28.000Z,"$TRV $MRK $AXP $GE $PFE $JPM
FAST Graphs Analysis","$TRV $MRK $AXP $GE $PFE $JPM
FAST Graphs Analysis
youtube.com
Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
Pfizer Inc. (PFE), J.P. Morgan Chase and Company and General Electric Company (GE) appear fairly valued.American Express Company (AXP), Merck and Co. Inc. (M...
3
2",,,3,2,[],https://twitter.com/MarketsUpChuck/status/931616043952459777
5441,Deep Dive,@deepxdive,2017-11-17T13:00:47.000Z,"$MRK Merck & Co., Inc.  MRK-US  Earnings Analysis  Q3, 2017 By the Numbers   November 16, 2017 https://online.capitalcube.com/#!/stock/US/exchange/MRK/Earningsreleaseaol‚Ä¶","$MRK Merck & Co., Inc.  MRK-US  Earnings Analysis  Q3, 2017 By the Numbers   November 16, 2017 https://online.capitalcube.com/#!/stock/US/exchange/MRK/Earningsreleaseaol‚Ä¶",,,,,['https://pbs.twimg.com/media/DO1hDMYW0AACV-d?format=jpg&name=small'],https://twitter.com/deepxdive/status/931507407334854656
5442,Patrick Byrd,@PByrd112,2017-11-15T20:26:43.000Z,"have you tried this? i've been getting in on some amazing trades through it http://bit.ly/2yraNK0
$MOD $MRK $MCD","have you tried this? i've been getting in on some amazing trades through it http://bit.ly/2yraNK0
$MOD $MRK $MCD",,,,,['https://pbs.twimg.com/media/DOsz78HVQAAeql7?format=jpg&name=small'],https://twitter.com/PByrd112/status/930894857098457089
5443,SmallCapOwl,@SmallCapOwl,2017-11-15T17:20:11.000Z,"$AHGIF ""Alternate Health is committed to continuing development and evolution in this exciting space and looks forward to meeting the top programmers and business minds that Devcon3 has to offer."" $IBB $GWPH $NVS $PFE $MRK $JNJ","$AHGIF ""Alternate Health is committed to continuing development and evolution in this exciting space and looks forward to meeting the top programmers and business minds that Devcon3 has to offer."" $IBB $GWPH $NVS $PFE $MRK $JNJ",,,,,[],https://twitter.com/SmallCapOwl/status/930847914297085953
5444,Chameleon Options,@MC_OptionTrades,2017-11-17T03:05:48.000Z,Price Moves vs Expected Moves $ENDP $CELG $MDCO $TEVA $AGN $BMY $GILD $MRK $PFE $ALXN $JNJ $VRX http://tinyurl.com/y7zbwhgq,Price Moves vs Expected Moves $ENDP $CELG $MDCO $TEVA $AGN $BMY $GILD $MRK $PFE $ALXN $JNJ $VRX http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DOzY3oTVAAEqTUx?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/931357675375546373
5445,Chameleon Options,@MC_OptionTrades,2017-11-17T22:33:23.000Z,Price Returns vs Expected Daily Move $TEVA $VRX $SRPT $OPK $CELG $MRK $GILD $AGN $ABT $PFE $BMY $CLVS http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $TEVA $VRX $SRPT $OPK $CELG $MRK $GILD $AGN $ABT $PFE $BMY $CLVS http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DO3kHAxW0AE0pgY?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/931651509414187008
5446,Chameleon Options,@MC_OptionTrades,2017-11-15T01:07:28.000Z,Price Returns vs Expected Daily Move $PFE $TEVA $MRK $BKD $THC $VRX $REGN $CELG $GILD $PTCT $AERI $SGYP http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $PFE $TEVA $MRK $BKD $THC $VRX $REGN $CELG $GILD $PTCT $AERI $SGYP http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DOoqmw5WkAEY_gV?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/930603121742663680
5447,G,@smokiemahoney,2017-11-17T21:13:13.000Z,$GALT is going to turn alot of heads with topline data on its #NASH Drug come early December. If $TBRA @ <$5was bought out on *failed* p3 data for 1.8bil/$28ps by $AGN that just goes to show the need in this niche by big pharma (my guess $MRK) Nice buying the last few sessions.,"$GALT is going to turn alot of heads with topline data on its #NASH Drug come early December. If $TBRA @ <$5was bought out on *failed* p3 data for 1.8bil/$28ps by $AGN that just goes to show the need in this niche by big pharma (my guess $MRK) Nice buying the last few sessions.
G
@smokiemahoney
 ¬∑ 13 Nov 2017
People finally realizing the value in $GALT news this morning. Filled the gap back down to the penny $2.65,  now breaking out‚Äîstrength in this move.   +6% educated guess is it will climb into Data beginning of Dec. https://twitter.com/gmaloneyy/status/930081707251904512‚Ä¶",,,,,['https://pbs.twimg.com/profile_images/1494747087954710528/GYTaV_YF_mini.jpg'],https://twitter.com/smokiemahoney/status/931631335529172993
5448,Jason Stewart,@JStewart2625,2017-11-16T19:48:07.000Z,"I highly recommend everyone check this out for finding good stocks to trade http://bit.ly/2yqIzzd
$KORS $MGM $MRK","I highly recommend everyone check this out for finding good stocks to trade http://bit.ly/2yqIzzd
$KORS $MGM $MRK",,,,,['https://pbs.twimg.com/media/DOx0sWEV4AAGeIU?format=jpg&name=small'],https://twitter.com/JStewart2625/status/931247531295760384
5449,Tim Reller,@TraderGuruNY,2017-11-15T00:59:29.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/930601111555276800
5450,Jack Allen,@JohnK_Allen,2017-11-15T23:13:13.000Z,"In your opinion which IDO inhibitor shows the most promise?

Please vote and RT to expand sample size

Comment with opinions supporting your choice

$NLNK $BMY $INCY $MRK $XBI $IBB #SITC17","In your opinion which IDO inhibitor shows the most promise?

Please vote and RT to expand sample size

Comment with opinions supporting your choice

$NLNK $BMY $INCY $MRK $XBI $IBB #SITC17
Indoximod (NLNK)
19.6%
BMS-986205 (BMY)
12.5%
Epacadostat (INCY)
51.8%
None are promising
16.1%
56 votes
¬∑
Final results
1
1
1",,1,1,1,[],https://twitter.com/JohnK_Allen/status/930936759118192642
5451,TickWatcher,@MITickWatcher,2017-11-16T21:05:04.000Z,"Top #moneyflow for #sp500 today
$CSCO $GE $C $JPM $ORCL $GOOG $MRK $CBS $FLR $EXPE ...","Top #moneyflow for #sp500 today
$CSCO $GE $C $JPM $ORCL $GOOG $MRK $CBS $FLR $EXPE ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/931266895109672960
5452,Andrea Magri,@magririzzi,2017-11-15T14:48:49.000Z,Agenus receives $4M from Merck for advancement of antibody $MRK $AGEN,"Agenus receives $4M from Merck for advancement of antibody $MRK $AGEN
seekingalpha.com
Agenus receives $4M from Merck for advancement of antibody (NYSE:MRK)
Merck (MRK -0.1%) has paid collaboration partner Agenus (AGEN) $4M for the advancement of an undisclosed candidate under their April 2014 agreement aimed at developing therapeutic...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/magririzzi/status/930809822529933313
5453,Kara Jill Stancell,@kjilly,2017-11-17T23:52:05.000Z,"$MRK will miss long-promised target for filing #Ebola #vaccine license with #FDA #pharma #biotech https://statnews.com/2017/11/17/merck-ebola-vaccine-fda/‚Ä¶ via 
@statnews","$MRK will miss long-promised target for filing #Ebola #vaccine license with #FDA #pharma #biotech https://statnews.com/2017/11/17/merck-ebola-vaccine-fda/‚Ä¶ via 
@statnews
statnews.com
Merck will miss long-promised target for filing Ebola vaccine license with FDA
Though Merck had repeatedly said it would file its application with the FDA by the end of 2017, the company will not meet that self-imposed target.",,,,,['https://pbs.twimg.com/card_img/1501445614730715138/7G2EDgFa?format=jpg&name=small'],https://twitter.com/kjilly/status/931671312732266496
5454,US Banking News,@AmericanBanking,2017-11-16T18:13:17.000Z,Merck & Company's buy rating reiterated at Sanford C. Bernstein. $64.00 PT. http://ift.tt/2AMkx21 $MRK #MRK,Merck & Company's buy rating reiterated at Sanford C. Bernstein. $64.00 PT. http://ift.tt/2AMkx21 $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/931223665756295172
5455,Billy Kaos,@billykaos,2017-11-16T00:25:51.000Z,"Omfg, $MRK's #Belsomra commercial is the funniest 
@nbcsnl
 skit in 20 years...#WTActualF","Omfg, $MRK's #Belsomra commercial is the funniest 
@nbcsnl
 skit in 20 years...#WTActualF
1",,,,1,[],https://twitter.com/billykaos/status/930955036657668097
5456,leahanne,@leahanneta,2017-11-16T16:11:54.000Z,"10:35 ET Volume Leader #94 - MRK 1,106,218 Merck & Company $MRK 55.06 +0.26 +0.47% High today of 55.15 day low","10:35 ET Volume Leader #94 - MRK 1,106,218 Merck & Company $MRK 55.06 +0.26 +0.47% High today of 55.15 day low
investorshangout.com
10:35 ET Volume Leader #94 - MRK - Stock DD Board #4844782 - Investors Hangout
Stock DD Board: 10:35 ET Volume Leader #94 - MRK 1,106,218 Merck Company $MRK 55.06 +0.26 +0.47% High today of 55. - #4844782",,,,,['https://pbs.twimg.com/card_img/1489662400739565568/VIdpQtc3?format=png&name=240x240'],https://twitter.com/leahanneta/status/931193118006960133
5457,MarketBeat,@MarketBeatCom,2017-11-16T18:34:31.000Z,"Merck & Company, Inc. $MRK Rating Reiterated by Sanford C. Bernstein http://ift.tt/2yOY6IY #acn","Merck & Company, Inc. $MRK Rating Reiterated by Sanford C. Bernstein http://ift.tt/2yOY6IY #acn",,,,,[],https://twitter.com/MarketBeatCom/status/931229007324033025
5458,AlpacaAlerts,@AlpacaAlerts,2017-11-17T01:29:00.000Z,$MRK is in MACD Golden Cross winning 61.36% in the past. https://goo.gl/wLrwVD,$MRK is in MACD Golden Cross winning 61.36% in the past. https://goo.gl/wLrwVD,,,,,[],https://twitter.com/AlpacaAlerts/status/931333314904035328
5459,F.A.S.T. Graphs,@FASTGraphs,2017-11-15T17:41:48.000Z,Commented on https://seekingalpha.com/article/4114628-6-dow-stocks-fairly-valued-part-4-5?source=tweet&sht=ozgzto&shu=950v#comment-76821505‚Ä¶ $PFE $JPM $GE $AXP $MRK $TRV,Commented on https://seekingalpha.com/article/4114628-6-dow-stocks-fairly-valued-part-4-5?source=tweet&sht=ozgzto&shu=950v#comment-76821505‚Ä¶ $PFE $JPM $GE $AXP $MRK $TRV,,,,,[],https://twitter.com/FASTGraphs/status/930853354778935296
5460,Transcript Daily,@TranscriptDaily,2017-11-15T09:58:28.000Z,"American Century Companies Inc. Has $403.61 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2hAUlmM","American Century Companies Inc. Has $403.61 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2hAUlmM",,,,,[],https://twitter.com/TranscriptDaily/status/930736752997912576
5461,Daily Political,@dailypoliticaln,2017-11-16T09:41:19.000Z,"Merck & Company, Inc. $MRK Stake Increased by Hanson McClain Inc. http://ift.tt/2zNkWBI","Merck & Company, Inc. $MRK Stake Increased by Hanson McClain Inc. http://ift.tt/2zNkWBI",,,,,[],https://twitter.com/dailypoliticaln/status/931094821883740160
5462,Roger Ocasio-Clinton,@Roger_Clinton1,2017-11-16T13:31:12.000Z,Agenus receives $4M from Merck for advancement of antibody $MRK $AGEN,"Agenus receives $4M from Merck for advancement of antibody $MRK $AGEN
seekingalpha.com
Agenus receives $4M from Merck for advancement of antibody (NYSE:MRK)
Merck (MRK -0.1%) has paid collaboration partner Agenus (AGEN) $4M for the advancement of an undisclosed candidate under their April 2014 agreement aimed at developing therapeutic...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/Roger_Clinton1/status/931152676993290240
5463,Watchlist News,@WatchlistN,2017-11-16T09:45:27.000Z,"Merck & Company, Inc. $MRK Holdings Boosted by GFS Advisors LLC http://ift.tt/2ijOgZc","Merck & Company, Inc. $MRK Holdings Boosted by GFS Advisors LLC http://ift.tt/2ijOgZc",,,,,[],https://twitter.com/WatchlistN/status/931095864633954304
5464,Watchlist News,@WatchlistN,2017-11-15T09:40:29.000Z,"Mastrapasqua Asset Management Inc. Sells 450 Shares of Merck & Company, Inc. $MRK http://ift.tt/2z3PLVK","Mastrapasqua Asset Management Inc. Sells 450 Shares of Merck & Company, Inc. $MRK http://ift.tt/2z3PLVK",,,,,[],https://twitter.com/WatchlistN/status/930732225317961728
5465,Ticker Report,@TickerReport,2017-11-16T09:44:14.000Z,"Merck & Company, Inc. $MRK Position Reduced by Essex Financial Services Inc. http://ift.tt/2jvePxY","Merck & Company, Inc. $MRK Position Reduced by Essex Financial Services Inc. http://ift.tt/2jvePxY",,,,,[],https://twitter.com/TickerReport/status/931095558848118784
5466,US Banking News,@AmericanBanking,2017-11-16T21:43:07.000Z,Merck & $MRK ‚Äì Analysts‚Äô Recent Ratings Changes http://ift.tt/2A4Vvi3,Merck & $MRK ‚Äì Analysts‚Äô Recent Ratings Changes http://ift.tt/2A4Vvi3,,,,,[],https://twitter.com/AmericanBanking/status/931276472328839169
5467,US Banking News,@AmericanBanking,2017-11-16T18:38:31.000Z,"Merck & Company, Inc. $MRK Rating Reiterated by Sanford C. Bernstein http://ift.tt/2z7QxRG","Merck & Company, Inc. $MRK Rating Reiterated by Sanford C. Bernstein http://ift.tt/2z7QxRG",,,,,[],https://twitter.com/AmericanBanking/status/931230013478850560
5468,Daily Political,@dailypoliticaln,2017-11-17T09:41:25.000Z,"Merck & Company, Inc. $MRK Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA http://ift.tt/2z8GQ5j","Merck & Company, Inc. $MRK Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA http://ift.tt/2z8GQ5j",,,,,[],https://twitter.com/dailypoliticaln/status/931457235989024768
5469,Finbox,@FinboxIO,2017-11-17T23:45:10.000Z,"Merck & Company, Inc. $MRK has 14% upside and this prominent investor owns it. Time to buy? http://ow.ly/aj0630gzqik","Merck & Company, Inc. $MRK has 14% upside and this prominent investor owns it. Time to buy? http://ow.ly/aj0630gzqik",,,,,[],https://twitter.com/FinboxIO/status/931669571722973184
5470,MarketBeat,@MarketBeatCom,2017-11-17T09:44:08.000Z,"Strategic Financial Group LLC Purchases 1,105 Shares of Merck & Company, Inc. $MRK http://ift.tt/2AOiAlp","Strategic Financial Group LLC Purchases 1,105 Shares of Merck & Company, Inc. $MRK http://ift.tt/2AOiAlp",,,,,[],https://twitter.com/MarketBeatCom/status/931457922198130689
5471,SwingTradeBot,@SwingTradeBot,2017-11-15T15:32:40.000Z,Recent $MRK technical alerts: NR7 plus 6 more alerts...,"Recent $MRK technical alerts: NR7 plus 6 more alerts...
swingtradebot.com
MRK Stock Technical Analysis | Merck & Company, Inc.
Current Technical Analysis and interactive chart for $MRK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.",,,,,['https://pbs.twimg.com/card_img/1498505809260650497/nUNAsUfD?format=jpg&name=small'],https://twitter.com/SwingTradeBot/status/930820855080288257
5472,Michael Goodman,@mikegoodma,2017-11-16T19:56:07.000Z,"Price pledges are nothing new, though the ceiling has moved up. In 1990, $MRK made a public pledge to keep drug price increases at or below the rate of inflation.","Price pledges are nothing new, though the ceiling has moved up. In 1990, $MRK made a public pledge to keep drug price increases at or below the rate of inflation.
1
1
1",,1,1,1,[],https://twitter.com/mikegoodma/status/931249544691638272
5473,BioPharm Insight,@BioPharmInsight,2017-11-16T14:59:51.000Z,"How has $MRK negotiated with the #UK‚Äôs #NICE on its #MS drug Mavenclad? Read 
@BioPharmInsight
 for the breaking #news http://bit.ly/2hE1S4x","How has $MRK negotiated with the #UK‚Äôs #NICE on its #MS drug Mavenclad? Read 
@BioPharmInsight
 for the breaking #news http://bit.ly/2hE1S4x",,,,,[],https://twitter.com/BioPharmInsight/status/931174985556791298
5474,BioPharm Insight,@BioPharmInsight,2017-11-17T14:30:00.000Z,"What‚Äôs the latest news on $MRK‚Äôs discussions with the #UK‚Äôs #NICE on #MS drug Mavenclad? 
@BioPharmInsight
 gets the scoop http://bit.ly/2hE1S4x","What‚Äôs the latest news on $MRK‚Äôs discussions with the #UK‚Äôs #NICE on #MS drug Mavenclad? 
@BioPharmInsight
 gets the scoop http://bit.ly/2hE1S4x
1",,,1,,[],https://twitter.com/BioPharmInsight/status/931529860773826565
5475,The Fly,@theflynews,2017-11-16T11:03:03.000Z,Jefferies names Roche new top global pick in Pharmaceuticals $RHHBY $ABBV $NVS $BAYRY $JNJ $ZTS $LLY $MRK $NVO $AZN,"Jefferies names Roche new top global pick in Pharmaceuticals $RHHBY $ABBV $NVS $BAYRY $JNJ $ZTS $LLY $MRK $NVO $AZN
thefly.com
Jefferies names Roche new top global pick in Pharmaceuticals
Jefferies analyst Jeffrey... RHHBY, ABBV, NVS, BAYRY, JNJ, ZTS, LLY, MRK, NVO, AZN
2",,,,2,[],https://twitter.com/theflynews/status/931115390398169089
5476,Zero Filter,@zerofiltertruth,2017-11-15T22:47:19.000Z,"How can Ind recount #Trian #NelsonPeltz be so far off $PG 's original ? - Scamatology committed by Co / Board ?? 

$SPY $QQQ $TBT $VXX $CL $MRK 
@CNBC
 @jimcramer
 @jlebenthal","How can Ind recount #Trian #NelsonPeltz be so far off $PG 's original ? - Scamatology committed by Co / Board ?? 

$SPY $QQQ $TBT $VXX $CL $MRK 
@CNBC
 @jimcramer
 @jlebenthal
1",,,,1,[],https://twitter.com/zerofiltertruth/status/930930238439284736
5477,Sue Sutter,@PinkSheetSutter,2017-11-15T14:59:12.000Z,"@US_FDA
's McKee - $MRK Keytruda received accelerated approval, not regular approval, for tissue-agnostic MSI high because agency wanted long term followup on durability of response @FriendsAM17","@US_FDA
's McKee - $MRK Keytruda received accelerated approval, not regular approval, for tissue-agnostic MSI high because agency wanted long term followup on durability of response @FriendsAM17
1",,,1,,[],https://twitter.com/PinkSheetSutter/status/930812435547779074
5478,MarketBeat,@MarketBeatCom,2017-11-16T21:49:19.000Z,Merck & $MRK ‚Äì Analysts‚Äô Recent Ratings Changes http://ift.tt/2yPTr9F #acn,Merck & $MRK ‚Äì Analysts‚Äô Recent Ratings Changes http://ift.tt/2yPTr9F #acn,,,,,[],https://twitter.com/MarketBeatCom/status/931278029539520512
5479,Siti van der Meij,@sitivandermeij,2017-11-15T14:50:22.000Z,Agenus receives $4M from Merck for advancement of antibody https://seekingalpha.com/news/3312474-agenus-receives-4m-merck-advancement-antibody?source=feed_f‚Ä¶ $MRK $AGEN #sitifatimah #malaysia #financialplanning,"Agenus receives $4M from Merck for advancement of antibody https://seekingalpha.com/news/3312474-agenus-receives-4m-merck-advancement-antibody?source=feed_f‚Ä¶ $MRK $AGEN #sitifatimah #malaysia #financialplanning
seekingalpha.com
Agenus receives $4M from Merck for advancement of antibody (NYSE:MRK)
Merck (MRK -0.1%) has paid collaboration partner Agenus (AGEN) $4M for the advancement of an undisclosed candidate under their April 2014 agreement aimed at developing therapeutic...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/930810210847023105
5480,Wayne,@wyv_123,2017-11-19T04:17:58.000Z,Melinda Welsh beat the odds with cancer drugs from $ONCS and $MRK.,"Melinda Welsh beat the odds with cancer drugs from $ONCS and $MRK.
latimes.com
Op-Ed: I have terminal cancer and I know my friends want to ask, 'Aren‚Äôt you dead yet?'
Last December I wrote an essay for The Times about what I wanted to do with my life after I was diagnosed with terminal cancer.
16
25",,,16,25,['https://pbs.twimg.com/card_img/1500091005365854216/yv27byeN?format=jpg&name=small'],https://twitter.com/wyv_123/status/932100614653382656
5481,Yahoo Finance,@YahooFinance,2017-11-20T21:03:31.000Z,"Today's #Stocks Losers: $LYV, $MRK, $CAH http://yhoo.it/2zYJYOI","Today's #Stocks Losers: $LYV, $MRK, $CAH http://yhoo.it/2zYJYOI
3
1",,,3,1,['https://pbs.twimg.com/media/DPGsTmaU8AAYLdi?format=jpg&name=small'],https://twitter.com/YahooFinance/status/932716058196217856
5482,Seeking Alpha,@SeekingAlpha,2017-11-20T15:58:33.000Z,https://seekingalpha.com/article/4126378-pfizer-scores-sutent-win-bristol-myers-looks-steal-thunder?source=feed_f‚Ä¶ $BMY $MRK $PFE,https://seekingalpha.com/article/4126378-pfizer-scores-sutent-win-bristol-myers-looks-steal-thunder?source=feed_f‚Ä¶ $BMY $MRK $PFE,,,,,[],https://twitter.com/SeekingAlpha/status/932639308690767872
5483,Adam Feuerstein,@adamfeuerstein,2017-11-20T11:34:52.000Z,Roche reshuffles lung cancer immunotherapy market with positive clinical trial results https://statnews.com/2017/11/20/roche-reshuffles-lung-cancer-immunotherapy-market-positive-clinical-trial-results/‚Ä¶ $RHHBY $MRK $AZN $BMY,"Roche reshuffles lung cancer immunotherapy market with positive clinical trial results https://statnews.com/2017/11/20/roche-reshuffles-lung-cancer-immunotherapy-market-positive-clinical-trial-results/‚Ä¶ $RHHBY $MRK $AZN $BMY
statnews.com
Roche reshuffles lung cancer immunotherapy market with positive clinical trial results
Roche‚Äôs checkpoint inhibitor Tecentriq combined with Avastin and chemotherapy demonstrated a ‚Äúclinically meaningful‚Äù reduction in disease worsening.
5
12",,,5,12,['https://pbs.twimg.com/card_img/1500529697079365633/oY3388TH?format=jpg&name=small'],https://twitter.com/adamfeuerstein/status/932572952700309504
5484,dough,@semodough,2017-11-18T19:32:06.000Z,JEFF Phenomenal catalyst chart $ABBV $BMY $PFE $MRK $ROG $AZN $FGEN $LLY $SPY,"JEFF Phenomenal catalyst chart $ABBV $BMY $PFE $MRK $ROG $AZN $FGEN $LLY $SPY
4
6",,,4,6,['https://pbs.twimg.com/media/DO8EMfFVAAE2Q3k?format=jpg&name=small'],https://twitter.com/semodough/status/931968272915992577
5485,Shift Signals,@shiftsignals,2017-11-20T19:03:13.000Z,Took a hit on $SD this morning. But still looking good in last 5 days. Let‚Äôs go $MRK $FEYE,Took a hit on $SD this morning. But still looking good in last 5 days. Let‚Äôs go $MRK $FEYE,,,,,['https://pbs.twimg.com/media/DPGQxjgW4AYeSPF?format=jpg&name=small'],https://twitter.com/shiftsignals/status/932685781818277888
5486,Brad Loncar,@bradloncar,2017-11-20T10:20:04.000Z,"Just now seeing this IMpower150 news from Roche. Success on PFS and OS is trending. HUGE 

Big congrats to them. Perhaps another big reshuffling of the lung cancer race. $BMY $MRK https://roche.com/investors/updates/inv-update-2017-11-20.htm‚Ä¶","Just now seeing this IMpower150 news from Roche. Success on PFS and OS is trending. HUGE 

Big congrats to them. Perhaps another big reshuffling of the lung cancer race. $BMY $MRK https://roche.com/investors/updates/inv-update-2017-11-20.htm‚Ä¶
2
11
20",,2,11,20,[],https://twitter.com/bradloncar/status/932554124922687489
5487,Helen Ong,@Lin_ling_88,2017-11-18T11:26:52.000Z,"Powerful new cancer drugs are saving lives, but can also ignite #diabetes or other #autoimmune conditions

#CheckpointInhibitors
$MRK $BMY $RBBHY","Powerful new cancer drugs are saving lives, but can also ignite #diabetes or other #autoimmune conditions

#CheckpointInhibitors
$MRK $BMY $RBBHY
science.org
Powerful new cancer drugs are saving lives, but can also ignite diabetes or other autoimmune...
Studies of people receiving immunotherapies may clarify how normal diabetes arises
1
9",,,1,9,[],https://twitter.com/Lin_ling_88/status/931846159848665089
5488,TraderMD,@TraderMD,2017-11-20T14:24:04.000Z,#ES_F Trade Ideas for 11/20/17 & Pre-market heatmap $$ $SPY $CRM $WMT $MRK,"#ES_F Trade Ideas for 11/20/17 & Pre-market heatmap $$ $SPY $CRM $WMT $MRK
1",,,,1,"['https://pbs.twimg.com/media/DPFQuohU8AIWmzW?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DPFQy9ZVQAA5xOg?format=jpg&name=small']",https://twitter.com/TraderMD/status/932615530481033218
5489,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-11-20T06:05:46.000Z,"Looks like Tecentriq+chemo+Avastin hit on PFS, but hasnt hit on OS.. yet. 
@roche
 moving fwd with regilatory filing on PFS $ROG $MRK $AZN $BMY","Looks like Tecentriq+chemo+Avastin hit on PFS, but hasnt hit on OS.. yet. 
@roche
 moving fwd with regilatory filing on PFS $ROG $MRK $AZN $BMY
2
3
7",,2,3,7,[],https://twitter.com/DrPaulyDeSantis/status/932490128915705857
5490,Vista Partners LLC,@VistaPResearch,2017-11-19T16:18:06.000Z,#SundayMorning See Vista Partners Featured Company Pages http://vistapglobal.com/coverage/#featured‚Ä¶ $MMM $AAPL $MRK $ATOS $HIIQ $V #investing #stocks,"#SundayMorning See Vista Partners Featured Company Pages http://vistapglobal.com/coverage/#featured‚Ä¶ $MMM $AAPL $MRK $ATOS $HIIQ $V #investing #stocks
GIF
1
1",,,1,1,[],https://twitter.com/VistaPResearch/status/932281840102268928
5491,Jacob Plieth,@JacobPlieth,2017-11-20T15:46:48.000Z,"Why $RHHBY's unexpected hit in Impower-150 is good news vs $MRK in US and EU alike. Via 
@EPVantage
 http://epvantage.com/Universal/View.aspx?type=Story&id=748442&isEPVantage=yes‚Ä¶","Why $RHHBY's unexpected hit in Impower-150 is good news vs $MRK in US and EU alike. Via 
@EPVantage
 http://epvantage.com/Universal/View.aspx?type=Story&id=748442&isEPVantage=yes‚Ä¶
2
12
5",,2,12,5,['https://pbs.twimg.com/media/DPFjd47XUAE7Owk?format=jpg&name=900x900'],https://twitter.com/JacobPlieth/status/932636352612577280
5492,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-11-20T12:58:53.000Z,BMO $RHHBY IMpower-150 Top Line: $MRK (Mixed); Incrementally Negative for $BMY & $AZN Roche announced (cont) http://tl.gd/n_1sqb1ok,"BMO $RHHBY IMpower-150 Top Line: $MRK (Mixed); Incrementally Negative for $BMY & $AZN Roche announced (cont) http://tl.gd/n_1sqb1ok
3
4",üÖ± üÖæ,,3,4,[],https://twitter.com/_B_I_O_T_E_C_H_/status/932594094014193665
5493,BioPharma Dive,@BioPharmaDive,2017-11-20T21:48:00.000Z,"New data makes $RHHBY a ""real competitor"" in the first-line non-small cell lung cancer market http://bit.ly/2AWG4oG $MRK","New data makes $RHHBY a ""real competitor"" in the first-line non-small cell lung cancer market http://bit.ly/2AWG4oG $MRK
biopharmadive.com
Roche lung cancer results boost Tecentriq versus I/O rivals
Tecentriq's success in the closely watched IMpower150 study could position the PD-L1 inhibitor to challenge Merck's Keytruda in first-line lung cancer.
2
3",,,2,3,['https://pbs.twimg.com/card_img/1501404738805395461/G5jtB0Jr?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/932727251480784898
5494,John Carroll,@JohnCendpts,2017-11-20T14:20:16.000Z,"I love these I/O stunners --
$RHHBY +6% ($12B)
$MRK -2%","I love these I/O stunners --
$RHHBY +6% ($12B)
$MRK -2%
endpts.com
Roche shares surge as a double-shot win in I/O and hemophilia raises blockbuster expectations
Roche has scored a win with one of the key immuno/oncology trials of the year, posting significant top-line gains for progression-free survival and risk of death for a segment of lung cancer patients...
1
2
3",,1,2,3,[],https://twitter.com/JohnCendpts/status/932614574058147840
5495,Equity Clock,@EquityClock,2017-11-20T15:30:49.000Z,"Merck $MRK, a Dow Jones Industrial stock  moved below $54.41 extending an intermediate downtrend.","Merck $MRK, a Dow Jones Industrial stock  moved below $54.41 extending an intermediate downtrend.",,,,,['https://pbs.twimg.com/media/DPFgKToV4AAmJeI?format=jpg&name=small'],https://twitter.com/EquityClock/status/932632330321227778
5496,Jacob Plieth,@JacobPlieth,2017-11-20T09:04:24.000Z,First $RHHBY Impower-150 analysis hits PFS (somewhat unexpected); OS not mature https://roche.com/media/store/releases/med-cor-2017-11-20.htm‚Ä¶ A reminder of what we were looking for --> http://epvantage.com/Universal/View.aspx?type=Story&id=731193&isEPVantage=yes‚Ä¶ $AZN $BMY $MRK,"First $RHHBY Impower-150 analysis hits PFS (somewhat unexpected); OS not mature https://roche.com/media/store/releases/med-cor-2017-11-20.htm‚Ä¶ A reminder of what we were looking for --> http://epvantage.com/Universal/View.aspx?type=Story&id=731193&isEPVantage=yes‚Ä¶ $AZN $BMY $MRK
evaluate.com
Event ‚Äì The next showdown in first-line lung cancer
4
5
4",,4,5,4,[],https://twitter.com/JacobPlieth/status/932535084653129730
5497,Chuck Mikolajczak,@ChuckMik,2017-11-20T14:10:20.000Z,"$RHHBY (+6.2% #premarket) gets stock boost from positive cancer, hemophilia results https://reut.rs/2B5N0Ri $MRK (-1.5%) #stocks #trading","$RHHBY (+6.2% #premarket) gets stock boost from positive cancer, hemophilia results https://reut.rs/2B5N0Ri $MRK (-1.5%) #stocks #trading
reuters.com
Roche stock up $12 billion on cancer, hemophilia trials; rivals hit
Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker is counting on to offset shrinking revenue from older...",,,,,[],https://twitter.com/ChuckMik/status/932612076408836096
5498,Quantcha Trade Ideas,@QuantchaIdeas,2017-11-20T16:59:34.000Z,52-Week Low Alert: Trading today‚Äôs movement in MERCK $MRK http://ideas.quantcha.com/2017/11/20/52-week-low-alert-trading-todays-movement-in-merck-mrk-2/‚Ä¶,52-Week Low Alert: Trading today‚Äôs movement in MERCK $MRK http://ideas.quantcha.com/2017/11/20/52-week-low-alert-trading-todays-movement-in-merck-mrk-2/‚Ä¶,,,,,['https://pbs.twimg.com/media/DPF0ebVUMAEewX9?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/932654666319650822
5499,Quantcha Trade Ideas,@QuantchaIdeas,2017-11-20T17:30:32.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/11/20/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-2/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/11/20/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-2/‚Ä¶,,,,,['https://pbs.twimg.com/media/DPF7j2dVwAU-RV0?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/932662455951650821
5500,Dennis M Winters,@m_denniswinters,2017-11-20T21:31:07.000Z,$oncs $incy waiting on news that $Mrk has ended collaboration with $incy,"$oncs $incy waiting on news that $Mrk has ended collaboration with $incy
2
5",,2,,5,[],https://twitter.com/m_denniswinters/status/932723001870749696
5501,TickWatcher,@MITickWatcher,2017-11-20T21:05:04.000Z,"Top #moneyflow for #sp500 today
$GE $AMZN $MRK $KO $ADI $ORCL $MSFT $T $AMD $KMX ...","Top #moneyflow for #sp500 today
$GE $AMZN $MRK $KO $ADI $ORCL $MSFT $T $AMD $KMX ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/932716447746359296
5502,Bio Stocks‚Ñ¢,@BioStocks,2017-11-20T12:57:14.000Z,$MRK PT lowered to $66 at Citi,"$MRK PT lowered to $66 at Citi
1",,,1,,[],https://twitter.com/BioStocks/status/932593678723325953
5503,MicroCapOwl,@MicroCapOwl,2017-11-20T20:25:04.000Z,$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù https://vimeo.com/177328744 $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU,"$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù https://vimeo.com/177328744 $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU
vimeo.com
Alternate Health - ""Innovation. Customization. Collaboration....
Alternate Health Corp (CSE:AHG) (OTC:AHGIF), is a diverse healthcare company revolutionizing patient care and research through compliance and technology in the emerging‚Ä¶
1",,,1,,['https://pbs.twimg.com/card_img/1501699223535902721/R-oTHLI0?format=jpg&name=240x240'],https://twitter.com/MicroCapOwl/status/932706378329845760
5504,ChartMill,@ChartMill,2017-11-19T01:07:15.000Z,$MRK has a Profit Margin of 7.15%. This is amongst the best returns in the industry. The industry average is -2 ... https://chartmill.com/analyze.php?utm_source=twitter&utm_medium=FA&utm_content=PROFITABILITY&utm_campaign=social-tracking#/MRK?r=fa&key=dba37a97-7034-4a1b-a157-abacc52f4366‚Ä¶,$MRK has a Profit Margin of 7.15%. This is amongst the best returns in the industry. The industry average is -2 ... https://chartmill.com/analyze.php?utm_source=twitter&utm_medium=FA&utm_content=PROFITABILITY&utm_campaign=social-tracking#/MRK?r=fa&key=dba37a97-7034-4a1b-a157-abacc52f4366‚Ä¶,,,,,['https://pbs.twimg.com/media/DO9Q6uKXcAE30Td?format=jpg&name=small'],https://twitter.com/ChartMill/status/932052620105207810
5505,Playbook Trading,@NDX100,2017-11-20T14:29:33.000Z,In Play Shorts: $BITA $DCIX $SHPG $MRK $CAH,"In Play Shorts: $BITA $DCIX $SHPG $MRK $CAH
1",,,,1,[],https://twitter.com/NDX100/status/932616911124344832
5506,FinInvTr,@FinInvTr,2017-11-18T07:52:03.000Z,"Dow 30 Weekly Stock Roundup: $GE Cuts Dividend, $WMT $HD Beat - https://buff.ly/2A8cEr7

includes $INTC $AAPL $CSCO $MAT $BA $DIS $MRK

#GE #walmart #homedepot #intel #apple #cisco #mattel #boeing #disney #merck","Dow 30 Weekly Stock Roundup: $GE Cuts Dividend, $WMT $HD Beat - https://buff.ly/2A8cEr7

includes $INTC $AAPL $CSCO $MAT $BA $DIS $MRK

#GE #walmart #homedepot #intel #apple #cisco #mattel #boeing #disney #merck",,,,,[],https://twitter.com/FinInvTr/status/931792102178086912
5507,Kara Jill Stancell,@kjilly,2017-11-20T15:53:09.000Z,UPDATED: Roche shares surge as a double-shot win in I/O and #hemophilia raises #blockbuster expectations #biotech #pharma #IO #immunooncology $RHHBY $MRK $BMY $AZN,"UPDATED: Roche shares surge as a double-shot win in I/O and #hemophilia raises #blockbuster expectations #biotech #pharma #IO #immunooncology $RHHBY $MRK $BMY $AZN
endpts.com
Roche shares surge as a double-shot win in I/O and hemophilia raises blockbuster expectations
Roche has scored a win with one of the key immuno/oncology trials of the year, posting significant top-line gains for progression-free survival and risk of death for a segment of lung cancer patients...",,,,,['https://pbs.twimg.com/card_img/1501994444190453787/RRYtivaB?format=png&name=small'],https://twitter.com/kjilly/status/932637951766302721
5508,Brad Loncar,@bradloncar,2017-11-20T12:40:43.000Z,$MRK's bad quarter got a little worse this morning. When it rains it pours.,"$MRK's bad quarter got a little worse this morning. When it rains it pours.
1
3",,1,,3,[],https://twitter.com/bradloncar/status/932589522004652032
5509,James Sikes,@wosaikeneriki,2017-11-18T16:41:17.000Z,"As Merck & Co $MRK Share Value Declined, Schnieders Capital Management Has Increased by $337,600 Its Position ...","As Merck & Co $MRK Share Value Declined, Schnieders Capital Management Has Increased by $337,600 Its Position ...",,,,,[],https://twitter.com/wosaikeneriki/status/931925285615874053
5510,Siti van der Meij,@sitivandermeij,2017-11-20T13:51:04.000Z,"Merck under pressure premarket on positive data Tecentriq data in lung cancer, shares down... https://seekingalpha.com/news/3313473-merck-pressure-premarket-positive-data-tecentriq-data-lung-cancer-shares-2-percent-premarket?source=feed_f‚Ä¶ #premarket $MRK $RHHBY #sitifatimah #malaysia #financialplanning","Merck under pressure premarket on positive data Tecentriq data in lung cancer, shares down... https://seekingalpha.com/news/3313473-merck-pressure-premarket-positive-data-tecentriq-data-lung-cancer-shares-2-percent-premarket?source=feed_f‚Ä¶ #premarket $MRK $RHHBY #sitifatimah #malaysia #financialplanning
seekingalpha.com
Merck under pressure premarket on positive data Tecentriq data in lung cancer, shares down 2%...
Merck (NYSE:MRK) is down 2% premarket on increased volume in apparent reaction to Roche's (OTCQX:RHHBY) announcement of positive Phase 3 data on the combination of TECENTRIQ...",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/932607227042639872
5511,Alex,@pablodesaavedra,2017-11-20T17:10:08.000Z,"Pressure on Merck $Mrk 
Good for #Oncosec $Oncs 
T-Cell iL-12 Electroporation + pembrozilumab #keytruda checkpoint inhibitor
#Melanoma Pd-1 Pd-L1","Pressure on Merck $Mrk 
Good for #Oncosec $Oncs 
T-Cell iL-12 Electroporation + pembrozilumab #keytruda checkpoint inhibitor
#Melanoma Pd-1 Pd-L1",,,,,[],https://twitter.com/pablodesaavedra/status/932657322840805376
5512,Hugh J. Robbins,@HughJRobbins,2017-11-20T14:22:23.000Z,"$ACST scary on open cause of low volume...will watch a bit.  Watching $BITA and $MRK short .. $NWL, $THS, $VSTO long #stocks #investing #tradeideas #trading","$ACST scary on open cause of low volume...will watch a bit.  Watching $BITA and $MRK short .. $NWL, $THS, $VSTO long #stocks #investing #tradeideas #trading",,,,,[],https://twitter.com/HughJRobbins/status/932615107196194816
5513,Ben Fidler,@BentheFidler,2017-11-20T13:25:36.000Z,Roche Gains Ground on Rivals With Drug Combo‚Äôs Success in Lung #Cancer https://xconomy.com/san-francisco/2017/11/20/roche-gains-ground-on-rivals-with-drug-combos-success-in-lung-cancer/‚Ä¶ $RHHBY $MRK $BMY $AZN,Roche Gains Ground on Rivals With Drug Combo‚Äôs Success in Lung #Cancer https://xconomy.com/san-francisco/2017/11/20/roche-gains-ground-on-rivals-with-drug-combos-success-in-lung-cancer/‚Ä¶ $RHHBY $MRK $BMY $AZN,,,,,[],https://twitter.com/BentheFidler/status/932600818037075968
5514,US Banking News,@AmericanBanking,2017-11-20T07:48:30.000Z,"Merck KGaA given ‚Ç¨100.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2AVhPXS $MRK #MRK","Merck KGaA given ‚Ç¨100.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2AVhPXS $MRK #MRK",,,,,[],https://twitter.com/AmericanBanking/status/932515984354799616
5515,Markus Teller,@MarkusTeller1,2017-11-20T19:58:53.000Z,$MRK approaching strong support at $53.00. Looking to pick some up. Solid pharma dividend play.,"$MRK approaching strong support at $53.00. Looking to pick some up. Solid pharma dividend play.
1
1",,,1,1,[],https://twitter.com/MarkusTeller1/status/932699791498338304
5516,FinInvTr,@FinInvTr,2017-11-19T00:01:08.000Z,11 Stocks Stanley Druckenmiller Completely Sold Out Of  https://buff.ly/2zfGWIy  $DAL $NOW $ADSK $NTES $CMCSA $CCI $AAL $MRK $PTC $UAL $SBAC,"11 Stocks Stanley Druckenmiller Completely Sold Out Of  https://buff.ly/2zfGWIy  $DAL $NOW $ADSK $NTES $CMCSA $CCI $AAL $MRK $PTC $UAL $SBAC
whotrades.com
Stanley Druckenmiller / Duquesne Family Office ‚Äì Equity Holdings (Q3)
Duquesne Family Office is run by billionaire Stanley Druckenmiller, formerly of two of the top performing hedge funds of all time ‚Äì George Soros‚Äôs Quantum Fund, which he headed from 1988‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1501262747694252035/0UIpRTWc?format=jpg&name=small'],https://twitter.com/FinInvTr/status/932035978017034240
5517,FinInvTr,@FinInvTr,2017-11-19T08:07:01.000Z,10 Frightening Lung-Cancer Statistics and 3 Top Companies Looking to Do Something About It - https://buff.ly/2zPaUCU | $MRK $BMY $RHHBY,"10 Frightening Lung-Cancer Statistics and 3 Top Companies Looking to Do Something About It - https://buff.ly/2zPaUCU | $MRK $BMY $RHHBY
whotrades.com
10 Frightening Lung-Cancer Statistics and 3 Top Companies Looking to Do Something About It
There's arguably no scarier six-letter word than ""cancer."" As the U.S. population has grown, so has the prevalence of cancer diagnoses... and deaths. The Centers for Disease Control and‚Ä¶",,,,,[],https://twitter.com/FinInvTr/status/932158255744380929
5518,MarketBeat,@MarketBeatCom,2017-11-20T07:45:19.000Z,"Merck KGaA given ‚Ç¨100.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2AVhPXS $MRK #MRK","Merck KGaA given ‚Ç¨100.00 PT by Goldman Sachs Group, Inc. (The). neutral rating. http://ift.tt/2AVhPXS $MRK #MRK",,,,,[],https://twitter.com/MarketBeatCom/status/932515181774520320
5519,Red Acre Investments,@redacre,2017-11-20T21:26:37.000Z,Biotech/HC New or revisited 52-Week Lows: $CAH $CHRS $CRIS $CYH $MRK $OCUL $OMI $PRTA $TSRO,Biotech/HC New or revisited 52-Week Lows: $CAH $CHRS $CRIS $CYH $MRK $OCUL $OMI $PRTA $TSRO,,,,,[],https://twitter.com/redacre/status/932721867630276609
5520,Ticker Report,@TickerReport,2017-11-19T22:22:18.000Z,"Merck & $MRK Receiving Somewhat Favorable Media Coverage, Study Finds http://ift.tt/2zOi0HH","Merck & $MRK Receiving Somewhat Favorable Media Coverage, Study Finds http://ift.tt/2zOi0HH",,,,,[],https://twitter.com/TickerReport/status/932373495354462212
5521,Jacob Bell,@realJacobBell,2017-11-20T21:48:00.000Z,"New data makes $RHHBY a ""real competitor"" in the first-line non-small cell lung cancer market http://bit.ly/2AWG4oG $MRK","New data makes $RHHBY a ""real competitor"" in the first-line non-small cell lung cancer market http://bit.ly/2AWG4oG $MRK
biopharmadive.com
Roche lung cancer results boost Tecentriq versus I/O rivals
Tecentriq's success in the closely watched IMpower150 study could position the PD-L1 inhibitor to challenge Merck's Keytruda in first-line lung cancer.",,,,,['https://pbs.twimg.com/card_img/1501404738805395461/G5jtB0Jr?format=jpg&name=small'],https://twitter.com/realJacobBell/status/932727250927144961
5522,Allison Gatlin,@IBD_AGatlin,2017-11-20T19:27:08.000Z,Why Roche's cancer trial is a kick in the teeth for Dow stock Merck $RHHBY $MRK $LLY,"Why Roche's cancer trial is a kick in the teeth for Dow stock Merck $RHHBY $MRK $LLY
investors.com
Roche Jumps After Cancer Trial Meets Goal, Sending Merck Stock Diving | Stock News & Stock Market...
Roche is now a real competitor with a potential first treatment in advanced lung cancer, an analyst said Monday.",,,,,[],https://twitter.com/IBD_AGatlin/status/932691799340208128
5523,avidresearch,@avidresearch,2017-11-20T12:46:17.000Z,"Replying to 
@lblegend33
 and 
@bradloncar","Replying to 
@lblegend33
 and 
@bradloncar
Agree. Very slow M&A. $MRK definitely needs to buy something
2",,,,2,[],https://twitter.com/avidresearch/status/932590923099377665
5524,Biotech2050,@Biotech2050,2017-11-20T14:35:12.000Z,"Replying to 
@JohnCendpts","Replying to 
@JohnCendpts
And both $rhhby & $BMY have entered into collaboration with $HALO for subcutaneous and it combo with #PEGPH20 whilst $MRK 
@Merck
 is yet to make the move before it is too late. More trouble could be brewing ....
1",,,,1,[],https://twitter.com/Biotech2050/status/932618331428917253
5525,Barchart,@Barchart,2017-11-20T17:01:48.000Z,"Technology companies, retailers send US #stock indexes higher $ZION $BBY $GE $MRO $MRK https://barchart.com/social/share?t=Technology%20companies%2C%20retailers%20send%20US%20stock%20indexes%20higher&d=NEW%20YORK%20(AP)%20%E2%80%94%20U.S.%20stocks%20are%20higher%20as%20technology%20and%20industrial%20companies%20and%20retailers%20make%20gains.&i=https%3A%2F%2Fs3.amazonaws.com%2Fbarchart-news-media%2Fap%2F6070d700704d47679d3fa45e16e2b802%2F434e85050bf04b50b779717349004ac0_financial_markets_wall_street_09948.jpg&r=https%3A%2F%2Fwww.barchart.com%2Fstory%2Fnews%2Ftop-stories%2F127785%2Ftechnology-companies-retailers-send-us-stock-indexes-higher&du=false‚Ä¶ via 
@Barchart","Technology companies, retailers send US #stock indexes higher $ZION $BBY $GE $MRO $MRK https://barchart.com/social/share?t=Technology%20companies%2C%20retailers%20send%20US%20stock%20indexes%20higher&d=NEW%20YORK%20(AP)%20%E2%80%94%20U.S.%20stocks%20are%20higher%20as%20technology%20and%20industrial%20companies%20and%20retailers%20make%20gains.&i=https%3A%2F%2Fs3.amazonaws.com%2Fbarchart-news-media%2Fap%2F6070d700704d47679d3fa45e16e2b802%2F434e85050bf04b50b779717349004ac0_financial_markets_wall_street_09948.jpg&r=https%3A%2F%2Fwww.barchart.com%2Fstory%2Fnews%2Ftop-stories%2F127785%2Ftechnology-companies-retailers-send-us-stock-indexes-higher&du=false‚Ä¶ via 
@Barchart
barchart.com
Technology companies, retailers send US stock indexes higher
NEW YORK (AP) ‚Äî U.S. stocks are higher as technology and industrial companies and retailers make gains.",,,,,[],https://twitter.com/Barchart/status/932655224245903360
5526,Titan V,@titan_v16,2017-11-20T18:23:55.000Z,"Replying to 
@titan_v16
 and 
@chickpea598","Replying to 
@titan_v16
 and 
@chickpea598
$ONCS Former Head of Business Development was also a direct hire from $MRK. He was Executive Director for Business Development & Licensing at Merck.

He‚Äôs now at Trianni, another startup that has a collaboration with $MRK. 
ir.oncosec.com
OncoSec Appoints David P. Meininger, PhD, MBA, as Senior Vice President of Business Development",ü§î ü§î,,,,['https://pbs.twimg.com/card_img/1501562947302313994/II6mbSwC?format=jpg&name=small'],https://twitter.com/titan_v16/status/932675893587267585
5527,Ticker Report,@TickerReport,2017-11-19T09:42:28.000Z,"Merck & Company, Inc. $MRK Shares Bought by Pacer Advisors Inc. http://ift.tt/2hM5VMf","Merck & Company, Inc. $MRK Shares Bought by Pacer Advisors Inc. http://ift.tt/2hM5VMf",,,,,[],https://twitter.com/TickerReport/status/932182276896645120
5528,Daily Political,@dailypoliticaln,2017-11-18T04:01:44.000Z,"Merck & Company, Inc. $MRK Receives Average Recommendation of ‚ÄúHold‚Äù from Analysts http://ift.tt/2isgLE9","Merck & Company, Inc. $MRK Receives Average Recommendation of ‚ÄúHold‚Äù from Analysts http://ift.tt/2isgLE9",,,,,[],https://twitter.com/dailypoliticaln/status/931734139690213377
5529,MarketBeat,@MarketBeatCom,2017-11-19T09:44:09.000Z,"Merck & Company, Inc. $MRK Stake Decreased by Airain ltd http://ift.tt/2yW1yBl","Merck & Company, Inc. $MRK Stake Decreased by Airain ltd http://ift.tt/2yW1yBl",,,,,[],https://twitter.com/MarketBeatCom/status/932182701649645569
5530,Dakota Financial,@dakotafinancial,2017-11-18T09:14:33.000Z,"Boys Arnold & Co. Inc. Sells 1,210 Shares of Merck & Company, Inc. $MRK http://ift.tt/2jCuP1i","Boys Arnold & Co. Inc. Sells 1,210 Shares of Merck & Company, Inc. $MRK http://ift.tt/2jCuP1i",,,,,[],https://twitter.com/dakotafinancial/status/931812865056690176
5531,Frank Sportolari,@UPS_FrankSp,2017-11-22T20:59:06.000Z,Report: UPS license lets it get into pharma supply chain $UPS $MRK,"Report: UPS license lets it get into pharma supply chain $UPS $MRK
seekingalpha.com
Report: UPS license lets it get into pharma supply chain (NYSE:UPS)
UPS (NYSE:UPS) has acquired a manufacturing pharmacy license in Georgia, a move that could give it a deeper foothold into the medication supply chain, CNBC says.
1
3",,,1,3,['https://pbs.twimg.com/card_img/1497724725002448899/2TZ3O23_?format=png&name=240x240'],https://twitter.com/UPS_FrankSp/status/933439721614790656
5532,Seeking Alpha,@SeekingAlpha,2017-11-22T14:56:13.000Z,https://seekingalpha.com/article/4127114-gilead-buying-new-growth?source=feed_f‚Ä¶ $ABBV $GSK $JNJ $KITE $MRK $GILD,"https://seekingalpha.com/article/4127114-gilead-buying-new-growth?source=feed_f‚Ä¶ $ABBV $GSK $JNJ $KITE $MRK $GILD
seekingalpha.com
Gilead: Buying New Growth (NASDAQ:GILD)
Gilead‚Äôs dominance in its respective markets is waning.",,,,,['https://pbs.twimg.com/card_img/1490113992374824960/2kBD4pQU?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/933348398320705541
5533,Dana Lyons,@JLyonsFundMgmt,2017-11-22T17:34:38.000Z,Merck $MRK (Still) Testing Post-2009 Up Trendline #TrendlineWednesday,"Merck $MRK (Still) Testing Post-2009 Up Trendline #TrendlineWednesday
1
3",,,1,3,['https://pbs.twimg.com/media/DPQPrfxVQAAZUn8?format=jpg&name=small'],https://twitter.com/JLyonsFundMgmt/status/933388265209679872
5534,The Banker's Tribune,@bankerstribune,2017-11-23T14:00:40.000Z,"Joel Greenblatt owns shares of Merck & Company, Inc. $MRK and expects a 14% jump http://ow.ly/AFxQ30gE77P","Joel Greenblatt owns shares of Merck & Company, Inc. $MRK and expects a 14% jump http://ow.ly/AFxQ30gE77P",,,,,['https://pbs.twimg.com/media/DPUoS-rXUAA9wIR?format=jpg&name=small'],https://twitter.com/bankerstribune/status/933696806613069824
5535,Arthur Hunt,@HuntTrader70,2017-11-22T18:20:21.000Z,"I really recommend trying this out for finding good stocks to trade http://bit.ly/2yCkVzD
$NVO $MRK $BMA","I really recommend trying this out for finding good stocks to trade http://bit.ly/2yCkVzD
$NVO $MRK $BMA",,,,,['https://pbs.twimg.com/media/DPQaJG7VAAAy4vC?format=jpg&name=small'],https://twitter.com/HuntTrader70/status/933399770206494725
5536,JT,@TCMLLC,2017-11-21T18:11:02.000Z,"$NKTR an absolute powerhouse. $BMY & $MRK can't afford to let the other one get it. These types of driving gap moves happen when a biotech truly has something that is desired by big pharma & institutions. They pay up before the big premium hits the tape. 
@brianzinman
 @RACFlash
 ","$NKTR an absolute powerhouse. $BMY & $MRK can't afford to let the other one get it. These types of driving gap moves happen when a biotech truly has something that is desired by big pharma & institutions. They pay up before the big premium hits the tape. 
@brianzinman
 @RACFlash
 3
4
7",üêµ,3,4,7,[],https://twitter.com/TCMLLC/status/933035038861602816
5537,Chameleon Options,@MC_OptionTrades,2017-11-21T23:49:31.000Z,Price Returns vs Expected Daily Move $MDT $LCI $VRX $TEVA $CVS $CELG $BMY $PFE $GILD $MRK $AGN $MNK http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $MDT $LCI $VRX $TEVA $CVS $CELG $BMY $PFE $GILD $MRK $AGN $MNK http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DPMb5KGV4AEGbwD?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/933120218712412160
5538,Michael Reid,@ReidOfWallSt4,2017-11-21T21:32:50.000Z,"I really recommend everyone check this out for finding good stocks to trade http://bit.ly/2whny8n
$MCO $MRK $MDT","I really recommend everyone check this out for finding good stocks to trade http://bit.ly/2whny8n
$MCO $MRK $MDT",,,,,['https://pbs.twimg.com/media/DPL8mz4VQAAKuo-?format=jpg&name=small'],https://twitter.com/ReidOfWallSt4/status/933085820130676741
5539,Breaking News,@MarketCurrents,2017-11-22T20:49:56.000Z,Report: UPS license lets it get into pharma supply chain https://seekingalpha.com/news/3314155-report-ups-license-lets-get-pharma-supply-chain?source=feed_f‚Ä¶ $UPS $MRK,"Report: UPS license lets it get into pharma supply chain https://seekingalpha.com/news/3314155-report-ups-license-lets-get-pharma-supply-chain?source=feed_f‚Ä¶ $UPS $MRK
seekingalpha.com
Report: UPS license lets it get into pharma supply chain (NYSE:UPS)
UPS (NYSE:UPS) has acquired a manufacturing pharmacy license in Georgia, a move that could give it a deeper foothold into the medication supply chain, CNBC says.
1",,,,1,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/933437414344867840
5540,Biotech2050,@Biotech2050,2017-11-22T14:48:08.000Z,"$HALO owns the one safe and effective Enzyme in #immunooncology
Which large pharma / biotech will own it in 3 years ?
$CELG $RHHBY $BMY $MRK
@Celgene
 @Roche
 @Merck","$HALO owns the one safe and effective Enzyme in #immunooncology
Which large pharma / biotech will own it in 3 years ?
$CELG $RHHBY $BMY $MRK
@Celgene
 @Roche
 @Merck
CELGENE
31.3%
ROCHE
29.2%
BMY
14.6%
MERCK
25%
48 votes
¬∑
Final results
4
3",,,4,3,[],https://twitter.com/Biotech2050/status/933346361768017921
5541,SmallCapOwl,@SmallCapOwl,2017-11-23T22:25:04.000Z,"$AHGIF ""Now that Alternate Health's CanaPass is proven and operational in Canada this quarter, it's time to take a global approach to our business,"" says Dr. Murphy.  $IBB $GILD $JNJ $PFE $AMGN $NVS $MRK $GWPH $BMY $BSX","$AHGIF ""Now that Alternate Health's CanaPass is proven and operational in Canada this quarter, it's time to take a global approach to our business,"" says Dr. Murphy.  $IBB $GILD $JNJ $PFE $AMGN $NVS $MRK $GWPH $BMY $BSX",,,,,[],https://twitter.com/SmallCapOwl/status/933823741171249152
5542,F.A.S.T. Graphs,@FASTGraphs,2017-11-21T13:47:04.000Z,"$TRV $MRK $AXP $GE $PFE $JPM
  Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
  https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶","$TRV $MRK $AXP $GE $PFE $JPM
  Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
  https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶",,,,,['https://pbs.twimg.com/media/DPKR93tW0AAEz3v?format=jpg&name=medium'],https://twitter.com/FASTGraphs/status/932968606677250048
5543,TickWatcher,@MITickWatcher,2017-11-22T21:05:03.000Z,"Top #moneyflow for #sp500 today
$CAT $F $NVDA $MDT $NWL $HD $MRK $MA $MAT $FLR ...","Top #moneyflow for #sp500 today
$CAT $F $NVDA $MDT $NWL $HD $MRK $MA $MAT $FLR ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/933441219555971078
5544,Trade Academy,@TradeAcademyCo,2017-11-22T13:12:04.000Z,11/22 52-Week Lo Watch List: $SQQQ $APRN $SPXU $TZA $VXX $NWL $SEAS $AGN $EGO $MRK $ABX $SLB $GE $AMJ $AMLP #trading,11/22 52-Week Lo Watch List: $SQQQ $APRN $SPXU $TZA $VXX $NWL $SEAS $AGN $EGO $MRK $ABX $SLB $GE $AMJ $AMLP #trading,,,,,[],https://twitter.com/TradeAcademyCo/status/933322187183927296
5545,James Sikes,@wosaikeneriki,2017-11-22T17:48:39.000Z,"Merck & Co $MRK Shareholder Schnieders Capital Management Has Boosted Stake by $337,600 ...","Merck & Co $MRK Shareholder Schnieders Capital Management Has Boosted Stake by $337,600 ...",,,,,[],https://twitter.com/wosaikeneriki/status/933391790807404547
5546,ChartMill,@ChartMill,2017-11-22T02:28:15.000Z,The technical rating of $MRK is bad and it also does not present a quality setup at the moment. Price movement ... https://chartmill.com/analyze.php?utm_source=twitter&utm_medium=TA&utm_content=SETUP&utm_campaign=social-tracking#/MRK?key=dba37a97-7034-4a1b-a157-abacc52f4366‚Ä¶,The technical rating of $MRK is bad and it also does not present a quality setup at the moment. Price movement ... https://chartmill.com/analyze.php?utm_source=twitter&utm_medium=TA&utm_content=SETUP&utm_campaign=social-tracking#/MRK?key=dba37a97-7034-4a1b-a157-abacc52f4366‚Ä¶,,,,,['https://pbs.twimg.com/media/DPNAOd2XUAAXOAR?format=jpg&name=small'],https://twitter.com/ChartMill/status/933160166777901056
5547,James Sikes,@wosaikeneriki,2017-11-22T18:26:59.000Z,Davis R M Raised Merck & Co $MRK Stake by $1.38 Million http://bzweekly.com/davis-r-m-raised-merck-market-value-declined-neville-rodie-shaw-has-upped-rio-tinto-plc-adr-sponsored-rio-position-by-403200-as-shares-declined/‚Ä¶,Davis R M Raised Merck & Co $MRK Stake by $1.38 Million http://bzweekly.com/davis-r-m-raised-merck-market-value-declined-neville-rodie-shaw-has-upped-rio-tinto-plc-adr-sponsored-rio-position-by-403200-as-shares-declined/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/933401441062047755
5548,biogemfinder,@biogemfinder,2017-11-22T17:15:48.000Z,Message to $GILD $BMY $MRK $RHHB $PFE: Please leave $EXEL alone unless your offer is $65 or higher right now. As a stand alone company we will do a lot better and the PPS will be ~ $100 in 2 years. So stop playing games. $IBB $XBI $BIB,Message to $GILD $BMY $MRK $RHHB $PFE: Please leave $EXEL alone unless your offer is $65 or higher right now. As a stand alone company we will do a lot better and the PPS will be ~ $100 in 2 years. So stop playing games. $IBB $XBI $BIB,,,,,[],https://twitter.com/biogemfinder/status/933383524744249344
5549,Donna Young,@DonnaYoungDC,2017-11-21T13:25:06.000Z,"Startup could bring back Vioxx for hemophilia https://apnews.com/e10de834beda45e9b8b08cd8396c609e‚Ä¶ 
@AP
 
#Vioxx $MRK #pharma #biotech #FDA","Startup could bring back Vioxx for hemophilia https://apnews.com/e10de834beda45e9b8b08cd8396c609e‚Ä¶ 
@AP
 
#Vioxx $MRK #pharma #biotech #FDA
apnews.com
Startup wants to bring back Vioxx for hemophilia joint pain
TRENTON, N.J. (AP) ‚Äî Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so...",üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/932963078215553026
5550,James Sikes,@wosaikeneriki,2017-11-22T17:42:44.000Z,Iguana Healthcare Management Has Lowered Stake in Merck & Co $MRK by $2.88 Million http://bzweekly.com/iguana-healthcare-management-has-lowered-stake-in-merck-as-whirlpool-whr-stock-value-rose-ameritas-investment-partners-has-boosted-stake-by-318015/‚Ä¶,Iguana Healthcare Management Has Lowered Stake in Merck & Co $MRK by $2.88 Million http://bzweekly.com/iguana-healthcare-management-has-lowered-stake-in-merck-as-whirlpool-whr-stock-value-rose-ameritas-investment-partners-has-boosted-stake-by-318015/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/933390305147179010
5551,Brad Loncar,@bradloncar,2017-11-21T13:59:02.000Z,Cautioned about this a few weeks ago when some analysts were brushing off the $MRK Keynote-189 delay.,"Cautioned about this a few weeks ago when some analysts were brushing off the $MRK Keynote-189 delay.
Brad Loncar
@bradloncar
 ¬∑ 30 Oct 2017
Umer left out an entire angle that's really important....competition. Delay doesn't just set back $MRK but gives others like Roche a window.
1
5",,,1,5,['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg'],https://twitter.com/bradloncar/status/932971619718516737
5552,Sweet Platform,@SweetPlatform,2017-11-23T00:07:13.000Z,"MRK Top news - Nov 22nd, 2017 $MRK http://https://goo.gl/RiZNwt","MRK Top news - Nov 22nd, 2017 $MRK http://https://goo.gl/RiZNwt",,,,,[],https://twitter.com/SweetPlatform/status/933487062715633665
5553,MicroCapOwl,@MicroCapOwl,2017-11-23T22:25:03.000Z,"$AHGIF ""Now that Alternate Health's CanaPass is proven and operational in Canada this quarter, it's time to take a global approach to our business,"" says Dr. Murphy.  $IBB $GILD $JNJ $PFE $AMGN $NVS $MRK $GWPH $BMY $BSX","$AHGIF ""Now that Alternate Health's CanaPass is proven and operational in Canada this quarter, it's time to take a global approach to our business,"" says Dr. Murphy.  $IBB $GILD $JNJ $PFE $AMGN $NVS $MRK $GWPH $BMY $BSX",,,,,[],https://twitter.com/MicroCapOwl/status/933823737178349568
5554,Trade Academy,@TradeAcademyCo,2017-11-21T13:23:09.000Z,11/21 52-Week Lo Watch List: $APRN $INCY $VXX $MRK $SEAS $TRIP $AGN $SLB $ABX $NWL #trading,11/21 52-Week Lo Watch List: $APRN $INCY $VXX $MRK $SEAS $TRIP $AGN $SLB $ABX $NWL #trading,,,,,[],https://twitter.com/TradeAcademyCo/status/932962589709127681
5555,SmallCapOwl,@SmallCapOwl,2017-11-23T22:25:04.000Z,$AHGIF Alternate Health Corp. Company's Website : http://alternatehealth.ca/index.php $IBB $GILD $NVS $MRK $BMY $BSX $AMGN $PFE $JNJ $OREX $SPY,$AHGIF Alternate Health Corp. Company's Website : http://alternatehealth.ca/index.php $IBB $GILD $NVS $MRK $BMY $BSX $AMGN $PFE $JNJ $OREX $SPY,,,,,[],https://twitter.com/SmallCapOwl/status/933823744421883904
5556,StockMarketVideo.com,@stockmarketvide,2017-11-23T02:04:03.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/933516465403318273
5557,c lark,@7LadyQ,2017-11-22T12:29:32.000Z,"Big implied vol spikes: $GME +6.0%, $SNAP +4.7%, $V +4.4%, $AXP +4.2%, $MRK +2.4%, $HAL +1.7%, $TRIP +1.7%","Big implied vol spikes: $GME +6.0%, $SNAP +4.7%, $V +4.4%, $AXP +4.2%, $MRK +2.4%, $HAL +1.7%, $TRIP +1.7%",,,,,[],https://twitter.com/7LadyQ/status/933311485731885057
5558,Ari Schiff,@reschiff,2017-11-23T05:30:57.000Z,Report: UPS license lets it get into pharma supply chain $UPS $MRK,"Report: UPS license lets it get into pharma supply chain $UPS $MRK
seekingalpha.com
Report: UPS license lets it get into pharma supply chain (NYSE:UPS)
UPS (NYSE:UPS) has acquired a manufacturing pharmacy license in Georgia, a move that could give it a deeper foothold into the medication supply chain, CNBC says.",üòé,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/reschiff/status/933568530381000706
5559,Buy Cryptocurrency,@cryptosbuy,2017-11-21T10:53:22.000Z,MRK weekly 0.618 retracem\u2026 $MRK http://tradingview.com/chart/MRK/wpJcdszS-MRK-weekly-0-618-retracement-and-demand-zone-combination/‚Ä¶ TV_TradingIdeas,"MRK weekly 0.618 retracem\u2026 $MRK http://tradingview.com/chart/MRK/wpJcdszS-MRK-weekly-0-618-retracement-and-demand-zone-combination/‚Ä¶ TV_TradingIdeas
tradingview.com
MRK weekly 0.618 retracement and demand zone combination for NYSE:MRK by Trader_Joe_Lee
MRK was one of my favorite companies to trade back to the days I worked for the bank. It suffered almost 20% pulled-back from its peak, and it might be time to look for mid-term positions! I would...",,,,,['https://pbs.twimg.com/card_img/1501994573643452430/4IgzhAgD?format=png&name=small'],https://twitter.com/cryptosbuy/status/932924893380972544
5560,Contagion,@Contagion_Live,2017-11-22T18:03:06.000Z,".
@US_FDA
 approved updates to $MRK's #Isentress (#raltegravir) label to expand patient population to include #HIV exposed full-term neonates. http://bit.ly/2hZh5Nz",".
@US_FDA
 approved updates to $MRK's #Isentress (#raltegravir) label to expand patient population to include #HIV exposed full-term neonates. http://bit.ly/2hZh5Nz",,,,,['https://pbs.twimg.com/media/DPQWL8qW0AERXAV?format=jpg&name=small'],https://twitter.com/Contagion_Live/status/933395427524825089
5561,Emylers,@Emylers,2017-11-21T00:13:31.000Z,"MRK Stock 54.10 Merck & Company $MRK Hit 17,176,600 52 week lows as of +0.88%. Currently trading at 54.10 -1.1","MRK Stock 54.10 Merck & Company $MRK Hit 17,176,600 52 week lows as of +0.88%. Currently trading at 54.10 -1.1
investorshangout.com
MRK Stock 54.10 Merck & Company - Top Investment Alerts #4851651 - Investors Hangout
Top Investment Alerts: MRK Stock 54.10 Merck Company $MRK Hit 17,176,600 52 week lows as of +0.88%. Currently trading at - #4851651",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/Emylers/status/932763870149660673
5562,tradingbrezz,@TradingBreeze,2017-11-22T20:19:41.000Z,$LEE   Still Long Up $0.30 Added $CYCC  ‚ÄôS Soon $NVAX  Long Added $GSUM  Reasons Tweeted $GNBT   Working With Giant $MRK  Long http://businesswire.com/news/home/20170731005304/en/Generex-Announces-Collaboration-Merck-Evaluate-KEYTRUDA‚Ä¶¬Æ-pembrolizumab.,"$LEE   Still Long Up $0.30 Added $CYCC  ‚ÄôS Soon $NVAX  Long Added $GSUM  Reasons Tweeted $GNBT   Working With Giant $MRK  Long http://businesswire.com/news/home/20170731005304/en/Generex-Announces-Collaboration-Merck-Evaluate-KEYTRUDA‚Ä¶¬Æ-pembrolizumab.
businesswire.com
Generex Announces Collaboration with Merck to Evaluate KEYTRUDA¬Æ (pembrolizumab) in Combination...
Generex Biotechnology Corporation (www.generex.com) (OTCPink:GNBT) today announced that its wholly-owned subsidiary, Antigen Express, Inc. (www.antige",‚úÖ ‚§¥ ‚úÖ üí≤ ‚úÖ ‚úÖ ‚úÖ ‚§¥ ‚úÖ,,,,['https://pbs.twimg.com/card_img/1499868464369987585/toLpDbRh?format=png&name=240x240'],https://twitter.com/TradingBreeze/status/933429802127814656
5563,Watchlist News,@WatchlistN,2017-11-23T09:23:29.000Z,"Merck & Company, Inc. $MRK Shares Bought by Boulegeris Investments Inc. http://ift.tt/2zdKJ4Z","Merck & Company, Inc. $MRK Shares Bought by Boulegeris Investments Inc. http://ift.tt/2zdKJ4Z",,,,,[],https://twitter.com/WatchlistN/status/933627050530934786
5564,Ticker Report,@TickerReport,2017-11-22T09:39:16.000Z,"Flippin Bruce & Porter Inc. Has $6.23 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2jeFJqg","Flippin Bruce & Porter Inc. Has $6.23 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2jeFJqg",,,,,[],https://twitter.com/TickerReport/status/933268635627298816
5565,Ticker Report,@TickerReport,2017-11-23T09:29:24.000Z,"TSP Capital Management Group LLC Cuts Position in Merck & Company, Inc. $MRK http://ift.tt/2jP4Y6f","TSP Capital Management Group LLC Cuts Position in Merck & Company, Inc. $MRK http://ift.tt/2jP4Y6f",,,,,[],https://twitter.com/TickerReport/status/933628537680130048
5566,SmallCapOwl,@SmallCapOwl,2017-11-23T22:40:03.000Z,$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù https://vimeo.com/177328744  $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU,$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù https://vimeo.com/177328744  $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU,,,,,[],https://twitter.com/SmallCapOwl/status/933827514820120576
5567,Daily Political,@dailypoliticaln,2017-11-23T09:27:10.000Z,"Evergreen Capital Management LLC Purchases New Stake in Merck & Company, Inc. $MRK http://ift.tt/2mWkE8O","Evergreen Capital Management LLC Purchases New Stake in Merck & Company, Inc. $MRK http://ift.tt/2mWkE8O",,,,,[],https://twitter.com/dailypoliticaln/status/933627976914268160
5568,bake mcbride,@ITRADEVOL,2017-11-21T19:10:26.000Z,Stock Option Trades Screener for trade Ideas $AAXJ $AAPL $C $CSL $SGYP $SPY $AAPL $DKS $MRK $AIG $DHI $HD $UAA https://marketchameleon.com/Screeners/OptionTrades‚Ä¶,Stock Option Trades Screener for trade Ideas $AAXJ $AAPL $C $CSL $SGYP $SPY $AAPL $DKS $MRK $AIG $DHI $HD $UAA https://marketchameleon.com/Screeners/OptionTrades‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/933049987222654976
5569,bake mcbride,@ITRADEVOL,2017-11-21T21:27:33.000Z,Stock Closing Order Imbalances $BAC $IVR $MRK $SQ $JNJ $CTL $ORCL $DE $CBS $XOM $SPGI $HAL $PFE $VIPS $NLY $GLW $JCP https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,Stock Closing Order Imbalances $BAC $IVR $MRK $SQ $JNJ $CTL $ORCL $DE $CBS $XOM $SPGI $HAL $PFE $VIPS $NLY $GLW $JCP https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/933084492444651520
5570,Dakota Financial,@dakotafinancial,2017-11-23T22:20:20.000Z,Somewhat Positive Press Coverage Somewhat Unlikely to Affect Merck & $MRK Stock Price http://ift.tt/2hZeUtF,Somewhat Positive Press Coverage Somewhat Unlikely to Affect Merck & $MRK Stock Price http://ift.tt/2hZeUtF,,,,,[],https://twitter.com/dakotafinancial/status/933822551205318657
5571,Chameleon,@MarketChmln,2017-11-21T21:46:29.000Z,Largest $Notional Buy On Close Order Imbalances $BAC $MRK $JNJ $DE $SPGI $IVR $XOM $WYN $SQ $CBS http://tinyurl.com/y8jo8mjb,Largest $Notional Buy On Close Order Imbalances $BAC $MRK $JNJ $DE $SPGI $IVR $XOM $WYN $SQ $CBS http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/933089255403921409
5572,JT,@TCMLLC,2017-11-21T20:40:01.000Z,Just looking over the monthly chart on $NKTR and this large 17yr inverted H&S has a measured move target of anywhere from 84 to 92 depending upon where you anchor the 68.30pt high to low move. $MRK $BMY $IBB $XBI,"Just looking over the monthly chart on $NKTR and this large 17yr inverted H&S has a measured move target of anywhere from 84 to 92 depending upon where you anchor the 68.30pt high to low move. $MRK $BMY $IBB $XBI
1
3",,,1,3,[],https://twitter.com/TCMLLC/status/933072532206432258
5573,BackToTheFutures,@Back2DaFutures,2017-11-23T14:10:01.000Z,"Replying to 
@BrianUherek
 and 
@dhovekamp42","Replying to 
@BrianUherek
 and 
@dhovekamp42
It would if Adi does a deal with $MRK - he hinted at some sort of potential deal in his last call.
1
3",,1,,3,[],https://twitter.com/Back2DaFutures/status/933699158506008576
5574,MicroCapOwl,@MicroCapOwl,2017-11-23T22:40:04.000Z,$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù https://vimeo.com/177328744  $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU,"$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù https://vimeo.com/177328744  $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU
vimeo.com
Alternate Health - ""Innovation. Customization. Collaboration....
Alternate Health Corp (CSE:AHG) (OTC:AHGIF), is a diverse healthcare company revolutionizing patient care and research through compliance and technology in the emerging‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1501699223535902721/R-oTHLI0?format=jpg&name=240x240'],https://twitter.com/MicroCapOwl/status/933827516955054080
5575,Biotech2050,@Biotech2050,2017-11-22T13:30:19.000Z,"Replying to 
@fezziwig2008","Replying to 
@fezziwig2008
$HALO PEGPH20 could more than double $CELG abraxane sales. 
$BMY $RHHBY $PFE $ABBV $CELG could all be interested in $HALO in addition to $MRK.
Any other company ...?
2
1
3",,2,1,3,[],https://twitter.com/Biotech2050/status/933326781658038272
5576,Aniu Student,@AniuStudent,2017-11-21T17:00:21.000Z,"...at least (and only if no partner by then).  I believe a top ten (preferably top 5) big pharma partner would take $ESPR much higher.

$MRK $PFE $AMGN $GILD","...at least (and only if no partner by then).  I believe a top ten (preferably top 5) big pharma partner would take $ESPR much higher.

$MRK $PFE $AMGN $GILD",,,,,[],https://twitter.com/AniuStudent/status/933017247232266306
5577,Ankur Banerjee,@AnkurBanerjee17,2017-11-21T11:53:40.000Z,"More importantly, the research note says drug distribution and PBMs are less likely to be disrupted by $AMZN entry. Sort of opposite to what Morgan Stanley said yesterday $CAH $ABC $MRK $ESRX $CVS","More importantly, the research note says drug distribution and PBMs are less likely to be disrupted by $AMZN entry. Sort of opposite to what Morgan Stanley said yesterday $CAH $ABC $MRK $ESRX $CVS
1",,1,,,[],https://twitter.com/AnkurBanerjee17/status/932940068104282117
5578,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-11-22T15:09:26.000Z,"Replying to 
@Slambucket
 and 
@Myeloma_Doc","Replying to 
@Slambucket
 and 
@Myeloma_Doc
Still the new $GSK SPEAR NY-ESO-1 trial in multiple myeloma is also designed to test auto GVHD in the non ASCT setting with and without $MRK Keytruda as $ADAP has not observed such in other trials http://ir.adaptimmune.com/phoenix.zhtml?c=253991&p=irol-newsArticle&ID=2316203‚Ä¶
1",,,,1,[],https://twitter.com/dhovekamp42/status/933351724886233088
5579,Watchlist News,@WatchlistN,2017-11-23T14:03:20.000Z,"Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2iJZWo8","Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2iJZWo8",,,,,[],https://twitter.com/WatchlistN/status/933697475562692609
5580,MarketBeat,@MarketBeatCom,2017-11-23T09:25:29.000Z,"Merck & Company, Inc. $MRK Shares Sold by Homrich & Berg http://ift.tt/2mS0zAw","Merck & Company, Inc. $MRK Shares Sold by Homrich & Berg http://ift.tt/2mS0zAw",,,,,[],https://twitter.com/MarketBeatCom/status/933627553318932480
5581,Biotech2050,@Biotech2050,2017-11-22T11:20:17.000Z,"Replying to 
@AdamSinger
, 
@BioStocks
 and 
@fezziwig2008","Replying to 
@AdamSinger
, 
@BioStocks
 and 
@fezziwig2008
I haven't read the $HALO report but new Enhanze deals and or PEGPH20 combo deals or a deal with $MRK could be new catalysts propelling price target higher.",,,,,[],https://twitter.com/Biotech2050/status/933294054888165376
5582,Dakota Financial,@dakotafinancial,2017-11-23T09:25:05.000Z,"Merck & Company, Inc. $MRK Shares Sold by Homrich & Berg http://ift.tt/2mS0zAw","Merck & Company, Inc. $MRK Shares Sold by Homrich & Berg http://ift.tt/2mS0zAw",,,,,[],https://twitter.com/dakotafinancial/status/933627451707723776
5583,Dakota Financial,@dakotafinancial,2017-11-23T03:00:31.000Z,"Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2jfW6Ts","Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2jfW6Ts",,,,,[],https://twitter.com/dakotafinancial/status/933530675206123520
5584,dough,@semodough,2017-11-26T16:56:53.000Z,COWEN KEY upcoming catalysts $ADAP $ADRO $ARRY $CRVS $DVAX $MRK $INCY $FPRX $TRIL,"COWEN KEY upcoming catalysts $ADAP $ADRO $ARRY $CRVS $DVAX $MRK $INCY $FPRX $TRIL
20
33",,,20,33,['https://pbs.twimg.com/media/DPktYzbWsAAZQF9?format=jpg&name=900x900'],https://twitter.com/semodough/status/934828317651472385
5585,dough,@semodough,2017-11-26T17:08:00.000Z,"JEFF nice slide Key presentations&posters at San Antonio Breast Cancer Symposium #SABCS17 annual meeting, San Antonio, December 6-8 $PBYI $PFE $AZN $LLY $AZN $MRK","JEFF nice slide Key presentations&posters at San Antonio Breast Cancer Symposium #SABCS17 annual meeting, San Antonio, December 6-8 $PBYI $PFE $AZN $LLY $AZN $MRK
1
4
8",,1,4,8,['https://pbs.twimg.com/media/DPkv75gXkAACJy-?format=jpg&name=small'],https://twitter.com/semodough/status/934831114425917441
5586,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-11-26T09:32:34.000Z,Commented on https://seekingalpha.com/article/4127429-adaptimmune-now-time-adopt-stock-stock-portfolio?source=tweet&sht=p00qia&shu=n7f6a#comment-76914235‚Ä¶ $BLCM $BMY $GSK $MRK $NVS $ADAP,"Commented on https://seekingalpha.com/article/4127429-adaptimmune-now-time-adopt-stock-stock-portfolio?source=tweet&sht=p00qia&shu=n7f6a#comment-76914235‚Ä¶ $BLCM $BMY $GSK $MRK $NVS $ADAP
seekingalpha.com
Adaptimmune: Is Now The Time To Adopt This Stock For Your Stock Portfolio? (NASDAQ:ADAP)
I will establish the need for looking at biotech investing with a long-term outlook for achieving your goal.
5",,,,5,['https://pbs.twimg.com/card_img/1501706747890835456/IxIHcHmM?format=jpg&name=240x240'],https://twitter.com/dhovekamp42/status/934716500396535809
5587,Joanne Fagg,@ByJoFagg,2017-11-24T16:40:49.000Z,"Event roundup: $MRK $PFE Ertugliflozin PDUFA due in December #SGLT2, and US PhIII data from Mesoblast #GvHD #Prochymal #MSC100IV","Event roundup: $MRK $PFE Ertugliflozin PDUFA due in December #SGLT2, and US PhIII data from Mesoblast #GvHD #Prochymal #MSC100IV
evaluate.com
Upcoming events ‚Äì Another SGLT2 approval due and stem cell data for Mesoblast
2",,,2,,[],https://twitter.com/ByJoFagg/status/934099495893291009
5588,Mark Wynn,@MWynn8098,2017-11-24T23:52:07.000Z,"I really recommend checking this out for finding good stocks to trade http://bit.ly/2w7vk4F
$MET $MTR $MRK","I really recommend checking this out for finding good stocks to trade http://bit.ly/2w7vk4F
$MET $MTR $MRK",,,,,['https://pbs.twimg.com/media/DPb5QYmVAAA5hg3?format=jpg&name=small'],https://twitter.com/MWynn8098/status/934208035710521344
5589,SmallCapOwl,@SmallCapOwl,2017-11-25T20:25:04.000Z,#Healthcare #Cannabis #Zika #Biotech Follow Alternate Health Now : https://twitter.com/Alternate_HG $IBB $GWPH $NVS $GILD $MRK $BSX $PFE $JNJ $TRTC $OWCP $MJNA $CBIS,"#Healthcare #Cannabis #Zika #Biotech Follow Alternate Health Now : https://twitter.com/Alternate_HG $IBB $GWPH $NVS $GILD $MRK $BSX $PFE $JNJ $TRTC $OWCP $MJNA $CBIS
1",,,1,,[],https://twitter.com/SmallCapOwl/status/934518320749006848
5590,Stocks Live App,@Stocks_Live,2017-11-24T20:09:44.000Z,"Large Cap Pharma via 
@Stocks_Live
 #stocks $ABBV $AZN $BMY $GSK $JNJ $LLY $MRK $NVO $NVS $PFE $SNY","Large Cap Pharma via 
@Stocks_Live
 #stocks $ABBV $AZN $BMY $GSK $JNJ $LLY $MRK $NVO $NVS $PFE $SNY",,,,,['https://pbs.twimg.com/media/DPbGW6eVAAAV1l4?format=jpg&name=small'],https://twitter.com/Stocks_Live/status/934152071539974144
5591,Trade Academy,@TradeAcademyCo,2017-11-24T14:14:11.000Z,11/24 52-Week Lo Watch List: $SEAS $SQQQ $APRN $SCO $VXX $NWL $SPXU $CTL $MRK $SHLD $GNC $HPE #trading,11/24 52-Week Lo Watch List: $SEAS $SQQQ $APRN $SCO $VXX $NWL $SPXU $CTL $MRK $SHLD $GNC $HPE #trading,,,,,[],https://twitter.com/TradeAcademyCo/status/934062596679983104
5592,JFBIII TRADER,@Lizardjb3,2017-11-26T19:16:06.000Z,"Play it safe ...
Go with these ....
Dividend Plays , Just To name a few 

$FUN 5.30 %
$VZ 5.27 %
$GM 3.41 %
$IBM 3.90 %
$MRK 3.41 %
 
If you have a pair 

$M 7.67 %","Play it safe ...
Go with these ....
Dividend Plays , Just To name a few 

$FUN 5.30 %
$VZ 5.27 %
$GM 3.41 %
$IBM 3.90 %
$MRK 3.41 %
 
If you have a pair 

$M 7.67 %
2
3",,,2,3,[],https://twitter.com/Lizardjb3/status/934863352827871232
5593,Edw,@EddyscornerNFL,2017-11-26T14:53:58.000Z,"$MRK U.S. Zetia Revenue has seen a decline of -84.18%, however it only makes up 0.63% of total revenue. #MRK https://free.hadeplatform.com/analysis/content/2017/11/26/98-832/Merck-&-Co-$MRK-US-Zetia‚Ä¶","$MRK U.S. Zetia Revenue has seen a decline of -84.18%, however it only makes up 0.63% of total revenue. #MRK https://free.hadeplatform.com/analysis/content/2017/11/26/98-832/Merck-&-Co-$MRK-US-Zetia‚Ä¶",,,,,[],https://twitter.com/EddyscornerNFL/status/934797381744451584
5594,Activist Blockchain,@activistbitcoin,2017-11-25T14:15:09.000Z,Gilead: Buying New Growth http://ow.ly/Ejtu30gNKNq $GILD $GSK $MRK $KITE $ABBV,"Gilead: Buying New Growth http://ow.ly/Ejtu30gNKNq $GILD $GSK $MRK $KITE $ABBV
seekingalpha.com
Gilead: Buying New Growth (NASDAQ:GILD)
Gilead‚Äôs dominance in its respective markets is waning.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/activistbitcoin/status/934425224887635970
5595,James Sikes,@wosaikeneriki,2017-11-24T11:00:41.000Z,"Merck & Co $Mrk $MRK Shareholder Augustine Asset Management Has Boosted Holding by $360,768 as Shares Decli...","Merck & Co $Mrk $MRK Shareholder Augustine Asset Management Has Boosted Holding by $360,768 as Shares Decli...",,,,,[],https://twitter.com/wosaikeneriki/status/934013901775220737
5596,Peter Blood,@ptrbld,2017-11-25T21:05:22.000Z,"Soothsayer "" $MRK with PD-1 Inhibitor technology is like a thoroughbred ready to run -> needs a new Jockey (CEO) to get it across the finish line. ""","Soothsayer "" $MRK with PD-1 Inhibitor technology is like a thoroughbred ready to run -> needs a new Jockey (CEO) to get it across the finish line. """,,,,,[],https://twitter.com/ptrbld/status/934528460982243328
5597,GuruFocus,@gurufocus,2017-11-24T15:44:47.000Z,"Details the 52-week lows of the following companies: General Electric, Merck & Co., Schlumberger, Kinder Morgan, Williams Companies and Archer-Daniels Midland http://gurufocus.com/news/600742  $MRK $SLB $KMI","Details the 52-week lows of the following companies: General Electric, Merck & Co., Schlumberger, Kinder Morgan, Williams Companies and Archer-Daniels Midland http://gurufocus.com/news/600742  $MRK $SLB $KMI
1",,,,1,['https://pbs.twimg.com/media/DPaJt-MW4AAttBf?format=jpg&name=small'],https://twitter.com/gurufocus/status/934085397335900160
5598,The Investor Network,@investornetwork,2017-11-24T19:30:34.000Z,Updated $MRK #Investor Kit now available - #QuarterlyResults #FullReport #Pharmaceuticals - Get Investment Info at http://ow.ly/sco830gNoRx,Updated $MRK #Investor Kit now available - #QuarterlyResults #FullReport #Pharmaceuticals - Get Investment Info at http://ow.ly/sco830gNoRx,,,,,[],https://twitter.com/investornetwork/status/934142214346854401
5599,Sweet Platform,@SweetPlatform,2017-11-25T02:37:24.000Z,"MRK Top news - Nov 24th, 2017 $MRK http://https://goo.gl/Zz8xsG","MRK Top news - Nov 24th, 2017 $MRK http://https://goo.gl/Zz8xsG",,,,,[],https://twitter.com/SweetPlatform/status/934249631260856320
5600,Buy Cryptocurrency,@cryptosbuy,2017-11-26T01:01:14.000Z,MRK Coiled Stochastic $MRK http://tradingview.com/chart/MRK/Qpf7k1N6-MRK-Coiled-Stochastic/‚Ä¶ TV_TradingIdeas,"MRK Coiled Stochastic $MRK http://tradingview.com/chart/MRK/Qpf7k1N6-MRK-Coiled-Stochastic/‚Ä¶ TV_TradingIdeas
tradingview.com
MRK Coiled Stochastic for NYSE:MRK by takemoreprofits
MRK has a coiled stochastic and has divergence on the hourly time frame. Buy: 54.92 Target: 56.20 - 57.79 (2.33% - 5.23%) jbzstocks.com @jbzstocks",,,,,[],https://twitter.com/cryptosbuy/status/934587817531006977
5601,FinInvTr,@FinInvTr,2017-11-25T18:11:04.000Z,"$JNJ & $GSK's Jucala Approval Puts Spotlight on HIV Space  https://buff.ly/2A4DBMd

incl. $GILD $MYL $MRK $ABBV","$JNJ & $GSK's Jucala Approval Puts Spotlight on HIV Space  https://buff.ly/2A4DBMd

incl. $GILD $MYL $MRK $ABBV",,,,,[],https://twitter.com/FinInvTr/status/934484597483679745
5602,The Fly,@theflynews,2017-11-24T12:48:03.000Z,"Deutsche cuts Merck target to $59 on competition from AbbVie, GSK $MRK $ABBV $GSK","Deutsche cuts Merck target to $59 on competition from AbbVie, GSK $MRK $ABBV $GSK
thefly.com
Deutsche cuts Merck target to $59 on competition from AbbVie, GSK
Deutsche Bank analyst Gre... MRK, ABBV, GSK
1
2",,,1,2,['https://pbs.twimg.com/card_img/1501061573762162691/g5GrJkIU?format=jpg&name=small'],https://twitter.com/theflynews/status/934040919010979841
5603,StockNews.com,@stocknewsdotcom,2017-11-24T12:52:33.000Z,$MRK Deutsche Bank cuts PT to $59 from $62 https://stocknews.com/news/mrk-deutsche-bank-cuts-pt-to-59-from-62/‚Ä¶,"$MRK Deutsche Bank cuts PT to $59 from $62 https://stocknews.com/news/mrk-deutsche-bank-cuts-pt-to-59-from-62/‚Ä¶
1",,,1,,[],https://twitter.com/stocknewsdotcom/status/934042052005892096
5604,Ticker Report,@TickerReport,2017-11-25T15:40:10.000Z,"Atwood & Palmer Inc. Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2zAJLUJ","Atwood & Palmer Inc. Raises Position in Merck & Company, Inc. $MRK http://ift.tt/2zAJLUJ",,,,,[],https://twitter.com/TickerReport/status/934446623513509888
5605,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-11-24T12:57:10.000Z,UPGRADES & DOWNGRADES ‚Äï $MRK: Deutsche Bank reits Hold http://dlvr.it/Q2dp0s via ‚Üí http://bit.do/BestTradeSetups,UPGRADES & DOWNGRADES ‚Äï $MRK: Deutsche Bank reits Hold http://dlvr.it/Q2dp0s via ‚Üí http://bit.do/BestTradeSetups,,,,,[],https://twitter.com/AlertTrade/status/934043213173633024
5606,Watchlist News,@WatchlistN,2017-11-24T13:16:29.000Z,"Merck & Company, Inc. $MRK Price Target Lowered to $59.00 at Deutsche Bank AG http://ift.tt/2zia9yp","Merck & Company, Inc. $MRK Price Target Lowered to $59.00 at Deutsche Bank AG http://ift.tt/2zia9yp",,,,,[],https://twitter.com/WatchlistN/status/934048073495572480
5607,Watchlist News,@WatchlistN,2017-11-26T14:46:16.000Z,"Chicago Equity Partners LLC Has $30.96 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2zqWghK","Chicago Equity Partners LLC Has $30.96 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2zqWghK",,,,,[],https://twitter.com/WatchlistN/status/934795444466716673
5608,Daily Political,@dailypoliticaln,2017-11-24T14:27:25.000Z,"Merck & Company, Inc. $MRK Holdings Held by Boston Research & Management Inc. http://ift.tt/2B7pF0C","Merck & Company, Inc. $MRK Holdings Held by Boston Research & Management Inc. http://ift.tt/2B7pF0C",,,,,[],https://twitter.com/dailypoliticaln/status/934065927972409345
5609,Daily Political,@dailypoliticaln,2017-11-25T15:20:34.000Z,"Cim Investment Mangement Inc. Has $1.17 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zATnil","Cim Investment Mangement Inc. Has $1.17 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zATnil",,,,,[],https://twitter.com/dailypoliticaln/status/934441689489510401
5610,Crypto Trader Pro,@CryptoTraderPro,2017-11-26T01:04:07.000Z,MRK Coiled Stochastic $MRK http://dlvr.it/Q2sslP powered by http://bit.do/BestTradeSetups,MRK Coiled Stochastic $MRK http://dlvr.it/Q2sslP powered by http://bit.do/BestTradeSetups,,,,,[],https://twitter.com/CryptoTraderPro/status/934588543103483905
5611,Briefing.com,@Briefingcom,2017-11-24T16:03:00.000Z,See the latest #broker #ratings changes http://bit.ly/1eLLpAY $MRK $WIX $NTNX $DE,See the latest #broker #ratings changes http://bit.ly/1eLLpAY $MRK $WIX $NTNX $DE,,,,,[],https://twitter.com/Briefingcom/status/934089981131235328
5612,MarketBeat,@MarketBeatCom,2017-11-26T14:41:33.000Z,"Pacad Investment Ltd. Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2BdMrE4","Pacad Investment Ltd. Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2BdMrE4",,,,,[],https://twitter.com/MarketBeatCom/status/934794256895668227
5613,MarketBeat,@MarketBeatCom,2017-11-25T15:16:08.000Z,"Zevin Asset Management LLC Lowers Position in Merck & Company, Inc. $MRK http://ift.tt/2A9Y6EE","Zevin Asset Management LLC Lowers Position in Merck & Company, Inc. $MRK http://ift.tt/2A9Y6EE",,,,,[],https://twitter.com/MarketBeatCom/status/934440574966534144
5614,TalkMarkets,@TalkMarkets,2017-11-24T18:53:02.000Z,"FDA Approves J&J, Glaxo HIV Drug, Roche Presents Data $AZN $BMY $MRK $RHHBY $PFE $GSK $JNJ $NVS https://goo.gl/61wbwU","FDA Approves J&J, Glaxo HIV Drug, Roche Presents Data $AZN $BMY $MRK $RHHBY $PFE $GSK $JNJ $NVS https://goo.gl/61wbwU",,,,,[],https://twitter.com/TalkMarkets/status/934132770015731714
5615,Anirban Maitra,@Aiims1742,2017-11-26T21:17:03.000Z,"Replying to 
@SMImmunology
, 
@PatelOncology
 and 
@NatureComms","Replying to 
@SMImmunology
, 
@PatelOncology
 and 
@NatureComms
That's work from 
@MDAndersonNews
! 
We have been begging $MRK & $AZN for the trials for a while in BRCA2 mutant #PancreaticCancer - hopefully someone will bite!
1
3",,1,,3,[],https://twitter.com/Aiims1742/status/934893789881294848
5616,Adam Mueller,@AMueller78,2017-11-26T17:39:28.000Z,"I really recommend trying this out for finding good stocks to trade http://bit.ly/2yqkeJz
$MRK $MDT $MTL","I really recommend trying this out for finding good stocks to trade http://bit.ly/2yqkeJz
$MRK $MDT $MTL",,,,,['https://pbs.twimg.com/media/DPk3JNcVoAAiQaU?format=jpg&name=small'],https://twitter.com/AMueller78/status/934839032797855744
5617,FirstToMarkets,@firsttomarkets,2017-11-24T15:15:18.000Z,Merck &amp; Co Inc  Lower Price Target by Deutsche Bank (Ranked 23rd) to $59 as Hold $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,Merck &amp; Co Inc  Lower Price Target by Deutsche Bank (Ranked 23rd) to $59 as Hold $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,,,,,[],https://twitter.com/firsttomarkets/status/934077977209352192
5618,Dakota Financial,@dakotafinancial,2017-11-26T14:43:42.000Z,"Pacad Investment Ltd. Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2BdMrE4","Pacad Investment Ltd. Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2BdMrE4",,,,,[],https://twitter.com/dakotafinancial/status/934794799726694403
5619,Dakota Financial,@dakotafinancial,2017-11-25T15:18:13.000Z,"Zevin Asset Management LLC Lowers Position in Merck & Company, Inc. $MRK http://ift.tt/2A9Y6EE","Zevin Asset Management LLC Lowers Position in Merck & Company, Inc. $MRK http://ift.tt/2A9Y6EE",,,,,[],https://twitter.com/dakotafinancial/status/934441099783036929
5620,TradingView Ideas,@TradingViewAlt,2017-11-26T00:59:08.000Z,MRK Coiled Stochastic $MRK http://tradingview.com/chart/MRK/Qpf7k1N6-MRK-Coiled-Stochastic/‚Ä¶,MRK Coiled Stochastic $MRK http://tradingview.com/chart/MRK/Qpf7k1N6-MRK-Coiled-Stochastic/‚Ä¶,,,,,[],https://twitter.com/TradingViewAlt/status/934587291762229248
5621,US Banking News,@AmericanBanking,2017-11-24T13:52:27.000Z,"Merck & Company, Inc. $MRK PT Lowered to $59.00 http://ift.tt/2A8NkOS","Merck & Company, Inc. $MRK PT Lowered to $59.00 http://ift.tt/2A8NkOS",,,,,[],https://twitter.com/AmericanBanking/status/934057126942662656
5622,Watchlist News,@WatchlistN,2017-11-25T15:36:28.000Z,"Merck & Company, Inc. $MRK Holdings Cut by Newman Dignan & Sheerar Inc. http://ift.tt/2n2xmTP","Merck & Company, Inc. $MRK Holdings Cut by Newman Dignan & Sheerar Inc. http://ift.tt/2n2xmTP",,,,,[],https://twitter.com/WatchlistN/status/934445692604559361
5623,TalkMarkets,@TalkMarkets,2017-11-24T13:43:45.000Z,"Deutsche Cuts Merck Target To $59 On Competition From AbbVie, GSK $MRK Also $GSK $ABBV https://goo.gl/4xgMQL","Deutsche Cuts Merck Target To $59 On Competition From AbbVie, GSK $MRK Also $GSK $ABBV https://goo.gl/4xgMQL",,,,,[],https://twitter.com/TalkMarkets/status/934054935590731777
5624,Transcript Daily,@TranscriptDaily,2017-11-26T07:53:12.000Z,"Merck & Company, Inc. $MRK Price Target Cut to $59.00 http://ift.tt/2n4doIm","Merck & Company, Inc. $MRK Price Target Cut to $59.00 http://ift.tt/2n4doIm",,,,,[],https://twitter.com/TranscriptDaily/status/934691492521791488
5625,Brad Loncar,@bradloncar,2017-11-29T19:43:40.000Z,"Given how the tax bill is in the news, Credit Suisse has a nice report showing for large companies what percent of their cash is overseas. Some biopharma names:

$JNJ 96%
$AMGN 94%
$GILD 85%
$PFE 90%
$MRK 85%
$CELG 77%
$BIIB 70%","Given how the tax bill is in the news, Credit Suisse has a nice report showing for large companies what percent of their cash is overseas. Some biopharma names:

$JNJ 96%
$AMGN 94%
$GILD 85%
$PFE 90%
$MRK 85%
$CELG 77%
$BIIB 70%
11
81
113",,11,81,113,[],https://twitter.com/bradloncar/status/935957450481717255
5626,Evaluate Vantage,@evaluatevantage,2017-11-28T16:16:02.000Z,Immuno-oncology combos ‚Äì what will be hot in 2018? http://epvantage.com/Universal/View.aspx?type=Story&id=749684&isEPVantage=yes‚Ä¶ $INCY $BMY $MRK $ARRY,"Immuno-oncology combos ‚Äì what will be hot in 2018? http://epvantage.com/Universal/View.aspx?type=Story&id=749684&isEPVantage=yes‚Ä¶ $INCY $BMY $MRK $ARRY
1
16
21",,1,16,21,['https://pbs.twimg.com/media/DPu20zSW0AEDn8K?format=jpg&name=900x900'],https://twitter.com/evaluatevantage/status/935542810983452672
5627,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-11-29T17:17:42.000Z,IO Monthly Sales Figures $AZN $BMY $MRK $ROG $PFE,"IO Monthly Sales Figures $AZN $BMY $MRK $ROG $PFE
1
4
11",,1,4,11,['https://pbs.twimg.com/media/DP0O6r6VQAEWydj?format=jpg&name=small'],https://twitter.com/DrPaulyDeSantis/status/935920716700049408
5628,pharmalot,@pharmalot,2017-11-28T14:17:11.000Z,Pharmalot.. Pharmalittle.. Good Morning.. What will Supreme Court do about IPRs?  https://statnews.com/pharmalot/2017/11/28/supreme-court-patent-china-gilead-vouchers/‚Ä¶ #pharma $MRK $PFE $SNY $GILD $ESRX $BMRN,"Pharmalot.. Pharmalittle.. Good Morning.. What will Supreme Court do about IPRs?  https://statnews.com/pharmalot/2017/11/28/supreme-court-patent-china-gilead-vouchers/‚Ä¶ #pharma $MRK $PFE $SNY $GILD $ESRX $BMRN
statnews.com
Pharmalittle: Supreme Court appears divided over patent reviews; Gilead hep C drug is cheaper in...
U.S. Supreme Court justices appeared divided over whether a process used for challenging patents violates the constitutional rights of patent owners.
2",,,2,,['https://pbs.twimg.com/card_img/1501064820937822212/YW68E-Ya?format=jpg&name=small'],https://twitter.com/pharmalot/status/935512902412455937
5629,Bobby Laughlin,@BobbyLaughlinPV,2017-11-28T04:11:37.000Z,https://seekingalpha.com/article/4127113-next-billion-dollar-blockbuster-value-investors-look-omeros-corporation-part-1‚Ä¶ $IBB $CELG $OMER $ALXN $PFE $XBI $BIB $ENDP $LLY $BMY $BAY $SAN $MRK $ABBV $ROG $NOVN $JNJ,"https://seekingalpha.com/article/4127113-next-billion-dollar-blockbuster-value-investors-look-omeros-corporation-part-1‚Ä¶ $IBB $CELG $OMER $ALXN $PFE $XBI $BIB $ENDP $LLY $BMY $BAY $SAN $MRK $ABBV $ROG $NOVN $JNJ
1
2",,,1,2,[],https://twitter.com/BobbyLaughlinPV/status/935360505547440128
5630,Odi Bruckman,@odibro,2017-11-29T16:40:36.000Z,Biopharma Stocks Facing FDA Decision In December $AMGN $MYL $NVO $ACRS $AGRX $VRX $AEZS $PFE $MRK http://rttnews.com/slideshow/3745/biotech-stocks-facing-fda-decision-in-december.aspx?Slide=1‚Ä¶,"Biopharma Stocks Facing FDA Decision In December $AMGN $MYL $NVO $ACRS $AGRX $VRX $AEZS $PFE $MRK http://rttnews.com/slideshow/3745/biotech-stocks-facing-fda-decision-in-december.aspx?Slide=1‚Ä¶
3
9",,,3,9,[],https://twitter.com/odibro/status/935911379915149312
5631,Drugdoctor1,@Drugdoctor2014,2017-11-27T04:20:39.000Z,"$GEQU.0047- HOTTEST PENNY STOCK last week! HUGE FUNDING NEWS hit! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TEVA $RDY $MNK $ASMB","$GEQU.0047- HOTTEST PENNY STOCK last week! HUGE FUNDING NEWS hit! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TEVA $RDY $MNK $ASMB
1",,,,1,"['https://pbs.twimg.com/media/DPnJ1V2UIAAW9bo?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DPnJ1UWUIAA4L8h?format=jpg&name=360x360']",https://twitter.com/Drugdoctor2014/status/935000391368003584
5632,David Crow,@bydavidcrow,2017-11-29T11:29:09.000Z,Brazilian health minister tells #FTLatAmHealth conf his country no longer buys Hep-C drugs and instead ‚Äúpays per cure‚Äù $GILD $ABBV $MRK,"Brazilian health minister tells #FTLatAmHealth conf his country no longer buys Hep-C drugs and instead ‚Äúpays per cure‚Äù $GILD $ABBV $MRK
1
5",,,1,5,['https://pbs.twimg.com/media/DPy_IBxUIAE5fLx?format=jpg&name=small'],https://twitter.com/bydavidcrow/status/935833004638900224
5633,Drugdoctor1,@Drugdoctor2014,2017-11-28T18:51:56.000Z,"$ICNB.0061-1150-store-PUBLIX-distribution-announced-on-Instagram-just-now! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TSCO $BBBY $TEVA $RDY $MNK $ASMB
$TCK $CC $CRBP $EXEL $HL $FNSR","$ICNB.0061-1150-store-PUBLIX-distribution-announced-on-Instagram-just-now! $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TSCO $BBBY $TEVA $RDY $MNK $ASMB
$TCK $CC $CRBP $EXEL $HL $FNSR
1",,,,1,"['https://pbs.twimg.com/media/DPvamceV4AAerVv?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DPvameiVQAAPCZm?format=jpg&name=360x360']",https://twitter.com/Drugdoctor2014/status/935582046453411841
5634,Drugdoctor1,@Drugdoctor2014,2017-11-28T14:03:47.000Z,"$ICNB.006 - 4th QTR Sales explode 1500% to 3 million dollars of Bellissima Wine. PUBLIX to sell in 1150 Stores - Rollout has started.  $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TEVA","$ICNB.006 - 4th QTR Sales explode 1500% to 3 million dollars of Bellissima Wine. PUBLIX to sell in 1150 Stores - Rollout has started.  $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TEVA
1",,,,1,"['https://pbs.twimg.com/media/DPuYrZ9UMAAqrCG?format=jpg&name=small', 'https://pbs.twimg.com/media/DPuYrZ9UIAAB1BR?format=jpg&name=360x360']",https://twitter.com/Drugdoctor2014/status/935509531756548096
5635,MAISA,@MaisaCorp,2017-11-27T21:25:07.000Z,"$DVAX #Buyout conversation with $GSK $MRK:

#Before FDA Approval:
$GSK CEO: $18/sh $DVAX
$MRK CEO: $20/sh $DVAX
$DVAX CEO: ?#@*&%! [hang up]

#After FDA Approval:
$GSK CEO: $21/sh $DVAX
$MRK CEO: $24/sh $DVAX
$DVAX CEO: ?#@*&%! [hang up]

stay tuned!","$DVAX #Buyout conversation with $GSK $MRK:

#Before FDA Approval:
$GSK CEO: $18/sh $DVAX
$MRK CEO: $20/sh $DVAX
$DVAX CEO: ?#@*&%! [hang up]

#After FDA Approval:
$GSK CEO: $21/sh $DVAX
$MRK CEO: $24/sh $DVAX
$DVAX CEO: ?#@*&%! [hang up]

stay tuned!
6",,,,6,[],https://twitter.com/MaisaCorp/status/935258205873229831
5636,Kara Jill Stancell,@kjilly,2017-11-28T19:12:36.000Z,Pharma's contentious inter partes reviews come under #SupremeCourt scrutiny #pharma #biotech #PhRMA #patentlitigation $AGN $PFE $MRK $SNY $NVS http://fiercepharma.com/legal/pharma-s-contentious-inter-partes-reviews-come-under-supreme-court-scrutiny‚Ä¶,"Pharma's contentious inter partes reviews come under #SupremeCourt scrutiny #pharma #biotech #PhRMA #patentlitigation $AGN $PFE $MRK $SNY $NVS http://fiercepharma.com/legal/pharma-s-contentious-inter-partes-reviews-come-under-supreme-court-scrutiny‚Ä¶
1",,,1,,[],https://twitter.com/kjilly/status/935587247453216768
5637,Odi Bruckman,@odibro,2017-11-28T13:05:43.000Z,$PFE $MRK Phase III JAVELIN Gastric 300 trial did not meet primary endpoint,"$PFE $MRK Phase III JAVELIN Gastric 300 trial did not meet primary endpoint
1
1
3",,1,1,3,[],https://twitter.com/odibro/status/935494918872752129
5638,MM+M Magazine,@MMMnews,2017-11-28T04:15:01.000Z,"5 things for #pharma #marketers to know: Mon., Nov. 27 $TEVA #pharmajobs $REGN $NVS #DryEye #drugdevelopment $CVS $AET $AMZN #pharmacy $MRK $AZN #China #biopharma #partnership http://bit.ly/2BgDkm3","5 things for #pharma #marketers to know: Mon., Nov. 27 $TEVA #pharmajobs $REGN $NVS #DryEye #drugdevelopment $CVS $AET $AMZN #pharmacy $MRK $AZN #China #biopharma #partnership http://bit.ly/2BgDkm3
2
1",,,2,1,['https://pbs.twimg.com/media/DPpmW7qWAAIEjFE?format=jpg&name=small'],https://twitter.com/MMMnews/status/935361360489218048
5639,Quantcha Trade Ideas,@QuantchaIdeas,2017-11-27T15:32:56.000Z,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/11/27/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-3/‚Ä¶,Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://ideas.quantcha.com/2017/11/27/price-target-alert-trading-the-zacks-price-target-change-for-merck-mrk-3/‚Ä¶,,,,,['https://pbs.twimg.com/media/DPpjxehVoAEzDi0?format=png&name=small'],https://twitter.com/QuantchaIdeas/status/935169577281081344
5640,Chameleon Options,@MC_OptionTrades,2017-11-28T22:34:38.000Z,Price Returns vs Expected Daily Move $BMY $JNJ $GILD $PFE $MRK $CELG $TEVA $ABBV $AGN $VRX $REGN $BSX http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $BMY $JNJ $GILD $PFE $MRK $CELG $TEVA $ABBV $AGN $VRX $REGN $BSX http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DPwN4b_X4AAQ4p2?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/935638088809926657
5641,Merck,@Merck,2017-11-28T19:38:21.000Z,Click here for our latest news: http://bit.ly/2juZzNZ $MRK,"Click here for our latest news: http://bit.ly/2juZzNZ $MRK
1
4",,,1,4,[],https://twitter.com/Merck/status/935593726726017025
5642,Bio Stocks‚Ñ¢,@BioStocks,2017-11-28T13:02:02.000Z,$MRK & $PFE Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer. #Fail,"$MRK & $PFE Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer. #Fail
2
1",,,2,1,[],https://twitter.com/BioStocks/status/935493989502918659
5643,ValueTrades,@StockTradePicks,2017-11-28T14:19:29.000Z,MUST READ: A blockchain and cannabis story. A little-known crypto play: http://nasdaqnewsreports.blogspot.com/2017/11/a-cannabis-and-blockchain-story-ii.html‚Ä¶ $F $DE $EEM $CIM $AKS $NEE $EEP $LQD $ARLP $HACK $MRK $DD $QCP $BUD $UGAZ $IRBT $LB $MORL $EWJ $RSO,"MUST READ: A blockchain and cannabis story. A little-known crypto play: http://nasdaqnewsreports.blogspot.com/2017/11/a-cannabis-and-blockchain-story-ii.html‚Ä¶ $F $DE $EEM $CIM $AKS $NEE $EEP $LQD $ARLP $HACK $MRK $DD $QCP $BUD $UGAZ $IRBT $LB $MORL $EWJ $RSO
1",,,,1,[],https://twitter.com/StockTradePicks/status/935513481566068739
5644,dough,@semodough,2017-11-29T18:00:27.000Z,"$MRK Keytruda was+5% in September and +10% in October, $BMY's Opdivo was -1% in September and +4% in October","$MRK Keytruda was+5% in September and +10% in October, $BMY's Opdivo was -1% in September and +4% in October
dough
@semodough
 ¬∑ 29 Nov 2017
MS $MRK Keytruda continued to grow strongly in October IMS monthly US oncology sales, October 2017: MRK Keytruda's monthly sales catching up to Opdivo $BMY
3",,,,3,['https://pbs.twimg.com/profile_images/1291066256813154304/n-v436nH_mini.jpg'],https://twitter.com/semodough/status/935931476339765250
5645,Sean McGrath,@sean_uk,2017-11-27T12:03:11.000Z,"UPDATED: Merck blueprints $1.3B research hub in a post-Brexit London, with 950 staffers - https://endpts.com/merck-blueprints-1-3b-research-hub-in-a-post-brexit-london-with-950-staffers/‚Ä¶ #pharma $MRK #brexit","UPDATED: Merck blueprints $1.3B research hub in a post-Brexit London, with 950 staffers - https://endpts.com/merck-blueprints-1-3b-research-hub-in-a-post-brexit-london-with-950-staffers/‚Ä¶ #pharma $MRK #brexit
2
1",,,2,1,[],https://twitter.com/sean_uk/status/935116791315083264
5646,MM+M Magazine,@MMMnews,2017-11-28T12:30:01.000Z,Missed yesterday's news? Here's what to know #pharma $TEVA #pharmajobs $REGN $NVS #DryEye #drugdevelopment $CVS $AET $AMZN #pharmacy $MRK $AZN #China #biopharma #partnership http://bit.ly/2BgDkm3,"Missed yesterday's news? Here's what to know #pharma $TEVA #pharmajobs $REGN $NVS #DryEye #drugdevelopment $CVS $AET $AMZN #pharmacy $MRK $AZN #China #biopharma #partnership http://bit.ly/2BgDkm3
1
1",,,1,1,['https://pbs.twimg.com/media/DPpmz8xXkAIewKT?format=jpg&name=small'],https://twitter.com/MMMnews/status/935485931771121666
5647,Chameleon Options,@MC_OptionTrades,2017-11-28T01:41:03.000Z,Price Moves vs Expected Moves $TEVA $OPK $HUM $JNJ $MRK $BMY $PFE $UNH $VRX $AGN $GILD $CELG http://tinyurl.com/y7zbwhgq,Price Moves vs Expected Moves $TEVA $OPK $HUM $JNJ $MRK $BMY $PFE $UNH $VRX $AGN $GILD $CELG http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DPru9YFXkAA_WLR?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/935322613685121025
5648,Option Runners,@OptionRunners,2017-11-28T19:34:57.000Z,"$MRK Merck raises quarterly dividend to 48c per share, authorizes $10B stock buyback","$MRK Merck raises quarterly dividend to 48c per share, authorizes $10B stock buyback
1",,,,1,[],https://twitter.com/OptionRunners/status/935592870664396804
5649,Breaking News,@MarketCurrents,2017-11-28T19:40:23.000Z,Merck announces increased quarterly dividend and $10B share repurchase authorization https://seekingalpha.com/news/3314859-merck-announces-increased-quarterly-dividend-10b-share-repurchase-authorization?source=feed_f‚Ä¶ $MRK,"Merck announces increased quarterly dividend and $10B share repurchase authorization https://seekingalpha.com/news/3314859-merck-announces-increased-quarterly-dividend-10b-share-repurchase-authorization?source=feed_f‚Ä¶ $MRK
seekingalpha.com
Merck announces increased quarterly dividend and $10B share repurchase authorization (NYSE:MRK)
Merck (NYSE:MRK) declares $0.48/share quarterly dividend, 2.1% increase from prior dividend of $0.47. Forward yield 3.50% Payable Jan 8; for shareholders of record Dec. 15; ex-div Dec. 14.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/MarketCurrents/status/935594237051015168
5650,Vista Partners LLC,@VistaPResearch,2017-11-28T10:03:36.000Z,@biotechIT thx for follow! #TuesdayThoughts See Vista Partners Featured Coverage Pages of $ATOS $MRK #Biotech http://vistapglobal.com/coverage/#featured‚Ä¶ $IBB,"@biotechIT thx for follow! #TuesdayThoughts See Vista Partners Featured Coverage Pages of $ATOS $MRK #Biotech http://vistapglobal.com/coverage/#featured‚Ä¶ $IBB
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DPth-kWUEAEkAxa.jpg'],https://twitter.com/VistaPResearch/status/935449087427489792
5651,StockSpotter,@StockSpotter,2017-11-27T01:53:54.000Z,"Bullish swing trade setups for Fri, Nov 24 include $ABX $MRK $EMR $JCI $GNW  #stocks http://bit.ly/1eJiqiZ","Bullish swing trade setups for Fri, Nov 24 include $ABX $MRK $EMR $JCI $GNW  #stocks http://bit.ly/1eJiqiZ",,,,,[],https://twitter.com/StockSpotter/status/934963458776240129
5652,FiercePharma,@FiercePharma,2017-11-29T16:37:10.000Z,Game plan for lung cancer: $MRK expands awareness push,"Game plan for lung cancer: $MRK expands awareness push
fiercepharma.com
Merck drafts game plan for lung cancer with awareness campaign expansion
As Merck & Co. stacks up indications for its cancer-fighter Keytruda, it‚Äôs also adding treatment areas to its cancer awareness umbrella campaign. | As Merck & Co. stacks up indications for its...
72
12",,,72,12,['https://pbs.twimg.com/card_img/1501707755681460226/tvBM12_3?format=jpg&name=small'],https://twitter.com/FiercePharma/status/935910516043669509
5653,Spherix Global Insights,@SpherixInsights,2017-11-27T20:40:11.000Z,Early Adopters in Germany and the United Kingdom Are Prescribing $MRK Mavenclad as First-Line Induction Therapy for the Treatment of Multiple Sclerosis http://bit.ly/2hHBN0P #insights #MSNews #MultipleSclerosis #EU5,"Early Adopters in Germany and the United Kingdom Are Prescribing $MRK Mavenclad as First-Line Induction Therapy for the Treatment of Multiple Sclerosis http://bit.ly/2hHBN0P #insights #MSNews #MultipleSclerosis #EU5
1",,,,1,[],https://twitter.com/SpherixInsights/status/935246900697206784
5654,FirstToMarkets,@firsttomarkets,2017-11-28T16:15:25.000Z,Merck &amp; Co Inc  Reiterated Rating by Bank of America (Ranked 49th) to Buy with $64PT $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,Merck &amp; Co Inc  Reiterated Rating by Bank of America (Ranked 49th) to Buy with $64PT $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,,,,,[],https://twitter.com/firsttomarkets/status/935542658453274624
5655,US Banking News,@AmericanBanking,2017-11-29T12:29:29.000Z,Merck KGaA given ‚Ç¨100.00 PT by Goldman Sachs Group Inc. neutral rating. http://ift.tt/2jvruxf $MRK #MRK,Merck KGaA given ‚Ç¨100.00 PT by Goldman Sachs Group Inc. neutral rating. http://ift.tt/2jvruxf $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/935848188006760449
5656,US Banking News,@AmericanBanking,2017-11-29T12:29:26.000Z,Merck KGaA given ‚Ç¨115.00 PT by Sanford C. Bernstein. buy rating. http://ift.tt/2i0Y0af $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Sanford C. Bernstein. buy rating. http://ift.tt/2i0Y0af $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/935848172206903296
5657,dough,@semodough,2017-11-29T17:49:13.000Z,"MS $MRK Keytruda continued to grow strongly in October IMS monthly US oncology sales, October 2017: MRK Keytruda's monthly sales catching up to Opdivo $BMY","MS $MRK Keytruda continued to grow strongly in October IMS monthly US oncology sales, October 2017: MRK Keytruda's monthly sales catching up to Opdivo $BMY
1
1
1",,1,1,1,[],https://twitter.com/semodough/status/935928651744468993
5658,Dakota Financial,@dakotafinancial,2017-11-28T17:39:41.000Z,"Pinnacle Associates Ltd. Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2AeDSvK","Pinnacle Associates Ltd. Increases Stake in Merck & Company, Inc. $MRK http://ift.tt/2AeDSvK",,,,,[],https://twitter.com/dakotafinancial/status/935563863461900289
5659,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-11-28T10:43:18.000Z,$ADAP Fiercebiotech article on $GSK NY-ESO-1 option taken in September 2017 and ongoing SPEAR combo study with $MRK Keytruda in #mmsm,"$ADAP Fiercebiotech article on $GSK NY-ESO-1 option taken in September 2017 and ongoing SPEAR combo study with $MRK Keytruda in #mmsm
About Medtech
@AboutMedtech
 ¬∑ 28 Nov 2017
GlaxoSmithKline hits 'go' on Adaptimmune's SPEAR T-cell program http://bit.ly/2AGGgwa",,,,,['https://pbs.twimg.com/profile_images/836351563434090501/P7_dmG2v_mini.jpg'],https://twitter.com/dhovekamp42/status/935459078544883712
5660,Watchlist News,@WatchlistN,2017-11-28T17:38:17.000Z,"Todd Asset Management LLC Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2kbxKhS","Todd Asset Management LLC Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2kbxKhS",,,,,[],https://twitter.com/WatchlistN/status/935563510519664640
5661,Transcript Daily,@TranscriptDaily,2017-11-29T05:17:55.000Z,"Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2BwkRTI","Traders Sell Merck & Company, Inc. $MRK on Strength $MRK http://ift.tt/2BwkRTI",,,,,[],https://twitter.com/TranscriptDaily/status/935739577477881856
5662,bake mcbride,@ITRADEVOL,2017-11-28T21:38:57.000Z,After Hours  Most Active $BAC $SPY $EEM $T $GDX $F $WFC $EFA $AABA $PFE $CSCO $GE $LUV $XOP $USO $MCK $CTL $MRK $VZ https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,After Hours  Most Active $BAC $SPY $EEM $T $GDX $F $WFC $EFA $AABA $PFE $CSCO $GE $LUV $XOP $USO $MCK $CTL $MRK $VZ https://marketchameleon.com/Reports/AfterHoursTrading‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/935624075732451329
5663,Stockboard Media Inc,@stockboardinc,2017-11-29T12:05:13.000Z,"$MRK Impassioned Lung Cancer Survivors Join Your Cancer Game Plan, Merck to Advocate for Others Facing Th... - http://sbml.co/854726d1","$MRK Impassioned Lung Cancer Survivors Join Your Cancer Game Plan, Merck to Advocate for Others Facing Th... - http://sbml.co/854726d1",,,,,[],https://twitter.com/stockboardinc/status/935842078931726336
5664,Daily Political,@dailypoliticaln,2017-11-29T16:55:27.000Z,"Merck & Company, Inc. $MRK Stake Held by Community Bank & Trust Waco Texas http://ift.tt/2nezbNj","Merck & Company, Inc. $MRK Stake Held by Community Bank & Trust Waco Texas http://ift.tt/2nezbNj",,,,,[],https://twitter.com/dailypoliticaln/status/935915118013177856
5665,shortvolumes,@shortvolumes,2017-11-27T13:39:01.000Z,Short sell volume ratio for $TEVA at 2017-11-24 is 0.59. http://shortvolumes.com/?t=TEVA $MYL 0.87 $SNY 0.66 $XLV 0.53 $MRK 0.25,"Short sell volume ratio for $TEVA at 2017-11-24 is 0.59. http://shortvolumes.com/?t=TEVA $MYL 0.87 $SNY 0.66 $XLV 0.53 $MRK 0.25
1",,,,1,[],https://twitter.com/shortvolumes/status/935140909922050048
5666,WLST.com,@wlstcom,2017-11-28T19:40:24.000Z,Merck announces increased quarterly dividend and $10B share repurchase authorization #MRK #Merck&amp;CoInc. $MRK,"Merck announces increased quarterly dividend and $10B share repurchase authorization #MRK #Merck&amp;CoInc. $MRK
seekingalpha.com
Merck announces increased quarterly dividend and $10B share repurchase authorization (NYSE:MRK)
Merck (NYSE:MRK) declares $0.48/share quarterly dividend, 2.1% increase from prior dividend of $0.47. Forward yield 3.50% Payable Jan 8; for shareholders of record Dec. 15; ex-div Dec. 14.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/wlstcom/status/935594240616394752
5667,FirstToMarkets,@firsttomarkets,2017-11-28T18:15:22.000Z,Merck &amp; Co Inc  Initiated Coverage by Bank of America (Ranked 49th) to Buy $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,Merck &amp; Co Inc  Initiated Coverage by Bank of America (Ranked 49th) to Buy $MRK #MRK http://firsttomarkets.com/FTMMobile/#/stock/305‚Ä¶,,,,,[],https://twitter.com/firsttomarkets/status/935572841730252800
5668,MarketBeat,@MarketBeatCom,2017-11-29T12:27:55.000Z,Merck KGaA given ‚Ç¨115.00 PT by Sanford C. Bernstein. buy rating. http://ift.tt/2i0Y0af $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Sanford C. Bernstein. buy rating. http://ift.tt/2i0Y0af $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/935847791422853121
5669,Bumbershoot Holdings,@BumbershootHlds,2017-11-28T13:13:29.000Z,$VKTX Viking Therapeutics: Welcome To The Glorious House of Gains! http://bumbershootholdings.com/2017/10/19/viking-therapeutics-vktxngs-welcome-to-the-glorious-house-of-gains/‚Ä¶ (Full PDF version at bottom) $IBB $XBI $XLV $LGND $GILD $MDGL $CELG $AMGN $AGN $MRK $PFE,"$VKTX Viking Therapeutics: Welcome To The Glorious House of Gains! http://bumbershootholdings.com/2017/10/19/viking-therapeutics-vktxngs-welcome-to-the-glorious-house-of-gains/‚Ä¶ (Full PDF version at bottom) $IBB $XBI $XLV $LGND $GILD $MDGL $CELG $AMGN $AGN $MRK $PFE
bumbershootholdings.com
Viking Therapeutics (VKTX:NGS) ‚Äî Welcome To The Glorious House of Gains
Viking Therapeutics: Welcome to the Glorious House of Gains Viking Therapeutics is a clinical-stage biotech company that is focused on developing novel therapies to various acute and chronic metabo‚Ä¶
1",,1,,,[],https://twitter.com/BumbershootHlds/status/935496872994668544
5670,Watchlist News,@WatchlistN,2017-11-29T16:58:14.000Z,"Merck & Company, Inc. $MRK Holdings Held by National Mutual Insurance Federation of Agricultural Cooperatives http://ift.tt/2kaKjd3","Merck & Company, Inc. $MRK Holdings Held by National Mutual Insurance Federation of Agricultural Cooperatives http://ift.tt/2kaKjd3",,,,,[],https://twitter.com/WatchlistN/status/935915818554183681
5671,bake mcbride,@ITRADEVOL,2017-11-28T15:37:35.000Z,Yesterdays Stock Closing OrderImbalances $LC $T $HL $MRK $OXY $STL $NYT $PSTG $WTI $HOV $CRM $SAIL $JCP $HAL $F $DYN https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,Yesterdays Stock Closing OrderImbalances $LC $T $HL $MRK $OXY $STL $NYT $PSTG $WTI $HOV $CRM $SAIL $JCP $HAL $F $DYN https://marketchameleon.com/Reports/StockOrderImbalanceReport‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/935533135722438657
5672,Allison Gatlin,@IBD_AGatlin,2017-11-28T21:11:53.000Z,"Dow's Merck announces $10 billion buyback, increases dividend $MRK","Dow's Merck announces $10 billion buyback, increases dividend $MRK
investors.com
Dow's Merck Announces $10 Billion Share Buyback, Increases Dividend | Stock News & Stock Market...
Dow stock Merck announced a $10 billion stock buyback Tuesday and will raise its quarterly dividend to 48 cents.",,,,,[],https://twitter.com/IBD_AGatlin/status/935617263964708864
5673,Bio Stocks‚Ñ¢,@BioStocks,2017-11-28T14:24:14.000Z,$MRK reinstated with at Buy at BofA/Merrill.  PT $64,"$MRK reinstated with at Buy at BofA/Merrill.  PT $64
1",,,1,,[],https://twitter.com/BioStocks/status/935514675785035776
5674,BooRad,@atticusMB,2017-11-27T15:44:30.000Z,"Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc. 
@themotleyfool
 #stocks $MRK, $LLY","Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc. 
@themotleyfool
 #stocks $MRK, $LLY
fool.com
Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc. @themotleyfool #stocks $LLY $MRK
Find out which big American pharma is best suited to provide big gains in the years to come.",,,,,[],https://twitter.com/atticusMB/status/935172487461179397
5675,TalkMarkets,@TalkMarkets,2017-11-29T01:34:03.000Z,2 Large-Cap Drug Stocks Missing Out on Industry Rally in '17  $GSK  $MRK Also $AZN  $JNJ  $NVO  $NVS  $PFE https://goo.gl/x48CX6,2 Large-Cap Drug Stocks Missing Out on Industry Rally in '17  $GSK  $MRK Also $AZN  $JNJ  $NVO  $NVS  $PFE https://goo.gl/x48CX6,,,,,[],https://twitter.com/TalkMarkets/status/935683242623152129
5676,Chameleon,@MarketChmln,2017-11-27T21:45:11.000Z,Largest $Notional Buy On Close Order Imbalances $CRM $OXY $MRK $T $EOG $HON $D $HD $DE $JNJ http://tinyurl.com/y8jo8mjb,Largest $Notional Buy On Close Order Imbalances $CRM $OXY $MRK $T $EOG $HON $D $HD $DE $JNJ http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/935263255035043840
5677,US Banking News,@AmericanBanking,2017-11-29T13:19:16.000Z,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2Bv8pDr $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2Bv8pDr $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/935860716044800000
5678,F.A.S.T. Graphs,@FASTGraphs,2017-11-29T16:43:10.000Z,"$TRV $MRK $AXP $GE $PFE $JPM
  Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
  https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶","$TRV $MRK $AXP $GE $PFE $JPM
  Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
  https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶",,,,,[],https://twitter.com/FASTGraphs/status/935912026186113024
5679,Ticker Report,@TickerReport,2017-11-29T13:44:19.000Z,"Merck & Company, Inc. $MRK Receives New Coverage from Analysts at Bank of America http://ift.tt/2Ai1lfZ","Merck & Company, Inc. $MRK Receives New Coverage from Analysts at Bank of America http://ift.tt/2Ai1lfZ",,,,,[],https://twitter.com/TickerReport/status/935867018452103169
5680,Stockboard Media Inc,@stockboardinc,2017-11-28T19:35:23.000Z,$MRK Merck Announces Increased Quarterly Dividend and $10 Billion Share Repurchase Authorization... - http://sbml.co/66459faf,$MRK Merck Announces Increased Quarterly Dividend and $10 Billion Share Repurchase Authorization... - http://sbml.co/66459faf,,,,,[],https://twitter.com/stockboardinc/status/935592980316147717
5681,Chameleon,@MarketChmln,2017-11-28T21:35:55.000Z,Largest $Notional Sell On Close Order Imbalances $BAC $MCK $DIS $MRK $IBM $AIG $GD $DAL $SYF $STI http://tinyurl.com/y8jo8mjb,Largest $Notional Sell On Close Order Imbalances $BAC $MCK $DIS $MRK $IBM $AIG $GD $DAL $SYF $STI http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/935623314827108353
5682,FirstWord Pharma,@fwpharma,2017-11-27T10:18:03.000Z,Merck & Co. to open new research centre in UK https://firstwordpharma.com/node/1525121 $MRK,"Merck & Co. to open new research centre in UK https://firstwordpharma.com/node/1525121 $MRK
old.firstwordpharma.com
Merck & Co. to open new research centre in UK
Merck & Co. announced Monday plans to open a new research centre in the UK that will support a total of 950 jobs, including 150 newly-created research roles. The site, which will be based in London,...
1",,,,1,['https://pbs.twimg.com/card_img/1501945360222019595/MaHaAd3b?format=jpg&name=240x240'],https://twitter.com/fwpharma/status/935090335566483456
5683,The Fly,@theflynews,2017-11-28T21:32:02.000Z,On The Fly: Top stock stories for Tuesday $ROK $EMER $BWLD $GOOG $GOOGL $MRK $THO $TECD $MOMO $PETX,"On The Fly: Top stock stories for Tuesday $ROK $EMER $BWLD $GOOG $GOOGL $MRK $THO $TECD $MOMO $PETX
thefly.com
On The Fly: Top stock stories for Tuesday
Stocks opened in positive... ROK, EMER, BWLD, GOOG, GOOGL, MRK, THO, TECD, MOMO, PETX
1",,,1,,['https://pbs.twimg.com/card_img/1501757230848249864/L6iEUcw8?format=jpg&name=small'],https://twitter.com/theflynews/status/935622334383251457
5684,Briefing.com,@Briefingcom,2017-11-28T21:35:28.000Z,$MRK: Merck increases quarterly common stock dividend to $0.48/share from $0.47/share; increases share repurchase... http://bit.ly/2AcLD5v,$MRK: Merck increases quarterly common stock dividend to $0.48/share from $0.47/share; increases share repurchase... http://bit.ly/2AcLD5v,,,,,[],https://twitter.com/Briefingcom/status/935623200737607680
5685,Zach Brennan,@ZacharyBrennan,2017-11-28T19:49:24.000Z,"As the US awaits generics of complex products like $AGN's Restasis, $PFE's Premarin, $SHPG's Lialda, $MRK's NuvaRing and $JAZZ's Xyrem, FDA is working on ways it can help http://raps.org/Regulatory-Focus/News/2017/11/28/28932/Gottlieb-More-Guidance-on-Complex-Generics-Coming/‚Ä¶","As the US awaits generics of complex products like $AGN's Restasis, $PFE's Premarin, $SHPG's Lialda, $MRK's NuvaRing and $JAZZ's Xyrem, FDA is working on ways it can help http://raps.org/Regulatory-Focus/News/2017/11/28/28932/Gottlieb-More-Guidance-on-Complex-Generics-Coming/‚Ä¶
1
1",,,1,1,[],https://twitter.com/ZacharyBrennan/status/935596506937266176
5686,MarketBeat,@MarketBeatCom,2017-11-29T13:22:17.000Z,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2Bv8pDr $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2Bv8pDr $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/935861474442047488
5687,StockNews.com,@stocknewsdotcom,2017-11-28T19:38:37.000Z,$MRK Increases quarterly common stock dividend to $0.48/share from $0.47/share https://stocknews.com/news/mrk-increases-quarterly-common-stock-dividend-to-0-48share-from-0-47share/‚Ä¶,$MRK Increases quarterly common stock dividend to $0.48/share from $0.47/share https://stocknews.com/news/mrk-increases-quarterly-common-stock-dividend-to-0-48share-from-0-47share/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/935593793620987909
5688,Siti van der Meij,@sitivandermeij,2017-11-28T19:41:10.000Z,Merck announces increased quarterly dividend and $10B share repurchase authorization https://seekingalpha.com/news/3314859-merck-announces-increased-quarterly-dividend-10b-share-repurchase-authorization?source=feed_f‚Ä¶ $MRK #sitifatimah #malaysia #financialplanning,"Merck announces increased quarterly dividend and $10B share repurchase authorization https://seekingalpha.com/news/3314859-merck-announces-increased-quarterly-dividend-10b-share-repurchase-authorization?source=feed_f‚Ä¶ $MRK #sitifatimah #malaysia #financialplanning
seekingalpha.com
Merck announces increased quarterly dividend and $10B share repurchase authorization (NYSE:MRK)
Merck (NYSE:MRK) declares $0.48/share quarterly dividend, 2.1% increase from prior dividend of $0.47. Forward yield 3.50% Payable Jan 8; for shareholders of record Dec. 15; ex-div Dec. 14.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/935594437148803074
5689,M,@bio_clouseau,2017-12-01T11:44:30.000Z,$BMY Opdivo drains HIV reservoirs in single patient https://bloomberg.com/news/articles/2017-12-01/bristol-myers-cancer-drug-opdivo-shows-surprising-hiv-impact‚Ä¶ $MRK $GILD $GSK,"$BMY Opdivo drains HIV reservoirs in single patient https://bloomberg.com/news/articles/2017-12-01/bristol-myers-cancer-drug-opdivo-shows-surprising-hiv-impact‚Ä¶ $MRK $GILD $GSK
bloomberg.com
Bristol-Myers Cancer Drug Opdivo Shows Surprising HIV Impact
Bristol-Myers Squibb Co.‚Äôs blockbuster drug Opdivo had a stunning effect on a lung-cancer patient treated at a Paris hospital: it drained hard-to-reach reservoirs of his HIV infection, too.
2
23
13",,2,23,13,['https://pbs.twimg.com/card_img/1500958702911856647/2g92CtSv?format=jpg&name=small'],https://twitter.com/bio_clouseau/status/936561643433193472
5690,Charles Gordon,@princetongb,2017-12-02T17:27:40.000Z,2018: Brave New World - Bold (and not so bold) New Year's predictions. What are yours? $IBB $BMY $QURE $RHHBY $SNY $MRK $DVAX,"2018: Brave New World - Bold (and not so bold) New Year's predictions. What are yours? $IBB $BMY $QURE $RHHBY $SNY $MRK $DVAX
10
15
59",,10,15,59,['https://pbs.twimg.com/media/DQDtXPVXcAEgri9?format=jpg&name=small'],https://twitter.com/princetongb/status/937010390906605570
5691,·îïTEI·ëé·ó∑E·ñáG ·ó∞·ó™,@DrSteinberg,2017-12-01T12:53:57.000Z,"The PD-1 checkpoint inhibitor landscape in frontline NSCLC is a mess.  Pembro and Nivo are virtually the same drug with vastly different outcomes.  Probably speaks more to non-reproducibility of clinical trials
$MRK  $BMY","The PD-1 checkpoint inhibitor landscape in frontline NSCLC is a mess.  Pembro and Nivo are virtually the same drug with vastly different outcomes.  Probably speaks more to non-reproducibility of clinical trials
$MRK  $BMY
1
3
5",üî¨,1,3,5,['https://pbs.twimg.com/media/DP9lcdrV4AABcau?format=jpg&name=small'],https://twitter.com/DrSteinberg/status/936579117725704192
5692,Meg Tirrell,@megtirrell,2017-11-30T21:51:24.000Z,"Watching at-times tense 'Pharma All Stars' panel at #ForbesHealth, w CEOs of $MRK $PFE $LLY $AGN $REGN. Me and 
@jodigralnick
:","Watching at-times tense 'Pharma All Stars' panel at #ForbesHealth, w CEOs of $MRK $PFE $LLY $AGN $REGN. Me and 
@jodigralnick
:
GIF
5
12
52",,5,12,52,['https://pbs.twimg.com/tweet_video_thumb/DP6XKJCUMAE4lml.jpg'],https://twitter.com/megtirrell/status/936351985841967111
5693,Evaluate Pharma,@evaluatepharma,2017-12-01T12:25:06.000Z,". 
@EPVantage
 on the #ImmunoOncology combos to watch in 2018?  http://ow.ly/iUTy30gVgco  $INCY $BMY $MRK $ARRY",". 
@EPVantage
 on the #ImmunoOncology combos to watch in 2018?  http://ow.ly/iUTy30gVgco  $INCY $BMY $MRK $ARRY
1
3",,,1,3,['https://pbs.twimg.com/media/DP9fJHCUQAAZU00?format=jpg&name=small'],https://twitter.com/evaluatepharma/status/936571860153782273
5694,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-12-01T13:29:15.000Z,"$AFMD AFM13 + $MRK Keytruda Phase 1b study in r/r classical Hodgkin Lymphoma (KEYNOTE- 206)

Primary Completion Date (DLT) September 2017 

has been confirmed in November update 

#ASH17 

https://clinicaltrials.gov/ct2/show/record/NCT02665650‚Ä¶","$AFMD AFM13 + $MRK Keytruda Phase 1b study in r/r classical Hodgkin Lymphoma (KEYNOTE- 206)

Primary Completion Date (DLT) September 2017 

has been confirmed in November update 

#ASH17 

https://clinicaltrials.gov/ct2/show/record/NCT02665650‚Ä¶
2
3
6",,2,3,6,['https://pbs.twimg.com/media/DP9tVHRX4AAVHii?format=jpg&name=small'],https://twitter.com/dhovekamp42/status/936588004667387905
5695,Donna Young,@DonnaYoungDC,2017-11-30T22:04:26.000Z,"$MRK Frazier: I don't think it makes sense for drug patents to be subject to both Hatch-Waxman & IPR
#pharma #biotech #ForbesHealth","$MRK Frazier: I don't think it makes sense for drug patents to be subject to both Hatch-Waxman & IPR
#pharma #biotech #ForbesHealth
2
1",üì∞,,2,1,[],https://twitter.com/DonnaYoungDC/status/936355263480770560
5696,Lisa LaMotta,@lisalamotta,2017-11-30T21:17:42.000Z,$MRK's Ken Frazier: I think this administration does value our industry...Our relationship with the government doesn't trouble me at the moment #ForbesHealth,"$MRK's Ken Frazier: I think this administration does value our industry...Our relationship with the government doesn't trouble me at the moment #ForbesHealth
3
1",,,3,1,[],https://twitter.com/lisalamotta/status/936343505806544896
5697,max pain,@optioncharts,2017-12-01T18:41:45.000Z,$MRK high OI range is 55.00 to 55.50 for option expiration 12/08/2017 #maxpain #options http://bit.ly/2j60R2n,$MRK high OI range is 55.00 to 55.50 for option expiration 12/08/2017 #maxpain #options http://bit.ly/2j60R2n,,,,,['https://pbs.twimg.com/media/DP-1WaUWsAE91MH?format=jpg&name=small'],https://twitter.com/optioncharts/status/936666646390956032
5698,George Marcovits,@GemsBot,2017-12-02T17:07:22.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,,,,,['https://pbs.twimg.com/media/DQDpVavW0AESbVC?format=jpg&name=small'],https://twitter.com/GemsBot/status/937005279690084352
5699,David York,@DavidYork918,2017-12-02T10:21:38.000Z,"have you used this? i've been getting in on some great trades because of it http://bit.ly/2yrvh5u
$MRK $MDT $MD","have you used this? i've been getting in on some great trades because of it http://bit.ly/2yrvh5u
$MRK $MDT $MD",,,,,['https://pbs.twimg.com/media/DQCMeP0VAAAxX7s?format=jpg&name=900x900'],https://twitter.com/DavidYork918/status/936903176954900481
5700,Lisa Jarvis,@lisamjarvis,2017-11-30T22:01:51.000Z,"$MRK's Frazier: ""The model that produces these drugs is a very fragile model."" He says if IP & pricing systems don‚Äôt reward inc cost of dev drugs, will not have cures. ""Capital markets don‚Äôt have compassion."" #ForbesHealth","$MRK's Frazier: ""The model that produces these drugs is a very fragile model."" He says if IP & pricing systems don‚Äôt reward inc cost of dev drugs, will not have cures. ""Capital markets don‚Äôt have compassion."" #ForbesHealth
1
5
2",,1,5,2,[],https://twitter.com/lisamjarvis/status/936354616429764608
5701,Douglas Allan,@Dougallan1,2017-11-30T02:32:33.000Z,"Replying to 
@semodough
 and 
@bradloncar","Replying to 
@semodough
 and 
@bradloncar
Combined cash of $gild + $amgn is about = to combined cash of $jnj + $pfe + $bmy + $lly + $mrk
2
5",,,2,5,[],https://twitter.com/Dougallan1/status/936060352990720000
5702,Volker Schulz,@portefeuillefun,2017-12-01T09:46:41.000Z,"Drastic decrease of the #HIV reservoir in a patient treated with #nivolumab for lung cancer https://academic.oup.com/annonc/advance-article/doi/10.1093/annonc/mdx696/4677259‚Ä¶. 
@NathaliaHolt
 $BMY $MRK $ROG","Drastic decrease of the #HIV reservoir in a patient treated with #nivolumab for lung cancer https://academic.oup.com/annonc/advance-article/doi/10.1093/annonc/mdx696/4677259‚Ä¶. 
@NathaliaHolt
 $BMY $MRK $ROG
2
2",,,2,2,[],https://twitter.com/portefeuillefun/status/936531992556003329
5703,Rocky3,@Colavito00,2017-12-02T20:03:12.000Z,"BBG numbers:

For weeks ending 11/17 and 11/24 (holiday week):

                      TRx   $ABBV $GILD $MRK $BBG","BBG numbers:

For weeks ending 11/17 and 11/24 (holiday week):

                      TRx   $ABBV $GILD $MRK $BBG
investorshub.advfn.com
Biotech Values Post # 215594
1",,,,1,[],https://twitter.com/Colavito00/status/937049531564347392
5704,BioPharma Dive,@BioPharmaDive,2017-11-30T21:40:02.000Z,#ICYMI $MRK unveils big plans for new UK HQ,"#ICYMI $MRK unveils big plans for new UK HQ
biopharmadive.com
UPS digs deeper into drug distribution
The logistics provider obtained a license to relabel drugs for pharmaceutical manufacturing clients in Georgia.",,,,,['https://pbs.twimg.com/card_img/1501707670977400835/fbHHNn6u?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/936349123736932352
5705,BioPharma Dive,@BioPharmaDive,2017-11-30T00:38:00.000Z,"$UPS' move could help protect its relationship with established drug manufacturers like $MRK http://bit.ly/2Bm4kAO 
@SupplyChainDive","$UPS' move could help protect its relationship with established drug manufacturers like $MRK http://bit.ly/2Bm4kAO 
@SupplyChainDive
biopharmadive.com
UPS digs deeper into drug distribution
The logistics provider obtained a license to relabel drugs for pharmaceutical manufacturing clients in Georgia.
2
2",,,2,2,['https://pbs.twimg.com/card_img/1501707670977400835/fbHHNn6u?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/936031523094040576
5706,TradeXchange,@TheTradeXchange,2017-11-30T15:11:03.000Z,$MRK.. MAR 57.5 CALL Activity .. 4950 block @$1.20 by the BID Side .. Expire Mar 16,$MRK.. MAR 57.5 CALL Activity .. 4950 block @$1.20 by the BID Side .. Expire Mar 16,,,,,[],https://twitter.com/TheTradeXchange/status/936251235207995392
5707,WallStreetGangsta,@WallStGangsta,2017-12-01T07:44:32.000Z,"$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY","$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY",,,,,[],https://twitter.com/WallStGangsta/status/936501252220968961
5708,Stockboard Media Inc,@stockboardinc,2017-11-30T14:05:43.000Z,$MRK Merck Commemorates 30 Years of MECTIZAN¬Æ Donation Program Progress... - http://sbml.co/09f8983e,$MRK Merck Commemorates 30 Years of MECTIZAN¬Æ Donation Program Progress... - http://sbml.co/09f8983e,,,,,[],https://twitter.com/stockboardinc/status/936234792215040000
5709,Chameleon Options,@MC_OptionTrades,2017-12-01T23:08:30.000Z,Price Moves vs Expected Moves $MYL $VRX $TEVA $CELG $MRK $AMGN $GILD $AET $JNJ $PFE $BMY $ABBV http://tinyurl.com/y7zbwhgq,Price Moves vs Expected Moves $MYL $VRX $TEVA $CELG $MRK $AMGN $GILD $AET $JNJ $PFE $BMY $ABBV http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DP_yZ2XWkAARXTH?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/936733775983251457
5710,Lydia Ramsey Pflanzer,@lydiapflanzer,2017-11-30T21:59:26.000Z,"$MRK CEO Ken Frazier: ""The model that produces these drugs is a very fragile model."" #ForbesHealth","$MRK CEO Ken Frazier: ""The model that produces these drugs is a very fragile model."" #ForbesHealth
2
2",,,2,2,[],https://twitter.com/lydiapflanzer/status/936354007181922304
5711,MomentumBeast,@momentumbeast,2017-12-01T19:03:35.000Z,"$AHGIF Alternate Health Labs Inc. converted its San Antonio
laboratory from a Reference Lab to a Clinical Lab. $IBB $GILD $GWPH $NVS $BMY $MRK $JNN $AMGN $BSX $VRX","$AHGIF Alternate Health Labs Inc. converted its San Antonio
laboratory from a Reference Lab to a Clinical Lab. $IBB $GILD $GWPH $NVS $BMY $MRK $JNN $AMGN $BSX $VRX",,,,,[],https://twitter.com/momentumbeast/status/936672140639789057
5712,MomentumBeast,@momentumbeast,2017-12-01T19:04:46.000Z,"$AHGIF expects its laboratory revenues will be back
on course in December. $IBB $GILD $GWPH $NVS $MRK $BMY $JNJ $AMGN $VRX","$AHGIF expects its laboratory revenues will be back
on course in December. $IBB $GILD $GWPH $NVS $MRK $BMY $JNJ $AMGN $VRX",,,,,[],https://twitter.com/momentumbeast/status/936672437869121539
5713,Tim Reller,@TraderGuruNY,2017-12-01T02:14:57.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/936418311243485184
5714,MomentumBeast,@momentumbeast,2017-12-01T07:44:32.000Z,"$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY","$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY",,,,,[],https://twitter.com/momentumbeast/status/936501252275531776
5715,Dakota Financial,@dakotafinancial,2017-12-02T00:18:17.000Z,"Intercontinental Wealth Advisors LLC Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2zFjkJz","Intercontinental Wealth Advisors LLC Takes Position in Merck & Company, Inc. $MRK http://ift.tt/2zFjkJz",,,,,[],https://twitter.com/dakotafinancial/status/936751337307598850
5716,Dakota Financial,@dakotafinancial,2017-12-02T17:13:14.000Z,"Tradition Capital Management LLC Has $8.51 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2AlBJOX","Tradition Capital Management LLC Has $8.51 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2AlBJOX",,,,,[],https://twitter.com/dakotafinancial/status/937006757892841472
5717,Confident Investor,@ConfidentInvest,2017-12-02T01:40:08.000Z,Largest gainers today 12/2/2017 on my Watch List were: $SUI $COF $MRK $SAM $REGN - http://bit.ly/2iBFs4r,Largest gainers today 12/2/2017 on my Watch List were: $SUI $COF $MRK $SAM $REGN - http://bit.ly/2iBFs4r,,,,,[],https://twitter.com/ConfidentInvest/status/936771936675233793
5718,Watchlist News,@WatchlistN,2017-12-02T15:19:14.000Z,"Bank of America Begins Coverage on Merck & Company, Inc. $MRK http://ift.tt/2iDYAhX","Bank of America Begins Coverage on Merck & Company, Inc. $MRK http://ift.tt/2iDYAhX",,,,,[],https://twitter.com/WatchlistN/status/936978069348380673
5719,shortvolumes,@shortvolumes,2017-12-02T19:00:01.000Z,The short sell volume ratio for $SNY on 2017-12-01 is 0.36. http://shortvolumes.com/?t=SNY $TEVA 0.60 $PFE 0.58 $MRK 0.26 $LLY 0.35,The short sell volume ratio for $SNY on 2017-12-01 is 0.36. http://shortvolumes.com/?t=SNY $TEVA 0.60 $PFE 0.58 $MRK 0.26 $LLY 0.35,,,,,[],https://twitter.com/shortvolumes/status/937033632820154368
5720,Transcript Daily,@TranscriptDaily,2017-12-01T19:18:42.000Z,"Merck & Company, Inc. $MRK Earns Buy Rating from Analysts at Bank of America http://ift.tt/2iCdOnH","Merck & Company, Inc. $MRK Earns Buy Rating from Analysts at Bank of America http://ift.tt/2iCdOnH",,,,,[],https://twitter.com/TranscriptDaily/status/936675943367806977
5721,M,@bio_clouseau,2017-11-30T18:03:12.000Z,$JNJ seems to be trying to sneak in a PD1 + darzalex in R/R MM with large controlled P1 https://clinicaltrials.gov/ct2/show/NCT03357952‚Ä¶ $MRK $BMY,"$JNJ seems to be trying to sneak in a PD1 + darzalex in R/R MM with large controlled P1 https://clinicaltrials.gov/ct2/show/NCT03357952‚Ä¶ $MRK $BMY
clinicaltrials.gov
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combinat...
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory...
1
1
2",,1,1,2,['https://pbs.twimg.com/card_img/1499934075531907072/UYy6jAXC?format=png&name=240x240'],https://twitter.com/bio_clouseau/status/936294557041528832
5722,Ticker Report,@TickerReport,2017-12-02T00:12:35.000Z,"Seizert Capital Partners LLC Sells 2,159 Shares of Merck & Company, Inc. $MRK http://ift.tt/2BCqlwh","Seizert Capital Partners LLC Sells 2,159 Shares of Merck & Company, Inc. $MRK http://ift.tt/2BCqlwh",,,,,[],https://twitter.com/TickerReport/status/936749904340443136
5723,Watchlist News,@WatchlistN,2017-12-02T00:19:17.000Z,"Merck & Company, Inc. $MRK Shares Bought by Synovus Financial Corp http://ift.tt/2jDBy7F","Merck & Company, Inc. $MRK Shares Bought by Synovus Financial Corp http://ift.tt/2jDBy7F",,,,,[],https://twitter.com/WatchlistN/status/936751589032976384
5724,Watchlist News,@WatchlistN,2017-12-02T17:14:17.000Z,"Meiji Yasuda Life Insurance Co Sells 2,900 Shares of Merck & Company, Inc. $MRK http://ift.tt/2j9sDLz","Meiji Yasuda Life Insurance Co Sells 2,900 Shares of Merck & Company, Inc. $MRK http://ift.tt/2j9sDLz",,,,,[],https://twitter.com/WatchlistN/status/937007023119650817
5725,Ticker Report,@TickerReport,2017-12-02T17:17:13.000Z,"Merck & Company, Inc. $MRK Holdings Raised by Farr Miller & Washington LLC DC http://ift.tt/2zWkEMq","Merck & Company, Inc. $MRK Holdings Raised by Farr Miller & Washington LLC DC http://ift.tt/2zWkEMq",,,,,[],https://twitter.com/TickerReport/status/937007759282835456
5726,Stockboard Media Inc,@stockboardinc,2017-11-30T12:06:58.000Z,$MRK New and Updated Data for Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) and Updated Data on LYNPARZA¬Æ (olapar... - http://sbml.co/01bb79d8,$MRK New and Updated Data for Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) and Updated Data on LYNPARZA¬Æ (olapar... - http://sbml.co/01bb79d8,,,,,[],https://twitter.com/stockboardinc/status/936204906909896705
5727,Daily Political,@dailypoliticaln,2017-12-02T17:23:07.000Z,"ACR Alpine Capital Research LLC Has $599,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2zHok06","ACR Alpine Capital Research LLC Has $599,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2zHok06",,,,,[],https://twitter.com/dailypoliticaln/status/937009243340857345
5728,Daily Political,@dailypoliticaln,2017-12-02T16:43:09.000Z,"Share Buyback Plan Announced by Merck & Company, Inc. $MRK Board of Directors http://ift.tt/2iBkeDD","Share Buyback Plan Announced by Merck & Company, Inc. $MRK Board of Directors http://ift.tt/2iBkeDD",,,,,[],https://twitter.com/dailypoliticaln/status/936999189128601600
5729,shortvolumes,@shortvolumes,2017-12-02T15:00:01.000Z,2017-12-01 Short sell volume ratio for $MNKD is 0.60. http://shortvolumes.com/?t=MNKD $ARDM 0.43 $PFE 0.58 $LLY 0.35 $MRK 0.26,2017-12-01 Short sell volume ratio for $MNKD is 0.60. http://shortvolumes.com/?t=MNKD $ARDM 0.43 $PFE 0.58 $LLY 0.35 $MRK 0.26,,,,,[],https://twitter.com/shortvolumes/status/936973234003759105
5730,Confident Investor,@ConfidentInvest,2017-11-30T12:10:08.000Z,Confident Investor indicator analysis for 11/30/2017. Interesting results from $MCK $DPZ $MRK $ULTA - http://bit.ly/2AoJa8n,Confident Investor indicator analysis for 11/30/2017. Interesting results from $MCK $DPZ $MRK $ULTA - http://bit.ly/2AoJa8n,,,,,[],https://twitter.com/ConfidentInvest/status/936205706419625984
5731,Market Realist,@MarketRealist,2017-12-02T00:00:58.000Z,What Drove GlaxoSmithKline‚Äôs Valuation in November 2017? http://marketrealist.com/?p=2470490 $GSK $MRK $VEA $NVS,What Drove GlaxoSmithKline‚Äôs Valuation in November 2017? http://marketrealist.com/?p=2470490 $GSK $MRK $VEA $NVS,,,,,[],https://twitter.com/MarketRealist/status/936746980348432384
5732,Margin Hunt,@MarginHunt,2017-11-30T13:30:19.000Z,"Value investors may want to look at Merck & Company, Inc. $MRK. George Soros is http://ow.ly/7nss30gTuWy","Value investors may want to look at Merck & Company, Inc. $MRK. George Soros is http://ow.ly/7nss30gTuWy",,,,,[],https://twitter.com/MarginHunt/status/936225884473823234
5733,US Banking News,@AmericanBanking,2017-12-01T09:54:33.000Z,"Merck & Company, Inc. $MRK ‚Äì Research Analysts‚Äô Weekly Ratings Changes http://ift.tt/2njln4d","Merck & Company, Inc. $MRK ‚Äì Research Analysts‚Äô Weekly Ratings Changes http://ift.tt/2njln4d",,,,,[],https://twitter.com/AmericanBanking/status/936533970992422913
5734,9/11 No Planer,@911NoPlaner,2017-12-01T04:58:07.000Z,"Government committee declares #HPV #vaccines should never be given to teenage boys ‚Ä¶ Media pursues total BLACKOUT on the story http://dcclothesline.com/2017/11/30/government-committee-declares-hpv-vaccines-should-never-be-given-to-teenage-boys-media-pursues-total-blackout-on-the-story/‚Ä¶ via 
@DCClothesline
 #gardasil #merck $mrk","Government committee declares #HPV #vaccines should never be given to teenage boys ‚Ä¶ Media pursues total BLACKOUT on the story http://dcclothesline.com/2017/11/30/government-committee-declares-hpv-vaccines-should-never-be-given-to-teenage-boys-media-pursues-total-blackout-on-the-story/‚Ä¶ via 
@DCClothesline
 #gardasil #merck $mrk
dcclothesline.com
Government committee declares HPV vaccines should never be given to teenage boys ‚Ä¶ Media pursues...
(Natural News) A finding by the U.K.‚Äôs Joint Committee on Vaccination and Immunisation (JCVI), that it is not advisable to administer the human papillomavirus (HPV) vaccine to boys, has been met with...",ü•∂,,,,[],https://twitter.com/911NoPlaner/status/936459372070428672
5735,MarketBeat,@MarketBeatCom,2017-11-30T16:58:15.000Z,"Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $13.02 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zBpE4W","Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $13.02 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zBpE4W",,,,,[],https://twitter.com/MarketBeatCom/status/936278212103065602
5736,vnmaster gupta,@Gupta_Calling,2017-12-02T19:40:36.000Z,"Replying to 
@R5ive8","Replying to 
@R5ive8
$DVAX $MRK knocking on their door soon? https://twitter.com/BayAreaBiotechI/status/919644677661368320‚Ä¶
This Tweet is unavailable.
1",,,,1,[],https://twitter.com/Gupta_Calling/status/937043843538735106
5737,MarketSmith,@MarketSmith,2017-12-01T17:35:36.000Z,"Stock Indexes Drop, But Oil Stocks Rise; Vote Likely On Tax-Cut Bill: http://ow.ly/i3Az30gX6PM $MRK $JNJ $GE $APA $FFTY $C $BK $KEY","Stock Indexes Drop, But Oil Stocks Rise; Vote Likely On Tax-Cut Bill: http://ow.ly/i3Az30gX6PM $MRK $JNJ $GE $APA $FFTY $C $BK $KEY
investors.com
Stock Indexes Drop, But Oil Stocks Rise; Vote Likely On Tax-Cut Bill | Stock News & Stock Market...
Amid a broad sell-off on Wall Street, two bank stocks are approaching buy points.
1",,,,1,[],https://twitter.com/MarketSmith/status/936649997562580993
5738,The Capitolist,@CapitolistPig,2017-12-01T14:38:22.000Z,So when someone (anyone) walks into a drug company like $MRK and proposes the beginning of a new distribution system (like $UPS) they get a high level meeting because the entire industry knows that $ESRX and its middle man model is dead,"So when someone (anyone) walks into a drug company like $MRK and proposes the beginning of a new distribution system (like $UPS) they get a high level meeting because the entire industry knows that $ESRX and its middle man model is dead
1
1",,1,,1,[],https://twitter.com/CapitolistPig/status/936605395094732801
5739,Bertrand Delsuc,@BertrandBio,2017-12-01T18:25:24.000Z,"Replying to 
@PDRennert","Replying to 
@PDRennert
$ADRO & $MRK on it then iTEOS, Nimbus, $SBHP, $BMY (IFM Therapeutics) and probably more
1
4",,1,,4,[],https://twitter.com/BertrandBio/status/936662529706774529
5740,Dakota Financial,@dakotafinancial,2017-11-30T16:54:09.000Z,"Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $13.02 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zBpE4W","Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $13.02 Million Holdings in Merck & Company, Inc. $MRK http://ift.tt/2zBpE4W",,,,,[],https://twitter.com/dakotafinancial/status/936277181617135618
5741,Benzinga,@Benzinga,2017-12-01T20:35:00.000Z,FDA Decisions In November: The Month In Review https://benzinga.com/z/10858623 $AZN $BMY $COLL $VRX $MRK $RARE $HRTX $DVAX,FDA Decisions In November: The Month In Review https://benzinga.com/z/10858623 $AZN $BMY $COLL $VRX $MRK $RARE $HRTX $DVAX,,,,,[],https://twitter.com/Benzinga/status/936695146904567808
5742,dough,@semodough,2017-12-03T21:34:08.000Z,#Antibiotic Market Share by $ Sales in 2022.    Big boys will be acquiring    $PRTK $AKAO $NBRV $AGN $MRK $GSK,"#Antibiotic Market Share by $ Sales in 2022.    Big boys will be acquiring    $PRTK $AKAO $NBRV $AGN $MRK $GSK
3
11
22",,3,11,22,['https://pbs.twimg.com/media/DQJv85OWkAATjEF?format=jpg&name=small'],https://twitter.com/semodough/status/937434805289017345
5743,Christian Fromhertz,@cfromhertz,2017-12-04T21:12:29.000Z,"TTG Top  Aggressive  #option activity  
CALLS: $TRN $CBI $KMX $AAP $FCX $TTWO $BABA $SAVE $ETSY $PYPL $MU $HIMX $DIS $NUE $STLD $UPS $CMCSA $MRK $OSTK 
PUTS: $QQQ $QQQ $RHY $RHT $AVTI","TTG Top  Aggressive  #option activity  
CALLS: $TRN $CBI $KMX $AAP $FCX $TTWO $BABA $SAVE $ETSY $PYPL $MU $HIMX $DIS $NUE $STLD $UPS $CMCSA $MRK $OSTK 
PUTS: $QQQ $QQQ $RHY $RHT $AVTI
2
8",,,2,8,['https://pbs.twimg.com/media/DQO0ngPXUAAaQRB?format=jpg&name=900x900'],https://twitter.com/cfromhertz/status/937791743851982848
5744,Meg Tirrell,@megtirrell,2017-12-05T21:27:07.000Z,Roy Vagelos cementing his position as one of most beloved pharma CEOs in recent history (a small group) $REGN $MRK,"Roy Vagelos cementing his position as one of most beloved pharma CEOs in recent history (a small group) $REGN $MRK
Zina Moukheiber
@ZinaMoukheiber
 ¬∑ 5 Dec 2017
Amazing gift from Merck's former chairman Roy Vagelos. With $250 Million Gift, Columbia Medical School Looks to End Student Debt https://nyti.ms/2nt0vrw
7
18
56",,7,18,56,['https://pbs.twimg.com/profile_images/1408197970/Zina.Moukheiber_mini.jpg'],https://twitter.com/megtirrell/status/938157814748532738
5745,Kevin Shannon,@kj_shannon15,2017-12-04T18:18:47.000Z,"Analyst podcast recorded 12/1 morning (using new and hopefully improved recording software)
- $MDCO divestature of ID business/Repatha $AMGN sBLA update-:35
- $AMGN and $TEVA migraine data-12:20
- Bavencio $PFE Phase III gastric failure ( $MRK $BMY )-22:15","Analyst podcast recorded 12/1 morning (using new and hopefully improved recording software)
- $MDCO divestature of ID business/Repatha $AMGN sBLA update-:35
- $AMGN and $TEVA migraine data-12:20
- Bavencio $PFE Phase III gastric failure ( $MRK $BMY )-22:15
soundcloud.com
12/1/2017
Zach McLellan, Kevin Shannon and Jack Allen discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast. Topics covered in this episode include: - MDCO divestiture o
4
5",,,4,5,['https://pbs.twimg.com/card_img/1499968131678482437/V6ETNoUC?format=jpg&name=240x240'],https://twitter.com/kj_shannon15/status/937748028097642496
5746,Activist Blockchain,@activistbitcoin,2017-12-05T16:55:14.000Z,Gilead: Buying New Growth http://ow.ly/ubXU30h04mS $GILD $MRK $GSK,"Gilead: Buying New Growth http://ow.ly/ubXU30h04mS $GILD $MRK $GSK
2",,,,2,[],https://twitter.com/activistbitcoin/status/938089391649644544
5747,Donna Young,@DonnaYoungDC,2017-12-04T19:17:07.000Z,"ICYMI: Capitol Checkup: Biopharmas debate patent system, industry image, pricing cures https://platform.mi.spglobal.com/web/client?auth=inherit#news/article?id=42820197&cdid=A-42820197-10804‚Ä¶ #pharma #biotech #FDA #drugprices #drugpricing $AGN $REGN $MRK $BLUE $ONCE #ForbesHealth","ICYMI: Capitol Checkup: Biopharmas debate patent system, industry image, pricing cures https://platform.mi.spglobal.com/web/client?auth=inherit#news/article?id=42820197&cdid=A-42820197-10804‚Ä¶ #pharma #biotech #FDA #drugprices #drugpricing $AGN $REGN $MRK $BLUE $ONCE #ForbesHealth
2
1",üì∞,,2,1,[],https://twitter.com/DonnaYoungDC/status/937762709394935809
5748,Finscreener,@Finscreener,2017-12-04T16:13:37.000Z,3 months performace of SP500 stocks $AMZN $WMT $HD $JNJ $PFE $UNH $AAPL $MRK $WFC $JPM https://finscreener.com/map,3 months performace of SP500 stocks $AMZN $WMT $HD $JNJ $PFE $UNH $AAPL $MRK $WFC $JPM https://finscreener.com/map,,,,,['https://pbs.twimg.com/media/DQNwNyTVoAA0u_N?format=jpg&name=small'],https://twitter.com/Finscreener/status/937716532045647872
5749,StockMarketVideo.com,@stockmarketvide,2017-12-05T02:32:25.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/937872256415485953
5750,Ben Fidler,@BentheFidler,2017-12-04T20:53:10.000Z,ICYMI earlier: 15 For ‚Äô18: Key Clinical Data to Watch For Next Year (Part 1) https://xconomy.com/national/2017/12/04/15-for-18-key-clinical-data-to-watch-for-next-year-part-1/‚Ä¶ $VTVT $GILD $BMY $MRK,"ICYMI earlier: 15 For ‚Äô18: Key Clinical Data to Watch For Next Year (Part 1) https://xconomy.com/national/2017/12/04/15-for-18-key-clinical-data-to-watch-for-next-year-part-1/‚Ä¶ $VTVT $GILD $BMY $MRK
1
3",,,1,3,[],https://twitter.com/BentheFidler/status/937786880279695360
5751,Chameleon Options,@MC_OptionTrades,2017-12-05T01:32:53.000Z,Price Moves vs Expected Moves $VRX $AMGN $MRK $CELG $JNJ $PFE $BMY $TEVA $AET $AGN $GILD $CVS http://tinyurl.com/y7zbwhgq,Price Moves vs Expected Moves $VRX $AMGN $MRK $CELG $JNJ $PFE $BMY $TEVA $AET $AGN $GILD $CVS http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DQPwN-xXkAAoQsn?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/937857272855834624
5752,James Sikes,@wosaikeneriki,2017-12-05T11:24:42.000Z,Merck & Co New Com $MRK Holder Blackhill Capital Lifted Stake by $9.76 Million as Share Price Declined ...,Merck & Co New Com $MRK Holder Blackhill Capital Lifted Stake by $9.76 Million as Share Price Declined ...,,,,,[],https://twitter.com/wosaikeneriki/status/938006211957489664
5753,MomentumBeast,@momentumbeast,2017-12-05T17:26:49.000Z,$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù http://vimeo.com/177328744  $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU $GRWG,"$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù http://vimeo.com/177328744  $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU $GRWG
vimeo.com
Alternate Health - ""Innovation. Customization. Collaboration....
Alternate Health Corp (CSE:AHG) (OTC:AHGIF), is a diverse healthcare company revolutionizing patient care and research through compliance and technology in the emerging‚Ä¶",,,,,['https://pbs.twimg.com/card_img/1501699223535902721/R-oTHLI0?format=jpg&name=240x240'],https://twitter.com/momentumbeast/status/938097339436339202
5754,Philip Calrissian,@Trading_Sunset,2017-12-05T00:22:15.000Z,"Merck $MRK settled higher for the 5th day of 6, +0.6% at $56.22. Soft target are the 58s. FPE 13s. Y 3.4% NM 7.2%. Not expensive, but arguably more interesting health/bio stocks out there.. not least $GILD or $TEVA  
@peterfarahani","Merck $MRK settled higher for the 5th day of 6, +0.6% at $56.22. Soft target are the 58s. FPE 13s. Y 3.4% NM 7.2%. Not expensive, but arguably more interesting health/bio stocks out there.. not least $GILD or $TEVA  
@peterfarahani
1",,,,1,['https://pbs.twimg.com/media/DQPfXn7WAAE0nZw?format=jpg&name=small'],https://twitter.com/Trading_Sunset/status/937839500025360384
5755,Robin Davison,@RobinDavison2,2017-12-04T13:53:21.000Z,"Suspicious given FT's puff piece and after last week's $MRK ""investment"" in London. Obvious coordinated PR campaign. Suspect taxpayer-funded Brexit bribery going on here.","Suspicious given FT's puff piece and after last week's $MRK ""investment"" in London. Obvious coordinated PR campaign. Suspect taxpayer-funded Brexit bribery going on here.
MedCity
@MedCityHQ
 ¬∑ 4 Dec 2017
US-based fund to invest $1bn in UK biotech https://ft.com/content/3bdf4e92-d806-11e7-a039-c64b1c09b482‚Ä¶ via @FT",,,,,['https://pbs.twimg.com/profile_images/1277635884620353536/hLV9nJyz_mini.jpg'],https://twitter.com/RobinDavison2/status/937681231055085568
5756,TWJ PRIVATE,@twj_private,2017-12-05T15:21:26.000Z,Team. Closing $MRK calls here - bid/ask is 153/159.,Team. Closing $MRK calls here - bid/ask is 153/159.,,,,,[],https://twitter.com/twj_private/status/938065785876025345
5757,WallStreetGangsta,@WallStGangsta,2017-12-05T17:25:04.000Z,"$AHGIF ‚ÄúNow that Alternate Health‚Äôs CanaPass is proven and operational in Canada this quarter, it‚Äôs time to take a global approach to our business,‚Äù says Dr. Murphy.  $IBB $GILD $JNJ $PFE $AMGN $NVS $MRK $GWPH $BMY $BSX $GRWG","$AHGIF ‚ÄúNow that Alternate Health‚Äôs CanaPass is proven and operational in Canada this quarter, it‚Äôs time to take a global approach to our business,‚Äù says Dr. Murphy.  $IBB $GILD $JNJ $PFE $AMGN $NVS $MRK $GWPH $BMY $BSX $GRWG",,,,,[],https://twitter.com/WallStGangsta/status/938096901559410689
5758,Activist Stocks,@activiststocks,2017-12-05T17:01:25.000Z,Gilead: Buying New Growth http://ow.ly/ubXU30h04mS $GILD $MRK $GSK,Gilead: Buying New Growth http://ow.ly/ubXU30h04mS $GILD $MRK $GSK,,,,,[],https://twitter.com/activiststocks/status/938090946780106752
5759,BioPharma Dive,@BioPharmaDive,2017-12-04T17:25:01.000Z,BioPharma Dive's 2017 Executive of the Year: $MRK's Kenneth Frazier http://bit.ly/2AKbaU7,"BioPharma Dive's 2017 Executive of the Year: $MRK's Kenneth Frazier http://bit.ly/2AKbaU7
1
1",,,1,1,[],https://twitter.com/BioPharmaDive/status/937734498296270848
5760,MomentumBeast,@momentumbeast,2017-12-05T17:25:05.000Z,"$AHGIF ‚ÄúNow that Alternate Health‚Äôs CanaPass is proven and operational in Canada this quarter, it‚Äôs time to take a global approach to our business,‚Äù says Dr. Murphy.  $IBB $GILD $JNJ $PFE $AMGN $NVS $MRK $GWPH $BMY $BSX $GRWG","$AHGIF ‚ÄúNow that Alternate Health‚Äôs CanaPass is proven and operational in Canada this quarter, it‚Äôs time to take a global approach to our business,‚Äù says Dr. Murphy.  $IBB $GILD $JNJ $PFE $AMGN $NVS $MRK $GWPH $BMY $BSX $GRWG",,,,,[],https://twitter.com/momentumbeast/status/938096902599598080
5761,WallStreetGangsta,@WallStGangsta,2017-12-05T17:19:49.000Z,"$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY $GRWG","$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY $GRWG",,,,,[],https://twitter.com/WallStGangsta/status/938095577665032192
5762,TWJ PRIVATE,@twj_private,2017-12-05T15:22:07.000Z,$MRK is stuck at that HVA. Don't like chart. They are in Dec. not enough time.,$MRK is stuck at that HVA. Don't like chart. They are in Dec. not enough time.,,,,,[],https://twitter.com/twj_private/status/938065957662191617
5763,leahanne,@leahanneta,2017-12-04T20:40:34.000Z,"15:09 ET Volume Leader #79 - MRK 8,236,971 Merck & Company $MRK 56.45 +0.58 +1.04% High today of 56.71 day low","15:09 ET Volume Leader #79 - MRK 8,236,971 Merck & Company $MRK 56.45 +0.58 +1.04% High today of 56.71 day low
investorshangout.com
15:09 ET Volume Leader #79 - MRK - Estrella's Sizzling Hot Stock Plays #4868071 - Investors Hangout
Estrella's Sizzling Hot Stock Plays: 15:09 ET Volume Leader #79 - MRK 8,236,971 Merck Company $MRK 56.45 +0.58 +1.04% High today of 56. - #",,,,,['https://pbs.twimg.com/card_img/1499876933328273409/n4UuReOd?format=png&name=240x240'],https://twitter.com/leahanneta/status/937783711759781889
5764,InvestorPlace,@InvestorPlace,2017-12-04T15:43:43.000Z,Walt Disney Leads 5 Dividend Stocks Boosting Payouts $DIS $MRK ...,"Walt Disney Leads 5 Dividend Stocks Boosting Payouts $DIS $MRK ...
investorplace.com
Walt Disney Co Leads 5 Dividend Stocks Boosting Payouts
Five notable dividend stocks recently raised their payouts, including Walt Disney (DIS). Here's what you need to know about each.
1",,,,1,[],https://twitter.com/InvestorPlace/status/937709005719339008
5765,Transcript Daily,@TranscriptDaily,2017-12-05T06:31:29.000Z,"Share Buyback Plan Announced by Merck & Company, Inc. $MRK http://ift.tt/2AYE7MB","Share Buyback Plan Announced by Merck & Company, Inc. $MRK http://ift.tt/2AYE7MB",,,,,[],https://twitter.com/TranscriptDaily/status/937932419814051840
5766,TWJ PRIVATE,@twj_private,2017-12-05T15:24:15.000Z,Same chart pattern with $UA as $MRK. Not taking out HVA.,"Same chart pattern with $UA as $MRK. Not taking out HVA.
1",,1,,,[],https://twitter.com/twj_private/status/938066496823201798
5767,Ticker Report,@TickerReport,2017-12-03T16:57:20.000Z,"Ffcm LLC Buys 9,350 Shares of Merck & Company, Inc. $MRK http://ift.tt/2nqDrtq","Ffcm LLC Buys 9,350 Shares of Merck & Company, Inc. $MRK http://ift.tt/2nqDrtq",,,,,[],https://twitter.com/TickerReport/status/937365143352209414
5768,Dakota Financial,@dakotafinancial,2017-12-04T16:30:08.000Z,"Bienville Capital Management LLC Acquires 3,000 Shares of Merck & Company, Inc. $MRK http://ift.tt/2A2IFRW","Bienville Capital Management LLC Acquires 3,000 Shares of Merck & Company, Inc. $MRK http://ift.tt/2A2IFRW",,,,,[],https://twitter.com/dakotafinancial/status/937720686407311360
5769,Ticker Report,@TickerReport,2017-12-05T23:35:18.000Z,"Merck & Co., Inc. $MRK Earning Favorable Press Coverage, Analysis Finds http://ift.tt/2koKbqw","Merck & Co., Inc. $MRK Earning Favorable Press Coverage, Analysis Finds http://ift.tt/2koKbqw",,,,,[],https://twitter.com/TickerReport/status/938190069965389824
5770,Watchlist News,@WatchlistN,2017-12-05T20:22:04.000Z,"Freestone Capital Holdings LLC Has $586,000 Stake in Merck & Co., Inc. $MRK http://ift.tt/2nuAI1T","Freestone Capital Holdings LLC Has $586,000 Stake in Merck & Co., Inc. $MRK http://ift.tt/2nuAI1T",,,,,[],https://twitter.com/WatchlistN/status/938141441930547200
5771,Transcript Daily,@TranscriptDaily,2017-12-05T20:26:41.000Z,"Merck & Co., Inc. $MRK Holdings Trimmed by Schroder Investment Management Group http://ift.tt/2jhrwcC","Merck & Co., Inc. $MRK Holdings Trimmed by Schroder Investment Management Group http://ift.tt/2jhrwcC",,,,,[],https://twitter.com/TranscriptDaily/status/938142605954691073
5772,Mike DeSenne,@mdesenne,2017-12-05T20:56:54.000Z,The 15 All-Time Best-Selling Prescription Drugs https://kiplinger.com/slideshow/investing/T027-S001-the-15-all-time-best-selling-prescription-drugs/index.html?rid=SOC-twitter#.WicHgf8J9CE.twitter‚Ä¶ $PFE $MRK $LLY $AMGN $GSK $JNJ $ABBV $SNY $NVS $TEVA,"The 15 All-Time Best-Selling Prescription Drugs https://kiplinger.com/slideshow/investing/T027-S001-the-15-all-time-best-selling-prescription-drugs/index.html?rid=SOC-twitter#.WicHgf8J9CE.twitter‚Ä¶ $PFE $MRK $LLY $AMGN $GSK $JNJ $ABBV $SNY $NVS $TEVA
kiplinger.com
The 15 All-Time Best-Selling Prescription Drugs | Kiplinger",,,,,[],https://twitter.com/mdesenne/status/938150208663408640
5773,Watchlist News,@WatchlistN,2017-12-03T17:02:57.000Z,"Vivaldi Capital Management LLC Invests $250,000 in Merck & Company, Inc. $MRK Stock http://ift.tt/2jbWK4Y","Vivaldi Capital Management LLC Invests $250,000 in Merck & Company, Inc. $MRK Stock http://ift.tt/2jbWK4Y",,,,,[],https://twitter.com/WatchlistN/status/937366558581682178
5774,Watchlist News,@WatchlistN,2017-12-04T16:29:05.000Z,"Sheaff Brock Investment Advisors LLC Buys 451 Shares of Merck & Company, Inc. $MRK http://ift.tt/2zNrUpO","Sheaff Brock Investment Advisors LLC Buys 451 Shares of Merck & Company, Inc. $MRK http://ift.tt/2zNrUpO",,,,,[],https://twitter.com/WatchlistN/status/937720422321311745
5775,Daily Political,@dailypoliticaln,2017-12-03T17:03:33.000Z,"Veritas Investment Management LLP Has $244,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2iIE6Vh","Veritas Investment Management LLP Has $244,000 Stake in Merck & Company, Inc. $MRK http://ift.tt/2iIE6Vh",,,,,[],https://twitter.com/dailypoliticaln/status/937366707588476936
5776,Chameleon Options,@MC_OptionTrades,2017-12-04T23:52:45.000Z,$MRK Merck Option Order Flow Sentiment is 87.3% Bullish. http://tinyurl.com/ydxxcwh5,$MRK Merck Option Order Flow Sentiment is 87.3% Bullish. http://tinyurl.com/ydxxcwh5,ü¶é,,,,[],https://twitter.com/MC_OptionTrades/status/937832076514078721
5777,Stocks Pastor,@stockspastor,2017-12-04T21:27:40.000Z,$GE looks bottomed at $17.46.  61% retracement level.  Insiders have been loading.  I like buying cheap and selling to suckers when they top just like $VRX $T $CMCSA $MRK $VZ http://bit.ly/1PWTzJR,$GE looks bottomed at $17.46.  61% retracement level.  Insiders have been loading.  I like buying cheap and selling to suckers when they top just like $VRX $T $CMCSA $MRK $VZ http://bit.ly/1PWTzJR,,,,,[],https://twitter.com/stockspastor/status/937795565118779393
5778,Activist Blockchain,@activistbitcoin,2017-12-05T20:50:04.000Z,"Gilead: Buying New Growth http://ow.ly/afPh30h1ZLi

$GILD $GSK $MRK $JNJ $KITE $ABBV","Gilead: Buying New Growth http://ow.ly/afPh30h1ZLi

$GILD $GSK $MRK $JNJ $KITE $ABBV",,,,,[],https://twitter.com/activistbitcoin/status/938148488067649537
5779,MomentumBeast,@momentumbeast,2017-12-05T17:19:49.000Z,"$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY $GRWG","$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY $GRWG",,,,,[],https://twitter.com/momentumbeast/status/938095577870594049
5780,Daily Political,@dailypoliticaln,2017-12-04T16:36:34.000Z,"Dearborn Partners LLC Has $18.09 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2iL9Mti","Dearborn Partners LLC Has $18.09 Million Stake in Merck & Company, Inc. $MRK http://ift.tt/2iL9Mti",,,,,[],https://twitter.com/dailypoliticaln/status/937722304347430912
5781,BioPharm Insight,@BioPharmInsight,2017-12-04T08:45:00.000Z,"Our post #ECTRIMS2017 report includes scoops and analysis on $ROG, $BIIB, $MRK, $NOVN, $ALKS and MedDay http://bit.ly/2nfs8nK","Our post #ECTRIMS2017 report includes scoops and analysis on $ROG, $BIIB, $MRK, $NOVN, $ALKS and MedDay http://bit.ly/2nfs8nK",,,,,[],https://twitter.com/BioPharmInsight/status/937603633297920000
5782,F.A.S.T. Graphs,@FASTGraphs,2017-12-04T18:49:14.000Z,"$TRV $MRK $AXP $GE $PFE $JPM
  Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
  https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶","$TRV $MRK $AXP $GE $PFE $JPM
  Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
  https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶",,,,,[],https://twitter.com/FASTGraphs/status/937755694001999873
5783,MarketBeat,@MarketBeatCom,2017-12-03T17:02:24.000Z,"Merck & Company, Inc. $MRK Position Raised by Fiduciary Trust Co. http://ift.tt/2ARyFes","Merck & Company, Inc. $MRK Position Raised by Fiduciary Trust Co. http://ift.tt/2ARyFes",,,,,[],https://twitter.com/MarketBeatCom/status/937366417590145025
5784,Joe Kunkle,@OptionsHawk,2017-12-04T15:37:43.000Z,"Merck $MRK IV jumpy with over 8,200 December $55 calls trading","Merck $MRK IV jumpy with over 8,200 December $55 calls trading",,,,,[],https://twitter.com/OptionsHawk/status/937707496004898818
5785,marianne toftegaard,@mtpoulsen,2017-12-03T12:01:46.000Z,"Replying to 
@fezziwig2008
 and 
@YahooFinance","Replying to 
@fezziwig2008
 and 
@YahooFinance
$MRK USD45M from real estate sale + USD4.8B from sale of consumer biz unit. Wonder what they will do with all that cash! Go Christmas shopping at $HALO ?
2
6",,2,,6,[],https://twitter.com/mtpoulsen/status/937290763980943360
5786,WallStreetGangsta,@WallStGangsta,2017-12-05T17:26:49.000Z,$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù http://vimeo.com/177328744  $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU $GRWG,$AHGIF Alternate Health - ‚ÄúInnovation. Customization. Collaboration. Dedication‚Äù http://vimeo.com/177328744  $SPY $IBB $GILD $NVS $AMGN $MRK $PFE $BSX $BMY $JNJ $GWPH $SMG $AAPL $FB $INTC $MSFT $NVDA $GOOG $AMZN $BABA $ROKU $GRWG,,,,,[],https://twitter.com/WallStGangsta/status/938097339427901440
5787,The Options Insider,@Options,2017-12-04T17:57:41.000Z,"The Most Active Equity Options And Strikes For Midday December 4th ‚Äì $BAC, $FB, $AAPL, $MRK, $CVS   http://theoptionsinsider.com/active-equity-options-strikes-midday-december-4th-bac-fb-aapl-mrk-cvs/‚Ä¶","The Most Active Equity Options And Strikes For Midday December 4th ‚Äì $BAC, $FB, $AAPL, $MRK, $CVS   http://theoptionsinsider.com/active-equity-options-strikes-midday-december-4th-bac-fb-aapl-mrk-cvs/‚Ä¶",,,,,[],https://twitter.com/Options/status/937742718180216832
5788,John Carroll,@JohnCendpts,2017-12-05T21:36:29.000Z,"Merck and PhRMA to FDA: Wait for ICH before finalizing guidance on toxicity testing for cancer drugs
$MRK
@ZacharyBrennan","Merck and PhRMA to FDA: Wait for ICH before finalizing guidance on toxicity testing for cancer drugs
$MRK
@ZacharyBrennan
endpts.com
Merck and PhRMA to FDA: Wait for ICH before finalizing guidance on toxicity testing for cancer drugs
Drugmakers and industry groups are calling on the FDA to hold off on finalizing a draft guidance until the International Council on Harmonisation (ICH) finalizes its own guidance on the topic of...
1
4",,1,,4,[],https://twitter.com/JohnCendpts/status/938160172303880192
5789,marianne toftegaard,@mtpoulsen,2017-12-03T12:23:59.000Z,"Replying to 
@Wattwurm73
, 
@fezziwig2008
 and 
@YahooFinance","Replying to 
@Wattwurm73
, 
@fezziwig2008
 and 
@YahooFinance
$MRK $HALO Habe ich geh√∂rt - but in the PR they say they will spend it ‚Äúto help fund more R&D into prescription drugs‚Äù Time will tell
1
3",,1,,3,[],https://twitter.com/mtpoulsen/status/937296351741792256
5790,BlueSkyBreakout,@Megafauna2,2017-12-05T13:06:28.000Z,"Replying to 
@twj_private","Replying to 
@twj_private
Which $MRK calls are in play?
1",,1,,,[],https://twitter.com/Megafauna2/status/938031821153095682
5791,Alex Keaton,@APKeyton,2017-12-05T18:22:25.000Z,"Replying to 
@mikegoodma","Replying to 
@mikegoodma
Willing to sell my remaining $RVNC shares for $100/share.  $PFE, $MRK, $GSK --- That's the bar when making your offers. 
@cnbc
 @DewDiligence",,,,,[],https://twitter.com/APKeyton/status/938111332414558215
5792,marianne toftegaard,@mtpoulsen,2017-12-03T12:14:42.000Z,"Replying to 
@Wattwurm73
, 
@fezziwig2008
 and 
@YahooFinance","Replying to 
@Wattwurm73
, 
@fezziwig2008
 and 
@YahooFinance
$MRK $HALO That is one strategy. With current interest rates it would make more sense to invest in a future revenue stream.
2
1",,2,,1,[],https://twitter.com/mtpoulsen/status/937294019192750080
5793,TalkMarkets,@TalkMarkets,2017-12-04T18:15:51.000Z,"The Most Active #Equity Options And Strikes For Midday - Monday, Dec. 4 $BAC $FB $AAPL $MRK $CVS https://goo.gl/2SkKtp","The Most Active #Equity Options And Strikes For Midday - Monday, Dec. 4 $BAC $FB $AAPL $MRK $CVS https://goo.gl/2SkKtp",,,,,[],https://twitter.com/TalkMarkets/status/937747292865662977
5794,Dakota Financial,@dakotafinancial,2017-12-03T16:58:27.000Z,"Merck & Company, Inc. $MRK Position Raised by Fiduciary Trust Co. http://ift.tt/2ARyFes","Merck & Company, Inc. $MRK Position Raised by Fiduciary Trust Co. http://ift.tt/2ARyFes",,,,,[],https://twitter.com/dakotafinancial/status/937365427067506688
5795,Bridgewater,@fourifbyair,2017-12-05T21:10:04.000Z,"Gilead: Buying New Growth http://ow.ly/afPh30h1ZLi

$GILD $GSK $MRK $JNJ $KITE $ABBV","Gilead: Buying New Growth http://ow.ly/afPh30h1ZLi

$GILD $GSK $MRK $JNJ $KITE $ABBV
seekingalpha.com
Gilead: Buying New Growth (NASDAQ:GILD)
Gilead‚Äôs dominance in its respective markets is waning.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/fourifbyair/status/938153520645144576
5796,Zach Brennan,@ZacharyBrennan,2017-12-05T15:22:48.000Z,"$MRK and 
@PhRMA
 call on FDA to wait for ICH on finalizing repro. toxicity testing guidance for cancer drugs http://raps.org/Regulatory-Focus/News/2017/12/04/28973/Merck-and-PhRMA-to-FDA-Wait-for-ICH-Before-Finalizing-Guidance-on-Toxicity-Testing-for-Cancer-Drugs/‚Ä¶","$MRK and 
@PhRMA
 call on FDA to wait for ICH on finalizing repro. toxicity testing guidance for cancer drugs http://raps.org/Regulatory-Focus/News/2017/12/04/28973/Merck-and-PhRMA-to-FDA-Wait-for-ICH-Before-Finalizing-Guidance-on-Toxicity-Testing-for-Cancer-Drugs/‚Ä¶",,,,,[],https://twitter.com/ZacharyBrennan/status/938066131734102018
5797,Bridgewater,@fourifbyair,2017-12-05T17:01:36.000Z,Gilead: Buying New Growth http://ow.ly/ubXU30h04mS $GILD $MRK $GSK,Gilead: Buying New Growth http://ow.ly/ubXU30h04mS $GILD $MRK $GSK,,,,,[],https://twitter.com/fourifbyair/status/938090995698290688
5798,pharmalot,@pharmalot,2017-12-08T14:20:54.000Z,"Pharmalot.. Pharmalittle.. Good Morning.. headlines, coffee & weekend daydreams are served.. https://statnews.com/pharmalot/2017/12/08/phillipines-sanofi-importation-canada/‚Ä¶ #pharma $PFE $SNY $GILD $ALXN $MRK","Pharmalot.. Pharmalittle.. Good Morning.. headlines, coffee & weekend daydreams are served.. https://statnews.com/pharmalot/2017/12/08/phillipines-sanofi-importation-canada/‚Ä¶ #pharma $PFE $SNY $GILD $ALXN $MRK
statnews.com
Pharmalittle: Philippines wants a refund from Sanofi; more U.S. cities buying meds from Canada
Dozens of cities, counties, and school districts have found a solution they say protects their budgets and saves workers money by helping employees: buying medicines from Canada and overseas.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1491368509573832704/D2DtOpvc?format=jpg&name=small'],https://twitter.com/pharmalot/status/939137715991404545
5799,Activist Stocks,@activiststocks,2017-12-08T15:40:15.000Z,"Gilead: Buying New Growth http://ow.ly/QZu630h67QL
$GILD $GSK $MRK $JNJ","Gilead: Buying New Growth http://ow.ly/QZu630h67QL
$GILD $GSK $MRK $JNJ
seekingalpha.com
Gilead: Buying New Growth (NASDAQ:GILD)
Gilead‚Äôs dominance in its respective markets is waning.
1
2",,,1,2,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/activiststocks/status/939157683378315264
5800,Seeking Alpha,@SeekingAlpha,2017-12-06T13:00:05.000Z,$ABBV $CELG $ONCYF $RHHBY $MRK https://seekingalpha.com/article/4129916-3-things-biotech-learn-today-december-6-2017?source=feed_f‚Ä¶,$ABBV $CELG $ONCYF $RHHBY $MRK https://seekingalpha.com/article/4129916-3-things-biotech-learn-today-december-6-2017?source=feed_f‚Ä¶,,,,,[],https://twitter.com/SeekingAlpha/status/938392600737759232
5801,pharmalot,@pharmalot,2017-12-08T15:49:17.000Z,Roche is investigated by Romania for anti-competitive practices.. a dawn raid to seize documents.. https://statnews.com/pharmalot/2017/12/08/roche-romania-anticompetitive-generics/‚Ä¶ #pharma $RHBBY $PFE $MRK $SNY,"Roche is investigated by Romania for anti-competitive practices.. a dawn raid to seize documents.. https://statnews.com/pharmalot/2017/12/08/roche-romania-anticompetitive-generics/‚Ä¶ #pharma $RHBBY $PFE $MRK $SNY
statnews.com
Roche is investigated by Romania for anticompetitive practices
Roche (RHHBY) is being investigated by Romanian authorities for allegedly pursuing anticompetitive practices, the latest instance in which a large drug
2",,,,2,[],https://twitter.com/pharmalot/status/939159958620442624
5802,üÖ∏üÜÉüÖ¥üÖ≤üÖ∑ STOP THE WAR,@_B_I_O_T_E_C_H_,2017-12-07T15:24:30.000Z,"#SABCS17 Cyclin Dependent Kinase ( #CDK ) 
Number of Drugs by Phase TOP10 companies
$CYCC Cyclacel $PFE Pfizer $MRK $LLY $NVS","#SABCS17 Cyclin Dependent Kinase ( #CDK ) 
Number of Drugs by Phase TOP10 companies
$CYCC Cyclacel $PFE Pfizer $MRK $LLY $NVS
3
5",üÖ± üÖæ,,3,5,['https://pbs.twimg.com/media/DQdBkDHUEAA_mDZ?format=jpg&name=small'],https://twitter.com/_B_I_O_T_E_C_H_/status/938791335687000065
5803,Jacob Plieth,@JacobPlieth,2017-12-07T09:08:21.000Z,"$RHHBY discloses Impower-150 PFS benefit. Statistically pretty strong data, no? $MRK $BMY","$RHHBY discloses Impower-150 PFS benefit. Statistically pretty strong data, no? $MRK $BMY
2
5
3",,2,5,3,['https://pbs.twimg.com/media/DQbrj8bU8AAIkFp?format=jpg&name=small'],https://twitter.com/JacobPlieth/status/938696671332093952
5804,John Carroll,@JohnCendpts,2017-12-07T10:05:31.000Z,"Looking for a come-from-behind win, Roche touts its pivotal victory for Tecentriq combo in front-line lung cancer
$RHHBY $MRK $BMY $AZN","Looking for a come-from-behind win, Roche touts its pivotal victory for Tecentriq combo in front-line lung cancer
$RHHBY $MRK $BMY $AZN
endpts.com
Looking for a come-from-behind win, Roche touts its pivotal success for Tecentriq combo in front-...
Trailing far behind Merck $MRK and Bristol-Myers Squibb $BMY, the leaders in the heated showdown for market supremacy in the PD-1/L1 commercial race, Roche is making its move in the key lung cancer...
6
11",,,6,11,['https://pbs.twimg.com/card_img/1500651659420127237/QvLkc6oQ?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/938711058952413184
5805,Vista Partners LLC,@VistaPResearch,2017-12-06T20:49:32.000Z,Learn more about #BreastCancer focused #biotech firm Atossa Genetics $ATOS at Vista Partners http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK $PFE #stocks,"Learn more about #BreastCancer focused #biotech firm Atossa Genetics $ATOS at Vista Partners http://vistapglobal.com/vp-coverage/atossa-genetics-inc-atos/‚Ä¶ $IBB $MRK $PFE #stocks
GIF
1
1",,,1,1,['https://pbs.twimg.com/tweet_video_thumb/DQZChGxU8AEjTeN.jpg'],https://twitter.com/VistaPResearch/status/938510743015530496
5806,MM+M Magazine,@MMMnews,2017-12-07T12:30:00.000Z,Missed yesterday's news? Here's what to know #pharma #FDA $NVO $LLY #diabetes $WBA #rebranding #CVSAetna #clinicaltrials #transparency #Brexit $GSK $MRK $BAYN $JNJ #lawsuit #hcmktg http://bit.ly/2krKwsD,"Missed yesterday's news? Here's what to know #pharma #FDA $NVO $LLY #diabetes $WBA #rebranding #CVSAetna #clinicaltrials #transparency #Brexit $GSK $MRK $BAYN $JNJ #lawsuit #hcmktg http://bit.ly/2krKwsD
1",,,,1,['https://pbs.twimg.com/media/DQY6AbeWAAA5TfR?format=jpg&name=900x900'],https://twitter.com/MMMnews/status/938747419650613248
5807,BioPharma Dive,@BioPharmaDive,2017-12-06T19:33:02.000Z,"$JNJ, $LLY, $MRK have best management in pharma, says report","$JNJ, $LLY, $MRK have best management in pharma, says report
biopharmadive.com
J&J, Lilly, Merck have best management in pharma, says report
The companies outpaced their healthcare and life science peers in several key measurements, including customer satisfaction and financial position, according to The Wall Street Journal.
1
2",,,1,2,['https://pbs.twimg.com/card_img/1501226836751122434/rELU-3p4?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/938491489923096576
5808,Drugdoctor1,@Drugdoctor2014,2017-12-08T13:44:41.000Z,"$ARLZ $1.40-Nasdaq-Pharma  2018 TURNAROUND STORY-Dec. 7 INVESTOR presentation-Must see.. http://ir.aralez.com/phoenix.zhtml?c=254163&p=irol-presentations‚Ä¶ $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
Retail drugs - $WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TSCO $BBBY","$ARLZ $1.40-Nasdaq-Pharma  2018 TURNAROUND STORY-Dec. 7 INVESTOR presentation-Must see.. http://ir.aralez.com/phoenix.zhtml?c=254163&p=irol-presentations‚Ä¶ $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
Retail drugs - $WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TSCO $BBBY
1
1",,,1,1,['https://pbs.twimg.com/media/DQh0NYUU8AACN0o?format=jpg&name=small'],https://twitter.com/Drugdoctor2014/status/939128603354238976
5809,Thom Hartle,@CQGThom,2017-12-07T14:47:44.000Z,"$SPY Top performer today in the $DJIA is Merck. $MRK  
@CQGInc
 @CQGThom","$SPY Top performer today in the $DJIA is Merck. $MRK  
@CQGInc
 @CQGThom
1",,,1,,['https://pbs.twimg.com/media/DQc5UxGV4AEiuy7?format=jpg&name=small'],https://twitter.com/CQGThom/status/938782079101349889
5810,Danny Hicks,@DHicks7692,2017-12-06T06:33:28.000Z,"I really recommend everyone check this out for discovering good stocks to trade http://bit.ly/2w88VnL
$MRK $MDT $MCX","I really recommend everyone check this out for discovering good stocks to trade http://bit.ly/2w88VnL
$MRK $MDT $MCX",,,,,['https://pbs.twimg.com/media/DQV-m3BWkAAAFdz?format=jpg&name=small'],https://twitter.com/DHicks7692/status/938295306621476864
5811,$PENNY KING,@groman100,2017-12-07T18:04:36.000Z,$fb $twtr $goog $nvs $kite $juno $clls $pfe $teva $oncs $zsan $amrn $amzn $Vrtx $mrk $alxn $edit $Sept $mbio $Fbio $tgtx $ckpt $chkp $blue $mrns $alny,"$fb $twtr $goog $nvs $kite $juno $clls $pfe $teva $oncs $zsan $amrn $amzn $Vrtx $mrk $alxn $edit $Sept $mbio $Fbio $tgtx $ckpt $chkp $blue $mrns $alny
Zack Capp
@zackcapp
 ¬∑ 1 Dec 2017
Fully human monoclonal antibody will change the future of Inflammation  https://buff.ly/2AtdMp9 $IMNP #BTS18 #smallcap @demycolton @ImmunePharma @EBDgroup",,,,,"['https://pbs.twimg.com/profile_images/696539389556625408/ZMgC9WNY_mini.jpg', 'https://pbs.twimg.com/media/DP9XHRAXkAEBz67?format=jpg&name=small']",https://twitter.com/groman100/status/938831622182281216
5812,kyookine,@kyookine,2017-12-06T23:23:07.000Z,Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares down 3% https://seekingalpha.com/news/3316736-merck-weak-ahead-roche-data-release-late-stage-study-tecentriq-lung-cancer-shares-3-percent?source=tweet‚Ä¶ $MRK $RHHBY,"Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares down 3% https://seekingalpha.com/news/3316736-merck-weak-ahead-roche-data-release-late-stage-study-tecentriq-lung-cancer-shares-3-percent?source=tweet‚Ä¶ $MRK $RHHBY
seekingalpha.com
Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares...
Merck (MRK -2.7%) slumps on over 50% higher volume ahead of an expected announcement tomorrow by Roche (OTCQX:RHHBY +1.4%) of results from a Phase 3 clinical trial, IMPOWER 150, assessing...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/kyookine/status/938549393879310336
5813,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-12-06T17:06:05.000Z,$MRK enters IDO1 inh into Phase 1 $BMY $INCY $NLNK,"$MRK enters IDO1 inh into Phase 1 $BMY $INCY $NLNK
clinicaltrials.gov
Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced...
Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002) - Full Text View.
1",,,,1,['https://pbs.twimg.com/card_img/1499578112115363861/JaVVFVxw?format=png&name=240x240'],https://twitter.com/DrPaulyDeSantis/status/938454509549797376
5814,StockMarketVideo.com,@stockmarketvide,2017-12-07T02:05:42.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/938590308622913537
5815,Chameleon Options,@MC_OptionTrades,2017-12-08T22:30:41.000Z,Price Returns vs Expected Daily Move $VRX $TEVA $MYL $CELG $BSX $CVS $GILD $ABBV $MRK $BMY $PFE $JNJ http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $VRX $TEVA $MYL $CELG $BSX $CVS $GILD $ABBV $MRK $BMY $PFE $JNJ http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DQjs4E_X0AEN6u3?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/939260973722099714
5816,Stocks Pastor,@stockspastor,2017-12-08T19:20:15.000Z,Stocks coming from oversold to bullish: $GSK $KMX $WDC $MRK $T http://bit.ly/1PWTzJR,"Stocks coming from oversold to bullish: $GSK $KMX $WDC $MRK $T http://bit.ly/1PWTzJR
1",,,,1,[],https://twitter.com/stockspastor/status/939213050288201730
5817,Siti van der Meij,@sitivandermeij,2017-12-06T20:48:28.000Z,Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares down 3% https://seekingalpha.com/news/3316736-merck-weak-ahead-roche-data-release-late-stage-study-tecentriq-lung-cancer-shares-3-percent?source=feed_f‚Ä¶ $MRK $RHHBY #sitifatimah #malaysia #financialplanning,"Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares down 3% https://seekingalpha.com/news/3316736-merck-weak-ahead-roche-data-release-late-stage-study-tecentriq-lung-cancer-shares-3-percent?source=feed_f‚Ä¶ $MRK $RHHBY #sitifatimah #malaysia #financialplanning
seekingalpha.com
Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares...
Merck (MRK -2.7%) slumps on over 50% higher volume ahead of an expected announcement tomorrow by Roche (OTCQX:RHHBY +1.4%) of results from a Phase 3 clinical trial, IMPOWER 150, assessing...",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/sitivandermeij/status/938510473443635200
5818,Bio&TechWebinar,@BioTechWebinar,2017-12-07T14:11:21.000Z,"Trailing far behind Merck $MRK and Bristol-Myers Squibb $BMY, the leaders in the heated showdown for market supremacy in the PD-1/L1 commercial race, Roche $RHHBY is making its move in the key #lungcancer #cancer market #pharma","Trailing far behind Merck $MRK and Bristol-Myers Squibb $BMY, the leaders in the heated showdown for market supremacy in the PD-1/L1 commercial race, Roche $RHHBY is making its move in the key #lungcancer #cancer market #pharma
endpts.com
Looking for a come-from-behind win, Roche touts its pivotal success for Tecentriq combo in front-...
Trailing far behind Merck $MRK and Bristol-Myers Squibb $BMY, the leaders in the heated showdown for market supremacy in the PD-1/L1 commercial race, Roche is making its move in the key lung cancer...",,,,,['https://pbs.twimg.com/card_img/1500651659420127237/QvLkc6oQ?format=jpg&name=small'],https://twitter.com/BioTechWebinar/status/938772924554760193
5819,WallStreetGangsta,@WallStGangsta,2017-12-08T07:18:47.000Z,"$AHGIF ‚ÄúAlternate Health is growing in momentum across all of our verticals, boosting our visibility in the American medical cannabis market,‚Äù says Dr. Michael Murphy, CEO of Alternate Health $IBB $GILD $GWPH $NVS $BMY $MRK $JNN $AMGN $BSX $VRX $GLD $GDX $SLV $SLW $RIC $RGLD $AEM","$AHGIF ‚ÄúAlternate Health is growing in momentum across all of our verticals, boosting our visibility in the American medical cannabis market,‚Äù says Dr. Michael Murphy, CEO of Alternate Health $IBB $GILD $GWPH $NVS $BMY $MRK $JNN $AMGN $BSX $VRX $GLD $GDX $SLV $SLW $RIC $RGLD $AEM",,,,,[],https://twitter.com/WallStGangsta/status/939031486921039872
5820,US Banking News,@AmericanBanking,2017-12-06T09:25:18.000Z,Merck KGaA given ‚Ç¨95.00 PT by Bank of America Corp. neutral rating. http://ift.tt/2iWbKqZ $MRK #MRK,Merck KGaA given ‚Ç¨95.00 PT by Bank of America Corp. neutral rating. http://ift.tt/2iWbKqZ $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/938338550164148224
5821,John Beagle,@johnbeagle,2017-12-07T19:19:59.000Z,"Added in November, $MRK has a strong 3.5% dividend yield that is secure based on a wide diversified portfolio of drugs.","Added in November, $MRK has a strong 3.5% dividend yield that is secure based on a wide diversified portfolio of drugs.",,,,,[],https://twitter.com/johnbeagle/status/938850596198678531
5822,Jacob Plieth,@JacobPlieth,2017-12-07T10:48:02.000Z,ESMO release on $RHHBY Impower-150 $MRK $BMY,"ESMO release on $RHHBY Impower-150 $MRK $BMY
Vamsi Velcheti, MD
@VamsiVelcheti
 ¬∑ 7 Dec 2017
ESMO IO 2017 Press Release: First Line Combination Therapy Improves PFS In Adv Lung Cancer | ESMO http://esmo.org/Latest-News/First-Line-Combination-Therapy-Improves-Progression-Free-Survival-In-Advanced-Lung-Cancer#.WikTiw_sI0w.twitter‚Ä¶
Show this thread
1
1",,1,,1,['https://pbs.twimg.com/profile_images/1304896507116761088/4Avz7u4p_mini.jpg'],https://twitter.com/JacobPlieth/status/938721758366052352
5823,Dakota Financial,@dakotafinancial,2017-12-07T17:59:20.000Z,"Modera Wealth Management LLC Has $575,000 Holdings in Merck & Co., Inc. $MRK http://ift.tt/2AjUYtf","Modera Wealth Management LLC Has $575,000 Holdings in Merck & Co., Inc. $MRK http://ift.tt/2AjUYtf",,,,,[],https://twitter.com/dakotafinancial/status/938830300162949120
5824,Watchlist News,@WatchlistN,2017-12-08T19:27:37.000Z,"Stevens Capital Management LP Sells 147,266 Shares of Merck & Co., Inc. $MRK http://ift.tt/2AGLrv8","Stevens Capital Management LP Sells 147,266 Shares of Merck & Co., Inc. $MRK http://ift.tt/2AGLrv8
1
1",,,1,1,[],https://twitter.com/WatchlistN/status/939214902090190849
5825,Eric Sagonowsky,@EricSFierce,2017-12-06T17:37:15.000Z,"In SCOTUS petition, $MRK strives to restore FDA preemption shield","In SCOTUS petition, $MRK strives to restore FDA preemption shield
fiercepharma.com
In Supreme Court petition, Merck argues that FDA power shields against liability
Years after suing drug giant Merck & Co. | A Merck & Co. appeal in the Fosamax liability litigation has drawn in the U.S. Solicitor General, and with its focus on the FDA's power to determine...
2",,,,2,['https://pbs.twimg.com/card_img/1500769638774366211/K2YDReWB?format=jpg&name=small'],https://twitter.com/EricSFierce/status/938462352307089408
5826,Ticker Report,@TickerReport,2017-12-07T18:04:37.000Z,"Merck & Co., Inc. $MRK Holdings Held by State Farm Mutual Automobile Insurance Co. http://ift.tt/2ktRz3R","Merck & Co., Inc. $MRK Holdings Held by State Farm Mutual Automobile Insurance Co. http://ift.tt/2ktRz3R",,,,,[],https://twitter.com/TickerReport/status/938831629107253248
5827,Ticker Report,@TickerReport,2017-12-06T18:33:52.000Z,"Merck & Co., Inc. $MRK Shares Sold by Edgestream Partners L.P. http://ift.tt/2AxP9XW","Merck & Co., Inc. $MRK Shares Sold by Edgestream Partners L.P. http://ift.tt/2AxP9XW",,,,,[],https://twitter.com/TickerReport/status/938476600387043329
5828,Stockboard Media Inc,@stockboardinc,2017-12-06T22:05:12.000Z,"$MRK New England Journal of Medicine Publishes Phase 3 Clinical Study of PREVYMIS‚Ñ¢ (letermovir), MerckÔøΩ... - http://sbml.co/8cb80b20","$MRK New England Journal of Medicine Publishes Phase 3 Clinical Study of PREVYMIS‚Ñ¢ (letermovir), MerckÔøΩ... - http://sbml.co/8cb80b20",,,,,[],https://twitter.com/stockboardinc/status/938529786128945154
5829,Daily Political,@dailypoliticaln,2017-12-08T19:23:53.000Z,"BT Investment Management Ltd Takes $25.72 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2iFRHsU","BT Investment Management Ltd Takes $25.72 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2iFRHsU",,,,,[],https://twitter.com/dailypoliticaln/status/939213965934067712
5830,Daily Political,@dailypoliticaln,2017-12-07T18:01:35.000Z,"Aberdeen Asset Management PLC UK Has $102.92 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2kAxTeZ","Aberdeen Asset Management PLC UK Has $102.92 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2kAxTeZ",,,,,[],https://twitter.com/dailypoliticaln/status/938830866658275328
5831,ChimeraResearchGroup,@ChimeraResearch,2017-12-07T15:18:06.000Z,December 7 Biotech Update $ALXN $HALO $MRK $ONCE $SAGE https://goo.gl/fASYRv,December 7 Biotech Update $ALXN $HALO $MRK $ONCE $SAGE https://goo.gl/fASYRv,,,,,[],https://twitter.com/ChimeraResearch/status/938789723748884480
5832,MarketBeat,@MarketBeatCom,2017-12-08T15:31:33.000Z,Merck KGaA given ‚Ç¨98.00 PT by Nord/LB. neutral rating. http://ift.tt/2AnfsRU $MRK #MRK,"Merck KGaA given ‚Ç¨98.00 PT by Nord/LB. neutral rating. http://ift.tt/2AnfsRU $MRK #MRK
marketbeat.com
MERCK Kommanditgesellschaft auf Aktien Price Target & Analyst Ratings (FRA:MRK) $MRK
What predictions are top-rated research analysts making about MERCK Kommanditgesellschaft auf Aktien (FRA:MRK)? View MRK's most recent analyst ratings, analyst estimates, and price targets at...",,,,,['https://pbs.twimg.com/card_img/1501622066654629893/09OWQZTg?format=jpg&name=240x240'],https://twitter.com/MarketBeatCom/status/939155496916996096
5833,MomentumBeast,@momentumbeast,2017-12-08T07:18:47.000Z,"$AHGIF ‚ÄúAlternate Health is growing in momentum across all of our verticals, boosting our visibility in the American medical cannabis market,‚Äù says Dr. Michael Murphy, CEO of Alternate Health $IBB $GILD $GWPH $NVS $BMY $MRK $JNN $AMGN $BSX $VRX $GLD $GDX $SLV $SLW $RIC $RGLD $AEM","$AHGIF ‚ÄúAlternate Health is growing in momentum across all of our verticals, boosting our visibility in the American medical cannabis market,‚Äù says Dr. Michael Murphy, CEO of Alternate Health $IBB $GILD $GWPH $NVS $BMY $MRK $JNN $AMGN $BSX $VRX $GLD $GDX $SLV $SLW $RIC $RGLD $AEM",,,,,[],https://twitter.com/momentumbeast/status/939031486639915010
5834,MomentumBeast,@momentumbeast,2017-12-08T07:17:01.000Z,"$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY $GRWG","$AHGIF  ‚ÄúWith the launch of our FlorPass software system and developments in adding Blockchain technology, Alternate Health is well prepared for this surge in interest in the United States.‚Äù $IBB $GWPH $JNJ $BSX $NVS $PFE $AMGN $MRK $GILD $BMY $GRWG",,,,,[],https://twitter.com/momentumbeast/status/939031041494343680
5835,The Market is Open,@themarketisopen,2017-12-08T21:43:16.000Z,"$MRK Big pharma to lay off 50, close Charlotte facility http://ift.tt/2iIXqhO","$MRK Big pharma to lay off 50, close Charlotte facility http://ift.tt/2iIXqhO",,,,,[],https://twitter.com/themarketisopen/status/939249042244210694
5836,c lark,@7LadyQ,2017-12-06T20:53:41.000Z,"$MRK
Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares down 3%","$MRK
Merck weak ahead of Roche data release from late-stage study of Tecentriq in lung cancer; shares down 3%",,,,,[],https://twitter.com/7LadyQ/status/938511788739620865
5837,Michael Goodman,@mikegoodma,2017-12-07T15:08:59.000Z,$MRK getting a nice bump from Roche's disappointing IMpower150 PFS results,"$MRK getting a nice bump from Roche's disappointing IMpower150 PFS results
1",,1,,,[],https://twitter.com/mikegoodma/status/938787428713758720
5838,bake mcbride,@ITRADEVOL,2017-12-08T18:16:34.000Z,Cost to protect downside 4 the next 30 days. $DWDP $PM $ORCL $PEP $MRK $ABBV $BA $MA $MMM $MCD $IBM $WMT $AMGN $HON https://marketchameleon.com/volReports/DownsidePutProtection‚Ä¶,Cost to protect downside 4 the next 30 days. $DWDP $PM $ORCL $PEP $MRK $ABBV $BA $MA $MMM $MCD $IBM $WMT $AMGN $HON https://marketchameleon.com/volReports/DownsidePutProtection‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/939197023441571840
5839,US Banking News,@AmericanBanking,2017-12-08T10:09:40.000Z,"Analysts Give Average Rating of Hold to Merck & Co., Inc. $MRK http://ift.tt/2qbDsRN","Analysts Give Average Rating of Hold to Merck & Co., Inc. $MRK http://ift.tt/2qbDsRN",,,,,[],https://twitter.com/AmericanBanking/status/939074489987555328
5840,Stocks Pastor,@stockspastor,2017-12-08T20:21:05.000Z,$T premarket alert.  Dividend increase news next week.  http://bit.ly/1PWTzJR. $MAC $MRK $CMCSA $GSK $KMX $WDC in play with $T next week.,"$T premarket alert.  Dividend increase news next week.  http://bit.ly/1PWTzJR. $MAC $MRK $CMCSA $GSK $KMX $WDC in play with $T next week.
1",,,1,,[],https://twitter.com/stockspastor/status/939228359833288704
5841,Allison Gatlin,@IBD_AGatlin,2017-12-07T19:21:59.000Z,Roche cancer drug combo effective for some -- but shares drop $RHHBY $MRK $BMY,"Roche cancer drug combo effective for some -- but shares drop $RHHBY $MRK $BMY
investors.com
Roche's Cancer Drug Combo Effective For Some ‚Äî But Shares Drop
Roche's Tecentriq plus older drugs doubled the percentage of lung cancer patients surviving a year without disease progression.",,,,,[],https://twitter.com/IBD_AGatlin/status/938851100324782085
5842,Crypto Trader Pro,@CryptoTraderPro,2017-12-07T18:27:41.000Z,"Unusual put buying: $SEE 22x average volume, $DG 6x, $CLF 6x, $AZN 5x, $XME 5x, $XBI 5x, $MRK 5x, $RRC 5x ‚Üí via http://bit.do/BestTradeSetups","Unusual put buying: $SEE 22x average volume, $DG 6x, $CLF 6x, $AZN 5x, $XME 5x, $XBI 5x, $MRK 5x, $RRC 5x ‚Üí via http://bit.do/BestTradeSetups",,,,,[],https://twitter.com/CryptoTraderPro/status/938837431301709824
5843,Teddi Knight,@BeFullyInformed,2017-12-07T17:50:47.000Z,Here is a combination strategy of using the Weekly Wanderer Strategy with the Put Options Selling Tool to profit while protecting capital from loss in $MRK. https://fullyinformed.com/combine-the-weekly-wanderer-strategy-and-put-options-selling-tool-to-trade-merck-stock-mrk-dec-7-2017/‚Ä¶,Here is a combination strategy of using the Weekly Wanderer Strategy with the Put Options Selling Tool to profit while protecting capital from loss in $MRK. https://fullyinformed.com/combine-the-weekly-wanderer-strategy-and-put-options-selling-tool-to-trade-merck-stock-mrk-dec-7-2017/‚Ä¶,,,,,[],https://twitter.com/BeFullyInformed/status/938828146651971584
5844,Brad Loncar,@bradloncar,2017-12-07T12:17:10.000Z,Roche is trading slightly down in Europe and $MRK seems not to be doing anything in this early pre-market hour. IMpower150 basically in line with high expectations.,Roche is trading slightly down in Europe and $MRK seems not to be doing anything in this early pre-market hour. IMpower150 basically in line with high expectations.,,,,,[],https://twitter.com/bradloncar/status/938744187612262400
5845,Allison Gatlin,@IBD_AGatlin,2017-12-08T15:58:57.000Z,Why biotech stocks may wait awhile before feeling the love $CELG $GILD $BLUE $JUNO $RDY $ABBV $REGN $VRTX $MRK $BMY $AZN $INCY,"Why biotech stocks may wait awhile before feeling the love $CELG $GILD $BLUE $JUNO $RDY $ABBV $REGN $VRTX $MRK $BMY $AZN $INCY
investors.com
Why Biotech Stocks May Wait A While Before Feeling The Love
Beleaguered biotech investors will likely have to wait until 2018 to get some much-needed relief, analysts say.",,,,,[],https://twitter.com/IBD_AGatlin/status/939162392306573314
5846,TradeTheNews.com,@Trade_The_News,2017-12-06T11:51:18.000Z,$DVA United Health's Optum to acquire Davita Medical Group for $4.9B in cash (DaVita Inc) https://tradethenews.com/twitter-action $UNH $CVS $MRK,$DVA United Health's Optum to acquire Davita Medical Group for $4.9B in cash (DaVita Inc) https://tradethenews.com/twitter-action $UNH $CVS $MRK,,,,,[],https://twitter.com/Trade_The_News/status/938375292845948928
5847,Daily Political,@DPolitical,2017-12-08T01:02:41.000Z,"$MRK - Merck & Co., Inc. #MRK Given Average Rating of ""Hold"" by Brokerages https://goo.gl/fb/9p6jPC","$MRK - Merck & Co., Inc. #MRK Given Average Rating of ""Hold"" by Brokerages https://goo.gl/fb/9p6jPC",,,,,[],https://twitter.com/DPolitical/status/938936838953324544
5848,Dakota Financial,@dakotafinancial,2017-12-06T18:38:19.000Z,"South Dakota Investment Council Sells 55,595 Shares of Merck & Co., Inc. $MRK http://ift.tt/2ACqe3w","South Dakota Investment Council Sells 55,595 Shares of Merck & Co., Inc. $MRK http://ift.tt/2ACqe3w",,,,,[],https://twitter.com/dakotafinancial/status/938477723252555777
5849,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-12-07T18:27:39.000Z,"Unusual put buying: $SEE 22x average volume, $DG 6x, $CLF 6x, $AZN 5x, $XME 5x, $XBI 5x, $MRK 5x, $RRC 5x ‚Üí via http://bit.do/BestTradeSetups","Unusual put buying: $SEE 22x average volume, $DG 6x, $CLF 6x, $AZN 5x, $XME 5x, $XBI 5x, $MRK 5x, $RRC 5x ‚Üí via http://bit.do/BestTradeSetups",,,,,[],https://twitter.com/AlertTrade/status/938837423089315840
5850,Briefing.com,@Briefingcom,2017-12-07T00:08:04.000Z,$MRK: Merck reports that results from the pivotal Phase 3 clinical study of PREVYMIS were published in New England... http://bit.ly/2zWRAQD,$MRK: Merck reports that results from the pivotal Phase 3 clinical study of PREVYMIS were published in New England... http://bit.ly/2zWRAQD,,,,,[],https://twitter.com/Briefingcom/status/938560706806345729
5851,FiercePharma,@FiercePharma,2017-12-06T17:37:15.000Z,"In SCOTUS petition, $MRK strives to restore FDA preemption shield https://fiercepharma.com/legal/scotus-petition-merck-argues-pharma-cases-are-especially-important-to-get-right‚Ä¶","In SCOTUS petition, $MRK strives to restore FDA preemption shield https://fiercepharma.com/legal/scotus-petition-merck-argues-pharma-cases-are-especially-important-to-get-right‚Ä¶",,,,,[],https://twitter.com/FiercePharma/status/938462352508358657
5852,24/7 Wall St.,@247WallSt,2017-12-06T15:42:54.000Z,"Biotechs selling off on Weds, but the preliminary 2018 BIOTECH OUTLOOK looks better for biotech than for Big Pharma in 2018. $PFE $MRK $ABBV $BMY","Biotechs selling off on Weds, but the preliminary 2018 BIOTECH OUTLOOK looks better for biotech than for Big Pharma in 2018. $PFE $MRK $ABBV $BMY
247wallst.com
2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.",,,,,['https://pbs.twimg.com/card_img/1501707301304291329/C_ttaANO?format=jpg&name=small'],https://twitter.com/247WallSt/status/938433577318014977
5853,Trader3X,@Trader3X,2017-12-07T21:41:54.000Z,"Replying to 
@SJosephBurns","Replying to 
@SJosephBurns
Actually, I think $IBB is bullish not because of the 200 sma, but because of an iH&S validated by RSI & MACD non-confirmations.  The same is true of $PJP and $MRK.  Possibly others, but that's all I'm looking at in that sector.  Thanks.
1",,,,1,[],https://twitter.com/Trader3X/status/938886308142964737
5854,Odi Bruckman,@odibro,2017-12-06T22:21:49.000Z,"$MRK 
@NEJM
 Publishes Phase 3 Clinical Study of PREVYMIS‚Ñ¢ (letermovir), New CMV Prophylaxis Medicine http://mrknewsroom.com/news-release/corporate-news/new-england-journal-medicine-publishes-phase-3-clinical-study-prevymis-l‚Ä¶","$MRK 
@NEJM
 Publishes Phase 3 Clinical Study of PREVYMIS‚Ñ¢ (letermovir), New CMV Prophylaxis Medicine http://mrknewsroom.com/news-release/corporate-news/new-england-journal-medicine-publishes-phase-3-clinical-study-prevymis-l‚Ä¶
1",,,,1,[],https://twitter.com/odibro/status/938533966860247040
5855,dough,@semodough,2017-12-07T13:35:36.000Z,"Replying to 
@JohnCendpts","Replying to 
@JohnCendpts
BMO $MRK bullish comments believe IMpower150 results is significantly positive for Merck. While the KN-21G PD-L1 subgroup PFS and ORR results are inconclusive, the overall PFS and OS results are not",,,,,[],https://twitter.com/semodough/status/938763927256788992
5856,Jon Ogg,@jonogg,2017-12-06T15:41:40.000Z,#Pharmaceutical #investing Preliminary 2018 BIOTECH OUTLOOK looks better for biotech than for Big Pharma in 2018.  $PFE $MRK $ABBV $BMY,"#Pharmaceutical #investing Preliminary 2018 BIOTECH OUTLOOK looks better for biotech than for Big Pharma in 2018.  $PFE $MRK $ABBV $BMY
247wallst.com
2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.",,,,,['https://pbs.twimg.com/card_img/1501707299966103557/xg2use4X?format=jpg&name=small'],https://twitter.com/jonogg/status/938433264884371456
5857,Daily Political,@dailypoliticaln,2017-12-08T00:51:28.000Z,"Merck & Co., Inc. $MRK Given Average Rating of ‚ÄúHold‚Äù by Brokerages http://ift.tt/2BdL3FN","Merck & Co., Inc. $MRK Given Average Rating of ‚ÄúHold‚Äù by Brokerages http://ift.tt/2BdL3FN",,,,,[],https://twitter.com/dailypoliticaln/status/938934017566572545
5858,Volatility,@getvolatility,2017-12-07T18:19:12.000Z,"Unusual put buying: $SEE 22x average volume, $DG 6x, $CLF 6x, $AZN 5x, $XME 5x, $XBI 5x, $MRK 5x, $RRC 5x","Unusual put buying: $SEE 22x average volume, $DG 6x, $CLF 6x, $AZN 5x, $XME 5x, $XBI 5x, $MRK 5x, $RRC 5x",,,,,[],https://twitter.com/getvolatility/status/938835298301153281
5859,StockNews.com,@stocknewsdotcom,2017-12-06T22:07:38.000Z,$MRK Reports that results from the pivotal Phase 3 clinical study of PREVYMIS were published in New England Journa‚Ä¶ https://stocknews.com/news/mrk-reports-that-results-from-the-pivotal-phase-3-clinical-study/‚Ä¶,$MRK Reports that results from the pivotal Phase 3 clinical study of PREVYMIS were published in New England Journa‚Ä¶ https://stocknews.com/news/mrk-reports-that-results-from-the-pivotal-phase-3-clinical-study/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/938530398044385280
5860,dough,@semodough,2017-12-11T12:21:14.000Z,$TGTX triplet $MRK,"$TGTX triplet $MRK
2
6",,,2,6,['https://pbs.twimg.com/media/DQw-JpuUEAA2gxQ?format=jpg&name=900x900'],https://twitter.com/semodough/status/940194764208648193
5861,Make Black Swans Great AGAIN,@RuniteDragon,2017-12-10T07:31:36.000Z,$KALV Oral drugs are much more convenient. $MRK has 10% ownership and bought shares at $8.50. Partnership deal.,"$KALV Oral drugs are much more convenient. $MRK has 10% ownership and bought shares at $8.50. Partnership deal.
1
3",üßä üß® üê≥ ‚ùÑ,,1,3,['https://pbs.twimg.com/media/DQqyQuRUIAAdagD?format=jpg&name=small'],https://twitter.com/RuniteDragon/status/939759486809473025
5862,Stockdog101,@Stockdog101,2017-12-11T19:23:07.000Z,"$EYES  just reached another new high and may supersede my $5 Price Target very soon!  $TWTR $AAPL $FB $WB $BABA $WUBA $TMUS $TSLA $AMZN $TSLA $ULTA $GPRO $ZFGN $MRK $BMY $AMGN $SNY $GILD $GOOG $RAD #NYSE #stocks  
RT ","$EYES  just reached another new high and may supersede my $5 Price Target very soon!  $TWTR $AAPL $FB $WB $BABA $WUBA $TMUS $TSLA $AMZN $TSLA $ULTA $GPRO $ZFGN $MRK $BMY $AMGN $SNY $GILD $GOOG $RAD #NYSE #stocks  
RT 
2",,,2,,"['https://pbs.twimg.com/media/DQyetliUMAAIah4?format=jpg&name=small', 'https://pbs.twimg.com/media/DQyetlkVAAEr_2P?format=jpg&name=small']",https://twitter.com/Stockdog101/status/940300935258968064
5863,Bursatil Biotech,@BursatilBiotech,2017-12-11T16:27:15.000Z,"#ASH17
Meanwhile, at the stock mkt...
$BLUE +21.6%
$CELG +2.18%
$MRK +1.6%
$GILD+1.59%
$BMY +1.2%
$NVS -0.07%
$BLCM - 1%
$JUNO -11%","#ASH17
Meanwhile, at the stock mkt...
$BLUE +21.6%
$CELG +2.18%
$MRK +1.6%
$GILD+1.59%
$BMY +1.2%
$NVS -0.07%
$BLCM - 1%
$JUNO -11%
3
4
7",,3,4,7,[],https://twitter.com/BursatilBiotech/status/940256675738636288
5864,WallStreetGangsta,@WallStGangsta,2017-12-11T20:19:04.000Z,$AHGIF Recent Company's HIGHLIGHTS $IBB $GILD $GWPH $NVS $BMY $MRK $JNJ $AMGN $BSX $VRX $GLD $GDX $RGLD $AEM $SPY,$AHGIF Recent Company's HIGHLIGHTS $IBB $GILD $GWPH $NVS $BMY $MRK $JNJ $AMGN $BSX $VRX $GLD $GDX $RGLD $AEM $SPY,,,,,['https://pbs.twimg.com/media/DQyrheSWsAAFKUd?format=jpg&name=small'],https://twitter.com/WallStGangsta/status/940315015646769165
5865,TA Scilab Ichimoku,@tasciccac,2017-12-09T08:17:12.000Z,$DJIA WKLY Best performance $BA $NKE $UTX $HD $V $CAT $JPM $JNJ $GS Worst $INTC $PFE $TRV $MMM $AAPL $XOM $GE $UNH $KO $MRK #Ichimoku #Dashboard,"$DJIA WKLY Best performance $BA $NKE $UTX $HD $V $CAT $JPM $JNJ $GS Worst $INTC $PFE $TRV $MMM $AAPL $XOM $GE $UNH $KO $MRK #Ichimoku #Dashboard
1",,,,1,['https://pbs.twimg.com/media/DQlzBusWsAAqqmK?format=jpg&name=small'],https://twitter.com/tasciccac/status/939408575356694528
5866,Bio Stocks‚Ñ¢,@BioStocks,2017-12-11T11:33:32.000Z,"$MRK FDA Accepts sBLA, Assigns Priority Review to KEYTRUDA for Treatment of Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL). 
PDUFA 04/03/18","$MRK FDA Accepts sBLA, Assigns Priority Review to KEYTRUDA for Treatment of Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL). 
PDUFA 04/03/18
4
2",,,4,2,[],https://twitter.com/BioStocks/status/940182759430963200
5867,max pain,@optioncharts,2017-12-10T14:58:08.000Z,$MRK open interest for maturity 12/15/2017. High put=55.00 High call=55.00 #maxpain #options http://bit.ly/2iNeVxw,$MRK open interest for maturity 12/15/2017. High put=55.00 High call=55.00 #maxpain #options http://bit.ly/2iNeVxw,,,,,['https://pbs.twimg.com/media/DQsYef8X0AALETd?format=jpg&name=small'],https://twitter.com/optioncharts/status/939871861206323200
5868,OptionsPro MaxPain,@OptionsMaxPain,2017-12-11T13:59:22.000Z,#Options #maxpain chart for $MRK. Free options app http://mystockstation.com,#Options #maxpain chart for $MRK. Free options app http://mystockstation.com,,,,,['https://pbs.twimg.com/media/DQxUnUAW4AAMMBp?format=jpg&name=small'],https://twitter.com/OptionsMaxPain/status/940219458639028225
5869,MomentumBeast,@momentumbeast,2017-12-11T20:19:04.000Z,$AHGIF Recent Company's HIGHLIGHTS $IBB $GILD $GWPH $NVS $BMY $MRK $JNJ $AMGN $BSX $VRX $GLD $GDX $RGLD $AEM $SPY,$AHGIF Recent Company's HIGHLIGHTS $IBB $GILD $GWPH $NVS $BMY $MRK $JNJ $AMGN $BSX $VRX $GLD $GDX $RGLD $AEM $SPY,,,,,['https://pbs.twimg.com/media/DQyrhdVWAAUgS01?format=jpg&name=small'],https://twitter.com/momentumbeast/status/940315016271728640
5870,George Marcovits,@GemsBot,2017-12-09T19:27:03.000Z,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,4 of 5 $MRK $MSFT $NKE $PFE $PG $TRV light colored arrows are confirmation or add signals. See a live presentation..,,,,,['https://pbs.twimg.com/media/DQoMcA1XcAADFLJ?format=jpg&name=small'],https://twitter.com/GemsBot/status/939577150633627649
5871,Finscreener,@Finscreener,2017-12-11T20:26:51.000Z,Forward PE ratio of SP 500 stocks $XOM $KO $PEP $PM $AMZN $WMT $JNJ $BAC $PYPL $PG $MRK $DIS https://finscreener.com/map,"Forward PE ratio of SP 500 stocks $XOM $KO $PEP $PM $AMZN $WMT $JNJ $BAC $PYPL $PG $MRK $DIS https://finscreener.com/map
2
1",,,2,1,['https://pbs.twimg.com/media/DQytTWpW0AA10uX?format=jpg&name=small'],https://twitter.com/Finscreener/status/940316973858213888
5872,WallStreetGangsta,@WallStGangsta,2017-12-11T19:20:25.000Z,$AHGIF Company Highlights - Alternate Health Lab conversion to a full clinical lab is expected to continue to generate long-term stable revenues. $GWPH $IBB $GILD $NVS $PFE $JNJ $MRK $BMY #Cannabis #Cannabinoids #Healthcare,$AHGIF Company Highlights - Alternate Health Lab conversion to a full clinical lab is expected to continue to generate long-term stable revenues. $GWPH $IBB $GILD $NVS $PFE $JNJ $MRK $BMY #Cannabis #Cannabinoids #Healthcare,,,,,[],https://twitter.com/WallStGangsta/status/940300256071254017
5873,Kara Jill Stancell,@kjilly,2017-12-09T04:43:52.000Z,Roche's latest #Tecentriq results shed little light on the #lungcancer market race: analyst #pharma #biotech #biopharma #cancer #oncology #clinicaltrials #IO #immunooncology #checkpointinhibitors #NSCLC #Avastin #Keytruda $RHHBY $MRK,"Roche's latest #Tecentriq results shed little light on the #lungcancer market race: analyst #pharma #biotech #biopharma #cancer #oncology #clinicaltrials #IO #immunooncology #checkpointinhibitors #NSCLC #Avastin #Keytruda $RHHBY $MRK
fiercepharma.com
Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst
More results may be out from a clos | More results may be out from a closely watched trial of Roche‚Äôs Tecentriq in lung cancer, but industry watchers still don‚Äôt have many of the answers they‚Äôre...",,,,,['https://pbs.twimg.com/card_img/1501706825552510976/6SHw0CbE?format=jpg&name=small'],https://twitter.com/kjilly/status/939354890509303809
5874,Daily Political,@DPolitical,2017-12-11T18:09:44.000Z,"$MRK - QS Investors LLC Has $23.59 Million Position in Merck & Co., Inc. #MRK https://goo.gl/fb/GgBsre","$MRK - QS Investors LLC Has $23.59 Million Position in Merck & Co., Inc. #MRK https://goo.gl/fb/GgBsre",,,,,[],https://twitter.com/DPolitical/status/940282469345046529
5875,Chameleon Options,@MC_OptionTrades,2017-12-11T15:27:13.000Z,Top Implied #Volatility Decliners $CSIQ $BLUE $JUNO $TNA $NOW $TEVA $CLF $MARA $FCX $AMD $MU $IWM $FB $MRK http://tinyurl.com/yaxs85ln,"Top Implied #Volatility Decliners $CSIQ $BLUE $JUNO $TNA $NOW $TEVA $CLF $MARA $FCX $AMD $MU $IWM $FB $MRK http://tinyurl.com/yaxs85ln
2",ü¶é,,,2,[],https://twitter.com/MC_OptionTrades/status/940241570498056193
5876,jc_trader,@cfm_trades,2017-12-11T16:33:47.000Z,Keep an eye on $MRK for weekly/monthly rotation and into gap.  Close over 56.72 highly constructive.,"Keep an eye on $MRK for weekly/monthly rotation and into gap.  Close over 56.72 highly constructive.
1",,,1,,[],https://twitter.com/cfm_trades/status/940258320329428993
5877,Drugdoctor1,@Drugdoctor2014,2017-12-11T14:40:42.000Z,"$ICNB.006-Massive 1150 Publix Stores rollout Confirmed- Revenues soaring on 100,000 cases 2017 distribution! Video proof!  $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO
https://youtube.com/watch?time_continue=19&v=N5oXavc4J7g‚Ä¶","$ICNB.006-Massive 1150 Publix Stores rollout Confirmed- Revenues soaring on 100,000 cases 2017 distribution! Video proof!  $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO
https://youtube.com/watch?time_continue=19&v=N5oXavc4J7g‚Ä¶
1",,,,1,[],https://twitter.com/Drugdoctor2014/status/940229860399689730
5878,Odi Bruckman,@odibro,2017-12-11T11:36:41.000Z,$MRK FDA Accepts sBLA Assigns Priority Review to KEYTRUDA¬Æfor Treatment of R/R PMBCL. Pdufa April 3 2018,"$MRK FDA Accepts sBLA Assigns Priority Review to KEYTRUDA¬Æfor Treatment of R/R PMBCL. Pdufa April 3 2018
businesswire.com
FDA Accepts Supplemental Biologics License Application (sBLA), Assigns Priority Review to Merck‚Äôs...
FDA Accepts sBLA, Assigns Priority Review to Merck‚Äôs KEYTRUDA¬Æ for Treatment of Relapsed or Refractory PMBCL
1
1",,,1,1,[],https://twitter.com/odibro/status/940183553198915584
5879,UrbanRyno,@ryanmathews,2017-12-10T22:09:01.000Z,"$XLV had a strong day Friday. chart looking pretty good.

Top holdings:
$JNJ nice daily 
$UNH multi yr stead climb 
$PFE
$ABBV
$MRK
$AMGN
$MDT
$BMY
$GILD
$LLY

some good charts for swingers in there and they all pay dividends.","$XLV had a strong day Friday. chart looking pretty good.

Top holdings:
$JNJ nice daily 
$UNH multi yr stead climb 
$PFE
$ABBV
$MRK
$AMGN
$MDT
$BMY
$GILD
$LLY

some good charts for swingers in there and they all pay dividends.
1",,,,1,[],https://twitter.com/ryanmathews/status/939980295834566656
5880,Seeking Alpha,@SeekingAlpha,2017-12-11T17:13:46.000Z,$BMRN $MRK $RHHBY,"$BMRN $MRK $RHHBY
seekingalpha.com
Roche Delivers Some Clinical Wins, But Skepticism Remains Largely Intact (OTCMKTS:RHHBY)
Despite positive results from arguably its riskiest front-line lung cancer trial, Roche hasn't gotten much credit for Tecentriq's renewed potential in the PD-1/PD-L1 space.",,,,,['https://pbs.twimg.com/card_img/1501782713631600646/FEOQQkOb?format=png&name=240x240'],https://twitter.com/SeekingAlpha/status/940268384423362560
5881,Stockboard Media Inc,@stockboardinc,2017-12-11T14:30:34.000Z,"$MRK FDA Accepts Supplemental Biologics License Application (sBLA), Assigns Priority Review to Merck‚Äôs ... - http://sbml.co/3c404285","$MRK FDA Accepts Supplemental Biologics License Application (sBLA), Assigns Priority Review to Merck‚Äôs ... - http://sbml.co/3c404285",,,,,[],https://twitter.com/stockboardinc/status/940227312821456897
5882,MomentumBeast,@momentumbeast,2017-12-11T19:20:25.000Z,$AHGIF Company Highlights - Alternate Health Lab conversion to a full clinical lab is expected to continue to generate long-term stable revenues. $GWPH $IBB $GILD $NVS $PFE $JNJ $MRK $BMY #Cannabis #Cannabinoids #Healthcare,$AHGIF Company Highlights - Alternate Health Lab conversion to a full clinical lab is expected to continue to generate long-term stable revenues. $GWPH $IBB $GILD $NVS $PFE $JNJ $MRK $BMY #Cannabis #Cannabinoids #Healthcare,,,,,[],https://twitter.com/momentumbeast/status/940300255949664256
5883,WallStreetGangsta,@WallStGangsta,2017-12-11T19:19:59.000Z,"$AHGIF Company Highlights - Acquisition of a Blockchain-Enabled Mobile Payment software application completed in November, adding mobile payment solutions and point of sale capabilities. $GWPH $IBB $GILD $NVS $PFE $JNJ $MRK $BMY #Cannabis #Cannabinoids #Healthcare","$AHGIF Company Highlights - Acquisition of a Blockchain-Enabled Mobile Payment software application completed in November, adding mobile payment solutions and point of sale capabilities. $GWPH $IBB $GILD $NVS $PFE $JNJ $MRK $BMY #Cannabis #Cannabinoids #Healthcare",,,,,[],https://twitter.com/WallStGangsta/status/940300146843283456
5884,1 min Stock Insights,@1MinuteStock,2017-12-10T08:32:02.000Z,Do you know that #Book Value for $MRK is $0,"Do you know that #Book Value for $MRK is $0
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/939774697830473728
5885,1 min Stock Insights,@1MinuteStock,2017-12-10T10:27:02.000Z,Not sure what to do with $MRK? Explore our #fundamental pros and cons.,"Not sure what to do with $MRK? Explore our #fundamental pros and cons.
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/939803635277430784
5886,1 min Stock Insights,@1MinuteStock,2017-12-09T10:22:02.000Z,"Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.73% of the current price https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=eps&utm_source=twitter‚Ä¶","Btw, Estimated #Earnings Per Share for $MRK is $0.96 it's 1.73% of the current price https://unicornbay.com/t/MRK.US?utm_medium=tweet&utm_campaign=eps&utm_source=twitter‚Ä¶",,,,,[],https://twitter.com/1MinuteStock/status/939439990068543488
5887,Guru Trader Tweet,@InvestorsGuru,2017-12-10T20:49:21.000Z,Poll: 2018 Dow Best Guess? Our #DogsOfTheDow $DJIA Value Ranks 1) $GE 17.71 2) $VZ 51.09 Verizon 3) $INTC 43.35 Intel 4) $MRK 55.57 Merck 5) $IBM 154.81 6) $XOM 82.66 Exxon 7) $CSCO 37.61 Cisco 8) $PFE 35.74 Pfizer 9) $TRV 133.75 Travelers 10) $JPM 105.93 http://investorsguru.com/Top30DJIAStocks.html‚Ä¶,"Poll: 2018 Dow Best Guess? Our #DogsOfTheDow $DJIA Value Ranks 1) $GE 17.71 2) $VZ 51.09 Verizon 3) $INTC 43.35 Intel 4) $MRK 55.57 Merck 5) $IBM 154.81 6) $XOM 82.66 Exxon 7) $CSCO 37.61 Cisco 8) $PFE 35.74 Pfizer 9) $TRV 133.75 Travelers 10) $JPM 105.93 http://investorsguru.com/Top30DJIAStocks.html‚Ä¶
Up 1% to 8%
40%
Down 1% to 8%
0%
Up more than 8%
60%
Down more than 8%
0%
5 votes
¬∑
Final results
1",,,,1,[],https://twitter.com/InvestorsGuru/status/939960250047848449
5888,Loncar Biotech ETFs,@LoncarFunds,2017-12-11T11:42:01.000Z,"FDA has assigned a decision date of April 3, 2018 for $MRK‚Äôs Keytruda marketing application for relapsed/refractory PMBCL. http://loncarfunds.com/cncr-holdings/","FDA has assigned a decision date of April 3, 2018 for $MRK‚Äôs Keytruda marketing application for relapsed/refractory PMBCL. http://loncarfunds.com/cncr-holdings/",,,,,['https://pbs.twimg.com/media/DQw0-ZXUMAIgraG?format=png&name=small'],https://twitter.com/LoncarFunds/status/940184894071853057
5889,MarketBeat,@MarketBeatCom,2017-12-10T17:19:48.000Z,"Merck & Co., Inc. $MRK Expected to Post Quarterly Sales of $10.44 Billion http://ift.tt/2B5e71E #acn","Merck & Co., Inc. $MRK Expected to Post Quarterly Sales of $10.44 Billion http://ift.tt/2B5e71E #acn",,,,,[],https://twitter.com/MarketBeatCom/status/939907513889312768
5890,FinInvTr,@FinInvTr,2017-12-11T20:28:00.000Z,"3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise: https://buff.ly/2nNvui5 $INCY $JUNO $BLUE

Are $SNY $PFE $MRK $AMGN Looking For Deals?","3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise: https://buff.ly/2nNvui5 $INCY $JUNO $BLUE

Are $SNY $PFE $MRK $AMGN Looking For Deals?",,,,,[],https://twitter.com/FinInvTr/status/940317264523513857
5891,Dakota Financial,@dakotafinancial,2017-12-09T15:19:14.000Z,"Numeric Investors LLC Sells 235,544 Shares of Merck & Co., Inc. $MRK http://ift.tt/2yTCygI","Numeric Investors LLC Sells 235,544 Shares of Merck & Co., Inc. $MRK http://ift.tt/2yTCygI",,,,,[],https://twitter.com/dakotafinancial/status/939514785871355904
5892,shortvolumes,@shortvolumes,2017-12-09T09:00:01.000Z,Short vol ratio for $GSK on 2017-12-08 is 0.42. http://shortvolumes.com/?t=GSK $DVAX 0.37 $MRK 0.26 $INVA 0.42 $TEVA 0.42,Short vol ratio for $GSK on 2017-12-08 is 0.42. http://shortvolumes.com/?t=GSK $DVAX 0.37 $MRK 0.26 $INVA 0.42 $TEVA 0.42,,,,,[],https://twitter.com/shortvolumes/status/939419352486604800
5893,Dakota Financial,@dakotafinancial,2017-12-10T16:16:33.000Z,"RKL Wealth Management LLC Purchases Shares of 3,908 Merck & Co., Inc. $MRK http://ift.tt/2nLfblP","RKL Wealth Management LLC Purchases Shares of 3,908 Merck & Co., Inc. $MRK http://ift.tt/2nLfblP",,,,,[],https://twitter.com/dakotafinancial/status/939891598103638016
5894,Dakota Financial,@dakotafinancial,2017-12-11T17:51:39.000Z,"Balyasny Asset Management LLC Acquires 44,894 Shares of Merck & Co., Inc. $MRK http://ift.tt/2jxuEVd","Balyasny Asset Management LLC Acquires 44,894 Shares of Merck & Co., Inc. $MRK http://ift.tt/2jxuEVd",,,,,[],https://twitter.com/dakotafinancial/status/940277915534675969
5895,Ticker Report,@TickerReport,2017-12-09T15:16:06.000Z,"Zacks Investment Management Purchases 66,556 Shares of Merck & Co., Inc. $MRK http://ift.tt/2A8Bpjh","Zacks Investment Management Purchases 66,556 Shares of Merck & Co., Inc. $MRK http://ift.tt/2A8Bpjh",,,,,[],https://twitter.com/TickerReport/status/939513995756756992
5896,Watchlist News,@WatchlistN,2017-12-09T15:13:11.000Z,"Merck & Co., Inc. $MRK Position Maintained by Nicholas Hoffman & Company LLC. http://ift.tt/2A5AfW2","Merck & Co., Inc. $MRK Position Maintained by Nicholas Hoffman & Company LLC. http://ift.tt/2A5AfW2",,,,,[],https://twitter.com/WatchlistN/status/939513261405474816
5897,Ticker Report,@TickerReport,2017-12-11T17:50:22.000Z,"Merck & Co., Inc. $MRK is Tekla Capital Management LLC‚Äôs 7th Largest Position http://ift.tt/2BWepEN","Merck & Co., Inc. $MRK is Tekla Capital Management LLC‚Äôs 7th Largest Position http://ift.tt/2BWepEN",,,,,[],https://twitter.com/TickerReport/status/940277594854961152
5898,shortvolumes,@shortvolumes,2017-12-09T16:31:02.000Z,2017-12-08 Short sell volume ratio for $RDUS is 0.52. http://shortvolumes.com/?t=RDUS $HZNP 0.57 $CRL 0.66 $ALDR 0.65 $MRK 0.26,2017-12-08 Short sell volume ratio for $RDUS is 0.52. http://shortvolumes.com/?t=RDUS $HZNP 0.57 $CRL 0.66 $ALDR 0.65 $MRK 0.26,,,,,[],https://twitter.com/shortvolumes/status/939532851795648512
5899,Daily Political,@dailypoliticaln,2017-12-11T17:49:05.000Z,"QS Investors LLC Has $23.59 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2Ab5yOY","QS Investors LLC Has $23.59 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2Ab5yOY
1",,1,,,[],https://twitter.com/dailypoliticaln/status/940277268764614656
5900,Clark Joseph Kent,@JorelLaraKalel,2017-12-11T03:39:31.000Z,"2018 Outlook: How Exxon, GE, IBM, Merck and Disney Could Be the Top Dow Stocks $XOM $GE $IBM $MRK $DIS $DJIA","2018 Outlook: How Exxon, GE, IBM, Merck and Disney Could Be the Top Dow Stocks $XOM $GE $IBM $MRK $DIS $DJIA
247wallst.com
2018 Outlook: How Exxon, GE, IBM, Merck and Disney Could Be the Top Dow Stocks
Some down and out stocks don't always stay down, and sometimes great turnarounds and recoveries can create huge victories for opportunistic and visionary investors.
1",,1,,,[],https://twitter.com/JorelLaraKalel/status/940063468526321664
5901,Giovanni Franchi,@giovfranchi,2017-12-09T08:51:14.000Z,"Our 10 Favorite Stocks for 2017 

$GOOGL, $AAPL, $C, $DIS, $MRK, $DAL, $DTEGY, $NVS, $UL, $TOL

http://barrons.com/articles/top-10-stock-picks-for-2017-1480748688‚Ä¶ via 
@Barronsonline","Our 10 Favorite Stocks for 2017 

$GOOGL, $AAPL, $C, $DIS, $MRK, $DAL, $DTEGY, $NVS, $UL, $TOL

http://barrons.com/articles/top-10-stock-picks-for-2017-1480748688‚Ä¶ via 
@Barronsonline
barrons.com
Top 10 Stock Picks for 2017
Alphabet, Apple, Citigroup, Deutsche Telekom, Disney, Toll Brothers, and Unilever are among the best bets.
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501995343226933257/P7CYqKji?format=jpg&name=small'],https://twitter.com/giovfranchi/status/939417141077512193
5902,Donna Young,@DonnaYoungDC,2017-12-11T11:37:42.000Z,"#FDA grants priority review to $MRK's sBLA for #Keytruda in relapsed/refractory primary mediastinal large B-cell lymphoma; Apr 3, 2018 PDUFA https://businesswire.com/news/home/20171211005235/en‚Ä¶ ‚Ä¶ 
#cancer #pharma #biotech","#FDA grants priority review to $MRK's sBLA for #Keytruda in relapsed/refractory primary mediastinal large B-cell lymphoma; Apr 3, 2018 PDUFA https://businesswire.com/news/home/20171211005235/en‚Ä¶ ‚Ä¶ 
#cancer #pharma #biotech",üì∞,,,,[],https://twitter.com/DonnaYoungDC/status/940183807495409665
5903,Matt Funaro,@mattfunaro,2017-12-11T14:54:10.000Z,"Buyout most likely by $MRK, as they already own 10% of the company","Buyout most likely by $MRK, as they already own 10% of the company
1",,,,1,[],https://twitter.com/mattfunaro/status/940233251557466112
5904,AlphaStreet News,@AlphSt_Live,2017-12-11T18:18:00.000Z,"$LLY FDA accepts to review Eli Lilly's migraine treatment drug.

Click here http://alph.st/bf3c0558
@EliLillyCo
 @LillyPad
 

$NVS $AMGN $TEVA $ALDR $BMY $AGN $MRK $ABT $GSK $JNJ $PFE

#WeAreLilly 
@LillyTrials
 @amfmigraine
 
#migraine #FDA #pharma #stocks","$LLY FDA accepts to review Eli Lilly's migraine treatment drug.

Click here http://alph.st/bf3c0558
@EliLillyCo
 @LillyPad
 

$NVS $AMGN $TEVA $ALDR $BMY $AGN $MRK $ABT $GSK $JNJ $PFE

#WeAreLilly 
@LillyTrials
 @amfmigraine
 
#migraine #FDA #pharma #stocks",,,,,[],https://twitter.com/AlphSt_Live/status/940284549560274944
5905,AlphaStreet News,@AlphSt_Live,2017-12-11T14:53:44.000Z,"$CELG Positive results from the trials with its development partners $BLUE and $JUNO in ASH presentations.
 
Check here:

http://alph.st/bd17bb56 http://alph.st/b40961a4

$BIIB $PFE $LLY $AGN $NVO $SNY $JNJ $MRK 
@Celgene
 @bluebirdbio
@JunoThera
 #ASH17 #pharma
#cancer #stocks","$CELG Positive results from the trials with its development partners $BLUE and $JUNO in ASH presentations.
 
Check here:

http://alph.st/bd17bb56 http://alph.st/b40961a4

$BIIB $PFE $LLY $AGN $NVO $SNY $JNJ $MRK 
@Celgene
 @bluebirdbio
@JunoThera
 #ASH17 #pharma
#cancer #stocks",,,,,[],https://twitter.com/AlphSt_Live/status/940233141251293184
5906,Pilar Nava-Parada MD.PhD,@pilarnavaparada,2017-12-10T02:19:28.000Z,"Replying to 
@TradeTexasBig","Replying to 
@TradeTexasBig
Yes. interesting bc these r heavily treated pt w durable response. Authors refered us to Pembro $MRK and nivo $BMY but didn't say if one was better than the other one. Overall, these abs provide a significant differential effect according to PD-L1 expression on tumor cells.
2
1",,2,,1,[],https://twitter.com/pilarnavaparada/status/939680936375062528
5907,dough,@semodough,2017-12-14T03:11:31.000Z,Few upcoming #PDUFA $ONCE $MRK $PTLA $SGYP $AMGN $IBB,"Few upcoming #PDUFA $ONCE $MRK $PTLA $SGYP $AMGN $IBB
3
14
33",,3,14,33,['https://pbs.twimg.com/media/DQ-dFSpXUAU6sNV?format=jpg&name=small'],https://twitter.com/semodough/status/941143588028723202
5908,Dan,@DanP19330,2017-12-12T18:17:01.000Z,"Tax cut is in the bag. The merger mania shall commence in 2018

$AMGN $GILD $MRK $PFE $ALIOY $BIIB $BMY $INCY $JNJ $KITE $XBI $IBB $BIB $LABU #biotech #bioscience #biopharma  https://seekingalpha.com/article/4130901-biotech-2018-will-repatriated-cash-fuel-feeding-frenzy?source=tweet‚Ä¶ https://seekingalpha.com/article/4130901-biotech-2018-will-repatriated-cash-fuel-feeding-frenzy‚Ä¶","Tax cut is in the bag. The merger mania shall commence in 2018

$AMGN $GILD $MRK $PFE $ALIOY $BIIB $BMY $INCY $JNJ $KITE $XBI $IBB $BIB $LABU #biotech #bioscience #biopharma  https://seekingalpha.com/article/4130901-biotech-2018-will-repatriated-cash-fuel-feeding-frenzy?source=tweet‚Ä¶ https://seekingalpha.com/article/4130901-biotech-2018-will-repatriated-cash-fuel-feeding-frenzy‚Ä¶
3
2",,,3,2,[],https://twitter.com/DanP19330/status/940646689802665989
5909,Seeking Alpha,@SeekingAlpha,2017-12-12T22:57:19.000Z,$BMRN $BMY $MRK $ONCE $RHHBY https://seekingalpha.com/article/4131438-3-things-biotech-learn-today-december-12-2017?source=feed_f‚Ä¶,"$BMRN $BMY $MRK $ONCE $RHHBY https://seekingalpha.com/article/4131438-3-things-biotech-learn-today-december-12-2017?source=feed_f‚Ä¶
1",,,1,,[],https://twitter.com/SeekingAlpha/status/940717229045252101
5910,FiercePharma,@FiercePharma,2017-12-12T17:11:00.000Z,Merck's Keytruda picks up FDA  priority review in non-Hodgkin lymphoma $MRK #ASH17,"Merck's Keytruda picks up FDA  priority review in non-Hodgkin lymphoma $MRK #ASH17
fiercepharma.com
ASH: Merck's Keytruda nabs speedy FDA review in non-Hodgkin lymphoma
ATLANTA‚Äî
10
9",,,10,9,['https://pbs.twimg.com/card_img/1499574338843930625/RIhfkRxg?format=jpg&name=small'],https://twitter.com/FiercePharma/status/940630074759540743
5911,M,@bio_clouseau,2017-12-14T20:39:33.000Z,Daiichi terminating pembro combo trials with its CSF1R $MRK $FPRX $BMY,"Daiichi terminating pembro combo trials with its CSF1R $MRK $FPRX $BMY
1
3
3",,1,3,3,['https://pbs.twimg.com/media/DRCM6fOXUAAUH07?format=jpg&name=900x900'],https://twitter.com/bio_clouseau/status/941407333372125184
5912,Jack Allen,@JohnK_Allen,2017-12-14T23:46:45.000Z,"Keytruda with another OS miss after being granted AA by FDA based on response rates

When if ever will these repeated OS failures by PD-1/L1s result in a more stringent FDA?

$MRK $BMY $RHHBY $AZN $PFE $REGN $SNY","Keytruda with another OS miss after being granted AA by FDA based on response rates

When if ever will these repeated OS failures by PD-1/L1s result in a more stringent FDA?

$MRK $BMY $RHHBY $AZN $PFE $REGN $SNY
Odi Bruckman
@odibro
 ¬∑ 15 Dec 2017
$MRK phase 3 KEYNOTE-061 trial of KEYTRUDA did not meet primary endpoint http://mrknewsroom.com/news-release/corporate-news/merck-provides-update-keynote-061-phase-3-study-keytruda-pembrolizumab-p‚Ä¶
1
4
5",,1,4,5,['https://pbs.twimg.com/profile_images/1182595151899836417/Y4fMBMd5_mini.jpg'],https://twitter.com/JohnK_Allen/status/941454444469858304
5913,TraderMD,@TraderMD,2017-12-12T14:28:10.000Z,#ES_F Trade Ideas 12/12/17 & Pre-market heatmap $$ $SPY $CMCSA $BA $MRK,"#ES_F Trade Ideas 12/12/17 & Pre-market heatmap $$ $SPY $CMCSA $BA $MRK
1
2",,1,,2,"['https://pbs.twimg.com/media/DQ2kq6JVoAAzNka?format=jpg&name=360x360', 'https://pbs.twimg.com/media/DQ2kxPPVAAEmPJo?format=jpg&name=small']",https://twitter.com/TraderMD/status/940589094345650176
5914,ItzStockChartz,@itzstockchartz,2017-12-12T23:19:02.000Z,$MRK ITZ BUY call up already... http://bit.ly/1dpwIF6,"$MRK ITZ BUY call up already... http://bit.ly/1dpwIF6
1
1",,,1,1,['https://pbs.twimg.com/media/DQ4eTbTVwAAZozR?format=jpg&name=small'],https://twitter.com/itzstockchartz/status/940722694278000640
5915,Drugdoctor1,@Drugdoctor2014,2017-12-12T20:07:03.000Z,"$ARLZ-$1.48-Nasdaq-Pharma-HUGE insider and Inst. Fund BUYING. Article.. $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TSCO $BBBY $TEVA $RDY $MNK $ASMB https://americanbankingnews.com/2017/12/12/aralez-pharmaceuticals-inc-arlz-director-purchases-73500-00-in-stock.html‚Ä¶","$ARLZ-$1.48-Nasdaq-Pharma-HUGE insider and Inst. Fund BUYING. Article.. $PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ $PFE $GSK $LLY $ABT $SNY $NVO $NVS
$WBA $RAD $HLF $CJJD $GNC $DPLO $IPXL $TSCO $BBBY $TEVA $RDY $MNK $ASMB https://americanbankingnews.com/2017/12/12/aralez-pharmaceuticals-inc-arlz-director-purchases-73500-00-in-stock.html‚Ä¶
1
2",,,1,2,[],https://twitter.com/Drugdoctor2014/status/940674379771457541
5916,ICEMAN,@IcemanTrading,2017-12-12T13:20:29.000Z,$SPY $XIV $UWT $IWM $SOXL $MARK $XNET $SSC $RIOT $CHFS $SYRS $UGAZ $NETE $SRAX $PTI $GLYC $OSTK $NVFY $TNXP $GROW $EDIT $FMSA $CLSN $COTY $LINU $ALGN $TS $BA $RIG $MMM $MRK $VZ,"$SPY $XIV $UWT $IWM $SOXL $MARK $XNET $SSC $RIOT $CHFS $SYRS $UGAZ $NETE $SRAX $PTI $GLYC $OSTK $NVFY $TNXP $GROW $EDIT $FMSA $CLSN $COTY $LINU $ALGN $TS $BA $RIG $MMM $MRK $VZ
2",,,2,,['https://pbs.twimg.com/media/DQ2VSsdUIAABITc?format=jpg&name=small'],https://twitter.com/IcemanTrading/status/940572061247983616
5917,Equity Clock,@EquityClock,2017-12-12T15:18:14.000Z,"Merck $MRK, a Dow Jones Industrial stock moved above $56.72 completing a short term reverse Head & Shoulders pattern","Merck $MRK, a Dow Jones Industrial stock moved above $56.72 completing a short term reverse Head & Shoulders pattern
1
1",,,1,1,['https://pbs.twimg.com/media/DQ2wQZeWsAA7Rs5?format=jpg&name=small'],https://twitter.com/EquityClock/status/940601696593596416
5918,Mandy Jackson,@ScripMandy,2017-12-14T21:55:12.000Z,$MRK Keytruda fails in KEYNOTE-061: indication unchanged; continue to evaluate KEYTRUDA for gastric/GEJ adenocarcinoma through KEYNOTE-062.,"$MRK Keytruda fails in KEYNOTE-061: indication unchanged; continue to evaluate KEYTRUDA for gastric/GEJ adenocarcinoma through KEYNOTE-062.
Merck
@Merck
 ¬∑ 15 Dec 2017
Click here for our latest news: http://bit.ly/2o2gOvw $MRK
1",,,1,,['https://pbs.twimg.com/profile_images/1410592409604476931/CnTzTRsz_mini.jpg'],https://twitter.com/ScripMandy/status/941426371087163393
5919,Jacob Plieth,@JacobPlieth,2017-12-14T22:01:48.000Z,Leaves US FDA with a nice quandary. Bet I know what happens though $MRK $BMY $RHHBY,"Leaves US FDA with a nice quandary. Bet I know what happens though $MRK $BMY $RHHBY
Brad Loncar
@bradloncar
 ¬∑ 15 Dec 2017
$MRK - Keytruda P3 in second line gastric cancer failed. Bummer. http://mrknewsroom.com/news-release/corporate-news/merck-provides-update-keynote-061-phase-3-study-keytruda-pembrolizumab-p‚Ä¶
1",,,1,,['https://pbs.twimg.com/profile_images/802810551923396608/HzKaIQom_mini.jpg'],https://twitter.com/JacobPlieth/status/941428030710349825
5920,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-12-13T14:48:09.000Z,"Unusual call buying: $XL 29x average volume, $TROW 25x, $K 12x, $STZ 7x, $NWL 7x, $TWX 7x, $BSX 6x, $MRK 6x ‚Üí via http://bit.do/BestTradeSetups","Unusual call buying: $XL 29x average volume, $TROW 25x, $K 12x, $STZ 7x, $NWL 7x, $TWX 7x, $BSX 6x, $MRK 6x ‚Üí via http://bit.do/BestTradeSetups
1",,,,1,[],https://twitter.com/AlertTrade/status/940956512293232641
5921,Dan,@DanP19330,2017-12-12T18:30:32.000Z,"Nasdaq: 3 Stocks in Focus as #BIOTECH M&A Hopes for 2018 Rise.

$GILD $JNJ $SNY $PFE $MRK $AMGN $INCY $JUNO $BLUE #biopharma #Health  http://nasdaq.com/article/3-stocks-in-focus-as-biotech-ma-hopes-for-2018-rise-cm889615‚Ä¶","Nasdaq: 3 Stocks in Focus as #BIOTECH M&A Hopes for 2018 Rise.

$GILD $JNJ $SNY $PFE $MRK $AMGN $INCY $JUNO $BLUE #biopharma #Health  http://nasdaq.com/article/3-stocks-in-focus-as-biotech-ma-hopes-for-2018-rise-cm889615‚Ä¶
1",,,1,,[],https://twitter.com/DanP19330/status/940650089835479040
5922,1 min Stock Insights,@1MinuteStock,2017-12-12T05:31:02.000Z,Explore #fundamental numbers and pros and cons for $MRK,"Explore #fundamental numbers and pros and cons for $MRK
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/940453922954555394
5923,Scott Gillam,@mallig,2017-12-13T12:27:36.000Z,"12/13 - 20/50 sma bull cross - $T, $TEVA, $TXT, $UTX
5/20 ema bull cross - $ATVI, $FLIR, $MRK, $THC
5/20 ema bear cross - $FB, $TOL, $VMC","12/13 - 20/50 sma bull cross - $T, $TEVA, $TXT, $UTX
5/20 ema bull cross - $ATVI, $FLIR, $MRK, $THC
5/20 ema bear cross - $FB, $TOL, $VMC",,,,,[],https://twitter.com/mallig/status/940921142012973056
5924,US Banking News,@AmericanBanking,2017-12-13T09:21:11.000Z,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2C5VfNz $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2C5VfNz $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/940874227993006080
5925,MomentumBeast,@momentumbeast,2017-12-12T17:49:17.000Z,$AHGIF Recent Company‚Äôs HIGHLIGHTS $IBB $GILD $GWPH $NVS $BMY $MRK $JNJ $AMGN $BSX $VRX $GLD $GDX $RGLD $AEM $SPY,$AHGIF Recent Company‚Äôs HIGHLIGHTS $IBB $GILD $GWPH $NVS $BMY $MRK $JNJ $AMGN $BSX $VRX $GLD $GDX $RGLD $AEM $SPY,,,,,['https://pbs.twimg.com/media/DQ3S1DIW0AEx2zV?format=jpg&name=small'],https://twitter.com/momentumbeast/status/940639708442513414
5926,Chameleon Options,@MC_OptionTrades,2017-12-13T23:48:37.000Z,Price Returns vs Expected Daily Move $ABBV $VRX $GILD $BMY $JNJ $PFE $MRK $CELG $AGN $CVS $TEVA $RIOT http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $ABBV $VRX $GILD $BMY $JNJ $PFE $MRK $CELG $AGN $CVS $TEVA $RIOT http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DQ9uqYVVwAAsGyQ?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/941092524004913152
5927,MarketBeat,@MarketBeatCom,2017-12-13T09:19:51.000Z,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2C5VfNz $MRK #MRK,Merck KGaA given ‚Ç¨115.00 PT by Warburg Research. buy rating. http://ift.tt/2C5VfNz $MRK #MRK,,,,,[],https://twitter.com/MarketBeatCom/status/940873891962130433
5928,1 min Stock Insights,@1MinuteStock,2017-12-13T11:59:02.000Z,Unicorn Bay rating for $MRK is 2.93 out of 5.,"Unicorn Bay rating for $MRK is 2.93 out of 5.
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/940913953374314501
5929,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-12-13T12:44:04.000Z,"Replying to 
@Brownynut","Replying to 
@Brownynut
IMO the $AFMD AFM13 path forward needs no change and with competitive results to adcetris/opdivo combo it should make a partnership 4 $MRK even more attractive to stay in the loop 
-- of note no ASCT & safety remarks  https://news.bms.com/press-release/corporatefinancial-news/seattle-genetics-and-bristol-myers-squibb-highlight-interim-re‚Ä¶
2",,,,2,"['https://pbs.twimg.com/media/DQ7RoFBXUAA3jFU?format=jpg&name=900x900', 'https://pbs.twimg.com/media/DQ7Wd3YWsAALDxU?format=jpg&name=900x900']",https://twitter.com/dhovekamp42/status/940925284743831552
5930,US Banking News,@AmericanBanking,2017-12-12T07:25:28.000Z,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2ygr0Aq $MRK #MRK,Merck KGaA given ‚Ç¨100.00 PT by J P Morgan Chase & Co. neutral rating. http://ift.tt/2ygr0Aq $MRK #MRK,,,,,[],https://twitter.com/AmericanBanking/status/940482719187918848
5931,SuperDuper Investor,@SuperDuperInvst,2017-12-12T18:08:17.000Z,"$DVAX $17.80 - Most likely might become an acquisition target for $MRK in 2018 #Merck #Pharma 
#Buy $DVAX","$DVAX $17.80 - Most likely might become an acquisition target for $MRK in 2018 #Merck #Pharma 
#Buy $DVAX",,,,,[],https://twitter.com/SuperDuperInvst/status/940644491094093826
5932,Carly Helfand,@CarlyHFierce,2017-12-13T22:09:00.000Z,#ICYMI last week: Can Roche's Tecentriq leapfrog rival meds in lung cancer? Jury's still out http://bit.ly/2j2RuQZ $RHHBY $MRK #pharma,"#ICYMI last week: Can Roche's Tecentriq leapfrog rival meds in lung cancer? Jury's still out http://bit.ly/2j2RuQZ $RHHBY $MRK #pharma
fiercepharma.com
Can Roche's Tecentriq leapfrog rival meds in lung cancer? Jury's still out
On Thursday, Roche unveiled positive results from its first-line lung-cancer combo trial‚Äîbut those results raised mor | On Thursday, Roche unveiled positive results from its first-line lung-cancer...",,,,,[],https://twitter.com/CarlyHFierce/status/941067456453410816
5933,Carly Helfand,@CarlyHFierce,2017-12-14T19:11:00.000Z,#ICYMI last week - Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst http://bit.ly/2BlUBOo $RHHBY $MRK #pharma,"#ICYMI last week - Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst http://bit.ly/2BlUBOo $RHHBY $MRK #pharma
fiercepharma.com
Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst
More results may be out from a clos | More results may be out from a closely watched trial of Roche‚Äôs Tecentriq in lung cancer, but industry watchers still don‚Äôt have many of the answers they‚Äôre...",,,,,['https://pbs.twimg.com/card_img/1501706825552510976/6SHw0CbE?format=jpg&name=small'],https://twitter.com/CarlyHFierce/status/941385049617895424
5934,TalkMarkets,@TalkMarkets,2017-12-13T21:28:48.000Z,"Hot #Options Report For End Of Day - Wednesday, December 13 $T $TWX $MRK $GILD $BX $M $MRO $AAPL https://goo.gl/nqf4Df","Hot #Options Report For End Of Day - Wednesday, December 13 $T $TWX $MRK $GILD $BX $M $MRO $AAPL https://goo.gl/nqf4Df",,,,,[],https://twitter.com/TalkMarkets/status/941057338319953921
5935,MomentumBeast,@momentumbeast,2017-12-13T19:12:51.000Z,"$AHGIF $TWMJF $APHQF $ACBFF Top 4 Canadian Stocks to Watch : Alternate Health Corp. (AHGIF), Canopy Growth Corp. (TWMJF), Aphria (APHQF) and Aurora Cannabis (ACBFF) http://nasdaqreporter.com/top-4-canadian-stocks-to-watch-alternate-health-corp-ahgif-canopy-growth-corp-twmjf-aphria-aphqf-and-aurora-cannabis-acbff/‚Ä¶ $GWPH $IBB $SPY $AAPL $NVS $GILD $PFE $JNJ $BA $VRX $BSX $MRK $BMY $AMGN $FB $ROKU $NVDA","$AHGIF $TWMJF $APHQF $ACBFF Top 4 Canadian Stocks to Watch : Alternate Health Corp. (AHGIF), Canopy Growth Corp. (TWMJF), Aphria (APHQF) and Aurora Cannabis (ACBFF) http://nasdaqreporter.com/top-4-canadian-stocks-to-watch-alternate-health-corp-ahgif-canopy-growth-corp-twmjf-aphria-aphqf-and-aurora-cannabis-acbff/‚Ä¶ $GWPH $IBB $SPY $AAPL $NVS $GILD $PFE $JNJ $BA $VRX $BSX $MRK $BMY $AMGN $FB $ROKU $NVDA",,,,,[],https://twitter.com/momentumbeast/status/941023126036598786
5936,TalkMarkets,@TalkMarkets,2017-12-12T15:27:02.000Z,"#Biotech Digest - $XENT Gets FDA Approval, $AGN Announces Acquisition, $IONS Licenses Product $MRK $SNY $REGN  https://goo.gl/QYTi1r","#Biotech Digest - $XENT Gets FDA Approval, $AGN Announces Acquisition, $IONS Licenses Product $MRK $SNY $REGN  https://goo.gl/QYTi1r",,,,,[],https://twitter.com/TalkMarkets/status/940603908908560387
5937,F.A.S.T. Graphs,@FASTGraphs,2017-12-12T14:24:44.000Z,"$TRV $MRK $AXP $GE $PFE $JPM
  Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
  https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶","$TRV $MRK $AXP $GE $PFE $JPM
  Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5
  https://fastgraphs.com/wp/why-are-these-6-dow-stocks-fairly-valued-part-4-of-5/‚Ä¶",,,,,[],https://twitter.com/FASTGraphs/status/940588230285647873
5938,bake mcbride,@ITRADEVOL,2017-12-14T15:21:25.000Z,3 Monthly Dividend Stocks To Buy Now $CLDT $LTC $STAG do u think these R better Buys then $MRK $GILD $TMO $BCE $FIS https://marketchameleon.com/Blog/post/2017/12/13/3-monthly-dividend-stocks-to-buy-now‚Ä¶,3 Monthly Dividend Stocks To Buy Now $CLDT $LTC $STAG do u think these R better Buys then $MRK $GILD $TMO $BCE $FIS https://marketchameleon.com/Blog/post/2017/12/13/3-monthly-dividend-stocks-to-buy-now‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/941327273394884613
5939,bake mcbride,@ITRADEVOL,2017-12-13T20:52:21.000Z,Option Trades Screener 4 trade Ideas $BAC $ORCL $XOM $SPY $IYR $C $IRM $PCLN $BA $MRK $AMGN $T $IWM $SQ $JNUG $TEVA https://marketchameleon.com/Screeners/OptionTrades‚Ä¶,Option Trades Screener 4 trade Ideas $BAC $ORCL $XOM $SPY $IYR $C $IRM $PCLN $BA $MRK $AMGN $T $IWM $SQ $JNUG $TEVA https://marketchameleon.com/Screeners/OptionTrades‚Ä¶,,,,,[],https://twitter.com/ITRADEVOL/status/941048165008060417
5940,Finbox,@FinboxIO,2017-12-13T00:00:44.000Z,"Ken Griffin did his homework on Merck & Company, Inc. $MRK. Stock's trading below fair value http://ow.ly/ijNy30h2yjb","Ken Griffin did his homework on Merck & Company, Inc. $MRK. Stock's trading below fair value http://ow.ly/ijNy30h2yjb",,,,,[],https://twitter.com/FinboxIO/status/940733185515835392
5941,Market Realist,@MarketRealist,2017-12-14T15:31:03.000Z,Checking in on Bristol-Myers Squibb in December 2017 http://marketrealist.com/?p=2496002 $BMY $IXJ $JNJ $MRK,Checking in on Bristol-Myers Squibb in December 2017 http://marketrealist.com/?p=2496002 $BMY $IXJ $JNJ $MRK,,,,,[],https://twitter.com/MarketRealist/status/941329698205896704
5942,MarketBeat,@MarketBeatCom,2017-12-14T15:54:14.000Z,"WINTON GROUP Ltd Has $2.87 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2ApyTFN","WINTON GROUP Ltd Has $2.87 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2ApyTFN",,,,,[],https://twitter.com/MarketBeatCom/status/941335530817708032
5943,MarketBeat,@MarketBeatCom,2017-12-13T17:49:34.000Z,"Merck & Co., Inc. $MRK Position Trimmed by Wealthsource Partners LLC http://ift.tt/2BipCmq","Merck & Co., Inc. $MRK Position Trimmed by Wealthsource Partners LLC http://ift.tt/2BipCmq",,,,,[],https://twitter.com/MarketBeatCom/status/941002166675877888
5944,Stocks Pastor,@stockspastor,2017-12-13T23:55:52.000Z,I couldn‚Äôt post my profit on $WDC.  It‚Äôs a lot.  http://bit.ly/1PWTzJR  $MU $CTRP $KMX $MRK $BABA $UPS lots of $$$ overnight.  Spending Xmas in Zurich,I couldn‚Äôt post my profit on $WDC.  It‚Äôs a lot.  http://bit.ly/1PWTzJR  $MU $CTRP $KMX $MRK $BABA $UPS lots of $$$ overnight.  Spending Xmas in Zurich,,,,,[],https://twitter.com/stockspastor/status/941094350154616832
5945,Reality Shares,@RealityShares,2017-12-13T21:08:12.000Z,"Bargain hunters: check dividend data too. Many of the stocks ""left behind in 2017"" show low potential for dividend growth in the next 12 months but a few are better than average on dividend growth potential. $NWL $HBI $XOM $MRK http://go.realityshares.com/divcon/","Bargain hunters: check dividend data too. Many of the stocks ""left behind in 2017"" show low potential for dividend growth in the next 12 months but a few are better than average on dividend growth potential. $NWL $HBI $XOM $MRK http://go.realityshares.com/divcon/
Philip van Doorn
@PhilipvanDoorn
 ¬∑ 12 Dec 2017
These S&P 500 stocks have been left behind during the 2017 rally. You can start your bargain hunt here. http://on.mktw.net/2yhPYzq",,,,,"['https://pbs.twimg.com/profile_images/2185396684/PVD3_mini.png', 'https://pbs.twimg.com/media/DQ2FEhYXUAAddm2?format=jpg&name=small']",https://twitter.com/RealityShares/status/941052157087825920
5946,Crypto Trader Pro,@CryptoTraderPro,2017-12-13T14:48:13.000Z,"Unusual call buying: $XL 29x average volume, $TROW 25x, $K 12x, $STZ 7x, $NWL 7x, $TWX 7x, $BSX 6x, $MRK 6x ‚Üí via http://bit.do/BestTradeSetups","Unusual call buying: $XL 29x average volume, $TROW 25x, $K 12x, $STZ 7x, $NWL 7x, $TWX 7x, $BSX 6x, $MRK 6x ‚Üí via http://bit.do/BestTradeSetups",,,,,[],https://twitter.com/CryptoTraderPro/status/940956530538508288
5947,Crypto Trader Pro,@CryptoTraderPro,2017-12-14T14:50:15.000Z,"Unusual call buying: $IRM 26x average volume, $TWX 13x, $FOXA 12x, $MRK 10x, $M 9x, $GILD 7x, $EQT 6x, $FTR 6x ‚Üí via http://bit.do/BestTradeSetups","Unusual call buying: $IRM 26x average volume, $TWX 13x, $FOXA 12x, $MRK 10x, $M 9x, $GILD 7x, $EQT 6x, $FTR 6x ‚Üí via http://bit.do/BestTradeSetups",,,,,[],https://twitter.com/CryptoTraderPro/status/941319428699856897
5948,Stocks Pastor,@stockspastor,2017-12-12T21:55:55.000Z,Current Long Stocks:  $UPS $WFT $WBA $MU $CTRP .  All positions must be exited on $MRK tomorrow ahead of Ex dividend on Thursday.  Entry at $53s http://bit.ly/1PWTzJR,Current Long Stocks:  $UPS $WFT $WBA $MU $CTRP .  All positions must be exited on $MRK tomorrow ahead of Ex dividend on Thursday.  Entry at $53s http://bit.ly/1PWTzJR,,,,,[],https://twitter.com/stockspastor/status/940701774473818112
5949,Chameleon,@MarketChmln,2017-12-12T21:36:24.000Z,Largest $Notional Sell On Close Order Imbalances $DWDP $PNC $MO $SPG $BRK.B $MMM $TWX $MRK $KO $JPM http://tinyurl.com/y8jo8mjb,Largest $Notional Sell On Close Order Imbalances $DWDP $PNC $MO $SPG $BRK.B $MMM $TWX $MRK $KO $JPM http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/940696864667652098
5950,Teddi Knight,@BeFullyInformed,2017-12-12T21:14:52.000Z,Here's are some $MRK trade ideas for tomorrow (Wed Dec 13 2017) in Merck Stock and further comments and outlook for the stock. This is the second trade since Dec 7 https://fullyinformed.com/merck-stock-mrk-trade-alerts-and-ideas-for-dec-12-and-dec-13-2017/‚Ä¶,Here's are some $MRK trade ideas for tomorrow (Wed Dec 13 2017) in Merck Stock and further comments and outlook for the stock. This is the second trade since Dec 7 https://fullyinformed.com/merck-stock-mrk-trade-alerts-and-ideas-for-dec-12-and-dec-13-2017/‚Ä¶,,,,,[],https://twitter.com/BeFullyInformed/status/940691445228322816
5951,SuperDuper Investor,@SuperDuperInvst,2017-12-12T20:26:26.000Z,"$DVAX $17.75 - Matter of time before some large #Pharma like $MRK offers $27/share to acquire the company
#Buy","$DVAX $17.75 - Matter of time before some large #Pharma like $MRK offers $27/share to acquire the company
#Buy
2",,,,2,[],https://twitter.com/SuperDuperInvst/status/940679257705123841
5952,Matthew Herper,@matthewherper,2017-12-12T14:12:29.000Z,"I asked this of the big pharma panel, too. $MRK's Ken Frazier had the best answer I've heard. (More later, video here: https://youtube.com/watch?v=nnozMq4WhfY‚Ä¶ ) Basically, don't judge me on the average.","I asked this of the big pharma panel, too. $MRK's Ken Frazier had the best answer I've heard. (More later, video here: https://youtube.com/watch?v=nnozMq4WhfY‚Ä¶ ) Basically, don't judge me on the average.
David Shaywitz
@DShaywitz
 ¬∑ 12 Dec 2017
Re-watched @VasNarasimhan @forbes intvw w/@matthewherper - MH asked ? I've also heard from @bhmunos: what, if anything, can reverse EROOM's Law? And specifically, can tech/data? https://forbes.com/forbes-live/event/healthcare-summit/#videos-12‚Ä¶; I think so, we need to figure out how.https://forbes.com/sites/davidshaywitz/2017/12/10/winning-health-tech-entrepreneurs-will-focus-on-implementation-not-fetishize-invention/#6d974ab43c20‚Ä¶ @eperakslis
2
3
5",,2,3,5,['https://pbs.twimg.com/profile_images/1474396883925798917/QT5Wk8dB_mini.jpg'],https://twitter.com/matthewherper/status/940585149993050112
5953,Donna Young,@DonnaYoungDC,2017-12-13T18:10:42.000Z,".
@MichaelCBurgess
 praising $MRK #Keytruda in saving #JimmyCarter's life.
""It is a fantastic story.""
""It's a gift.""
#pharma #biotech #drugpricing #drugprices #SubHealth",".
@MichaelCBurgess
 praising $MRK #Keytruda in saving #JimmyCarter's life.
""It is a fantastic story.""
""It's a gift.""
#pharma #biotech #drugpricing #drugprices #SubHealth
1",üì∞,,1,,[],https://twitter.com/DonnaYoungDC/status/941007487343448064
5954,The Options Insider,@Options,2017-12-13T21:21:18.000Z,"Hot Options Report For End Of Day December 13th ‚Äì $T, $TWX, $MRK, $GILD, $BX, $M, $MRO, $AAPL   http://theoptionsinsider.com/hot-options-report-end-day-december-13th-t-twx-mrk-gild-bx-m-mro-aapl/‚Ä¶","Hot Options Report For End Of Day December 13th ‚Äì $T, $TWX, $MRK, $GILD, $BX, $M, $MRO, $AAPL   http://theoptionsinsider.com/hot-options-report-end-day-december-13th-t-twx-mrk-gild-bx-m-mro-aapl/‚Ä¶
1
1",,,1,1,[],https://twitter.com/Options/status/941055453190086656
5955,Volatility,@getvolatility,2017-12-13T14:43:00.000Z,"Unusual call buying: $XL 29x average volume, $TROW 25x, $K 12x, $STZ 7x, $NWL 7x, $TWX 7x, $BSX 6x, $MRK 6x","Unusual call buying: $XL 29x average volume, $TROW 25x, $K 12x, $STZ 7x, $NWL 7x, $TWX 7x, $BSX 6x, $MRK 6x",,,,,[],https://twitter.com/getvolatility/status/940955217864089600
5956,Dakota Financial,@dakotafinancial,2017-12-14T15:51:25.000Z,"WINTON GROUP Ltd Has $2.87 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2ApyTFN","WINTON GROUP Ltd Has $2.87 Million Position in Merck & Co., Inc. $MRK http://ift.tt/2ApyTFN",,,,,[],https://twitter.com/dakotafinancial/status/941334821967720448
5957,"Trade Alerts, Trade Ideas and Crypto",@AlertTrade,2017-12-14T14:50:15.000Z,"Unusual call buying: $IRM 26x average volume, $TWX 13x, $FOXA 12x, $MRK 10x, $M 9x, $GILD 7x, $EQT 6x, $FTR 6x ‚Üí via http://bit.do/BestTradeSetups","Unusual call buying: $IRM 26x average volume, $TWX 13x, $FOXA 12x, $MRK 10x, $M 9x, $GILD 7x, $EQT 6x, $FTR 6x ‚Üí via http://bit.do/BestTradeSetups",,,,,[],https://twitter.com/AlertTrade/status/941319429949857793
5958,Dakota Financial,@dakotafinancial,2017-12-13T17:51:23.000Z,"Merck & Co., Inc. $MRK Position Trimmed by Wealthsource Partners LLC http://ift.tt/2BipCmq","Merck & Co., Inc. $MRK Position Trimmed by Wealthsource Partners LLC http://ift.tt/2BipCmq",,,,,[],https://twitter.com/dakotafinancial/status/941002626266812418
5959,Adan Media,@Adan_Media_,2017-12-13T18:01:13.000Z,"RT 
@kjilly
: Pionyr Immunotherapeutics gains meaty $62M series B #biotechstartups #startups #biotech #pharma #biopharma #tumortreatments #NEA #Yervoy #Keytruda $MRK GILD $BMY","RT 
@kjilly
: Pionyr Immunotherapeutics gains meaty $62M series B #biotechstartups #startups #biotech #pharma #biopharma #tumortreatments #NEA #Yervoy #Keytruda $MRK GILD $BMY
fiercebiotech.com
Pionyr Immunotherapeutics gains meaty $62M series B
California startup Pionyr is using $62 million of VC-backed funding to target antibodies in the tumor microenvironment. | California startup Pionyr is using $62 million of VC-backed funding to target...",,,,,['https://pbs.twimg.com/card_img/1501098566554726405/j0_S4vfG?format=jpg&name=small'],https://twitter.com/Adan_Media_/status/941005101275271169
5960,Chameleon,@MarketChmln,2017-12-13T17:17:26.000Z,$MRK goes ex div tomorrow for $0.48. It has increased its div 3 times in 3 years. Annual Yld is 3.4% http://tinyurl.com/yaaftd2x,$MRK goes ex div tomorrow for $0.48. It has increased its div 3 times in 3 years. Annual Yld is 3.4% http://tinyurl.com/yaaftd2x,ü¶é,,,,[],https://twitter.com/MarketChmln/status/940994083102822400
5961,Briefing.com,@Briefingcom,2017-12-14T23:49:40.000Z,$MRK: Merck's Phase 3 KEYNOTE-061 study of KEYTRUDA (pembrolizumab) did not meet its primary endpoint http://bit.ly/2AGhPiN,$MRK: Merck's Phase 3 KEYNOTE-061 study of KEYTRUDA (pembrolizumab) did not meet its primary endpoint http://bit.ly/2AGhPiN,,,,,[],https://twitter.com/Briefingcom/status/941455177000787968
5962,Matthew Herper,@matthewherper,2017-12-14T21:52:40.000Z,"$MRK's Keytruda fails against a type of stomach cancer. Drug remains approved as a third-line option, and a larger study is continuing.
http://mrknewsroom.com/news-release/corporate-news/merck-provides-update-keynote-061-phase-3-study-keytruda-pembrolizumab-p‚Ä¶","$MRK's Keytruda fails against a type of stomach cancer. Drug remains approved as a third-line option, and a larger study is continuing.
http://mrknewsroom.com/news-release/corporate-news/merck-provides-update-keynote-061-phase-3-study-keytruda-pembrolizumab-p‚Ä¶
1
3",,,1,3,[],https://twitter.com/matthewherper/status/941425735234924545
5963,Clark Joseph Kent,@JorelLaraKalel,2017-12-14T23:53:04.000Z,"Jim Cramer Mad Money Lighting Round 
@jimcramer
 @madmoneyoncnbc
 @cnbc
 http://cnb.cx/2zcwboD $EA $TTWO $ATVI $TMUS $REGN $OC $ACOR $MRK $PFE","Jim Cramer Mad Money Lighting Round 
@jimcramer
 @madmoneyoncnbc
 @cnbc
 http://cnb.cx/2zcwboD $EA $TTWO $ATVI $TMUS $REGN $OC $ACOR $MRK $PFE
cnbc.com
Cramer's lightning round: Buy Regeneron, it's not getting the credit it deserves
Jim Cramer zoomed through his take on callers' favorite stocks, including a pharma play.",,,,,['https://pbs.twimg.com/card_img/1501125151508910082/hhUdlYzX?format=jpg&name=small'],https://twitter.com/JorelLaraKalel/status/941456034140389377
5964,Tim,@tstamm7002,2017-12-12T19:05:23.000Z,"Replying to 
@lblegend33","Replying to 
@lblegend33
FWIW I think $MRK will make the first move. Januvia decline,  Mavyret pressuring Zepatier & IMpower150 about to take a bite out of the 21G pop in 1L LC
1
1",,1,,1,[],https://twitter.com/tstamm7002/status/940658859093438464
5965,Volatility,@getvolatility,2017-12-14T14:45:40.000Z,"Unusual call buying: $IRM 26x average volume, $TWX 13x, $FOXA 12x, $MRK 10x, $M 9x, $GILD 7x, $EQT 6x, $FTR 6x","Unusual call buying: $IRM 26x average volume, $TWX 13x, $FOXA 12x, $MRK 10x, $M 9x, $GILD 7x, $EQT 6x, $FTR 6x",,,,,[],https://twitter.com/getvolatility/status/941318275463557120
5966,StockNews.com,@stocknewsdotcom,2017-12-14T21:50:16.000Z,$MRK Merck's Phase 3 KEYNOTE-061 study of KEYTRUDA (pembrolizumab) did not meet its primary endpoint https://stocknews.com/news/mrk-mercks-phase-3-keynote-061-study-of-keytruda-pembrolizumab-did-not/‚Ä¶,$MRK Merck's Phase 3 KEYNOTE-061 study of KEYTRUDA (pembrolizumab) did not meet its primary endpoint https://stocknews.com/news/mrk-mercks-phase-3-keynote-061-study-of-keytruda-pembrolizumab-did-not/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/941425130642857991
5967,Ôº†ÔΩÅÔΩåÔΩêÔΩÖÔΩêÔΩâÔΩéÔΩéÔΩÅÔΩöÔΩöÔΩè,@alpepinnazzo,2017-12-14T21:51:14.000Z,$MRK Merck's Phase 3 KEYNOTE-061 study of KEYTRUDA (pembrolizumab) did not meet its primary endpoint AH 56.03,$MRK Merck's Phase 3 KEYNOTE-061 study of KEYTRUDA (pembrolizumab) did not meet its primary endpoint AH 56.03,,,,,[],https://twitter.com/alpepinnazzo/status/941425372704493569
5968,Seeking Alpha,@SeekingAlpha,2017-12-16T12:29:29.000Z,$CLRB $FOLD $MRK https://seekingalpha.com/article/4132282-3-things-biotech-learn-today-december-16-2017?source=feed_f‚Ä¶,$CLRB $FOLD $MRK https://seekingalpha.com/article/4132282-3-things-biotech-learn-today-december-16-2017?source=feed_f‚Ä¶,,,,,[],https://twitter.com/SeekingAlpha/status/942008781021503488
5969,pharmalot,@pharmalot,2017-12-15T19:15:42.000Z,Memo to R&D chiefs: the returns on R&D investments are falling.. see the numbers here.. https://statnews.com/pharmalot/2017/12/15/blockbusters-roi-r-and-d/‚Ä¶ #pharma $MRK $PFE $JNJ $LLY $ABBV $GILD $BIIB $AMGN $BMY $GSK $AZN $NVS,"Memo to R&D chiefs: the returns on R&D investments are falling.. see the numbers here.. https://statnews.com/pharmalot/2017/12/15/blockbusters-roi-r-and-d/‚Ä¶ #pharma $MRK $PFE $JNJ $LLY $ABBV $GILD $BIIB $AMGN $BMY $GSK $AZN $NVS
statnews.com
Blockbusters aside, the return on pharma R&D investments is falling
On the bright side, 50 percent of regulatory approvals were first-in-class medicines, while drugs designated as orphans, breakthroughs, or fast-tracked amounted to 70 percent of approvals, which tend...
1
3",,,1,3,['https://pbs.twimg.com/card_img/1501706739988807682/T-vgaGpl?format=jpg&name=small'],https://twitter.com/pharmalot/status/941748620977754112
5970,pharmalot,@pharmalot,2017-12-15T14:22:34.000Z,Pharmalot.. Pharmalittle.. Good Morning.. a pricey Gilead drug is hard to get & a key Teva exec leaves & more news.. https://statnews.com/pharmalot/2017/12/15/gilead-drug-prices-sanofi-vaccine-dengue/‚Ä¶ #pharma $GILD $TEVA $MRK $JNJ $ALNY$SNY #vaccines,"Pharmalot.. Pharmalittle.. Good Morning.. a pricey Gilead drug is hard to get & a key Teva exec leaves & more news.. https://statnews.com/pharmalot/2017/12/15/gilead-drug-prices-sanofi-vaccine-dengue/‚Ä¶ #pharma $GILD $TEVA $MRK $JNJ $ALNY$SNY #vaccines
statnews.com
Pharmalittle: Pricey Gilead cancer drug is hard to get; Sanofi is mum on Dengvaxia compensation
A Sanofi official declined to say whether the company will compensate people who got sick due to its dengue vaccine.
1",,,,1,['https://pbs.twimg.com/card_img/1500534343600644098/wAHXYJa7?format=jpg&name=small'],https://twitter.com/pharmalot/status/941674850258702338
5971,Activist Stocks,@activiststocks,2017-12-15T19:35:10.000Z,Gilead: Buying New Growth http://ow.ly/1rQl30hfVI6 $GILD $GSK $MRK $JNJ,"Gilead: Buying New Growth http://ow.ly/1rQl30hfVI6 $GILD $GSK $MRK $JNJ
seekingalpha.com
Gilead: Buying New Growth (NASDAQ:GILD)
Gilead‚Äôs dominance in its respective markets is waning.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/activiststocks/status/941753518079213568
5972,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-12-15T10:05:50.000Z,Commented on $BLCM $BMY $GSK $MRK $NVS $ADAP,"Commented on $BLCM $BMY $GSK $MRK $NVS $ADAP
seekingalpha.com
Adaptimmune: Is Now The Time To Adopt This Stock For Your Stock Portfolio? (NASDAQ:ADAP)
I will establish the need for looking at biotech investing with a long-term outlook for achieving your goal.",,,,,['https://pbs.twimg.com/card_img/1501706747890835456/IxIHcHmM?format=jpg&name=240x240'],https://twitter.com/dhovekamp42/status/941610240302137344
5973,BioValues,@BioValues,2017-12-15T15:57:05.000Z,"$KALV Merck $MRK can exercise its option(s) early, if it chooses. Literally can happen any moment once the KVD001 PH2 trial starts this month.","$KALV Merck $MRK can exercise its option(s) early, if it chooses. Literally can happen any moment once the KVD001 PH2 trial starts this month.
1
1
1",,1,1,1,['https://pbs.twimg.com/media/DRGV0hQV4AcnRS1?format=jpg&name=900x900'],https://twitter.com/BioValues/status/941698635619635200
5974,Stockdog101,@Stockdog101,2017-12-15T20:00:29.000Z,"$EYES within the $2 range, which is a good potential for a bounce! $5 price target. $TWTR $AAPL $FB $WB $BABA $WUBA $TMUS $TSLA $AMZN $TSLA $ULTA $GPRO $JD $ZFGN $MRK $BMY $AMGN $SNY $GILD $GOOG $RAD #NYSE #stocks  
@megtirrell
 @CNBCClosingBell
 @CNBCFastMoney
 @jimcramer
 
RT ","$EYES within the $2 range, which is a good potential for a bounce! $5 price target. $TWTR $AAPL $FB $WB $BABA $WUBA $TMUS $TSLA $AMZN $TSLA $ULTA $GPRO $JD $ZFGN $MRK $BMY $AMGN $SNY $GILD $GOOG $RAD #NYSE #stocks  
@megtirrell
 @CNBCClosingBell
 @CNBCFastMoney
 @jimcramer
 
RT 
1
2",,,1,2,['https://pbs.twimg.com/media/DRHNoNHV4AAgzWF?format=jpg&name=small'],https://twitter.com/Stockdog101/status/941759891659563008
5975,TickWatcher,@MITickWatcher,2017-12-15T21:05:04.000Z,"Top #moneyflow for #sp500 today
$XOM $MCD $IBM $KO $PEP $MRK $MO $NEE $ADBE $AXP ...","Top #moneyflow for #sp500 today
$XOM $MCD $IBM $KO $PEP $MRK $MO $NEE $ADBE $AXP ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings
1",,,,1,[],https://twitter.com/MITickWatcher/status/941776142285107201
5976,donga,@donga126,2017-12-15T15:38:58.000Z,$NLNK $INCY $BMY $MRK Discovery of IDO1 Inhibitors: From Bench to Bedside http://cancerres.aacrjournals.org/content/77/24/6795‚Ä¶,"$NLNK $INCY $BMY $MRK Discovery of IDO1 Inhibitors: From Bench to Bedside http://cancerres.aacrjournals.org/content/77/24/6795‚Ä¶
1",,,,1,[],https://twitter.com/donga126/status/941694075576733696
5977,Chameleon Options,@MC_OptionTrades,2017-12-15T00:30:11.000Z,Price Moves vs Expected Moves $TEVA $RIOT $MYL $AGN $CELG $PFE $MRK $LLY $BMY $GILD $JUNO $VRX http://tinyurl.com/y7zbwhgq,Price Moves vs Expected Moves $TEVA $RIOT $MYL $AGN $CELG $PFE $MRK $LLY $BMY $GILD $JUNO $VRX http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DRDBxLOW4AAOOdW?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/941465375669145602
5978,FirstWord Pharma,@fwpharma,2017-12-15T09:32:54.000Z,Merck & Co.'s Keytruda fails late-stage study as second-line treatment for gastric cancer https://firstwordpharma.com/node/1530397 $MRK,"Merck & Co.'s Keytruda fails late-stage study as second-line treatment for gastric cancer https://firstwordpharma.com/node/1530397 $MRK
old.firstwordpharma.com
Merck & Co.'s Keytruda fails late-stage study as second-line treatment for gastric cancer
Merck & Co. announced that a pivotal Phase III study of Keytruda (pembrolizumab) as a second-line treatment for patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma failed...
4
1",,,4,1,[],https://twitter.com/fwpharma/status/941601953515229184
5979,Obi - #85club,@crypt0biwan,2017-12-16T16:30:28.000Z,$MKR doesn‚Äôt care what BTC does..  https://twitter.com/crypt0biwan/status/891002273303859200‚Ä¶ $MRK,"$MKR doesn‚Äôt care what BTC does..  https://twitter.com/crypt0biwan/status/891002273303859200‚Ä¶ $MRK
Obi - #85club
@crypt0biwan
 ¬∑ 28 Jul 2017
Replying to @loomdart
$MKR because it has been under the radar way too long..
1",üöÄ,,,1,['https://pbs.twimg.com/profile_images/1496562296730103809/ocXWlTx2_mini.jpg'],https://twitter.com/crypt0biwan/status/942069423879393280
5980,TickWatcher,@MITickWatcher,2017-12-15T21:05:00.000Z,"Top #moneyflow for whole #market today
$XOM $UNH $BRK.B $WFC $DWDP $MCD $IBM $KO $PEP $MRK ...","Top #moneyflow for whole #market today
$XOM $UNH $BRK.B $WFC $DWDP $MCD $IBM $KO $PEP $MRK ...
Super Stocks with Options
Super Stocks is a free all-in-one stock market station, intelligent stocks portfolio tracker with comprehensive real-time alerts, and advanced options research. ALL-IN-ONE MARKET STATION ---------...
4.46731/5.0 stars ‚Äì 5,628 ratings",,,,,[],https://twitter.com/MITickWatcher/status/941776128007655425
5981,Daily Political,@DPolitical,2017-12-15T19:14:51.000Z,"$MRK - Merck & Co., Inc. #MRK Stake Lowered by Ashburton Jersey Ltd https://goo.gl/fb/UNkTdG","$MRK - Merck & Co., Inc. #MRK Stake Lowered by Ashburton Jersey Ltd https://goo.gl/fb/UNkTdG",,,,,[],https://twitter.com/DPolitical/status/941748406657191936
5982,Activist Blockchain,@activistbitcoin,2017-12-15T21:20:05.000Z,Gilead: Buying New Growth http://ow.ly/1rQl30hfVI6 $GILD $GSK $MRK $JNJ,"Gilead: Buying New Growth http://ow.ly/1rQl30hfVI6 $GILD $GSK $MRK $JNJ
seekingalpha.com
Gilead: Buying New Growth (NASDAQ:GILD)
Gilead‚Äôs dominance in its respective markets is waning.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/activistbitcoin/status/941779923412422656
5983,Daily Political,@DPolitical,2017-12-17T22:22:14.000Z,"$MRK - Merck & Co., Inc. #MRK Getting Somewhat Favorable Press Coverage, Analysis Shows https://goo.gl/fb/BHtXiC","$MRK - Merck & Co., Inc. #MRK Getting Somewhat Favorable Press Coverage, Analysis Shows https://goo.gl/fb/BHtXiC",,,,,[],https://twitter.com/DPolitical/status/942520340026142720
5984,James Sikes,@wosaikeneriki,2017-12-16T18:32:23.000Z,Merck & Co $MRK Holding Raised by Brown Advisory Securities Llc http://bzweekly.com/merck-thrivent-financial-for-lutherans-boosted-holding-in-toll-brothers-tol-as-valuation-rose/‚Ä¶,Merck & Co $MRK Holding Raised by Brown Advisory Securities Llc http://bzweekly.com/merck-thrivent-financial-for-lutherans-boosted-holding-in-toll-brothers-tol-as-valuation-rose/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/942100107473965057
5985,James Sikes,@wosaikeneriki,2017-12-17T15:55:46.000Z,Canal Insurance Company Continues to Hold Stake in Merck & Co Ord $MRK http://bzweekly.com/canal-insurance-company-continues-to-hold-stake-in-merck-as-unitedhealth-group-unh-stock-rose-morgens-waterfall-vintiadis-co-has-trimmed-by-666000-its-stake/‚Ä¶,Canal Insurance Company Continues to Hold Stake in Merck & Co Ord $MRK http://bzweekly.com/canal-insurance-company-continues-to-hold-stake-in-merck-as-unitedhealth-group-unh-stock-rose-morgens-waterfall-vintiadis-co-has-trimmed-by-666000-its-stake/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/942423082257526786
5986,James Sikes,@wosaikeneriki,2017-12-16T13:09:35.000Z,"As Merck & Co $MRK Share Price Declined, Alethea Capital Management Has Cut Holding http://bzweekly.com/as-merck-liberty-global-plc-cl-c-lbtyk-shareholder-delphi-management-boosted-position/‚Ä¶","As Merck & Co $MRK Share Price Declined, Alethea Capital Management Has Cut Holding http://bzweekly.com/as-merck-liberty-global-plc-cl-c-lbtyk-shareholder-delphi-management-boosted-position/‚Ä¶",,,,,[],https://twitter.com/wosaikeneriki/status/942018873439776769
5987,_Quad 7 Capital_,@_Quad7Capital_,2017-12-17T03:00:33.000Z,"$ALK $SPG $MRK $PEP $XOM 

All have key mentions from Barron's 

http://quad7capital.com/2017/12/16/key-stocks-watch-week-4/‚Ä¶","$ALK $SPG $MRK $PEP $XOM 

All have key mentions from Barron's 

http://quad7capital.com/2017/12/16/key-stocks-watch-week-4/‚Ä¶",,,,,[],https://twitter.com/_Quad7Capital_/status/942227989810548736
5988,FinInvTr,@FinInvTr,2017-12-15T02:08:13.000Z,"Switzerland Keeps Printing Money and Buying These Stocks: https://buff.ly/2CnjYgK

$T $PG $PFE $VZ $CVX $V $GE $HD $UNH $KO $CMCSA $MRK $PEP","Switzerland Keeps Printing Money and Buying These Stocks: https://buff.ly/2CnjYgK

$T $PG $PFE $VZ $CVX $V $GE $HD $UNH $KO $CMCSA $MRK $PEP",,,,,[],https://twitter.com/FinInvTr/status/941490044082249728
5989,C. Scott Garliss Stansberry,@SG_Stansberry,2017-12-15T15:08:53.000Z,"$MRK looking to challenge $BIIB, $SNY, $NVS in U.S. market for oral multiple sclerosis treatment drug.","$MRK looking to challenge $BIIB, $SNY, $NVS in U.S. market for oral multiple sclerosis treatment drug.
Reuters Business
@ReutersBiz
 ¬∑ 15 Dec 2017
Germany's Merck in fresh bid to enter U.S. MS pill market http://reut.rs/2AyG0LQ",,,,,"['https://pbs.twimg.com/profile_images/877263475034042368/xbU9vTKw_mini.jpg', 'https://pbs.twimg.com/media/DRGI4GWUIAAmTSH?format=jpg&name=small']",https://twitter.com/SG_Stansberry/status/941686505902411776
5990,WallStreetGangsta,@WallStGangsta,2017-12-15T20:22:23.000Z,"$VICT 0.0024 x 0.0025 ! Very Low FLOAT Construction Stock , Keep a Close Eye on it $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU !","$VICT 0.0024 x 0.0025 ! Very Low FLOAT Construction Stock , Keep a Close Eye on it $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU !",,,,,[],https://twitter.com/WallStGangsta/status/941765402287378432
5991,Gnoel,@pipsnticks,2017-12-15T16:40:50.000Z,Can we see all DOW component stocks close GREEN today ? $DJI $MRK $DWDP $IBM,Can we see all DOW component stocks close GREEN today ? $DJI $MRK $DWDP $IBM,,,,,[],https://twitter.com/pipsnticks/status/941709644677783553
5992,TalkMarkets,@TalkMarkets,2017-12-15T16:08:41.000Z,"Pharma Stock Roundup: #Teva Announces Major Job Cuts, #Lilly Provides 2018 Outlook $TEVA $LLY $RHHBY $BMY $MRK $SNY  https://goo.gl/CQmt2u","Pharma Stock Roundup: #Teva Announces Major Job Cuts, #Lilly Provides 2018 Outlook $TEVA $LLY $RHHBY $BMY $MRK $SNY  https://goo.gl/CQmt2u",,,,,[],https://twitter.com/TalkMarkets/status/941701554721181696
5993,MarketBeat,@MarketBeatCom,2017-12-16T04:28:31.000Z,"Brokers Issue Forecasts for Merck & Co., Inc.‚Äôs FY2020 Earnings $MRK http://ift.tt/2Bhw2jr #acn","Brokers Issue Forecasts for Merck & Co., Inc.‚Äôs FY2020 Earnings $MRK http://ift.tt/2Bhw2jr #acn",,,,,[],https://twitter.com/MarketBeatCom/status/941887740647497728
5994,MarketBeat,@MarketBeatCom,2017-12-16T02:08:07.000Z,"Merck & Co., Inc. $MRK ‚Äì Investment Analysts‚Äô Recent Ratings Updates http://ift.tt/2BfBT8D #acn","Merck & Co., Inc. $MRK ‚Äì Investment Analysts‚Äô Recent Ratings Updates http://ift.tt/2BfBT8D #acn",,,,,[],https://twitter.com/MarketBeatCom/status/941852406190608385
5995,Transcript Daily,@TranscriptDaily,2017-12-17T06:13:35.000Z,"BMO Capital Markets Reiterates $68.00 Price Target for Merck & Co., Inc. $MRK http://ift.tt/2Cqps9y","BMO Capital Markets Reiterates $68.00 Price Target for Merck & Co., Inc. $MRK http://ift.tt/2Cqps9y",,,,,[],https://twitter.com/TranscriptDaily/status/942276570080841728
5996,StockNews.com,@stocknewsdotcom,2017-12-16T14:47:13.000Z,$MRK Named one of Barron's top income ideas for 2018. Currently yields 3.4%. https://stocknews.com/news/mrk-named-one-of-barrons-top-income-ideas-for-2018-currently/‚Ä¶,$MRK Named one of Barron's top income ideas for 2018. Currently yields 3.4%. https://stocknews.com/news/mrk-named-one-of-barrons-top-income-ideas-for-2018-currently/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/942043442976346113
5997,1 min Stock Insights,@1MinuteStock,2017-12-15T03:47:58.000Z,Unicorn Bay rating for $MRK is 2.89 out of 5.,"Unicorn Bay rating for $MRK is 2.89 out of 5.
unicornbay.com
MRK ‚Äî Merck & Co. Inc - comprehensive stock analysis.
Merck & Co. Inc - MRK comprehensive stock analysis. Make proper investment decisions with analytics from Unicorn Bay.",,,,,['https://pbs.twimg.com/card_img/1501385999561236483/OspvcAjT?format=jpg&name=small'],https://twitter.com/1MinuteStock/status/941515148971319296
5998,Tim Reller,@TraderGuruNY,2017-12-15T01:41:59.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,,,,,[],https://twitter.com/TraderGuruNY/status/941483443099025408
5999,WallStreetGangsta,@WallStGangsta,2017-12-15T19:00:20.000Z,Top Sub Penny Stocks To BUY & HOLD : $PDXP $VICT $CHIT ! Huge Upside Potential ... $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU,Top Sub Penny Stocks To BUY & HOLD : $PDXP $VICT $CHIT ! Huge Upside Potential ... $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU,,,,,[],https://twitter.com/WallStGangsta/status/941744751484850176
6000,Bridgewater,@fourifbyair,2017-12-15T21:45:06.000Z,Gilead: Buying New Growth http://ow.ly/1rQl30hfVI6 $GILD $GSK $MRK $JNJ,"Gilead: Buying New Growth http://ow.ly/1rQl30hfVI6 $GILD $GSK $MRK $JNJ
seekingalpha.com
Gilead: Buying New Growth (NASDAQ:GILD)
Gilead‚Äôs dominance in its respective markets is waning.",,,,,['https://pbs.twimg.com/card_img/1500261442888609794/RU36R6cw?format=png&name=240x240'],https://twitter.com/fourifbyair/status/941786217716346882
6001,Daily Political,@dailypoliticaln,2017-12-16T15:48:26.000Z,"Merck & Co., Inc. $MRK Shares Bought by Aldebaran Financial Inc. http://ift.tt/2Codhdh","Merck & Co., Inc. $MRK Shares Bought by Aldebaran Financial Inc. http://ift.tt/2Codhdh",,,,,[],https://twitter.com/dailypoliticaln/status/942058847006613506
6002,Daily Political,@dailypoliticaln,2017-12-17T15:38:25.000Z,"Merck & Co., Inc. $MRK Stake Increased by M Holdings Securities Inc. http://ift.tt/2AHppFR","Merck & Co., Inc. $MRK Stake Increased by M Holdings Securities Inc. http://ift.tt/2AHppFR",,,,,[],https://twitter.com/dailypoliticaln/status/942418716393910272
6003,Watchlist News,@WatchlistN,2017-12-15T19:20:29.000Z,"RNC Capital Management LLC Has $1.01 Million Stake in Merck & Co., Inc. $MRK http://ift.tt/2Ayfand","RNC Capital Management LLC Has $1.01 Million Stake in Merck & Co., Inc. $MRK http://ift.tt/2Ayfand",,,,,[],https://twitter.com/WatchlistN/status/941749823610478593
6004,Watchlist News,@WatchlistN,2017-12-15T21:05:43.000Z,"Contrasting Merck & Co., Inc. $MRK and Cadence Pharmaceuticals $CADX http://ift.tt/2ARvsf1","Contrasting Merck & Co., Inc. $MRK and Cadence Pharmaceuticals $CADX http://ift.tt/2ARvsf1",,,,,[],https://twitter.com/WatchlistN/status/941776305657401344
6005,Ticker Report,@TickerReport,2017-12-16T15:55:38.000Z,"Achmea Investment Management B.V. Sells 111,717 Shares of Merck & Co., Inc. $MRK http://ift.tt/2Bw9IoE","Achmea Investment Management B.V. Sells 111,717 Shares of Merck & Co., Inc. $MRK http://ift.tt/2Bw9IoE",,,,,[],https://twitter.com/TickerReport/status/942060658912350209
6006,Daily Political,@dailypoliticaln,2017-12-17T22:23:24.000Z,"Merck & Co., Inc. $MRK Getting Somewhat Favorable Press Coverage, Analysis Shows http://ift.tt/2CskMjm","Merck & Co., Inc. $MRK Getting Somewhat Favorable Press Coverage, Analysis Shows http://ift.tt/2CskMjm",,,,,[],https://twitter.com/dailypoliticaln/status/942520633958813707
6007,Ticker Report,@TickerReport,2017-12-15T19:37:11.000Z,"Sentry Investment Management LLC Acquires 2,333 Shares of Merck & Co., Inc. $MRK http://ift.tt/2AV3SO3","Sentry Investment Management LLC Acquires 2,333 Shares of Merck & Co., Inc. $MRK http://ift.tt/2AV3SO3",,,,,[],https://twitter.com/TickerReport/status/941754027427196929
6008,Dakota Financial,@dakotafinancial,2017-12-17T15:42:16.000Z,"75,000 Shares in Merck & Co., Inc. $MRK Purchased by Davidson Kempner Capital Management LP http://ift.tt/2k6MPOF","75,000 Shares in Merck & Co., Inc. $MRK Purchased by Davidson Kempner Capital Management LP http://ift.tt/2k6MPOF",,,,,[],https://twitter.com/dakotafinancial/status/942419681343877120
6009,Carly Helfand,@CarlyHFierce,2017-12-15T18:14:25.000Z,Merck's Keytruda misses the mark in second-line stomach cancer study: http://bit.ly/2kAkyiK $MRK #pharma,Merck's Keytruda misses the mark in second-line stomach cancer study: http://bit.ly/2kAkyiK $MRK #pharma,,,,,[],https://twitter.com/CarlyHFierce/status/941733197825630209
6010,US Banking News,@AmericanBanking,2017-12-16T04:26:33.000Z,"Brokers Issue Forecasts for Merck & Co., Inc.‚Äôs FY2020 Earnings $MRK http://ift.tt/2CBW6G2","Brokers Issue Forecasts for Merck & Co., Inc.‚Äôs FY2020 Earnings $MRK http://ift.tt/2CBW6G2",,,,,[],https://twitter.com/AmericanBanking/status/941887244679503874
6011,Hottest Stocks Now,@HottestStockNow,2017-12-15T00:14:04.000Z,Late-Stage Study testing $MRK 's KEYTRUDA in gastric/GEJ adenocarcinoma patients did not meet its primary endpoint http://crweworld.com/article/news-provided-by-business-wire/195389/merck-provides-update-on-keynote-061-a-phase-3-study-of-keytruda-pembrolizumab-in-previously-treated-patients-with-gastric-or-gastroesophageal-junction-adenocarcinoma‚Ä¶,Late-Stage Study testing $MRK 's KEYTRUDA in gastric/GEJ adenocarcinoma patients did not meet its primary endpoint http://crweworld.com/article/news-provided-by-business-wire/195389/merck-provides-update-on-keynote-061-a-phase-3-study-of-keytruda-pembrolizumab-in-previously-treated-patients-with-gastric-or-gastroesophageal-junction-adenocarcinoma‚Ä¶,,,,,[],https://twitter.com/HottestStockNow/status/941461320347594755
6012,US Banking News,@AmericanBanking,2017-12-16T02:06:25.000Z,"Merck & Co., Inc. $MRK ‚Äì Investment Analysts‚Äô Recent Ratings Updates http://ift.tt/2AU8eVO","Merck & Co., Inc. $MRK ‚Äì Investment Analysts‚Äô Recent Ratings Updates http://ift.tt/2AU8eVO",,,,,[],https://twitter.com/AmericanBanking/status/941851982062645248
6013,StockMarketVideo.com,@stockmarketvide,2017-12-15T01:37:42.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,,,,,[],https://twitter.com/stockmarketvide/status/941482363552280578
6014,WallStreetGangsta,@WallStGangsta,2017-12-15T20:20:58.000Z,$PDXP 0.0013 UP ! Break of 0.0015 And We Can Welcome 0.0020+ in a HEART BEAT $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU !,$PDXP 0.0013 UP ! Break of 0.0015 And We Can Welcome 0.0020+ in a HEART BEAT $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU !,,,,,[],https://twitter.com/WallStGangsta/status/941765045205323776
6015,Market Realist,@MarketRealist,2017-12-15T13:00:33.000Z,Why Merck Raised Its Revenue Guidance for Fiscal 2017 http://marketrealist.com/?p=2495365 $GSK $MRK $PFE $SNY,Why Merck Raised Its Revenue Guidance for Fiscal 2017 http://marketrealist.com/?p=2495365 $GSK $MRK $PFE $SNY,,,,,[],https://twitter.com/MarketRealist/status/941654209572765696
6016,Lila G Purinton,@PurintonL,2017-12-17T21:28:38.000Z,"These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016 
@themotleyfool
 #stocks $PFE, $MRK, $AMGN, $LLY, $BIIB, $AGN, $ABBV https://fool.com/investing/2017/04/28/these-7-drugmakers-relied-on-price-hikes-for-100-o.aspx‚Ä¶","These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016 
@themotleyfool
 #stocks $PFE, $MRK, $AMGN, $LLY, $BIIB, $AGN, $ABBV https://fool.com/investing/2017/04/28/these-7-drugmakers-relied-on-price-hikes-for-100-o.aspx‚Ä¶",,,,,[],https://twitter.com/PurintonL/status/942506847566622720
6017,Chameleon,@MarketChmln,2017-12-15T21:45:46.000Z,Largest $Notional Buy On Close Order Imbalances $BABA $ORCL $V $JPM $BAC $UNP $CI $MCD $ANTM $MRK http://tinyurl.com/y8jo8mjb,Largest $Notional Buy On Close Order Imbalances $BABA $ORCL $V $JPM $BAC $UNP $CI $MCD $ANTM $MRK http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/941786387476631552
6018,Jacob Bell,@realJacobBell,2017-12-15T21:57:00.000Z,New Ph. 3 results hurt $MRK's plans for expanding use of Keytruda in gastric cancer patients,"New Ph. 3 results hurt $MRK's plans for expanding use of Keytruda in gastric cancer patients
biopharmadive.com
Trial miss sets back Merck's Keytruda plans in stomach cancer
Keytruda's failure to show a survival benefit comes three months after winning an accelerated approval as a third-line treatment for advanced gastric cancer.",,,,,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/realJacobBell/status/941789212088528896
6019,Jon Ogg,@jonogg,2017-12-16T15:38:25.000Z,What $stockmarket bubble? 20 recent stock buyback announcements for $100 billion being led by $BA $HD $MRK $ORCL $HON $ANTH $BAC,"What $stockmarket bubble? 20 recent stock buyback announcements for $100 billion being led by $BA $HD $MRK $ORCL $HON $ANTH $BAC
247wallst.com
20 Fresh Stock Buybacks Could Send $100 Billion Back to Shareholders
With the passage of tax reform looking almost certain, and with companies continuing to prove that all-time highs in the market will not hurt spending cash on share buybacks, the continuation of...",,,,,[],https://twitter.com/jonogg/status/942056328507379712
6020,Briefing.com,@Briefingcom,2017-12-15T04:13:42.000Z,$MRK: Merck's phase 3 KEYNOTE-061 study of KEYTRUDA (pembrolizumab) did not meet its primary endpoint http://bit.ly/2AGhPiN,"$MRK: Merck's phase 3 KEYNOTE-061 study of KEYTRUDA (pembrolizumab) did not meet its primary endpoint http://bit.ly/2AGhPiN
2",,,,2,[],https://twitter.com/Briefingcom/status/941521623382867969
6021,BioPharma Dive,@BioPharmaDive,2017-12-16T14:00:01.000Z,"Since Kenneth Frazier took over in 2011, $MRK has won approval for 9 NMEs, which earned more than $2.4B combined in 2016 http://bit.ly/2AKbaU7","Since Kenneth Frazier took over in 2011, $MRK has won approval for 9 NMEs, which earned more than $2.4B combined in 2016 http://bit.ly/2AKbaU7
1",,,1,,[],https://twitter.com/BioPharmaDive/status/942031564040323072
6022,BioPharma Dive,@BioPharmaDive,2017-12-16T18:58:00.000Z,"In a ranking of 250 companies across many industries, $JNJ came in at 4th while $LLY finished 40th and $MRK finished 42nd http://bit.ly/2kq3jUZ","In a ranking of 250 companies across many industries, $JNJ came in at 4th while $LLY finished 40th and $MRK finished 42nd http://bit.ly/2kq3jUZ",,,,,[],https://twitter.com/BioPharmaDive/status/942106553989062657
6023,APM Health Europe,@apmhealtheurope,2017-12-15T12:58:00.000Z,"Trial disappointment for 
@Merck
's Keytruda in gastric or gastroesophageal junction adenocarcinoma http://bit.ly/2oclgIe #pharma $MRK","Trial disappointment for 
@Merck
's Keytruda in gastric or gastroesophageal junction adenocarcinoma http://bit.ly/2oclgIe #pharma $MRK
1",,,1,,[],https://twitter.com/apmhealtheurope/status/941653568389558272
6024,The Chronicles of Chris Young PSA scrub-your-hands,,2017-12-15T02:28:14.000Z,"Replying to 
@JohnK_Allen","Replying to 
@JohnK_Allen
Really surprised! Pembro is generally the gold standard in a comparable population without increased toxicity. For PD-1 I generally, expect to see ORR confirmed above 50% and DCR >70%. $MRK
1
1",,,1,1,[],https://twitter.com/YoungChris27040/status/941495080740839425
6025,Annar Folles√∏ #SaveSilwan #SaveSheikhJarrah,@Afolleso,2017-12-15T14:07:05.000Z,"Replying to 
@lblegend33
 and 
@adamfeuerstein","Replying to 
@lblegend33
 and 
@adamfeuerstein
It must an will happen. BP's pipelines are drying up, and their legacy drugs don't generate enough revenue. $CELG $AGN $GILD $PFE $MRK
1",,,,1,[],https://twitter.com/Afolleso/status/941670952244580352
6026,MomentumBeast,@momentumbeast,2017-12-15T20:22:23.000Z,"$VICT 0.0024 x 0.0025 ! Very Low FLOAT Construction Stock , Keep a Close Eye on it $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU !","$VICT 0.0024 x 0.0025 ! Very Low FLOAT Construction Stock , Keep a Close Eye on it $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU !",,,,,[],https://twitter.com/momentumbeast/status/941765401826021376
6027,BioPharma Dive,@BioPharmaDive,2017-12-15T21:57:00.000Z,New Ph. 3 results hurt $MRK's plans for expanding use of Keytruda in gastric cancer patients,"New Ph. 3 results hurt $MRK's plans for expanding use of Keytruda in gastric cancer patients
biopharmadive.com
Trial miss sets back Merck's Keytruda plans in stomach cancer
Keytruda's failure to show a survival benefit comes three months after winning an accelerated approval as a third-line treatment for advanced gastric cancer.
1",,,,1,['https://pbs.twimg.com/card_img/1499271875196768256/gnZmG75K?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/941789212331913217
6028,MomentumBeast,@momentumbeast,2017-12-15T19:00:20.000Z,Top Sub Penny Stocks To BUY & HOLD : $PDXP $VICT $CHIT ! Huge Upside Potential ... $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU,Top Sub Penny Stocks To BUY & HOLD : $PDXP $VICT $CHIT ! Huge Upside Potential ... $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU,,,,,[],https://twitter.com/momentumbeast/status/941744751581323264
6029,MomentumBeast,@momentumbeast,2017-12-15T20:20:58.000Z,$PDXP 0.0013 UP ! Break of 0.0015 And We Can Welcome 0.0020+ in a HEART BEAT $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU !,$PDXP 0.0013 UP ! Break of 0.0015 And We Can Welcome 0.0020+ in a HEART BEAT $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU !,,,,,[],https://twitter.com/momentumbeast/status/941765044945195009
6030,"Dr. Paul DeSantis, PharmD",@DrPaulyDeSantis,2017-12-18T16:56:50.000Z,"After $GILD net pricing deflation of -50% or so, appears HCV pricing concerns abating with payers, indeed, payers now focus their attention to IO costs $BMY $MRK $AZN $ROG $JUNO $REGN","After $GILD net pricing deflation of -50% or so, appears HCV pricing concerns abating with payers, indeed, payers now focus their attention to IO costs $BMY $MRK $AZN $ROG $JUNO $REGN
1
10
20",,1,10,20,['https://pbs.twimg.com/media/DRWAMsNVwAEs0AB?format=jpg&name=small'],https://twitter.com/DrPaulyDeSantis/status/942800836672962560
6031,Matthew Herper,@matthewherper,2017-12-19T13:35:49.000Z,"All the folks who asked for video of #ForbesHealth, here you go. Featuring $MRK, $PFE, $UNH, $UTHR, $REGN, $BLUE, $GILD, and many more...","All the folks who asked for video of #ForbesHealth, here you go. Featuring $MRK, $PFE, $UNH, $UTHR, $REGN, $BLUE, $GILD, and many more...
forbes.com
Here, You Can Watch Every Second Of The Forbes Healthcare Summit
This post links to videos of The Forbes Healthcare Summit, which featured many of the biggest leaders in the pharmaceutical, insurance, and hospital industries.
3
20
32",,3,20,32,['https://pbs.twimg.com/card_img/1500991060767649793/Gln-QRdn?format=jpg&name=small'],https://twitter.com/matthewherper/status/943112638933929984
6032,zach,@zbiotech,2017-12-20T17:52:23.000Z,"IO monthly sales, symphony health

per LR note 
$BMY $AZN $MRK $RHHBY $PFE","IO monthly sales, symphony health

per LR note 
$BMY $AZN $MRK $RHHBY $PFE
5
7",,,5,7,['https://pbs.twimg.com/media/DRggQAWU8AAmckQ?format=jpg&name=small'],https://twitter.com/zbiotech/status/943539590375395333
6033,Seeking Alpha,@SeekingAlpha,2017-12-18T15:46:31.000Z,$MRK $CUE,"$MRK $CUE
seekingalpha.com
Cue Biopharma Proposes $60 Million IPO Terms (NASDAQ:CUE)
Cue Biopharma has filed terms for its IPO of up to $60 million. The firm is preparing to enter Phase 1 trials for its lead candidate.",,,,,[],https://twitter.com/SeekingAlpha/status/942783142057750528
6034,MM+M Magazine,@MMMnews,2017-12-18T12:30:01.000Z,Missed Friday's news? Here's what to know #pharma $ACRS #dermatology #FDA $TEVA $NVS #oncology $PRGO $NESN #acquisition $MRK $STDAF #Clinicaltrial http://bit.ly/2AQ8FQW,"Missed Friday's news? Here's what to know #pharma $ACRS #dermatology #FDA $TEVA $NVS #oncology $PRGO $NESN #acquisition $MRK $STDAF #Clinicaltrial http://bit.ly/2AQ8FQW
1",,,,1,['https://pbs.twimg.com/media/DRGJIq_X4AEBhEw?format=jpg&name=small'],https://twitter.com/MMMnews/status/942733690894987264
6035,max pain,@optioncharts,2017-12-19T19:34:54.000Z,$MRK open interest for maturity 12/22/2017. High put=54.00 High call=57.50 #maxpain #options http://bit.ly/2CDZsHG,$MRK open interest for maturity 12/22/2017. High put=54.00 High call=57.50 #maxpain #options http://bit.ly/2CDZsHG,,,,,['https://pbs.twimg.com/media/DRbuIigWAAg7owF?format=jpg&name=small'],https://twitter.com/optioncharts/status/943203004899045382
6036,jodi gralnick,@jodigralnick,2017-12-19T13:43:54.000Z,"I highly recommend the ""Pharma All Stars"" panel, featuring CEOs of $MRK $PFE $LLY $AGN $REGN. Some words were exchanged...","I highly recommend the ""Pharma All Stars"" panel, featuring CEOs of $MRK $PFE $LLY $AGN $REGN. Some words were exchanged...
Matthew Herper
@matthewherper
 ¬∑ 19 Dec 2017
All the folks who asked for video of #ForbesHealth, here you go. Featuring $MRK, $PFE, $UNH, $UTHR, $REGN, $BLUE, $GILD, and many more... https://forbes.com/sites/matthewherper/2017/12/19/here-you-can-watch-every-second-of-the-forbes-healthcare-summit/#46e8b2ee5720‚Ä¶
2
5",,,2,5,['https://pbs.twimg.com/profile_images/1490391236255100928/gJqcVT_B_mini.jpg'],https://twitter.com/jodigralnick/status/943114669652398080
6037,Prudent Biotech,@PrudentBiotech,2017-12-20T13:50:03.000Z,"Biotech Bonanza: Biotech Stocks To Keep Shining In 2018
https://buff.ly/2oSVrgv
$qqq $spy $dia $iwm $ibb $xbi $xlv $vrtx $gild $pfe $mrk $juno $blue $exas $celg $exel $dvax $jnj $nvs $sage $nktr $alny $zgnx $sppi $arna $insm $gbt $loxo $espr $mrtx $abeo $clls $alny $incy $bmy","Biotech Bonanza: Biotech Stocks To Keep Shining In 2018
https://buff.ly/2oSVrgv
$qqq $spy $dia $iwm $ibb $xbi $xlv $vrtx $gild $pfe $mrk $juno $blue $exas $celg $exel $dvax $jnj $nvs $sage $nktr $alny $zgnx $sppi $arna $insm $gbt $loxo $espr $mrtx $abeo $clls $alny $incy $bmy",,,,,[],https://twitter.com/PrudentBiotech/status/943478605350400005
6038,Deep Dive,@deepxdive,2017-12-18T18:32:11.000Z,"$MRK Merck & Co., Inc.   MRK-US  Dividend Analysis   December 15th, 2017 (record date)   By the numbers   December 18,  https://online.capitalcube.com/#!/stock/US/exchange/MRK/yahooDividend‚Ä¶","$MRK Merck & Co., Inc.   MRK-US  Dividend Analysis   December 15th, 2017 (record date)   By the numbers   December 18,  https://online.capitalcube.com/#!/stock/US/exchange/MRK/yahooDividend‚Ä¶",,,,,['https://pbs.twimg.com/media/DRWWL70X0AMwBt8?format=jpg&name=small'],https://twitter.com/deepxdive/status/942824830696599553
6039,Prudent Biotech,@PrudentBiotech,2017-12-20T19:37:20.000Z,"Biotech Stocks To Keep Shining In 2018
https://buff.ly/2DfZlDD
$qqq $spy $dia $iwm $ibb $xbi $xlv $vrtx $gild $pfe $mrk $juno $blue $exas $celg $exel $dvax $jnj $nvs $sage $nktr $alny $zgnx $sppi $arna $insm $gbt $loxo $espr $mrtx $abeo $clls $alny $incy $bmy #biotechnology","Biotech Stocks To Keep Shining In 2018
https://buff.ly/2DfZlDD
$qqq $spy $dia $iwm $ibb $xbi $xlv $vrtx $gild $pfe $mrk $juno $blue $exas $celg $exel $dvax $jnj $nvs $sage $nktr $alny $zgnx $sppi $arna $insm $gbt $loxo $espr $mrtx $abeo $clls $alny $incy $bmy #biotechnology
prudentbiotech.com
2018 Outlook - Biotech Bonanza: Biotech Stocks To Keep Shining ‚Ä¢ Prudent Biotech
Biotechnology delivered a solid year in 2017. Multiple reasons exist for Biotech stocks to continue performing strongly in 2018... read more
1",,1,,,['https://pbs.twimg.com/card_img/1501306596051374083/XFkmLnm0?format=jpg&name=240x240'],https://twitter.com/PrudentBiotech/status/943566004231208961
6040,Drugdoctor1,@Drugdoctor2014,2017-12-19T14:08:41.000Z,"$ICNB.0054- VERIFIED! 1/2 cent stock rolling out Prosecco Wine in 1185 Store PUBLIX CHAIN! Huge sale - next week! WATCH! $MNST $MDLZ $WFM $SBAC  $VOD $TMUS $FAST $DAL $AAL $WFM $CERN $HSIC 
$PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ

https://youtube.com/watch?time_continue=2&v=N5oXavc4J7g‚Ä¶","$ICNB.0054- VERIFIED! 1/2 cent stock rolling out Prosecco Wine in 1185 Store PUBLIX CHAIN! Huge sale - next week! WATCH! $MNST $MDLZ $WFM $SBAC  $VOD $TMUS $FAST $DAL $AAL $WFM $CERN $HSIC 
$PG $MRK $MYL $VRX $VRTX $BIIB $BMY $JNJ $CELG $AKRX $REGN $JNJ

https://youtube.com/watch?time_continue=2&v=N5oXavc4J7g‚Ä¶
1",,,,1,[],https://twitter.com/Drugdoctor2014/status/943120908662792193
6041,Donna Young,@DonnaYoungDC,2017-12-20T16:11:22.000Z,And you can read my story from earlier this month here: https://platform.mi.spglobal.com/web/client?auth=inherit#news/article?id=42820197&cdid=A-42820197-10804‚Ä¶ #ForbesHealth #pharma #biotech #innovation #drugprices #drugpricing #genetherapy $ONCE $NVS $GILD $BLUE $REGN $AGN $MRK,"And you can read my story from earlier this month here: https://platform.mi.spglobal.com/web/client?auth=inherit#news/article?id=42820197&cdid=A-42820197-10804‚Ä¶ #ForbesHealth #pharma #biotech #innovation #drugprices #drugpricing #genetherapy $ONCE $NVS $GILD $BLUE $REGN $AGN $MRK
Robert West, PhD
@westr
 ¬∑ 20 Dec 2017
Here, You Can Watch Every Second Of The Forbes Healthcare Summit via @matthewherper @forbes https://forbes.com/sites/matthewherper/2017/12/19/here-you-can-watch-every-second-of-the-forbes-healthcare-summit/#31c42ef35720‚Ä¶
1",üì∞ ‚úù,,,1,['https://pbs.twimg.com/profile_images/500040415697833989/p8hvJ9_i_mini.jpeg'],https://twitter.com/DonnaYoungDC/status/943514170049228800
6042,Mike Auten,@mikeauten,2017-12-19T21:17:11.000Z,"RT @DARTH_ALERT: ""Confirmation From Merck $MRK On Discussions With Northwest Biotherapeutics $NWBO In Bethesda Coming Shortly""
http://sierraworldequity.blogspot.com/2017/12/bet-farmconfirmation-from-merck-mrk-on.html‚Ä¶

#BITCOIN #PENNYSTOCKS #CRYPTOCURRENCY #NASDAQ #NYSE $BTCS $ONCI $SANP $ANDI $INTV $DPW $OTIV $VRX $MN‚Ä¶ https://pic.twitter.com/FfSP5VgMsQ","RT @DARTH_ALERT: ""Confirmation From Merck $MRK On Discussions With Northwest Biotherapeutics $NWBO In Bethesda Coming Shortly""
http://sierraworldequity.blogspot.com/2017/12/bet-farmconfirmation-from-merck-mrk-on.html‚Ä¶

#BITCOIN #PENNYSTOCKS #CRYPTOCURRENCY #NASDAQ #NYSE $BTCS $ONCI $SANP $ANDI $INTV $DPW $OTIV $VRX $MN‚Ä¶ https://pic.twitter.com/FfSP5VgMsQ",,,,,[],https://twitter.com/mikeauten/status/943228744147324929
6043,SuperDuper Investor,@SuperDuperInvst,2017-12-20T17:02:51.000Z,"$DVAX : LOADING UP even more @$18.15 to #DayTrade #SwingTrade - Should close $18.75 - $19.75 today
SCREAMING BUY for LONG TERM LOAD UP 
Most likely buyout by $MRK #Merck at $27+/Share in 2018 
FDA approved drug launch coming soon in early 2018
#Buy - Don't miss out hot #Pharma","$DVAX : LOADING UP even more @$18.15 to #DayTrade #SwingTrade - Should close $18.75 - $19.75 today
SCREAMING BUY for LONG TERM LOAD UP 
Most likely buyout by $MRK #Merck at $27+/Share in 2018 
FDA approved drug launch coming soon in early 2018
#Buy - Don't miss out hot #Pharma
2",,,,2,[],https://twitter.com/SuperDuperInvst/status/943527127848189952
6044,James Sikes,@wosaikeneriki,2017-12-20T12:34:53.000Z,Merck & Co $MRK Holder Barometer Capital Management Lowered Holding as Shares Declined http://bzweekly.com/merck-xerox-corp-xrx-shares-declined-while-hanson-doremus-investment-management-has-lowered-holding-by-3-96-mil/‚Ä¶,Merck & Co $MRK Holder Barometer Capital Management Lowered Holding as Shares Declined http://bzweekly.com/merck-xerox-corp-xrx-shares-declined-while-hanson-doremus-investment-management-has-lowered-holding-by-3-96-mil/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/943459689970401281
6045,Clark Joseph Kent,@JorelLaraKalel,2017-12-20T22:22:04.000Z,"Wells Fargo, GM, Marathon and Their Investors Seen as GOP Tax Plan Winners  http://bit.ly/2BTxfQu $WFC $GM $MRO $HRB $PFE $MRK $GS $AAPL","Wells Fargo, GM, Marathon and Their Investors Seen as GOP Tax Plan Winners  http://bit.ly/2BTxfQu $WFC $GM $MRO $HRB $PFE $MRK $GS $AAPL
1",,,1,,[],https://twitter.com/JorelLaraKalel/status/943607459683491841
6046,Chameleon Options,@MC_OptionTrades,2017-12-19T01:31:48.000Z,Price Moves vs Expected Moves $RIOT $VRX $MYL $ABBV $BMY $MRK $PFE $JNJ $TEVA $GILD $CELG $CVS http://tinyurl.com/y7zbwhgq,Price Moves vs Expected Moves $RIOT $VRX $MYL $ABBV $BMY $MRK $PFE $JNJ $TEVA $GILD $CELG $CVS http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DRX2OtMW0AA3hhj?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/942930432408072193
6047,NAVY CAPITAL,@navycapital,2017-12-19T18:03:30.000Z,"#NavyCapital #barronsonline: Why J&J, Merck, Allergan Could Be Winners in 2018 http://on.barrons.com/2By5bQ2 $JNJ $MRK $AGN","#NavyCapital #barronsonline: Why J&J, Merck, Allergan Could Be Winners in 2018 http://on.barrons.com/2By5bQ2 $JNJ $MRK $AGN
barrons.com
Why J&J, Merck, Allergan Could Be Winners in 2018
A benign regulatory environment and less focus on drug pricing could allow pharma innovators to shine in 2018.",,,,,['https://pbs.twimg.com/card_img/1499836742639435777/BewBCQeB?format=jpg&name=small'],https://twitter.com/navycapital/status/943180002241273856
6048,Justin Pulitzer,@JustinPulitzer,2017-12-20T20:43:31.000Z,$MRK 20MA is a RORO long IMHO. Have some orders in to sell Puts if it tests.,"$MRK 20MA is a RORO long IMHO. Have some orders in to sell Puts if it tests.
3",üçä,,,3,[],https://twitter.com/JustinPulitzer/status/943582660034736129
6049,BZ Contributors,@BZContributors,2017-12-20T17:42:39.000Z,3 Biotech Pipeline Areas To Keep An Eye On In 2018 https://benzinga.com/z/10939349 $NVS $GILD $JUNO $BLUE $MRK $LLY $JNJ $BIIB $GWPH,"3 Biotech Pipeline Areas To Keep An Eye On In 2018 https://benzinga.com/z/10939349 $NVS $GILD $JUNO $BLUE $MRK $LLY $JNJ $BIIB $GWPH
benzinga.com
3 Biotech Pipeline Areas To Keep An Eye On In 2018
Although there are still a few days left for the year to end, 2017 has turned out to be pretty good for the pharma and biotech sector where FDA approvals are concerned. Till date...",,,,,['https://pbs.twimg.com/card_img/1499224544283877377/6ijvwYCi?format=png&name=240x240'],https://twitter.com/BZContributors/status/943537140725616640
6050,Tim Reller,@TraderGuruNY,2017-12-20T01:51:33.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...
1",,,,1,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/943297789877997568
6051,Obi,@aaaamhim,2017-12-20T16:10:32.000Z,"$FLCR  unlike 99% of OTC HAS A REAL PRODUCT OWNS A MOVIE THEATER $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $XOM $UNH $DIS $HSY $NVDA $MRNS $UNP $BAC $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ","$FLCR  unlike 99% of OTC HAS A REAL PRODUCT OWNS A MOVIE THEATER $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $XOM $UNH $DIS $HSY $NVDA $MRNS $UNP $BAC $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ",,,,,[],https://twitter.com/aaaamhim/status/943513960065781761
6052,Obi,@aaaamhim,2017-12-20T05:32:21.000Z,"$FLCR REAL PENNYSTOCK  unlike 99.99% of OTC ACTUALLY HAS A REAL PRODUCT. OWNS A MOVIE THEATRE. Will not be down below 2 cents for long 1000% run COMING $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ  $S $T $P","$FLCR REAL PENNYSTOCK  unlike 99.99% of OTC ACTUALLY HAS A REAL PRODUCT. OWNS A MOVIE THEATRE. Will not be down below 2 cents for long 1000% run COMING $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ  $S $T $P",üçæ üí∏ üî•,,,,[],https://twitter.com/aaaamhim/status/943353357313499136
6053,c lark,@7LadyQ,2017-12-20T20:11:57.000Z,"$MRK
FDA OKs Merck's ertugliflozin for T2D
The FDA approves Merck's (MRK -0.2%) Steglujan (ertugliflozin) for glycemic control in type 2 diabetics.","$MRK
FDA OKs Merck's ertugliflozin for T2D
The FDA approves Merck's (MRK -0.2%) Steglujan (ertugliflozin) for glycemic control in type 2 diabetics.",,,,,[],https://twitter.com/7LadyQ/status/943574716127895555
6054,AlpacaAlerts,@AlpacaAlerts,2017-12-19T03:20:00.000Z,$MRK is in Three Inside Up winning 61.11% in the past. https://goo.gl/AV3DiK,$MRK is in Three Inside Up winning 61.11% in the past. https://goo.gl/AV3DiK,,,,,[],https://twitter.com/AlpacaAlerts/status/942957662198788097
6055,Ticker Report,@TickerReport,2017-12-20T10:40:17.000Z,"Summit X LLC Has $582,000 Stake in Merck & Co., Inc. $MRK http://ift.tt/2kP7vtX","Summit X LLC Has $582,000 Stake in Merck & Co., Inc. $MRK http://ift.tt/2kP7vtX",,,,,[],https://twitter.com/TickerReport/status/943430852134031360
6056,Daily Political,@dailypoliticaln,2017-12-19T14:16:22.000Z,"Merck & Co., Inc. $MRK Shares Bought by Shell Asset Management Co. http://ift.tt/2klHxiC","Merck & Co., Inc. $MRK Shares Bought by Shell Asset Management Co. http://ift.tt/2klHxiC",,,,,[],https://twitter.com/dailypoliticaln/status/943122840995487744
6057,Daily Political,@dailypoliticaln,2017-12-18T14:33:15.000Z,"Merck & Co., Inc. $MRK Shares Sold by Sit Investment Associates Inc. http://ift.tt/2B96d8g","Merck & Co., Inc. $MRK Shares Sold by Sit Investment Associates Inc. http://ift.tt/2B96d8g",,,,,[],https://twitter.com/dailypoliticaln/status/942764703826268161
6058,Dakota Financial,@dakotafinancial,2017-12-18T14:32:40.000Z,"Cacti Asset Management LLC Buys 35,997 Shares of Merck & Co., Inc. $MRK http://ift.tt/2AUAeV1","Cacti Asset Management LLC Buys 35,997 Shares of Merck & Co., Inc. $MRK http://ift.tt/2AUAeV1",,,,,[],https://twitter.com/dakotafinancial/status/942764553854734336
6059,Dakota Financial,@dakotafinancial,2017-12-20T10:38:43.000Z,"Asset Dedication LLC Has $1.23 Million Stake in Merck & Co., Inc. $MRK http://ift.tt/2BlkUFo","Asset Dedication LLC Has $1.23 Million Stake in Merck & Co., Inc. $MRK http://ift.tt/2BlkUFo",,,,,[],https://twitter.com/dakotafinancial/status/943430455029886976
6060,Watchlist News,@WatchlistN,2017-12-19T13:07:20.000Z,"Private Capital Advisors Inc. Reduces Holdings in Merck & Co., Inc. $MRK http://ift.tt/2kNRvZ8","Private Capital Advisors Inc. Reduces Holdings in Merck & Co., Inc. $MRK http://ift.tt/2kNRvZ8",,,,,[],https://twitter.com/WatchlistN/status/943105469723430912
6061,Watchlist News,@WatchlistN,2017-12-20T10:37:13.000Z,"Ingalls & Snyder LLC Buys 17,550 Shares of Merck & Co., Inc. $MRK http://ift.tt/2oXv9di","Ingalls & Snyder LLC Buys 17,550 Shares of Merck & Co., Inc. $MRK http://ift.tt/2oXv9di",,,,,[],https://twitter.com/WatchlistN/status/943430079903879169
6062,Ticker Report,@TickerReport,2017-12-20T10:43:07.000Z,"Robeco Institutional Asset Management B.V. Cuts Stake in Merck & Co., Inc. $MRK http://ift.tt/2oWt7Kn","Robeco Institutional Asset Management B.V. Cuts Stake in Merck & Co., Inc. $MRK http://ift.tt/2oWt7Kn",,,,,[],https://twitter.com/TickerReport/status/943431563320217606
6063,Margin Hunt,@MarginHunt,2017-12-18T15:20:13.000Z,"Jim Simons owns shares of Merck & Company, Inc. $MRK and expects a 14% jump http://ow.ly/AQ0R30heOtr","Jim Simons owns shares of Merck & Company, Inc. $MRK and expects a 14% jump http://ow.ly/AQ0R30heOtr",,,,,[],https://twitter.com/MarginHunt/status/942776522368266240
6064,Dakota Financial,@dakotafinancial,2017-12-19T14:22:13.000Z,"Moloney Securities Asset Management LLC Raises Position in Merck & Co., Inc. $MRK http://ift.tt/2kMANJF","Moloney Securities Asset Management LLC Raises Position in Merck & Co., Inc. $MRK http://ift.tt/2kMANJF",,,,,[],https://twitter.com/dakotafinancial/status/943124312353099776
6065,Allison Gatlin,@IBD_AGatlin,2017-12-19T19:40:21.000Z,Why these biotech stocks could be taken over in 2018 $CLVS $PBYI $SAGE $AMGN $CELG $GILD $BMY $JNJ $MRK $AGN,"Why these biotech stocks could be taken over in 2018 $CLVS $PBYI $SAGE $AMGN $CELG $GILD $BMY $JNJ $MRK $AGN
investors.com
Clovis Oncology, Sage Therapeutics, Puma Biotechnology Eyed As Takeover Candidates In 2018 | Stock...
Clovis, Sage and Puma could stoke acquisitive appetites in 2018 as large-cap biotechs struggle with slowing growth and major patent cliffs, analysts said Tuesday.",,,,,['https://pbs.twimg.com/card_img/1496244653946982404/DPF2LBuI?format=jpg&name=small'],https://twitter.com/IBD_AGatlin/status/943204374620274688
6066,Chameleon,@MarketChmln,2017-12-20T21:34:34.000Z,Largest $Notional Sell On Close Order Imbalances $JNJ $MRK $HON $JPM $DWDP $PM $WMT $XOM $BCR $CVX http://tinyurl.com/y8jo8mjb,Largest $Notional Sell On Close Order Imbalances $JNJ $MRK $HON $JPM $DWDP $PM $WMT $XOM $BCR $CVX http://tinyurl.com/y8jo8mjb,ü¶é,,,,[],https://twitter.com/MarketChmln/status/943595505275334656
6067,SuperDuper Investor,@SuperDuperInvst,2017-12-20T20:22:39.000Z,"$DVAX : LOADING UP like crazy @$18.15 to #DayTrade #SwingTrade
Should close $18.75 - $19.75 today
SCREAMING BUY for LONG TERM
LOAD UP
Most likely buyout by $MRK #Merck at $27+/Share in 2018
FDA approved drug launch coming soon in early 2018
#Buy - Don't miss out this hot #Pharma","$DVAX : LOADING UP like crazy @$18.15 to #DayTrade #SwingTrade
Should close $18.75 - $19.75 today
SCREAMING BUY for LONG TERM
LOAD UP
Most likely buyout by $MRK #Merck at $27+/Share in 2018
FDA approved drug launch coming soon in early 2018
#Buy - Don't miss out this hot #Pharma",,,,,[],https://twitter.com/SuperDuperInvst/status/943577406614507520
6068,Evaluate Pharma,@evaluatepharma,2017-12-18T13:45:06.000Z,"Better Buy: Johnson & Johnson vs. Merck http://ow.ly/Oq8Z30hhXVL via 
@Nasdaq
 ""EvaluatePharma projects that Keytruda will become the third-biggest-selling cancer drug in the world by 2022"" $JNJ $MRK","Better Buy: Johnson & Johnson vs. Merck http://ow.ly/Oq8Z30hhXVL via 
@Nasdaq
 ""EvaluatePharma projects that Keytruda will become the third-biggest-selling cancer drug in the world by 2022"" $JNJ $MRK",,,,,['https://pbs.twimg.com/media/DRVUevpWAAAJF2p?format=jpg&name=small'],https://twitter.com/evaluatepharma/status/942752586171633664
6069,Briefing.com,@Briefingcom,2017-12-20T21:30:28.000Z,$MRK: Merck: FDA approves STEGLUJAN for the treatment of type 2 diabetes http://bit.ly/2kR7mpW,$MRK: Merck: FDA approves STEGLUJAN for the treatment of type 2 diabetes http://bit.ly/2kR7mpW,,,,,[],https://twitter.com/Briefingcom/status/943594474524917760
6070,"`((,(Dieter 'Hovekamp)))",@dhovekamp42,2017-12-19T08:39:14.000Z,"Replying to 
@biosleuth
 and 
@Aesculapius1898","Replying to 
@biosleuth
 and 
@Aesculapius1898
No doubt Adi has made mistakes - we all do - we may differ in what main issues are: Combination of AFM13 with Anti-PD1 IMO was and is a right one given their market penetration. $MRK was also a very good choice for future deals, recruitement & attention.
1",,,,1,[],https://twitter.com/dhovekamp42/status/943038000786759680
6071,Ozgur Ogut,@Ogut_Ozgur,2017-12-19T20:35:48.000Z,"Replying to 
@biosleuth","Replying to 
@biosleuth
This may be an internal preference? The one I highlighted actually has a Keynote-xxx trial designation suggesting $MRK is aware.
1",,1,,,[],https://twitter.com/Ogut_Ozgur/status/943218329103167488
6072,MarketBeat,@MarketBeatCom,2017-12-19T01:03:15.000Z,"Head-To-Head Analysis: Adamis Pharmaceuticals $ADMP vs. Merck & Co., Inc. $MRK http://ift.tt/2kJ8JXR #acn","Head-To-Head Analysis: Adamis Pharmaceuticals $ADMP vs. Merck & Co., Inc. $MRK http://ift.tt/2kJ8JXR #acn",,,,,[],https://twitter.com/MarketBeatCom/status/942923248236400640
6073,StockNews.com,@stocknewsdotcom,2017-12-20T19:30:41.000Z,$MRK FDA approves STEGLUJAN for the treatment of type 2 diabetes https://stocknews.com/news/mrk-fda-approves-steglujan-for-the-treatment-of-type-2-diabetes/‚Ä¶,$MRK FDA approves STEGLUJAN for the treatment of type 2 diabetes https://stocknews.com/news/mrk-fda-approves-steglujan-for-the-treatment-of-type-2-diabetes/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/943564331534479363
6074,SuperDuper Investor,@SuperDuperInvst,2017-12-20T15:44:00.000Z,"$DVAX : Bought on dips @$18.20 - $18.25 to #DayTrade #SwingTrade - Should close $18.75 - $19.75 today 
SCREAMING BUY for LONG TERM
LOAD UP
Most likely buyout by $MRK #Merck at $27+/Share in 2018
FDA approved drug launch coming soon
#Buy - Don't miss out","$DVAX : Bought on dips @$18.20 - $18.25 to #DayTrade #SwingTrade - Should close $18.75 - $19.75 today 
SCREAMING BUY for LONG TERM
LOAD UP
Most likely buyout by $MRK #Merck at $27+/Share in 2018
FDA approved drug launch coming soon
#Buy - Don't miss out",,,,,[],https://twitter.com/SuperDuperInvst/status/943507281446129665
6075,"Daniel Ward, CFA",@danwardbio,2017-12-23T05:06:25.000Z,Bought starter early this morning in $KALV at $8.97. Collaboration with $MRK. ~$25-$30mil EV way too cheap. A few thoughts on name attached.,"Bought starter early this morning in $KALV at $8.97. Collaboration with $MRK. ~$25-$30mil EV way too cheap. A few thoughts on name attached.
3
3
36",,3,3,36,['https://pbs.twimg.com/media/DRtMLt_WAAAV_i4?format=jpg&name=small'],https://twitter.com/danwardbio/status/944433994011115521
6076,Open Outcrier,@OpenOutcrier,2017-12-21T13:33:21.000Z,"$MRK (+0.1% pre) FDA OKs Merck's ertugliflozin/sitagliptin for T2D -SA

http://ooc.bz/l/19080","$MRK (+0.1% pre) FDA OKs Merck's ertugliflozin/sitagliptin for T2D -SA

http://ooc.bz/l/19080
1",,,1,,[],https://twitter.com/OpenOutcrier/status/943836793606213632
6077,ÂåöÂçÑÂçÇÂ∞∫„Ñí‰∏Ç‰πá‰πáÂ∞∫,@chartseer,2017-12-23T19:19:51.000Z,Short setups $DISH $FLS $MRK $EXPE $BG $GE $CCE $VEEV $AAOI,"Short setups $DISH $FLS $MRK $EXPE $BG $GE $CCE $VEEV $AAOI
2
5",üìà üìâ,,2,5,['https://pbs.twimg.com/media/DRwQ7jLVQAAS7EW?format=jpg&name=small'],https://twitter.com/chartseer/status/944648766283378688
6078,dough,@semodough,2017-12-23T16:26:31.000Z,Jeff key regulatory dates $SGYP $DOVA $VRTX $GILD $MRK $ONCE $PFE $FGEN China approval nice to see one analyst on board,"Jeff key regulatory dates $SGYP $DOVA $VRTX $GILD $MRK $ONCE $PFE $FGEN China approval nice to see one analyst on board
5
17",,,5,17,['https://pbs.twimg.com/media/DRvpXcrXUAAAuI_?format=jpg&name=small'],https://twitter.com/semodough/status/944605145215721472
6079,pharmalot,@pharmalot,2017-12-21T14:13:35.000Z,Pharmalot.. Pharmalittle.. Good Morning.. coffee & headlines are served.. https://statnews.com/pharmalot/2017/12/21/fda-insulin-abbvie-deaths/‚Ä¶ #pharma $MRK $PFE $GILD $NVS $AZN $LLY $JNJ,"Pharmalot.. Pharmalittle.. Good Morning.. coffee & headlines are served.. https://statnews.com/pharmalot/2017/12/21/fda-insulin-abbvie-deaths/‚Ä¶ #pharma $MRK $PFE $GILD $NVS $AZN $LLY $JNJ
statnews.com
Pharmalittle: FDA to boost insulin competition; AbbVie's experimental RA drug is plagued by deaths
Top of the morning to you, and what a fine one it is. A warm and shiny sun is enveloping the Pharmalot campus this morning, where one of the short people
2",,,2,,['https://pbs.twimg.com/card_img/1501064820937822212/YW68E-Ya?format=jpg&name=small'],https://twitter.com/pharmalot/status/943846917905305601
6080,John Carroll,@JohnCendpts,2017-12-21T12:15:53.000Z,"Merck, Pfizer make a late ‚Äî very late ‚Äî arrival at the SGLT2 party for diabetes
$MRK $PFE $LLY $JNJ $AZN","Merck, Pfizer make a late ‚Äî very late ‚Äî arrival at the SGLT2 party for diabetes
$MRK $PFE $LLY $JNJ $AZN
endpts.com
Merck, Pfizer make a late ‚Äî very late ‚Äî arrival at the SGLT2 party for diabetes
Merck and Pfizer have landed an FDA approval to start marketing ertugliflozin, marking a late arrival for a therapy that will now go toe-to-toe with some deeply entrenched rivals in the SGLT2 niche....
4
12",,,4,12,['https://pbs.twimg.com/card_img/1499352899393966082/aMNxgziF?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/943817296887328768
6081,John Carroll,@JohnCendpts,2017-12-21T13:09:51.000Z,"Did you ever see a big pharma not run out a PR on a new drug approval?
What's up $MRK, $PFE?","Did you ever see a big pharma not run out a PR on a new drug approval?
What's up $MRK, $PFE?
endpts.com
Merck, Pfizer make a late ‚Äî very late ‚Äî arrival at the SGLT2 party for diabetes
Merck and Pfizer have landed an FDA approval to start marketing ertugliflozin, marking a late arrival for a therapy that will now go toe-to-toe with some deeply entrenched rivals in the SGLT2 niche....
2
6",,,2,6,['https://pbs.twimg.com/card_img/1499352899393966082/aMNxgziF?format=jpg&name=small'],https://twitter.com/JohnCendpts/status/943830877540372480
6082,Adam Mueller,@AMueller78,2017-12-22T03:57:22.000Z,"have you used this? i've been getting in on some great trades because of it http://bit.ly/2w8GLZO
$MTH $MRK $MRT","have you used this? i've been getting in on some great trades because of it http://bit.ly/2w8GLZO
$MTH $MRK $MRT",,,,,['https://pbs.twimg.com/media/DRn0UK7VwAU1HKK?format=jpg&name=small'],https://twitter.com/AMueller78/status/944054227864657920
6083,Ken Lloyd,@KenLloyd67,2017-12-21T00:24:52.000Z,"has anyone tried this? i've been getting in on some amazing trades through it http://bit.ly/2wgm1PZ
$MRK $MDT $MD","has anyone tried this? i've been getting in on some amazing trades through it http://bit.ly/2wgm1PZ
$MRK $MDT $MD",,,,,['https://pbs.twimg.com/media/DRh6FwvVQAAMmTY?format=jpg&name=small'],https://twitter.com/KenLloyd67/status/943638364187750403
6084,Stockwinners.com,@STOCKWINNERScom,2017-12-22T13:18:19.000Z,"FDA approves drugs for adults with type 2 diabetes https://stockwinners.com/blog/2017/12/22/fda-approves-drugs-for-adults-with-type-2-diabetes/‚Ä¶

$PFE $MRK #Pfizer #Merck #Stockwinners","FDA approves drugs for adults with type 2 diabetes https://stockwinners.com/blog/2017/12/22/fda-approves-drugs-for-adults-with-type-2-diabetes/‚Ä¶

$PFE $MRK #Pfizer #Merck #Stockwinners",,,,,[],https://twitter.com/STOCKWINNERScom/status/944195396557004800
6085,Kara Jill Stancell,@kjilly,2017-12-21T17:03:59.000Z,"Warning to I-O drugmakers: If investors were hyperfocused on data this year, just wait till 2018 #pharma #biotech #biopharma #IO #immunooncology #lungcancer #checkpointinhibitors #NSCLC #Keytruda #opdivo #Imfinzi #Tecentriq $RHHBY $AZN $BMY $MRK","Warning to I-O drugmakers: If investors were hyperfocused on data this year, just wait till 2018 #pharma #biotech #biopharma #IO #immunooncology #lungcancer #checkpointinhibitors #NSCLC #Keytruda #opdivo #Imfinzi #Tecentriq $RHHBY $AZN $BMY $MRK
fiercepharma.com
Warning to I-O drugmakers: If investors were hyperfocused on data this year, just wait till 2018
If 2016 was the year immuno-oncology first stopped looking invincible thanks to a shocking phase 3",,,,,['https://pbs.twimg.com/card_img/1500901725582110721/4PZNCX8j?format=png&name=small'],https://twitter.com/kjilly/status/943889800704036864
6086,Chameleon Options,@MC_OptionTrades,2017-12-22T22:31:22.000Z,Price Returns vs Expected Daily Move $RXDX $EXEL $TEVA $PFE $MRK $GILD $VRX $JNJ $BMY $CELG $AGN $RIOT http://tinyurl.com/y7zbwhgq,Price Returns vs Expected Daily Move $RXDX $EXEL $TEVA $PFE $MRK $GILD $VRX $JNJ $BMY $CELG $AGN $RIOT http://tinyurl.com/y7zbwhgq,ü¶é,,,,['https://pbs.twimg.com/media/DRrzSlPXUAIcHiX?format=jpg&name=small'],https://twitter.com/MC_OptionTrades/status/944334575202963456
6087,James Sikes,@wosaikeneriki,2017-12-22T19:27:18.000Z,Kdi Capital Partners Has Lowered Its Stake in Merck & Co $MRK by $1.44 Million http://bzweekly.com/kdi-capital-partners-has-lowered-its-stake-in-merck-sva-plumb-wealth-management-cut-position-in-bristol-myers-squibb-co-com-bmy-as-stock-declined/‚Ä¶,Kdi Capital Partners Has Lowered Its Stake in Merck & Co $MRK by $1.44 Million http://bzweekly.com/kdi-capital-partners-has-lowered-its-stake-in-merck-sva-plumb-wealth-management-cut-position-in-bristol-myers-squibb-co-com-bmy-as-stock-declined/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/944288253846474752
6088,Tim Reller,@TraderGuruNY,2017-12-22T02:03:34.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/TraderGuruNY/status/944025590298005505
6089,BioPharma Dive,@BioPharmaDive,2017-12-21T17:08:00.000Z,"$MRK, $PFE face uphill battle for new diabetes med","$MRK, $PFE face uphill battle for new diabetes med
biopharmadive.com
Merck, Pfizer face uphill battle for new diabetes med
The big pharma partners got an FDA nod for their SGLT-2 inhibitor, but will struggle as a late-entry to a crowded market. 
1",,,,1,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/943890810650624001
6090,StockMarketVideo.com,@stockmarketvide,2017-12-22T02:00:10.000Z,Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones,"Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://stockmarketvideo.com/dow-jones-video/‚Ä¶ #stockmarket #stocks #trading #DowJones
stockmarketvideo.com
Watch Dow Jones DJIA Analysis Video
Get Expert Analysis for the Dow Jones Industrial Index DJIA Now! This video provides easy-to-follow technical analysis that entails forecasted strategies, trends, market direction and patterns. Click...",,,,,['https://pbs.twimg.com/card_img/1501208336292888581/T09Aanhh?format=jpg&name=360x360'],https://twitter.com/stockmarketvide/status/944024733280071685
6091,WallStreetGangsta,@WallStGangsta,2017-12-21T16:38:57.000Z,"$CHIT 0.0001 x 0.0002 BUY ALL YOU CAN ! THE NEXT Marijuana Stock To See UP to 10,000% Gain $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU","$CHIT 0.0001 x 0.0002 BUY ALL YOU CAN ! THE NEXT Marijuana Stock To See UP to 10,000% Gain $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU",,,,,[],https://twitter.com/WallStGangsta/status/943883500939304960
6092,,@BioGraphica1,2017-12-21T15:38:14.000Z,Plenty of potential gap fills in bioland $MRK $AFMD $ONCE,Plenty of potential gap fills in bioland $MRK $AFMD $ONCE,üëæ,,,,[],https://twitter.com/BioGraphica1/status/943868218917249024
6093,DigitalDeath,@itchibahn,2017-12-21T20:13:14.000Z,"$VSAR visiting from $MRK. The website doesn't have info on their pipeline. After the failed trial, what do they got besides cash?","$VSAR visiting from $MRK. The website doesn't have info on their pipeline. After the failed trial, what do they got besides cash?
1",,,,1,[],https://twitter.com/itchibahn/status/943937425516191745
6094,Obi,@aaaamhim,2017-12-22T16:37:48.000Z,"$HMLA IS MY NEXT 1000%+ RUNNER SET IT & FORGET IT IMO. TOO EASY  $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $XOM $UNH $DIS $HSY $NVDA $MRNS $UNP $BAC $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ","$HMLA IS MY NEXT 1000%+ RUNNER SET IT & FORGET IT IMO. TOO EASY  $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $XOM $UNH $DIS $HSY $NVDA $MRNS $UNP $BAC $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ",,,,,[],https://twitter.com/aaaamhim/status/944245597686640642
6095,SuperDuper Investor,@SuperDuperInvst,2017-12-21T13:51:22.000Z,"$DVAX : LOAD UP like crazy @$18.10 to #DayTrade #SwingTrade #Investment 

1St Anti #HEPATITIS B Vaccine approved in 25+ yrs by FDA to be launched by http://Dynavax.com in early'18

Most likely buyout by $MRK #Merck at $27+/Share in 2018
SCREAMING BUY for LONG TERM 
#Buy","$DVAX : LOAD UP like crazy @$18.10 to #DayTrade #SwingTrade #Investment 

1St Anti #HEPATITIS B Vaccine approved in 25+ yrs by FDA to be launched by http://Dynavax.com in early'18

Most likely buyout by $MRK #Merck at $27+/Share in 2018
SCREAMING BUY for LONG TERM 
#Buy
1
2",,1,,2,[],https://twitter.com/SuperDuperInvst/status/943841324557578241
6096,@Stockhoot,@Stockhoot,2017-12-22T01:41:24.000Z,$MRK - Symmetry Options - Looks ready after consolidating recently. https://stockhoot.com/ExtAnalyst.aspx?id=a97fdfc1-8728-4ee8-838b-057c07213235&srid=42bfb65d-a1e3-4ffe-8a94-c51d479ef323‚Ä¶,$MRK - Symmetry Options - Looks ready after consolidating recently. https://stockhoot.com/ExtAnalyst.aspx?id=a97fdfc1-8728-4ee8-838b-057c07213235&srid=42bfb65d-a1e3-4ffe-8a94-c51d479ef323‚Ä¶,,,,,[],https://twitter.com/stockhoot/status/944020010497921025
6097,Dakota Financial,@dakotafinancial,2017-12-23T11:03:18.000Z,"Merck & Co., Inc. $MRK Position Lowered by BB&T Corp http://ift.tt/2kIMaDt","Merck & Co., Inc. $MRK Position Lowered by BB&T Corp http://ift.tt/2kIMaDt",,,,,[],https://twitter.com/dakotafinancial/status/944523806437199872
6098,APM Health Europe,@apmhealtheurope,2017-12-21T14:22:00.000Z,"Two new #diabetes drugs approved by 
@US_FDA
 http://bit.ly/2zbbJkV $MRK $PFE","Two new #diabetes drugs approved by 
@US_FDA
 http://bit.ly/2zbbJkV $MRK $PFE
1",,,,1,[],https://twitter.com/apmhealtheurope/status/943849035261132800
6099,Briefing.com,@Briefingcom,2017-12-21T20:15:39.000Z,$MRK: Merck and Pfizer (PFE) announce that the FDA has granted Breakthrough Therapy Designation for avelumab in... http://bit.ly/2kAwP7W,"$MRK: Merck and Pfizer (PFE) announce that the FDA has granted Breakthrough Therapy Designation for avelumab in... http://bit.ly/2kAwP7W
1",,,1,,[],https://twitter.com/Briefingcom/status/943938032889032704
6100,Watchlist News,@WatchlistN,2017-12-22T11:33:28.000Z,"Investors Buy Merck & Co., Inc. $MRK on Weakness http://ift.tt/2BORSe8","Investors Buy Merck & Co., Inc. $MRK on Weakness http://ift.tt/2BORSe8",,,,,[],https://twitter.com/WatchlistN/status/944169011675389952
6101,Dakota Financial,@dakotafinancial,2017-12-23T14:48:19.000Z,"Reviewing Adamis Pharmaceuticals $ADMP & Merck & Co., Inc. $MRK http://ift.tt/2BVPUbU","Reviewing Adamis Pharmaceuticals $ADMP & Merck & Co., Inc. $MRK http://ift.tt/2BVPUbU",,,,,[],https://twitter.com/dakotafinancial/status/944580434385620997
6102,Daily Political,@dailypoliticaln,2017-12-22T11:16:08.000Z,"Mycio Wealth Partners LLC Increases Stake in Merck & Co., Inc. $MRK http://ift.tt/2BnnMO9","Mycio Wealth Partners LLC Increases Stake in Merck & Co., Inc. $MRK http://ift.tt/2BnnMO9",,,,,[],https://twitter.com/dailypoliticaln/status/944164650156933120
6103,Daily Political,@dailypoliticaln,2017-12-21T13:11:09.000Z,"Merck & Co., Inc. $MRK Stake Lowered by State Treasurer State of Michigan http://ift.tt/2kTZbcq","Merck & Co., Inc. $MRK Stake Lowered by State Treasurer State of Michigan http://ift.tt/2kTZbcq",,,,,[],https://twitter.com/dailypoliticaln/status/943831205962747906
6104,shortvolumes,@shortvolumes,2017-12-23T08:52:01.000Z,Short vol percent for $XOP on 2017-12-22 is 76%. http://shortvolumes.com/?t=XOP $TRXC 60% $MRK 42% $MT 64% $NXTD 48%,Short vol percent for $XOP on 2017-12-22 is 76%. http://shortvolumes.com/?t=XOP $TRXC 60% $MRK 42% $MT 64% $NXTD 48%,,,,,[],https://twitter.com/shortvolumes/status/944490768965816320
6105,Ticker Report,@TickerReport,2017-12-22T11:19:18.000Z,"21,540 Shares in Merck & Co., Inc. $MRK Acquired by Carnick & Kubik Group LLC http://ift.tt/2BxISgx","21,540 Shares in Merck & Co., Inc. $MRK Acquired by Carnick & Kubik Group LLC http://ift.tt/2BxISgx",,,,,[],https://twitter.com/TickerReport/status/944165444382023681
6106,MomentumBeast,@momentumbeast,2017-12-21T16:38:57.000Z,"$CHIT 0.0001 x 0.0002 BUY ALL YOU CAN ! THE NEXT Marijuana Stock To See UP to 10,000% Gain $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU","$CHIT 0.0001 x 0.0002 BUY ALL YOU CAN ! THE NEXT Marijuana Stock To See UP to 10,000% Gain $SANP $FERN $ONCI $OTTV $RCGR $AMFE $INTV $WMIH $FNMA $IPIX $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX $BABA $ROKU",,,,,[],https://twitter.com/momentumbeast/status/943883500968710144
6107,Ticker Report,@TickerReport,2017-12-22T23:33:23.000Z,"Head-To-Head Analysis: Merck & Co., Inc. $MRK and Cadence Pharmaceuticals $CADX http://ift.tt/2BpIBZj","Head-To-Head Analysis: Merck & Co., Inc. $MRK and Cadence Pharmaceuticals $CADX http://ift.tt/2BpIBZj",,,,,[],https://twitter.com/TickerReport/status/944350181784543233
6108,MarketBeat,@MarketBeatCom,2017-12-23T11:02:17.000Z,"Merck & Co., Inc. $MRK Position Raised by Whittier Trust Co. of Nevada Inc. http://ift.tt/2l3xJt0","Merck & Co., Inc. $MRK Position Raised by Whittier Trust Co. of Nevada Inc. http://ift.tt/2l3xJt0",,,,,[],https://twitter.com/MarketBeatCom/status/944523549934579712
6109,StockNews.com,@stocknewsdotcom,2017-12-22T12:05:27.000Z,"$MRK Merck, Pfizer diabetes drugs Steglatro and Steglujan receive FDA approval https://stocknews.com/news/mrk-merck-pfizer-diabetes-drugs-steglatro-and-steglujan-receive-fda-approval/‚Ä¶","$MRK Merck, Pfizer diabetes drugs Steglatro and Steglujan receive FDA approval https://stocknews.com/news/mrk-merck-pfizer-diabetes-drugs-steglatro-and-steglujan-receive-fda-approval/‚Ä¶",,,,,[],https://twitter.com/stocknewsdotcom/status/944177058946613248
6110,Finbox,@FinboxIO,2017-12-22T16:15:15.000Z,"Value investors may want to look at Merck & Company, Inc. $MRK. Andrew Feldstein is http://ow.ly/l2cz30hiB1b","Value investors may want to look at Merck & Company, Inc. $MRK. Andrew Feldstein is http://ow.ly/l2cz30hiB1b",,,,,[],https://twitter.com/FinboxIO/status/944239922046783488
6111,MarketBeat,@MarketBeatCom,2017-12-23T11:02:16.000Z,"Merck & Co., Inc. $MRK Position Lowered by BB&T Corp http://ift.tt/2kIMaDt","Merck & Co., Inc. $MRK Position Lowered by BB&T Corp http://ift.tt/2kIMaDt",,,,,[],https://twitter.com/MarketBeatCom/status/944523546574782464
6112,MarketBeat,@MarketBeatCom,2017-12-23T14:52:22.000Z,"Reviewing Adamis Pharmaceuticals $ADMP & Merck & Co., Inc. $MRK http://ift.tt/2BVPUbU","Reviewing Adamis Pharmaceuticals $ADMP & Merck & Co., Inc. $MRK http://ift.tt/2BVPUbU",,,,,[],https://twitter.com/MarketBeatCom/status/944581452733341697
6113,StockNews.com,@stocknewsdotcom,2017-12-21T18:18:08.000Z,$MRK Merck and Pfizer announce that the FDA has granted Breakthrough Therapy Designation for avelumab in combinati‚Ä¶ https://stocknews.com/news/mrk-merck-and-pfizer-announce-that-the-fda-has-granted-breakthrough/‚Ä¶,$MRK Merck and Pfizer announce that the FDA has granted Breakthrough Therapy Designation for avelumab in combinati‚Ä¶ https://stocknews.com/news/mrk-merck-and-pfizer-announce-that-the-fda-has-granted-breakthrough/‚Ä¶,,,,,[],https://twitter.com/stocknewsdotcom/status/943908459879325696
6114,Patrick S Blood,@psbfoto,2017-12-22T11:33:49.000Z,FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA¬Æ in Advanced Renal Cell Carcinoma $mrk $MRK https://finance.yahoo.com/news/fda-grants-breakthrough-therapy-designation-190400079.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAM3bDFsczcxZDNwcjgyBGcDZFhWcFpEeHVjejR5TWpsbE1XTTVNeTFpWVRBMkxUTmlObUV0WVdZNFlTMHhNMk5qWmpBd1lqSTNORE4xZFdsa1BHNXpQazFTU3c9PQ0KBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwMwBHJlZ2lvbgNVUwRzeW1ib2wDTVJL?.tsrc=applewf‚Ä¶,FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA¬Æ in Advanced Renal Cell Carcinoma $mrk $MRK https://finance.yahoo.com/news/fda-grants-breakthrough-therapy-designation-190400079.html;_ylc=X1MDMTE5Nzc4NDE4NQRfZXgDMQRfeXJpZAM3bDFsczcxZDNwcjgyBGcDZFhWcFpEeHVjejR5TWpsbE1XTTVNeTFpWVRBMkxUTmlObUV0WVdZNFlTMHhNMk5qWmpBd1lqSTNORE4xZFdsa1BHNXpQazFTU3c9PQ0KBGxhbmcDZW4tVVMEb3JpZ19sYW5nA2VuBG9yaWdfcmVnaW9uA1VTBHBvcwMwBHJlZ2lvbgNVUwRzeW1ib2wDTVJL?.tsrc=applewf‚Ä¶,üèÜ,,,,[],https://twitter.com/psbfoto/status/944169096597393408
6115,Stocks Pastor,@stockspastor,2017-12-23T16:27:35.000Z,The website is working now. Enter your email address to enjoy one month trial starting in January. $WFT $JD $CMCSA $T $MRK $NRG $ICE $NWL $PM $VZ. All these stocks did turn $1000 to $1 million dollar. 10 stocks alert with 100% profit each if reinvested. http://bit.ly/1PWTzJR,"The website is working now. Enter your email address to enjoy one month trial starting in January. $WFT $JD $CMCSA $T $MRK $NRG $ICE $NWL $PM $VZ. All these stocks did turn $1000 to $1 million dollar. 10 stocks alert with 100% profit each if reinvested. http://bit.ly/1PWTzJR
1
1
1",,1,1,1,[],https://twitter.com/stockspastor/status/944605413206618114
6116,Briefing.com,@Briefingcom,2017-12-22T14:03:47.000Z,$MRK: Merck and Pfizer announce FDA has approved STEGLATRO (ertugliflozin) and fixed-dose combination STEGLUJAN... http://bit.ly/2kXCZhS,"$MRK: Merck and Pfizer announce FDA has approved STEGLATRO (ertugliflozin) and fixed-dose combination STEGLUJAN... http://bit.ly/2kXCZhS
1",,,1,,[],https://twitter.com/Briefingcom/status/944206840065245184
6117,Trader Dave,@DNev47,2017-12-22T11:58:53.000Z,"3 Promising Cancer Immunotherapies to Watch in 2018 
@themotleyfool
 #stocks $MRK, $BMY, $NKTR, $AZN, $RHHBY, $INCY","3 Promising Cancer Immunotherapies to Watch in 2018 
@themotleyfool
 #stocks $MRK, $BMY, $NKTR, $AZN, $RHHBY, $INCY
fool.com
3 Promising Cancer Immunotherapies to Watch in 2018 @themotleyfool #stocks $INCY $MRK $BMY $NKTR...
Bristol-Myers Squibb, Incyte, and Nektar Therapeutics could provide the biggest fireworks next year on the immunotherapy scene.",,,,,[],https://twitter.com/DNev47/status/944175406978097152
6118,Todd Campbell,@ebcapital,2017-12-22T13:12:09.000Z,"If I Could Only Buy 1 Healthcare Stock in January, It Would Be This One 
@themotleyfool
 #stocks $MRK, $PFE, $EXEL https://fool.com/investing/2017/12/22/if-i-could-only-buy-1-healthcare-stock-in-january.aspx‚Ä¶","If I Could Only Buy 1 Healthcare Stock in January, It Would Be This One 
@themotleyfool
 #stocks $MRK, $PFE, $EXEL https://fool.com/investing/2017/12/22/if-i-could-only-buy-1-healthcare-stock-in-january.aspx‚Ä¶",,,,,[],https://twitter.com/ebcapital/status/944193845713100800
6119,Zero Filter,@zerofiltertruth,2017-12-21T01:19:16.000Z,"Awesome holiday season news from lotto & very wild #biotech $AEZS 

$IBB $XBI $MRK $CELG $NVS 
@petenajarian
 @GuyAdami
 @jimcramer
 @TheDomino
#AeternaZentaris Announces #FDA Approval #Macrilen (macimorelin) for Diagnosis Adult Growth Hormone Deficiency","Awesome holiday season news from lotto & very wild #biotech $AEZS 

$IBB $XBI $MRK $CELG $NVS 
@petenajarian
 @GuyAdami
 @jimcramer
 @TheDomino
#AeternaZentaris Announces #FDA Approval #Macrilen (macimorelin) for Diagnosis Adult Growth Hormone Deficiency
crweworld.com
Aeterna Zentaris Announces FDA Approval of Macrilen‚Ñ¢ (macimorelin) for Diagnosis of Adult Growth...
CHARLESTON, S.C., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS), a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical...",üò¨,,,,['https://pbs.twimg.com/card_img/1500250131861540870/E2xo1-g1?format=jpg&name=240x240'],https://twitter.com/zerofiltertruth/status/943652054056218624
6120,David Elman,@_davidelman,2017-12-21T13:54:04.000Z,"$AAPL $PFE $MRK among tech and healthcare companies that stand to gain through repatriation under tax bill per 
@AndersKeitz
 @JohnPickering16
.","$AAPL $PFE $MRK among tech and healthcare companies that stand to gain through repatriation under tax bill per 
@AndersKeitz
 @JohnPickering16
.
thestreet.com
Wells Fargo, GM, Marathon and Their Investors Seen as GOP Tax Plan Winners
U.S. corporations including GM, H&R Block and Wells Fargo and the people who own their stock are seen as among the biggest winners from the new tax plan.",,,,,[],https://twitter.com/_davidelman/status/943842007000154113
6121,Obi,@aaaamhim,2017-12-22T16:49:58.000Z,"$HMLA #PENNYSTOCK 3 FILINGS AFTER BEING DARK 4 A YEAR BOTTOM $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $XOM $UNH $DIS $HSY $NVDA $MRNS $UNP $BAC $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ","$HMLA #PENNYSTOCK 3 FILINGS AFTER BEING DARK 4 A YEAR BOTTOM $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $XOM $UNH $DIS $HSY $NVDA $MRNS $UNP $BAC $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ",üí∏ üí∏,,,,[],https://twitter.com/aaaamhim/status/944248657964126213
6122,Dakota Financial,@dakotafinancial,2017-12-23T11:03:18.000Z,"Merck & Co., Inc. $MRK Position Raised by Whittier Trust Co. of Nevada Inc. http://ift.tt/2l3xJt0","Merck & Co., Inc. $MRK Position Raised by Whittier Trust Co. of Nevada Inc. http://ift.tt/2l3xJt0",,,,,[],https://twitter.com/dakotafinancial/status/944523808190410752
6123,"welch james, gery",@poncho2860,2017-12-23T16:10:29.000Z,"3 Promising Cancer Immunotherapies to Watch in 2018 
@themotleyfool
 #stocks $MRK, $BMY, $NKTR, $AZN, $RHHBY, $INCY","3 Promising Cancer Immunotherapies to Watch in 2018 
@themotleyfool
 #stocks $MRK, $BMY, $NKTR, $AZN, $RHHBY, $INCY
fool.com
3 Promising Cancer Immunotherapies to Watch in 2018 @themotleyfool #stocks $INCY $MRK $BMY $NKTR...
Bristol-Myers Squibb, Incyte, and Nektar Therapeutics could provide the biggest fireworks next year on the immunotherapy scene.",,,,,['https://pbs.twimg.com/card_img/1501706225582489601/AhEFOgdY?format=jpg&name=small'],https://twitter.com/poncho2860/status/944601110274281472
6124,Jonathon Walker,@jonny_red32,2017-12-22T20:37:43.000Z,"Pick up some MJ insurance at $PDXP --->
$WDRP $UAMM Top 2 Marijuana Stocks To BUY & HOLD : UA Multimedia, Inc. (UAMM), Wanderport Corp. (WDRP) http://247marijuanastocks.com/2017/12/20/top-2-marijuana-stocks-to-buy-hold-ua-multimedia-inc-uamm-wanderport-corp-wdrp/‚Ä¶ $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX","Pick up some MJ insurance at $PDXP --->
$WDRP $UAMM Top 2 Marijuana Stocks To BUY & HOLD : UA Multimedia, Inc. (UAMM), Wanderport Corp. (WDRP) http://247marijuanastocks.com/2017/12/20/top-2-marijuana-stocks-to-buy-hold-ua-multimedia-inc-uamm-wanderport-corp-wdrp/‚Ä¶ $OWCP $MJNA $CBIS $TRTC $IMLFF $SPY $AAPL $FB $NVDA $INTC $MSFT $GWPH $IBB $GILD $PFE $NVS $AMGN $MRK $BMY $BSX
1
1",‚õΩ üî• üìä,1,,1,[],https://twitter.com/jonny_red32/status/944305976773107712
6125,Watchlist News,@WatchlistN,2017-12-23T10:58:27.000Z,"Merck & Co., Inc. $MRK Shares Sold by Whittier Trust Co. http://ift.tt/2BDPgTI","Merck & Co., Inc. $MRK Shares Sold by Whittier Trust Co. http://ift.tt/2BDPgTI",,,,,[],https://twitter.com/WatchlistN/status/944522584342876160
6126,Prudent Biotech,@PrudentBiotech,2017-12-24T02:13:45.000Z,"Biotech Bonanza: Biotech Stocks To Keep Shining In 2018
https://buff.ly/2pq2zRM
$qqq $spy $dia $iwm $ibb $xbi $xlv $vrtx $gild $pfe $mrk $juno $blue $exas $celg $exel $dvax $jnj $nvs $sage $nktr $alny $zgnx $sppi $arna $insm $gbt $loxo $espr $mrtx $abeo $clls $alny $incy","Biotech Bonanza: Biotech Stocks To Keep Shining In 2018
https://buff.ly/2pq2zRM
$qqq $spy $dia $iwm $ibb $xbi $xlv $vrtx $gild $pfe $mrk $juno $blue $exas $celg $exel $dvax $jnj $nvs $sage $nktr $alny $zgnx $sppi $arna $insm $gbt $loxo $espr $mrtx $abeo $clls $alny $incy
1",,,,1,[],https://twitter.com/PrudentBiotech/status/944752926660194304
6127,max pain,@optioncharts,2017-12-26T13:56:33.000Z,$MRK open interest for maturity 12/29/2017. High put=56.50 High call=59.00 #maxpain #options http://bit.ly/2D7TPlF,$MRK open interest for maturity 12/29/2017. High put=56.50 High call=59.00 #maxpain #options http://bit.ly/2D7TPlF,,,,,['https://pbs.twimg.com/media/DR-j0hUW0AAllGp?format=jpg&name=small'],https://twitter.com/optioncharts/status/945654571413721089
6128,Obi,@aaaamhim,2017-12-26T20:15:14.000Z,"$HMLA IS MY NEXT 1000%+ RUNNER SET IT & FORGET IT IMO. TOO EASY  $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $XOM $UNH $DIS $HSY $NVDA $MRNS $UNP $BAC $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ","$HMLA IS MY NEXT 1000%+ RUNNER SET IT & FORGET IT IMO. TOO EASY  $AAPL $GOOG $INTC $AMZN $MSFT $AKAM $CMCSA $PFE $MU $NFLX $NOK $XOM $UNH $DIS $HSY $NVDA $MRNS $UNP $BAC $ORCL $WMT $CHK
$GLUU $AKS $TWTR $VZ $CTL $FCX $AMAT $TSLA $JPM $WFT $PTI $BIDU $MRK $BETR $AXP $RIG $APA $HPQ
2",,,,2,[],https://twitter.com/aaaamhim/status/945749867229573122
6129,Paul,@rpmtraders,2017-12-26T05:24:48.000Z,$MRK trend is up at the moment but starts a seasonal down bias in early January. I'm waiting to see More seasonals at http://bit.ly/2Bb4Hyn,$MRK trend is up at the moment but starts a seasonal down bias in early January. I'm waiting to see More seasonals at http://bit.ly/2Bb4Hyn,,,,,['https://pbs.twimg.com/media/DR8usJrX0AAeSp0?format=png&name=small'],https://twitter.com/rpmtraders/status/945525785594679296
6130,Lewis Gregory,@LewisGregory37,2017-12-26T06:03:45.000Z,"have you used this? i've been getting in on some amazing trades from it http://bit.ly/2yqQZ9w
$MCY $MRK $MDT","have you used this? i've been getting in on some amazing trades from it http://bit.ly/2yqQZ9w
$MCY $MRK $MDT",,,,,['https://pbs.twimg.com/media/DR83mmwVoAEgLr1?format=jpg&name=small'],https://twitter.com/LewisGregory37/status/945535586168950785
6131,Simon Taylor,@SimonTaylor47,2017-12-24T05:58:28.000Z,"has anyone else tried this? i've been getting in on some amazing trades through it http://bit.ly/2w7KKpz
$MTOR $MDP $MRK","has anyone else tried this? i've been getting in on some amazing trades through it http://bit.ly/2w7KKpz
$MTOR $MDP $MRK",,,,,['https://pbs.twimg.com/media/DRyjNrNVoAMkl4y?format=jpg&name=small'],https://twitter.com/SimonTaylor47/status/944809480159748096
6132,Dan,@DanP19330,2017-12-26T04:35:59.000Z,"#Roche Bets $1.7B More on Precision #Oncology With #Ignyta Deal

#merger mania 2018 has already began

$RXDX $RHHBY $MRK $FMI $LOXO $XBI $LABU #health #cancer $XLV 
https://xconomy.com/san-diego/2017/12/22/roche-bets-1-7b-more-on-precision-oncology-with-ignyta-deal/‚Ä¶ via 
@xconomy","#Roche Bets $1.7B More on Precision #Oncology With #Ignyta Deal

#merger mania 2018 has already began

$RXDX $RHHBY $MRK $FMI $LOXO $XBI $LABU #health #cancer $XLV 
https://xconomy.com/san-diego/2017/12/22/roche-bets-1-7b-more-on-precision-oncology-with-ignyta-deal/‚Ä¶ via 
@xconomy
2
2",üõë,,2,2,[],https://twitter.com/DanP19330/status/945513500285087744
6133,James Sikes,@wosaikeneriki,2017-12-25T13:10:10.000Z,Dynamic Capital Management LTD Has Raised Stake in Merck & Co $MRK by $1.41 Million http://bzweekly.com/dynamic-capital-management-ltd-has-raised-stake-in-merck-as-china-mobile-limited-chl-market-valuation-declined-matthews-international-capital-management-trimmed-its-hol/‚Ä¶,Dynamic Capital Management LTD Has Raised Stake in Merck & Co $MRK by $1.41 Million http://bzweekly.com/dynamic-capital-management-ltd-has-raised-stake-in-merck-as-china-mobile-limited-chl-market-valuation-declined-matthews-international-capital-management-trimmed-its-hol/‚Ä¶,,,,,[],https://twitter.com/wosaikeneriki/status/945280507906060288
6134,Jon Ogg,@jonogg,2017-12-26T19:05:51.000Z,"#investing #dividend Have you met the preliminary Dogs of the Dow for 2018 in big DJIA dividends? 10 of these companies will be in the list 
$VZ $IBM $PFE $XOM $CVX $MRK $KO $CSCO $PG $GE $JNJ","#investing #dividend Have you met the preliminary Dogs of the Dow for 2018 in big DJIA dividends? 10 of these companies will be in the list 
$VZ $IBM $PFE $XOM $CVX $MRK $KO $CSCO $PG $GE $JNJ
247wallst.com
Meet the Preliminary Dogs of the Dow for 2018
One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the Dow.
1",,,,1,[],https://twitter.com/jonogg/status/945732406442635266
6135,Daily Political,@dailypoliticaln,2017-12-24T13:06:12.000Z,"Merck & Co., Inc. $MRK Stake Lifted by Adviser Investments LLC http://ift.tt/2znlWL3","Merck & Co., Inc. $MRK Stake Lifted by Adviser Investments LLC http://ift.tt/2znlWL3",,,,,[],https://twitter.com/dailypoliticaln/status/944917124933455872
6136,shortvolumes,@shortvolumes,2017-12-25T20:00:01.000Z,Short sell volume percent for $VOO at 2017-12-22 is 61%. http://shortvolumes.com/?t=VOO $XOP 76% $DHR 41% $MRK 42% $GROW 47%,Short sell volume percent for $VOO at 2017-12-22 is 61%. http://shortvolumes.com/?t=VOO $XOP 76% $DHR 41% $MRK 42% $GROW 47%,,,,,[],https://twitter.com/shortvolumes/status/945383653366026241
6137,Daily Political,@dailypoliticaln,2017-12-26T11:24:15.000Z,"Rathbone Brothers plc Has $3.58 Million Holdings in Merck & Co., Inc. $MRK http://ift.tt/2lbbUHX","Rathbone Brothers plc Has $3.58 Million Holdings in Merck & Co., Inc. $MRK http://ift.tt/2lbbUHX",,,,,[],https://twitter.com/dailypoliticaln/status/945616240202145792
6138,shortvolumes,@shortvolumes,2017-12-25T10:00:02.000Z,The short sell volume percent for $PFE on 2017-12-22 is 50%. http://shortvolumes.com/?t=PFE $MYL 72% $LLY 47% $XLV 71% $MRK 42%,The short sell volume percent for $PFE on 2017-12-22 is 50%. http://shortvolumes.com/?t=PFE $MYL 72% $LLY 47% $XLV 71% $MRK 42%,,,,,[],https://twitter.com/shortvolumes/status/945232661110509568
6139,Dakota Financial,@dakotafinancial,2017-12-24T13:43:20.000Z,"Merck & Co., Inc. $MRK Shares Sold by Schmidt P J Investment Management Inc. http://ift.tt/2BYgl0S","Merck & Co., Inc. $MRK Shares Sold by Schmidt P J Investment Management Inc. http://ift.tt/2BYgl0S",,,,,[],https://twitter.com/dakotafinancial/status/944926467313537024
6140,Margin Hunt,@MarginHunt,2017-12-24T00:00:16.000Z,LTM EBITDA multiple of Sanofi $SNY is currently below all peers: $GSK $AZN $BAYRY $NVS $MRK http://ow.ly/XQOV30hlN9y,LTM EBITDA multiple of Sanofi $SNY is currently below all peers: $GSK $AZN $BAYRY $NVS $MRK http://ow.ly/XQOV30hlN9y,,,,,[],https://twitter.com/MarginHunt/status/944719336719167488
6141,Confident Investor,@ConfidentInvest,2017-12-25T12:10:05.000Z,Confident Investor indicator analysis for 12/25/2017. Interesting results from $MRK $DPZ $AYI $SWKS - http://bit.ly/2C1Sb5B,Confident Investor indicator analysis for 12/25/2017. Interesting results from $MRK $DPZ $AYI $SWKS - http://bit.ly/2C1Sb5B,,,,,[],https://twitter.com/ConfidentInvest/status/945265388241035266
6142,US Banking News,@AmericanBanking,2017-12-26T17:52:18.000Z,$MRK - Merck KGaA #MRK - Research Analysts' Recent Ratings Changes https://goo.gl/fb/C5NJDC,$MRK - Merck KGaA #MRK - Research Analysts' Recent Ratings Changes https://goo.gl/fb/C5NJDC,,,,,[],https://twitter.com/AmericanBanking/status/945713899843870721
6143,MarketBeat,@MarketBeatCom,2017-12-25T10:52:31.000Z,"OLD Point Trust & Financial Services N A Acquires 3,350 Shares of Merck & Co., Inc. $MRK http://ift.tt/2C1GkED","OLD Point Trust & Financial Services N A Acquires 3,350 Shares of Merck & Co., Inc. $MRK http://ift.tt/2C1GkED",,,,,[],https://twitter.com/MarketBeatCom/status/945245866545373185
6144,BioPharma Dive,@BioPharmaDive,2017-12-24T20:51:01.000Z,$MRK and $PFE expect their SGLT-2 inhibitor Steglatro to enter the market in early 2018,"$MRK and $PFE expect their SGLT-2 inhibitor Steglatro to enter the market in early 2018
biopharmadive.com
Merck, Pfizer face uphill battle for new diabetes med
The big pharma partners got an FDA nod for their SGLT-2 inhibitor, but will struggle as a late-entry to a crowded market. 
1
1",,,1,1,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/945034097386315778
6145,BioPharma Dive,@BioPharmaDive,2017-12-24T23:00:00.000Z,"Since Frazier took the top spot at $MRK in 2011, the big pharma has gained the FDA OK on 9 NMEs, which collectively earned more than $2.4B in 2016 http://bit.ly/2D75H7a","Since Frazier took the top spot at $MRK in 2011, the big pharma has gained the FDA OK on 9 NMEs, which collectively earned more than $2.4B in 2016 http://bit.ly/2D75H7a
1",,,,1,[],https://twitter.com/BioPharmaDive/status/945066558682009600
6146,max pain,@optioncharts,2017-12-24T18:18:54.000Z,$MRK high OI range is 56.50 to 59.00 for option expiration 12/29/2017 #maxpain #options http://bit.ly/2D7TPlF,$MRK high OI range is 56.50 to 59.00 for option expiration 12/29/2017 #maxpain #options http://bit.ly/2D7TPlF,,,,,['https://pbs.twimg.com/media/DR1MsBQX0AE1xE0?format=jpg&name=small'],https://twitter.com/optioncharts/status/944995817785577472
6147,Daily Political,@DPolitical,2017-12-24T13:08:27.000Z,"$MRK - Merck & Co., Inc. #MRK Stake Lifted by Adviser Investments LLC https://goo.gl/fb/ph2766","$MRK - Merck & Co., Inc. #MRK Stake Lifted by Adviser Investments LLC https://goo.gl/fb/ph2766",,,,,[],https://twitter.com/DPolitical/status/944917687309864960
6148,Prudent Biotech,@PrudentBiotech,2017-12-26T20:55:53.000Z,"Biotech Stocks To Keep Shining In 2018
https://buff.ly/2C9iyGV
$qqq $spy $dia $iwm $ibb $xbi $xlv $vrtx $gild $pfe $mrk $juno $blue $exas $celg $exel $dvax $jnj $nvs $sage $nktr $alny $zgnx $sppi $arna $insm $gbt $loxo $espr $mrtx $abeo $clls $alny $incy $bmy #biotechnology","Biotech Stocks To Keep Shining In 2018
https://buff.ly/2C9iyGV
$qqq $spy $dia $iwm $ibb $xbi $xlv $vrtx $gild $pfe $mrk $juno $blue $exas $celg $exel $dvax $jnj $nvs $sage $nktr $alny $zgnx $sppi $arna $insm $gbt $loxo $espr $mrtx $abeo $clls $alny $incy $bmy #biotechnology
prudentbiotech.com
2018 Outlook - Biotech Bonanza: Biotech Stocks To Keep Shining ‚Ä¢ Prudent Biotech
Biotechnology delivered a solid year in 2017. Multiple reasons exist for Biotech stocks to continue performing strongly in 2018... read more",,,,,['https://pbs.twimg.com/card_img/1501306596051374083/XFkmLnm0?format=jpg&name=240x240'],https://twitter.com/PrudentBiotech/status/945760097942278145
6149,Watchlist News,@WatchlistN,2017-12-25T10:51:23.000Z,"Merck & Co., Inc. $MRK Shares Sold by Marathon Asset Management LLP http://ift.tt/2C4ycDv","Merck & Co., Inc. $MRK Shares Sold by Marathon Asset Management LLP http://ift.tt/2C4ycDv",,,,,[],https://twitter.com/WatchlistN/status/945245584860033024
6150,shortvolumes,@shortvolumes,2017-12-26T14:52:02.000Z,2017-12-22 Short sell volume percent for $AZN is 42%. http://shortvolumes.com/?t=AZN $XLV 71% $PFE 50% $SNY 35% $MRK 42%,2017-12-22 Short sell volume percent for $AZN is 42%. http://shortvolumes.com/?t=AZN $XLV 71% $PFE 50% $SNY 35% $MRK 42%,,,,,[],https://twitter.com/shortvolumes/status/945668530673995778
6151,Dakota Financial,@dakotafinancial,2017-12-25T10:53:14.000Z,"OLD Point Trust & Financial Services N A Acquires 3,350 Shares of Merck & Co., Inc. $MRK http://ift.tt/2C1GkED","OLD Point Trust & Financial Services N A Acquires 3,350 Shares of Merck & Co., Inc. $MRK http://ift.tt/2C1GkED",,,,,[],https://twitter.com/dakotafinancial/status/945246050830430208
6152,Clark Joseph Kent,@JorelLaraKalel,2017-12-26T16:33:06.000Z,Meet the Preliminary Dogs of the Dow for 2018  http://bit.ly/2BEBVXc $DJIA $VZ $IBM $PFE $XOM $CVX $MRK $KO $CSCO $PG $GE $JNJ,"Meet the Preliminary Dogs of the Dow for 2018  http://bit.ly/2BEBVXc $DJIA $VZ $IBM $PFE $XOM $CVX $MRK $KO $CSCO $PG $GE $JNJ
247wallst.com
Meet the Preliminary Dogs of the Dow for 2018
One strategy that has been popular each year as investors rebalance and make changes is the so-called Dogs of the Dow.",,,,,[],https://twitter.com/JorelLaraKalel/status/945693965709381632
6153,BioPharma Dive,@BioPharmaDive,2017-12-26T19:34:00.000Z,"In addition to being approved as a monotherapy, Steglatro got an OK in combination with $MRK's blockbuster drug, Januvia","In addition to being approved as a monotherapy, Steglatro got an OK in combination with $MRK's blockbuster drug, Januvia
biopharmadive.com
Merck, Pfizer face uphill battle for new diabetes med
The big pharma partners got an FDA nod for their SGLT-2 inhibitor, but will struggle as a late-entry to a crowded market. ",,,,,['https://pbs.twimg.com/card_img/1501168043287724035/WhKBPijn?format=jpg&name=small'],https://twitter.com/BioPharmaDive/status/945739492538777600
6154,Watchlist News,@WatchlistN,2017-12-25T10:51:23.000Z,"Merck & Co., Inc. $MRK Shares Sold by Marathon Asset Management LLP http://ift.tt/2DagCwX","Merck & Co., Inc. $MRK Shares Sold by Marathon Asset Management LLP http://ift.tt/2DagCwX",,,,,[],https://twitter.com/WatchlistN/status/945245581768904705
6155,Watchlist News,@WatchlistN,2017-12-25T10:51:18.000Z,"Merck & Co., Inc. $MRK Shares Sold by Marathon Asset Management LLP http://ift.tt/2C3o1ip","Merck & Co., Inc. $MRK Shares Sold by Marathon Asset Management LLP http://ift.tt/2C3o1ip",,,,,[],https://twitter.com/WatchlistN/status/945245564240891904
